{"docstore/data": {"0072325b-63d7-4325-941e-47f2eed7b3a3": {"__data__": {"id_": "0072325b-63d7-4325-941e-47f2eed7b3a3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Harling (2005).pdf", "node_type": "4", "metadata": {}, "hash": "dbe77f3787589e39c8cfb8ea65d8a06ebe5c0f4eebc8fd5dc13a98ab0fbbaacc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b5ea6b0e-bf6d-4d14-a523-7e66e0c1fe73", "node_type": "1", "metadata": {}, "hash": "b5e673f708bc32d9ab84ad6805988629d22cd82b2d1334d14a3062a68b341982", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine 23 (2005) 4070\u20134074\nThe effectiveness of the mumps component of the MMR vaccine:\na case control study\nRichard Harling a,\u2217, Joanne M. White a, Mary E. Ramsay a,\nKaren F. Macsween b, Corry van den Bosch c\na HPA-CDSC, 61 Colindale Avenue, London NW9 5EQ, UK\nb Clinical Infection Unit, St. George\u2019s Hospital, London SW17 0QT, UK\nc East London and the City Health Authority, 81-91 Commercial Road, London E1 1RD, UK\nReceived 21 May 2004; accepted 22 October 2004\nAbstract\nIn 1998/1999, an outbreak of mumps occurred among children of a religious community in North East London. A case control study\nwas conducted to assess the effectiveness of the mumps component of the MMR vaccine. One hundred and sixty-one cases of mumps were\nidenti\ufb01ed and 192 controls were selected. Fifty-one percent of cases and 77% of controls had a history at least one MMR vaccination. The\nobserved effectiveness of any MMR vaccination adjusted for age, sex and general practice was 69% (95% CI: 41\u201384%). This is consistent\nwith the results of other observational studies of mumps containing vaccines, but lower than the immunogenicity of mumps vaccines reported\nby clinical trials. This discrepancy is because observational studies tend to underestimate vaccine effectiveness, and because immunogenicity\nis not necessarily an accurate biological marker of vaccine effectiveness. Two doses of vaccine were more effective (88% (95% CI: 62\u201396%))\nthan a single dose (64% (95% CI: 40\u201378%)). The current two-dose vaccination programme remains the best method for controlling mumps\ninfection in the community.\n\u00a9 2004 Elsevier Ltd. All rights reserved.\nKeywords: Mumps; Vaccine; Case-control\n1. Introduction\nMumps is a potentially serious viral infection, the inci-\ndence of which has declined dramatically since the intro-\nduction of the MMR vaccine in October 1988.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1840, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b5ea6b0e-bf6d-4d14-a523-7e66e0c1fe73": {"__data__": {"id_": "b5ea6b0e-bf6d-4d14-a523-7e66e0c1fe73", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Harling (2005).pdf", "node_type": "4", "metadata": {}, "hash": "dbe77f3787589e39c8cfb8ea65d8a06ebe5c0f4eebc8fd5dc13a98ab0fbbaacc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0072325b-63d7-4325-941e-47f2eed7b3a3", "node_type": "1", "metadata": {}, "hash": "199df34ac296075596fc900af3a31704f7f507116e1635b9d21ad6534f8d5d24", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "119c4351-9042-4a6c-a897-4ebcbb8a0cbd", "node_type": "1", "metadata": {}, "hash": "d3e953501177640494be7aabe334684af068812016f16efb302bf899f9b56060", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Introduction\nMumps is a potentially serious viral infection, the inci-\ndence of which has declined dramatically since the intro-\nduction of the MMR vaccine in October 1988. In England\nand Wales the number of noti\ufb01ed cases fell from 20,713 in\n1989 to 1587 in 1998 [2], and similarly dramatic declines\nin have followed the introduction of mumps vaccines in the\nUS [3], Sweden [4] and Finland [5]. However, outbreaks of\nmumps occur where vaccination coverage is low. Mumps has\nre-emerged as an important infection of childhood and early\nadulthood as uptake of the MMR vaccine has fallen in Eng-\nland and Wales [2,6,7].\n\u2217Corresponding author.\nBetween June 1998 and May 1999, an outbreak of\nmumps occurred in North East London due to genotype\nC virus, thought to have been imported from abroad [1].\nAs the outbreak became apparent, the local Consultant\nin Communicable Disease Control (CCDC) wrote to all\nlocal general practitioners (GPs) to encourage statutory\nnoti\ufb01cations of clinical cases of mumps. Of the 144 cases\nnoti\ufb01ed, 142 were children of a single religious community\nand were noti\ufb01ed by two general practices, A and B, which\nserved this community. The community was concentrated\ninto a relatively small geographical area and had its own\nschools and amenities. MMR vaccination coverage was\nlow, between 67 and 86%. A case control study was\nconducted to identify unreported cases and to assess\nthe effectiveness of the mumps component of the MMR\nvaccine.\n0264-410X/$ \u2013 see front matter \u00a9 2004 Elsevier Ltd. All rights reserved.\ndoi:10.1016/j.vaccine.2004.10.020\nR. Harling et al. / Vaccine 23 (2005) 4070\u20134074\n4071\n2. Methods\n2.1. Selection of cases and controls\nA case was de\ufb01ned as a clinical or laboratory diagnosis of\nmumps with date of onset from 18 June 1998 to 2 May 1999.", "mimetype": "text/plain", "start_char_idx": 1668, "end_char_idx": 3452, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "119c4351-9042-4a6c-a897-4ebcbb8a0cbd": {"__data__": {"id_": "119c4351-9042-4a6c-a897-4ebcbb8a0cbd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Harling (2005).pdf", "node_type": "4", "metadata": {}, "hash": "dbe77f3787589e39c8cfb8ea65d8a06ebe5c0f4eebc8fd5dc13a98ab0fbbaacc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b5ea6b0e-bf6d-4d14-a523-7e66e0c1fe73", "node_type": "1", "metadata": {}, "hash": "b5e673f708bc32d9ab84ad6805988629d22cd82b2d1334d14a3062a68b341982", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c69556f8-3e61-4b9f-9c7c-42aeb698ceda", "node_type": "1", "metadata": {}, "hash": "8bd1aaece13f0e1ebfdde76f7910cf24ede8b3dc1a28a2204782eb606dfbc4df", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Methods\n2.1. Selection of cases and controls\nA case was de\ufb01ned as a clinical or laboratory diagnosis of\nmumps with date of onset from 18 June 1998 to 2 May 1999.\nAll cases in children aged between 1 and 18 years old from\nthereligiouscommunitywereincluded.Caseswereidenti\ufb01ed\nin three ways. Firstly from statutory noti\ufb01cations of mumps\nfrom general practices A and B to the local CCDC. Secondly\nfrom searches of the electronic practice lists. Both practices\nused the EMIS system and patients\u2019 notes were updated fol-\nlowing all consultations. These were searched for relevant\ndiagnoses using the term \u201cmumps\u201d. The clinical records of\nthe cases retrieved were checked by hand to establish whether\nthey \ufb01tted the case de\ufb01nition. Finally cases were identi\ufb01ed\nfrom verbal reports by members of the community. Member-\nship of the community was ascertained by religious practice\nas recorded in general practice records, by using surname,\nor from school attended. For cases that were noti\ufb01ed, labora-\ntory testing of oral \ufb02uid for mumps IgM antibody and mumps\nRNA was offered at the Enteric, Respiratory and Neurologi-\ncal Virus Laboratory (ERNVL).\nControls were selected from children of the same com-\nmunity registered with practices A and B. Membership of\nthe community was ascertained as for cases. All children in\nthe same age range as cases were eligible for inclusion. A\nstrati\ufb01ed random sample of these children was taken from\nthe electronic practice lists, using random number tables, to\nmatch the age and sex pro\ufb01le of cases.\n2.2. Data collection\nDetails of the age, sex, school and vaccination status of\ncases and controls, and clinical details about cases were ob-\ntained from practice records. Vaccination histories of cases\nand controls were cross-checked with the local health author-\nity child health immunisation database. Laboratory results\nwere obtained from the ERNVL.\n2.3. Statistical methods\nEpi Info version 6 was used for data entry, cleaning and\ndescriptive analysis.", "mimetype": "text/plain", "start_char_idx": 3291, "end_char_idx": 5274, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c69556f8-3e61-4b9f-9c7c-42aeb698ceda": {"__data__": {"id_": "c69556f8-3e61-4b9f-9c7c-42aeb698ceda", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Harling (2005).pdf", "node_type": "4", "metadata": {}, "hash": "dbe77f3787589e39c8cfb8ea65d8a06ebe5c0f4eebc8fd5dc13a98ab0fbbaacc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "119c4351-9042-4a6c-a897-4ebcbb8a0cbd", "node_type": "1", "metadata": {}, "hash": "d3e953501177640494be7aabe334684af068812016f16efb302bf899f9b56060", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9b4f136e-3ce9-4774-89d5-6056298b5368", "node_type": "1", "metadata": {}, "hash": "0589f6ae4890ec733a3c0dd2eb1725cddb413731b6686d761e3da4cca2e25410", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Laboratory results\nwere obtained from the ERNVL.\n2.3. Statistical methods\nEpi Info version 6 was used for data entry, cleaning and\ndescriptive analysis. Data were then transferred into Stata\nversion 7 to calculate an odds ratio (OR) for cases having\nreceived MMR vaccination (one or two doses) compared to\ncontrols, and to take into account the effect of potential con-\nfounding factors: age, sex and GP practice. Vaccine effec-\ntiveness was determined from 100 X (1-OR).\n3. Results\nA total of 161 cases aged between 1 and 18 years were\nidenti\ufb01ed with dates of onset during the outbreak period\n(Fig. 1). One hundred and forty-two cases were noti\ufb01ed by\ngeneral practices A and B, 12 were identi\ufb01ed through elec-\ntronic searches of the practice lists, and seven were reported\nby parents. Forty-three (30.3%) of the noti\ufb01ed cases were\ncon\ufb01rmed in the laboratory by IgM radio immunoassay, de-\ntection of mumps RNA by PCR, or both. Six cases (3.7%)\nof complications associated with mumps were recorded: two\nFig. 1. Epidemic curve for the outbreak. Note: One case had no date of onset speci\ufb01ed, although the illness occurred during the outbreak period.\n4072\nR. Harling et al. / Vaccine 23 (2005) 4070\u20134074\nof meningism, two of orchiditis, one of prolonged parotiditis\nand one of abdominal pain.\nOne hundred and ninety-two controls were selected at ran-\ndom from the electronic lists of the two practices. Vaccination\nstatus was available for 156 (96.9%) cases and 175 (91.1%)\ncontrols. Further analysis was limited to these cases. Mem-\nbership of the religious community was ascertained for 96\ncases and controls from computerised or paper records or\ndiscussion with the GP, 234 from surname, and one from\nschool attended.", "mimetype": "text/plain", "start_char_idx": 5122, "end_char_idx": 6838, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9b4f136e-3ce9-4774-89d5-6056298b5368": {"__data__": {"id_": "9b4f136e-3ce9-4774-89d5-6056298b5368", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Harling (2005).pdf", "node_type": "4", "metadata": {}, "hash": "dbe77f3787589e39c8cfb8ea65d8a06ebe5c0f4eebc8fd5dc13a98ab0fbbaacc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c69556f8-3e61-4b9f-9c7c-42aeb698ceda", "node_type": "1", "metadata": {}, "hash": "8bd1aaece13f0e1ebfdde76f7910cf24ede8b3dc1a28a2204782eb606dfbc4df", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2d65ebc3-8265-4b82-bb4c-36964cd2b75f", "node_type": "1", "metadata": {}, "hash": "feb473499289c5e3031158758ddb82dc866ee098614f94cbcf6794b1056a62b3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Mem-\nbership of the religious community was ascertained for 96\ncases and controls from computerised or paper records or\ndiscussion with the GP, 234 from surname, and one from\nschool attended. Cases and controls were similar to cases\nin terms of age, sex and the proportion registered with each\npractice: at the end of the outbreak, the mean ages of cases\nand controls were 9.4 (S.D. = 3.4) and 9.7 (S.D. = 3.8) years,\nrespectively (p = 0.41); 87 (56%) cases and 92 (53%) controls\nwere male (p = 0.56); and 78 (50%) cases and 84 (48%) of\ncontrols were registered with practice A (p = 0.72). Seventy-\nnine (51%) cases and 134 (77%) controls had a history of at\nleast one MMR vaccination, at least 1 month prior to onset\nof illness in cases. Five cases and 22 controls had a history\nof two MMR vaccinations.\nThe crude OR for cases having received any MMR vac-\ncination compared to controls was 0.31 (95% CI: 0.20\u20130.50)\n(p < 0.00001), giving a crude vaccine effectiveness of 69%\n(95% CI: 50\u201380%). The OR of cases compared to controls\nhaving received any MMR vaccination was higher for males\nthan females: 0.39 (95% CI: 0.20\u20130.78) compared to 0.25\n(95% CI: 0.14\u20130.50), and higher for children registered with\npractice A than practice B: 0.49 (95% CI: 0.24\u20130.98) com-\npared to 0.20 (95% CI: 0.10\u20130.39). This latter interaction\nverged on signi\ufb01cance (p = 0.08).\nAfter adjustment for age, sex and general practice the\neffectiveness of any MMR vaccination was 69% (95% CI:\n41\u201384%).", "mimetype": "text/plain", "start_char_idx": 6647, "end_char_idx": 8119, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2d65ebc3-8265-4b82-bb4c-36964cd2b75f": {"__data__": {"id_": "2d65ebc3-8265-4b82-bb4c-36964cd2b75f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Harling (2005).pdf", "node_type": "4", "metadata": {}, "hash": "dbe77f3787589e39c8cfb8ea65d8a06ebe5c0f4eebc8fd5dc13a98ab0fbbaacc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9b4f136e-3ce9-4774-89d5-6056298b5368", "node_type": "1", "metadata": {}, "hash": "0589f6ae4890ec733a3c0dd2eb1725cddb413731b6686d761e3da4cca2e25410", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d0f5bfc4-5b76-4c5f-b065-a6ed195766e0", "node_type": "1", "metadata": {}, "hash": "a38b87235b266aadab1ab4e1ba902146f4ea51b4291f4eed80eebd4d80ee658f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "After adjustment for age, sex and general practice the\neffectiveness of any MMR vaccination was 69% (95% CI:\n41\u201384%). Considering just cases that were con\ufb01rmed by the\nlaboratory, the adjusted effectiveness of any MMR vaccina-\ntion was 65% (95% CI: 25\u201384%). The effectiveness of two\ndoses of MMR was 88% (95% CI: 62\u201396%), higher than that\nof a single dose (64% (95% CI: 40\u201378%)), although small\nnumbers limited the signi\ufb01cance of this \ufb01nding.\n4. Discussion\nThe mumps component of the MMR vaccine used in the\nUK, which contains the Jeryl Lyn strain, is generally ac-\ncepted to confer protection to around 90% of recipients [8].\nThis \ufb01gure is based mainly on trials that have examined the\nimmunogenicity of mumps vaccines [9\u201312]. Observational\nstudies conducted during mumps outbreaks have generally\nfound the effectiveness of mumps vaccines to be lower. Our\nobserved vaccine effectiveness of 64% for a single dose of\nMMR is similar to the results of other observational studies\nof vaccines containing the Jeryl Lynn and Urabe Am9 strains\nof mumps virus (see Table 1 [13\u201329]).\nThere are several possible explanations for the discrep-\nancy between vaccine effectiveness reported by observational\nstudies and immunogenicity reported by clinical trials. On the\none hand, vaccine effectiveness may be underestimated by\nobservational studies. Outbreaks of mumps are more likely\nto occur when poorly protective vaccines have been used,\nand observational studies are liable to a number of method-\nological weaknesses that limit the validity of their results, as\ndiscussed below. On the other hand, the protection afforded\nby vaccination may be overestimated by pre-licensure trials,\nwhich have often been uncontrolled and of poor methodol-\nogy, and immunogenicity may not correlate fully with clin-\nical protection. Vaccines may also be less effective under\n\ufb01eld conditions due to problems with distribution, storage or\nadministration\u2014for example a failure to correctly maintain\nthe cold chain.", "mimetype": "text/plain", "start_char_idx": 8002, "end_char_idx": 9986, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d0f5bfc4-5b76-4c5f-b065-a6ed195766e0": {"__data__": {"id_": "d0f5bfc4-5b76-4c5f-b065-a6ed195766e0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Harling (2005).pdf", "node_type": "4", "metadata": {}, "hash": "dbe77f3787589e39c8cfb8ea65d8a06ebe5c0f4eebc8fd5dc13a98ab0fbbaacc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2d65ebc3-8265-4b82-bb4c-36964cd2b75f", "node_type": "1", "metadata": {}, "hash": "feb473499289c5e3031158758ddb82dc866ee098614f94cbcf6794b1056a62b3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "524abb49-1a47-4c96-8e5a-5dbc499b436e", "node_type": "1", "metadata": {}, "hash": "e741c0391b473e6a71c6ff052cabda83024cac34c15f8f15078c062daa154bad", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccines may also be less effective under\n\ufb01eld conditions due to problems with distribution, storage or\nadministration\u2014for example a failure to correctly maintain\nthe cold chain.\nThere are four key methodological considerations for ob-\nservational studies of vaccine effectiveness: case de\ufb01nition,\nascertainment of cases and vaccination status, and similarity\nof cases and controls [30]. The clinical diagnosis of mumps\nlacks speci\ufb01city and sensitivity. Where mumps is rare, clin-\nicians and parents unfamiliar with its presentation may re-\nport illnesses mimicking the clinical features of mumps. This\ncan lead to underestimation of vaccine effectiveness as these\ncases fall disproportionately into the vaccinated group since\nmumps vaccination cannot protect against other conditions.\nThis was not a major concern in our study because the es-\ntimates of vaccine effectiveness based on clinical diagnosis\nand laboratory con\ufb01rmation were similar.\nConversely, genuine cases of mumps will be missed. Some\nwill have a sub-clinical presentation, and others will go un-\nreported: there is considerable underreporting of infectious\ndiseases through statutory noti\ufb01cation systems. This should\nnot affect estimates of vaccine effectiveness unless a different\nproportionofcasesaremissedinvaccinatedandunvaccinated\ngroups. This potential bias was minimised in our study by\nactive case \ufb01nding in each practice. However, children who\nwere unregistered with a GP would not have consulted with\nmumps and would not have been vaccinated, which would\nhave lead to underestimation of vaccine effectiveness. Con-\nversely, observer bias may have produced better case ascer-\ntainment in the unvaccinated group if clinicians were more\nwilling to make a diagnosis of mumps in children they knew\nto be unvaccinated, which would have lead to overestimation\nof vaccine effectiveness.\nWe used two sources of information to improve accuracy\nof vaccination history of cases and controls and limit bias due\nto misclassi\ufb01cation of vaccination status. In addition, there\nis no reason to believe that vaccinations were systematically\nrecorded better or worse in the case and control groups. Vac-\ncine storage and administration was investigated as part of the\noutbreak control, but no failures of the cold chain or problems\nwith vaccination technique were identi\ufb01ed.", "mimetype": "text/plain", "start_char_idx": 9808, "end_char_idx": 12140, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "524abb49-1a47-4c96-8e5a-5dbc499b436e": {"__data__": {"id_": "524abb49-1a47-4c96-8e5a-5dbc499b436e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Harling (2005).pdf", "node_type": "4", "metadata": {}, "hash": "dbe77f3787589e39c8cfb8ea65d8a06ebe5c0f4eebc8fd5dc13a98ab0fbbaacc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d0f5bfc4-5b76-4c5f-b065-a6ed195766e0", "node_type": "1", "metadata": {}, "hash": "a38b87235b266aadab1ab4e1ba902146f4ea51b4291f4eed80eebd4d80ee658f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ab8b2fd3-1a25-4715-af5b-1b32993344fe", "node_type": "1", "metadata": {}, "hash": "997308d39b6064aa501153b1299076d60bec952e412d604e1df8b90f5ffeb301", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vac-\ncine storage and administration was investigated as part of the\noutbreak control, but no failures of the cold chain or problems\nwith vaccination technique were identi\ufb01ed.\nA \ufb01nal concern with the validity of our results is whether\ncases and controls had an equal risk of exposure to infection.\nFirstly, selection of controls was not con\ufb01ned to those who\nwere known to be susceptible to mumps prior to this outbreak.\nControls who had previous mumps infection would have ac-\nquired immunity without vaccination, which could have lead\nR. Harling et al. / Vaccine 23 (2005) 4070\u20134074\n4073\nTable 1\nEffectiveness of mumps vaccines in other \ufb01eld evaluations\nSetting and study population\nStudy design\nCase de\ufb01nition\nCase \ufb01nding\nSelection of controls\nAscertainment of vaccination\nstatus\nAttack rates and vaccine ef\ufb01cacy\n867 children, aged 1\u201313 years, exposed\nto mumps over a 4\u20139-month period,\nin Philadelphia, US, 1965\u20131966 [13]\nProspective cohort\nLaboratory con\ufb01rmation of\nmumps\nChildren visited twice weekly and\nassessed for symptoms\nFrom 505 children who did\nnot develop mumps\nAll children were initially\nseronegative, 362 were vaccinated\n2/100 vaccinated children and 115/721\nunvaccinated pupils developed mumps:\nVE = 97% (87\u201399%)\n121 cases in a kindergarden with 899\nchildren in New York State, US,\n1973 [14]. Mumps vaccine coverage\n<20%\nRetrospective cohort\n6/178 vaccinated pupils and 115/721\nunvaccinated pupils developed mumps:\nVE = 79% (53\u201391%)\n84 cases in six schools with 757 pupils\nin Ontario, Canada, 1977 [15]\nRetrospective cohort\nParental report of symptoms\nand con\ufb01rmation by clinical\ndiagnosis\nActive contact with parents of all\nchildren\nAll remaining consenting\nchildren\nParental questionnaire\n8/200 vaccinated and 508 unvaccinated\npupils developed mumps VE = 73%\n(46\u201387%)\n62 cases in a school with 500 pupils in\nOhio, US, 1981 [16].", "mimetype": "text/plain", "start_char_idx": 11965, "end_char_idx": 13812, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ab8b2fd3-1a25-4715-af5b-1b32993344fe": {"__data__": {"id_": "ab8b2fd3-1a25-4715-af5b-1b32993344fe", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Harling (2005).pdf", "node_type": "4", "metadata": {}, "hash": "dbe77f3787589e39c8cfb8ea65d8a06ebe5c0f4eebc8fd5dc13a98ab0fbbaacc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "524abb49-1a47-4c96-8e5a-5dbc499b436e", "node_type": "1", "metadata": {}, "hash": "e741c0391b473e6a71c6ff052cabda83024cac34c15f8f15078c062daa154bad", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "15b1478d-8936-4738-8dee-d810375d162c", "node_type": "1", "metadata": {}, "hash": "5ec664bf6f3c8bdd66a89f8a838c46df0f15d1e3c0968cced944263fdd2e7b92", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Mumps\nvaccine coverage 73%\nRetrospective cohort\nParotid swelling for one or\nmore days\nActive follow up of all absent pupils\nAll remaining consenting\nchildren\nSchool immunisation records and\nparental questionnaire\n34/393 vaccinated and 28/88\nunvaccinated pupils developed mumps:\nVE = 73% (58\u201383%)\n110 cases in a school with 357 pupils in\nOhio, US, 1982 [17]\nRetrospective cohort\nParotid swelling for two or\nmore days\nDiagnoses made by school nurse and\nactive contact with parents of all\nchildren\nAll remaining consenting\nchildren\nSchool immunisation records and\nparental questionnaire\n19/128 vaccinated and 70/142\nunvaccinated pupils developed mumps:\nVE = 70% (51\u201381%)\n25 cases in sixth grade (165 pupils) of\nschool in New Jersey, US, 1983 [18]\nRetrospective cohort\nParotid swelling for two or\nmore days\nReports from schools\nAll remaining children\nSchool vaccination records\n5/122 vaccinated and 19/43 unvaccinated\npupils developed mumps: VE = 91%\n(77\u201396%)\n332 cases in a school with 1764 pupils\nin Tennessee, US, 1986 [19].\nMumps vaccine coverage in the\ncounty as a whole was >95% but\nlower in the affected school\nCase control\nParotid swelling\nActive contact with parents of all\nchildren\nStrati\ufb01ed random sample of\nremaining children\nMedical records\n31/184 cases and 97/201 controls had a\nhistory of vaccination: VE = 78%\n(65\u201386%)\n138 cases in three schools with 1721\npupils in Kansas, US, 1988\u20131989\n[20]. Mumps vaccine coverage 99%\nRetrospective cohort\nParotid swelling\nReports from local clinicians, review\nof absentees and questionnaire for\npupils\nAll remaining children\nSchool immunisation records with\nsome veri\ufb01cation from medical\nrecords\n135/1713 vaccinated pupils and 3/8\nunvaccinated pupils developed mumps:\nVE = 83% (57\u201394%)\n54 cases in school with 318 pupils in\nTexas, US, 1990 [21].", "mimetype": "text/plain", "start_char_idx": 13813, "end_char_idx": 15607, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "15b1478d-8936-4738-8dee-d810375d162c": {"__data__": {"id_": "15b1478d-8936-4738-8dee-d810375d162c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Harling (2005).pdf", "node_type": "4", "metadata": {}, "hash": "dbe77f3787589e39c8cfb8ea65d8a06ebe5c0f4eebc8fd5dc13a98ab0fbbaacc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ab8b2fd3-1a25-4715-af5b-1b32993344fe", "node_type": "1", "metadata": {}, "hash": "997308d39b6064aa501153b1299076d60bec952e412d604e1df8b90f5ffeb301", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "774490ad-fe86-45fe-916f-f2b0914b98f4", "node_type": "1", "metadata": {}, "hash": "b6e895c6664883d1367e31711c2348c55687166f24dde1c99fd13af5ccbcd530", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Mumps\nvaccine coverage 98%\nRetrospective cohort\nParotid swelling for two or\nmore days\nQuestionnaire for pupils\nAll remaining consenting\nchildren\nSchool immunisation records with\nveri\ufb01cation from medical records\n53/299 vaccinated pupils developed\nmumps\n68 cases in school with 1460 pupils\nschool with Tennessee, US, 1991\n[22]. Mumps vaccine coverage 98%\nRetrospective cohort\nParotid swelling with acute\nonset and lasting two or more\ndays\nActive contact with local clinicians\nAll remaining consenting\nchildren\nSchool immunisation records with\nsome veri\ufb01cation from medical\nrecords\n67/1090 vaccinated pupils and 1/26\nunvaccinated pupils developed mumps\nCommunity outbreak. Geneva,\nSwitzerland, 1991 [23]. Mumps\nvaccine coverage 80%\nProspective cohort\n63 secondary cases observed in\nhousehold contacts of 283 primary\ncases\nAll other household contacts\nof the primary cases\nVE by strain: Jeryl Lynn 62% (0\u201385)%;\nUrabe 73% (42\u201388%)\n88 con\ufb01rmed cases in Switzerland,\n1992\u20131993 [24]. Overall mumps\nvaccine coverage 61%\nCase control\nViral isolation\nSalivary swabs for laboratory\ndiagnosis taken from 102 patients\naged 2\u201316 years presenting with\nparotiditis at 2 paediatric practices\nover 15 months\n92 children registered with\nthe same paediatric practices\nMedical records\n3/16 cases and 18/54 controls had a\nhistory of vaccination.", "mimetype": "text/plain", "start_char_idx": 15608, "end_char_idx": 16930, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "774490ad-fe86-45fe-916f-f2b0914b98f4": {"__data__": {"id_": "774490ad-fe86-45fe-916f-f2b0914b98f4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Harling (2005).pdf", "node_type": "4", "metadata": {}, "hash": "dbe77f3787589e39c8cfb8ea65d8a06ebe5c0f4eebc8fd5dc13a98ab0fbbaacc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "15b1478d-8936-4738-8dee-d810375d162c", "node_type": "1", "metadata": {}, "hash": "5ec664bf6f3c8bdd66a89f8a838c46df0f15d1e3c0968cced944263fdd2e7b92", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "80bca55e-44c9-4153-b904-90a271535b99", "node_type": "1", "metadata": {}, "hash": "1f22f9993e57bef6d86a792067d93f2829d2cafd457a26d5a7e01556df3638fd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "VE of Jeryl Lynn\nstrain: 54% (\u2212108\u201391%)\n216 cases in 19 schools in Toledo,\nSpain, 1993 [25]\nRetrospective cohort\nClinical diagnosis\nAll remaining 4059 children\nVE = 76% (66\u201387%)\n10 classes with 205 children in a school\nin Geneva, Switzerland, 1994 [26]\nRetrospective cohort\nClinical diagnosis\n63 secondary cases observed\nfollowing a single primary case in\neach class\nAll remaining 132 children\nVE by strain: Jeryl Lynn 65% (11\u201386)%;\nUrabe 75% (36\u201391%)\n66 cases in a cohort of 165 children\naged 5\u201313 in a small community in\na rural area of Switzerland [27].\nMumps vaccine coverage >95%\nProspective cohort\nClinical diagnosis or viral\nisolation from culture\nQuestionnaire for parents of all\nchildren\nAll remaining children\nParental questionnaire\nVE by strain: Jeryl-Lynn 78% (64\u201382%);\nUrabe 87% (76\u201394%)\n283 cases among children in an urban\narea of Spain, 1996 [28]\nRetrospective cohort\nClinical diagnosis\nInfectious disease register\nOther children selected from\nthe local population census\nSchool vaccination records,\nvaccination cards and health\nregister\nVE = 46% (0\u201384%)\nOutbreak of mumps associated with\nattendance at a rave party in Canada,\n1997 [29]\nCase control\nClinical diagnosis\nSelf reported vaccination status\nVE = 80% (29\u201396%)\n4074\nR. Harling et al. / Vaccine 23 (2005) 4070\u20134074\nto underestimation of vaccine effectiveness. Secondly, the\noutbreak lasted for over 10 months, and controls were there-\nfore collectively exposed to infection for longer than cases.\nThis was not taken into account in the analysis and could\nalso have lead to underestimation of vaccine effectiveness.\nFinally, we had no information about potential confounding\nfactors other than age, sex and general practice that may have\nin\ufb02uenced the risk of infection and the vaccination status of\ncases and controls. It was not possible to accurately de\ufb01ne\nour population because the religious community did not have\na clearly de\ufb01ned census category or geographical district for\nenumeration.", "mimetype": "text/plain", "start_char_idx": 16931, "end_char_idx": 18898, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "80bca55e-44c9-4153-b904-90a271535b99": {"__data__": {"id_": "80bca55e-44c9-4153-b904-90a271535b99", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Harling (2005).pdf", "node_type": "4", "metadata": {}, "hash": "dbe77f3787589e39c8cfb8ea65d8a06ebe5c0f4eebc8fd5dc13a98ab0fbbaacc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "774490ad-fe86-45fe-916f-f2b0914b98f4", "node_type": "1", "metadata": {}, "hash": "b6e895c6664883d1367e31711c2348c55687166f24dde1c99fd13af5ccbcd530", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "21899d0b-a719-4851-9129-27cbd2ac0e3a", "node_type": "1", "metadata": {}, "hash": "1f22ae227238b479b50bbee7ce21ca93d259075f529e96e45d39f16830dfe32d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "It was not possible to accurately de\ufb01ne\nour population because the religious community did not have\na clearly de\ufb01ned census category or geographical district for\nenumeration. We made a number of checks to ensure that\nboth cases and controls were drawn from this community,\nalthough the use of names to ascertain membership of ethnic\nand religious groups is subject to inaccuracies [31]. However,\nit was not possible to determine whether cases and controls\nwere drawn from the same parts of the community or whether\nthey were drawn from different residential areas or distinct\ngroups with different levels of herd immunity and different\nbehaviours.\nOur study found that mumps vaccine was effective at\npreventing mumps. Vaccine effectiveness was lower than\nimmunogenicity reported by clinical trials. This discrepancy\nis expected because observational studies tend to underes-\ntimate vaccine effectiveness, and because immunogenicity\nis not necessarily an accurate biological marker of vaccine\neffectiveness. Two doses of vaccine provided greater protec-\ntion than a single dose, and this emphasises the need to have\nhigh coverage of a two-dose programme to prevent mumps\noutbreaks in the future.\nAcknowledgements\nDr. Bernard Cohen, HPA-CDSC, 61 Colindale Avenue,\nLondon, NW9 5EQ. All staff of the two General Practices\nwho contributed data to the study.\nReferences\n[1] Van den Bosch CA, Cohen T, Walters L. Mumps outbreak con\ufb01ned\nto a religious community. Eurosurveillance 2000;5:58\u201360.\n[2] Health Protection Agency. Mumps Noti\ufb01cations, by Sex 1989\u20132003.\nhttp://www.hpa.org.uk/infections/topics az/mumps/data not sex.htm.\n[3] Measles, mumps, and rubella\u2014vaccine use and strategies for elim-\nination of measles, rubella, and congenital rubella syndrome and\ncontrol of mumps. Recommendations of the Advisory Committee\non Immunization Practices (ACIP) MMWR 1998;47(RR-8): 1\u201357.\n[4] Bottiger M, Christenson B, Taranger J, Bergman M. Swedish ex-\nperience of two dose vaccination programme aimed at eliminating\nmeasles, mumps and rubella in Sweden. BMJ 1987;295:1264\u20137.", "mimetype": "text/plain", "start_char_idx": 18724, "end_char_idx": 20786, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "21899d0b-a719-4851-9129-27cbd2ac0e3a": {"__data__": {"id_": "21899d0b-a719-4851-9129-27cbd2ac0e3a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Harling (2005).pdf", "node_type": "4", "metadata": {}, "hash": "dbe77f3787589e39c8cfb8ea65d8a06ebe5c0f4eebc8fd5dc13a98ab0fbbaacc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "80bca55e-44c9-4153-b904-90a271535b99", "node_type": "1", "metadata": {}, "hash": "1f22f9993e57bef6d86a792067d93f2829d2cafd457a26d5a7e01556df3638fd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "45242edb-dac4-4f8f-9f5a-458c6ef4025e", "node_type": "1", "metadata": {}, "hash": "bdc63b15fda7c493f3e1cfd5d29c94b4539866816d5b75d8ea696bd0a4ecf434", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BMJ 1987;295:1264\u20137.\n[5] Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko\nV, et al. The elimination of indigenous measles, mumps, and rubella\nfrom Finland by a 12-year, two-dose vaccination program. NEJM\n1994;331:1397\u2013402.\n[6] Reaney EA, Tohani VK, Devine MJ, Smithson RD, Smyth B. Mumps\noutbreak among young people in Northern Ireland. Commun Dis\nPublic Health 2001;4:311\u20135.\n[7] Pugh RN, Akinosi B, Pooransingh S, Kumar J, Grant S, Livesley\nE, et al. An outbreak of mumps in the metropolitan area of Walsall,\nUK. Int J Infect Dis 2002;6:283\u20137.\n[8] Immunisation against infectious disease. The Green Book. Depart-\nment of Health; 1996.\n[9] Weibel RE, Stokes J, Buynak EB, Whitman Jr JE, Hilleman MR.\nLive attenuated mumps virus vaccine: clinical and serological aspects\nin a \ufb01eld trial. NEJM 1967;276:245\u201351.\n[10] Sugg WC, Finger JA, Levine RH, Pagano JS. Field evaluation of\nlive virus mumps vaccine. J Pediatr 1968;72:461\u20136.\n[11] Brunell PA, Brickman A, Steinberg S. Evaluation of a live attenuated\nmumps vaccine (Jeryl Lynn). Am J Dis Child 1969;118:435\u201340.\n[12] Vesikari T, Andre FE, Simoen E, Florent G, Ala-Laurila EL, Heikki-\nnen A, et al. Evaluation in young children of the Urabe am 9-strain\nof live attenuated mumps vaccine in comparison with the Jeryl Lynn\nstrain. Acta Paediatr Scand 1983;72:37\u201340.\n[13] Hilleman MR, Buynak EB, Weibel RE, Stokes Jr J, Whitman Jr JE.", "mimetype": "text/plain", "start_char_idx": 20766, "end_char_idx": 22158, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "45242edb-dac4-4f8f-9f5a-458c6ef4025e": {"__data__": {"id_": "45242edb-dac4-4f8f-9f5a-458c6ef4025e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Harling (2005).pdf", "node_type": "4", "metadata": {}, "hash": "dbe77f3787589e39c8cfb8ea65d8a06ebe5c0f4eebc8fd5dc13a98ab0fbbaacc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "21899d0b-a719-4851-9129-27cbd2ac0e3a", "node_type": "1", "metadata": {}, "hash": "1f22ae227238b479b50bbee7ce21ca93d259075f529e96e45d39f16830dfe32d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b362d4b3-850e-465e-bc69-3592add02d33", "node_type": "1", "metadata": {}, "hash": "9831d2833abf0e859ad723d1f8225f04e856424f051e9645b2dc2a5db5bee7ea", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Acta Paediatr Scand 1983;72:37\u201340.\n[13] Hilleman MR, Buynak EB, Weibel RE, Stokes Jr J, Whitman Jr JE.\nLive, attenuated mumps virus vaccine: protective ef\ufb01cacy as mea-\nsured in a \ufb01eld evaluation. NEJM 1967;276:252\u20138.\n[14] CDC. Mumps in an elementary school. MMWR 1973;22:185\u20136.\n[15] Lewis JE, Chernesky MA, Rawls ML, Rawls WE. Epidemic of\nmumps in a partially immune population. CMAJ 1979;121:751\u20134.\n[16] Sullivan KM, Halpin TJ, Marks JS, Kim-Farley R. Effective-\nness of mumps vaccine in a school outbreak. Am J Dis Child\n1985;139:909\u201312.\n[17] Kim-Farley R, Bart S, Stetler H, Orenstein W, Bart K, Sulli-\nvan K, et al. Clinical mumps vaccine ef\ufb01cacy. Am J Epidemiol\n1985;121:593\u20137.\n[18] CDC. Mumps outbreak. MMWR 1984;33:421\u201330.\n[19] Wharton M, Cochi S, Hutcheson RH, et al. A large outbreak of\nmumps in the postvaccine era. J Infect Dis 1988;158:1253\u201360.\n[20] Hersh BS, Fine PEM, Kent WK, et al. Mumps outbreak in a highly\nvaccinated population. J Pediatr 1991;119:187\u201393.\n[21] Cheek JE, Baron R, Atlas H, et al. Mumps outbreak in a highly vacci-\nnated school population. Arch Pediatr Adolesc Med 1995;149:774\u20138.\n[22] Briss PA, Fehrs LJ, Parker RA, Wright PF, Sannella EC, Hutcheson\nRH, et al. Sustained transmission of mumps in highly vaccinated\npopulation: assessment of primary vaccine failure and waning im-\nmunity. J Infect Dis 1994;169:77\u201382.", "mimetype": "text/plain", "start_char_idx": 22056, "end_char_idx": 23406, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b362d4b3-850e-465e-bc69-3592add02d33": {"__data__": {"id_": "b362d4b3-850e-465e-bc69-3592add02d33", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Harling (2005).pdf", "node_type": "4", "metadata": {}, "hash": "dbe77f3787589e39c8cfb8ea65d8a06ebe5c0f4eebc8fd5dc13a98ab0fbbaacc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "45242edb-dac4-4f8f-9f5a-458c6ef4025e", "node_type": "1", "metadata": {}, "hash": "bdc63b15fda7c493f3e1cfd5d29c94b4539866816d5b75d8ea696bd0a4ecf434", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dbd875df-9895-402f-a065-0ecb6bd47e70", "node_type": "1", "metadata": {}, "hash": "8c86a1fa8303d531c827351d77f4e84de03f7e5915b3357531c20f42749d88e6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Sustained transmission of mumps in highly vaccinated\npopulation: assessment of primary vaccine failure and waning im-\nmunity. J Infect Dis 1994;169:77\u201382.\n[23] Chamot E, Toscani L, Egger P, Germann D, Bourquin C. Estimation\nof the ef\ufb01cacy of three strains of mumps vaccines during an epidemic\nof mumps in the Geneva canton. Revue d\u2019Epidemiologie et de Sante\nPublique 1998;46:100\u20137.\n[24] Germann D, Strohle A, Eggenberger K, Steiner C, Matter L. An\noutbreak of mumps in a population partially vaccinated with the\nRubini strain. Scand J Infect Dis 1996;28:235\u20138.\n[25] De la Hoz F, Zeitler K, Gracia Colmenero C, Puchades Belenguer\nMJ, Verde Lopez C, Carpintero Redondo JL, et al. Mumps epidemic\nin the health area of Toledo with immunisation intervention. Esti-\nmation of vaccine ef\ufb01cacy. Medicina Clinica 1997;108:175\u20139.\n[26] Toscani L, Batou M, Bouvier P, Schlaepfer Al. Comparison of the\nef\ufb01cacy of various strains of mumps vaccine: a school, survey. Sozial\nund Praventivmedizin 1996;41:341\u20137.\n[27] Schlegal M, Osterwalder JJ, Galeazzi L, Vernazza PL. Compara-\ntive ef\ufb01cacy of three mumps vaccines in eastern Switzerland: cohort\nstudy. BMJ 1999;319:352\u20133.\n[28] Lopez Hernandez B, Martin Velez RM, Garcia R, et al. An epi-\ndemic of mumps: a study of vaccine ef\ufb01cacy. Atencion Primaria\n2000;25:148\u201352.\n[29] Buxton J, Craig C, Daly P, Bigham M, Bell A, Fyfe M. An outbreak\nof mumps among young people in Vancouver, British Columbia,\nassociated with rave parties. Can J Public Health 1999;90:160\u20133.", "mimetype": "text/plain", "start_char_idx": 23252, "end_char_idx": 24747, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dbd875df-9895-402f-a065-0ecb6bd47e70": {"__data__": {"id_": "dbd875df-9895-402f-a065-0ecb6bd47e70", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Harling (2005).pdf", "node_type": "4", "metadata": {}, "hash": "dbe77f3787589e39c8cfb8ea65d8a06ebe5c0f4eebc8fd5dc13a98ab0fbbaacc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b362d4b3-850e-465e-bc69-3592add02d33", "node_type": "1", "metadata": {}, "hash": "9831d2833abf0e859ad723d1f8225f04e856424f051e9645b2dc2a5db5bee7ea", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Can J Public Health 1999;90:160\u20133.\n[30] Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine ef\ufb01cacy\nin the \ufb01eld. Epidemiol Rev 1988;10:212\u201341.\n[31] Hani Barag C. What\u2019s not in a name. The accuracy of using names\nto ascribe religious and geographical origin in a British population.\nJ Epidemiol Commun Health 1998;52:336\u20137.", "mimetype": "text/plain", "start_char_idx": 24713, "end_char_idx": 25038, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bcca9640-96fa-4b00-9261-c2927b8c36d8": {"__data__": {"id_": "bcca9640-96fa-4b00-9261-c2927b8c36d8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4398996b-2c76-407d-b6d8-cff1ca576a24", "node_type": "1", "metadata": {}, "hash": "88db3cd4ae7fa675d40c5cbe4bdb91b1e9d04eb0afa6e71b61e90539da3df1ce", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BRIEF REPORTS\nCROSS-REACTIVE NEUTRALIZING ANTIBODY\nAGAINST PANDEMIC 2009 H1N1 INFLUENZA A\nVIRUS IN INTRAVENOUS IMMUNOGLOBULIN\nPREPARATIONS\nDavid K. Hong, MD,*\u2020 Adriana H. Tremoulet, MD,\u2021\nJane C. Burns, MD,\u2021 and David B. Lewis, MD*\u2020\nAbstract: Prepandemic intravenous immunoglobulin (IVIG) and sera from\nKawasaki disease patients treated with this IVIG were analyzed for 2009\nH1N1-speci\ufb01c microneutralization and hemagglutination inhibition anti-\nbodies. All 6 different IVIG preparations tested had signi\ufb01cant levels of\ncross-reactive-speci\ufb01c antibody at a concentration of 2.0 g/dL of immu-\nnoglobulin. Sera from 18 of 19 Kawasaki disease patients had signi\ufb01cant\nincreases of cross-reactive-speci\ufb01c antibody after 2.0 g/kg of prepandemic\nIVIG. These results suggest a role for adjunctive IVIG therapy for severe\nand/or drug-resistant 2009 H1N1 virus and other highly antigenically\ndrifted in\ufb02uenza strains, particularly in the immunocompromised.\nKey Words: 2009 H1N1, in\ufb02uenza A, neutralizing antibody,\nintravenous immunoglobulin, Kawasaki disease\nAccepted for publication June 21, 2010.\nFrom the Divisions of *Infectious Diseases, and \u2020Immunology and Allergy,\nDepartment of Pediatrics, Stanford University School of Medicine and\nLucile Packard Children\u2019s Hospital, Stanford, CA; and \u2021Department of\nPediatrics, Kawasaki Disease Research Center, University of California,\nSan Diego and Rady Children\u2019s Hospital, San Diego, CA.\nSupported by National Institute of Allergy and Infectious Disease (NIAID)\ngrants K08-AI-079269 (to D.K.H.) and U01-AI-074512 (to D.B.L.),\nthe National Heart, Lung, and Blood Institute (NHLBI) grant R01\nHL-69413 (to J.C.B.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1647, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4398996b-2c76-407d-b6d8-cff1ca576a24": {"__data__": {"id_": "4398996b-2c76-407d-b6d8-cff1ca576a24", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bcca9640-96fa-4b00-9261-c2927b8c36d8", "node_type": "1", "metadata": {}, "hash": "5592efde7df8dd30bf8b750eac54cf69b907ec0f826743a7934350c57d910a8e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "75f6f1fb-c9b5-49d4-8594-990a7d9af86d", "node_type": "1", "metadata": {}, "hash": "a59af63d2d0d136c87336214ec9e9c34b0fa251b2efff74afc454d009630303b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "and U01-AI-074512 (to D.B.L.),\nthe National Heart, Lung, and Blood Institute (NHLBI) grant R01\nHL-69413 (to J.C.B.), a Medimmune Research Development/Pediatric\nInfectious Disease Society Award (to D.K.H.), and the Jeffrey Modell\nFoundation (to D.B.L.).\nAddress for correspondence: David B. Lewis, MD, Division of Immunol-\nogy and Allergy, Department of Pediatrics, CCSR Building, Room\n2115b, 269 Campus Dr, Stanford, CA 94305\u20135164. E-mail: dblewis@\nstanford.edu.\nSupplemental digital content is available for this article. Direct URL\ncitations appear in the printed text and are provided in the HTML and\nPDF versions of this article on the journal\u2019s Web site (www.pidj.com).\nCopyright \u00a9 2010 by Lippincott Williams & Wilkins\nDOI: 10.1097/INF.0b013e3181f127be\nH\n1N1 swine-origin in\ufb02uenza A virus (2009 H1N1) initiated a\nhuman pandemic in April 2009.1 Although by the spring of\n2010, the activity of this virus declined below pandemic levels in\nmost parts of the world, it is likely to re-emerge during the next\nseasonal epidemic, as a substantial proportion of the population\nwere not immunized with 2009 H1N1 monovalent vaccine. For\nexample, in the United States, only 40% of children aged between\n6 months and 14 years were immunized.2 Interestingly, early in the\npandemic, older individuals appeared to be relatively protected\nfrom severe disease from 2009 H1N1, with most infection-asso-\nciated hospitalizations occurring in young adults (\u000149 years of\nage) and children.3 This contrasts with seasonal in\ufb02uenza epidem-\nics, for which morbidity and mortality are concentrated in the\nelderly.4 The relative protection in older adults may be due to\npre-existing cross-reactive neutralizing antibody from prior natural\ninfection with H1N1, particularly with 1918 H1N1 and its deriv-\natives,5 which caused seasonal outbreaks between 1918 and 1957.", "mimetype": "text/plain", "start_char_idx": 1533, "end_char_idx": 3377, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "75f6f1fb-c9b5-49d4-8594-990a7d9af86d": {"__data__": {"id_": "75f6f1fb-c9b5-49d4-8594-990a7d9af86d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4398996b-2c76-407d-b6d8-cff1ca576a24", "node_type": "1", "metadata": {}, "hash": "88db3cd4ae7fa675d40c5cbe4bdb91b1e9d04eb0afa6e71b61e90539da3df1ce", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fb3326ca-c29b-4fe2-b9a4-53a7fe69f922", "node_type": "1", "metadata": {}, "hash": "3b1e2f5ec354cdb76d4de43d85fc143847f16dac57ed18b84cda5a3a5bba879b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The formation of protective cross-reactive antibodies from natural\ninfection with H1N1 is plausible, as the hemagglutinin glycopro-\ntein of 2009 H1N1 and the 1918 H1N1 virus and its early\nderivatives are structurally similar,6 and hemagglutinin is a well-\nestablished target for antibody-mediated protection in humans.7\nGiven the existence of cross-reactive antibodies to 2009\nH1N1 in a substantial number of adults, we reasoned that com-\nmercial intravenous immunoglobulin (IVIG) products produced\nprior to the 2009 pandemic, which combine plasma from thou-\nsands of adult donors, might contain signi\ufb01cant levels of these\nantibodies. We tested IVIG preparations for cross-reactive micro-\nneutralization (MN) and hemagglutination inhibition (HI) antibody\nagainst 2009 H1N1, and we also determined whether administra-\ntion of high-dose IVIG to patients with Kawasaki Disease (KD)\npatients treated prior to 2009 signi\ufb01cantly raised their serum titers\nof these antibodies.\nMATERIALS AND METHODS\nImmunoglobulin Preparations. IVIG solutions of 10% (g/dL)\nimmunoglobulin concentration (Gamunex \u00023 lots\u0003, Talecris Bio-\ntherapeutics; Gammagard, Baxter Pharmaceuticals; Cytogam and\nPrivigen, CSL Behring), all of which were produced prior to the\nemergence of 2009 H1N1 in April 2009, were tested. These\npreparations were diluted in phosphate-buffered saline (PBS) to\n\ufb01nal concentrations of 1.0, 2.0, and 4.0 g/dL, which encompass the\nnormal IgG concentration in human serum and the peak achievable\nserum IgG concentration after a 2.0 g/kg dose of IVIG (approxi-\nmately 3.0 g/dL).8\nSerum Samples. Sera were obtained from KD patients, aged\nbetween 10 months and 10 years, treated in San Diego County, CA\nfrom December 2007 to March 2009 with IVIG (Gammagard),\nfollowing parental informed consent and Institutional Review\nBoard of the University of California at San Diego approval.", "mimetype": "text/plain", "start_char_idx": 3378, "end_char_idx": 5248, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fb3326ca-c29b-4fe2-b9a4-53a7fe69f922": {"__data__": {"id_": "fb3326ca-c29b-4fe2-b9a4-53a7fe69f922", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "75f6f1fb-c9b5-49d4-8594-990a7d9af86d", "node_type": "1", "metadata": {}, "hash": "a59af63d2d0d136c87336214ec9e9c34b0fa251b2efff74afc454d009630303b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6fc83280-069d-47cb-8794-76ee676141aa", "node_type": "1", "metadata": {}, "hash": "d4f0fadf1bd4be8448b7385c2a5f08a266dfd3fcda89a5d2fb737a5e0c552040", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "One\ngroup of sera was collected immediately prior to and 1 to 3 days\nafter KD patients received a single 2.0 g/kg dose of IVIG. A\nsecond group of sera were collected immediately prior to and 5 to\n13 days after other KD patients received two 2.0 g/kg doses of\nIVIG. Aliquots of sera were frozen at \u000480\u00b0C until thawed for later\nanalysis.\nViral Isolation and Propagation. The 2009 H1N1 in\ufb02uenza A\nstrain, which was obtained from a deidenti\ufb01ed primary clinical\nsample of bronchoalveolar lavage \ufb02uid, was grown in Madin-\nDarby canine kidney cells.9 This isolate was con\ufb01rmed as 2009\nH1N1 by the California State Department of Public Health using a\nreverse-transcriptase real-time polymerase chain reaction assay.\nHI and MN Assays. HI and MN assays were performed as de-\nscribed previously.5,10 For the HI assay, serum samples treated\nwith receptor-destroying enzyme (Denka Seiken) were diluted\n10-fold (vol/vol) in PBS from which serial 2-fold dilutions were\nprepared. Diluted sera were mixed with 2009 H1N1 in\ufb02uenza,\nturkey red blood cells (0.5% vol/vol) were added (Rockland\nImmunochemicals), and hemagglutination was noted after 30 min-\nutes of incubation. The HI titer was identi\ufb01ed as the last dilution\nthat prevented hemagglutination of red blood cells. For the MN\nassay, heat-inactivated samples were initially diluted 10-fold in\nPBS and mixed with live 2009 H1N1 in\ufb02uenza. Madin-Darby\ncanine kidney infection was determined by an in\ufb02uenza A nucleo-\nprotein enzyme-linked immunosorbent assay using a mouse anti-\nnucleoprotein antibody (Millipore). The MN antibody titer was\nidenti\ufb01ed as the last serum dilution that prevents infection by 50%\nas measured by enzyme-linked immunosorbent assay.", "mimetype": "text/plain", "start_char_idx": 5249, "end_char_idx": 6942, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6fc83280-069d-47cb-8794-76ee676141aa": {"__data__": {"id_": "6fc83280-069d-47cb-8794-76ee676141aa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fb3326ca-c29b-4fe2-b9a4-53a7fe69f922", "node_type": "1", "metadata": {}, "hash": "3b1e2f5ec354cdb76d4de43d85fc143847f16dac57ed18b84cda5a3a5bba879b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6091fb79-c4d6-4187-bb0e-b2415ae2a46f", "node_type": "1", "metadata": {}, "hash": "e43a22dfbf775bbce94776447f8445c62020bcd582a95ccc02b94d0011aec6db", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The MN antibody titer was\nidenti\ufb01ed as the last serum dilution that prevents infection by 50%\nas measured by enzyme-linked immunosorbent assay. For calcu-\nlation of geometric mean titers (GMT), titers were expressed as\nreciprocal titers (eg, 1:40 was expressed as 40) and an undetectable\nMN or HI titer was recorded as a reciprocal titer of 5 or one-half\nthe lowest dilution tested.10 Both the HI and MN assays were\nvalidated with negative control serum from an unvaccinated,\nuninfected volunteer and with positive control serum from an\nindividual who had been infected with H1N1.\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\nwww.pidj.com\n| 67\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\nStatistical Analysis. Paired, 2-tailed Student t test were used to\ncompare (1) MN and HI titers measured in the same IVIG\npreparation or serum sample and (2) pre- and post-treatment MN\nor HI antibody titers for sera from the same individual. Pearson r\nvalues were used to calculate the correlation between MN and HI\ntiters. Prism 5 software (GraphPad) was used for statistical calcu-\nlations.\nRESULTS\nSix different commercial preparations of IVIG were tested\nfor the presence of MN and HI titers. All IVIG preparations had\ndetectable levels of MN antibody to 2009 H1N1 at the lowest\nconcentration tested of 1.0 g/dL, which increased in a dose-\ndependent manner (Fig. 1A).", "mimetype": "text/plain", "start_char_idx": 6799, "end_char_idx": 8318, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6091fb79-c4d6-4187-bb0e-b2415ae2a46f": {"__data__": {"id_": "6091fb79-c4d6-4187-bb0e-b2415ae2a46f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6fc83280-069d-47cb-8794-76ee676141aa", "node_type": "1", "metadata": {}, "hash": "d4f0fadf1bd4be8448b7385c2a5f08a266dfd3fcda89a5d2fb737a5e0c552040", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cd210aa1-f1d5-47b6-b19f-c38ee8bdbf87", "node_type": "1", "metadata": {}, "hash": "cc827ea3a1daaaa5d08632e65d93e79c204294fa2be0c5de4e6b7707815d53d0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1A). The MN GMT of all preparations\nwas 28.3 at the highest dilution tested of 4.0 g/dL, with some\nvariation between different commercial brands (titers from indi-\nvidual IVIG preparations are presented in Table, Supplemental\nDigital Content 1, http://links.lww.com/INF/A568). All tested\nIVIG brands achieved a MN titer of 1:20 at 2.0 g/dL, a concen-\ntration that can be readily achieved with the high-doses of IVIG\ngiven in KD.8 Similarly, all IVIG preparations demonstrated\ndose-dependent increases in HI titers, with a HI GMT of 15.9 at the\nhighest concentration tested of 4.0 g/dL, though there was variation\nbetween different lots of the same brand in addition to between\nbrands. There was a signi\ufb01cant correlation between the MN titer and\nHI titer of the IVIG samples at each concentration (Pearson r \u0005 0.64,\n95% con\ufb01dence interval \u0005 0.25\u20130.85, P \u0005 0.004), with the MN titer\napproximately 2-fold higher than the HI titer.\nWe next determined whether high-dose therapy using\nprepandemic produced IVIG raised the serum titer of HI and MN\nantibodies in patients. A single treatment of KD patients with 2.0\ng/kg of IVIG increased MN titers against 2009 H1N1 in 18 of 19\nsubjects (95%) when measured 1 to 3 days postinfusion. Similarly,\nHI titers also increased in 17/19 (89%) of subjects after 1 dose of\nIVIG (individual patient titers are presented in Table, Supplemen-\ntal Digital Content 2, http://links.lww.com/INF/A569). In KD\npatients who received a single dose of IVIG, both MN and HI titers\nincreased signi\ufb01cantly after treatment (Fig. 1B). MN GMT in-\ncreased from 6.9 to 35.9 (P \u0001 0.0001), whereas HI GMT increased\nfrom 5.0 to 12.5 (P \u0001 0.0001).", "mimetype": "text/plain", "start_char_idx": 8314, "end_char_idx": 9969, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cd210aa1-f1d5-47b6-b19f-c38ee8bdbf87": {"__data__": {"id_": "cd210aa1-f1d5-47b6-b19f-c38ee8bdbf87", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6091fb79-c4d6-4187-bb0e-b2415ae2a46f", "node_type": "1", "metadata": {}, "hash": "e43a22dfbf775bbce94776447f8445c62020bcd582a95ccc02b94d0011aec6db", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9822c839-e974-4d47-9844-58817545fb19", "node_type": "1", "metadata": {}, "hash": "844b9dee5232512b66328b307e7828d3935b45f4cf9c60f3195aa2fc0df1ddb8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Again, as in the IVIG preparations,\nthe GMT for MN antibody was approximately 2 times the titer of\nHI antibody in post-IVIG sera, and this difference was signi\ufb01cant\n(P \u0001 0.0001).\nIn KD patients receiving 2 doses of IVIG, there was also\nsigni\ufb01cant increase in MN and HI titers measured within 14 days\nafter the second dose (Fig. 1C). All 8 subjects had increases in the\nMN titer while 7/8 (88%) of subjects had increases in the HI titer\n(individual patient titers are presented in Table, Supplemental\nDigital Content 3, http://links.lww.com/INF/A570). The MN GMT\nincreased from 5.9 to 23.8 (P \u0005 0.0005), whereas HA GMTs\nincreased from 5.4 to 13.0 (P \u0005 0.0038).\nDISCUSSION\nAlthough the 2009 H1N1 in\ufb02uenza A viral pandemic spread\nrapidly due to the lack of pre-existing immunity in much of the\nhuman population, older adults appeared to be relatively protected\ndue to pre-existing cross-protective antibodies that were most\nlikely generated in response to natural infection with 1918 H1N1\nand its early derivatives.5 In this article, we show that commercial\npreparations of IVIG, produced prior to the 2009 H1N1 pandemic,\ncontain cross-reactive antibodies against 2009 H1N1 as assessed\nby both HI and MN assays. In addition, we found that adminis-\ntration of high-dose IVIG signi\ufb01cantly increased the levels of\ncross-reactive HI and MN antibodies against 2009 H1N1. Thus,\nFIGURE 1. A, Microneutralization (MN) and hemagglutina-\ntion inhibition (HI) antibody titers against 2009 H1N1 in\ncommercial preparations of intravenous immunoglobulin\n(IVIG). Geometric mean titer (GMT) of MN and HI titers\nagainst 2009 H1N1 were determined at 3 different con-\ncentrations. Error bars represent 95% confidence interval\n(CI).", "mimetype": "text/plain", "start_char_idx": 9970, "end_char_idx": 11679, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9822c839-e974-4d47-9844-58817545fb19": {"__data__": {"id_": "9822c839-e974-4d47-9844-58817545fb19", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cd210aa1-f1d5-47b6-b19f-c38ee8bdbf87", "node_type": "1", "metadata": {}, "hash": "cc827ea3a1daaaa5d08632e65d93e79c204294fa2be0c5de4e6b7707815d53d0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ad82d4a2-7edf-493e-9fad-a15c83dd640a", "node_type": "1", "metadata": {}, "hash": "dec590d84bdf43420ec79ff042c79efd623073989c594c70a4c477d0d6599c78", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Geometric mean titer (GMT) of MN and HI titers\nagainst 2009 H1N1 were determined at 3 different con-\ncentrations. Error bars represent 95% confidence interval\n(CI). B, MN and HI antibody titers against 2009 H1N1 be-\nfore and after 1 treatment of 2.0 g/kg of IVIG are shown\nusing serum samples that were drawn 1 to 3 days apart.\nError bars represent 95% CI. P values were determined us-\ning the 2-tailed, paired Student t test with respect to the\npre-IVIG sera sample from the same subject. C, GMT for\nboth MN and HI assays against 2009 H1N1 at baseline,\nand after 2 treatments of 2.0 g/kg of IVIG, are shown us-\ning serum samples that were drawn 5 to 13 days apart fol-\nlowing the second dose. Error bars represent 95% CI. P\nvalues were determined using the 2-tailed, paired Student t\ntest with respect to the pre-IVIG sera sample from the\nsame subject.\nHong et al\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\n\u00a9 2010 Lippincott Williams & Wilkins\n68\n|\nwww.pidj.com\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\ncommercially available IVIG produced prior to the pandemic\ncould potentially be used as an adjunctive treatment for 2009\nH1N1 infection in severe cases or in patients with limitations in\nadaptive immunity. Since newer IVIG preparations will likely\ninclude plasma from donors who have been vaccinated for 2009\nH1N1 or who were infected with 2009 H1N1, the HI and MN\nantibody titers will likely increase.", "mimetype": "text/plain", "start_char_idx": 11515, "end_char_idx": 13086, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ad82d4a2-7edf-493e-9fad-a15c83dd640a": {"__data__": {"id_": "ad82d4a2-7edf-493e-9fad-a15c83dd640a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9822c839-e974-4d47-9844-58817545fb19", "node_type": "1", "metadata": {}, "hash": "844b9dee5232512b66328b307e7828d3935b45f4cf9c60f3195aa2fc0df1ddb8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9916b2ef-db94-452a-bdde-1e26190c9298", "node_type": "1", "metadata": {}, "hash": "f2f58ee6042bbc9cc048a973b86e7dda8b71545d23d0c1a6e3eb03259a9ca572", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "However, our results indicate\nthat such inclusion is not necessary for IVIG to provide substantial\npassive immunity to 2009 H1N1, and suggest that the approach of\nusing existing IVIG preparations might also be considered in\nfuture in\ufb02uenza pandemics or if highly drifted strains circulate.\nAlthough there has been no reported clinical experience\nwith the use of passive antibodies in treating 2009 H1N1, there\nwere many attempts to use convalescent blood products in treating\nacute in\ufb02uenza during the in\ufb02uenza pandemic in 1918. The ther-\napeutic administration of blood products enriched in anti-in\ufb02uenza\nantibodies appeared to confer a survival advantage particularly if\nthe treatment was given within the \ufb01rst 4 days of illness.11 In\naddition, convalescent plasma has been used anecdotally for severe\nH5N1 infection.12 Furthermore, in animal models, therapeutic\nmonoclonal anti-in\ufb02uenza IgG antibodies have been shown to\nclear in\ufb02uenza virus after infection in severe combined immuno-\nde\ufb01ciency (SCID) mice, which lack B cells and T cells.13 Thus, it\nis plausible that the therapeutic administration of immunoglobulin\ncontaining neutralizing antibody against 2009 H1N1 could aid in\nhalting the progression of infection as well as in viral clearance.\nPassive immunotherapy for 2009 H1N1 in\ufb02uenza and other\npandemic in\ufb02uenza A strains may be of particular importance in\ncases of antiviral resistance. While the 2009 H1N1 virus has\nremained largely susceptible to the neuraminidase inhibitors, os-\neltamivir and zanamivir, there have been sporadic reports of\noseltamivir-resistant strains. Resistance has been particularly fre-\nquent in hosts with impaired adaptive immunity who shed virus for\nprolonged periods.14 Adjunctive therapy with IVIG could be partic-\nularly useful in this population.\nIn summary, we have identi\ufb01ed signi\ufb01cant titers of cross-\nreactive antibody against 2009 H1N1 in commercial preparations\nof IVIG despite the low prevalence of pre-existing cross-reactive\nimmunity in the general population.", "mimetype": "text/plain", "start_char_idx": 13087, "end_char_idx": 15104, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9916b2ef-db94-452a-bdde-1e26190c9298": {"__data__": {"id_": "9916b2ef-db94-452a-bdde-1e26190c9298", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ad82d4a2-7edf-493e-9fad-a15c83dd640a", "node_type": "1", "metadata": {}, "hash": "dec590d84bdf43420ec79ff042c79efd623073989c594c70a4c477d0d6599c78", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6b1839a0-ccf9-402a-938f-d464cda531fe", "node_type": "1", "metadata": {}, "hash": "82cc61df5a3769ab3f41684661ff57d48ba63bbf1f84cc38ceb19d72ba81a916", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Administration of high-dose\nIVIG increased the serum titer of these antibodies, and this may be\na useful adjunctive therapy in severe infections with 2009 H1N1\nin\ufb02uenza, particularly in the immunocompromised, those who are\nrefractory to neuraminidase inhibitor therapy, and immunologi-\ncally naive children.\nACKNOWLEDGMENTS\nThe authors thank DeeAnna Scherrer (UCSD) and Kira\nDionis (Stanford University) for technical support, Benjamin Pin-\nsky, Stanford Clinical Microbiology Laboratory, for providing\nclinical samples, and Roshni Mathew and David Nguyen for\ncritique of the manuscript.\nREFERENCES\n1. Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin\nin\ufb02uenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605\u20132615.\n2. Centers for Disease Control and Prevention (CDC). Interim results: state-\nspeci\ufb01c seasonal in\ufb02uenza vaccine coverage\u2014United States, August 2009-\nJanuary 2010. Morb Mortal Wkly Rep. 2010;59:477\u2013484.\n3. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009\nH1N1 in\ufb02uenza in the United States, April-June 2009. N Engl J Med.\n2009;361:1935\u20131944.\n4. Thompson WW, Shay DK, Weintraub E, et al. In\ufb02uenza-associated hospi-\ntalizations in the United States. JAMA. 2004;292:1333\u20131340.\n5. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to\nthe 2009 pandemic H1N1 in\ufb02uenza virus. N Engl J Med. 2009;361:1945\u2013\n1952.\n6. Xu R, Ekiert DC, Krause JC, et al. Structural basis of preexisting immunity\nto the 2009 H1N1 pandemic in\ufb02uenza virus. Science.", "mimetype": "text/plain", "start_char_idx": 15105, "end_char_idx": 16620, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6b1839a0-ccf9-402a-938f-d464cda531fe": {"__data__": {"id_": "6b1839a0-ccf9-402a-938f-d464cda531fe", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9916b2ef-db94-452a-bdde-1e26190c9298", "node_type": "1", "metadata": {}, "hash": "f2f58ee6042bbc9cc048a973b86e7dda8b71545d23d0c1a6e3eb03259a9ca572", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "049c3368-5add-40ee-9e40-d0b276d7d821", "node_type": "1", "metadata": {}, "hash": "2dec15548e3a3548a80871d55817193b50a4f1b5f5803e130597ff950c964a30", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "6. Xu R, Ekiert DC, Krause JC, et al. Structural basis of preexisting immunity\nto the 2009 H1N1 pandemic in\ufb02uenza virus. Science. 2010;328:357\u2013360.\n7. de Jong JC, Palache AM, Beyer WE, et al. Haemagglutination-inhibiting\nantibody to in\ufb02uenza virus. Dev Biol (Basel). 2003;115:63\u201373.\n8. Lee KY, Han JW, Lee JS, et al. Alteration of biochemical pro\ufb01les after\nhigh-dose intravenous immunoglobulin administration in Kawasaki disease.\nActa Paediatr. 2002;91:164\u2013167.\n9. Webster R, Cox N, Stohr K. WHO Manual on Animal In\ufb02uenza Diagnosis\nand Surveillance. Geneva, Switzerland: World Health Organization; 2002.\n10. Rowe T, Abernathy RA, Hu-Primmer J, et al. Detection of antibody to avian\nin\ufb02uenza A (H5N1) virus in human serum by using a combination of\nserologic assays. J Clin Microbiol. 1999;37:937\u2013943.\n11. Luke TC, Kilbane EM, Jackson JL, et al. Meta-analysis: convalescent blood\nproducts for Spanish in\ufb02uenza pneumonia: a future H5N1 treatment? Ann\nIntern Med. 2006;145:599\u2013609.\n12. Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for\nin\ufb02uenza A (H5N1) infection. N Engl J Med. 2007;357:1450\u20131451.\n13. Palladino G, Mozdzanowska K, Washko G, et al. Virus-neutralizing anti-\nbodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure\nin\ufb02uenza virus pneumonia in SCID mice. J Virol. 1995;69:2075\u20132081.\n14. Centers for Disease Control and Prevention (CDC).", "mimetype": "text/plain", "start_char_idx": 16491, "end_char_idx": 17868, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "049c3368-5add-40ee-9e40-d0b276d7d821": {"__data__": {"id_": "049c3368-5add-40ee-9e40-d0b276d7d821", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6b1839a0-ccf9-402a-938f-d464cda531fe", "node_type": "1", "metadata": {}, "hash": "82cc61df5a3769ab3f41684661ff57d48ba63bbf1f84cc38ceb19d72ba81a916", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a1fabe26-1bb4-470d-979e-e3edc08d0bb6", "node_type": "1", "metadata": {}, "hash": "70d8b38d3e089c947881c6934ae7cfda1db7dbffd74ba615b3dad9525609c80f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "J Virol. 1995;69:2075\u20132081.\n14. Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant\nnovel in\ufb02uenza A (H1N1) virus infection in two immunosuppressed pa-\ntients\u2014Seattle, Washington, 2009. Morb Mortal Wkly Rep. 2009;58:893\u2013\n896.\nSAFETY AND IMMUNOGENICITY OF A BOOSTER\nDOSE OF THE 10-VALENT PNEUMOCOCCAL\nNONTYPEABLE HAEMOPHILUS INFLUENZAE\nPROTEIN D CONJUGATE VACCINE\nCOADMINISTERED WITH DTPW-HBV/HIB\nAND POLIOVIRUS VACCINES\nNancy Bermal, MD,* Leszek Szenborn, MD,\u2020 Edison Alberto, MD,*\nMarina Hernandez, MD,* Jerzy Pejcz, MD,\u2021\nEwa Majda-Stanislawska, MD,\u00a7 Salvacion Gatchalian, MD,\u00b6\u0001\nAure\u00b4lie Fanic, MSC,** Ilse Dieussaert, IR,**\nand Lode Schuerman, MD**\nAbstract: The safety and reactogenicity pro\ufb01les of the 10-valent pneumo-\ncoccal conjugate vaccine, PHiD-CV, and 7vCRM were comparable within\nthe Philippines and Poland when coadministered as a booster dose with\nDTPw-HBV/Hib and poliovirus vaccines to toddlers primed with the same\nvaccines. Robust immune responses for all 10 vaccine pneumococcal\nserotypes and protein D following PHiD-CV booster vaccination were\nindicative of effective priming.\nKey Words: pneumococcal conjugate vaccine, safety, immunogenicity,\nbooster vaccination\nAccepted for publication June 30, 2010.", "mimetype": "text/plain", "start_char_idx": 17787, "end_char_idx": 19031, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a1fabe26-1bb4-470d-979e-e3edc08d0bb6": {"__data__": {"id_": "a1fabe26-1bb4-470d-979e-e3edc08d0bb6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "049c3368-5add-40ee-9e40-d0b276d7d821", "node_type": "1", "metadata": {}, "hash": "2dec15548e3a3548a80871d55817193b50a4f1b5f5803e130597ff950c964a30", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5f665828-58ba-4c37-ad50-8c2708fa5d85", "node_type": "1", "metadata": {}, "hash": "a520bacf47a5caab20dd08636e45056a619316f9b7ad2306801061274abe7a09", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Key Words: pneumococcal conjugate vaccine, safety, immunogenicity,\nbooster vaccination\nAccepted for publication June 30, 2010.\nFrom the *Research Institute for Tropical Medicine, Muntinlupa, Philippines;\n\u2020Department of Pediatric Infectious Diseases, Medical University Wroclaw,\nWroclaw, Poland; \u2021Department of Pediatrics, St Hedwig of Silesia District\nHospital, Trzebnica, Poland; \u00a7Department of Infectious Diseases and Hepa-\ntology, Medical University of Lodz, Kniaziewicza, Poland; \u00b6GlaxoSmith-\nKline Biologicals, Makati, Philippines; \u0001University of the Philippines Ma-\nnila, the Philippines; and **GlaxoSmithKline Biologicals, Wavre, Belgium.\nSupported by GlaxoSmithKline Biologicals, Rixensart, Belgium (study\nnumber: 109509; www.ClinicalTrials.gov: NCT00547248).\nGlaxoSmithKline Biologicals was involved in all stages of the study\nconduct and analysis. GlaxoSmithKline Biologicals also took charge of\nall costs involved in the development and the publishing of the present\nmanuscript. The corresponding author had full access to the data and\n\ufb01nal responsibility for submission of the publication.\nN. B., L.S., E.M.S., and J.P. declare to have received honoraria, paid expert\ntestimony, or travel grants from GlaxoSmithKline Biologicals; E.A.\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\nPHiD-CV Coadministered With DTPw-HBV/Hib\n\u00a9 2010 Lippincott Williams & Wilkins\nwww.pidj.com\n| 69\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\nand M.H.", "mimetype": "text/plain", "start_char_idx": 18905, "end_char_idx": 20505, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5f665828-58ba-4c37-ad50-8c2708fa5d85": {"__data__": {"id_": "5f665828-58ba-4c37-ad50-8c2708fa5d85", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a1fabe26-1bb4-470d-979e-e3edc08d0bb6", "node_type": "1", "metadata": {}, "hash": "70d8b38d3e089c947881c6934ae7cfda1db7dbffd74ba615b3dad9525609c80f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2aa27631-6a39-499e-8b8e-bc395a532fc8", "node_type": "1", "metadata": {}, "hash": "e1e9aa03f7211564ef55ef6cf1cef17d421bc47306828c5b68f54a30b1b4e131", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "declare to have no con\ufb02ict of interest; S.G., I.D., and L.S. are\nemployed by GlaxoSmithKline Biologicals and have stock ownership;\nA.F. works as a consultant for GlaxoSmithKline Biologicals.\nPrevenar/Prevnar is a trademark of P\ufb01zer Inc; Syn\ufb02orix, Tritanrix\nHepB, Hiberix, Polio Sabin, and Poliorix are trademarks of the\nGlaxoSmithKline group of companies.\nAddress for correspondence: Nancy Bermal, MD, Research Institute for\nTropical Medicine, Filinvest Corporate City, Alabang, Muntinlupa\nCity, 1781 Philippines. E-mail: nnbid02@yahoo.com.\nSupplemental digital content is available for this article. Direct URL\ncitations appear in the printed text and are provided in the HTML and\nPDF versions of this article on the journal\u2019s Web site (www.pidj.com).\nDOI: 10.1097/INF.0b013e3181f2da06\nT\nhe\npneumococcal\nnontypeable\nHaemophilus\nin\ufb02uenzae\n(NTHi) protein D conjugate vaccine (PHiD-CV; Syn\ufb02orix,\nGlaxoSmithKline Biologicals, Rixensart, Belgium) contains\npneumococcal serotypes 1, 5, and 7F in addition to the 7\nserotypes contained in the 7-valent pneumococcal conjugate\nvaccine (7vCRM; Prevenar/Prevnar, P\ufb01zer Inc, New York, NY). A\nprimary vaccination study conducted in the Philippines (6\u201310\u201314\nweeks schedule, N \u0005 400) and Poland (2\u20134\u20136 months schedule,\nN \u0005 406) assessed the reactogenicity and safety of PHiD-CV as\ncompared with 7vCRM (3:1 ratio) when both were coadministered\nwith the combined diphtheria-tetanus-whole-cell pertussis-hepati-\ntis B/H.", "mimetype": "text/plain", "start_char_idx": 20506, "end_char_idx": 21958, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2aa27631-6a39-499e-8b8e-bc395a532fc8": {"__data__": {"id_": "2aa27631-6a39-499e-8b8e-bc395a532fc8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5f665828-58ba-4c37-ad50-8c2708fa5d85", "node_type": "1", "metadata": {}, "hash": "a520bacf47a5caab20dd08636e45056a619316f9b7ad2306801061274abe7a09", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9b042a23-136a-4468-b17e-668fc9648637", "node_type": "1", "metadata": {}, "hash": "d859ed52cb4bb37da3dde6ba3a36bc99f035af03fb05f28be2a185b455ae68e0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "in\ufb02uenzae type b (DTPw-HBV vaccine, Tritanrix HepB,\nadministered in 1 injection with Hib-conjugate vaccine, Hiberix)\nand either oral live attenuated (Polio Sabin, the Philippines) or\ninjectable inactivated poliovirus vaccines (IPV, Poliorix, Poland).1\nPHiD-CV was immunogenic for each of the 10 pneumococcal\nvaccine serotypes1 and was well tolerated, with a reactogenicity\nand safety pro\ufb01le in line with that of 7vCRM vaccine.2 In the\npresent study, reactogenicity and immunogenicity were evaluated\nin both countries after a fourth (booster) dose of PHiD-CV or\n7vCRM vaccine coadministered at 12 to 18 months of age with the\nsame vaccines.\nMATERIALS AND METHODS\nVaccines were administered intramuscularly into the right\n(PHiD-CV or 7vCRM), the upper left (DTPw-HBV/Hib), or lower\nleft (IPV) thigh. Study vaccines composition and inclusion/exclu-\nsion criteria were as described previously.1,3\nThe primary objective of the study was to demonstrate that\na PHiD-CV booster dose was noninferior to 7vCRM in terms of\nthe percentage of subjects reporting fever with rectal temperature\n\u000639.0\u00b0C after vaccination, on the basis of standardized asymptotic\n95% con\ufb01dence intervals (CIs) for the difference between groups\n(PHiD-CV minus 7vCRM), and the corresponding 1-sided P value\nfor the null hypothesis (H0) that the increase in the percentage of\nsubjects with rectal temperature \u000639.0\u00b0C was above 5% plus half\nthe incidence in the control group.4 The noninferiority objective\nwas reached if H0 could be rejected with P value \u00010.025.\nAssessments of reactogenicity and safety were as described\nfor previous PHiD-CV booster trials.2 Speci\ufb01c local and general\nadverse events (AEs) were solicited for 4 days after vaccination\nand scored on a 3-grade intensity scale, and subjects were moni-\ntored up to 31 days after vaccination for unsolicited events.", "mimetype": "text/plain", "start_char_idx": 21959, "end_char_idx": 23799, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9b042a23-136a-4468-b17e-668fc9648637": {"__data__": {"id_": "9b042a23-136a-4468-b17e-668fc9648637", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2aa27631-6a39-499e-8b8e-bc395a532fc8", "node_type": "1", "metadata": {}, "hash": "e1e9aa03f7211564ef55ef6cf1cef17d421bc47306828c5b68f54a30b1b4e131", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "054f2ba4-577f-4f11-95c8-b954254cfbaf", "node_type": "1", "metadata": {}, "hash": "591b348f6ce907fba0c3c5bea030e115b8fb735119677a078dca34e329a7927c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Large\nswelling reactions were also recorded. Serious adverse events\n(SAEs) were monitored throughout the entire study period.\nImmunogenicity was assessed in blood samples taken before\n(day 0) and 1 month after the booster dose, as described\npreviously.1,5 In a subset of 200 subjects from each country,\nserum antipneumococcal IgG concentrations were measured us-\ning GlaxoSmithKline\u2019s 22F-inhibition enzyme-linked immunosor-\nbent assay (ELISA), with a reference antibody concentration of 0.2\n\u0001g/mL, opsonophagocytic activity (OPA) by a killing assay, with\na cut-off opsonic titer of 8, and antibodies against NTHi protein D\nby ELISA. ELISA geometric mean antibody concentrations\n(GMCs) and/or OPA geometric mean titers (GMTs) were calcu-\nlated for each vaccine serotype, protein D, and cross-reactive\nserotypes 6A and 19A. Antibodies to the coadministered vaccine\nantigens were also analyzed (Text and Table, Supplemental Digital\nContent 1, http://links.lww.com/INF/A576).\nRESULTS\nOf the 756 children enrolled and included in the total vacci-\nnated cohort (383 in Poland and 373 in the Philippines), 12 (all from\nPoland; 10 in PHiD-CV group, 2 in 7vCRM group) did not complete\nthe booster study because of consent withdrawal and not due to an\nAE, protocol violation, or move from study area. A total of 703 were\nincluded in the according-to-protocol cohort for immunogenicity\n(Fig., Supplemental Digital Content 2, http://links.lww.com/INF/A577).\nIn each country, demographic characteristics of the PHiD-CV and\n7vCRM groups were comparable (Table, Supplemental Digital Con-\ntent 3, http://links.lww.com/INF/A578).", "mimetype": "text/plain", "start_char_idx": 23800, "end_char_idx": 25413, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "054f2ba4-577f-4f11-95c8-b954254cfbaf": {"__data__": {"id_": "054f2ba4-577f-4f11-95c8-b954254cfbaf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9b042a23-136a-4468-b17e-668fc9648637", "node_type": "1", "metadata": {}, "hash": "d859ed52cb4bb37da3dde6ba3a36bc99f035af03fb05f28be2a185b455ae68e0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8ee82aa2-7c3c-44f2-a7a7-e91bb33eb78a", "node_type": "1", "metadata": {}, "hash": "d98a4d21c002125a41cf2fec2404bf7bd93c5392746b0eaad6f97b5b4c1c4411", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In each country, demographic characteristics of the PHiD-CV and\n7vCRM groups were comparable (Table, Supplemental Digital Con-\ntent 3, http://links.lww.com/INF/A578).\nThe primary objective of noninferiority in terms of the\noccurrence of rectal temperature \u000639.0\u00b0C following PHiD-CV\nbooster vaccination in both countries (11.5%) compared with\n7vCRM booster vaccination (10.6%) was reached since the upper\nlimit of the 95% CI for the difference between groups (0.89%\n\u000295% CI: \u00044.82%\u20135.59%\u0003; P \u0001 0.001) was lower than 10.3%.\nOpposite trends in incidences of postvaccination febrile reactions\n(rectal temperature \u000639\u00b0C) were however observed in the indi-\nvidual countries, with a trend for higher fever incidence in 7vCRM\nversus PHiD-CV recipients in the Philippines and an inverse trend\nin Poland (Table 1). Only 1 case of grade 3 fever (rectal temper-\nature \u000640.0\u00b0C) was reported (PHiD-CV group, Poland).\nIn each country, the incidence of each solicited AE (of any\nintensity) was in the same range for both groups (overlapping 95%\nCIs) (Table 1). However, incidences of solicited AEs tended to be\nhigher in Poland than in the Philippines (Table 1), including high\n(\u000240.6%) incidences of grade 3 pain in both groups in Poland.\nIncidences of grade 3 solicited general AEs were low (maximum\n5.2%) in both countries, except for irritability (14.4%) in\nPHiD-CV recipients in Poland (Table 1).\nLarge swelling reactions were reported in 5 subjects in the\nPhilippines (4 at DTPw-HBV/Hib, 1 at PHiD-CV injection site)\nand 14 subjects in Poland (10 at DTPw-HBV/Hib, 3 at PHiD-CV,\n1 at IPV injection site). All were local or diffuse swelling reactions\nnot involving adjacent joints and resolved without sequelae.", "mimetype": "text/plain", "start_char_idx": 25247, "end_char_idx": 26946, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8ee82aa2-7c3c-44f2-a7a7-e91bb33eb78a": {"__data__": {"id_": "8ee82aa2-7c3c-44f2-a7a7-e91bb33eb78a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "054f2ba4-577f-4f11-95c8-b954254cfbaf", "node_type": "1", "metadata": {}, "hash": "591b348f6ce907fba0c3c5bea030e115b8fb735119677a078dca34e329a7927c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "28838138-079c-497d-a473-0a155276f25f", "node_type": "1", "metadata": {}, "hash": "a1609eb16bbf9d7aeed06f367c8202fbe28d0cc166b67179c31895591aa5e862", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All were local or diffuse swelling reactions\nnot involving adjacent joints and resolved without sequelae. The\nincidence of unsolicited AEs was lower in the Philippines (8.9%,\nPHiD-CV vs. 9.7%, 7vCRM) than in Poland (37.2% vs. 35.7%).\nSAEs were reported in 2 subjects in the Philippines (2/280 chil-\ndren, PHiD-CV) and 7 subjects in Poland (5/285, PHiD-CV; 2/98,\n7vCRM). One SAE (fever with pharyngitis that started on day of\nPHiD-CV vaccination in Poland) was assessed to be causally\nrelated to vaccination. No fatal SAEs were reported up to the 1\nmonth follow-up visit. During an extended safety follow-up period\n(up to approximately 6 months after booster vaccination), 1 SAE\nreported in the Philippines had a fatal outcome; persistent vomiting\nstarted 33 days after the 7vCRM booster dose and resulted in\nhospitalization 1 month later, after which intracranial mass was\ndiagnosed, complicated with acute respiratory distress and death 1\nweek later. The fatal SAE was not considered to be causally related\nto vaccination.\nFor each of the pneumococcal serotypes common to both\nvaccines, robust immune responses were observed 1 month after\nthe booster dose in both groups in each country.", "mimetype": "text/plain", "start_char_idx": 26841, "end_char_idx": 28029, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "28838138-079c-497d-a473-0a155276f25f": {"__data__": {"id_": "28838138-079c-497d-a473-0a155276f25f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8ee82aa2-7c3c-44f2-a7a7-e91bb33eb78a", "node_type": "1", "metadata": {}, "hash": "d98a4d21c002125a41cf2fec2404bf7bd93c5392746b0eaad6f97b5b4c1c4411", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "604d8e78-1d35-4029-ad96-c1997a329b76", "node_type": "1", "metadata": {}, "hash": "262ab979ce9f332cbd12a52576bb4ca03d584cc37f640054e7ca7ad7ff30b610", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For each of the pneumococcal serotypes common to both\nvaccines, robust immune responses were observed 1 month after\nthe booster dose in both groups in each country. The range of pre-\nBermal et al\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\n\u00a9 2010 Lippincott Williams & Wilkins\n70\n|\nwww.pidj.com\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\nto postbooster fold increases in antibody GMC was 10.7 to 27.6 in\nPHiD-CV and 15.0 to 41.0 in 7vCRM vaccinees in the Philippines,\nand 7.0 to 16.6 in PHiD-CV and 14.5 to 28.0 in 7vCRM vaccinees\nin Poland. In the Philippines, postbooster antibody GMCs were\nsigni\ufb01cantly higher in PHiD-CV than in 7vCRM recipients for\nantibodies against serotypes 18C and 19F, and lower for serotypes\n14 and 9V, whereas in Poland GMCs were signi\ufb01cantly higher in\nthe PHiD-CV group for serotype 19F and lower for serotypes 4,\n6B, 9V, 14, and 23F (Table, Supplemental Digital Content 4,\nhttp://links.lww.com/INF/A579). In both countries, percentages of\nsubjects with postbooster antibody concentrations \u00020.2 \u0001g/mL\nwere at least 95.3% for each of the 7 common serotypes and within\nthe same range between groups.", "mimetype": "text/plain", "start_char_idx": 27865, "end_char_idx": 29153, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "604d8e78-1d35-4029-ad96-c1997a329b76": {"__data__": {"id_": "604d8e78-1d35-4029-ad96-c1997a329b76", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "28838138-079c-497d-a473-0a155276f25f", "node_type": "1", "metadata": {}, "hash": "a1609eb16bbf9d7aeed06f367c8202fbe28d0cc166b67179c31895591aa5e862", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "acf86d59-341b-4c83-90a4-6eccdf40bb3e", "node_type": "1", "metadata": {}, "hash": "35ade7d00ebb1f21051f85691282280a0835b8ffc6ab644dfb090bbf35fcdecc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In both countries, percentages of\nsubjects with postbooster antibody concentrations \u00020.2 \u0001g/mL\nwere at least 95.3% for each of the 7 common serotypes and within\nthe same range between groups.\nOPA seropositivity rates in the Philippines were at least 92.9%\nand in the same range for all 7 common serotypes except 19F (tended\nto be lower in 7vCRM group), and OPA GMTs were in the same\nrange, except for serotypes 18C and 19F (higher in PHiD-CV group)\nand 6B, 9V, and 23F (higher in 7vCRM group) (Table, Supplemental\nDigital Content 5, http://links.lww.com/INF/A580). In Poland, al-\nthough OPA GMTs were higher in the 7vCRM group for the 7\ncommon serotypes, except serotypes 19F (higher in PHiD-CV group)\nand 18C (within same range), OPA seropositivity rates (at least\n88.3%) were within the same range in both groups (Table, Supple-\nmental Digital Content 5, http://links.lww.com/INF/A580). For each\nof the additional serotypes 1, 5, and 7F, in both PHiD-CV groups, at\nleast 99.2% of subjects had antibody concentrations \u00020.2 \u0001g/mL and\nat least 95.0% had OPA titers \u00028.\nFor cross-reactive serotype 6A, at least 79.2% of subjects\nhad antibody concentrations \u00020.2 \u0001g/mL or OPA titers \u00028 after\nPHiD-CV or 7vCRM booster vaccination in both countries (Tables,\nSupplemental Digital Content 4 and 5, http://links.lww.com/INF/A579\nand http://links.lww.com/INF/A580, respectively). Percentages for\ncross-reactive serotype 19A were lower in 7vCRM than in\nPHiD-CV recipients.", "mimetype": "text/plain", "start_char_idx": 28962, "end_char_idx": 30424, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "acf86d59-341b-4c83-90a4-6eccdf40bb3e": {"__data__": {"id_": "acf86d59-341b-4c83-90a4-6eccdf40bb3e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "604d8e78-1d35-4029-ad96-c1997a329b76", "node_type": "1", "metadata": {}, "hash": "262ab979ce9f332cbd12a52576bb4ca03d584cc37f640054e7ca7ad7ff30b610", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2b7e277f-5418-45e9-8271-789c4e97fd04", "node_type": "1", "metadata": {}, "hash": "95868bdea926d99328ac2ae9226ef8e9007f06e853b8d985b02d92e1f5c41092", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Percentages for\ncross-reactive serotype 19A were lower in 7vCRM than in\nPHiD-CV recipients. Antiprotein D antibody GMCs increased to\n2769.6 EL.U/mL in Poland and 4973.9 EL.U/mL in the Philip-\npines following PHiD-CV booster vaccination, compared with\n91.6 and 124.1 EL.U/mL, respectively, following 7vCRM booster\nvaccination.\nDISCUSSION\nThis study in Filipino and Polish children showed that a\nPHiD-CV booster dose had a safety and reactogenicity pro\ufb01le that\nwas in line with that of a 7vCRM booster dose, when both vaccines\nwere coadministered with DTPw-HBV/Hib and poliovirus vac-\ncines. Also, for the 7 pneumococcal serotypes common to both\nvaccines, the percentages of subjects reaching ELISA and OPA\nthresholds were within the same range after PHiD-CV and 7vCRM\nbooster vaccination.\nWithin the same country, incidences of AEs were in the\nsame range for the PHiD-CV and 7vCRM groups, apart from a\ntrend for a higher incidence of fever in the PHiD-CV group in\ncomparison with the 7vCRM group in Poland. This trend was not\nobserved in the Philippines, where incidences of fever were within\nthe same range or (for overall fever and fever \u000639.0\u00b0C) tended to\nbe lower in PHiD-CV recipients. With DTPw-based vaccines,\nincidences of AEs tend to increase with age at priming and the\nnumber of injections,6 so it is possible that higher reactogenicity in\nPolish children was at least partly associated with the later age for\nprimary vaccination in this group, although it is not clear whether\nthis effect persists with the booster dose.\nRobust increases in ELISA antibody concentrations and\nOPA titers after booster vaccination for all pneumococcal vaccine\nserotype-speci\ufb01c antibodies and protein D indicate effective prim-\ning of the immune system.", "mimetype": "text/plain", "start_char_idx": 30333, "end_char_idx": 32077, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2b7e277f-5418-45e9-8271-789c4e97fd04": {"__data__": {"id_": "2b7e277f-5418-45e9-8271-789c4e97fd04", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "acf86d59-341b-4c83-90a4-6eccdf40bb3e", "node_type": "1", "metadata": {}, "hash": "35ade7d00ebb1f21051f85691282280a0835b8ffc6ab644dfb090bbf35fcdecc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0199d9f7-b86c-4092-8654-79e13f9e3c79", "node_type": "1", "metadata": {}, "hash": "90ed1de1758d22ffa6708af1b3a6e9415ca00330db49434d6136435931d79ff6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Robust increases in ELISA antibody concentrations and\nOPA titers after booster vaccination for all pneumococcal vaccine\nserotype-speci\ufb01c antibodies and protein D indicate effective prim-\ning of the immune system. Moreover, for the 7 serotypes common\nto PHiD-CV and 7vCRM, the proportions of children reaching the\n22F-ELISA threshold or OPA cut-off were high after booster\nvaccination with both vaccines. As found after primary vaccina-\ntion,1 generally higher immune responses were observed in the\nPhilippines compared with the Polish groups, and antibody GMCs\nand OPA GMTs in the Philippines were higher than in previous\nEuropean PHiD-CV booster studies.7\u20139 We reported previously\nthat this could not be accounted for by differences in Bacillus\nCalmette-Gue\u00b4rin vaccine administration at birth,1 and this was\ncon\ufb01rmed on the basis of the postbooster results (data not shown).\nIn Poland, ELISA GMCs and OPA GMTs for the 7 pneumo-\ncoccal serotypes in common were usually lower in the PHiD-CV\nTABLE 1.\nIncidences of Solicited Local (Any Injection Site) and General Adverse Events (% \u000295% CI\u0003) Within 4\nDays (Days 0\u20133) After Booster Vaccination (Total Vaccinated Cohort)\nSymptom\nIntensity*\nPhilippines\nPoland\nPHiD-CV\n(N \u0005 280)\n7vCRM\n(N \u0005 93)\nPHiD-CV\n(N \u0005 278)\n7vCRM\n(N \u0005 96)\nPain\nAny\n72.5 (66.9\u201377.6)\n71.0 (60.6\u201379.9)\n89.2 (85.0\u201392.6)\n80.2 (70.8\u201387.6)\nGrade 3\n14.3 (10.4\u201318.9)\n21.5 (13.7\u201331.2)\n42.1 (36.2\u201348.1)\n40.6 (30.7\u201351.1)\nRedness\nAny\n38.2 (32.5\u201344.2)\n39.8 (29.8\u201350.5)\n70.9 (65.1\u201376.1)\n68.8 (58.5\u201377.", "mimetype": "text/plain", "start_char_idx": 31865, "end_char_idx": 33367, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0199d9f7-b86c-4092-8654-79e13f9e3c79": {"__data__": {"id_": "0199d9f7-b86c-4092-8654-79e13f9e3c79", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2b7e277f-5418-45e9-8271-789c4e97fd04", "node_type": "1", "metadata": {}, "hash": "95868bdea926d99328ac2ae9226ef8e9007f06e853b8d985b02d92e1f5c41092", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "977c0a86-9759-4dc4-8924-409bb946e467", "node_type": "1", "metadata": {}, "hash": "2937ba0c8603c48ea2c2b44ae7179bdbdb4863383f7edd5d723eccd409a5ce90", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2 (32.5\u201344.2)\n39.8 (29.8\u201350.5)\n70.9 (65.1\u201376.1)\n68.8 (58.5\u201377.8)\n\u000630 mm\n2.9 (1.2\u20135.6)\n3.2 (0.7\u20139.1)\n12.6 (8.9\u201317.1)\n11.5 (5.9\u201319.6)\nSwelling\nAny\n32.9 (27.4\u201338.7)\n34.4 (24.9\u201345.0)\n56.8 (50.8\u201362.7)\n54.2 (43.7\u201364.4)\n\u000630 mm\n7.5 (4.7\u201311.2)\n9.7 (4.5\u201317.6)\n12.2 (8.6\u201316.7)\n8.3 (3.7\u201315.8)\nIrritability\nAny\n61.8 (55.8\u201367.5)\n68.8 (58.4\u201378.0)\n87.4 (82.9\u201391.1)\n82.3 (73.2\u201389.3)\nGrade 3\n4.3 (2.2\u20137.4)\n3.2 (0.7\u20139.1)\n14.4 (10.5\u201319.1)\n5.2 (1.7\u201311.7)\nDrowsiness\nAny\n32.1 (26.7\u201338.0)\n34.4 (24.9\u201345.0)\n68.3 (62.5\u201373.8)\n68.8 (58.5\u201377.8)\nGrade 3\n1.8 (0.6\u20134.1)\n1.1 (0.0\u20135.8)\n2.5 (1.0\u20135.1)\n2.1 (0.3\u20137.3)\nLoss of appetite\nAny\n34.6 (29.1\u201340.5)\n30.1 (21.0\u201340.5)\n66.2 (60.3\u201371.7)\n59.4 (48.9\u201369.3)\nGrade 3\n2.9 (1.2\u20135.6)\n1.1 (0.0\u20135.8)\n4.7 (2.5\u20137.9)\n1.", "mimetype": "text/plain", "start_char_idx": 33305, "end_char_idx": 34027, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "977c0a86-9759-4dc4-8924-409bb946e467": {"__data__": {"id_": "977c0a86-9759-4dc4-8924-409bb946e467", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0199d9f7-b86c-4092-8654-79e13f9e3c79", "node_type": "1", "metadata": {}, "hash": "90ed1de1758d22ffa6708af1b3a6e9415ca00330db49434d6136435931d79ff6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7d2d8d2d-797c-4228-ae74-2dd9f47378f5", "node_type": "1", "metadata": {}, "hash": "ecbe301dcadd63244a1c242fffb534cb7c12da7b0cd453e23aa8461d7c6051f6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "9\u201369.3)\nGrade 3\n2.9 (1.2\u20135.6)\n1.1 (0.0\u20135.8)\n4.7 (2.5\u20137.9)\n1.0 (0.0\u20135.7)\nFever (rectal temperature)\n\u000238.0\u00b0C\n49.3 (43.3\u201355.3)\n54.8 (44.2\u201365.2)\n77.3 (72.0\u201382.1)\n67.7 (57.4\u201376.9)\n\u000638.5\u00b0C\n19.3 (14.8\u201324.4)\n20.4 (12.8\u201330.1)\n46.0 (40.1\u201352.1)\n36.5 (26.9\u201346.9)\n\u000639.0\u00b0C\n4.3 (2.2\u20137.4)\n8.6 (3.8\u201316.2)\n18.7 (14.3\u201323.8)\n12.5 (6.6\u201320.8)\n\u000639.5\u00b0C\n1.1 (0.2\u20133.1)\n3.2 (0.7\u20139.1)\n7.6 (4.7\u201311.3)\n3.1 (0.6\u20138.9)\n\u000640.0\u00b0C\n0.0 (0.0\u20131.3)\n0.0 (0.0\u20133.9)\n0.4 (0.0\u20132.0)\n0.0 (0.0\u20133.8)\n*Adverse event of grade 3 intensity: pain, crying when limb was moved or limb was spontaneously painful; irritability, crying that could not be comforted/prevented normal\neveryday activity; drowsiness, prevented normal everyday activity; loss of appetite, child did not eat at all.\nN indicates number of subjects with documented dose; PHiD-CV, protein D conjugate vaccine; 7vCRM, 7-valent pneumococcal conjugate vaccine.", "mimetype": "text/plain", "start_char_idx": 33967, "end_char_idx": 34837, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7d2d8d2d-797c-4228-ae74-2dd9f47378f5": {"__data__": {"id_": "7d2d8d2d-797c-4228-ae74-2dd9f47378f5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "977c0a86-9759-4dc4-8924-409bb946e467", "node_type": "1", "metadata": {}, "hash": "2937ba0c8603c48ea2c2b44ae7179bdbdb4863383f7edd5d723eccd409a5ce90", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bdea3ea8-1b26-40bc-bb57-0950cbe040ee", "node_type": "1", "metadata": {}, "hash": "f6e93eebfb36dd14b7237807782487f081a3906a9aaf495c524266ba879cffc5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "loss of appetite, child did not eat at all.\nN indicates number of subjects with documented dose; PHiD-CV, protein D conjugate vaccine; 7vCRM, 7-valent pneumococcal conjugate vaccine.\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\nPHiD-CV Coadministered With DTPw-HBV/Hib\n\u00a9 2010 Lippincott Williams & Wilkins\nwww.pidj.com\n| 71\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\ngroup than in the 7vCRM group. In contrast, in the Philippines,\nimmune responses in the PHiD-CV group were within the same range\nfor most of the 7 serotypes and higher for serotypes 18C and 19F,\nwhich was consistent with the primary study results.1\nIn conclusion, the safety and reactogenicity pro\ufb01les of\nPHiD-CV and 7vCRM were comparable when used for booster\nvaccination coadministered with DTPw-HBV/Hib and poliovirus\nvaccines in the second year of life. Robust immune responses for\nall 10 vaccine pneumococcal serotypes and NTHi protein D\nfollowing PHiD-CV booster vaccination in both the Philippines\nand Poland are indicative of effective priming with the 2 different\nprimary vaccination schedules and therefore lend further support\nto the protective effect of PHiD-CV against vaccine serotype\npneumococcal infections.\nACKNOWLEDGMENTS\nThe authors thank the parents and their children who\nparticipated in this study; the investigators, study nurses, and\nother staff members for their contributions to the study; the\nclinical and serologic laboratory teams of GlaxoSmithKline Bio-\nlogicals, in particular Dr.", "mimetype": "text/plain", "start_char_idx": 34655, "end_char_idx": 36294, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bdea3ea8-1b26-40bc-bb57-0950cbe040ee": {"__data__": {"id_": "bdea3ea8-1b26-40bc-bb57-0950cbe040ee", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7d2d8d2d-797c-4228-ae74-2dd9f47378f5", "node_type": "1", "metadata": {}, "hash": "ecbe301dcadd63244a1c242fffb534cb7c12da7b0cd453e23aa8461d7c6051f6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6cf68996-d2f4-4cc4-9754-f865df09a6e5", "node_type": "1", "metadata": {}, "hash": "5d4fb3661e8119fcc5840715ee2c3ba8d54da54b5cfcc75c50ff805430045a95", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Mireille Venken for writing the protocol\nand study report and Stefanie Deckers for study coordination; Dr.\nJoanne Knowles (freelance, United Kingdom) for drafting the\nmanuscript, Dr. Avishek Pal (GSK Biologicals, CDOC-B, Banga-\nlore, India) for assistance with \ufb01gures, and Dr. Natalie Denef\n(XPE Pharma c/o GSK Biologicals) for manuscript coordination.\nREFERENCES\n1. Bermal N, Szenborn L, Chrobot A, et al. The 10-valent pneumococcal non-\ntypeable Haemophilus in\ufb02uenzae protein D conjugate vaccine (PHiD-CV) co-\nadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of\nimmunogenicity. Pediatr Infect Dis J. 2009;28(suppl):S89\u2013S96.\n2. Chevallier B, Vesikari T, Brzostek J, et al. Safety and reactogenicity of the\n10-valent pneumococcal non-typeable Haemophilus in\ufb02uenzae protein D\nconjugate vaccine (PHiD-CV) when coadministered with routine childhood\nvaccines. Pediatr Infect Dis J. 2009;28(suppl):S109\u2013S118.\n3. Prymula R, Plisek S. Clinical experience with DTPw-HBV and DTPw-HBV/\nHib combination vaccines. Expert Opin Biol Ther. 2008;8:503\u2013513.\n4. Phillips KF. A new test of non-inferiority for anti-infective trials. Stat Med.\n2003;22:201\u2013212.\n5. Knuf M, Szenborn L, Moro M, et al. Immunogenicity of routinely used\nchildhood vaccines when coadministered with the 10-valent pneumococcal\nnon-typeable Haemophilus in\ufb02uenzae protein D conjugate vaccine (PHiD-CV).\nPediatr Infect Dis J. 2009;28(suppl):S97\u2013S108.\n6. World Health Organization.", "mimetype": "text/plain", "start_char_idx": 36295, "end_char_idx": 37746, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6cf68996-d2f4-4cc4-9754-f865df09a6e5": {"__data__": {"id_": "6cf68996-d2f4-4cc4-9754-f865df09a6e5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bdea3ea8-1b26-40bc-bb57-0950cbe040ee", "node_type": "1", "metadata": {}, "hash": "f6e93eebfb36dd14b7237807782487f081a3906a9aaf495c524266ba879cffc5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "253fb3e3-f169-47e6-a7cc-3869f515e06a", "node_type": "1", "metadata": {}, "hash": "18706c90fb6d7b70739e1a17c069c6ce860e458c632a83acdf9a471824f07ff9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Pediatr Infect Dis J. 2009;28(suppl):S97\u2013S108.\n6. World Health Organization. Pertussis vaccines WHO position paper. Wkly\nEpidemiol Rec. 2005;80:31\u201339.\n7. Vesikari T, Wysocki J, Chevallier B, et al. Immunogenicity of the 10-valent\npneumococcal non-typeable Haemophilus in\ufb02uenzae protein D conjugate\nvaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Pediatr Infect\nDis J. 2009;28(suppl):S66\u2013S76.\n8. Wysocki J, Tejedor JC, Grunert D, et al. Immunogenicity of the 10-valent\npneumococcal non-typeable Haemophilus in\ufb02uenzae protein D conjugate\nvaccine (PHiD-CV) when coadministered with different Neisseria meningi-\ntidis serogroup C conjugate vaccines. Pediatr Infect Dis J. 2009;28(suppl):\nS77\u2013S88.\n9. Vesikari T, Karvonen A, Lindblad N, et al. Safety and immunogenicity of a\nbooster dose of the 10-valent pneumococcal NTHi protein D conjugate\nvaccine coadministered with measles-mumps-rubella-varicella vaccine in\nchildren aged 12 to 16 months. Pediatr Infect Dis J. 2010;29:e47\u2013e56.\nLATE PREGNANCY SCREENING FOR HUMAN\nIMMUNODEFICIENCY VIRUS\nRussell W. Steele, MD\nAbstract: Three cases are presented of infants born to mothers who were\nscreened and tested negative for HIV during their \ufb01rst trimesters. None of\nthese pregnant women were retested late in their pregnancies, as they were\nnot considered at high risk for HIV infection. All were found to be infected\nshortly after giving birth. Of the 3 infants, 2 developed HIV infection.\nThese cases support a recommendation for late pregnancy HIV screening\nof all women.", "mimetype": "text/plain", "start_char_idx": 37670, "end_char_idx": 39194, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "253fb3e3-f169-47e6-a7cc-3869f515e06a": {"__data__": {"id_": "253fb3e3-f169-47e6-a7cc-3869f515e06a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6cf68996-d2f4-4cc4-9754-f865df09a6e5", "node_type": "1", "metadata": {}, "hash": "5d4fb3661e8119fcc5840715ee2c3ba8d54da54b5cfcc75c50ff805430045a95", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ca4be5ef-909c-47ba-ba91-c4ab01b16b26", "node_type": "1", "metadata": {}, "hash": "b4bd156639643de7c578087ff4d756bd40805262d12e8c2e6a56d81927c6a2ff", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All were found to be infected\nshortly after giving birth. Of the 3 infants, 2 developed HIV infection.\nThese cases support a recommendation for late pregnancy HIV screening\nof all women.\nKey Words: HIV screening, pediatric AIDS, pediatric HIV, HIV\nprevention, pregnancy screening\nAccepted for publication July 8, 2010.\nFrom the Division of Infectious Diseases, Department of Pediatrics, Ochsner\nChildren\u2019s Health Center and, Tulane University School of Medicine, New\nOrleans, LA.\nAddress for Correspondence: Russell W. Steele, MD, Division of Infec-\ntious Diseases, Department of Pediatrics, Ochsner Children\u2019s Health\nCenter and, Tulane University School of Medicine, New Orleans, LA,\n1315 Jefferson Hwy, New Orleans, LA 70121. E-mail: RWSteele@\naol.com.\nDOI: 10.1097/INF.0b013e3181f1e704\nT\nhe Centers for Disease Control and Prevention (CDC) and\nAmerican Academy of Pediatrics (AAP) currently recommend\nroutine HIV-1 testing of all pregnant women. In the current CDC\nguidelines1 it is stated that testing should be performed \u201cas early\nduring pregnancy as possible,\u201d whereas the 2009 Red Book2 does\nnot indicate timing for testing. These 2 sources are used by most\nobstetricians, pediatricians, and primary care physicians who care\nfor pregnant women and their newborn infants. Neither of these\ndocuments clearly recommends repeat testing late in pregnancy\nregardless of maternal risk factors.\nThe CDC subsequently revised their guidelines for HIV\ntesting of pregnant women to recommend that a second screening\nenzyme immunoassay (EIA) for HIV antibody be performed late\nin pregnancy, but \u000136 weeks gestation for women with high-risk\nbehavior and those living in 20 HIV high-incidence states (AL,\nCT, DE, FL, GA, IL, LA, MD, MA, MS, NV, NJ, NY, NC, PA, RI,\nSC, TN, TX, and VA), the District of Columbia, and Puerto Rico.3\nAlso included are those pregnant women who receive their health\ncare in facilities where the incidence of HIV infection is \u00061/1000\nwomen screened.", "mimetype": "text/plain", "start_char_idx": 39008, "end_char_idx": 40976, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ca4be5ef-909c-47ba-ba91-c4ab01b16b26": {"__data__": {"id_": "ca4be5ef-909c-47ba-ba91-c4ab01b16b26", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "253fb3e3-f169-47e6-a7cc-3869f515e06a", "node_type": "1", "metadata": {}, "hash": "18706c90fb6d7b70739e1a17c069c6ce860e458c632a83acdf9a471824f07ff9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "55bdacb0-c668-446a-af57-e53cfd43b712", "node_type": "1", "metadata": {}, "hash": "55937231551efe765b7d074c82c0be9c00290930162b9c2812b841b6fa0af5ae", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The present report describes 3 neonates born to mothers\nwho were tested for HIV early in their pregnancies, did not ful\ufb01ll\nrisk categories for late pregnancy testing according to current\nguidelines, and were reported negative, but who acquired infection\nlater in their pregnancies. All 3 mothers lived in New Orleans, LA,\nand delivered at private hospitals in the city. Two of their children\nwere subsequently diagnosed with HIV infection. A recommenda-\ntion for testing both early and late in pregnancy for all pregnant\nwomen is supported by these cases.\nCASE REPORTS\nCase 1. A 4-month-old female infant was admitted from the\nemergency department with respiratory failure requiring intuba-\ntion. She was afebrile and had extensive bilateral pneumonia.\nReview of maternal history documented that the mother was\nscreened for HIV during her \ufb01rst trimester and was negative. She\nhad denied injection drug use. It was not known that she had a new\nconjugal partner during her pregnancy. She did live in Louisiana\nwhich is considered a high-risk state, but was followed up and\ndelivered at a medical facility where the incidence of HIV infec-\ntion is well less than 1/1000 women screened. Late HIV testing\nwas not considered necessary, and so was not performed. The\nmother breast-fed her infant until the time of her infant\u2019s illness\nand hospitalization.\nEvaluation of the infant revealed that she was HIV-positive\nwith a viral load of 130,755 copies/mL. The cause of her pneu-\nSteele\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\n\u00a9 2010 Lippincott Williams & Wilkins\n72\n|\nwww.pidj.com\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\nmonia was cytomegalovirus, documented with a blood PCR.", "mimetype": "text/plain", "start_char_idx": 40977, "end_char_idx": 42815, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "55bdacb0-c668-446a-af57-e53cfd43b712": {"__data__": {"id_": "55bdacb0-c668-446a-af57-e53cfd43b712", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ca4be5ef-909c-47ba-ba91-c4ab01b16b26", "node_type": "1", "metadata": {}, "hash": "b4bd156639643de7c578087ff4d756bd40805262d12e8c2e6a56d81927c6a2ff", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "62d81115-8fd7-4f73-8246-127cf5b85bcc", "node_type": "1", "metadata": {}, "hash": "a6f72432a580f9520d3c2f32a3e67da7595eec8e0859c84835e9740d59865aed", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Her\ncytomegalovirus was treated with ganciclovir and she was started\non HAART therapy with lopinavir/ritonavir, zidovudine, and lami-\nvudine. Her mother was evaluated and shown to be HIV-positive\nwith a viral load of 19,502 copies/mL.\nCase 2. A female infant was delivered to a mother whose prenatal\ncare was given outside of Louisiana in a state considered low risk\nfor HIV infection. The mother recently moved to New Orleans and\nhad established contact with a local obstetrician but had not yet\nbeen seen. She presented to the emergency department in labor\nwith a history that she had been screened for HIV and was\nnegative. This could not be con\ufb01rmed. When screening tests for\nsyphilis, chlamydia, and hepatitis B, surface antigen were all\npositive; an EIA for HIV was performed and was positive. The\nneonate was started on zidovudine therapy on day 3 of life but was\nsubsequently positive for HIV by PCR-DNA at birth and 1 month\nof age and was started on HAART therapy.\nCase 3. A 6-week-old male infant was referred when the child\u2019s\nfather had recently been diagnosed with acute HIV infection,\nmanifest by persistent fever, night sweats, lymphadenopathy, and\na 20-pound weight loss. The infant\u2019s mother had been screened\nearly in her pregnancy, was negative, and was not considered to\nhave any risk factors for HIV disease. When her husband was\ndiagnosed with AIDS, she was tested and was positive. She had\nbeen breast-feeding her infant. HIV-PCR DNA on the infant was\nnegative at the time of referral, at 2 months, and at 4 months of\nage. Follow-up indicates that the infant is not infected.", "mimetype": "text/plain", "start_char_idx": 42816, "end_char_idx": 44412, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "62d81115-8fd7-4f73-8246-127cf5b85bcc": {"__data__": {"id_": "62d81115-8fd7-4f73-8246-127cf5b85bcc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "55bdacb0-c668-446a-af57-e53cfd43b712", "node_type": "1", "metadata": {}, "hash": "55937231551efe765b7d074c82c0be9c00290930162b9c2812b841b6fa0af5ae", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d6fd9591-d93f-451e-b8ab-244b079196dd", "node_type": "1", "metadata": {}, "hash": "9f20701d0113456b1dc294e4c7fc20b5b6edb1f5c7ee9af2a05960753722bafc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "HIV-PCR DNA on the infant was\nnegative at the time of referral, at 2 months, and at 4 months of\nage. Follow-up indicates that the infant is not infected.\nDISCUSSION\nA\nmarked\nreduction\nin\nmother-to-child\ntransmission\n(MTCT) of human immunode\ufb01ciency virus type 1 followed pub-\nlication of the clinical trial of maternal zidovudine treatment\n(protocol 076) in 19944 and recommendations for its routine\napplication published by CDC the same year.5A further decrease in\nvertical transmission is attributed to 2 additional interventions:\navoidance of breast-feeding and cesarean delivery before onset of\nlabor and before rupture of membranes. More recent studies have\nshown that highly active antiretroviral therapy given to HIV-\ninfected mothers can reduce MTCT of HIV to just 1%.6 However,\nthe obvious \ufb01rst step in assuring these preventive interventions is\nidenti\ufb01cation of all HIV-positive mothers.\nA statement published by the Committee on Pediatric AIDS\nin 2008 suggested, but did not clearly recommend, repeat testing in\nthe third trimester or rapid testing at labor and delivery to further\nreduce the rate of perinatal HIV transmission.7 The committee\npointed out that testing late in pregnancy or even after delivery of\nthe newborn infant allowed bene\ufb01cial interventions that have been\nshown to reduce HIV infection in exposed neonates. Even when\nmothers are not identi\ufb01ed as HIV infected until onset of labor,\ntreatment with intravenous zidovudine along with treatment of the\nneonate with oral zidovudine for 6 weeks may reduce the likeli-\nhood of infection in infants by as much as 60%.7,8 This bene\ufb01t\nmay be lower as the original study8 demonstrating reduction used\nan observational cohort format, and there was a wide con\ufb01dence\ninterval because of the low number of HIV infected neonates.\nAn additional factor to consider in making a decision for\nroutine repeat testing of all pregnant women is the high levels of\nviral replication with acute HIV infection that signi\ufb01cantly in-\ncrease the likelihood of vertical transmission for mothers who\nacquire disease during their pregnancies.7\nThe only suggested downside to routine rescreening late in\npregnancy is cost.", "mimetype": "text/plain", "start_char_idx": 44259, "end_char_idx": 46428, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d6fd9591-d93f-451e-b8ab-244b079196dd": {"__data__": {"id_": "d6fd9591-d93f-451e-b8ab-244b079196dd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "62d81115-8fd7-4f73-8246-127cf5b85bcc", "node_type": "1", "metadata": {}, "hash": "a6f72432a580f9520d3c2f32a3e67da7595eec8e0859c84835e9740d59865aed", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fc02603f-e10f-4dbd-9696-b0e58ecf640e", "node_type": "1", "metadata": {}, "hash": "037026ed3abea3f805c463f61e140a9c18805057116ac8049a7a37bd95dcabef", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "However, under most current circumstances, a\nsecond HIV test during the third trimester has been shown to be\ncost-effective when the HIV incidence is 1.0 per 1000 person-years or\nhigher.9 Moreover, studies have shown that rescreening with the rapid\nHIV test in the third trimester of pregnancy is well-accepted by both\nlow and high risk mothers and can direct treatment that is effective in\npreventing perinatal HIV transmission.10\nCurrent management of HIV-infected women identi\ufb01ed late\nin their pregnancies is essentially the same as that for women\ndiagnosed earlier, that is, 3 antiretroviral drugs for prophylaxis\ncontinued to the time of delivery. Intravenous zidovudine is then\nadministered to the pregnant woman at the time of labor and\ncontinued until the cord is clamped, while the other anti-retroviral\ncomponents of the regimen are continued orally during labor. Oral\nzidovudine is then administered to the infant for the \ufb01rst 6 weeks\nof life. For women diagnosed late, particularly if this is not\naccomplished until they are in labor, consideration might be given\nto the administration of nevirapine intrapartum and to the neonate\nto further reduce the likelihood of MTCT.11\nThe present cases support a recommendation for routine\nrescreening of pregnant women late in pregnancy, ie, at 36 to 37\nweeks gestation or at the time of labor and delivery. However,\nunless this becomes an of\ufb01cial recommendation from the Ameri-\ncan Academy of Pediatrics or the Centers for Disease Control and\nPrevention, insurance companies will not reimburse for such\nlaboratory testing. At present, few health insurance policies in-\nclude payment for a second HIV screen. This is our current\nsituation, a major limitation for its routine implementation in most\nhospitals.\nOur case 1 brings up another issue related to routine child\ncare. This infant might have become infected from the mother\u2019s\nbreast milk, if the mother had not acquired her disease until after\nshe delivered. Such a situation suggests that pediatricians should\ninclude a detailed maternal social history during routine visits of\nbreast-fed infants.", "mimetype": "text/plain", "start_char_idx": 46429, "end_char_idx": 48536, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fc02603f-e10f-4dbd-9696-b0e58ecf640e": {"__data__": {"id_": "fc02603f-e10f-4dbd-9696-b0e58ecf640e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d6fd9591-d93f-451e-b8ab-244b079196dd", "node_type": "1", "metadata": {}, "hash": "9f20701d0113456b1dc294e4c7fc20b5b6edb1f5c7ee9af2a05960753722bafc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e3e89a02-7152-4dc1-896a-c5c304982251", "node_type": "1", "metadata": {}, "hash": "575ccf94ea9d23d3ac86783c8cc7bb3421b027b28ca8fbb9674aa19340e92abe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Such a situation suggests that pediatricians should\ninclude a detailed maternal social history during routine visits of\nbreast-fed infants. High-risk maternal behavior or known disease\nin their partners warrants repeat testing of these mothers for HIV\ninfection while they are breast-feeding.\nREFERENCES\n1. CDC. Sexually transmitted diseases treatment guidelines, 2006. Morb\nMortal Wkly Rep. 2006;55(RR-11):14.\n2. American Academy of Pediatrics. Human immunode\ufb01ciency virus infec-\ntion. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009\nReport of the Committee on Infectious Diseases. 28th ed. Elk Grove\nVillage, IL: American Academy of Pediatrics; 2009:396\u2013397.\n3. CDC. Revised recommendations for HIV testing in adults, adolescents, and\npregnant women in health-care settings. Morb Mortal Wkly Rep Recomm\nRep. 2006;55(RR-14):1\u201317.\n4. Connor EM, Sperling RS, Gelber R, et al; Pediatric AIDS Clinical Trials\nGroup Protocol 076 Study Group. Reduction of maternal-infant MTCT of\nhuman immunode\ufb01ciency virus type 1 with zidovudine treatment. N Engl\nJ Med. 1994;331:1173\u20131180.\n5. Centers for Disease Control and Prevention. Recommendations of the US\npublic health service task force on the use of zidovudine to reduce perinatal\nMTCT of human immunode\ufb01ciency virus. Morb Mortal Wkly Rep. 1994;\n43(RR-11):1\u201320.\n6. European Collaborative Study. Mother-to-child MTCT of HIV infection in\nthe era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:\n458\u2013465.\n7. Committee on Pediatric AIDS. HIV testing and prophylaxis to prevent mother-\nto-child MTCT in the United States. Pediatrics. 2008;122:1127\u20131134.\n8. Wade NA, Zielinski MA, Butsashvili M, et al.", "mimetype": "text/plain", "start_char_idx": 48397, "end_char_idx": 50073, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e3e89a02-7152-4dc1-896a-c5c304982251": {"__data__": {"id_": "e3e89a02-7152-4dc1-896a-c5c304982251", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fc02603f-e10f-4dbd-9696-b0e58ecf640e", "node_type": "1", "metadata": {}, "hash": "037026ed3abea3f805c463f61e140a9c18805057116ac8049a7a37bd95dcabef", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f5a6705c-1c6d-44cb-b4e2-d4be07d3860d", "node_type": "1", "metadata": {}, "hash": "79a8146af69478f874367bb92a1bf10513826b19cb8f019fee8c4bb84949159d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Pediatrics. 2008;122:1127\u20131134.\n8. Wade NA, Zielinski MA, Butsashvili M, et al. Decline in perinatal HIV\nMTCT in New York State (1997\u20132000). J Acquir Immune De\ufb01c Syndr.\n2004;36:1075\u20131082.\n9. Sansom SL, Jamieson DJ, Farnham PG, et al. Human immunode\ufb01ciency\nvirus retesting during pregnancy: costs and effectiveness in preventing\nperinatal MTCT. Obstet Gynecol. 2003;102:782\u2013790.\n10. Criniti SM, Aaron E, Levine AB. Using the rapid HIV test to rescreen\nwomen in the third trimester of pregnancy. J Midwifery Womens Health.\n2009;54:492\u2013496.\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\nHIV Screening\n\u00a9 2010 Lippincott Williams & Wilkins\nwww.pidj.com\n| 73\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\n11. Jackson JB, Musoke P, Fleming T, et al. Intrapartum and neonatal single-\ndose nevirapine compared with zidovudine for prevention of mother-to-\nchild MTCT of HIV-1 in Kampala, Uganda: 18-month follow-up of the\nHIVNET 012 randomized trial. Lancet. 2003;362:859\u2013868.", "mimetype": "text/plain", "start_char_idx": 49994, "end_char_idx": 51117, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f5a6705c-1c6d-44cb-b4e2-d4be07d3860d": {"__data__": {"id_": "f5a6705c-1c6d-44cb-b4e2-d4be07d3860d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e3e89a02-7152-4dc1-896a-c5c304982251", "node_type": "1", "metadata": {}, "hash": "575ccf94ea9d23d3ac86783c8cc7bb3421b027b28ca8fbb9674aa19340e92abe", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1ad9e93a-2aaa-46a7-8825-07ab5fc6e2ca", "node_type": "1", "metadata": {}, "hash": "7b8213c7ff5acf8ad17fe358f45097e259e1772453fe6df8f25186e98ac7ad02", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Lancet. 2003;362:859\u2013868.\nNASAL STAPHYLOCOCCUS AUREUS COLONIZATION\nAMONG MOTHERS OF TERM AND LATE PRETERM\nPREVIOUSLY HEALTHY NEONATES WITH\nCOMMUNITY-ACQUIRED STAPHYLOCOCCUS\nAUREUS INFECTIONS\nRe\u00b4gine M. Fortunov, MD, Kristina G. Hulten, PhD,\nCoburn H. Allen, MD, Wendy A. Hammerman, RN,\nLinda B. Lamberth, BS, Edward O. Mason, Jr., PhD,\nand Sheldon L. Kaplan, MD\nAbstract: We enrolled 35 case neonates with community-acquired Staph-\nylococcus aureus infection and their mothers and 19 control mother-\nneonate pairs. We obtained neonatal and maternal anterior nasal cultures,\nand clinical isolates. S. aureus nasal colonization was greater in case than\ncontrol pairs. Neonates were more often infected with their nasal strain\nthan their mother\u2019s nasal strain.\nKey Words: Staphylococcus aureus, community-acquired infections,\ncolonization, infant, mother\nAccepted for publication June 15, 2010.\nFrom the Department of Pediatrics, Baylor College of Medicine and Texas\nChildren\u2019s Hospital, Houston, TX.\nSupported by grant from P\ufb01zer for S. aureus study (to S.L.K.). The project also\nwas supported, in part by a grant, from the Vivian L Smith Foundation.\nRe\u00b4gine M. Fortunov is currently at Neonatology Associates Ltd, Phoenix, AZ.\nAddress for correspondence: Sheldon L. Kaplan, MD, Texas Children\u2019s\nHospital, Suite 1150, 1102 Bates Ave, Houston, TX 77030. E-mail:\nskaplan@bcm.edu.\nSupplemental digital content is available for this article. Direct URL\ncitations appear in the printed text and are provided in the HTML and\nPDF versions of this article on the journal\u2019s Web site (www.pidj.com).", "mimetype": "text/plain", "start_char_idx": 51092, "end_char_idx": 52679, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1ad9e93a-2aaa-46a7-8825-07ab5fc6e2ca": {"__data__": {"id_": "1ad9e93a-2aaa-46a7-8825-07ab5fc6e2ca", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f5a6705c-1c6d-44cb-b4e2-d4be07d3860d", "node_type": "1", "metadata": {}, "hash": "79a8146af69478f874367bb92a1bf10513826b19cb8f019fee8c4bb84949159d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "889fc074-4691-4196-8121-c44da471cf73", "node_type": "1", "metadata": {}, "hash": "7a36c3527efea01d82848710055e23f4d2161127e87d16a38b01aa3f2a0c3616", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Supplemental digital content is available for this article. Direct URL\ncitations appear in the printed text and are provided in the HTML and\nPDF versions of this article on the journal\u2019s Web site (www.pidj.com).\nDOI: 10.1097/INF.0b013e3181fbec1a\nM\nethicillin resistant Staphylococcus aureus (MRSA) infec-\ntions are increasing in previously healthy neonates without\ntraditional risk factors.1,2 At Texas Children\u2019s Hospital (TCH), we\nnoted a peak of community-acquired S. aureus infections at 7 to 12\ndays after delivery in both mothers and neonates, suggesting the\nacquisition of S. aureus from the mother during or after delivery,\nbirth hospital, home, or from family members.\nOur primary hypotheses were (1) previously healthy term\nand late preterm neonates with S. aureus infections and their\nmothers were more likely to have nasal colonization with S. aureus\nthan control subjects and their mothers and (2) the microbiologic\nand molecular characteristics of S. aureus clinical isolates will be\nidentical to those of the S. aureus nasal isolates of the neonates and\ntheir mothers.\nPATIENTS AND METHODS\nThe Baylor College of Medicine Institutional Review Board\napproved this study. From September 2005 to May 2007, after the\nparent\u2019s consent, we enrolled previously healthy neonates with\nsuspected S. aureus infections or fever without localizing source\n(control subjects) and their mother during the \ufb01rst 24 hours of\ntreatment. We enrolled additional mother-neonate pairs when a\npreviously unsuspected S. aureus infection was diagnosed by\nculture within 48 hours of TCH admission. Cases were neonates\nwith a culture-con\ufb01rmed S. aureus infection. Controls included\nneonates initially suspected to have S. aureus infection but subse-\nquently diagnosed with an infection caused by another organism.\nPreviously healthy neonates were 36 weeks gestation or\ngreater at birth and 30 days of age or less at TCH admission as\nde\ufb01ned previously.1,2 After a detailed medical history using a\nstandardized interview instrument, maternal and neonatal anterior\nnasal cultures were obtained.", "mimetype": "text/plain", "start_char_idx": 52468, "end_char_idx": 54544, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "889fc074-4691-4196-8121-c44da471cf73": {"__data__": {"id_": "889fc074-4691-4196-8121-c44da471cf73", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1ad9e93a-2aaa-46a7-8825-07ab5fc6e2ca", "node_type": "1", "metadata": {}, "hash": "7b8213c7ff5acf8ad17fe358f45097e259e1772453fe6df8f25186e98ac7ad02", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "80844067-38f8-49ae-9e5b-2fabec648e4a", "node_type": "1", "metadata": {}, "hash": "0bc8f9d8d2dcc37ed3c3a1cdc2ed3d4ee2458cb4f1ab901e8b92d9c006675150", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Nasal swabs were inoculated onto Columbia agar with 5%\nsheep blood, colistin, and nalidixic acid directly and after the swab\nwas agitated in 100 uL normal saline. One colony with typical S.\naureus morphologic features was subcultured on to a second TSA\nsheep blood agar plate. S. aureus was identi\ufb01ed by the presence of\ncoagulase, using a latex agglutination test (StaphTEX Kit, Hardy\nDiagnostics, Santa Maria, CA). S. aureus strains isolated from\nclinical specimens were collected from the TCH microbiology\nlaboratory. Antibiotic susceptibility was determined by disk diffu-\nsion or broth dilution, using Clinical and Laboratory Standards\nInstitute guidelines.3\nS. aureus pulsed-\ufb01eld gel electrophoresis was performed and\ninterstrain relationships were determined as described previously.4\nBanding patterns (pulsotypes) of the mother\u2019s and the neonate\u2019s\npaired isolates had to be identical to be considered the same.\nStatistical analysis was performed by using Fisher exact test\nor \u00032 for dichotomous variables or Student t test for comparison of\nmeans by using VassarStats: Web Site for Statistical Computa-\ntion.5 Analyses were 2-tailed, and a P value of \u00040.05 was\nconsidered signi\ufb01cant.\nRESULTS\nWe enrolled 60 mother-neonate pairs with suspected neo-\nnatal S. aureus infection and 11 pairs with neonatal fever (control\nsubjects). After \ufb01nal culture results, subjects were classi\ufb01ed as 35\ncase and 19 control mother-neonate pairs. Non S. aureus patho-\ngens were isolated from 8 other infected neonates subsequently\nclassi\ufb01ed as controls. Infections of subjects enrolled after the\nsecond hospital day included bacteremia, empyema, omphalitis,\nsacral abscess, and lacrimal duct in\ufb02ammation (a control subject).\nMore case (25/35 \u000271%\u0003) than control neonates (4/19 \u000221%\u0003)\nhad S. aureus nasal colonization (P \u0001 0.001).", "mimetype": "text/plain", "start_char_idx": 54545, "end_char_idx": 56361, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "80844067-38f8-49ae-9e5b-2fabec648e4a": {"__data__": {"id_": "80844067-38f8-49ae-9e5b-2fabec648e4a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "889fc074-4691-4196-8121-c44da471cf73", "node_type": "1", "metadata": {}, "hash": "7a36c3527efea01d82848710055e23f4d2161127e87d16a38b01aa3f2a0c3616", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f8db0ec0-d6af-48e7-b6ea-72e26ed76e50", "node_type": "1", "metadata": {}, "hash": "6409a00c8f2da25d67c07dca1c773974f48b7837ee1b77f85d36208be1973742", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "More case (25/35 \u000271%\u0003) than control neonates (4/19 \u000221%\u0003)\nhad S. aureus nasal colonization (P \u0001 0.001). More case (12/35\n\u000234%\u0003) than control mothers (1/19 \u00025%\u0003) had S. aureus nasal coloni-\nzation (P \u0005 0.02). However, the proportion of case and control\nmother-neonate pairs with identical nasal colonizing isolate pulso-\ntypes (6/35 \u000217%\u0003 vs. 0/19 \u00020%\u0003) did not differ signi\ufb01cantly.\nIdentical maternal nasal and neonatal clinical isolate pulso-\ntypes were found in 8/34 (24%) case mother-neonate pairs. Iden-\ntical neonatal nasal and neonatal clinical isolate pulsotypes were\nfound in 21/34 (62%) case mother-neonate pairs. Identical mater-\nnal nasal, neonatal nasal, and neonatal clinical isolate pulsotypes\nwere found in 6/35 (17%) of case mother-neonate pairs.\nUSA300 isolates were not found in control mother-neonate\npairs (Table 1). Most MRSA isolates (46/48 \u000296%\u0003) and 5 methicillin-\nsusceptible S. aureus (MSSA) isolates were USA300. Two MRSA\nisolates were USA400 and a unique pulsotype. The other MSSA\nisolates were 2 USA700 pulsotypes, 3 USA400 pulsotypes, and 29\nunique pulsotypes; 2 were related to USA300. In 4 mother-infant\npairs, isolate pulsotypes differed by only 1 or 2 bands (Fig., Supple-\nmental Digital Content 1, http://links.lww.com/INF/A619).\nInfants were born at 27 different hospitals and 1 at home.\nAfter excluding USA300, only 1 large nearby hospital had 2\nneonates, born 1 month apart, affected by the same unique MSSA\npulsotype.", "mimetype": "text/plain", "start_char_idx": 56257, "end_char_idx": 57714, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f8db0ec0-d6af-48e7-b6ea-72e26ed76e50": {"__data__": {"id_": "f8db0ec0-d6af-48e7-b6ea-72e26ed76e50", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "80844067-38f8-49ae-9e5b-2fabec648e4a", "node_type": "1", "metadata": {}, "hash": "0bc8f9d8d2dcc37ed3c3a1cdc2ed3d4ee2458cb4f1ab901e8b92d9c006675150", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1542bc85-5f93-41b9-9d01-800f2b2eb2b6", "node_type": "1", "metadata": {}, "hash": "8250c5c29b6af63aaed9566d0b45984f4e7f0b2de0d41ffb94adced0fa2cacfa", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "After excluding USA300, only 1 large nearby hospital had 2\nneonates, born 1 month apart, affected by the same unique MSSA\npulsotype.\nThe characteristics and medical histories of case and control\nsubjects were not signi\ufb01cantly different except for racial distribu-\ntion and male circumcision (Table, Supplemental Digital Content\nFortunov et al\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\n\u00a9 2010 Lippincott Williams & Wilkins\n74\n|\nwww.pidj.com\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\n2, http://links.lww.com/INF/A618). Case subjects were more often\nwhite and control subjects were more often Hispanic (P \u0005 0.01).\nMale case subjects were more likely to be circumcised than male\ncontrol subjects (P \u0005 0.001).\nA current or past skin or soft-tissue infection history was\npresent more often for case mothers (P \u0005 0.01) and case families\n(P \u0005 0.04) than control mothers or families. All MRSA colonized\nmothers had a maternal or family history of skin or soft-tissue\ninfection, which was signi\ufb01cantly greater than mothers not colonized\nby S. aureus or mothers colonized by MSSA (P \u0005 0.003, P \u0005 0.01,\nrespectively). Mothers colonized with MRSA were more likely to\nhave received antibiotics during or after delivery compared with\nmothers not colonized (P \u0005 0.02, P \u0005 0.04, respectively).\nDISCUSSION\nWe describe the \ufb01rst study to evaluate the association of\nnasal colonization status and other infection risk factors in previ-\nously healthy neonates infected with S. aureus and their mothers\ncompared with control subjects and their mothers.", "mimetype": "text/plain", "start_char_idx": 57582, "end_char_idx": 59276, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1542bc85-5f93-41b9-9d01-800f2b2eb2b6": {"__data__": {"id_": "1542bc85-5f93-41b9-9d01-800f2b2eb2b6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f8db0ec0-d6af-48e7-b6ea-72e26ed76e50", "node_type": "1", "metadata": {}, "hash": "6409a00c8f2da25d67c07dca1c773974f48b7837ee1b77f85d36208be1973742", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e40aee59-19aa-4e0f-b1df-fa3ce391201d", "node_type": "1", "metadata": {}, "hash": "64b7d91b563bf34fef0510ffe857df5bd95115ae14d4357c0cfc10d5fae9b18e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Increasing S.\naureus infections in previously healthy neonates underscores the\nimportance of understanding the source of neonatal S. aureus\nacquisition and infectious risk factors.1,2 We found a signi\ufb01cant\nrelationship between nasal colonization of the mother and neonate\nwith neonatal infection. Nasal colonization was greater in previ-\nously healthy term and late preterm neonates with S. aureus\ninfections and their mothers than in control neonates and mothers.\nHowever, the strain causing the infection in neonates was not\nrecovered from the anterior nares of their mothers 76% of the time.\nOne-third of the case mothers were nasally colonized with\nS. aureus. Two-thirds of these mothers had identical nasal strains\nby pulsotype and antimicrobial susceptibilities to their infected neo-\nnates\u2019 clinical isolate. In some nonidentical cases, strain pulsotypes\ndiffered by only 1 or 2 bands. The minimally different isolates within\none family may re\ufb02ect simultaneous acquisition of similar but non-\nidentical bacteria from a shared environment or genome modi\ufb01cations\nafter transmission between the mother and child.\nMost MRSA isolates were USA300 pulsotypes and most\nMSSA isolates were non-USA300 pulsotypes, consistent with our\nstudies of community infections.1,6 Case neonates and mothers\nwere more likely to carry USA300 nasally than control neonates\nand mothers. In fact, USA300 isolates were not found in any\ncontrol neonates or their mothers.\nPotential infection risk factors identi\ufb01ed by this study in-\nclude ethnicity, circumcision, family and maternal skin, and soft-\ntissue infection history, and maternal antibiotic use. Identi\ufb01cation\nof families with infection history should prompt diligent observa-\ntion of the mother and neonate for infectious symptoms. Case\nfamilies were more often white, and control families were more\noften Hispanic. The case family ethnicity was similar to our previ-\nously reported population.1 The greater circumcision rate in case\nfamilies may re\ufb02ect an entry portal for the organism or the enrolled\nsubjects\u2019 ethnicity. Our prior observational study with a larger sample\nsize did not reveal any association with circumcision.1\nWe only investigated one of many possible sources of\nacquisition.", "mimetype": "text/plain", "start_char_idx": 59277, "end_char_idx": 61511, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e40aee59-19aa-4e0f-b1df-fa3ce391201d": {"__data__": {"id_": "e40aee59-19aa-4e0f-b1df-fa3ce391201d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1542bc85-5f93-41b9-9d01-800f2b2eb2b6", "node_type": "1", "metadata": {}, "hash": "8250c5c29b6af63aaed9566d0b45984f4e7f0b2de0d41ffb94adced0fa2cacfa", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4b23f3cb-0635-4ee0-958e-224c3b0c8111", "node_type": "1", "metadata": {}, "hash": "5e45b2d69fb6943f134f74dfd6130cd55efc359a15e023518eff9aca9bead777", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Our prior observational study with a larger sample\nsize did not reveal any association with circumcision.1\nWe only investigated one of many possible sources of\nacquisition. Other sources could include: (1) the delivery hospital,\nalthough many hospitals were affected in this study, (2) other\nfamily members, (3) simultaneous maternal and infant acquisition\nof the \ufb02ora, or (4) maternal colonization at another site including\nthroat, skin, breast milk, or vaginal \ufb02ora.7\nPrevention of neonatal S. aureus infection is the ultimate goal.\nIf mothers are the primary reservoir, identifying the carriage site and\nmode of transmission is crucial.8 S. aureus colonization of healthy\nneonates within the \ufb01rst 2 weeks of life has correlated with maternal\nS. aureus colonization in some studies,9 but not in others.10\nThe strengths of our study include the assessment for\ninfection risk factors, the evaluation of mothers and neonates, and\ndirect family interviews. Limitations of our study are the retro-\nspective assessment for infection risk factors, assessment for\ncolonization at only 1 site, and fewer enrolled control families than\ncase families related, in part, to the reluctance of some families to\nhave their neonate participate without a suspected S. aureus\ninfection. Our sensitivity for detection of S. aureus nasal coloni-\nzation may not have been optimal, as we did not subculture the\nnasal swabs in broth. However, many investigators use this\nmethod, and all cultures were handled the same way.\nIn conclusion, nasal colonization was more likely in previ-\nously healthy term and late preterm neonates with S. aureus\ninfections and their mothers than in control subjects and their\nmothers. Neonates were more often infected with their own nasal\nstrain than with their mother\u2019s nasal strain. Maternal nasal colo-\nnizing strains are likely not the sole source of neonatal nasal\ncolonization or infection.\nACKNOWLEDGMENTS\nThe authors thank Brittany Hodgson for her assistance with\nisolate analysis.\nREFERENCES\n1. Fortunov RM, Hulten KG, Hammerman WA, et al. Community-acquired\nStaphylococcus aureus infections in term and near-term previously healthy\nneonates. Pediatrics. 2006;118:874\u2013881.\n2.", "mimetype": "text/plain", "start_char_idx": 61339, "end_char_idx": 63533, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4b23f3cb-0635-4ee0-958e-224c3b0c8111": {"__data__": {"id_": "4b23f3cb-0635-4ee0-958e-224c3b0c8111", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e40aee59-19aa-4e0f-b1df-fa3ce391201d", "node_type": "1", "metadata": {}, "hash": "64b7d91b563bf34fef0510ffe857df5bd95115ae14d4357c0cfc10d5fae9b18e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "40c9f61f-3297-40c2-adb4-3f462b526b20", "node_type": "1", "metadata": {}, "hash": "c4a83925789418332e174e3645d23e3899f8bac68243e3424d33ea6c234a2ad9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Community-acquired\nStaphylococcus aureus infections in term and near-term previously healthy\nneonates. Pediatrics. 2006;118:874\u2013881.\n2. Fortunov RM, Hulten KG, Hammerman WA, et al. Evaluation and treat-\nment of community-acquired Staphylococcus aureus infections in term and\nlate-preterm previously healthy neonates. Pediatrics. 2007;120:937\u2013945.\n3. Clinical and Laboratory Standards Institute. Performance standards for\nantimicrobial susceptibility testing: 16th informational supplement M100-\nS16. Wayne, PA: Clinical and Laboratory Standards Institute; 2007.\n4. Hulten KG, Kaplan SL, Gonzalez BE, et al. Three-year surveillance of\ncommunity onset health care-associated Staphylococcus aureus infections\nin children. Pediatr Infect Dis J. 2006;25:349\u2013353.\n5. Lowry R. VassarStats: Web Site for Statistical Computation. Available at:\nhttp://faculty.vassar.edu/lowry/VassarStats.html.\n6. McCaskill ML, Mason EO Jr, Kaplan SL, et al. Increase of the USA300 clone\namong community-acquired methicillin-susceptible Staphylococcus aureus\ncausing invasive infections. Pediatr Infect Dis J. 2007;26:1122\u20131127.\n7. Andrews JL, Fleener DK, Messer SA, et al. Screening for Staphylococcus\naureus carriage in pregnancy: usefulness of novel sampling and culture\nstrategies. Am J Obstet Gynecol. 2009;201:396.e1\u2013e5.\n8. Chen KT, Campbell H, Borrell LN, et al. Predictors and outcomes for pregnant\nwomen with vaginal-rectal carriage of community-associated methicillin-resis-\ntant Staphylococcus aureus. Am J Perinatol. 2007;24:235\u2013240.\nTABLE 1.", "mimetype": "text/plain", "start_char_idx": 63398, "end_char_idx": 64926, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "40c9f61f-3297-40c2-adb4-3f462b526b20": {"__data__": {"id_": "40c9f61f-3297-40c2-adb4-3f462b526b20", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4b23f3cb-0635-4ee0-958e-224c3b0c8111", "node_type": "1", "metadata": {}, "hash": "5e45b2d69fb6943f134f74dfd6130cd55efc359a15e023518eff9aca9bead777", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1843683d-ffa7-4ecf-915f-57a63d0996c8", "node_type": "1", "metadata": {}, "hash": "29b4d9bc7cd0140f88d1fbe383c0ec0e0254674e85f8e6cf2c581c0ef33b53d5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Am J Perinatol. 2007;24:235\u2013240.\nTABLE 1.\nDistribution of Pulsed-field Gel Electrophoresis\nPatterns for Case and Control Mother-infant Pairs\nCase Subjects\nControl Subjects\nClinical\nNeonate\nNasal\nMother\nNasal\nNeonate\nNasal\nMother\nNasal\nUSA300\nMRSA\n22\n16\n6\n\u2014\n\u2014\nMSSA\n2\n1\n2\n\u2014\n\u2014\nOther\nMRSA\n\u2014\n\u2014\n\u2014\n2\n\u2014\nMSSA\n8\n8\n4\n2\n1\nUnknown\nMRSA\n3\n\u2014\n\u2014\n\u2014\n\u2014\n\u2014 indicates no isolates; MRSA, methicillin-resistant Staphylococcus aureus;\nMSSA, methicillin-susceptible S. aureus.\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\nMaternal S. aureus\n\u00a9 2010 Lippincott Williams & Wilkins\nwww.pidj.com\n| 75\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\n9. Huang YC, Chao AS, Chang SD, et al. Association of Staphylococcus\naureus colonization in parturient mothers and their babies. Pediatr Infect\nDis J. 2009;28:742\u2013744.\n10. Gries DM, Zemzars TF, Gibson KA, et al. A pilot study to assess frequency\nof carriage and routes of acquisition of Staphylococcus aureus by healthy\ninfants. Am J Infect Control. 2009;37:598\u2013600.", "mimetype": "text/plain", "start_char_idx": 64885, "end_char_idx": 66024, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1843683d-ffa7-4ecf-915f-57a63d0996c8": {"__data__": {"id_": "1843683d-ffa7-4ecf-915f-57a63d0996c8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "40c9f61f-3297-40c2-adb4-3f462b526b20", "node_type": "1", "metadata": {}, "hash": "c4a83925789418332e174e3645d23e3899f8bac68243e3424d33ea6c234a2ad9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d4d5a6c7-ec07-4605-9ee0-87367d43de7f", "node_type": "1", "metadata": {}, "hash": "f163802400664c6154123016ad584a2db0c0bb758352fb35a885afd6b4af7bf1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "A pilot study to assess frequency\nof carriage and routes of acquisition of Staphylococcus aureus by healthy\ninfants. Am J Infect Control. 2009;37:598\u2013600.\nSTREPTOCOCCUS PNEUMONIAE\nNASOPHARYNGEAL COLONIZATION IN CHILDREN\nIN BRASOV, CENTRAL ROMANIA\nHIGH ANTIBIOTIC RESISTANCE AND COVERAGE BY\nCONJUGATE VACCINES\nOana Falup-Pecurariu, MD,* Laura Bleotu, MD,*\nCristina Zavarache, MD,* Nechama Peled, MSc,\u2020\u2021\nOana Anton, MD,* Michaela Robu, MD,*\nCristian Falup-Pecurariu, MD,* Liliana Rogozea, MD,*\nNurith Porat, MD,\u2021\u00a7 David Greenberg, MD,\u2021\u00a7\nRon Dagan, MD,\u2021\u00a7 and Eugene Leibovitz, MD\u2021\u00a7\nAbstract: We report high colonization rates among 400 healthy infants and\nchildren, and moderate (66%) coverage by PCV7 and PCV10, with a\nsuperior (80%) PCV13 coverage. Most frequent serotypes were 23F, 6B,\n19F, and 14. Resistance to penicillin, ceftriaxone, erythromycin, and\ntrimethoprim/sulfamethoxazole was 83%, 18%, 62%, and 66%, respec-\ntively. 67% isolates were multidrug resistant. Pneumococcal conjugate\nvaccines covered 80% to 93% of multidrug resistant isolates.\nKey Words: Streptococcus pneumoniae, nasopharyngeal colonization,\nchildren, Romania, conjugate vaccines\nAccepted for publication July 20, 2010.\nFrom the *Department of Pediatrics, Children\u2019s Hospital, Faculty of Medicine,\nTransilvania University, Brasov, Romania; \u2020Clinical Microbiology Labora-\ntories, Soroka University Medical Center, Beer-Sheva, Israel; \u2021Faculty of\nHealth Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel;\nand \u00a7Pediatric Infectious Disease Unit, Soroka University Medical Center,\nBeer-Sheva, Israel.", "mimetype": "text/plain", "start_char_idx": 65870, "end_char_idx": 67458, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d4d5a6c7-ec07-4605-9ee0-87367d43de7f": {"__data__": {"id_": "d4d5a6c7-ec07-4605-9ee0-87367d43de7f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1843683d-ffa7-4ecf-915f-57a63d0996c8", "node_type": "1", "metadata": {}, "hash": "29b4d9bc7cd0140f88d1fbe383c0ec0e0254674e85f8e6cf2c581c0ef33b53d5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4454de05-53cf-4e1b-b77e-bb7ade65e93f", "node_type": "1", "metadata": {}, "hash": "1403ad5986f487990f6932c93f6734a856d466635c5679d3b348c50a895dd753", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Supported by an ESPID Grant Award.\nAddress for correspondence: Eugene Leibovitz, MD, Pediatric Infectious\nDisease Unit, Soroka University Medical Center, PO Box 151, Beer-\nSheva 84101, Israel. E-mail: eugenel@bgu.ac.il.\nDOI: 10.1097/INF.0b013e3181f42bb6\nA\ncquisition of resistance of Streptococcus pneumoniae to anti-\nmicrobial agents was sporadically reported in Romania during\nthe last 2 decades. In a multinational study, 41% of the 82 S.\npneumoniae isolates obtained from Romanian children with acute\notitis media (AOM) were intermediately or fully resistant to\npenicillin.1 An additional study, investigating pneumococcal na-\nsopharyngeal (NP) colonization in HIV-negative and HIV-positive\nchildren living in an orphanage in Northeastern Romania, revealed\nhigh multidrug resistant (MDR) rates, high rates of recovery of\nserotypes 19A and 23F, and the presence of unique Romanian S.\npneumoniae clones.2,3\nThe aims of this study was to analyze the antimicrobial\nsusceptibility and serotype distribution of NP S. pneumoniae\nisolated from 4 groups of infants and children (attending DCCs,\ncommunity immunization clinics, emergency room \u0002ER\u0003, and\nsurgery department) in the city of Brasov, Central Romania.\nPATIENTS AND METHODS\nStudy Population. Brasov has a population of \u0007400,000; the\nChildren\u2019s Hospital is the only pediatric hospital in the city. Starting\nApril 1, 2008 and ending January 31, 2009, NP cultures for S.\npneumoniae were performed in: (1) 100 healthy children, 2 to 5 years\nold, attending 6 DCCs in the city. The great majority of children \u00062\nyears of age in Romania attend DCCs while all children \u00012 years stay\nat home until the DCC age.", "mimetype": "text/plain", "start_char_idx": 67459, "end_char_idx": 69114, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4454de05-53cf-4e1b-b77e-bb7ade65e93f": {"__data__": {"id_": "4454de05-53cf-4e1b-b77e-bb7ade65e93f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d4d5a6c7-ec07-4605-9ee0-87367d43de7f", "node_type": "1", "metadata": {}, "hash": "f163802400664c6154123016ad584a2db0c0bb758352fb35a885afd6b4af7bf1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "268d6229-ffc8-47ed-a4be-78d80aefac70", "node_type": "1", "metadata": {}, "hash": "fa820db73d2652264965ffa75adc9443f6082ee3a03113d327667b22bb7260c9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The great majority of children \u00062\nyears of age in Romania attend DCCs while all children \u00012 years stay\nat home until the DCC age. Each DCC was visited only once for\nsamples collection; (2) 100 consecutive healthy children \u00015 years old\nvisiting the clinics of 5 community pediatricians for completion of\nimmunizations; (3) 100 consecutive healthy children \u00015 years old\nexamined at ER with trauma or noninfectious diseases; (4) 100\nconsecutive healthy children \u00015 years old hospitalized for elective\nsurgical procedures. The research protocol was approved by the\nEthics Committee of the hospital.\nLaboratory Procedures (Sampling and Identi\ufb01cation). The NP\nspecimens were collected by swabs in MW173Amies transport\nmedium (Transwab; Medical Wire and Equipment) and cultured at\nthe Microbiology Laboratories of the hospital within 24 hours as\npreviously described.4 The identi\ufb01ed organisms were subcultured\nand stored at \u000470\u00b0C. The stored organisms were further trans-\nported by air to Israel for organism con\ufb01rmation, determination of\nantimicrobial susceptibility and serotyping. All 52 serotype 23F\nisolates were also analyzed by disk susceptibility to cipro\ufb02oxacin,\no\ufb02oxacin, levo\ufb02oxacin, and moxi\ufb02oxacin.\nRESULTS\nOverall, 400 infants and young children \u00015 years old were\nenrolled, 100 at each of the 4 sampling centers. Mean age was\n31.4 \b 19 months; the youngest patients were those visiting the\nimmunization clinics (mean age: 9.4 \b 8.2 months) and the oldest\nthose attending DCCs (42.5 \b 13.2 months). One hundred sixty-\ntwo (40.5%) were \u00012 years old. Sixty (15%) children received\nantibiotics during the 48 hours preceding enrollment and 97 (24%)\nduring the previous month. Data on the speci\ufb01c antibiotics re-\nceived were available in 82/97(85%) patients.", "mimetype": "text/plain", "start_char_idx": 68985, "end_char_idx": 70744, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "268d6229-ffc8-47ed-a4be-78d80aefac70": {"__data__": {"id_": "268d6229-ffc8-47ed-a4be-78d80aefac70", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4454de05-53cf-4e1b-b77e-bb7ade65e93f", "node_type": "1", "metadata": {}, "hash": "1403ad5986f487990f6932c93f6734a856d466635c5679d3b348c50a895dd753", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "82294b88-ec20-4e27-a2b0-b0700debd9e9", "node_type": "1", "metadata": {}, "hash": "b7d1cc4a463913eba243fe7a695a2d3f77799858bc6e0ff3c420ac24a314b005", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Data on the speci\ufb01c antibiotics re-\nceived were available in 82/97(85%) patients. The most commonly\nused antibiotics were amoxicillin (20/82 patients, 24%), amoxicil-\nlin/clavulanate (19, 23%), and clarithromycin (13, 16%).\nTotal S. pneumoniae colonization rate was 51% (205/400\npatients) (Table 1). The highest colonization rates were recorded in\nDCCs (71%) and the lowest at ER (34%), P \u0001 0.001. The\ncolonization rates among children \u000112 months and 13 to 24\nmonths were 59% and 73%, respectively (P \u0005 0.1). Of the 92\npatients who received antibiotics during the previous month, 53\n(58%) had positive NP cultures. The most frequently isolated\nserotypes among these patients were 23F (20 isolates, 38%), 19F\n(6, 11%), 6B (6, 11%), and 14 (3, 6%); 12/53 (23%) and 37/53\n(70%) were susceptible to penicillin and ceftriaxone, respectively;\n34 (64%) isolates were MDR.\nTwenty-four serotypes were identi\ufb01ed; the most frequently\nisolated were 23F, 6B, 19F, and 14 (25%, 15%, 13%, and 10%,\nrespectively, of all isolates). The PCV7-associated serotypes 6A\nand 19A represented 8% and 5%, respectively, of all isolates; 9/11\n(82%) of serotype 19A isolates were recovered at the DCC. The\ndistribution of the other main serotypes was similar between the 4\nsampling centers and between the patient age groups. Serotypes\n11A (6 isolates, 3% of all isolates) and 15 B/C (4, 2%) were the\nmost commonly isolated nonvaccine serotypes.\nThe serotypes included in PCV7 represented 66% (135/\n205) of all isolates.", "mimetype": "text/plain", "start_char_idx": 70663, "end_char_idx": 72154, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "82294b88-ec20-4e27-a2b0-b0700debd9e9": {"__data__": {"id_": "82294b88-ec20-4e27-a2b0-b0700debd9e9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "268d6229-ffc8-47ed-a4be-78d80aefac70", "node_type": "1", "metadata": {}, "hash": "fa820db73d2652264965ffa75adc9443f6082ee3a03113d327667b22bb7260c9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bc50da0b-b4e2-4f88-8639-45d2d503893c", "node_type": "1", "metadata": {}, "hash": "265447964ad170863f87a32ece7214193f92d8047a9654b2a98d5afaf96e1c3e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The serotypes included in PCV7 represented 66% (135/\n205) of all isolates. By including the closely related serotype 6A\n(8% of all isolates), PCV7 and PCV10 each covered 74% of all\nisolates; 164/205 (80%) of the isolates were included in the\nPCV13, with no differences between the isolates recovered at\neach of the sampling centers.\nEighty-three percent and 18% of all isolates were nonsuscep-\ntible to penicillin and ceftriaxone, respectively; 40.5% and 16% of all\nisolates were highly-resistant to penicillin and ceftriaxone. The non-\nsusceptibility percentages among the S. pneumoniae isolates were\nsimilar among the isolates recovered at each of the 4 sampling centers.\nFalup-Pecurariu et al\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\n\u00a9 2010 Lippincott Williams & Wilkins\n76\n|\nwww.pidj.com\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\nResistance to \u00023 antibiotic classes (MDR) was found in\n138/205 (67%) isolates, and resistance for \u00025 antibiotic classes\nwas found in 88/205 (43%) isolates. PCV7 and PCV10 covered\n110/138 (80%) of MDR isolates. When the closely related serotype\n6A was added, 123/138 (89%) of the MDR isolates were covered\nby PCV7 and PCV10. Ninety-three percent (129/138) of MDR\nisolates were covered by PCV13.", "mimetype": "text/plain", "start_char_idx": 72080, "end_char_idx": 73473, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bc50da0b-b4e2-4f88-8639-45d2d503893c": {"__data__": {"id_": "bc50da0b-b4e2-4f88-8639-45d2d503893c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "82294b88-ec20-4e27-a2b0-b0700debd9e9", "node_type": "1", "metadata": {}, "hash": "b7d1cc4a463913eba243fe7a695a2d3f77799858bc6e0ff3c420ac24a314b005", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1c187eb2-7341-4875-b47c-1ade48bd7ebf", "node_type": "1", "metadata": {}, "hash": "1d757ad8ae6ce54139978faa13e7c629efadf1dbeebccf79e50aae542483bf2c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Ninety-three percent (129/138) of MDR\nisolates were covered by PCV13.\nHigh percentages of nonsusceptibility to penicillin were\nrecorded among serotypes 6A, 6B, 14, 19A, 19F, and 23F (94%,\n94%, 100%, 100%, 92%, and 92%, respectively) (Table 2). High\nresistance to penicillin was recorded in serotypes 6B, 14, 19F, and\n23F (58%, 45%, 62%, and 67% of all isolates, respectively). None\nof the 6A and 19A isolates was highly-resistant to penicillin. High\nresistance to ceftriaxone was found only among serotype 23F\nisolates (33/52, 63%).\nOf the 41 nonvaccine serotype isolated, 23 (56%), 15\n(37%), and 3 (7%) were susceptible, intermediate, and highly\nresistant to penicillin, respectively.\nOf the 52 isolates of serotype 23F-S. pneumoniae, 4 (8%)\nwere susceptible to penicillin. Of the 48 isolates nonsusceptible to\npenicillin, 35 (73%) had penicillin MIC \u00022 \u0001g/mL. Thirty-three\n(63%) were nonsusceptible to ceftriaxone (MIC \u0002 4 \u0001g/mL). All\n52 isolates were susceptible to the 4 quinolones tested. Of the\n23F-S. pneumoniae isolates, 49 (94%) were nonsusceptible to \u00023\nantibiotic classes and 28/52 (54%) to \u00025 antibiotic classes.", "mimetype": "text/plain", "start_char_idx": 73404, "end_char_idx": 74528, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1c187eb2-7341-4875-b47c-1ade48bd7ebf": {"__data__": {"id_": "1c187eb2-7341-4875-b47c-1ade48bd7ebf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bc50da0b-b4e2-4f88-8639-45d2d503893c", "node_type": "1", "metadata": {}, "hash": "265447964ad170863f87a32ece7214193f92d8047a9654b2a98d5afaf96e1c3e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ae8229a3-cae2-4725-8a55-32a8702889a0", "node_type": "1", "metadata": {}, "hash": "2a5533441b3d62b62e4c3d282b4a2d1c142666f2896d8c4fc775579b0db4a8ae", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Of the\n23F-S. pneumoniae isolates, 49 (94%) were nonsusceptible to \u00023\nantibiotic classes and 28/52 (54%) to \u00025 antibiotic classes.\nDISCUSSION\nThe \ufb01ndings reported in this study on the NP colonization with\nS. pneumoniae in healthy children attending DCC, immunizations\nclinics or admitted for elective surgical procedures and sick children\nexamined at the ER are not unexpected, taking into consideration the\nprevious information available from 2 other regions of Romania.1\u20133\nThe colonization rates with S. pneumoniae were age and sampling\ncenter-related, with the highest rates recorded in infants and children\n\u00012 years old and those attending DCCs. The distribution of the\ncolonizing serotypes established the PCV7 serotypes 23F, 6B, 19F,\nand 14, and the vaccine related serotypes 6A and 19A as the leading\nserotypes recovered in the NP of the children enrolled in this area in\nCentral Romania. The present analysis reveals lower PCV7 coverage\nof NP pneumococci isolated in Central Romania compared with that\nreported in pneumococcal diseases in United States, Canada, and\nAustralia (80%\u201390%) or Europe (70%\u201375%).5\u20137 On the other hand,\nour \ufb01ndings were similar to those reported on PCV7 coverage (42%\u2013\n70%) of NP isolates in healthy children from many regions of the\nworld.5,6 The relatively low PCV7 coverage in the patients enrolled in\nthis study could be explained, at least in part, by the older age of the\npatients.5,6 The fact that PCV10 coverage was identical to that of\nPCV7 should not be surprising, since the 3 major invasive disease-\ncausing serotypes (1, 5, and 7F) added in the PCV10 are, in fact,\nrarely detected in NP carriage studies.5,6,8\nThis study revealed extremely high rates of resistance of\nS. pneumoniae NP isolates, similar to those reported in other\nregions of Romania.", "mimetype": "text/plain", "start_char_idx": 74398, "end_char_idx": 76194, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ae8229a3-cae2-4725-8a55-32a8702889a0": {"__data__": {"id_": "ae8229a3-cae2-4725-8a55-32a8702889a0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1c187eb2-7341-4875-b47c-1ade48bd7ebf", "node_type": "1", "metadata": {}, "hash": "1d757ad8ae6ce54139978faa13e7c629efadf1dbeebccf79e50aae542483bf2c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "15e38c69-7725-4ebc-a38a-4877498bfda5", "node_type": "1", "metadata": {}, "hash": "4ebd190dc5992f7348927886f8bc05d417495327e631f86a77b20c5fca5c8456", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Recently, Leibovitz et al9 reported on the\nresistance patterns of S. pneumoniae isolated from patients with\ninvasive diseases, AOM, and conjunctivitis, hospitalized in Iasi,\nNortheastern Romania; 74%, 86%, and 63% of invasive dis-\neases, AOM, and conjunctivitis isolates, respectively, were\nnonsusceptible to penicillin.\nIn this study, 83% and 18% of all isolates were nonsusceptible\nto penicillin and ceftriaxone, respectively; furthermore, 40.5% and\n16%, respectively, of all isolates were highly-resistant to penicillin\nand ceftriaxone. The nonsusceptibility rates to erythromycin, TMP/\nSMX, tetracyclin and clindamycin were also very high (\u000650% of all\nisolates for each antibiotic). Multidrug resistance was highly prevalent\n(67% for \u00023 antibiotic classes and 43% for \u00025 antibiotic classes).\nThe majority of serotypes 6A, 6B, 14, 19A, 19F, and 23F were\nnonsusceptible to penicillin; high resistance to ceftriaxone was found\nonly among serotype 23F isolates. The encouraging \ufb01nding in this\nTABLE 1.", "mimetype": "text/plain", "start_char_idx": 76195, "end_char_idx": 77196, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "15e38c69-7725-4ebc-a38a-4877498bfda5": {"__data__": {"id_": "15e38c69-7725-4ebc-a38a-4877498bfda5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ae8229a3-cae2-4725-8a55-32a8702889a0", "node_type": "1", "metadata": {}, "hash": "2a5533441b3d62b62e4c3d282b4a2d1c142666f2896d8c4fc775579b0db4a8ae", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "705eeea2-dbd3-4556-880b-289de4102112", "node_type": "1", "metadata": {}, "hash": "08f235ada6e11dd651e3a7cc081ffa924597cd2ba9f9a6107fd4fbb5b47da0cd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The encouraging \ufb01nding in this\nTABLE 1.\nColonization Data on Various Age Group Among 400 Infants and Children Enrolled at 4\nSampling Centers\nAge (mo)\nDaycare Center\n(n \u0005 100)\nElective Surgery\n(n \u0005 100)\nImmunization Clinics\n(n \u0005 100)\nEmergency Room\n(n \u0005 100)\nTotal\n(n \u0005 400)\n\u000112\n1/2 (50)*\n9/18 (50)\n53/90 (59)\n7/8 (88)\n70/118 (59)\n13\u201324\n11/11 (100)\n12/17 (71)\n6/7 (86)\n3/9 (33)\n32/44 (73)\n\u000424\n12/13 (92)\n21/35 (60)\n59/97 (61)\n10/17 (59)\n102/162 (63)\n25\u201336\n13/16 (82)\n5/17 (29)\n0/0\n4/18 (22)\n22/51 (43)\n37\u201348\n33/35 (94)\n7/23 (30)\n2/2 (100)\n14/37 (38)\n56/97 (58)\n49\u201360\n13/36 (36)\n5/25 (20)\n1/1\n6/28 (21)\n25/90 (28)\nTotal colonized\n71\u2020\n38\u2020\n62\n34\u2020\n205/400 (51)\n*In parentheses: % colonized of all patients of same age.\n\u2020P \u0001 0.001.\nTABLE 2.\nResistance Patterns to Various Antibiotics According to S. pneumoniae Serotypes\nSerotype\nNo.", "mimetype": "text/plain", "start_char_idx": 77157, "end_char_idx": 77984, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "705eeea2-dbd3-4556-880b-289de4102112": {"__data__": {"id_": "705eeea2-dbd3-4556-880b-289de4102112", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "15e38c69-7725-4ebc-a38a-4877498bfda5", "node_type": "1", "metadata": {}, "hash": "4ebd190dc5992f7348927886f8bc05d417495327e631f86a77b20c5fca5c8456", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "587c1eee-4cf4-4cae-8620-20be695fe7d7", "node_type": "1", "metadata": {}, "hash": "a0b3bccd4d345fb24c3c1d001a3a822f05c4059374c999ccf991b59e60bb9440", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2020P \u0001 0.001.\nTABLE 2.\nResistance Patterns to Various Antibiotics According to S. pneumoniae Serotypes\nSerotype\nNo. Isolates\nPEN\nTMP/SMX\nERY\nCLIN\nTETR\nCHL\nCRO\n6A\n16\n15/16 (94) 0/16*\n13/16 (81)\n15/16 (94)\n15/16 (94)\n15/16 (94)\n0/16\n0/16\n6B\n31\n29/31 (94) 18/31 (58)*\n28/31 (90)\n27/31 (87)\n28/31 (90)\n24/31 (77)\n0/31\n0/31\n11A\n6\n3/6 (50) 0/6*\n2/6 (33)\n0/6\n0/6\n0/6\n0/6\n0/6\n14\n20\n20/20 (100) 9/20 (45)*\n20/20 (100)\n6/20 (30)\n6/20 (30)\n5/20 (25)\n0/20\n0/20\n19A\n11\n11/11 (100) 0/11*\n11/11 (100)\n6/11 (55)\n6/11 (55)\n6/11 (55)\n0/11\n0/11\n19F\n26\n24/26 (92) 16/26 (62)*\n24/26 (92)\n23/29 (79)\n11/26 (42)\n23/26 (88)\n0/26\n0/26\n23F\n52\n48/52 (92) 35/52 (67)*\n46/52 (88)\n41/52 (79)\n41/52 (79)\n12/52 (23)\n0/52\n33/52 (63)\nIn parentheses: % of all isolates.\n*High penicillin resistance (MIC \u0002mtequ\u0003 2.0 &mu;g/mL).\nPEN indicates penicillin; TMP/SMX, trimetoprim/sulfamethoxazole; ERY, erythromycin; CLIN, clindamycin; TETR, tetracycline; CHL, chloramphenicol;\nCR0, ceftriaxone.", "mimetype": "text/plain", "start_char_idx": 77871, "end_char_idx": 78822, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "587c1eee-4cf4-4cae-8620-20be695fe7d7": {"__data__": {"id_": "587c1eee-4cf4-4cae-8620-20be695fe7d7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "705eeea2-dbd3-4556-880b-289de4102112", "node_type": "1", "metadata": {}, "hash": "08f235ada6e11dd651e3a7cc081ffa924597cd2ba9f9a6107fd4fbb5b47da0cd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a3ebd531-2a42-4518-af7c-6b1e69e2f40f", "node_type": "1", "metadata": {}, "hash": "c412f2c87ebc43fb91062e6ee5014f62119c901e6c4577261748b3e0709c2f80", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\nS. pneumoniae Nasopharyngeal Colonization\n\u00a9 2010 Lippincott Williams & Wilkins\nwww.pidj.com\n| 77\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\nstudy was that none of the vaccine-related serotypes 6A and 19A had\nMIC \u00022 \u0001g/mL and that the great majority (80%\u201393%) of the MDR\nisolates belong to serotypes included in the pneumococcal conjugate\nvaccines.\nOf the 52 isolates of 23F-S. pneumoniae, the majority had\nunusually high MIC values to penicillin and ceftriaxone. In a\nrecent study characterizing 9 serotype 23-S. pneumoniae isolates\nfrom Bucharest, these isolates had very high penicillin, cefo-\ntaxime, cefuroxime, cefpodoxime, cefditoren, erythromycin, and\ngentamicin MICs.10 All isolates were nonsusceptible to imipenem\nbut susceptible to levo\ufb02oxacin and vancomycin. MLST-predicted\nserotype was 23F in all but one strain (19F) but 3 strains were 19A\nby Quellung reaction. These Romanian strains presented a new\ncluster in the 595\u2013600 region of PBP2X conferring 98% homol-\nogy with Streptococcus mitis PBP2X. Although genotypic studies\nwere not performed, the data emerging from our study raise the\npossibility of emergence and spread to different areas of Romania\nof similar pneumococcal strains with a breakthrough increase in\nthe magnitude of \u0005-lactam resistance.\nREFERENCES\n1.", "mimetype": "text/plain", "start_char_idx": 78823, "end_char_idx": 80311, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a3ebd531-2a42-4518-af7c-6b1e69e2f40f": {"__data__": {"id_": "a3ebd531-2a42-4518-af7c-6b1e69e2f40f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "587c1eee-4cf4-4cae-8620-20be695fe7d7", "node_type": "1", "metadata": {}, "hash": "a0b3bccd4d345fb24c3c1d001a3a822f05c4059374c999ccf991b59e60bb9440", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f55db0f1-a4c2-4f8f-bd43-4bf8e943dda8", "node_type": "1", "metadata": {}, "hash": "892ca980c468bab593d87d90842dfedf50ffa9224cedc5913c52c18affcd4065", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "REFERENCES\n1. Jacobs MR, Dagan R, Appelbaum PC, et al. Prevalence of antimicrobial-\nresistant pathogens in middle ear \ufb02uid: multinational study of 917 children\nwith acute otitis media. Antimicrob Agents Chemother. 1998;42:589\u2013595.\n2. Leibovitz E, Dragomir C, Sfartz S, et al. Nasopharyngeal carriage of\nmultidrug-resistant Streptococcus pneumoniae in institutionalized HIV-\ninfected and HIV-negative children in northeastern Romania. Intern J Infect\nDis. 1999;3:211\u2013215.\n3. Porat N, Leibovitz E, Dagan R, et al. Molecular typing of Streptococcus\npneumoniae in Northeastern Romania: unique clones of S. pneumoniae\nisolated from children hospitalized for infections and from healthy and\nhuman immunode\ufb01ciency virus-infected children in the community. J In-\nfect Dis. 2000;181:966\u2013974.\n4. Clinical and Laboratory Standards Institute. Performance standards for antimi-\ncrobial susceptibility testing: 18th informational supplement. Document M100-\nS18. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.\n5. Hausdorff WP, Bryant J, Paradiso PR, et al. Which pneumococcal sero-\ngroups cause the most invasive disease: implications for conjugate vaccine\nformulation and use, part I. Clin Infect Dis. 2000;30:100\u2013121.\n6. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences\namong pneumococcal serotypes. Lancet Infect Dis. 2005;5:83\u201393.\n7. Cohen R, Levy C, de La Rocque et al. Impact of pneumococcal conjugate\nvaccine and of reduction of antibiotic use on nasopharyngeal carriage of\nnonsusceptible pneumococci in children with acute otitis media. Pediatr\nInfect Dis J. 2006;25:1001\u20131007.\n8. Shouval DS, Greenberg D, Givon-Lavi N, et al.", "mimetype": "text/plain", "start_char_idx": 80298, "end_char_idx": 81948, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f55db0f1-a4c2-4f8f-bd43-4bf8e943dda8": {"__data__": {"id_": "f55db0f1-a4c2-4f8f-bd43-4bf8e943dda8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a3ebd531-2a42-4518-af7c-6b1e69e2f40f", "node_type": "1", "metadata": {}, "hash": "c412f2c87ebc43fb91062e6ee5014f62119c901e6c4577261748b3e0709c2f80", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3617cea9-fc77-45de-83ff-405fb4a423aa", "node_type": "1", "metadata": {}, "hash": "2131635b0f9eb53276c5f2a297e1c0f46c368e2943760745734ad324edf6b740", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Pediatr\nInfect Dis J. 2006;25:1001\u20131007.\n8. Shouval DS, Greenberg D, Givon-Lavi N, et al. Serotype coverage of\ninvasive and mucosal pneumococcal disease in Israeli children younger\nthan 3 years by various pneumococcal conjugate vaccines. Pediatr Infect\nDis J. 2009;28:277\u2013282.\n9. Leibovitz E, Petraru E, Porat N, et al. Antimicrobial susceptibility, serotype\ndistribution and vaccine coverage of Streptococcus pneumoniae from in-\nvasive and mucosal diseases in children in Northeastern Romania. In: 5th\nWorld Congress of the World Society for Pediatric Infectious Diseases;\nNovember 15\u201318, 2007; Bangkok, Thailand. Abstract 0421.\n10. Soriano F, Ca\ufb01ni F, Aguilar L, et al. Breakthrough in penicillin resistance?\nStreptococcus pneumoniae isolates with penicillin/cefotaxome MICs of 16\nmg/L and their genotypic and geographical relatedness. J Antimicrob\nChemother. 2008;62:1234\u20131240.\nEFFECTIVENESS OF MEASLES VACCINATION FOR\nCONTROL OF EXPOSED CHILDREN\nIrene Barrabeig, MD,* Ariadna Rovira, MD,*\nCristina Rius, PhD,\u2020\u2021 Pilar Mun\u02dcoz, PhD,\u2021\u00a7 Nuria Soldevila, MD,\u2021\u00a7\nJoan Batalla, PhD,\u2021\u00b6 and A`ngela Dom\u00ednguez, PhD\u2021\u00a7\u0001\nAbstract: The effectiveness of measles vaccine for postexposure prophy-\nlaxis at educational centers was investigated. A total of 166 children who\nshared the classroom with 10 con\ufb01rmed cases during the infectious period\nof cases were studied. Of total susceptible exposed children, 72% (54/75)\nwere vaccinated and 25 contracted measles. Vaccine effectiveness in\nchildren vaccinated within 72 hours of exposure was 90.5% (95% con\ufb01-\ndence interval, 34%\u201399%).", "mimetype": "text/plain", "start_char_idx": 81859, "end_char_idx": 83425, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3617cea9-fc77-45de-83ff-405fb4a423aa": {"__data__": {"id_": "3617cea9-fc77-45de-83ff-405fb4a423aa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f55db0f1-a4c2-4f8f-bd43-4bf8e943dda8", "node_type": "1", "metadata": {}, "hash": "892ca980c468bab593d87d90842dfedf50ffa9224cedc5913c52c18affcd4065", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "40c9202d-d320-4148-a2ee-b3ccfac60252", "node_type": "1", "metadata": {}, "hash": "7d790dfe7996fb549beafae399444fe950241610fd100752dd90f2175cbea35e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine effectiveness in\nchildren vaccinated within 72 hours of exposure was 90.5% (95% con\ufb01-\ndence interval, 34%\u201399%).\nKey Words: outbreak, measles, vaccine effectiveness, postexposure\nprophylaxis\nAccepted for publication July 21, 2010.\nFrom the *Epidemiological Surveillance Unit of Costa Ponent, Department of\nHealth, Generalitat of Catalonia, Barcelona, Spain; \u2020Epidemiology Service\nof Public Health Agency of Barcelona, Barcelona, Spain; \u2021CIBER Epide-\nmiolog\u00eda y Salut Pu\u00b4blica (CIBERESP), Barcelona, Spain; \u00a7Department of\nStatistics and Operations Research, University Polite`cnica de Catalunya\n(UPC), Barcelona, Spain; \u00b6Vaccine Service, Department of Health, Gener-\nalitat of Catalonia, Barcelona, Spain; and \u0001Department of Public Health,\nSchool of Medicine, University of Barcelona, Barcelona, Spain.\nSupported partially by CIBER Epidemiolog\u00eda y Salud Pu\u00b4blica (CIBERESP)\nSpain, FEDER and AGAUR (expedient number 2009 SGR 42).\nAddress for correspondence: Irene Barrabeig, MD, Epidemiological Sur-\nveillance Unit of Costa Ponent, Department of Health, Generalitat of\nCatalonia, Av. de la Granvia, 8\u201310, 5th \ufb02oor, 08902 L\u2019Hospitalet de\nLlobregat, Barcelona. E-mail: ibarrabeig@catsalut.cat.\nSupplemental digital content is available for this article. Direct URL\ncitations appear in the printed text and are provided in the HTML and\nPDF versions of this article on the journal\u2019s Web site (www.pidj.com).\nDOI: 10.1097/INF.0b013e3181f7001c\nM\neasles is a highly infectious disease that can cause wide-\nspread outbreaks. The most effective preventive measure\nis vaccination with 2 doses of the trivalent measles, mumps,\nand rubella (MMR) vaccine.", "mimetype": "text/plain", "start_char_idx": 83306, "end_char_idx": 84953, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "40c9202d-d320-4148-a2ee-b3ccfac60252": {"__data__": {"id_": "40c9202d-d320-4148-a2ee-b3ccfac60252", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3617cea9-fc77-45de-83ff-405fb4a423aa", "node_type": "1", "metadata": {}, "hash": "2131635b0f9eb53276c5f2a297e1c0f46c368e2943760745734ad324edf6b740", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2371b6f0-d552-423f-bdab-d6393be3a74c", "node_type": "1", "metadata": {}, "hash": "8cdc959e80173280eb8ab0e65d07048a503aa2b4b94f37f32e2038a3efe5993a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The most effective preventive measure\nis vaccination with 2 doses of the trivalent measles, mumps,\nand rubella (MMR) vaccine. Vaccine uptake of at least 95%\nwith 2 doses of MMR is considered to be necessary to achieve\nelimination.1\nAlthough the objective of disease elimination in the Euro-\npean Region by 2010 was established, 120 outbreaks were reported\nin 2005 to 2008, 17 of which had more than 250 cases, and there\nwere 25 deaths.2\nIf given within 72 hours of exposure to measles, immuni-\nzation is the intervention of choice for the control of measles\noutbreaks in schools and child care centers.1,3 However, the\nstudies on which this recommendation is based are old and dif\ufb01cult\nto replicate.4,5 More recent studies suggest that administering the\nMMR vaccine within 72 hours does not avoid the appearance of\nnew cases.6,7\nIn Catalonia, a region in the northeast of Spain, a measles\noutbreak occurred between August 2006 and June 2007 causing\n381 cases, mainly in infants aged \u000115 months.8 The vaccination\nschedule at that time \ufb01xed the age of administration of 2 doses of\nvaccine at 15 months and 4 years. The objective of this study was\nto determine the vaccine effectiveness (VE) of the MMR vaccine\nas postexposure prophylaxis (PEP) in school children, taking into\naccount different time periods from exposure to vaccination.\nMATERIALS AND METHODS\nWe carried out a retrospective cohort study. The study\npopulation comprised children attending child-care centers and\nschools of the Barcelona-South Health Region (population\n2,853,658 inhabitants) which a con\ufb01rmed case of measles had\nattended during the infectious period.\nA con\ufb01rmed case of measles was a laboratory-con\ufb01rmed\ncase (positive serology for measles immunoglobulin M antibody\nby enzyme-linked immunosorbent assay testing or positive poly-\nmerase chain reaction for measles virus in urine sample) or a case\nthat met the World Health Organization clinical case de\ufb01nition and\nwas epidemiologically linked to a laboratory-con\ufb01rmed case.", "mimetype": "text/plain", "start_char_idx": 84828, "end_char_idx": 86830, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2371b6f0-d552-423f-bdab-d6393be3a74c": {"__data__": {"id_": "2371b6f0-d552-423f-bdab-d6393be3a74c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "40c9202d-d320-4148-a2ee-b3ccfac60252", "node_type": "1", "metadata": {}, "hash": "7d790dfe7996fb549beafae399444fe950241610fd100752dd90f2175cbea35e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e3a2bf53-00de-417f-8573-e19224eeb7ca", "node_type": "1", "metadata": {}, "hash": "04b2cd667ddeb46f14e455bc4b62956ed59681bba33c21f8cbb8f79fe93f7852", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Barrabeig et al\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\n\u00a9 2010 Lippincott Williams & Wilkins\n78\n|\nwww.pidj.com\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\nAn index case was the \ufb01rst case of measles in the classroom;\na contact was a child who had shared the same classroom as the\nindex case for at least 1 day during the infectious period of the\nindex case (4 days before rash onset to 4 days after); a secondary\ncase was a contact with rash onset 7 to 18 days after rash onset in\nthe index case. Candidates for the intervention were susceptible\ncontacts (who had not received either measles-containing vaccine\nor had not suffered measles); intervention time was the period\nbetween rash onset of the index case and the day of vaccination of\nthe susceptible contact.\nCases were investigated by public health staff. Suscepti-\nble contacts were identi\ufb01ed and PEP immunization was offered.\nActive surveillance of centers was performed to detect second-\nary cases.\nA network of public health clinics that maintain written\nimmunizations records provided the immunity status to the re-\ngional public health units (either measles vaccination status or\nhistory of measles disease).\nWe obtained the secondary attack rate (SAR). Taylor series\n95% con\ufb01dence intervals (CIs) were calculated around the relative\nrisk, and then calculated the VE and its 95% CI using the SAR\nbase on the methodology described by Orenstein et al.9 A multi-\nvariate analysis that used unconditional logistic regression was\nconducted. Analyses were performed using SPSS/PCv 18 and\nEpidat.\nRESULTS\nThe contacts of 10 unvaccinated index cases (8 aged 6\u201314\nmonths, and 2 aged 15 months\u20134 years) were included.", "mimetype": "text/plain", "start_char_idx": 86831, "end_char_idx": 88666, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e3a2bf53-00de-417f-8573-e19224eeb7ca": {"__data__": {"id_": "e3a2bf53-00de-417f-8573-e19224eeb7ca", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2371b6f0-d552-423f-bdab-d6393be3a74c", "node_type": "1", "metadata": {}, "hash": "8cdc959e80173280eb8ab0e65d07048a503aa2b4b94f37f32e2038a3efe5993a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2a568958-637c-4e31-aaa7-34ac03d416bd", "node_type": "1", "metadata": {}, "hash": "be5d61eb60358ce37f5a47be4e13b3a87437826001eda75b8f17ce14ac067552", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "RESULTS\nThe contacts of 10 unvaccinated index cases (8 aged 6\u201314\nmonths, and 2 aged 15 months\u20134 years) were included. The\nmedian infectious period in the classroom was 2 days (range, 1\u20134\ndays).\nExposed Contacts. In total, 166 children shared a classroom with\nthe index cases, with a median age of 16.5 months (range, 6\u201347\nmonths). The median class size was 14.5 children (range,\n9\u201339). In all, 90 (54%) children had received 1 dose of MMR\nand 1 (1%) received 2 doses; 75 (45%) had received no dose nor\nhad suffered measles.\nOf the 75 candidates for the intervention, 25 contracted\nmeasles, of which 12 had received the vaccine as PEP. The\nmedian age of candidates was 12.2 months (range, 6\u201343\nmonths).\nVaccine Effectiveness. Fifty-four susceptible contacts were vacci-\nnated (72%). The median intervention time was 5 days (1\u201312 days).\nThe SAR among vaccinated children was 22% (12/54)\ncompared with 62% (13/21) in unvaccinated children (relative risk,\n0.4; 95% CI, 0.2\u20130.6). Among children who received the vaccine\nin \u000472 hours the SAR was 5.9% (1/17), with a VE of 90.5% (95%\nCI, 34%\u201399%) compared with unvaccinated children (P \u0001 0.001).\nAdministration of the vaccine was not effective in children who\nreceived the vaccine within 4 to 5 days of exposure (VE, 54%;\n95% CI, 0%\u201381%), within 6 to 7 days (VE, 42%; 95% CI,\n0%\u201373%) or later (Table 1). Neither age nor gender had any\neffect on the SAR (mentioned in Table, Supplemental Digital\nContent 1, http://links.lww.com/INF/A596).", "mimetype": "text/plain", "start_char_idx": 88549, "end_char_idx": 90029, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2a568958-637c-4e31-aaa7-34ac03d416bd": {"__data__": {"id_": "2a568958-637c-4e31-aaa7-34ac03d416bd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e3a2bf53-00de-417f-8573-e19224eeb7ca", "node_type": "1", "metadata": {}, "hash": "04b2cd667ddeb46f14e455bc4b62956ed59681bba33c21f8cbb8f79fe93f7852", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0253b27b-ae7d-4790-be90-69ece29c8991", "node_type": "1", "metadata": {}, "hash": "58ee502071eae917598c462cab7a423ea64283e0f395cab30dd8acfb4addbd14", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Neither age nor gender had any\neffect on the SAR (mentioned in Table, Supplemental Digital\nContent 1, http://links.lww.com/INF/A596). Multivariate anal-\nysis showed that the only association was with the administration of\nthe measles vaccine within 72 hours (mentioned in Table, Supple-\nmental Digital Content 2, http://links.lww.com/INF/A597).\nDISCUSSION\nThe results of this study show that 1 dose of MMR vaccine\nreduces the risk of measles when administered in the 3 \ufb01rst days\nafter rash onset in the index case, with an effectiveness of 90.5%\n(95% CI, 34%\u201399%), and are consistent with the results of the 2\npreviously-mentioned studies4,5 and of a more recent one.10\nWatson et al studied 4 susceptible members of the same\nfamily; 2 siblings received the vaccine a day after rash onset in the\nindex case (3 days of exposure) and did not contract measles,\nwhereas the 2 who were not vaccinated did contract the disease.4\nIn the second report, Ruuskanen et al5 evaluated the protective role\nof MMR administered during the 14 days after exposure among 5\nschool contacts. However, the time from exposure to vaccination\nwas not detailed. Although the number of people included in these\nstudies is low, in the most recent study by Sheppeard et al, in\nwhich 82 susceptible contacts were vaccinated within 3 days of\nexposure, no secondary cases were identi\ufb01ed and the effectiveness\nof PEP with the MMR was 100%.10\nOther studies found no protection as King et al6 showing\nthat the effectiveness conferred by MMR for PEP was negligible,\nbut they could only administer the vaccine to 15 children, of which\n9 were within 3 days after the onset of index case rash. This study\ncan have an important memory bias because interviews were\ncompleted from 1 to 7 months after occurrence of illness. More-\nover, authors suggest that these children had probably been ex-\nposed for 7 days before being vaccinated.", "mimetype": "text/plain", "start_char_idx": 89896, "end_char_idx": 91788, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0253b27b-ae7d-4790-be90-69ece29c8991": {"__data__": {"id_": "0253b27b-ae7d-4790-be90-69ece29c8991", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2a568958-637c-4e31-aaa7-34ac03d416bd", "node_type": "1", "metadata": {}, "hash": "be5d61eb60358ce37f5a47be4e13b3a87437826001eda75b8f17ce14ac067552", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "002ec97d-7a4e-4803-a963-5f5fdead98bc", "node_type": "1", "metadata": {}, "hash": "60393015e6c4df108874917e6a00375f901224d8a9c0ef9a97be69677d404b5e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "More-\nover, authors suggest that these children had probably been ex-\nposed for 7 days before being vaccinated. Rice et al7 in the United\nKingdom administered MMR to 4 children who had been in close\ncontact during the entire coryzal period of 1 case in a nursery, and\nall 4 children developed measles. The small number of subjects in\nboth studies makes generalization of the results dif\ufb01cult.\nIn our study, the number of children exposed (75) and\nvaccinated (54) was higher than those of other studies6,7 and\nshowed that there were fewer cases in children vaccinated within\n3 days than in unvaccinated children, and that in vaccinated\nchildren from day 4 onwards the point estimation of effectiveness\nwas much lower, with a lower limit of nought.\nFor the implementation of the current recommendation of\nvaccination within 72 hours of exposure, 2 aspects have to be\nconsidered about the nature and timing of exposure. First of all, if\nthe exposure has been continuous, it is not easy to determine when\nexactly it occurred. In \ufb01eld epidemiology, it is established the limit\nof 72 hours from the onset of rash in the index case. Second,\nTABLE 1.\nVaccination Status of Contacts, Secondary Attack Rate (SAR), and Vaccine Effectiveness\n(VE) According to Different Intervention Times in Educational Centers\nVaccination Status\nNo. Contacts\nNo.", "mimetype": "text/plain", "start_char_idx": 91677, "end_char_idx": 93012, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "002ec97d-7a4e-4803-a963-5f5fdead98bc": {"__data__": {"id_": "002ec97d-7a4e-4803-a963-5f5fdead98bc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0253b27b-ae7d-4790-be90-69ece29c8991", "node_type": "1", "metadata": {}, "hash": "58ee502071eae917598c462cab7a423ea64283e0f395cab30dd8acfb4addbd14", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f3d02287-1589-4ed1-8af9-553806f87c92", "node_type": "1", "metadata": {}, "hash": "979b7501aba01a3427dfafea67c645f3dd5cf923142ad06803946bcaaf3dbcf8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Second,\nTABLE 1.\nVaccination Status of Contacts, Secondary Attack Rate (SAR), and Vaccine Effectiveness\n(VE) According to Different Intervention Times in Educational Centers\nVaccination Status\nNo. Contacts\nNo. Secondary Cases\nSAR (%)\nRR (95% CI)\nVE, % (95% CI)\nP\nUnvaccinated\n21\n13\n61.9\n1.0 (reference)\n\u2014\nVaccinated\n54\n12\n22.2\n0.4 (0.2\u20130.6)\n64.1 (34.5\u201380.3)\n\u00010.001\n\u00043 d\n17\n1\n5.9\n0.1 (0.01\u20130.6)\n90.5 (34.5\u201398.6)\n\u00010.001\n4\u20135 d\n14\n4\n28.6\n0.5 (0.2\u20131.1)\n53.8 (0.0\u201381.1)\n0.08\n6\u20137 d\n14\n5\n35.7\n0.6 (0.3\u20131.3)\n42.3 (0.0\u201373.5)\n0.2\n8\u20139 d\n8\n1\n12.5\n0.2 (0.03\u20131.3)\n79.8 (0.0\u201396.9)\n0.06\n10\u201312 d\n1\n1\n100.0\n\u2014\n\u2014\nRR indicates relative risk; CI, confidence interval.\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\nPostexposure Measles Vaccination\n\u00a9 2010 Lippincott Williams & Wilkins\nwww.pidj.com\n| 79\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\ncompliance to the established period of time is dif\ufb01cult outside home.", "mimetype": "text/plain", "start_char_idx": 92803, "end_char_idx": 93855, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f3d02287-1589-4ed1-8af9-553806f87c92": {"__data__": {"id_": "f3d02287-1589-4ed1-8af9-553806f87c92", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "002ec97d-7a4e-4803-a963-5f5fdead98bc", "node_type": "1", "metadata": {}, "hash": "60393015e6c4df108874917e6a00375f901224d8a9c0ef9a97be69677d404b5e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b4ed3a3d-b3b7-4a2e-8f51-30141cb1c82f", "node_type": "1", "metadata": {}, "hash": "34d21bc3b84421a07c88ad2e336932f2b17b2f7c3780587d7710a3153bdb901d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Even in an outbreak situation, when control measures are applied\nwhen a measles case is suspected (normally erythematous macular\nrash onset in a child with fever), and considering that children usually\nhave fever 3 days before rash onset, and so are excluded from the\neducational center, the last exposure when the case is suspected is next\nto 72 hours. So, establishing vaccination of susceptible contacts in the\ncenters cannot be achieved on the same day of the index case\ndiagnosis. In this study, vaccination on the day after clinical suspicion\nwas only achieved in 2 day-care centers (12 children) and only 17 of\nthe 54 susceptible contacts were vaccinated within 72 hours. To carry\nout the intervention within the recommended time (72 hours), it is\nessential that the suspected case is reported urgently (less than 24\nhours after the diagnosis), active surveillance is implemented and a\nclose coordination between physicians and public health practitioners\nis held on.\nOur results indicate that the recommendation of vaccinating\nsusceptible exposed people in the \ufb01rst 72 hours should be contin-\nued. Vaccination of susceptible contacts acts in 2 ways. First, it\nprovides direct immunity to the vaccinated person (avoiding sec-\nondary cases). Second, it increases herd immunity by increasing\nthe proportion of immunized people, making transmission of the\nvirus more dif\ufb01cult (avoiding tertiary and quaternary cases).\nAlthough, unfortunately, herd immunity is no longer\napplicable once direct exposure occurs, the indirect bene\ufb01t of\nmeasles vaccination in the community is clear, because disci-\nplined use of measles vaccine can raise immunity levels above\nthe threshold required to eliminate continued transmission in\nlarge populations.11\nIn conclusion, measles vaccine administered within 72\nhours can be effective in preventing measles in susceptible con-\ntacts. However, given the dif\ufb01culty of carrying out vaccination\nwithin this time, achieving and maintaining high routine vaccina-\ntion coverages from 12 months onwards is the essential strategy to\navoid measles outbreaks.\nACKNOWLEDGMENTS\nThe authors thank the reporting physicians and public\nhealth practitioners of the Epidemiological Surveillance Units, of\nthe Department of Health and Public Health Agency of Barcelona.\nREFERENCES\n1. Gershon AA. Measles virus. In: Mandell GL, Bennett JE, Dolin R, eds.", "mimetype": "text/plain", "start_char_idx": 93856, "end_char_idx": 96224, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b4ed3a3d-b3b7-4a2e-8f51-30141cb1c82f": {"__data__": {"id_": "b4ed3a3d-b3b7-4a2e-8f51-30141cb1c82f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f3d02287-1589-4ed1-8af9-553806f87c92", "node_type": "1", "metadata": {}, "hash": "979b7501aba01a3427dfafea67c645f3dd5cf923142ad06803946bcaaf3dbcf8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dc69620c-13fb-4791-b1b7-754dc8bff01d", "node_type": "1", "metadata": {}, "hash": "d0c92ebd8501d21a4699987d76932fc1228577fe129a220a7065a2edfac6d326", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "REFERENCES\n1. Gershon AA. Measles virus. In: Mandell GL, Bennett JE, Dolin R, eds.\nPrinciples and Practice of Infectious Diseases. 7th ed. Philadelphia:\nElsevier; 2009:2229\u20132236.\n2. Martin R, Eshevoi S, Jankovi D, et al. Progress toward measles elimina-\ntion\u2014European Region, 2005\u20132008. MMWR. 2009;58:142\u2013145.\n3. American Academy of Pediatrics. 2009 Report of the Committee on Infec-\ntious Diseases. 28th ed. Elk grove Village, IL: American Academy of\nPediatrics; 2009.\n4. Watson GI. Protection after exposure to measles by attenuated vaccine\nwithout gamma globulin. Br Med J. 1963;1:860\u2013861.\n5. Ruuskanen O, Salmi TT, Halonen P. Measles vaccination after exposure to\nnatural measles. J Pediatr. 1978;93:43\u201346.\n6. King GE, Markowitz LE, Patriarca PE, et al. Clinical ef\ufb01cacy of measles vaccine\nduring the 1990 measles epidemic. Pediatr Infect Dis J. 1991;10:883\u2013887.\n7. Rice P, Young Y, Cohen B, et al. MMR immunization after contact with\nmeasles virus. Lancet. 2004;363:569\u2013570.\n8. Dom\u00ednguez A, Torner N, Barrabeig I, et al. Large measles outbreak in a community\nwith high vaccination coverage. Clin Infect Dis. 2008;47:1143\u20131149.\n9. Orenstein WA, Bernier RH, Dondero TJ, et al. Field evaluation of vaccine\nef\ufb01cacy. Bull World Health Organ. 1985;63:1055\u20131068.\n10. Sheppeard V, Forssman B, Ferson MJ, et al. The effectiveness of\nprophylaxis for measles contacts in NSW. NSW Public Health Bull.\n2009;20:81\u201385.\n11.", "mimetype": "text/plain", "start_char_idx": 96142, "end_char_idx": 97554, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dc69620c-13fb-4791-b1b7-754dc8bff01d": {"__data__": {"id_": "dc69620c-13fb-4791-b1b7-754dc8bff01d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b4ed3a3d-b3b7-4a2e-8f51-30141cb1c82f", "node_type": "1", "metadata": {}, "hash": "34d21bc3b84421a07c88ad2e336932f2b17b2f7c3780587d7710a3153bdb901d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5347124b-e311-40e1-9214-ef68828ff18b", "node_type": "1", "metadata": {}, "hash": "131f94d81ff200b352f703390615cc1b4fcf993ef5adfe7496509a3184ccbbf4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The effectiveness of\nprophylaxis for measles contacts in NSW. NSW Public Health Bull.\n2009;20:81\u201385.\n11. Fine PE, Mulholland K. Community immunity. In: Plotkin SA, Orenstein\nWA, Of\ufb01t P, eds. Vaccine. 5th ed. Philadelphia: Saunders; 2008:1573\u2013\n1592.\nTHREE CHILDREN WITH PLASTIC BRONCHITIS\nASSOCIATED WITH 2009 H1N1 INFLUENZA VIRUS\nINFECTION\nChikako Terano, MD,* Masaru Miura, MD,*\nRyuji Fukuzawa, MD,\u2020 Yuya Saito, MD,* Hiromi Arai, MD,*\nMari Sasaki, MD,* Daisuke Ariyasu, MD,*\nand Yukihiro Hasegawa, MD*\nAbstract: We report the cases of 3 children with plastic bronchitis\nassociated with 2009 H1N1 in\ufb02uenza virus infection. These 3 children\nshared common clinical and radiologic features: rapid and progressive\nrespiratory distress with whole lung atelectasis on chest radiograph. In\nchildren with severe respiratory symptoms accompanied by H1N1 in\ufb02u-\nenza, plastic bronchitis should be considered.\nKey Words: 2009 H1N1 in\ufb02uenza virus infection, bronchial asthma,\nbronchial cast, bronchoscopy, plastic bronchitis\nAccepted for publication July 9, 2010.\nFrom the Departments of *General Medicine, and \u2020Pathology and Laboratory\nMedicine, Tokyo Metropolitan Children\u2019s Medical Center, Fuchu, Tokyo,\nJapan.\nAddress for correspondence: Ryuji Fukuzawa, MD, Department of Pathol-\nogy and Laboratory Medicine, Tokyo Metropolitan Children\u2019s Medical\nCenter, 2-8-29 Musashidai, Fuchu, Tokyo 183-8561, Japan. E-mail:\nfukuzawa@1998.jukuin.keio.ac.jp.", "mimetype": "text/plain", "start_char_idx": 97450, "end_char_idx": 98885, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5347124b-e311-40e1-9214-ef68828ff18b": {"__data__": {"id_": "5347124b-e311-40e1-9214-ef68828ff18b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dc69620c-13fb-4791-b1b7-754dc8bff01d", "node_type": "1", "metadata": {}, "hash": "d0c92ebd8501d21a4699987d76932fc1228577fe129a220a7065a2edfac6d326", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1d70940f-28ef-4df9-bfb2-31cd50c4870a", "node_type": "1", "metadata": {}, "hash": "1ef9dcafe3b62a4d3123cdc269f24ecf3dbcd46eb8c8c054d6b77388ac1d9f66", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "E-mail:\nfukuzawa@1998.jukuin.keio.ac.jp.\nDOI: 10.1097/INF.0b013e3181f10fff\nT\nhe H1N1 in\ufb02uenza virus emerged in the spring of 2009 and\nspread globally, leading to an epidemic of in\ufb02uenza in Tokyo,\nlast fall. Infection with this virus caused severe disease, requiring\nhospitalization, mainly in children and young adults.1\nPlastic bronchitis is an uncommon condition characterized\nby bronchial casts typically containing \ufb01brin exudates with vary-\ning amounts of in\ufb02ammatory cells in the central airways, which\ninduces acute respiratory failure.2,3 It is most commonly associ-\nated with asthma, cystic \ufb01brosis, and sickle-cell anemia, and can\noccur after surgical operation for congenital heart disease.4,5\nThis report describes 3 cases of plastic bronchitis in children\nwith 2009 H1N1 in\ufb02uenza virus infection, who had severe dyspnea\nand whole lung atelectasis, requiring bronchoscopic removal of\nbronchial casts.\nCASE REPORTS\nCase 1. A previously healthy 2-year-old boy with a 2-day history\nof cough and a 1-day history of fever was transferred to the\nemergency department because of acute respiratory distress on\nSeptember 20, 2009. He had been receiving oseltamivir therapy for\nin\ufb02uenza type A and was already intubated since the oxygen\nsaturation was 70% in room air. In spite of no history of allergy or\nbronchial asthma, wheezing had sometimes occurred when he had\nhad common colds. A chest radiograph showed complete opaci\ufb01-\ncation of the left hemithorax with a mediastinal shift to the left and\nincreased pulmonary markings with hyperin\ufb02ation of the right\nlung. Bronchoscopic examination showed redness of the mucous\nmembranes of the trachea and the left bronchus, with voluminous\nserous discharge, but no obvious casts were detected.", "mimetype": "text/plain", "start_char_idx": 98845, "end_char_idx": 100585, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1d70940f-28ef-4df9-bfb2-31cd50c4870a": {"__data__": {"id_": "1d70940f-28ef-4df9-bfb2-31cd50c4870a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5347124b-e311-40e1-9214-ef68828ff18b", "node_type": "1", "metadata": {}, "hash": "131f94d81ff200b352f703390615cc1b4fcf993ef5adfe7496509a3184ccbbf4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e278cf35-dc45-4baa-a67d-ffdc909a04a0", "node_type": "1", "metadata": {}, "hash": "7da49d89e6131fa34f1c6d024327b3ce77a85308cc10660a75c5b073a1518fa3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Bronchoscopic examination showed redness of the mucous\nmembranes of the trachea and the left bronchus, with voluminous\nserous discharge, but no obvious casts were detected. After re-\npeated attempts at bronchial aspiration, a bronchial cast was\nremoved on the day of admission, his condition improved, and the\nchest radiograph showed marked improvement. Histologically, the\ncast showed \ufb01brinous exudates with a moderate amount of in\ufb02am-\nTerano et al\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\n\u00a9 2010 Lippincott Williams & Wilkins\n80\n|\nwww.pidj.com\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\nmatory cells consisting of 70% neutrophils, 20% macrophages,\nand 10% lymphocytes. He required mechanical ventilation for 11\ndays and received broad-spectrum antibiotics, systemic steroids,\nand a bronchodilator. His symptoms resolved, and he was dis-\ncharged 18 days after admission. He continued to receive bron-\nchodilator therapy.\nCase 2. A 5-year-old boy was hospitalized with a 1-day history of\ncough, wheezing, and fever. The patient became increasingly\ndyspneic despite inhalation of salbutamol and intravenous infusion\nof steroids. He was transferred to our hospital on October 10, 2009,\nabout 10 hours after admission to the previous hospital. Type A\nin\ufb02uenza was diagnosed, and he was treated with oseltamivir. He\nhad been healthy with no history of bronchial asthma, but used to\nwheeze occasionally when he had had common colds.", "mimetype": "text/plain", "start_char_idx": 100413, "end_char_idx": 102005, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e278cf35-dc45-4baa-a67d-ffdc909a04a0": {"__data__": {"id_": "e278cf35-dc45-4baa-a67d-ffdc909a04a0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1d70940f-28ef-4df9-bfb2-31cd50c4870a", "node_type": "1", "metadata": {}, "hash": "1ef9dcafe3b62a4d3123cdc269f24ecf3dbcd46eb8c8c054d6b77388ac1d9f66", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a20cf248-5c4c-4aab-862c-64c86bef9d2e", "node_type": "1", "metadata": {}, "hash": "11adea4da20107a41ab01c567cd97259939743471c9b241f64720173ee3ff1fb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "He\nhad been healthy with no history of bronchial asthma, but used to\nwheeze occasionally when he had had common colds. On physical\nexamination, no breath sounds were audible over the left lung, and\na chest radiograph showed complete opaci\ufb01cation of the left lung,\nwith a mediastinal shift to the left, hyperin\ufb02ation, and increased\npulmonary markings in the right lung (Fig. 1A). He was immedi-\nately intubated in the emergency department and underwent bron-\nchoscopy, which demonstrated total obstruction of the main left\nbronchus by a large cast (Fig. 1C). The anatomy of the upper and\nlower lobes to the segment divisions was preserved. After removal\nof the cast, his respiratory condition improved, and the chest\nradiograph showed marked resolution of abnormalities (Fig. 1B).\nHe required mechanical ventilation for 7 days and received intra-\nvenous \ufb02uids, antibiotics, bronchodilators, steroids, and oseltami-\nvir. The histology of the cast was consistent with the typical\nfeatures of plastic bronchitis: \ufb01brinous exudates with abundant\neosinophilic in\ufb01ltration (Fig. 1D). The cellular content was 95%\neosinophils, 2% neutrophils, 2% macrophages, and 1% lympho-\ncytes. Charcot-Leyden crystals, which are often seen in sputum\nfrom patients with bronchial asthma, were absent. No bacteria\nwere detected on culture. He was discharged without any compli-\ncations 18 days after admission.\nCase 3. A 6-year-old girl presented to a local clinic after 1 day of\nillness with fever, chest pain, and worsening dyspnea. A chest\nradiograph showed extensive pneumomediastinum and subcutane-\nous emphysema. She became increasingly dyspneic while waiting\nin the outpatient clinic and was transferred to our hospital on\nOctober 16, 2009. Physical examination showed diminished breath\nsounds over the left lung on auscultation, and the patient was\ntachypneic, dyspneic, and cyanotic.", "mimetype": "text/plain", "start_char_idx": 101887, "end_char_idx": 103756, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a20cf248-5c4c-4aab-862c-64c86bef9d2e": {"__data__": {"id_": "a20cf248-5c4c-4aab-862c-64c86bef9d2e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e278cf35-dc45-4baa-a67d-ffdc909a04a0", "node_type": "1", "metadata": {}, "hash": "7da49d89e6131fa34f1c6d024327b3ce77a85308cc10660a75c5b073a1518fa3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "34ca1773-5109-4631-81b4-6a21df0d0852", "node_type": "1", "metadata": {}, "hash": "b9b0bd269812ece50ec91c37c5cb43edb126f45eef8a1b906a9ee37d588ddbec", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Physical examination showed diminished breath\nsounds over the left lung on auscultation, and the patient was\ntachypneic, dyspneic, and cyanotic. The rapid nasal swab diagnos-\ntic test showed type A in\ufb02uenza. She was intubated after admis-\nsion, and casts were removed by subsequent aspiration. Bronchos-\ncopy showed reddish, edematous mucous membranes of the\nrespiratory tract. Histopathologic examination of the cast specimen\nrevealed \ufb01brinous exudates with a small amount of in\ufb02ammatory\nin\ufb01ltrates. The cellular components in the cast comprised approx-\nimately 40% neutrophils, 40% eosinophils, 15% macrophages, and\n5% lymphocytes. On admission (3 hours after the previous radio-\ngraphic examination of the chest), chest radiography showed\natelectasis of the left lung, pneumomediastinum, and subcutaneous\nemphysema. The patient required mechanical ventilation for 6\ndays and received intravenous \ufb02uids, antibiotics, bronchodilators,\nsteroids, and oseltamivir. She was discharged 11 days after admis-\nsion. She had been well except for a history of bronchial asthma;\nthe last attack was 1 month before admission. No bacteria were\ndetected on culture of the aspirated specimen.\nThe 2009 H1N1 in\ufb02uenza infection was con\ufb01rmed by\npolymerase-chain-reaction based testing in the all 3 patients.\nDISCUSSION\nTo our knowledge, this is the \ufb01rst report of plastic bronchitis\nin children associated with 2009 H1N1 in\ufb02uenza infection in the\nFIGURE 1. A, Chest radiograph in case 2. A chest radio-\ngraph obtained on admission, showing complete opacifica-\ntion of the left lung with a mediastinal shift to the left, hy-\nperinflation, and increased pulmonary markings in the\nright lung. B, Chest radiograph in case 2. A chest radio-\ngraph obtained after bronchoscopy and removal of the\ncast, showing marked improvement. C, Gross findings in\ncase 2.", "mimetype": "text/plain", "start_char_idx": 103612, "end_char_idx": 105446, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "34ca1773-5109-4631-81b4-6a21df0d0852": {"__data__": {"id_": "34ca1773-5109-4631-81b4-6a21df0d0852", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a20cf248-5c4c-4aab-862c-64c86bef9d2e", "node_type": "1", "metadata": {}, "hash": "11adea4da20107a41ab01c567cd97259939743471c9b241f64720173ee3ff1fb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1c6b9e35-845a-40c7-90aa-a1bdd3fa85bc", "node_type": "1", "metadata": {}, "hash": "6bd5838a2d97d21e8f24f9aa2d91af3946ca35243f65103e18010bf4ef32aba9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "B, Chest radiograph in case 2. A chest radio-\ngraph obtained after bronchoscopy and removal of the\ncast, showing marked improvement. C, Gross findings in\ncase 2. Cast measuring 6.5 \t 4.3 cm, extracted from the\nleft lung, demonstrating preserved anatomy of the upper\nand lower lobe to subsegment divisions. D, Histopatho-\nlogic findings in case 2. Histopathology of the bronchial\ncast reveals a fibrinous exudate with eosinophilic infiltra-\ntion. Inset shows a hyper-power view of eosinophils.\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\nPlastic Bronchitis\n\u00a9 2010 Lippincott Williams & Wilkins\nwww.pidj.com\n| 81\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\nEnglish language literature. Interestingly, these patients had plastic\nbronchitis, irrespective of the presence or absence of the known\nunderlying diseases for plastic bronchitis; only 1 patient had\nbronchial asthma which is known to be an underlying cause for\nplastic bronchitis.5 The other 2 patients had no obvious history of\nasthma or allergy, although they sometimes had wheezing when\nthey had had common colds. We suggest that H1N1 in\ufb02uenza can\nbe associated with plastic bronchitis, irrespective of presence or\nabsence of underlying cardiopulmonary diseases. We also suggest\nthat patients who have a history of wheezing episodes may be at\nhigher risk for plastic bronchitis during the course of infection.\nPatients with wheezing may have similar pathologic conditions in\nthe bronchus to those with asthma that underlie formation of\nbronchial casts.", "mimetype": "text/plain", "start_char_idx": 105285, "end_char_idx": 106956, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1c6b9e35-845a-40c7-90aa-a1bdd3fa85bc": {"__data__": {"id_": "1c6b9e35-845a-40c7-90aa-a1bdd3fa85bc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "34ca1773-5109-4631-81b4-6a21df0d0852", "node_type": "1", "metadata": {}, "hash": "b9b0bd269812ece50ec91c37c5cb43edb126f45eef8a1b906a9ee37d588ddbec", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aaf34641-6822-4462-ad58-2a74e61dbf1e", "node_type": "1", "metadata": {}, "hash": "1a72faea9ca32e37297789c0fdbe266297650112d27194f79fd591bd9b263618", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Patients with wheezing may have similar pathologic conditions in\nthe bronchus to those with asthma that underlie formation of\nbronchial casts. Those pathologic conditions in the central airway\nmight include temperature, humidity, pressure, viscosity, or\namount of \ufb01brin or mucin exudates, degrees of in\ufb02ammation, or\nimmune response.\nWhile 2009 H1N1 in\ufb02uenza infection induces acute respi-\nratory distress syndrome in adults,6 it might induce plastic bron-\nchitis preferentially in children. The question arises as to why there\nhave been no reports concerning plastic bronchitis in patients with\n2009 H1N1 in\ufb02uenza infection. It is speculative that broncho-\nscopic examinations might not have been performed in most\nchildren who had severe respiratory distress, and repeated bron-\nchoscopy may sometimes be required for detection of bronchial\ncasts, as we experienced in case 1.\nThe time from symptom onset to admission was 1 to 2 days\nin our patients. The course is so rapid that anti-in\ufb02uenza virus\nagents may not be effective for the treatment of plastic bronchitis.\nBecause patients with plastic bronchitis are at high risk for serious\ncomplications, admission to an intensive care unit is mandatory.\nOne of the most effective treatments for plastic bronchitis is\nbronchoscopic removal of bronchial casts.\nWe conclude that in children with H1N1 in\ufb02uenza virus\ninfection, who develop rapid and progressive respiratory dis-\ntress with whole lung atelectasis, clinicians should be aware of\nthe possibility of plastic bronchitis and consider bronchoscopic\nevaluation.\nREFERENCES\n1. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009\nH1N1 in\ufb02uenza in the United States, April-June 2009. N Engl J Med.\n2009;361:1935\u20131944.\n2. Johnson RS, Sita-Lumsden EG. Plastic bronchitis. Thorax. 1960;15:325\u2013\n332.\n3. Bowen A, Oudjhane K, Odagiri K, et al.", "mimetype": "text/plain", "start_char_idx": 106814, "end_char_idx": 108672, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aaf34641-6822-4462-ad58-2a74e61dbf1e": {"__data__": {"id_": "aaf34641-6822-4462-ad58-2a74e61dbf1e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1c6b9e35-845a-40c7-90aa-a1bdd3fa85bc", "node_type": "1", "metadata": {}, "hash": "6bd5838a2d97d21e8f24f9aa2d91af3946ca35243f65103e18010bf4ef32aba9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "126d4d7a-9101-4a5b-8220-67d710e55954", "node_type": "1", "metadata": {}, "hash": "c2fc92522d1037ffac10be4790677268e5f9d6bfadf5f5fecf978ef56c4f976b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Plastic bronchitis. Thorax. 1960;15:325\u2013\n332.\n3. Bowen A, Oudjhane K, Odagiri K, et al. Plastic bronchitis: large, branching,\nmucoid bronchial casts in children. Am J Roentgenol. 1985;144:371\u2013375.\n4. Ishman S, Book DT, Conley SF, et al. Plastic bronchitis: an unusual\nbronchoscopic challenge associated with congenital heart disease repair. Int\nJ Pediatr Otorhinolaryngol. 2003;67:543\u2013548.\n5. Morgan AD, Bogomoletz W. Mucoid impaction of the bronchi in relation to\nasthma an plastic bronchitis. Thorax. 1968;23:356\u2013369.\n6. Davies A, Jones D, Bailey M, et al. Extracorporeal membrane oxygenation\nfor 2009 in\ufb02uenza A(H1N1) acute respiratory distress syndrome. JAMA.\n2009;302:1888\u20131895.\nPERSISTENCE OF HUMAN BOCAVIRUS DNA IN\nIMMUNOCOMPROMISED CHILDREN\nThomas Schenk, MD,* Barbara Maier, MD,*\nMarkus Hufnagel, MD,\u2020 Brigitte Strahm, MD,\u2020 Udo Kontny, MD,\u2020\nDieter Neumann-Haefelin, MD,* and Valeria Falcone, PhD*\nAbstract: Human bocavirus is frequently detected in immunocompetent as\nwell as in immunocompromised children. However, the course of infection\nin immunocompromised children is still poorly investigated. In the present\nstudy, we describe 4 cases of repeat human bocavirus detection in the\npresence of severe immunode\ufb01ciency. In the view of homologous viral\nsequences identi\ufb01ed in serial samples, possible persistence and reactivation\nin these patients are discussed.\nKey Words: respiratory virus infection, human bocavirus, hematopoietic\nstem cell transplantation\nAccepted for publication July 1, 2010.", "mimetype": "text/plain", "start_char_idx": 108585, "end_char_idx": 110092, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "126d4d7a-9101-4a5b-8220-67d710e55954": {"__data__": {"id_": "126d4d7a-9101-4a5b-8220-67d710e55954", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aaf34641-6822-4462-ad58-2a74e61dbf1e", "node_type": "1", "metadata": {}, "hash": "1a72faea9ca32e37297789c0fdbe266297650112d27194f79fd591bd9b263618", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "992b4ada-cd12-4145-a7b7-cb4d0d25928f", "node_type": "1", "metadata": {}, "hash": "0988e13efc3d2604ea07ef664ac75c71c1773752db33f83752542bb136a54fc5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Key Words: respiratory virus infection, human bocavirus, hematopoietic\nstem cell transplantation\nAccepted for publication July 1, 2010.\nFrom the *Department of Virology, Freiburg University Medical Center,\nFreiburg, Germany; and \u2020Center for Pediatrics and Adolescent Medicine,\nFreiburg University Medical Center, Freiburg, Germany.\nThomas Schenk is currently at LADR GmbH, Medizinisches Versorgung-\nszentrum Baden-Baden, Lange Str.65 76530, Baden-Baden, Germany.\nAddress for correspondence: Valeria Falcone, PhD, Department of Virol-\nogy, Freiburg University Medical Center, Hermann-Herder-Strasse 11,\n79104 Freiburg, Germany. E-mail: valeria.kapper-falcone@uniklinik-\nfreiburg.de.\nDOI: 10.1097/INF.0b013e3181f12fcf\nV\niral acute respiratory infections represent a frequent complica-\ntion among immunocompromised patients. Virus identi\ufb01cation\nis relevant for preventive and therapeutic measures, including\nisolation and avoidance of unnecessary antibiotic therapies. The\nemergence of new respiratory viruses such as human bocavirus\n(HBoV)1 in immunocompetent children raises questions regarding\nthe signi\ufb01cance of this newly described virus in the immunocom-\npromised host.\nIn the present study, various respiratory samples were col-\nlected from immunocompromised pediatric patients treated at our\ninstitution in a 3-year period (2004\u20132007), whenever new respi-\nratory symptoms occurred. The respiratory samples\u2014together\nwith nonrespiratory specimens (ie, plasma and feces) collected for\nother medical reasons around the time when respiratory symptoms\nbegan\u2014were retrospectively screened by quantitative real-time\npolymerase chain reaction (PCR) for HBoV DNA.2 Patients\u2019\ncharts were reviewed for relevant clinical data. Additionally, all\nrespiratory specimens were screened for other respiratory viruses\nby multiplex PCR, using the ID-TAG Respiratory Viral Panel (TM\nBioscience Corporation, Toronto, ON).3 PCRs were performed\nprospectively on plasma samples for the detection of Epstein Barr\nvirus (EBV) and cytomegalovirus (CMV).", "mimetype": "text/plain", "start_char_idx": 109957, "end_char_idx": 111986, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "992b4ada-cd12-4145-a7b7-cb4d0d25928f": {"__data__": {"id_": "992b4ada-cd12-4145-a7b7-cb4d0d25928f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "126d4d7a-9101-4a5b-8220-67d710e55954", "node_type": "1", "metadata": {}, "hash": "c2fc92522d1037ffac10be4790677268e5f9d6bfadf5f5fecf978ef56c4f976b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2060ace3-3f84-4ab8-8afb-275e4a603aed", "node_type": "1", "metadata": {}, "hash": "e16870364f2b755a99403a5edb649f3583b31174727153a28f8e94b2d0bedebe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In total, 135 separate\nrespiratory episodes occurring in 69 immunocompromised patients\nwere included. In the present study, we describe 4 cases in which\nHBoV DNA was repeatedly detected during a prolonged period.\nCASE REPORTS\nCase 1. A 2-year-old girl with severe combined immunode\ufb01ciency\nsyndrome was hospitalized in July 2004 with an EBV-associated\nB-cell lymphoma and active EBV infection. She presented with\nfever, lymphadenopathy, and mucosal in\ufb01ltrates. Her general con-\ndition improved with rituximab and cidofovir treatment. Trans-\nplantation of allogenic hematopoietic stem cells (HSC) from an\nEBV-positive donor was planned. A reduced conditioning protocol\n(thiotepa, 5 mg/kg; \ufb02udarabine, 40 mg/m2; and ATG) was adopted.\nWith this regimen, the EBV DNA load declined from 153,000 to\n7000 copies/mL and later was negative. However, the patient was\nseverely granulocytopenic, and developed pulmonary aspergillo-\nsis. Pulmonary symptoms continued to deteriorate, despite aggres-\nsive antimicrobial and antifungal therapy. At this time, a nasopha-\nryngeal aspirate (NPA), and 2 plasma samples taken 1 day before\nand 4 days thereafter, tested positive for HBoV (Fig. 1). Coinfec-\ntion with rhinovirus was assessed by multiplex PCR.3 A lung\nbiopsy con\ufb01rmed invasive aspergillosis with focal and intraalveo-\nlar bleeding and it also harbored HBoV DNA (Fig. 1).", "mimetype": "text/plain", "start_char_idx": 111987, "end_char_idx": 113349, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2060ace3-3f84-4ab8-8afb-275e4a603aed": {"__data__": {"id_": "2060ace3-3f84-4ab8-8afb-275e4a603aed", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "992b4ada-cd12-4145-a7b7-cb4d0d25928f", "node_type": "1", "metadata": {}, "hash": "0988e13efc3d2604ea07ef664ac75c71c1773752db33f83752542bb136a54fc5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "725c72ad-6a76-495e-9c9e-7c252344ccb0", "node_type": "1", "metadata": {}, "hash": "8c29f0443edda2d2f592064ccea2c0d3e094d214f98627892615bc05fa56a5c0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1). The patient\nSchenk et al\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\n\u00a9 2010 Lippincott Williams & Wilkins\n82\n|\nwww.pidj.com\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\neventually died of acute pulmonary decompensation and general-\nized capillary leakage.\nCase 2. An 8-month-old EBV-positive boy with hemophagocytic\nlymphohistiocytosis was admitted to the bone marrow transplan-\ntation unit in July 2006. Treatment with cyclosporine A and\nsteroids resulted in an increase of EBV DNA load from 518 to\n9450 copies/mL in whole blood. The patient was treated with\nrituximab. At this time point, he also developed respiratory symp-\ntoms (tachypnea and supplemental oxygen requirement) with fe-\nver. Chest radiography showed lung in\ufb01ltrates in the basal lower\nlobes. Two NPAs obtained at the beginning of the respiratory\nsymptoms harbored high load of HBoV DNA (5 \t 1012 and 7 \t\n109 copies/mL). Codetection of rhinovirus and human coronavirus\nNL63 RNA was assessed by multiplex PCR.3 Viremia with low\nHBoV DNA load (1 \t 102 and 2.3 \t 103 copies /mL) was\nobserved before (ie, day 11 and day 3) but not after HBoV\ndetection in NPA (Fig. 1). The peak of HBoV DNA load in the\nrespiratory tract was concomitant to EBV reactivation. The patient\nrecovered, and subsequent serum samples and NPA were negative\nfor HBoV DNA.", "mimetype": "text/plain", "start_char_idx": 113346, "end_char_idx": 114818, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "725c72ad-6a76-495e-9c9e-7c252344ccb0": {"__data__": {"id_": "725c72ad-6a76-495e-9c9e-7c252344ccb0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2060ace3-3f84-4ab8-8afb-275e4a603aed", "node_type": "1", "metadata": {}, "hash": "e16870364f2b755a99403a5edb649f3583b31174727153a28f8e94b2d0bedebe", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7a3727d1-d832-4c62-a307-e798ff3e0a4c", "node_type": "1", "metadata": {}, "hash": "446bacc846a3884f383d7225fb8933bbb6f186dcfe5d11f8744b9e46d3a834eb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The peak of HBoV DNA load in the\nrespiratory tract was concomitant to EBV reactivation. The patient\nrecovered, and subsequent serum samples and NPA were negative\nfor HBoV DNA. Two weeks later, the patient underwent HSC\ntransplantation and died of hepatic veno-occlusive disease.\nCase 3. An 18-year-old boy with myelodysplastic syndrome and a\nhistory of HSC transplantation, completed 2 years previously, was\nhospitalized in March 2007 for acute respiratory symptoms. He\npresented with fever, productive cough, and tachypnea. Peribron-\nchial in\ufb01ltrates were evident on chest radiograph. The patient was\nunder intensive immunosuppression to treat chronic GvHD of skin\nand mucosa. A bronchoalveolar lavage (BAL) and a serum sample\ntaken at this time point were retrospectively tested for the presence\nof HBoV. The samples revealed extremely high DNA load in the\nBAL (\u00061015 copies/mL) and relatively high load (4.7 \t 107\ncopies /mL) in plasma. Additionally, the BAL sample was positive\nfor PIV-3 in the multiplex PCR.3 Microbiologic analysis of the\nBAL revealed the presence of extended-spectrum beta-lactamase-\nproducing Escherichia coli and Aspergillus fumigatus, as well as\nPneumocystis jirovecii DNA, although no cysts were detected.\nAntifungal and antibacterial therapy was started and the patient\u2019s\ngeneral condition improved. Later serum samples as well as an\nNPA and a stool sample were negative for HBoV (Fig. 1). The\npatient also had chronic sinusitis, and 5 months later underwent\nsurgery for suspected aspergilloma. However, this diagnosis was\nnot con\ufb01rmed and microbiologic analysis of the sphenoid sinus\nbiopsy and exudates was negative for the presence of fungi.\nAnalyses of both materials for the presence of respiratory viruses\nrevealed HBoV as the sole agent in the biopsy and HBoV and\nrhinovirus in the exudate. No NPA was available at the time of\ntesting.", "mimetype": "text/plain", "start_char_idx": 114643, "end_char_idx": 116514, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7a3727d1-d832-4c62-a307-e798ff3e0a4c": {"__data__": {"id_": "7a3727d1-d832-4c62-a307-e798ff3e0a4c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "725c72ad-6a76-495e-9c9e-7c252344ccb0", "node_type": "1", "metadata": {}, "hash": "8c29f0443edda2d2f592064ccea2c0d3e094d214f98627892615bc05fa56a5c0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dc8bab62-f2bf-4951-84bd-7bf12125dc3a", "node_type": "1", "metadata": {}, "hash": "82e132e714b16f2fcd2aba509613e6fbcee6deb7a714ada544cede1b89a5e03f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "No NPA was available at the time of\ntesting. Partial sequencing of the VP1 gene of HBoV from BAL,\nplasma, and sphenoid sinus samples was performed as described,4\nand revealed 100% identity. This \ufb01nding is in accordance with\npersistence of the same HBoV strain over a 5-month period.\nCase 4. A 4-year-old boy with dyskeratosis congenita developed\npneumonia with perihilar in\ufb01ltrates 17 days after HSCT. Repeat\ndetection of high HBoV DNA load in NPA during a 2-month\nperiod with codetection of rhinovirus, which was accompanied by\nHBoV viremia and prolonged HBoV shedding (3 months) in the\nfeces even after resolution of respiratory symptoms, has already\nbeen reported in detail.5 As described previously, the patient\nshowed a simultaneous CMV reactivation concomitant to the peak\nin HBoV load in NPS.5 Partial sequencing of the VP1 gene of\nHBoV DNA obtained from the different samples was performed as\ndescribed,4 and revealed 100% identity, suggesting persistence of\nthe same HBoV strain.\nDISCUSSION\nThe present study shows that HBoV can be detected at\nmoderate to high viral loads in samples from immunocompro-\nmised patients with underlying hematologic diseases or primary\nimmunode\ufb01ciencies undergoing HSC transplantation. Previous\nstudies have shown that prolonged HBoV shedding can be ob-\nserved during immunosuppression, which possibly indicate persis-\ntence and/or reactivation in these patients.5,6 A recent work also\nshows prolonged detection of HBoV in immunocompetent chil-\ndren with respiratory tract disease.7\nIn the 4 cases described in this study, we repeatedly detected\nHBoV DNA in the respiratory tract and/or in plasma, and in one\ncase also in the gastrointestinal tract, for a period of up to 5\nmonths. In all cases, HBoV replication in the respiratory tract was\naccompanied by viremia. However, the clinical relevance of pro-\nlonged detection of HBoV in respiratory samples and plasma is\nFIGURE 1. HBoV DNA load.", "mimetype": "text/plain", "start_char_idx": 116470, "end_char_idx": 118401, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dc8bab62-f2bf-4951-84bd-7bf12125dc3a": {"__data__": {"id_": "dc8bab62-f2bf-4951-84bd-7bf12125dc3a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7a3727d1-d832-4c62-a307-e798ff3e0a4c", "node_type": "1", "metadata": {}, "hash": "446bacc846a3884f383d7225fb8933bbb6f186dcfe5d11f8744b9e46d3a834eb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "83539b8f-24f9-457e-8b51-112ce37ac806", "node_type": "1", "metadata": {}, "hash": "2e7b40b2234f7b600b2e66d2c18822c39492c40c0be5e3007f2126632329946e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "However, the clinical relevance of pro-\nlonged detection of HBoV in respiratory samples and plasma is\nFIGURE 1. HBoV DNA load. HBoV quantification was performed in NPA (f), plasma (F), lung biopsy (*), BAL (\n), sphenoid\nsinus biopsy (E), sphenoid sinus secretion (\u0001), and feces (\u0002). Time point of first HBoV identification in respiratory samples\nis defined as day 0. Time points before or after day 0 are depicted as negative or positive figures, respectively.\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\nBocavirus in the Immunocompromised\n\u00a9 2010 Lippincott Williams & Wilkins\nwww.pidj.com\n| 83\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\nunclear. Failure of the immune system in all 4 cases was charac-\nterized by severe granulocytopenia (below 500 granulocytes/\u0001L)\nand/or impairment of both the T-cell and the B-cell compartment\nwith opportunistic infection (aspergillosis) in case 1, EBV reacti-\nvation in case 2, aspergillosis and P. jirovecii infection in case 3,\nand CMV reactivation in case 4. This strongly indicates that severe\nimmunode\ufb01ciency may lead to high levels of HBoV replication.\nDetection of HBoV in the lung biopsy of patient 1 should be\ninterpreted with caution, because HBoV DNA was detected at the\nsame time point in plasma, and we cannot exclude blood contam-\nination of lung biopsy.", "mimetype": "text/plain", "start_char_idx": 118275, "end_char_idx": 119743, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "83539b8f-24f9-457e-8b51-112ce37ac806": {"__data__": {"id_": "83539b8f-24f9-457e-8b51-112ce37ac806", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dc8bab62-f2bf-4951-84bd-7bf12125dc3a", "node_type": "1", "metadata": {}, "hash": "82e132e714b16f2fcd2aba509613e6fbcee6deb7a714ada544cede1b89a5e03f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cc230894-2625-42e6-b17d-b3bf2f63c291", "node_type": "1", "metadata": {}, "hash": "4afe1bb0829f82879b44ba3dafc553e69de81eb0da3cee4a64ac6f7bb35a3106", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Detection of HBoV in the lung biopsy of patient 1 should be\ninterpreted with caution, because HBoV DNA was detected at the\nsame time point in plasma, and we cannot exclude blood contam-\nination of lung biopsy. Most intriguing was the detection of HBoV\nDNA in a sphenoid sinus biopsy 5 months after detection of more\nthan 1015 and 107 copies/mL in BAL and in plasma, respectively,\nin the absence of HBoV DNA in blood. HBoV may have played a\nrole in the pathogenesis of chronic sinusitis in this case; alterna-\ntively, the mucosal tissue of nasal sinuses may represent a site of\nHBoV persistence after high-level replication in the respiratory\ntract. Similarly, recent \ufb01ndings have suggested that HBoV may\nestablish persistent infections of mucosal lymphocytes and/or\ncontribute to tonsillar hyperplasia in children.8 Further investiga-\ntions, with appropriate matched controls, are needed to understand\nthe bystander or causative role of HBoV in chronic sinusitis in\nimmunocompromised and immunocompetent patients.\nIn cases 1, 2, and 4, HBoV was detected during the late\nspring and summer months, whereas HBoV infections in immu-\nnocompetent patients predominantly have been described to occur\nduring the winter season, and only rarely in spring or summer.4\nThis observation, together with the fact that in these cases HBoV\nwas detected after 3 to 5 weeks of strict isolation, further favors the\nhypothesis of reactivation of persistent HBoV infection during\nimmunosuppression. Although it cannot be excluded, nosocomial\ninfection appears to be less likely because of general prevention\nmeasures. The patient described in case 3 was 18 years old. Recent\nseroepidemiologic data suggest that antibodies to HBoV are\npresent in more than 90% of children at the age of 6 years,9 which\nmakes primary infection in this patient unlikely.", "mimetype": "text/plain", "start_char_idx": 119534, "end_char_idx": 121362, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cc230894-2625-42e6-b17d-b3bf2f63c291": {"__data__": {"id_": "cc230894-2625-42e6-b17d-b3bf2f63c291", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "83539b8f-24f9-457e-8b51-112ce37ac806", "node_type": "1", "metadata": {}, "hash": "2e7b40b2234f7b600b2e66d2c18822c39492c40c0be5e3007f2126632329946e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7bc25279-3a53-492f-b388-6b4bb5251317", "node_type": "1", "metadata": {}, "hash": "f498454696d116fbbe6a7f706811fbd65fbd28fd67ced030fe046a26221776f4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Recent\nseroepidemiologic data suggest that antibodies to HBoV are\npresent in more than 90% of children at the age of 6 years,9 which\nmakes primary infection in this patient unlikely. Moreover, se-\nquence identity of HBoV DNA from samples taken 5 months apart\nwas detected by partial sequencing of a region of the VP1 gene\n(819 nucleotides) known to display the greatest frequency of\nnucleotide polymorphisms.4 This \ufb01nding, further supported by\nidentity of HBoV sequences in subsequent samples from a second\npatient (case 4), is compatible with persistent infection.\nWe found coinfections with one or more viruses in all 4\ncases. A high frequency of codetection is a signi\ufb01cant feature of\nHBoV and may argue against its causative role in respiratory\ninfections. Moreover, Esposito et al10 have recently shown that the\nclinical impact of HBoV in infected children may become signif-\nicant when it is present together with other viruses. Potentially,\nHBoV may act as an exacerbating factor increasing the severity of\ninfections caused by other pathogens.\nApart from the unsolved question of pathogenicity, our\nobservations suggest the following 2 possibilities: (i) HBoV may\nbe able to persist at low levels in the setting of an ef\ufb01cient immune\nsystem, thus making its detection dif\ufb01cult unless an immunocom-\npromised status and/or coinfection with other viruses and subse-\nquent increased replication occur; (ii) exposure to HBoV during\nimmunosuppression can lead to persistent infection and prolonged\nviral shedding.\nREFERENCES\n1. Allander T, Tammi MT, Eriksson M, et al. Cloning of a human parvovirus\nby molecular screening of respiratory tract samples. Proc Natl Acad Sci\nU S A. 2005;102:12891\u201312896.\n2. Schenk T, Huck B, Forster J, et al. Human bocavirus DNA detected by\nquantitative real-time PCR in two children hospitalized for lower respira-\ntory tract infection. Eur J Clin Microbiol Infect Dis. 2007;26:147\u2013149.\n3. Pabbaraju K, Tokaryk KL, Wong S, et al.", "mimetype": "text/plain", "start_char_idx": 121180, "end_char_idx": 123142, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7bc25279-3a53-492f-b388-6b4bb5251317": {"__data__": {"id_": "7bc25279-3a53-492f-b388-6b4bb5251317", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cc230894-2625-42e6-b17d-b3bf2f63c291", "node_type": "1", "metadata": {}, "hash": "4afe1bb0829f82879b44ba3dafc553e69de81eb0da3cee4a64ac6f7bb35a3106", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f040eb24-1455-4579-a091-ab0bf63affcb", "node_type": "1", "metadata": {}, "hash": "f67c442610aa60646bfbb5d3dbcd00ed838ed4294bed8d0d40d975a20581d97e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Eur J Clin Microbiol Infect Dis. 2007;26:147\u2013149.\n3. Pabbaraju K, Tokaryk KL, Wong S, et al. Comparison of the Luminex\nxTAG respiratory viral panel with in-house nucleic acid ampli\ufb01cation tests\nfor diagnosis of respiratory virus infections. J Clin Microbiol. 2008;46:\n3056\u20133062.\n4. Kesebir D, Vazquez M, Weibel C, et al. Human bocavirus infection in\nyoung children in the United States: molecular epidemiological pro\ufb01le and\nclinical characteristics of a newly emerging respiratory virus. J Infect Dis.\n2006;194:1276\u20131282.\n5. Schenk T, Strahm B, Kontny U, et al. Disseminated bocavirus infection\nafter stem cell transplant. Emerg Infect Dis. 2007;13:1425\u20131427.\n6. Koskenvuo M, Mottonen M, Waris M, et al. Human bocavirus in children\nwith acute lymphoblastic leukemia. Eur J Pediatr. 2008;167:1011\u20131015.\n7. Blessing K, Neske F, Herre U, et al. Prolonged detection of human\nbocavirus DNA in nasopharyngeal aspirates of children with respiratory\ntract disease. Pediatr Infect Dis J. 2009;28:1018\u20131019.\n8. Lu X, Gooding LR, Erdman DD. Human bocavirus in tonsillar lympho-\ncytes. Emerg Infect Dis. 2008;14:1332\u20131334.\n9. Kahn JS, Kesebir D, Cotmore SF, et al. Seroepidemiology of human\nbocavirus de\ufb01ned using recombinant virus-like particles. J Infect Dis.\n2008;198:41\u201350.\n10. Esposito S, Bosis S, Niesters HG, et al. Impact of human bocavirus on\nchildren and their families. J Clin Microbiol. 2008;46:1337\u20131342.", "mimetype": "text/plain", "start_char_idx": 123050, "end_char_idx": 124455, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f040eb24-1455-4579-a091-ab0bf63affcb": {"__data__": {"id_": "f040eb24-1455-4579-a091-ab0bf63affcb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7bc25279-3a53-492f-b388-6b4bb5251317", "node_type": "1", "metadata": {}, "hash": "f498454696d116fbbe6a7f706811fbd65fbd28fd67ced030fe046a26221776f4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7b56425e-2f83-456d-94ff-f51d94ed20a3", "node_type": "1", "metadata": {}, "hash": "1274167c3f8d5fe393258c08eec5a88031a9a5ddf106f9f863ce0bc3f1702117", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Esposito S, Bosis S, Niesters HG, et al. Impact of human bocavirus on\nchildren and their families. J Clin Microbiol. 2008;46:1337\u20131342.\nADVERSE NEUROLOGIC REACTIONS AFTER BOTH\nDOSES OF PANDEMIC H1N1 INFLUENZA VACCINE\nWITH OPTIC NEURITIS AND DEMYELINATION\nKeswadee Lapphra, MD,* Linda Huh, MD,\u2020\nand David W. Scheifele, MD*\nAbstract: When a neurologic condition develops after vaccination of a\npatient, the causal relationship is dif\ufb01cult to determine. We report an\nunusual case in which neurologic signs occurred in a previously healthy\nchild after both doses of H1N1 2009 in\ufb02uenza vaccine, culminating in\nbilateral optic neuritis and disseminated encephalomyelitis. A causal asso-\nciation is more likely with repeated injury following in\ufb02uenza vaccination.\nKey Words: optic neuritis, acute disseminated encephalomyelitis, post-\nvaccination, pandemic H1N1 in\ufb02uenza vaccine\nAccepted for publication July 9, 2010.\nFrom the *Vaccine Evaluation Center, Department of Pediatrics, British Co-\nlumbia Children\u2019s Hospital, University of British Columbia, Vancouver,\nBritish Columbia, Canada; and \u2020Division of Neurology, Department of\nPediatrics, British Columbia Children\u2019s Hospital, University of British\nColumbia, Vancouver, British Columbia, Canada.\nAddress for correspondence: Keswadee Lapphra, MD, Vaccine Evaluation\nCenter, University of British Columbia and BC Children\u2019s Hospital,\n950 West 28th Ave, Vancouver, British Columbia V5Z 4H4, Canada.\nE-mail: klapphra@cfri.ca.\nDOI: 10.1097/INF.0b013e3181f11126\nI\nn response to the H1N1 pandemic of 2009, Canada deployed a\ndomestically manufactured H1N1 vaccine adjuvanted with\nsqualene and alpha tocopherol (Arepanrix, adjuvanted, inactivated,\nmonovalent H1N1 vaccine, GSK Laval Quebec).", "mimetype": "text/plain", "start_char_idx": 124320, "end_char_idx": 126050, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7b56425e-2f83-456d-94ff-f51d94ed20a3": {"__data__": {"id_": "7b56425e-2f83-456d-94ff-f51d94ed20a3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f040eb24-1455-4579-a091-ab0bf63affcb", "node_type": "1", "metadata": {}, "hash": "f67c442610aa60646bfbb5d3dbcd00ed838ed4294bed8d0d40d975a20581d97e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e5eaa04c-65f5-446b-97fc-f3e061994196", "node_type": "1", "metadata": {}, "hash": "39813abc407303e8eecdb0ea4df3985eef4151739010d65177d4bcac735f8983", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Children, 6 to 35\nmonths old, were recommended to receive 2 doses, at least 21 days\napart. Surveillance activities in Canada and elsewhere detected\nrare instances of various demyelinating neurologic conditions in\nrecently vaccinated persons. However, with vaccination programs\noccurring in the midst of an in\ufb02uenza pandemic, it was dif\ufb01cult to\ndetermine in individual cases whether the cause was infection,\nvaccination, or another etiology. In the absence of a diagnostic\nlaboratory test for the trigger for demyelination, a useful but rare\nclinical clue to the cause is recurrence of injury upon re-exposure\nto the stimulus.1,2 We report an unusual case in which neurologic\nLapphra et al\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\n\u00a9 2010 Lippincott Williams & Wilkins\n84\n|\nwww.pidj.com\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\nsymptoms followed both doses of pandemic H1N1 in\ufb02uenza\nvaccine, culminating in bilateral optic neuritis and acute dissemi-\nnated encephalomyelitis (ADEM).\nCASE REPORT\nA 2-year-old Filipino boy presented in late December 2009\nwith a history of unsteady gait starting 4 days after initial inacti-\nvated H1N1 in\ufb02uenza vaccination. His mother noted that he was\nunsteady while walking, leaning to his right side, and often falling.\nHis mother took him to a local hospital where a computed\ntomography brain scan was done and read as normal. He was sent\nhome and 4 days later his gait unsteadiness resolved. He remained\nwell and was given his second H1N1 in\ufb02uenza vaccination 24 days\nafter the \ufb01rst one.", "mimetype": "text/plain", "start_char_idx": 126051, "end_char_idx": 127740, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e5eaa04c-65f5-446b-97fc-f3e061994196": {"__data__": {"id_": "e5eaa04c-65f5-446b-97fc-f3e061994196", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7b56425e-2f83-456d-94ff-f51d94ed20a3", "node_type": "1", "metadata": {}, "hash": "1274167c3f8d5fe393258c08eec5a88031a9a5ddf106f9f863ce0bc3f1702117", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7a740802-b4bb-4cdd-86e4-93183006f2f3", "node_type": "1", "metadata": {}, "hash": "249ef12baa58074b71e79fcfeba6d4e7a52d4ec65c02b3a41ce806c1366324af", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "He remained\nwell and was given his second H1N1 in\ufb02uenza vaccination 24 days\nafter the \ufb01rst one. Six days later, his mother noticed that his left\neye was turning in intermittently. This symptom resolved within 4\ndays. Eleven days after the second H1N1 in\ufb02uenza vaccination, his\nmother noticed that he was holding picture books much too close\nto see them.\nNo signi\ufb01cant medical or family history was noted but 2\nweeks before he received the \ufb01rst dose of H1N1 in\ufb02uenza vaccine,\nhe had a febrile illness lasting for 3 days with cough and nausea.\nNo diagnostic test was done; however, there was peak pandemic\nH1N1 in\ufb02uenza activity locally in British Columbia at that time.3\nImmunization dates were con\ufb01rmed from a written record. The\nonly vaccine given was Arepanrix.\nOn admission, the patient was afebrile with normal vital\nsigns. He had evidence of myopia, as he needed to come close to\nobjects to see them. Other than a mild, low amplitude, fast\nfrequency action tremor present bilaterally, the remainder of the\nneurologic examination was normal. An ophthalmologist con-\n\ufb01rmed that his visual acuity was decreased. He seemed to prefer\neccentric \ufb01xation, looking off to the side when viewing objects\nplaced straight ahead of him. He had normal anterior segments but\nbilateral optic disc swelling, with venous engorgement and hem-\norrhages on the disc surface in the right eye.\nA lumbar puncture was performed, and cerebrospinal \ufb02uid\n(CSF) analysis showed 2 mononuclear cells/\u0001L with normal pro-\ntein and glucose concentrations. His complete blood cell counts,\nserum chemistries, and liver enzymes were normal. Bacterial\ncultures of CSF were negative. Cranial magnetic resonance imag-\ning performed on hospital day 2 demonstrated diffuse high inten-\nsity white matter lesions in the cerebellum and left basal ganglia,\nwith increased signal in the optic nerves, consistent with ADEM.", "mimetype": "text/plain", "start_char_idx": 127645, "end_char_idx": 129524, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7a740802-b4bb-4cdd-86e4-93183006f2f3": {"__data__": {"id_": "7a740802-b4bb-4cdd-86e4-93183006f2f3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e5eaa04c-65f5-446b-97fc-f3e061994196", "node_type": "1", "metadata": {}, "hash": "39813abc407303e8eecdb0ea4df3985eef4151739010d65177d4bcac735f8983", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "46eef006-d8cb-4cda-b796-dab3f58d1428", "node_type": "1", "metadata": {}, "hash": "a938ff09be4dc66fcdf563cb02cb9f5b65b3579ff1441a271e408b31f7809c0b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Cranial magnetic resonance imag-\ning performed on hospital day 2 demonstrated diffuse high inten-\nsity white matter lesions in the cerebellum and left basal ganglia,\nwith increased signal in the optic nerves, consistent with ADEM.\nCSF polymerase chain reaction for enteroviruses, herpes sim-\nplex virus 1 and 2, and varicella zoster virus were negative.\nFurther investigations including antinuclear antibodies, an-\ntineutrophil cytoplasmic antibodies, serum rheumatoid factor,\nhuman immunode\ufb01ciency virus serology, and IgM serology for\nEpstein-Barr virus and cytomegalovirus were negative. IgM se-\nrology for Mycoplasma was reactive, which was interpreted as\ninfection in the past 6 months.\nThe patient\u2019s symptoms improved after a 5-day course of\nintravenous pulse methylprednisolone (30 mg/kg/d) treatment,\nwhereupon his visual acuity improved and the optic nerve\nswelling resolved. He continued to improve without recurrence\nof symptoms. His neurologic examination was normal at\n6-month follow-up.\nDISCUSSION\nThe remarkable feature of this case was the occurrence of\nneurologic changes shortly after both doses of pandemic H1N1\nvaccine, with spontaneous remission between episodes. The initial\nepisode of gait unsteadiness eluded speci\ufb01c diagnosis, but was\nlikely the \ufb01rst clinical manifestation of the cerebellar demyelina-\ntion documented by his magnetic resonance imaging 3 weeks later.\nAfter the second vaccination, the presenting syndrome was dom-\ninated by bilateral optic neuritis. The unifying diagnosis proved to\nbe acute disseminated encephalomyelitis (ADEM), which seem-\ningly evolved in 2 stages, remitting after the \ufb01rst vaccination. This\nsequence of events is consistent with production of greater\namounts of antibodies to myelin after each vaccination, perhaps\naided by the presence of adjuvant in the vaccine that can induce\npotent nonspeci\ufb01c immune and in\ufb02ammatory stimulation in ani-\nmal models.", "mimetype": "text/plain", "start_char_idx": 129294, "end_char_idx": 131209, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "46eef006-d8cb-4cda-b796-dab3f58d1428": {"__data__": {"id_": "46eef006-d8cb-4cda-b796-dab3f58d1428", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7a740802-b4bb-4cdd-86e4-93183006f2f3", "node_type": "1", "metadata": {}, "hash": "249ef12baa58074b71e79fcfeba6d4e7a52d4ec65c02b3a41ce806c1366324af", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c2b891c9-0bf8-4846-ae83-84b4d33c9afe", "node_type": "1", "metadata": {}, "hash": "99a315fbf7c13a41b78c090a6a0802aac3d8ae444f5b98c178b19e28d03c5c4c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The clinical signi\ufb01cance of this is unknown.4 Given\nthe child\u2019s history of a febrile respiratory illness 3 weeks before\ninitial vaccination, we cannot exclude the possibility that ADEM\nwas initiated by pandemic in\ufb02uenza infection and exacerbated by\nthe subsequent vaccinations. Another possibility that has been\nlinked to ADEM and optic neuritis was Mycoplasma infection, for\nwhich serologic evidence existed for recent infection. However,\nthe patient\u2019s neurologic symptoms occurred shortly after the \ufb01rst\ndose of vaccine and resolved and additional symptoms occurred\nshortly after the second dose of vaccine. This pattern strongly\nsuggests that vaccine was a causative factor in producing these\nneurologic \ufb01ndings. Our case is consistent with the Brighton\nCollaboration case de\ufb01nition for ADEM with level 1 certainty.5\nThe most frequent side effects reported from pandemic\nH1N1 vaccine trials, related to the injection site.6 Neurologic\ncomplications following in\ufb02uenza vaccination are uncommon, but\nvarious clinical syndromes have been reported such as encepha-\nlopathy, meningoencephalitis, Guillain-Barre\u00b4 syndrome, polyneu-\nropathy, peripheral neuritis, and various combinations of these.\nThe interval to onset varies from several hours to 6 weeks, perhaps\nstarting late in the \ufb01rst week.7,8\nADEM is an in\ufb02ammatory demyelinating disease of the\ncentral nervous system (CNS). ADEM may occur at any age but is\nmore common in children and young adults. Approximately three-\nquarters of cases follow infection or immunization, as an enceph-\nalomyelitis.", "mimetype": "text/plain", "start_char_idx": 131210, "end_char_idx": 132763, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c2b891c9-0bf8-4846-ae83-84b4d33c9afe": {"__data__": {"id_": "c2b891c9-0bf8-4846-ae83-84b4d33c9afe", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "46eef006-d8cb-4cda-b796-dab3f58d1428", "node_type": "1", "metadata": {}, "hash": "a938ff09be4dc66fcdf563cb02cb9f5b65b3579ff1441a271e408b31f7809c0b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "640ac5e9-f3f7-45bb-afc5-89a251dab860", "node_type": "1", "metadata": {}, "hash": "d682e951470d86d81c52c6b622cfed55b3cf914a336a1a636e9a7fe6ed16c683", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ADEM may occur at any age but is\nmore common in children and young adults. Approximately three-\nquarters of cases follow infection or immunization, as an enceph-\nalomyelitis. Postvaccination ADEM is associated with several\nvaccines such as rabies, diphtheria-tetanus-polio, smallpox, mea-\nsles, mumps, rubella, Japanese B encephalitis, pertussis, hepatitis\nB, and in\ufb02uenza vaccine.9 The incidence rates after most vaccines\nare as low as 0.1 to 0.2 per 100,000 vaccinated individuals.10\nHowever, there is no estimated incidence rate for ADEM after\nin\ufb02uenza vaccine and a causal relationship has not been estab-\nlished with certainty.2\nThe pathogenesis of ADEM is incompletely understood.\nThe consensus is that an immune attack develops against CNS\nmyelin.11 It has been speculated that killed virus vaccines, such as\ntrivalent in\ufb02uenza or swine in\ufb02uenza vaccines, may share similar\nantigens (molecular mimicry) with CNS proteins.12 The viral\nantigens are believed to stimulate autoimmune reactions that\nproduce CNS in\ufb02ammation and demyelination.13 A supportive\nstudy demonstrated induction of autoimmunity in healthy people\nafter in\ufb02uenza vaccination, although this was of unknown clinical\nsigni\ufb01cance.14 Other factors such as genetic predisposition may\nincrease the odds of developing ADEM postvaccination.9\nOptic neuritis may be a manifestation of ADEM. Optic\nneuritis after in\ufb02uenza vaccination is very rare and is a diagnosis\nof exclusion. Since 1971, 17 cases of optic neuropathy associated\nwith in\ufb02uenza vaccination have been reported in the literature,\nincluding 2 associated with swine in\ufb02uenza vaccine and 1 recent\ncase\nassociated\nwith\ntrivalent,\ninactivated\nin\ufb02uenza\nvac-\ncine.9,12,15\u201319 Among these cases, our case is the youngest.\nAs in our case, most cases involve unilateral or bilateral\noptic neuropathy or ADEM, rather than simultaneous onset of both\nconditions.", "mimetype": "text/plain", "start_char_idx": 132589, "end_char_idx": 134466, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "640ac5e9-f3f7-45bb-afc5-89a251dab860": {"__data__": {"id_": "640ac5e9-f3f7-45bb-afc5-89a251dab860", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c2b891c9-0bf8-4846-ae83-84b4d33c9afe", "node_type": "1", "metadata": {}, "hash": "99a315fbf7c13a41b78c090a6a0802aac3d8ae444f5b98c178b19e28d03c5c4c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "99f75413-c160-49fd-9d0f-665a236075be", "node_type": "1", "metadata": {}, "hash": "6a34cb69ef7081e673e2991b954e32c0cf3d7e07d57b4314ff65fe175484cb9b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "As in our case, most cases involve unilateral or bilateral\noptic neuropathy or ADEM, rather than simultaneous onset of both\nconditions. Most cases recover spontaneously or improve after\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\nAdverse Reactions After 2009 H1N1 Influenza\n\u00a9 2010 Lippincott Williams & Wilkins\nwww.pidj.com\n| 85\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\ncorticosteroid therapy, although permanent visual loss has been\ndescribed in 2 cases with anterior ischemic optic neuropathy.18\nA previous report described the occurrence of optic neuritis\non 2 occasions after consecutive annual in\ufb02uenza vaccinations.17\nWe recommended that our patient not receive annual in\ufb02uenza\nvaccination with a killed virus vaccine or a live-attenuated vaccine\nin the future, to avoid any recurrence risk. Early neurologic\nconsultation and ophthalmologic evaluation should be considered\nin children presenting with these rare events.\nREFERENCES\n1. GACVS. Causality assessment of adverse events following immunization.\nWkly Epidemiol Rec. 2001;76:85\u201389.\n2. Institute of medicine. Immunization safety review: in\ufb02uenza vaccines and\nneurological complications 2004. Available at: http://www.nap.edu/catalog/\n10822.html. Accessed May 7, 2010.\n3. In\ufb02uenza Surveillance Reports. BC In\ufb02uenza Surveillance Bulletins: 2009\u2013\n2010. Available at: http://www.bccdc.ca/discond/DiseaseStatsReports/\nin\ufb02uSurveillanceReports.htm. Accessed June 28, 2010.\n4.", "mimetype": "text/plain", "start_char_idx": 134331, "end_char_idx": 135925, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "99f75413-c160-49fd-9d0f-665a236075be": {"__data__": {"id_": "99f75413-c160-49fd-9d0f-665a236075be", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "640ac5e9-f3f7-45bb-afc5-89a251dab860", "node_type": "1", "metadata": {}, "hash": "d682e951470d86d81c52c6b622cfed55b3cf914a336a1a636e9a7fe6ed16c683", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "16faa05a-01cb-458f-8b01-f4e48f341fa3", "node_type": "1", "metadata": {}, "hash": "12c7dc6e2985e14c7104b69887429994b70088843f0278d0c5856ba4fe23e92a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Available at: http://www.bccdc.ca/discond/DiseaseStatsReports/\nin\ufb02uSurveillanceReports.htm. Accessed June 28, 2010.\n4. Kuroda Y, Nacionales DC, Akaogi J, et al. Autoimmunity induced by\nadjuvant hydrocarbon oil components of vaccine. Biomed Pharmacother.\n2004;58:325\u2013337.\n5. Sejvar JJ, Kohl KS, Bilynsky R, et al; Brighton Collaboration Encephalitis\nWorking Group. Encephalitis, myelitis, and acute disseminated encephalo-\nmyelitis (ADEM): case de\ufb01nitions and guidelines for collection, analysis,\nand presentation of immunization safety data. Vaccine. 2007;25:5771\u2013\n5792.\n6. Roman F, Vaman T, Gerlach B, et al. Immunogenicity and safety in adults\nof one dose of in\ufb02uenza A H1N1v 2009 vaccine formulated with and\nwithout AS03A-adjuvant: preliminary report of an observer-blind, random-\nised trial. Vaccine. 2010;28:1740\u20131745.\n7. Fenichel GM. Neurological complications of immunization. Ann Neurol.\n1982;12:119\u2013128.\n8. Haber P, DeStefano F, Angulo FJ, et al. Guillain-Barre\u00b4 syndrome following\nin\ufb02uenza vaccination. JAMA. 2004;292:2478\u20132481.\n9. Huynh W, Cordato DJ, Kehdi E, et al. Post-vaccination encephalitis:\nliterature review and illustrative case. J Clin Neurosci. 2008;15:1315\u20131322.\n10. Menge T, Hemmer B, Nessler S, et al. Acute disseminated encephalomy-\nelitis: an update. Arch Neurol. 2005;62:1673\u20131680.\n11. Davis LE, Booss J. Acute disseminated encephalomyelitis in children: a\nchanging picture. Pediatr Infect Dis J. 2003;22:829\u2013831.", "mimetype": "text/plain", "start_char_idx": 135807, "end_char_idx": 137249, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "16faa05a-01cb-458f-8b01-f4e48f341fa3": {"__data__": {"id_": "16faa05a-01cb-458f-8b01-f4e48f341fa3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "99f75413-c160-49fd-9d0f-665a236075be", "node_type": "1", "metadata": {}, "hash": "6a34cb69ef7081e673e2991b954e32c0cf3d7e07d57b4314ff65fe175484cb9b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "147dfc5b-2672-4bd9-a5d8-d37c8b830839", "node_type": "1", "metadata": {}, "hash": "335c7a0f4bcd440473545dee463102ac0647ff76196cefa0cd3ffe864f1c48f6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "11. Davis LE, Booss J. Acute disseminated encephalomyelitis in children: a\nchanging picture. Pediatr Infect Dis J. 2003;22:829\u2013831.\n12. Poser C. Neurological complications of swine \ufb02u in\ufb02uenza vaccination.\nActa Neurol Scand. 1982;66:413\u2013431.\n13. Shams PN, Plant GT. Optic neuritis: a review. Int MS J. 2009;16:82\u201389.\n14. Toplak N, Kveder T, Trampus-Bakija A, et al. Autoimmune response\nfollowing annual in\ufb02uenza vaccination in 92 apparently healthy adults.\nAutoimmun Rev. 2008;8:134\u2013138.\n15. Blumberg S, Bienfang D, Kantrowitz FG. A possible association between\nin\ufb02uenza vaccination and small-vessel vasculitis. Arch Intern Med. 1980;\n140:847\u2013848.\n16. Ray CL, Dreizin IJ. Bilateral optic neuropathy associated with in\ufb02uenza\ninfection. J Neuroophthalmol. 1996;16:182\u2013184.\n17. Hull TP, Bates JH. Optic neuritis after in\ufb02uenza vaccination. Am J Oph-\nthalmol. 1997;124:703\u2013704.\n18. Kawasaki A, Purvin VA, Tang R. Bilateral anterior ischemic optic neurop-\nathy following in\ufb02uenza vaccination. J Neuroophthalmol. 1998;18:56\u201359.\n19. Tan FU, Akarsu C, Gullu R, et al. Bilateral optic neuritis after in\ufb02uenza\nvaccination. Neuro-ophthalmology. 2010;34:115\u2013117.", "mimetype": "text/plain", "start_char_idx": 137118, "end_char_idx": 138268, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "147dfc5b-2672-4bd9-a5d8-d37c8b830839": {"__data__": {"id_": "147dfc5b-2672-4bd9-a5d8-d37c8b830839", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "16faa05a-01cb-458f-8b01-f4e48f341fa3", "node_type": "1", "metadata": {}, "hash": "12c7dc6e2985e14c7104b69887429994b70088843f0278d0c5856ba4fe23e92a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c6609416-296d-4996-aca4-2e2d660bc359", "node_type": "1", "metadata": {}, "hash": "cf7cd19f7bef87bbd062c421f8d8c9a79f7c802f2fe345022249a396e4ffaede", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Bilateral optic neuritis after in\ufb02uenza\nvaccination. Neuro-ophthalmology. 2010;34:115\u2013117.\nPOWASSAN VIRUS INFECTION PRESENTING AS\nACUTE DISSEMINATED ENCEPHALOMYELITIS IN\nTENNESSEE\nMark D. Hicar, MD, PhD,* Kathryn Edwards, MD,*\nand Karen Bloch, MD\u2020\nAbstract: Powassan virus is a rarely diagnosed cause of encephalitis, and\nis associated with signi\ufb01cant neurologic sequelae. Although symptomatic\ninfections with Powassan virus occur primarily in adults, we report a case\nof con\ufb01rmed Powassan neuroinvasive disease in a child presenting to a\nTennessee hospital, with symptoms and imaging studies suggestive of\nacute disseminated encephalomyelitis.\nKey Words: \ufb02avivirus, Powassan, ADEM, encephalitis\nAccepted for publication July 20, 2010.\nFrom the Departments of *Pediatrics and \u2020Medicine, Vanderbilt University\nMedical Center, Nashville, TN.\nSupported in part by a grant from the Emerging Infections Program\ncooperative agreement with the Centers for Disease Control and Pre-\nvention (U50/CCU416123\u201309) awarded to Vanderbilt University. The\nNew York State Department of Health Bureau of Communicable\nDisease Control was instrumental in the epidemiologic investigation.\nLaboratory con\ufb01rmation was performed at the Centers for Disease\nControl and Prevention Arbovirus Research Branch Diagnostic and\nReference Laboratory, Fort Collins, Colorado and the Diagnostic Im-\nmunology Laboratory, Wadsworth Center, New York State Department\nof Health, Albany, NY.\nAddress for correspondence: Mark D. Hicar, MD, PhD, Vanderbilt Med-\nical School and The Monroe Carell Jr. Children\u2019s Hospital, D-7235\nMCN, 1161 21st Avenue South, Nashville, TN 37232. E-mail:\nmark.d.hicar@vanderbilt.edu.\nDOI: 10.1097/INF.0b013e3181f2f492\nP\nowassan virus is an uncommon cause of arboviral enceph-\nalitis in North America, and has exclusively been identi\ufb01ed\nin the Northern United States and Southeastern Canada.", "mimetype": "text/plain", "start_char_idx": 138178, "end_char_idx": 140056, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c6609416-296d-4996-aca4-2e2d660bc359": {"__data__": {"id_": "c6609416-296d-4996-aca4-2e2d660bc359", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "147dfc5b-2672-4bd9-a5d8-d37c8b830839", "node_type": "1", "metadata": {}, "hash": "335c7a0f4bcd440473545dee463102ac0647ff76196cefa0cd3ffe864f1c48f6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8f308ea1-14be-4986-b9d0-6a583f786280", "node_type": "1", "metadata": {}, "hash": "3a604ca51d961cbc951525d341fcbb8ab0246cd12929df2d72d36285e856877b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "A\n9-year-old female presented to the Emergency Department (ED)\nof Vanderbilt Children\u2019s Hospital in July of 2008 with fever and\nheadache. She had been healthy until 3 days earlier when she\nnoted the sudden onset of headache, abdominal pain, and\nemesis. Physical examination in the ED revealed fever to 103\u00b0F\nand nuchal rigidity, but no rash, arthritis, or conjunctivitis.\nInitial laboratory studies showed a peripheral WBC 19,500/\u0001L\nwith a differential of 90% neutrophils, 7% lymphocytes, and\n3% monocytes; hematocrit of 44%; and platelet count of\n237,000/\u0001L. She had normal urinalysis, electrolytes, liver func-\ntions studies, and C-reactive protein of 4.5 mg/L (normal \u0005\n0.0\u201310.0 mg/L). A cerebrospinal \ufb02uid (CSF) examination re-\nvealed 68 nucleated cells (65% polymorphonuclear cells, 25%\nlymphocytes, 15% monocytes), no red blood cells, protein of\n52 mg/dL, and glucose of 63 mg/dL. She was administered\ndoxycycline, vancomycin, and ceftriaxone and admitted to the\nhospital.\nThe patient lived in Westchester County, NY and had 2\ndogs, horses, gerbils, \ufb01sh, and turtles. The patient had received a\nvaricella vaccine booster 10 days before admission. She had\nattended a summer camp in rural New York State 10 days before\nadmission, but she reported no known arthropod bites. The week\nbefore symptom onset she vacationed on the coast of Long Island,\nNY where she had cut her left foot while hunting for mussels in the\nocean. She denied sick contacts, including those with recent\nmeningitis or encephalitis.\nDuring the \ufb01rst 3 hospital days, her fever persisted and\nher mental status, which was initially intact, declined to a\nGlasgow coma score of 12. With this decline, acyclovir was\nempirically added.", "mimetype": "text/plain", "start_char_idx": 140057, "end_char_idx": 141760, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8f308ea1-14be-4986-b9d0-6a583f786280": {"__data__": {"id_": "8f308ea1-14be-4986-b9d0-6a583f786280", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c6609416-296d-4996-aca4-2e2d660bc359", "node_type": "1", "metadata": {}, "hash": "cf7cd19f7bef87bbd062c421f8d8c9a79f7c802f2fe345022249a396e4ffaede", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5b8b8817-2dd0-4418-9349-6c1f5b734f7a", "node_type": "1", "metadata": {}, "hash": "109688ce3870349516776a7c876d480b578a894f2c8c24b36f9a85dced0c75e9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "With this decline, acyclovir was\nempirically added. She also developed bilateral ankle clonus,\nrigidity in her upper extremities, and a waxing and waning of\nher level of alertness. A magnetic resonance imaging (MRI)\nwas performed on hospital day 5 which revealed multiple\nscattered T2 hyperintense lesions predominately affecting the\nwhite matter, with additional left putamen and caudate nucleus\ninvolvement (Fig. 1). The MR study showed no restricted\ndiffusion, and no abnormal enhancement. These \ufb01ndings were\nHicar et al\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\n\u00a9 2010 Lippincott Williams & Wilkins\n86\n|\nwww.pidj.com\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\nbelieved to be compatible with acute disseminated encephalo-\nmyelitis (ADEM), and she was treated with 500 mg methyl-\nprednisolone daily for 5 days. Over the next several days, she\nbecame afebrile and more alert, but her generalized weakness\npersisted. She was discharged after 9 days of total hospitaliza-\ntion with continued lower extremity weakness, imbalance, and\npersistent headaches.\nLaboratory studies performed during her hospitalization\nincluded negative bacterial cultures of the blood and CSF;\nnegative polymerase chain reaction studies on the CSF for\nherpes simplex virus, enteroviruses, adenovirus, Epstein-Barr\nvirus, human herpes virus 6, varicella zoster virus, and La\nCrosse encephalitis virus.", "mimetype": "text/plain", "start_char_idx": 141709, "end_char_idx": 143248, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5b8b8817-2dd0-4418-9349-6c1f5b734f7a": {"__data__": {"id_": "5b8b8817-2dd0-4418-9349-6c1f5b734f7a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8f308ea1-14be-4986-b9d0-6a583f786280", "node_type": "1", "metadata": {}, "hash": "3a604ca51d961cbc951525d341fcbb8ab0246cd12929df2d72d36285e856877b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1e4feb1c-c51a-44db-b152-87e5eb62cf72", "node_type": "1", "metadata": {}, "hash": "18db76fa0a2139e2200bb01889e14952065bc3b4bb001c720b0eaf70bd2f017a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Acute serology was negative for\nEpstein-Barr virus, Ehrlichia chaffeensis, Rickettsia rickettsii,\nCalifornia encephalitis serogroup viruses, Eastern equine en-\ncephalitis virus, Western equine encephalitis virus, and West\nNile virus. Acute serum tested positive for St. Louis encepha-\nlitis virus (SLE) with enzyme immunoassay (EIA) immuno-\nglobulin M (IgM) elevated at 3.49 (\u00063.0 is positive). Addi-\ntional testing performed by the Centers for Disease Control and\nPrevention, Atlanta, GA, revealed a Powassan virus-negative\nEIA IgG, but both a positive Powassan virus EIA IgM and\nplaque-neutralization test. Residual CSF was not available for\ntesting at this time. Testing of convalescent serum identi\ufb01ed\nPowassan virus IgG antibody by 2 methods. In microimmuno-\n\ufb02uorescence test, the median \ufb02uorescent intensity (MFI) bead\ncutoff was set at 1808 with acute sera MFI of 2641 and\nconvalescent sera MFI of 16,330. Additionally, serum plaque-\nreduction neutralization tests were 10 on acute sera and 160 on\nconvalescent sera. Both methods demonstrated a greater than\n4-fold rise in activity thus con\ufb01rming the diagnosis as acute\nPowassan virus infection.\nAt 3-month follow-up examination by a local neurologist\nin New York, she showed persistent subtle imbalance, but was\noverall greatly improved. On return to school, her grades were\nlower than when compared with the previous year. She had\nproblems in mathematics, reading comprehension, and expres-\nsive reading. A follow-up MRI done 6 months after hospital-\nization showed almost complete resolution of the demyelina-\ntion. At 15-month follow-up, her grades had returned to her\nprevious standards although she still had subjective de\ufb01cits in\nmath and reading. She had returned to all of her normal\nactivities including a martial arts class.", "mimetype": "text/plain", "start_char_idx": 143249, "end_char_idx": 145041, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1e4feb1c-c51a-44db-b152-87e5eb62cf72": {"__data__": {"id_": "1e4feb1c-c51a-44db-b152-87e5eb62cf72", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5b8b8817-2dd0-4418-9349-6c1f5b734f7a", "node_type": "1", "metadata": {}, "hash": "109688ce3870349516776a7c876d480b578a894f2c8c24b36f9a85dced0c75e9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a31f1939-7751-417c-abfb-8efca3561716", "node_type": "1", "metadata": {}, "hash": "c71a7bc10667e3a6eca4aee8999b42553b842b1163251aa01029003da6ebda73", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "At 15-month follow-up, her grades had returned to her\nprevious standards although she still had subjective de\ufb01cits in\nmath and reading. She had returned to all of her normal\nactivities including a martial arts class.\nDISCUSSION\nThis is the \ufb01rst reported case of Powassan virus infection\nwith a coincident, and potentially incorrect, diagnosis of\nADEM. Radiographic \ufb01ndings with Powassan encephalitis are\ninfrequently described. Previous reports of MRI \ufb01ndings con-\nsistent with acute ischemia or demyelination localizing to the\nparietal or temporal lobe have been reported, however, basal\nganglia changes have not been previously described.1 Powassan\nvirus is a member of the Flaviviridae family of RNA viruses\nand is predominantly spread by ticks.2 Other \ufb02aviviral enceph-\nalitides, including West Nile virus, Japanese encephalitis virus,\ntick-borne encephalitis virus, and SLE virus variably involve\nthe basal ganglia and thalamus on MRI examination. For the\nmajority of these \ufb02aviviruses, mosquitoes serve as the vector\nwith an exception of tick-borne encephalitis virus, a \ufb02avivirus\nendemic to most of Europe and spread by the Ixodes ricinus.\nThis infection is associated with lesions in the thalamus, putat-\nmen, pallidum, and caudate nucleus on T2 MRI images.3\nThis patient\u2019s course was consistent with a classic pre-\nsentation of Powassan encephalitis. The typical clinical presen-\ntation of Powassan central nervous system disease includes a 1\nto 3 day prodrome of nonspeci\ufb01c symptoms such as sore throat,\nmalaise, headache, and nausea, progressing to neurologic in-\nvolvement, ranging from confusion to frank coma. Previous\nPowassan infections have been reported from May through\nDecember with the peak incidence reported from June through\nSeptember.2 In experimental conditions, unlike rickettsial ill-\nnesses, transmission of Powassan virus can occur within 30\nminutes of tick attachment. Powassan virus has been isolated\nfrom a variety of ticks, including Ixodes cookie, Ix. scapularis,\nIx.", "mimetype": "text/plain", "start_char_idx": 144825, "end_char_idx": 146827, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a31f1939-7751-417c-abfb-8efca3561716": {"__data__": {"id_": "a31f1939-7751-417c-abfb-8efca3561716", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1e4feb1c-c51a-44db-b152-87e5eb62cf72", "node_type": "1", "metadata": {}, "hash": "18db76fa0a2139e2200bb01889e14952065bc3b4bb001c720b0eaf70bd2f017a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ab82e223-0226-4a71-8bb4-1290975cd63c", "node_type": "1", "metadata": {}, "hash": "f26af4580b638c4b22147fbbd387d8c71886502c5cecd44380f15d589e2ee918", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Powassan virus has been isolated\nfrom a variety of ticks, including Ixodes cookie, Ix. scapularis,\nIx. marxi, Ix. spinipalpus, and Dermacentor andersonii. Re-\nported cases primarily occur in Southeast Ontario, New York,\nand Southern New England. A molecularly similar virus, deer\ntick encephalitis virus, has been recently reported in both the\nNew England area and the Western Great Lakes4 and has been\nisolated from Ixodes dammini. The amino acid homology is\ngreater than 90% between these 2 viruses and it is currently\nFIGURE 1. Axial T2-weighted FLAIR MR images in a patient with Powassan fever. Hyperintense signal is present in the (A)\nbilateral high cerebral white matter in a patchy distribution (white arrowheads), left caudate body, (B) bilateral caudate\nheads (black asterisks), left superior putamen (white arrow), and (C) left cerebellum white matter.\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\nPowassan Virus Presenting as ADEM\n\u00a9 2010 Lippincott Williams & Wilkins\nwww.pidj.com\n| 87\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\nunclear whether Powassan virus and deer tick virus can be\nserologically distinguished.5 Due to the conservation of major\nportions of the envelope protein, there is signi\ufb01cant serologic\ncross-reactivity among \ufb02aviviruses. This was true in the case\nabove, where the initial evidence of infection was based on a\npositive serologic test to SLE virus.", "mimetype": "text/plain", "start_char_idx": 146725, "end_char_idx": 148273, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ab82e223-0226-4a71-8bb4-1290975cd63c": {"__data__": {"id_": "ab82e223-0226-4a71-8bb4-1290975cd63c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a31f1939-7751-417c-abfb-8efca3561716", "node_type": "1", "metadata": {}, "hash": "c71a7bc10667e3a6eca4aee8999b42553b842b1163251aa01029003da6ebda73", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3fd9745a-e8f4-4285-add6-21b637f8b5b2", "node_type": "1", "metadata": {}, "hash": "e2ac91573a614840e18f445c78c8a8cc95fc14e77dc548c5df1ce4e52972d33d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This was true in the case\nabove, where the initial evidence of infection was based on a\npositive serologic test to SLE virus. Species speci\ufb01c neutral-\nization assays are required to con\ufb01rm individual infections.6\nCase fatality rates of 10% to 15% for Powassan neuroinva-\nsive infection have been reported. In a recent review, 11 of 20\ninfected patients had long-term neurologic sequelae, including\nheadache, hemiplegia, and memory problems. Signi\ufb01cant numbers\nof subclinical cases occur because up to 5% of individuals in\nendemic areas are seropositive for Powassan virus.7\nThe initial Powassan strain was isolated from a 5-year-\nold Canadian boy with fatal encephalitis in 1958 and the\nmajority of early cases were reported in children and adoles-\ncents. Recently, however, of the reported cases, greater than\n90% have occurred in adults.1,2 The incidence of Powassan\nneuroinvasive infection may be increasing. In 2007, there were\n6 cases of Powassan virus infection from New York State\nreported to the CDC, whereas in the previous 6 years, there had\nonly been 1 case. Other states with sporadic cases in the last 8\nyears include Minnesota, Wisconsin, Michigan, and Maine. In\n1999\u20132001, there was a mini-outbreak in Maine and Ver-\nmont.1,5,8 Between 1958 and 1998, only 27 human cases were\nreported from Canada and the Northeast United States.7\nWhether the recent cases represent a true rise in incidence or\nre\ufb02ect a surveillance artifact after the introduction of West Nile\nvirus into the United States is uncertain.\nThis case highlights the need to include Powassan infec-\ntion in the differential diagnosis of patients presenting with\nencephalitis. In the present case, the positive antibody to a\nrelated \ufb02avivirus, SLE virus, coupled with the history of recent\nexposure in an endemic area led to con\ufb01rmatory testing for this\nunusual pathogen.\nThis case is the \ufb01rst to associate Powassan virus infection\nwith basal ganglia MRI changes.", "mimetype": "text/plain", "start_char_idx": 148148, "end_char_idx": 150087, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3fd9745a-e8f4-4285-add6-21b637f8b5b2": {"__data__": {"id_": "3fd9745a-e8f4-4285-add6-21b637f8b5b2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ab82e223-0226-4a71-8bb4-1290975cd63c", "node_type": "1", "metadata": {}, "hash": "f26af4580b638c4b22147fbbd387d8c71886502c5cecd44380f15d589e2ee918", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fbaa9766-028a-40ac-80d6-c9abecbc2b29", "node_type": "1", "metadata": {}, "hash": "71f594e9d6f2b6dcc3cb688ad65edcb284b41a5128f734ab9ee71e6a222df4cc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This case is the \ufb01rst to associate Powassan virus infection\nwith basal ganglia MRI changes. It is unclear whether these\nchanges were truly immune mediated as would be found in\nADEM, or represented neurotropism of the Powassan virus.\nHowever, due to the clinical course and description of other\n\ufb02aviviral infections affecting the basal ganglia, it is most likely\nsolely an effect of the Powassan virus infection. This is a\nsigni\ufb01cant issue, because although there is no antiviral treat-\nment available, corticosteroids are often bene\ufb01cial for treatment\nof ADEM but may be counter-indicated in acute Powassan viral\ninfection.\nACKNOWLEDGMENTS\nThe authors thank Drs. Curt Wuchensky and Joseph Aulino for\ntheir informative comments on this manuscript.\nREFERENCES\n1. Hinten SR, Beckett GA, Gensheimer KF, et al. Increased recognition of\nPowassan encephalitis in the United States, 1999\u20132005. Vector Borne\nZoonotic Dis. 2008;8:733\u2013740.\n2. Romero JR, Simonsen KA. Powassan encephalitis and Colorado tick fever.\nInfect Dis Clin North Am. 2008;22:545\u2013559.\n3. Alkadhi H, Kollias SS. MRI in tick-borne encephalitis. Neuroradiology.\n2000;42:753\u2013755.\n4. Ebel GD, Spielman A, Telford SR III. Phylogeny of North American\nPowassan virus. J Gen Virol. 2001;82:1657\u20131665.\n5. Ebel GD. Update on Powassan virus: emergence of a North American\ntick-borne \ufb02avivirus. Annu Rev Entomol. 2010;55:95\u2013110.\n6. Gubler DJ, Kuno G, Markoff L. Flaviviruses. In: Fields BN, Knipe DM,\nHowley PM. Fields Virology. 5th ed. Philadelphia: Wolters Kluwer Health/\nLippincott Williams & Wilkins; 2007.\n7.", "mimetype": "text/plain", "start_char_idx": 149996, "end_char_idx": 151557, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fbaa9766-028a-40ac-80d6-c9abecbc2b29": {"__data__": {"id_": "fbaa9766-028a-40ac-80d6-c9abecbc2b29", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011a).pdf", "node_type": "4", "metadata": {}, "hash": "db2458e1e123bf61259b8b3b18a68c9b368a98c42830af97e9e35f0bb6b390f5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3fd9745a-e8f4-4285-add6-21b637f8b5b2", "node_type": "1", "metadata": {}, "hash": "e2ac91573a614840e18f445c78c8a8cc95fc14e77dc548c5df1ce4e52972d33d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In: Fields BN, Knipe DM,\nHowley PM. Fields Virology. 5th ed. Philadelphia: Wolters Kluwer Health/\nLippincott Williams & Wilkins; 2007.\n7. Gholam BI, Puksa S, Provias JP. Powassan encephalitis: a case\nreport with neuropathology and literature review. CMAJ. 1999;161:\n1419\u20131422.\n8. Centers for Disease Control and Prevention (CDC). Outbreak of Powassan\nencephalitis\u2014Maine and Vermont, 1999\u20132001. MMWR Morb Mortal Wkly\nRep. 2001;50:761\u2013764.\nHicar et al\nThe Pediatric Infectious Disease Journal \u2022 Volume 30, Number 1, January 2011\n\u00a9 2010 Lippincott Williams & Wilkins\n88\n|\nwww.pidj.com\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025", "mimetype": "text/plain", "start_char_idx": 151420, "end_char_idx": 152173, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4bdcbfe5-ee0b-47ae-acd3-4d333fb274d7": {"__data__": {"id_": "4bdcbfe5-ee0b-47ae-acd3-4d333fb274d7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Bloom (1975).pdf", "node_type": "4", "metadata": {}, "hash": "158a1fc8b43f694d52da22bf95666c247ab4b5082df6d30909c29a74c6945da5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ced21b70-51e1-4333-893e-6caf411ceaea", "node_type": "1", "metadata": {}, "hash": "27927355b8c7684ca002f3b0b8c4a7263f1f7b8b98c54ad0778fc2d606f7ac05", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Volume 87 \nBrief clinical and laboratory observations \n8 5 \nNumber 1 \nEvaluation of a \ntrivalent measles, \nmumps, rubella vaccine \nin children \nJ. L. Bloom, M.D., G. M. Schiff, M.D.,* \nCincinnati, Ohio, H. Graubarth, M.D., \nR. W. Lipp, Jr., M.D., J. E. Jackson, \nM.D., Dr.P.H., R. L. Osborn, B.S., and \nM. T. Kenny, Ph.D., Indianapolis, Ind. \nLIVE ATTENUATED VIRUS VACCINES can be admin- \nistered simultaneously without increase in reactivity or \ndiminution in immunologic responses? Recently, a \nsecond measles, mumps, and rubella trivalent vaccine has \nbeen licensed. This study describes the reactivity and \nimmunologic efficacy.of this newer trivalent vaccine. \nMATERIALS \nAND METHODS \nVaccine. The vaccine was a combination of Schwarz \nstrain live, attenuated measles virus, 2 Jeryl Lynn strain \nfive, attenuated mumps virus? and Cendehill strain live, \nand attenuated rubella virus? Three different production \nlots were used in this study. All lots contained at least \n1,000 50% tissue culture infective doses of measles and \nrubella viruses and 5,000 TCIDs0 of mumps virus. The \ntrivalent vaccine was dispensed into single dose vials, \nlyophilized, and stored at 5~ until administered. \nPlacebo. The placebo used in the study was identical to \nthe vaccine in all respects except it did not contain \nvirus. \nSerology. All serologic assays were performed in the \nAssay Laboratory of The Dow Chemical Company in \nZionsville, Indiana. Antibodies to measles and rubella \nviruses were determined by the hemagglutination inhibi- \ntion method in microtiter plates?, 6 Four units of hemag- \nglutination antigen were used; the end point was taken as \nthe highest serum dilution that completely inhibited \nFrom the Infectious Disease Division, Department of \nInternal Medicine and the Department of Pediatrics, \nUniversity of Cincinnati Medical Center, and the \nHuman Health Research and Development \nLaboratories of The Dow Chemical Company. \nDr.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1944, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ced21b70-51e1-4333-893e-6caf411ceaea": {"__data__": {"id_": "ced21b70-51e1-4333-893e-6caf411ceaea", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Bloom (1975).pdf", "node_type": "4", "metadata": {}, "hash": "158a1fc8b43f694d52da22bf95666c247ab4b5082df6d30909c29a74c6945da5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4bdcbfe5-ee0b-47ae-acd3-4d333fb274d7", "node_type": "1", "metadata": {}, "hash": "3acf90a74ad9cd71fdea68891c655d642c180a510bdba1022ddef6599effee88", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8f8a15ae-7760-476a-8584-e8be10ae9faf", "node_type": "1", "metadata": {}, "hash": "4075714e286a597d1fee4edcc658e0226135627e20c7749ea5cf8b79e81f2607", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Dr. Schiff is a Research Career Development \nAwardee, Grant No. 5 K03 HD 13566, United States \nPublic Health Service. \n*Reprint address: Infectious Disease Division, 7th Floor, U. \nC. College of Medicine, Cincinnati, Ohio 45267. \nTable I. Percentage of children exhibiting positive clinical \nfindings from Day 7 through Day 21 after inoculation \nVaccinees* \n(%) \nTemperature elevationt: Degrees above normal:~ \n1.5-2.4~ \n10.6 \n5.7 \n2.5 - 3.4~ \n0.6 \n5.7 \n3.5 - 4.4~ \n3.1 \n0.0 \n4.5 - 4.9~ \n1.2 \n0.0 \nQualitative findingsw \nRash \n12.0 \n5.0 \nLymphadenopathy \n1.1 \n2.5 \nCoryza \n2.2 \n10.0 \nRhinitis \n1.1 \n10.0 \nCough \n2.7 \n2.5 \nOther \n19.1 \n20.0 \nPlacebo \nsubjects (%) \n*All vaecinees are triple susceptible. Twenty-three vaccinees and five \nplacebo subjects were omitted from the upper part of the table because of \ninadequate temperature records. \n~One-hundred sixty vaccinees and 35 placebo subjects \n:~Normal is defined as 99.6~ \nrectal (163 children), 98.6~ \noral (6 \nchildren), and 97.6~ axillary (26 children). \nw \neighty three vaccinees and 40 placebo subjects. \nagglutination of the test erythrocytes. Mumps antibody \ntiters were determined by the VERO cell microtiter serum \nneutralization technique. 7 Ifpostinoculation antibody was \nnot detected by this technique, paired sera were retested \nundiluted and at 1:2 dilution by a plaque technique in \nVERO cells (Kenny, M. T. and Schetl, K. R., to be \npublished).", "mimetype": "text/plain", "start_char_idx": 1941, "end_char_idx": 3357, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8f8a15ae-7760-476a-8584-e8be10ae9faf": {"__data__": {"id_": "8f8a15ae-7760-476a-8584-e8be10ae9faf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Bloom (1975).pdf", "node_type": "4", "metadata": {}, "hash": "158a1fc8b43f694d52da22bf95666c247ab4b5082df6d30909c29a74c6945da5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ced21b70-51e1-4333-893e-6caf411ceaea", "node_type": "1", "metadata": {}, "hash": "27927355b8c7684ca002f3b0b8c4a7263f1f7b8b98c54ad0778fc2d606f7ac05", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f3c61168-eddc-44d5-967f-8654a533be9c", "node_type": "1", "metadata": {}, "hash": "82e8250dea0a14f3cec70ee84f204858294670310d8307a85d5edc6d71aacd4d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Abbreviations used \nTCIDs0: 50% tissue culture infective doses \nHI: \nhemagglutination inhibition \nSN: \nserum neutralization \nGMT: \ngeometric mean titers \nChildren were considered susceptible to each disease if \nantibody was not detectable (measles HI titer < \n1:2; \nmumps SN titer < 1:2; rubella HI titer < 1:8) in the \npreinoculation serum. Seroconversion after inoculation \nwas determined by the appearance of antibody in the \npostinoculation serum sample of a previously susceptible \nchild. Pre- and postvaccination paired sera were always \ntested simultaneously. All assays were done with double- \nblind samples and the results were decoded, tabulated, \nand analyzed by computer. \nPopulation. Subjects were admitted to the study from a \nprivate pediatrician's office. Criteria for admission in- \neluded: (1) 11 months to four years of age; (2) absence of \nany history of natural measles, mumps, or rubella, or \nimmunization against these diseases; (3) parental consent; \nand (4) the absence of any of the usual medical contrain- \n8 6 \nBrief clinical and laboratory observations \nThe Journal of Pediatrics \nJuly 1975 \nTable II. Immune responses of triple susceptible children 1 to 4 years of age inoculated with trivalent (measles/ \nmumps/rubella) live-virus vaccine or placebo \nGMT \nNo. \nMeasles seroconversion \nNo.", "mimetype": "text/plain", "start_char_idx": 3359, "end_char_idx": 4678, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f3c61168-eddc-44d5-967f-8654a533be9c": {"__data__": {"id_": "f3c61168-eddc-44d5-967f-8654a533be9c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Bloom (1975).pdf", "node_type": "4", "metadata": {}, "hash": "158a1fc8b43f694d52da22bf95666c247ab4b5082df6d30909c29a74c6945da5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8f8a15ae-7760-476a-8584-e8be10ae9faf", "node_type": "1", "metadata": {}, "hash": "4075714e286a597d1fee4edcc658e0226135627e20c7749ea5cf8b79e81f2607", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5caa5813-73ad-4d5f-85ac-bf0c4cf6da8c", "node_type": "1", "metadata": {}, "hash": "8ba81e4389e49a2c6d8480a1957d4463d66a552f3e06de8b92182fae09291efc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Measles seroconversion \nNo. \nI \n% \nNumber \nof \nsubjects \nImmune responses \nLot 1 \n62 \n62 \n100.0 \n43.7 \n59 \nLot 2 \n65 \n64 \n98.5 \n36.0 \n65 \nLot 3 \n55 \n55 \n100.0 \n37.2 \n55 \nTotals \n182 \n181 \n99.4 \n38.9 \n179 \nPlacebo \n40 \n0 \n0 \n0 \n0 \nMumps seroconversion \nRubella seroconversion \n95.2 \n4.1 \n61 \n98.4 \n21.7 \n100.0 \n3.9 \n64 \n98.5 \n23.6 \n100.0 \n4.7 \n52 \n94.___~5 \n21.2 \n98.4 \n4.2 \n177 \n97.3 \n22.2 \n0 \n0 \n0 \n0 \n0 \ndications to immunization with measles, mumps, or ru- \nbella live, attenuated virus vaccines. \nStudy design. A randomized, double-blind design was \nused to distribute the study population among the three \nlots of vaccine and the placebo in a ratio of one placebo to \nevery five vaccinees. Pre-inoculation blood samples were \ncollected, and vaccine or placebo administered. Double- \nblind observations for possible vaccine reactions and \nintercurrent illnesses were made approximately three \ntimes per child during the period from Day 7 to Day 21. \nAdditional observations were recorded after Day 21 in the \nevent of illness, and an interval history was recorded for \neach child at the time an eight-week blood sample was \ndrawn. The results of these observations were decoded \nand tabulated by computer. \nRESULTS \nTwo hundred and eighty-two children participated in \nthe study. Two hundred and twenty-five of the children \nwere one year old, and 34 children were between 11 and \n12 months of age. Overall 91.9% of the children were \ntriple susceptible. There was a total of 709 follow-up \nclinical evaluations excluding the evaluations made at the \ntime of collection of the eight-week blood sample. No \nlocal reactions were reported.", "mimetype": "text/plain", "start_char_idx": 4651, "end_char_idx": 6291, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5caa5813-73ad-4d5f-85ac-bf0c4cf6da8c": {"__data__": {"id_": "5caa5813-73ad-4d5f-85ac-bf0c4cf6da8c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Bloom (1975).pdf", "node_type": "4", "metadata": {}, "hash": "158a1fc8b43f694d52da22bf95666c247ab4b5082df6d30909c29a74c6945da5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f3c61168-eddc-44d5-967f-8654a533be9c", "node_type": "1", "metadata": {}, "hash": "82e8250dea0a14f3cec70ee84f204858294670310d8307a85d5edc6d71aacd4d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a80ed783-7f29-4da5-bc70-97530d4c5d53", "node_type": "1", "metadata": {}, "hash": "e0319b3fbc1dcb351d8be4ad8c483cfb1d97b192b0bd88e24d7c8d09c155bc06", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "There was a total of 709 follow-up \nclinical evaluations excluding the evaluations made at the \ntime of collection of the eight-week blood sample. No \nlocal reactions were reported. \nThe frequencies of clinical findings between Days 7 and \n21 are presented in Table I. Temperature elevations tend \nto occur more often in vaccinees, but the excess frequency \nin vaccinees (4.1% overall and 4.3% at _> 3.5~ \nis not \nstatistically significant (Fisher's exact probability: p = \n0.37 overall and 0.24 at _> 3.5~ \nOther clinical findings were of low frequency in both \nsusceptible and placebo subjects. The higher frequency of \nrash reported in vaccinated triple susceptible subjects \ncompared with susceptible placebo subjects was nrt \nstatistically significant (X 2 = 0.752, 0.1 < p < 0.5). No \nlimb or joint symptoms were reported either before or \nafter Day 21. \nPaired sera were obtained from 222 triple susceptible \nsubjects one to four years of age. The serologic results \nfrom these children are summarized in Table II. The \nseroconversion rates in triple susceptible vaccinees one to \nfour years of age ranged from 98.5% to 100% for measles, \nfrom 96.8% to 100% for mumps, and from 94.5% to 98.5% \nfor rubella. The geometric mean titers of antibodies \nagainst all three viruses were as high as those found after \nmonovalent vaccination. \nPaired sera were obtained from 33 triple susceptible \ninfants who were 11 months old at the time of vaccination. \nOf these, 29 were vaccinees and four were placebo \nsubjects. Among these infant vaccinees seroconversion \nrates were 93.1% for measles and rubella and 96.5% for \nmumps, and the GMT's were 36.2 for measles, 4.3 for \nmumps, and 23.2 for rubella. \nNone of the recipients of the placebo experienced \nseroconversion. \nDISCUSSION \nThe availability of effective trivalent vaccines has im- \nportant implications in achieving successful immunization \nprograms.", "mimetype": "text/plain", "start_char_idx": 6110, "end_char_idx": 8016, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a80ed783-7f29-4da5-bc70-97530d4c5d53": {"__data__": {"id_": "a80ed783-7f29-4da5-bc70-97530d4c5d53", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Bloom (1975).pdf", "node_type": "4", "metadata": {}, "hash": "158a1fc8b43f694d52da22bf95666c247ab4b5082df6d30909c29a74c6945da5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5caa5813-73ad-4d5f-85ac-bf0c4cf6da8c", "node_type": "1", "metadata": {}, "hash": "8ba81e4389e49a2c6d8480a1957d4463d66a552f3e06de8b92182fae09291efc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d6b319c3-c436-4e8f-b165-46142290b014", "node_type": "1", "metadata": {}, "hash": "299bc3bea062d80bb510f89dc8b22d6c658c0bb76614d9bd0c1f4686ec85d53e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "None of the recipients of the placebo experienced \nseroconversion. \nDISCUSSION \nThe availability of effective trivalent vaccines has im- \nportant implications in achieving successful immunization \nprograms. Besides being more economical, the trivalent \nvaccines permit fuller vaccine coverage in the segments of \nthe populations which have been traditionally hard to \nimmunize. Reduction in the number of visits required for \nimmunization makes this possible. \nMeasles, mumps, and rubella live-virus vaccines are \ngenerally considered to be less than fully effective in \nchildren less than one year old because of the occasional \npersistence of maternal antibodies. In this study, 29 11- \nmonth-old triple-susceptible triple vaccinees gave sero- \nconversion rates and GMT's within the ranges to be ex- \npected from older children receiving the same vaccines \nalone or combined. However, this number of infant \nvaccinees is too small to justify advocating administration \nof this trivalent vaccine prior to one year of age. There- \nfore, this vaccine should not be given to children under \nVolume 87 \nBrief clinical and laboratory observations \n8 7 \nNumber 1 \none year of age unless required by epidemic conditions. \nInfants thus vaccinated should be revaccinated after they \nhave attained one year of age unless an antibody response \nto the earlier vaccination can be documented. \nA trivalent measles, mumps, rubella vaccine, M-M-R, \nhas been available for more than two years. The trivalent \nvaccine we evaluated has been recently licensed and \nprovides physicians with a choice of product. The two \nvaccines differ in the strains of measles and rubella, but \nutilize similar dosage of all three components. The tri- \nvalent vaccines have resulted in adequate antibody \nresponse; little reactivity, and indications for persistence \nof antibody similar to the monovalent vaccines? \nREFERENCES \n1. Meyer HM Jr, Hopps BC, Bernheim BC, and Douglas RD: \nCombined measles-smallpox and other vaccines, First Inter- \nnational Conference on Vaccines Against Viral and Rickett- \nsial Diseases of Man, Pan Am Health Organ, Washington, \n1967. \n2.", "mimetype": "text/plain", "start_char_idx": 7810, "end_char_idx": 9945, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d6b319c3-c436-4e8f-b165-46142290b014": {"__data__": {"id_": "d6b319c3-c436-4e8f-b165-46142290b014", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Bloom (1975).pdf", "node_type": "4", "metadata": {}, "hash": "158a1fc8b43f694d52da22bf95666c247ab4b5082df6d30909c29a74c6945da5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a80ed783-7f29-4da5-bc70-97530d4c5d53", "node_type": "1", "metadata": {}, "hash": "e0319b3fbc1dcb351d8be4ad8c483cfb1d97b192b0bd88e24d7c8d09c155bc06", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "457370e7-1207-486b-be46-66b9b0fe8828", "node_type": "1", "metadata": {}, "hash": "7eb171d3b0cc431fd1b7cc599d12aa1f48113bcdefb06b36039e9d41ed5f8962", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2. Schwarz AJF: Preliminary tests of a highly attenuated \nmeasles vaccine, Am J Dis Child 103:386, 1962. \n3. Weibel RE, Stokes J Jr, Buynak EB, Whitman JE Jr, and \n\" Hilleman MR: Live attenuated mumps-virus vaccine. 3. \nClinical and serologic aspects in a field evaluation, N Engl J \nMed 276:245, 1967. \n4. DuPan RM, Huygelen C, Peetermans J, and Prinzie A: \nClinical trials with a live, attenuated rubella virus vaccine: \nCendehill 51 strain, Am J Dis Child 115:658, 1968. \n5. Linnernann CC Jr, Rotte TC, Schiff GM, and Youtsey JL: \nA seroepidemiologic study of a measles epidemic in a highly \nimmunized population, Am J Epidemiol 95:238, 1972. \n6. Cooper LZ, Matters E, Rosenblum JK, et al: Experience \nwith a modified rubella hemagglutination-inhibition anti- \nbody test, JAMA 207:89, 1969. \n7. Kenny MT, Albright KL, and Sanderson RP: Microneutral- \nization test for the determination of mumps antibody in \nVERO cells, Appl Microbiol 20:371, 1970. \n8. Weibel RE, Buynak EB, Stokes J Jr, and Hilleman MR: \nPersistence of immunity following monovatent and com- \nbined live measles, mumps, and rubella virus vaccines, \nPediatrics 51:467, 1973. \nDefective neutrophil \nchemotaxis in patients \nwith Down syndrome \nAbdul J. Khan, M.D., Hugh E. Evans, M.D., \nLeonard Glass, M.D., Yong Ho Shin, M.D., \nand Diogenes Almonte, M.D., Brooklyn, N. Y. \nDOW~ SYNDROME (trisomy 21) is associated with \nincreased susceptibility to infection.", "mimetype": "text/plain", "start_char_idx": 9943, "end_char_idx": 11370, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "457370e7-1207-486b-be46-66b9b0fe8828": {"__data__": {"id_": "457370e7-1207-486b-be46-66b9b0fe8828", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Bloom (1975).pdf", "node_type": "4", "metadata": {}, "hash": "158a1fc8b43f694d52da22bf95666c247ab4b5082df6d30909c29a74c6945da5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d6b319c3-c436-4e8f-b165-46142290b014", "node_type": "1", "metadata": {}, "hash": "299bc3bea062d80bb510f89dc8b22d6c658c0bb76614d9bd0c1f4686ec85d53e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This phenomenon \nmay be due partially to such defects in leukocyte function \nas decreased phagocytosis 1 and bactericidal capacity ~ and \npoor nitroblue tetrazolium dye reduction. 2 We have \nrecently studied chemotactic migration of polymorphonu- \nclear leukocytes obtained from children with Down \nsyndrome and have observed significantly decreased \nvalues when compared to cells from normal control \nsubjects. \nFrom the Division of Infectious Disease and \nImmunology, Department of Pediatrics, Jewish \nHospital and Medical Center of Brooklyn. \nReprint address: Department of Pediatrics, Jewish Hospital \nand Medical Center of Brooklyn, 555 Prospect Place, \nBrooklyn, N. Y. 11238. \nSUBJECTS AND METHODS \nTen infants and children (six boys and four girls) with \nDown syndrome, currently free of infection, were studied. \nTheir ages ranged from 9 months to 12 years with a \nmedian of 4.5 years; they had never been in an institu- \ntional environment. The diagnosis of Down syndrome \nwas confirmed as trisomy 21 by cytogenetic studies in all \ncases. \nAn equal number of age-matched children \n(admitted to the hospital for elective surgery) served as \ncontrol subjects. \n- \nAbbreviations used \nHBS: Hanks balanced salt \nNBT: nitroblue tetrazolium \nChemotaxis was performed by the technique of \nBoyden 3 as modified by Baum and associates? Leuko- \ncytes were harvested by methyl cellulose sedimentation as \ndescribed previously:' Cell counts were adjusted by \nadding Hank balanced salt solution. Three-tenths of a \nmilliliter of this suspension was used to deposit 1.0 x 106 \nto 2.6 x 10 ~ cells (with 75-90% granulocytes) to a 3/~ \nmillipore filter, utilizing a Shandon Elliot cytocentrifuge. \nThe filters were then placed in a Sykes Moore tissue \nculture chamber. The upper compartment was filled with \nHBS while the lower compartment contained a 20% \nmixture of type AB serum in HBS containing Escherichia \ncoti endotoxin (Difco Laboratories), 1 /~g/ml of HBS.", "mimetype": "text/plain", "start_char_idx": 11371, "end_char_idx": 13330, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d43abda5-6a41-4b26-8383-199c98d07abc": {"__data__": {"id_": "d43abda5-6a41-4b26-8383-199c98d07abc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "550d182c-e186-4126-9de2-7c9f2f93a088", "node_type": "1", "metadata": {}, "hash": "532f89f08eed85ffdd45de10ec969f793bcdea734f99354e8853afb67253c068", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ORIGINAL STUDIES\nEncephalopathy After Whole-Cell Pertussis or\nMeasles Vaccination\nLack of Evidence for a Causal Association in a Retrospective\nCase\u2013Control Study\nPaula Ray, MPH,* Jean Hayward, MD,* David Michelson, MD,* Edwin Lewis, MPH,*\nJoan Schwalbe, MS,* Steve Black, MD,* Henry Shine\ufb01eld, MD,\u0001 Michael Marcy, MD,\u2020\nKen Huff, MD,\u2020 Joel Ward, MD,\u2020 John Mullooly, MD,\u2021 Robert Chen, MD,\u00a7 Robert Davis, MD,\u00a7\nand The Vaccine Safety Datalink Group\nBackground: Whole-cell pertussis (wP) and measles vaccines are\neffective in preventing disease but have also been suspected of increas-\ning the risk of encephalopathy or encephalitis. Although many countries\nnow use acellular pertussis vaccines, wP vaccine is still widely used in\nthe developing world. It is therefore important to evaluate whether wP\nvaccine increases the risk of neurologic disorders.\nMethods: A retrospective case\u2013control study was performed at 4\nhealth maintenance organizations. Records from January 1, 1981,\nthrough December 31, 1995, were examined to identify children aged 0\nto 6 years old hospitalized with encephalopathy or related conditions.\nThe cause of the encephalopathy was categorized as known, unknown\nor suspected but uncon\ufb01rmed. Up to 3 controls were matched to each\ncase. Conditional logistic regression was used to analyze the relative\nrisk of encephalopathy after vaccination with diphtheria\u2013tetanus\u2013per-\ntussis (DTP) or measles\u2013mumps\u2013rubella (MMR) vaccines in the 90\ndays before disease onset as de\ufb01ned by chart review compared with an\nequivalent period among controls indexed by matching on case onset\ndate.\nResults: Four-hundred \ufb01fty-two cases were identi\ufb01ed. Cases were\nno more likely than controls to have received either vaccine during\nthe 90 days before disease onset.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1760, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "550d182c-e186-4126-9de2-7c9f2f93a088": {"__data__": {"id_": "550d182c-e186-4126-9de2-7c9f2f93a088", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d43abda5-6a41-4b26-8383-199c98d07abc", "node_type": "1", "metadata": {}, "hash": "44b01e31bbf27013dd7e828f91e1f61d860c413228ca7bf4967560c78040cdd5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c045a63a-0bab-4075-85ed-4b7c1b78ce95", "node_type": "1", "metadata": {}, "hash": "2ab23aed09278a55759ee8b0fe7f56cd3d69841452cba23bf3af07d3dfb6c237", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Results: Four-hundred \ufb01fty-two cases were identi\ufb01ed. Cases were\nno more likely than controls to have received either vaccine during\nthe 90 days before disease onset. When encephalopathies of known\netiology were excluded, the odds ratio for case children having\nreceived DTP within 7 days before onset of disease was 1.22 (95%\ncon\ufb01dence interval \u0001CI\u0002 \u0003 0.45\u20133.31, P \u0003 0.693) compared with\ncontrol children. For MMR in the 90 days before onset of enceph-\nalopathy, the odds ratio was 1.23 (95% con\ufb01dence interval \u0003\n0.51\u20132.98, P \u0003 0.647).\nConclusions: In this study of more than 2 million children, DTP and\nMMR vaccines were not associated with an increased risk of\nencephalopathy after vaccination.\nKey Words: encephalopathy, vaccine, MMR, DTP\n(Pediatr Infect Dis J 2006;25: 768\u2013773)\nV\naccination has proved effective in controlling several\ninfectious diseases, including pertussis and measles.1\u20133\nHowever, some reports have attributed serious adverse events\nto the use of the pertussis and measles vaccines. In particular,\nencephalopathy or encephalitis has been reported to occur\nafter receipt of whole-cell pertussis vaccine (wP) or com-\nbined measles\u2013mumps\u2013rubella (MMR) vaccine.4 In the\n1970s, concerns among the public regarding possible neuro-\nlogic reactions led to a decline in pertussis vaccine use in the\nUnited Kingdom; unfortunately, this decrease in vaccine\nacceptance was quickly followed by outbreaks of disease in\n1977\u20131979 and 1982. Similar events took place in Japan4 and\nSweden5 in the late 1970s.\nThe purported association between vaccine use and\nencephalopathy remains controversial.6 The largest and best\nknown of the studies that have examined this issue was a\ncase\u2013control study, the National Childhood Encephalopathy\nStudy (NCES), conducted in the United Kingdom from 1976\nto 1979.", "mimetype": "text/plain", "start_char_idx": 1595, "end_char_idx": 3400, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c045a63a-0bab-4075-85ed-4b7c1b78ce95": {"__data__": {"id_": "c045a63a-0bab-4075-85ed-4b7c1b78ce95", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "550d182c-e186-4126-9de2-7c9f2f93a088", "node_type": "1", "metadata": {}, "hash": "532f89f08eed85ffdd45de10ec969f793bcdea734f99354e8853afb67253c068", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "112ec265-0f66-4079-8725-8e08984f1fae", "node_type": "1", "metadata": {}, "hash": "f34750f768d899186c12f0dfd514f91dd8fd403344144bbbc822396799425160", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All pediatricians, infectious disease specialists and\nneurosurgeons in the country were asked to report cases of\nneurologic illness in children 2 to 36 months old. Two\ncontrols were matched to each case and vaccine histories\nwere obtained for the month before admission to the hospital\nor for the corresponding month for controls. The relative risk\n(RR)\nof\ndiphtheria\u2013tetanus\u2013pertussis\n(DTP)\nvaccination\nwithin the 7 days before the onset of encephalitis was 3.1\n(95% con\ufb01dence interval \u0001CI\u0002 \u0003 1.0\u201310.5).7 This was not\nstatistically signi\ufb01cant and the investigators therefore con-\ncluded that the results were suggestive of but did not prove an\nassociation between vaccination and neurologic illness. How-\never, others maintain that the NCES experienced method-\nologic problems and that the evidence does not even suggest\nAccepted for publication June 16, 2006.\nFrom the *Kaiser Permanente Vaccine Study Center, Oakland, CA; the\n\u2020Division of Neurology, Department of Pediatrics, Harbor\u2013UCLA Med-\nical Center, Torrance, CA; the \u2021Center for Health Research, Kaiser\nPermanente, Portland, OR; the \u00a7National Immunization Program, Cen-\nters for Disease Control and Prevention, Atlanta, GA; and \u0001Clinical\nProfessor of Pediatrics, University of California San Francisco, CA.\nFunded by the American Association of Health Plans as part of the CDC\nVaccine Safety Datalink Project.\nAddress for correspondence: Steve Black, MD, Kaiser Vaccine Study Cen-\nter, One Kaiser Plaza, 16th Floor Bayside, Oakland, CA 94612. E-mail\nsteve.black@kp.org.", "mimetype": "text/plain", "start_char_idx": 3401, "end_char_idx": 4930, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "112ec265-0f66-4079-8725-8e08984f1fae": {"__data__": {"id_": "112ec265-0f66-4079-8725-8e08984f1fae", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c045a63a-0bab-4075-85ed-4b7c1b78ce95", "node_type": "1", "metadata": {}, "hash": "2ab23aed09278a55759ee8b0fe7f56cd3d69841452cba23bf3af07d3dfb6c237", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "24804042-bb5b-4fbe-be0c-1f23ff810a4d", "node_type": "1", "metadata": {}, "hash": "f42ab3574e2c980027dc435e12fb52f273b2d583a97853075b15adc9346efbcd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Address for correspondence: Steve Black, MD, Kaiser Vaccine Study Cen-\nter, One Kaiser Plaza, 16th Floor Bayside, Oakland, CA 94612. E-mail\nsteve.black@kp.org.\nCopyright \u00a9 2006 by Lippincott Williams & Wilkins\nISSN: 0891-3668/06/2509-0768\nDOI: 10.1097/01.inf.0000234067.84848.e1\nThe Pediatric Infectious Disease Journal \u2022 Volume 25, Number 9, September 2006\n768\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 01/09/2025\nsuch an association.6 The interpretation of the NCES was\nlimited by the small number of cases exposed to vaccine; only\n26 of the \ufb01rst 1000 reported cases (2.6%) had received DTP\nvaccine within 7 days of the onset of the encephalopathy; 30\nof 2000 controls (1.5%) had received vaccine during the\nequivalent period.8 Most affected children recovered without\nlong-term sequelae and a 10-year follow up of the NCES\npopulation found that there was no signi\ufb01cant difference in\ndeath or rate of neurologic dysfunction between the children\nwho were vaccinated shortly before the onset of their acute\nillness and those who were not.9 The NCES study found that\nchildren with convulsions or encephalopathy were more\nlikely to have received MMR vaccine 7 to 14 days before the\nonset of symptoms (RR \u0003 2.3, P \u0004 0.05).", "mimetype": "text/plain", "start_char_idx": 4771, "end_char_idx": 6109, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "24804042-bb5b-4fbe-be0c-1f23ff810a4d": {"__data__": {"id_": "24804042-bb5b-4fbe-be0c-1f23ff810a4d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "112ec265-0f66-4079-8725-8e08984f1fae", "node_type": "1", "metadata": {}, "hash": "f34750f768d899186c12f0dfd514f91dd8fd403344144bbbc822396799425160", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f3299ac7-7419-4573-9440-faf93a274f95", "node_type": "1", "metadata": {}, "hash": "1d0722664fe60995217d8f7b2989313b60428d6d8fc1927418aa54a6b5ac19c5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "A similar study in the northwestern United States also\nfound no signi\ufb01cant association between DTP vaccination\nand acute neurologic illness; however, this study evaluated a\nsmaller population (218,000, including 424 cases) so that a\nweak association may have been missed.10 An independent\nanalysis of the NCES and other data by the U.S. Institute of\nMedicine (IOM) concluded that the evidence was consistent\nwith a causal (albeit rare) relationship between DTP vacci-\nnation and acute encephalopathy in the immediate postvac-\ncination period but that there was insuf\ufb01cient evidence to\nconclude that DTP causes permanent brain damage.4 Subse-\nquent analyses by the American Academy of Pediatrics11 and\nthe IOM12 reaf\ufb01rmed the earlier conclusions that there is no\nde\ufb01nitive, causal link between encephalopathy and DTP\nvaccination. All advisory groups continue to recommend\npertussis vaccination because the bene\ufb01ts are irrefutable.\nAs a result of general concerns about the safety and\nconsistency of the wP vaccine, the United States and many other\ncountries have adopted the use of several acellular pertussis\nvaccines that have similar effectiveness13,14 and lower reacto-\ngenicity15,16 than the wP vaccine. However, the wP vaccine is\neasier and less expensive to manufacture and remains the pre-\nferred pertussis vaccine in most developing countries.17 Thus,\nthe safety of the wP vaccine is still of relevance to most\ncountries, as is the safety of the MMR vaccine, which is also\nused worldwide. This retrospective case\u2013control study was con-\nducted at 4 study sites in the western United States as part of the\nongoing Vaccine Safety Datalink project of the Centers for\nDisease Control and Prevention (Atlanta, GA), which was ini-\ntiated in 1991.18 Our objective was to reevaluate the issue of\nwhether wP and measles vaccination are associated with en-\ncephalopathy or encephalitis.\nMATERIALS AND METHODS\nThis retrospective study was carried out at 4 health main-\ntenance organizations: Group Health Cooperative, based in\nWashington State; Northern California Kaiser Permanente;\nNorthwest Kaiser Permanente, in Oregon and Washington; and\nSouthern California Kaiser Permanente.", "mimetype": "text/plain", "start_char_idx": 6110, "end_char_idx": 8287, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f3299ac7-7419-4573-9440-faf93a274f95": {"__data__": {"id_": "f3299ac7-7419-4573-9440-faf93a274f95", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "24804042-bb5b-4fbe-be0c-1f23ff810a4d", "node_type": "1", "metadata": {}, "hash": "f42ab3574e2c980027dc435e12fb52f273b2d583a97853075b15adc9346efbcd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e976a8b5-029f-48cd-a7bb-31b6ccd6fadc", "node_type": "1", "metadata": {}, "hash": "7bf13ca288cace9116d12aa4560d1d8ebee55127a85e07bbffaf96b5d5df8fbd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "It involved children 0 to\n6 years of age hospitalized with encephalopathy or related\nconditions during the period from January 1, 1981, through\nDecember 31, 1995. Southern California Kaiser Permanente\nparticipated from August 1, 1988, through December 31, 1995.\nIdenti\ufb01cation of Cases. The case de\ufb01nition included hospital-\nized patients with a primary or secondary diagnosis of enceph-\nalopathy, Reye syndrome, or encephalitis. Patients were eligible\nfor inclusion if they had been members of the health plan for at\nleast 60 days before hospital admission or since birth if the\npatient was less than 60 days old. Hospital charts were reviewed\nand abstracted. A case was accepted by the abstracter if there\nwas a diagnosis of encephalopathy by a neurologist and a clear\netiology of congenital anomaly/syndrome, birth anoxia, drug or\ntoxin ingestion or trauma. Cases for which there was a de\ufb01nitive\ndiagnosis by a neurologist of a condition other than encephalop-\nathy were rejected by the abstracter. All other neurologic cases\nwere reviewed by an independent neurologist blind to the vac-\ncination status of the patient to determine whether the patient\nmet the case de\ufb01nition, the speci\ufb01c diagnosis, whether the\ncondition was acute or chronic, the underlying cause and the\ncondition on follow up. The information included in the chart\nabstract included the presence of seizures, laboratory results,\nliver biopsy, electroencephalography results, magnetic reso-\nnance image results, vaccination history, preexisting neurologic\ndisorders, specialties of diagnosing physicians, patient condition\nat each follow-up visit, neurologist\u2019s diagnosis, presence of\nstupor or coma, brain or meningeal biopsy, patient demograph-\nics, patient diagnoses, the chronic or acute nature of the condi-\ntion, the date of illness onset and the etiology of the illness.\nDe\ufb01nitions Used to Identify Cases. The de\ufb01nitions of enceph-\nalopathy, Reye syndrome and encephalitis used to identify\ncases were as follows:\n1.", "mimetype": "text/plain", "start_char_idx": 8288, "end_char_idx": 10280, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e976a8b5-029f-48cd-a7bb-31b6ccd6fadc": {"__data__": {"id_": "e976a8b5-029f-48cd-a7bb-31b6ccd6fadc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f3299ac7-7419-4573-9440-faf93a274f95", "node_type": "1", "metadata": {}, "hash": "1d0722664fe60995217d8f7b2989313b60428d6d8fc1927418aa54a6b5ac19c5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ed9c7574-97da-4551-8edb-cc9bec0d7738", "node_type": "1", "metadata": {}, "hash": "96bc6a4a83a079dcfec9d06455aac7dc1836238c44da13e671e2e537c6a5ce8f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "De\ufb01nitions Used to Identify Cases. The de\ufb01nitions of enceph-\nalopathy, Reye syndrome and encephalitis used to identify\ncases were as follows:\n1. Encephalopathy: acute generalized disturbance of brain\nfunction requiring hospitalization and consisting of coma\nor stupor that cannot be attributed to medication or pos-\ntictal state. Such cases must have altered consciousness,\ndelirium, obtundation and/or confusion.\n2. Reye syndrome: clinical symptoms of acute encephalop-\nathy with altered level of consciousness as well as:\na. Absence of in\ufb02ammatory changes in cerebrospinal \ufb02uid as\nindicated by \u00045 white blood cells/mm3 or brain histology\nshowing cerebral edema without perivascular or menin-\ngeal in\ufb02ammation, plus\nb. Evidence of hepatitis or liver failure documented by a\n3-fold or greater elevation in serum glutamic oxaloacetic\ntransaminase, serum glutamate pyruvate transaminase\nor serum ammonia or fatty changes of hepatocytes on\nliver biopsy or autopsy, plus\nc. Absence of other etiologies for cerebral or hepatic\nabnormalities.\n3. Encephalitis/encephalomyelitis: evidence of acute neuro-\nlogic disease presenting with nonspeci\ufb01c signs such as\nfever, seizures, altered consciousness, headache, vomiting,\nmeningismus or anorexia. We required multifocal involve-\nment of the central nervous system and evidence of cere-\nbrospinal \ufb02uid in\ufb02ammation (\u00057 white blood cells/mm3).\nWe excluded disease with other known etiologies.\nSelection of Controls. Up to 3 controls were selected for each\ncase. The controls were matched to cases according to health\nmaintenance organization location, age (within 7 days), sex\nand length of enrollment in the health plan.\nFor both cases and controls, vaccine exposure was\nascertained from the medical record.", "mimetype": "text/plain", "start_char_idx": 10136, "end_char_idx": 11881, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ed9c7574-97da-4551-8edb-cc9bec0d7738": {"__data__": {"id_": "ed9c7574-97da-4551-8edb-cc9bec0d7738", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e976a8b5-029f-48cd-a7bb-31b6ccd6fadc", "node_type": "1", "metadata": {}, "hash": "7bf13ca288cace9116d12aa4560d1d8ebee55127a85e07bbffaf96b5d5df8fbd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dc44b349-a31c-454c-aad5-a1b4e4f0f339", "node_type": "1", "metadata": {}, "hash": "eb8c827688342e8dade0ecc3b325904d76a9c3a012953ca202bb078be9cdb720", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For both cases and controls, vaccine exposure was\nascertained from the medical record. Abstractors were not\nThe Pediatric Infectious Disease Journal \u2022 Volume 25, Number 9, September 2006\nEncephalopathy and DTP or MMR Vaccine\n\u00a9 2006 Lippincott Williams & Wilkins\n769\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 01/09/2025\nblinded to case/control status because the abstractors had to\nreview the entire chart to ascertain vaccine status and a child\nwith encephalopathy would be obvious on this review. How-\never, the review of each case to ascertain clinical criteria for\ninclusion was conducted by a neurologist blinded to the\nvaccine status of the child.\nAnalysis. Cases were categorized according to whether the\netiology of the encephalopathy was known, unknown or\nsuspected but uncon\ufb01rmed. Assessment of vaccination risk\nfor various exposure intervals was conducted using condi-\ntional logistic regression for all cases versus controls, cases\nwith unknown or suspected but uncon\ufb01rmed cause versus\ncontrols and cases with unknown cause versus controls. A\nsuspected but uncon\ufb01rmed cause included cases in which a\ndiagnosis such as viral meningitis had not been con\ufb01rmed by\na speci\ufb01c laboratory test.\nRESULTS\nApproximately 2,197,000 children at 4 health mainte-\nnance organizations were eligible for inclusion in this retro-\nspective case\u2013control study. A total of 452 encephalopathy\ncases were identi\ufb01ed at the 4 sites: 20 at Group Health\nCooperative, 236 at Northern California Kaiser Permanente,\n39 at Northwest Kaiser Permanente and 157 at Southern\nCalifornia Kaiser Permanente.\nEight of the cases received MMR vaccine within the 60\ndays before admission and 49 of the cases received DTP\n(Table 1).", "mimetype": "text/plain", "start_char_idx": 11795, "end_char_idx": 13613, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dc44b349-a31c-454c-aad5-a1b4e4f0f339": {"__data__": {"id_": "dc44b349-a31c-454c-aad5-a1b4e4f0f339", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ed9c7574-97da-4551-8edb-cc9bec0d7738", "node_type": "1", "metadata": {}, "hash": "96bc6a4a83a079dcfec9d06455aac7dc1836238c44da13e671e2e537c6a5ce8f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7556660d-6a22-40e3-ab48-2436679a9789", "node_type": "1", "metadata": {}, "hash": "fa59c338dd1dfd1021b745af23bcf300ec94c2f7a050a49e3162dd39fa444d2c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Eight of the cases received MMR vaccine within the 60\ndays before admission and 49 of the cases received DTP\n(Table 1). Only one case exposed to MMR (13%) had an\nencephalopathy of known cause; 15 (31%) of the cases\nexposed to DTP were of known cause.\nEach immunization exposure was strati\ufb01ed into time\nwindows (Table 2). In no time window were the cases more\nlikely than controls to have received DTP or MMR vaccine.\nIn fact, controls were signi\ufb01cantly more likely than cases to\nhave received DTP vaccine within 60 or 90 days.\nThe cases were then further strati\ufb01ed into those whose\nencephalopathy was of a known cause (etiology con\ufb01rmed by\na diagnostic test) and those for whom the cause was unknown\nor suspected but uncon\ufb01rmed. When the unknown and sus-\npected but uncon\ufb01rmed cases were combined, the odds of\nexposure to DTP vaccine within 7 days was numerically\nslightly greater for cases than for controls, but this did not\napproach statistical signi\ufb01cance (odds ratio \u0001OR\u0002 \u0003 1.22;\n95% CI \u0003 0.45\u20133.31; P \u0003 0.693; Table 3). The relative risk\nestimate declined when the time window was lengthened to\n14 days or longer and it was substantially reduced when only\ncases of unknown cause were considered (OR \u0003 1.04; 95%\nCI \u0003 0.26\u20134.11; P \u0003 0.953; Table 4).\nLikewise, cases were no more likely than controls to\nhave received MMR vaccine during any time window, re-\ngardless of etiologic category, except during the 90-day\nwindow (Tables 2, 3 and 4). During the 90-day window,\nchildren with neurologic disease of unknown or suspected but\nuncon\ufb01rmed cause were numerically more likely to have\nreceived MMR vaccine but not signi\ufb01cantly so (OR \u0003 1.23;\n95% CI \u0003 0.51\u20132.98; P \u0003 0.647).", "mimetype": "text/plain", "start_char_idx": 13494, "end_char_idx": 15169, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7556660d-6a22-40e3-ab48-2436679a9789": {"__data__": {"id_": "7556660d-6a22-40e3-ab48-2436679a9789", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dc44b349-a31c-454c-aad5-a1b4e4f0f339", "node_type": "1", "metadata": {}, "hash": "eb8c827688342e8dade0ecc3b325904d76a9c3a012953ca202bb078be9cdb720", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6c0bb162-f1cd-4777-b94b-369aabaa801f", "node_type": "1", "metadata": {}, "hash": "277ccbf7ebb276b58906adec79209b329fbc998a1eb22c7dfc9d5d1dff5d078d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Table 5 contains a clinical summary of each case of\nunknown or suspected but uncon\ufb01rmed etiology in which the\nchild received DTP vaccine within the 14 days before the\nonset of symptoms or MMR vaccine within the 30 days\nbefore onset. No distinct pattern of symptoms is seen among\nthese cases. Of the 8 children who received DTP within 14\ndays of disease onset, 3 had a full recovery, 3 had a partial\nrecovery and 2 had no recovery or died. Two of the 3 children\nwho received MMR within 30 days had a full recovery and\nthe third died. No cases had received MMR within 14 days,\nthe interval associated with increased risk in the NCES study.\nDISCUSSION\nIn this analysis of a possible relationship between\nvaccination with DTP or MMR and the occurrence of en-\ncephalopathy or encephalitis, we found that cases were no\nmore likely to have been vaccinated with DTP vaccine in the\nmonth before disease onset than control children. Only 6\ncases were exposed to DTP in the 7 days before symptom\nonset (the period of increased risk in the NCES study) and the\nOR between cases and controls was not signi\ufb01cant. Although\nthe small number of vaccinated cases limits our ability to\nassess possible associations, it also means that the possible\nattributable risk of encephalopathy after DTP is extremely\nsmall. In all other timeframes, the OR of the case risk to the\ncontrol risk of DTP immunization was less than one, provid-\ning no evidence of any association. There were signi\ufb01cant\ndifferences between cases and controls only for the 60- and\n90-day windows when all cases were considered and these\ndifferences re\ufb02ected a higher rate of vaccine exposure among\nthe controls than the cases. This could be the result of less\nimmunization in children with progressive neurologic disease\nfor whom wP vaccination is contraindicated.\nIn the British NCES evaluation of MMR vaccination,\nthe period associated with increased risk was 7 to 14 days.\nTABLE 1.", "mimetype": "text/plain", "start_char_idx": 15170, "end_char_idx": 17101, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6c0bb162-f1cd-4777-b94b-369aabaa801f": {"__data__": {"id_": "6c0bb162-f1cd-4777-b94b-369aabaa801f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7556660d-6a22-40e3-ab48-2436679a9789", "node_type": "1", "metadata": {}, "hash": "fa59c338dd1dfd1021b745af23bcf300ec94c2f7a050a49e3162dd39fa444d2c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "740f4e25-a8d6-411f-82c9-cf88b0cae0d8", "node_type": "1", "metadata": {}, "hash": "beda3403f17c0f0a79e1af8d84089d35b5d5f4c0d5ab252b07d3456f98ea7fa6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In the British NCES evaluation of MMR vaccination,\nthe period associated with increased risk was 7 to 14 days.\nTABLE 1.\nExposure to Diphtheria\u2013Tetanus\u2013Pertussis (DTP) or Measles\u2013Mumps\u2013Rubella\n(MMR) Within 60 Days of Onset of Neurologic Illness of the Designated Etiologic Category\nEtiology\nDTP\nMMR\nExposed\nn (row %)\nUnexposed\nn (row %)\nTotal\nn (col %)\nExposed\nn (row %)\nUnexposed\nn (row %)\nTotal\nn (col %)\nKnown\n15 (7)\n205 (93)\n220 (49)\n1 (0)\n219 (100)\nSuspected/unconfirmed*\n15 (17)\n71 (83)\n86 (19)\n4 (5)\n82 (95)\nUnknown\n19 (13)\n127 (87)\n146 (32)\n3 (2)\n143 (98)\n146 (32)\nAll\n49 (11)\n403 (89)\n452 (100)\n8 (2)\n444 (98)\n452 (100)\n*Includes cases in which a diagnosis such as viral meningitis was unconfirmed by a specific laboratory test.", "mimetype": "text/plain", "start_char_idx": 16982, "end_char_idx": 17718, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "740f4e25-a8d6-411f-82c9-cf88b0cae0d8": {"__data__": {"id_": "740f4e25-a8d6-411f-82c9-cf88b0cae0d8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6c0bb162-f1cd-4777-b94b-369aabaa801f", "node_type": "1", "metadata": {}, "hash": "277ccbf7ebb276b58906adec79209b329fbc998a1eb22c7dfc9d5d1dff5d078d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e582f22a-f2c8-4c18-be99-07624670f51f", "node_type": "1", "metadata": {}, "hash": "a1f60b89ca00a95e30386512d6eaff8e9270e7b79e9dcdc4b44c245020be0a0b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Ray et al\nThe Pediatric Infectious Disease Journal \u2022 Volume 25, Number 9, September 2006\n\u00a9 2006 Lippincott Williams & Wilkins\n770\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 01/09/2025\nAlso, Weibel reported an increased risk of encephalopathy\nwith subsequent permanent brain damage or death on days 8\nand 9 after measles vaccination, but this was based on 48\ncases voluntarily reported to the National Vaccine Injury\nCompensation Program (NVICP) in the United States.19 We\ndid not \ufb01nd an increased OR for MMR vaccination during\nthis time; in fact, no case children had received MMR vaccine\nwithin 14 days of the onset of encephalopathy. The NVICP\nonly documents encephalopathies that occur within 15 days\nof vaccination and thus would not have captured encephalop-\nathies that were diagnosed at longer intervals after vaccina-\ntion. In our study, we observed a slightly (but not signi\ufb01-\ncantly) increased OR with MMR vaccination within 90 days\nfor cases of unknown or suspected but uncon\ufb01rmed cause.\nAlthough it is possible that there is such a delayed reaction to\nthe vaccine, the lack of a consistent time association between\nTABLE 2.", "mimetype": "text/plain", "start_char_idx": 17719, "end_char_idx": 18972, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e582f22a-f2c8-4c18-be99-07624670f51f": {"__data__": {"id_": "e582f22a-f2c8-4c18-be99-07624670f51f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "740f4e25-a8d6-411f-82c9-cf88b0cae0d8", "node_type": "1", "metadata": {}, "hash": "beda3403f17c0f0a79e1af8d84089d35b5d5f4c0d5ab252b07d3456f98ea7fa6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "986bc4c9-6385-439c-9faa-2cb314330bd8", "node_type": "1", "metadata": {}, "hash": "617c80d0bfc3a44c29ac564602a283956dcea4f5bdd7cacff520cb73a4217332", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Although it is possible that there is such a delayed reaction to\nthe vaccine, the lack of a consistent time association between\nTABLE 2.\nFrequency of Diphtheria\u2013Tetanus\u2013Pertussis (DTP) and Measles\u2013Mumps\u2013Rubella (MMR)\nVaccination Among all Cases and Controls for Specified Intervals Relative to Onset of Encephalopathy\nVaccine Exposure\nInterval (days)\nExposed\nCases (N)\nExposed\nCases (%)\nExposed\nControls (N)\nExposed\nControls (%)\nP\nValue*\nOdds\nRatio*\nConfidence\nInterval\nDTP\n0\u201390\n60\n13.3\n233\n18.2\n0.001\n0.43\n0.27\u20130.70\n0\u201360\n49\n10.8\n189\n14.7\n0.004\n0.49\n0.30\u20130.80\n0\u201330\n26\n5.8\n111\n8.7\n0.024\n0.54\n0.32\u20130.92\n0\u201314\n13\n2.9\n52\n4.1\n0.247\n0.67\n0.34\u20131.32\n0\u20137\n7\n1.5\n25\n2.0\n0.597\n0.79\n0.33\u20131.89\nMMR\n0\u201390\n15\n3.3\n44\n3.4\n0.951\n0.98\n0.47\u20132.01\n0\u201360\n8\n1.8\n33\n2.6\n0.304\n0.64\n0.27\u20131.50\n0\u201330\n4\n0.9\n13\n1.0\n0.778\n0.85\n0.27\u20132.68\n0\u201314\n1\n0.2\n7\n0.5\n0.337\n0.35\n0.04\u20132.95\n7\u201314\n1\n0.2\n6\n0.5\n0.408\n0.40\n0.05\u20133.46\n*Conditional logistic regression.\nTABLE 3.", "mimetype": "text/plain", "start_char_idx": 18836, "end_char_idx": 19755, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "986bc4c9-6385-439c-9faa-2cb314330bd8": {"__data__": {"id_": "986bc4c9-6385-439c-9faa-2cb314330bd8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e582f22a-f2c8-4c18-be99-07624670f51f", "node_type": "1", "metadata": {}, "hash": "a1f60b89ca00a95e30386512d6eaff8e9270e7b79e9dcdc4b44c245020be0a0b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d1fc5fee-261c-4bc7-aa40-afb5da35e523", "node_type": "1", "metadata": {}, "hash": "d66c81c4d6604140dac0fb00ff59e0d99dc7da0f5e083c589f3fdb35ca375ae3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "TABLE 3.\nVaccine Exposure Interval (\u000190 days) in Cases of Unknown or Suspected but\nUnconfirmed* Cause\nVaccine Exposure\nInterval (days)\nExposed\nCases (N)\nCases\nExposed (%)\nExposed\nControls (N)\nControls\nExposed (%)\nP\u2020\nOdds\nRatio\u2020\nConfidence\nInterval\nDiphtheria\u2013tetanus\u2013pertussis\n0\u201390\n41\n17.7\n145\n22.2\n0.052\n0.54\n0.29\u20131.01\n0\u201360\n34\n14.7\n118\n18.1\n0.129\n0.62\n0.33\u20131.15\n0\u201330\n18\n7.8\n73\n11.2\n0.101\n0.58\n0.30\u20131.11\n0\u201314\n8\n3.4\n33\n5.1\n0.294\n0.63\n0.27\u20131.49\n0\u20137\n6\n2.6\n14\n2.1\n0.693\n1.22\n0.45\u20133.31\nMeasles\u2013mumps\u2013rubella\n0\u201390\n11\n4.7\n28\n4.3\n0.647\n1.23\n0.51\u20132.98\n0\u201360\n7\n3.0\n19\n2.9\n0.903\n1.06\n0.41\u20132.74\n0\u201330\n3\n1.3\n10\n1.5\n0.746\n0.80\n0.21\u20133.05\n0\u201314\n0\n0.0\n7\n1.1\n0.991\n0.00\n0.00\n7\u201314\n0\n0.0\n6\n0.9\n0.992\n0.00\n0.00\n*Includes cases in which a diagnosis such as viral meningitis, was unconfirmed by a specific laboratory test.\n\u2020Conditional logistic regression.\nTABLE 4.", "mimetype": "text/plain", "start_char_idx": 19747, "end_char_idx": 20586, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d1fc5fee-261c-4bc7-aa40-afb5da35e523": {"__data__": {"id_": "d1fc5fee-261c-4bc7-aa40-afb5da35e523", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "986bc4c9-6385-439c-9faa-2cb314330bd8", "node_type": "1", "metadata": {}, "hash": "617c80d0bfc3a44c29ac564602a283956dcea4f5bdd7cacff520cb73a4217332", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "88502d7f-25d5-40b2-99a2-8fe0d6787bc4", "node_type": "1", "metadata": {}, "hash": "5adcf2d8c8e3572e087ec62300513b38293677f5c23f22f77191cea4efa0ca1c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2020Conditional logistic regression.\nTABLE 4.\nVaccine Exposure Interval (\u000190 days) in Cases of Unknown Cause\nVaccine Exposure\nInterval (days)\nExposed\nCases (N)\nCases\nExposed (%)\nExposed\nControls (N)\nControls\nExposed (%)\nP*\nOdds\nRatio*\nConfidence\nInterval\nDiphtheria\u2013tetanus\u2013pertussis\n0\u201390\n24\n16.4\n80\n19.6\n0.283\n0.63\n0.28\u20131.46\n0\u201360\n19\n13.0\n65\n15.9\n0.296\n0.65\n0.29\u20131.46\n0\u201330\n9\n6.2\n40\n9.8\n0.138\n0.52\n0.22\u20131.24\n0\u201314\n4\n2.7\n17\n4.2\n0.396\n0.59\n0.18\u20131.99\n0\u20137\n3\n2.1\n8\n2.0\n0.953\n1.04\n0.26\u20134.11\nMeasles\u2013mumps\u2013rubella\n0\u201390\n6\n4.1\n19\n4.7\n0.763\n0.83\n0.25\u20132.76\n0\u201360\n3\n2.1\n13\n3.2\n0.428\n0.57\n0.14\u20132.28\n0\u201330\n0\n0.0\n8\n2.0\n0.991\n0.00\n0.00\n0\u201314\n0\n0.0\n5\n1.2\n0.993\n0.00\n0.00\n7\u201314\n0\n0.0\n4\n1.0\n0.993\n0.00\n0.00\n*Conditional logistic regression.", "mimetype": "text/plain", "start_char_idx": 20544, "end_char_idx": 21256, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "88502d7f-25d5-40b2-99a2-8fe0d6787bc4": {"__data__": {"id_": "88502d7f-25d5-40b2-99a2-8fe0d6787bc4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d1fc5fee-261c-4bc7-aa40-afb5da35e523", "node_type": "1", "metadata": {}, "hash": "d66c81c4d6604140dac0fb00ff59e0d99dc7da0f5e083c589f3fdb35ca375ae3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7e347ccc-4c72-49d1-8930-617d0f064d75", "node_type": "1", "metadata": {}, "hash": "f7331e10648e46e9c4e281b2c4a8860d1ecc1b4be038e0f542de2d301cf85399", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The Pediatric Infectious Disease Journal \u2022 Volume 25, Number 9, September 2006\nEncephalopathy and DTP or MMR Vaccine\n\u00a9 2006 Lippincott Williams & Wilkins\n771\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 01/09/2025\nvaccination and the onset of encephalopathy makes a causal\nrelationship unlikely.\nThere is also no indication of a \u201cclinically distinctive\npertussis vaccine-induced encephalopathy.\u201d4,8 A review of\nour cases (Table 5) supports this conclusion. The symptoms\nof the 8 children who developed an encephalopathy of un-\nknown or suspected but uncon\ufb01rmed cause within 14 days of\nDTP vaccination or 30 days of MMR vaccination varied\nTABLE 5.\nReview of Cases of Encephalopathies of Unknown or Suspected but Unconfirmed Etiology\nPatient No.\nSex\nAge at\nVaccination\nInterval in\nDays\nTest Results\nOutcome\nComment\nCSF\nNeurology/Imaging\nCases who received DTP 14 d or less before the onset of encephalopathy\nDTP\u2014unknown\netiology\n1\nF\n2 mo\n0\nCSF WBC 40/\nmm3, CSF\nRBC 1872/\nmm3, CSF\nprotein 60 mg/\ndL\nCT and EEG \u0003 normal\nFull recovery\nUnknown etiology\n2\nF\n7 mo\n1\nMRI \u0003 marked hemiatrophy of\nleft cerebral hemisphere;\nright side also showed\napparent prominent sulci\nanteriorly; comparison with\nprevious films shows\nprogressive encephalopathy;\nEEG \u0003 markedly abnormal\nleft recording\nChronic\nencephalopathy,\ndied\nProgressive seizure\ndisorder,", "mimetype": "text/plain", "start_char_idx": 21257, "end_char_idx": 22707, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7e347ccc-4c72-49d1-8930-617d0f064d75": {"__data__": {"id_": "7e347ccc-4c72-49d1-8930-617d0f064d75", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "88502d7f-25d5-40b2-99a2-8fe0d6787bc4", "node_type": "1", "metadata": {}, "hash": "5adcf2d8c8e3572e087ec62300513b38293677f5c23f22f77191cea4efa0ca1c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "65231cf1-6629-4e2c-bdc4-4ba5d743d100", "node_type": "1", "metadata": {}, "hash": "06245959e991e4de0373605daad011e09ed2b627d0f73b3be7403d4fb61f49dc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "comparison with\nprevious films shows\nprogressive encephalopathy;\nEEG \u0003 markedly abnormal\nleft recording\nChronic\nencephalopathy,\ndied\nProgressive seizure\ndisorder, died\nFeb 1991\n3\nF\n4 yr 11 mo\n7\nCSF glucose 94\nmg/dL\nMRI \u0003 increased signal in\nright parietal; CT \u0003 normal;\nEEG \u0003 probably abnormal\nas a result of persistent\nbihemispheric high-voltage\nslowing without focal\ndysrhythmia\nFull recovery\nHSV mentioned as\na result of\ntemporal/parietal\nfocalizing of\ncerebritis seen on\nimaging but no\nconfirmatory test\nand CSF not\nsuggestive\n4\nM\n4 mo\n13\nCSF protein 125\nmg/dL, CSF\nglucose 131\nmg/dL\nCT \u0003 multiple infarcts;\nEEG \u0003 seizure foci in\nmultiple areas of brain\nPartial recovery\nafter 6 mo\nUnknown etiology,\nresiduae include\nCP, blindness,\nquadriplegia\nDTP\u2014suspected but unconfirmed etiology\n5\nF\n3 mo\n1\nCSF WBC 29/\nmm3, CSF\nProtein 75\nmg/dL,\nglucose 13\nmg/dL\nEEG \u0003 normal\nPartial recovery\nPossible\nhypoglycemia\n6\nM\n6 mo\n5\nCSF normal\nMRI \u0003 normal\nPartial recovery\nProbable\npostinfectious\nencephalomyelitis\n7\nF\n5 mo\n\u00067*\nMRI, CT, and EEG all\nabnormal;", "mimetype": "text/plain", "start_char_idx": 22545, "end_char_idx": 23589, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "65231cf1-6629-4e2c-bdc4-4ba5d743d100": {"__data__": {"id_": "65231cf1-6629-4e2c-bdc4-4ba5d743d100", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7e347ccc-4c72-49d1-8930-617d0f064d75", "node_type": "1", "metadata": {}, "hash": "f7331e10648e46e9c4e281b2c4a8860d1ecc1b4be038e0f542de2d301cf85399", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "980da00c-e8ab-4009-9ae9-3817e2066d99", "node_type": "1", "metadata": {}, "hash": "0ac89677f740ef3fa227fc02ac6b64a92ef53bd9ca8607389178b6e8637e6294", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CT, and EEG all\nabnormal; severe and diffuse\ncerebral atrophy\nNo recovery\nDegenerative\ndisorder\nunknown etiology\n(possible Rett\nsyndrome)\n8\nF\n6 mo (HDTP)\n12\nCSF WBC\n11/mm3\nCT and EEG \u0003 normal\nFull recovery\nPossible viral\nmeningitis\nCases who received MMR 30 d or less before the onset of encephalopathy (suspected but unconfirmed etiology)\n1\nF\n1 yr 6 mo\n19\nCSF WBC\n15/mm3\nMRI \u0003 normal\nFull recovery\nPossible postviral\nacute cerebellar\nataxia\n2\nF\n3 yr 9 mo\n21\nCSF glucose \u0003\n91 mg/dL\nCT \u0003 normal\nFull recovery\nViral encephalitis\nversus delirium\nwith high fever\n105\u00b0 F\n3\nF\n1 yr 1 mo\n29\nDied\nPossible AIDS-\nrelated\nencephalopathy\u2014\nperinatally\nacquired\n*Exact date of symptom onset is not known.\nDTP indicates diphtheria\u2013tetanus\u2013pertussis; CSF, cerebrospinal fluid; CT, computed tomography; MRI, magnetic resonance imaging; WBC, white blood cells; RBC, red blood cells;\nEEG, electroencephalogram; HSV, herpes simplex virus; CP, cerebral palsy; HDTP, DTP vaccine given in conjunction with Haemophilus influenzae B vaccine; MMR, measles\u2013mumps\u2013\nrubella.\nRay et al\nThe Pediatric Infectious Disease Journal \u2022 Volume 25, Number 9, September 2006\n\u00a9 2006 Lippincott Williams & Wilkins\n772\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 01/09/2025\nwidely as did the interval between vaccination and onset of\nsymptoms.", "mimetype": "text/plain", "start_char_idx": 23564, "end_char_idx": 24981, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "980da00c-e8ab-4009-9ae9-3817e2066d99": {"__data__": {"id_": "980da00c-e8ab-4009-9ae9-3817e2066d99", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "65231cf1-6629-4e2c-bdc4-4ba5d743d100", "node_type": "1", "metadata": {}, "hash": "06245959e991e4de0373605daad011e09ed2b627d0f73b3be7403d4fb61f49dc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aa1ce4c2-89f7-4bef-8ca1-f752275fe104", "node_type": "1", "metadata": {}, "hash": "deb182d3b6825487d210c3082fae8d14de0b312409bef2985238d6e25b624c52", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This argues against a speci\ufb01c disorder caused by\nthe pertussis or measles vaccines.\nWe performed a case\u2013control study in part because of\nthe low incidence of encephalopathy among young children\nand because the analysis was retrospective. In this study, only\n452 cases were identi\ufb01ed in a population of approximately\n2,197,000 at 4 large institutions over a period of 15 years. Of\nthese 452 children, only a small fraction had been exposed to\nvaccine in the months before the onset of encephalopathy. A\nprospective cohort study would have required an impractical\nnumber of enrolled subjects to generate enough cases to\nanalyze. In fact, the NCES researchers estimated that every\nchild born in Britain would have had to be enrolled in a\ncohort study to encounter a suf\ufb01cient number of cases for\nanalysis.8 The known ef\ufb01cacy of these vaccines precludes the\nethical use of a randomized, placebo-controlled design.\nOur results are consistent with those of previous stud-\nies, although in contrast to the NCES study, we found no\nevidence for a relationship between vaccination and enceph-\nalopathy. In our study, 6 cases were exposed to DTP within\n7 days of onset and 11 were exposed to MMR within 90 days.\nThis corresponds roughly to an all-cause incidence (not an\nattributable risk) of one in 370,000 after DTP and one in\n200,000 after MMR, a rate that is not statistically different\nfrom background. In the NCES, the attributable risk of a\nserious neurologic disorder of any clinical outcome within 7\ndays of DTP vaccination was reported to be one in 110,000\nvaccinations8; the attributable risk for a serious neurologic\ndisorder resulting in death or neurologic sequelae 12 months\nafter the onset of illness was one in 330,000 for previously\nnormal children,20 although it has been noted that the NCES\nrates include children with febrile seizures as well as frank\nencephalopathy.", "mimetype": "text/plain", "start_char_idx": 24982, "end_char_idx": 26859, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aa1ce4c2-89f7-4bef-8ca1-f752275fe104": {"__data__": {"id_": "aa1ce4c2-89f7-4bef-8ca1-f752275fe104", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "980da00c-e8ab-4009-9ae9-3817e2066d99", "node_type": "1", "metadata": {}, "hash": "0ac89677f740ef3fa227fc02ac6b64a92ef53bd9ca8607389178b6e8637e6294", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d0ed2038-935d-41a7-a09a-aec456c2ab9d", "node_type": "1", "metadata": {}, "hash": "6ebb0ff7a24a036a04060c385e6ddedbeea04f5b059b190a941262ddaae1003b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "It should be emphasized that all of these\nrates for encephalopathy after DTP vaccination are signi\ufb01-\ncantly less than the attributable risk for encephalopathy of\none in 11,000 after pertussis itself.21 The report based on data\nfrom the NVICP conservatively estimated that the risk of\nacute encephalopathy within 15 days of measles vaccination\nthat was followed by permanent brain impairment or death\nwas approximately one in 1,500,000 vaccinations.19 In com-\nparison, the risk of encephalitis after measles is one in 1000\nwith death or permanent neural impairment as frequent se-\nquelae.3 Thus, the risk of encephalopathy or encephalitis\nresulting from pertussis and measles disease is much higher\nthan any potential risk from vaccination.\nOur \ufb01ndings do not support a conclusion that there is an\nincreased risk of encephalitis or encephalopathy after DTP or\nMMR vaccination. Although this study is large, encephalop-\nathy is rare and thus it is not possible to exclude completely\na small increase in the risk of encephalopathy after DTP or\nMMR vaccination. However, if such an increased risk exists,\nthe absolute risk is extremely small and it is much lower after\nvaccination than after pertussis or measles. Therefore, our\nresults support the continued use of DTP and MMR vaccines.\nACKNOWLEDGMENTS\nThe authors acknowledge the assistance of Dr. Naomi\nRuff in the preparation of the manuscript.\nREFERENCES\n1. Malleson PN, Bennett JC. Whooping-cough admissions to a paediatric\nhospital over ten years. The protective value of immunisation. Lancet.\n1977;1:237\u2013239.\n2. Miller DL, Alderslade R, Ross EM. Whooping cough and whooping cough\nvaccine: The risks and bene\ufb01ts debate. Epidemiol Rev. 1982;4:1\u201324.\n3. Markowitz LE, Katz SL. Measles Vaccine. pp. 229\u2013276.\n4. Institute of Medicine. Adverse Effects of Pertussis and Rubella Vaccines.\nThe National Academy of Sciences; 1991.\n5.", "mimetype": "text/plain", "start_char_idx": 26860, "end_char_idx": 28736, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d0ed2038-935d-41a7-a09a-aec456c2ab9d": {"__data__": {"id_": "d0ed2038-935d-41a7-a09a-aec456c2ab9d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aa1ce4c2-89f7-4bef-8ca1-f752275fe104", "node_type": "1", "metadata": {}, "hash": "deb182d3b6825487d210c3082fae8d14de0b312409bef2985238d6e25b624c52", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e81d5508-1bfb-471f-9805-1fe516560d2e", "node_type": "1", "metadata": {}, "hash": "c53a024bd7f6d42d0fb6900e69617fcaa8bd59c30295d4b59149edadccc43783", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Measles Vaccine. pp. 229\u2013276.\n4. Institute of Medicine. Adverse Effects of Pertussis and Rubella Vaccines.\nThe National Academy of Sciences; 1991.\n5. Romanus V, Jonsell R, Bergquist SO. Pertussis in Sweden after the cessa-\ntion of general immunization in 1979. Pediatr Infect Dis J. 1987;6:364\u2013\n371.\n6. Marcuse EK, Wentz KR. The NCES reconsidered: Summary of a 1989\nworkshop. National Childhood Encephalopathy Study. Vaccine. 1990;\n8:531\u2013535.\n7. Miller D, Wadsworth J, Ross E. Severe neurological illness: Further\nanalyses of the British National Childhood Encephalopathy Study. Tokai\nJ Exp Clin Med. 1988;13(suppl):145\u2013155.\n8. Alderslade R, Bellman MH, Rawson NSB, Ross EM, Miller DL. The\nNational Childhood Encephalopathy Study: A Report on 1000 Cases of\nSerious Neurological Disorders in Infants and Young Children From the\nNCES Research Team. Department of Health and Social Security.\nWhooping Cough: Reports from the Committee on the Safety of Med-\nicines and the Joint Committee on Vaccination and Immunization.\nLondon: Her Majesty\u2019s Stationery Of\ufb01ce; 1981:79\u2013169.\n9. Miller D, Madge N, Diamond J, Wadsworth J, Ross E. Pertussis\nimmunisation and serious acute neurological illnesses in children. BMJ.\n1993;307:1171\u20131176.\n10. Gale JL, Thapa PB, Wassilak SG, Bobo JK, Mendelman PM, Foy HM.\nRisk of serious acute neurological illness after immunization with\ndiphtheria\u2013tetanus\u2013pertussis vaccine. A population-based case\u2013control\nstudy. JAMA. 1994;271:37\u201341.\n11. Committee on Infectious Diseases. The relationship between pertussis\nvaccine and central nervous system sequelae: Continuing assessment.\nAmerican Academy of Pediatrics. Pediatrics. 1996;97:279\u2013281.\n12.", "mimetype": "text/plain", "start_char_idx": 28587, "end_char_idx": 30252, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e81d5508-1bfb-471f-9805-1fe516560d2e": {"__data__": {"id_": "e81d5508-1bfb-471f-9805-1fe516560d2e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d0ed2038-935d-41a7-a09a-aec456c2ab9d", "node_type": "1", "metadata": {}, "hash": "6ebb0ff7a24a036a04060c385e6ddedbeea04f5b059b190a941262ddaae1003b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8bfa9866-05c9-493c-9b0a-a41520229ba8", "node_type": "1", "metadata": {}, "hash": "537046607c8d041bded2fb3fd2bcc73f8b33afdf543dc14c565b4729eb73b7ef", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Committee on Infectious Diseases. The relationship between pertussis\nvaccine and central nervous system sequelae: Continuing assessment.\nAmerican Academy of Pediatrics. Pediatrics. 1996;97:279\u2013281.\n12. Institute of Medicine. DPT Vaccine and Chronic Nervous System Dys-\nfunction: A New Analysis. The National Academy of Sciences; 1994.\n13. Stehr K, Cherry JD, Heininger U, et al. A comparative ef\ufb01cacy trial in\nGermany in infants who received either the Lederle/Takeda acellular\npertussis component DTP (DTaP) vaccine, the Lederle whole-cell com-\nponent DTP vaccine, or DT vaccine. Pediatrics. 1998;101:1\u201311.\n14. Heininger U, Cherry JD, Stehr K, et al. Comparative ef\ufb01cacy of the\nLederle/Takeda acellular pertussis component DTP (DTaP) vaccine and\nLederle whole-cell component DTP vaccine in German children after\nhousehold exposure. Pertussis Vaccine Study Group. Pediatrics. 1998;\n102:546\u2013553.\n15. Schmitt-Grohe S, Stehr K, Cherry JD, et al. Minor adverse events in a\ncomparative ef\ufb01cacy trial in Germany in infants receiving either the\nLederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the\nLederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis\nVaccine Study Group. Dev Biol Stand. 1997;89:113\u2013118.\n16. Uberall MA, Stehr K, Cherry JD, et al. Severe adverse events in a\ncomparative ef\ufb01cacy trial in Germany in infants receiving either the\nLederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the\nLederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis\nVaccine Study Group. Dev Biol Stand. 1997;89:83\u201389.\n17. World Health Organization. Pertussis vaccines. Wkly Epidemiol Rec.\n1999;74:137\u2013143.", "mimetype": "text/plain", "start_char_idx": 30051, "end_char_idx": 31695, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8bfa9866-05c9-493c-9b0a-a41520229ba8": {"__data__": {"id_": "8bfa9866-05c9-493c-9b0a-a41520229ba8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ray (2006).pdf", "node_type": "4", "metadata": {}, "hash": "4c30def3f19bde58be6b033ccec13f7a1cbed9263f0a6346372170bde9d19b54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e81d5508-1bfb-471f-9805-1fe516560d2e", "node_type": "1", "metadata": {}, "hash": "c53a024bd7f6d42d0fb6900e69617fcaa8bd59c30295d4b59149edadccc43783", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Dev Biol Stand. 1997;89:83\u201389.\n17. World Health Organization. Pertussis vaccines. Wkly Epidemiol Rec.\n1999;74:137\u2013143.\n18. Chen RT, Glasser JW, Rhodes PH, et al. Vaccine Safety Datalink project:\nA new tool for improving vaccine safety monitoring in the United States.\nThe Vaccine Safety Datalink Team. Pediatrics. 1997;99:765\u2013773.\n19. Weibel RE, Caserta V, Benor DE, Evans G. Acute encephalopathy followed\nby permanent brain injury or death associated with further attenuated\nmeasles vaccines: A review of claims submitted to the National Vaccine\nInjury Compensation Program. Pediatrics. 1998;101:383\u2013387.\n20. Miller D, Wadsworth J, Diamond J, Ross E. Pertussis vaccine and\nwhooping cough as risk factors in acute neurological illness and death in\nyoung children. Dev Biol Stand. 1985;61:389\u2013394.\n21. Rantala H, Uhari M. Occurrence of childhood encephalitis: A popula-\ntion-based study. Pediatr Infect Dis J. 1989;8:426\u2013430.\nThe Pediatric Infectious Disease Journal \u2022 Volume 25, Number 9, September 2006\nEncephalopathy and DTP or MMR Vaccine\n\u00a9 2006 Lippincott Williams & Wilkins\n773\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 01/09/2025", "mimetype": "text/plain", "start_char_idx": 31577, "end_char_idx": 32831, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "68ad193b-50d1-4438-a3f3-d66e897ad8de": {"__data__": {"id_": "68ad193b-50d1-4438-a3f3-d66e897ad8de", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Ceyhan (2001).pdf", "node_type": "4", "metadata": {}, "hash": "1f5f458198e0abaf49c17420d3c3c4144e96c0dfc2d97ec180a4b832a0b23a8c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a771e287-9a7c-4454-88c4-3c6295f56faf", "node_type": "1", "metadata": {}, "hash": "5c6578792849b085762186a5f41a4409a9fb3e8eb396241f63206a2be047d404", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine 19 (2001) 4473\u20134478\nImmunogenicity and ef\ufb01cacy of one dose measles\u2013mumps\u2013rubella\n(MMR) vaccine at twelve months of age as compared to\nmonovalent measles vaccination at nine months followed by\nMMR revaccination at \ufb01fteen months of age\nMehmet Ceyhan a,*, Guler Kanra a, Guliz Erdem b, Berkand Kanra c\na Di\u0001ision of Pediatric Infectious Diseases, Hacettepe Uni\u0001ersity School of Medicine, Ankara, 06100 Turkey\nb Department of Pediatrics, Kapiolani Medical Center for Women and Children, Uni\u0001ersity of Hawaii John A. Burns School of Medicine,\nHonolulu, HI, USA\nc Di\u0001ision of Pediatric Infectious Diseases, Hacettepe Uni\u0001ersity School of Medicine, Ankara, Turkey\nReceived 11 September 2000; received in revised form 14 May 2001; accepted 21 May 2001\nAbstract\nBackground and methods: measles is a common cause of morbidity and mortality in developing countries. Although the\nmeasles\u2013mumps\u2013rubella vaccine (MMR) is currently in use in developed countries, monovalent measles vaccine (MV) is routinely\nrecommended by World Health Organization (WHO) at 9 months of age in Turkey, as in many other developing countries. In\nthis study, 442 Turkish children received MV at 9 months of age and were revaccinated with MMR vaccine at 15 months of age.\nIn the second group 495 children received MMR at 12 months of age with no earlier measles vaccination. Antibodies were\nmeasured before the \ufb01rst vaccination and 6 weeks after the MMR. All children had been followed for occurrence of measles\ninfection for 60 months. Two vaccination schedules were compared for immunogenicity and protection rates. Conclusions:\nseroconversion and clinical protection rates were signi\ufb01cantly higher in children who received only MMR at 12 months of age\nthan in children revaccinated at 15 months of age. Seroconversion rate for measles was 69.9% in children who received MMR at\n12 months of age and 90.3% in children revaccinated at 15 months of age (P=0.0003).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1935, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a771e287-9a7c-4454-88c4-3c6295f56faf": {"__data__": {"id_": "a771e287-9a7c-4454-88c4-3c6295f56faf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Ceyhan (2001).pdf", "node_type": "4", "metadata": {}, "hash": "1f5f458198e0abaf49c17420d3c3c4144e96c0dfc2d97ec180a4b832a0b23a8c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "68ad193b-50d1-4438-a3f3-d66e897ad8de", "node_type": "1", "metadata": {}, "hash": "564dbd71fe0c64b60005b7c1e279da5e4ee9fecafc43c587adafda5152be734b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "23713cb7-39cd-4bc6-9c3a-829add7c33e9", "node_type": "1", "metadata": {}, "hash": "1854825572b7564caca9c79c5aefcafb8d31cae18ddcbbb608b8684be36eea65", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Seroconversion rate for measles was 69.9% in children who received MMR at\n12 months of age and 90.3% in children revaccinated at 15 months of age (P=0.0003). While there was no measles case in\nchildren who were revaccinated, 12 (2.7%) children in the \ufb01rst group acquired measles during the follow-up period. Vaccination\nat 12 months of age appeared to be better than the current national standard. The late elimination of maternal antibodies and\nthe inhibitory effect of a weak antibody response after the \ufb01rst dose of vaccine at 9 months may explain the better immunogenicity\nand ef\ufb01cacy of the MMR vaccine given at 12 months of age. \u00a9 2001 Published by Elsevier Science Ltd.\nKeywords: Monovalent measles vaccine; MMR vaccine; Developing countries\nwww.elsevier.com/locate/vaccine\n1. Introduction\nDespite the advent of the measles vaccine (MV) in\n1959, measles still remains as an important public\nhealth problem in the developing world. National rec-\nommendations for measles vaccination differ signi\ufb01-\ncantly between developing and developed countries. In\nareas without recurrent measles transmission, the \ufb01rst\ndose of measles immunization is recommended as\nmeasles\u2013mumps\u2013rubella vaccine (MMR) at 12\u201315\nmonths of age. In areas with recurrent measles trans-\nmission, a two-dose schedule with monovalent measles\nvaccine at 9 months of age and a second dose, using\nMMR at 15 months of age is recommended [1]. MV\nwas shown as immunogenic at 12 months of age (97%\nseroconversion) as at 15 months of age (98% serocon-\nversion) in Australia [2]. In another study, 15\u201321% of\nvaccine recipients at 9\u201312 months of age failed to\nseroconvert in contrast to less than 6% of children\nimmunized at 13\u201318 months [3]. The World Health\nOrganization (WHO) recommends that immunization\nwith a live attenuated MV should be carried out when\n* Corresponding author. Tel.: +90-312-311-4963; fax: +90-312-\n324-3284.", "mimetype": "text/plain", "start_char_idx": 1778, "end_char_idx": 3670, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "23713cb7-39cd-4bc6-9c3a-829add7c33e9": {"__data__": {"id_": "23713cb7-39cd-4bc6-9c3a-829add7c33e9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Ceyhan (2001).pdf", "node_type": "4", "metadata": {}, "hash": "1f5f458198e0abaf49c17420d3c3c4144e96c0dfc2d97ec180a4b832a0b23a8c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a771e287-9a7c-4454-88c4-3c6295f56faf", "node_type": "1", "metadata": {}, "hash": "5c6578792849b085762186a5f41a4409a9fb3e8eb396241f63206a2be047d404", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "836c8174-4b2e-47a7-a733-5aabeabe57cd", "node_type": "1", "metadata": {}, "hash": "12e9aa812d1125bb18d70df8d7db2aa4f4d3d198ef10bf938c83f6111d4603fc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Tel.: +90-312-311-4963; fax: +90-312-\n324-3284.\nE-mail address: mceyhan@genetic.gen.hun.edu.tr (M. Ceyhan).\n0264-410X/01/$ - see front matter \u00a9 2001 Published by Elsevier Science Ltd.\nPII: S0264-410X(01)00207-9\nM. Ceyhan et al. / Vaccine 19 (2001) 4473\u20134478\n4474\nthe child is around the age of 9 months. At this age the\ntransplacental antibodies in most children have disap-\npeared [4]. Children can be vaccinated then in order to\ninduce protection before the age of risk. Despite early\nvaccination at 9 months of age, measles continues to be\na major child health problem in the developing coun-\ntries [5]. Many children are now being revaccinated\nwith measles or MMR vaccines at 15 months of age\nafter initial vaccination. This two dose schedule is\nimplemented in 12 of 22 countries in the Eastern Med-\niterranean Region of WHO including Bahrain, Islamic\nRepublic of Iran, Iraq, Kuwait, Lebanon, Libyan Arab\nJamahiriya, Oman, Qatar, Saudia Arabia, Syrian Arab\nRepublic, Tunusia, United Arab Emirates [5,6]. The\nTurkish Ministry of Health provides the monocompo-\nnent live MV to children at 9 months of age free of\ncharge. Most of the pediatricians also recommend the\nadministration of MMR (not covered under the gov-\nernment insurance policies) at 15 months of age, after\nthis \ufb01rst dose of MV.\nThe effectiveness of early vaccination and revaccina-\ntion against measles is not clearly established in devel-\noping countries. The purpose of this study was to\ninvestigate the immunogenicity and protection rate of\nrevaccination with MMR vaccine at 15 months of age\nafter initial vaccination at 9 months of age in compari-\nson with children who received single dose of MMR\nvaccine at 12 months of age.\n2. Materials and methods\n2.1.", "mimetype": "text/plain", "start_char_idx": 3623, "end_char_idx": 5350, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "836c8174-4b2e-47a7-a733-5aabeabe57cd": {"__data__": {"id_": "836c8174-4b2e-47a7-a733-5aabeabe57cd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Ceyhan (2001).pdf", "node_type": "4", "metadata": {}, "hash": "1f5f458198e0abaf49c17420d3c3c4144e96c0dfc2d97ec180a4b832a0b23a8c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "23713cb7-39cd-4bc6-9c3a-829add7c33e9", "node_type": "1", "metadata": {}, "hash": "1854825572b7564caca9c79c5aefcafb8d31cae18ddcbbb608b8684be36eea65", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cc19cf07-a542-4d3b-acba-45aedac94b71", "node_type": "1", "metadata": {}, "hash": "0c69a6e7988e0eb4f5464b05046d634c7532f076950b8fc2b9b7886a163902e3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2. Materials and methods\n2.1. Subjects\nStudy subjects were 1000 healthy infants aged 9\nmonths (38\u201340 weeks) who had been given primary\nhealth care in \ufb01ve different maternity and child health\ncare centers in Ankara, Turkey. Patients were enrolled\nin a 6 month period. Healthy children with no known\nhistory of chronic disease as immunode\ufb01ciency, asthma,\natopy were recruited for the study. The infants that do\nnot have these inclusion criteriae, infants younger than\n9 months of age were excluded from the study. Ap-\nprovals for this study were obtained from the ethic\ncommittees of Hacettepe University and Turkish Min-\nistry of Health prior to the study. After obtaining\nwritten informed consents from parents, the infants\nwere randomly allocated to either Group A or B. The\nsystemic allocation was used for the randomization and\n500 infants were assigned to each group. In Group A,\n442 infants completed the study and 58 infants were\nexcluded\nfrom\nthe\nstudy\n(four\nimmigration,\nfour\nparental decision change, 50 due to the use of a differ-\nent batch of vaccine). In Group B, 495 infants com-\npleted\nthe\nstudy\nand\n\ufb01ve\nwere\nexcluded\n(three\nimmigration, two parental decision change).\n2.2. Vaccines\nMV (Rouvax\u00ae, batch no J1183, Schwarz strain, 1.000\nTCID50) and MMR vaccine (Trimovax\u00ae, batch no\nJ1023; Schwarz measles strain, 1.000 TCID50; Urabe\nAm 9 mumps strain, 5.000 TCID50; Wistar RA 27/3\nrubella\nstrain,\n1.000\nTCID50)\nof\nPasteur-Merieux\nSerums and Vaccines, Lyon, France were administered\nsubcutaneously into the right deltoid region.\n2.3. Study plan\nInfants in Group A received MV at 9 months of age\nand MMR at 15 months of age. Blood samples were\ncollected just before measles vaccination and 6 weeks\nafter MMR vaccination. Subjects in Group B received\nMMR at 12 months of age. Blood samples were col-\nlected just before and 6 weeks after the vaccination.", "mimetype": "text/plain", "start_char_idx": 5321, "end_char_idx": 7182, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cc19cf07-a542-4d3b-acba-45aedac94b71": {"__data__": {"id_": "cc19cf07-a542-4d3b-acba-45aedac94b71", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Ceyhan (2001).pdf", "node_type": "4", "metadata": {}, "hash": "1f5f458198e0abaf49c17420d3c3c4144e96c0dfc2d97ec180a4b832a0b23a8c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "836c8174-4b2e-47a7-a733-5aabeabe57cd", "node_type": "1", "metadata": {}, "hash": "12e9aa812d1125bb18d70df8d7db2aa4f4d3d198ef10bf938c83f6111d4603fc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "47eff50b-be12-48b1-9658-d082eca28293", "node_type": "1", "metadata": {}, "hash": "c28ff8a5765b3a50db1d2365cdb6ad290bd966f0484295ad3fd26f43409980dd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Subjects in Group B received\nMMR at 12 months of age. Blood samples were col-\nlected just before and 6 weeks after the vaccination.\nAfter each vaccination, all vaccine recipients were vis-\nited by midwives in child health care at their homes on\n7, 14, and 28th postvaccination days to collect adverse\nreaction records that the parents were asked to make\nnotes. Adverse reactions were de\ufb01ned as a temperature\nof 39.4 \u00b0C (103 \u00b0F), cough, runny nose, diarrhea, any\nrash after vaccination, local reactions as redness and\nswelling and also change in the alertness and overall\nactivity of the child, seizures, hypersensitivity reactions.\nSubjects were followed with phone calls and/or home\nvisits every 3 months for 60 months after vaccination.\nA standard questionnaire including the possible adverse\nreactions was used during these phone calls. Parents\nwere asked to report occurrence of measles in the\nvaccines and a measles case was de\ufb01ned as a subject\ndiagnosed by a physician with pathognomonic enan-\nthem (Koplik\u2019s spots), cough, coryza and conjunctivitis\nand maculopapular rash. In patients with no pathog-\nnomonic sign measles serologies were obtained. The\nsevere cases were described as patients with acute en-\ncephalitis, bronchopneumonia, and respiratory distress.\n2.4. Serological tests\nTotal speci\ufb01c levels of measles, mumps, and rubella\nIg Gs were determined by commercial ELISA (Trinity\nBiotech Plc, Jamestown, USA). The test sera, positive\nand negative control sera, and calibrator were diluted\n1:21 in serum diluent, 100 \u0001l of them were added to the\nwells with additional 100 \u0001l serum diluent to reagent\nblank well. Each well was incubated at room tempera-\nture for 20 min and aspirated, washed with wash buffer\nfour times. Then, 100 \u0001l conjugate was added to the\nwells followed by 20 min incubation at room tempera-\nture and washing \ufb01ve times with wash buffer.", "mimetype": "text/plain", "start_char_idx": 7051, "end_char_idx": 8923, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "47eff50b-be12-48b1-9658-d082eca28293": {"__data__": {"id_": "47eff50b-be12-48b1-9658-d082eca28293", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Ceyhan (2001).pdf", "node_type": "4", "metadata": {}, "hash": "1f5f458198e0abaf49c17420d3c3c4144e96c0dfc2d97ec180a4b832a0b23a8c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cc19cf07-a542-4d3b-acba-45aedac94b71", "node_type": "1", "metadata": {}, "hash": "0c69a6e7988e0eb4f5464b05046d634c7532f076950b8fc2b9b7886a163902e3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "34fc559e-8978-4356-bae6-95abb438674a", "node_type": "1", "metadata": {}, "hash": "46f1911acfd16a110e3559f46bfe17b8b544e2596dc3d7dcd8c0c10d83c6044f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Then, 100 \u0001l conjugate was added to the\nwells followed by 20 min incubation at room tempera-\nture and washing \ufb01ve times with wash buffer. The wells\nwere \ufb01lled with 100 \u0001l chromogen/substrate solution\nand incubated at room temperature for 10 min. Reac-\ntion was stopped by addition of 100 \u0001l stop solution (1\nM. Ceyhan et al. / Vaccine 19 (2001) 4473\u20134478\n4475\nTable 1\nAdverse reactions after vaccinations\nReactions\nGroup B (n=495)\nGroup A (n=442)\nMMR\nMMR\nMeasles\nSystemic\n40 (9.1)\nFever\n55 (11.2)\n38 (8.7)a\n7 (1.6)\n19 (4.3)\n22 (4.4)b\nRunny nose\n36 (8.1)\nCough\n34 (6.8)\n28 (6.2)\n16 (3.6)\n2 (0.4)\n19 (3.8)\nRash\nDiarrhea\n5 (1.1)\n2 (0.4)\n5 (1.0)\nLocal\nRedness\n14 (3.2)\n7 (1.6)\n19 (4.3)\n2 (0.4)\nSwelling\n2 (0.4)\n3 (0.6)\na Numbers in parenthesis indicate percentages.\nb P\u00010.01.\nfourfold increase in antibody titers after vaccination for\ninfants with positive pre-existing antibodies.\n2.5. Statistical tests\nStatistical evaluation was done by using SPSS (Ver-\nsion 6, SPSS Inc, Chicago, IL, USA) and Statistica\n(version 5, Stat Soft Inc, Tulsa, OK, USA) computer\nprograms. Mann\u2013Whitney U test for comparison of\nmean titers, t-test for comparison of seroconversion\nrates and \u00012-test for comparison of nominal attributes\nwere used for statistical analysis.\n3. Results\nThere was no signi\ufb01cant difference between the two\ngroups with regard to sex and age (P=0.24 and 0.38,\nrespectively).", "mimetype": "text/plain", "start_char_idx": 8786, "end_char_idx": 10162, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "34fc559e-8978-4356-bae6-95abb438674a": {"__data__": {"id_": "34fc559e-8978-4356-bae6-95abb438674a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Ceyhan (2001).pdf", "node_type": "4", "metadata": {}, "hash": "1f5f458198e0abaf49c17420d3c3c4144e96c0dfc2d97ec180a4b832a0b23a8c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "47eff50b-be12-48b1-9658-d082eca28293", "node_type": "1", "metadata": {}, "hash": "c28ff8a5765b3a50db1d2365cdb6ad290bd966f0484295ad3fd26f43409980dd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "97c61abe-8bf3-4702-b629-0fa6bc2b61db", "node_type": "1", "metadata": {}, "hash": "65a123ecedd2be0668a1067967fc647a7e489980c8af4b9c81fec0d2fcad698a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3. Results\nThere was no signi\ufb01cant difference between the two\ngroups with regard to sex and age (P=0.24 and 0.38,\nrespectively). The time interval between immunization\nand\npostvaccination\nblood\nsample\ncollection\nwas\n42.7\u00023.6 days for Group A and 42.5\u00024.1 days for\nGroup B. Adverse reactions to vaccinations are shown\nin Table 1. With the exception of runny nose which was\nmore common in Group B (P\u00010.01), there was no\ndifference for systemic or local adverse events between\nthe two groups.\nThe geometric mean titers (GMT) of speci\ufb01c anti-\nbodies against measles, mumps, and rubella before and\nafter vaccination for both groups are given in Table 2.\nPrevaccination measles GMT was higher in Group A in\nwhich children were younger (9-month-old) during the\nblood sample collection (P\u00010.0001). Postvaccination\nantibody titers were higher in Group B (P\u00010.0001).\nNo difference was detected between the two groups for\nN H2SO4). The developed color was read on ELISA\nplate reader at 450 nm. Calibrator value was calculated\nby multiplying the mean absorbance of the calibrators\nby the factor recorded on the kit packing (correction\nfactor) and immune status ratio (ISR) was found by\ndeviding the sample absorbance by the calibrator value.\nThen, ISR was changed to IU/ml using the formula\nspeci\ufb01c for each lot as noted on the manufacturer\u2019s\norder. The cut off value was 0.29 IU/ml for measles\nantibodies, 0.83 IU/ml for mumps antibodies, and 5.1\nIU/ml for rubella antibodies. The values below the\ncut-off were accepted as negative in calculation of\nseroconversion, but all measurable values were taken in\naccount in GMT evaluations.", "mimetype": "text/plain", "start_char_idx": 10034, "end_char_idx": 11656, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "97c61abe-8bf3-4702-b629-0fa6bc2b61db": {"__data__": {"id_": "97c61abe-8bf3-4702-b629-0fa6bc2b61db", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Ceyhan (2001).pdf", "node_type": "4", "metadata": {}, "hash": "1f5f458198e0abaf49c17420d3c3c4144e96c0dfc2d97ec180a4b832a0b23a8c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "34fc559e-8978-4356-bae6-95abb438674a", "node_type": "1", "metadata": {}, "hash": "46f1911acfd16a110e3559f46bfe17b8b544e2596dc3d7dcd8c0c10d83c6044f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1fea1f89-ee51-47f6-809f-c760f9fb083a", "node_type": "1", "metadata": {}, "hash": "c6bd4c91877fd851b6462042f0f2e7345023271809a724a651ebe8b784a13a5a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The values below the\ncut-off were accepted as negative in calculation of\nseroconversion, but all measurable values were taken in\naccount in GMT evaluations.\nSeroconversion was de\ufb01ned as any positive antibody\nresponse in earlier seronegative infants and at least\nTable 2\nAntibody titers before and after vaccinations, seroconversion and clinical protection\nGroup B (n=495)\nGroup A (n=442)\nP\nPre\nPost\nPre\nPost\nMeasles\n0.742\n0.035\n0.360\n0.082\n\u00010.0001 (Pre)\nGMT\n0.063\u20130.111\n95% CI\n0.323\u20130.395\n0.001\u20130.050\n0.670\u20130.814\n\u00010.0001 (Post)\nSeroconv\nNA\n69.9\nNA\n90.3\n0.0003\n0\n\u00010.0001\nNA\nInfection\n12 (2.7%)\nNA\n1.20\u20134.23\n95% CI\nMumps\n0.045\nGMT\n1.074\n0.039\n1.096\n0.27\n0.003\u20130.076\n0.873\u20131.259\n95% CI\n0.005\u20130.066\n0.965\u20131.248\n0.19\n98.4\nSeroconv\n0.24\n97.3\nNA\nNA\nRubella\n3.645\nGMT\n7.649\n3.761\n7.527\n0.38\n0.130\u20134.86\n4.96\u20139.018\n0.163\u20134.754\n5.001\u20138.88\n95% CI\n0.36\nNA\n0.21\n93.7\nNA\n95.2\nSeroconv\nCI, con\ufb01dence interval; GMT, geometric mean titer (IU/ml); NA, not applicable; Pre, prevaccination; Post, postvaccination; Seroconv,\nseroconversion (percentage).\nM. Ceyhan et al.", "mimetype": "text/plain", "start_char_idx": 11500, "end_char_idx": 12548, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1fea1f89-ee51-47f6-809f-c760f9fb083a": {"__data__": {"id_": "1fea1f89-ee51-47f6-809f-c760f9fb083a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Ceyhan (2001).pdf", "node_type": "4", "metadata": {}, "hash": "1f5f458198e0abaf49c17420d3c3c4144e96c0dfc2d97ec180a4b832a0b23a8c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "97c61abe-8bf3-4702-b629-0fa6bc2b61db", "node_type": "1", "metadata": {}, "hash": "65a123ecedd2be0668a1067967fc647a7e489980c8af4b9c81fec0d2fcad698a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f0868f32-ac14-4ca2-9acc-606cb5cff72e", "node_type": "1", "metadata": {}, "hash": "80799eb9dd7ac19ade9dda3f65b84077e555b3f0425d71b6adc650ae8ed75aad", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "M. Ceyhan et al. / Vaccine 19 (2001) 4473\u20134478\n4476\nTable 3\nSeropositive infants before vaccination\nGroup Ba (n=495)\nGroup Aa (n=442)\nMeasles\n36 (8.1)b\n7 (1.4)\n7 (1.4)\n14 (3.1)\nMumps\n2 (0.4)\nRubella\n9 (2.0)\na Group A, 9 months of age; Group B, 12 months of age.\nb Numbers in parenthesis indicate percentages.\nously not be considered for this high rate of vaccine\nfailure. In our study, 8.1% of children at 9 months of\nage was seropositive when MV was administered, in\ncontrast to 1.4% seropositivity rate at 12 months of\nage when one dose MMR was administered. The pos-\nsibility of contracting measles before or at the time of\nvaccination seemed unlikely given the low titers and\ncomparison of the seroprevalance of both groups.\nPassive transfer and interference by maternal antibod-\nies appeared to be the most important reason for\nprimary vaccine failure.\nPersistence of maternal antibodies could be a major\ncause of reduction in seroconversion rates to live MV\nadministered to infants under the age of 12 months.\nAlbrecht et al. [10] reported measles neutralizing anti-\nbodies in children up to 12 months of age and a\ndirect correlation between persisting levels of maternal\nantibody in the infant and response to vaccination.\nSimilar results were observed in an animal model us-\ning macaques in the presence of passively acquired\nantibodies [11].\nThe results of our study indicated a higher vaccine\nfailure rate (30.1%) after early (9 months of age)\nmeasles vaccination followed by MMR vaccine at 15\nmonths of age than MMR vaccination at 12 months\nof age (9.7%). Although much higher than the \ufb01rst\ngroup, the seroconversion rate of 90.7% in children\nwho were vaccinated at 12 months of age with a\nsingle batch of the vaccine appear to be less than in\nsome of the earlier reported studies for unknown rea-\nsons [12,13].", "mimetype": "text/plain", "start_char_idx": 12532, "end_char_idx": 14354, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f0868f32-ac14-4ca2-9acc-606cb5cff72e": {"__data__": {"id_": "f0868f32-ac14-4ca2-9acc-606cb5cff72e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Ceyhan (2001).pdf", "node_type": "4", "metadata": {}, "hash": "1f5f458198e0abaf49c17420d3c3c4144e96c0dfc2d97ec180a4b832a0b23a8c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1fea1f89-ee51-47f6-809f-c760f9fb083a", "node_type": "1", "metadata": {}, "hash": "c6bd4c91877fd851b6462042f0f2e7345023271809a724a651ebe8b784a13a5a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8636e930-aeb5-4714-a8d7-13ece4dddd82", "node_type": "1", "metadata": {}, "hash": "3bff6cdebf04b8b9b6f96fa91aaea45117632b54d8d2e36958f372d945acc06c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The early vaccination seemed to alter the\nimmune responses to revaccination. The results of the\nearly studies for determining the immune response to\nthe vaccination at 15 months after measles vaccina-\ntion at 9 months of age were con\ufb02icting. Two studies\nincluding small numbers of children indicated that the\nimmune responses of some infants vaccinated before\n10 months of age were altered enough to suggest\nlower protection rates even with revaccination after\none year of age [14,15]. Murphy et al. [16] found\ngood measles antibody responses after immunization\nwith MMR vaccine at 15 months of age in children\nwho had been vaccinated with MV at 5\u201310 months\nof age. They suggested that the reason for lower anti-\nbody response after reimmunization in the other stud-\nies, was related to the different serological method.\nThey used a more sensitive method (ELISA) instead\nof hemagglutination inhibition assay. In our study,\nwe used ELISA and found lower antibody response\nafter reimmunization than that after one dose vaccine\nat 12 months of age. Similarly, in another study com-\nparing antimeasles antibody titers in German and\nNigerian cohort of paired mothers and newborns\nHartter et al. [17] found that the passively acquired\nantimeasles antibodies decayed rapidly. The cause of\npre- and postvaccination mumps and rubella antibod-\nies (P=0.27 and 0.38, respectively, for prevaccination\nand 0.19 and 0.36, respectively, for post vaccination).\nSeroconversion rate was 69.9% in Group A and\n90.3% in Group B for measles and this difference was\nstatistically signi\ufb01cant (P=0.0003) (Table 2). Clinical\nprotection was also signi\ufb01cantly better in Group B\n(P\u00010.0001). While there was no measles case in\nGroup B, 12 (2.7%) children in Group A acquired\nmeasles during the follow-up period. These cases were\ncon\ufb01rmed with serological testing. None of these\ncases had severe measles and they did not require\nhospitalization.", "mimetype": "text/plain", "start_char_idx": 14355, "end_char_idx": 16269, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8636e930-aeb5-4714-a8d7-13ece4dddd82": {"__data__": {"id_": "8636e930-aeb5-4714-a8d7-13ece4dddd82", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Ceyhan (2001).pdf", "node_type": "4", "metadata": {}, "hash": "1f5f458198e0abaf49c17420d3c3c4144e96c0dfc2d97ec180a4b832a0b23a8c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f0868f32-ac14-4ca2-9acc-606cb5cff72e", "node_type": "1", "metadata": {}, "hash": "80799eb9dd7ac19ade9dda3f65b84077e555b3f0425d71b6adc650ae8ed75aad", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3babe2cc-f06b-413b-b3d9-53d9cb31566d", "node_type": "1", "metadata": {}, "hash": "876dda1a5d20f2765ced5ecebd36324acd8bb10823d0d1b1b87bbc3aaf6cd535", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "These cases were\ncon\ufb01rmed with serological testing. None of these\ncases had severe measles and they did not require\nhospitalization. All of these children were shown to\nhave seroconversion prior to developing disease. They\nwere diagnosed with measles 12\u201336 months after vac-\ncination. The diagnosis was con\ufb01rmed with serologic\ntesting and no further serologies were obtained from\nthese patients. These cases were scattered between the\n\ufb01ve different centers and there was no known epi-\ndemiologic link between these cases. There was no\ndifference in seroconversion for mumps and rubella\n(P=0.24 and 0.21, respectively).\nThe ratio of seropositive infants before vaccination\nis given in Table 3. Ratio of seropositive infants for\nmeasles was 8.1% in Group A and 1.4% in Group B.\nThis ratio was 3.1 and 1.4% for mumps and 2.0 and\n0.4% for rubella in Groups A and B, respectively.\n4. Discussion\nMeasles continues to be an important cause of\nmorbidity and mortality in Turkey. Since routine vac-\ncination against measles at 9 months of age is pro-\nvided to most of these children, primary vaccine\nfailure in addition to the unvaccinated population\nneeds to be considered for the measles endemicity\n[7,8]. Risk factors for primary vaccine failure are\nmostly due to improper vaccine handling, use of\nkilled\nvirus\nvaccine,\nconcomitant\nuse\nof\nimmune\nserum globulin, and interference by maternally ac-\nquired measles antibody [9]. Killed virus vaccine has\nnot been used in Turkey for a long time and con-\ncomitant use of immune serum globulin could obvi-\nM. Ceyhan et al. / Vaccine 19 (2001) 4473\u20134478\n4477\nthis con\ufb02iction might be purely due to the geographic\nand regional differences of maternal antibody elimina-\ntion, not the serological method. In these studies, the\nvaccines were not followed after vaccination and the\nonly parameter for vaccine protectiveness was the\nserological response. Stetler et al.", "mimetype": "text/plain", "start_char_idx": 16137, "end_char_idx": 18037, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3babe2cc-f06b-413b-b3d9-53d9cb31566d": {"__data__": {"id_": "3babe2cc-f06b-413b-b3d9-53d9cb31566d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Ceyhan (2001).pdf", "node_type": "4", "metadata": {}, "hash": "1f5f458198e0abaf49c17420d3c3c4144e96c0dfc2d97ec180a4b832a0b23a8c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8636e930-aeb5-4714-a8d7-13ece4dddd82", "node_type": "1", "metadata": {}, "hash": "3bff6cdebf04b8b9b6f96fa91aaea45117632b54d8d2e36958f372d945acc06c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c3ef59b6-540f-41af-80e7-95ea1f4258f4", "node_type": "1", "metadata": {}, "hash": "398c7362a9d548bd5cd630e11740a3e7bdec2302e5de049d0aa89b7ff5dfb21f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In these studies, the\nvaccines were not followed after vaccination and the\nonly parameter for vaccine protectiveness was the\nserological response. Stetler et al. [18] revaccinated\n254 infants who had received MV at less than 10\nmonths of age and determined immune responses 3\nweeks and 8 months later. Despite almost equal anti-\nbody responses at 3 weeks postvaccination in both\ngroups, infants who received their \ufb01rst doses of MV\nat or after 15 months of age had higher antibody\nresponses 8 months after the vaccination. The authors\nsuggested that infants who did not respond were also\nprotected after revaccination. No comparative studies\nfor ef\ufb01cacy of revaccination after early measles vacci-\nnation including clinical protection have been done\nbefore our study. Although serologic testing was not\ndone in the end of the study for all subjects, and\ntheoretically few cases could be missed, we followed\nthe subjects for 60 months and observed that one\ndose MMR was apparently more protective than\nearly vaccination/revaccination (zero versus 12 cases).\nThe role of transplacental antibodies in primary\nvaccine failure may vary in different populations. Al-\nthough maternal malnutrition can result in lower ma-\nternal measles antibody titers in many underdeveloped\ncountries, most of the children are still expected to\nhave maternal antibodies derived from maternal infec-\ntion\nin\ndeveloping\nand\nunderdeveloped\ncountries.\nElimination of high maternal antibodies secondary to\ninfection is expected to be later than that of maternal\nvaccine induced antibody responses. Thus, maternal\nantibody transfer may have a more important in-\nhibitory effect in early vaccination in developing re-\ngions\nthan\nin\nthe\nunderdeveloped\nregions.\nThese\nresults do not exclude the need for early vaccination\nduring\nmeasles\nepidemics\nto\nprevent\nthe\ninfants\nyounger than one year of age until development of a\nnew potent MV for infants younger than 12 months\nof age. Higher incidence of running nose observed in\none dose MMR vaccine group may be related to sea-\nsonal variations of vaccination.", "mimetype": "text/plain", "start_char_idx": 17876, "end_char_idx": 19949, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c3ef59b6-540f-41af-80e7-95ea1f4258f4": {"__data__": {"id_": "c3ef59b6-540f-41af-80e7-95ea1f4258f4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Ceyhan (2001).pdf", "node_type": "4", "metadata": {}, "hash": "1f5f458198e0abaf49c17420d3c3c4144e96c0dfc2d97ec180a4b832a0b23a8c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3babe2cc-f06b-413b-b3d9-53d9cb31566d", "node_type": "1", "metadata": {}, "hash": "876dda1a5d20f2765ced5ecebd36324acd8bb10823d0d1b1b87bbc3aaf6cd535", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eca27f4b-8a62-499b-b9aa-07520f3c9c41", "node_type": "1", "metadata": {}, "hash": "fd2973fddd5ebfb681c65d0b6f17197571647c0d53c3f6f0eaf977e3bd3e4c76", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Higher incidence of running nose observed in\none dose MMR vaccine group may be related to sea-\nsonal variations of vaccination.\nIn conclusion, seroconversion and clinical protec-\ntion of MV at early ages and revaccination at or\nafter one year of age may differ between countries\ndepending on the maternal antibody status. The elim-\nination time of maternal antibodies might be related\nto vaccine coverage and infection prevalence of moth-\ners and may vary in different geographic locations.\nSince most of the mothers who live in developing\ncountries have high measles antibody levels gained by\ninfection, their children were expected to lose mater-\nnal measles antibodies later than children of devel-\noped countries.\nAcknowledgements\nWe would like to thank Professor Ergun Karaa-\ngaoglu for his invaluable assistance in statistical anal-\nysis. This study was supported by the United Nations\nDevelopment\nProgramme\n(UNDP)\ngrant\nand\nwas\npartly presented in 39th Interscience Conference on\nAntimicrobial\nAgents\nand\nChemotherapy,\n26\u201329th\nSeptember, 1999, San Francisco, CA, USA.\nReferences\n[1] WHO. Strategies for reducing global measles mortality. Wkly\nEpidemiol Rec. 2000; 75:411\u20136.\n[2] Kakakios AM, Burgess MA, Bransby RD, Quinn AA, Allars\nHM. Optimal age for measles and mumps vaccination in Aus-\ntralia. Med J Aust 1990;152:472\u20133.\n[3] Sherrod JL, Kane R, Cherry JD, Fricker J, Maples K. Effect\nof timing of measles vaccination on compliance with immu-\nnizations\nduring\nthe\nsecond\nyear\nof\nlife.\nJ\nPediatr\n1983;102:186\u201390.\n[4] Hall AJ, Greenwood BM, Whittle H. Modern vaccines: prac-\ntice in developing countries. Lancet 1990;335:774\u20137.\n[5] Mitchell LA, Tingle AJ, Decarie D, Lajeunesse C. Serologic\nresponses to measles, mumps, and rubella (MMR) vaccine in\nhealthy infants: failure to respond to measles and mumps com-\nponents may in\ufb02uence decisions on timing of the second dose\nof MMR.", "mimetype": "text/plain", "start_char_idx": 19822, "end_char_idx": 21708, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "eca27f4b-8a62-499b-b9aa-07520f3c9c41": {"__data__": {"id_": "eca27f4b-8a62-499b-b9aa-07520f3c9c41", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Ceyhan (2001).pdf", "node_type": "4", "metadata": {}, "hash": "1f5f458198e0abaf49c17420d3c3c4144e96c0dfc2d97ec180a4b832a0b23a8c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c3ef59b6-540f-41af-80e7-95ea1f4258f4", "node_type": "1", "metadata": {}, "hash": "398c7362a9d548bd5cd630e11740a3e7bdec2302e5de049d0aa89b7ff5dfb21f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c3d19289-39f2-43c3-a22a-ee7ce7a4f65f", "node_type": "1", "metadata": {}, "hash": "3ab3f8142892b49631b016751427749fc5fba982b44d3263f59395bf503a19ce", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Can J Public Health 1998;89:325\u20138.\n[6] WHO. Expanded Programme on Immunization: Immunization\nschedules in the WHO. Eastern Mediterranean Region, 1995.\nWeekly Epidemiological Record 1996; 71:173\u201380\n[7] WHO. Expanded programme on immunization: Measles, 1994.\nWkly Epidemiol Rec. 1995; 70:284\u20138\n[8] Ceyhan M, Kanra G, Vargel S, Isikc\u00b8elik Y. The evaluation of\nvaccination against measles at nine months of age: report of\nan epidemic. Turk J Pediatr 1992;34:127\u201333.\n[9] Mast EE, Berg JL, Hanrahan LP, Wassell JT, Davis JP. Risk\nfactors for measles in a previously vaccinated population and\ncost-effectiveness of the vaccination strategies. J Am Med As-\nsoc 1990;264:2529\u201333.\n[10] Albrecht P, Ennis FA, Saltzman EJ, Krugman S. Persistence\nof maternal antibody in infants beyond 12 months: mechanism\nof measles vaccine failure. J Pediatr 1977;91:715\u20138.\n[11] Van Binnendijik RS, Poelen MCM, van Amerongen G, de\nVries P, Osterhaus ADME. Protective immunity in macaques\nvaccinated\nwith\nlive\nattenuated,\nrecombinant,\nand\nsubunit\nmeasles vaccines in the presence of passively acquired antibod-\nies. J Infect Dis 1997;175:524\u201332.\n[12] Sarno MJ, Blase E, Galindo N, Ramirez R, Schirmer CL,\nTrujillo-Juarez\nDF.\nClinical\nimmunogenicity\nof\nmeasles,\nmumps, rubella vaccine delivered by the Injex jet injector:\ncomparison with the standard syringe injection. Pediatr Infect\nDis J 2000;19:839\u201342.\n[13] Samailovic EO, Kapustik LA, Feldman EV, Yermolovich MA,\nSvirchevskaya AJ, Zakherenko, et al.", "mimetype": "text/plain", "start_char_idx": 21709, "end_char_idx": 23184, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c3d19289-39f2-43c3-a22a-ee7ce7a4f65f": {"__data__": {"id_": "c3d19289-39f2-43c3-a22a-ee7ce7a4f65f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Ceyhan (2001).pdf", "node_type": "4", "metadata": {}, "hash": "1f5f458198e0abaf49c17420d3c3c4144e96c0dfc2d97ec180a4b832a0b23a8c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eca27f4b-8a62-499b-b9aa-07520f3c9c41", "node_type": "1", "metadata": {}, "hash": "fd2973fddd5ebfb681c65d0b6f17197571647c0d53c3f6f0eaf977e3bd3e4c76", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "[13] Samailovic EO, Kapustik LA, Feldman EV, Yermolovich MA,\nSvirchevskaya AJ, Zakherenko, et al. Cent Eur J Public\nHealth 2000;8:160\u20133.\n[14] Wilkins J, Wehrle PF. Additional evidence against measles\nvaccine administration to infants less than 12 months of age:\naltered immune response following active/passive immuniza-\ntion. J Pediatr 1979;94:865\u20139.\n[15] Linnemann CC Jr, Dine MS, Roselle GA, Askey AA. Measles\nimmunity after revaccination: results in children vaccinated be-\nfore 10 months of age. Pediatrics 1982;69:332\u20135.\nM. Ceyhan et al. / Vaccine 19 (2001) 4473\u20134478\n4478\n[16] Murphy MD, Brunell PA, Lievens AW, Shehab ZM. Effect\nof early immunization on antibody response to reimmuni-\nzation\nwith\nmeasles\nvaccine\nas\ndemonstrated\nby\nenzyme-\nlinked\nimmunosorbent\nassay\n(ELISA).\nPediatrics\n1984;74:\n90\u20133.\n[17] Hartter HK, Oyedele OI, Dietz K, Kreis S, Hoffman JP, Muller\nCP. Placental transfer and decay of maternally acquired an-\ntimeasles antibodies in Nigerian children. Pediatr Infect Dis J\n2000;19:635\u201341.\n[18] Stetler HC, Orenstein WA, Bernier RH, et al. Impact of revacci-\nnating children who initially received measles vaccine before 10\nmonths of age. Pediatrics 1986;77:471\u20136.\n.", "mimetype": "text/plain", "start_char_idx": 23087, "end_char_idx": 24279, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b4649b97-19f7-4509-9d84-8f6012a0f4d9": {"__data__": {"id_": "b4649b97-19f7-4509-9d84-8f6012a0f4d9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5774bd5d-358c-463b-94d6-7fba145dd828", "node_type": "1", "metadata": {}, "hash": "13c061b324c541eca4113c66a279f7d8c0f126a7867df1305233b765e9ab88d5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Study\nPopulation\n18\nPEDIATRICS\nVol.\n68\nNo.\n1 July\n1981\nClinical\nand\nSerologic\nEvaluation\nof\nMeasles,\nMumps,\nand\nRubella\n(HPV-77:DE-5\nand\nRA\n27/\n3)\nVirus\nVaccines,\nSingly\nand\nin Combination\nStephen\nJ. Lerman,\nMD,\nMitzi\nBollinger,\nRN,\nand\nJan\nM.\nBrunken,\nRN\nFrom\nthe\nDepartments\nof Pediatrics\nand\nMedical\nMicrobiology,\nCollege\nof Medicine,\nUniversity\nof Nebraska,\nOmaha\nABSTRACT.\nA double-blind,\nplacebo-controlled\ncompar-\nison\nof\nsingle\ncomponent\nand\ncombination\nmeasles,\nmumps,\nand\nrubella\n(HPV-77:DE-5\nand\nRA\n27/3)\nvirus\nvaccines\ninvolving\n502\nyoung\nchildren\nwas\nconducted.\nThe\nrubella\nantibody\nresponse\nwas\nsimilar\nwith\nRA\n27/3\nrubella\nand\nmeasles-mumps-rubella\n(RA\n27/3)\nvaccines,\nbut\nwas\ndiminished\nwith\nthe\ncombination\nvaccine\nthat\nincorporated\nHPV-77:DE-5\nrubella.\nThere\nwas\nno\nevi-\ndence\nof\nenhanced\nclinical\nreactivity\nwith\neither\nof\nthe\nmeasles-mumps-rubella\nvaccines.\nPediatrics\n68:18-22,\n1981;\nrneasles-rnurnps-rubella\nvaccine,\nrneasles\nvaccine,\nrnurnps\nvaccine,\nrubella\nvaccine,\nviral\ninterference,\nviral\nvaccines.\nWhen\na\nnew\ncomponent\nis\nintroduced\ninto\na live\nattenuated\nviral\nvaccine\ncombination,\nit\nmust\nbe\ndemonstrated\nthat\nthe\nantibody\nresponse\nis\nnot\ndiminished\nand\nthat\nclinical\nreactions\nare\nnot\nen-\nhanced.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1228, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5774bd5d-358c-463b-94d6-7fba145dd828": {"__data__": {"id_": "5774bd5d-358c-463b-94d6-7fba145dd828", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b4649b97-19f7-4509-9d84-8f6012a0f4d9", "node_type": "1", "metadata": {}, "hash": "483b1da43920654f355a711925421831defc28bab5628c30a48549f8bbaa7b65", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b5b1f0c3-64c0-499e-a305-ebe24142b6d8", "node_type": "1", "metadata": {}, "hash": "4b8e0979610ec4dc60bf52cb86357217164354d533da49b61ccd1ce5726722b4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Wistar\nRA\n27/3\nrubella\nvirus\nvaccine\nis felt\nto\nhave\ngreater\nimmunologic\npotency\nthan\nHPV-77:\nDE-5\nrubella\nvirus\nvaccine.\nThis\nstudy\nwas\ncon-\nducted\nto\nevaluate\nRA\n27/3\nrubella\nvaccine\nas\na\nreplacement\nfor\nHPV-77:DE-5\nrubella\nvaccine\nin\ncombination\nmeasles-mumps-rubella\nvirus\nvaccine.\nFurthermore,\nthe\nstudy\nwas\nspecifically\ndesigned\nto\nexplore\nthe\nfeasibility\nof\nconducting\na double-blind,\nplacebo-controlled\nvaccine\ntrial\nas\npart\nof\nongoing\nhealth\ncare\nin\nmultiple\npediatric\nclinics\nand\nprivate\noffices.\nMATERIALS\nAND\nMETHODS\nVaccines\nand\nPlacebo\nWe\ntested\nthe\nfollowing\nsix\nlive\nattenuated\nviral\nvaccines:\nmore\nattenuated\nEnders\u2019\n(Moraten)\nmea-\nsles;\nJeryl\nLynn\nmumps;\nHPV-77:DE-5\nrubella;\nmeasles-mumps-rubella,\nwith\nHPV-77:DE-5\nas\nthe\nrubella\ncomponent;\nWistar\nRA\n27/3\nrubella;\nand\nmeasles-mumps-rubella,\nwith\nWistar\nRA\n27/3\nas\nthe\nrubella\ncomponent.\nThe\nRA\n27/3\nstrain\nof\nru-\nbella\nvirus\nwas\nisolated\nfrom\nan\naborted\nrubella-\ninfected\nhuman\nfetus\nand\nattenuated\nby\n29\npassages\nin\nWI-38\nhuman\ndiploid\nfibroblast\ntissue\nculture.\nThe\ntwo\nRA\n27/3\nrubella\nvirus\nvaccines,\nsingle\ncomponent\nand\ncombination,\nwere\ntested\nfor\np0-\ntency\nand\nsafety\nby\nthe\nMerck\nInstitute\nfor\nThera-\npeutic\nResearch.", "mimetype": "text/plain", "start_char_idx": 1229, "end_char_idx": 2424, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b5b1f0c3-64c0-499e-a305-ebe24142b6d8": {"__data__": {"id_": "b5b1f0c3-64c0-499e-a305-ebe24142b6d8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5774bd5d-358c-463b-94d6-7fba145dd828", "node_type": "1", "metadata": {}, "hash": "13c061b324c541eca4113c66a279f7d8c0f126a7867df1305233b765e9ab88d5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2f05a9c1-5af5-4b45-b67b-f6ce6f0b7e6b", "node_type": "1", "metadata": {}, "hash": "6e030fea22673d59cdce65fb54ed86e2d06d23cabaae03744a97d2b1116f8849", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\nfour\nother\nvaccines\nwere\ncorn-\nmercial\nproducts\nof\nMerck\nSharp\n&\nDohme.\nThe\nplacebo\nconsisted\nof\nvaccine\ndiluent.\nAll\nvials\nwere\nrelabeled\nwith\na\ncode\nnumber\nand\ncontents\nwere\nunknown\nto\nthose\nwho\nadministered\nand\nthose\nwho\nreceived\nthe\nvaccine.\nWe\nentered\nthree\ntimes\nas\nmany\nvials\nof\neach\nof\nthe\ntwo\ncombination\nvaccines\nas\neach\nof\nthe\nsingle\ncomponent\nvaccines\nand\npla-\ncebo.\nReceived\nfor\npublication\nJuly\n14, 1980;\naccepted\nSept\n16, 1980.\nPresented,\nin part,\nat\nthe\nTwentieth\nInterscience\nConference\non\nAntimicrobial\nAgents\nand\nChemotherapy,\nNew\nOrleans,\nSept\n23,\n1980.\nReprint\nrequests\nto\n(S.J.L.)\nPediatric\nInfectious\nDisease\nUnit,\nUniversity\nof\nNebraska\nMedical\nCenter,\n42nd\nand\nDewey\nAye,\nOmaha,\nNE\n68105\nPEDIATRICS\n(ISSN\n0031\n4005).\nCopyright\n\u00a9\n1981\nby\nthe\nAmerican\nAcademy\nof\nPediatrics.\nThe\nchildren\nwere\nrecruited\ninto\nthe\nstudy\nwhen\nthey\ncame\nto\ntheir\nclinic\nor\nphysician\u2019s\noffice\nfor\nroutine\nmeasles-mumps-rubella\nvirus\nvaccination.\nThey\nwere\n15\nmonths\nto\n4 years\nof\nage,\nhealthy,\nand\nhad\nnegative\ndisease\nand\nvaccination\nhistories\nfor\nmeasles,\nmumps,\nand\nrubella.\nChildren\nwith\ntern-\nperature\n\u0012100.5\nF were\nexcluded,\nbut\nchildren\nwith\nafebrile\nupper\nrespiratory\ninfection\nwere\nnot.", "mimetype": "text/plain", "start_char_idx": 2425, "end_char_idx": 3625, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2f05a9c1-5af5-4b45-b67b-f6ce6f0b7e6b": {"__data__": {"id_": "2f05a9c1-5af5-4b45-b67b-f6ce6f0b7e6b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b5b1f0c3-64c0-499e-a305-ebe24142b6d8", "node_type": "1", "metadata": {}, "hash": "4b8e0979610ec4dc60bf52cb86357217164354d533da49b61ccd1ce5726722b4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b975d129-aeb9-4a30-ae9e-13270caad675", "node_type": "1", "metadata": {}, "hash": "310c4b2169968db8a2fc0faa9f49018ceb1a6a517fd0f33fa82682fea8c38855", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Children\nwith\ntern-\nperature\n\u0012100.5\nF were\nexcluded,\nbut\nchildren\nwith\nafebrile\nupper\nrespiratory\ninfection\nwere\nnot.\nDownloaded from http://publications.aap.org/pediatrics/article-pdf/68/1/18/957786/18.pdf\nby CAMPUS PICPUS - APHP user\nARTICLES\n19\nInformed\nConsent\nParents\nread\na\ndetailed\ndescription\nof\nthe\nback-\nground,\nprocedures,\nbenefits,\nand\nhazards\nof\nthe\nstudy\nthat\nhad\nbeen\napproved\nby\nthe\nUniversity\nof\nNebraska\nInstitutional\nReview\nBoard\nfor\nthe\nPro-\ntection\nof\nHuman\nSubjects,\nthe\nUniversity\nof\nNe-\nbraska\nMedical\nCenter\nHuman\nInvestigation\nand\nEthics\nCommittee,\nand\nthe\nUnited\nStates\nAir\nForce\nSurgeon\nGeneral\u2019s\nClinical\nInvestigation\nCommit-\ntee.\nThey\nwere\nalso\nencouraged\nto\nask\nquestions\nbefore\nsigning\nthe\nconsent\nform.\nPlan\nof\nStudy\nEach\nparticipating\nclinic\nor\noffice\nhad\na supply\nof\nrandomly\nselected\ncoded\nvaccine\nor\nplacebo\nvials.\nA\nvial\nwas\npicked,\ndiluent\nadded,\nand\nthe\ncontents\nadministered\nsubcutaneously.\nThe\nparent\nwas\ngiven\na 42-day\nrecord\nthat\nlisted\na variety\nof\nspecific\nlocal\nand\nsystemic\nsymptoms\nand\nalso\ncontained\nspace\nfor\nopen-ended\ncomments.\nThe\nparent\nalso\nreceived\na\nthermometer,\nalong\nwith\ninstruction\nin\nits\nuse,\nand\nwas\nurged\nto\ntake\nand\nrecord\nthe\ntemperature\nif\nthe\nchild\nappeared\nifi\nin\nany\nway.\nThe\nclinic\nor\noffice\nscheduled\na six\nweeks\nreturn\nappointment.\nAt\nthat\ntime,\nthe\nsymptom\nrecord\nwas\nreviewed\nand\nadditional\ndetails\nwere\nelicited,\nif necessary.", "mimetype": "text/plain", "start_char_idx": 3508, "end_char_idx": 4912, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b975d129-aeb9-4a30-ae9e-13270caad675": {"__data__": {"id_": "b975d129-aeb9-4a30-ae9e-13270caad675", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2f05a9c1-5af5-4b45-b67b-f6ce6f0b7e6b", "node_type": "1", "metadata": {}, "hash": "6e030fea22673d59cdce65fb54ed86e2d06d23cabaae03744a97d2b1116f8849", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "18b63421-ae10-49b6-ba08-49f96fcd95a2", "node_type": "1", "metadata": {}, "hash": "b7d440aaefa6e2993d9e5b7a76562682ef05cf0df4fe76f7d4c51f53e7ad5a6b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "At\nthat\ntime,\nthe\nsymptom\nrecord\nwas\nreviewed\nand\nadditional\ndetails\nwere\nelicited,\nif necessary.\nAt\nthe\nconclusion\nof\nthe\nreturn\nvisit,\na sealed\nbox\nbearing\nthe\nchild\u2019s\ncode\nnumber\nwas\ntaken\nfrom\nthe\nrefrig-\nerator\nand\nopened.\nIf the\nchild\nhad\ninitially\nreceived\na\nsingle\ncomponent\nvaccine\nor\nplacebo,\nthe\nbox\ncontained\nvaccine\nincorporating\nthe\ntwo\nor\nthree\nviral\nantigens\nthat\nthe\nchild\nhad\nnot\nreceived.\nIf the\nchild\nhad\ninitially\nreceived\none\nof\nthe\ntwo\ncombi-\nnation\nvaccines,\nthe\nbox\ncontained\nno\nvaccine.\nIn\nthis\nway,\nwe\ngave\nthe\nchildren\nall\nthree\nviral\nanti-\ngens\nwithout\nrepetition\nof\nany\nantigens\nand\nstifi\nmaintained\nthe\ndouble-blind\nnature\nof\nthe\nstudy.\nBlood\nsamples\nfor\nserologic\ntesting\nwere\ndrawn\njust\nbefore,\nand\nsix\nweeks\nafter,\nvaccination.\nConduct\nof\nStudy\nWe\ncontacted\nall\n15\nprivate\npediatric\npractices\nin\nthe\nmetropolitan\nOmaha\narea\nabout\nthe\nstudy.\nFive\nprivate\npractices,\nranging\nin\nsize\nfrom\nsolo\nto\nsix-\nperson,\nagreed\nto\nparticipate.\nIn\naddition,\na univer-\nsity\nmedical\ncenter\npediatric\nclinic,\nthe\nimmuniza-\ntion\nclinics\nof\ntwo\nmetropolitan\nOmaha\ncounties,\nand\nthe\nimmunization\nclinic\nof\na\nnearby\nair\nforce\nbase\nparticipated\nin\nthe\nstudy.\nAt\nthe\nair\nforce\nbase\nclinic,\na\nresearch\nnurse\n(M.B.\nor\nJ.B.),\nassisted\nby\na\nphiebotomist,\ncarried\nout\nthe\nstudy\nprocedure\nfollowing\ninitial\nrecruitment\nby\nclinic\npersonnel.", "mimetype": "text/plain", "start_char_idx": 4815, "end_char_idx": 6158, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "18b63421-ae10-49b6-ba08-49f96fcd95a2": {"__data__": {"id_": "18b63421-ae10-49b6-ba08-49f96fcd95a2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b975d129-aeb9-4a30-ae9e-13270caad675", "node_type": "1", "metadata": {}, "hash": "310c4b2169968db8a2fc0faa9f49018ceb1a6a517fd0f33fa82682fea8c38855", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e92e388b-93c1-4b1b-a5c0-5169e8e6d4e8", "node_type": "1", "metadata": {}, "hash": "c65ba9f78eb02e910d169cc53deabf68eb168c021c2185aeeea378c6d693a2c0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "or\nJ.B.),\nassisted\nby\na\nphiebotomist,\ncarried\nout\nthe\nstudy\nprocedure\nfollowing\ninitial\nrecruitment\nby\nclinic\npersonnel.\nIn\nthe\nother\nsettings,\nmedical,\nnursing\nand\nlaboratory\npersonnel\nconducted\nthe\nstudy\nwithout\noutside\nas-\nsistance.\nParticipating\nclinics\nand\nprivate\noffices\nwere\npaid\na stipend\nof\n$25\nfor\neach\nchild\nwho\ncompleted\nthe\nstudy\nto\ncompensate\nthem\nfor\nthe\nextra\ntime\nand\neffort\nexpended\nand\nfor\nthe\nadditional\npatient\nvisit\nrequired.\nPatients\nwere\nnot\ncharged\nfor\nvaccine\nor\nfor\nthe\nsix\nweeks\nreturn\nvisit.\nThe\nstudy\nextended\nfrom\nMay\n1977\nto\nApril\n1979.\nSerologic\nTesting\nAntibody\ntiters\nwere\nmeasured\nat\nthe\nMerck\nIn-\nstitute\nfor\nTherapeutic\nResearch\nunder\ncode.\nStandard\nhemagglutination\ninhibition\n(HI)\ntech-\nniques\nfor\nmeasles\nand\nrubella\nwere\nemployed,\u201d2\nusing\nserial\ntwofold\nserum\ndilutions\nstarting\nat\n1:5\nfor\nmeasles\nand\n1:8\nfor\nrubella\nand\nexpressing\nre-\nstilts\nas\nthe\nreciprocal\nof\nthe\nhighest\nserum\ndilution\nthat\ncaused\ncomplete\ninhibition\nof\nhemagglutina-\ntion.\nA\nnewly\ndeveloped\nindirect\nimmunofluores-\ncent\nassay\nwas\nused\nto\nmeasure\nmumps\nantibody\nconcentrations\n(FlAX,\nInternational\nDiagnostic\nTechnology,\nSanta\nClara,\nCA\n95050;\nM.\nM.\nHitch-\nings,\nunpublished\ndata,\n1978).\nThe\ndegree\nof\nfluo-\nrescence\nmeasured\nby\nthis\nassay\nyielded\ncontinuous\nvalues\naccording\nto\nthe\namount\nof\nantibody\nin\nthe\nserum\nsample.", "mimetype": "text/plain", "start_char_idx": 6038, "end_char_idx": 7376, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e92e388b-93c1-4b1b-a5c0-5169e8e6d4e8": {"__data__": {"id_": "e92e388b-93c1-4b1b-a5c0-5169e8e6d4e8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "18b63421-ae10-49b6-ba08-49f96fcd95a2", "node_type": "1", "metadata": {}, "hash": "b7d440aaefa6e2993d9e5b7a76562682ef05cf0df4fe76f7d4c51f53e7ad5a6b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a40236bf-cccc-43d0-9b0c-b9e98147703d", "node_type": "1", "metadata": {}, "hash": "a4de47ce9ed92ed42a4e43d18df073f8bd272280d166cf5a39cc1865438ea52f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "These\nvalues\nwere\ncorrelated\nwith\nthe\nresults\nof\nthe\nstandard\nmumps\nneutralizing\nan-\ntibody\ntest,\nso\nthat\nan\nimmunofluorescent\nvalue\nof\n2 corresponded\nto\nthe\npresence\nof\nneutralizing\nan-\ntibody\nat\na serum\ndilution\nof\n1:2.\nClinical\nReactions\nSymptoms\nand\nsigns\nwere\nanalyzed\nfor\ntheir\noc-\ncurrence\nwithin\nthe\nfollowing\nintervals:\ndays\n0\nto\n4,\n5\nto\n12,\n13\nto\n18,\n19\nto\n28,\n29\nto\n42,\nand\n0\nto\n42.\nMaximum\ntemperatures\nwere\ngrouped\nas\nfollows:\n<99\nF,\n99\nto\n100.9\nF,\n101\nto\n102.9\nF,\nand\n103\nto\n104.9\nF.\nRashes\nwere\nclassified\nas\neither\na\nspecific\nder-\nmatologic\nentity\nsuch\nas\ndiaper\nrash,\npityriasis\nno-\nsea,\nor\nvaricella,\nor\nas\na\nlocalized\n(one\narea\nof\nthe\nbody)\nor\ngeneralized\n(two\nor\nmore\nareas\nof\nthe\nbody)\nnonspecific\nerythematous\nmaculopapular\nrash.\nStatistical\nMethods\nSerologic\nresults\nwere\ncompared\nby\nanalysis\nof\nvariance\nand\nclinical\nreactions\nby\nFisher\u2019s\nexact\ntest.\nRESULTS\nSerologic\nThere\nwere\n502\nchildren\nin\nthe\nstudy.\nTwo\nsera,\nprevaccination\nand\nsix\nweeks\npostvaccination,\nwere\nobtained\nfrom\n308\n(61%)\nchildren\nand\nwere\nused\nto\nDownloaded from http://publications.aap.org/pediatrics/article-pdf/68/1/18/957786/18.pdf\nby CAMPUS PICPUS - APHP user\n20\nMEASLES,\nMUMPS,\nAND\nRUBELLA\nanalyze\nserologic\nresponses.", "mimetype": "text/plain", "start_char_idx": 7377, "end_char_idx": 8596, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a40236bf-cccc-43d0-9b0c-b9e98147703d": {"__data__": {"id_": "a40236bf-cccc-43d0-9b0c-b9e98147703d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e92e388b-93c1-4b1b-a5c0-5169e8e6d4e8", "node_type": "1", "metadata": {}, "hash": "c65ba9f78eb02e910d169cc53deabf68eb168c021c2185aeeea378c6d693a2c0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "52a6b198-21bb-4c7c-942a-228f6da1d60d", "node_type": "1", "metadata": {}, "hash": "c196204cd09ceaf9b3a7555a87888082e5b05293e8eb3feebc17cbea0ab66874", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "An\nadditional\n135\nchil-\ndren\n(27%)\nhad\neither\na\npre-\nor\na\npostvaccination\nserum\nsample\ntaken,\nbut\nnot\nboth.\nSerum\nwas\nunob-\ntamable\nat\nboth\nvisits\nfrom\nonly\n59\n(12%)\nchildren.\nPrior\nto\nvaccination,\n96%,\n82%,\nand\n94%\nof\nthe\nchildren\nwere\nseronegative\nfor\nmeasles,\nmumps,\nand\nrubella,\nrespectively.\nAs\nshown\nin\nTable\n1,\nthe\nmumps\nantibody\ntiter\nof\none\nchild\nchanged\nfrom\n<2\nto\n6\nduring\nthe\nsix\nweeks\nfollowing\nplacebo\ninjection.\nThe\nproportions\nof\nchildren\nwho\ndevel-\noped\ndetectable\nantibody\nfor\neach\nof\nthe\nthree\nantigens\nwere\nsimilar,\nwhether\nthe\nantigen\nwas\ngiven\nalone\nor\nas\npart\nof\na\ncombination\nproduct.\nAmong\nthose\nwho\nbecome\nseropositive,\nthe\nmeasles\ngeometric\nmean\ntiters\n(GMT)\nfor\nthe\nmeasles-con-\ntaming\nvaccines\nwere\nsimilar.\nMumps\ninduced\na\nhigher\nGMT\nas\npart\nof measles-mumps-rubella\n(RA\n27/3)\nvaccine\nthan\nas\npart\nof\nmeasles-mumps-ru-\nbella\n(HPV-77:DE-5)\nvaccine\n(P\n<\n.05),\nalthough\nneither\nwas\nsignificantly\ndifferent\nfrom\nthe\nGMT\nof\nmumps\nvaccine\nalone.", "mimetype": "text/plain", "start_char_idx": 8597, "end_char_idx": 9566, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "52a6b198-21bb-4c7c-942a-228f6da1d60d": {"__data__": {"id_": "52a6b198-21bb-4c7c-942a-228f6da1d60d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a40236bf-cccc-43d0-9b0c-b9e98147703d", "node_type": "1", "metadata": {}, "hash": "a4de47ce9ed92ed42a4e43d18df073f8bd272280d166cf5a39cc1865438ea52f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d6ae9f94-00d4-4673-870b-12c0e4be539e", "node_type": "1", "metadata": {}, "hash": "a21c895bba8d42bf1a71da39e683fde1d8ca74d26ae1d558e799d79e83433d1c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Rubella\nantibody\nlevels\nwere\nsimilar\nwhen\nRA\n27/3\nrubella\nwas\ngiven\nas\na\nsingle\ncomponent\nvaccine\nor\nin\na combination\nvaccine,\nbut\nlevels\nwere\nsignificantly\nlower\n(P\n<\n.05)\nwith\nmea-\nsles-mumps-rubella\n(HPV-77:DE-5)\nvaccine\nthan\nwith\nsingle\ncomponent\nHPV-77:DE-5\nrubella\nvac-\ncine.\nThe\nrubella\nGMTs\ninduced\nby\nHPV-77:DE-5\nrubella\nvaccine\nwere\nas\nhigh\nas\nthose\nof\nRA\n27/3\nrubella\nand\nmeasles-mumps-rubella\n(RA\n27/3)\nvac-\ncines.\nClinical\nLocal\nand\nsystemic\nsymptoms\nand\nsigns\nduring\nthe\n42-day\nstudy\nperiod\nand\nduring\ntime\nintervals\nwithin\nthis\nperiod,\nanalyzed\nfor\njust\nthose\nchildren\nwith\ndocumented\nseroconversion\nor\nfor\nthe\ntotal\ngroup,\nwere\nsimilar\nwith\neach\nvaccine;\nthey\nwere\nno\ngreater\nthan\nexperienced\nby\nplacebo\nrecipients\u0001\nSe-\nlected\nreaction\nrates\nfor\nthe\ntotal\nstudy\ngroup\nare\nshown\nin\nTable\n2.\nNone\nof\nthe\nchildren\nwho\nreceived\neither\nof\nthe\ntwo\nsingle\ncomponent\nrubella\nvaccines\nhad\narthritis\nor\narthralgia.", "mimetype": "text/plain", "start_char_idx": 9567, "end_char_idx": 10487, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d6ae9f94-00d4-4673-870b-12c0e4be539e": {"__data__": {"id_": "d6ae9f94-00d4-4673-870b-12c0e4be539e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "52a6b198-21bb-4c7c-942a-228f6da1d60d", "node_type": "1", "metadata": {}, "hash": "c196204cd09ceaf9b3a7555a87888082e5b05293e8eb3feebc17cbea0ab66874", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "48bb7875-e7b3-40e8-98f8-befbb60ec43b", "node_type": "1", "metadata": {}, "hash": "6e55203bff17ca5b53d2fc98c108f3b3daf06761b3b6ba48be8f85719e0f993b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "None\nof\nthe\nchildren\nwho\nreceived\neither\nof\nthe\ntwo\nsingle\ncomponent\nrubella\nvaccines\nhad\narthritis\nor\narthralgia.\nOnly\none\nchild\nin\neach\nof\nthe\ntwo\ncombination\nvaccine\ngroups\nhad\nmild\narthralgia\nand,\nmoreover,\nthe\nearly\nonset\nin\nboth\ninstances\nsuggested\nthat\nit\nwas\nunrelated\nto\nvaccine:\nthe\nhips\nof\none\nchild\nseemed\nsore\nwhen\nhis\ndiaper\nwas\nchanged\non\ndays\n5, 6,\nand\n15\nafter\nreceiving\nmeasles-\nmumps-rubella\n(HPV-77:DE-5)\nvaccine\nand\nthe\nshoulders\nand\nknees\nof\nanother\nchild\nseemed\nstiff\non\ndays\n1 and\n2 following\nadministration\nof\nmeasles-\nmumps-rubella\n(RA\n27/3)\nvaccine.\nNeither\nfever\nnor\nrash\nwas\nmore\nfrequent\nor\nsevere\non\ndays\n5 to\n12\nin\nchildren\ngiven\nany\nof\nthe\nthree\nmeasles-con-\ntaming\nvaccines\nthan\nin\nplacebo\nrecipients.\nTwo\nchildren\nhad\nrashes\nthat\nmay\nhave\nbeen\nallergic\nin\nnature\nand\nare\nnot\nincluded\namong\nthe\nnonspecific\ngeneralized\nerythematous\nmaculopapular\nrashes\nin\nTable\n2.", "mimetype": "text/plain", "start_char_idx": 10373, "end_char_idx": 11271, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "48bb7875-e7b3-40e8-98f8-befbb60ec43b": {"__data__": {"id_": "48bb7875-e7b3-40e8-98f8-befbb60ec43b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d6ae9f94-00d4-4673-870b-12c0e4be539e", "node_type": "1", "metadata": {}, "hash": "a21c895bba8d42bf1a71da39e683fde1d8ca74d26ae1d558e799d79e83433d1c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "333631cc-b477-421a-84f3-2400efca1adb", "node_type": "1", "metadata": {}, "hash": "24698978941c257cd76aba2b6173596a9fbe70e5d00830ab1833905337876fd7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "However,\nconcurrent\nillness,\nrather\nthan\nvaccine,\nmay\nhave\nbeen\nresponsible:\none\nchild\nhad\nnonpruritic\nwheals\non\nhis\nface\non\ndays\n1 to\n10\nafter\nadministration\nof\nRA\n27/3\nrubella\nvaccine\nin\nasso-\nciation\nwith\nfever,\nlymphadenopathy,\nand\na variety\nof\nrespiratory\nand\ngastrointestinal\nsymptoms;\nan-\nother\nchild\nhad\na rash\ndiagnosed\nby\na physician\nas\nerythema\nmultiforme\nalong\nwith\nfever,\notitis\nmedia,\nand\ndiaper\nrash\non\ndays\n8 to\n12\nfollowing\nadminis-\ntration\nof\nmeasles-mumps-rubella\n(HPV-77:DE-5)\nvaccine.\nConduct\nof\nStudy\nOf\nthe\n502\nstudy\nvolunteers,\n298\n(59%)\nwere\nseen\nat\nthe\nair\nforce\nbase\nimmunization\nclinic\nin\nwhich\nthe\nresearch\nnurse\nworked\nthree\nmornings\nper\nweek.\nThe\nuniversity\nmedical\ncenter\nclinic\nand\nthe\ncounty\nimmunization\nclinics\nrecruited\n129\n(26%)\nchildren.\nThe\nfive\nprivate\npediatric\npractices\ntogether\nen-\ntered\n75\n(15%)\nchildren\nin\nthe\nstudy,\nwith\nthe\nnum-\nber\nfrom\neach\npractice\nranging\nfrom\ntwo\nto\n49.\nIn\nthese\nvarious\nsettings,\nblood\ndrawing\nsuccess\nrates\nTABLE\n1 .\nDevelopment\nof\nAntibody\nin\nInitially\nSeronegative\nChildren\nSix\nWeeks\nFol-\nlowing\nAdministration\nof\nPlacebo\nor\nVaccine\nPlacebo/Vaccine\nNo.\nPaired\nSera\nMeasles\n%*\nGMTf\nMu\n%\nmps\nGMT\nRub\n%\nella\nGMT\nPlacebo\n23\n0\n.\n.\n.", "mimetype": "text/plain", "start_char_idx": 11272, "end_char_idx": 12475, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "333631cc-b477-421a-84f3-2400efca1adb": {"__data__": {"id_": "333631cc-b477-421a-84f3-2400efca1adb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "48bb7875-e7b3-40e8-98f8-befbb60ec43b", "node_type": "1", "metadata": {}, "hash": "6e55203bff17ca5b53d2fc98c108f3b3daf06761b3b6ba48be8f85719e0f993b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f2def86b-b77f-4fa9-89ec-3af1fd662c01", "node_type": "1", "metadata": {}, "hash": "0256fd9f05969d2c898040579072d7225cdfd10c725725d5a255c5b0c634e8e4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Paired\nSera\nMeasles\n%*\nGMTf\nMu\n%\nmps\nGMT\nRub\n%\nella\nGMT\nPlacebo\n23\n0\n.\n.\n.\n5\n6\n0\n...\nMeasles\n23\n100\n82\nMumps\n33\n92\n19\nHPV-77:DE-5\nrubella\n20\n95\n296k\nMeasles-mumps-rubella\n(HPV-77:DE-5)\n85\n99\n77\n89\n15\u0001\n99\n144k\nRA\n27/3\nrubella\n33\n100\n306\nMeasles-mumps-rubella\n(RA\n27/3)\n91\n96\n89\n90\n31t\n100\n301\n*\nPercent\nof\nthose\nwho\ndeveloped\ndetectable\nantibody.\nt Geometric\nmean\ntiter\nof\nthose\nwho\nbecame\nseropositive.\n:1:P\n<\n.05\nfor\nmumps\nGMTs\nwith\nmeasles-mumps-rubella\n(HPV-77:DE-5)\nvs\nmeasles-\nmumps-rubella\n(RA\n27/3)\nand\nfor\nrubella\nGMTs\nwith\nHPV-77:DE-5\nrubella\nvs\nmeasles-\nmumps-rubella\n(HPV-77:DE-5).\nDownloaded from http://publications.aap.org/pediatrics/article-pdf/68/1/18/957786/18.pdf\nby CAMPUS PICPUS - APHP user\nARTICLES\n21\nTABLE\n2.\nProportion\n(%)\nof\nChildren\nWho\nExperienced\nSymptoms\nand\nSigns\nDuring\nthe\nSix\nWeeks\nFollowing\nAdministration\nof\nPlacebo\nor\nVaccine\nPlacebo/Vaccine\nNo.", "mimetype": "text/plain", "start_char_idx": 12401, "end_char_idx": 13282, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f2def86b-b77f-4fa9-89ec-3af1fd662c01": {"__data__": {"id_": "f2def86b-b77f-4fa9-89ec-3af1fd662c01", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "333631cc-b477-421a-84f3-2400efca1adb", "node_type": "1", "metadata": {}, "hash": "24698978941c257cd76aba2b6173596a9fbe70e5d00830ab1833905337876fd7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3eb9b1a2-da23-4959-86b4-f6788b860e86", "node_type": "1", "metadata": {}, "hash": "e12265d4dc119d6cb6981a37fc86ae2a3a240dfdaaf2d3838028d0f81eeffa99", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Local\nRe-\naction*\nFever\n(F)\n101-102.9\n103-104.9\nRespira-\ntory\nSymp-\ntoms\nRasht\nLymph-\nadenop-\nathy\nSore\nEyes\nJoint\nSymp-\ntoms\nPlacebo\n42\n7\n24\n0\n74\n9\n0\n9\n0\nMeasles\n43\n2\n28\n5\n79\n12\n2\n14\n0\nMumps\n41\n14\n15\n7\n63\n2\n5\n19\n0\nHPV-77:DE-5\nrubella\n47\n6\n13\n6\n66\n13\n4\n17\n0\nMeasles-mumps-rubella\n142\n5\n22\n8\n68\n17\n4\n17\n0.7\n(HPV-77:DE-5)\nRA\n27/3\nrubella\n46\n4\n24\n4\n67\n11\n4\n17\n0\nMeasles-mumps-rubella\n(RA\n141\n8\n25\n11\n72\n20\n8\n16\n0.7\n27/3)\n*\nPain,\nredness,\nor\nswelling\nat\nthe\ninjection\nsite\non\ndays\n0 to\n4.\nt Nonspecific\nerythematous\nmaculopapular\nrash\ninvolving\ntwo\nor\nmore\nareas\nof the\nbody.\nand\nparental\ncooperation\nin\nrecording\nclinical\nob-\nservations\nand\nreturning\nfor\nthe\nsix\nweeks\nvisits\nwere\nsimilar.\nDISCUSSION\nWistar\nRA\n27/3\nrubella\nvaccine\nhas\npotential\nimmunologic\nadvantages\nover\nHPV-77:DE-5\nand\nCendehill\nrubella\nvaccines.", "mimetype": "text/plain", "start_char_idx": 13283, "end_char_idx": 14097, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3eb9b1a2-da23-4959-86b4-f6788b860e86": {"__data__": {"id_": "3eb9b1a2-da23-4959-86b4-f6788b860e86", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f2def86b-b77f-4fa9-89ec-3af1fd662c01", "node_type": "1", "metadata": {}, "hash": "0256fd9f05969d2c898040579072d7225cdfd10c725725d5a255c5b0c634e8e4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c47c7bb1-bfc9-40c0-9c5e-0d4d240bcfbb", "node_type": "1", "metadata": {}, "hash": "f02b752ebc6cbac590239e52572a43dea71bd22aa4ca328d48163506c0cec917", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In\naddition\nto\nstimulat-\ning\nHI\nantibody,\nRA\n27/3\nrubella\nvaccine\nregularly\ninduced\nserum\ncomplement\nfixation,\nneutralization,\nand\niota-precipitin\nantibodies,39\nevoked\nsecretory\nIgA\nantibody,3\u201d#{176}12\nand\ngave\na\nhigh\ndegree\nof\npro-\ntection\nagainst\nreinfection\nwith\nrubella\nvirus\nchal-\nlenge.3\u201d3\u201d4\nWith\nthese\ncharacteristics,\nRA\n27/3\nru-\nbella\nvaccine\nclosely\nresembled\nnatural\nrubella\nin-\nfection.\nHowever,\nlike\nthe\nother\ntwo\nvaccines,\nit was\nnoncontagious\nand\nhad\nlow\nreaction\nrates\nin\nchil-\ndren.3\u20194\u201d5\u201d6\nFurthermore,\nbecause\nit\nwas\ngrown\nin\nhuman\ntissue\nculture,\nRA\n27/3\nrubella\nvaccine\nob-\nviated\nthe\npotential\nproblem\nof\nallergic\nreaction\nto\nnonhuman\nprotein.\nThis\nstudy\nconfirmed\nthat\nHPV-77:DE-5\nand\nRA\n27/3\nrubella\nvaccines\nshow\na\ncomparably\nhigh\nde-\ngree\nof\neffectiveness\nin\neliciting\nserum\nHI\nantibody\nand\nthat\nboth\nhave\nvery\nlow\nreactivity\nrates\nin\nyoung\nchildren.\nThis\nstudy\nalso\nestablished\nfor\nthe\nfirst\ntime\nthat\nmeasles\nand\nmumps\nvaccines\nneither\ndiminished\nantibody\nresponse\nnor\nenhanced\nclinical\nreactivity\nwhen\ncombined\nwith\nRA\n27/3\nrubella\nvaccine.", "mimetype": "text/plain", "start_char_idx": 14098, "end_char_idx": 15166, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c47c7bb1-bfc9-40c0-9c5e-0d4d240bcfbb": {"__data__": {"id_": "c47c7bb1-bfc9-40c0-9c5e-0d4d240bcfbb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3eb9b1a2-da23-4959-86b4-f6788b860e86", "node_type": "1", "metadata": {}, "hash": "e12265d4dc119d6cb6981a37fc86ae2a3a240dfdaaf2d3838028d0f81eeffa99", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dcbc23d2-d207-4e5a-bab0-a9d60e5b954e", "node_type": "1", "metadata": {}, "hash": "e1707cc76277aa0ccf8eb91cd02cfc28947753d15f58091b5bf60897f4ea6d7d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "However,\nwe\nunexpectedly\nfound\nthat\nrubella\nHI\nantibody\ntiters\nwere\nsignificantly\nlower\nwhen\nHPV-\n77:DE-5\nrubella\nvaccine\nwas\nadministered\nin\ncom-\nbination\nwith\nmeasles\nand\nmumps\nvaccines\nthan\nwhen\nit\nwas\ngiven\nalone.\nPrevious\nfield\ntrials\nof\nmeasles\n-mumps\n-rubella\n( HPV\n- 77:DE\n- 5)\nvac-\ncine,\u2019\u201dTM\nas\nwell\nas\nmumps-rubella\n(HPV-77:DE-5)\n\u00019\nand\nmeasles-rubella\n(HPV-\n77:DE-5)\nvac-\ncine,2#{176}\u20192\u2019 had\nshown\nno\nsuch\ninterference,\neither\nin\nterms\nof\nseroconversion\nrates\nor\nGMTs.\nThese\npre-\nvious\nfield\ntrials,\nin\ncontrast\nto\nthe\ncurrent\nstudy,\ninvolved\ncomparisons\nof\nthe\nrubella-containing\ncombination\nvaccines\nwith\nsingle\ncomponent\nru-\nbella\nvaccine\nthat\nwas\nnot\nadministered\nconcur-\nrently.\nThis\ndisparate\nfinding\nneeds\nto\nbe\nfurther\ninvestigated,\nin\nview\nof the\nlarge\nnumber\nof\nchildren\nwho\nhave\nreceived\nmeasles-mumps-rubella\n(HPV-\n77:DE-5)\nvaccine\nsince\n1969.\nThere\nare\nprecedents\nfor\nimmunologic\ninterfer-\nence\nwhen\ntwo\nor\nmore\nlive\nvirus\nvaccines\nare\ngiven\nsimultaneously\nand\nat\nthe\nsame\nsite.", "mimetype": "text/plain", "start_char_idx": 15167, "end_char_idx": 16169, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dcbc23d2-d207-4e5a-bab0-a9d60e5b954e": {"__data__": {"id_": "dcbc23d2-d207-4e5a-bab0-a9d60e5b954e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c47c7bb1-bfc9-40c0-9c5e-0d4d240bcfbb", "node_type": "1", "metadata": {}, "hash": "f02b752ebc6cbac590239e52572a43dea71bd22aa4ca328d48163506c0cec917", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "67509cee-d37e-4828-b878-a3debd4f016b", "node_type": "1", "metadata": {}, "hash": "f7bc338add0e53e4baa2e594eaa665dec6900fba97a6ad359040024985450d48", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "When\nvaccinia\nvirus\nand\n17D\nyellow\nfever\nvirus\nwere\ncombined,\nthe\ndermal\nresponse\nto\nvaccinia\nwas\nnormal,\nbut\nthe\nnumber\nof\nyellow\nfever\nseroconversions\nwas\nreduced.22\u20192\u2019\nThere\nwas\nno\nsuppression\nof the\nyellow\nfever\nantibody\nresponse\nwhen\nvaccinia\nand\nyellow\nfever\nwere\ngiven\nsimultaneously,\nbut\nat\nseparate\nsites.22\u201924\u201925\nMeyer\net\nal.26\nfound\nthat\ncombining\nmea-\nsles\nor\nmeasles\nand\nyellow\nfever\nwith\nsmallpox\nvaccine\nreduced\nthe\nlevel\nof\nsmallpox\nantibody,\nwithout\nreducing\nthe\nnumber\nof\nseroconverions\nor\nthe\ndermal\nresponses.\nThe\nyellow\nfever\nseroconver-\nsion\nrate\nwas\nalso\nreduced\nsomewhat.\nThe\npresumed\nmechanism\nfor\nthese\nobservations\nis\nlocal\ninduction\nby\none\nvirus\nof\na\nsubstance,\nsuch\nas\ninterferon,\nwhich\ninhibits\nreplication\nof\nanother\nvirus,\nthus\nreducing\nor\neliminating\nthe\namount\nof\nantigenic\nstimulation.\nLocal\ninterferon\nhas\nbeen\ndetected\nin\nvaccinia\nvirus\nvaccination\ncrusts,27\nbut\nlocal\ninterferon\nstimulated\nby\nmeasles\nvirus\nvaccine\nhas\nnot\nbeen\nstudied.\nWhatever\nthe\nmechanism,\nit\nappears\nfrom\nthis\nstudy\nthat\nHPV-77:DE-5\nrubella\nvirus\nis\nmore\nsusceptible\nto\nlocal\ninhibition\nthan\nRA\n27/3\nrubella\nvirus.", "mimetype": "text/plain", "start_char_idx": 16170, "end_char_idx": 17294, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "67509cee-d37e-4828-b878-a3debd4f016b": {"__data__": {"id_": "67509cee-d37e-4828-b878-a3debd4f016b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dcbc23d2-d207-4e5a-bab0-a9d60e5b954e", "node_type": "1", "metadata": {}, "hash": "e1707cc76277aa0ccf8eb91cd02cfc28947753d15f58091b5bf60897f4ea6d7d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c4d02321-0411-405c-a0c9-713bc7d5b62d", "node_type": "1", "metadata": {}, "hash": "5bf6a1c713e57d4badf7591df771ffbaed3be921652359eb3490729b6695bf2a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We\nwere\nunable\nto\ndetect\nany\nsignificant\ndiffer-\nences\nin\nthe\nrates\nof\nfever\nand\nrash\nwhen\nchildren\nwho\nreceived\nmore\nattenuated\nEnders\u2019\n(Moraten)\nmeasles\nvaccine,\neither\nsingly\nor\nin\none\nof\nthe\ntwo\ncombinations,\nwere\ncompared\nwith\nplacebo\nrecipi-\nents.\nThis\nobservation\nstands\nin\ncontrast\nto\nseveral\nprevious\ncontrolled\ntrials\nwith\nthe\nsame\nmeasles\nDownloaded from http://publications.aap.org/pediatrics/article-pdf/68/1/18/957786/18.pdf\nby CAMPUS PICPUS - APHP user\n22\nMEASLES,\nMUMPS,\nAND\nRUBELLA\nvaccine\nthat\nfound\nfever\n(\u0001101\nF)\nrates\nof\n6%\nto\n20%\nand\nrash\nrates\nof\n8%\nto\n18%?\u0001#{176} The\ndifference\nrelative\nto\nfever\nmay\nhave\nbeen\ndue\nto\na\nspecific\ndifference\nin\nstudy\ndesign.\nWe\nasked\nthe\nparent\nto\ntake\nthe\ntemperature\nif the\nchild\nappeared\nifi in\nany\nway;\nprevious\nstudies\ninvolved\nroutine\ndaily\ntern-\nperatures\nduring\nthe\ncritical\nperiod\nfive\nto\n12\ndays\npostvaccination.\nIt\nhas\nbeen\nnoted\nthat\nchildren\nwith\nfever\nfrom\nmeasles\nvaccine\nwere\noften\nasymp-\ntomatic,\nand\nfever\nwithout\naccompanying\nillness\nwould\nnot\nhave\nbeen\ndetected\nin\nour\nstudy.\nWe\nhave\nno\nexplanation\nfor\nthe\ndifferences\nrelative\nto\nrash.\nEthical\nconsiderations\nhave\nmade\nincreasingly\nuntenable\nthe\nconduct\nof vaccine\nstudies\nin\ncircum-\nscribed\ngroups\nof retarded,\npoor,\nor\notherwise\nhand-\nicapped\nchildren.", "mimetype": "text/plain", "start_char_idx": 17295, "end_char_idx": 18576, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c4d02321-0411-405c-a0c9-713bc7d5b62d": {"__data__": {"id_": "c4d02321-0411-405c-a0c9-713bc7d5b62d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "67509cee-d37e-4828-b878-a3debd4f016b", "node_type": "1", "metadata": {}, "hash": "f7bc338add0e53e4baa2e594eaa665dec6900fba97a6ad359040024985450d48", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "91e0ceaf-a6b2-405b-9801-9686311c2fa5", "node_type": "1", "metadata": {}, "hash": "ee96b63aa807c1c3bccd72b8ec43ce2d0c2a476908a58fb17ac9dc09fde2fe96", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Therefore,\nnew\nvaccines\nmust\nbe\ntested\nin\nopen\npopulations\nthat\nare\nnot\nsubject\nto\nunusual\nmedical\nor\nsocial\npressures.\nOur\nexperience\nindicates\nthat\na large\ndouble-blind\nvaccine\ntrial\ncan\nbe\ncarried\nout\nas\npart\nof\nroutine\nhealth\ncare\nin\na\nvariety\nof\nclinic\nand\noffice\nsettings,\nwith\nthe\nactive\nsupport\nof\ninterested\nmedical,\nnursing,\nand\nlabora-\ntory\npersonnel.\nACKNOWLEDGMENTS\nMerck\nSharp\n& Dohme\n(West\nPoint,\nPA)\ncontributed\nfinancial\nsupport\nand\nvaccine.\nTim\nSchofield\nand\nBarbara\nJ.\nKuter\nat\nthe\nMerck\nInstitute\nfor\nTherapeutic\nResearch\nprovided\nliaison\nand\nstatistical\nanalysis.\nOur\nthanks\nto the\nfollowing\nindividuaLs\nwho\nwere\nactive\ncollaborators\nin\nthis\nstudy:\nMargaret\nBenson,\nPeter\nW.\nBickers,\nMD,\nKimberly\nCampbell,\nJoseph\nEllison,\nMD,\nRose\nF. Faithe,\nMD,\nValerie\nGallup,\nLPN,\nChris\nGrimes,\nJames\nHart,\nMD,\nMark\nHorton,\nMD,\nYuksel\nInankur,\nMD,\nPhilip\nG.\nItkin,\nMD,\nIzzat\nJabro,\nMD,\nWarren\nJacobsen,\nMD,\nDennis\nS. Jones,\nMD,\nBeverley\nMcAttee,\nRN,\nWilliam\nJ.\nMcAveney,\nMD,\nJames\nT.\nMuiry,\nMD,\nPaul\nJ.\nNelson,\nMD,\nLarry\nRice,\nMD,\nJames\nI. Wax,\nMD,\nStaff\nSgt\nCharles\nWilliams,\nRobert\nI. Wingert,\nMD,\nand\nF.\nMarshall\nZahiler,\nMD.\nREFERENCES\n1.\nRosen\nL:\nHemagglutination\nand\nhemagglutination\ninhibition\nwith\nmeasles\nvirus.\nVirology\n13:139,\n1961\n2.\nStewart\nGL,\nParkman\nPD,\nHopes\nHE,\net a!", "mimetype": "text/plain", "start_char_idx": 18577, "end_char_idx": 19870, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "91e0ceaf-a6b2-405b-9801-9686311c2fa5": {"__data__": {"id_": "91e0ceaf-a6b2-405b-9801-9686311c2fa5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c4d02321-0411-405c-a0c9-713bc7d5b62d", "node_type": "1", "metadata": {}, "hash": "5bf6a1c713e57d4badf7591df771ffbaed3be921652359eb3490729b6695bf2a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ff7938e7-9338-4ab3-a2c5-85927f9d7ac3", "node_type": "1", "metadata": {}, "hash": "128de7d671856f815c7f97a0d922bb775539dc2439bbc8757287b3054a64f29f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Virology\n13:139,\n1961\n2.\nStewart\nGL,\nParkman\nPD,\nHopes\nHE,\net a!: Rubella-virus\nhemagglutination-inhibition\ntest.\nN\nEngi\nJ\nMed\n276:554,\n1967\n3.\nPlotkin\nSA,\nFarquhar\nJD,\nOgra\nPL:\nImmunologic\nproperties\nof RA\n27/3\nrubella\nvirus\nvaccine:\nA\ncomparison\nwith\nstrains\npresently\nlicensed\nin the\nUnited\nStates.\nJAMA\n225:585,\n1973\n4.\nWallace\nRB,\nIsacson\nP:\nComparative\ntrial\nof\nHPV-77,DE-5\nand\nRA\n27/3\nlive-attenuated\nrubella\nvaccines.\nAm\nJ\nDis\nChild\n124:536,\n1972\n5.\nGrillner\nL,\nHedstrom\nC,\nBergstrom\nH,\net\na!:\nVaccination\nagainst\nrubella\nof\nnewly\ndelivered\nwomen.\nScand\nJ\nInfect\nDis\n5:237,\n1973\n6.\nBest\nJM,\nBanatvala\nJE,\nBowen\nJM:\nNew\nJapanese\nrubella\nvaccine:\nComparative\ntrials.\nBr\nMed\nJ\n3:221,\n1974\n7.\nGrillner\nL: Neutralizing\nantibodies\nafter\nrubella\nvaccination\nof\nnewly\ndelivered\nwomen:\nA\ncomparison\nbetween\nthree\nvaccines.\nScand\nJ Infect\nDis\n7:169,\n1975\n8.\nSchleuderberg\nA,\nHorstmann\nDM,\nAndiman\nWA,\net\nal:\nNeutralizing\nand\nhemagglutination-inhibiting\nantibodies\nto\nrubella\nvirus\nas\nindicators\nof\nprotective\nimmunity\nin\nvacci-\nnees\nand\nnaturally\nimmune\nindividuals.\nJ Infect\nDis\n138:877,\n1978\n9.\nLa\nBouvier\nGL,\nPlotkin\nSA:\nPrecipitin\nresponses\nto\nrubella\nvaccine\nHA\n27/3.\nJ Infect\nDis\n123:\n220,\n1971\n10.", "mimetype": "text/plain", "start_char_idx": 19806, "end_char_idx": 21008, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ff7938e7-9338-4ab3-a2c5-85927f9d7ac3": {"__data__": {"id_": "ff7938e7-9338-4ab3-a2c5-85927f9d7ac3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "91e0ceaf-a6b2-405b-9801-9686311c2fa5", "node_type": "1", "metadata": {}, "hash": "ee96b63aa807c1c3bccd72b8ec43ce2d0c2a476908a58fb17ac9dc09fde2fe96", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1807b73c-6e9e-4e57-bd02-d142121e7aa3", "node_type": "1", "metadata": {}, "hash": "fb0aa8416a7a497be7ac558226f8dcfdc3abdc995f55769c2619dc5bbd40330e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "La\nBouvier\nGL,\nPlotkin\nSA:\nPrecipitin\nresponses\nto\nrubella\nvaccine\nHA\n27/3.\nJ Infect\nDis\n123:\n220,\n1971\n10.\nOgra\nPL,\nKerr-Grant\nD,\nUmana\nG, et al:\nAntibody\nresponse\nin\nserum\nand\nnasopharynx\nafter\nnaturally\nacquired\nand\nvaccine-induced\ninfection\nwith\nrubella\nvirus.\nN\nEngi\nJ Med\n285:1333,\n1971\n11.\nCradock-Watson\nJE,\nMacDonald\nH,\nRidehalgh\nMKS,\net\nal:\nSpecific\nimmunoglobulin\nresponses\nin\nserum\nand\nnasal\nse-\ncretions\nafter\nthe\nadministration\nof\nattenuated\nrubella\nvac-\ncine.\nJ Hyg\n73:127,\n1974\n12.\nBanatvala\nJE,\nBest\nJM,\nO\u2019Shea\nS, et\nal:\nRubella-immunity\ngap:\nIs intranasal\nvaccination\nthe\nanswer?\nLancet\n1:970,\n1979\n13.\nGrillner\nL:\nImmunity\nto\nintranasal\nchallenge\nwith\nrubella\nvirus\ntwo\nyears\nafter\nvaccination:\nComparison\nof three\nvac-\ncines.\nJ Infect\nDis\n133:637,\n1976\n14.\nFogel\nA,\nGerichter\nCLB,\nBarnea\nB,\net\nal:\nResponse\nto\nexperimental\nchallenge\nin persons\nimmunized\nwith\ndifferent\nrubella\nvaccines.\nJ Pediatr\n92:26,\n1978\n15.\nSchiff\nGM,\nLinneman\nCC,\nShea\nL,\net\na!:\nEvaluation\nof RA\n27/3\nrubella\nvaccine.\nJ Pediatr\n85:379,\n1974\n16.\nBalfour\nHH,\nBalfour\nCL,\nEdelman\nCK,\net al: Evaluation\nof\nWiStar\nRA\n27/3\nrubella\nvirus\nvaccine\nin\nchildren.\nAm\nJ Dis\nChild\n130:1089,\n1976\n17.", "mimetype": "text/plain", "start_char_idx": 20901, "end_char_idx": 22079, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1807b73c-6e9e-4e57-bd02-d142121e7aa3": {"__data__": {"id_": "1807b73c-6e9e-4e57-bd02-d142121e7aa3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ff7938e7-9338-4ab3-a2c5-85927f9d7ac3", "node_type": "1", "metadata": {}, "hash": "128de7d671856f815c7f97a0d922bb775539dc2439bbc8757287b3054a64f29f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "53fc5a5c-1e84-4072-a34c-103f88eaaaba", "node_type": "1", "metadata": {}, "hash": "1460baecc70ffcbc03a83aad2df620cbaab6cfcaa56dae2a1a5c2f4b96ce59b9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Am\nJ Dis\nChild\n130:1089,\n1976\n17.\nBuynak\nEB,\nWeibel\nRE,\nWhitman\nJE,\net\na!: Combined\nlive\nmeasles,\nmumps,\nand\nrubella\nvirus\nvaccines.\nJAMA\n207:2259,\n1969\n18.\nStokes\nJ,\nWeibel\nRE,\nVillaregos\nVM,\net\nal:\nTrivalent\ncorn-\nbined\nmeasles-mumps-rubella\nvaccine.\nFindings\nin\nclinical\nand\nlaboratory\nstudies.\nJAMA\n218:57,\n1971\n19.\nWeibel\nRE,\nStokes\nJ,\nVillarejos\nVM,\net\nal:\nCombined\nlive\nrubella-mumps\nvirus\nvaccine.\nFindings\nin clinical-laboratory\nstudies.\nJAMA\n216:983,\n1971\n20.\nVillarejos\nVM,\nArgeudas\nJA,\nBuynak\nEB,\net\nal:\nCombined\nlive\nmeasles-rubella\nvirus\nvaccine.\nJ Pediatr\n79:599,\n1971\n21.\nLandrigan\nPJ,\nMurphy\nKB,\nMeyer\nHM,\net\nal:\nCombined\nmeasles-rubella\nvaccines:\nVirus\ndose\nand\nserologic\nresponse.\nAm\nJDiS\nChild\n125:65,\n1973\n22.\nDick\nGWA,\nHorgan\nES:\nVaccination\nby\nscarification\nwith\na\ncombined\n17D\nyellow\nfever\nand\nvaccinia\nvaccine.\nJ Hyg\n50:\n376,\n1952\n23.\nMeers\nPD:\nCombined\nsmallpox-17D\nyellow\nfever\nvaccine\nfor\nscratch\nvaccination.\nTrans\nR\nSoc\nTrop\nMed\nHyg\n53:196,\n1959\n24.\nMeers\nPD:\nFurther\nobservations\nof 17D\nyellow\nfever\nvacci-\nnation,\nwith\nand\nwithout\nsimultaneous\nsmallpox\nvaccination.\nTrans\nR Soc\nTrop\nMed\nHyg\n54:493,\n1960\n25.", "mimetype": "text/plain", "start_char_idx": 22046, "end_char_idx": 23185, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "53fc5a5c-1e84-4072-a34c-103f88eaaaba": {"__data__": {"id_": "53fc5a5c-1e84-4072-a34c-103f88eaaaba", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Lerman (1981).pdf", "node_type": "4", "metadata": {}, "hash": "52801fa3c914c248554bbe67e5a4d3d59c810c422e80cf354e50ca8b9e7cdf95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1807b73c-6e9e-4e57-bd02-d142121e7aa3", "node_type": "1", "metadata": {}, "hash": "fb0aa8416a7a497be7ac558226f8dcfdc3abdc995f55769c2619dc5bbd40330e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Trans\nR Soc\nTrop\nMed\nHyg\n54:493,\n1960\n25.\nTauraso\nNM,\nMyers\nMG,\nNau\nEV,\net\nal:\nEffect\nof interval\nbetween\ninoculation\nof live\nsmallpox\nand\nyellow-fever\nvac-\ncines\non\nantigenicity\nin man.\nJ Infect\nDis\n126:362,\n1972\n26.\nMeyer\nHM,\nHopps\nHE,\nBernheim\nBC,\net\na!:\nCombined\nmeasles-smallpox\nand\nother\nvaccines,\nin First\nInternational\nConference\non\nVaccines\nAgainst\nViral\nand\nRickettsial\nDis-\neases\nofMan.\nPAHO\nScientific\nPublication\nNo.\n147.\nWash-\nington,\nDC,\nPAHO,\n1967,\npp\n336-342\n27.\nWheelock\nFE:\nInterferon\nin dermal\ncrusts\nof human\nvaccinia\nvirus\nvaccinations:\nPossible\nexplanation\nof relative\nbenignity\nof\nvariolation\nsmallpox.\nProc\nSoc\nExp\nBiol\nMed\n117:650,\n1964\n28.\nStokes\nJ,\nWhitman\nJE,\nLeagus\nMB:\nDevelopment\nand\neval-\nuation\nof the\nMoraten\nmeasles\nvirus\nvaccine.\nJAMA\n206:587,\n1968\n29.\nSwartz\nT,\nKlingberg\nW,\nNishmi\nM,\net\nal:\nA\ncomparative\nstudy\nof four\nlive\nmeasles\nvaccines\nin\nIsrael.\nBull\nWHO\n39:\n285,\n1968\n30.\nKrugman\n5,\nConstantinidis\nP,\nMedovy\nH,\net\nal:\nComparison\nof two\nfurther\nattenuated\nlive\nmeasles-virus\nvaccines.\nAm\nJ\nDis\nChild\n117:137,\n1969\nDownloaded from http://publications.aap.org/pediatrics/article-pdf/68/1/18/957786/18.pdf\nby CAMPUS PICPUS - APHP user", "mimetype": "text/plain", "start_char_idx": 23144, "end_char_idx": 24320, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a8b734ff-07c1-449f-9320-8f8c9e04002b": {"__data__": {"id_": "a8b734ff-07c1-449f-9320-8f8c9e04002b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c2f67558-7b4b-4492-8fc7-446e8b547fce", "node_type": "1", "metadata": {}, "hash": "5ff9899e2dcaf17cac0b4904b8fb2869fcb13e6644ae5fdfcb4a0db5e7c4b564", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "RESEARCH ARTICLE\nOpen Access\nImpact of a vaccination programme in\nchildren vaccinated with ProQuad, and\nProQuad-specific effectiveness against\nvaricella in the Veneto region of Italy\nCarlo Giaquinto1, Giovanni Gabutti2, Vincenzo Baldo3, Marco Villa4, Lara Tramontan5, Nadia Raccanello6,\nFrancesca Russo6, Chiara Poma6, Antonio Scamarcia7, Luigi Cantarutti7, Rebecca Lundin8, Emilia Perinetti9,\nXavier Cornen10, St\u00e9phane Thomas10, C\u00e9line Ballandras10, Audrey Souverain11 and Susanne Hartwig12*\nAbstract\nBackground: Monovalent varicella vaccines have been available in the Veneto Region of Italy since 2004. In 2006, a\nsingle vaccine dose was added to the immunisation calendar for children aged 14 months. ProQuad\u00ae, a quadrivalent\nmeasles-mumps-rubella-varicella vaccine, was introduced in May 2007 and used, among other varicella vaccines, until\nOctober 2008. This study aimed to evaluate the effectiveness of a single dose of ProQuad, and the population impact\nof a vaccination program (VP) against varicella of any severity in children who received a first dose of ProQuad at\n14 months of age in the Veneto Region,\nMethods: All children born in 2006/2007, i.e., eligible for varicella vaccination after ProQuad was introduced, were\nretrospectively followed through individual-level data linkage between the Pedianet database (varicella cases) and the\nRegional Immunization Database (vaccination status). The direct effectiveness of ProQuad was estimated as the\nincidence rate of varicella in ProQuad-vaccinated children aged < 6 years compared to children with no varicella\nvaccination from the same birth cohort. The impact of the VP on varicella was measured by comparing children\neligible for the VP to an unvaccinated historical cohort from 1997/1998.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1757, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c2f67558-7b4b-4492-8fc7-446e8b547fce": {"__data__": {"id_": "c2f67558-7b4b-4492-8fc7-446e8b547fce", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a8b734ff-07c1-449f-9320-8f8c9e04002b", "node_type": "1", "metadata": {}, "hash": "e03d82849f0c073c2a3a5917b528f4a91eb8b6eaa40f7ab6434fed6b82d2934c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4836e8db-cb6c-4b25-9778-8a58655227aa", "node_type": "1", "metadata": {}, "hash": "99ce9251a3d57ffe929aca980856c8076bc214644e25c6c3c7cc4921fa278430", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The impact of the VP on varicella was measured by comparing children\neligible for the VP to an unvaccinated historical cohort from 1997/1998. The vaccine impact measures were: total effect\n(the combined effect of ProQuad vaccination and being covered by the Veneto VP); indirect effect (the effect of the VP\non unvaccinated individuals); and overall effect (the effect of the VP on varicella in the entire population of the Veneto\nRegion, regardless of their vaccination status).\nResults: The adjusted direct effectiveness of ProQuad was 94%. The vaccine impact measures total, indirect, and overall\neffect were 97%, 43%, and 90%, respectively.\nConclusions: These are the first results on the effectiveness and impact of ProQuad against varicella; data confirmed its\nhigh effectiveness, based on immunological correlates for protection. Direct effectiveness is our only ProQuad-specific\nmeasure; all impact measures refer at least partially to the VP and should be interpreted in the context of high vaccine\ncoverage and the use of various varicella vaccines in this region. The Veneto Region offered a unique opportunity for\nthis study due to an individual data linkage between Pedianet and the Regional Immunization database.\nKeywords: Varicella, Vaccine, Effectiveness, Impact, ProQuad, Italy, Pedianet\n* Correspondence: susanne.hartwig@merck.com\n12Epidemiology, MSD, 162 avenue Jean Jaur\u00e8s, Lyon, France\nFull list of author information is available at the end of the article\n\u00a9 The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0\nInternational License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and\nreproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to\nthe Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver\n(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.\nGiaquinto et al.", "mimetype": "text/plain", "start_char_idx": 1616, "end_char_idx": 3720, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4836e8db-cb6c-4b25-9778-8a58655227aa": {"__data__": {"id_": "4836e8db-cb6c-4b25-9778-8a58655227aa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c2f67558-7b4b-4492-8fc7-446e8b547fce", "node_type": "1", "metadata": {}, "hash": "5ff9899e2dcaf17cac0b4904b8fb2869fcb13e6644ae5fdfcb4a0db5e7c4b564", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "20922e2b-35f0-4f05-994c-7e253de08d1d", "node_type": "1", "metadata": {}, "hash": "a09d26d3a2ea8c6452f238b842e3eb2ae027763061661ec79e02e178d18d3d87", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The Creative Commons Public Domain Dedication waiver\n(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.\nGiaquinto et al. BMC Infectious Diseases  (2018) 18:103 \nhttps://doi.org/10.1186/s12879-018-3017-9\nBackground\nVaricella-zoster virus is the causal agent of varicella\n(chickenpox) and herpes zoster (shingles). Varicella is\npredominantly a childhood disease in unvaccinated pop-\nulations, with a lifetime risk of acquisition of over 95%.\nVaricella is highly contagious, with secondary attack\nrates of 60% to 100% in susceptible individuals [1]. Al-\nthough varicella is commonly considered a mild disease,\nit may cause serious complications [2] and represents a\nsizeable societal burden for patients and their caregivers,\nsometimes leading to school and work absence [3].\nVaricella vaccines have proven to be effective in pre-\nventing varicella. Models of the economic impact of\nchildhood varicella vaccination have been performed in\nItaly, France, and Germany and have projected that rou-\ntine vaccination programmes could dramatically reduce\nvaricella-related morbidity and lead to a decrease in the\nnumber of varicella-related deaths (ranging from 57% to\n87% across different strategies and settings) [4, 5]. A vac-\ncine coverage of 90% is projected to lead to savings from\nboth a societal (40% to 60%) and a third-party payer (7%\nto 61%) perspective [4, 5]. The World Health Organisa-\ntion advocates routine childhood immunisation against\nvaricella in countries where the disease is an important\npublic health and socioeconomic problem, where the\nvaccine is affordable, and where high (\u226580%) vaccine\ncoverage can be achieved and sustained [6].\nIn 1974, Takahashi and colleagues developed an atten-\nuated strain of the varicella virus at the University of\nOsaka, called the OKA strain. Several monovalent and\ncombined live attenuated varicella vaccines that are cur-\nrently authorised in Europe were derived from this\nstrain.", "mimetype": "text/plain", "start_char_idx": 3522, "end_char_idx": 5529, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "20922e2b-35f0-4f05-994c-7e253de08d1d": {"__data__": {"id_": "20922e2b-35f0-4f05-994c-7e253de08d1d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4836e8db-cb6c-4b25-9778-8a58655227aa", "node_type": "1", "metadata": {}, "hash": "99ce9251a3d57ffe929aca980856c8076bc214644e25c6c3c7cc4921fa278430", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a7ca7dd1-bf02-49ef-9fa6-31aa12f6aeba", "node_type": "1", "metadata": {}, "hash": "f756fede5ad8d882accff21fa0e2a4894f6154e98f9234b3e8736cfd5d292c2f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Several monovalent and\ncombined live attenuated varicella vaccines that are cur-\nrently authorised in Europe were derived from this\nstrain. These include the two monovalent vaccines: Vari-\nvax\u00ae (OKA/Merck strain, Merck & Co., Westpoint,\nUnited States) and Varilrix\u00ae (OKA/RIT strain, GlaxoS-\nmithKline, Rixensart, Belgium), which were licensed in\nEurope in the 1990s, and two combined live attenuated\nquadrivalent vaccines against measles, mumps, rubella,\nand varicella (MMRV): ProQuad\u00ae (OKA/Merck strain,\nMerck & Co.) and Priorix Tetra\u00ae (OKA/RIT strain, Glax-\noSmithKline), which were licensed in Europe as from\n2006. The quadrivalent vaccines were developed to fa-\ncilitate childhood vaccination programmes and to sup-\nport the implementation of routine varicella vaccination.\nClinical trials on ProQuad demonstrated that one dose\nof the vaccine was immunologically comparable to con-\ncomitant\nadministration\nof\nthe\nM-M-R\u00aeII\nvaccine\n(Merck & Co.), a combined measles, mumps, and rubella\nvaccine, and Varivax [7, 8]. However, there have been no\nformal\nstudies\non\nthe\nefficacy\nor\neffectiveness\nof\nProQuad.\nThe Veneto Region is located in Northeastern Italy.\nMonovalent varicella vaccines have been available for\nprivate purchase there since\n2004, and they were\nintroduced into the vaccination programme (free of\ncharge) in 2006 for children aged 14 months (2005 birth\ncohort). Catch-up vaccination was also included for\nthose aged 12 years (1994 birth cohort) with no history\nof varicella [9]. In 2008, the Veneto Region added a sec-\nond\ndose\nof\nvaricella\nvaccine\nto\nthe\nvaccination\nprogramme, which is to be administered at 6 years of\nage.", "mimetype": "text/plain", "start_char_idx": 5390, "end_char_idx": 7029, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a7ca7dd1-bf02-49ef-9fa6-31aa12f6aeba": {"__data__": {"id_": "a7ca7dd1-bf02-49ef-9fa6-31aa12f6aeba", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "20922e2b-35f0-4f05-994c-7e253de08d1d", "node_type": "1", "metadata": {}, "hash": "a09d26d3a2ea8c6452f238b842e3eb2ae027763061661ec79e02e178d18d3d87", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d9448665-c074-48a3-915c-965cf1d58186", "node_type": "1", "metadata": {}, "hash": "1d2e5b15129dde7761f71717f38e500dc3193b782d0d03114e170a33b4435153", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "From 2004 to April 2007 in the Veneto Region, a\nmonovalent varicella vaccine, mostly Varivax but also\nVarilrix, was usually administered concomitantly with\nthe first dose of the measles-mumps-rubella vaccine. In\nMay 2007, the Veneto Region was using ProQuad as a\nfirst dose, and in 2008 it began to use it for the second\ndose as well. However, in October 2008 ProQuad be-\ncame unavailable and was replaced by the quadrivalent\nvaccine Priorix Tetra. Monovalent varicella vaccines\nwere also distributed and administered throughout the\nabove-mentioned period (Fig. 1).\nIn July 2012, the Italian Ministry of Health recom-\nmended concomitant injection of a measles-mumps-\nrubella vaccine and a monovalent varicella vaccine at age\n14 months, due to concerns over a small increase in fe-\nbrile convulsions when injecting MMRV vaccines as a\nfirst dose [10]. The use of MMRV vaccines was reserved\nfor the second dose at age 6, where no safety concern\nhad been observed.\nThe aim of our study was to evaluate the effectiveness\nof a single dose of ProQuad, and the population impact\nof a vaccination program against varicella of any severity\nin children who received a first dose of ProQuad at\n14 months of age in the Veneto Region of Italy.\nMethods\nStudy setting\nThe Veneto Region is the fifth-largest region in Italy\n(after Lombardy, Campania, Lazio, and Sicily) with 21\nLocal Health Authorities (LHAs) and just over 4.9 mil-\nlion inhabitants. About 700,000 children under 14 years\nof age live in the Veneto Region, with an annual birth\ncohort of about 40,000 neonates [11]. After the birth of\na child, parents choose a family paediatrician (FP) as an\nidentified primary care provider, as per the requirements\nof the Italian National Health Service (NHS). It is pos-\nsible to change FPs, but NHS requirements state that a\nchild must always be registered with one FP.", "mimetype": "text/plain", "start_char_idx": 7030, "end_char_idx": 8886, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d9448665-c074-48a3-915c-965cf1d58186": {"__data__": {"id_": "d9448665-c074-48a3-915c-965cf1d58186", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a7ca7dd1-bf02-49ef-9fa6-31aa12f6aeba", "node_type": "1", "metadata": {}, "hash": "f756fede5ad8d882accff21fa0e2a4894f6154e98f9234b3e8736cfd5d292c2f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eec22ca8-ae20-4dd6-8064-f6285d5e2509", "node_type": "1", "metadata": {}, "hash": "458530e84a33cdf9b98e5b7675cac61423aaed28ee15a1d251b4ce2b1e876ecf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "It is pos-\nsible to change FPs, but NHS requirements state that a\nchild must always be registered with one FP. In turn,\nFPs provide health care services free of charge and are\nresponsible for referring children 0 to 6 years of age to\nNHS secondary and tertiary care when necessary.\nData sources\nPedianet\nIn 1999, Pedianet, an independent network of more than\n400 FPs, was set up in Italy. Data from children whose\nGiaquinto et al. BMC Infectious Diseases  (2018) 18:103 \nPage 2 of 9\nparents have signed an informed consent are collected\nand transmitted to a central Pedianet database in Padova\nafter anonymisation. There are 46 FPs in the Veneto Re-\ngion that belong to Pedianet, representing about 8% of\nthe paediatricians (n = 574) in the region and covering a\ncatchment area of 12 LHAs (Fig. 2). These 46 FPs care\nfor about 52,000 children 0\u201314 years of age, including\nan annual birth cohort of 3500 to 4500 neonates, corre-\nsponding to about 10% of the regional birth cohort [11].\nVeneto regional immunization database\nThe Veneto Regional Immunization Database stores data\non all immunisations administered in the region. All\npaediatric vaccinations included in the Veneto vaccin-\nation programme are administered free of charge at the\ndistrict\nlevel\nby\nthe\nLHAs.\nAll\nLHAs\nrecord\nimmunisation data using the same software (the Sistema\nInformativo Anagrafe Vaccinale regionale, SIAVr appli-\ncation), and this data is then sent to the Regional\nImmunization Database.\nData collection and linkage\nThe 46 FPs participating in Pedianet in the Veneto Re-\ngion identified all children in their patient files who were\nborn in 2006/2007. The Pedianet ID numbers and corre-\nsponding fiscal codes (a unique identifier for each per-\nson\nliving\nin\nItaly)\nfor\nthese\nchildren\nwere\nthen\nencrypted and sent by the FP through a secure channel\nto the Regional Immunization Database.", "mimetype": "text/plain", "start_char_idx": 8776, "end_char_idx": 10642, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "eec22ca8-ae20-4dd6-8064-f6285d5e2509": {"__data__": {"id_": "eec22ca8-ae20-4dd6-8064-f6285d5e2509", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d9448665-c074-48a3-915c-965cf1d58186", "node_type": "1", "metadata": {}, "hash": "1d2e5b15129dde7761f71717f38e500dc3193b782d0d03114e170a33b4435153", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "acbb9940-332e-460b-80d9-933fb731008e", "node_type": "1", "metadata": {}, "hash": "8f4f1fa622b93041be24a1453d34c84a45148a10a735facd4d41fe2efd903af4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Information on the varicella vaccination status of these\nchildren and the vaccine brand used was taken from the\nRegional Immunization Database. Vaccine brand was\nmissing for 67% of the children, as this field was not\nmandatory until 2010. We extracted information on vac-\ncine type (monovalent or MMRV) whenever possible\nwhen information on vaccine brand was missing. As\nProQuad was the only MMRV vaccine available in Italy\nuntil October 2008, all MMRV vaccines recorded prior\nthis date were attributed to ProQuad. This increased the\nproportion of vaccines identified as ProQuad to 35%,\nand decreased the proportion of unknown vaccines to\n58%. Vaccination data were then anonymised by discard-\ning the fiscal code and keeping only the Pedianet ID and\nsent to Arsen\u00e0l.IT, Veneto\u2019s Research Centre for eHealth\nInnovation.\nInformation on the occurrence of varicella was ex-\ntracted from the Pedianet database and sent with the\nPedianet ID number to Arsen\u00e0l.IT, where it was linked\nto varicella vaccination data. Varicella cases recorded in\nthe Pedianet database are based on physician confirm-\nation only; no laboratory tests were performed.\nFig. 1 Timeline of varicella vaccine availability and vaccination programs in Veneto region of Italy in relation to study cohort vaccination periods.\nMoH: Minister of Health; MMR/V: concomitant vaccination with measles, mumps, rubella vaccine and monovalent varicella vaccine\nFig. 2 Veneto region with Local Health Authorities (LHAs) that are\nincluded in the analysis\nGiaquinto et al. BMC Infectious Diseases  (2018) 18:103 \nPage 3 of 9\nThe study was conducted in accordance with the Dec-\nlaration of Helsinki, Good Pharmacoepidemiology Prac-\ntice Guidelines, and local laws, rules, and regulations.\nThe ethics committee of the Azienda Ospedaliera of Pa-\ndova reviewed the study-related documents and ap-\nproved the study.\nStudy sample\nFPs identified 9343 children from the 2006/2007 birth\ncohort in their records, of whom 1720 were excluded\n(Table 1).", "mimetype": "text/plain", "start_char_idx": 10643, "end_char_idx": 12634, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "acbb9940-332e-460b-80d9-933fb731008e": {"__data__": {"id_": "acbb9940-332e-460b-80d9-933fb731008e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eec22ca8-ae20-4dd6-8064-f6285d5e2509", "node_type": "1", "metadata": {}, "hash": "458530e84a33cdf9b98e5b7675cac61423aaed28ee15a1d251b4ce2b1e876ecf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "460f6a3d-5284-4a18-9ffe-75dd62f88002", "node_type": "1", "metadata": {}, "hash": "de805e276d5362da2a88f1d5b6b2dab08572d582bd7a6fbd0f9caebb367b643a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Study sample\nFPs identified 9343 children from the 2006/2007 birth\ncohort in their records, of whom 1720 were excluded\n(Table 1). Thus the final number of children in the study\nsample was 7623:\nStatistical analyses\nChildren were followed from age 1 year until the occur-\nrence of varicella, until they received the second dose of\nvaricella vaccine (if vaccinated), their 6th birthday, or\nexit from the Pedianet database, whichever occurred\nfirst.\nDirect effectiveness of a single dose of ProQuad\nWe measured the direct effectiveness (i.e., protection of\nvaccinee) of a single dose of ProQuad as the relative re-\nduction in the incidence rate of varicella in the 2357\nchildren who received ProQuad as a first dose of vari-\ncella vaccine (ProQuad-vaccinated children) in our study\nsample compared to the 912 unvaccinated children\n(Fig. 3). All these children belonged to the same popula-\ntion, were exposed to the same vaccination programme,\nand were followed over the same time period. Direct ef-\nfectiveness was calculated according to the following\nformula:\nVE \u00bc 1\u2212\u03bbv\n\u03bbu\n\u00bc 1\u2212hr\nwhere \u03bbv denotes the incidence rate in the ProQuad-\nvaccinated group, \u03bbu the incidence rate in the unvaccin-\nated group and hr. the hazard ratio estimated by means\nof a Cox proportional hazards model with vaccination\nstatus as a time-dependent variable. Sex, birth cohort,\nand number of visits to the FP were tested as covariates.\nThey were entered into the model as strata (not as ac-\ntual predictors) if they caused the failure of the key as-\nsumption\nof\nproportionality.\nTo\naccount\nfor\nthe\npossibility that events within each LHA (or within FPs)\nare correlated, a Cox proportional hazards model for\nclustered events was fitted. The vaccination status of\neach child was set to 0 at the beginning of follow-up and\nremained at 0 throughout follow-up for unvaccinated\nchildren. For\nvaccinated children vaccination status\nswitched 42 days after vaccination from 0 to 1.", "mimetype": "text/plain", "start_char_idx": 12505, "end_char_idx": 14451, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "460f6a3d-5284-4a18-9ffe-75dd62f88002": {"__data__": {"id_": "460f6a3d-5284-4a18-9ffe-75dd62f88002", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "acbb9940-332e-460b-80d9-933fb731008e", "node_type": "1", "metadata": {}, "hash": "8f4f1fa622b93041be24a1453d34c84a45148a10a735facd4d41fe2efd903af4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cb325113-9ade-41ef-aa62-675e17a2faad", "node_type": "1", "metadata": {}, "hash": "2ae928df3a75411c99d0c1c6c3aac801d51590e083c2f729a04ef399df6eb05e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For\nvaccinated children vaccination status\nswitched 42 days after vaccination from 0 to 1.\nImpact of the vaccination programme on varicella in the\nVeneto region\nWe assessed three different vaccine impact measures:\n(1)the total effect, i.e., the combined effect of ProQuad\nvaccination and being covered by the vaccination\nprogramme in the Veneto Region, thus\ncorresponding to the combination of direct and\nindirect effects.\n(2)the indirect effect, i.e., the population-level effect of\nwidespread vaccination on unvaccinated individuals\nin the Veneto Region as a result of reduced\ntransmission.\n(3)the overall effect, i.e., the effect of the vaccination\nprogramme on varicella in the entire population of\nthe Veneto Region, regardless of their varicella\nvaccination status (Fig. 3) [12].\nData from a historical cohort [13] from the pre-\nvaccine era was used as the reference population. This\ncohort consisted of 33,343 children aged 0\u201314 registered\nwith 35 Pedianet physicians across Italy (with an over-\nrepresentation of Veneto and Marche regions) between\n1 October 1997 and 30 September 1998, of whom\n21,783 were estimated to be susceptible to varicella. Inci-\ndence rates among unvaccinated subjects from the same\nhistorical birth cohort were calculated by dividing re-\nported numbers of varicella by estimated person-years.\nThe person-years were estimated based on the number\nof susceptible children and varicella cases reported in\nthe historical cohort [13] with assumption of uniform\nTable 1 Reasons for exclusion\nReasons for exclusiona\nNumber of children\nFailure to register in the Pedianet database before 6 months of age\n683\nNo visit to FP in the first year of life\n430\n< 4 visits to FP in the first 6 years of life\n389\nVaricella diagnosis in the first year of life\n200\nVaricella immunisation in the first year of life\n26\nReceived varicella vaccination from FP/missing date of varicella vaccination\n16\nFP family paediatrician\nasome of the children had more than one reason for exclusion\nGiaquinto et al.", "mimetype": "text/plain", "start_char_idx": 14361, "end_char_idx": 16372, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cb325113-9ade-41ef-aa62-675e17a2faad": {"__data__": {"id_": "cb325113-9ade-41ef-aa62-675e17a2faad", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "460f6a3d-5284-4a18-9ffe-75dd62f88002", "node_type": "1", "metadata": {}, "hash": "de805e276d5362da2a88f1d5b6b2dab08572d582bd7a6fbd0f9caebb367b643a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ac2379e7-d0c4-4ef2-bc56-bc97e0628d7e", "node_type": "1", "metadata": {}, "hash": "1463070fd9b42398c7bd31aca926b997f8f367ccdad8a156a1da52c2daf23fb0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BMC Infectious Diseases  (2018) 18:103 \nPage 4 of 9\ndistribution for the onset of the disease, i.e., a child who\ndid not have a varicella diagnosis contributed a full year of\nexposed person-time, while a child diagnosed with vari-\ncella contributed only 6 months of exposed person-time.\nTotal effect The estimation of the total effect of the\nvaccination programme in the Veneto Region was evalu-\nated by comparing the observed incidence rate of vari-\ncella in the first 6 years of life among the 2357\nProQuad-vaccinated\nchildren\nto\ncorresponding inci-\ndence rates from the historical cohort (Fig. 3). It was cal-\nculated according to the following formula:\nVE \u00bc 1\u2212\u03bbv\n\u03bbp\n\u00bc 1\u2212RR\nWhere \u03bbv denotes the varicella incidence rate among\nProQuad-vaccinated children and \u03bbp represents the rate\nin the unvaccinated historical cohort. The relative risk\n(RR) denotes the ratio of the varicella incidence rate\namong ProQuad-vaccinated children to the susceptibility-\nadjusted incidence rate in the pre-vaccination period [13].\nRR and corresponding 95% confidence intervals (CIs)\nwere estimated with the Mantel-Haenszel method for inci-\ndence rates. Vaccinated person-time was calculated from\ndate of first varicella vaccination plus 42 days to date of\nfirst censoring event, allowing for the delayed onset of im-\nmunity after vaccination.\nIndirect effect In order to evaluate the indirect effect,\nthe incidence rate of varicella in the 912 unvaccinated\nchildren in our study sample was compared to incidence\nrates from the historical cohort [13] (Fig. 3). The indirect\neffect was defined as:\nVE \u00bc 1\u2212\u03bbu\n\u03bbp\n\u00bc 1\u2212RR\nwhere \u03bbu denotes the incidence rate in unvaccinated\nchildren, \u03bbp the incidence rate in the historical cohort,\nand RR the incidence rate ratio. RR and corresponding\n95% CIs were estimated with the Mantel-Haenszel\nmethod for incidence rates. Unvaccinated person-time\nwas calculated from age 1 year until either a first dose of\nProQuad or first censoring event, whichever occurred\nfirst.", "mimetype": "text/plain", "start_char_idx": 16373, "end_char_idx": 18355, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ac2379e7-d0c4-4ef2-bc56-bc97e0628d7e": {"__data__": {"id_": "ac2379e7-d0c4-4ef2-bc56-bc97e0628d7e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cb325113-9ade-41ef-aa62-675e17a2faad", "node_type": "1", "metadata": {}, "hash": "2ae928df3a75411c99d0c1c6c3aac801d51590e083c2f729a04ef399df6eb05e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b1ebf17b-fc82-48ba-b303-a6c26977502e", "node_type": "1", "metadata": {}, "hash": "3f79e84496c697edb36b58a5a32f2391285a6ebe7b394c8b76859a483b0822c3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Unvaccinated person-time\nwas calculated from age 1 year until either a first dose of\nProQuad or first censoring event, whichever occurred\nfirst.\nOverall effect In order to evaluate the overall effect, the\nincidence rate of varicella among all 7623 children\n(vaccinated and unvaccinated) in our study sample was\ncompared to incidence rates from the historical cohort\n(Fig. 3) [13]. The overall effect was defined as follows:\nVE \u00bc 1\u2212\u03bboverall\n\u03bbp\n\u00bc 1\u2212RR\nwhere \u03bboverall denotes the average incidence rate in the\npopulation covered by the vaccination programme, \u03bbp\nthe incidence rate in the historical cohort, and RR the\nincidence rate ratio. RR and corresponding 95% CIs were\nestimated with the Mantel-Haenszel method for inci-\ndence rates. Person-time was calculated from age 1 year\nuntil date of first censoring event.\nResults\nAmong the 7623 children in our study sample, 6711\n(88%) were vaccinated against varicella. Among vacci-\nnated children, 2357 (35.1%) received ProQuad and 4354\n(64.9%) received a different varicella-containing vaccine\n(Varivax, Varilrix, Priorix Tetra, or an unknown brand).\nOur unvaccinated population numbered 912 (Fig. 4). We\ncompared sex distribution, birth cohort (2006 and 2007)\nand the affiliation to different LHAs in vaccinated and\nunvaccinated children in our study sample. The sex\ndistribution was equal in both populations and no differ-\nence was observed in the distribution of vaccinated and\nunvaccinated children across the two birth cohorts.\nFig. 3 Types of effect and choice of populations\nGiaquinto et al. BMC Infectious Diseases  (2018) 18:103 \nPage 5 of 9\nAmong the 2357 ProQuad-vaccinated children, 43\nvaricella cases were reported, compared to 287 cases\namong the 912 unvaccinated children.", "mimetype": "text/plain", "start_char_idx": 18211, "end_char_idx": 19946, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b1ebf17b-fc82-48ba-b303-a6c26977502e": {"__data__": {"id_": "b1ebf17b-fc82-48ba-b303-a6c26977502e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ac2379e7-d0c4-4ef2-bc56-bc97e0628d7e", "node_type": "1", "metadata": {}, "hash": "1463070fd9b42398c7bd31aca926b997f8f367ccdad8a156a1da52c2daf23fb0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "74ebfd9a-228f-40a5-bb16-ff2c8208d5b1", "node_type": "1", "metadata": {}, "hash": "228a0f8ebbbf99a0b2a9b7c4ab7a8c472b5ffebed7843c601b21bf0a2f13b99a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Of these 287\nvaricella\ncases,\n110\noccurred\nbetween\n12\nand\n<\n24 months of age, 34 occurred in children aged 24 to\n< 36 months, 58 in children 36 to < 48 months of\nage, 41 cases in children aged 48 to < 60 months and\n44 cases occurred in children between 60 and <\n72 months of age. Among ProQuad-vaccinated chil-\ndren, only two varicella cases occurred in the second\nand third year of life, 16 in the fourth, 9 in the fifth\nand 14 in the sixth. No varicella cases were observed\nduring the first 42 days after vaccination.\nEffectiveness of a single dose of ProQuad\nVaricella incidence among ProQuad-vaccinated children\nwas 0.43 (95% CI: 0.31\u20130.57) per 100 person-years com-\npared to 6.37 (95% CI: 5.66\u20137.16) per 100 person-years\namong unvaccinated children. The crude direct vaccine\neffectiveness was estimated at 93% (95% CI: 90\u201395%)\nand 94% (95% CI: 91\u201395%) when adjusted for number of\nvisits to the FP (Table 2).\nVaccine impact: Total, indirect and overall effects\nWhen\ncomparing\nthe\nvaricella\nincidence\namong\nProQuad-vaccinated children (0.43 per 100 person years,\n95% CI: 0.31\u20130.57) with that of the historical cohort\n(11.87 per 100 person-years, 95% CI: 11.22\u201312.54), the\ntotal effect of ProQuad was estimated at 97% (95% CI:\n96\u201398%) (Table 2).\nWhen comparing the varicella incidence among the\nunvaccinated children (6.37 per 100 person-years, 95%\nCI: 5.66\u20137.16) in our study cohort to that of the histor-\nical cohort, an indirect effect of 43% (95% CI: 35\u201350%)\nwas estimated (Table 2).", "mimetype": "text/plain", "start_char_idx": 19947, "end_char_idx": 21436, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "74ebfd9a-228f-40a5-bb16-ff2c8208d5b1": {"__data__": {"id_": "74ebfd9a-228f-40a5-bb16-ff2c8208d5b1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b1ebf17b-fc82-48ba-b303-a6c26977502e", "node_type": "1", "metadata": {}, "hash": "3f79e84496c697edb36b58a5a32f2391285a6ebe7b394c8b76859a483b0822c3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8e10dd72-e77e-44af-8ae3-f0c37acd9a93", "node_type": "1", "metadata": {}, "hash": "05b054b26551110b9e72df7ca4df79ade1236cbf85f002c95da861fb4d694557", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The overall effect was calculated by comparing the\naverage incidence among both vaccinated and unvaccin-\nated children in our study sample (1.2 per 100 person-\nyears, 95% CI: 1.09\u20131.32) with that of the historical co-\nhort, yielding an overall effect of 90% (95% CI: 89\u201391%)\n(Table 2).\nFig. 4 Flow chart\nTable 2 Summary of vaccine effectiveness and population\nimpact results\nVaccine effect\nVE\n95% CI\nDirect effectiveness\nCrude\n0.93\n(0.90\u20130.95)\nAdjusted\n0.94\n(0.91\u20130.95)\nTotal effect\n0.97\n(0.96\u20130.98)\nIndirect effect\n0.43\n(0.35\u20130.50)\nOverall effect\n0.90\n(0.89\u20130.91)\nVE please define, CI confidence interval\nGiaquinto et al. BMC Infectious Diseases  (2018) 18:103 \nPage 6 of 9\nDiscussion\nTo the best of our knowledge, this study was the first\nto measure ProQuad-specific effectiveness and the\nimpact of a vaccination programme against varicella\nin children vaccinated with the quadrivalent MMRV\nvaccine ProQuad. The Veneto Region of Italy offered\na unique possibility to conduct this study for two\nreasons. First, the region is covered by the Pedianet\nnetwork, which includes data generated by FPs during\nroutine\npatient\ncare\nand\nstored\nin\nfiles\nusing\na\nunique, anonymised Pedianet ID that can be linked\nthrough the fiscal code to data from the Regional\nImmunization Database, where all vaccination data\nare stored. Second, the Veneto Region was the only\nplace\nin\nEurope\nwhere\nthe\nquadrivalent\nMMRV\nvaccine ProQuad was used shortly after varicella vac-\ncination\nwas\nintroduced\ninto\nthe\nvaccination\nprogramme.", "mimetype": "text/plain", "start_char_idx": 21437, "end_char_idx": 22943, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8e10dd72-e77e-44af-8ae3-f0c37acd9a93": {"__data__": {"id_": "8e10dd72-e77e-44af-8ae3-f0c37acd9a93", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "74ebfd9a-228f-40a5-bb16-ff2c8208d5b1", "node_type": "1", "metadata": {}, "hash": "228a0f8ebbbf99a0b2a9b7c4ab7a8c472b5ffebed7843c601b21bf0a2f13b99a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ac01ed96-a4ba-4cc0-a931-175852c31fd5", "node_type": "1", "metadata": {}, "hash": "60d1e3c2b83216e9ce002564396996dff7c731b6c1cb2ae4ac9f56b774c72907", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Values for direct effectiveness and impact were very\nhigh, with a direct vaccine effectiveness of 93% (95% CI:\n90\u201395%), and impacts of 97% (95% CI: 96\u201398%), 43%\n(95% CI: 35\u201353%), and 90% (95% CI: 89\u201391%) for the\ntotal, indirect, and overall effects, respectively, confirm-\ning the vaccine efficacy and effectiveness reported in\nprevious studies conducted with the monovalent vaccine\nVarivax, which contains the same varicella component\nas ProQuad [14].\nWhen interpreting vaccine effectiveness and impact,\nsome limitations have to be considered. When estimat-\ning direct vaccine effectiveness, we made the assumption\nthat vaccine status was random, i.e., that the characteris-\ntics of vaccinated and unvaccinated children from the\nsame birth cohorts did not differ. We found no differ-\nences in sex distribution or birth cohort affiliation, and\nadjusted for number of visits to the FP. A further\nassumption was equal susceptibility and an equal oppor-\ntunity to be exposed to varicella (random mixing), which\nmay not always apply when incidence rates are very low.\nFor the measures of vaccine impact (as measured by\ntotal, indirect, and overall effect), the study used a histor-\nical cohort to represent a pre-vaccination period [13],\nassuming this cohort was reasonably similar and that the\nmethod of collection of cases and susceptibility to varicella\ndid not differ between the two time periods. While we do\nnot know how many children in the historical cohort\ncame from the Veneto Region, they were all registered\nwith Pedianet FPs in Italy, and the Veneto Region was\nover-represented. Considering that the same software used\nby FPs in their routine practice (junior Bit) was used as a\ndata collection system in both studies, differences in data\ncollection should be limited. The historical cohort repre-\nsents a population completely unexposed to varicella\nvaccination, as the vaccine was not yet on the Italian mar-\nket, but other than this key difference, we assumed there\nwas no other difference in susceptibility to varicella\nbetween the two populations.\nOur historical cohort was based on the study sam-\nple from Nicolosi et al. [13]. However, these children\nwere only followed for 1 year.", "mimetype": "text/plain", "start_char_idx": 22944, "end_char_idx": 25141, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ac01ed96-a4ba-4cc0-a931-175852c31fd5": {"__data__": {"id_": "ac01ed96-a4ba-4cc0-a931-175852c31fd5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8e10dd72-e77e-44af-8ae3-f0c37acd9a93", "node_type": "1", "metadata": {}, "hash": "05b054b26551110b9e72df7ca4df79ade1236cbf85f002c95da861fb4d694557", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3866d82f-d642-430e-bda9-1016a897d7ae", "node_type": "1", "metadata": {}, "hash": "0aa37fdec7a728e40a4bd864440b9b917e5930629ca652ceff2e5dfc96ef6452", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Our historical cohort was based on the study sam-\nple from Nicolosi et al. [13]. However, these children\nwere only followed for 1 year. To rule out the possi-\nbility that this was a high- or low-incidence year for\nvaricella, we performed a sensitivity analysis using the\n2006/2007 birth cohorts from a neighbouring region\nwithout a varicella vaccination programme (Lombar-\ndia)\nregistered\nwith\nPedianet\nas\ncomparator\nand\nfollowed them up to their 6th birthday. The total ef-\nfect of 97% (95% CI: 96\u201398) that we obtained con-\nfirmed our results.\nBased on a previously conducted pilot study in which\nwe\nextracted\nvaccination\ndata\nfrom\nthe\nRegional\nImmunization Database for all children born between\n2003 and 2013, we have a good picture of varicella vac-\ncine coverage in the Veneto Region for these birth\ncohorts. Varicella vaccines have been available in the\nVeneto Region since 2004, and vaccination coverage\nincreased rapidly, from 15% in the 2004 birth cohort to\n72% in the 2005 birth cohort, who were of vaccinating\nage when the varicella vaccine became part of the Ven-\neto Region\u2019s vaccination programme. For the 2006 to\n2013 birth cohorts, vaccine coverage was high and\nstable, between 83% and 90%.\nThe three vaccine impact measures (total, overall, and\nindirect effects) relate to the vaccination programme\nand depend on vaccine coverage in the population. For\nthe total effect we compared varicella incidence in\nProQuad-vaccinated children to that in the historical\ncohort, but this effect cannot be fully attributed to Pro-\nQuad. It is partly attributable to all varicella vaccines\nthat were administered to children between 2004 and\nthe end of follow-up in 2013, as it consists not only of\nthe direct effectiveness of the vaccine that the child\nreceived but also the indirect protection associated with\nthe herd immunity that comes with increasing vaccine\ncoverage [12].", "mimetype": "text/plain", "start_char_idx": 25006, "end_char_idx": 26888, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3866d82f-d642-430e-bda9-1016a897d7ae": {"__data__": {"id_": "3866d82f-d642-430e-bda9-1016a897d7ae", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ac01ed96-a4ba-4cc0-a931-175852c31fd5", "node_type": "1", "metadata": {}, "hash": "60d1e3c2b83216e9ce002564396996dff7c731b6c1cb2ae4ac9f56b774c72907", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "11bf6f0d-99f2-4187-8cec-8963849dbb5e", "node_type": "1", "metadata": {}, "hash": "aaba433f2aaa84660c1ea07a16a411c49b4d30f5894bc9be97bd9dc0bfb23926", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "If the effectiveness of other varicella vac-\ncines was lower than that of ProQuad, the level of\nexposure to varicella of the children vaccinated with\nProQuad would be higher than expected in a hypothet-\nical cohort of children vaccinated with ProQuad only,\nthus leading to an underestimation of the total effect,\nthat can be attributed to ProQuad. On the contrary, if\nthe effectiveness of other varicella vaccines was higher,\nwe would have observed an overestimation of the total\neffect compared to a hypothetical cohort vaccinated with\nProQuad only. Therefore, the estimation of direct vac-\ncine effectiveness is the best estimate of the performance\nof ProQuad that is not confounded by the use of other\nvaricella vaccines. Indirect and overall vaccine effects are\nnot vaccine-specific; they are attributable to all vaccines\nused in the study period.\nGiaquinto et al. BMC Infectious Diseases  (2018) 18:103 \nPage 7 of 9\nA general limitation of this study is that information\non vaccine brand was missing for almost 60% of the\nchildren in our study sample. Therefore we performed a\nsensitivity analysis using the same methodology as\ndescribed above, but including all vaccinated children\n(whatever the brand) and compared the results to the\nProQuad-specific analyses. Crude direct vaccine effect-\niveness was 91% (95% CI: 89\u201393%) and 92% (95% CI:\n90\u201393%) when adjusted for the number of visits to the\nFP, and the total effect of varicella vaccination with any\nbrand was 95% (95% CI: 96\u201397%). These results are very\nsimilar to the ones we report here; however, as the vac-\ncine brand was unknown in almost 60% of vaccinated\nchildren, and as we assume, based on procurement fig-\nures, that most of them were vaccinated with ProQuad,\nwe cannot draw conclusions about the potential effect-\niveness of other varicella vaccines that were used in chil-\ndren in the Veneto Region in 2003\u20132013.\nConclusion\nOur study was the first to measure the ProQuad-specific\neffectiveness and impact of a vaccination program\nagainst varicella in ProQuad-vaccinated children.", "mimetype": "text/plain", "start_char_idx": 26889, "end_char_idx": 28941, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "11bf6f0d-99f2-4187-8cec-8963849dbb5e": {"__data__": {"id_": "11bf6f0d-99f2-4187-8cec-8963849dbb5e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3866d82f-d642-430e-bda9-1016a897d7ae", "node_type": "1", "metadata": {}, "hash": "0aa37fdec7a728e40a4bd864440b9b917e5930629ca652ceff2e5dfc96ef6452", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7498c2d8-1106-42b4-80de-c560b2b37676", "node_type": "1", "metadata": {}, "hash": "68c8d779e1d52423dc9d2b96c0100e260c5a87318d2907dc3e0d584721a6dac7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Conclusion\nOur study was the first to measure the ProQuad-specific\neffectiveness and impact of a vaccination program\nagainst varicella in ProQuad-vaccinated children. Effect-\niveness and impact results were very high in the Veneto\nRegion, with an adjusted direct vaccine effectiveness of\n94% (95% CI: 90\u201395%) and a total effect of 97% (95% CI:\n96\u201398%), confirming the vaccine efficacy and effective-\nness reported in previous studies on a single dose of the\nmonovalent vaccine, Varivax, which contains the same\nvaricella component as ProQuad [15, 16]. The overall ef-\nfect of the vaccination program against varicella in the\nregion was 90% (95% CI: 89\u201391%) and an indirect effect\nof 43% (95% CI: 35\u201353%) was also demonstrated in the\nunvaccinated population. For methodological reasons\nthe Proquad-specific vaccine effectiveness was estimated\nfor a single dose schedule, however, it is worth to point\nout that varicella vaccination is recommended to be\ngiven as a two dose schedule, as two vaccine doses have\nbeen shown to result in higher seroconversion rates and\nhigher vaccine efficacy against both, severe and mild\ndisease. The Veneto Region in Italy offered a unique\nopportunity to conduct this study, due to the possibility\nto link information from the Regional Immunization\nDatabase with data from the Pedianet database.", "mimetype": "text/plain", "start_char_idx": 28775, "end_char_idx": 30101, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7498c2d8-1106-42b4-80de-c560b2b37676": {"__data__": {"id_": "7498c2d8-1106-42b4-80de-c560b2b37676", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "11bf6f0d-99f2-4187-8cec-8963849dbb5e", "node_type": "1", "metadata": {}, "hash": "aaba433f2aaa84660c1ea07a16a411c49b4d30f5894bc9be97bd9dc0bfb23926", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d4c57282-731b-4433-abf9-9599037e027f", "node_type": "1", "metadata": {}, "hash": "077dde1a00dbdd3758e39b719ea925b1909cb7aaa0871c6aec81b9a4ad5545c3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The Veneto Region in Italy offered a unique\nopportunity to conduct this study, due to the possibility\nto link information from the Regional Immunization\nDatabase with data from the Pedianet database.\nAbbreviations\nCI: Confidence interval; FP: Family paediatrician; LHA: Local Health Authority;\nMMRV: Measles, mumps, rubella, varicella; NHS: National Health Services;\nRR: Relative risk; VP: Vaccination programme\nAcknowledgements\nWe would like to thank all Pedianet FPs involved in the study: Balliana\nFranco, Barbazza Maria Carolina, Barbieri Patrizia, Belluzzi Gabriele, Benetti\nEleonora, Bonaiuto Francesco, Brusaterra Ivana, Cantarutti Luigi, Carnazza\nSilvia, Castaldo Massimo, Cavedagni Monica, Ciscato Carla, Cozzani Sandra,\nD\u2019Amanti Vito Francesco, De Marchi Annamaria, Dell\u2019Antonia Fabio, Doria\nMattia, Drago Stefano, Fama Mario, Ferrara Enrico, Ferrarese Marta, Frison\nEzio, Fusco Fabrizio, Gallo Giovanni, Giancola Giuseppe, Giaretta Letizia,\nGirotto Silvia, Lista Cinzia, Luise Francesco, Macropodio Nadia, Meneghetti\nStefano, Milani Massimo, Pandolfini Vittorio, Pasinato Angela, Passarella\nAndrea, Pisanello Lorena, Pittarello Daniele, Ruffato Bruno, Sambugaro\nDaniela, Saretta Luigi, Savastano Renato, Semenzato Flavio, Spanevello Valter,\nTamassia Gianni, Toderini Luisa, and Toffol Giacomo.\nAdditional thanks go to Anne Schuyleman for study coordination during the\nfirst year, Lamia Lafi for the preparation of the graphs, Sonia Twardowski for\nstudy assistance, and Trudy Perdrix-Thoma for editing of the manuscript. Fi-\nnally, we would like to thank Filippo Da Re (Veneto Region) for providing\nuseful information about vaccinations in the Veneto Region.\nAn abstract of this manuscript was published at the annual ESPID\nConference 2017.\nFunding\nThe work was funded by Sanofi Pasteur MSD.", "mimetype": "text/plain", "start_char_idx": 29902, "end_char_idx": 31703, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d4c57282-731b-4433-abf9-9599037e027f": {"__data__": {"id_": "d4c57282-731b-4433-abf9-9599037e027f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7498c2d8-1106-42b4-80de-c560b2b37676", "node_type": "1", "metadata": {}, "hash": "68c8d779e1d52423dc9d2b96c0100e260c5a87318d2907dc3e0d584721a6dac7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bd04f3b3-20a8-4f10-91b9-cb084f16de1d", "node_type": "1", "metadata": {}, "hash": "ec2c926a65913141482cf10d492c7ae1eded0408e9a10975843e5383f489e1b7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "An abstract of this manuscript was published at the annual ESPID\nConference 2017.\nFunding\nThe work was funded by Sanofi Pasteur MSD.\nAvailability of data and materials\nThe data that support the findings of this study are available from Pedianet\nor Regione Veneto but restrictions apply to the availability of these data,\nwhich were used under license for the current study, and so are not publicly\navailable. Data are however available from the authors upon reasonable\nrequest and with permission of Pedianet and Regione Veneto.\nAuthors\u2019 contributions\nCG, GG, VB, LT, EP, ST, CB, and SH contributed to the study design, data\nanalysis, and interpretation of findings. LT, NR, FR, CP, ASc, LC, and XC\ncontributed to the data collection and interpretation of findings. MV, ST,\nand AS contributed to the data analysis and interpretation of findings. RL\ncontributed to the interpretation of findings. All authors critically reviewed\nthe manuscript and approved the final version.\nEthics approval and consent to participate\nThe ethics committee of the Azienda Ospedaliera of Padova reviewed the\nstudy related documents and approved the study.\nEthics approval and consent to participate\nData from children whose parents have signed an informed consent are\ncollected and transmitted to a central Pedianet database in Padova after\nanonymisation.\nCompeting interests\nCG received consultancy and research grants to his referral Institutions from\nSPMSD, Merck, GSK-Bio, Gilead, ViiV-Healthcare; GG received grants from\nSanofi Pasteur MSD, GSK Biologicals SA, Novartis, Pfizer, and Sequirus for\ntaking part to advisory boards, expert meetings, for acting as speaker and/or\norganizer of meetings/congresses and as principal investigator and chief of\nO.U.", "mimetype": "text/plain", "start_char_idx": 31571, "end_char_idx": 33311, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bd04f3b3-20a8-4f10-91b9-cb084f16de1d": {"__data__": {"id_": "bd04f3b3-20a8-4f10-91b9-cb084f16de1d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d4c57282-731b-4433-abf9-9599037e027f", "node_type": "1", "metadata": {}, "hash": "077dde1a00dbdd3758e39b719ea925b1909cb7aaa0871c6aec81b9a4ad5545c3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eca410df-939d-4b67-98fa-0354efc69608", "node_type": "1", "metadata": {}, "hash": "3eebb5597ed9a3c733ebc7020b01121292f24a87de81aac4ac05f1d2b723662b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "in randomized controlled trials, and he recently became a member of\nthe Regional Commission on Vaccines (Emilia Romagna Region, Italy)\nwithout any decision making role; the Commission has only a technical and\nscientific role; VB received grants from GSK, SPMSD, Novartis, and Pfizer for\ntaking part in advisory boards, expert meetings, being a speaker or an organ-\nizer of congresses/conferences, and acting as promoter of epidemiological\nstudies partially supported by vaccine producers; LC received research grants\nfrom SPMSD, and GSK-Bio; EP, XC, ST, CB, and SH were employees of Sanofi\nPasteur MSD during the study period; AS was working as a consultant for\nSanofi Pasteur MSD, mandated by AIXIAL; MV, LT, NR, FR, ChP, ASc, and RL\ndon\u2019t have any competing interests to declare.\nPublisher\u2019s Note\nSpringer Nature remains neutral with regard to jurisdictional claims in\npublished maps and institutional affiliations.\nAuthor details\n1Department of Women and Child Health, University of Padova, Padova, Italy.\n2Department of Medical Sciences, University of Ferrara, Ferrara, Italy.\n3Department of Cardiac, Thoracic, and Vascular Sciences, Hygiene and Public\nHealth Unit, University of Padova, Padova, Italy. 4ATS della Valpadana,\nCremona, Italy. 5Consorzio Arsen\u00e0l. IT, Viale Oberdan 5, 31100 Treviso, Italy.\n6Service of Hygiene Promotion and development, Veneto Region, Venice,\nItaly. 7Societ\u00e0 Servizi Telematici, Pedianet, Padova, Italy. 8Penta Foundation,\nGiaquinto et al. BMC Infectious Diseases  (2018) 18:103 \nPage 8 of 9\nCorso Stati Uniti 4, Padova, Italy. 9MSD Italia S.r.l., Via Vitorchiano, 151 Rome,\nItaly. 10Study management, Sanofi Pasteur MSD, 162 avenue Jean Jaur\u00e8s,\nLyon, France. 11AIXIAL, 4 Rue Barthelemy Danjou, Boulogne-Billancourt,\nFrance. 12Epidemiology, MSD, 162 avenue Jean Jaur\u00e8s, Lyon, France.", "mimetype": "text/plain", "start_char_idx": 33312, "end_char_idx": 35130, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "eca410df-939d-4b67-98fa-0354efc69608": {"__data__": {"id_": "eca410df-939d-4b67-98fa-0354efc69608", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bd04f3b3-20a8-4f10-91b9-cb084f16de1d", "node_type": "1", "metadata": {}, "hash": "ec2c926a65913141482cf10d492c7ae1eded0408e9a10975843e5383f489e1b7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "675523ea-d308-487f-b318-557c781329d2", "node_type": "1", "metadata": {}, "hash": "199fb82c411e3084f5cb24269aaf236ab59cec525ba5d93a37f98e9466ebef65", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "11AIXIAL, 4 Rue Barthelemy Danjou, Boulogne-Billancourt,\nFrance. 12Epidemiology, MSD, 162 avenue Jean Jaur\u00e8s, Lyon, France.\nReceived: 17 February 2017 Accepted: 28 February 2018\nReferences\n1.\nHeininger U, Seward JF. Varicella. Lancet. 2006;368:1365\u201376.\n2.\nHeymann DL. Control of communicable diseases manual. 18th ed.\nWashington DC: American Public Health Association; 2003. p. 204.\n3.\nCoudeville L, Paree F, Lebrun T, Sailly J. The value of varicella vaccination in\nhealthy children: cost-benefit analysis of the situation in France. Vaccine.\n1999;17:142\u201351.\n4.\nCoudeville L, Brunot A, Giaquinto C, Lucioni C, Dervaux B. Varicella\nvaccination in Italy: an economic evaluation of different scenarios.\nPharmacoEconomics. 2004;22:839\u201355.\n5.\nCoudeville L, Brunot A, Szucs TD, Dervaux B. The economic value of\nchildhood varicella vaccination in France and Germany. Value Health. 2005;\n8:209\u201322.\n6.\nVaricella and herpes zoster vaccines. WHO position paper, June 2014. Wkly\nEpidemiol Rec. 2014;89:265\u201387.\n7.\nShinefield H, Black S, Williams WR, Marchant C, Reisinger K, Stewart T, et al.\nDose-response study of a quadrivalent measles, mumps, rubella and\nvaricella vaccine in healthy children. Pediatr Infect Dis J. 2005;24:670\u20135.\n8.\nShinefield H, Black S, Digilio L, Reisinger K, Blatter M, Gress JO, et al.\nEvaluation of a quadrivalent measles, mumps, rubella and varicella vaccine\nin healthy children. Pediatr Infect Dis J. 2005;24:665\u20139.\n9.", "mimetype": "text/plain", "start_char_idx": 35007, "end_char_idx": 36443, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "675523ea-d308-487f-b318-557c781329d2": {"__data__": {"id_": "675523ea-d308-487f-b318-557c781329d2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eca410df-939d-4b67-98fa-0354efc69608", "node_type": "1", "metadata": {}, "hash": "3eebb5597ed9a3c733ebc7020b01121292f24a87de81aac4ac05f1d2b723662b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3dfac74b-4c7c-42ba-8946-89e72f98b0ce", "node_type": "1", "metadata": {}, "hash": "576e21d6851413108c7a7d75ac51af627754e2952bd6cab047ecc57a29acc892", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine\nin healthy children. Pediatr Infect Dis J. 2005;24:665\u20139.\n9.\nBaldo V, Ferro A, Napoletano G, Milani S, Bertoncello L, Baldovin T, et al.\nUniversal varicella vaccination in the Veneto region, Italy: launch of a\nprogramme targeting all children aged 14 months and susceptible\nadolescents. Euro Surveill. 2007;12:E071101.\n10.\nMinistero della Salute. Indicazioni in merito alla somministrazione della\nvaccinazione contro la varicella in et\u00e0 pediatrica. Circolare 10/10/2012, n.\n21509. 2012. http://www.trovanorme.salute.gov.it/norme/\nrenderNormsanPdf?anno=0&codLeg=44156&parte=1%20&serie=. Accessed\n26 Dec 2016. Italian.\n11.\nItalian National Institute of Statistics. I.stat website. Popolazione e famiglie:\nIndicatori demografici. http://dati.istat.it/Index.aspx?DataSetCode=DCIS_\nINDDEMOG1. Accessed 26 Dec 2016.\n12.\nHanquet G, Valenciano M, Simondon F, Moren A. Vaccine effects and\nimpact of vaccination programmes in post-licensure studies. Vaccine. 2013;\n31:5634\u201342.\n13.\nNicolosi A, Sturkenboom M, Mannino S, Arpinelli F, Cantarutti L, Giaquinto\nC. The incidence of varicella: correction of a common error. Epidemiology.\n2003;14:99\u2013102.\n14.\nKuter BJ, Brown ML, Hartzel J, Williams WR, EvesiKaren A, Black S, et al.\nSafety and immunogenicity of a combination measles, mumps, rubella and\nvaricella vaccine (ProQuad). Hum Vaccin. 2006;2:205\u201314.\n15.\nBaxter R, Ray P, Tran TN, Black S, Shinefield HR, Coplan PM, et al.", "mimetype": "text/plain", "start_char_idx": 36308, "end_char_idx": 37796, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3dfac74b-4c7c-42ba-8946-89e72f98b0ce": {"__data__": {"id_": "3dfac74b-4c7c-42ba-8946-89e72f98b0ce", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Giaquinto (2018).pdf", "node_type": "4", "metadata": {}, "hash": "0b76c64cbaf855051a79ab23150e765432580abc7b83aaf4fe1280e2e0fbee6c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "675523ea-d308-487f-b318-557c781329d2", "node_type": "1", "metadata": {}, "hash": "199fb82c411e3084f5cb24269aaf236ab59cec525ba5d93a37f98e9466ebef65", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Hum Vaccin. 2006;2:205\u201314.\n15.\nBaxter R, Ray P, Tran TN, Black S, Shinefield HR, Coplan PM, et al. Long-term\neffectiveness of varicella vaccine: a 14-year, prospective cohort study.\nPediatrics. 2013;131:e1389\u201396.\n16.\nKuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, et al. Ten\nyear follow-up of healthy children who received one or two injections of\nvaricella vaccine. Pediatr Infect Dis J. 2004;23:132\u20137.\n\u2022  We accept pre-submission inquiries \n\u2022  Our selector tool helps you to \ufb01nd the most relevant journal\n\u2022  We provide round the clock customer support \n\u2022  Convenient online submission\n\u2022  Thorough peer review\n\u2022  Inclusion in PubMed and all major indexing services \n\u2022  Maximum visibility for your research\nSubmit your manuscript at\nwww.biomedcentral.com/submit\nSubmit your next manuscript to BioMed Central \nand we will help you at every step:\nGiaquinto et al. BMC Infectious Diseases  (2018) 18:103 \nPage 9 of 9", "mimetype": "text/plain", "start_char_idx": 37698, "end_char_idx": 38629, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "89f6eee5-cbf5-45fb-9099-e4155562b7d9": {"__data__": {"id_": "89f6eee5-cbf5-45fb-9099-e4155562b7d9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Peltola (1986).pdf", "node_type": "4", "metadata": {}, "hash": "2fa74cafac5f27950951b6fb25c5a1c4b45a6d10150b94440d0699187e473db2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7774f92b-7938-4039-869f-04155511f9a0", "node_type": "1", "metadata": {}, "hash": "24e4f2a42ec51af0768fb0e799b78abfb200129ac18fb22d278b54fe10a069e3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "939\nnegative pressure is directly proportional to nasal resistance\n(for a given respiratory effort), any reduction in nasal\nresistance upon clearance of retained secretions will reduce\nthe inspiratory suction pressure and the risk oforopharyngeal\nclosure. This change may partly explain why children who\nwere severely obstructed before starting on CIP had only\nmild obstruction with low pressure-time indices when it was\ninterrupted (fig-4). Perhaps CIP also acts to increase muscle\ntone through stimulation of airway mechanoreceptors, as has\nbeen proposed for some patients with nasal CPAP23 but too\nlittle is known of these receptors to permit speculation on the\nmatter. 25\nCIP only relieves the symptoms in airway obstruction, so it\nis important to guard against a false sense of security and\nensure that CIP is not inadvertently discontinued. On its\nwithdrawal, the patient should be carefully observed during\nsleep to ensure that the OPO has resolved.\nThe method is deceptively simple. Scrupulous attention\nmust be paid to the tube\u2019s position and selection of the\nappropriate flow rate. The gas needs to be humidified and\nwarmed to render the patient comfortable and to prevent\ninspissation of secretions, which could raise nasal airway\nresistance and aggravate the degree of obstruction. Coughing\nand spluttering with rhinorrhoea is common at the start of\ntherapy and should not deter one. Abdominal distension,\ngagging,, and persistent cough occur when the catheter has\nbeen advanced too far or when gas flow rates are too high. CIP\nmay be ineffective when the oropharynx is occluded by a\nmass.\nThe simplicity of CIP and the fact that it can be applied\nwith equipment readily available in any large hospital renders\nit ideal for prompt relief of severe OPO. Subsequent\ndefinitive therapy depends on the underlying disorder. When\nthis can be corrected surgically or is expected to resolve\nwithin a reasonable period, CIP can be the sole form of airway\nrelief. Otherwise an elective tracheostomy is recommended.\nCIP may also help in diagnosis. When snoring cannot be\neasily distinguished from laryngeal stridor in infants, a\nresponse to CIP implicates the oropharynx.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2172, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7774f92b-7938-4039-869f-04155511f9a0": {"__data__": {"id_": "7774f92b-7938-4039-869f-04155511f9a0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Peltola (1986).pdf", "node_type": "4", "metadata": {}, "hash": "2fa74cafac5f27950951b6fb25c5a1c4b45a6d10150b94440d0699187e473db2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "89f6eee5-cbf5-45fb-9099-e4155562b7d9", "node_type": "1", "metadata": {}, "hash": "7bb7e8b83bbf5a3a232d58a76f4fa5caf11e72505995df5cd9956dfd6c02f493", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ff1cba29-c0ac-41c5-ab8b-27d2fe8c520b", "node_type": "1", "metadata": {}, "hash": "1024980b1f46672320c8bb77a35be8993e1968f92caba5dfcaf74e74a65596ef", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CIP may also help in diagnosis. When snoring cannot be\neasily distinguished from laryngeal stridor in infants, a\nresponse to CIP implicates the oropharynx. We believe that\nCIP may be of value in adults and in domiciliary care but this\nhas yet to be established.\nPreliminary results of this study were presented at the University of\nCalifornia, San Francisco, during the 25th Anniversary celebration of the\nCardiovascular Research Institute (C.V.R.I.) in October 1983.\nWe thank the Hospitals Department, Cape of Good Hope Provincial\nAdministration, for the recording equipment; Dr J. G. L. Strauss, medical\nsuperintendent, Red Cross War Memorial Children\u2019s Hospital, for permission\nto publish patient data; Ms Beverley Peper for technical assistance; Mrs\nLynore Heuer for help with the manuscript; and Mrs Asa Smith for\nphotography.\nCorrespondence should be addressed to M. K., Red Cross War, Memorial\nChildren\u2019s Hospital, Rondebosch 7700, South Africa. Reprints will not be\navailable.\nREFERENCES\n1. Ingbar DH, Gee JBL. Pathophysiology and treatment of sleep apnea. Annu Rev Med\n1985; 36: 369-95.\n2 Lugaresi E, Coccagna G, Cirignotta F. Snoring and its clinical implications. In:\nGuilleminault C, Dement WC, eds. Sleep apnea syndromes. New York: Alan R.\nLiss, 1978: 13-21.\n3. Orr WC. Sleep-related breathing disorders: an update. Chest 1983; 84: 475-80.\n4 Bradley D, Phillipson EA. The treatment of obstructive sleep apnea: separating the\nwheat from the chaff. Am Rev Respir Dis 1983; 128: 583-86.\n5. Weitzman ED, Pollak CP, Borowiecki B, et al. The hypersomnia-sleep apnea\nsyndrome: site and mechanism of upper airway obstruction. In: Guilleminault C,\nDement WC, eds. Sleep apnea syndromes. New York. Alan R. Liss, 1978- 235-48.", "mimetype": "text/plain", "start_char_idx": 2017, "end_char_idx": 3745, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ff1cba29-c0ac-41c5-ab8b-27d2fe8c520b": {"__data__": {"id_": "ff1cba29-c0ac-41c5-ab8b-27d2fe8c520b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Peltola (1986).pdf", "node_type": "4", "metadata": {}, "hash": "2fa74cafac5f27950951b6fb25c5a1c4b45a6d10150b94440d0699187e473db2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7774f92b-7938-4039-869f-04155511f9a0", "node_type": "1", "metadata": {}, "hash": "24e4f2a42ec51af0768fb0e799b78abfb200129ac18fb22d278b54fe10a069e3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8fb550d7-04fb-4084-aec7-ea0049241050", "node_type": "1", "metadata": {}, "hash": "3615a8b4a1415198154de7d36e17cc7bdb33596621a1030890d6141ecfb8e3a2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In: Guilleminault C,\nDement WC, eds. Sleep apnea syndromes. New York. Alan R. Liss, 1978- 235-48.\n6 Remmers JE, deGroot WJ, Sauerland EK, Anch AM. Pathogenesis of upper airway\nocclusion during sleep. J Appl Physiol 1978; 44: 931-38.\n7 Block AJ, Faulkner JA, Huges RL, et al. Factors influencing upper airway closure.\nChest 1984; 86: 114-22.\n8. Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Annu Rev Med\n1976; 27: 465-84.\n9. Guilleminault C, Eldrigde FI, Tilkian A, et al. Sleep apnea syndrome due to upper\nairway obstruction: a review of 25 cases. Arch Intern Med 1977; 137: 296-300.\n10. Brouillette RT, Fernbach SK, Hunt CE. Obstructive sleep apnea in infants and\nchildren. J Pediatr 1982; 100: 31-40.\n11. Tonkin S. Sudden infant death syndrome: hypothesis of causation. Pediatrics 1975; 55:\n650-61.\n12. Cozzi F, Pierro A. Glossoptosis-apnea syndrome in infancy. Pediatrics 1985; 75:\n836-43.\n13. Roberts JL, Reed WR, Mathew OP, et al. Assessment of pharyngeal airway stability in\nnormal and micrognathic infants. J Appl Physiol 1985; 58: 290-99.\n14. Guilleminault C. New surgical approaches for obstructive sleep apnea syndrome. Sleep\n1984; 7: 1-2.\n15. Guilleminault C, Simmons FB, Motta J, et al. Obstructive sleep apnea syndrome and\ntracheostomy: long-term follow-up experience. Arch Intern Med 1981; 141: 985-88.\n16.", "mimetype": "text/plain", "start_char_idx": 3648, "end_char_idx": 4988, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8fb550d7-04fb-4084-aec7-ea0049241050": {"__data__": {"id_": "8fb550d7-04fb-4084-aec7-ea0049241050", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Peltola (1986).pdf", "node_type": "4", "metadata": {}, "hash": "2fa74cafac5f27950951b6fb25c5a1c4b45a6d10150b94440d0699187e473db2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ff1cba29-c0ac-41c5-ab8b-27d2fe8c520b", "node_type": "1", "metadata": {}, "hash": "1024980b1f46672320c8bb77a35be8993e1968f92caba5dfcaf74e74a65596ef", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5767c3c4-e893-426f-90f5-c0d055525115", "node_type": "1", "metadata": {}, "hash": "8f4bcb803276000952c983788fee39a55c6b30bc360a1b3591ab6b4ff43724e4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Obstructive sleep apnea syndrome and\ntracheostomy: long-term follow-up experience. Arch Intern Med 1981; 141: 985-88.\n16. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea\nby continuous positive airway pressure applied through the nares. Lancet 1981; i:\n862-65.\n17. Frith RW, Cant BR. Severe obstructive sleep apnoea treated with long term nasal\ncontinuous positive airway pressure. Thorax 1985; 40: 45-50.\n18. Schmidt-Nowara WW. Continuous positive airway pressure for long-term treatment of\nsleep apnea. Am J Dis Child 1984; 138: 82-84.\n19. George CF, Kryger MH. When is an apnea not an apnea? Am Rev Respir Dis 1985; 131:\n485-86.\n20. Burton AC. Physiology and biophysics of the circulation. Chicago: Year Book, 1965:\n106-12.\n21. McGregor M, Becklake MR. The relationship of oxygen cost of breathing to\nrespiratory mechanical work and respiratory force. J Clin Invest 1961; 40: 971-80.\n22. Collett PW, Perry C, Engel LA. Pressure-time product, flow and oxygen cost of\nresistive breathing in humans. J Appl Physiol 1985, 58: 1263-72.\n23. Rapoport DM, Garay SM, Goldring RM. Nasal CPAP in obstructive sleep apnea:\nmechanisms of action. Bull Eur Physiopathol Respir 1983; 19: 616-20.\n24 Conway CM. Anaesthetic circuits. In: Scurr C, Feldman S, eds. Scientific foundations\nof anaesthesia, 2nd ed. London: Heinemann, 1974: 509-15.\n25. McBride B, Whitelaw WA. A physiological stimulus to upper airway receptors m\nhumans. J Appl Physiol 1981; 51: 1189-97.", "mimetype": "text/plain", "start_char_idx": 4867, "end_char_idx": 6351, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5767c3c4-e893-426f-90f5-c0d055525115": {"__data__": {"id_": "5767c3c4-e893-426f-90f5-c0d055525115", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Peltola (1986).pdf", "node_type": "4", "metadata": {}, "hash": "2fa74cafac5f27950951b6fb25c5a1c4b45a6d10150b94440d0699187e473db2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8fb550d7-04fb-4084-aec7-ea0049241050", "node_type": "1", "metadata": {}, "hash": "3615a8b4a1415198154de7d36e17cc7bdb33596621a1030890d6141ecfb8e3a2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3addb771-d90d-4b93-996e-fb4724df85d9", "node_type": "1", "metadata": {}, "hash": "33a7509fe7e4f86665a9396228efda4685f2c32f020352ac633f562f949fd0d7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "25. McBride B, Whitelaw WA. A physiological stimulus to upper airway receptors m\nhumans. J Appl Physiol 1981; 51: 1189-97.\nFREQUENCY OF TRUE ADVERSE REACTIONS\nTO MEASLES-MUMPS-RUBELLA VACCINE\nA Double-blind Placebo-controlled Trial in Twins\nHEIKKI PELTOLA\nOLLI P. HEINONEN\nNational Public Health Institute and Children\u2019s Hospital,\nUniversity of Helsinki, Finland\nSummary \nThe vast majority of adverse reactions\nfollowing immunisation of children with\nlive measles-mumps-rubella (MMR) vaccine were shown in a\ndouble-blind, placebo-controlled, cross-over study in 581\ntwin pairs to be only temporally but not causally related to the\nvaccination. The true frequency of side-effects caused by\nMMR vaccine, estimated from the discordance rates of\nindividual signs and symptoms between MMR \nvaccinees and\ntheir placebo-injected twins, was between 0&middot;5 and 4&middot;0%.\nMoreover, respiratory symptoms, nausea, and vomiting were\nobserved more frequently in the placebo-injected group than\nin the MMR vaccinated group.\nIntroduction\nA VACCINATION programme to eliminate measles, mumps,\nand rubella (MMR) from Finland began in 1982.\u2019 The live\ncombined vaccine (\u2019Virivac\u2019, Merck Sharp & Dohme)2-5 is\nadministered in two doses, the first at age 14-18 months and\nthe second at 6 years. In the early stages of the programme,\nhowever, children between these age limits are also being\nimmunised.\nOne of the major concerns in any large-scale vaccination\nprogramme is the occurrence of adverse reactions. The\nmeasles component6-9 and, to a lesser extent, the rubella\nantigen 10, 11 are known to be reactogenic, whereas the mumps\ncomponent is thought to be almost harmless.12-15 Few\nstudies 3,15,16 have compared common symptoms and signs\noccurring in vaccinees and controls. In particular, little\nattention has been paid to reactions caused by the combined\nMMR vaccine.", "mimetype": "text/plain", "start_char_idx": 6229, "end_char_idx": 8085, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3addb771-d90d-4b93-996e-fb4724df85d9": {"__data__": {"id_": "3addb771-d90d-4b93-996e-fb4724df85d9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Peltola (1986).pdf", "node_type": "4", "metadata": {}, "hash": "2fa74cafac5f27950951b6fb25c5a1c4b45a6d10150b94440d0699187e473db2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5767c3c4-e893-426f-90f5-c0d055525115", "node_type": "1", "metadata": {}, "hash": "8f4bcb803276000952c983788fee39a55c6b30bc360a1b3591ab6b4ff43724e4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d4412bd7-624d-457e-8d08-22cab9456a54", "node_type": "1", "metadata": {}, "hash": "520823407045ff3b12fd4677a36733ef24749a5564d3933e50b24592a84a4273", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In particular, little\nattention has been paid to reactions caused by the combined\nMMR vaccine.\n940\nWe now report the results of a double-blind, placebo-\ncontrolled, crossover study on the reactogenicity of MMR\nvaccine. The study was carried out in twins to maximise the\nreliability of the results.\nSubjects and Methods\nThe study population consisted of pairs of twins who were to be\nMMR \nvaccinated between Nov 1,1982, and Oct 31,1983. 686 twin\npairs (aged 14 months to 6 years) were entered into the study. For\n104 pairs, however, only the first follow-up forms were completed,\nand the nurse helped the parents of 1 other pair to fill in their forms;\nthese 105 pairs were excluded. Thus, data on 581 twin pairs were\nincluded in the analysis.\nWhen the twins were brought to the child health centre the\npublic-health nurse described the study to the parents and invited\nthem to take part. If the parents were not willing, the children were\nvaccinated according to the normal procedure. If they agreed to\nparticipate and \nthere were no contraindications for MMR\nvaccination, each pair of twins was allocated a colour-coded\nvaccination package (one orange, one green), consisting of two doses\nof vaccine (one active, one placebo) and a questionnaire.\nVaccination\nThe vaccines were administered blind, but one twin of each pair\nfirst received active vaccine then, 3 weeks later, placebo; whereas\nthe other twin was first given placebo and then, after 3 weeks,\nactive vaccine. The injections consisted of 0\u2019 5 ml of vaccine 2-5 or\nplacebo (the same product including neomycin and phenol-red\nindicator but without the viral antigens) and were administered\nsubcutaneously by the nurse to the left deltoid or gluteal region.\nReporting of Reactions\nEach twin was given a colour-coded questionnaire to be filled in\ndaily by the parents for 21 days after each injection. Findings were\nto be marked positive, negative, or \"point not checked\" for 15 items\n(table I). The parents were given a thermometer to guarantee daily\ntemperature recording.", "mimetype": "text/plain", "start_char_idx": 7991, "end_char_idx": 10023, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d4412bd7-624d-457e-8d08-22cab9456a54": {"__data__": {"id_": "d4412bd7-624d-457e-8d08-22cab9456a54", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Peltola (1986).pdf", "node_type": "4", "metadata": {}, "hash": "2fa74cafac5f27950951b6fb25c5a1c4b45a6d10150b94440d0699187e473db2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3addb771-d90d-4b93-996e-fb4724df85d9", "node_type": "1", "metadata": {}, "hash": "33a7509fe7e4f86665a9396228efda4685f2c32f020352ac633f562f949fd0d7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "951f0630-346c-477a-8839-d22e3f35b9dd", "node_type": "1", "metadata": {}, "hash": "ccb23fc1896186843d85b3c38174fe7e09972d656dfe2fb1504ef4b39d6514dc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Findings were\nto be marked positive, negative, or \"point not checked\" for 15 items\n(table I). The parents were given a thermometer to guarantee daily\ntemperature recording.\nIf either twin had respiratory or other relevant symptoms at the \u2019\ntime of the second injection, vaccination of both children was\npostponed for 2 weeks.\nAnalysis of Data\nThe codes were broken only after all questionnaires had been\nreturned. The discordance rate was calculated by subtracting the\nfrequency of each symptom or sign reported in the placebo-injected\ntwins from that observed in the MMR vaccinated twins. This\ndifference was regarded as the true adverse-reaction rate\nTABLE I-SYMPTOMS AND SIGNS CAUSED BY MMR VACCINATION\nAND DAY OF PEAK OCCURRENCE\n*Between MMR group and placebo group.\ntMore in placebo-injected children.\nTABLE II-FEVER AFTER MMR VACCINATION OR PLACEBO INJECTION\nIN 581 TWIN PAIRS: MEAN NO OF CHILDREN AFFECTED PER DAY AND\nMEAN RATE PER 1000\nattributable to the MMR vaccine. Confidence intervals were\ncomputed from the poisson distribution of the frequencies of the\nsymptom or sign in the placebo-injected and the MMR vaccinated\ntwins.\nResults\nThe order in which the injections had been given seemed to\nhave no major effect on the reaction rates. Therefore the\nresults are presented only according to the type of\ninjection (MMR vaccine or placebo). Table I shows, for each\nsign and symptom, the maximum discordance rate between\nthe MMR and placebo groups and the day of peak frequency.\nThe most common adverse reaction was irritability; its\nmaximum discordance rate was 4 - 1 % on day 10. On the other\nhand, respiratory symptoms, nausea, and vomiting were less\ncommon in the MMR \nvaccinees than in the placebo-injected\nchildren. The only true rates which may have exceeded a\nmaximum of 6% were those for mild fever and irritability\ntable I). Tables II-v show that many of the symptoms and\nsigns observed in the vaccinated children were also common\nin the placebo group.", "mimetype": "text/plain", "start_char_idx": 9851, "end_char_idx": 11822, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "951f0630-346c-477a-8839-d22e3f35b9dd": {"__data__": {"id_": "951f0630-346c-477a-8839-d22e3f35b9dd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Peltola (1986).pdf", "node_type": "4", "metadata": {}, "hash": "2fa74cafac5f27950951b6fb25c5a1c4b45a6d10150b94440d0699187e473db2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d4412bd7-624d-457e-8d08-22cab9456a54", "node_type": "1", "metadata": {}, "hash": "520823407045ff3b12fd4677a36733ef24749a5564d3933e50b24592a84a4273", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7d3622bc-8e05-4894-a24f-16c109adc616", "node_type": "1", "metadata": {}, "hash": "04bd256322df62106eddf1d22cff38faa14f058c578406d0bc4b97a058763a9e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Tables II-v show that many of the symptoms and\nsigns observed in the vaccinated children were also common\nin the placebo group.\nFever (Table 11)\nThe vast majority of mild fever (up to 38\u20195&deg;C) episodes\nwere not due to the MMR vaccine, but high fever (above\n39\u2019 5&deg;C) was seldom caused by factors other than the MMR\nvaccine. A fever due to MMR vaccination usually occurred\nduring days 7-12, and high fever was most likely on days\n9-10. In the period of peak occurrence 88% of mild fever,\n24% of moderate fever, and 7% of high fever episodes were\nnot caused by the MMR vaccine.\nUnusual Behaviour (Table III)\nExcessive irritability, drowsiness, or willingness to stay in\nbed had similar time sequences. Virtually no differences were\nobserved between twins during the first 6 days, except that\nirritability and drowsiness were slightly more common in the\nplacebo-injected controls than in the MMR vaccinees. On\ndays 9-10, however, these signs were reported more often in\nthe MMR \nchildren (excess frequency up to 33 per 1000). The\nbehaviour of the two groups was again similar from day 13\nonwards.", "mimetype": "text/plain", "start_char_idx": 11695, "end_char_idx": 12794, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7d3622bc-8e05-4894-a24f-16c109adc616": {"__data__": {"id_": "7d3622bc-8e05-4894-a24f-16c109adc616", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Peltola (1986).pdf", "node_type": "4", "metadata": {}, "hash": "2fa74cafac5f27950951b6fb25c5a1c4b45a6d10150b94440d0699187e473db2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "951f0630-346c-477a-8839-d22e3f35b9dd", "node_type": "1", "metadata": {}, "hash": "ccb23fc1896186843d85b3c38174fe7e09972d656dfe2fb1504ef4b39d6514dc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "198d121c-5e10-443f-90b6-2c1093372c2b", "node_type": "1", "metadata": {}, "hash": "0271ecbc79900a5daad3bb2df88cbca20edcafc9b8ff1ba6906345a5458d2180", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\nbehaviour of the two groups was again similar from day 13\nonwards.\nMeasles Signs (Table IV)\nClassical signs of measles (generalised rash and\nconjunctivitis) affected the MMR group only during the\n941\nTABLE III-UNUSUAL BEHAVIOUR AFTER MMR VACCINATION\nOR PLACEBO INJECTION IN 581 TWIN PAIRS: MEAN NO OF CHILDREN\nAFFECTED PER DAY AND MEAN RATE PER 1000\nTABLE IV-RASH, CONJUNCTIVITIS, ARTHROPATHY, AND PERIPHERAL\nTREMOR AFTER MMR VACCINATION OR PLACEBO INJECTION IN 581\nTWIN PAIRS: MEAN NO OF CHILDREN AFFECTED PER DAY AND MEAN\nRATE PER 1000\nTABLE V-RESPIRATORY AND GASTROINTESTINAL SYMPTOMS OR SIGNS\nAFTER MMR VACCINATION OR PLACEBO INJECTION IN 581 TWIN PAIRS:\nMEAN NO OF CHILDREN AFFECTED PER DAY AND MEAN RATE PER 1000\nsecond week. The frequency of rash and eye irritation\nattributable to the MMR \nvaccine was, however, surprisingly\nsmall (maximum 17 per 1000). Arthropathy and peripheral\ntremor were both observed at a rate of less than 10 per 1000.\nRespiratory and Gastrointestinal Symptoms (Table v)\nThe most unexpected findings concerned respiratory\nsymptoms and, to a lesser extent, nausea and vomiting.\nDuring the first week cough and running nose were slightly\nmore common in the MMR vaccinees, but from day 9 these\nwere clearly more prevalent (12-13 per 1000) in the placebo-\ninjected controls. The difference was so consistent and large\nthat chance is unlikely. Nausea and vomiting, too, tended to\nbe as common in the placebo-injected children as in the\nMMR vaccinated children, but the numbers were small.\nDiscussion\nThe results of the present study show that adverse reactions\nto the widely used MMR \nvaccine are much less common than\nwas previously thought.", "mimetype": "text/plain", "start_char_idx": 12724, "end_char_idx": 14397, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "198d121c-5e10-443f-90b6-2c1093372c2b": {"__data__": {"id_": "198d121c-5e10-443f-90b6-2c1093372c2b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Peltola (1986).pdf", "node_type": "4", "metadata": {}, "hash": "2fa74cafac5f27950951b6fb25c5a1c4b45a6d10150b94440d0699187e473db2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7d3622bc-8e05-4894-a24f-16c109adc616", "node_type": "1", "metadata": {}, "hash": "04bd256322df62106eddf1d22cff38faa14f058c578406d0bc4b97a058763a9e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7c685245-867d-4240-8bc1-d3629544fc02", "node_type": "1", "metadata": {}, "hash": "f97e86233e872b54e0a32d6e156e867457dae5681df242baa76dce8d85c4904f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Discussion\nThe results of the present study show that adverse reactions\nto the widely used MMR \nvaccine are much less common than\nwas previously thought. A temporal association between\nvaccination and symptoms appearing in the following days or\nweeks does not necessarily imply a causal relationship, 3,15,16\nand the results of the preserit investigation further emphasise\nthe importance of studying a control group for comparison in\nestimating the frequencies of adverse reactions caused by\nvaccines. Little attention has been paid to the true\nreactogenicity of the MMR \nvaccine, although in the USA, for\ninstance, it is given routinely to almost every child. We are\naware of only one study that compared reactions in an MMR\nvaccinated group and a placebo group.3 The results are in\naccordance with those of our study; respiratory symptoms,\nfor example, were reported in 72% of vaccinees and 74% of\ncontrols.\nThe design of a twin study may reduce differences in\nbehavioural symptoms or signs within pairs. In our study it is\nlikely that irritability or willingness to stay in bed due to\nMMR \nvaccination was reflected in the behaviour of the other\ntwin too, especially in the youngest age groups. On the other\nhand, there are no grounds to suspect that reporting of clearly\nmeasurable events, such as fever, or skin, eye, or joint signs,\nor respiratory or gastrointestinal symptoms, would have been\nbiased.\nThe study was designed to explore relatively common\nsymptoms and signs occurring after the vaccination. The\nconfidence intervals show that our sample size has the power\nto detect adverse reactions attributable to the MMR \nvaccine\ndown to a frequency of 1-3%, depending on the background\nfrequency of that particular symptom or sign. The upper\nlimits of the intervals also show that no symptom or sign\naffected more than 6% of vaccinees (table i).\nRare reactions due to the MMR \nvaccine cannot be studied\nwith this small sample. We are, however, collecting data on\n500 000 vaccinees, which should reveal all essential compli-\ncations caused by this live vaccine.\nAt least two factors may explain the small difference\nbetween the vaccinated and placebo groups and the high\nfrequency of various \"reactions\" attributed to vaccinations in\ngeneral.", "mimetype": "text/plain", "start_char_idx": 14244, "end_char_idx": 16494, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7c685245-867d-4240-8bc1-d3629544fc02": {"__data__": {"id_": "7c685245-867d-4240-8bc1-d3629544fc02", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Peltola (1986).pdf", "node_type": "4", "metadata": {}, "hash": "2fa74cafac5f27950951b6fb25c5a1c4b45a6d10150b94440d0699187e473db2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "198d121c-5e10-443f-90b6-2c1093372c2b", "node_type": "1", "metadata": {}, "hash": "0271ecbc79900a5daad3bb2df88cbca20edcafc9b8ff1ba6906345a5458d2180", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "95e1a054-f62e-49ca-8a8c-ee7a669b3d0a", "node_type": "1", "metadata": {}, "hash": "01fd30c67696779cd11a87c53fa1990f1778d601fbe0ce9916665e9374366622", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "At least two factors may explain the small difference\nbetween the vaccinated and placebo groups and the high\nfrequency of various \"reactions\" attributed to vaccinations in\ngeneral. Firstly, if a child has been immunised, the parents\nobserve him, intentionally or not, more closely than usual,\nand will tend to blame the vaccination for any signs or\nsymptoms. Secondly, acute infectious diseases are common\nin a normal, otherwise healthy child population. An\nepidemiological survey conducted among 7000 children\n942\nunder 16 years of age in Helsinki in 197817 showed that at any\ntime symptoms of common cold were found in 10% of the\nchildren, diarrhoea in 5-9% of the boys and 4-5% of the\ngirls, and otitis media in 5-9% of the boys and 2-3% of the\ngirls. Because most of the \"vaccination reactions\" are\nsymptoms and signs found also in the common infections-a\nfever being a classical example-the possibility of concurrent\ninfection is often ignored.\nRespiratory symptoms, nausea, and vomiting were more\ncommon in the controls than in the vaccinees from the second\nweek onwards, as though the MMR vaccine had had a\nprotective effect. In the early 1950s the combination of\nvaccinia and yellow-fever vaccines was found to reduce the\nfrequency of yellow-fever seroconversions,18 and the\ncombination of measles (with or without yellow fever) and\nsmallpox vaccines showed a similar effect.19 Production of\ninterferon in these circumstances might explain this\nfinding.3,2o Thus the MMR \nvaccine might, in fact, give some\ntransient protection against the common cold.\nThis study examined common reactions attributable to the\nMMR vaccine, but similar results might be obtained with\nother vaccines if studied under controlled conditions. Many\nvaccines may be safer than is at present recognised.\nWe thank Mr Pekka Pulkkinen for computer programming, Ms Laura\nKannas for clerical assistance, and the nurses and parents who took part in this\nstudy for their cooperation.\nCorrespondence should be addressed to H. P., National Public Health\nInstitute, Salus Hospital, Mannerheimintie 166, SF-00280 Helsinki, Finland.\nREFERENCES\n1.", "mimetype": "text/plain", "start_char_idx": 16314, "end_char_idx": 18430, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "95e1a054-f62e-49ca-8a8c-ee7a669b3d0a": {"__data__": {"id_": "95e1a054-f62e-49ca-8a8c-ee7a669b3d0a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Peltola (1986).pdf", "node_type": "4", "metadata": {}, "hash": "2fa74cafac5f27950951b6fb25c5a1c4b45a6d10150b94440d0699187e473db2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7c685245-867d-4240-8bc1-d3629544fc02", "node_type": "1", "metadata": {}, "hash": "f97e86233e872b54e0a32d6e156e867457dae5681df242baa76dce8d85c4904f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a516b913-d062-4c22-838f-41a75bf41b11", "node_type": "1", "metadata": {}, "hash": "c92f03ffc03019d8b0162567704ebe2d257d553d9fc367b412ce610c02554b94", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Correspondence should be addressed to H. P., National Public Health\nInstitute, Salus Hospital, Mannerheimintie 166, SF-00280 Helsinki, Finland.\nREFERENCES\n1. Peltola H, Karanko V, Kurki T, Hukkanen V, Virtanen M, Nissinen M, Penttinen K,\nHeinonen OP. Rapid effect on endemic measles, mumps, and rubella of nationwide\nvaccination programme in Finland. Lancet 1986; i: 137-39.\n2. Weibel RE, Carlson AJ Jr, Villarejos VM, Buynak EB, McLean AA, Hilleman MR.\nClinical and laboratory studies on combined live measles, mumps, and rubella\nvaccinees using the RA 27/3 rubella virus (40979). Proc Soc Exp Biol Med 1980; 165:\n323-26.\n3. Lerman SJ, Bollinger M, Brunken JM. Clinical and serological evaluation of measles,\nmumps, and rubella (HPV-77: DE-5 and RA 27/3) virus vaccines, singly and in\ncombination. Pediatrics 1981; 68: 18-22.\n4. Christenson B, B&ouml;ttiger M, Heller L. Mass vaccination programme aimed at\neradicating measles, mumps, and rubella in Sweden: first experience. Br Med J\n1983; 287: 389-91.\n5. Vesikari T, Ala-Laurila E-L, Heikkinen A, Terho A, D\u2019Hondt E, Andre FE. Clinical\ntrial of a new trivalent measles-mumps-rubella vaccine in young children. Am J Dis\nChild 1984; 138: 843-47.\n6. Landrigan PJ, Witte JJ. Neurologic disorders following live measles vaccination.\nJAMA 1973; 223: 1459-62.\n7. Aukrust L, Almeland TL, Rafsum D, Aas K. Severe hypersensitivity or intolerance\nreactions to measles vaccine in six children. Clinical and immunological studies.\nAllergy 1980; 35: 581-87.\n8.", "mimetype": "text/plain", "start_char_idx": 18273, "end_char_idx": 19772, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a516b913-d062-4c22-838f-41a75bf41b11": {"__data__": {"id_": "a516b913-d062-4c22-838f-41a75bf41b11", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Peltola (1986).pdf", "node_type": "4", "metadata": {}, "hash": "2fa74cafac5f27950951b6fb25c5a1c4b45a6d10150b94440d0699187e473db2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "95e1a054-f62e-49ca-8a8c-ee7a669b3d0a", "node_type": "1", "metadata": {}, "hash": "01fd30c67696779cd11a87c53fa1990f1778d601fbe0ce9916665e9374366622", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "96a56b84-cc59-468a-abdc-0addbcdd3a65", "node_type": "1", "metadata": {}, "hash": "3675f3eb0d895edfeae623103a177bfe656c36fd9aef26b05c7b954e34e53941", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Clinical and immunological studies.\nAllergy 1980; 35: 581-87.\n8. Herman JJ, Radm R, Schneiderman R. Allergic reactions to measles (rubeola) vaccine\nin patients hypersensitive to egg protein. J Pediatr 1983; 102: 196-99.\n9. Pollock TM, Morris J. A 7-year survey of disorders attributed to vaccination in North\nWest Thames region. Lancet 1983; i: 753-57.\n10. Spruance SL, Smith CB. Joint complications associated with derivatives of HPV-77\nrubella virus vaccine. Am J Dis Child 1971; 122: 105-11.\n11. Judelsohn RG, Wyll SA. Rubella in Bermuda. Termination of an epidemic by mass\nvaccination. JAMA 1973; 223: 401-06.\n12. Hilleman MR, Buynak EB, Weibel RE, Stokes J Jr. Live, attenuated mumps-virus\nvaccine. N Engl J Med 1968; 278: 227-32.\n13. Hayden GF, Preblud SR, Orenstein WA, Condrad JL. Current status of mumps and\nmumps vaccine in the United States. Pediatrics 1978; 62: 965-69.\n14. Immunization Practices Advisory Committee. Mumps vaccine. Morbid Mortal Wkly\nRep 1982; 31: 617-23.\n15. Visakorpi R, Helve A, Koli T. Vihurirokkorokotuksen aiheuttamat rokotusreaktiot\n(Reactions caused by the rubella vaccine). Hallinto ja terveys 1975; No 5: 307-08.\n16. Centers for Disease Control. Measles vaccination reactions among college\nstudents-North Carolina, Massachusetts. Morbid Mortal Wkly Rep 1980; 29:\n549-51.\n17. Peltola H. Observations on the seasonal variation of the most common acute pediatric\ndiseases in the Helsinki area (Finland). J Comm Hlth 1982; 7: 159-70.\n18.", "mimetype": "text/plain", "start_char_idx": 19708, "end_char_idx": 21180, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "96a56b84-cc59-468a-abdc-0addbcdd3a65": {"__data__": {"id_": "96a56b84-cc59-468a-abdc-0addbcdd3a65", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Peltola (1986).pdf", "node_type": "4", "metadata": {}, "hash": "2fa74cafac5f27950951b6fb25c5a1c4b45a6d10150b94440d0699187e473db2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a516b913-d062-4c22-838f-41a75bf41b11", "node_type": "1", "metadata": {}, "hash": "c92f03ffc03019d8b0162567704ebe2d257d553d9fc367b412ce610c02554b94", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b003ffa2-4983-444c-8898-461367faf906", "node_type": "1", "metadata": {}, "hash": "deef92c3c5c2b5f269716de24620ded9536c4c3a4f243bbc40dcf72ad7a46e1e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Peltola H. Observations on the seasonal variation of the most common acute pediatric\ndiseases in the Helsinki area (Finland). J Comm Hlth 1982; 7: 159-70.\n18. Dick GWA, Horgan ES Vaccination by scarification with a combined 17D yellow fever\nand vaccinia vaccine. J Hyg 1952; 50: 376-82.\n19. Meyer HM, Hopps HE, Bernheim BC. Combined measles-smallpox and other\nvaccines. In: First international conference on vaccines against viral and rickettsial\ndiseases of man. PAHO scient publ no 147. Washington, DC: PAHO, 1967:\n336-42.\n20. Petralli JK, Merigan TC, Wilbur JR. Action of endogenous interferon against vaccinia\ninfection in children. Lancet 1965; ii: 401-05.\nNOCTURNAL ADRENAL SUPPRESSION IN\nASTHMATIC CHILDREN TAKING INHALED\nBECLOMETHASONE DIPROPIONATE\nC. M. LAW1,2\nJ. W. HONOUR3\nJ. L. MARCHANT2\nM. A. PREECE1\nJ. O. WARNER2\nInstitute of Child Health, University of London;1 Brompton\nHospital, London SW3;2 and Middlesex Hospital, London W13\nSummary \nPlasma cortisol was measured every 20 min\nand sleep was monitored in nineteen\nasthmatic children, twelve of whom were receiving various\ndoses of inhaled beclomethasone dipropionate (BDP).\nChildren receiving inhaled BDP had lower cortisol secretion\nduring the night than those who were not taking inhaled\nBDP, a delayed rise from the nocturnal nadir, and low early\nmorning levels. Inhaled BDP produces a dose-dependent\nadrenal suppression.", "mimetype": "text/plain", "start_char_idx": 21022, "end_char_idx": 22414, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b003ffa2-4983-444c-8898-461367faf906": {"__data__": {"id_": "b003ffa2-4983-444c-8898-461367faf906", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Peltola (1986).pdf", "node_type": "4", "metadata": {}, "hash": "2fa74cafac5f27950951b6fb25c5a1c4b45a6d10150b94440d0699187e473db2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "96a56b84-cc59-468a-abdc-0addbcdd3a65", "node_type": "1", "metadata": {}, "hash": "3675f3eb0d895edfeae623103a177bfe656c36fd9aef26b05c7b954e34e53941", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1c3bcf3b-99f1-40ec-a3af-3f7a1dc8fabf", "node_type": "1", "metadata": {}, "hash": "d832ceda6914219e81b64e629c7dd6d258e532214123cdbffa8de9b344beb1d0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Inhaled BDP produces a dose-dependent\nadrenal suppression.\nIntroduction\nTHE introduction in 1972 of inhaled corticosteroids in the\ntreatment of asthma was seen as an important advance,\u2019 since\nthey had the potential to replace oral corticosteroids of which\nthe side-effects include adrenal suppression and extend in\nchildren to permanent stunting of growth.2,3 Subsequent\nstudies on inhaled corticosteroids have been divided on the\noccurrence of adrenal suppression, some finding non&eacute; 12 and\nothers that it occurs at high doses.l3-1\u2019 Many of these studies\nused non-physiological measurements of the pituitary/\nadrenal axis (eg, tetracosactrin or insulin tolerance test) or\nsingle plasma cortisol measurements, which are difficult to\ninterpret in the face of a broad normal range.\nWhile studying the causes of growth delay in asthma, we\nhad the opportunity to measure nocturnal plasma cortisol\nconcentrations in small blood samples taken regularly\nthroughout the night under optimum sleep laboratory\nconditions; we now report our findings using these\nmeasurements to assess adrenal function.\nPatients and Methods\nNineteen asthmatic children (fourteen male, five female) took part\nin a study to investigate the pathophysiology of growth delay in\nasthma. They were aged 10-15 years (mean 13 - 5; bone age\n8,1-14,9 \"years\", mean 12\u20193). Twelve were taking inhaled\nbeclomethasone dipropionate (BDP) as part of their anti-asthma\ntherapy, 300-1000 ug daily (mean 530&plusmn;220 ug) divided into 2-4\ndoses (mean 2 - .4&plusmn;0 7 doses per day); seven were taking no inhaled\ncorticosteroids. No patients were taking oral corticosteroids\nregularly but three had had one or more short courses (<7 \ndays) for\nan acute asthmatic attack in the previous year but not within the\npreceding 3 months. In twelve patients there had been no change in\ninhaled steroid therapy for at least a year. Of those whose therapy\nhad changed, only two had previously been on a higher dose.", "mimetype": "text/plain", "start_char_idx": 22356, "end_char_idx": 24319, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1c3bcf3b-99f1-40ec-a3af-3f7a1dc8fabf": {"__data__": {"id_": "1c3bcf3b-99f1-40ec-a3af-3f7a1dc8fabf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Peltola (1986).pdf", "node_type": "4", "metadata": {}, "hash": "2fa74cafac5f27950951b6fb25c5a1c4b45a6d10150b94440d0699187e473db2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b003ffa2-4983-444c-8898-461367faf906", "node_type": "1", "metadata": {}, "hash": "deef92c3c5c2b5f269716de24620ded9536c4c3a4f243bbc40dcf72ad7a46e1e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In twelve patients there had been no change in\ninhaled steroid therapy for at least a year. Of those whose therapy\nhad changed, only two had previously been on a higher dose.\nThe study took place over 48 h; it included monitoring of sleep,\nendocrinological profiles, and respiratory function throughout a\ntest (second) night. Care was taken to ensure that administration of\ndrugs, bedtime, meals, and so on, were as near to home conditions as\npossible. The patients spent one night accustoming themselves to\nthe sleep laboratory and the monitoring procedures. Between 1700\nh and 2000 h on the test day an indwelling intravenous cannula was\npositioned in a forearm or antecubital vein so that venous access\ncould be ensured during the night without disturbing the patient.\nBlood samples were taken every 20 min from midnight until 0600 h.\nSleep was monitored with an electroencephalograph and an electro-\noculograph by conventional methods. 18 Three measures of sleep\nadequacy were used: the sleep efficiency index (the ratio of the time", "mimetype": "text/plain", "start_char_idx": 24145, "end_char_idx": 25181, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1713277e-c4a7-444e-b04e-627280a8395d": {"__data__": {"id_": "1713277e-c4a7-444e-b04e-627280a8395d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Castilla-2 (2009).pdf", "node_type": "4", "metadata": {}, "hash": "a7926adb86f5ec7233916a8fa0b01e0cbf850e6e2076a072d766983cfd322e3c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "990b22cf-3e85-4b37-9e7e-512c1fefac6d", "node_type": "1", "metadata": {}, "hash": "cb631641c916250d87a83c0d8eed326778a8e763e4960dd168598b888f2eb669", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine 27 (2009) 2089\u20132093\nContents lists available at ScienceDirect\nVaccine\njournal homepage: www.elsevier.com/locate/vaccine\nEffectiveness of Jeryl Lynn-containing vaccine in Spanish children\nJes\u00fas Castilla a,b,\u2217, Manuel Garc\u00eda Cenoz a,b, Maite Arriazu a,b, Mirian Fern\u00e1ndez-Alonso c,\nV\u00edctor Mart\u00ednez-Artola d, Jaione Etxeberria a,b, F\u00e1tima Irisarri a,b, Aurelio Barricarte a,b\na Instituto de Salud P\u00fablica de Navarra, Pamplona, Spain\nb CIBER de Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), Spain\nc Cl\u00ednica Universitaria de Navarra, Pamplona, Spain\nd Hospital Virgen del Camino, Pamplona, Spain\na r t i c l e\ni n f o\nArticle history:\nReceived 23 December 2008\nReceived in revised form 23 January 2009\nAccepted 2 February 2009\nAvailable online 12 February 2009\nKeywords:\nMumps\nVaccine\nCase\u2013control study\nEffectiveness\nWaning of immunity\nChildhood\na b s t r a c t\nWe evaluated the effectiveness of the Jeryl Lynn strain vaccine in a large outbreak of mumps in Navarre,\nSpain, 2006\u20132008. Each of the 241 cases of mumps occurring in children over 15 months of age born\nbetween 1998 and 2005 was compared with 5 controls individually matched by sex, birth date, district of\nresidence and paediatrician. Vaccination history was obtained blindly from clinical records. Conditional\nlogistic regression was used to obtain the matched odds ratios (ORs), and effectiveness was calculated\nas 1 \u2212OR. Some 70% of cases had received one dose of measles\u2013mumps\u2013rubella vaccine, and 24% had\nreceived two doses. Overall vaccine effectiveness was 72% (95% CI, 39\u201387%). Two doses were more effective\n(83%; 54\u201394%) than a single dose (66%; 25\u201385%).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1626, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "990b22cf-3e85-4b37-9e7e-512c1fefac6d": {"__data__": {"id_": "990b22cf-3e85-4b37-9e7e-512c1fefac6d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Castilla-2 (2009).pdf", "node_type": "4", "metadata": {}, "hash": "a7926adb86f5ec7233916a8fa0b01e0cbf850e6e2076a072d766983cfd322e3c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1713277e-c4a7-444e-b04e-627280a8395d", "node_type": "1", "metadata": {}, "hash": "9b7664706a67ab460bb11dd14b58d8bcaf99f626e9c6007246a960c302da8085", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "26e555cc-405f-4ba3-828a-851efb4a4038", "node_type": "1", "metadata": {}, "hash": "011026f7b21c88cdbfa38f314be4ee9b04525c9586c95960dad7e7d89a1d60ee", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Overall vaccine effectiveness was 72% (95% CI, 39\u201387%). Two doses were more effective\n(83%; 54\u201394%) than a single dose (66%; 25\u201385%). Among vaccinated children, risk was higher in those\nwho had received the \ufb01rst dose after 36 months of age (OR = 3.1; 1.2\u20138.4) and those who had received the\nsecond dose 3 or more years before study enrolment (OR = 10.2; 1.5\u201370.7). Early waning of immunity in\nchildren after the second dose may contribute to reduced vaccine effectiveness for mumps prevention.\n\u00a9 2009 Elsevier Ltd. All rights reserved.\n1. Introduction\nThe existence of an effective vaccine against mumps has led\nsome countries to propose the objective of eliminating or con-\ntrolling this disease [1,2]. Initially, mumps outbreaks were related\nwith failures in vaccination coverage [3]. However, some areas with\nhigh coverage with two doses of trivalent measles\u2013mumps\u2013rubella\n(MMR) vaccine have also experienced mumps outbreaks affecting\nboth vaccinated and unvaccinated children and young adults [4\u20136].\nIn evaluations of mumps vaccine in outbreak settings, the mean\neffectiveness has been estimated as 77% (range 61\u201391%), lower than\nthe ef\ufb01cacy estimated in experimental studies [7]. Waning immu-\nnity could be one reason for this limited effectiveness, and may\nexplain the emergence of mumps outbreaks in older vaccinated\npopulations [8\u201310].\nMumps outbreaks have occurred in various regions of Spain\nbetween 2006 and 2008, affecting a substantial number of vacci-\nnated persons, with predominance of the G1 genotype [11,12]. In the\nregion of Navarre, with over 95% vaccination coverage in the pop-\nulation born since 1980 and hardly any mumps virus in circulation\nsince 1993, a widespread outbreak resulting in some 3000 cases\n\u2217Corresponding author at: Instituto de Salud P\u00fablica de Navarra, Leyre 15, 31003\nPamplona, Navarra, Spain. Tel.: +34 848 421477; fax: +34 848 423474.", "mimetype": "text/plain", "start_char_idx": 1493, "end_char_idx": 3371, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "26e555cc-405f-4ba3-828a-851efb4a4038": {"__data__": {"id_": "26e555cc-405f-4ba3-828a-851efb4a4038", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Castilla-2 (2009).pdf", "node_type": "4", "metadata": {}, "hash": "a7926adb86f5ec7233916a8fa0b01e0cbf850e6e2076a072d766983cfd322e3c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "990b22cf-3e85-4b37-9e7e-512c1fefac6d", "node_type": "1", "metadata": {}, "hash": "cb631641c916250d87a83c0d8eed326778a8e763e4960dd168598b888f2eb669", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "62133204-8ef2-4376-a21d-8b062ff05286", "node_type": "1", "metadata": {}, "hash": "9325baae607b211d8ac0c87ed4c5dbcf959419a4bfdf733da5f637671563332b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Tel.: +34 848 421477; fax: +34 848 423474.\nE-mail address: jcastilc@navarra.es (J. Castilla).\nof mumps occurred between August 2006 and June 2008. In the\ncontext of this population-based outbreak, we evaluated the effec-\ntiveness of the vaccine containing the Jeryl Lynn strain in preventing\nmumps cases in children and investigated the possible existence of\nwaning immunity.\n2. Materials and methods\n2.1. Study setting\nThis study used various sources of health information covering a\npopulation of some 600,000 persons in Navarre. The trivalent MMR\nvaccine is included in the childhood immunization schedule and\nhas been covered by public \ufb01nancing since 1982. The schedule calls\nfor one dose of vaccine at 15 months of age and a second dose, which\nwas initially given at 11 years of age and was subsequently moved\nup to 6 years of age in 1999 and to 3 years of age in 2007, with the\nobjective of eliminating measles. In the cohorts born since 1998,\nonly MMR vaccine containing the Jeryl Lynn strain has been used.\nThe vaccine doses given are recorded on the child\u2019s vaccination card,\nin the primary care clinical record, and in the regional vaccination\nregistry.\nMumps is a noti\ufb01able disease in Navarre, and both clinically\nsuspected and laboratory-con\ufb01rmed cases are routinely reported\nthrough a computerized information system to regional health\nauthorities. Cases are considered clinically compatible if there is\n0264-410X/$ \u2013 see front matter \u00a9 2009 Elsevier Ltd. All rights reserved.\ndoi:10.1016/j.vaccine.2009.02.001\n2090\nJ. Castilla et al. / Vaccine 27 (2009) 2089\u20132093\nTable 1\nCharacteristics of mumps cases according to measles\u2013mumps\u2013rubella vaccination\nstatus.", "mimetype": "text/plain", "start_char_idx": 3329, "end_char_idx": 5000, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "62133204-8ef2-4376-a21d-8b062ff05286": {"__data__": {"id_": "62133204-8ef2-4376-a21d-8b062ff05286", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Castilla-2 (2009).pdf", "node_type": "4", "metadata": {}, "hash": "a7926adb86f5ec7233916a8fa0b01e0cbf850e6e2076a072d766983cfd322e3c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "26e555cc-405f-4ba3-828a-851efb4a4038", "node_type": "1", "metadata": {}, "hash": "011026f7b21c88cdbfa38f314be4ee9b04525c9586c95960dad7e7d89a1d60ee", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b9a2b559-f1e8-422e-88b2-9afc7b26ef5d", "node_type": "1", "metadata": {}, "hash": "dbb6baaf90f3b65fd91c3cdfc6806a4011d6d46e92537d8d110371d2563a8202", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "/ Vaccine 27 (2009) 2089\u20132093\nTable 1\nCharacteristics of mumps cases according to measles\u2013mumps\u2013rubella vaccination\nstatus.\nNon-vaccinated\nOne dose\nTwo doses\nTotal\nN (%)\nN (%)\nN (%)\nN\nSex\nMale\n10 (9)\n79 (68)\n27 (23)\n116\nFemale\n3 (2)\n90 (72)\n32 (26)\n125\nAge, years\n1\u20133\n5 (8)\n54 (90)\n1 (2)\n60\n4\u20136\n6 (5)\n109 (85)\n13 (10)\n128\n7\u201310\n2 (4)\n6 (11)\n45 (85)\n53\nResidence in the capital city\n8 (5)\n112 (74)\n32 (21)\n152\nViral isolate by culture\n1 (11)\n8 (89)\n0\n9\nSerology result\nIgM+\n2 (20)\n6 (60)\n2 (20)\n10\nIgM\u2212/IgG+\n0 (0)\n21 (66)\n12 (34)\n33\nTotal\n13 (5)\n169 (70)\n59 (24)\n241\nswelling of one or more salivary glands lasting at least 2 days.\nCon\ufb01rmation is made by virus isolation, by detection of RNA by\npolymerase chain reaction (PCR), or by elevated speci\ufb01c IgM. Cases\nepidemiologically linked with another clinical case of mumps are\nalso considered con\ufb01rmed [13].\nBetween August 2006 and June 2008 an extensive outbreak of\nmumps occurred in Navarre, with some 3000 cases and an attack\nrate of 1% of the population under 30 years of age. The highest\nincidence was reported in young adults aged 19 years, although\ncases occurred in all ages. About 14% of the cases were con\ufb01rmed\nby laboratory. The seven strains processed in the National Refer-\nence Laboratory belonged to genotype G1. The highest incidence\nwas registered in adolescent cohorts vaccinated with the Rubini\nstrain, but incidences were also high in the cohort vaccinated with\nthe Jeryl Lynn strain [14].\n2.2.", "mimetype": "text/plain", "start_char_idx": 4877, "end_char_idx": 6339, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b9a2b559-f1e8-422e-88b2-9afc7b26ef5d": {"__data__": {"id_": "b9a2b559-f1e8-422e-88b2-9afc7b26ef5d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Castilla-2 (2009).pdf", "node_type": "4", "metadata": {}, "hash": "a7926adb86f5ec7233916a8fa0b01e0cbf850e6e2076a072d766983cfd322e3c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "62133204-8ef2-4376-a21d-8b062ff05286", "node_type": "1", "metadata": {}, "hash": "9325baae607b211d8ac0c87ed4c5dbcf959419a4bfdf733da5f637671563332b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e13c1e0b-95f1-4736-be2e-f067dfc27676", "node_type": "1", "metadata": {}, "hash": "8939d8f185b5cad81f8cb3652a9ac808010f59143266e2faa3153c784c990476", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The highest incidence\nwas registered in adolescent cohorts vaccinated with the Rubini\nstrain, but incidences were also high in the cohort vaccinated with\nthe Jeryl Lynn strain [14].\n2.2. Information sources and study design\nTo assess the effectiveness of this vaccine, we designed an indi-\nvidually matched case\u2013control study. The cases were all children\nresiding in Navarre born between 1998 and 2005 who had a diag-\nnosis of mumps con\ufb01rmed microbiologically or epidemiologically\nbetween August 2006 and June 2008. Cases occurring before age 15\nmonths were excluded, as were those whose paediatrician could\nnot be identi\ufb01ed. For each case, 5 individually matched controls\nwere selected among children with the same sex, municipality, dis-\ntrict of residence and paediatrician. Matching was performed by\nselecting controls with the closest birth date within the same cal-\nendar semester to the corresponding case. We excluded as controls\nthose children who had been diagnosed with mumps before the\ndate the case was diagnosed or who had not ful\ufb01lled all the pairing\ncriteria since the beginning of 2006; these children were replaced\nwith the next child who met the inclusion criteria.\n2.3. Vaccine status assessment\nThe number of doses and dates of vaccination of cases and con-\ntrols were ascertained in a blinded review of the primary care\nvaccination registry. In the event that an age-appropriate vaccina-\ntion was missing without documentation of the reason, the parents\nwere contacted by phone to con\ufb01rm this information and check it\nagainst the vaccination card. For both cases and controls, vaccina-\ntion with strains other than Jeryl Lynn was ruled out. Some children\nwith severe allergy to eggs had received the vaccine obtained in\ncell cultures that included measles and rubella, but not mumps\n(MoruviratenTM), therefore these doses were not considered for the\npurpose of mumps vaccination. We considered only doses admin-\nistered up to 30 days before the date of symptom onset in the\ncorresponding case.\nThe Ethics Committee of the Health Department of Navarre\napproved the protocol of this study.\n2.4.", "mimetype": "text/plain", "start_char_idx": 6153, "end_char_idx": 8267, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e13c1e0b-95f1-4736-be2e-f067dfc27676": {"__data__": {"id_": "e13c1e0b-95f1-4736-be2e-f067dfc27676", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Castilla-2 (2009).pdf", "node_type": "4", "metadata": {}, "hash": "a7926adb86f5ec7233916a8fa0b01e0cbf850e6e2076a072d766983cfd322e3c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b9a2b559-f1e8-422e-88b2-9afc7b26ef5d", "node_type": "1", "metadata": {}, "hash": "dbb6baaf90f3b65fd91c3cdfc6806a4011d6d46e92537d8d110371d2563a8202", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "65bc5800-4a90-4307-a91f-bf26eabde2d6", "node_type": "1", "metadata": {}, "hash": "50aad6aa288e14f5ff2b52ae0586ab39de321ef11bda16a9833bcfeca4697fc1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The Ethics Committee of the Health Department of Navarre\napproved the protocol of this study.\n2.4. Statistical analysis\nWe \ufb01rst compared all cases with their respective controls to esti-\nmate the effectiveness of one or two doses of vaccine in preventing\nmumps. Vaccinated cases were compared with theirrespectivecon-\ntrols who had also been vaccinated to evaluate the effect of the\nsecond dose and the effect of the time of administration of the \ufb01rst\ndose in preventing mumps. Finally, cases who had received two\ndoses of vaccine were compared with their respective controls who\nhad also been vaccinated with two doses to determine the in\ufb02uence\nof the time since application of the last vaccine dose on the risk of\ndisease.\nUnmatched dichotomous variables were compared by \u00022 or\nFisher\u2019s exact tests, and continuous variables by Wilcoxon\u2019s test.\nMatched odds ratios (ORs) for vaccination, with their 95% con-\n\ufb01dence intervals (CIs), were calculated with conditional logistic\nregression. Vaccine effectiveness was calculated as 1 minus the\nmatched odds ratio. We set the level of signi\ufb01cance as two-sided\nP < 0.05.\n3. Results\n3.1. Characteristics of cases and controls\nOf the 251 cases of mumps con\ufb01rmed in children born since\n1998, we excluded 6 who had not reached 15 months of age and\n4 whose paediatrician in Navarre could not be identi\ufb01ed. Of the\n241 cases analysed, 48% were males and 63% resided in the capital\ncity. The median age of cases at time of diagnosis was 64 months,\nranging from 16 to 124 months. Some 5.4% (13 cases) were not vac-\ncinated, 70.1% (169 cases) had received one dose of MMR vaccine,\nand 24.5% (59 cases) had received two doses. The vaccinated chil-\ndren had received the \ufb01rst dose between 11 and 72 months of age,\nwith a median of 15 months, and the second dose between 37 and\n88 months of age, with a median of 77 months.", "mimetype": "text/plain", "start_char_idx": 8169, "end_char_idx": 10023, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "65bc5800-4a90-4307-a91f-bf26eabde2d6": {"__data__": {"id_": "65bc5800-4a90-4307-a91f-bf26eabde2d6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Castilla-2 (2009).pdf", "node_type": "4", "metadata": {}, "hash": "a7926adb86f5ec7233916a8fa0b01e0cbf850e6e2076a072d766983cfd322e3c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e13c1e0b-95f1-4736-be2e-f067dfc27676", "node_type": "1", "metadata": {}, "hash": "8939d8f185b5cad81f8cb3652a9ac808010f59143266e2faa3153c784c990476", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "73a5fc3e-e278-445c-84a9-7e942faf63a3", "node_type": "1", "metadata": {}, "hash": "1e8a2e2d83c05d71ff6ca8dc93197ec1398c3234435558a091918d7461cce710", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Table 2\nEstimates of effectiveness of the MMR vaccine for mumps prevention. Conditional logistic regression analysis.\nCases/controls\nVaccine effectiveness (%)\n95% con\ufb01dence interval\nP-value\nModel 1\nNon-vaccinated\n13/23\nVaccinated\n228/1182\n72\n39\u201387\n0.0013\nModel 2\nNon-vaccinated\n13/23\n1 dose\n169/852\n66\n25\u201385\n0.0075\n2 doses\n59/330\n83\n54\u201394\n0.0005\nJ. Castilla et al. / Vaccine 27 (2009) 2089\u20132093\n2091\nTable 3\nEffect of number of doses and age at \ufb01rst dose on risk of mumps among children vaccinated with any dose of measles\u2013mumps\u2013rubella vaccine. Multivariate conditional\nlogistic regression analysis.\nCases/controls\nMatched odds ratio\n95% con\ufb01dence interval\nP-value\nDoses of vaccine\n1\n169/809\n1\n2\n59/314\n0.51\n0.20\u20131.27\n0.1463\nAge at \ufb01rst dose, in months\n<14\n9/25\n1.98\n0.91\u20134.29\n0.0845\n14\u201335\n212/1087\n1\n\u226536\n7/11\n3.11\n1.15\u20138.43\n0.0254\nNine cases were con\ufb01rmed by virus isolation, another 10 by\npositive IgM, 7 by epidemiologic relation with another laboratory-\ncon\ufb01rmed case, and all the rest, by epidemiologic relation with\nother cases with a clinical diagnosis of mumps (Table 1). Thirty-\nthree cases had positive IgG and negative IgM, although this was not\nconsidered a con\ufb01rmation criterion. About 84% of the laboratory-\ncon\ufb01rmed cases were vaccinated and 11% had received two doses.\nAmong the controls, 98.1% were vaccinated, and 95.7% of those\nolder than 6 years had received two doses of MMR vaccine.", "mimetype": "text/plain", "start_char_idx": 10024, "end_char_idx": 11429, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "73a5fc3e-e278-445c-84a9-7e942faf63a3": {"__data__": {"id_": "73a5fc3e-e278-445c-84a9-7e942faf63a3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Castilla-2 (2009).pdf", "node_type": "4", "metadata": {}, "hash": "a7926adb86f5ec7233916a8fa0b01e0cbf850e6e2076a072d766983cfd322e3c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "65bc5800-4a90-4307-a91f-bf26eabde2d6", "node_type": "1", "metadata": {}, "hash": "50aad6aa288e14f5ff2b52ae0586ab39de321ef11bda16a9833bcfeca4697fc1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0e7810e8-171c-4d22-aec7-e76c28b43865", "node_type": "1", "metadata": {}, "hash": "a65b2b12d2c53ecdf04e53a1ec23349ef4dbc41e86861817185967b8ccbc7974", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Among the controls, 98.1% were vaccinated, and 95.7% of those\nolder than 6 years had received two doses of MMR vaccine.\nThe unmatched comparison of cases and controls showed a\nhigher percentage of non-vaccinated persons in the \ufb01rst group\n(5.4% vs. 1.9%, P = 0.005). The median age in vaccinated cases was\n15 months (range 11\u201372) at the \ufb01rst dose and 77 months (range\n37\u201388) at the second dose. Vaccinated cases and controls did not\ndiffer in the age at which they received each dose.\n3.2. Effectiveness of the vaccine\nTable 2 shows the results of the conditional logistic regression\nanalysis. The effectiveness of having received any dose of MMR vac-\ncine was 72% (95% CI, 39\u201387%). The effectiveness of two doses of\nvaccine reached 83% (95% CI, 54\u201394%), and that of one dose was\n66% (95% CI, 25\u201385%).\nThe analysis limited only to those children who had received\nany dose of MMR vaccine showed that the second dose provided a\nnon-statistically signi\ufb01cant additional protection of 49% compared\nto those who had only one dose. Administration of the \ufb01rst dose\nbefore 14 months or after 36 months of age was associated with a\nhigher risk of mumps compared to those who had been vaccinated\nwithin this age interval, although the risk reached statistical signif-\nicance only in the latter age group (OR = 1.98; 95% CI 0.91\u20134.29 and\nOR = 3.11; 95% CI 1.15\u20138.43, respectively) (Table 3). In 57% of cases\nand 56% of controls who received the \ufb01rst dose after 36 months\nof age the MMR vaccine had been co-administered with other vac-\ncines.\nThe analysis limited only to children vaccinated with two doses\nshowed that the risk of mumps was higher with increasing time\nsince the last dose of MMR vaccine (Table 4).", "mimetype": "text/plain", "start_char_idx": 11310, "end_char_idx": 13010, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0e7810e8-171c-4d22-aec7-e76c28b43865": {"__data__": {"id_": "0e7810e8-171c-4d22-aec7-e76c28b43865", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Castilla-2 (2009).pdf", "node_type": "4", "metadata": {}, "hash": "a7926adb86f5ec7233916a8fa0b01e0cbf850e6e2076a072d766983cfd322e3c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "73a5fc3e-e278-445c-84a9-7e942faf63a3", "node_type": "1", "metadata": {}, "hash": "1e8a2e2d83c05d71ff6ca8dc93197ec1398c3234435558a091918d7461cce710", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d66ffa74-b647-4ce4-8314-76b59afb535f", "node_type": "1", "metadata": {}, "hash": "70948fc8dc95babfbc61ab54d16f99e551a24fa2c9327179ec3d7981af80ab07", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The analysis limited only to children vaccinated with two doses\nshowed that the risk of mumps was higher with increasing time\nsince the last dose of MMR vaccine (Table 4). Those who had\nreceived the second dose 3 or more years before study enrolment\nhad a higher risk of mumps than those who had received the second\ndose within the last 3 years (OR = 10.19; 95% CI 1.47\u201370.73). Another\nwell-adjusted model was obtained using the square of time since\nthe second dose, in years, as a continuous variable (OR per square\nyear 1.22; 95% CI 1.02\u20131.46).\n4. Discussion\nIn children age 1\u201310 years we found the MMR vaccine contain-\ning the Jeryl Lynn strain to be 72% effective in preventing cases of\nmumps. The effectiveness was 66% for one dose and reached 83%\nafter the second dose. These results are similar to the ranges of effec-\ntiveness found in previous studies conducted in outbreak settings\n[8\u201310,14\u201316], although some of these studies analysed adolescents\nand young adults for whom the time since vaccination was much\nlonger. Since the birth of the study children, there had been scarcely\nany mumps virus in circulation in Navarre, therefore previous nat-\nural immunity or the booster of the vaccine effect by asymptomatic\ninfections was highly unlikely. Between August 2006 and July 2008\nthe virus came into general circulation, as shown by the fact that\n1% of the population under age 30 was affected despite high vacci-\nnation coverage. It can thus be af\ufb01rmed that a large portion of the\npopulation, including the controls, would probably also have been\nexposed to the infection during this outbreak.\nPossible explanations for the moderate effectiveness of the vac-\ncine are primary vaccine failure, loss of secondary effectiveness, and\ninfection by heterologous viruses [17\u201320].\nPrimary vaccine failure could be due to problems with vaccine\nconservation and to failure of the immune response. However, fol-\nlowing the guidelines for maintaining and managing the vaccine\ncold chain, when any relevant problem was detected all affected\ndoses were discarded [21].", "mimetype": "text/plain", "start_char_idx": 12839, "end_char_idx": 14905, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d66ffa74-b647-4ce4-8314-76b59afb535f": {"__data__": {"id_": "d66ffa74-b647-4ce4-8314-76b59afb535f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Castilla-2 (2009).pdf", "node_type": "4", "metadata": {}, "hash": "a7926adb86f5ec7233916a8fa0b01e0cbf850e6e2076a072d766983cfd322e3c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0e7810e8-171c-4d22-aec7-e76c28b43865", "node_type": "1", "metadata": {}, "hash": "a65b2b12d2c53ecdf04e53a1ec23349ef4dbc41e86861817185967b8ccbc7974", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eb3adba2-a092-488c-81d9-135b0e85e239", "node_type": "1", "metadata": {}, "hash": "3bef40536db522bc455424e147dbbc17bec85f2fc594363da476e0e66320023b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "However, fol-\nlowing the guidelines for maintaining and managing the vaccine\ncold chain, when any relevant problem was detected all affected\ndoses were discarded [21]. Furthermore, we did not \ufb01nd mumps\ncases to be especially concentrated in children vaccinated with a\nparticular batch, nor in those vaccinated at the same time and place.\nThe lower response in vaccinated children as a function of age, espe-\ncially before 12 months, has been described [17]. We found that\nadministration of the \ufb01rst dose of MMR vaccine after the third year\nof life was associated with lower protection. These late vaccinations\nsometimes occur when missed vaccinations are brought up to date,\na situation in which the MMR vaccine is frequently co-administered\nwith other vaccines. However, our results do not permit any con-\nclusion about the relation between simultaneous vaccination and\nloss of effectiveness.\nTable 4\nEffect of the time of administration of each dose on the risk of mumps among children vaccinated with two doses of measles\u2013mumps\u2013rubella vaccine. Multivariate conditional\nlogistic regression analysis.\nCases/controls\nMatched odds ratio\n95% con\ufb01dence interval\nP-value\nAge at \ufb01rst dose, in months\n<14\n3/9\n1.89\n0.47\u20137.64\n0.3710\n14\u201335\n54/262\n1\n\u226536\n2/3\n3.88\n0.63\u201324.01\n0.1452\nTime since second dose, in months\n<24\n42/206\n1\n24\u201335\n13/61\n2.00\n0.55\u20137.24\n0.2934\n\u226536\n4/7\n10.19\n1.47\u201370.73\n0.0189\n2092\nJ. Castilla et al. / Vaccine 27 (2009) 2089\u20132093\nConsistent with other studies, we found that vaccine effective-\nness was lower with increasing time since the last dose, which has\nbeen explained by waning immunity [9,10,18].", "mimetype": "text/plain", "start_char_idx": 14738, "end_char_idx": 16352, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "eb3adba2-a092-488c-81d9-135b0e85e239": {"__data__": {"id_": "eb3adba2-a092-488c-81d9-135b0e85e239", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Castilla-2 (2009).pdf", "node_type": "4", "metadata": {}, "hash": "a7926adb86f5ec7233916a8fa0b01e0cbf850e6e2076a072d766983cfd322e3c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d66ffa74-b647-4ce4-8314-76b59afb535f", "node_type": "1", "metadata": {}, "hash": "70948fc8dc95babfbc61ab54d16f99e551a24fa2c9327179ec3d7981af80ab07", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "840ab5e6-b14b-4134-ac9b-78b7c9f4bcd4", "node_type": "1", "metadata": {}, "hash": "08f7d330cb09107151017b4a0edefcecd64d62101316f66be6bbf393939ce5d4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "One study of mumps\nvaccine immunogenicity showed that a second dose of vaccine 4\u20135\nyears after the \ufb01rst dose at age 14\u201318 months increased seropositiv-\nity rates from 86% to 95%, but 9 years after the \ufb01rst vaccination, the\nseropositivity rate had returned to 86% [19]. In another study, 19%\nof children who had received one dose of vaccine had no detectable\nantibodies 4 years after vaccination [20]. Our results indicate that\nthis effect of waning immunity begins early, as seen in the fact that\n3 or more years after the second dose of MMR vaccine, the risk of\nmumps was 10 times higher. This increased risk does not appear to\nbe linear, but rather is accentuated over time. This effect may have\nfavoured the absence of a booster effect given the lack of circulating\nmumps virus during the lifetimes of these children. In view of these\nresults, moving the second MMR dose to 3 years of age, a strategy\ndesigned to strengthen measles elimination, could be detrimen-\ntal for mumps control given that there is no plan for a subsequent\nbooster dose and there are no natural booster infections.\nInfection by heterologous viruses facilitated by a genotype-\nspeci\ufb01c neutralising antibody response could be a cause of\nlower effectiveness [22]. Thus, mumps vaccine induced immu-\nnity (derived from genotype A virus) may be less effective against\ngenotype G, which was the cause of this outbreak [14]. However,\nthe vaccine effectiveness we found in an outbreak due to geno-\ntype G does not appear to differ substantially from that described\nin outbreaks caused by other genotypes, although our evaluation\nincluded children younger than those in most of the other studies\n[7].\nThe estimate of vaccine effectiveness in this observational study\nmay be subject to some limitations. Problems of comparability\nbetween the vaccinated and unvaccinated groups could bias the\nestimate of vaccine effectiveness downward when evaluating it in\nthe context of an outbreak [23].", "mimetype": "text/plain", "start_char_idx": 16353, "end_char_idx": 18308, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "840ab5e6-b14b-4134-ac9b-78b7c9f4bcd4": {"__data__": {"id_": "840ab5e6-b14b-4134-ac9b-78b7c9f4bcd4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Castilla-2 (2009).pdf", "node_type": "4", "metadata": {}, "hash": "a7926adb86f5ec7233916a8fa0b01e0cbf850e6e2076a072d766983cfd322e3c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eb3adba2-a092-488c-81d9-135b0e85e239", "node_type": "1", "metadata": {}, "hash": "3bef40536db522bc455424e147dbbc17bec85f2fc594363da476e0e66320023b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "50d58dea-e6d8-46d8-b1e5-cbe7f85f8ecd", "node_type": "1", "metadata": {}, "hash": "877d729c4ecb16dc9c088f9cabf328eb3c2e620016f7dc13493f077759cbaf12", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Problems of comparability\nbetween the vaccinated and unvaccinated groups could bias the\nestimate of vaccine effectiveness downward when evaluating it in\nthe context of an outbreak [23]. The selection of controls, paired\nby sex, year of birth, municipality, district of residence and paedi-\natrician, provides good comparability with the cases with regard\nto opportunities for vaccination, registering of the doses adminis-\ntered, probabilities of exposure to the virus, and access to disease\ndiagnosis. Unlike other outbreaks con\ufb01ned to a single study centre\nor residence, the controls may have had less exposure to infection\nthan the cases in this population-based outbreak. This would not\nbe a problem, however, so long as they accurately re\ufb02ect vacci-\nnation status in the population from which the cases were taken\n[24].\nWe included only clinical cases con\ufb01rmed by laboratory or by\na de\ufb01ned epidemiologic criterion [13], which makes classi\ufb01ca-\ntion bias with regard to diagnosis unlikely. Vaccination histories\nwere obtained blindly from documented clinical sources. When\nmumps vaccination was not documented in these sources, we\nchecked to con\ufb01rm that it had not been received and to deter-\nmine the reason why not; lack of data was not assumed to\nbe equivalent to non-vaccination. Vaccination coverage in both\ncases and controls was very high in accordance with the recom-\nmended schedule, which makes it unlikely that vaccine status was\nunderestimated.\n5. Conclusions\nThis study adds to the literature showing moderate effective-\nness of the mumps vaccine containing the Jeryl Lynn strain, which\nseems to be related with early and progressive waning immunity.\nThis effect, seen in children vaccinated with both one and two doses,\nmakes it dif\ufb01cult to control the disease even when high vaccination\ncoverage is achieved, and leaves open the possibility that outbreaks\nwill occur when the infection is reintroduced. Possible solutions\nto attain higher and more lasting levels of protection include the\ndevelopment of new vaccines, adding a third dose of MMR vac-\ncine [25] and exploring modi\ufb01cations to childhood immunization\nschedules to optimise the performance of the current vaccine for\nmumps control [26].", "mimetype": "text/plain", "start_char_idx": 18123, "end_char_idx": 20338, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "50d58dea-e6d8-46d8-b1e5-cbe7f85f8ecd": {"__data__": {"id_": "50d58dea-e6d8-46d8-b1e5-cbe7f85f8ecd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Castilla-2 (2009).pdf", "node_type": "4", "metadata": {}, "hash": "a7926adb86f5ec7233916a8fa0b01e0cbf850e6e2076a072d766983cfd322e3c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "840ab5e6-b14b-4134-ac9b-78b7c9f4bcd4", "node_type": "1", "metadata": {}, "hash": "08f7d330cb09107151017b4a0edefcecd64d62101316f66be6bbf393939ce5d4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cbe91ee3-f074-446c-b899-95c6c09c4e44", "node_type": "1", "metadata": {}, "hash": "d57932339a4338545dca802639493074f2e1a42adc77e470157af1844d7b3423", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Acknowledgements\nThis study was supported in part by the Plan Nacional de I+D+I\nthrough the Instituto de Salud Carlos III (FIS PI061346).\nReferences\n[1] Peltola H, Davidkin I, Paunio M, Valle M, Leinikki P, Heinonen OP. Mumps and\nrubella eliminated from Finland. JAMA 2000;284:2643\u20137.\n[2] Centers for Disease Control and Prevention. Measles, mumps, and rubella-\nvaccine use and strategies for elimination of measles, rubella, and congenital\nrubella syndrome and control of mumps: recommendations of Advisory\nCommittee on Immunization Practices (ACIP). MMWR 1998;47(RR-8):1\u2013\n57.\n[3] Savage E, Ramsay M, White J, Beard S, Lawson H, Hunjan R, et al. Mumps\noutbreaks across England and Wales in 2004: observational study. BMJ\n2005;330:1119\u201320.\n[4] Sartorius B, Penttinen P, Nilsson J, Johansen K, Jonsson K, Arneborn M,\net al. An outbreak of mumps in Sweden, February\u2013April 2004. Euro\nSurveill 2005;10:191\u20133, http://www.eurosurveillance.org/em/v10n09/1009-\n221.asp.\n[5] Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM,\net al. Recent resurgence of mumps in the United States. N Engl J Med\n2008;358:1580\u20139.\n[6] Hviid A, Rubin S, M\u00fchlemann K. Mumps. Lancet 2008;371:932\u201344.\n[7] Plotkin SA. Mumps vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. 4th\nedn. Philadelphia: WB Saunders; 2004. p. 452.", "mimetype": "text/plain", "start_char_idx": 20339, "end_char_idx": 21656, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cbe91ee3-f074-446c-b899-95c6c09c4e44": {"__data__": {"id_": "cbe91ee3-f074-446c-b899-95c6c09c4e44", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Castilla-2 (2009).pdf", "node_type": "4", "metadata": {}, "hash": "a7926adb86f5ec7233916a8fa0b01e0cbf850e6e2076a072d766983cfd322e3c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "50d58dea-e6d8-46d8-b1e5-cbe7f85f8ecd", "node_type": "1", "metadata": {}, "hash": "877d729c4ecb16dc9c088f9cabf328eb3c2e620016f7dc13493f077759cbaf12", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bef7fc85-5114-4702-b813-1335e852a846", "node_type": "1", "metadata": {}, "hash": "811b37e6c1ecfaf129e8dfeaba097b613bbb3806cbf1a7ec648036a524d6eff0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Mumps vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. 4th\nedn. Philadelphia: WB Saunders; 2004. p. 452.\n[8] Vandermeulen C, Roelants M, Vermoere M, Roseeuw K, Goubau P, Hoppen-\nbrouwers K. Outbreak of mumps in a vaccinated child population: a question\nof vaccine failure? Vaccine 2004;22:2713\u20136.\n[9] Briss PA, Fehrs LJ, Parker RA, Wright PF, Sannella EC, Hutcheson RH, et al. Sus-\ntained transmission of mumps in a highly vaccinated population: assessment\nof a primary vaccine failure and waning vaccine-induced immunity. J Infect Dis\n1994;169:77\u201382.\n[10] Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effec-\ntiveness estimates, 2004\u20132005 mumps outbreak, England. Emerg Infect Dis\n2007;13:12\u20137.\n[11] Centro Nacional de Epidemiolog\u00eda. Situaci\u00f3n de la parotiditis en Espa\u02dcna.\nMadrid:\nInstituto\nde\nSalud\nCarlos\nIII,\nJunio;\n2008.\nhttp://www.isciii.\nes/htdocs/centros/epidemiologia/epi vacunables.jsp.\n[12] Sanz JC, de Ory F, Fern\u00e1ndez M, Herranz N, M\u00e9ndez N, Ram\u00edrez R. Evoluci\u00f3n\nde los casos de parotiditis con\ufb01rmados serol\u00f3gicamente en las Comunidad\nde Madrid durante un periodo de 7 a\u02dcnos (2000\u20132006). Med Clin (Barc)\n2008;130:292\u20134.\n[13] Centers for Disease Control. Case de\ufb01nitions for infectious conditions under\npublic health surveillance. MMWR 1997;46(RR-10):1\u201358.\n[14] Castilla J, Garc\u00eda Cenoz M, Irisarri F, N\u00fa\u02dcnez-C\u00f3rdoba JM, Barricarte A.\nMumps\noutbreak\nin\nNavarre\nregion,\nSpain,\n2006\u20132007.", "mimetype": "text/plain", "start_char_idx": 21543, "end_char_idx": 22979, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bef7fc85-5114-4702-b813-1335e852a846": {"__data__": {"id_": "bef7fc85-5114-4702-b813-1335e852a846", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Castilla-2 (2009).pdf", "node_type": "4", "metadata": {}, "hash": "a7926adb86f5ec7233916a8fa0b01e0cbf850e6e2076a072d766983cfd322e3c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cbe91ee3-f074-446c-b899-95c6c09c4e44", "node_type": "1", "metadata": {}, "hash": "d57932339a4338545dca802639493074f2e1a42adc77e470157af1844d7b3423", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "54c68dc7-b08c-43b1-bfba-488a7508bd1d", "node_type": "1", "metadata": {}, "hash": "fb0ed34c6cc26d979c425825202b0b803be2d628420723deadcd701b4609a7f5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Euro\nSurvell\n2007;12(2):E070215.1.\nhttp://www.eurosurveillance.org/ViewArticle.aspx?\nPublicationType=W&Volume=12&Issue=7&OrderNumber=1.\n[15] Hersh BS, Fine PE, Kent WK, Cochi SL, Kahn LH, Zell ER, et al. Mumps outbreak\nin a highly vaccinated population. J Pediatr 1991;119:187\u201393.\n[16] Harling R, White JM, Ramsay ME, Macsween KF, van den Bosch C. The effec-\ntiveness of the mumps component of the MMR vaccine: a case control study.\nVaccine 2005;23:4070\u20134.\n[17] Gans H, DeHovitz R, Forghani B, Beeler J, Maldonado Y, Arvin AM. Measles\nand mumps vaccination as a model to investigate the developing immune\nsystem: passive and active immunity during the \ufb01rst year of life. Vaccine\n2003;21:3398\u2013405.\n[18] Cheek JE, Baron R, Atlas H, Wilson DL, Crider Jr RD. Mumps outbreak in a highly\nvaccinated school population. Evidence for large scale vaccination failure. Arch\nPediatr Adolesc Med 1995;149:774\u20138.\n[19] Davidkin I, Valle M, Julkunen I. Persistence of anti-mumps virus antibodies after\na two-dose MMR vaccination. A nine-year follow-up. Vaccine 1995;13:1617\u2013\n22.\n[20] Miller E, Hill A, Morgan-Capner P, Forsey T, Rush M. Antibodies to measles,\nmumps and rubella in UK children 4 years after vaccination with different MMR\nvaccines. Vaccine 1995;13:799\u2013802.\n[21] Centres for Disease Control and Prevention. Guidelines for maintaining\nand managing the vaccine cold chain. MMWR Morb Mortal Wkly Rep\n2003;52:1023\u20135.\n[22] Nojd J, Tecle T, Samuelsson A, Orvell C. Mumps virus neutralizing antibodies\ndo not protect against reinfection with a heterologous mumps virus genotype.", "mimetype": "text/plain", "start_char_idx": 22980, "end_char_idx": 24550, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "54c68dc7-b08c-43b1-bfba-488a7508bd1d": {"__data__": {"id_": "54c68dc7-b08c-43b1-bfba-488a7508bd1d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Castilla-2 (2009).pdf", "node_type": "4", "metadata": {}, "hash": "a7926adb86f5ec7233916a8fa0b01e0cbf850e6e2076a072d766983cfd322e3c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bef7fc85-5114-4702-b813-1335e852a846", "node_type": "1", "metadata": {}, "hash": "811b37e6c1ecfaf129e8dfeaba097b613bbb3806cbf1a7ec648036a524d6eff0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "[22] Nojd J, Tecle T, Samuelsson A, Orvell C. Mumps virus neutralizing antibodies\ndo not protect against reinfection with a heterologous mumps virus genotype.\nVaccine 2001;19:1727\u201331.\n[23] Fine PE, Zell ER. Outbreaks in highly vaccinated populations: implica-\ntions for studies of vaccine performance. Am J Epidemiol 1994;139:77\u2013\n90.\nJ. Castilla et al. / Vaccine 27 (2009) 2089\u20132093\n2093\n[24] Rothman KJ, Greenland S. Case\u2013control studies. In: Rothman KJ, Greenland S,\neditors. Modern epidemiology. 2nd edn. Philadelphia: Lippincott-Raven Pub-\nlishers; 1998. p. 93\u2013114.\n[25] Date AA, Kyaw MH, Rue AM, Klahn J, Obrecht L, Krohn T, et al. Long-term per-\nsistence of mumps antibody after receipt of 2 measles\u2013mumps\u2013rubella (MMR)\nvaccinations and antibody response after a third MMR vaccination among a\nuniversity population. J Infect Dis 2008;197:1662\u20138.\n[26] Dayan GH, Rubin S. Mumps outbreaks in vaccinated populations: are avail-\nable mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis\n2008;47:1458\u201367.", "mimetype": "text/plain", "start_char_idx": 24392, "end_char_idx": 25413, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e2629ae6-1cd1-400d-a4ef-0428ac885d0b": {"__data__": {"id_": "e2629ae6-1cd1-400d-a4ef-0428ac885d0b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Da Dalt (2016).pdf", "node_type": "4", "metadata": {}, "hash": "7d5a946739c9e5405e7f7766bc1e06af16eb8cdf26137073b375384301e37ce4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "003f21c3-020e-4a8a-9475-aad2a94c0e8e", "node_type": "1", "metadata": {}, "hash": "057a957187dc8fb8272607de3426f47b667ed2145bc89d1e7f64afbe87070380", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "RESEARCH\nOpen Access\nHenoch-Sch\u00f6nlein purpura and drug and\nvaccine use in childhood: a case-control\nstudy\nLiviana Da Dalt1, Claudia Zerbinati2, Maria Stefania Strafella2, Salvatore Renna3, Laura Riceputi3, Pasquale Di Pietro3,\nPaola Barabino3, Stefania Scanferla1, Umberto Raucci4, Nadia Mores5, Adele Compagnone5, Roberto Da Cas6,\nFrancesca Menniti-Ippolito6* and the Italian Multicenter Study Group for Drug and Vaccine Safety in Children\nAbstract\nBackground: Henoch-Sch\u00f6nlein purpura (HSP) is the most common vasculitis in childhood; nevertheless, its\netiology and pathogenesis remain unknown despite the fact that a variety of factors, mainly infectious agents,\ndrugs and vaccines have been suggested as triggers for the disease. The aim of this study was to estimate the\nassociation of HSP with drug and vaccine administration in a pediatric population.\nMethods: An active surveillance on drug and vaccine safety in children is ongoing in 11 clinical centers in Italy. All\nchildren hospitalized through the local Paediatric Emergency Department for selected acute clinical conditions of\ninterest were enrolled in the study. Data on drug and vaccine use in children before the onset of symptoms\nleading to hospitalization were collected by parents interview. A case-control design was applied for risk estimates:\nexposure in children with HSP, included as cases, was compared with similar exposure in children with gastroduodenal\nlesions, enrolled as controls. HSP cases were validated according to EULAR/PRINTO/PRES criteria. Validation was\nconducted retrieving data from individual patient clinical record.\nResults: During the study period (November 1999\u2013April 2013), 288 cases and 617 controls were included. No increased\nrisk of HSP was estimated for any drug. Among vaccines, measles-mumps-rubella (MMR) vaccine showed an increased\nrisk of HSP (OR 3.4; 95 % CI 1.2\u201310.0).\nConclusions: This study provides further evidence on the possible role of MMR vaccine in HSP occurrence.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1985, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "003f21c3-020e-4a8a-9475-aad2a94c0e8e": {"__data__": {"id_": "003f21c3-020e-4a8a-9475-aad2a94c0e8e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Da Dalt (2016).pdf", "node_type": "4", "metadata": {}, "hash": "7d5a946739c9e5405e7f7766bc1e06af16eb8cdf26137073b375384301e37ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e2629ae6-1cd1-400d-a4ef-0428ac885d0b", "node_type": "1", "metadata": {}, "hash": "7cc1f9765595d8a1e9155360de5eb74dbf0c996223d0905a598f6df600de048f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "452fe716-154b-4737-9e0c-f35e9ea5a2cd", "node_type": "1", "metadata": {}, "hash": "90d5cd669d99aa38b3925ab0cbe9b9af67c175da224e3bd54e2a6a4dd3e00283", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Conclusions: This study provides further evidence on the possible role of MMR vaccine in HSP occurrence.\nKeywords: Children, Adverse drug reaction, Henoch-Sch\u00f6nlein purpura, Vaccine\nBackground\nHenoch-Sch\u00f6nlein purpura (HSP), recently renamed as\nIgA vasculitis, is a systemic leukocytoplastic vasculitis\ncharacterized by IgA1 dominant immune deposits [1, 2].\nHSP is the most common vasculitis in childhood with\nan incidence of 10\u201320 cases per 100,000 in children\nunder 17 years with a peak incidence of 70 cases per\n100,000 in the 4\u20136 year age group [1, 2].\nAccording to the last endorsed criteria by the EULAR/\nPINTO/PRES and American College of Rheumatology\n(ACR) the HSP diagnosis requires the presence of the\npalpable purpura and at least one of the following: arth-\nritis or arthralgia, diffuse abdominal pain, renal involve-\nment with haematuria and/or proteinuria or any biopsy\nshowing predominant IgA deposition [2\u20134].\nThe HSP has an excellent outcome in the majority of\ncases with a complete remission in four weeks, about\n20\u201355 % of children have a renal involvement but only\n<1 % develop an end-stage kidney disease. The patho-\ngenesis of this vasculitis should be attributed to the IgA1\ncontaining immune complexes deposition on the small\nvessels causing the damage and consequently all clinical\nmanifestations. Although HSP clinical manifestations\nand prognosis are well-defined, the etiology of the dis-\nease remains unknown. It is clear that genetics and an\n* Correspondence: francesca.menniti@iss.it\n6National Center for Epidemiology, Surveillance and Health Promotion,\nNational Institute of Health, Viale Regina Elena, 299 - 00161 Rome, Italy\nFull list of author information is available at the end of the article\n\u00a9 2016 The Author(s).", "mimetype": "text/plain", "start_char_idx": 1881, "end_char_idx": 3632, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "452fe716-154b-4737-9e0c-f35e9ea5a2cd": {"__data__": {"id_": "452fe716-154b-4737-9e0c-f35e9ea5a2cd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Da Dalt (2016).pdf", "node_type": "4", "metadata": {}, "hash": "7d5a946739c9e5405e7f7766bc1e06af16eb8cdf26137073b375384301e37ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "003f21c3-020e-4a8a-9475-aad2a94c0e8e", "node_type": "1", "metadata": {}, "hash": "057a957187dc8fb8272607de3426f47b667ed2145bc89d1e7f64afbe87070380", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "938ae48d-8af1-41df-a9a0-a6d16691b6a4", "node_type": "1", "metadata": {}, "hash": "36b81b5d94e968a7735ce21caa3ed386ef11c02cdbd580c61246d125e164882d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0\nInternational License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and\nreproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to\nthe Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver\n(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.\nDa Dalt et al. Italian Journal of Pediatrics  (2016) 42:60 \nDOI 10.1186/s13052-016-0267-2\nabnormal immune response play a pivotal role in the\npathogenesis of HSP [2, 5\u20137].\nHowever a combination of additional factors has been\nsuggested to trigger the disease, as infectious agents,\ndrugs and vaccinations [8\u201314].\nHSP following drug and vaccine administration has\nbeen described in case reports and in a small number of\nobservational studies conducted during vaccination cam-\npaigns [15\u201334].\nSince 1999 the Italian National Institute of Health is\ncoordinating an active surveillance on the role of drugs\nand vaccines in the occurrence of specific clinical condi-\ntions responsible for hospitalization of pediatric patients.\nNon-infectious muco-cutaneous diseases are among the\nclinical conditions of interest and the present study fo-\ncused on HSP cases to estimate their association with\ndrug and vaccine use in the pediatric population.\nMethods\nSetting and study population\nThe Italian multicenter study on drug and vaccine safety\nin children involved 11 Italian Pediatric hospitals/wards\nspread throughout the country (Treviso, Padua, Naples,\nGenoa, Turin, Florence, Perugia, Palermo, Messina and\nRome, with two centers).", "mimetype": "text/plain", "start_char_idx": 3633, "end_char_idx": 5442, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "938ae48d-8af1-41df-a9a0-a6d16691b6a4": {"__data__": {"id_": "938ae48d-8af1-41df-a9a0-a6d16691b6a4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Da Dalt (2016).pdf", "node_type": "4", "metadata": {}, "hash": "7d5a946739c9e5405e7f7766bc1e06af16eb8cdf26137073b375384301e37ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "452fe716-154b-4737-9e0c-f35e9ea5a2cd", "node_type": "1", "metadata": {}, "hash": "90d5cd669d99aa38b3925ab0cbe9b9af67c175da224e3bd54e2a6a4dd3e00283", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "77fc7df6-b34f-4b06-8826-959923110b04", "node_type": "1", "metadata": {}, "hash": "bcee0e71b7df53eb6882f45ecab3fe7ba67ea9f9d67378b1b2001c6a92ba0e2c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Were\nenrolled\nin\nthe\nstudy\nall\nchildren\n(age >\n1 month and \u226418 years)\nhospitalized through the\nEmergency Departments (ED) for the following acute\nconditions: thrombocytopenia (platelet count <100 \u00d7\n103/L); acute non-infectious, non-febrile neurological\ndisorders; endoscopically confirmed gastroduodenal le-\nsions and/or clinically defined haematemesis and melena\nand non-infectious muco-cutaneous diseases and vascu-\nlitis. Exclusion criteria were represented by a concomitant\ndiagnosis of cancer or immunodeficiency.\nData collection\nDuring\nhospital\nadmission\nof\nthe\nchild,\na\ntrained\npharmacist/physician\ninterviewed\nparents\nto\ncollect\ndemographic and clinical information using a structured\nquestionnaire.\nData on drug exposure in a time window of 3 weeks\npreceding hospitalization, extended to 12 weeks for vac-\ncines, were collected.\nFor all children the inclusion in the study was based\non the diagnosis retrieved from the ED records inde-\npendently of drug and vaccine exposure.\nEthical approval and consent to participate\nAccording to the Italian regulation, retrospective obser-\nvational studies are only required to be notified to eth-\nical committees. The study protocol was notified to the\nethical committee of each participating Center. Before\nparents interview, a written informed consent to use\ndata for research purposes was obtained.\nDefinition of cases and controls\nAll children hospitalized with a diagnosis of HSP at ad-\nmission were included as cases. Discharge diagnosis was\nretrieved from clinical records and validated by clini-\ncians, according to EULAR/PRINTO/PRES criteria for\nclassification of HSP [3, 4]. Validation was conducted re-\ntrieving data from individual patient clinical record,\nblinded with respect to drug and vaccine exposure. Only\nvalidated cases were analyzed.\nChildren hospitalized for gastroduodenal lesions were\nconsidered as appropriate controls, since they represent\nan acute condition admitted through the EDs in the\nsame clinical centers in which cases were identified.\nStatistical analysis\nDescriptive analyses of demographic characteristics of\ncase and control patients, drug and vaccine exposure\nwere performed.", "mimetype": "text/plain", "start_char_idx": 5443, "end_char_idx": 7607, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "77fc7df6-b34f-4b06-8826-959923110b04": {"__data__": {"id_": "77fc7df6-b34f-4b06-8826-959923110b04", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Da Dalt (2016).pdf", "node_type": "4", "metadata": {}, "hash": "7d5a946739c9e5405e7f7766bc1e06af16eb8cdf26137073b375384301e37ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "938ae48d-8af1-41df-a9a0-a6d16691b6a4", "node_type": "1", "metadata": {}, "hash": "36b81b5d94e968a7735ce21caa3ed386ef11c02cdbd580c61246d125e164882d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1f12261d-eda7-4d28-9c19-4860d928ac6b", "node_type": "1", "metadata": {}, "hash": "e74fa8d0a02b5843535579b9d89d3f3c2200cf086c2f223b30dae88ea23242c8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Statistical analysis\nDescriptive analyses of demographic characteristics of\ncase and control patients, drug and vaccine exposure\nwere performed. Categorical variables, presented as\nnumbers and percentages, were compared using the Chi\nSquare test, while continuous variables, reported as me-\ndian and range were compared using the Mann-Whitney\nU test. All tests were two sided and significance was set\nat p < 0.05.\nA case-control study design was applied to compare\ndrug and vaccine exposure in children with HSP, (cases)\nand children with gastroduodenal lesions (controls). A\nmultiple logistic regression model was used to estimate\nadjusted Odds Ratios (ORs) and related 95 % confidence\ninterval (CI). Age and concomitant use of any other drug\nwere considered potential confounding factors. Statis-\ntical analysis was performed by means of IBM\u00ae SPSS\u00ae\nstatistics (version 22).\nResults\nDuring the period November 1999\u2013April 2013, a total of\n2600 patients with a diagnosis of muco-cutaneous dis-\nease were enrolled in the study. Among these hospital-\nized pediatric patients, 366 were diagnosed as HSP at\nthe ED. For the validation phase of HSP cases, clinical\nrecords of 298 children (81 % of total), were retrieved.\nOnly 10 cases did not fulfill the diagnostic criteria for\nthe disease as described in the score according to\nEULAR/PRINTO/PRES\ncriteria\n(Fig.\n1).\nIn\nall\nthe\nremaining 288 HSP validated cases, a palpable purpura\nwas present, accompanied by arthralgia/arthritis in 85 %;\nabdominal involvement with abdominal pain, melena,\nintussusception in 65 %; renal involvement with haema-\nturia, proteinuria in 35 % and scrotal swelling in 7 %. In\nthe same period 617 children were enrolled with gastro-\nduodenal lesions. Haematemesis and melena accounted\nDa Dalt et al. Italian Journal of Pediatrics  (2016) 42:60 \nPage 2 of 5\nfor most of gastrointestinal diagnosis. Characteristics of\ncases and controls are reported in Table 1.", "mimetype": "text/plain", "start_char_idx": 7463, "end_char_idx": 9394, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1f12261d-eda7-4d28-9c19-4860d928ac6b": {"__data__": {"id_": "1f12261d-eda7-4d28-9c19-4860d928ac6b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Da Dalt (2016).pdf", "node_type": "4", "metadata": {}, "hash": "7d5a946739c9e5405e7f7766bc1e06af16eb8cdf26137073b375384301e37ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "77fc7df6-b34f-4b06-8826-959923110b04", "node_type": "1", "metadata": {}, "hash": "bcee0e71b7df53eb6882f45ecab3fe7ba67ea9f9d67378b1b2001c6a92ba0e2c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fc8a70f0-59f3-467c-b311-b5ba57e0e820", "node_type": "1", "metadata": {}, "hash": "bd59510453dbbebe7af959caad74e7b879d7cb3a0e6e0068d62d339c4af65ff4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Italian Journal of Pediatrics  (2016) 42:60 \nPage 2 of 5\nfor most of gastrointestinal diagnosis. Characteristics of\ncases and controls are reported in Table 1.\nMedian duration of hospitalization was similar in both\ngroups, even if the statistical test was statistically signifi-\ncant, indicating difference in the distribution around the\nmedian. Controls were significantly younger than cases\n(6 vs. 3 years). Drug and vaccine exposure resulted sig-\nnificantly higher in controls.\nCrude and adjusted ORs were estimated for each\ndrug considering at least five exposed cases. No sig-\nnificant increased risk was estimated for any drug\n(Table 2).\nThe risk estimated for HSP within 12 weeks after vac-\ncination resulted higher, more than 3 times, for MMR\nvaccines with an OR of 3.4 (95 % CI 1.2\u201310.0) while no\nsignificant increased risks were observed for diphtheria,\ntetanus, acellular pertussis (DTaP) and any vaccine\n(Table 3).\nDiscussion\nDespite the fact that HSP is the commonest, mainly self-\nlimiting, systemic vasculitis in childhood, its etiology\nand pathogenesis remain still to be fully understood.\nMany chemical and infectious triggers have been rec-\nognized for the HSP typical vascular IgA deposition,\nincluding drugs and vaccines beside the role played\nby immunological, genetic and environmental factors\n[13, 14, 35]. Furthermore no risk estimates for HSP\nand drug or vaccine exposure have been published.\nThis study aimed to investigate the association and\nthe potential role of drugs and vaccines in the occur-\nrence of HSP in a pediatric population.\nHSP diagnosis is difficult at admission since there are\nno\ndisease-specific\nlaboratory\nabnormalities,\nneither\nsigns\nand\nsymptoms,\nhistopathological\nfindings\nare\nneeded to properly identify HSP cases. Only HSP vali-\ndated cases, according to the EULAR/PRINTO/PRES\ncriteria, were considered for the statistical analyses. The\ncausality assessment on each HSP case was not per-\nformed and was beyond the scope of this study.\nThe clinical presentation of the 288 validated cases\nconfirmed what previously reported as main clinical fea-\ntures for HSP [2].", "mimetype": "text/plain", "start_char_idx": 9235, "end_char_idx": 11349, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fc8a70f0-59f3-467c-b311-b5ba57e0e820": {"__data__": {"id_": "fc8a70f0-59f3-467c-b311-b5ba57e0e820", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Da Dalt (2016).pdf", "node_type": "4", "metadata": {}, "hash": "7d5a946739c9e5405e7f7766bc1e06af16eb8cdf26137073b375384301e37ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1f12261d-eda7-4d28-9c19-4860d928ac6b", "node_type": "1", "metadata": {}, "hash": "e74fa8d0a02b5843535579b9d89d3f3c2200cf086c2f223b30dae88ea23242c8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "554a968d-b24e-41dc-8b6b-a8135eeb9320", "node_type": "1", "metadata": {}, "hash": "898cdf9be077c2f302cb93395f5ae91d28f2d4cf97639d09582b4bb1b6763366", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The clinical presentation of the 288 validated cases\nconfirmed what previously reported as main clinical fea-\ntures for HSP [2]. In addition to the palpable purpura,\nhallmark of the disease, articular and abdominal involve-\nment has been described in the majority of the patients\nwhereas renal and genital involvement were less fre-\nquent. According to the literature, the median age of\nHSP cases was in accordance with that reported else-\nwhere (4-6 years), so as the equal distribution among\nmale and female subjects [1, 2, 5].\nThe characteristics of the 68 cases in which clinical re-\ncords were not retrieved were similar for age, gender,\nprevious febrile infections, drug and/or vaccine exposure\nto the retrieved cases thus excluding a possibility for se-\nlection bias.\nTable 1 Characteristics of the study population\nCases\nControlsa\nNumber\n288\n617\nMedian age (range)\n6y (2 m\u201318y)\n3y (1 m\u201318y)\np < 0.001\n% Females\n48\n45\np = 0.8\nMedian length of hospital\nstay (range, days)\n4 (1\u201331)\n3 (1\u201337)\np < 0.001\nMedian interval from\ndrug/vaccine to symptom\nonset (range, days)\n2 (0\u201360)\n0 (0\u201390)\np < 0.001\nChildren exposed to\ndrugs: N (%)\n175 (61)\n435 (71)\np < 0.08\nChildren exposed to\nvaccines: N (%)\n21 (7)\n68 (11)\np = 0.08\nagastroduodenal lesions\nTable 2 Odds ratio of developing HSP associated with drugs\nDrugs\nCases (288)\nControlsa\n(617)\nCrude OR\n(95 % CI)\nAdjusted ORb\n(95 % CI)\nAntibiotics\n65\n156\n0.7 (0.5\u20131.0)\n1.0 (0.7\u20131.5)\nPenicillins\n38\n72\n0.9 (0.5\u20131.4)\n1.3 (0.8\u20132.0)\nCephalosporin\n21\n49\n0.7 (0.4\u20131.3)\n1.1 (0.7\u20132.", "mimetype": "text/plain", "start_char_idx": 11221, "end_char_idx": 12737, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "554a968d-b24e-41dc-8b6b-a8135eeb9320": {"__data__": {"id_": "554a968d-b24e-41dc-8b6b-a8135eeb9320", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Da Dalt (2016).pdf", "node_type": "4", "metadata": {}, "hash": "7d5a946739c9e5405e7f7766bc1e06af16eb8cdf26137073b375384301e37ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fc8a70f0-59f3-467c-b311-b5ba57e0e820", "node_type": "1", "metadata": {}, "hash": "bd59510453dbbebe7af959caad74e7b879d7cb3a0e6e0068d62d339c4af65ff4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d35fb1d9-7c3a-45b3-a73b-4626c2269ab2", "node_type": "1", "metadata": {}, "hash": "ea708205f008b55a9efe0e4311cd75651c083ee6dbef2e1d74480da600e163c9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "4)\n1.3 (0.8\u20132.0)\nCephalosporin\n21\n49\n0.7 (0.4\u20131.3)\n1.1 (0.7\u20132.0)\nMacrolides\n7\n37\n0.3 (0.1\u20130.7)\n0.4 (0.2\u20130.9)\nNSAIDs\n47\n101\n0.8 (0.5\u20131.2)\n0.9 (0.6\u20131.4)\nNiflumic acid\n12\n14\n1.4 (0.6\u20133.3)\n1.9 (0.6\u20131.4)\nIbuprofen\n29\n61\n0.8 (0.5\u20131.3)\n1.1 (0.7\u20131.7)\nParacetamol\n62\n163\n0.6 (0.4\u20130.9)\n0.8 (0.6\u20131.1)\nCorticosteroids\n31\n104\n0.5 (0.3\u20130.8)\n0.8 (0.5\u20131.3)\nNon users\n113\n182\nagastroduodenal lesions bOR adjusted by age and concomitant use of other drug\n366 registered\n288 validated\n68 not retrieved \nfor validation\n298 retrieved\n10 not validated\nFig. 1 Enrollment, retrieving and validation process of HSP patients\nTable 3 Odds ratio of developing HSP associated with vaccines\nVaccine\nCases (288)\nControlsa (617)\nCrude OR\n(95 % CI)\nAdjusted ORb\n(95 % CI)\nMMR\n8 (2.8 %)\n6 (1 %)\n2.7 (0.8\u20139.7)\n3.4 (1.2\u201310.0)\nDTaP\n4 (1.4)\n6 (1 %)\n1.4 (0.3\u20136.1)\n2.0 (0.5\u20137.7)\nAny vaccine\n21 (7.3 %)\n68 (11 %)\n0.6 (0.4\u20131.1)\n0.9 (0.5\u20131.4)\nagastroduodenal lesions bOR adjusted by age\nDa Dalt et al.", "mimetype": "text/plain", "start_char_idx": 12675, "end_char_idx": 13633, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d35fb1d9-7c3a-45b3-a73b-4626c2269ab2": {"__data__": {"id_": "d35fb1d9-7c3a-45b3-a73b-4626c2269ab2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Da Dalt (2016).pdf", "node_type": "4", "metadata": {}, "hash": "7d5a946739c9e5405e7f7766bc1e06af16eb8cdf26137073b375384301e37ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "554a968d-b24e-41dc-8b6b-a8135eeb9320", "node_type": "1", "metadata": {}, "hash": "898cdf9be077c2f302cb93395f5ae91d28f2d4cf97639d09582b4bb1b6763366", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bbce3c97-7a59-4ff8-b552-e16eb7541320", "node_type": "1", "metadata": {}, "hash": "62ac90a3e02bdd7777255ec0d13f8eb81dc3c5635268e22db5f3d8866e509837", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Italian Journal of Pediatrics  (2016) 42:60 \nPage 3 of 5\nChildren hospitalized for gastroduodenal lesions have\nbeen considered as a suitable control group for HSP pa-\ntients. In this study both cases and controls have been\nidentified through EDs for an acute condition in the same\nclinical centers and, consequently, drug and vaccine ex-\nposure, preceding symptoms causing hospitalization, have\nbeen ascertained with the same procedure by interviewing\nparents during their child hospitalization.\nOur results provide no evidence of an increased risk of\ndeveloping HSP\nassociated with\nany of\nthe drugs\nconsidered.\nA three-fold increase risk of developing HSP associ-\nated with MMR vaccine was estimated.\nProspective studies conducted during MMR vaccin-\nation campaign reported HSP cases following vaccine\nadministration [28\u201330]. Within the Italian Pharmacov-\nigilance System some spontaneous reports of HSP were\nreported after MMR vaccine [36]. During the Chinese\nMMR vaccination campaign, 30 severe adverse reactions\nout of 14.3 millions of administered doses were reported;\namong these, 28 cases were diagnosed as HSP with an\nestimated incidence of 2.1 per million/doses [30]. Our\nstudy confirmed these observational data, providing a\nrisk estimate for this association.\nGiven the case-control design we could not calculate\nany incidence estimate.\nThis article confirms that HSP is a rare condition (288\nchildren hospitalized in 14 years). Furthermore, the vac-\ncinated cases were only 8, suggesting a very low absolute\nrisk of the condition in children vaccinated with MMR\nvaccine. Thus, the benefit/risk profile of MMR vaccine is\nnot affected by our results, being MMR vaccination an\neffective\nand\nsafe\ntool\nagainst\nserious\ndiseases\nin\nchildhood.\nWith regard to drugs an association of gastroduodenal\nlesions with NSAIDs has been previously highlighted\n[37]. This could have lead to an underestimation of the\nresults obtained in the present study concerning the role\nof NSAIDs in the development of HSP. It was beyond\nthe objective of the present study to investigate the\npathogenetic role of drugs and vaccines in the HSP\noccurrence.", "mimetype": "text/plain", "start_char_idx": 13634, "end_char_idx": 15770, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bbce3c97-7a59-4ff8-b552-e16eb7541320": {"__data__": {"id_": "bbce3c97-7a59-4ff8-b552-e16eb7541320", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Da Dalt (2016).pdf", "node_type": "4", "metadata": {}, "hash": "7d5a946739c9e5405e7f7766bc1e06af16eb8cdf26137073b375384301e37ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d35fb1d9-7c3a-45b3-a73b-4626c2269ab2", "node_type": "1", "metadata": {}, "hash": "ea708205f008b55a9efe0e4311cd75651c083ee6dbef2e1d74480da600e163c9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1a5ffec5-b436-468e-a637-41088bdf72d5", "node_type": "1", "metadata": {}, "hash": "7727849f4bc229d0d0aa64ca726397d318b6f152282e70019569a4c11b15a2c0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "It was beyond\nthe objective of the present study to investigate the\npathogenetic role of drugs and vaccines in the HSP\noccurrence.\nConclusions\nThe association between MMR vaccination and HSP\nconfirms previous published findings and adds a risk es-\ntimate. Further studies are needed to increase our un-\nderstanding of the role of drugs and vaccines in the\netiology of HSP, a disease with important effects on\nhealth of children for its potential, though rare, chronic\noutcomes.\nAbbreviations\nHSP, Henoch-Sch\u00f6nlein purpura; Ig, Immunoglobulin\nFunding\nThe study was partially funded by the Italian Medicines Agency (AIFA).\nAuthors\u2019 contributions\nFMI, RDC conceived and designed the study, coordinated and supervised data\ncollection at all sites, analyzed the data, critically reviewed and approved the final\nmanuscript as submitted. LDD conceived and designed the study, coordinated\nand supervised data collection at two sites, drafted, critically reviewed and\napproved the final manuscript as submitted. CZ, MSS, NM, AC, UR collected data,\nvalidated cases, drafted and reviewed the manuscript. SR, LR, PDP, PB, SS collected\nand validated data, reviewed and approved the final manuscript as submitted.\nAll components of the Italian Multicenter Study Group for Drug and Vaccine\nSafety in Children collected and validated the data within the clinical centers,\nread, commented and approved the final version of the manuscript. All authors\nread and approved the final manuscript.\nCompeting interests\nThe authors declare that they have no competing interests.\nEthical approval and consent to participate\nAccording to the Italian regulation, retrospective observational studies are only\nrequired to be notified to ethical committees (Determinazione AIFA 20 marzo\n2008 - http://www.agenziafarmaco.gov.it/allegati/det_20marzo2008.pdf). The\nstudy protocol was notified to the ethical committee of each participating\nCenter. Before parents interview, a written informed consent to use data for\nresearch purposes was obtained.", "mimetype": "text/plain", "start_char_idx": 15640, "end_char_idx": 17653, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1a5ffec5-b436-468e-a637-41088bdf72d5": {"__data__": {"id_": "1a5ffec5-b436-468e-a637-41088bdf72d5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Da Dalt (2016).pdf", "node_type": "4", "metadata": {}, "hash": "7d5a946739c9e5405e7f7766bc1e06af16eb8cdf26137073b375384301e37ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bbce3c97-7a59-4ff8-b552-e16eb7541320", "node_type": "1", "metadata": {}, "hash": "62ac90a3e02bdd7777255ec0d13f8eb81dc3c5635268e22db5f3d8866e509837", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8bace470-19f8-4d23-971d-d654635516b2", "node_type": "1", "metadata": {}, "hash": "2755dfdaf83b24c3eb598a2b2bdbc9d247b5547ac7ab800c1190736d59080a8d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\nstudy protocol was notified to the ethical committee of each participating\nCenter. Before parents interview, a written informed consent to use data for\nresearch purposes was obtained.\nMembers of the Italian Multicenter Study Group for Drug and Vaccine\nSafety in Children\nFrancesca Menniti-Ippolito, Roberto Da Cas, Giuseppe Traversa (National Center\nfor Epidemiology, National Institute of Health, Roma); Carmela Santuccio, Patrizia\nFelicetti, Loriana Tartaglia, Francesco Trotta (Italian Medicines Agency, Roma);\nPasquale Di Pietro, Paola Barabino, Salvatore Renna, Laura Riceputi (Giannina\nGaslini Pediatric Hospital, Genova); Pier-Angelo Tovo, Clara Gabiano, Antonio\nUrbino, Luca Baroero, Daniele Le Serre, Silvia Virano (Department of public\nhealth and pediatrics, Torino University, Regina Margherita Pediatric Hospital,\nTorino); Liviana Da Dalt, Chiara Stefani, Claudia Zerbinati (Department of\nPediatrics, Treviso Hospital, Treviso); Giorgio Perilongo, Marco Daverio, Michela\nMaretti, Beatrice Galeazzo, Giulia Rubin, Stefania Scanferla (Department of\nPediatrics, University of Padova); Elena Chiappini, Sara Sollai, Maurizio De\nMartino, Sabrina Becciani, Martina Giacalone, Simona Montano, Giulia\nRemaschi, Alessia Stival (Anna Meyer Children\u2019s University Hospital, Firenze); Piera\nAbate, Ilaria Leonardi (Department of Pediatrics, University of Perugia); Nicola\nPirozzi, Umberto Raucci, Antonino Reale, Rossella Rossi (Pediatric Emergency\nDepartment, Bambino Ges\u00f9 Children Hospital, Roma); Nadia Mores, Giulia\nBersani, Adele Compagnone, Antonio Chiaretti, Riccardo Riccardi, Costantino\nRomagnoli (Pharmacology and Pediatrics, Universit\u00e0 Cattolica S. Cuore, Roma);\nVincenzo Tipo, Michele Dinardo, Fabiana Auricchio, Teodoro Polimeno, Maria\nColomba Bonagura (Santobono Pediatric Hospital, Napoli); Alessandra Maccariello\n(Department of Experimental Medicine, Section of Pharmacology \u201cL.", "mimetype": "text/plain", "start_char_idx": 17466, "end_char_idx": 19363, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8bace470-19f8-4d23-971d-d654635516b2": {"__data__": {"id_": "8bace470-19f8-4d23-971d-d654635516b2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Da Dalt (2016).pdf", "node_type": "4", "metadata": {}, "hash": "7d5a946739c9e5405e7f7766bc1e06af16eb8cdf26137073b375384301e37ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1a5ffec5-b436-468e-a637-41088bdf72d5", "node_type": "1", "metadata": {}, "hash": "7727849f4bc229d0d0aa64ca726397d318b6f152282e70019569a4c11b15a2c0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c45d1c31-43ec-42ac-a1a7-6d915ab4d96b", "node_type": "1", "metadata": {}, "hash": "ac58616021dd0269f684067e512f95258235021cfe7de6c81e3fee14fa86125a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Donatelli\u201d,\nSecond University of Napoli); Fortunata Fuc\u00e0, Eleonora Di Rosa (Giovanni Di\nCristina Pediatric Hospital, Palermo); Domenica Altavilla, Anna Mecchio, Teresa\nArrigo (Department of Pediatrics, Gynecologic, Microbiologic and Biomedical\nSciences, University Hospital, Messina).\nAuthor details\n1Department of Woman and Child Health, University of Padua, Padua, Italy.\n2Pediatric Department, Treviso Hospital, Treviso, Italy. 3Giannina Gaslini\nChildren Hospital, Genoa, Italy. 4Pediatric Emergency Department, Bambino\nGes\u00f9 Children\u2019s Hospital, IRCCS, Rome, Italy. 5Pharmacology and Pediatrics,\nUniversit\u00e0 Cattolica S. Cuore, Rome, Italy. 6National Center for Epidemiology,\nSurveillance and Health Promotion, National Institute of Health, Viale Regina\nElena, 299 - 00161 Rome, Italy.\nReceived: 11 February 2016 Accepted: 30 May 2016\nReferences\n1.\nTrnka P. Henoch-Schonlein purpura in children. J Paediatr Child Health.\n2013;49(12):995\u20131003.\nDa Dalt et al. Italian Journal of Pediatrics  (2016) 42:60 \nPage 4 of 5\n2.\nMcCarthy HJ, Tizard EJ. Clinical practice: Diagnosis and management of\nHenoch-Sch\u00f6nlein purpura. Eur J Pediatr. 2010;169(6):643\u201350.\n3.\nJennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012\nRevised International Chapel Hill Consensus Conference Nomenclature of\nVasculitides. Arthritis Rheum. 2013;65(1):1\u201311.\n4.\nOzen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/\nPRINTO/PRES criteria for Henoch-Sch\u00f6nlein purpura, childhood polyarteritis\nnodosa, childhood Wegener granulomatosis and childhood Takayasu\narteritis: Ankara 2008. Part II: Final classification criteria.", "mimetype": "text/plain", "start_char_idx": 19364, "end_char_idx": 20991, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c45d1c31-43ec-42ac-a1a7-6d915ab4d96b": {"__data__": {"id_": "c45d1c31-43ec-42ac-a1a7-6d915ab4d96b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Da Dalt (2016).pdf", "node_type": "4", "metadata": {}, "hash": "7d5a946739c9e5405e7f7766bc1e06af16eb8cdf26137073b375384301e37ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8bace470-19f8-4d23-971d-d654635516b2", "node_type": "1", "metadata": {}, "hash": "2755dfdaf83b24c3eb598a2b2bdbc9d247b5547ac7ab800c1190736d59080a8d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "85692f1f-a2fc-4905-9079-9c9d8b233568", "node_type": "1", "metadata": {}, "hash": "1cf2b7ed50460aea9cca9f9313775495acbf591d3659c110b58080c2614ca6c4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Part II: Final classification criteria. Ann Rheum Dis.\n2010;69(5):798\u2013806.\n5.\nSaulsubry FT. Henoch-Sch\u00f6nlein purpura. Curr Opin Rheumatol.\n2001;13(1):35\u201340.\n6.\nYang YH, Chuang YH, Wang LC, Huang HY, Gershwin ME, Chiang BL, et al.\nThe immunobiology of Henoch-Sch\u00f6nlein purpura. Autoimmun Rev.\n2008;7(3):179\u201384.\n7.\nHe X, Yu C, Zhao P, Ding Y, Liang X, Zhao Y, et al. The genetics of Henoch\u2013\nSchonlein purpura: a systematic review and meta-analysis. Rheumatol Int.\n2013;33(6):1387\u201395.\n8.\nWeiss PF, Klink AJ, Luan X, Feudtner C. Temporal association of Streptococcus,\nStaphylococcus, and parainfluenza pediatric hospitalizations and hospitalized\ncases of Henoch-Sch\u00f6nlein purpura. J Rheumatol. 2010;37(12):2587\u201394.\n9.\nGonzalez-Gay MA, Calvino MC, Vazquez-Lopez ME, Garcia-Porrua C,\nFernandez-Iglesias JL, Dierssen T, et al. Implications of upper respiratory tract\ninfections and drugs in the clinical spectrum of Henoch-Sch\u00f6nlein purpura in\nchildren. Clin Exp Rheumatol. 2004;22(6):781\u20134.\n10.\nErcan G, Kasapcopur O, Akdenizli E, Arisoy N. The role of Streptococcal\ninfection in Henoch-Schonlein purpura. J Trop Pediatr. 2004;50(3):187\u20138.\n11.\nHeegaard ED, Taaning EB. Parvovirus B19 and parvovirus V9 are not associated\nwith Henoch-Sch\u00f6nlein purpura in children. Pediatr Infect Dis J. 2002;21(1):31\u20134.\n12.", "mimetype": "text/plain", "start_char_idx": 20952, "end_char_idx": 22252, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "85692f1f-a2fc-4905-9079-9c9d8b233568": {"__data__": {"id_": "85692f1f-a2fc-4905-9079-9c9d8b233568", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Da Dalt (2016).pdf", "node_type": "4", "metadata": {}, "hash": "7d5a946739c9e5405e7f7766bc1e06af16eb8cdf26137073b375384301e37ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c45d1c31-43ec-42ac-a1a7-6d915ab4d96b", "node_type": "1", "metadata": {}, "hash": "ac58616021dd0269f684067e512f95258235021cfe7de6c81e3fee14fa86125a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1dce144b-830b-46aa-b81c-a74ff293fa7a", "node_type": "1", "metadata": {}, "hash": "0d9a5ec8c9e20996cb98175033e091848614cada493cd135d2ce7af3d445db1d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Pediatr Infect Dis J. 2002;21(1):31\u20134.\n12.\nVermeulen MJ, Peeters MF, Verbakel H, de Moor RA, Roord JJ, van Dijken PJ.\nNo etiological role for Bartonella henselae infection in Henoch-Sch\u00f6nlein\npurpura. Pediatr Infect Dis J. 2009;28(12):1142\u20133.\n13.\nRigante D, Castellazzi L, Bosco A, Esposito S. Is there a crossroad between\ninfections, genetics, and Henoch-Sch\u00f6nlein purpura? Autoimmun Rev. 2013;\n12(10):1016\u201321.\n14.\nChen JY, Mao JH. Henoch-Sch\u00f6nlein purpura nephritis in children: incidence,\npathogenesis and management. World J Pediatr. 2015;11(1):29-34.\n15.\nSantoro D, Stella M, Castellino S. Henoch-Sch\u00f6nlein purpura associated with\nacetaminophen and codeine. Clin Nephrol. 2006;66(2):131\u20134.\n16.\nRichards AJ, Lindley DC. Henoch-Sch\u00f6nlein purpura associated with co-dydramol.\nBr J Rheumatol. 1987;26(1):65.\n17.\nDussarat G, Dalger J, Mafart B, Chagnon A. Vascular purpura caused by\nparacetamol. A case. Presse Med. 1988;17(31):1587.\n18.\nMichail S, Vaiopoulos G, Nakopoulou L, Revenas C, Aroni K, Karam P, et al.\nHenoch-Schoenlein purpura and acute interstitial nephritis after intravenous\nvancomycin administration in a patient with a staphylococcal infection.\nScand J Rheumatol. 1998;27(3):233\u20135.\n19.\nBataille S, Daumas A, Tasei AM, Jourde-Chiche N, Dussol B, Burtey S, et al.\nVancomycin-induced Henoch-Sch\u00f6nlein purpura:a case report. J Med Case\nRep.", "mimetype": "text/plain", "start_char_idx": 22210, "end_char_idx": 23563, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1dce144b-830b-46aa-b81c-a74ff293fa7a": {"__data__": {"id_": "1dce144b-830b-46aa-b81c-a74ff293fa7a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Da Dalt (2016).pdf", "node_type": "4", "metadata": {}, "hash": "7d5a946739c9e5405e7f7766bc1e06af16eb8cdf26137073b375384301e37ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "85692f1f-a2fc-4905-9079-9c9d8b233568", "node_type": "1", "metadata": {}, "hash": "1cf2b7ed50460aea9cca9f9313775495acbf591d3659c110b58080c2614ca6c4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "12a22081-6624-4514-ab13-b23224a4d056", "node_type": "1", "metadata": {}, "hash": "18766df20b644ee65839198d1a7a3565f962fedfb008da814cfa9eb80775fd97", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vancomycin-induced Henoch-Sch\u00f6nlein purpura:a case report. J Med Case\nRep. 2012;6:106.\n20.\nGamboa F, Rivera JM, Gomez Mateos JM, Gomez-Gras E. Ciprofloxacin-induced\nHenoch-Sch\u00f6nlein purpura. Ann Pharmacother. 1995;29(1):84.\n21.\nPons R, Escutia B. Ciprofloxacin-induced vasculitis with cutaneous and renal\ninvolvement. Nefrologia. 2001;21(2):209\u201312.\n22.\nBorr\u00e0s-Blasco J, Enriquez R, Amoros F, Cabezuelo JB, Navarro-Ruiz A, P\u00e9rez\nM, et al. Henoch-Sch\u00f6nlein purpura associated with clarithromycin. Case\nreport and review of literature. Int J Clin Pharmacol Ther. 2003;41(5):213\u20136.\n23.\nDe Vega T, Blanco S, L\u00f2pez C, Pascual E, S\u00e1nchez M, Zamarr\u00f3n A.\nClarithromycin-induced leukocytoclastic vasculitis. Eur J Clin Microbiol\nInfect Dis. 1993;12(7):563.\n24.\nGavura SR, Nusinowitz S. Leukocytoclastic vasculitis associated with\nclarithromycin. Ann Pharmacother. 1998;32(5):543\u20135.\n25.\nGoldberg EI, Shoji T, Spadin AN. Henoch-Sch\u00f6nlein purpura induced by\nclarithromycin. Int J Dermatol. 1999;38(9):706\u20138.\n26.\nZink A, Erni S, Fliegner M. Antibiotics, purpura and ulcers: a leukocytoclastic\nvasculitis after clarithromycin. Dtsch Med Wochenschr. 2006;131(40):2217\u201320.\n27.\nSchapira D, Balbir-Gurman A, Nahir AM. Naproxen-induced leukocytoclastic\nvasculitis. Clin Rheumatol. 2000;19(3):242\u20134.\n28.", "mimetype": "text/plain", "start_char_idx": 23489, "end_char_idx": 24771, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "12a22081-6624-4514-ab13-b23224a4d056": {"__data__": {"id_": "12a22081-6624-4514-ab13-b23224a4d056", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Da Dalt (2016).pdf", "node_type": "4", "metadata": {}, "hash": "7d5a946739c9e5405e7f7766bc1e06af16eb8cdf26137073b375384301e37ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1dce144b-830b-46aa-b81c-a74ff293fa7a", "node_type": "1", "metadata": {}, "hash": "0d9a5ec8c9e20996cb98175033e091848614cada493cd135d2ce7af3d445db1d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f28d4263-d446-4573-a07a-f80d07c97d02", "node_type": "1", "metadata": {}, "hash": "9616b45c63501ef10265be8dfdba186763b6722423a785b554e5f81548a80156", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Naproxen-induced leukocytoclastic\nvasculitis. Clin Rheumatol. 2000;19(3):242\u20134.\n28.\nPatja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltole H. Serious adverse\nevents after measles-mumps-rubella vaccination during a fourteen-year\nprospective follow-up. Pediatr Infect Dis J. 2000;19(12):1127\u201334.\n29.\nPatjia A, Makinen-Kiljunen S, Davidkin I, Paunio M, Peltola H. Allergic reactions\nto measles-mumps-rubella vaccination. Pediatrics. 2001;107(2):E27.\n30.\nShu M, Liu Q, Wang J, Rui Ao R, Yang C, Fang G, et al. Measles vaccine\nadverse events reported in the mass vaccination campaign of Sichuan\nprovince, China from 2007 to 2008. Vaccine. 2011;29(18):3507\u201310.\n31.\nGoodman MJ, Nordin JD, Belongia EA, Mullooly JP, Baggs J. Henoch-Sch\u00f6lein\npurpura and polysaccharide meningococcal vaccine. Pediatrics.\n2010;126(2):325\u20139.\n32.\nSexton K, McNicholas A, Galloway Y, Sexton K, McNicholas A, Galloway Y,\net al. Henoch-Sch\u00f6nlein purpura and meningococcal B vaccination. Arch Dis\nChild. 2009;94(3):224\u20136.\n33.\nWatanabe T. Henoch-Sch\u00f6nlein purpura following influenza vaccinations\nduring the pandemic of influenza A (H1N1). Pediatr Nephrol. 2011;26(5):795\u20138.\n34.\nJariwala S, Vernon N, Shliozberg J. Henoch-Sch\u00f6nlein purpura after hepatitis\nA vaccination. Ann Allergy Asthma Immunol. 2011;107(2):180\u20131.\n35.\nYang YH, Yu HH, Chiang BL. The diagnosis and classification of Henoch-\nSch\u00f6nlein purpura: an updated review. Autoimmun Rev.", "mimetype": "text/plain", "start_char_idx": 24688, "end_char_idx": 26102, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f28d4263-d446-4573-a07a-f80d07c97d02": {"__data__": {"id_": "f28d4263-d446-4573-a07a-f80d07c97d02", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Da Dalt (2016).pdf", "node_type": "4", "metadata": {}, "hash": "7d5a946739c9e5405e7f7766bc1e06af16eb8cdf26137073b375384301e37ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "12a22081-6624-4514-ab13-b23224a4d056", "node_type": "1", "metadata": {}, "hash": "18766df20b644ee65839198d1a7a3565f962fedfb008da814cfa9eb80775fd97", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "35.\nYang YH, Yu HH, Chiang BL. The diagnosis and classification of Henoch-\nSch\u00f6nlein purpura: an updated review. Autoimmun Rev. 2014;13(4-5):355\u20138.\n36.\nRapporto sulla sorveglianza postmarketing dei vaccini in Italia - Anno 2012\nhttp://www.agenziafarmaco.gov.it/sites/default/files/Rapporto_sulla_\nsorveglianza_postmarketing_dei_vaccin_%20in_Italia_Anno_2012.pdf.\nAccessed 8 May 2015.\n37.\nBianciotto M, Chiappini E, Raffaldi I, Gabiano C, Tovo PA, Sollai S, et al. Drug\nuse and upper gastrointestinal complications in children: a case-control\nstudy. Arch Dis Child. 2013;98(3):218\u20132.\n\u2022  We accept pre-submission inquiries \n\u2022  Our selector tool helps you to \ufb01nd the most relevant journal\n\u2022  We provide round the clock customer support \n\u2022  Convenient online submission\n\u2022  Thorough peer review\n\u2022  Inclusion in PubMed and all major indexing services \n\u2022  Maximum visibility for your research\nSubmit your manuscript at\nwww.biomedcentral.com/submit\nSubmit your next manuscript to BioMed Central \nand we will help you at every step:\nDa Dalt et al. Italian Journal of Pediatrics  (2016) 42:60 \nPage 5 of 5", "mimetype": "text/plain", "start_char_idx": 25975, "end_char_idx": 27070, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2a82c6ab-ecb9-4cff-b7f4-9351a9b2715e": {"__data__": {"id_": "2a82c6ab-ecb9-4cff-b7f4-9351a9b2715e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5cc2527c-c840-4f00-994c-ccc06acca6b6", "node_type": "1", "metadata": {}, "hash": "76bc8f41c737d5aebf7c4b4055818c790f78f7f35f66f8de6098ed2c2992fb65", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine\n 33\n (2015)\n 3223\u20133227\nContents\n lists\n available\n at\n ScienceDirect\nVaccine\nj\n our\n na\n l ho\n me\n page:\n www.elsevier.com/locate/vaccine\nEffectiveness\n of\n Rubella\n vaccine\n in\n a\n rubella\n outbreak\n in\n Guangzhou\ncity,\n China,\n 2014\nCaiyun\n Chang a,b,1, Xianghuan\n Mo c,d,1,  Pei\n Hu e,1,  Wenjia\n Liang e,  Huilai\n Ma b,  Zhijie\n An f,\nJun\n Liu e, Huizhen\n Zheng e,\u2217\na Jinan\n Center\n for\n Disease\n Control\n and\n Prevention,\n Jinan\n 250021,\n Shandong,\n China\nb Chinese\n Field\n Epidemiology\n Training\n Program\n (CFETP),\n Chinese\n Center\n for\n Disease\n Control\n and\n Prevention,\n Beijing\n 100050,\n China\nc Dongguan\n Center\n for\n Disease\n Control\n and\n Prevention,\n Dongguan\n 523000,\n Guangdong,\n China\nd Guangdong\n Field\n Epidemiology\n Training\n Program\n (GDFETP),\n Guangdong\n Provincial\n Center\n for\n Disease\n Control\n and\n Prevention,\n Guangzhou\n 511430,\nGuangdong,\n China\ne Guangdong\n Provincial\n Center\n for\n Disease\n Control\n and\n Prevention,\n Guangzhou\n 511430,\n Guangdong,\n China\nf National\n Center\n of\n Immunization\n Program,\n Chinese\n Center\n for\n Disease\n Control\n and\n Prevention,\n Beijing\n 100050,", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1117, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5cc2527c-c840-4f00-994c-ccc06acca6b6": {"__data__": {"id_": "5cc2527c-c840-4f00-994c-ccc06acca6b6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2a82c6ab-ecb9-4cff-b7f4-9351a9b2715e", "node_type": "1", "metadata": {}, "hash": "10ec9e158cf45fdad8e34f8fee28f681ea124ae6d8c910913a89a06ba8db91f6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "40546cc7-1b15-4fb9-8488-d47cd21aa768", "node_type": "1", "metadata": {}, "hash": "30ce418950fe5bb45857420878aa2c4017f72264d7c3ce08b1a561aa975a859e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Guangzhou\n 511430,\n Guangdong,\n China\nf National\n Center\n of\n Immunization\n Program,\n Chinese\n Center\n for\n Disease\n Control\n and\n Prevention,\n Beijing\n 100050,\n China\na\n r\n t  i  c  l  e  \ni  n\n f  o\nArticle\n history:\nReceived\n 13\n January\n 2015\nReceived\n in\n revised\n form\n 5\n April\n 2015\nAccepted\n 23\n April\n 2015\nAvailable\n online\n 16\n May\n 2015\nKeywords:\nRubella\nVaccine\n effectiveness\nOutbreak\nSecondary\n attack\n rate\na\n b\n s  t  r\n a  c  t\nBackground:\n WHO\n recommends\n the  use  of rubella-containing\n vaccine\n (RCVs)  to prevent  rubella\n and  con-\ngenital\n rubella\n syndrome\n (CRS).  Most  licensed\n rubella\n vaccines\n in  use  globally\n are\n based\n on RA27/3  strains\nand\n have  estimated\n vaccine\n effectiveness\n (VE)\n rates  of 95\u2013100%.  In  contrast,\n China  uses  a BRD-II\n strain-\nbased\n rubella\n vaccine.\n Few\n \ufb01eld  studies\n have  been\n conducted\n that  estimate\n VE  of  China\u2019s\n RCV.  On  March\n17,\n 2014,\n a rubella\n outbreak\n was  reported  in  a middle\n school\n in  Guangzhou\n city,  China.\n We  conducted\n an\ninvestigation\n to  understand\n reasons\n for  the  outbreak,\n and  we  used  that  investigation\n to  estimate\n vaccine\neffectiveness\n of  China\u2019s\n rubella\n vaccine.\nMethods:\n To  identify\n cases,  investigators\n reviewed\n records\n kept  by  the  school\n doctor  and  absentee\n records\nkept\n by teachers.\n Self-administered\n questionnaires\n were\n sent  to  parents\n of  all\n students\n to  collect  infor-\nmation\n about  the  students\u2019\n symptoms,\n the  results  of  any  physician\n consultation,\n and  disease  history.", "mimetype": "text/plain", "start_char_idx": 957, "end_char_idx": 2507, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "40546cc7-1b15-4fb9-8488-d47cd21aa768": {"__data__": {"id_": "40546cc7-1b15-4fb9-8488-d47cd21aa768", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5cc2527c-c840-4f00-994c-ccc06acca6b6", "node_type": "1", "metadata": {}, "hash": "76bc8f41c737d5aebf7c4b4055818c790f78f7f35f66f8de6098ed2c2992fb65", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "33969ee0-64f4-490d-a08a-722322847058", "node_type": "1", "metadata": {}, "hash": "076ded33c45ade2a2e6615542e8274dff1c129f658e7a3e9442ad58cb3cd9c0d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We\nobtained\n demographic\n information\n and  illness\n information\n for  all  students\n in the  school;\n vaccination\nstatus\n was  determined\n by  inspection\n of  of\ufb01cial,\n parent-held\n vaccination\n records.\n A  retrospective\n cohort\nstudy\n was  conducted\n in  13  classes\n that had  secondary\n cases  of  rubella.  Using\n the  secondary\n attack\n rates,\nwe\n evaluated\n VE by  the number\n of  RCV  doses\n received\n and  age  at  vaccination.\nResults:\n During\n the  period  February\n 17\u2013May\n 23,  2014,  162  students\n (50 suspected\n cases,  88  probable\ncases,\n 24  con\ufb01rmed\n cases)  were\n diagnosed\n with\n rubella,\n yielding\n an  overall\n attack\n rate  of 10%  (162/1621).\nCases\n occurred\n in  27  classes\n (73%)  of 37  classrooms.\n Secondary\n cases  occurred\n in 13 classes\n (35%) of  37\nclassrooms.\n A  total  of  1130  students\n (69.7%)\n have  vaccination\n certi\ufb01cates;\n 419  (37%) students\n were\n record-\ncon\ufb01rmed\n to have  received\n RCV.  For  those\n vaccinated\n using  BRD-II  strain  vaccine,  vaccine\n effectiveness\n(VE)\n was 94%  (95%CI:  75\u201398).  VE  for  measles,\n mumps,  and  rubella  (MMR)\n vaccine  which\n is  based\n on\neither\n BRD-II\n or  RA27/3  strain  was  89%  (95%CI:  56\u201397).  VE of  a single  dose  of domestic\n monovalent\nrubella\n vaccine\n that  used  BRD-II  strain\n vaccine  was\n 93%  (95%CI:  73\u201398).", "mimetype": "text/plain", "start_char_idx": 2509, "end_char_idx": 3834, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "33969ee0-64f4-490d-a08a-722322847058": {"__data__": {"id_": "33969ee0-64f4-490d-a08a-722322847058", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "40546cc7-1b15-4fb9-8488-d47cd21aa768", "node_type": "1", "metadata": {}, "hash": "30ce418950fe5bb45857420878aa2c4017f72264d7c3ce08b1a561aa975a859e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4b19b7e0-9338-4554-a362-78a44b37d612", "node_type": "1", "metadata": {}, "hash": "dfc447ba94c8726df485bc4c4877b2b97f590d363f695f12fa0fe531d5a04e55", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "VE of  a single  dose  of domestic\n monovalent\nrubella\n vaccine\n that  used  BRD-II  strain\n vaccine  was\n 93%  (95%CI:  73\u201398).  VE  for  those\n who  received  the\nvaccine\n between\n 1 and  2 years\n of age\n was  95%  (95%  CI: 67\u201399)  while  the VE was 100%  for  those\n vaccinated\nafter\n 2 years\n of age.  VE among  those\n who  received\n RCV  <12  years  ago\n was  100%\n while  VE  among\n those\nwho\n received\n RCV  \u226512  years\n ago  was  92%  (95%CI:\n 70\u201398).\nConclusions:\n The\n rubella\n vaccines\n used  in  China  that  are  based  on  the  BRD-II  rubella  vaccine\n strain\n have\nVE\n of\n 94%,\n which\n is  similar  to the  more\n commonly\n used  RA27/3-based\n RCVs.  Low\n vaccination\n coverage\ncontributed\n to  this  outbreak;\n early  reporting\n of  an  outbreak\n is  necessary\n for  effective\n outbreak\n response\nimmunization.\n\u00a9\n 2015\n Elsevier\n Ltd. All  rights\n reserved.\n\u2217Corresponding\n author.\n Tel.:\n +86\n 13922743925.\nE-mail\n address:\n zhzgdcdc@163.com\n (H.\n Zheng).\n1 Caiyun\n Chang,\n Xianghuan\n Mo  and\n Pei\n Hu\n contributed\n equally\n to\n this\n work.\n1.\n Introduction\nRubella\n is\n a\n viral\n illness\n characterized\n by\n a\n mild,\n maculopapular\nrash\n [1]. The\n virus\n is\n transmitted\n through\n direct\n or\n droplet\n contact\nfrom\n nasopharyngeal\n secretions\n [2]. Rubella\n infection\n in\n pregnant\nhttp://dx.doi.org/10.1016/j.vaccine.2015.04.083\n0264-410X/\u00a9\n 2015\n Elsevier\n Ltd.\n All\n rights\n reserved.", "mimetype": "text/plain", "start_char_idx": 3706, "end_char_idx": 5111, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4b19b7e0-9338-4554-a362-78a44b37d612": {"__data__": {"id_": "4b19b7e0-9338-4554-a362-78a44b37d612", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "33969ee0-64f4-490d-a08a-722322847058", "node_type": "1", "metadata": {}, "hash": "076ded33c45ade2a2e6615542e8274dff1c129f658e7a3e9442ad58cb3cd9c0d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f92e145b-761e-4311-98ea-19d958d09838", "node_type": "1", "metadata": {}, "hash": "ef2654587d2630757588d5ffc6352768c621416d3c2360a026130616ad638fa7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All\n rights\n reserved.\n3224\n \nC.\n Chang\n et\n al.\n / Vaccine\n 33\n (2015)\n 3223\u20133227\nwomen,\n especially\n during\n the\n \ufb01rst\n trimester,\n can\n result\n in\n mis-\ncarriages,\n stillbirths,\n and\n congenital\n rubella\n syndrome\n (CRS)\n [3,4].\nRubella\n and\n CRS\n are\n preventable\n through\n vaccination.\n In\n 2000,\n the\nWorld\n Health\n Organization\n (WHO)\n recommended\n that\n all\n countries\nuse\n rubella-containing\n vaccine\n (RCVs)\n to\n prevent\n rubella\n and\n CRS.\nVaccines\n based\n on\n the\n RA27/3\n strain\n of\n rubella\n vaccine\n virus\n are\n the\nmost\n widely\n used\n RCVs\n globally.\nA\n BRD-II\n rubella\n strain\n vaccine\n was\n developed\n in\n the\n 1980s\n in\nChina\n [5], and\n has\n been\n available\n in\n the\n Chinese\n private\n market\n since\n1993\n [6]. All\n monovalent\n rubella\n and\n measles\n and\n rubella\n combined\n(MR)\n vaccines\n in\n use\n in\n China\n are\n based\n on\n the\n BRD-II\n rubella\n strain.\nA\n domestic\n measles,\n mumps\n and\n rubella\n combined\n vaccine\n (MMR)\nbased\n on\n BRD-II\n strain\n has\n been\n available\n in\n China\u2019s\n private\n market\nsince\n 2003.\n There\n is\n also\n an\n imported\n RA27/3\n strain-based\n vaccine\navailable\n in\n China.\n The\n reactogenicity\n and\n immunogenicity\n of\n the\nBRD-II\n strain\n is\n similar\n to\n RA27/3\n rubella\n vaccine\n strain\n [7]. How-\never,\n there\n are\n few\n \ufb01eld\n vaccine\n effectiveness\n (VE)\n studies\n of\n BRD-II\nstrain\n RCVs.", "mimetype": "text/plain", "start_char_idx": 5089, "end_char_idx": 6429, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f92e145b-761e-4311-98ea-19d958d09838": {"__data__": {"id_": "f92e145b-761e-4311-98ea-19d958d09838", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4b19b7e0-9338-4554-a362-78a44b37d612", "node_type": "1", "metadata": {}, "hash": "dfc447ba94c8726df485bc4c4877b2b97f590d363f695f12fa0fe531d5a04e55", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "16bd29b8-9cc9-4e03-91c6-68b1585e111f", "node_type": "1", "metadata": {}, "hash": "3665105c3b14a6b2ac0332ad3b475e2fa9c0e98128cb46621880c2fdbec1e520", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "How-\never,\n there\n are\n few\n \ufb01eld\n vaccine\n effectiveness\n (VE)\n studies\n of\n BRD-II\nstrain\n RCVs.\nOn\n March\n 17,\n the\n Chinese\n Center\n for\n Disease\n Control\n and\n Pre-\nvention\n (China\n CDC)\n was\n noti\ufb01ed\n of\n a\n rubella\n outbreak\n in\n a\n middle\nschool\n in\n a\n suburb\n of\n Guangzhou\n city,\n located\n in\n the\n south\n of\n China.\nDespite\n implementation\n of\n control\n measures,\n the\n epidemic\n spread\nrapidly.\n An\n outbreak\n investigation\n was\n initiated\n to\n identify\n fac-\ntors\n contributing\n to\n the\n high\n rate\n of\n transmission\n and\n to\n assess\nthe\n effectiveness\n of\n BRD-II\n strain\n RCVs.\n We  report\n results\n from\n that\ninvestigation.\n2.\n Materials\n and\n methods\n2.1.\n Case\n de\ufb01nitions\nFor\n this\n school-based\n outbreak,\n a\n suspected\n rubella\n case\n was\nde\ufb01ned\n as\n a\n teacher\n or\n student\n with\n a\n generalized\n rash\n lasting\n 1\u20133\ndays\n that\n had\n onset\n between\n February\n 17\n and\n May\n 23,\n 2014.\n A\n prob-\nable\n rubella\n case\n was\n de\ufb01ned\n as\n a\n suspected\n rubella\n case\n with\n fever\n>37.5 \u25e6C\n and\n at\n least\n one\n of\n the\n following\n symptoms:\n arthralgia,\narthritis,\n lymphadenopathy,\n or\n conjunctivitis\n [1]. A\n laboratory-\ncon\ufb01rmed\n case\n required\n a\n positive\n serologic\n test\n for\n rubella\n IgM\nantibody.\n An\n epidemiologically\n linked,\n con\ufb01rmed\n case\n was\n de\ufb01ned\nas\n a\n suspected\n case\n or\n a\n probable\n case\n that\n was\n not\n laboratory-\ncon\ufb01rmed,\n but\n that\n was\n geographically\n and\n temporally\n related\n to\na\n laboratory-con\ufb01rmed\n case.", "mimetype": "text/plain", "start_char_idx": 6331, "end_char_idx": 7793, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "16bd29b8-9cc9-4e03-91c6-68b1585e111f": {"__data__": {"id_": "16bd29b8-9cc9-4e03-91c6-68b1585e111f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f92e145b-761e-4311-98ea-19d958d09838", "node_type": "1", "metadata": {}, "hash": "ef2654587d2630757588d5ffc6352768c621416d3c2360a026130616ad638fa7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2141b6eb-9bf1-423d-a7bd-865a7211d9d9", "node_type": "1", "metadata": {}, "hash": "a517d82e74df697e082d1b0654fdb28afafcb1d616688537ba250b2c3ecd77ea", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We  classi\ufb01ed\n cases\n into\n primary\n and\n secondary\n cases.\n A\n primary\ncase\n was\n the\n \ufb01rst\n student\n with\n rubella\n in\n a\n classroom.\n Secondary\ncases\n were\n classmates\n in\n the\n same\n class\n with\n rubella\n onset\n 14\u201321\ndays\n after\n rubella\n onset\n of\n a\n primary\n case.\n A\n coprimary\n case\n was\nde\ufb01ned\n as\n a\n classmate\n with\n rubella\n onset\n earlier\n than\n 14\n days\n fol-\nlowing\n a\n primary\n case\n onset.\n2.2.\n Case\n \ufb01nding\n efforts\nTo\n identify\n cases,\n investigators\n reviewed\n medical\n records\n kept\nby\n the\n school\u2019s\n doctor\n and\n absentee\n records\n kept\n by\n teachers.\n Self-\nadministered\n standard\n questionnaires\n were\n sent\n to\n parents\n of\n all\nstudents\n to\n collect\n information\n on\n symptoms,\n results\n of\n physician\nconsultation,\n and\n disease\n history.\n Parents\n were\n interviewed\n by\n tele-\nphone\n to\n obtain\n information\n that\n was\n missing\n or\n unclear\n in\n the\nrecords.\n2.3.\n Vaccination\n status\nStudents\n were\n asked\n to\n provide\n their\n vaccination\n certi\ufb01cate.\n All\nvaccination\n histories\n were\n veri\ufb01ed\n against\n these\n of\ufb01cial\n immuniza-\ntion\n records,\n and\n included\n vaccine\n type,\n date\n of\n vaccination,\n and\ndose\n number.\n We  considered\n the\n vaccination\n history\n as\n unknown\nif\n no\n vaccination\n card\n was\n available.\n A\n person\n was\n categorized\n as\nvaccinated\n if\n an\n RCV\n had\n been\n administered\n at\n least\n 30\n days\n prior\nto\n onset\n of\n the\n outbreak.\n2.4.\n Emergency\n vaccination\nWe  used\n MR  vaccine\n and\n MMR\n vaccine\n to\n conduct\n emergency\nvaccination.", "mimetype": "text/plain", "start_char_idx": 7794, "end_char_idx": 9292, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2141b6eb-9bf1-423d-a7bd-865a7211d9d9": {"__data__": {"id_": "2141b6eb-9bf1-423d-a7bd-865a7211d9d9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "16bd29b8-9cc9-4e03-91c6-68b1585e111f", "node_type": "1", "metadata": {}, "hash": "3665105c3b14a6b2ac0332ad3b475e2fa9c0e98128cb46621880c2fdbec1e520", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "53401598-0851-448e-bfa3-68f13210a3ed", "node_type": "1", "metadata": {}, "hash": "134b88a5fca46cf8746d377ff7cbdd6d42e5175016db6eb07ccdd3cd51fa9f6f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2.4.\n Emergency\n vaccination\nWe  used\n MR  vaccine\n and\n MMR\n vaccine\n to\n conduct\n emergency\nvaccination.\n Students\n with\n a\n history\n of\n rubella,\n fever\n or\n acute\n illness,\nand\n whose\n parents\n refused\n vaccine\n for\n their\n child\n were\n excluded\nfrom\n emergency\n vaccination.\n2.5.\n Laboratory\n testing\nIn\n accordance\n with\n WHO\n recommendations\n [7], we\n tested\nrubella\n IgM\n and\n IgG\n using\n enzyme-linked\n immunosorbent\n assay\n(Institute\n Virion/Serion,\n Germany).\n2.6.\n Statistical\n analyses\nExcel\n software\n and\n Epi\n InfoTM 7.1.4\n statistical\n software\n were\nused\n for\n data\n analysis.\n Differences\n between\n proportions\n were\n cal-\nculated\n by\n using\n \u00022 tests;\n P\n values\n were\n 2-sided\n and\n considered\nsigni\ufb01cant\n at\n the\n 0.05\n level.\n Secondary\n attack\n rates\n (SARs)\n were\ncalculated\n by\n dividing\n the\n number\n of\n secondary\n cases\n by\n the\n num-\nber\n of\n students\n with\n no\n history\n of\n current\n rubella\n minus\n those\nwith\n primary\n and\n coprimary\n cases\n [8]. Secondary\n attack\n rates\n were\nused\n to\n calculate\n risk\n ratio\n (RR),\n and\n 95%\n con\ufb01dence\n intervals\n (CIs)\nwere\n calculated\n using\n the\n log\n rate\n of\n the\n SE\n of\n the\n ratio\n [9]. We\nestimated\n vaccine\n effectiveness\n using\n the\n secondary\n attack\n rate.\nVaccine\n effectiveness\n (%)\n =\n [(secondary\n attack\n rate\n in\n unvaccinated\ncontacts\n \u2212\n secondary\n attack\n rate\n in\n vaccinated\n contacts)/secondary\nattack\n rate\n in\n unvaccinated\n contacts]\n \u00d7\n 100\n [10]. We  only\n used\nlaboratory-\n or\n epidemiologically\n con\ufb01rmed\n cases\n to\n calculate\n VE.\n3.\n Results\n3.1.", "mimetype": "text/plain", "start_char_idx": 9186, "end_char_idx": 10736, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "53401598-0851-448e-bfa3-68f13210a3ed": {"__data__": {"id_": "53401598-0851-448e-bfa3-68f13210a3ed", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2141b6eb-9bf1-423d-a7bd-865a7211d9d9", "node_type": "1", "metadata": {}, "hash": "a517d82e74df697e082d1b0654fdb28afafcb1d616688537ba250b2c3ecd77ea", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cf96e409-2b9f-4c66-ac31-c5f0c4eca753", "node_type": "1", "metadata": {}, "hash": "fa70f41d5922e48ce6694ef0e3981d36fb9b783285a4bc7738f7fd56b2fe163d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We  only\n used\nlaboratory-\n or\n epidemiologically\n con\ufb01rmed\n cases\n to\n calculate\n VE.\n3.\n Results\n3.1.\n Outbreak\n setting\nSchool\n A\n is\n a\n middle\n school\n with\n a\n total\n of\n 1621\n students\n enrolled\nin\n the\n seventh,\n eighth,\n and\n ninth\n grades,\n with\n a\n total\n of\n 37\n classes.\nAll\n students\n are\n day\n students,\n and\n they\n eat\n their\n meals\n at\n home.\n The\nschool\n canteen\n only\n provides\n meals\n for\n some\n teachers.\n No\n school\nbus\n is\n available\n to\n students.\n This\n school\n has\n no\n full-time\n school\n doc-\ntor,\n only\n a\n part-time\n health\n teacher.\n Students\n were\n born\n between\n1998\n and\n 2001.\n3.2.\n Outbreak\n epidemiology\nAll\n cases\n were\n students;\n no\n teachers\n had\n rubella\n during\n the\n out-\nbreak.\n Between\n February\n 17\n and\n May\n 23,\n 162\n rubella\n cases\n among\n1621\n students\n were\n detected,\n including\n 50\n suspected\n cases,\n 88\nprobable\n cases,\n and\n 24\n con\ufb01rmed\n cases.\n No\n cases\n were\n severe.\nThe\n overall\n attack\n rate\n was\n 9.99%.\n In\n addition\n to\n characteristic\nrash\n (100%),\n 69\n (42.59%)\n students\n had\n a\n temperature\n >37.5 \u25e6C;\n 34\n(20.99%)\n had\n lymphadenopathy;\n 7\n (4.32%)\n had\n conjunctivitis,\n and\n2\n (1.23%)\n had\n arthralgia.\nBy\n the\n end\n of\n the\n outbreak,\n cases\n had\n occurred\n in\n 27\n classes\n(72.97%)\n across\n 37\n classrooms.\n The\n highest\n class\n attack\n rate\n was\n58.14%,\n and\n the\n second\n highest\n was\n 53.85%.", "mimetype": "text/plain", "start_char_idx": 10633, "end_char_idx": 12003, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cf96e409-2b9f-4c66-ac31-c5f0c4eca753": {"__data__": {"id_": "cf96e409-2b9f-4c66-ac31-c5f0c4eca753", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "53401598-0851-448e-bfa3-68f13210a3ed", "node_type": "1", "metadata": {}, "hash": "134b88a5fca46cf8746d377ff7cbdd6d42e5175016db6eb07ccdd3cd51fa9f6f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c1e28fc8-1ddd-4f1f-8043-3d76a86dbcf4", "node_type": "1", "metadata": {}, "hash": "8a024eecfe180f56e9c8163b31e4983419242002b8212d986d05ee8a5a79a99e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\n highest\n class\n attack\n rate\n was\n58.14%,\n and\n the\n second\n highest\n was\n 53.85%.\n A\n total\n of\n 68\n (5.06%)\n sec-\nondary\n cases\n were\n found\n to\n have\n signs\n and\n symptoms\n of\n the\n rubella.\nSecondary\n cases\n occurred\n in\n 13\n classes\n (35.14%)\n of\n 37\n classrooms.\nAlthough\n cases\n began\n to\n appear\n in\n February,\n of\ufb01cial\n noti\ufb01cation\nof\n an\n outbreak\n did\n not\n occur\n until\n March\n 17.\n The\n outbreak\n lasted\nfor\n 95\n days\n and\n ended\n on\n May\n 23.\n Distinct\n peaks\n of\n cases\n occurred\nat\n 7-day\n intervals\n during\n March\n and\n May\n (Fig.\n 1).\nC.\n Chang\n et\n al.\n / Vaccine\n 33\n (2015)\n 3223\u20133227\n \n3225\nFig.\n 1.\n Weekly\n distribution\n of\n rubella\n cases\n in\n a\n middle\n school\n Guangzhou\n from\n February\n 17\n to\n May\n 23,\n 2014.\n3.3.\n Vaccination\n status\nAll\n registered\n students\n completed\n questionnaires.\n A\n total\n of\n1130\n students\n (69.7%)\n provided\n vaccination\n certi\ufb01cates;\n 419\n(37.08%)\n students\n were\n con\ufb01rmed\n to\n have\n received\n RCV.\n The\n high-\nest\n class\n rubella\n vaccination\n coverage\n rate\n was\n 65.22%;\n the\n lowest\ncoverage\n rate\n was\n 18.18%\n (Fig.\n 2).\n Among\n the\n 419\n vaccinated\n stu-\ndents,\n 239\n students\n received\n monovalent\n rubella\n vaccine\n as\n their\n\ufb01rst\n rubella\n vaccine\n dose,\n 4\n students\n received\n MR  vaccine.\n All\nmonovalent\n rubella\n and\n MR  vaccines\n were\n based\n on\n the\n BRD-II\nrubella\n strain.", "mimetype": "text/plain", "start_char_idx": 11916, "end_char_idx": 13274, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c1e28fc8-1ddd-4f1f-8043-3d76a86dbcf4": {"__data__": {"id_": "c1e28fc8-1ddd-4f1f-8043-3d76a86dbcf4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cf96e409-2b9f-4c66-ac31-c5f0c4eca753", "node_type": "1", "metadata": {}, "hash": "fa70f41d5922e48ce6694ef0e3981d36fb9b783285a4bc7738f7fd56b2fe163d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ecb8e59d-9d21-4cee-979b-c4e29f0b5d68", "node_type": "1", "metadata": {}, "hash": "e744e6900a26eb6134b05173a5c3f544760e1836914aad87eef59a3ee371e0aa", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All\nmonovalent\n rubella\n and\n MR  vaccines\n were\n based\n on\n the\n BRD-II\nrubella\n strain.\n However,\n 176\n students\n received\n MMR\n vaccine\n which\nwas\n based\n on\n either\n the\n RA27/3\n strain\n or\n the\n BRD-II\n strain\n as\n their\n\ufb01rst\n rubella\n vaccination.\n3.4.\n Vaccine\n effectiveness\nTo\n diminish\n the\n in\ufb02uence\n of\n subclinical\n rubella\n and\n bias\nof\n differential\n exposure\n in\n the\n classroom,\n we\n used\n secondary\nattack\n rate\n to\n estimate\n vaccine\n effectiveness;\n 13\n classes\n with\n sec-\nondary\n cases\n were\n selected\n for\n this\n analysis.\n We  selected\n students\nwith\n known\n immunization\n status\n in\n the\n 13\n classes,\n and\n catego-\nrized\n them\n into\n a\n vaccinated\n group\n and\n a\n not\n vaccinated\n group\n(Fig.\n 3).\nThe\n secondary\n attack\n rates\n among\n students\u2019\n contacts\n that\n were\nvaccinated\n with\n monovalent\n rubella\n and\n aggregated\n BRD-II\n strain\nvaccine\n were\n 2.35%\n and\n 2.33%,\n respectively\n (Table\n 1).\n For\n those\n vac-\ncinated\n using\n BRD-II\n strain\n vaccine,\n VE\n was\n 94%\n (95%CI:\n 75\u201398).\nThe\n VE\n for\n MMR\n vaccine\n which\n based\n on\n BRD-II\n or\n RA27/3\n strain\nwas\n 89%\n (95%CI:\n 56\u201397).\n We  considered\n the\n vaccination\n status\n as\nunknown\n if\n no\n card\n or\n no\n record\n was\n available\n to\n verify\n vaccination\nstatus.", "mimetype": "text/plain", "start_char_idx": 13185, "end_char_idx": 14434, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ecb8e59d-9d21-4cee-979b-c4e29f0b5d68": {"__data__": {"id_": "ecb8e59d-9d21-4cee-979b-c4e29f0b5d68", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c1e28fc8-1ddd-4f1f-8043-3d76a86dbcf4", "node_type": "1", "metadata": {}, "hash": "8a024eecfe180f56e9c8163b31e4983419242002b8212d986d05ee8a5a79a99e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1995bf94-8c4b-47b1-9a0f-3fdb876e6ada", "node_type": "1", "metadata": {}, "hash": "5aba4bd32dfa3724dd2ba968c9e48765a6b4c6f0bdcac59ad428e67bdb76a70d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We  considered\n the\n vaccination\n status\n as\nunknown\n if\n no\n card\n or\n no\n record\n was\n available\n to\n verify\n vaccination\nstatus.\n With\n the\n assumption\n that\n vaccine\n ef\ufb01cacy\n is\n the\n same\n for\nvaccinated\n students\n in\n this\n group\n compared\n with\n record-proved\nvaccinated\n students,\n estimated\n VE\n for\n this\n unknown\n vaccination\nstatus\n group\n was\n 58%,\n which\n implies\n that\n approximately\n 63.2%\n stu-\ndents\n in\n the\n unknown\n status\n group\n had\n been\n vaccinated\n prior\n to\n the\noutbreak.\nFig.\n 2.\n Distribution\n of\n rubella\n vaccination\n statuses\n for\n students,\n by\n class,\n in\n a\n middle\n school\n in\n Guangzhou\n from\n February\n 17\n to\n May\n 23,\n 2014.\n3226\n \nC.\n Chang\n et\n al.\n / Vaccine\n 33\n (2015)\n 3223\u20133227\nTable  1\nRubella\n vaccine\n effectiveness\n for\n different\n types\n of\n vaccine\n in\n a\n middle\n school,\n Guangzhou\n city,\n 2014.", "mimetype": "text/plain", "start_char_idx": 14303, "end_char_idx": 15155, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1995bf94-8c4b-47b1-9a0f-3fdb876e6ada": {"__data__": {"id_": "1995bf94-8c4b-47b1-9a0f-3fdb876e6ada", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ecb8e59d-9d21-4cee-979b-c4e29f0b5d68", "node_type": "1", "metadata": {}, "hash": "e744e6900a26eb6134b05173a5c3f544760e1836914aad87eef59a3ee371e0aa", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0deb71ea-139d-464d-96b9-e845e67cdb8e", "node_type": "1", "metadata": {}, "hash": "35b4b960ca0f4eec0cf327b0028e401d3d64b1fdabeba2eb1103ee6f56719d56", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccination\n status\n \nSecondary\n cases\n \nExposed\n persons\n \nSARs(%)\n \nRR\n (95%CI)\n \nVE\n (%,95%CI)\n \nP\n value\nNot\n vaccinated\n \n65\n \n171\n \n38.01\n \nRef\n \nRef\n \nRef\nMonovalent\n \n2\n \n85\n \n2.35\n \n0.06\n (0.02\u20130.25)\n \n94(75\u201398)\n \n0.000\nMR\n \n0\n \n1\n \n0\n \n0.441\nAggregate(BRD-II)\n \n2\n \n86\n \n2.33\n \n0.06\n (0.02\u20130.24)\n \n94\n (75\u201398)\n \n0.000\nMMR(BRD-IIor\n RA27/3)\n \n2\n \n47\n \n4.26\n \n0.11\n (0.03\u20130.44)\n \n89\n (56\u201397)\n \n0.000\nUnknown\n \n20\n \n125\n \n16\n \n0.42\n (0.27\u20130.66)\n \n58\n (34\u201373)\n \n0.000\nTable\n 2\nRubella\n containing\n vaccines\n effectiveness\n for\n different\n vaccine\n dose\n numbers\n in\n a middle\n school,\n Guangzhou\n city,\n 2014.\nVaccination\n status\nSecondary\n cases\nExposed\n persons\nSARs\n (%)\nRR\n (95%CI)\nVE\n (%,\n 95%CI)\nP\n value\n0\n dose\n65\n \n171\n \n38.01\nRef\n \nRef\n \nRef\n1\n dose\n2\n \n78\n \n2.56\n \n0.07\n (0.02\u20130.27)\n \n93\n (73\u201398)\n \n0.000\n2\n doses\n or\n more\n \n0\n \n7\n \n0\n \n\u2013\n \n\u2013\n \n0.041\nTable\n 3\nRubella-containing\n vaccine\n effectiveness\n for\n different\n vaccination\n ages\n in\n a\n middle\n school,\n Guangzhou\n city,2014.", "mimetype": "text/plain", "start_char_idx": 15156, "end_char_idx": 16158, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0deb71ea-139d-464d-96b9-e845e67cdb8e": {"__data__": {"id_": "0deb71ea-139d-464d-96b9-e845e67cdb8e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1995bf94-8c4b-47b1-9a0f-3fdb876e6ada", "node_type": "1", "metadata": {}, "hash": "5aba4bd32dfa3724dd2ba968c9e48765a6b4c6f0bdcac59ad428e67bdb76a70d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "25ca4f5b-18a5-441c-862f-a2b311391b9d", "node_type": "1", "metadata": {}, "hash": "b2312352cac5c36b3e94b28ea3ed63c3943d829aef7cd59ac15af2b62135492d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Age\n at\n vaccination\nSecondary\n cases\nExposed\n persons\nSARs(%)\n \nRR\n (95%CI)\n \nVE\n (%,\n 95%CI)\n \nP\n value\nNot\n vaccinated\n \n65\n \n171\n \n38.01\n \nRef\n \nRef\n \nRef\n<1years\n old\n \n1\n \n10\n \n10\n \n0.26\n (0.04\u20131.71)\n \n74\n (0\u201396)\n \n0.074\n1\u20132\n years\n old\n \n1\n \n56\n \n1.79\n \n0.05\n (0.01\u20130.33)\n \n95\n (67\u201399)\n \n0.000\n>2\n years\n old\n \n0 \n19\n \n0 \n\u2013\n \n\u2013\n \n0.001\nTable\n 4\nRubella\n vaccine\n effectiveness\n relating\n to\n the\n number\n of\n years\n since\n vaccination\n in\n a\n middle\n school,\n Guangzhou\n city,\n 2014.\nYears\n since\n vaccination\n \nSecondary\n cases\n \nExposed\n person\n \nSARs\n (%)\n \nRR\n (95%CI)\n \nVE\n (%,95%CI)\n \nP\n value\nNot\n vaccinated\n \n65\n \n171\n \n38.01\n \nRef\n \nRef\n \nRef\n<12\n years\n \n0\n \n15\n \n0\n \n\u2013\n \n\u2013\n \n0.004\n\u226512\n years\n2\n \n70\n \n2.86\n \n0.08\n (0.02\u20130.30)\n \n92\n (70\u201398)\n \n0.000\nFig.\n 3.\n Pro\ufb01le\n of\n study\n cases.\nOur\n study\n focused\n on\n VE\n for\n a\n domestic\n monovalent\n vaccine\n that\nused\n the\n BRD-II\n strain.\n We  evaluated\n VE\n of\n different\n vaccine\n doses\nnumbers,\n age\n at\n vaccination,\n and\n persistence\n of\n antibody\n using\n the\nsecondary\n attack\n rate.\nAmong\n the\n 256\n exposed\n students,\n 0.33%\n (2/256)\n had\n received\n at\nleast\n 1\n dose\n of\n rubella-containing\n vaccine\n before\n the\n outbreak.", "mimetype": "text/plain", "start_char_idx": 16159, "end_char_idx": 17355, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "25ca4f5b-18a5-441c-862f-a2b311391b9d": {"__data__": {"id_": "25ca4f5b-18a5-441c-862f-a2b311391b9d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0deb71ea-139d-464d-96b9-e845e67cdb8e", "node_type": "1", "metadata": {}, "hash": "35b4b960ca0f4eec0cf327b0028e401d3d64b1fdabeba2eb1103ee6f56719d56", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4fcf3457-84ce-4fa0-86fa-1ab4f59eaac6", "node_type": "1", "metadata": {}, "hash": "7b63acb9bb4898d181ddb06a93f1ba2ac41cec54aba770c1905238aae8ce6ad5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Among\n the\n 256\n exposed\n students,\n 0.33%\n (2/256)\n had\n received\n at\nleast\n 1\n dose\n of\n rubella-containing\n vaccine\n before\n the\n outbreak.\n The\nsecondary\n attack\n rate\n among\n students\n who\n received\n zero,\n one,\n or\ntwo\n doses\n was\n 38.01%,\n 2.56%,\n and\n 0%,\n respectively\n (Table\n 2).\n Single-\ndose\n domestic\n monovalent\n vaccine\n effectiveness\n was\n 93%\n (95%CI,\n73\u201398).\nThe\n secondary\n attack\n rate\n among\n students\u2019\n contacts\n who\n were\nvaccinated\n at\n <1\n year\n of\n age,\n 1\u20132\n years\n old,\n and\n >2\n years\n old\n was\n10.00%,\n 1.79%\n and\n 0%,\n respectively\n (Table\n 3).\n Vaccination\n effective-\nness\n for\n those\n who\n received\n the\n vaccine\n between\n 1\n and\n 2\n years\n of\nage\n was\n 95%\n (95%\n CI:\n 67\u201399)\n while\n the\n vaccine\n effectiveness\n was\n100%\n for\n those\n vaccinated\n after\n 2\n years\n of\n age.\nThe\n secondary\n attack\n rates\n of\n rubella\n among\n students\u2019\n contacts\nwho\n had\n been\n vaccinated\n <12\n years\n ago\n and\n \u226512\n years\n were\n 0%\nand\n 2.86%,\n respectively\n (Table\n 4).\n VE\n among\n those\n who\n received\nRCV\n <12\n years\n ago\n was\n 100%\n while\n VE\n among\n those\n who\n received\nRCV\n \u226512\n years\n ago\n was\n 92%\n (95%\n CI:\n 70\u201398).\n3.5.\n Emergency\n vaccination\n activities\nDuring\n the\n outbreak,\n rubella\n emergency\n vaccination\n activities\nwere\n launched\n twice.\n On\n March\n 18\u201322,\n 33\n students\n received\n MMR\nvaccine\n in\n a\n community\n service\n center.", "mimetype": "text/plain", "start_char_idx": 17213, "end_char_idx": 18582, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4fcf3457-84ce-4fa0-86fa-1ab4f59eaac6": {"__data__": {"id_": "4fcf3457-84ce-4fa0-86fa-1ab4f59eaac6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "25ca4f5b-18a5-441c-862f-a2b311391b9d", "node_type": "1", "metadata": {}, "hash": "b2312352cac5c36b3e94b28ea3ed63c3943d829aef7cd59ac15af2b62135492d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3bf559de-e4a9-4cf8-bfca-4408cb96dbb5", "node_type": "1", "metadata": {}, "hash": "bc3307a7aac64f7ed4dab3a442a6c6944772b8b13bdfe91181c45fee41d8bc71", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "On\n March\n 18\u201322,\n 33\n students\n received\n MMR\nvaccine\n in\n a\n community\n service\n center.\n After\n investigating\n the\n out-\nbreak,\n we  suggested\n that\n the\n school\n should\n conduct\n an\n emergency\nvaccination\n program\n targeting\n all\n students\n whose\n parents\n agreed\n to\nhave\n them\n vaccinated.\n On\n March\n 26,\n 957\n students\n received\n an\n MR\nvaccine\n at\n temporary\n vaccination\n points\n set\n up\n by\n the\n community\nservice\n center\n at\n the\n school.\n After\n the\n second\n emergency\n vaccina-\ntion,\n 44\n students\n were\n reported\n to\n have\n rubella\n before\n the\n epidemic\nended.\n The\n last\n case\n happened\n on\n May\n 22.\n4.\n Discussion\nWe  have\n shown\n that\n the\n rubella\n vaccines\n used\n in\n China\n that\n are\nbased\n on\n the\n BRD-II\n rubella\n vaccine\n strain\n have\n a\n vaccine\n effec-\ntiveness\n of\n 94%,\n which\n is\n similar\n to\n the\n more\n commonly\n used\nRA27/3-based\n RCVs.\n Our\n study\n also\n showed\n that\n VE\n for\n those\n who\nreceived\n the\n vaccine\n between\n 1\n and\n 2\n years\n of\n age\n was\n 95%,\n while\nit\n was\n 100%\n for\n those\n vaccinated\n after\n 2\n years\n of\n age.\n The\n dura-\ntion\n protection\n is\n apparently\n at\n least\n 12\n years,\n as\n VE\n among\n those\nwho\n received\n RCV\n <12\n years\n ago\n was\n 100%,\n while\n VE\n among\n those\nvaccinated\n over\n 12\n years\n prior\n to\n the\n outbreak\n was\n 92%.\n A\n single\ndose\n of\n RCV\n reduced\n the\n risk\n of\n rubella\n by\n 93%,\n and\n among\n students\nwho\n received\n two\n doses,\n the\n rubella\n risk\n was\n reduced\n by\n 100%.\n Our\nC.\n Chang\n et\n al.", "mimetype": "text/plain", "start_char_idx": 18492, "end_char_idx": 19973, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3bf559de-e4a9-4cf8-bfca-4408cb96dbb5": {"__data__": {"id_": "3bf559de-e4a9-4cf8-bfca-4408cb96dbb5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4fcf3457-84ce-4fa0-86fa-1ab4f59eaac6", "node_type": "1", "metadata": {}, "hash": "7b63acb9bb4898d181ddb06a93f1ba2ac41cec54aba770c1905238aae8ce6ad5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5e0397c4-b95a-4633-b07d-cf7958e8ca78", "node_type": "1", "metadata": {}, "hash": "f180845ecd300d10803d9a2f09851b6954d587bf52a3e692ebb70a7a7535b6bc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Our\nC.\n Chang\n et\n al.\n / Vaccine\n 33\n (2015)\n 3223\u20133227\n \n3227\nestimate\n of\n VE\n for\n the\n group\n of\n students\n with\n unknown\n vaccina-\ntion\n status\n was\n 58%,\n which\n implied\n that\n approximately\n 63.2%\n of\n the\nstudents\n in\n that\n group\n had\n been\n vaccinated\n prior\n to\n the\n outbreak.\nLow\n vaccination\n coverage\n levels\n contributed\n to\n this\n outbreak,\nwhich\n re\ufb02ects\n the\n relatively\n recent\n inclusion\n of\n RCV\n into\n the\n immu-\nnization\n program\n in\n China.\n Initial\n outbreak\n response\n vaccination\nefforts\n were\n not\n effective,\n and\n it\n is\n not\n clear\n the\n degree\n to\n which\nthe\n second\n vaccination\n response\n effort\n curtailed\n the\n outbreak.\n4.1.\n Strengths\n and\n weaknesses\nOur\n study\n took\n advantage\n of\n the\n rubella\n outbreak\n to\n evaluate\n VE\nof\n BRD-II\n strain\n RCVs\n in\n China.\n We  used\n secondary\n attack\n rate\n to\ncalculate\n the\n VE\n to\n diminish\n the\n in\ufb02uence\n of\n subclinical\n rubella\n and\nbias\n of\n differential\n exposure\n in\n the\n classroom.\n Although\n we\n had\n a\ngroup\n of\n students\n with\n unknown\n vaccination\n status,\n all\n vaccination\nhistories\n were\n veri\ufb01ed\n with\n vaccination\n cards.\n Our\n study\n has\n poten-\ntial\n for\n recall\n bias\n in\n which\n students\n may\n not\n remember\n important\ncharacteristics\n of\n their\n illnesses,\n making\n clinical\n inference\n subject\nto\n this\n bias.\n Not\n all\n the\n cases\n had\n laboratory\n con\ufb01rmation\n of\n rubella,\nhowever,\n all\n suspected\n and\n probable\n cases\n were\n geographically\nand\n temporally\n related\n to\n at\n least\n one\n laboratory-con\ufb01rmed\n case.", "mimetype": "text/plain", "start_char_idx": 19951, "end_char_idx": 21476, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5e0397c4-b95a-4633-b07d-cf7958e8ca78": {"__data__": {"id_": "5e0397c4-b95a-4633-b07d-cf7958e8ca78", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3bf559de-e4a9-4cf8-bfca-4408cb96dbb5", "node_type": "1", "metadata": {}, "hash": "bc3307a7aac64f7ed4dab3a442a6c6944772b8b13bdfe91181c45fee41d8bc71", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b11544b7-0799-4e3b-9ae3-72cc3aaa93dc", "node_type": "1", "metadata": {}, "hash": "00d80a4f63228df3e786c6b21b852a114a0fc790f4a7e16815bb22ce5acdc3f4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We\n estimated\n the\n apparent\n RCV\n coverage\n of\n the\n students\n with\nunknown\n vaccination\n status,\n but\n to\n do\n so,\n we\n had\n to\n assume\n VE\nwas\n the\n same\n as\n with\n other\n students.\n4.2.\n Strengths\n and\n weaknesses\n in\n the\n context\n of\n other\n literature\nIn\n our\n study,\n no\n student\n who\n received\n 2\n RCV\n doses\n had\n rubella\n in\nthis\n school-based\n outbreak.\n Although\n only\n one\n routine\n RCV\n dose\n is\nfelt\n to\n be\n essential\n for\n rubella\n elimination,\n a\n second\n dose\n appeared\nto\n have\n some\n additional\n bene\ufb01t\n over\n one\n dose\n in\n our\n study.\n This\nmay\n be\n re\ufb02ected\n in\n other\n industrialized\n countries\u2019\n use\n of\n a\n sec-\nond\n dose\n of\n MMR\n vaccine,\n which\n can\n boost\n low\n rubella\n antibody\nlevels\n [11]. In\n general,\n however,\n the\n high\n seroconversion\n rate\n and\nlong-term\n protection\n of\n a\n single\n dose\n of\n rubella\n vaccine\n does\n not\nsupport\n the\n need\n for\n a\n routine\n second\n dose\n of\n rubella\n vaccine\n [12].\nOne\n study\n has\n reported\n that\n a\n rubella\n seroconversion\n rate\n of\n \u226590%\nwhen\n children\n are\n vaccinated\n at\n 9\u201312\n months\n of\n age.\n Rubella\n vac-\ncine\n is\n usually\n administered\n routinely\n at\n 12\n months\n of\n age\n or\n older,\nand\n maternal\n antibodies\n have\n usually\n disappeared\n by\n then\n [12]. Our\nstudy\n was\n consistent\n with\n vaccination\n at\n or\n after\n 12\n months\n of\n age,\nsince\n students\n vaccinated\n at\n <1\n year\n of\n age\n had\n a\n slightly\n higher\n rate\nof\n rubella\n compared\n with\n children\n vaccinated\n at\n or\n after\n one\n year\nof\n age.", "mimetype": "text/plain", "start_char_idx": 21477, "end_char_idx": 22971, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b11544b7-0799-4e3b-9ae3-72cc3aaa93dc": {"__data__": {"id_": "b11544b7-0799-4e3b-9ae3-72cc3aaa93dc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5e0397c4-b95a-4633-b07d-cf7958e8ca78", "node_type": "1", "metadata": {}, "hash": "f180845ecd300d10803d9a2f09851b6954d587bf52a3e692ebb70a7a7535b6bc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9275ca13-8c98-4aed-851b-3c7f698445fb", "node_type": "1", "metadata": {}, "hash": "478786dfb6682039348ee534ecff6d6477c8ce80e493ee78a5c09a3d76233025", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We  found\n that\n signi\ufb01cant\n protection\n did\n extend\n to\n at\n least\n12\n years\n following\n vaccination,\n which\n is\n similar\n to\n other\n studies,\n[13,14]\n which\n have\n shown\n that\n 95%\n of\n vaccine\n recipients\n remain\nseropositive\n 10\n years\n after\n immunization.\n4.3.\n Program\n implications\nOur\n study\n provided\n supportive\n evidence\n that\n the\n BRD-II-based\nRCV\n is\n comparable\n in\n effectiveness\n with\n the\n RA27/3\n vaccine,\n sup-\nporting\n the\n vaccine\u2019s\n use\n in\n the\n Chinese\n immunization\n program.\nWithout\n considering\n vaccine\n failure,\n the\n rubella\n vaccine\n coverage\nrate\n must\n be\n at\n least\n 85%\n to\n interrupt\n rubella\n virus\n transmission\nand\n lead\n to\n elimination\n of\n rubella.\n However,\n only\n 37%\n of\n students\nwere\n able\n to\n be\n con\ufb01rmed\n by\n of\ufb01cial\n records\n to\n have\n received\n RCV.\nPrior\n to\n 2008,\n the\n cost\n of\n rubella\n vaccination\n had\n to\n be\n paid\n by\nthe\n child\u2019s\n family;\n in\n 2008,\n China\n induced\n rubella\n vaccine\n in\n the\nnational\n immunization\n program,\n which\n not\n only\n made\n the\n vaccine\nfree\n for\n all\n families,\n but\n it\n put\n rubella\n prevention\n into\n the\n program\u2019s\nstrategic\n planning\n [15]. Of\n interest,\n all\n of\n the\n students\n involved\n in\nthe\n outbreak\n were\n born\n between\n 1998\n and\n 2001\n when\n the\n rubella\nvaccine\n coverage\n rate\n was\n lower\n and\n when\n the\n program\n was\n not\nimplementing\n a\n rubella\n prevention\n strategy.\nWe did\n not\n \ufb01nd\n rubella\n cases\n among\n family\n members.", "mimetype": "text/plain", "start_char_idx": 22973, "end_char_idx": 24412, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9275ca13-8c98-4aed-851b-3c7f698445fb": {"__data__": {"id_": "9275ca13-8c98-4aed-851b-3c7f698445fb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b11544b7-0799-4e3b-9ae3-72cc3aaa93dc", "node_type": "1", "metadata": {}, "hash": "00d80a4f63228df3e786c6b21b852a114a0fc790f4a7e16815bb22ce5acdc3f4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "70d0bd37-d530-4d46-95e3-305e1e05d4bb", "node_type": "1", "metadata": {}, "hash": "0e413e57de1d1aa1c793e69e23668e8433f1c7aa8eed1ff38c6c4ec7496fbfc7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We did\n not\n \ufb01nd\n rubella\n cases\n among\n family\n members.\n All\n of\n the\nstudents\n ate\n meals\n at\n home\n and\n did\n not\n take\n the\n bus\n to\n school,\nimplying\n that\n rubella\n virus\n spread\n during\n class\n time.\n The\n school\ninvolved\n in\n the\n outbreak\n had\n no\n full-time\n doctor,\n and\n the\n part-time\nhealth\n educator\n had\n not\n received\n training\n on\n infectious\n disease\nsurveillance\n and\n outbreak\n control.\n Perhaps\n as\n a\n consequence,\nalthough\n cases\n began\n to\n appear\n in\n February,\n of\ufb01cial\n noti\ufb01cation\n of\nan\n outbreak\n did\n not\n occur\n until\n March\n 17.\n We  therefore\n missed\n the\nbest\n chance\n to\n control\n the\n epidemic.\n4.4.\n Recommendations\n and\n next\n steps\nOur\n \ufb01ndings\n support\n several\n recommendations.\n First,\n BRD-II-\nbased\n rubella\n vaccine\n should\n remain\n in\n the\n national\n immunization\nprogram.\n It\n appears\n to\n be\n suf\ufb01ciently\n effective\n to\n achieve\n the\n pro-\ntective\n levels\n necessary\n to\n eliminate\n rubella.\n Second,\n achieving\n high\nvaccination\n coverage\n level\n through\n routine\n immunization\n will\n be\nnecessary\n for\n effective\n control\n and\n elimination\n of\n rubella.\n Third,\nuse\n of\n additional\n training\n or\n guidelines\n on\n identi\ufb01cation\n and\n repor-\nting\n of\n an\n infectious\n disease\n outbreak\n should\n be\n considered\n for\nthe\n school\n systems\n in\n China.\n Earlier\n detection\n and\n reporting\n may\nhave\n allowed\n a\n more\n effective\n outbreak\n response\n vaccination\n effort.\nFourth,\n because\n long-term\n protection\n afforded\n by\n RCV\n is\n not\n known\nwith\n certainty,\n VE\n should\n be\n assessed\n periodically\n when\n opportu-\nnities\n arise.", "mimetype": "text/plain", "start_char_idx": 24355, "end_char_idx": 25933, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "70d0bd37-d530-4d46-95e3-305e1e05d4bb": {"__data__": {"id_": "70d0bd37-d530-4d46-95e3-305e1e05d4bb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9275ca13-8c98-4aed-851b-3c7f698445fb", "node_type": "1", "metadata": {}, "hash": "478786dfb6682039348ee534ecff6d6477c8ce80e493ee78a5c09a3d76233025", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dc86d51c-ddce-4d5e-9b5e-60a648574057", "node_type": "1", "metadata": {}, "hash": "c8408b454a309e180ef7d0f77c88ca0d43bf0e76db19a3db48ac3337f7bcdf71", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Fourth,\n because\n long-term\n protection\n afforded\n by\n RCV\n is\n not\n known\nwith\n certainty,\n VE\n should\n be\n assessed\n periodically\n when\n opportu-\nnities\n arise.\nAcknowledgments\nWe\n gratefully\n acknowledge\n the\n health\n workers\n from\n Panyu\n CDC\nand\n their\n af\ufb01liate\n community\n health\n service\n center\n who\n partici-\npated\n in\n the\n \ufb01eld\n investigation.\n We  thank\n teacher\n Peiqin\n Wei,\n Dr\nHuiming\n Luo,\n Chenggang\n Wu,\n Shuqing\n Zhao,\n Xiaoping\n Shao,\n Qi\n Zhu,\nYu\n Liu,\n Qiru\n Su\n and\n Yan\n Li\n for\n your\n critical\n support\n for\n this\n study.\n We\nthank\n Dr\n Shannon\n Rutherford\n for\n critically\n reading\n the\n manuscript.\nWe thank\n Dr\n Lawrence\n Rodewald\n for\n critical\n support\n and\n review\n of\nthe\n manuscript\n and\n response\n to\n the\n editor\u2019s\n and\n reviewer\u2019s\n com-\nments.\nReferences\n[1]\n Centers\n for\n Diseases\n Control\n and\n Prevention.\n Epidemiology\n and\n prevention\n of\nvaccine-preventable\n disease.\n 12th\n ed.\n Washington,\n DC:\n Public\n Health\n Founda-\ntion;\n 2011.\n p.\n 275\u201390.\n[2]\n David\n L,\n Heymann.\n Control\n of\n communicable\n disease\n Manual.\n 18th\n ed.\n Wash-\nington,\n DC:\n American\n Public\n Health\n Association;\n 2004.\n p.\n 468\u201372.\n[3]\n Miller\n E,\n Cradock-Watson\n JE,\n Pollock\n TM.\n Consequences\n of\n con\ufb01rmed\n maternal\nrubella\n at\n successive\n stages\n of\n pregnancy.\n Lancet\n 1982;2:781\u20134.\n[4]\n Enders\n G,\n Nickerl-Pacher\n U,\n Miller\n E,\n Cradock-Watson\n JE.\n Outcome\n of\n con\ufb01rmed\npericonceptional\n maternal\n rubella.\n Lancet\n 1988;1:1445\u20137.", "mimetype": "text/plain", "start_char_idx": 25771, "end_char_idx": 27237, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dc86d51c-ddce-4d5e-9b5e-60a648574057": {"__data__": {"id_": "dc86d51c-ddce-4d5e-9b5e-60a648574057", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "70d0bd37-d530-4d46-95e3-305e1e05d4bb", "node_type": "1", "metadata": {}, "hash": "0e413e57de1d1aa1c793e69e23668e8433f1c7aa8eed1ff38c6c4ec7496fbfc7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "629f49b9-c0b0-4f42-b68f-a890a58f4040", "node_type": "1", "metadata": {}, "hash": "f6442fbcd280bfa954a2a704c65e034f814e745649a11f016f506504b33b6e34", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Outcome\n of\n con\ufb01rmed\npericonceptional\n maternal\n rubella.\n Lancet\n 1988;1:1445\u20137.\n[5]\n Han\n YR,\n Zhao\n K,\n Gong\n YX.\n Rubella\n vaccine\n in\n the\n People\u2019s\n Republic\n of\n China.\n Rev\nInfect\n Dis\n 1985;7(Suppl.\n 1):S79.\n[6]\n Ze\n WY,\n Diao\n LD,\n Xu\n AQ.\n Expanded\n program\n on\n immunization.\n 2nd\n ed.\n Shanghai:\nShanghai\n Publishing\n House\n of\n Scienti\ufb01c\n and\n Technological\n Literature;\n 2001.\np. 549.\n[7]\n World\n Health\n Organization.\n Rubella\n vaccine:\n WHO\n position\n paper.\n Wkly\n Epi-\ndemiol\n Rec\n 2011;86:301\u201316.\n[8]\n Ma  H,\n Fontaine\n R.\n Varicella\n outbreak\n among\n primary\n school\n students-Beijing,\nChina,\n 2004.\n MMWR\n Morb\n Mortal\n Wkly\n Rep\n 2006;55(April\n (Suppl.\n 1)):39\u201343.\n[9]\n Kleinbaum\n DG,\n Kupper\n LL,\n Morgenstern\n H.\n Epidemiologic\n research:\n principles\nand quantitative\n methods.\n Belmont,\n CA:\n Wadsworth\n Inc.;\n 1982.\n[10]\n Orenstein\n WA,\n Bernier\n RH,\n Dondero\n TJ,\n Hinman\n AR,\n Marks\n JS,\n Bart\n KJ,\n et\n al.\n Field\nevaluation\n of\n vaccine\n ef\ufb01cacy.\n Bull\n World\n Health\n Organ\n 1985;63:1055\u201368.\n[11]\n Johnson\n CE.\n Antibody\n persistence\n after\n primary\n measles-mumps-rubella\n vac-\ncine  and\n response\n to\n a\n second\n dose\n given\n at\n four\n to\n six\n vs.\n eleven\n to\n thirteen\nyears.\n Pediatric\n Infect\n Dis\n J 1996;15(8):687\u201392.\n[12]\n World\n Health\n Organization.", "mimetype": "text/plain", "start_char_idx": 27155, "end_char_idx": 28448, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "629f49b9-c0b0-4f42-b68f-a890a58f4040": {"__data__": {"id_": "629f49b9-c0b0-4f42-b68f-a890a58f4040", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Chang (2015).pdf", "node_type": "4", "metadata": {}, "hash": "08301e9d797451b873b6d62d70c6454eedb6a5469004dd928826e7d8e00ed875", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dc86d51c-ddce-4d5e-9b5e-60a648574057", "node_type": "1", "metadata": {}, "hash": "c8408b454a309e180ef7d0f77c88ca0d43bf0e76db19a3db48ac3337f7bcdf71", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "eleven\n to\n thirteen\nyears.\n Pediatric\n Infect\n Dis\n J 1996;15(8):687\u201392.\n[12]\n World\n Health\n Organization.\n The\n immunological\n basis\n for\n immunization\n series:\nModule\n 11:\n Rubella.\n Washington,\n DC:\n World\n Health\n Organization;\n 2008.\n p.\n 29.\n[13]\n Xu\n FG,\n Yao\n HF,\n Jiang\n JX,\n Chen\n KK,\n Huang\n CX,\n Li\n L,\n et\n al.\n Persistence\n of\n antibody\n10-11\n years\n agter\n vaccination\n with\n BRDII\n strain\n live\n attenuated\n rubella\n vaccine.\nChin\n J Vaccines\n Immun\n 1998;4(3):147\u201350.\n[14]\n Christenson\n B,\n Bottiger\n M.\n Long-term\n follow-up\n of\n rubella\n antibodies\n in\n natu-\nrally\n immune\n and\n vaccinated\n young\n adults.\n Vaccine\n 1994;12:41\u20135.\n[15]\n Wu CG,\n Shu\n J,\n Han\n K,\n Tan\n Q,\n Lin\n JZ.\n Impact\n of\n different\n rubella\n immuniza-\ntion\n strategies\n on\n incidence\n of\n rubella\n in\n Guangdong\n province.\n Dis\n Surveill\n2012;27(2):110\u20133.", "mimetype": "text/plain", "start_char_idx": 28340, "end_char_idx": 29188, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "73016733-65dd-4d18-b9d1-a415114efe0e": {"__data__": {"id_": "73016733-65dd-4d18-b9d1-a415114efe0e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e1289309-8886-496d-80e5-ea5d11f984b3", "node_type": "1", "metadata": {}, "hash": "80b880a941aa17533d14a1096d7d529c3ae26b900aafb73961720d39fe39de5d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine\n 30 (2012) 4676\u2013\n 4680\nContents\n lists\n available\n at\n SciVerse\n ScienceDirect\nVaccine\nj\n ourna\n l\n ho\n me\n pag\n e:\n www.elsevier.com/locate/vaccine\nMumps\n outbreak\n among\n vaccinated\n university\n students\n associated\nwith\n a\n large\n party,\n the\n Netherlands,\n 2010\nKatie\n Greenland a,b,  Jane\n Whelan a,b,  Ewout\n Fanoy a,c,  Marjon\n Borgert d,  Koen\n Hulshof e,\nKioe-Bing\n Yap f,  Corien\n Swaan a, Tjibbe\n Donker a,  Rob\n van\n Binnendijk a,  Hester\n de  Melker a,\nSusan\n Hahn\u00e9 a,\u2217\na National\n Institute\n for\n Public\n Health\n and\n the\n Environment,\n RIVM,\n Bilthoven,\n The\n Netherlands\nb European\n Programme\n for\n Intervention\n Epidemiology\n Training\n (EPIET),\n European\n Centre\n for\n Disease\n Prevention\n and\n Control\n (ECDC),\n Stockholm,\n Sweden\nc Municipal\n Health\n Service\n Midden-Nederland,\n Zeist,\n The\n Netherlands\nd Municipal\n Health\n Service\n Hollands-Midden,\n Leiden,\n The\n Netherlands\ne Municipal\n Health\n Service\n Utrecht,\n The\n Netherlands\nf Municipal\n Health\n Service\n Zuid-Holland\n West,\n Zoetermeer,", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1024, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e1289309-8886-496d-80e5-ea5d11f984b3": {"__data__": {"id_": "e1289309-8886-496d-80e5-ea5d11f984b3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "73016733-65dd-4d18-b9d1-a415114efe0e", "node_type": "1", "metadata": {}, "hash": "42d232fa75b5e98942eb397bd9518351016aaf40f210c261083bb8e8b385b4e2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0ec127bb-0a26-46ca-b403-5fed1f9937ab", "node_type": "1", "metadata": {}, "hash": "f332c479f6925fcbcd81f7e44ef25d8d693f317b26cd8829723edb2e3280eb20", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Leiden,\n The\n Netherlands\ne Municipal\n Health\n Service\n Utrecht,\n The\n Netherlands\nf Municipal\n Health\n Service\n Zuid-Holland\n West,\n Zoetermeer,\n The\n Netherlands\na  r  t\n i  c  l  e  \ni n\n f\n o\nArticle\n history:\nReceived\n 18\n November\n 2011\nReceived\n in\n revised\n form\n 20\n April\n 2012\nAccepted\n 24\n April\n 2012\nAvailable online 8 May 2012\nKeywords:\nOutbreak\nMumps\nMMR\n vaccine\nRisk\n factors\nStudents\nVaccine\n effectiveness\na\n b  s  t  r  a\n c  t\nWe\n investigated\n a mumps\n outbreak\n within\n a  highly\n vaccinated\n university\n student\n population\n in  the\nNetherlands\n by conducting\n a  retrospective\n cohort\n study\n among\n members\n of  university\n societies\n in  Delft,\nLeiden\n and  Utrecht.  We  used  an  online\n questionnaire\n asking\n for  demographic\n information,\n potential\nbehavioural\n risk  factors\n for  mumps\n and  the  occurrence\n of  mumps.\n Vaccine\n status\n from\n the  national\n vac-\ncination\n register\n was  used.  Overall,  989\n students\n participated\n (20%  response\n rate).\n Registered\n vaccination\nstatus\n was available\n for  776\n individuals,\n of  whom\n 760  (98%)\n had  been\n vaccinated  at  least\n once  and\n 729\n(94%)\n at  least  twice.  The  mumps\n attack\n rate  (AR)\n was  13.2%  (95%CI\n 11.1\u201315.5%).", "mimetype": "text/plain", "start_char_idx": 879, "end_char_idx": 2106, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0ec127bb-0a26-46ca-b403-5fed1f9937ab": {"__data__": {"id_": "0ec127bb-0a26-46ca-b403-5fed1f9937ab", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e1289309-8886-496d-80e5-ea5d11f984b3", "node_type": "1", "metadata": {}, "hash": "80b880a941aa17533d14a1096d7d529c3ae26b900aafb73961720d39fe39de5d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "820a1d60-a9de-4af8-a67c-a5ccecb82621", "node_type": "1", "metadata": {}, "hash": "bd34886c6c9599c1f6e9701b05ccc610be7d0ba977129b849dcbaa0d96abb8c6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The  mumps\n attack\n rate  (AR)\n was  13.2%  (95%CI\n 11.1\u201315.5%).\n Attending\n a  large  stu-\ndent\n party,\n being\n unvaccinated\n and  living\n with\n more\n than  15  housemates\n were\n independently\n associated\nwith\n mumps\n ((RR\n 42 (95%CI  10.1\u2013172.4);\n 3.1  (95%CI\n 1.7\u20135.6)  and  1.8  (95%CI  1.1\u20133.1),  respectively).\n The\nadjusted\n VE  estimate\n for  two  doses  of MMR\n was\n 68%\n (95%CI  41\u201382%).\n We  did  not  identify\n additional\nrisk\n factors  for  mumps\n among\n party  attendees.\n The  most\n likely\n cause\n of  this  outbreak\n was intense  social\nmixing\n during  the  party\n and  the  dense  communal\n living  environment\n of  the  students.\n High  coverage  of\nMMR\n vaccination\n in  childhood\n did  not  prevent\n an  outbreak\n of  mumps\n in  this  student\n population.\n\u00a9 2012 Elsevier Ltd. All rights reserved.\n1.\n Introduction\nThe\n Netherlands\n introduced\n mumps\n vaccination\n into\n the\nNational\n Immunisation\n Programme\n in\n 1987\n using\n the\n measles,\nmumps\n and\n rubella\n vaccine\n (MMR).\n The\n MMR\n vaccine\n used\n con-\ntains\n the\n Jeryl-Lynn\n mumps\n virus\n strain\n and\n is\n administered\n in\n a\ntwo-dose\n schedule\n at\n 14\n months\n and\n nine\n years\n of\n age.\n Nationally,\nthe\n MMR\n vaccination\n coverage\n at\n 10\n years\n of\n age\n for\n the\n second\nMMR\n dose\n has\n been\n consistently\n above\n 90%\n since\n the\n programme\u2019s\ninception\n [1].", "mimetype": "text/plain", "start_char_idx": 2042, "end_char_idx": 3383, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "820a1d60-a9de-4af8-a67c-a5ccecb82621": {"__data__": {"id_": "820a1d60-a9de-4af8-a67c-a5ccecb82621", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0ec127bb-0a26-46ca-b403-5fed1f9937ab", "node_type": "1", "metadata": {}, "hash": "f332c479f6925fcbcd81f7e44ef25d8d693f317b26cd8829723edb2e3280eb20", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "89ac91b9-1605-4949-8492-5968b14696b3", "node_type": "1", "metadata": {}, "hash": "89eda0db8cf476d3317067f632609818a084c9b37362f451b57b824404e1503b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Nevertheless,\n in\n recent\n years\n the\n Netherlands\n has\nexperienced\n localised\n outbreaks\n of\n mumps:\n in\n 2004\n (genotype\n G5)\namong\n students\n at\n an\n international\n university\n of\n hospitality\n man-\nagement\n (105\n cases\n reported,\n of\n whom\n 62\n of\n 64\n (97%)\n with\n known\nvaccination\n status\n were\n vaccinated\n with\n a\n least\n one\n MMR\n dose)\n [2];\n\u2217Corresponding\n author\n at:\n RIVM,\n National\n Institute\n of\n Public\n Health\n and\n the\n Envi-\nronment,\n P.O.\n Box\n 1,\n 3720\n BA\n Bilthoven,\n The\n Netherlands.\n Tel.:\n +31\n 30\n 274\n 4011;\nfax:\n +31\n 30\n 274\n 4409.\nE-mail\n address:\n susan.hahne@rivm.nl\n (S.\n Hahn\u00e9).\nand\n between\n 2007\n and\n 2009\n in\n the\n so-called\n Bible\n Belt\n (genotype\nD4)\n [3], an\n area\n traditionally\n associated\n with\n low\n vaccine\n uptake\nand\n outbreaks\n of\n vaccine-preventable\n diseases\n [4\u20136].\n Whereas\n the\noccurrence\n of\n mumps\n in\n communities\n religiously\n opposed\n to\n vacci-\nnation\n can\n be\n anticipated,\n mumps\n in\n highly\n vaccinated\n adult\n pop-\nulations\n is\n concerning\n and\n warrants\n investigation,\n particularly\n as\nthe\n rate\n of\n certain\n complications\n of\n mumps\n increases\n with\n age\n [7].\nMumps\n became\n a\n noti\ufb01able\n disease\n in\n the\n Netherlands\n in\nDecember\n 2008.\n From\n 1\n December\n 2009\n to\n 20\n April\n 2010,\n 172\nmumps\n cases\n were\n noti\ufb01ed\n to\n municipal\n health\n authorities\n across\nthe\n country,\n a\n marked\n increase\n from\n the\n 65\n cases\n noti\ufb01ed\n in\nthe\n eleven\n preceding\n months\n in\n 2009.", "mimetype": "text/plain", "start_char_idx": 3385, "end_char_idx": 4834, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "89ac91b9-1605-4949-8492-5968b14696b3": {"__data__": {"id_": "89ac91b9-1605-4949-8492-5968b14696b3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "820a1d60-a9de-4af8-a67c-a5ccecb82621", "node_type": "1", "metadata": {}, "hash": "bd34886c6c9599c1f6e9701b05ccc610be7d0ba977129b849dcbaa0d96abb8c6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cf34d22d-c706-4d25-8eb9-1c99e45bb86a", "node_type": "1", "metadata": {}, "hash": "91671026ffbe072afd738536437b708ff5b23f81e0e707845a50d36624ae9c60", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Seventy-nine\n cases\n were\nnoti\ufb01ed\n to\n Municipal\n Health\n Service\n (MHS)\n Zuid-Holland\n West\n(including\n the\n city\n of\n Delft),\n 44\n were\n noti\ufb01ed\n in\n the\n Leiden\n region\n(MHS\n Hollands-Midden),\n 11\n were\n noti\ufb01ed\n to\n MHS\n Utrecht\n and\n 38\nwere\n noti\ufb01ed\n in\n other\n regions\n across\n the\n country.\n The\n majority\n of\ncases\n (70%;\n n\n =\n 114/164\n cases\n with\n known\n vaccination\n status)\n had\nreceived\n at\n least\n one\n dose\n of\n MMR.\n Overall,\n 65%\n of\n cases\n (n\n =\n 112)\nwere\n students,\n of\n whom\n 27\n (24%)\n reported\n having\n attended\n at\n least\none\n evening\n of\n a\n large\n four-day\n party\n in\n Leiden\n (23\u201326\n February,\n0264-410X/$\n \u2013\n see\n front\n matter \u00a9\n \n 2012 Elsevier Ltd. All rights reserved.\nhttp://dx.doi.org/10.1016/j.vaccine.2012.04.083\nK.\n Greenland\n et\n al.\n / Vaccine\n 30 (2012) 4676\u2013\n 4680\n4677\nweek\n 8).\n This\n party\n was\n organised\n and\n hosted\n by\n students\n in\n nine\nrooms\n spread\n across\n several\n \ufb02oors\n of\n a\n members-only\n student\n asso-\nciation\n building.\n It\n was\n attended\n by\n 1175\n Leiden\n students\n and\n 1850\nstudents\n from\n other\n cities.\n The\n majority\n of\n cases\n reported\n to\n MHS\nHollands-Midden\n occurred\n in\n week\n 11,\n one\n incubation\n period\n after\nthe\n party,\n further\n implicating\n the\n event\n as\n a\n source\n of\n transmission,\ndescribed\n in\n earlier\n communication\n about\n this\n outbreak\n [8].", "mimetype": "text/plain", "start_char_idx": 4836, "end_char_idx": 6173, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cf34d22d-c706-4d25-8eb9-1c99e45bb86a": {"__data__": {"id_": "cf34d22d-c706-4d25-8eb9-1c99e45bb86a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "89ac91b9-1605-4949-8492-5968b14696b3", "node_type": "1", "metadata": {}, "hash": "89eda0db8cf476d3317067f632609818a084c9b37362f451b57b824404e1503b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6f1170d9-71c6-4c9d-b24b-6b2eb168db2f", "node_type": "1", "metadata": {}, "hash": "1adfa1159f849464c88ef6f62fcd0522ed502be7146a897f4ba8a81b664ac10f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Outbreaks\n of\n mumps\n in\n educational\n settings\n such\n as\n schools\nand\n colleges\n have\n been\n previously\n reported\n [9\u201312].\n Explanations\nfor\n this\n include\n the\n close\n contact\n environment\n that\n facilitates\ntransmission\n and\n possibly\n a\n particular\n susceptibility\n for\n mumps\nin\n adolescents\n who\n were\n vaccinated\n in\n childhood\n [12,13].  The\n2009\u20132010\n mumps\n outbreak\n in\n a\n highly\n vaccinated\n student\n popu-\nlation\n provided\n an\n opportunity\n to\n assess\n risk\n factors\n for\n mumps\n in\nthis\n population\n and\n to\n investigate\n factors\n associated\n with\n mumps\nvaccine\n failure\n among\n vaccinated\n party\n attendees.\n2.\n Methods\nWe\n conducted\n a\n retrospective\n cohort\n study\n among\n students\nfrom\n the\n three\n university\n cities\n most\n affected\n by\n the\n outbreak:\n Delft,\nUtrecht\n and\n Leiden.\n Within\n these\n cities\n the\n study\n was\n restricted\nto\n student\n associations\n invited\n to\n the\n party\n in\n Leiden\n to\n permit\ninvestigation\n of\n party-related\n risk\n factors.\n Student\n associations\n in\nthe\n Netherlands\n are\n similar\n to\n North\n American\n fraternities\n and\nsororities\n in\n that\n membership\n is\n applied\n for\n and\n approved\n after\n an\ninitiation\n period.\n Members\n have\n close\n social\n ties:\n they\n typically\n live\ntogether\n and\n social\n events\n are\n frequently\n organised\n and\n attended\nby\n members\n only.\n Each\n of\n the\n eight\n student\n associations\n of\n this\ntype\n in\n the\n Netherlands\n hosts\n a\n three-\n or\n four-day\n party\n once\n a\nyear\n which\n is\n open\n to\n members\n of\n the\n other\n associations.", "mimetype": "text/plain", "start_char_idx": 6174, "end_char_idx": 7696, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6f1170d9-71c6-4c9d-b24b-6b2eb168db2f": {"__data__": {"id_": "6f1170d9-71c6-4c9d-b24b-6b2eb168db2f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cf34d22d-c706-4d25-8eb9-1c99e45bb86a", "node_type": "1", "metadata": {}, "hash": "91671026ffbe072afd738536437b708ff5b23f81e0e707845a50d36624ae9c60", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2406422a-ab5b-4d23-a769-2a5238bb9b7d", "node_type": "1", "metadata": {}, "hash": "f91042c539c85cbbfe9f06be473bae85a160bf9a15425a61f1c9a067fd8826c1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In\n May\n2010,\n all\n 4988\n members\n of\n the\n four\n selected\n student\n associations\n in\nDelft\n (n\n =\n 356\n women;\n n\n =\n 1044\n men),\n Leiden\n (n\n =\n 1400;\n sex\n break-\ndown\n of\n members\n not\n provided\n but\n estimated\n by\n society\n to\n be\n an\napproximately\n equal\n sex\n ratio)\n and\n Utrecht\n (two\n societies:\n n\n =\n 1288\nwomen;\n n\n =\n 900\n men)\n were\n invited\n to\n the\n study\n by\n email.\n Invitation\nand\n reminder\n emails\n (sent\n one\n week\n later)\n were\n circulated\n via\n the\nsociety\u2019s\n mailing\n list\n and\n contained\n a\n link\n to\n the\n online\n question-\nnaire\n (Questback,\n Oslo,\n Norway).\nTo\n investigate\n risk\n factors\n associated\n with\n mumps\n among\n these\nstudent\n associations\n the\n questionnaire\n asked\n about\n demographic\ncharacteristics\n including\n current\n living\n arrangements,\n MMR\n vacci-\nnation\n history,\n and\n history\n of\n mumps\n infection.\n Informed\n consent\nwas\n sought\n to\n verify\n MMR\n vaccination\n status\n using\n the\n national\nvaccination\n register.\n A\n case\n was\n de\ufb01ned\n as\n a\n student\n with\n self-\nreported\n mumps\n (swelling\n of\n one\n or\n both\n cheeks\n with\n symptoms\nlasting\n at\n least\n two\n days)\n since\n 1st\n September\n 2009.", "mimetype": "text/plain", "start_char_idx": 7698, "end_char_idx": 8845, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2406422a-ab5b-4d23-a769-2a5238bb9b7d": {"__data__": {"id_": "2406422a-ab5b-4d23-a769-2a5238bb9b7d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6f1170d9-71c6-4c9d-b24b-6b2eb168db2f", "node_type": "1", "metadata": {}, "hash": "1adfa1159f849464c88ef6f62fcd0522ed502be7146a897f4ba8a81b664ac10f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4282b136-a878-478a-9294-cbf69624d90d", "node_type": "1", "metadata": {}, "hash": "0bd10a19c0dd96c607e90d9a1fce98e09f51cd10a1d50298953f0fbbbf1023f9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "To\n investi-\ngate\n risk\n factors\n associated\n with\n vaccine\n failure\n among\n vaccinated\nparty\n attendees,\n additional\n information\n was\n requested\n from\n party-\nattendees;\n speci\ufb01cally,\n the\n day(s)\n of\n party\n attendance,\n locations\nvisited\n at\n the\n party\n (from\n a\n list\n of\n nine\n rooms\n or\n areas\n within\n the\nstudent\n association\n including\n several\n bars,\n themed\n rooms\n with\n DJs\nand\n two\n smoking\n rooms),\n contact\n with\n shared\n items\n including\n food,\ndrinks\n and\n cigarettes,\n and\n close\n personal\n contact\n (kissing)\n during\nthe\n party\n or\n at\n an\n after\n party.\nQuestionnaire\n responses\n were\n downloaded\n from\n the\n password-\nprotected\n website\n and\n imported\n to\n STATA\n 10\n for\n analysis\n [14].\nIndividuals\n with\n a\n history\n of\n mumps\n prior\n to\n September\n 2009\n(n\n =\n 13)\n or\n whose\n MMR\n vaccination\n status\n could\n not\n be\n determined\nfrom\n the\n vaccine\n register\n (n\n =\n 30)\n were\n excluded\n from\n the\n anal-\nysis.\n Associations\n between\n risk\n factors\n and\n self-reported\n mumps\nwere\n \ufb01rst\n explored\n in\n univariable\n analysis.\n Variables\n with\n a\n p-value\n<0.25\n (from\n the\n univariable\n analysis),\n as\n well\n as\n age\n and\n sex,\n were\nentered\n into\n the\n multivariable\n regression\n model.\n When\n we  found\nevidence\n of\n collinearity\n among\n explanatory\n variables\n we\n selected\nthe\n variable\n which\n gave\n the\n best\n model\n \ufb01t\n (based\n on\n the\n Bayesian\nInformation\n Criterion\n \u2013\n BIC)\n into\n the\n \ufb01nal\n model.\n We\n estimated\nvaccine\n effectiveness\n (VE)\n as\n 1\n minus\n the\n relative\n risk\n (RR)\n (VE\n =\n 1-\nRR),\n using\n the\n adjusted\n RR\n for\n mumps\n in\n vaccinated\n compared\n to\nunvaccinated\n participants.", "mimetype": "text/plain", "start_char_idx": 8847, "end_char_idx": 10481, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4282b136-a878-478a-9294-cbf69624d90d": {"__data__": {"id_": "4282b136-a878-478a-9294-cbf69624d90d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2406422a-ab5b-4d23-a769-2a5238bb9b7d", "node_type": "1", "metadata": {}, "hash": "f91042c539c85cbbfe9f06be473bae85a160bf9a15425a61f1c9a067fd8826c1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d4fe7c92-6d3a-4dbe-a528-3c7c20824ef1", "node_type": "1", "metadata": {}, "hash": "55e0ee2906ade68960d1978e3b0ae70ef66f155d7e3a6ba1487ba0b727734991", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Persons\n who\n were\n not\n susceptible\n to\n mumps\n at\n the\n time\n of\n the\nparty\n (mumps\n with\n date\n of\n onset\n prior\n to\n the\n minimum\n incubation\ntime\n of\n 12\n days\n after\n the\n \ufb01rst\n day\n of\n the\n party\n (23rd\n February))\n were\nexcluded\n from\n the\n analysis\n of\n party-related\n risk\n factors\n associated\nwith\n mumps\n failure.\n Cases\n arising\n after\n the\n maximum\n incubation\ntime\n (25\n days\n after\n the\n last\n day\n of\n the\n party\n (26th\n February))\n were\nincluded\n as\n non-cases\n so\n risk\n factors\n associated\n with\n the\n party\n could\nbe\n investigated.\n3.\n Results\n3.1.\n Study\n population\nOverall,\n \n989\n \nindividuals\n \nresponded\n \nto\n \nthe\n \nquestionnaire\n(response\n rate\n =\n 20%;\n 10%\n among\n male\n students,\n 31%\n among\n female\nstudents)\n and\n reported\n studying\n in\n Delft\n (n\n =\n 212),\n Utrecht\n (n\n =\n 517)\nor\n Leiden\n (n\n =\n 195).\n For\n 65\n respondents,\n the\n city\n of\n study\n was\nnot\n available.\n Respondents\n were\n aged\n between\n 17\n and\n 28\n years\n(median\n age\n 21\n years)\n and\n were\n predominantly\n female\n (75%;\nn\n =\n 738).\n The\n median\n age\n of\n the\n invited\n population\n of\n society\n mem-\nbers\n in\n these\n cities\n was\n also\n 21\n years,\n 47%\n were\n female.\nMMR\n vaccination\n status\n was\n veri\ufb01ed\n for\n 91%\n (776/853)\n of\n con-\nsenting\n survey\n respondents:\n 94%\n (n\n =\n 729)\n had\n received\n two\n doses\nof\n MMR\n vaccine,\n 4%\n (n\n =\n 31)\n were\n vaccinated\n with\n one\n dose\n of\n MMR\nand\n 2%\n (n\n =\n 16)\n had\n never\n been\n vaccinated\n with\n MMR\n (Table\n 1).", "mimetype": "text/plain", "start_char_idx": 10482, "end_char_idx": 11949, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d4fe7c92-6d3a-4dbe-a528-3c7c20824ef1": {"__data__": {"id_": "d4fe7c92-6d3a-4dbe-a528-3c7c20824ef1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4282b136-a878-478a-9294-cbf69624d90d", "node_type": "1", "metadata": {}, "hash": "0bd10a19c0dd96c607e90d9a1fce98e09f51cd10a1d50298953f0fbbbf1023f9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7aa965c1-c31c-4daf-818a-047057d6f7a4", "node_type": "1", "metadata": {}, "hash": "6d64eebc17d9dda1021cca30c4a68db9755fef7c768d1bbc9789c2e3b2e3e488", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Overall,\n 946\n of\n the\n 989\n survey\n respondents\n answered\n questions\nabout\n mumps\n disease,\n of\n whom\n 125\n reported\n having\n had\n mumps\n(attack\n rate\n 13.2%,\n 95%CI\n 11.1\u201315.5%).\n Half\n the\n cases\n (54%)\n reported\nvisiting\n their\n GP,\n of\n whom\n seven\n were\n diagnosed\n with\n compli-\ncations,\n speci\ufb01cally\n meningitis\n (1;\n 0.8%\n of\n cases),\n pancreatitis\n (2;\n1.6%),\n orchitis\n (3;\n 8%\n of\n male\n cases)\n and\n deafness\n (4;\n 3.2%).\n One\nadditional\n individual\n was\n admitted\n to\n hospital\n for\n one\n night\n due\n to\nthe\n severity\n of\n symptoms\n but\n had\n no\n complications.\nDate\n of\n symptom\n onset\n ranged\n from\n 25th\n December\n 2009\n to\n 1st\nJune\n 2010\n (n\n =\n 110)\n (Fig.\n 1).\n The\n number\n of\n cases\n peaked\n in\n mid-\nMarch\n (week\n 11),\n about\n one\n incubation\n period\n [15]\n after\n the\n party.\n3.2.\n Risk\n factors\n associated\n with\n mumps\nThe\n attack\n rate\n among\n men\n was\n higher\n than\n among\n women\n(17%\n \nvs.\n \n12%,\n \np\n =\n 0.06).\n \nAge-speci\ufb01c\n \nattack\n \nrates,\n \ndid\n \nnot\nsigni\ufb01cantly\n differ\n (p\n =\n 0.12)\n and\n there\n was\n no\n difference\n in\nthe\n mean\n number\n of\n years\n since\n last\n vaccination\n between\n cases\nFig.\n 1.\n Epidemic\n curve\n showing\n the\n number\n of\n mumps\n cases\n by\n week\n of\n symptom\nonset\n and\n city\n of\n study,\n December\n 2009\u2013June\n 2010,\n the\n Netherlands\n (n\n =\n 110).\n4678\nK.\n Greenland\n et\n al.", "mimetype": "text/plain", "start_char_idx": 11950, "end_char_idx": 13284, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7aa965c1-c31c-4daf-818a-047057d6f7a4": {"__data__": {"id_": "7aa965c1-c31c-4daf-818a-047057d6f7a4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d4fe7c92-6d3a-4dbe-a528-3c7c20824ef1", "node_type": "1", "metadata": {}, "hash": "55e0ee2906ade68960d1978e3b0ae70ef66f155d7e3a6ba1487ba0b727734991", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "250e01ca-2f8f-4ffe-8d10-199eed7285dc", "node_type": "1", "metadata": {}, "hash": "e6a33c67b867a4196bb259409e9b6e8ef427dc063f300ca0e9ed4aca75363510", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "4678\nK.\n Greenland\n et\n al.\n / Vaccine\n 30 (2012) 4676\u2013\n 4680\nTable\n 1\nCharacteristics\n and\n risk\n factors\n for\n mumps\n among\n the\n entire\n study\n population\n (n\n =\n 946).\nN\n \nNo.\n (%)\n mumpsa\nUnivariable\n relative\n risk\n (95%CI)\n \nMultivariable\n relative\n risk\n (95%CI)\nGender\nMale\n231\n39\n (16.9)\n \n1.4\n (1.0\u20132.0)\n \n1.1\n (0.7\u20131.6)\nFemale\n713\n \n86\n (12.1)\n \nRef.\n \nRef.\nAge\n17\u201319\n \n188\n \n30\n (16.0)\n \nRef.\n \nRef.\n20\u201321\n \n397\n \n42\n (10.6)\n \n0.7\n (0.4\u20131.0)\n \n0.7\n (0.4\u20131.1)\n22\n and\n over\n \n357\n \n52\n (14.6)\n \n0.9\n (0.6\u20131.4)\n \n0.8\n (0.5\u20131.3)\nVaccination\n statusb\nUnvaccinated\n16\n \n7\n (43.8)\n \n3.4\n (1.9\u20136.0)\n \n3.1\n (1.7\u20135.6)\nVaccinated\n (twice)\n \n706\n \n92\n (13.0)\n \nRef.\n \nRef.\nAttended\n party\nYes\n \n267\n \n61\n (22.9)\n \n2.4\n (1.7\u20133.3)\n \n1.8\n (1.2\u20132.6)\nNo\n674\n \n64\n (9.5)\n \nRef.\n \nRef.\nNumber\n of\n housemates\n<5\n \n352\n \n34\n (9.7)\n \nRef.\n \nRef.", "mimetype": "text/plain", "start_char_idx": 13257, "end_char_idx": 14095, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "250e01ca-2f8f-4ffe-8d10-199eed7285dc": {"__data__": {"id_": "250e01ca-2f8f-4ffe-8d10-199eed7285dc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7aa965c1-c31c-4daf-818a-047057d6f7a4", "node_type": "1", "metadata": {}, "hash": "6d64eebc17d9dda1021cca30c4a68db9755fef7c768d1bbc9789c2e3b2e3e488", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2db8fedc-92e5-4eb8-b439-0ff1f72b57a7", "node_type": "1", "metadata": {}, "hash": "51089546be96cc80bf72553f7a322e8b5285bb2f7b46338c7738c21e3f275d8f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Ref.\nNumber\n of\n housemates\n<5\n \n352\n \n34\n (9.7)\n \nRef.\n \nRef.\n5\u201315\n \n470\n65 (13.8)\n \n1.4\n (1.0\u20132.1)\n \n1.3\n (0.8\u20132.0)\n>15\n \n122\n \n26\n (21.3)\n \n2.2\n (1.4\u20133.5)\n \n1.8\n (1.1\u20133.1)\na n =\n 125,\n all\n mumps\n cases\n since\n September\n 2009\n (excluding\n 3\n cases\n with\n past\n infections).\nb Con\ufb01rmed\n with\n vaccination\n records.\n 776\n records\n were\n veri\ufb01ed\n out\n of\n 853\n consenting\n participants.\n Not\n all\n individuals\n with\n con\ufb01rmed\n vaccination\n status\n provided\ninformation\n on\n whether\n or\n not\n they\n had\n had\n mumps.\n Of\n 735\n individuals\n vaccinated\n at\n least\n once,\n 706\n were\n vaccinated\n twice.\n The\n 29\n once-vaccinated\n individuals\n are\n excluded\nfrom\n analysis.\n(12.2\n years)\n and\n non-cases\n (12.5\n years),\n p\n =\n 0.54.\n The\n attack\n rate\nwas\n higher\n among\n respondents\n from\n Leiden\n (25%)\n than\n among\nthose\n from\n Delft\n (12%)\n and\n Utrecht\n (9%)\n (p\n =\n 0.05)\n and\n was\n also\nhigher\n among\n party-attendees\n than\n non-attendees\n (23%\n vs.\n 10%\nrespectively)\n (Table\n 1).\n The\n attack\n rate\n increased\n with\n the\n number\nof\n household\n contacts,\n with\n individuals\n living\n with\n \ufb01fteen\n or\n more\nhousemates\n (large\n society\n houses\n of\n up\n to\n 40\n students,\n not\n dorms)\ntwice\n as\n likely\n to\n have\n had\n mumps\n than\n those\n living\n with\n fewer\nthan\n \ufb01ve\n other\n people\n (p-trend\n =\n 0.001)\n (Table\n 1).", "mimetype": "text/plain", "start_char_idx": 14033, "end_char_idx": 15350, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2db8fedc-92e5-4eb8-b439-0ff1f72b57a7": {"__data__": {"id_": "2db8fedc-92e5-4eb8-b439-0ff1f72b57a7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "250e01ca-2f8f-4ffe-8d10-199eed7285dc", "node_type": "1", "metadata": {}, "hash": "e6a33c67b867a4196bb259409e9b6e8ef427dc063f300ca0e9ed4aca75363510", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a041df7f-3acf-42ea-b7a8-07ef09891632", "node_type": "1", "metadata": {}, "hash": "a27d090d82ea0f11e64927d75a6d05fc6acf4ac8adb2ddd26e2f416eb7b5bf1f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Among\n cases,\nattending\n the\n party\n and\n studying\n in\n Leiden\n was\n closely\n correlated:\n93%\n of\n cases\n in\n Leiden\n attended\n the\n party,\n compared\n with\n 29%\nin\n Delft\n and\n 14%\n in\n Utrecht.\n After\n adjusting\n for\n age\n and\n sex\n and\nobserving\n that\n party\n attendance\n gave\n a\n better\n model\n \ufb01t\n than\n city\nof\n study,\n not\n being\n vaccinated,\n having\n more\n than\n 15\n housemates\nand\n attending\n the\n party\n were\n independently\n associated\n with\ndeveloping\n mumps\n (Table\n 1).\nWhen\n restricting\n the\n cases\n to\n those\n who\n were\n susceptible\n at\n the\ntime\n of\n the\n party\n (n\n =\n 35),\n and\n including\n cases\n that\n arose\n more\n than\none\n incubation\n time\n after\n the\n party\n as\n non-cases,\n the\n relative\n risk\n of\nacquiring\n mumps\n associated\n with\n party\n attendance\n was\n 42\n (95%CI\n10.1\u2013172.4;\n p\n <\n 0.0001).\n3.3.\n Vaccine\n effectiveness\nIn\n total,\n 92\n of\n 101\n (91%)\n mumps\n cases\n with\n known\n vaccination\nhistory\n had\n been\n twice-vaccinated\n with\n MMR.\n Among\n individuals\nwith\n known\n vaccination\n history\n and\n known\n mumps\n disease\n sta-\ntus\n (n\n =\n 751),\n the\n attack\n rate\n was\n 44%\n (7/16)\n among\n unvaccinated\nindividuals\n and\n 7%\n (2/29)\n and\n 13%\n (92/706)\n among\n once\n and\n twice-\nvaccinated\n individuals\n respectively.\n The\n adjusted\n VE\n estimate\n for\ntwo\n doses\n of\n MMR\n was\n 68%\n (95%CI\n 40.6\u201382.2%).\n3.4.", "mimetype": "text/plain", "start_char_idx": 15352, "end_char_idx": 16688, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a041df7f-3acf-42ea-b7a8-07ef09891632": {"__data__": {"id_": "a041df7f-3acf-42ea-b7a8-07ef09891632", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2db8fedc-92e5-4eb8-b439-0ff1f72b57a7", "node_type": "1", "metadata": {}, "hash": "51089546be96cc80bf72553f7a322e8b5285bb2f7b46338c7738c21e3f275d8f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e58752c0-5a65-43f6-a8d6-cf30ba79fae8", "node_type": "1", "metadata": {}, "hash": "8a6aee8b4c744aff73fc1982fda2a3336bde37d88b241380ad30fdd801db49e4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\n adjusted\n VE\n estimate\n for\ntwo\n doses\n of\n MMR\n was\n 68%\n (95%CI\n 40.6\u201382.2%).\n3.4.\n Factors\n associated\n with\n vaccine\n failure\n among\n vaccinated\nparty-attendees\nAnalysis\n was\n restricted\n to\n vaccinated\n party-attendees\n with\nknown\n mumps\n disease\n status\n (n\n =\n 206).\n The\n attack\n rate\n among\nparty-attendees\n was\n similar\n among\n men\n (14.2%)\n and\n women\n(11.6%)\n (p\n =\n 0.54)\n and\n across\n all\n age\n groups\n (p\n =\n 0.66).\n Two\n thirds\n(67%)\n of\n students\n who\n attended\n the\n party\n were\n from\n Leiden\n (the\nhost\n city),\n 21%\n from\n Utrecht\n and\n 12%\n from\n Delft.\n The\n majority\n of\nDelft\n and\n Utrecht\n students\n (84%\n and\n 98%,\n respectively)\n bought\n a\none-day\n ticket,\n typically\n attending\n on\n the\n third\n day.\n Conversely,\nLeiden\n students\n more\n frequently\n bought\n four-day\n tickets:\n 87%\n of\nstudents\n from\n Leiden\n attended\n on\n at\n least\n three\n evenings.\n The\n attack\nrate\n was\n higher\n among\n students\n who\n attended\n the\n party\n on\n the\nthird\n day\n (14.1%)\n than\n those\n who\n did\n not\n attend\n on\n this\n day\n (4.6%)\nbut\n this\n difference\n was\n not\n statistically\n signi\ufb01cant\n (RR\n 3.1;\n 95%CI\n0.8\u201312.4,\n p\n =\n 0.08).\n We  found\n no\n association\n between\n any\n of\n the\n spe-\nci\ufb01c\n behaviours\n at\n the\n party\n or\n other\n potential\n risk\n factors\n studied\nand\n the\n occurrence\n of\n mumps.\n4.", "mimetype": "text/plain", "start_char_idx": 16599, "end_char_idx": 17917, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e58752c0-5a65-43f6-a8d6-cf30ba79fae8": {"__data__": {"id_": "e58752c0-5a65-43f6-a8d6-cf30ba79fae8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a041df7f-3acf-42ea-b7a8-07ef09891632", "node_type": "1", "metadata": {}, "hash": "a27d090d82ea0f11e64927d75a6d05fc6acf4ac8adb2ddd26e2f416eb7b5bf1f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "28bf89a7-dd8d-42b1-bb5d-5455f11c3bf9", "node_type": "1", "metadata": {}, "hash": "b58f7807d72c4e655f24ee502fdafb53036264d17acefe83a83e108f3b995ce9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "4.\n Discussion\nWe\n report\n a\n large\n mumps\n outbreak\n with\n a\n self-reported\n attack\nrate\n of\n 13%\n among\n a\n university\n student\n population\n of\n whom\n 94%\nwas\n fully\n vaccinated.\n Our\n \ufb01ndings\n suggest\n that,\n together\n with\nreduced\n vaccine\n effectiveness\n at\n student\n age,\n the\n most\n likely\n cause\nof\n this\n outbreak\n is\n a\n combination\n of\n intense\n social\n mixing\n during\na\n student\n party\n in\n Leiden\n and\n the\n dense\n communal\n living\n environ-\nment\n of\n the\n students.\n The\n shape\n of\n the\n epidemic\n curve\n is\n consistent\nwith\n a\n point-source\n exposure\n at\n the\n party:\n one\n third\n of\n reported\ncases\n arose\n about\n one\n incubation\n period\n after\n the\n party,\n and\n party\nattendance\n was\n found\n to\n be\n an\n independent\n risk\n factor\n for\n mumps.\nAmong\n students\n who\n attended\n the\n party,\n no\n speci\ufb01c\n risk\n factor\n was\nidenti\ufb01ed.\n It\n seems\n plausible\n that\n the\n circumstances\n of\n this\n party\n\u2013\n taking\n place\n over\n four\n days\n and\n attended\n by\n students\n from\n mul-\ntiple\n cities\n at\n a\n time\n when\n mumps\n was\n known\n to\n be\n circulating\n \u2013\nprovided\n an\n environment\n that\n promoted\n transmission.\n Consider-\ning\n that\n the\n number\n of\n cases\n in\n the\n period\n after\n the\n peak\n following\nthe\n party\n quickly\n declined\n may\n suggest\n that\n sustained\n mumps\ntransmission\n in\n this\n population\n is\n unlikely.\n However,\n increased\ntransmission\n at\n other\n social\n events\n or\n in\n the\n winter\n season\n could\nprove\n this\n assumption\n too\n optimistic.\nLiving\n with\n a\n large\n number\n of\n housemates\n increased\n the\n risk\nof\n mumps.\n This\n is\n consistent\n with\n results\n found\n elsewhere\n [16].", "mimetype": "text/plain", "start_char_idx": 17915, "end_char_idx": 19526, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "28bf89a7-dd8d-42b1-bb5d-5455f11c3bf9": {"__data__": {"id_": "28bf89a7-dd8d-42b1-bb5d-5455f11c3bf9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e58752c0-5a65-43f6-a8d6-cf30ba79fae8", "node_type": "1", "metadata": {}, "hash": "8a6aee8b4c744aff73fc1982fda2a3336bde37d88b241380ad30fdd801db49e4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6676acf4-c655-4a9e-a9f1-e3876f7ccae1", "node_type": "1", "metadata": {}, "hash": "e668cef70f003e8969bab16e3ed2e939ecb0d0e19f203144a5fc1abd1abbf1de", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Living\n with\n a\n large\n number\n of\n housemates\n increased\n the\n risk\nof\n mumps.\n This\n is\n consistent\n with\n results\n found\n elsewhere\n [16].\nIn\n addition\n to\n the\n number\n of\n housemates,\n dormitory\n residence\nhas\n also\n been\n associated\n with\n an\n increased\n risk\n of\n mumps\n among\nstudents\n [2,17].\n However,\n student\n dormitories\n do\n not\n exist\n in\n the\nNetherlands.\nIn\n addition\n to\n the\n above-discussed\n risk\n factors\n for\n exposure\nto\n the\n mumps\n virus,\n risk\n factors\n for\n vaccine\n failure\n should\n also\nbe\n considered\n when\n studying\n an\n outbreak\n of\n a\n vaccine\n pre-\nventable\n disease\n in\n a\n highly\n vaccinated\n population\n [17\u201319].  Precise\nK.\n Greenland\n et\n al.\n / Vaccine\n 30 (2012) 4676\u2013\n 4680\n4679\nestimation\n of\n vaccine\n effectiveness\n in\n this\n setting\n is\n not\n feasible\ndue\n to\n the\n low\n numbers\n of\n unvaccinated\n cases\n as\n re\ufb02ected\n in\n the\nwide\n con\ufb01dence\n interval\n around\n the\n VE\n estimated\n in\n our\n study.\nHowever,\n even\n with\n the\n large\n con\ufb01dence\n interval,\n our\n estimated\n VE\nsupports\n the\n growing\n body\n of\n evidence\n that\n two\n doses\n of\n MMR\n do\nnot\n confer\n long-term\n protection\n against\n mumps\n [12,13,18].  Poten-\ntial\n reasons\n for\n vaccine\n failure\n include\n primary\n vaccine\n failure,\nwaning\n immunity\n over\n time\n (secondary\n vaccine\n failure)\n and\n the\npossibility\n that\n the\n vaccine\n strain\n (genotype\n A)\n affords\n lower\n than\noptimal\n protection\n against\n heterologous\n genotypes\n such\n as\n the\n G\ngenotypes\n which\n caused\n this\n outbreak\n and\n outbreaks\n in\n other\n coun-\ntries\n [13,18,20\u201324].", "mimetype": "text/plain", "start_char_idx": 19385, "end_char_idx": 20939, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6676acf4-c655-4a9e-a9f1-e3876f7ccae1": {"__data__": {"id_": "6676acf4-c655-4a9e-a9f1-e3876f7ccae1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "28bf89a7-dd8d-42b1-bb5d-5455f11c3bf9", "node_type": "1", "metadata": {}, "hash": "b58f7807d72c4e655f24ee502fdafb53036264d17acefe83a83e108f3b995ce9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b4da066c-5f85-4d65-b532-26d266ff1cf6", "node_type": "1", "metadata": {}, "hash": "04c6eadb20d1dbcde4994be5133a9e4f17cd56b4ed702bc33af84a444c94e245", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Unfortunately\n we\n could\n not\n assess\n the\n effect\n of\neither\n of\n these\n factors\n in\n this\n outbreak,\n as\n it\n was\n a\n single\n genotype\noutbreak\n affecting\n a\n group\n of\n individuals\n within\n a\n narrow\n age-range\nand\n a\n long\n time\n has\n elapsed\n since\n vaccination.\nThe\n key\n limitation\n we\n faced\n in\n this\n study\n was\n the\n relatively\n low\nresponse\n rate,\n although\n in\n a\n large,\n multi-centre\n study\n of\n web-based\nsurveys\n in\n student\n populations\n in\n the\n USA,\n the\n response\n rate\n was\nsimilar\n (20%)\n [25].\n The\n low\n response\n rate\n may\n not\n necessarily\n have\nintroduced\n bias\n into\n our\n study\n [26].\n While\n we\n had\n no\n speci\ufb01c\n infor-\nmation\n on\n non-respondents,\n student\n association\n members\n invited\nto\n participate\n were\n a\n socio-demographically\n homogenous\n group.\nIt\n is\n unknown\n how\n in\n this\n context,\n non-respondents\u2019\n behaviour\nmight\n differ\n and\n what\n impact,\n if\n any,\n this\n would\n have\n on\n the\n risk\n of\ndisease.\nNon-responders\n were\n more\n frequently\n male\n (53%\n of\n invitees\nwere\n male\n compared\n with\n 25%\n of\n respondents),\n again\n not\n atypical\n in\nsurvey\n research\n [25].\n It\n is\n also\n possible\n that\n those\n who\n attended\n the\nparty\n and\n people\n with\n mumps\n were\n more\n likely\n to\n have\n responded\nto\n the\n survey.\n This\n may\n have\n caused\n an\n overestimation\n of\n the\n attack\nrate\n and\n the\n risk\n of\n acquisition\n of\n mumps\n among\n respondents.\nAs\n nearly\n all\n cases\n in\n Leiden\n attended\n the\n party\n we\n were\n unable\nto\n disentangle\n the\n effect\n of\n living\n in\n Leiden\n from\n that\n of\n attending\nthe\n party.", "mimetype": "text/plain", "start_char_idx": 20941, "end_char_idx": 22502, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b4da066c-5f85-4d65-b532-26d266ff1cf6": {"__data__": {"id_": "b4da066c-5f85-4d65-b532-26d266ff1cf6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6676acf4-c655-4a9e-a9f1-e3876f7ccae1", "node_type": "1", "metadata": {}, "hash": "e668cef70f003e8969bab16e3ed2e939ecb0d0e19f203144a5fc1abd1abbf1de", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0e2c1309-3f37-4de9-b714-598517d33dc9", "node_type": "1", "metadata": {}, "hash": "a3ea3823376ca01d4be48024eaf3099b4539834c954044fc6d6a8f6038308c83", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We  believe\n selective\n participation\n of\n students\n with\n other\nrisk\n factors\n is\n unlikely,\n suggesting\n all\n other\n measures\n of\n association\nare\n not\n biased\n by\n non-response.\n The\n slight\n delay\n between\n the\n party\nand\n the\n study\n could\n have\n affected\n recall\n of\n party-related\n risk\n fac-\ntors\n but\n it\n is\n unlikely\n that\n recall\n would\n have\n been\n associated\n with\nmumps\n disease\n status.\nNational\n recommendations\n to\n control\n the\n mumps\n outbreak\namong\n university\n students\n in\n the\n Netherlands\n have\n included\n the\nadvice\n to\n ensure\n students\n have\n received\n two\n doses\n of\n MMR.\n The\nimportance\n of\n this\n is\n underlined\n by\n the\n observation\n that\n vaccinated\nindividuals\n with\n mumps\n are\n less\n likely\n to\n develop\n complications\nthan\n unvaccinated\n individuals\n with\n mumps\n [27,28]. Even\n though\nindividuals\n with\n asymptomatic\n mumps\n virus\n infection\n are\n still\ninfectious,\n the\n potential\n for\n transmission\n may\n be\n reduced\n by\n rec-\nommending\n students\n suffering\n from\n mumps\n not\n to\n attend\n large\nindoor\n social\n gatherings.\n Cancellation\n of\n a\n party\n or\n large\n social\nevent\n when\n mumps\n is\n known\n to\n be\n circulating\n in\n a\n population\nis\n also\n likely\n to\n be\n a\n useful\n control\n measure.\n Other\n options\n for\ncontrol\n include\n delaying\n the\n age\n of\n the\n second\n MMR\n dose\n in\n the\nroutine\n vaccination\n schedule\n or\n adding\n a\n third\n MMR\n [16,21,23,29].\nThe\n former\n is\n unlikely\n to\n be\n favourable,\n given\n that\n it\n would\nlead\n to\n an\n increase\n in\n measles,\n mumps\n and\n rubella\n susceptibil-\nity\n among\n children.", "mimetype": "text/plain", "start_char_idx": 22504, "end_char_idx": 24073, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0e2c1309-3f37-4de9-b714-598517d33dc9": {"__data__": {"id_": "0e2c1309-3f37-4de9-b714-598517d33dc9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b4da066c-5f85-4d65-b532-26d266ff1cf6", "node_type": "1", "metadata": {}, "hash": "04c6eadb20d1dbcde4994be5133a9e4f17cd56b4ed702bc33af84a444c94e245", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5c58ac3d-bd03-4ead-b080-3fc77511262a", "node_type": "1", "metadata": {}, "hash": "bd46c223c353cb020a9c8d91bc33ae0dfa90da3f931eae5aead0312f63b590da", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "A\n national\n outbreak\n control\n team\n convened\nin\n the\n Netherlands\n in\n January\n 2011,\n during\n which\n the\n addition\n of\na\n third\n MMR\n dose\n to\n the\n vaccination\n schedule\n was\n discussed.\n It\nwas\n advised\n that,\n given\n the\n cost,\n logistics\n and\n expected\n low\n vac-\ncine\n uptake\n among\n students,\n and\n the\n low\n morbidity\n related\n to\nmumps,\n this\n intervention\n could\n not\n be\n justi\ufb01ed\n based\n on\n the\n cur-\nrent\n available\n evidence\n and\n the\n uncertain\n effectiveness\n of\n a\n third\ndose.\nStudies\n that\n can\n shed\n more\n light\n on\n the\n reasons\n for\n waning\nimmunity\n are\n needed\n so\n that\n appropriate\n solutions\n can\n be\n devel-\noped\n and\n policy\n recommendations\n can\n be\n made.\nAcknowledgments\nWe\n are\n very\n grateful\n to\n the\n President\n and\n other\n board\n mem-\nbers\n of\n the\n student\n associations\n in\n Delft,\n Utrecht\n and\n Leiden\n who\npiloted\n the\n questionnaire\n and\n sent\n the\n questionnaire\n to\n the\n society\nmailing\n list.\n We  also\n wish\n to\n thank\n all\n members\n of\n the\n student\n asso-\nciations\n in\n Delft,\n Leiden\n and\n Utrecht\n who\n completed\n the\n survey.\n We\nwould\n also\n like\n to\n thank\n Hein\n Boot\n and\n Marianne\n van\n der\n Sande\n for\nreviewing\n the\n manuscript.\nReferences\n[1]\n van\n Lier\n EA,\n Oomen\n PJ,\n Giesbers\n H,\n Drijfhout\n IH,\n de\n Hoogh\n PAAM,\n de\n Melker\nH. Vaccinatiegraad\n Rijksvaccinatieprogramma\n Nederland.\n Verslagjaar\n 2011.\n(National\n Immunisation\n Programme\n in\n the\n Netherlands.\n Annual\n Report\n 2011).\nBilthoven:\n National\n Institute\n for\n Public\n Health\n and\n the\n Environment\n (RIVM).", "mimetype": "text/plain", "start_char_idx": 24075, "end_char_idx": 25614, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5c58ac3d-bd03-4ead-b080-3fc77511262a": {"__data__": {"id_": "5c58ac3d-bd03-4ead-b080-3fc77511262a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0e2c1309-3f37-4de9-b714-598517d33dc9", "node_type": "1", "metadata": {}, "hash": "a3ea3823376ca01d4be48024eaf3099b4539834c954044fc6d6a8f6038308c83", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b64443a8-dd8f-4347-bb30-37f90bba1bc6", "node_type": "1", "metadata": {}, "hash": "ae0802e816a15e005d0acc7251ec663fee4e71b3ef2c0975135ef59851bab3e5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "(National\n Immunisation\n Programme\n in\n the\n Netherlands.\n Annual\n Report\n 2011).\nBilthoven:\n National\n Institute\n for\n Public\n Health\n and\n the\n Environment\n (RIVM).\nAvailable\n from:\n http://www.rivm.nl/bibliotheek/rapporten/210021014.html;\n2011.\n[2] Brockhoff\n HJ,\n Mollema\n L,\n Sonder\n GJ,\n Postema\n CA,\n van\n Binnendijk\n RS,\n Kohl\n RH.\nMumps\n outbreak\n in\n a highly\n vaccinated\n student\n population,\n the\n Netherlands,\n2004.\n Vaccine\n 2010;28(17):2932\u20136.\n[3]\n Karagiannis\n I,\n van\n Lier\n A,\n van\n Binnendijk\n R,\n Ruijs\n H,\n Fanoy\n E,\n Conyn-Van\n Spaen-\ndonck\n MA,\n et\n al.\n Mumps\n in\n a\n community\n with\n low\n vaccination\n coverage\n in\n the\nNetherlands.\n Eurosurveillance\n 2008;13(24.).\n[4]\n Oostvogel\n PM,\n van\n Wijngaarden\n JK,\n van\n der\n Avoort\n HG,\n Mulders\n MN,\n Conyn-van\nSpaendonck\n MA,\n Rumke\n HC,\n et\n al.\n Poliomyelitis\n outbreak\n in\n an\n unvacci-\nnated community\n in\n the\n Netherlands:\n 1992\u201393.\n Lancet\n 1994;344(8923):\n665\u201370.\n[5] Hahn\u00e9\n S,\n Macey\n J,\n van\n Binnendijk\n R,\n Kohl\n R,\n Dolman\n S,\n van\n der\n Veen\n Y,\n et\n al.\nRubella\n outbreak\n in\n the\n Netherlands,\n 2004-2005:\n high\n burden\n of\n congeni-\ntal  infection\n and\n spread\n to\n Canada.\n The\n Pediatric\n Infectious\n Disease\n Journal\n2009;28(9):795\u2013800.\n[6]\n R\u00fcmke\n HC,\n Visser\n HK.\n Childhood\n vaccinations\n anno\n 2004.", "mimetype": "text/plain", "start_char_idx": 25448, "end_char_idx": 26743, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b64443a8-dd8f-4347-bb30-37f90bba1bc6": {"__data__": {"id_": "b64443a8-dd8f-4347-bb30-37f90bba1bc6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5c58ac3d-bd03-4ead-b080-3fc77511262a", "node_type": "1", "metadata": {}, "hash": "bd46c223c353cb020a9c8d91bc33ae0dfa90da3f931eae5aead0312f63b590da", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ad2cf0fe-e160-4995-897b-e1a6a82da68a", "node_type": "1", "metadata": {}, "hash": "91e181548ee3375cb417ae0fa6402d3750d49914f46dfaba76c58b5f6649065c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\n Pediatric\n Infectious\n Disease\n Journal\n2009;28(9):795\u2013800.\n[6]\n R\u00fcmke\n HC,\n Visser\n HK.\n Childhood\n vaccinations\n anno\n 2004.\n I. Effectiveness\n and\nacceptance\n of\n the\n Dutch\n National\n Vaccination\n Programme.\n Nederlands\n Tijd-\nschrift\n Voor\n Geneeskunde\n 2004;148(8):356\u201363.\n[7] Fine\n P,\n Mulholland\n K.\n Community\n immunity.\n In:\n Plotkin\n SA,\n Orenstein\n WA,\n Of\ufb01t\nPA,\n editors.\n Vaccines.\n 5th\n ed.\n Philadelphia,\n PA:\n Elsevier\n Inc.;\n 2008.\n p.\n 1573\u201392,\nchap.\n 71.\n[8] Whelan\n J, van\n Binnendijk\n R,\n Greenland\n K,\n Fanoy\n E,\n Khargi\n M,\n Yap\n K,\n et\n al.\n Ongo-\ning  mumps\n outbreak\n in\n a\n student\n population\n with\n high\n vaccination\n coverage,\nNetherlands,\n 2010.\n Eurosurveillance\n 2010;15(17).\n[9] Wharton\n M,  Cochi\n SL,\n Hutcheson\n RH,\n Bistowish\n JM,\n Schaffner\n W.  A\n large\noutbreak\n of\n mumps\n in\n the\n postvaccine\n era.\n Journal\n of\n Infectious\n Diseases\n1988;158(6):1253\u201360.\n[10]\n Kancherla\n VS,\n Hanson\n IC.\n Mumps\n resurgence\n in\n the\n United\n States.\n Journal\n of\nAllergy\n and\n Clinical\n Immunology\n 2006;118(4):938\u201341.\n[11] Huang\n AS,\n Cortese\n MM,\n Curns\n AT,\n Bitsko\n RH,\n Jordan\n HT,\n Soud\n F,\n et\n al.\n Risk\n factors\nfor\n mumps\n at\n a\n university\n with\n a\n large\n mumps\n outbreak.\n Public\n Health\n Reports\n2009;124(3):419\u201326.", "mimetype": "text/plain", "start_char_idx": 26612, "end_char_idx": 27874, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ad2cf0fe-e160-4995-897b-e1a6a82da68a": {"__data__": {"id_": "ad2cf0fe-e160-4995-897b-e1a6a82da68a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b64443a8-dd8f-4347-bb30-37f90bba1bc6", "node_type": "1", "metadata": {}, "hash": "ae0802e816a15e005d0acc7251ec663fee4e71b3ef2c0975135ef59851bab3e5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f924f5a8-0bfb-42e0-94b9-3434116fce7f", "node_type": "1", "metadata": {}, "hash": "4145590f0055fc92e6dd453d69a0470b89d21a2a1fd974f8185dcf14d66cdf30", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Risk\n factors\nfor\n mumps\n at\n a\n university\n with\n a\n large\n mumps\n outbreak.\n Public\n Health\n Reports\n2009;124(3):419\u201326.\n[12]\n Whyte\n D,\n O\u2019Dea\n F,\n McDonnell\n C,\n O\u2019Connell\n NH,\n Callinan\n S,\n Brosnan\n E,\net\n al.\n Mumps\n epidemiology\n in\n the\n mid-west\n of\n Ireland\n 2004\u20132008:\n increas-\ning  disease\n burden\n in\n the\n university/college\n setting.\n Eurosurveillance\n 2009;\n14(16).\n[13] Dayan\n GH,\n Quinlisk\n MP,\n Parker\n AA,\n Barskey\n AE,\n Harris\n ML,\n Schwartz\n JM,\n et\n al.\nRecent\n resurgence\n of\n mumps\n in\n the\n United\n States.\n New\n England\n Journal\n of\nMedicine\n 2008;358(15):1580\u20139.\n[14]\n StataCorp.\n Statistical\n Software:\n Release\n 10.\n College\n Station:\n Stata\n Corporation;\n2008.\n[15]\n Sartwell\n PE.\n The\n incubation\n period\n and\n the\n dynamics\n of\n infectious\n disease.\nAmerican\n Journal\n of\n Epidemiology\n 1966;83(2):204\u20136.\n[16]\n Update:\n mumps\n outbreak\n \u2013\n New\n York\n and\n New\n Jersey,\n June\n 2009\u2013January\n 2010.\nMMWR\n Morbidity\n and\n Mortality\n Weekly\n Report\n 2010;59(5):125\u20139.\n[17]\n Cortese\n MM,\n Jordan\n HT,\n Curns\n AT,\n Quinlan\n PA,\n Ens\n KA,\n Denning\n PM,\n et\n al.\n Mumps\nvaccine\n performance\n among\n university\n students\n during\n a mumps\n outbreak.\nClinical\n Infectious\n Diseases\n 2008;46(8):1172\u201380.\n[18]\n Dayan\n GH,\n Rubin\n S.\n Mumps\n outbreaks\n in\n vaccinated\n populations:\n are\n avail-\nable mumps\n vaccines\n effective\n enough\n to\n prevent\n outbreaks?\n Clinical\n Infectious\nDiseases\n 2008;47(11):1458\u201367.", "mimetype": "text/plain", "start_char_idx": 27752, "end_char_idx": 29184, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f924f5a8-0bfb-42e0-94b9-3434116fce7f": {"__data__": {"id_": "f924f5a8-0bfb-42e0-94b9-3434116fce7f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ad2cf0fe-e160-4995-897b-e1a6a82da68a", "node_type": "1", "metadata": {}, "hash": "91e181548ee3375cb417ae0fa6402d3750d49914f46dfaba76c58b5f6649065c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d9919bff-8eec-4d4e-beb8-1d62182e4cc4", "node_type": "1", "metadata": {}, "hash": "c570a7af2372d12aeac82adf553032181c85b9c5feb4034fbe7890a10f98d9d1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Clinical\n Infectious\nDiseases\n 2008;47(11):1458\u201367.\n[19]\n Marin\n M,\n Quinlisk\n P,\n Shimabukuro\n T,\n Sawhney\n C,\n Brown\n C,\n Lebaron\n CW.\n Mumps\nvaccination\n coverage\n and\n vaccine\n effectiveness\n in\n a\n large\n outbreak\n among\n col-\nlege\n students\n \u2013\n Iowa,\n 2006.\n Vaccine\n 2008;26(29\u201330):3601\u20137.\n[20] Bernard\n H,\n Schwarz\n NG,\n Melnic\n A,\n Bucov\n V,\n Caterinciuc\n N,\n Pebody\n RG,\n et\n al.\nMumps\n outbreak\n ongoing\n since\n October\n 2007\n in\n the\n Republic\n of\n Moldova.\nEurosurveillance\n 2008;13(13).\n[21]\n Quinlisk\n \nMP.\n \nMumps\n \ncontrol\n \ntoday.\n \nJournal\n \nof\n \nInfectious\n \nDiseases\n2010;202(5):655\u20136.\n[22]\n Watson-Creed\n G,\n Saunders\n A,\n Scott\n J,\n Lowe\n L,\n Pettipas\n J, Hatchette\n TF.\n Two\n suc-\ncessive\n outbreaks\n of\n mumps\n in\n Nova\n Scotia\n among\n vaccinated\n adolescents\n and\nyoung\n adults.\n Canadian\n Medical\n Association\n Journal\n 2006;175(5):483\u20138.\n[23] Dominguez\n A,\n Torner\n N,\n Castilla\n J,\n Batalla\n J, Godoy\n P,\n Guevara\n M,\n et\n al.\nMumps\n vaccine\n effectiveness\n in\n highly\n immunized\n populations.\n Vaccine\n2010;28(20):3567\u201370.\n4680\nK.\n Greenland\n et\n al.\n / Vaccine\n 30 (2012) 4676\u2013\n 4680\n[24]\n Rubin\n SA,\n Qi\n L,\n Audet\n SA,\n Sullivan\n B,\n Carbone\n KM,\n Bellini\n WJ,\n et\n al.", "mimetype": "text/plain", "start_char_idx": 29133, "end_char_idx": 30335, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d9919bff-8eec-4d4e-beb8-1d62182e4cc4": {"__data__": {"id_": "d9919bff-8eec-4d4e-beb8-1d62182e4cc4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Greenland (2012).pdf", "node_type": "4", "metadata": {}, "hash": "15995b43626fb8764019c527b5cb06f8643143eab617660907b7d27f5644eac2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f924f5a8-0bfb-42e0-94b9-3434116fce7f", "node_type": "1", "metadata": {}, "hash": "4145590f0055fc92e6dd453d69a0470b89d21a2a1fd974f8185dcf14d66cdf30", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Antibody\n induced\n by\n immunization\n with\n the\n Jeryl\n Lynn\n mumps\n vaccine\nstrain\n effectively\n neutralizes\n a heterologous\n wild-type\n mumps\n virus\n asso-\nciated\n with\n a large\n outbreak.\n Journal\n of\n Infectious\n Diseases\n 2008;198(4):\n508\u201315.\n[25]\n Sax\n LJ,\n Gilmartin\n SK,\n Bryant\n AN.\n Assessing\n response\n rates\n and\n nonresponse\nbias\n in\n web\n and\n paper\n surveys.\n Research\n in\n Higher\n Education\n 2003;44(4):\n409\u201332.\n[26] Krosnick\n JA.\n Survey\n research.\n Annual\n Review\n of\n Psychology\n 1999;50:537\u201367.\n[27]\n Yung\n CF,\n Andrews\n N,\n Bukasa\n A,\n Brown\n KE,\n Ramsay\n M.  Mumps\n Complications\nand Effects\n of\n Mumps\n Vaccination:\n England\n and\n Wales,\n 2002\u20132006.\n Emerging\nInfectious\n Diseases\n 2011;17(4):661\u20137.\n[28]\n Hahn\u00e9\n S,\n Whelan\n J, van\n Binnendijk\n R,\n Swaan\n C,\n Fanoy\n E,\n Boot\n H,\n et\n al.\nMumps\n vaccine\n effectiveness\n against\n orchitis.\n Emerging\n Infectious\n Diseases\n2012;18(1):191\u20133.\n[29]\n Vandermeulen\n C,\n Leroux-Roels\n G,\n Hoppenbrouwers\n K.\n Mumps\n outbreaks\n in\nhighly\n vaccinated\n populations:\n what\n makes\n good\n even\n better?\n Human\n Vaccines\n2009;5(7):494\u20136.", "mimetype": "text/plain", "start_char_idx": 30336, "end_char_idx": 31430, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "061190ad-53a3-4452-8551-18326ba7547a": {"__data__": {"id_": "061190ad-53a3-4452-8551-18326ba7547a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-1 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "e3d32d3de22e158088e5a633cafb5fcd5c4017392067c52b02c2f6aac1192e4f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5c7dc29b-3410-4f8a-9cd5-bd27bca63b0b", "node_type": "1", "metadata": {}, "hash": "cd574b30f51473a1a9a74175b682679d9543881a57876c790a74a0b8d9860d19", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "VACCINE EVALUATION\nClinical evaluation of a new measles-mumps-\nrubella combined live virus vaccine\nin the Dominican Republic *\nN. JOEL EHRENKRANZ,' ARNOLDO K. VENTURA,2 EDWARD M. MEDLER,3\nJOSEPH E. JACKSON,4 & MICHAEL T. KENNY5\nOver 900 children were enrolled in a double-blind placebo-controlled clinical study of\nmeasles (Schwarz strain), mumps (Jeryl Lynn strain), and rubella (Cendehill strain)\ntrivalent vaccine. The trivalent vaccine caused about the same degree of reactivity as is\ngenerally associated with the Schwarz strain measles vaccine. Paired sera from triple-\nsusceptible vaccinees had seroconversion rates of 99 % for measles, 94 % for mumps, and\n93 % for rubella. The results ofthis study show that this trivalent vacci-le is as well tolerated\nand as effective as its component vaccines.\nThe growing list of virus diseases becoming ame-\nnable to control by vaccination necessitates improve-\nments in the system for delivery of this type of\npreventive medical care. The efficiency of immuniza-\ntion programmes, both private and public, can be\ngreatly increased by the use of polyvalent vaccines\nprovided that the individual components were all\nintended for the same populations. The polyvalent\ncombinations should be no more reactive and no less\neffective than the components used singly. For live,\nattenuated virus vaccines, both the practical and\ntechnical requirements have been met by a variety of\ndouble and triple combinations (1, 2) each prepared\nfor use in certain countries or populations.\nA double-blind, placebo-controlled study was con-\nducted to evaluate clinically a new measles-mumps-\nrubella trivalent live virus vaccine. Consultation with\nhealth authorities in the Dominican Republic re-\nvealed that country to be an appropriate site for a\nproject of this type. In intercity and rural popula-\ntions the use of measles vaccine had been so recently\nintroduced that it had not yet made an impact on the\n* From Cedars of Lebanon Hospital, Miami, FL 33125,\nUSA, and the Human Health Research Laboratories, Dow\nChemical Co., Indianapolis, IN 46268, USA.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2081, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5c7dc29b-3410-4f8a-9cd5-bd27bca63b0b": {"__data__": {"id_": "5c7dc29b-3410-4f8a-9cd5-bd27bca63b0b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-1 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "e3d32d3de22e158088e5a633cafb5fcd5c4017392067c52b02c2f6aac1192e4f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "061190ad-53a3-4452-8551-18326ba7547a", "node_type": "1", "metadata": {}, "hash": "cb94719a0dfab5eefed525c608b79446549e679a00796ab0dc7846e51a5b16f0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ec68ddde-0362-41d5-af8f-fcc50acbd5a1", "node_type": "1", "metadata": {}, "hash": "41ea816a665057bd6258f69e1a03de2d75143178d556e1c5393fa188c0e0e429", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Requests for\nreprints should be addressed to Dr Ehrenkranz.\nI Chief of Medicine, Cedars of Lebanon Hospital.\n2 Department of Medicine, Cedars of Lebanon Hospital.\nAssociate Clinical Investigator, Dow Chemical Co.\n'Director, Biological Clinical Research, Dow Chemical\nCo.\n5 Senior Research Immunologist, Dow Chemical Co.\nage-specific susceptibility rates. In these same popu-\nlations, mumps and rubella vaccines had not yet\ncome into use.\nMATERIALS AND METHODS\nVaccines\nThe vaccine was a combination of live attenuated\nmeasles virus vaccine, Schwarz strain (3, 4), live\nmumps virus vaccine, Jeryl Lynn strain (5-7), and\nlive rubella virus vaccine, Cendehill strain (8, 9).\nThree lots of this trivalent vaccine were used in these\nstudies. Each lot was made from separate mono-\nvalent components and contained a minimum of\n1 000 TCID50 (50% tissue culture infective doses) of\nmeasles and rubella vaccine viruses and 5 000 TCIDF0\nof mumps vaccine virus per dose. The trivalent\nvaccine was dispensed into single dose vials, lyophil-\nized, and stored at 5\u00b0C until use. Single-dose vials\nwere reconstituted with sterile diluent from pre-\nfilled syringes just prior to subcutaneous inocula-\ntion. The vaccine and placebo were produced at the\nBiological Laboratories of the Dow Chemical Co.\nThe placebo was prepared in a similar manner but\nwithout the addition of any virus, and was indistin-\nguishable from the vaccine whether lyophilized or\nreconstituted.\nSerology\nAntibodies to measles and rubella viruses were\ndetermined by the hemagglutination-inhibition (HI)\n3326\n- 81 -\nBULL. WORLD HEALTH ORGAN., Vol. 52, 1975\nN. JOEL EHRENKRANZ ET AL.\nmethod (10, 11). Antibodies to mumps virus were\ndetermined\nby\nthe\nserum\nneutralization\n(SN)\nmethod.", "mimetype": "text/plain", "start_char_idx": 2082, "end_char_idx": 3816, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ec68ddde-0362-41d5-af8f-fcc50acbd5a1": {"__data__": {"id_": "ec68ddde-0362-41d5-af8f-fcc50acbd5a1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-1 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "e3d32d3de22e158088e5a633cafb5fcd5c4017392067c52b02c2f6aac1192e4f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5c7dc29b-3410-4f8a-9cd5-bd27bca63b0b", "node_type": "1", "metadata": {}, "hash": "cd574b30f51473a1a9a74175b682679d9543881a57876c790a74a0b8d9860d19", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7cd07369-9d45-4b31-928a-5b6b89dd4319", "node_type": "1", "metadata": {}, "hash": "52e5ed658eed3d1c78ab07281c8ef2d96baa315f0ff3f39b4c5ba849b5958c9c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "method (10, 11). Antibodies to mumps virus were\ndetermined\nby\nthe\nserum\nneutralization\n(SN)\nmethod. Serum for HI testing was pretreated with\nkaolin (for measles) or with manganese chloride and\nheparin (for rubella) and then adsorbed with the\nappropriate\ntest erythrocytes\n(i.e., African\ngreen\nmonkey\nerythrocytes\nfor\nmeasles,\nnewly-hatched\nchick erythrocytes for rubella). The HI assays were\ndone in microtitre plates, in which 0.025-ml volumes\nof serial 2-fold dilutions of treated serum were tested\nagainst 4 hemagglutination (HA) units of Norrby-\ntype measles HA antigen, or against 4 HA units of\ncommercial rubella HA antigen. The highest dilution\nof serum completely\ninhibiting hemagglutination\nwas taken as the antibody endpoint. Although this\nmicrotitre system yields considerably lower\ntitres\nthan the tube hemagglutination technique, its con-\nvenience for large-scale work outweighed this dis-\nadvantage. Pairs of serum samples that failed to\nshow obvious seroconversion in the microtitre sys-\ntem were retested by the conventional tube technique\n(12).\nMumps antibody titres were determined by the\nVERO\ncell\nmicrotitre serum neutralization (SN)\ntechnique (13). If postinoculation antibody was not\ndetected by this technique, paired serum samples\nwere retested undiluted and at\n1: 2 dilution by a\nplaque reduction technique in VERO cells (14).\nChildren were considered susceptible to a disease\nif antibody\nto\nthat\ndisease\nwas\nnot\ndetectable\n(measles HI titre <1: 2, mumps SN titre <1: 2,\nrubella HI titre <1: 8) in the preinoculation serum.\nSeroconversion after inoculation was determined by\nthe appearance of antibody in the postinoculation\nserum sample of a previously\nsusceptible\nchild.\nSerum samples\nwere always\ntested\nas pairs.\nAll\nserologic assays were double blind.", "mimetype": "text/plain", "start_char_idx": 3717, "end_char_idx": 5497, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7cd07369-9d45-4b31-928a-5b6b89dd4319": {"__data__": {"id_": "7cd07369-9d45-4b31-928a-5b6b89dd4319", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-1 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "e3d32d3de22e158088e5a633cafb5fcd5c4017392067c52b02c2f6aac1192e4f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ec68ddde-0362-41d5-af8f-fcc50acbd5a1", "node_type": "1", "metadata": {}, "hash": "41ea816a665057bd6258f69e1a03de2d75143178d556e1c5393fa188c0e0e429", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bd8ee1cf-6ba1-4675-9ebc-2d2ceb5dc2e3", "node_type": "1", "metadata": {}, "hash": "120dfc391614701edd032875f2f6d165a40ecdb52ca375541709206238bfa53e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Serum samples\nwere always\ntested\nas pairs.\nAll\nserologic assays were double blind.\nResults were\nthen entered into a computer for automated decod-\ning and calculation and tabulation of seroconversion\nrates and geometric mean titres.\nStudy design\nA randomized double-blind design was used to\ndistribute the study population among the 3 lots of\nvaccine and 1 lot of placebo in the ratio of 1 placebo\nsubject to every 5 vaccinees. Each vial of vaccine or\nplacebo was labelled with a unique serial number\nthat became the subject number of the child inocu-\nlated from that vial. A blood sample was obtained\nprior to vaccination. Clinical observations for pos-\nsible vaccine reactions and intercurrent illnesses were\nmade approximately 3 times per child during the\nstudy period from about day 7 to day 21. The results\nof these observations were decoded and tabulated by\ncomputer. A second blood sample was taken 8 weeks\nafter vaccination. The children who had originally\nreceived the placebo were then vaccinated.\nStudy population\nThe children admitted to this study were residents\nof the Herrera District of Santo Domingo, Domin-\nican Republic. Requirements for inclusion in the\nstudy were: (a) informed consent of the parents;\n(b) absence of any\nhistory\nof natural\nmeasles,\nmumps, or rubella, or of immunization against these\ndiseases; and (c) absence of all the usual medical\ncontraindications\nto immunization with\nlive,\nat-\ntenuated virus vaccine.\nRESULTS\nClinical findings\nA total of 926 children participated in the study.\nTheir age distribution and age-specific susceptibility\nrates are shown in Table 1. The sharp drop in triple\nsusceptibility rate in those aged 2 and 3 years is due\nmainly to natural measles infection. The apparently\nhigher triple susceptibility rate in those 5 and 6 years\nof age is an artifact probably caused by the small\nnumber of that age sampled. Other serologic surveys\nof children in and around Santo Domingo revealed\nno such unevenness in the decline of triple suscepti-\nbility rate with age (15). There were no reports of\nany reactions at the injection site, and no immediate\nor early adverse systemic effects of the injection.\nTable\n1.", "mimetype": "text/plain", "start_char_idx": 5415, "end_char_idx": 7581, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bd8ee1cf-6ba1-4675-9ebc-2d2ceb5dc2e3": {"__data__": {"id_": "bd8ee1cf-6ba1-4675-9ebc-2d2ceb5dc2e3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-1 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "e3d32d3de22e158088e5a633cafb5fcd5c4017392067c52b02c2f6aac1192e4f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7cd07369-9d45-4b31-928a-5b6b89dd4319", "node_type": "1", "metadata": {}, "hash": "52e5ed658eed3d1c78ab07281c8ef2d96baa315f0ff3f39b4c5ba849b5958c9c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2a5c8876-b6f7-4303-b669-06a2a7dd224d", "node_type": "1", "metadata": {}, "hash": "6adf596ff66bb88739169d11689d12370d4c096592b5ac796824bf594f4b00ff", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "There were no reports of\nany reactions at the injection site, and no immediate\nor early adverse systemic effects of the injection.\nTable\n1.\nAge\ndistribution\nand\nage-specific\ntriple\nsusceptibility rates in the study population\nAge in years\nNumber\nTriple\nof subjects\nsusceptible (%)\n1\n181\n50.3\n2\n179\n26.8\n3\n209\n14.3\n4\n247\n7.3\n5\n94\n10.6\n6\n4\n50.0\n7\n1\n0.0\nunknown\n11\n9.1\ntotal\n926\n21.6\n82\nNEW MEASLES-MUMPS-RUBELLA COMBINED LIVE VIRUS VACCINE\nTable 2. Distribution of maximum axillary temperature\nreadings from the 7th to the 21 st day after vaccination\nTemperature\nTriple-susceptible\nPlacebo\nrange (\u00b0C)\nvaccinees (all lots)\nsubjects\n36.7\n6 (3.7) a\n6 (4.7) a\n36.7-37.2\n122 (74.8)\n96 (75.6)\n37.3-37.7\n27 (16.6)\n22 (17.3)\n37.8-38.3\n3 (1.8)\n2 (1.6)\n38.4-38.8\n1 (0.6)\n1 (0.8)\n38.9-39.4\n2 (1.2)\n0\n39.5-40.0\n2 (1.2)\n0\ntotal\n163\n127\na Figures in parentheses are percentages.\nThe distribution of axillary temperature readings\nfrom the 7th to the 21st day after vaccination are\nshown in Table 2. The vaccinees showed slightly\nhigher frequencies than those given placebos at the\nupper limits of the temperature range, but these\ndifferences in distribution were not statistically signi-\nficant (Fisher's Exact Probability: P =\n0.22 for\ntemperatures >37.8\u00b0C and P = 0.18 for tempera-\ntures >38.3\u00b0C).\nThe frequencies of clinical findings other than\nfever during the 2nd and 3rd weeks after vaccination\nare shown\nin Table\n3.", "mimetype": "text/plain", "start_char_idx": 7442, "end_char_idx": 8847, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2a5c8876-b6f7-4303-b669-06a2a7dd224d": {"__data__": {"id_": "2a5c8876-b6f7-4303-b669-06a2a7dd224d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-1 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "e3d32d3de22e158088e5a633cafb5fcd5c4017392067c52b02c2f6aac1192e4f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bd8ee1cf-6ba1-4675-9ebc-2d2ceb5dc2e3", "node_type": "1", "metadata": {}, "hash": "120dfc391614701edd032875f2f6d165a40ecdb52ca375541709206238bfa53e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e5bb471b-24c4-4bc0-bed6-c65f47c3c3be", "node_type": "1", "metadata": {}, "hash": "8f70a73acebad165d0bfb55ad0094fe4dc8a98d71726f1694feb49c238a7d2f2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The frequencies of clinical findings other than\nfever during the 2nd and 3rd weeks after vaccination\nare shown\nin Table\n3. Rash was\nslightly more\nTable 3. The frequencies of positive clinical findings\nfrom the 7th to the 21 st day after vaccination\nTriple-susceptible\nSusceptible\nvaccinees\nplacebo\n(all lots)\nsubjects\nrash\n11 (6.7) a\n6 (4.7) a\nlymphadenopathy\n1 (0.6)\n2 (1.6)\nconjunctivitis\n7 (4.3)\n5 (3.9)\notitis media\n4 (2.5)\n1 (0.8)\ncoryza\n3 (1.0)\n1 (0.8)\nrhinitis\n65 (39.9)\n55 (43.3)\npharyngitis\n2 (1.2)\n2 (1.6)\ncough\n1 (0.6)\n0\nheadache\n1 (0.6)\n1 (0.8)\na Figures in parentheses are percentages.\nfrequent in triple-susceptible vaccinees (6.7%) than\nin susceptible placebo subjects (4.7 %). Although this\nslight excess of rash in vaccinees is similar to that\nwhich may occur with measles vaccine used singly,\nthe difference between vaccinees and placebo con-\ntrols in this study was not statistically significant (X2\n= 0.53, P >0.1). None of the other clinical findings\nshowed any statistically\nsignificant difference be-\ntween triple-susceptible vaccinees and placebo con-\ntrols. The most frequent finding was rhinitis, which\nwas reported more frequently in placebo subjects\n(43.3 %) than in triple-susceptible vaccinees (39.9 %).\nSymptoms that were specifically looked for but not\nfound in this study population included bronchitis,\nparotitis, orchitis, and paraesthesia.\nJoint pain was reported for only one child, a 4-\nyear-old\ntriple-susceptible male\nvaccinee.\nIt was\ndescribed as minimal, and occurred on the 14th day\nafter vaccination at which time the child also had\nrhinitis, pharyngitis, and an axillary temperature of\n37.8\u00b0C.", "mimetype": "text/plain", "start_char_idx": 8725, "end_char_idx": 10363, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e5bb471b-24c4-4bc0-bed6-c65f47c3c3be": {"__data__": {"id_": "e5bb471b-24c4-4bc0-bed6-c65f47c3c3be", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-1 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "e3d32d3de22e158088e5a633cafb5fcd5c4017392067c52b02c2f6aac1192e4f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2a5c8876-b6f7-4303-b669-06a2a7dd224d", "node_type": "1", "metadata": {}, "hash": "6adf596ff66bb88739169d11689d12370d4c096592b5ac796824bf594f4b00ff", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e188ea5f-16be-4632-bf2c-952c0fec0809", "node_type": "1", "metadata": {}, "hash": "ad2705e7f4d4ee32132d87f0564336317be43d2f94c7199ae322f9a3d3f3fee1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "It was\ndescribed as minimal, and occurred on the 14th day\nafter vaccination at which time the child also had\nrhinitis, pharyngitis, and an axillary temperature of\n37.8\u00b0C. This child was free of symptoms on sub-\nsequent observations.\nMiscellaneous clinical findings unrelated to vac-\ncination, but characteristic of this tropical intercity\npopulation, included a wide variety of enteric, respi-\nratory, and dermatologic symptoms. Such findings\nwere as prevalent in placebo subjects as in triple-\nsusceptible vaccinees.\nSerologic results\nPostvaccination\nserum\nsamples\nwere\nobtained\nfrom 439 children, of whom 84 were triple-suscep-\ntible. The serologic results obtained with these triple-\nsusceptible\nsubjects\nare shown\nin\nTable\n4.\nIn\n72 susceptible vaccinees the seroconversion rates\nwere 99% for measles, 94% for mumps, and 93 %\nfor rubella. The geometric mean antibody\ntitres\nwere 35.6 for measles, 3.9 for mumps, and 34.4\nTable 4. Immune responses of 72 triple-susceptible\nchildren inoculated with the trivalent vaccine and of\n12 triple-susceptible children inoculated with placebo\nSero-\ntriple-susceptible\nvaccinees\nPlacebo\nconversion\nsubjects\nto:\nNo.\n%\nGMTa\nmeasles\n71\n99\n35.6\n0\nmumps\n68\n94\n3.9\n0\nrubella\n67\n93\n34.4\n0\na Geometric mean titre.\n83\nN. JOEL EHRENKRANZ ET AL.\nfor rubella. These values are no\ndifferent from\nthose usually found following the use of the same\nvirus strains as monovalent vaccines. There were\nno seroconversions among the 12 triple-susceptible\nplacebo subjects, or among 47 others with various\nsingle and double susceptibilities.", "mimetype": "text/plain", "start_char_idx": 10193, "end_char_idx": 11751, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e188ea5f-16be-4632-bf2c-952c0fec0809": {"__data__": {"id_": "e188ea5f-16be-4632-bf2c-952c0fec0809", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-1 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "e3d32d3de22e158088e5a633cafb5fcd5c4017392067c52b02c2f6aac1192e4f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e5bb471b-24c4-4bc0-bed6-c65f47c3c3be", "node_type": "1", "metadata": {}, "hash": "8f70a73acebad165d0bfb55ad0094fe4dc8a98d71726f1694feb49c238a7d2f2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "721d2bfb-91b0-4087-8fea-a4b7ba94af43", "node_type": "1", "metadata": {}, "hash": "51dadb5d4e40a8896f7e3d08e8af4ae001eaaa41fc3ba74c6f0971959093a3d9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "There were\nno seroconversions among the 12 triple-susceptible\nplacebo subjects, or among 47 others with various\nsingle and double susceptibilities.\nDISCUSSION\nThe occurrence of transient fever within the range\n38.90C-40.00C in 4 (2.3%) of the triple-susceptible\nvaccinees and none of the placebo controls is con-\nsistent with that which would be expected following\nadministration of the Schwarz strain measles vaccine\nalone (4). This, together with the lack of any statisti-\ncally significant difference between the distributions\nof temperature readings in triple-susceptible vac-\ncinees and placebo subjects, indicates that combin-\ning the vaccines did not enhance their known minor\nfebrile effects. The same may be said of rash, the\nfrequency of which was only 2% higher in triple-\nsusceptible vaccinees than in placebo subjects, and\nwas well within the range generally reported for the\nSchwarz strain measles vaccine (4, 16). Comparison\nof the frequencies of these and other symptoms in\ntriple-susceptible\ntrivalent\nvaccinees and placebo\nsubjects indicates that there is no enhancement of\nside effects when the three vaccines are combined to\nmake a trivalent vaccine.\nThe evidence also indicates that the 3 vaccines are\nas effective when given together as when used in-\ndividually.\nSince\nthe\nseroconversion\nrates\nand\ngeometric mean titres induced by the trivalent vac-\ncine are quantitatively equivalent to those generally\ninduced by the component vaccines used singly, it is\nto be expected that the qualitative aspects of the\nimmune response, particularly its long duration, will\nalso be the same for the trivalent vaccine.\nACKNOWLEDGMENTS\nThanks are especially due to the Secretary of Health of\nthe Dominican Republic and to members of his staff for\ntheir support. This work would not have been possible\nwithout the cooperation of the people of Santo Domingo\nand the help of many local physicians. We also acknow-\nledge the work of our field teams, and esp:cially that of\nMrs Joan Ventura whose skill enabled us to obtain\nrepeated blood samples. The manuscript was prepared by\nMrs Doris Brown.", "mimetype": "text/plain", "start_char_idx": 11604, "end_char_idx": 13702, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "721d2bfb-91b0-4087-8fea-a4b7ba94af43": {"__data__": {"id_": "721d2bfb-91b0-4087-8fea-a4b7ba94af43", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-1 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "e3d32d3de22e158088e5a633cafb5fcd5c4017392067c52b02c2f6aac1192e4f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e188ea5f-16be-4632-bf2c-952c0fec0809", "node_type": "1", "metadata": {}, "hash": "ad2705e7f4d4ee32132d87f0564336317be43d2f94c7199ae322f9a3d3f3fee1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c2ee3628-16ec-4ac2-b414-d21be14d79a2", "node_type": "1", "metadata": {}, "hash": "9faa3773dac0e735a42acb7e8c69c32b883d3657633a7abe8b4e09c2b67ec65b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We also acknow-\nledge the work of our field teams, and esp:cially that of\nMrs Joan Ventura whose skill enabled us to obtain\nrepeated blood samples. The manuscript was prepared by\nMrs Doris Brown.\nRItSUMI2\nEVALUATION CLINIQUE EN RfPUBLIQUE DOMINICAINE D'UN NOUVEAU VACCIN VIVANT\nMIXTE ANTIROUGEOLEUX, ANTIOURLIEN ET ANTIRUBE'OLEUX\nUn vaccin trivalent antirougeoleux (souche Schwartz),\nantiourlien (souche Jeryl Lynn) et antirubeoleux (souche\nCendehill) a fait l'objet, en Republique Dominicaine,\nd'une etude clinique portant sur 926 enfants et visant\na determiner le taux de r6actions cliniques ainsi que\nl'efficacit6 de ce vaccin comme agent immunisant. Trois\nlots du vaccin en question ont ete compares a un placebo,\nla methode du double insu dtant employee de telle fagon\nqu'un enfant sur six, designe au hasard, regoive le pla-\ncebo. Un echantillon de sang a et\npreleve sur chaque\nenfant avant la vaccination. Du septieme ou vingt et\nunieme jour inclus suivant la vaccination, on a procede,\ntoujours selon la methode du double insu, a environ\ntrois examens cliniques de chaque enfant pour detecter\nles r6actions postvaccinales et les maladies intercurrentes\npossibles. Un dernier echantillon de sang a e't\npreleve'\nhuit semaines\napres la vaccination et les enfants qui\navaient recu le placebo ont alors ete vaccines.\nDes donnees\ncliniques\nont\netd\nobtenues\nchez\nles\n290 enfants suivis, dont 163 vaccines sensibles aux trois\nvirus en cause et 127 sujets ayant requ le placebo. On a\nobserv6 de la fievre un peu plus fr6quemment parmi les\nvaccines que parmi les autres, mais la difference n'est pas\nstatistiquement significative.", "mimetype": "text/plain", "start_char_idx": 13507, "end_char_idx": 15135, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c2ee3628-16ec-4ac2-b414-d21be14d79a2": {"__data__": {"id_": "c2ee3628-16ec-4ac2-b414-d21be14d79a2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-1 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "e3d32d3de22e158088e5a633cafb5fcd5c4017392067c52b02c2f6aac1192e4f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "721d2bfb-91b0-4087-8fea-a4b7ba94af43", "node_type": "1", "metadata": {}, "hash": "51dadb5d4e40a8896f7e3d08e8af4ae001eaaa41fc3ba74c6f0971959093a3d9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ced8905b-3983-4732-adcb-75c6448f3d43", "node_type": "1", "metadata": {}, "hash": "b40286a770ef73263cf62ce79187d29b746a55cdefb14c5525fe6cf1e93e9abd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "On a\nobserv6 de la fievre un peu plus fr6quemment parmi les\nvaccines que parmi les autres, mais la difference n'est pas\nstatistiquement significative. Une eruption s'est produite\nchez 6,7% des vaccines sensibles aux trois virus et chez\n4,7% des sujets ayant regu le placebo. La proportion\nlegerement plus elevee d'eruptions dans le groupe des\nvaccines sensibles correspond a ce qu'on aurait pu escomp-\nter avec un vaccin antirougeoleux monovalent, la diff&e\nrence n'etant pas statistiquement significative. La conjonc-\ntivite a egalement ete plus fr6quente parmi les vaccines\nsensibles, mais la difference est inferieure a 1 %. Un seul\nenfant, vaccine' sensible, a souffert de douleurs articu-\nlaires; elles ont et6 minimes et de courte duree.\nL'analyse des echantillons de sang preleves avant et\napres la vaccination sur 84 enfants sensibles aux trois\n84\nNEW MEASLES-MUMPS-RUBELLA COMBINED LIVE VIRUS VACCINE\n85\nvirus, dont 72 sujets vaccines et 12 sujets ayant requ le\nplacebo, a donn6 les r6sultats suivants: parmi les vac-\ncines, acquisition d'une immunit6 a la rougeole chez 99 %,\nla moyenne geometrique des titres etant de 35,6, d'une\nimmunit6 aux oreillons chez 94% (moyenne:\n3,9), et\nd'une immunite a la rubeole chez 93% (moyenne: 34,4).\nCes donnees cliniques et serologiques indiquent que\nles trois vaccins consid6res presentent la meme securit6\nd'emploi et la meme efficacite lorsqu'ils sont administres\nensemble que lorsqu'ils sont utilis6s separement.\nREFERENCES\n1., MEYER, H. M. El AL.", "mimetype": "text/plain", "start_char_idx": 14985, "end_char_idx": 16483, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ced8905b-3983-4732-adcb-75c6448f3d43": {"__data__": {"id_": "ced8905b-3983-4732-adcb-75c6448f3d43", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-1 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "e3d32d3de22e158088e5a633cafb5fcd5c4017392067c52b02c2f6aac1192e4f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c2ee3628-16ec-4ac2-b414-d21be14d79a2", "node_type": "1", "metadata": {}, "hash": "9faa3773dac0e735a42acb7e8c69c32b883d3657633a7abe8b4e09c2b67ec65b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8eb66fc3-e352-42be-bb8c-453d5bc70034", "node_type": "1", "metadata": {}, "hash": "9b37f68177c84a8aa4bbe95be9d36e2e34b11d6bb3e601e399b888ae958e2ad1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "REFERENCES\n1., MEYER, H. M. El AL. In: First International Confer-\nence on Vaccines\nagainst\nViral and\nRickettsial\nDiseases\nof Man,\nWashington, DC, November,\n1966. Washington, DC, Pan American Health Orga-\nnization, 1967, pp. 336-342.\n2. REY, M. In: Proceedings of the International Confer-\nence on the Application of Vaccines against Viral,\nRickettsial, and Bacterial Diseases of Man, Wash-\nington, DC, December, 1970. Washington, DC, Pan\nAmerican Health Organization, 1971, pp. 407-412.\n3. SCHWARZ, A. J. F. Annales de pediatrie, 202: 241-252\n(1964).\n4. ScHWARZ, A. J. F. ET AL. Journal of the American\nMedical Association, 199: 26-30 (1967).\n5. WEIBEL,\nR.\nE. ET AL. New England journal of\nmedicine, 276: 245-251 (1967).\n6. HILLEMAN, M. R. ET AL. New England journal of\nmedicine, 276: 252-258 (1967).\n7. HELLEMAN, M. R. ET AL. New England journal of\nmedicine, 278: 227-232 (1968).\n8. DUPAN, R. M. ET AL. American journal ofdiseases of\nchildren, 115: 658-662 (1968).\n9. PINziE, A. ET AL. American journal of diseases of\nchildren, 118: 172-177 (1969).\n10. LiNNEMANN, C. C. JR ET AL. American journal of\nepidemiology, 95: 238-246 (1972).\n11. COOPER, L. Z. ET AL. Journal ofthe American Medical\nAssociation, 207: 89-93 (1969).\n12. ROSEN, L. Virology, 13: 139-141 (1961).\n13. KENNY, M. T. ET AL.", "mimetype": "text/plain", "start_char_idx": 16449, "end_char_idx": 17740, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8eb66fc3-e352-42be-bb8c-453d5bc70034": {"__data__": {"id_": "8eb66fc3-e352-42be-bb8c-453d5bc70034", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-1 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "e3d32d3de22e158088e5a633cafb5fcd5c4017392067c52b02c2f6aac1192e4f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ced8905b-3983-4732-adcb-75c6448f3d43", "node_type": "1", "metadata": {}, "hash": "b40286a770ef73263cf62ce79187d29b746a55cdefb14c5525fe6cf1e93e9abd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "12. ROSEN, L. Virology, 13: 139-141 (1961).\n13. KENNY, M. T. ET AL. Applied microbiology, 20: 371-\n373 (1970).\n14. KrENNY, M. T. ET AL. Journal of biological standard-\nization, 3: 291-306 (1975).\n15. KENNY, M. T. ET AL. American journal of epidemi-\nology, 103 (1976) (in press).\n16. ANDELMAN, M. B. ET AL. American journal ofpublic\nhealth, 56: 1891-1897 (1966).", "mimetype": "text/plain", "start_char_idx": 17673, "end_char_idx": 18034, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "47429d00-ed9f-4af7-9cc8-50842d93e1b2": {"__data__": {"id_": "47429d00-ed9f-4af7-9cc8-50842d93e1b2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4e628428-4cbe-40dd-b2e1-731e16cf88b7", "node_type": "1", "metadata": {}, "hash": "7b3bfb0deb8da52712a301c2e98ff682e81f1fc4088099e89e1b6d92b5e4afae", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Single-dose varicella vaccine effectiveness in Brazil: A case-control study\nAna Lucia Andrade a,\u21d1, Maria Aparecida da Silva Vieira b, Ruth Minamisava c,\nCristiana Maria Toscano a, Menira Borges de Lima Souza a, Fab\u00edola Fiaccadori a,\nCristina Adelaide Figueiredo d, Suely Pires Curti d, Maria L\u00edgia Bacciotte Ramos Nerger e,\nAna Luiza Bierrenbach a, Varicella Study Group\na Institute of Tropical Pathology and Public Health, Federal University of Goias, Brazil\nb Department of Nursing, Ponti\ufb01cal Catholic University of Goias, Brazil\nc School of Nursing, Federal University of Goias, Brazil\nd Adolfo Lutz Institute, S\u00e3o Paulo, Brazil\ne S\u00e3o Paulo Municipal Health Department, S\u00e3o Paulo, Brazil\na r t i c l e\ni n f o\nArticle history:\nReceived 23 April 2017\nReceived in revised form 1 December 2017\nAccepted 6 December 2017\nAvailable online 14 December 2017\nKeywords:\nVaricella vaccination\nBreakthrough\nUniversal routine vaccination\nVaccine effectiveness\na b s t r a c t\nBackground: Varicella vaccine was introduced into the Brazilian Immunization Program in October 2013,\nas a single-dose schedule administered at 15 months of age. Its effectiveness had not yet been assessed in\nthe country.\nMethods: A matched case-control study was carried out in S\u00e3o Paulo and Goi\u00e2nia (Southeast and Midwest\nregions, respectively), Brazil. Suspected cases, were identi\ufb01ed through a prospective surveillance estab-\nlished in the study sites. All cases had specimens from skin lesion collected for molecular laboratory test-\ning. Cases were con\ufb01rmed by either clinical or PCR of skin lesions and classi\ufb01ed as mild, moderate, and\nsevere disease.\nMethods: Two neighborhood controls were selected for each case. Cases and controls were aged 15\u201332\nmonths and interviewed at home. Evidence of prior vaccination was obtained from vaccination cards.\nUnivariate and multivariate logistic regression models were used, and odds ratio and its respective\n95% con\ufb01dence intervals were estimated. Vaccine effectiveness was estimated by comparing de odds\nof having received varicella vaccine among cases and controls.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2082, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4e628428-4cbe-40dd-b2e1-731e16cf88b7": {"__data__": {"id_": "4e628428-4cbe-40dd-b2e1-731e16cf88b7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "47429d00-ed9f-4af7-9cc8-50842d93e1b2", "node_type": "1", "metadata": {}, "hash": "2d147b263afd6ce1fa36074a34322cfcacbc6014239c8d83c47a3c9003d535f0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "18d2775c-25a4-49a1-ae96-ff2495410f03", "node_type": "1", "metadata": {}, "hash": "b9d2d34d645b667c28ecbf7128f34064aa06b54cfebdbf513808641df1689f4b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine effectiveness was estimated by comparing de odds\nof having received varicella vaccine among cases and controls.\nResults: A total of 168 cases and 301 controls were enrolled. Moderate and severe illness, was found in\n33.3% and 9.9% of the cases. Effectiveness of a single dose varicella vaccine was 86% (95%CI 72\u201392%)\nagainst disease of any severity and 93% (95%CI 82\u201397%) against moderate and severe disease. Out of\n168 cases, 81.8% had positive PCR results for wild-type strains, and 22.0% were breakthrough varicella\ncases. Breakthrough cases were milder compared to non-breakthrough cases (p < .001).\nConclusions: Effectiveness of single dose varicella vaccine in Brazil is comparable to that in other coun-\ntries where breakthrough varicella cases have also been found to occur. The goal of the varicella vaccina-\ntion program, along with disease burden and affordability should be taken into consideration when\nconsidering the adoption of a second dose of varicella vaccine into national immunization programs.\n\u0001 2017 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND\nlicense (http://creativecommons.org/licenses/by-nc-nd/4.0/).\n1. Introduction\nVaricella is a highly infectious disease caused by the varicella-\nzoster virus (VZV). Transmission occurs by either direct contact\nwith contagious skin lesions or by airborne spread from respiratory\nsecretions or infected lesions. Although symptoms are generally\nmild in children, severe complications may follow, such as sec-\nondary bacterial infections, pneumonia, encephalitis, and even\ndeath [1,2]. Among vaccinated individuals, varicella can emerge\nas a modi\ufb01ed disease, known as breakthrough varicella [3,4]. This\ninfection may present a diagnostic challenge, due to its atypical\nand milder presentation [5,6].\nVaricella surveillance is not mandatory in Brazil. However, since\n2000 varicella outbreaks in daycare centers, preschools, schools,\nand in the community, are to be reported to the National Noti\ufb01able\nDiseases Surveillance System.", "mimetype": "text/plain", "start_char_idx": 1963, "end_char_idx": 4011, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "18d2775c-25a4-49a1-ae96-ff2495410f03": {"__data__": {"id_": "18d2775c-25a4-49a1-ae96-ff2495410f03", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4e628428-4cbe-40dd-b2e1-731e16cf88b7", "node_type": "1", "metadata": {}, "hash": "7b3bfb0deb8da52712a301c2e98ff682e81f1fc4088099e89e1b6d92b5e4afae", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4a96653a-80af-4a9e-bc9c-df73c465f057", "node_type": "1", "metadata": {}, "hash": "d296435470a72f45d0f55d742b2913e15706be61cac0b8f924112aaa2c90bd1b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "However, since\n2000 varicella outbreaks in daycare centers, preschools, schools,\nand in the community, are to be reported to the National Noti\ufb01able\nDiseases Surveillance System. Furthermore, in addition to out-\nhttps://doi.org/10.1016/j.vaccine.2017.12.011\n0264-410X/\u0001 2017 The Author(s). Published by Elsevier Ltd.\nThis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).\n\u21d1Corresponding author.\nE-mail address: ana@pq.cnpq.br (A.L. Andrade).\nVaccine 36 (2018) 479\u2013483\nContents lists available at ScienceDirect\nVaccine\njournal homepage: www.elsevier.com/locate/vaccine\nbreaks, severe cases or varicella-related deaths are to be reported\nsince 2014 [7].\nIn October 2013 varicella vaccine was introduced into the routine\npublic Brazilian National Immunization Program (NIP) to prevent\nmoderate and severe disease among the target population, including\nvaricella-related deaths. A combined tetravalent vaccine containing\nmeasles, mumps, rubella, and varicella antigens (MMRV), manufac-\ntured by GlaxoSmithKline\u0003 was introduced. Despite surveillance\nevidence indicating varicella community outbreaks, Brazil opted\nfor a one dose schedule, administered at the age of 15 months [8].\nDecision on the adoption of a 2-dose schedule was deferred for later,\nonce evaluation of the vaccine effectiveness was available.\nPrior to 2013, the vaccine was available only for high-risk\ngroups such as susceptible individuals who had contact with a\nvaricella case, particularly in outbreak control settings. Coverage\nwas thus very low, reported at 3% in children aged 1\u20134 years old\n[9]. In the private healthcare setting, varicella vaccine is available\nsince 1996.\nPost-licensure studies are crucial to evaluate vaccination effec-\ntiveness and impact [10]. The impact of single dose varicella vacci-\nnation is still unknown in Brazil. Worldwide, information is scarce\nto what extent one-dose schedule prevents cases of breakthrough\ninfection soon after vaccine introduction.", "mimetype": "text/plain", "start_char_idx": 3834, "end_char_idx": 5845, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4a96653a-80af-4a9e-bc9c-df73c465f057": {"__data__": {"id_": "4a96653a-80af-4a9e-bc9c-df73c465f057", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "18d2775c-25a4-49a1-ae96-ff2495410f03", "node_type": "1", "metadata": {}, "hash": "b9d2d34d645b667c28ecbf7128f34064aa06b54cfebdbf513808641df1689f4b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f8f5d9b2-5208-4dac-8403-08846d36eca5", "node_type": "1", "metadata": {}, "hash": "829fed9cf6adf051e425c7597da9518d32d8779ec987c09c73821e402ccf2488", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The impact of single dose varicella vacci-\nnation is still unknown in Brazil. Worldwide, information is scarce\nto what extent one-dose schedule prevents cases of breakthrough\ninfection soon after vaccine introduction. We evaluated the effec-\ntiveness of varicella vaccine in a case-control study conducted\nwithin the \ufb01rst two years of its introduction into the NIP.\n2. Methods\n2.1. Study population and setting\nFrom\nNovember/2013\nto\nDecember/2015,\na\nprospective\nmatched case-control methodology on varicella [11] was con-\nducted in two Brazilian State Capital cities, S\u00e3o Paulo (Southeast\nregion) and Goi\u00e2nia (Midwest region). Varicella vaccination cover-\nage rates reached 83% and 60% in Goi\u00e2nia and 69% and 66% in S\u00e3o\nPaulo, respectively, during 2014 and 2015 [12]. Children targeted\nfor vaccination (aged \u0001 15 months) born from June 2012 onwards,\nand residing in any of the two study municipalities included in the\nstudy, were eligible. Children without vaccination cards to con\ufb01rm\nvaccination history; children with contraindications for varicella\nvaccination; and children who received varicella vaccine within\nthe prior 42 days were excluded.\n2.2. Case de\ufb01nition\nSuspected cases were de\ufb01ned as children aged 15\u201332 months\nwith rash and either suspected as having varicella by an attending\nphysician or being a contact to a con\ufb01rmed varicella case. Cases\nwere con\ufb01rmed by either clinical or laboratory criteria. Clinically\ncon\ufb01rmed cases were those with a clinical diagnosis given by the\nphysician. Laboratory con\ufb01rmation was by means of identi\ufb01cation\nof DNA varicella-zoster virus by real-time PCR (RT-PCR) from a skin\nlesions, as further described below.", "mimetype": "text/plain", "start_char_idx": 5628, "end_char_idx": 7288, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f8f5d9b2-5208-4dac-8403-08846d36eca5": {"__data__": {"id_": "f8f5d9b2-5208-4dac-8403-08846d36eca5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4a96653a-80af-4a9e-bc9c-df73c465f057", "node_type": "1", "metadata": {}, "hash": "d296435470a72f45d0f55d742b2913e15706be61cac0b8f924112aaa2c90bd1b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7df26906-5f1f-4d9b-8d85-6a47a3ee2872", "node_type": "1", "metadata": {}, "hash": "54f73770f991e9dfa8b6ecea6d140f7f20f89970070203dbcfe8f6a7f6c96717", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Laboratory con\ufb01rmation was by means of identi\ufb01cation\nof DNA varicella-zoster virus by real-time PCR (RT-PCR) from a skin\nlesions, as further described below.\nCases were furtherclassi\ufb01ed by severity of disease based on num-\nber of skin lesions, being either: (1) Mild \u2013 fewer than 50 lesions; (2)\nMild/moderate \u2013 between 50 and 249 lesions; (3) Moderate \u2013\nbetween 250 and 499 lesions; and (4) Severe \u2013 500 lesions or more,\nhaving been hospitalized or having any complication.\nCases of varicella in vaccinated children 42 days or more before\nthe onset of a rash was de\ufb01ned as breakthrough cases [13,14].\n2.3. Case ascertainment\nSuspected\nvaricella\ncases\nwere\nidenti\ufb01ed\nthrough\nactive\nprospective surveillance in selected primary health services (PHS)\nand day-care centers integrating the study network, which were\ncontacted twice weekly. Whenever a case of varicella was detected,\ncases and their legal guardians were asked periodically, during a\nthree-week period after rash onset, if they knew about another\nsuspected varicella case within the age group of the study, follow-\ning a snowball sampling rationale. By so doing, our aim was to \ufb01nd\nthe younger home and neighborhood contacts that did not attend\nday-care centers, as well as the mild cases that did not seek\nhealthcare.\nThe study network was comprised of 104 PHS in Goi\u00e2nia\nlocated throughout all regions in the city. In S\u00e3o Paulo, cases were\nascertained in 5 PHS located in the Western (4 services) and in the\nSoutheast (1 service) regions of the city.\nWhen a varicella suspected case was identi\ufb01ed, the PHS pedia-\ntrician or infectious disease physician was responsible for clinical\ncon\ufb01rmation and ascertainment of disease severity.\n2.4. Control de\ufb01nition and selection\nFor each case of varicella two neighborhood controls were\nselected, matched by age (15\u201332 months). Controls were de\ufb01ned\nas children residing in the neighborhood of the case, in which no\nhistory of varicella or outpatient clinics visits due to skin lesion\nwas reported.", "mimetype": "text/plain", "start_char_idx": 7131, "end_char_idx": 9132, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7df26906-5f1f-4d9b-8d85-6a47a3ee2872": {"__data__": {"id_": "7df26906-5f1f-4d9b-8d85-6a47a3ee2872", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f8f5d9b2-5208-4dac-8403-08846d36eca5", "node_type": "1", "metadata": {}, "hash": "829fed9cf6adf051e425c7597da9518d32d8779ec987c09c73821e402ccf2488", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8bfe67e0-bb11-4ac4-8ee7-762299fd5eac", "node_type": "1", "metadata": {}, "hash": "12add2f8decd8010f862a01d8c1e8cdb2165d750970a047ac3ed5851e66cfe0a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Controls were de\ufb01ned\nas children residing in the neighborhood of the case, in which no\nhistory of varicella or outpatient clinics visits due to skin lesion\nwas reported. To identify controls, houses nearby the cases were\nvisited following a systematic sampling procedure.\n2.5. Data collection\nStudy data collectors were trained prior to study start on stan-\ndardized case de\ufb01nitions; and processes for requesting verbal con-\nsent, \ufb01lling out the case reporting form (CRF), and collection of\nclinical samples. Parents or legal guardians of case and controls\nwere interviewed at their respective homes. For cases, interviews\ntook place up to 5 days after the case\u2019s disease onset. Controls were\ninterviewed within up to 2 weeks of the corresponding case dis-\nease onset date. The data collection form captured data on child\u2019s\nname, date of birth, gender, varicella history, vaccine receipt and\nnumber of doses, types and dates of MMRV and MMR vaccines,\nunderlying and chronic diseases, use of corticosteroids; day care\nattendance of other children living in the same household; and\nmother\u2019s name, age, education and address. For cases, additional\ninformation was collected: date of symptom onset, date of swab\ncollection of the lesion, and number of lesions.\nClinical samples were collected from all children with a clinical\ndiagnosis of varicella and sent for PCR testing to either the Virology\nLaboratories of the Federal University of Goi\u00e1s, or the Adolfo Lutz\nInstitute. All samples were processed using PCR detection assay\nand Real Time PCR, as described by Watzinger et al. [15]. The use\nof restriction reactions made it possible to differentiate the\nwild-type varicella-zoster (WT-VZV) from the vaccine strain\n(Oka strain), as described by Loparev et al. [16].\nEvidence of prior vaccination was obtained from vaccine cards.\nFor the purpose of this analysis, children were considered as\nimmunized if they received vaccine at least 42 days before the rash\nonset (cases) or study interview (controls). All other cases and con-\ntrols were considered as non-immunized.", "mimetype": "text/plain", "start_char_idx": 8963, "end_char_idx": 11031, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8bfe67e0-bb11-4ac4-8ee7-762299fd5eac": {"__data__": {"id_": "8bfe67e0-bb11-4ac4-8ee7-762299fd5eac", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7df26906-5f1f-4d9b-8d85-6a47a3ee2872", "node_type": "1", "metadata": {}, "hash": "54f73770f991e9dfa8b6ecea6d140f7f20f89970070203dbcfe8f6a7f6c96717", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c45bdbad-97e3-4f01-a9f5-9ccb2a3654ae", "node_type": "1", "metadata": {}, "hash": "3b3bad4fcdb3f9ccdb6ef66db02140753eb1e5f17daf36dc6b4d88b485229a27", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All other cases and con-\ntrols were considered as non-immunized. Cases who received vari-\ncella vaccine within 42 days of rash onset (for cases) or date of the\ninterview (for controls) were not eligible for participation.\n2.6. Statistical considerations\nAssuming that the odds of becoming ill is 60% lower in vacci-\nnated children when compared to non-vaccinated children, vac-\ncine\ncoverage\nof\n90%,\nand\n90%\npower\nand\na\ntwo-sided\nsigni\ufb01cance level of 5%, a sample size of 167 cases and 334 controls\n(1:2 ratio) was estimated. Enrollment of 175 cases and 350 was\n480\nA.L. Andrade et al. / Vaccine 36 (2018) 479\u2013483\nplanned, to compensate for an estimated 5% of children from\nwhom it would be impossible to collect timely lesion samples in\naddition to screen failure or refusal.\nAnalysis of vaccine effectiveness considered all clinically-\ncon\ufb01rmed varicella cases, regardless of laboratory con\ufb01rmation\nby PCR. Descriptive analysis of cases and controls was performed.\nWe also conducted a descriptive analysis of clinical and demo-\ngraphic\ncharacteristics\ncontrasting\nimmunized\nand\nnon-\nimmunized study subjects, including all cases and controls. Cate-\ngorical variables were compared by Pearson chi-square test or\nFisher\u2019s exact test, as appropriate. Continuous variables were com-\npared\nby\nWilcoxon\nrank-sum\ntest.\nBreakthrough\nand\nnon-\nbreakthrough cases were compared according to clinical and\nsocio-demographic characteristics using a chi-square test and\nt-test when appropriate. Matched odds ratios (OR) of having been\nimmunized among cases and controls, and its respective 95% con-\n\ufb01dence interval (CI), were calculated considering all cases and also\nstrati\ufb01ed by severity of illness. Multiple conditional logistic regres-\nsion models were used to adjust for potential confounding. The\nbackward selection was used to build the \ufb01nal model.\nVaccine effectiveness was estimated as the percent reduction in\nthe varicella disease odds (1 \u0003 OR) \u0004 100.", "mimetype": "text/plain", "start_char_idx": 10967, "end_char_idx": 12916, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c45bdbad-97e3-4f01-a9f5-9ccb2a3654ae": {"__data__": {"id_": "c45bdbad-97e3-4f01-a9f5-9ccb2a3654ae", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8bfe67e0-bb11-4ac4-8ee7-762299fd5eac", "node_type": "1", "metadata": {}, "hash": "12add2f8decd8010f862a01d8c1e8cdb2165d750970a047ac3ed5851e66cfe0a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "82024a5b-5749-4c8d-8fa4-28bcade8a6c9", "node_type": "1", "metadata": {}, "hash": "22a7d591caf69468a89a8f008faa14a517bf88b6c3ea62f19b9ba827cf0b2027", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\nbackward selection was used to build the \ufb01nal model.\nVaccine effectiveness was estimated as the percent reduction in\nthe varicella disease odds (1 \u0003 OR) \u0004 100. All p-values are two-\nsided, with signi\ufb01cance levels of .05.\n2.7. Ethical approval\nThis study was approved by the Research Ethics Committee of\nthe Federal University of Goi\u00e1s, Goiania (#162.53, #751.383 and\n#979.713), and by the Secretary of Health of S\u00e3o Paulo municipal-\nity (#800.776).\n3. Results\n3.1. Case and control subject characteristics\nDuring the study period, a total of 168 cases and 301 controls\nwere enrolled. All cases had 2 controls, except for 35 cases that\nhad only one control. Characteristics of cases and controls are pre-\nsented in Table 1. Demographic characteristics were generally sim-\nilar among cases and controls, except for cases were older than\ncontrols, and proportion of cases having siblings attending day-\ncare centers was higher (63.1% vs.13.0%). Chronic pulmonary con-\nditions were more frequent among cases. Varicella vaccination was\nsigni\ufb01cantly lower for cases when compared to controls (22.0 vs\n57.1%). Prior MMR vaccination was similar for cases and controls.\nTable 2 describes vaccination characteristics among vaccinated\nchildren, comparing the 37 vaccinated cases and 172 vaccinated\ncontrols. Cases had received the vaccine at an older age than con-\ntrols. Time since vaccination was longer for cases than controls.\n3.2. Breakthrough varicella case characteristics\nAmong 168 varicella cases, thirty-seven (22.0%) were break-\nthrough cases. Breakthrough and non-breakthrough cases were\nstatistically different only in terms of number of varicella lesions.\nMild (<100 lesions), moderate (100\u2013499 lesions) and severe\n(\u0001500 lesions) illness, were found in 53.4%, 36.6% and 9.9% of\nnon-breakthrough cases; and 5.4%, 21.6% and 0% of breakthrough\ncases respectively. All children presenting \u0001500 lesions were\nnon-breakthrough cases (Table 3).\n3.3.", "mimetype": "text/plain", "start_char_idx": 12753, "end_char_idx": 14701, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "82024a5b-5749-4c8d-8fa4-28bcade8a6c9": {"__data__": {"id_": "82024a5b-5749-4c8d-8fa4-28bcade8a6c9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c45bdbad-97e3-4f01-a9f5-9ccb2a3654ae", "node_type": "1", "metadata": {}, "hash": "3b3bad4fcdb3f9ccdb6ef66db02140753eb1e5f17daf36dc6b4d88b485229a27", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a009f680-bc03-4f30-809d-a6a46e3d4a56", "node_type": "1", "metadata": {}, "hash": "f3ea59602b219138252a4de85fc38d44270b061d2667b80066bb85c748978f9e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All children presenting \u0001500 lesions were\nnon-breakthrough cases (Table 3).\n3.3. Vaccine effectiveness\nIn the unadjusted model having received a valid dose of vari-\ncella vaccine (OR = 0.19; 95%CI 0.11\u20130.31; p = .000), having previ-\nous respiratory disease or asthma (OR = 4.62; 95%CI 1.45\u201314.74;\np = .010), and having older sibling attending day-care center\n(OR = 14.51; 95%CI 8.06\u201329.83; p = .000), were associated with\nvaricella cases of any severity. After adjusting for these variables\nand for age, vaccine effectiveness was 86% (95%CI 72\u201392%), con-\nsidering cases of any severity and their matched controls, and\n93% (95%CI 82\u201397%) considering moderate/severe cases, as shown\nin Table 4.\nHaving an older sibling attending day-care center (OR = 16.31;\n95%CI 6.41\u201341.49; p = .000) was found to be independently associ-\nated with moderate/severe cases, and respiratory disease or\nasthma did not remain independently associated to varicella cases.\nAs expected, MMR vaccination had no effect in preventing the\noccurrence of varicella cases of any severity (VE = 37%; 95%CI;\n121\u201382, p-value .475).\n4. Discussion\nThis is the \ufb01rst study to assess the effectiveness of varicella vac-\ncine in Brazil. We found that the VE of single dose of varicella\nTable 1\nDemographic, clinical, and vaccination characterization of varicella cases and\ncontrols. Brazil, 2013\u20132015.", "mimetype": "text/plain", "start_char_idx": 14621, "end_char_idx": 15981, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a009f680-bc03-4f30-809d-a6a46e3d4a56": {"__data__": {"id_": "a009f680-bc03-4f30-809d-a6a46e3d4a56", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "82024a5b-5749-4c8d-8fa4-28bcade8a6c9", "node_type": "1", "metadata": {}, "hash": "22a7d591caf69468a89a8f008faa14a517bf88b6c3ea62f19b9ba827cf0b2027", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7c04e516-00c5-4d53-8647-e4420b8d6973", "node_type": "1", "metadata": {}, "hash": "ca58c1f282c2e57a8026403025a111082ea9b665ff18f566ef23a294c414a2ec", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We found that the VE of single dose of varicella\nTable 1\nDemographic, clinical, and vaccination characterization of varicella cases and\ncontrols. Brazil, 2013\u20132015.\nCharacteristics\nCases\nN = 168a\nControls\nN = 301a\np-value\nAge in months\n28 (21\u201332)\n23 (19\u201328)\n<.001\nMales\n90 (53.6)\n151 (50.2)\n.479\nNumber of children under 5 years of\nage living at same home\n1 (1\u20132)\n1 (1\u20132)\n.930\nNumber of people (children or adults)\nsleeping at same room\n2 (1\u20133)\n2 (1\u20133)\n.818\nRace/skin color\n.827\nWhite\n68 (40.5)\n131 (43.5)\nBlack\n9 (5.4)\n15 (5.0)\nBrown\n91 (54.2)\n155 (51.5)\nEducation of mother\n.543\nIlliterate\n0 (0.0)\n2 (0.7)\nMiddle-school\n69 (41.1)\n122 (40.5)\nHigh-school\n88 (52.4)\n148 (49.2)\nCollege\n11 (6.5)\n29 (9.6)\nFamily Health Program enrollment\n117 (69.6)\n210 (69.8)\n1.000\nDay-care attendance of household\ncontact\n106 (63.1)\n39 (13.0)\n<.001\nRespiratory disease or asthma\n17 (10.1)\n10 (3.3)\n.003\nUse of corticosteroidsc\n6 (3.6)\n8 (2.7)\n.569\nVaricella vaccination\n37 (22.0)\n172 (57.1)\n<.001\nMMRb vaccination\n159 (94.6)\n283 (94.0)\n.781\na All continuous variables summarized by their median and inter-quartile range.\nAll categorical variables presented as numbers and percentages.\nb MMR: measles, mumps and rubella vaccine.\nc 1 control = missing.\nTable 2\nCharacteristics of varicella vaccination among cases and controls, only for children\nthat had been vaccinated. Brazil, 2013\u20132015.", "mimetype": "text/plain", "start_char_idx": 15817, "end_char_idx": 17187, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7c04e516-00c5-4d53-8647-e4420b8d6973": {"__data__": {"id_": "7c04e516-00c5-4d53-8647-e4420b8d6973", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a009f680-bc03-4f30-809d-a6a46e3d4a56", "node_type": "1", "metadata": {}, "hash": "f3ea59602b219138252a4de85fc38d44270b061d2667b80066bb85c748978f9e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "88194bcd-903a-4406-97fc-1cb60157ffdf", "node_type": "1", "metadata": {}, "hash": "9182b8f22daebb175215fb8c667aab71f6875842ce6f784ac52b26d70d77e749", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "c 1 control = missing.\nTable 2\nCharacteristics of varicella vaccination among cases and controls, only for children\nthat had been vaccinated. Brazil, 2013\u20132015.\nVaccination characteristicsa\nCases\nControls\np-value\nn = 37\nn = 172\nAge at varicella vaccination in\nmonthsb\n25 (22\u201332)\n23 (20\u201327)\n.005\nInterval between varicella\nvaccination and study\ninterview in monthsb\n9.8 (6.7\u201314.1)\n7.3 (4.0\u201310.5)\n.005\nType of varicella vaccineb\n.529\nMono Glaxo/Varilrix\n0 (0)\n9 (5.2)\nMono Merck/Varilrix\n0 (0)\n2 (1.2)\nMono Biogenetech/Green Cross\n1 (2.7)\n0 (0)\nTetraviral Glaxo\n36 (97.3)\n160 (93.6)\na All continuous variables summarized by their median and inter-quartile range.\nAll categorical variables presented as numbers and percentages.\nb Missing data for one child: 1 control.\nA.L. Andrade et al. / Vaccine 36 (2018) 479\u2013483\n481\nvaccine administered at 15 months of age and measured in chil-\ndren aged up to 32 months was 86% (95%CI 72\u201392%) against all\ngrades of disease severity, and 93% (95%CI 82\u201397%) against moder-\nate and severe disease. These results are comparable to those of a\nrecent meta-analysis of 42 studies of varicella VE assessment con-\nducted within the \ufb01rst decade after vaccine introduction in which\npooled VE was 81% against all cases, and 98% against moderate and\nsevere cases [10].\nOnly nine (35%) Latin American countries had introduced uni-\nversal vaccination against varicella by 2015. To date, the impact\nof varicella vaccination had only been assessed in the \ufb01rst two\ncountries in the region to introduce varicella vaccine into their\nNIPs \u2013 Uruguay and Costa Rica.", "mimetype": "text/plain", "start_char_idx": 17027, "end_char_idx": 18607, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "88194bcd-903a-4406-97fc-1cb60157ffdf": {"__data__": {"id_": "88194bcd-903a-4406-97fc-1cb60157ffdf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7c04e516-00c5-4d53-8647-e4420b8d6973", "node_type": "1", "metadata": {}, "hash": "ca58c1f282c2e57a8026403025a111082ea9b665ff18f566ef23a294c414a2ec", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "11afe8af-f94d-4992-abf7-e82fc945537e", "node_type": "1", "metadata": {}, "hash": "ed1268602ad5e61c18e8dcc637afeb7e11ed1efabb7aa9458dc04487c6147fd9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "To date, the impact\nof varicella vaccination had only been assessed in the \ufb01rst two\ncountries in the region to introduce varicella vaccine into their\nNIPs \u2013 Uruguay and Costa Rica. In Uruguay, where more than\n90% coverage has been rapidly achieved with one dose and main-\ntained since vaccine introduction in 1999, a study performed with\ndata up to 2005 showed 81% reductions in varicella hospitaliza-\ntions, and 86% reductions in outpatient visits in the age-groups eli-\ngible for vaccination, compared to the pre-vaccination period\n(1997\u201399) [17]. In Costa Rica, varicella vaccine was introduced in\n2007 and coverage has increased from 76% in 2008 to 95% in\n2015. A study conducted in 2005 with secondary national data\nshowed 79.1% reduction in noti\ufb01ed cases, and 87% reduction in\nhospitalization in children under 5 years of age [18].\nAs in Uruguay, in Brazil the uptake of a new children\u2019s vaccina-\ntion program is commonly high from the start [19], even though in\none of the cities of the study it remained less than 70% in the \ufb01rst\nyear after vaccination start. At a population level, if the country is\nable to keep a high coverage, we expect that the bene\ufb01cial effect of\nthe vaccine will rise as new cohorts of children are vaccinated and\nherd protection expands, as documented in other studies [17,20\u2013\n22]. But the 22% of breakthrough cases in our study may be an indi-\ncation that sporadic cases and outbreaks of varicella among vacci-\nnated individuals will continue to happen in Brazil as they did in\nother countries, despite the milder disease of breakthrough cases\n[6,14,23]. Breakthrough cases in our study can be attributed to pri-\nmary vaccine failure, as data collection took place in the \ufb01rst two\nyears after vaccine introduction, and cases had on average been\nvaccinated only 9 months before [24]. Waning of vaccine-induced\nimmunity may also increase varicella susceptibility many years\nafter vaccination, even though there is con\ufb02icting evidence on this\ntopic [4,25].", "mimetype": "text/plain", "start_char_idx": 18427, "end_char_idx": 20414, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "11afe8af-f94d-4992-abf7-e82fc945537e": {"__data__": {"id_": "11afe8af-f94d-4992-abf7-e82fc945537e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "88194bcd-903a-4406-97fc-1cb60157ffdf", "node_type": "1", "metadata": {}, "hash": "9182b8f22daebb175215fb8c667aab71f6875842ce6f784ac52b26d70d77e749", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8224b931-1d9d-475e-8885-d99931b444ac", "node_type": "1", "metadata": {}, "hash": "f764268f65224b8c11fde8291eacc0248b4e29168afaa2a98d002a251de2eec8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Waning of vaccine-induced\nimmunity may also increase varicella susceptibility many years\nafter vaccination, even though there is con\ufb02icting evidence on this\ntopic [4,25].\nDiscussions on varicella vaccine schedule change, in particular\nadding a second vaccine dose, have already started in the Brazil.\nIn other countries, second dose introduction has been justi\ufb01ed by\nthe need for an even higher degree of protection to prevent out-\nbreaks in settings with high contact rates and to reduce severe\nbreakthrough disease [25\u201327]. Local evidence provided by surveil-\nlance data, in particular regarding the occurrence of outbreaks and\nsevere cases among highly vaccinated individuals is important to\ncharacterize the remaining disease burden, despite known data\nquality issues in varicella surveillance data [3,4,28].\nThis case-control study has strengths and limitations. While we\ncannot be certain that all cases in our study age group have been\nidenti\ufb01ed by the active surveillance that was put in place in the\nstudy areas, PCR positivity was over 80%, which suggests that the\nclinical diagnosis by the physicians had high speci\ufb01city, minimiz-\ning misclassi\ufb01cations for both cases and controls. It is also possible\nthat they had a lower risk of developing varicella disease once\ninfected given their lower age and rates chronic respiratory disease\nrates, including asthma. Although the association of asthma and\nincreased risk for breakthrough varicella has been suggested in a\nTable 3\nCharacteristics of breakthrough and non-breakthrough varicella cases. Brazil, 2013\u2013\n2015.\nCharacteristicsa\nBreakthrough varicella\np-value\nYes\nn = 37\nNo\nn = 131\nAge in months\n25 (22\u201331)\n29 (20\u201332)\n.620\nNumber of children under 5 years\nof age living at same home\n1 (1\u20132)\n1 (1\u20132)\n.987\nNumber of people (children or\nadults) living at same home\n4 (3\u20134)\n4 (3\u20135)\n.979\nInterval between onset of rash and\nstudy interview in days\n6 (4\u20138)\n6 (3\u20138)\n.563\nPrematurity, <37 weeks gestational\nage\n4 (10.8)\n12 (9.2)\n.", "mimetype": "text/plain", "start_char_idx": 20244, "end_char_idx": 22227, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8224b931-1d9d-475e-8885-d99931b444ac": {"__data__": {"id_": "8224b931-1d9d-475e-8885-d99931b444ac", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "11afe8af-f94d-4992-abf7-e82fc945537e", "node_type": "1", "metadata": {}, "hash": "ed1268602ad5e61c18e8dcc637afeb7e11ed1efabb7aa9458dc04487c6147fd9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b3af395e-7ba4-4df2-b5ec-af356673f22e", "node_type": "1", "metadata": {}, "hash": "de62d7f44ab7283f42fd0ffe91e9ebebc8d32894185de38208bfd90196e9cfa3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "563\nPrematurity, <37 weeks gestational\nage\n4 (10.8)\n12 (9.2)\n.763\nFemale sex\n18 (48.6)\n60 (45.8)\n.759\nRace/skin color\n1.000\nWhite\n15 (40.5)\n53 (40.5)\nBrown\n20 (54.1)\n71 (54.2)\nBlack\n2 (6.4)\n7 (5.3)\nEducation of mother\n.196\nMiddle-school\n11 (35.5)\n58 (44.3)\nHigh-school\n22 (59.5)\n66 (50.4)\nCollege\n4 (10.8)\n7 (5.3)\nChild registered in Family Health\nProgram\n29 (78.4)\n88 (67.2)\n.259\nDay-care attendance of household\ncontact\n28 (75.7)\n78 (59.5)\n.084\nPulmonary disease or asthma\n5 (13.5)\n12 (9.2)\n.624\nUse of corticosteroidsb\n3 (8.1)\n3 (2.3)\n.307\nPrevious history of varicella\n0 (0.0)\n3 (2.3)\n.353\nExposure to varicella or zoster in\nprior 3 weeksc\n28 (77.8)\n97 (74.6)\n.697\nEstimated number of varicella\nlesions\n<.001\n<50\n23 (62.2)\n26 (19.8)\n50\u201399\n6 (16.2)\n44 (33.6)\n100\u2013249\n6 (16.2)\n27 (20.6)\n250\u2013499\n2 (5.4)\n21 (16.0)\n\u0001500\n0 (0.0)\n13 (9.9)\nFever two days prior to rashc\n13 (36.1)\n58 (44.6)\n.361\nAbdominal pain two days prior to\nrashd\n5 (13.5)\n27 (20.9)\n.313\nAnorexia two days prior to rash\n12 (32.4)\n52 (39.7)\n.422\nMalaise two days prior to rash\n18 (48.6)\n79 (60.3)\n.205\na All continuous variables summarized by their median and inter-quartile range.\nAll categorical variables presented as numbers and percentages.", "mimetype": "text/plain", "start_char_idx": 22165, "end_char_idx": 23376, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b3af395e-7ba4-4df2-b5ec-af356673f22e": {"__data__": {"id_": "b3af395e-7ba4-4df2-b5ec-af356673f22e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8224b931-1d9d-475e-8885-d99931b444ac", "node_type": "1", "metadata": {}, "hash": "f764268f65224b8c11fde8291eacc0248b4e29168afaa2a98d002a251de2eec8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6d3793f2-7289-4bf3-8d0c-f3050a34fc3a", "node_type": "1", "metadata": {}, "hash": "ba3d2c9f21a8e9e485748eb6fad8e96873cfbdf8407d6f52b6c50fe67add06b4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "422\nMalaise two days prior to rash\n18 (48.6)\n79 (60.3)\n.205\na All continuous variables summarized by their median and inter-quartile range.\nAll categorical variables presented as numbers and percentages.\nb Missing data: 1 breakthrough case.\nc Missing data: 1 breakthrough case and 1 non-breakthrough case.\nd Missing data: 2 non-breakthrough cases.\nTable 4\nVaricella vaccine effectiveness, according to disease severity. Brazil, 2013\u20132015.\nDisease severity\nUnadjusted\nAdjusted\nOR\n(95%CI)\n% VE\n(95%CI)\nOR\n(95%CI)\n% VE\n(95%CI)\nP-value\nAny severity of disease (1)\n0.19\n(0.11\u20130.31)\n81\n(69\u201389)\n0.14\n(0.07\u20130.28)\n86\n(72\u201392)\n<.001\nModerate/severe cases, \u000150 lesions (2)\n0.09\n(0.04\u20130.19)\n91\n(81\u201396)\n0.07\n(0.03\u20130.18)\n93\n(82\u201397)\n<.001\nNumber of observations in each model: (1) unadjusted = 469, adjusted = 469 (2) unadjusted = 333, adjusted = 333.\nAdjusted for confounders: age in months, day-care attendance and pulmonary diseases.\n482\nA.L. Andrade et al. / Vaccine 36 (2018) 479\u2013483\nrecent study [29], our \ufb01ndings showed that asthma did not remain\nindependently associated with varicella cases in the adjusted\nmodel. While these differences indicate that our controls were\nnot fully representative of the population from which cases arose,\nit is of note that the adjustment for these three variables (age, day-\ncare attendance and presence of chronic respiratory disease rates),\nin our multiple conditional regression analysis did not change by\nmuch the observed estimates. The fact that we did not \ufb01nd any sig-\nni\ufb01cant association of MMR vaccine on varicella cases, as expected,\nis also an indication that selection bias was likely not an important\nissue [30]. Neighborhood matching has likely helped us to control\nfor some confounding and to improve the precision of our esti-\nmates [11].", "mimetype": "text/plain", "start_char_idx": 23173, "end_char_idx": 24953, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6d3793f2-7289-4bf3-8d0c-f3050a34fc3a": {"__data__": {"id_": "6d3793f2-7289-4bf3-8d0c-f3050a34fc3a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b3af395e-7ba4-4df2-b5ec-af356673f22e", "node_type": "1", "metadata": {}, "hash": "de62d7f44ab7283f42fd0ffe91e9ebebc8d32894185de38208bfd90196e9cfa3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f36e5450-53f4-46d2-be29-5e26dff66503", "node_type": "1", "metadata": {}, "hash": "e916eed41b7283cb67cc06f1c09a07a26660104e05db0ede79cb8a4edb12e9a0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Neighborhood matching has likely helped us to control\nfor some confounding and to improve the precision of our esti-\nmates [11]. We also believe that we have avoided information bias\non vaccination exposure by interviewing parents and guardians in\ntheir homes, which allowed us easy access to vaccination cards.\nAnother issue is that the diagnosis of the number of lesions was\nperformed in only one evaluation, at the time of the interview\n(we did not follow the patient). Thus, it is not possible to be sure\nif the number of lesions increased or not in the subsequent days\nof the interview, which could lead to bias in the number of lesions\nin varicella breakthrough. Finally, the study areas were limited to\nthe city of Goi\u00e2nia and some regions of the city of S\u00e3o Paulo, so that\nrepresentativeness of the country as a whole is not guaranteed.\nIn conclusion, this study showed that the effectiveness of the\none-dose varicella vaccine schedule introduced into the Brazilian\nNIP is comparable to that found in other countries, where break-\nthrough cases have also been found to occur. The goal of the vari-\ncella\nvaccination\nprogram,\nalong\nwith\ndisease\nburden\nand\naffordability should be taken into consideration when considering\nthe adoption of a second dose of varicella vaccine into national\nimmunization programs.\nAcknowledgements\nFunding provided by the Brazilian Ministry or Health, Secretary of\nHealth Surveillance, National Immunization Program (grant#\n01/2012). ALA (# 313286/2014\u20130), and CMT (# 312532/2014\u20138)\nreceive scienti\ufb01c productivity scholarships from the Brazilian\nNational Council for Scienti\ufb01c and Technological Development\n(CNPq).\nCon\ufb02ict of interests\nALA has received research grant from GSK and also grants from\nP\ufb01zer and GSK for participation at meetings. RM has received\ngrants from GSK for participation at meetings. All other authors\ndeclare having no con\ufb02icts of interest.\nReferences\n[1] Meyer PA, Seward JF, Jumaan AO, Wharton M. Varicella mortality: trends\nbefore vaccine licensure in the United States, 1970\u20131994. J Infect Dis\n2000;182:383\u201390. https://doi.org/10.1086/315714.", "mimetype": "text/plain", "start_char_idx": 24825, "end_char_idx": 26930, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f36e5450-53f4-46d2-be29-5e26dff66503": {"__data__": {"id_": "f36e5450-53f4-46d2-be29-5e26dff66503", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6d3793f2-7289-4bf3-8d0c-f3050a34fc3a", "node_type": "1", "metadata": {}, "hash": "ba3d2c9f21a8e9e485748eb6fad8e96873cfbdf8407d6f52b6c50fe67add06b4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "55061f8d-f73b-4825-87c4-78d126c39626", "node_type": "1", "metadata": {}, "hash": "58ddfe6c4d862a52cbd1949ca917a6e350d58917433470dcc24f538adc7d63f7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "J Infect Dis\n2000;182:383\u201390. https://doi.org/10.1086/315714.\n[2] Rawson H, Crampin A, Noah N. Deaths from chickenpox in England and Wales\n1995\u20137: analysis of routine mortality data. BMJ 2001;323:1091\u20133.\n[3] Black S, Ray P, Shine\ufb01eld H, Saddier P, Nikas A. Lack of association between age\nat varicella vaccination and risk of breakthrough varicella, within the Northern\nCalifornia Kaiser Permanente Medical Care Program. J Infect Dis 2008;197\n(Suppl 2):S139\u201342. https://doi.org/10.1086/522124.\n[4] Tafuri S, Guerra R, Cappelli MG, Martinelli D, Prato R, Germinario C.\nDeterminants of varicella breakthrough: results of a 2012 case control study.\nHum Vaccin Immunother 2014;10:667\u201370. https://doi.org/10.4161/hv.27382.\n[5] Vazquez M. Varicella zoster virus infections in children after the introduction\nof live attenuated varicella vaccine. Curr Opin Pediatr 2004;16:80\u20134.\n[6] Watson BM, Piercy SA, Plotkin SA, Starr SE. Modi\ufb01ed chickenpox in children\nimmunized with the Oka/Merck varicella vaccine. Pediatrics 1993;91:17\u201322.\n[7] Brasil. Minist\u00e9rio da Sa\u00fade. Guia de vigil\u00e2ncia epidemiol\u00f3gica. 1st ed. Bras\u00edlia:\nMinist\u00e9rio da Sa\u00fade; 2014.\n[8] Brasil. Minist\u00e9rio da Sa\u00fade. Informe t\u00e9cnico de introdu\u00e7\u00e3o da vacina Tetra Viral\n\u2013 Vacina sarampo, caxumba, rub\u00e9ola e varicela. Minist\u00e9rio da Sa\u00fade; 2013.\nAvailable\nfrom:\n<http://www.sopape.com.br/data/conteudo/arquivos/\ninforme_tecnico_introducao_vacina_tetraviral.pdf> [last accessed: Apr 18,\n2017].\n[9] Brasil.", "mimetype": "text/plain", "start_char_idx": 26869, "end_char_idx": 28324, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "55061f8d-f73b-4825-87c4-78d126c39626": {"__data__": {"id_": "55061f8d-f73b-4825-87c4-78d126c39626", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f36e5450-53f4-46d2-be29-5e26dff66503", "node_type": "1", "metadata": {}, "hash": "e916eed41b7283cb67cc06f1c09a07a26660104e05db0ede79cb8a4edb12e9a0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dd7bb911-e35d-4634-ac2e-57729dcd8f1e", "node_type": "1", "metadata": {}, "hash": "5d20750ab7d8806968886913cfbc8e3e94567badbe9c281b951f714d1ba7ccd7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "[9] Brasil.\nMinist\u00e9rio\nda\nSa\u00fade.\nInforma\u00e7\u00f5es\nestat\u00edsticas.\nDoses\naplicadas.\nDATASUS; 2017. Available from: <http://tabnet.datasus.gov.br/cgi/tabcgi.exe?\npni/cnv/DPniuf.def> [last accessed: Nov 30, 2017].\n[10] Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global varicella\nvaccine\neffectiveness:\na\nmeta-analysis.\nPediatrics\n2016;137:e20153741.\nhttps://doi.org/10.1542/peds.2015-3741.\n[11] Niccolai LM, Ogden LG, Muehlenbein CE, Dziura JD, Vazquez M, Shapiro ED.\nMethodological issues in design and analysis of a matched case-control study\nof a vaccine\u2019s effectiveness. J Clin Epidemiol 2007;60:1127\u201331. https://doi.org/\n10.1016/j.jclinepi.2007.02.009.\n[12] Brasil. Minist\u00e9rio da Sa\u00fade. Informa\u00e7\u00f5es estat\u00edsticas. Coberturas. DATASUS;\n2017.\nAvailable\nfrom:\n<http://pni.datasus.gov.br/inf_estatistica_cobertura.\nasp> [last accessed: Apr 20, 2017].\n[13] Clements DA. Modi\ufb01ed varicella-like syndrome. Infect Dis Clin North Am\n1996;10:617\u201329.\n[14] White CJ, Kuter BJ, Ngai A, Hildebrand CS, Isganitis KL, Patterson CM, et al.\nModi\ufb01ed cases of chickenpox after varicella vaccination: correlation of\nprotection with antibody response. Pediatr Infect Dis J 1992;11:19\u201323.\n[15] Watzinger F, Suda M, Preuner S, Baumgartinger R, Ebner K, Baskova L, et al.\nReal-time quantitative PCR assays for detection and monitoring of pathogenic\nhuman viruses in immunosuppressed pediatric patients. J Clin Microbiol\n2004;42:5189\u201398.", "mimetype": "text/plain", "start_char_idx": 28313, "end_char_idx": 29728, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dd7bb911-e35d-4634-ac2e-57729dcd8f1e": {"__data__": {"id_": "dd7bb911-e35d-4634-ac2e-57729dcd8f1e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "55061f8d-f73b-4825-87c4-78d126c39626", "node_type": "1", "metadata": {}, "hash": "58ddfe6c4d862a52cbd1949ca917a6e350d58917433470dcc24f538adc7d63f7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "32881efd-16db-490a-a1ae-28f44e0fa744", "node_type": "1", "metadata": {}, "hash": "696294f04626fcf2c623a476b54f653e47aafa0bb34832678e798b77af3bb4fd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Real-time quantitative PCR assays for detection and monitoring of pathogenic\nhuman viruses in immunosuppressed pediatric patients. J Clin Microbiol\n2004;42:5189\u201398. https://doi.org/10.1128/JCM.42.11.5189-5198.2004.\n[16] Loparev VN, Argaw T, Krause PR, Takayama M, Schmid DS. Improved\nidenti\ufb01cation and differentiation of varicella-zoster virus (VZV) wild-type\nstrains and an attenuated varicella vaccine strain using a VZV open reading\nframe 62-based PCR. J Clin Microbiol 2000;38:3156\u201360.\n[17] Quian J, Ruttimann R, Romero C, Dall\u2019Orso P, Cerisola A, Breuer T, et al. Impact\nof universal varicella vaccination on 1-year-olds in Uruguay: 1997\u20132005. Arch\nDis Child 2008;93:845\u201350. https://doi.org/10.1136/adc.2007.126243.\n[18] Avila-Aguero ML, Ulloa-Gutierrez R, Camacho-Badilla K, Soriano-Fallas A,\nArroba-Tijerino R, Morice-Trejos A. Varicella prevention in Costa Rica: impact\nof\na\none-dose\nschedule\nuniversal\nvaccination.\nExpert\nRev\nVacc\n2017;16:229\u201334. https://doi.org/10.1080/14760584.2017.1247700.\n[19] Queiroz LL, Monteiro SG, Mochel EG, Veras MA, Sousa FG, Bezerra ML, et al.\nCoverage of the basic immunization schedule in the \ufb01rst year of life in State\ncapitals in Northeast Brazil. Cad Saude Publica 2013;29:294\u2013302. https://doi.\norg/10.1590/S0102-311X2013000200016.\n[20] Giammanco G, Ciriminna S, Barberi I, Titone L, Lo Giudice M, Biasio LR.", "mimetype": "text/plain", "start_char_idx": 29564, "end_char_idx": 30916, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "32881efd-16db-490a-a1ae-28f44e0fa744": {"__data__": {"id_": "32881efd-16db-490a-a1ae-28f44e0fa744", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dd7bb911-e35d-4634-ac2e-57729dcd8f1e", "node_type": "1", "metadata": {}, "hash": "5d20750ab7d8806968886913cfbc8e3e94567badbe9c281b951f714d1ba7ccd7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "116fb4b6-e68e-412b-86fd-17fe3e14de55", "node_type": "1", "metadata": {}, "hash": "5a445de3d50a870c89c727f0f4bf0950a10564d94649114a1a9a8627d4eb0a7e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "org/10.1590/S0102-311X2013000200016.\n[20] Giammanco G, Ciriminna S, Barberi I, Titone L, Lo Giudice M, Biasio LR.\nUniversal varicella vaccination in the Sicilian paediatric population: rapid\nuptake of the vaccination programme and morbidity trends over \ufb01ve years.\nEuro Surveill 2009;14.\n[21] Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after\nimplementation of varicella vaccination in the United States. N Engl J Med\n2005;352:450\u20138. https://doi.org/10.1056/NEJMoa042271.\n[22] Papaloukas O, Giannouli G, Papaevangelou V. Successes and challenges in\nvaricella vaccine. Ther Adv Vacc 2014;2:39\u201355. https://doi.org/10.1177/\n2051013613515621.\n[23] Vessey SJ, Chan CY, Kuter BJ, Kaplan KM, Waters M, Kutzler DP, et al. Childhood\nvaccination against varicella: persistence of antibody, duration of protection,\nand vaccine ef\ufb01cacy. J Pediatr 2001;139:297\u2013304. https://doi.org/10.1067/\nmpd.2001.116051.\n[24] Vazquez M, LaRussa PS, Gershon AA, Niccolai LM, Muehlenbein CE, Steinberg\nSP, et al. Effectiveness over time of varicella vaccine. JAMA 2004;291:851\u20135.\nhttps://doi.org/10.1001/jama.291.7.8511.\n[25] SAGE Working Group on Varicella and Herpes Zoster Vaccines. Systematic\nreview of available evidence on effectiveness and duration of protection of\nvaricella vaccines. World Health Organization; 2014. Available from: <http://\nwww.who.int/immunization/sage/meetings/2014/april/4_Systematic_review_\non_effectiveness_and_duration_of_protection_of_varicella_vaccines.pdf> [last\naccessed: Apr 18, 2017].", "mimetype": "text/plain", "start_char_idx": 30803, "end_char_idx": 32324, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "116fb4b6-e68e-412b-86fd-17fe3e14de55": {"__data__": {"id_": "116fb4b6-e68e-412b-86fd-17fe3e14de55", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Andrade (2018).pdf", "node_type": "4", "metadata": {}, "hash": "ac0b1f416253b2e80854cd1328e06a250299054d98c236b166bbe2ac50813ace", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "32881efd-16db-490a-a1ae-28f44e0fa744", "node_type": "1", "metadata": {}, "hash": "696294f04626fcf2c623a476b54f653e47aafa0bb34832678e798b77af3bb4fd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "[26] Marin M, Guris D, Chaves SS, Schmid S, Seward JF, Advisory Committee on\nImmunization Practices CfDC, et al. Prevention of varicella: recommendations\nof the Advisory Committee on Immunization Practices (ACIP). MMWR\nRecomm Rep 2007;56:1\u201340.\n[27] Seward JF, Marin M, Vazquez M. Varicella vaccine effectiveness in the US\nvaccination program: a review. J Infect Dis 2008;197(Suppl 2):S82\u20139. https://\ndoi.org/10.1086/522145.\n[28] Bardach A, Cafferata ML, Klein K, Cormick G, Gibbons L, Ruvinsky S. Incidence\nand use of resources for chickenpox and herpes zoster in Latin America and the\nCaribbean\u2013a systematic review and meta-analysis. Pediatr Infect Dis J\n2012;31:1263\u20138. https://doi.org/10.1097/INF.0b013e31826ff3a5.\n[29] Umaretiya PJ, Swanson JB, Kwon HJ, Grose C, Lohse CM, Juhn YJ. Asthma and\nrisk of breakthrough varicella infection in children. Aller Asthma Proc\n2016;37:207\u201315. https://doi.org/10.2500/aap.2016.37.3951.\n[30] Khagayi S, Tate JE, Onkoba R, Parashar U, Odhiambo F, Burton D, et al. A sham\ncase-control study of effectiveness of DTP-Hib-hepatitis B vaccine against\nrotavirus acute gastroenteritis in Kenya. BMC Infect Dis 2014;14:77. https://\ndoi.org/10.1186/1471-2334-14-77.\nA.L. Andrade et al. / Vaccine 36 (2018) 479\u2013483\n483", "mimetype": "text/plain", "start_char_idx": 32325, "end_char_idx": 33572, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aa243b3e-93fc-4252-9166-d7b4fdc51168": {"__data__": {"id_": "aa243b3e-93fc-4252-9166-d7b4fdc51168", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Kim (2012).pdf", "node_type": "4", "metadata": {}, "hash": "1e9cd92a05110df3376b5fa192d5b9b6718ebd93001532191dcc9a91bc197974", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "71c283b1-d0cf-48cf-ba31-eca7aceea162", "node_type": "1", "metadata": {}, "hash": "d7bfdf385e80ed8f3c0e6a4d40a787cd447a1796b4e652cff0bf93014cb67f6e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "e306\n15th ICID Abstracts / International Journal of Infectious Diseases 16S (2012) e158\u2013e316\nType: Poster Presentation\nFinal Abstract Number: 48.014\nSession: Vaccines & Vaccine Development\nDate: Friday, June 15, 2012\nTime: 12:45-14:15\nRoom: Poster & Exhibition Area\nImmunogenicity of single-dose hepatitis A vaccines in young\nadults\nM. Ki 1,\u2217, J. Lim 2, C.-B. Kim 3, H. Kim 4, W.-S. Park 5, H. Sohn 6, D.-H.\nShin 7, G.-J. Oh 8, M.-S. Lee 9, Y.-J. Song 1\n1 Department of preventive medicine, Yongdu-dong, Jung-gu, Daejeon,\nKorea, Republic of\n2 School of medicine, Eulji university, Daejoen, Korea, Republic of\n3 Yonsei University Wonju College of Medicine, Wonju, Korea, Republic\nof\n4 Medical college Soonchunhyang University, Asan, Korea, Republic of\n5 College of medicine, Kwandong university, Gangneung, Korea,\nRepublic of\n6 School of Medicine, Inje University, Gim-hae, Korea, Republic of\n7 School of Medicine Keimyung University, Daegu, Korea, Republic of\n8 Wonkwang University Medical School, Iksan, Korea, Republic of\n9 College of Medicine, Konyang University, Daejeon, Korea, Republic of\nBackground: In many countries, hepatitis A virus (HAV)\ninfection has become an important public health issue with\nimprovement in socioeconomic status. In Korea, a HAV vaccination\nprogram for young adults has recently been under consideration\nbecause of the low seroprotection rate in this age group.\nTo ensure long-term immunity, the vaccine manufacturers rec-\nommend 2 doses of the vaccine, but in some countries, a single-dose\nHAV vaccine is used for infants. The immunogenicity of the single-\ndose HAV vaccine is a key factor for deciding the vaccination\nschedule, but only a few studies have evaluated this immunogenic-\nity in adults.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1733, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "71c283b1-d0cf-48cf-ba31-eca7aceea162": {"__data__": {"id_": "71c283b1-d0cf-48cf-ba31-eca7aceea162", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Kim (2012).pdf", "node_type": "4", "metadata": {}, "hash": "1e9cd92a05110df3376b5fa192d5b9b6718ebd93001532191dcc9a91bc197974", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aa243b3e-93fc-4252-9166-d7b4fdc51168", "node_type": "1", "metadata": {}, "hash": "dc5321e98a87d84a82058d8840dfb4891e05b20bb4baeb64f1087299db92e88e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2976b789-f63a-4e42-a882-7d33a608add6", "node_type": "1", "metadata": {}, "hash": "03a9bc79422863083975c117dc4e054af8831e0e3bb419221bc66387ea2844a7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The immunogenicity of the single-\ndose HAV vaccine is a key factor for deciding the vaccination\nschedule, but only a few studies have evaluated this immunogenic-\nity in adults.\nThis study was performed to examine the immunogenicity of\nthe single-dose HAV vaccine in young adults.\nMethods: The study population comprised a total of 582 college\nstudents from 8 medical schools in Korea. Total 451 participants\nwho had negative results for anti-HAV antibody (cut-off value: 20\nmIU/ml) and met the inclusion criteria were randomly allocated\ninto 2 groups for receiving either of the 2 vaccines: Havrix (n = 225)\nand Epaxal (n = 226) groups. We checked the seroconversion rate\nat 7\u201312 months after vaccination.\nResults: The seroconversion rate in Havrix group (84.9%) was\nsigni\ufb01cantly higher than that in Epaxal group (76.5%; P = 0.031),\nand the male participants (75.3%) showed signi\ufb01cantly lower sero-\nconversion rates than the female participants (91.4%; P < 0.001). In\nthe logistic regression model, only gender was a statistically signif-\nicant factor affecting seroconversion rates (OR= 2.7, P = 0.016) and\nvaccine type showed borderline signi\ufb01cance (OR = 1.6, P = 0.051).\nThe other covariates (follow-up time, age, and body weight) were\nnot signi\ufb01cant. In the logistic regression model analysis according\nto the vaccine type, gender showed a signi\ufb01cant effect only in the\nEpaxal group (OR = 5.0, P = 0.011).\nConclusion: After single-dose vaccination, the HavrixTM and\nEpaxal\u00ae vaccines showed immunogenicity of more than 75.0%\nat 7\u201312 months after the vaccination, and the male participants\nshowed lower seroconversion rates than the female participants,\nparticularly in the Epaxal group. The seroconversion rate after the\nsecond dose and the long-term immunogenicity will be compared\nfor the 2 vaccine types in future studies.", "mimetype": "text/plain", "start_char_idx": 1557, "end_char_idx": 3385, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2976b789-f63a-4e42-a882-7d33a608add6": {"__data__": {"id_": "2976b789-f63a-4e42-a882-7d33a608add6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Kim (2012).pdf", "node_type": "4", "metadata": {}, "hash": "1e9cd92a05110df3376b5fa192d5b9b6718ebd93001532191dcc9a91bc197974", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "71c283b1-d0cf-48cf-ba31-eca7aceea162", "node_type": "1", "metadata": {}, "hash": "d7bfdf385e80ed8f3c0e6a4d40a787cd447a1796b4e652cff0bf93014cb67f6e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "42c513f7-3ed2-463f-b373-88e8452e0680", "node_type": "1", "metadata": {}, "hash": "3eefb076734cf652a84e2888f243e90420d0730debff311cd4c0f0bb3db3eb56", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The seroconversion rate after the\nsecond dose and the long-term immunogenicity will be compared\nfor the 2 vaccine types in future studies.\nhttp://dx.doi.org/10.1016/j.ijid.2012.05.996\nType: Poster Presentation\nFinal Abstract Number: 48.015\nSession: Vaccines & Vaccine Development\nDate: Friday, June 15, 2012\nTime: 12:45-14:15\nRoom: Poster & Exhibition Area\nEf\ufb01cacy of mumps vaccine in Korea\nH.W. Kim 1,\u2217, H.K. Cho 1, K.M. Choi 2, B.W. Eun 3, S.Y. Lee 4, K.H.\nKim 1\n1 Ewha Womans University School of Medicine, Seoul, Korea, Republic\nof\n2 Kwandong University College of Medicine, Goyang, Korea, Republic\nof\n3 Gacheon Medical school, Incheon, Korea, Republic of\n4 The catholic university of Korea, Incheon, Korea, Republic of\nBackground: Although mumps is a vaccine-preventable disease\nand mumps vaccine has more than 95% of its vaccination rate as a\ncomponent of MMR vaccine, disease occurrence is continued. We\naimed to assess the effectiveness of the mumps component of the\nMMR vaccine.\nMethods: This study evaluated the ef\ufb01cacy of mumps vaccine\nthrough the prospective and retrospective case-control studies in\nfour university hospitals. Another achievement is to establish the\nmumps virus RT-PCR assays for diagnosis in the research team.\nResults: In prospective case-control study, 55 cases of mumps\nwere identi\ufb01ed and 165 controls were selected from March 2010\nto October 2011. Data about their demographic characteristics and\nMMR vaccination status were collected in cases and controls. Risk\nfor disease estimated by conditional logistic analysis is OR 0.67\n(95%CI 0.06-7.35) in vaccinated that is lower than in nonvaccinated.\nRisk for mumps is OR 0.58 (95%CI 0.05-6.90) for 1 dose and OR\n1.10 (95% CI 0.09-13.31) for 2 doses.", "mimetype": "text/plain", "start_char_idx": 3247, "end_char_idx": 4979, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "42c513f7-3ed2-463f-b373-88e8452e0680": {"__data__": {"id_": "42c513f7-3ed2-463f-b373-88e8452e0680", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Kim (2012).pdf", "node_type": "4", "metadata": {}, "hash": "1e9cd92a05110df3376b5fa192d5b9b6718ebd93001532191dcc9a91bc197974", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2976b789-f63a-4e42-a882-7d33a608add6", "node_type": "1", "metadata": {}, "hash": "03a9bc79422863083975c117dc4e054af8831e0e3bb419221bc66387ea2844a7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In retrospective studies, 122\ncases of mumps were identi\ufb01ed and 449 controls were selected. In\n2008-2009 in western Seoul, Incheon and Goyang, an outbreak of\nmumps occurred among children most of whom were born before\n1994. 98% of cases whose vaccination status were available had a\nhistory at least one MMR vaccination. Estimated risk for disease is\nOR 0.33 (95% CI 0.02-5.33) in vaccinated that is lower than in non-\nvaccinated. Risk for mumps is OR 0.33 (95% CI 0.02-5.33) for 1 dose\nand OR 0.11 (95% CI 0.01-2.12) for 2 doses. And, we analyzed data\ncollected in the prospective and retrospective study. Estimated risk\nfor disease is OR 0.50 (95% CI 0.08-2.99) in vaccinated that is lower\nthan in nonvaccinated. Risk for mumps is OR 0.58 (95% CI 0.10-3.56)\nfor 1 dose and OR 0.42 (95% CI 0.06-2.81) for 2 doses.\nConclusion: Mumps vaccine had preventive effect and two dose\nvaccination had superior effect than one dose, even though there\nwas no statistically signi\ufb01cant difference. In addition to the ef\ufb01-\ncacy of the vaccine, it is needed to consider other factors that are\ninvolved in occurrence of mumps outbreak.\nhttp://dx.doi.org/10.1016/j.ijid.2012.05.997", "mimetype": "text/plain", "start_char_idx": 4980, "end_char_idx": 6144, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "40f2d7cf-88bd-40ed-a9f1-83e16a6ad753": {"__data__": {"id_": "40f2d7cf-88bd-40ed-a9f1-83e16a6ad753", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-4 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "a710433325ea77c6cfb6ca900d8f4627a3d9e82cce763d5de3e3fe46dac6be17", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b3e81449-ddc4-4cf5-9613-9d2e9d3b039d", "node_type": "1", "metadata": {}, "hash": "7c40646784768e69713bfa426f121973c94e6572bcc572e26a47db1a7b33545a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "928\nIMMUNIZATION\nA Field Trial\nwith a Live\nMeasles-Mumps-\nRubella Vaccine\nSuccessful Use of a New\nCombination of Virus Strains\nVernon W. Walters, M.D.,\nStephen A. Miller, M.S.,\nJoseph E. Jackson, M.D., Dr. P.H.,\nMichael T. Kenny, Ph.D.\nFrom the Coco Solo Hospital, Cristabol, Canal Zone,\nand The Dow Chemical Company, Human Health Re-\nsearch Laboratories, Indianapolis, Ind.\nCorrespondence to Joseph E. Jackson, M.D., Biological\nClinical Research, The Dow Chemical Company, P. O.\nBox 68511, Indianapolis, Ind. 46268.\nThree lots of Lirutrin (measles-mumps-rubella\nlive, attenuated virus vaccine) were evaluated in\na double-blind, placebo-controlled clinical study\ninvolving 273 children. The vaccine consisted of\na combination of Schwarz strain measles, Jeryl\nLynn strain mumps, and Cendehill strain rubella\nvaccine viruses. The frequency of positive clinical\nfindings was essentially the same in susceptible\nvaccinees, immune vaccinees, and placebo recipi-\nents ; indicating that the observed symptoms\nwere not caused by the vaccine. Antibody assay\nof paired serum samples revealed that measles,\nmumps, and rubella seroconversion rates in triple\nsusceptible vaccinees were excellent, ranging\nfrom 96 to 98 per cent with all three lots com-\nbined. Results of this study show that Lirutrin\ntrivalent vaccine is well tolerated and highly\neffective.\ncombines VACCINES in pediatric use\nlead to fewer patient visits and reduce the\noverall cost of immunization, without loss of\nimmunizing effectiveness. A recent study re-\nvealed that Schwarz strain measles and Cende-\nhill strain rubella vaccines were safe and effec-\ntive when administered as a bivalent, single\ninjection.8 The present study was conducted\nto determine the clinical reaction rate and\nimmunizing efficacy of a trivalent mixture of\nSchwarz strain measles, Jeryl Lynn strain\nmumps, and Cendehill strain rubella vaccines\n(Lirutrin) administered as a single injection.\nSelected as the locale of these studies were\ncertain communities in Panama in which the\nchildren are highly susceptible to the three\ninfectious diseases represented by the vaccine.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2105, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b3e81449-ddc4-4cf5-9613-9d2e9d3b039d": {"__data__": {"id_": "b3e81449-ddc4-4cf5-9613-9d2e9d3b039d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-4 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "a710433325ea77c6cfb6ca900d8f4627a3d9e82cce763d5de3e3fe46dac6be17", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "40f2d7cf-88bd-40ed-a9f1-83e16a6ad753", "node_type": "1", "metadata": {}, "hash": "b1bb39daa304a4bc3b9feaa80bdbfbeeff63aea7f3bd4b97dbff8571a1d53909", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a6166427-a67f-4ecb-a765-8934319c6d8b", "node_type": "1", "metadata": {}, "hash": "9622f90633305af01308850c4c4252448e23fe1e5a6f56e316f9c1a790e81e26", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Selected as the locale of these studies were\ncertain communities in Panama in which the\nchildren are highly susceptible to the three\ninfectious diseases represented by the vaccine.\nThe populations here consist of the Cuna\nIndians of the San Blas Islands, the native\nPanamanians (a mixed Indian race of the in-\nterior of Panama), and children living in the\ncity of Colon who have a racial background\nincluding African, Indian, Spanish, and Ori-\nental.\n929\nTABLE 1. Age Distribution of the 273 Children Used in this Study, and of Those Triply Susceptible\n* Susceptible to measles, mumps, and rubella,.\nImmunization records of the Ministerio de\nSalude, Republic of Panama indicated that\nnone of the components of the vaccine had\never been given in these communities and,\nfurther, there were no records of any epi-\ndemics of measles, mumps, or rubella in the\npast five years in these areas. \n\u2019\nAnother factor~ in the choice of these areas\nwas the high incidence of complications of\nmeasles among the Cuna and interior Indians.\nThis was evidenced by local hospital records\nand by accounts by the Cunas of large epi-\ndemics in previous years which caused deaths\nof large numbers of children.\nMaterials and Methods\nVaccine\nLirutrin is a combination of Schwarz strain\n(Lirugen) measles vaccine9,10 licensed in 1965,\nJeryl Lynn strain mumps vaccine2>3>11 \norig-\ninally licensed in 1967, and Cendehill strain\nrubella vaccine\u2019 .6 originally licensed in 1969.\nThree lots of Lirutrin were used in this\nstudy. Each dose contained a minimum of\n1,000 50 per cent tissue culture infective doses\n(TCID50) of measles and of rubella vaccine\nviruses and 5,000 TCID50 of mumps vaccine\nvirus. The vaccines were produced at the\nBiological Laboratories of The Dow Chemical\nCompany, Indianapolis, Indiana over a\nperiod of about six months. For each child,\na single dose vial of Lirutrin (or placebo)\nwas reconstituted with sterile diluent from\na prefilled syringe just prior to subcutaneous\ninoculation.", "mimetype": "text/plain", "start_char_idx": 1925, "end_char_idx": 3902, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a6166427-a67f-4ecb-a765-8934319c6d8b": {"__data__": {"id_": "a6166427-a67f-4ecb-a765-8934319c6d8b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-4 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "a710433325ea77c6cfb6ca900d8f4627a3d9e82cce763d5de3e3fe46dac6be17", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b3e81449-ddc4-4cf5-9613-9d2e9d3b039d", "node_type": "1", "metadata": {}, "hash": "7c40646784768e69713bfa426f121973c94e6572bcc572e26a47db1a7b33545a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "430033b1-295c-4d42-81f6-88b8d1ef94e3", "node_type": "1", "metadata": {}, "hash": "c4bd34b5291937266adc90b18e587aec08afd4917326f2c91e4f38a2d1d06b99", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For each child,\na single dose vial of Lirutrin (or placebo)\nwas reconstituted with sterile diluent from\na prefilled syringe just prior to subcutaneous\ninoculation.\nPlacebo\nPlacebo was prepared from the same\nmaterials as the vaccine, but without added\nvirus. Whether lyophilized or reconstituted,\nthe placebo was indistinguishable from the\nvaccine in appearance.\nSerology Methods\nAntibodies to measles and rubella viruses\nwere determined double-blind by the hemag-\nglutination-inhibition (HI) method in micro-\ntiter plates. Sera for testing were pretreated\nwith kaolin (measles HI test) or with manga-\nnese chloride and heparin (rubella HI test)\nand adsorbed with the appropriate test eryth-\nrocytes. Erythrocytes of newly hatched chicks\nwere used as the indicator in the rubella HI\ntest, and African green monkey erthrocytes\nwere used in the measles HI test. Serial two-\nfold serum dilutions were tested against four\nunits of HA antigen. The highest serum\ndilution that completely inhibited agglutina-\ntion of the test erythrocytes was the endpoint.\nAlthough these microtiter methods yield sig-\nnificantly lower titers than conventional\nmacrotiter methods, this disadvantage is\ncounterbalanced by the convenience of the\nmicrotiter system for large numbers of assays.\nPairs of sera which failed to show obvious\nseroconversion in the microtiter test were\nretested by the conventional macrotiter\nmethod.\nMumps antibody titers were determined by\nthe Vero cell microtiter serum neutralization\n(SN) technique .4 When postinoculation anti-\n930\nTABLE 2. Distribution of Axillary Temperature Readings from the\nSeventh Through 21st Day Postvaccination\n* Placebo susceptibility is defined as a patient\u2019s being susceptible to any one vaccine component; however, 12 of the 36\nchildren were triply susceptible.\n** N = Number of subjects observed.\nt Includes five children without an eight-week serum sample. \n\u2019\n* Number and per cent of children within the indicated temperature interval.", "mimetype": "text/plain", "start_char_idx": 3739, "end_char_idx": 5712, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "430033b1-295c-4d42-81f6-88b8d1ef94e3": {"__data__": {"id_": "430033b1-295c-4d42-81f6-88b8d1ef94e3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-4 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "a710433325ea77c6cfb6ca900d8f4627a3d9e82cce763d5de3e3fe46dac6be17", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a6166427-a67f-4ecb-a765-8934319c6d8b", "node_type": "1", "metadata": {}, "hash": "9622f90633305af01308850c4c4252448e23fe1e5a6f56e316f9c1a790e81e26", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cf0a777c-bc16-490a-b79d-d98bf141bdec", "node_type": "1", "metadata": {}, "hash": "79ee186111370c88ce4fa3222e4a39c3e84bfcd840e6659af21c17deb8cd6cab", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "** N = Number of subjects observed.\nt Includes five children without an eight-week serum sample. \n\u2019\n* Number and per cent of children within the indicated temperature interval.\nbody was not detected by this technique,\npaired sera were retested undiluted and at\n1:2 dilution by a plaque reduction technique\nin Vero cells.-\u2019\nChildren were deemed susceptible to each\ndisease when their preinoculation serum did\nnot contain detectable antibody (measles HI\ntiter <1:8; \nmumps SN titer <1:2; \nrubella\nHI titer <1:8). \nSeroconversion after inocula-\ntion was defined as the appearance of anti-\nbody in the postinoculation serum sample of\na child whose serum was previously negative.\nChildren Tested\nApproximately half the children enrolled\nin the study were from the Red Cross Nursery\nSchool in the City of Colon. In Colon, measles\nis more or less continually endemic, with sea-\nsonal variation.\nThe rest of the children were enrolled from\nrural areas in the Provinces of Colon and San\nBlas. In these relatively isolated areas, measles\noccurs only as an epidemic, the last of which\nhad been several years before.\nThe total number of children enrolled,\nprebled and injected, was 273. The essentials\nfor entry into the study series were: 1) in-\nformed parental consent; 2) absence of many\nhistory of natural measles, mumps, or rubella,\nor immunizations against these diseases; and\n3) absence of any of the usual medical contra-\nindications of immunization with live virus\nvaccines. Entry into the study was offered\nprimarily to children aged one through four\nyears, but occasionally parental insistence\nnecessitated admission of a few younger\n(age 10 to 11 months) or older children.\nStudy Design\nThree lots of vaccine and one lot of placebo\nwere used. A randomized double-blind design\nwas used to distribute these within the study\npopulation, in a ratio of one placebo subject\nThe essentials for entry into the study\nseries were: 1) informed parental consent;\n2) absence of any history of natural measles,\nmumps, or rubella, or immunizations\nagainst these diseases; and 3) absence of\nany of the usual medical contraindications\nto immunization with live virus vaccines.", "mimetype": "text/plain", "start_char_idx": 5536, "end_char_idx": 7695, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cf0a777c-bc16-490a-b79d-d98bf141bdec": {"__data__": {"id_": "cf0a777c-bc16-490a-b79d-d98bf141bdec", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-4 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "a710433325ea77c6cfb6ca900d8f4627a3d9e82cce763d5de3e3fe46dac6be17", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "430033b1-295c-4d42-81f6-88b8d1ef94e3", "node_type": "1", "metadata": {}, "hash": "c4bd34b5291937266adc90b18e587aec08afd4917326f2c91e4f38a2d1d06b99", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "060b5109-b2b4-4b8b-9a1f-14a9011b892a", "node_type": "1", "metadata": {}, "hash": "3b897bbb624d077e780143fb6477039ccd34a1b2d0b1ca61c49b2b0b2515ecd1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "to approximately five vaccinees. After the\ninjections (Day 1), each child was examined\nclinically for possible vaccine reactions and\nintercurrent illnesses approximately three\ntimes between Day 7 and Day 21, The axil-\nlary temperature was measured during each\nexamination. The examiners were ignorant\nof what each child had received. The results\n_ \nof these double-blind clinical observations\nwere decoded and tabulated by a computer.\nEight weeks after the injection, a second\nblood sample was drawn and additional clini-\ncal data were obtained.\n. \nThe distributions with respect to age of the\n273 children who received the three different\n931\nvaccines or placebo are shown in Table 1.\nThe randomized double-blind code effec-\ntively provided the desired distributions of\nchildren with respect to the three lots of\nvaccine and the one lot of placebo. The male/\nfemale ratio was 0.9. A total of 75 children\nsusceptible to all three diseases (i.e., triple\nsusceptible) entered the study.\nClinical Symptoms Following Lirutrin\nVaccine\nInquiries at the time of the first follow-up\nvisit failed to elicit any history of any injection\nsite reactions or of any immediate symptoms\nfollowing the injection.\nFrom the seventh through the 21st day\nafter vaccination, 674 clinical visits were com-\npleted. There were also 223 clinical follow-\nup visits at the time the 8-week blood sample\nwas taken, and notations were made of any\nhistory of symptoms since the 2I-day follow-\nup visit. \n, \n\u2019\nThe distribution of temperature readings is\nshown in Table 2. In addition to the placebo\ncontrol group built into the study design,\n20 vaccinees who were found to have been\nimmune to all three viruses (i.e.9 triple im-\nmune) provide another standard against\nwhich the triple susceptible vaccinees may\nbe compared. Statistical analysis showed no\nsignificant temperature difference between\nthe latter and either of the control groups.\nEven at the highest temperature range ( 1 cm, 1\nto 101.0 F), the difference between triple\nsusceptible vaccinees (3.8%) and triple im-\nmune vaccinees (0.0%) was not significant\n(chi-square \n= 0.79, p > \n0.1).", "mimetype": "text/plain", "start_char_idx": 7696, "end_char_idx": 9814, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "060b5109-b2b4-4b8b-9a1f-14a9011b892a": {"__data__": {"id_": "060b5109-b2b4-4b8b-9a1f-14a9011b892a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-4 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "a710433325ea77c6cfb6ca900d8f4627a3d9e82cce763d5de3e3fe46dac6be17", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cf0a777c-bc16-490a-b79d-d98bf141bdec", "node_type": "1", "metadata": {}, "hash": "79ee186111370c88ce4fa3222e4a39c3e84bfcd840e6659af21c17deb8cd6cab", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7dfc6cf1-8c62-484d-970f-2302029e9179", "node_type": "1", "metadata": {}, "hash": "b0dac79545808574b83fe4e5eef58122ad2afc124ad5619618c5de81f12c7f0e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The frequency of clinical findings other\nthan fever seven thru 21 days postvaccination\nare shown in Table 3. None of the differences\nbetween triple susceptible vaccinees and\neither immune vaccinees or susceptible\nplacebo recipients was statistically significant\nin the chi-square test. Therefore, on a statisti-\ncal basis, the observed symptoms were not\nattributable to the vaccine.\n~mmur~ity Following Lirutrin Vaccine\nEighth week postinoculation blood samples\nwere obtained from 209 children, of whom\n59 (47 vaccinees and 12 placebo subjects)\nhad been triple susceptible at the time of\ninoculation. Table 4 shows the seroconver-\nsion rates and geometric mean titers (GMT)\nTABLE 3. Positive Findings in Double-Blind Clinical Examinatians fram the Seventh through the 21st Day after Vaccination\n~ \n~~~ \n---------\n* Placebo susceptibility is defined as a patient\u2019s being susceptible to any one vaccine component.\n** Number of subjects observed.\nt Number and per cent of children with the indicated symptom.\nt Other symptoms in~clude malaria, malnutrition, anemia, diarrhea, G. 1. symptoms, etc.\n932\nTABLE 4. Seroconversion Rates and Geometric Mean Antibody Titers, According to Vaccine Lot, Among Initially Triply\nSusceptible Children Given Lirutrin and Bled Eight Weeks Later\nof the triple susceptible subjects. Serocon-\nversion rates ranged from 95 to 100 per cent\nfor measles and from 94 to 100 per cent\nfor both mumps and rubella. The GMTs\nwere 55.0 for measles, 5.0 for mumps, and\n27.0 for rubella. The immune responses\ninduced by this trivalent vaccine did not\ndiffer significantly from those reported for\nthe three monovalent vaccines given sep-\narately.1-3.6.9-11 \n&dquo; \n\u2019\nOf the ten subjects under one year of age,\nblood samples were obtained eight weeks\npostvaccination from eight, of whom six (five\nvaccinees and one placebo subject) had been\ntriple susceptible. All five triple susceptible\nvaccinees seroconverted to all three vaccine\ncomponents except for one infant who failed\nto convert to rubella.", "mimetype": "text/plain", "start_char_idx": 9815, "end_char_idx": 11829, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7dfc6cf1-8c62-484d-970f-2302029e9179": {"__data__": {"id_": "7dfc6cf1-8c62-484d-970f-2302029e9179", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-4 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "a710433325ea77c6cfb6ca900d8f4627a3d9e82cce763d5de3e3fe46dac6be17", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "060b5109-b2b4-4b8b-9a1f-14a9011b892a", "node_type": "1", "metadata": {}, "hash": "3b897bbb624d077e780143fb6477039ccd34a1b2d0b1ca61c49b2b0b2515ecd1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3eb22b53-64f8-4eac-9c43-f67da2757e64", "node_type": "1", "metadata": {}, "hash": "f021b73662b2b7f0c86b7a6a997c1a2262f45db6b33e2aa26b6425749be7544d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All five triple susceptible\nvaccinees seroconverted to all three vaccine\ncomponents except for one infant who failed\nto convert to rubella. The GMTs developed\nby these infants were 73.5 for measles, 5.3\nfor mumps, and 22.5 for rubella.\nThirty-three vaccinees in the study were\nsusceptible to only one vaccine component\nand all 33 seroconverted to that particular\ncomponent (one to measles, titer 128; eight\nto mumps, GMT 4.9; and 24 to rubella,\nGMT 31.1). Essentially, no difference existed\nbetween the titers developed by these mono-\nsusceptible vaccinees and those developed by\nthe triple susceptible vaccinees. Double sus-\nceptible vaccinees also responded similarly.\nNo seroconversion occurred in any of the\nplacebo subjects. \n,\nDiscussion\nClinical safety and efficacy of each of the\ncomponents of Lirutrin have been repeatedly ,\ndocumented.1-3.6.8-11 Giving these licensed\nmonovalent products to millions of children\u2019 \n7\nwithout untoward effects is compelling evi-\ndence of their safety and efficacy.\nThe main purposes of the present study\nwere to detect whether any special symptoms\nmight result from these vaccines in combina-\ntion and to observe whether any increase\nmight occur in either frequency or severity\nof mild side effects known to be associated\nThese observations indicate that there is\nneither viral nor immunologic interference\nbetween any of the components of the\ntrivalent vaccine.\nwith the individual components. Symptoms\nsuch as fever, rash, arthritis, arthralgia, and\nparotitis were of particular interest. The ob-\nservations made in this study show the vaccine\ncomponents to be comparible in vzvo with re-\nspect both to efficacy and to freedom from\nundesirable reactions.\nSome of the observed fevers and rashes\nmay have been vaccine-induced, but the\nfrequency of these known minor reactions to\nmeasles and rubella vaccines did not seem\nenhanced when these vaccines were given in\na trivalent mixture with mumps vaccine.\nSimilarly, the nonoccurrence of other symp-\ntoms in this study population indicates that\nthese are not stimulated by combination of\nthe vaccines.", "mimetype": "text/plain", "start_char_idx": 11690, "end_char_idx": 13780, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3eb22b53-64f8-4eac-9c43-f67da2757e64": {"__data__": {"id_": "3eb22b53-64f8-4eac-9c43-f67da2757e64", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-4 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "a710433325ea77c6cfb6ca900d8f4627a3d9e82cce763d5de3e3fe46dac6be17", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7dfc6cf1-8c62-484d-970f-2302029e9179", "node_type": "1", "metadata": {}, "hash": "b0dac79545808574b83fe4e5eef58122ad2afc124ad5619618c5de81f12c7f0e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ad806b6d-f82b-43e3-985d-e2617eae0ab1", "node_type": "1", "metadata": {}, "hash": "255c46761a27c83650431b1c20106968fb4c5518d0f3ebc2e05b42912b18b33d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Similarly, the nonoccurrence of other symp-\ntoms in this study population indicates that\nthese are not stimulated by combination of\nthe vaccines.\nIn this study, all the Lirutrin components\ninduced seroconversion in 96 to 98 per cent of\nthe triply susceptible children. The levels of\nimmunity, expressed as GMT, induced in\n933\nthese children by this trivalent vaccine were\ncomparable to those induced by the individual\ncomponents used as monovalent vaccines.\nFurthermore, the trivalent vaccine induced\nequivalent GMTs in triple susceptible and\nsingle susceptible vaccinees. These observa-\ntions indicate that there is neither viral nor\nimmunologic interference between any of the\ncomponents of the trivalent vaccine.\nData from this study indicate that Lirutrin\n(trivalent, live, attenuated measles-mumps-\nrubella vaccine) is well tolerated and highly\neffective.\nAcknowledgments\nWe are indebted to Dr. Ernesto Rothery, Chief of the\nEastern Health Region, Ministry of Health, Republic\nof Panama, and to Dr. Hugo Spadafora and Dr. Susana\nJones-C., Chief and Assistant Chief, respectively, of\nHealth for the Province of Colon, and to the Cuna\nIndian Council for advice and guidance in planning of the\nproject.\nWe are grateful to the Reverend Dean Flora and Mr.\nLynn Williams of the Church of God Mission for local\ncoordination, transportation, and translation of Spanish\nand Cuna into English.\nMs. Margery Walters and Ms. Nina Flora provided\nfood, lodging, clerical help, and general logistic support\nduring the field work.\nDrs. Richard Whittacker and Harold Williams, of\nGorgas Hospital, drew bloods and administered vaccine.\nSra. Geraldina de Emiliani and her staff at the Red Cross\nNursery in Colon provided critical help in administrative\nmatters.\nComputer programs, data analysis, and statistical\ncomputations were made by Messrs. Clement J. Maurath\nand Daniel W. Short; and the manuscript was prepared\nby Ms. Doris Brown.\nReferences\n1.", "mimetype": "text/plain", "start_char_idx": 13635, "end_char_idx": 15571, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ad806b6d-f82b-43e3-985d-e2617eae0ab1": {"__data__": {"id_": "ad806b6d-f82b-43e3-985d-e2617eae0ab1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-4 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "a710433325ea77c6cfb6ca900d8f4627a3d9e82cce763d5de3e3fe46dac6be17", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3eb22b53-64f8-4eac-9c43-f67da2757e64", "node_type": "1", "metadata": {}, "hash": "f021b73662b2b7f0c86b7a6a997c1a2262f45db6b33e2aa26b6425749be7544d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ec75bb58-c57c-4680-882e-57488526baa0", "node_type": "1", "metadata": {}, "hash": "9f4a21ad0c15bc931546c395945fda9cf069278ae42f88f7955e74326d6109d9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Computer programs, data analysis, and statistical\ncomputations were made by Messrs. Clement J. Maurath\nand Daniel W. Short; and the manuscript was prepared\nby Ms. Doris Brown.\nReferences\n1. DuPan, R. M., Huygelen, C., Petermans, J., and\nPrinzie, A.: Clinical trials with a live, attenuated\nrubella virus vaccine: Cendehill 51 strain. Am J.\nDis. Child. 115: 658, 1968.\n2. Hilleman, M. R., Weibel, R. E., Buynak, E. B.,\nStokes, J. Jr., and Whitman, J. E., Jr.: Live,\nattenuated mumps-virus vaccine. 4. Protective ef-\nficacy as measured in a field evaluation. N. Engl.\nJ. Med. \n276: 252, 1967.\n3. &mdash;, Buynak, E. B., Weibel, R. E., and Stokes, J.,\nJr.: Live, attenuated mumps-virus vaccine. N.\nEngl. J. Med. 278: 227, 1968.\n4. Kenny, M. T., Albright, K. L., and Sanderson, R. P.:\nMicroneutranization test for the determination of\nmumps antibody in Vero cells. Appl. Microbiol.\n20: 371, 1970.\n5. &mdash;, and Schell, K. R.: Assay of measles and\nmumps virus and antibody in Vero cells. J. Biol.\nStandardization \n3:\n 291, 1975.\n6. Prinzie, A., Huygelen, C., Gold, J., Farguhar, J., and\nMcKee, J.: Experimental live attenuated rubella\nvirus vaccine. Clinical evaluation of \"Cendehill\"\nstrain. Am. J. Dis. Child. 118: 172, 1969.\n7. Public Health Service Advisory Committee on Im-\nmunization Practices: Recommendations. Mor-\nbidity and Mortality Weekly Report 21\n(25) Sup-\nplement, 1972.\n8.", "mimetype": "text/plain", "start_char_idx": 15382, "end_char_idx": 16767, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ec75bb58-c57c-4680-882e-57488526baa0": {"__data__": {"id_": "ec75bb58-c57c-4680-882e-57488526baa0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-4 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "a710433325ea77c6cfb6ca900d8f4627a3d9e82cce763d5de3e3fe46dac6be17", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ad806b6d-f82b-43e3-985d-e2617eae0ab1", "node_type": "1", "metadata": {}, "hash": "255c46761a27c83650431b1c20106968fb4c5518d0f3ebc2e05b42912b18b33d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "590c58cf-3a21-46a2-a6be-5896ee31cb7a", "node_type": "1", "metadata": {}, "hash": "f9251c2831e74052d5c6b17ec6d7ddc82bd476a01a6ff4f523709560da4913e3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "7. Public Health Service Advisory Committee on Im-\nmunization Practices: Recommendations. Mor-\nbidity and Mortality Weekly Report 21\n(25) Sup-\nplement, 1972.\n8. Ramos-Alvarez, M., Miller, B. H., Jackson, J. E.,\nSchwarz, A. J., and Bessudo, L.: Immunization\nof children with attenuated measles-rubella bi-\nvalent vaccine. Am. J. Dis. Child. 129: 474, 1975.\n9. Schwarz, A. J. F.: Immunization against measles:\ndevelopment and evaluation of a highly attenuated\nlive measles vaccine. Ann. Pediatr. 202: 241, 1964.\n10. &mdash;\n, \net \nal.: Extensive clinical evaluations of a\nhighly attenuated live measles vaccine. JAMA\n199: 26, 1967.\n11. Weibel, R. E., Stokes, J. Jr., Buynak, E. B., Whit-\nman, J. E., Jr., and Hilleman, M. R.: Live, at-\ntenuated mumps-virus vaccine. 3. Clinical and\nserologic aspects in a field evaluation. N. Engl. J.\nMed. 276: 245, 1967.\nIn our society, love has frequently\nbecome a euphemism for sex.\nTherefore many youth search for a\nlasting relationship through sex\nrelations. In this search, indis-\ncriminate sexual contacts increase.\nA better understanding of what is\ndesired in a love relationship, what\ncommitments and responsibilities\nare involved and whether the emo-\ntional void and loneliness that some\nstudents may feel can be filled solely\nthrough sex relations should be\nexamined in class from various per-\nspectives. Students must learn to\nunderstand the role of sex in a love\nrelationship.\nThis concept demonstrates how\nan additional dimension can be\nadded to venereal disease educa-\ntion in the health education class-\nroom or when counseling an in-\ndividual student. It presents a dif-\nficult task for the health educator\nbut much can be accomplished.", "mimetype": "text/plain", "start_char_idx": 16607, "end_char_idx": 18292, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "590c58cf-3a21-46a2-a6be-5896ee31cb7a": {"__data__": {"id_": "590c58cf-3a21-46a2-a6be-5896ee31cb7a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Schwarz-4 (1975).pdf", "node_type": "4", "metadata": {}, "hash": "a710433325ea77c6cfb6ca900d8f4627a3d9e82cce763d5de3e3fe46dac6be17", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ec75bb58-c57c-4680-882e-57488526baa0", "node_type": "1", "metadata": {}, "hash": "9f4a21ad0c15bc931546c395945fda9cf069278ae42f88f7955e74326d6109d9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "It presents a dif-\nficult task for the health educator\nbut much can be accomplished.\nDealing with students\u2019 motives and\npreparing lessons centering around\nchallenging attitudinal and be-\nhavioral concepts and issues re-\nquires innovativeness, insight, and\nconcern. By complementing the\nknowledge and the facts that often\ncomprise the entire venereal dis-\nease education program, the gap\nbetween knowledge and behavior\ncan be narrowed further.-Stanley\nSnegroff, Ed.D. in The Journal of\nSchool Health, Ja~Mary, 1975.\nVenereal Disease Education:\nThe Concept of Love", "mimetype": "text/plain", "start_char_idx": 18208, "end_char_idx": 18770, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e28e97ba-f3e5-4e08-9049-8b226930752e": {"__data__": {"id_": "e28e97ba-f3e5-4e08-9049-8b226930752e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Choe (2017).pdf", "node_type": "4", "metadata": {}, "hash": "d0f8982d9b25f939d12ed6dca4bf1240948fe91420a37e9674d6a9933dd67bcd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3676c032-fcfa-4653-9b0f-ed4cacd350a1", "node_type": "1", "metadata": {}, "hash": "29be7083db6f3ba9b0aaff934fb627cacaebf601d7128917b4b02ed0a793eb37", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u00a9 2017 The Korean Academy of Medical Sciences.\nThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) \nwhich permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.\npISSN 1011-8934\neISSN 1598-6357\nAn Outbreak of Measles in a University in Korea, 2014\nMeasles has been declared eliminated from the Korea since 2006. In April 2014, a measles \noutbreak occurred at a University in Seoul. A total of 85 measles cases were identified. In \norder to estimate vaccine effectiveness of measles vaccine, we reviewed the vaccination \nrecords of the university students. The vaccine effectiveness of two doses of measles \ncontaining vaccine was 60.0% (95% CI, 38.2\u201374.1; P < 0.05). Transmission was \ninterrupted after the introduction of outbreak-response immunization. The outbreak \nshows that pockets of under-immunity among college students may have facilitated the \ndisease transmission despite the high 2-dose vaccination coverage in the community.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1129, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3676c032-fcfa-4653-9b0f-ed4cacd350a1": {"__data__": {"id_": "3676c032-fcfa-4653-9b0f-ed4cacd350a1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Choe (2017).pdf", "node_type": "4", "metadata": {}, "hash": "d0f8982d9b25f939d12ed6dca4bf1240948fe91420a37e9674d6a9933dd67bcd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e28e97ba-f3e5-4e08-9049-8b226930752e", "node_type": "1", "metadata": {}, "hash": "30b9c4728fac482d4330b96c2e282e90626a0cca1badcaa1222da01845dc7a73", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "83144482-627b-4218-b47d-7503b5fad02a", "node_type": "1", "metadata": {}, "hash": "e46b52a7e00117500cf1e807dbd89221c95bcdac7916096c43364a1aa521811a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Transmission was \ninterrupted after the introduction of outbreak-response immunization. The outbreak \nshows that pockets of under-immunity among college students may have facilitated the \ndisease transmission despite the high 2-dose vaccination coverage in the community.\nKeywords:\u2002 Measles; MMR; Outbreak; College; University; Korea\nYoung June Choe,1,2 Young-Joon Park,3 \nJu Whi Kim,3 Hye Eun Eom,3 Ok Park,3 \nMyoung-don Oh,1,4 and Jong-koo Lee1,5,6\n1Seoul Center for Infectious Disease Control, Seoul, \nKorea; 2Department of Epidemiology, Graduate \nSchool of Public Health, Seoul National University, \nSeoul, Korea; 3Division of VPD Control and NIP, \nKorea Centers for Disease Control and Prevention, \nCheongju, Korea; 4Department of Internal Medicine, \nSeoul National University College of Medicine, \nSeoul, Korea; 5Department of Family Medicine, \nSeoul National University College of Medicine, \nSeoul, Korea; 6JW Lee Center for Global Medicine, \nSeoul National University College of Medicine, \nSeoul, Korea\nReceived: 26 May 2017\nAccepted: 16 July 2017\nAddress for Correspondence:\nJong-koo Lee, MD, PhD\nJW LEE Center for Global Medicine, Seoul National University \nCollege of Medicine, 71 Ihwajang-gil, Jongno-gu, Seoul 03087, \nKorea\nE-mail: docmohw@snu.ac.kr, kcdc7000@gmail.com\nhttps://doi.org/10.3346/jkms.2017.32.11.1876 \u2022 J Korean Med Sci 2017; 32: 1876-1878\nMeasles is a highly contagious disease that is now vaccine-pre\u00ad\nventable. Following a nationwide epidemic with 55,696 report\u00ad\ned cases, the Korean government introduced the Five-Year Mea\u00ad\nsles Elimination Program, which includes maintaining the cov\u00ad\nerage rate of 2-dose vaccination rate higher than 95% (1,2).", "mimetype": "text/plain", "start_char_idx": 858, "end_char_idx": 2535, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "83144482-627b-4218-b47d-7503b5fad02a": {"__data__": {"id_": "83144482-627b-4218-b47d-7503b5fad02a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Choe (2017).pdf", "node_type": "4", "metadata": {}, "hash": "d0f8982d9b25f939d12ed6dca4bf1240948fe91420a37e9674d6a9933dd67bcd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3676c032-fcfa-4653-9b0f-ed4cacd350a1", "node_type": "1", "metadata": {}, "hash": "29be7083db6f3ba9b0aaff934fb627cacaebf601d7128917b4b02ed0a793eb37", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fc2dc9ba-facf-46b8-b822-8c3b2384392e", "node_type": "1", "metadata": {}, "hash": "1f568b202f0d4a520a56e3c9918e972fd8d2675e9bc19b87ab3b5a7b061c1243", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Af\u00ad\nter the implementation of the program, the number of annual \nmeasles cases dramatically declined to less than 1 per 1 million, \nand Korea became the first Western Pacific nation to declare \nthat measles was eliminated in 2006 (3) and was verified to be \nmeasles-free along with Australia, Mongolia, Macau, and China \nin 2014 because overall incidence and surveillance indicators \nmet the World Health Organization criteria for measles elimi\u00ad\nnation (4).\n\u2003 During April\u2013June 2014, a measles outbreak occurred at a \nUniversity in Seoul, Korea. A total of 85 cases of measles were \ndiagnosed among students and employees. To characterize the \noutbreak, the Seoul Center for Infectious Disease Control and \nthe Korea Centers for Disease Control and Prevention (KCDC) \nconducted a field investigation, active surveillance, and review \nof the immunization records.\n\u2003 The university had approximately 14,000 undergraduate and \ngraduate students and 3,000 faculty members. The university \noccupies around 200,000 m2 campus area covered with multi\u00ad\nple buildings and facilities. Through routine surveillance sys\u00ad\ntem, the KCDC was informed of laboratory confirmed cases of \nmeasles on April 8, 2014. Subsequently, active surveillance was \nestablished and field epidemiologic study was initiated.\n\u2003 The definition of suspected measles case was individuals with \nfollowing features: fever, and rash, and at least one of cough, co\u00ad\nryza, or conjunctivitis. Suspected measles cases were identified \nthrough the school\u2019s health center. All suspected cases were quar\u00ad\nantined and were interviewed using standardized questionnaire, \nand physical examinations were performed by trained physicians. \nPresence of symptoms (fever, rash, cough, coryza, or conjuncti\u00ad\nvitis), travel history, and days of illnesses were assessed.\n\u2003 We reviewed the measles vaccination records in the National \nImmunization Registry.", "mimetype": "text/plain", "start_char_idx": 2536, "end_char_idx": 4432, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fc2dc9ba-facf-46b8-b822-8c3b2384392e": {"__data__": {"id_": "fc2dc9ba-facf-46b8-b822-8c3b2384392e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Choe (2017).pdf", "node_type": "4", "metadata": {}, "hash": "d0f8982d9b25f939d12ed6dca4bf1240948fe91420a37e9674d6a9933dd67bcd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "83144482-627b-4218-b47d-7503b5fad02a", "node_type": "1", "metadata": {}, "hash": "e46b52a7e00117500cf1e807dbd89221c95bcdac7916096c43364a1aa521811a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d2c9ca65-f22c-442d-99bb-428a8628174a", "node_type": "1", "metadata": {}, "hash": "69e366720b2038599b639f2b9432803a3c28590aa62e5db75738f54785124f32", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We reviewed the measles vaccination records in the National \nImmunization Registry. Measles-specific antibody was tested \nat Seoul Metropolitan City Research Institute of Health and En\u00ad\nvironment and Division of Respiratory Viruses of KCDC by us\u00ad\ning a measles enzyme-linked immunosorbent assay (ELISA) \nfor immunoglobulin M (IgM) and immunoglobulin G (IgG) \n(enzyme immunoassay [EIA]; Siemens Healthcare Diagnostics \nInc., Erlangen, Germany). Primary care providers in the nearby \narea were informed about the outbreak and were asked to re\u00ad\nport any suspected cases.\n\u2003 The index case was an 18-year-old male with the document\u00ad\ned two-dose immunization history, and had developed rash on \nApril 8, 2014 (Fig. 1). On April 19\u201321, five secondary cases in the \nBRIEF COMMUNICATION\nInfectious Diseases, Microbiology & Parasitology\nChoe YJ, et al.\u2002 \u2022\u2002 Measles Outbreak in a University in Korea\nhttp://jkms.org\u2003 \u2002 1877\nhttps://doi.org/10.3346/jkms.2017.32.11.1876\nsame club had developed rash. On May 2, two cases with epi\u00ad\ndemiological linkage were notified, and the incident cases have \nincreased until mid-May. The last case had symptom onset on \nMay 28. A total of 85 cases were confirmed in the University. The \nmedian age was 20 years (range, 19 to 44 years), 67% (n = 57) \ncases were born during 1984\u20131993 (the recipients of measles \nand rubella [MR] vaccine catch-up campaign in 2001), and 61% \n(n = 52) were male. Five (5.9%) were foreign-nationals, 16 (18.8%) \nwere living in dormitory, and 52 (61%) had documentation of \nimmunization history.\n\u2003 Attack rate was significantly lower in the cohort born before \n1993 compared to the cohort born after 1994 (0.3 vs. 1.3; P < 0.05) \n(Table 1).", "mimetype": "text/plain", "start_char_idx": 4349, "end_char_idx": 6041, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d2c9ca65-f22c-442d-99bb-428a8628174a": {"__data__": {"id_": "d2c9ca65-f22c-442d-99bb-428a8628174a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Choe (2017).pdf", "node_type": "4", "metadata": {}, "hash": "d0f8982d9b25f939d12ed6dca4bf1240948fe91420a37e9674d6a9933dd67bcd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fc2dc9ba-facf-46b8-b822-8c3b2384392e", "node_type": "1", "metadata": {}, "hash": "1f568b202f0d4a520a56e3c9918e972fd8d2675e9bc19b87ab3b5a7b061c1243", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1171826d-4c53-4fff-bf9e-75f23e05c743", "node_type": "1", "metadata": {}, "hash": "aee2c80ecbb24c08887650580eccb316fdd972a9b99290be645380c061fe30ea", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Attack rate was significantly lower in the cohort born before \n1993 compared to the cohort born after 1994 (0.3 vs. 1.3; P < 0.05) \n(Table 1). Difference in attack rate between Korean and foreign \nnationalities were not significant. A total of 1.6% of those living \nin dormitory were affected, whereas 0.5% of those not living in \ndormitory were affected. The estimated vaccine effectiveness of \ntwo doses of measles containing vaccine (measles, mumps, and \nrubella [MMR] or MR) was 60.0% (95% CI, 38.2\u201374.1; P < 0.05) \n(Table 2).\n\u2003 From May 15 to 25, the outbreak response immunization was \nconducted on 1,691 students and employees of the University \nwho had no documentation of 2 doses of measles containing \nvaccine immunization. During the outbreak period, measles \ntransmission was confirmed in 2 high schools and 1 junior high \nschool and community, causing a total of 480 reported cases \nand 143 confirmed cases. The outbreak has prompted height\u00ad\nened monitoring that include active surveillance and imple\u00ad\nmentation of disease awareness campaign. A total of 2,592 stu\u00ad\ndents and faculty members among 3,195 candidates without \nprevious vaccination history (coverage rate of 81.2%) were vac\u00ad\ncinated during the campaign.\n\u2003 Nonetheless, the measles outbreak continues to occur, de\u00ad\nspite satisfying the core criteria of the elimination of the disease. \nAs the population immunity is sustained at a higher level, a right-\nward shift in age of measles infection has been reported in oth\u00ad\ner occasions (5,6). In Korea, the outbreaks of measles have af\u00ad\nfected in various group setting. In 2010, a measles outbreak has \noccurred in a junior high school involving 127 suspected cases \nof measles resulting in 14.7% of attack rate (7). Most of the af\u00ad\nfected cases were aged from 13 to 15 years.", "mimetype": "text/plain", "start_char_idx": 5899, "end_char_idx": 7695, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1171826d-4c53-4fff-bf9e-75f23e05c743": {"__data__": {"id_": "1171826d-4c53-4fff-bf9e-75f23e05c743", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Choe (2017).pdf", "node_type": "4", "metadata": {}, "hash": "d0f8982d9b25f939d12ed6dca4bf1240948fe91420a37e9674d6a9933dd67bcd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d2c9ca65-f22c-442d-99bb-428a8628174a", "node_type": "1", "metadata": {}, "hash": "69e366720b2038599b639f2b9432803a3c28590aa62e5db75738f54785124f32", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cccc3b89-29a7-47d0-9dc6-6de3a7c83c9d", "node_type": "1", "metadata": {}, "hash": "a3843fe76d515d5ca9b1f56c9b838c8752c8fc5d3def4e7f551129fd0b54aedb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Most of the af\u00ad\nfected cases were aged from 13 to 15 years. An outbreak occurred \nin 2011 in Gyeongnam Province has shown that non-immune \nincluding infants less than 1 years of age may have played role \nin transmission in nosocomial and community settings (8). The \n2014 outbreak in Korea has resulted in a total of 220 cases con\u00ad\nfirmed as measles until mid-2014, with 10 imported cases iden\u00ad\ntified (4). The average age was 11.6 years (range, 3 months to 47 \nyears) with a peak in young adults aged 19\u201329 years. The recent \nincrease of cases in adolescents and young adults indicate the \nneed for a vigilant monitoring in this population in Korea.\n\u2003 The present outbreak shows that pockets of under-immunity \namong young adult population may have contributed to the \nmeasles transmission. It is crucial to maintain a two-dose vac\u00ad\ncination strategy with high coverage rates in this group for the \nsustained elimination of measles. Further study to investigate \nthe cause of vaccine failures despite high 2-doses vaccination \ncoverage should be warranted in the near future. This is the first \nreport of measles outbreak in university setting in Korea, which \nhighlights the importance of prompt reporting of suspected \nmeasles cases among young adults. In 2014, sporadic cases of \nmeasles that are potentially related to the current outbreak had \nbeen reported in other universities. Transmission to the com\u00ad\nmunity, high school, and junior high school in related to this \noutbreak was documented. We recommend to monitor the \nvaccination coverage in students entering the universities, and \nFig. 1. Outbreak of measles on a university campus in Seoul, Korea, 2014. The dif\u00ad\nferent colors of the bars represent the places where the patients were exposed to \nmeasles virus.\nNo.", "mimetype": "text/plain", "start_char_idx": 7636, "end_char_idx": 9415, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cccc3b89-29a7-47d0-9dc6-6de3a7c83c9d": {"__data__": {"id_": "cccc3b89-29a7-47d0-9dc6-6de3a7c83c9d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Choe (2017).pdf", "node_type": "4", "metadata": {}, "hash": "d0f8982d9b25f939d12ed6dca4bf1240948fe91420a37e9674d6a9933dd67bcd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1171826d-4c53-4fff-bf9e-75f23e05c743", "node_type": "1", "metadata": {}, "hash": "aee2c80ecbb24c08887650580eccb316fdd972a9b99290be645380c061fe30ea", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "23e45c0e-fe72-4116-a167-0e8e9939ad24", "node_type": "1", "metadata": {}, "hash": "6ba254baff89de644c1386e0ce83aedbba4e99d6fdbb61ac84fa6de088ff21fa", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1. Outbreak of measles on a university campus in Seoul, Korea, 2014. The dif\u00ad\nferent colors of the bars represent the places where the patients were exposed to \nmeasles virus.\nNo. of cases\nDate of rash onset\n4/5\t\n4/10\t 4/15\t 4/20\t 4/25\t 4/30\t\n5/5\t\n5/10\t 5/15\t 5/20\t 5/25\t 5/30\n18\n16\n14\n12\n10\n8\n6\n4\n2\n0\nClub\nDormitory\nClassroom\nUnknown\nActive surveillance \nand quarantine\nOutbreak response \nimmunization\nTable 1. Attack rate of measles according to the demographic characteristics during \nthe outbreak on a university campus, Korea, 2014\nVariables\nNo. of confirmed cases/total population\nAttack rate, %\nBirth cohort\n   Before 1993\n30/10,252\n0.3\n   After 1994*\n55/4,298\n1.3\nNationality\n   Korean-national\n80/14,550\n0.6\n   Foreign-national\n5/921\n0.5\nResidence\n   Dormitory*\n16/1,016\n1.6\n   Non-dormitory\n69/14,455\n0.5\n*Significantly higher incidence; P < 0.05.\nTable 2. Vaccine effectiveness of two doses of measles containing vaccine during the \noutbreak on a university campus, Korea, 2014\nVariables\nConfirmed measles\nNo disease\nAttack rate, %\nDocumentation of MCV2\n   None*\n33\n3,017\n1.1\n   Present\u2020\n52\n11,448\n0.5\n*Significantly higher incidence; P < 0.05. \u2020MCV2, two doses of measles containing \nvaccine; vaccine effectiveness calculated as 1 \u2212 risk ratio = 60.0% (95% CI, 38.2\u2013\n74.1; P < 0.05); note that 2,213 employees were excluded from the vaccine effec\u00ad\ntiveness analysis.\nChoe YJ, et al.", "mimetype": "text/plain", "start_char_idx": 9236, "end_char_idx": 10630, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "23e45c0e-fe72-4116-a167-0e8e9939ad24": {"__data__": {"id_": "23e45c0e-fe72-4116-a167-0e8e9939ad24", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Choe (2017).pdf", "node_type": "4", "metadata": {}, "hash": "d0f8982d9b25f939d12ed6dca4bf1240948fe91420a37e9674d6a9933dd67bcd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cccc3b89-29a7-47d0-9dc6-6de3a7c83c9d", "node_type": "1", "metadata": {}, "hash": "a3843fe76d515d5ca9b1f56c9b838c8752c8fc5d3def4e7f551129fd0b54aedb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "218c516a-fd58-4a01-9543-279ec2031693", "node_type": "1", "metadata": {}, "hash": "34023319d6fa6bf9f34fd23515182f03c1f205c7a1c1b4805674705ecb7fdd2f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Choe YJ, et al.\u2002 \u2022\u2002 Measles Outbreak in a University in Korea\n1878\u2003 \u2002 http://jkms.org\nhttps://doi.org/10.3346/jkms.2017.32.11.1876\nheighten the level of surveillance in settings where young adults \ngroup together.\nDISCLOSURE\nThe authors have no potential conflicts of interest to disclose.\nAUTHOR CONTRIBUTION\nConceptualization: Choe YJ, Park YJ, Park O, Oh MD, Lee JK. Data \ncuration: Choe YJ, Park YJ, Kim JW, Eom HE. Investigation: Park \nYJ, Eom HE, Park O. Writing - original draft: Choe YJ, Park YJ, \nKim JH, Eom HE, Park O, Oh MD, Lee JK. \nORCID\nYoung-June Choe\u2002 https://orcid.org/0000-0003-2733-0715\nYoung-Joon Park\u2002 https://orcid.org/0000-0001-9697-4173\nJu Whi Kim\u2002 https://orcid.org/0000-0001-8011-3547\nHye Eun Eom\u2002 https://orcid.org/0000-0002-8213-5026\nOk Park\u2002 https://orcid.org/0000-0002-9477-9523\nMyoung-don Oh\u2002 https://orcid.org/0000-0002-2344-7695\nJong-koo Lee\u2002 https://orcid.org/0000-0003-4833-1178\nREFERENCES\n1. Centers for Disease Control and Prevention (CDC). Elimination of mea\u00ad\nsles--South Korea, 2001\u20132006. MMWR Morb Mortal Wkly Rep 2007; 56: \n304-7.\n2. Choe YJ, Jee Y, Oh MD, Lee JK. Measles elimination activities in the West\u00ad\nern Pacific region: experience from the Republic of Korea. J Korean Med \nSci 2015; 30 Suppl 2: S115-21.\n3. Choe YJ, Bae GR.", "mimetype": "text/plain", "start_char_idx": 10615, "end_char_idx": 11889, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "218c516a-fd58-4a01-9543-279ec2031693": {"__data__": {"id_": "218c516a-fd58-4a01-9543-279ec2031693", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Choe (2017).pdf", "node_type": "4", "metadata": {}, "hash": "d0f8982d9b25f939d12ed6dca4bf1240948fe91420a37e9674d6a9933dd67bcd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "23e45c0e-fe72-4116-a167-0e8e9939ad24", "node_type": "1", "metadata": {}, "hash": "6ba254baff89de644c1386e0ce83aedbba4e99d6fdbb61ac84fa6de088ff21fa", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "J Korean Med \nSci 2015; 30 Suppl 2: S115-21.\n3. Choe YJ, Bae GR. Current status of measles in the Republic of Korea: an \noverview of case-based and seroepidemiological surveillance scheme. \nKorean J Pediatr 2012; 55: 455-61.\n4. Yang TU, Kim JW, Eom HE, Oh HK, Kim ES, Kang HJ, Nam JG, Kim KS, \nKim SS, Lee CK, et al. Resurgence of measles in a country of elimination: \ninterim assessment and current control measures in the Republic of Ko\u00ad\nrea in early 2014. Int J Infect Dis 2015; 33: 12-4.\n5. Gibney KB, Brahmi A, O\u2019Hara M, Morey R, Franklin L. Challenges in man\u00ad\naging a school-based measles outbreak in Melbourne, Australia, 2014. \nAust N Z J Public Health 2017; 41: 80-4.\n6. Ma R, Lu L, Suo L, Li X, Yang F, Zhou T, Zhai L, Bai H, Pang X. An expen\u00ad\nsive adult measles outbreak and response in office buildings during the \nera of accelerated measles elimination, Beijing, China. Vaccine 2017; 35: \n1117-23.\n7. Choe YJ, Hu JK, Song KM, Cho H, Yoon HS, Kim ST, Lee HJ, Kim K, Bae \nGR, Lee JK. Evaluation of an expanded case definition for vaccine-modi\u00ad\nfied measles in a school outbreak in South Korea in 2010. Jpn J Infect Dis \n2012; 65: 371-5.\n8. Park YJ, Eom HS, Kim ES, Choe YJ, Bae GR, Lee DH. Reemergence of mea\u00ad\nsles in South Korea: implications for immunization and surveillance pro\u00ad\ngrams. Jpn J Infect Dis 2013; 66: 6-10.", "mimetype": "text/plain", "start_char_idx": 11825, "end_char_idx": 13158, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b7235ce1-9762-4b87-ad66-b13999026a9a": {"__data__": {"id_": "b7235ce1-9762-4b87-ad66-b13999026a9a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9a3c4d58-5eb5-46a1-a537-ff771b73a835", "node_type": "1", "metadata": {}, "hash": "42519793a92d6f036c4cec96ff3c498aa35617545e3bd2a6f99e86f412c6ec84", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Human Vaccines & Immunotherapeutics\nISSN: 2164-5515 (Print) 2164-554X (Online) Journal homepage: www.tandfonline.com/journals/khvi20\nThe e\ufb00ectiveness of measles-mumps-rubella\n(MMR) vaccination in the prevention of pediatric\nhospitalizations for targeted and untargeted\ninfections: A retrospective cohort study\nGiuseppe La Torre, Rosella Saulle, Brigid Unim, Angela Meggiolaro, Angelo\nBarbato, Alice Mannocci & Antonietta Spadea\nTo cite this article: Giuseppe La Torre, Rosella Saulle, Brigid Unim, Angela Meggiolaro, Angelo\nBarbato, Alice Mannocci & Antonietta Spadea (2017) The e\ufb00ectiveness of measles-mumps-\nrubella (MMR) vaccination in the prevention of pediatric hospitalizations for targeted and\nuntargeted infections: A retrospective cohort study, Human Vaccines & Immunotherapeutics,\n13:8, 1879-1883, DOI: 10.1080/21645515.2017.1330733\nTo link to this article:  https://doi.org/10.1080/21645515.2017.1330733\nPublished online: 26 Jun 2017.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 945, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9a3c4d58-5eb5-46a1-a537-ff771b73a835": {"__data__": {"id_": "9a3c4d58-5eb5-46a1-a537-ff771b73a835", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b7235ce1-9762-4b87-ad66-b13999026a9a", "node_type": "1", "metadata": {}, "hash": "a7c91908657c81578f59542b8167b5dff8ce0bb76967ecc53fd9a127a4cb979e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "967cbd78-e42f-4538-a650-b86bbdcbe2f9", "node_type": "1", "metadata": {}, "hash": "8e90c63de89050c80ecfff81fe001754cef581f52092b0f8d2b00125e935229b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Submit your article to this journal \nArticle views: 3371\nView related articles \nView Crossmark data\nCiting articles: 9 View citing articles \nFull Terms & Conditions of access and use can be found at\nhttps://www.tandfonline.com/action/journalInformation?journalCode=khvi20\nSHORT REPORT\nThe effectiveness of measles-mumps-rubella (MMR) vaccination in the prevention\nof pediatric hospitalizations for targeted and untargeted infections: A retrospective\ncohort study\nGiuseppe La Torrea, Rosella Saullea, Brigid Unima, Angela Meggiolaroa, Angelo Barbatob, Alice Mannoccia,\nand Antonietta Spadeab\naDepartment of Public Health and Infectious Diseases, \u201cSapienza\u201d University of Rome, Rome, Italy; bRM/1 Local Health Unit, Rome, Italy\nARTICLE HISTORY\nReceived 28 March 2017\nRevised 4 May 2017\nAccepted 11 May 2017\nABSTRACT\nObjectives: To evaluate the effectiveness of the measles-mumps-rubella (MMR) vaccine in reducing\nhospitalizations for infectious disease, targeted and not targeted, as well as from respiratory diseases in\nchildren in Rome.\nMethods: The cohort was recomposed through record linkage of 2 archives (vaccination register and\nhospital discharge records.\nResults: The analysis included 11,004 children. 20.9% did not receive the MMR vaccination, 49% and 30.1%\nreceived one and 2 doses. There were no hospitalizations for rubella, 2 for mumps, and 12 for measles. The\nvaccine was highly protective against measles and mumps hospitalizations (HR D 0.10; 95% CI: 0.03.0.34).\nRegarding all infectious diseases there were 414 hospitalizations, and the vaccine was protective (HR D\n0.29; 95% CI: 0.25 to 0.34). Concerning respiratory diseases, there were 809 admissions (7.4%), and the\nvaccine was highly protective (HR: 0.18; 95% CI: 0.07 to 0.48).\nConclusions: MMR vaccination is effective for the primary prevention of target and not targeted infectious\ndiseases and may also limit hospitalizations for respiratory diseases.", "mimetype": "text/plain", "start_char_idx": 946, "end_char_idx": 2875, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "967cbd78-e42f-4538-a650-b86bbdcbe2f9": {"__data__": {"id_": "967cbd78-e42f-4538-a650-b86bbdcbe2f9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9a3c4d58-5eb5-46a1-a537-ff771b73a835", "node_type": "1", "metadata": {}, "hash": "42519793a92d6f036c4cec96ff3c498aa35617545e3bd2a6f99e86f412c6ec84", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8d28964a-c55f-401c-b607-ed088663e4fa", "node_type": "1", "metadata": {}, "hash": "ef666cb8fc1b6005d61364fbe49096fafb53ff59d35a307b7f8885c87b48ecd4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Conclusions: MMR vaccination is effective for the primary prevention of target and not targeted infectious\ndiseases and may also limit hospitalizations for respiratory diseases.\nKEYWORDS\nhospital discharge; measles;\nmumps; respiratory diseases;\nrubella; vaccine\nIntroduction\nChildhood vaccinations recommended around the world are\nbased on the scienti\ufb01c principle of their preventive and protec-\ntive effect. An appropriate well-planned vaccination card, based\non scienti\ufb01c evidence, could bring great bene\ufb01t by reducing\nmorbidity and mortality in high and low income countries.1\nVaccines may have a \u2018non-speci\ufb01c\u2019 protective effect on mor-\nbidity and mortality due to diseases not susceptible to vaccina-\ntion, as demonstrated by different types of studies, both\nobservational and clinical trials performed in low income coun-\ntries,2-8 for example as in the case of the bene\ufb01cial effects of\nnon-speci\ufb01c measles and tuberculosis vaccines (BCG); on the\ncontrary, the inactivated vaccines, such as those against diph-\ntheria and tetanus,9 polio10 and hepatitis B,11 have been associ-\nated with different mortality rates between man and women.\nMeasles, mumps, and rubella are typical childhood infectious\ndiseases, highly contagious, and yet despite this generally have a\ngood prognosis, though they may lead to serious complications\nand cause an avoidable burden on the health care system.12\nThe measles infection causes immune depression for about 6\nweeks.13 The complications (otitis, pneumonia, bronchitis) that\noccur in approximately 30% of cases, may arise especially in\nthis period of time. One particularly feared and dangerous\ncomplication can be post-infectious encephalitis, while a\nparticularly serious long-term consequence is represented by\nsubacute sclerosing panencephalitis (SSPE), often fatal.12\nThe best known complications of mumps infection instead\nare: meningitis, orchitis, and pancreatitis. There have been rare\ncases of unilateral deafness. Orchitis occurs in about 25% of\nmen infected after puberty and, in the case of bilateral orchitis,\nmay result in infertility.", "mimetype": "text/plain", "start_char_idx": 2698, "end_char_idx": 4786, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8d28964a-c55f-401c-b607-ed088663e4fa": {"__data__": {"id_": "8d28964a-c55f-401c-b607-ed088663e4fa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "967cbd78-e42f-4538-a650-b86bbdcbe2f9", "node_type": "1", "metadata": {}, "hash": "8e90c63de89050c80ecfff81fe001754cef581f52092b0f8d2b00125e935229b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "615e5e00-076a-4976-b6ce-b81f475ca745", "node_type": "1", "metadata": {}, "hash": "7bbefe057b7935d5274214df60e761cb981efad48262ef5683aa4420ef3d70f6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "There have been rare\ncases of unilateral deafness. Orchitis occurs in about 25% of\nmen infected after puberty and, in the case of bilateral orchitis,\nmay result in infertility. This complication tends to occur dur-\ning the \ufb01rst few days of infection, causing swelling, pain and\nfever.14\nComplications of postnatal rubella are rare, but become\nmore common with advancing age. Rubella infection which is\ntransmitted to the fetus through the placenta is certainly the\nmost critical. The danger of provoking birth defects is higher if\nthe infection is contracted by the mother during the \ufb01rst tri-\nmester of pregnancy: inner ear deafness and cataracts are the\nmost common defects. Other possible fetal complications may\ninclude: developmental disorders, locomotor disorders, enceph-\nalitis and low birth weight.15\nThe likelihood of complications and sequelae of measles,\nmumps, rubella and other infections, increases with the\nage.12 On the contrary, the likelihood of adverse events and\nother complications as a result of MMR vaccination are\nvery rare. They may occur especially in individuals with\nhypersensitivity to certain vaccine components, technical\nproblems or incorrect administration.12 On the other hand,\nthere is evidence that MMR vaccination is not only effec-\ntive, but also cost saving, from both direct cost and societal\nperspectives.12,16-17\nCONTACT Prof. Giuseppe La Torre\ngiuseppe.latorre@uniroma1.it\nDepartment of Public Health and Infectious Diseases; \u201cSapienza\u201d University of Rome Italy;\nPiazzale Aldo Moro 5 \u2013 00185 Rome, Italy.\n\u00a9 2017 Taylor & Francis\nHUMAN VACCINES & IMMUNOTHERAPEUTICS\n2017, VOL. 13, NO. 8, 1879\u20131883\nhttps://doi.org/10.1080/21645515.2017.1330733\nDue to the median coverage of the vaccination, Italy is still\none of the European countries with a high number of measles\ncases per million person18 placing it far from the desired elimi-\nnation level, In Italy, the MMR vaccine is recommended by the\nMinistry of Health.", "mimetype": "text/plain", "start_char_idx": 4610, "end_char_idx": 6566, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "615e5e00-076a-4976-b6ce-b81f475ca745": {"__data__": {"id_": "615e5e00-076a-4976-b6ce-b81f475ca745", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8d28964a-c55f-401c-b607-ed088663e4fa", "node_type": "1", "metadata": {}, "hash": "ef666cb8fc1b6005d61364fbe49096fafb53ff59d35a307b7f8885c87b48ecd4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ae3f5656-3125-4bb2-96df-2bc7a4fbb1e0", "node_type": "1", "metadata": {}, "hash": "f7f90ac88f9ff527f5410e00381da5a3a3a6f3c087b6e98152aa93b3582e8a86", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "According to the national calendar of vacci-\nnations which are actively offered to the entire population, the\nanti MMR vaccine is given in 2 doses: at 13th -15th month,\n5\u20136 y (and eventually at 11\u201318 years)18\nA recent research, conducted in a cohort of Danish children,\nrevealed that administration of live MMR vaccine versus inacti-\nvated DTaP-IPV-Hib, is associated with a lower rate of hospital\nadmissions for generic type infections.19\nThis retrospective cohort study aims to evaluate the impact\nof MMR vaccination on hospitalization for infectious events\nand respiratory pathologies (including asthma), and focuses on\nthe pediatric population in the areas of competence of the local\nhealth unit ASL Rome1, for a follow up of 2 y. Therefore, it\nintends to evaluate the effectiveness of the MMR vaccine in\nreducing hospitalizations from any target infectious disease,\nand from respiratory diseases and refers to children born in the\nperiod ranged between 2008 -2010, who subsequently under-\nwent vaccination in 2009\u20132011 and resident in the territories of\nthe ASL Rome1.\nResults\nThe study involved the analysis of 11,004 children (5535 males,\n5469 females) of mainly Italian nationality (89.1%), resident in\nthe territory of ASL Rome 1.\n2302 of these children (20.9%) did not receive the MMR\nvaccination, 5392 (49%) received one dose and 3310 (30.1%)\nreceived 2 doses of this vaccine.\nWith regard to the target diseases of vaccination, over the\nperiod studied, no hospitalizations occurred for Rubella, 2 hos-\npitalizations were seen for Mumps (1 among vaccinated and 1\namong unvaccinated children) and 12 occurred for Measles, of\nwhich 9 (0.4%) among not vaccinated group, 3 (0.1%) among\nthose vaccinated with one dose, and none among those who\nreceived 2 doses of vaccine (p < 0.001) (Table 1).", "mimetype": "text/plain", "start_char_idx": 6567, "end_char_idx": 8366, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ae3f5656-3125-4bb2-96df-2bc7a4fbb1e0": {"__data__": {"id_": "ae3f5656-3125-4bb2-96df-2bc7a4fbb1e0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "615e5e00-076a-4976-b6ce-b81f475ca745", "node_type": "1", "metadata": {}, "hash": "7bbefe057b7935d5274214df60e761cb981efad48262ef5683aa4420ef3d70f6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "028390e9-3bf2-4bf9-b222-a79381132c67", "node_type": "1", "metadata": {}, "hash": "a1ae89683cb182e011006219c3559495ee126429e04c0fbf29c0968d3e5f4b50", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Overall, the\nvaccine was highly protective against measles (HR D 0.09;\n95%CI: 0.01- 0,32) or measles and mumps hospitalizations\n(HR: 0.10; 95% CI: 0.03 to 0.34) (Table 2).\nAs for all infectious diseases, the target and non-target of\nvaccination, 414 hospitalizations were noted, of which 262\n(11.4%) among those non-vaccinated, 82 (1.5%) among those\nwho had received one dose of vaccine and 70 between those\nwho had received 2 doses (p < 0.001) (Table 3). Overall, the\nvaccine was highly protective against hospitalizations for all\ninfectious diseases (HR:0.29; 95% CI: 0.25 to 0.34).\nWith regard to respiratory disease, there were 809 admis-\nsions (7.4%), of which 424 (18.4%) among those who had not\nbeen vaccinated, 202 (3.7%) among children vaccinated having\nreceived just the \ufb01rst dose and 183 (5.5%) among children vac-\ncinated with 2 doses (p < 0.001) (Table 4). Overall, the vaccine\nwas highly protective against hospitalizations for respiratory\ndiseases, with an HR of 0.18 (95% CI: 0.:07 to 00.48).\nDiscussion\nIn our study it resulted that receiving the live MMR vaccine is\nassociated with a lower rate of hospital admissions for any tar-\nget infectious disease, and for respiratory diseases in children.\nAs far as concerns the target infectious diseases, no hospital-\nization was recorded for rubella, while the MMR vaccine was\neffective in preventing hospitalization for measles and mumps.\nIt is interesting to note that data from this research suggest that\nthe effect of MMR vaccination is mainly due to the measles\ncomponent, and not to all 3 components of MMR vaccine.", "mimetype": "text/plain", "start_char_idx": 8367, "end_char_idx": 9950, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "028390e9-3bf2-4bf9-b222-a79381132c67": {"__data__": {"id_": "028390e9-3bf2-4bf9-b222-a79381132c67", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ae3f5656-3125-4bb2-96df-2bc7a4fbb1e0", "node_type": "1", "metadata": {}, "hash": "f7f90ac88f9ff527f5410e00381da5a3a3a6f3c087b6e98152aa93b3582e8a86", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ead53e04-4528-4856-b8db-540e63184b3f", "node_type": "1", "metadata": {}, "hash": "cec83332c3b22096bd444089965a993373f2e9da64e6a747e6a1263bf813ada0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "It is interesting to note that data from this research suggest that\nthe effect of MMR vaccination is mainly due to the measles\ncomponent, and not to all 3 components of MMR vaccine.\nThe association was particularly strong for lower respiratory\ntract infections (HR of 0.18; 95% CI: 0:07 to 00:48) and resulted\nhighly protective against hospitalizations for all infectious dis-\neases (HR: 0.29; 95% CI: 0:25 to 00:34).\nVaccination remains one of the safest and effective interven-\ntions available in public health for the primary prevention of\ninfectious diseases, resulting in a medical practice that induces\nboth direct and indirect immunity in individuals vaccinated\n(herd immunity).12,20\nThe immunological mechanism underlying this effect is not\nyet entirely understood, but may involve genetic modulation\nsystems; many studies are being performed to investigate the\nprotective effects of non-speci\ufb01c vaccines in low-income coun-\ntries with a high prevalence of infectious diseases.12,20\nThe mechanisms of immunization induced by the MMR\nvaccine and the long persistence of B-cell antigen-speci\ufb01c\nmemory (MBCS) in children and young adults still remain\nunclear.21-22\nGenetic polymorphisms may be signi\ufb01cantly associated with\nthe variability of response mechanisms to infection and vacci-\nnation. In particular, the genetic polymorphisms of various\nfamilies of genes with known immune function, including HLA\ngenes, cytokine and the cytokine receptors, genes that control\nthe innate and humoral immunity, are signi\ufb01cantly associated\nwith changes in the immune response to therubella vaccine.23\nOn the contrary, the determinants of immunity induced by\nthe mumps vaccine have not yet been completely clari\ufb01ed.24\nThe variability of the immune response modulated by the\nhuman leukocyte antigen gene (HLA) and by genes for cyto-\nkines, appears to be an important factor in the protection\nTable 1. Hospitalizations for measles and mumps, all infectious diseases and respiratory diseases for all MMR vaccine doses.", "mimetype": "text/plain", "start_char_idx": 9769, "end_char_idx": 11778, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ead53e04-4528-4856-b8db-540e63184b3f": {"__data__": {"id_": "ead53e04-4528-4856-b8db-540e63184b3f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "028390e9-3bf2-4bf9-b222-a79381132c67", "node_type": "1", "metadata": {}, "hash": "a1ae89683cb182e011006219c3559495ee126429e04c0fbf29c0968d3e5f4b50", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6f8340d8-9106-4b80-b120-a9b49ea3ac02", "node_type": "1", "metadata": {}, "hash": "d201e5d0d13d59c962d1332c8d194cb0c1098f05366c9802ee10e0b4df4e2a9d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Hospitalizations for measles and mumps, all infectious diseases and respiratory diseases for all MMR vaccine doses.\nMeasles\nMumps\nMeasles and Mumps\nAll infectious diseases\nAll respiratory diseases\nVaccine\nN (%)\nN (%)\nN (%)\nN (%)\nN (%)\nNo dose\n9 (0.4)\n1 (0.04)\n10 (0.4)\n262 (11.4)\n424 (18.4)\n1 dose\n3 (0.06)\n1 (0.01)\n4 (0.1)\n82 (1.5)\n202 (3.7)\n2 doses\n0 (0)\n0 (0)\n0 (0)\n70 (2.1)\n183 (5.5)\nTotal\n12 (0.1)\n2 (0.01)\n14 (0.1)\n414 (3.8)\n809 (7.4)\np\n<0.001\nNs\n<0.001\n<0.001\n<0.001\n1880\nG. LA TORRE ET AL.\nagainst measles; understanding the genetic factors that in\ufb02u-\nence changes in the secretion of cytokines after vaccination\nagainst measles would allow a better understanding of the fac-\ntors that in\ufb02uence the cell-mediated and humoral immunity\nduring this infection.25\nArecentstudyreportedthatreceivingtheliveMMRvaccineafter\nthe inactivated DTaPIPV- Hib vaccine was associated with a lower\nrateofhospitaladmissionsforanyinfection.19Onthecontrary,chil-\ndren who received DTaP-IPVHib after MMR had a signi\ufb01cantly\nhigher rate of infectious disease admission. However vaccinations\nwere registered by general practitioners to obtain reimbursement,\nthereforetheremighthavebeensomeunderreporting.19\nThis study has some limitation that must be acknowledged.\nFirst of all, we were not able to have data on family income or\nat least parents\u2019 educational level that could have an impact on\nvaccination attitude. But there is evidence that in Italy socio-\neconomic factors are not associated with low likelihood of\ngetting vaccinated against MMR.25,26\nMoreover, at the moment of the research, no data on other\nvaccinations were available, so that we were not able to adjust\nthe analysis for possible confounders.", "mimetype": "text/plain", "start_char_idx": 11663, "end_char_idx": 13361, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6f8340d8-9106-4b80-b120-a9b49ea3ac02": {"__data__": {"id_": "6f8340d8-9106-4b80-b120-a9b49ea3ac02", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ead53e04-4528-4856-b8db-540e63184b3f", "node_type": "1", "metadata": {}, "hash": "cec83332c3b22096bd444089965a993373f2e9da64e6a747e6a1263bf813ada0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4a6773e4-a202-4502-8c16-11264f7423ad", "node_type": "1", "metadata": {}, "hash": "8fd414b03e35ed7af6033e4d26d7fcd2f91d458db3359e342be0b86569fbcefe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Finally, we choose the\nstarting point of the follow-up of the non-vaccinated children\nat the median month when they should have been vaccinated.\nThis choice was taken to have the same probability of follow-\nup of the vaccinated children. However, same results were\nfound, without taking into consideration the follow-up period,\nusing a logistic regression approach and not a Cox proportional\nhazard model,\nIn conclusion, even if the study is not novel in the interna-\ntional panorama, we believe it adds some new insight, in\nTable 3. Description of the hospitalization for infectious diseases (by ICD code) in\nchildren not vaccinated, vaccinated with one and 2 doses.\nICD code\n0 dose\n1 dose\n2 doses\nTyphoid or Paratyphoid fever 002\n1\n0\n0\nOther salmonella infections 003\n5\n2\n2\nShigellosis 004\n1\n0\n0\nOther protozoal intestinal diseases 007\n1\n0\n0\nIntestinal infections due to other\norganisms 008\n52\n22\n10\nIll-de\ufb01ned intestinal infections 009\n63\n20\n15\nTuberculosis of other organs 017\n1\n1\n0\nWhooping cough 033\n9\n3\n2\nStreptococcal sore throat and scarlet\nfever 034\n6\n1\n0\nMeningococcal infection 036\n1\n0\n1\nSepticemia 038\n4\n4\n2\nActinomycotic infections 039\n1\n0\n0\nBacterial infection in conditions classi\ufb01ed\nelsewhere and of unspeci\ufb01ed site 041\n24\n1\n2\nHuman immunode\ufb01ciency virus [HIV]\ndisease 042\n2\n0\n0\nMeningitis due to enterovirus 047\n1\n0\n0\nChickenpox 052\n5\n3\n3\nHerpes simplex 054\n4\n0\n0\nMeasles 055\n9\n3\n0\nOther viral exanthemata 057\n9\n2\n4\nViral hepatitis 070\n0\n0\n1\nMumps 072\n1\n1\n0\nInfectious mononucleosis 075\n11\n4\n5\nOther diseases of conjunctiva due", "mimetype": "text/plain", "start_char_idx": 13362, "end_char_idx": 14907, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4a6773e4-a202-4502-8c16-11264f7423ad": {"__data__": {"id_": "4a6773e4-a202-4502-8c16-11264f7423ad", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6f8340d8-9106-4b80-b120-a9b49ea3ac02", "node_type": "1", "metadata": {}, "hash": "d201e5d0d13d59c962d1332c8d194cb0c1098f05366c9802ee10e0b4df4e2a9d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6a0caeb5-100c-49c1-94c9-c11a66ecf482", "node_type": "1", "metadata": {}, "hash": "582db1c9ae895e9e996e12d75c729a36ab0b2eeeba457da48c09b1d212b90ef9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hepatitis 070\n0\n0\n1\nMumps 072\n1\n1\n0\nInfectious mononucleosis 075\n11\n4\n5\nOther diseases of conjunctiva due to\nviruses and chlamydiae 077\n0\n0\n4\nOther diseases due to viruses and\nchlamydiae 078\n16\n1\n5\nViral and chlamydial infection in\nconditions classi\ufb01ed elsewhere and of\nunspeci\ufb01ed site 079\n18\n4\n8\nLeishmaniasis 085\n1\n1\n0\nRelapsing fever 087\n11\n5\n6\nCongenital syphilis 090\n1\n0\n0\nOther cestode infection 123\n1\n0\n0\nOther and unspeci\ufb01ed helminthiases 128\n1\n0\n0\nIntestinal parasitism, unspeci\ufb01ed 129\n1\n0\n0\nOther and unspeci\ufb01ed infectious and\nparasitic diseases 136\n1\n1\n0\nLate effects of other infectious and\nparasitic diseases 139\n0\n3\n0\nTOTAL\n262\n82\n70\nTable 2. Cox regression model results relating to the correlation between MMR vaccine and Measles and Mumps, all infectious diseases and all respiratory diseases.\nVaccine\nMeasles\nMeasles and Mumps\nAll infectious diseases\nAll respiratory diseases\nHR (95%CI)\nHR (95%CI)\nHR (95%CI)\nHR (95%CI)\nNo (reference)\n1\n1\n1\n1\nYes\n0.09 (0.01 \u2013 0.32)\n0.10 (0.03 \u2013 0.34)\n0.29 (0.25 \u2013 0.34).\n0.18 (0.07 \u2013 0.48).\nTable 4. Description of the hospitalization for respiratory (by ICD code) in children\nnot vaccinated, vaccinated with one and 2 doses.", "mimetype": "text/plain", "start_char_idx": 14802, "end_char_idx": 15979, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6a0caeb5-100c-49c1-94c9-c11a66ecf482": {"__data__": {"id_": "6a0caeb5-100c-49c1-94c9-c11a66ecf482", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4a6773e4-a202-4502-8c16-11264f7423ad", "node_type": "1", "metadata": {}, "hash": "8fd414b03e35ed7af6033e4d26d7fcd2f91d458db3359e342be0b86569fbcefe", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "76b7adb8-966b-4883-9e9c-ab75b605204e", "node_type": "1", "metadata": {}, "hash": "7097f5025d9f350b3beb8bbb35fa06e825fa2331574d9e2bd4a87c429e96aa04", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "0.18 (0.07 \u2013 0.48).\nTable 4. Description of the hospitalization for respiratory (by ICD code) in children\nnot vaccinated, vaccinated with one and 2 doses.\nICD code\n0 dose\n1 dose\n2 doses\nAcute nasopharyngitis 460\n0\n3\n1\nAcute sinusitis 461\n0\n2\n0\nAcute pharyngitis 462\n15\n1\n4\nAcute tonsillitis 463\n9\n1\n1\nAcute laryngitis and tracheitis 464\n11\n3\n5\nAcute upper respiratory infections of\nmultiple or unspeci\ufb01ed sites 465\n12\n5\n3\nAcute bronchitis and bronchiolitis 466\n61\n38\n16\nChronic pharyngitis and nasopharyngitis 472\n3\n3\n4\nChronic sinusitis 473\n0\n0\n2\nChronic disease of tonsils and adenoids 474\n102\n38\n64\nPeritonsillar abscess 475\n0\n0\n1\nAllergic rhinitis 477\n11\n5\n3\nOther diseases of upper respiratory tract 478\n16\n6\n12\nViral pneumonia 480\n3\n0\n1\nPneumococcal pneumonia 481\n0\n1\n1\nOther bacterial pneumonia 482\n7\n4\n2\nPneumonia due to other speci\ufb01ed\norganism 483\n4\n1\n1\nPneumonia in infectious diseases classi\ufb01ed\nelsewhere 484\n0\n1\n1\nBronchopneumonia, organism unspeci\ufb01ed 485\n13\n13\n4\nPneumonia, organism unspeci\ufb01ed 486\n67\n18\n20\nIn\ufb02uenza 487\n6\n1\n1\nBronchitis, not speci\ufb01ed as acute or chronic 490\n0\n1\n0\nChronic bronchitis 491\n4\n0\n0\nAsthma 493\n54\n30\n18\nBronchiectasis 494\n0\n0\n2\nChronic airway obstruction,", "mimetype": "text/plain", "start_char_idx": 15825, "end_char_idx": 17020, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "76b7adb8-966b-4883-9e9c-ab75b605204e": {"__data__": {"id_": "76b7adb8-966b-4883-9e9c-ab75b605204e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6a0caeb5-100c-49c1-94c9-c11a66ecf482", "node_type": "1", "metadata": {}, "hash": "582db1c9ae895e9e996e12d75c729a36ab0b2eeeba457da48c09b1d212b90ef9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9f46c312-ae96-41e5-85ea-d61a02010207", "node_type": "1", "metadata": {}, "hash": "fd56577ea86740b598857e70d82399cc8c73274d9909fc878291c60da5a98498", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "not elsewhere\nclassi\ufb01ed 496\n0\n1\n0\nPneumonitis due to solids and liquids 507\n0\n1\n0\nPleurisy 511\n7\n1\n0\nPneumothorax and air leak 512\n1\n0\n0\nOther diseases of lung 518\n15\n16\n11\nOther diseases of respiratory system 519\n3\n8\n5\nTOTAL\n424\n202\n183\nHUMAN VACCINES & IMMUNOTHERAPEUTICS\n1881\nparticular for what concerns the protective effect of MMR vac-\ncination against hospitalizations for respiratory diseases in chil-\ndren This result could be a very good argument to reduce the\nbarriers against this vaccination among parents. However, the\n\ufb01ndings require replication in a larger sample and possibly in a\nprospective cohort study of high quality, controlling for other\ntypes of variables in hospitalized children rather than in a retro-\nspective cohort.\nMaterials and methods\nStudy design and setting\nThe population eligible for enrollment in this retrospective\ncohort study is represented by children resident in the ASL\nRome1, who were present in vaccination registers and had been\nvaccinated (or not) in the period between 2009\u20132011 for the\nMMR. The follow-up started as follows: a) for vaccinated chil-\ndren at the time of vaccination and ending after 24 months; b)\nfor unvaccinated children, the start of the follow-up was con-\nsidered as the median month when children should have\nreceived the vaccine for their birth cohort and ending after 24\nmonths (Fig. 1). In this sample T0 and T1 represent the starting\nand ending points of study.\nFor each component of the cohort the status of MMR vacci-\nnation was ascertained in the register of ASL, a database that\nincluded the names of children vaccinated both at immuniza-\ntion clinics of the ASL and with family pediatricians.\nDatabase\nThe effectiveness of MMR vaccine in reducing hospitalizations\nfor any infection was assessed by analyzing 2 distinct databases:\na) the vaccination records of the database of the ASL RM-A,\nfrom which relevant data were extracted, such as date of\nbirth; MMR vaccination (yes vs no); MMR dose (only for\nvaccinated); Personal Tax code.", "mimetype": "text/plain", "start_char_idx": 17021, "end_char_idx": 19034, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9f46c312-ae96-41e5-85ea-d61a02010207": {"__data__": {"id_": "9f46c312-ae96-41e5-85ea-d61a02010207", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "76b7adb8-966b-4883-9e9c-ab75b605204e", "node_type": "1", "metadata": {}, "hash": "7097f5025d9f350b3beb8bbb35fa06e825fa2331574d9e2bd4a87c429e96aa04", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "91b8df91-5475-4ad3-aab5-d500508f7f3b", "node_type": "1", "metadata": {}, "hash": "b802759d15fc3cfb00d615fff272c17296bf944cabf8ed0affd3d44036880d15", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "b) the hospital discharge diagnosis which contained the\nfollowing ICD-9 codes (International Classi\ufb01cation of\nDiseases), in primary or secondary diagnosis:\n\u2013 001 to 139 for infectious and parasitic diseases;\n\u2013 from 460 to 519 for respiratory diseases.\nThe cohort was recomposed through record linkage of the 2\narchives, registration and vaccination of hospital discharge\nrecords (HDR), using personal tax codes as a common identi\ufb01-\ncation in both archives.\nOutcome measures and exposure\nAll children included in the cohort were divided into 2 groups,\nexposed and unexposed, considering \u201cexposure\u201d as the adminis-\ntration\nof\nthe\nMMR\nvaccine\nand\n\u201coutcome\u201d\nas\nthe\nhospitalization for any infectious disease related to the vaccine\n(measles, mumps and rubella) and all respiratory diseases in\nthe considered time-window.\nStatistical analysis\nA descriptive analysis was conducted to represent the main\ncharacteristics of the sample. A univariate analysis, to evaluate\nthe possible associations between the number of doses of\nvaccination and the 3 different outcomes considered was also\nperformed. Finally, Cox regression models were constructed to\nassess the association between the vaccination status and\noutcomes The results are presented as Hazard ratios (HR) and\n95% con\ufb01dence intervals (95% CI). The models were adjusted\nconsidering age and gender as possible confounders.\nThe statistical analysis was performed using SPSS version 23\nfor Windows, with the level of signi\ufb01cance set at p < 0.05.\nDisclosure of potential con\ufb02icts of interest\nNone of the authors have any competing interests.\nAuthorship\nG.L.T. A.B. and A.S. designed the study, and together with R.S wrote the\nprotocol and oversaw all aspects of the study. U.B. and A.M. collected data\nfrom the sample; G.L.T. conducted and performed the statistical analysis;\nG.L.T., R.S., U.B., A.M. wrote the manuscript in all his sections. A.S. and\nA.B contributed to the discussion. All authors contributed to and have\napproved the \ufb01nal manuscript.\nReferences\n[1] Aaby P, Whittle H, Benn CS.", "mimetype": "text/plain", "start_char_idx": 19035, "end_char_idx": 21076, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "91b8df91-5475-4ad3-aab5-d500508f7f3b": {"__data__": {"id_": "91b8df91-5475-4ad3-aab5-d500508f7f3b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9f46c312-ae96-41e5-85ea-d61a02010207", "node_type": "1", "metadata": {}, "hash": "fd56577ea86740b598857e70d82399cc8c73274d9909fc878291c60da5a98498", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a98a5da6-d3f8-4eb7-abd4-f13142d39243", "node_type": "1", "metadata": {}, "hash": "2b76851f9997dccd64e213f972031070c070c5bf5b003156019c5e8061972824", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "A.S. and\nA.B contributed to the discussion. All authors contributed to and have\napproved the \ufb01nal manuscript.\nReferences\n[1] Aaby P, Whittle H, Benn CS. Vaccine programmes must consider\ntheir\neffect\non\ngeneral\nresistance.\nBMJ\n2012;344:e3769;\nPMID:22700785; https://doi.org/10.1136/bmj.e3769\n[2] Benn CS, Netea MG, Selin LK, Aaby P. A small jab\u2014a big effect: non-\nspeci\ufb01c immunomodulation by vaccines. Trends Immunol 2013;34\n(9):431-9; PMID:23680130; https://doi.org/10.1016/j.it.2013.04.004\n[3] Aaby P, Samb B, Simondon F, Seck AM, KnudsenK, Whittle H. Non-\nspeci\ufb01c bene\ufb01cial effect of measles immunization: analysis of mortal-\nity studies from developing countries. BMJ 1995; 311(7003):481-5;\nPMID:7647643; https://doi.org/10.1136/bmj.311.7003.481\n[4] Aaby P, Martins CL, Garly ML, Bal\u0001e C, Andersen A, Rodrigues A,\nRavn H, Lisse IM, Benn CS, Whittle HC. Non-speci\ufb01c effects of stan-\ndard measles vaccine at 4.5 and 9 months of age on childhood mor-\ntality:\nrandomized\ncontrolled\ntrial.\nBMJ\n2010;\n341:c6495;\nPMID:21118875; https://doi.org/10.1136/bmj.c6495\n[5] Aaby P, Roth A, Ravn H, Napirna BM, Rodrigues A, Lisse IM, Sten-\nsballe L, Diness BR, Lausch KR, Lund N, et al. Randomized trial of\nBCG vaccination at birth to low-birth-weight children: bene\ufb01cial\nnonspeci\ufb01c effects in the neonatal period?", "mimetype": "text/plain", "start_char_idx": 20924, "end_char_idx": 22225, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a98a5da6-d3f8-4eb7-abd4-f13142d39243": {"__data__": {"id_": "a98a5da6-d3f8-4eb7-abd4-f13142d39243", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "91b8df91-5475-4ad3-aab5-d500508f7f3b", "node_type": "1", "metadata": {}, "hash": "b802759d15fc3cfb00d615fff272c17296bf944cabf8ed0affd3d44036880d15", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8c23af5a-a06d-4fa5-a962-d4ee6790dadd", "node_type": "1", "metadata": {}, "hash": "1ca9133d6b356f167104d90b1c72c998459ae4674823ed90edea6ab19f3bf3dd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Randomized trial of\nBCG vaccination at birth to low-birth-weight children: bene\ufb01cial\nnonspeci\ufb01c effects in the neonatal period? J Infect Dis 2011; 204\n(2):245-52; PMID:21673035; https://doi.org/10.1093/infdis/jir240\n[6] Biering-S\u00f8rensen S, Aaby P, Napirna BM, Roth A, Ravn H, Rodrigues\nA, Whittle H, Benn CS. Small randomized trial among low-birth-\nweight children receiving bacillus Calmette-Gu\u0001erin vaccination at \ufb01rst\nFigure 1. Period of the study follow-up T0 T1 1/1/2009 follow-up 24 31/12/2013.\n1882\nG. LA TORRE ET AL.\nhealth\ncenter\ncontact.\nPediatr\nInfect\nDis\nJ\n2012;\n31(3):306-8;\nPMID:22189537; https://doi.org/10.1097/INF.0b013e3182458289\n[7] Roth AE, Benn CS, Ravn H, Rodrigues A, Lisse IM, Yazdanbakhsh\nM, Whittle H, Aaby P. Effect of revaccination with BCG in early\nchildhood on mortality: randomized trial in Guinea-Bissau. BMJ\n2010; 340:c671; PMID:20231251; https://doi.org/10.1136/bmj.c671\n[8] Shann F. The non-speci\ufb01c effects of vaccines. Arch Dis Child 2010; 95\n(9):662-667; PMID:20716675; https://doi.org/10.1136/adc.2009.157537\n[9] Aaby P, Benn C, Nielsen J, Lisse IM, Rodrigues A, Ravn H. Testing\nthe hypothesis that diphtheria-tetanus-pertussis vaccine has negative\nnon-speci\ufb01c and sex-differential effects on child survival in high-\nmortality countries.", "mimetype": "text/plain", "start_char_idx": 22098, "end_char_idx": 23373, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8c23af5a-a06d-4fa5-a962-d4ee6790dadd": {"__data__": {"id_": "8c23af5a-a06d-4fa5-a962-d4ee6790dadd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a98a5da6-d3f8-4eb7-abd4-f13142d39243", "node_type": "1", "metadata": {}, "hash": "2b76851f9997dccd64e213f972031070c070c5bf5b003156019c5e8061972824", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4fc8ef7c-a2ee-46f3-85f0-03ed1353c1eb", "node_type": "1", "metadata": {}, "hash": "32b8760934e6134e192671a1323c7989dfd9a1b2ac14134950bb255d13ded424", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BMJ Open 2012; 2(3):e000707; PMID:22619263;\nhttps://doi.org/10.1136/bmjopen-2011-000707\n[10] Aaby P, Garly ML, Nielsen J, Ravn H, Martins C, Bal\u0001e C, Rodrigues\nA, Benn CS, Lisse IM. Increased female-male mortality ratio associ-\nated with inactivated polio and diphtheria-tetanus-pertussis vaccines:\nobservations from vaccination trials in Guinea-Bissau. Pediatr Infect\nDis J 2007; 26(3):247-252; PMID:17484223; https://doi.org/10.1097/\n01.inf.0000256735.05098.01\n[11] Garly ML, Jensen H, Martins CL, Bal\u0001e C, Bald\u0001e MA, Lisse IM, Aaby\nP. Hepatitis B vaccination associated with higher female than male\nmortality in Guinea-Bissau: an observational study. Pediatr Infect\nDis J 2004; 23(12):1086-1092; PMID:15626943\n[12] Rosian-Schikuta I, Fr\u20acoschl B, Habl C, St\u20acurzlinger H. The Measles-\nMumps-Rubella Vaccination from a health political and economical\npoint of view. GMS Health Technol Assess 2007; 3:Doc12.\n[13] Grif\ufb01n DE. Measles virus-induced suppression of immune responses.\nImmunol\nRev\n2010;\n236:176-89;\nhttps://doi.org/10.1111/j.1600-\n065X.2010.00925.x\n[14] Centers for Disease Control and Prevention. Mumps. In: Epidemiol-\nogy and Prevention of Vaccine-Preventable Diseases, 13th Edition.\nApril 2015, 247-60.\n[15] Centers for Disease Control and Prevention. Rubella. In: Epidemiol-\nogy and Prevention of Vaccine-Preventable Diseases, 13th Edition.\nApril 2015, 325-40.", "mimetype": "text/plain", "start_char_idx": 23374, "end_char_idx": 24747, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4fc8ef7c-a2ee-46f3-85f0-03ed1353c1eb": {"__data__": {"id_": "4fc8ef7c-a2ee-46f3-85f0-03ed1353c1eb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8c23af5a-a06d-4fa5-a962-d4ee6790dadd", "node_type": "1", "metadata": {}, "hash": "1ca9133d6b356f167104d90b1c72c998459ae4674823ed90edea6ab19f3bf3dd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "60f3e837-dac1-4011-b262-7d9419c62e63", "node_type": "1", "metadata": {}, "hash": "f304eb896a824e03475b4b61f09f963d10fbea316ac2753045576b08a9e7405b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "[15] Centers for Disease Control and Prevention. Rubella. In: Epidemiol-\nogy and Prevention of Vaccine-Preventable Diseases, 13th Edition.\nApril 2015, 325-40.\n[16] Zhou F, Shefer A, Wenger J, Messonnier M, Wang LY, Lopez A,\nMoore M, Murphy TV, Cortese M, Rodewald L. Economic evalua-\ntion of the routine childhood immunization program in the United\nStates,\n2009.\nPediatrics\n2014;\n133(4):577-85;\nPMID:24590750;\nhttps://doi.org/10.1542/peds.2013-0698\n[17] Rivi\u0003ere M, Tretiak R, Levinton C, Fitzsimon C, Leclerc C. Economic\nbene\ufb01ts of a routine second dose of combined measles, mumps and\nrubella vaccine in Canada. Can J Infect Dis 1997; 8(5):257-64;\nhttps://doi.org/10.1155/1997/215175\n[18] Ministero della Salute. Piano Nazionale Prevenzione Vaccinale\n(PNPV) 2012\u20132014.\n[19] S\u00f8rup S, Benn CS, Poulsen A, Krause TG, Aaby P, Ravn H. Live Vac-\ncine Against Measles, Mumps, and Rubella and the Risk of Hospital\nAdmissions for Nontargeted Infections. JAMA 2014; 311(8):826-835;\nPMID:24570246; https://doi.org/10.1001/jama.2014.470\n[20] Plans-Rubi\u0001o P. Evaluation of the establishment of herd immunity in\nthe population by means of serological surveys and vaccination cov-\nerage. Hum Vaccin Immunother 2012; 8: 184\u00a1188; PMID:22426372;\nhttps://doi.org/10.4161/hv.18444\n[21] Kakoulidou M, Ingelman-Sundberg H, Johansson E, Cagigi A, Far-\nouk SE, Nilsson A, Johansen K. Kinetics of antibody and memory B\ncell responses after MMR immunization in children and young\nadults.", "mimetype": "text/plain", "start_char_idx": 24589, "end_char_idx": 26051, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "60f3e837-dac1-4011-b262-7d9419c62e63": {"__data__": {"id_": "60f3e837-dac1-4011-b262-7d9419c62e63", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4fc8ef7c-a2ee-46f3-85f0-03ed1353c1eb", "node_type": "1", "metadata": {}, "hash": "32b8760934e6134e192671a1323c7989dfd9a1b2ac14134950bb255d13ded424", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5914c0a4-63af-4ff4-a2e2-42c3822daf6e", "node_type": "1", "metadata": {}, "hash": "2eb9dc54d58f800bd29ccb78f2ea0139b6b154b7804f9f5314cb2cdc05a7dc3c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine\n2013;\n31(4):711-7;\nhttps://doi.org/10.1016/j.\nvaccine.2012.11.031\n[22] Kennedy RB, Ovsyanniko IG, Haralambieva IH, Lambert ND, Pan-\nkratz VS, Poland GA. Genetic polymorphisms associated with rubella\nvirus-speci\ufb01c cellular immunity following MMR vaccination. Human\nGenetics 2014; 133(11):1407-17; https://doi.org/10.1007/s00439-014-\n1471-z\n[23] Kyaw MH, Rue AM, Klahn J, Obrecht LA, Krohn T, Rowland J,\nRubin S, Safranek Thomas J, Bellini WJ, Dayan GH. Long-Term Per-\nsistence of Mumps Antibody after Receipt of 2 Measles-Mumps-\nRubella (MMR) Vaccinations and Antibody Response after a Third\nMMR Vaccination among a University Population. J Infect Dis 2008;\n197(12):1662-8; https://doi.org/10.1086/588197\n[24] Ovsyannikova IG, Ryan JE, Vierkant RA, Pankratz VS, Jacobson RM,\nPoland GA. Immunologic signi\ufb01cance of HLA class I genes in mea-\nsles virus-speci\ufb01c IFN-gamma and IL-4 cytokine immune responses.\nImmunogenetics\n2005;\n57(11):828-36;\nhttps://doi.org/10.1007/\ns00251-005-0061-6\n[25] Restivo V, Napoli G, Marsala MG, Bonanno V, Sciuto V, Amodio E,\nCalamusa G, Vitale F, Firenze A. Factors associated with poor adher-\nence to MMR vaccination in parents who follow vaccination sched-\nule. Hum VaccinImmunother 2014; 11(1).\n[26] Impicciatore P, Bosetti C, Schiavio S, Pandol\ufb01ni C, Bonati M. Moth-\ners as active partners in the prevention of childhood diseases: mater-\nnal factors related to immunization status of preschool children in\nItaly.", "mimetype": "text/plain", "start_char_idx": 26052, "end_char_idx": 27502, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5914c0a4-63af-4ff4-a2e2-42c3822daf6e": {"__data__": {"id_": "5914c0a4-63af-4ff4-a2e2-42c3822daf6e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010La Torre (2017).pdf", "node_type": "4", "metadata": {}, "hash": "0e9be36ecfbcb07b3c7e81d49b8b60e5eef63b51988cf7f6076196135cc8353b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "60f3e837-dac1-4011-b262-7d9419c62e63", "node_type": "1", "metadata": {}, "hash": "f304eb896a824e03475b4b61f09f963d10fbea316ac2753045576b08a9e7405b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Prev\nMed\n2000;\n31(1):49-55;\nhttps://doi.org/10.1006/\npmed.2000.0677\nHUMAN VACCINES & IMMUNOTHERAPEUTICS\n1883", "mimetype": "text/plain", "start_char_idx": 27503, "end_char_idx": 27611, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5ff1928a-3cd3-4c4e-a817-a0756d5f7d34": {"__data__": {"id_": "5ff1928a-3cd3-4c4e-a817-a0756d5f7d34", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5618ed92-fe2a-4bd7-84cb-b9c9b73853d0", "node_type": "1", "metadata": {}, "hash": "366733d907bcf8c1fa11f494aafe2729f4fa73a6d89eea14992b7aa618313571", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine\n 30 (2012) 4292\u2013\n 4298\nContents\n lists\n available\n at\n SciVerse\n ScienceDirect\nVaccine\nj\n ourna\n l\n ho\n me\n pag\n e:\n www.elsevier.com/locate/vaccine\nThe\n combined\n measles,\n mumps,\n and\n rubella\n vaccines\n and\n the\n total\n number\n of\nvaccines\n are\n not\n associated\n with\n development\n of\n autism\n spectrum\n disorder:\nThe\n \ufb01rst\n case\u2013control\n study\n in\n Asia\nYota\n Uno a,b,\u2217,  Tokio\n Uchiyama b,c,  Michiko\n Kurosawa d,  Branko\n Aleksic a,  Norio\n Ozaki a\na Department\n of\n Psychiatry\n and\n Psychiatry\n for\n Parents\n and\n Children,\n Nagoya\n University\n Graduate\n School\n of\n Medicine,\n Nagoya,\n Japan\nb Yokohama\n Psycho-Developmental\n Clinic,\n Yokohama,\n Japan\nc Department\n of\n Faculty\n of\n Human\n Development,\n Fukushima\n University\n Graduate\n school,\n Fukushima,\n Japan\nd Department\n of\n Epidemiology\n and\n Environmental\n Health,\n Juntendo\n University\n Graduate\n School\n of\n Medicine,\n Tokyo,\n Japan\na  r  t\n i  c  l  e  \ni n\n f\n o\nArticle\n history:\nReceived\n 9\n September\n 2011\nReceived\n in\n revised\n form\n 6\n January\n 2012\nAccepted\n 7\n January\n 2012\nAvailable online 20 April 2012\nKeywords:\nAutism\n spectrum\n disorder\nVaccination\nMeasles\u2013mumps\u2013rubella\n Vaccine\nRisk\n factors\nMedical\n record\nCase\u2013control\n studies\na\n b  s  t  r  a\n c  t\nObjective:\n The\n aim  of  this\n study  was  to  investigate\n the  relationship\n between\n autism  spectrum\n disorder\n(ASD)\n and\n general\n vaccinations,\n including\n measles\u2013mumps\u2013rubella\n (MMR)\n vaccine,\n in  Japanese\n subjects,\na\n population\n with  high\n genetic\n homogeneity.\nPatients\n and  methods:\n A case\u2013control\n study\n was  performed.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1587, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5618ed92-fe2a-4bd7-84cb-b9c9b73853d0": {"__data__": {"id_": "5618ed92-fe2a-4bd7-84cb-b9c9b73853d0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5ff1928a-3cd3-4c4e-a817-a0756d5f7d34", "node_type": "1", "metadata": {}, "hash": "d703aab317b78b129a5b636eff4b3dd59eab2be6bd619caf6950afd6bfce0b34", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "59763974-5c91-4e00-82ba-d9e225faa8f0", "node_type": "1", "metadata": {}, "hash": "ce22a16788babc7982fe3a9299eba590c2c84b8d51915d0de5670bfda77af01e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Patients\n and  methods:\n A case\u2013control\n study\n was  performed.\n Cases  (n =  189)  were\n diagnosed\n with\n ASD,\nwhile\n controls\n (n  =  224)\n were\n volunteers\n from  general\n schools,\n matched\n by  sex  and  birth\n year  to  cases.\nVaccination\n history\n and  prenatal,\n perinatal,\n and  neonatal\n factors  from\n the  Maternal\n and  Child  Health\nhandbook,\n which\n was  part  of  each\n subject\u2019s\n \ufb01le,  were\n examined.\n To  determine\n the  relationship\n between\npotential\n risk  factors\n and  ASD,  crude  odds\n ratios  (ORs)  and  95%  con\ufb01dence\n intervals\n (95%  CIs)\n were\ncalculated,\n and\n the  differences\n in  mean\n values  of  the  quantitative\n variables\n between\n cases\n and\n controls\nwere\n analyzed\n using  an  unpaired\n t-test.\n Moreover,\n MMR\n vaccination\n and  the  effect  of  the\n number\n of\nvaccine\n injections\n were  investigated\n using\n a conditional\n multiple\n regression\n model.\nResults:\n For\n MMR  vaccination,\n the  OR  was  1.04  (95%  CI,  0.65\u20131.68),\n and  no  signi\ufb01cant\n differences\n were\nfound\n for  the  other  vaccines.\n For  all  of the  prenatal,\n perinatal\n and  neonatal\n factors,\n there  were\n no sig-\nni\ufb01cant\n differences\n between\n cases\n and  controls.\n Furthermore,\n regarding\n the  presence\n of  ASD,\n MMR\nvaccination\n and  the  number\n of vaccine\n injections\n had  ORs  of  1.10  (95%  CI,  0.64\u20131.90)\n and  1.10\n (95%\nCI,\n 0.95\u20131.26),\n respectively,\n in  the  conditional\n multiple\n regression\n model;\n no  signi\ufb01cant\n differences\n were\nfound.", "mimetype": "text/plain", "start_char_idx": 1524, "end_char_idx": 3007, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "59763974-5c91-4e00-82ba-d9e225faa8f0": {"__data__": {"id_": "59763974-5c91-4e00-82ba-d9e225faa8f0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5618ed92-fe2a-4bd7-84cb-b9c9b73853d0", "node_type": "1", "metadata": {}, "hash": "366733d907bcf8c1fa11f494aafe2729f4fa73a6d89eea14992b7aa618313571", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3914fbfe-d743-4231-9881-dad6ffa831b6", "node_type": "1", "metadata": {}, "hash": "d104f16f0235df37669478bc736de0add7f1373024f8db439724381879b71bcb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Conclusions:\n In this\n study,\n there\n were  not  any  convincing\n evidences\n that  MMR  vaccination\n and  increasing\nthe\n number\n of vaccine\n injections\n were  associated\n with\n an  increased\n risk  of ASD  in  a  genetically\n homoge-\nneous\n population.\n Therefore,\n these  \ufb01ndings\n indicate\n that  there\n is  no  basis  for  avoiding  vaccination\n out  of\nconcern\n for  ASD.\n\u00a9 2012 Elsevier Ltd. All rights reserved.\n1.\n Introduction\nAutism\n is\n a\n life-long\n neurodevelopmental\n disorder.\n Its\n preva-\nlence\n was\n long\n considered\n to\n be\n approximately\n 4\n in\n 10,000\n [1].\nDue\n to\n broadening\n of\n the\n nosological\n categorization\n and\n more\nwidespread\n recognition,\n however,\n in\n recent\n years\n the\n prevalence\nof\n autism\n spectrum\n disorder\n (ASD)\n [2,3],\n which\n includes\n autism,\nAsperger\n syndrome,\n and\n Pervasive\n developmental\n disorder\n not\n\u2217Corresponding\n author\n at:\n Yokohama\n Psycho-Developmental\n Clinic,\n 7-7-2F\nChigasaki-cyuo,\n Tsuzuki-ku,\n Yokohama-city,\n Kanagawa\n 224-0032,\n Japan.\nTel.:\n +81\n 45\n 942\n 1077;\n fax:\n +81\n 45\n 942\n 1099.\nE-mail\n addresses:\n yota\n u@ypdc.net\n (Y.\n Uno),\n tokiouch@ca2.so-net.ne.jp\n(T.\n Uchiyama),\n mic@med.juntendo.ac.jp\n (M.\n Kurosawa),\nbranko@med.nagoya-u.ac.jp\n (B.\n Aleksic),\n ozaki-n@med.nagoya-u.ac.jp\n (N.\n Ozaki).\notherwise\n speci\ufb01ed,\n has\n been\n reported\n at\n approximately\n 1%\n world-\nwide\n [4\u20136].", "mimetype": "text/plain", "start_char_idx": 3008, "end_char_idx": 4370, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3914fbfe-d743-4231-9881-dad6ffa831b6": {"__data__": {"id_": "3914fbfe-d743-4231-9881-dad6ffa831b6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "59763974-5c91-4e00-82ba-d9e225faa8f0", "node_type": "1", "metadata": {}, "hash": "ce22a16788babc7982fe3a9299eba590c2c84b8d51915d0de5670bfda77af01e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ee3b8dde-6a80-4eca-998c-da8f0b5c7d33", "node_type": "1", "metadata": {}, "hash": "247881e9ad124def2dbf66db02c4c32f58d4d2ad337c43b78a9e2bb98aba5018", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "otherwise\n speci\ufb01ed,\n has\n been\n reported\n at\n approximately\n 1%\n world-\nwide\n [4\u20136].\n Although\n the\n pathogenesis\n of\n ASD\n has\n not\n yet\n been\nelucidated,\n genetic\n risk\n factors\n are\n strongly\n implicated,\n because\n the\nrelative\n risk\n (\u0002s) among\n siblings\n is\n greater\n than\n 20,\n and\n heritability\nis\n estimated\n to\n be\n as\n high\n as\n 38\u201390%\n [7\u20139]. In\n contrast,\n because\n the\nconcordance\n rate\n of\n identical\n twins\n is\n not\n 100%,\n one\n can\n infer\n that\nenvironmental\n factors\n are\n also\n involved,\n and\n the\n recent\n increase\n in\nprevalence\n also\n indicates\n the\n involvement\n of\n various\n types\n of\n \u201cnovel\nenvironmental\n exposure\u201d.\n A\n debate\n has\n arisen\n over\n the\n contribution\nof\n vaccination\n as\n one\n environmental\n trigger\n of\n ASD.\nThe\n view\n that\n vaccination\n and\n ASD\n onset\n are\n related\n dates\n back\nto\n 1998\n when\n the\n Lancet\n article\n by\n Wake\ufb01eld\n et\n al.\n appeared\n[10]\n (the\n paper\n was\n retracted\n in\n 2010\n because\n of\n ethical\n and\nmethodological\n problems\n [11]).\n Thereafter,\n other\n published\n reports\nsuggested\n a\n link\n between\n the\n measles\u2013mumps\u2013rubella\n vaccine\n0264-410X/$\n \u2013\n see\n front\n matter \u00a9\n \n 2012 Elsevier Ltd. All rights reserved.\nhttp://dx.doi.org/10.1016/j.vaccine.2012.01.093\nY.\n Uno\n et\n al.", "mimetype": "text/plain", "start_char_idx": 4285, "end_char_idx": 5532, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ee3b8dde-6a80-4eca-998c-da8f0b5c7d33": {"__data__": {"id_": "ee3b8dde-6a80-4eca-998c-da8f0b5c7d33", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3914fbfe-d743-4231-9881-dad6ffa831b6", "node_type": "1", "metadata": {}, "hash": "d104f16f0235df37669478bc736de0add7f1373024f8db439724381879b71bcb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "41050adb-ca9a-402a-b03f-2996b44171a8", "node_type": "1", "metadata": {}, "hash": "d11cd8f397ca89b1ca1256b0409dd5de9d05d9acf6a57cc2dcd8ee0808fc85ba", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All rights reserved.\nhttp://dx.doi.org/10.1016/j.vaccine.2012.01.093\nY.\n Uno\n et\n al.\n /\n Vaccine\n 30 (2012) 4292\u2013\n 4298\n4293\n(MMR)\n and\n ASD\n [12\u201314],  and\n concerns\n emerged\n that\n thimerosal,\nwhich\n is\n included\n in\n other\n vaccines\n as\n a\n preservative,\n and\n vac-\ncination\n with\n combined\n vaccines\n might\n be\n risks\n for\n ASD\n onset\n[15\u201317].  Other\n studies,\n however,\n that\n examined\n retrospective\n data\nand\n rejected\n any\n such\n link\n were\n published\n in\n rapid\n succession\n[18\u201326].\n For\n example,\n some\n reported\n an\n increase\n in\n ASD\n prevalence\ndespite\n a\n decline\n in\n the\n MMR\n vaccination\n rate\n [27,28].  In\n Japan,\n only\ntwo\n reports\n have\n been\n based\n on\n a\n time-series\n design,\n and\n the\n results\nsuggested\n no\n relationship\n between\n MMR\n and\n ASD\n [29,30].  The\n most\nprominent\n articles\n in\n the\n past\n have\n focused\n mainly\n on\n the\n results\n of\necologic\n studies,\n and\n we\n will\n discuss\n the\n few\n existing\n case\u2013control\nstudies\n [31\u201333].  Each\n study\n demonstrated\n no\n differences\n between\nASD\n cases\n and\n controls,\n failing\n to\n support\n a\n conclusion\n that\n immu-\nnization\n using\n MMR\n increases\n the\n risk\n of\n ASD\n onset.\nWorldwide,\n reports\n on\n studies\n of\n immunization\n with\n vaccines\nother\n than\n MMR\n are\n rare.\n Moreover,\n parents\n or\n legal\n guardians\nremain\n apprehensive\n about\n the\n perceived\n risk\n of\n ASD\n posed\n by\nvaccination\n [34\u201337].", "mimetype": "text/plain", "start_char_idx": 5447, "end_char_idx": 6833, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "41050adb-ca9a-402a-b03f-2996b44171a8": {"__data__": {"id_": "41050adb-ca9a-402a-b03f-2996b44171a8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ee3b8dde-6a80-4eca-998c-da8f0b5c7d33", "node_type": "1", "metadata": {}, "hash": "247881e9ad124def2dbf66db02c4c32f58d4d2ad337c43b78a9e2bb98aba5018", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "24eaef6e-c334-45d2-a5ea-346712a332b6", "node_type": "1", "metadata": {}, "hash": "8ba7023772fdeca72094f7c03a45ab23926f7c2385686d432821a43365fc908c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Moreover,\n parents\n or\n legal\n guardians\nremain\n apprehensive\n about\n the\n perceived\n risk\n of\n ASD\n posed\n by\nvaccination\n [34\u201337].  Therefore,\n the\n purpose\n of\n this\n study\n was\n to\ninvestigate\n Japanese\n subjects,\n a\n genetically\n homogeneous\n popula-\ntion,\n regarding\n links\n between\n ASD\n and\n immunization\n with\n various\nvaccines,\n including\n MMR,\n as\n well\n as\n the\n association\n between\nASD\n and\n the\n number\n of\n vaccine\n injections\n [38].\n This\n is\n the\n \ufb01rst\ncase\u2013control\n study\n in\n Asia\n investigating\n links\n between\n vaccina-\ntion\n and\n ASD\n onset.\n These\n links\n were\n examined\n in\n ASD\n cases\n and\ncontrols\n matched\n for\n sex\n and\n year\n of\n birth\n based\n on\n data\n found\nin\n the\n Maternal\n and\n Child\n Health\n (MCH)\n handbook.\n This\n hand-\nbook,\n provided\n to\n all\n mothers\n by\n the\n relevant\n Japanese\n health\nsystem\n institution,\n is\n a\n highly\n reliable\n record\n of\n early\n develop-\nment,\n health,\n and\n immunization,\n and\n health\n professionals\n (e.g.\npublic\n health\n nurses,\n obstetricians,\n and\n pediatricians)\n keep\n record\nof\n most\n of\n the\n data\n listed\n in\n it\n [39,40]. In\n this\n study,\n therefore,\ndata\n from\n the\n MCH\n handbook\n in\n terms\n of\n vaccination\n history,\n as\nwell\n as\n potential\n prenatal,\n perinatal,\n and\n neonatal\n risk\n factors,\n were\nexamined.\n2.\n Patients\n and\n methods\n2.1.\n Study\n population\n2.1.1.\n Cases\n (Fig.\n 1)\nThe\n study\n analyzed\n case\n data\n from\n patients\n of\n the\n Yokohama\nPsycho-Developmental\n Clinic\n (YPDC),\n Kanto\n area,\n Japan,\n which\naccepts\n only\n patients\n with\n suspected\n developmental\n disorders.", "mimetype": "text/plain", "start_char_idx": 6701, "end_char_idx": 8271, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "24eaef6e-c334-45d2-a5ea-346712a332b6": {"__data__": {"id_": "24eaef6e-c334-45d2-a5ea-346712a332b6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "41050adb-ca9a-402a-b03f-2996b44171a8", "node_type": "1", "metadata": {}, "hash": "d11cd8f397ca89b1ca1256b0409dd5de9d05d9acf6a57cc2dcd8ee0808fc85ba", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "815f6bda-403e-462a-96a1-e841c513d4d6", "node_type": "1", "metadata": {}, "hash": "8dd5a431de33d296a497c175374a89aaa1136e8fcaa999538ceedf5b0687e097", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Of\nthe\n patients\n who\n initially\n consulted\n the\n YPDC\n from\n April\n 1997\n(opening\n of\n the\n clinic)\n until\n March\n 2011,\n the\n cases\n consisted\n of\npatients\n who:\n (1)\n were\n diagnosed\n with\n ASD,\n and\n (2)\n had\n been\n born\nbetween\n April\n 1,\n 1984\n and\n April\n 30,\n 1992,\n the\n possible\n time\n period\nfor\n MMR\n vaccination.\n Subjects\n whose\n records\n in\n the\n MCH\n handbook\nwere\n missing\n or\n illegible\n and\n those\n with\n a\n history\n of\n vaccination\n in\nanother\n country\n were\n excluded.\n2.1.1.1.\n Diagnosis\n of\n ASD.\n Patients\n were\n diagnosed\n based\n on\nthe\n classi\ufb01cations\n of\n pervasive\n developmental\n disorders\n in\n the\nDiagnostic\n and\n Statistical\n Manual\n 4th\n edition\n (DSM-IV)\n and\n stan-\ndardized\n criteria\n using\n the\n Diagnostic\n Interview\n for\n Social\n and\nCommunication\n Disorder\n (DISCO)\n [41,42].  The\n DISCO\n is\n recognized\nas\n one\n of\n the\n best\n ways\n to\n obtain\n a\n reliable\n and\n valid\n diagnosis\n of\nASD\n [43].\nOne\n of\n several\n child\n psychiatrists\n on\n the\n team\n met\n the\n patient\u2019s\nparents\n and\n used\n the\n DISCO\n to\n take\n the\n patient\u2019s\n developmental\n his-\ntory.\n Another\n child\n psychiatrist\n or\n clinical\n psychologist\n conducted\nintellectual\n or\n developmental\n tests,\n such\n as\n the\n Psycho-Educational\nPro\ufb01le-Revised\n and\n Wechsler\n Intelligence\n Scale\n for\n Children-Third\nEdition.\n After\n the\n interview\n and\n testing,\n the\n diagnosis\n was\n made\n by\nthe\n team\n according\n to\n the\n DSM-IV\n criteria.\n2.1.1.2.\n Period\n of\n birth.\n MMR\n vaccination\n in\n Japan\n was\n conducted\nunder\n speci\ufb01c\n circumstances.", "mimetype": "text/plain", "start_char_idx": 8273, "end_char_idx": 9815, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "815f6bda-403e-462a-96a1-e841c513d4d6": {"__data__": {"id_": "815f6bda-403e-462a-96a1-e841c513d4d6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "24eaef6e-c334-45d2-a5ea-346712a332b6", "node_type": "1", "metadata": {}, "hash": "8ba7023772fdeca72094f7c03a45ab23926f7c2385686d432821a43365fc908c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d9dd3f07-7c23-4ad9-85ca-fc7f4abb0232", "node_type": "1", "metadata": {}, "hash": "e838a813ebeb305be440db2fa5256d4586e852920b5bfe471f86c5ad02812cb8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2.1.1.2.\n Period\n of\n birth.\n MMR\n vaccination\n in\n Japan\n was\n conducted\nunder\n speci\ufb01c\n circumstances.\n It\n was\n introduced\n in\n April\n 1989,\n and\nonly\n one\n vaccination\n using\n MMR\n was\n included\n in\n the\n immunization\nschedule.\n The\n monovalent\n mumps\n and\n rubella\n vaccines\n remained\nthe\n optimal\n choice\n of\n vaccine\n for\n those\n who\n did\n not\n participate\n in\nthe\n MMR\n program.\n However,\n soon\n after\n the\n immunization\n program\ncommenced,\n there\n were\n several\n cases\n of\n aseptic\n meningitis,\n which\nmay have\n been\n caused\n by\n the\n mumps\n vaccine\n [44].\n As\n a\n result,\nin\n April\n 1993,\n the\n Japanese\n government\n ceased\n extensive\n inocu-\nlation\n with\n MMR.\n Therefore,\n children\n born\n from\n April\n 1984\n to\n April\n1992\n could\n receive\n the\n MMR\n vaccination,\n and\n those\n children\n were\nincluded\n in\n the\n present\n study.\n2.1.2.\n Controls\n (Fig.\n 1)\nOne\n to\n two\n controls\n were\n selected\n for\n each\n case,\n matched\n by\n sex\nand\n year\n of\n birth\n and\n recruited\n as\n volunteers\n from\n general\n schools\nin\n the\n Kanto\n area,\n the\n same\n area\n where\n YPDC\n patients\n reside.\n Con-\nsent\n for\n participation\n in\n the\n present\n study\n was\n obtained\n from\n the\nparents\n (or\n legal\n guardians)\n of\n the\n students.\n Students\n who\n had\n pre-\nviously\n been\n recognized\n as\n having\n developmental\n problems\n and\nwere\n already\n receiving\n care\n were\n excluded,\n as\n were\n those\n whose\nrecords\n in\n the\n MCH\n handbook\n were\n missing\n or\n illegible\n and\n those\nwith\n a\n history\n of\n vaccination\n in\n another\n country.\n2.2.", "mimetype": "text/plain", "start_char_idx": 9711, "end_char_idx": 11235, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d9dd3f07-7c23-4ad9-85ca-fc7f4abb0232": {"__data__": {"id_": "d9dd3f07-7c23-4ad9-85ca-fc7f4abb0232", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "815f6bda-403e-462a-96a1-e841c513d4d6", "node_type": "1", "metadata": {}, "hash": "8dd5a431de33d296a497c175374a89aaa1136e8fcaa999538ceedf5b0687e097", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "07378c42-9506-4173-891f-7719a5676e13", "node_type": "1", "metadata": {}, "hash": "609e6e6237d6b1687e067ac39cd41746fe195209e27e5e3521a3c2883777b5f6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2.2.\n Source\n of\n data\nThe\n vaccination\n history\n and\n potential\n prenatal,\n perinatal,\n and\nneonatal\n risk\n factors\n collected\n based\n on\n the\n MCH\n handbook,\nwhich\n was\n routinely\n attached\n to\n each\n patient\u2019s\n \ufb01le,\n were\n exam-\nined.\n The\n targeted\n vaccines\n were\n the\n MMR,\n generally\n used\nfor\n infants,\n and\n the\n individual\n vaccines\n of\n the\n same\n type:\n the\ndiphtheria\u2013pertussis\u2013tetanus\n vaccine\n (DPT);\n the\n polio\n vaccine;\n the\nB-encephalitis\n vaccine;\n and\n the\n Bacillus\n of\n Calmette\n and\n Guerin\n vac-\ncine\n (BCG).\n For\n DPT,\n Polio,\n and\n B-encephalitis,\n there\n were\n many\nsubjects\n who\n received\n these\n vaccines\n more\n than\n once.\n Therefore,\nthe\n times\n of\n exposure\n to\n these\n vaccines\n were\n counted\n within\n the\nperiod\n of\n the\n \ufb01rst\n three\n years,\n when\n ASD\n features\n \ufb01rst\n appeared.\nMaternal\n hypertension\n (systolic\n blood\n pressure\n \u2265140\n mmHg\n or\ndiastolic\n blood\n pressure\n \u226590\n mmHg),\n albuminuria\n or\n edema,\n and\nanemia\n were\n examined\n as\n prenatal\n factors.\n The\n birth\n weight,\n head\nand\n chest\n circumference,\n duration\n of\n labor,\n delivery\n method\n (nor-\nmal\n delivery,\n cesarean\n section,\n and\n obstetrical\n vacuum\n extraction\nor\n forceps\n delivery),\n and\n Apgar\n score\n were\n examined\n as\n perina-\ntal\n and\n neonatal\n factors.\n Hypertension,\n albuminuria\n or\n edema,\n and\nanemia\n were\n recorded\n using\n a\n two-category\n scale\n (yes/no),\n and\n the\nApgar\n score\n was\n recorded\n as\n an\n ordinal\n variable.\n Duration\n of\n labor,\nbirth\n weight,\n and\n head\n and\n chest\n circumference\n were\n handled\n as\ncontinuous\n variables.", "mimetype": "text/plain", "start_char_idx": 11231, "end_char_idx": 12797, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "07378c42-9506-4173-891f-7719a5676e13": {"__data__": {"id_": "07378c42-9506-4173-891f-7719a5676e13", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d9dd3f07-7c23-4ad9-85ca-fc7f4abb0232", "node_type": "1", "metadata": {}, "hash": "e838a813ebeb305be440db2fa5256d4586e852920b5bfe471f86c5ad02812cb8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c93b98e1-ded6-46d9-b143-e99e3cc5b8c6", "node_type": "1", "metadata": {}, "hash": "0f1f09a49d4298bcfaf63c13b338d0b32f4210c5ff74b2e4a1bbc526250465ab", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Duration\n of\n labor,\nbirth\n weight,\n and\n head\n and\n chest\n circumference\n were\n handled\n as\ncontinuous\n variables.\n The\n delivery\n method\n was\n recorded\n using\n a\ntwo-category\n scale\n (performed/not\n performed)\n for\n each\n delivery\ntechnique.\n2.3.\n Selection\n of\n case\n children\n and\n matched\n control\n children\nAmong\n the\n patients\n who\n initially\n consulted\n the\n clinic\n between\nApril\n 1997\n and\n March\n 2011,\n 1875\n cases\n of\n ASD\n were\n identi\ufb01ed.\nOf\n these,\n 89\n cases\n were\n excluded\n because\n the\n MCH\n handbook\n was\nmissing\n or\n the\n vaccination\n record\n in\n the\n handbook\n could\n not\n be\nread,\n and\n 3\n were\n excluded\n because\n they\n had\n received\n MMR\n vac-\ncination\n overseas.\n Of\n the\n remaining\n 1783\n cases,\n 1429\n were\n born\nbefore\n March\n 1984\n or\n after\n May\n 1992,\n leaving\n 354\n cases\n (males:\nn\n =\n 286,\n 80.8%)\n born\n between\n April\n 1984\n and\n April\n 1992,\n the\n pos-\nsible\n time\n period\n for\n MMR\n vaccination.\n The\n ASD\n group\n consisted\nof\n 280\n subjects\n with\n Autistic\n disorder\n (79.1%),\n 27\n subjects\n with\nAsperger\n disorder\n (7.6%),\n and\n 47\n subjects\n with\n Pervasive\n develop-\nmental\n disorder\n not\n otherwise\n speci\ufb01ed\n (13.3%).\n4294\nY.\n Uno\n et\n al.\n /\n Vaccine\n 30 (2012) 4292\u2013\n 4298\nFig.\n 1.\n Numbers\n of\n potential\n cases\n and\n controls\n identi\ufb01ed,\n excluded,\n and\n included\n in\n analysis.\n YPDC,\n Yokohama\n Psycho-Developmental\n Clinic;\n ASD,\n autism\n spectrum\n disorder;\nMCH\n handbook,\n maternal\n and\n child\n health\n handbook;\n MMR,\n measles\u2013mumps\u2013rubella\n vaccine.", "mimetype": "text/plain", "start_char_idx": 12682, "end_char_idx": 14189, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c93b98e1-ded6-46d9-b143-e99e3cc5b8c6": {"__data__": {"id_": "c93b98e1-ded6-46d9-b143-e99e3cc5b8c6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "07378c42-9506-4173-891f-7719a5676e13", "node_type": "1", "metadata": {}, "hash": "609e6e6237d6b1687e067ac39cd41746fe195209e27e5e3521a3c2883777b5f6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f50a5b2b-ada5-4cc3-bda1-f064062f7841", "node_type": "1", "metadata": {}, "hash": "eac0c9eee8bdee47bcf3e96c46e9607d692cd481737bb68d9b1d107b63db03e9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "YPDC,\n Yokohama\n Psycho-Developmental\n Clinic;\n ASD,\n autism\n spectrum\n disorder;\nMCH\n handbook,\n maternal\n and\n child\n health\n handbook;\n MMR,\n measles\u2013mumps\u2013rubella\n vaccine.\nAs\n controls,\n 252\n subjects\n from\n the\n general\n school\n population\nwere\n recruited\n into\n the\n present\n study.\n Of\n these,\n 28\n cases\n were\n sub-\nsequently\n excluded\n because\n the\n MCH\n handbook\n was\n missing\n or\nthe\n vaccination\n record\n could\n not\n be\n read.\n The\n goal\n was\n to\n have\na\n matched\n control\n for\n each\n case.\n However,\n since\n there\n were\n not\nenough\n controls\n to\n match\n to\n all\n cases,\n 189\n subjects\n were\n chosen\nrandomly\n from\n the\n ASD\n group\n as\n a\n case\n group.\n The\n controls\n were\nindividually\n matched\n to\n cases\n by\n age\n and\n sex.\n There\n were\n 189\n cases,\nmean\n age\n 22.6\n years\n (SD\n 2.2),\n and\n 224\n controls,\n mean\n age\n 22.6\n years\n(SD\n 2.2),\n with\n case-to-control\n ratios\n ranging\n from\n 1:1\n to\n 1:2\n (Fig.\n 1).\n2.4.\n Statistical\n analysis\n2.4.1.\n Analysis\n 1\nDuration\n of\n labor\n was\n divided\n into\n 2\n categories\n of\n normal\n (\u226420\n h)\nversus\n prolonged\n labor\n (>20\n h).\n Because\n an\n Apgar\n score\n of\n less\n than\n7\n has\n been\n associated\n with\n increased\n ASD\n risk\n [45\u201348],  the\n Apgar\nscore\n was\n divided\n into\n 2\n categories\n of\n normal\n (\u22657\n points)\n and\n low\n(<7\n points).", "mimetype": "text/plain", "start_char_idx": 14013, "end_char_idx": 15311, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f50a5b2b-ada5-4cc3-bda1-f064062f7841": {"__data__": {"id_": "f50a5b2b-ada5-4cc3-bda1-f064062f7841", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c93b98e1-ded6-46d9-b143-e99e3cc5b8c6", "node_type": "1", "metadata": {}, "hash": "0f1f09a49d4298bcfaf63c13b338d0b32f4210c5ff74b2e4a1bbc526250465ab", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "36d2be3d-805f-49f5-a081-8e153c0b2f2e", "node_type": "1", "metadata": {}, "hash": "fbaebc06b0751da716807d5d746facf0b762e3e1412c2b25d169a7d42f351b1e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In\n order\n to\n compare\n the\n backgrounds\n of\n the\n cases\n and\ncontrols,\n the\n crude\n odds\n ratios\n (ORs)\n and\n 95%\n con\ufb01dence\n intervals\n(CIs)\n were\n determined\n for\n each\n outcome.\n The\n relationship\n between\nASD\n onset\n and\n the\n total\n number\n of\n vaccine\n injections\n was\n also\ninvestigated.\n The\n crude\n ORs\n and\n 95%\n CI\n were\n determined\n for\n each.\nThe\n differences\n in\n the\n mean\n values\n of\n the\n quantitative\n variables\nbetween\n cases\n and\n controls\n were\n examined\n by\n an\n unpaired\n t-test.\nWhen\n necessary,\n the\n t-test\n was\n modi\ufb01ed\n for\n unequal\n variances.\n2.4.2.\n Analysis\n 2\nBecause\n this\n study\n was\n only\n concerned\n with\n the\n theoretical\nincrease\n in\n the\n risk\n of\n ASD\n onset\n due\n to\n the\n MMR\n vaccine\n injection,\na\n conditional\n logistic\n model\n was\n applied\n to\n evaluate\n the\n ORs\n of\nMMR\n vaccination\n after\n adjusting\n for\n other\n risk\n factors.\n2.4.3.\n Analysis\n 3\nThe\n OR\n of\n the\n total\n number\n of\n vaccine\n injections\n after\n adjusting\nfor\n other\n risk\n factors\n was\n evaluated\n with\n the\n conditional\n logistic\nmodel.\n2.4.4.\n Power\n analysis\nPower\n analysis\n was\n performed\n in\n accordance\n to\n general\n power\ncalculation\n model\n for\n chi\n squared\n statistics,\n t-test,\n and\n a\n condi-\ntional\n multiple\n regression\n model.\n In\n brief,\n power\n is\n determined\nwith\n respect\n to\n degree\n of\n freedom\n and\n prede\ufb01ned\n alpha\n level\n of\n the\nstudy\n (0.05),\n number\n of\n predictors\n (in\n case\n of\n a\n conditional\n multiple\nregression\n model,\n 4)\n after\n assuming\n effect\n size\n (in\n accordance\n with\nCohen\u2019s\n criteria).", "mimetype": "text/plain", "start_char_idx": 15313, "end_char_idx": 16863, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "36d2be3d-805f-49f5-a081-8e153c0b2f2e": {"__data__": {"id_": "36d2be3d-805f-49f5-a081-8e153c0b2f2e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f50a5b2b-ada5-4cc3-bda1-f064062f7841", "node_type": "1", "metadata": {}, "hash": "eac0c9eee8bdee47bcf3e96c46e9607d692cd481737bb68d9b1d107b63db03e9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c8ccd7db-97f5-4b90-b3ab-cc46c3619b1c", "node_type": "1", "metadata": {}, "hash": "e00505def544224b1c5a615b477b4259b9669eea17d25e943a5b6c1460d13c39", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Analysis\n 1\n was\n performed\n using\n SPSS\n 17.0\n for\n Japan,\n and\n Anal-\nyses\n 2\n and\n 3\n used\n the\n HALBAU\n 7.\n ORs\n were\n considered\n signi\ufb01cant\nwhen\n the\n lower\n 95%\n CI\n exceeded\n 1.0.\n The\n t-tests\n were\n two-sided,\nand\n signi\ufb01cance\n was\n de\ufb01ned\n as\n p\n <\n 0.05.\n For\n power\n calculation\nG*power\n v3.1\n was\n used.\n2.5.\n Ethical\n considerations\nThis\n study\n was\n approved\n by\n the\n ethics\n committee\n at\n Nagoya\nUniversity.\n All\n data\n used\n in\n this\n study\n were\n clinical\n data\n obtained\nin\n the\n course\n of\n conventional\n diagnosis\n and\n therapy,\n and\n cooper-\nation\n in\n the\n study\n placed\n no\n burden\n on\n individual\n patients.\n The\nparents\n or\n legal\n guardians\n of\n all\n of\n the\n children\n in\n the\n control\n group\nprovided\n their\n written,\n informed\n consent\n to\n participate.\n Personal\ninformation\n regarding\n subjects\n in\n this\n study\n and\n the\n resulting\n data\nY.\n Uno\n et\n al.\n /\n Vaccine\n 30 (2012) 4292\u2013\n 4298\n4295\nTable 1\nThe\n proportions\n and\n crude\n odds\n ratios\n (ORs)\n and\n 95%\n con\ufb01dence\n intervals\n (CI)\n for\n ASD\n according\n to\n vaccines,\n prenatal\n factors,\n perinatal\n factors\n and\n neonatal\n factors.\nVariable\n category\n \nn\n (%)\n \nORs\n \n95%\n CI\n \np-Value\nCases\n (n\n = 189)\n \nControls\n (n\n =\n 224)\nVaccines\nMMR\n \n47\n (24.9)\n \n54\n (24.1)\n \n1.04\n \n0.65\u20131.68\n \n.86\nMeasles\n126\n (66.7)\n141\n (62.9)\n1.18\n0.77\u20131.80\n \n.43\nMumps\n110\n (58.", "mimetype": "text/plain", "start_char_idx": 16864, "end_char_idx": 18220, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c8ccd7db-97f5-4b90-b3ab-cc46c3619b1c": {"__data__": {"id_": "c8ccd7db-97f5-4b90-b3ab-cc46c3619b1c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "36d2be3d-805f-49f5-a081-8e153c0b2f2e", "node_type": "1", "metadata": {}, "hash": "fbaebc06b0751da716807d5d746facf0b762e3e1412c2b25d169a7d42f351b1e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4c848230-58af-4f84-8f15-627bbf357a63", "node_type": "1", "metadata": {}, "hash": "9e23e8ff4313d8aa412ffc8a4c4002f9e2ec9785c3cdb56458ed868b958f355c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "65\u20131.68\n \n.86\nMeasles\n126\n (66.7)\n141\n (62.9)\n1.18\n0.77\u20131.80\n \n.43\nMumps\n110\n (58.2)\n110\n (49.1)\n \n1.44\n \n0.96\u20132.17\n \n.06\nRubella\n108\n (57.1)\n \n120\n (53.6)\n \n1.16\n \n0.77\u20131.74\n \n.47\nDPT\n \n185\n (97.9)\n \n219\n (97.8)\n \n1.06\n \n0.24\u20134.75\n \n.94\nPolio\n \n184\n (97.4)\n \n221\n (98.7)\n \n0.5\n \n0.09\u20132.43\n \n.73\nB-encephalitis\n \n167\n (88.4)\n \n206\n (92.0)\n \n0.66\n \n0.33\u20131.34\n \n.22\nBCG\n182\n (96.3)\n218\n (97.3)\n0.72\n0.21\u20132.42\n \n.55\nPrenatal\n factors\nMaternal\n hypertension\n6\n (3.2)\n \n3\n (1.3)\n \n2.42\n \n0.53\u201312.36\n \n.20\nAlbuminuria,\n edema\n \n18\n (9.5)\n \n19\n (8.5)\n \n1.13\n \n0.55\u20132.35\n \n.71\nAnemia\n59\n (31.2)\n \n69\n (30.8)\n \n1.02\n \n0.66\u20131.58\n \n.93\nPerinatal\n and\n neonatal\n factors\nProlonged\n labor\n (>20\n h)a\n8/169\n (4.7)\n \n9/200\n (4.5)\n \n1.06\n \n0.36\u20133.06\n \n.92\nMethod\n of\n delivery\nCesarean\n section\n \n21\n (11.1)\n \n24\n (10.7)\n \n1.04\n \n0.54\u20132.02\n \n.90\nObstetrical\n vacuum\n extraction\n or\n forceps\n deliverya\n23/168\n (13.7)\n \n22/200\n (11.0)\n \n1.28\n \n0.66\u20132.", "mimetype": "text/plain", "start_char_idx": 18138, "end_char_idx": 19072, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4c848230-58af-4f84-8f15-627bbf357a63": {"__data__": {"id_": "4c848230-58af-4f84-8f15-627bbf357a63", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c8ccd7db-97f5-4b90-b3ab-cc46c3619b1c", "node_type": "1", "metadata": {}, "hash": "e00505def544224b1c5a615b477b4259b9669eea17d25e943a5b6c1460d13c39", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fe9b0c82-9b44-4f87-b4ca-45b78ed44eec", "node_type": "1", "metadata": {}, "hash": "8fba094ad4f97780540ba208433babdf912bee253a6575a7ef5c07707897a04a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "90\nObstetrical\n vacuum\n extraction\n or\n forceps\n deliverya\n23/168\n (13.7)\n \n22/200\n (11.0)\n \n1.28\n \n0.66\u20132.51\n \n.43\nLow\n Apgar\n score\n (<7)\n6\n (3.2)\n2\n (0.9)\n3.64\n0.66\u201326.39\n \n.09\nORs,\n odds\n ratios;\n CI,\n con\ufb01dence\n intervals;\n ASD,\n autism\n spectrum\n disorder;\n MMR,\n measles\u2013mumps\u2013rubella\n vaccines;\n DPT,\n diphtheria\u2013pertussis\u2013tetanus\n vaccines;\n BCG,\n Bacillus\nof\n Calmette\n and\n Guerin\n vaccine.\na There\n were\n 20\n cases\n and\n 24\n controls\n who\n did\n a\n cesarean\n section,\n and\n 1\n case\n who\n did\n a\n cesarean\n section\n because\n of\n prolonged\n labor.\n Thus,\n They\n were\n excluded\n from\npopulation\n of\n prolonged\n labor\n and\n obstetrical\n vacuum\n extraction\n or\n forceps\n delivery.\nwere\n rendered\n anonymous,\n and\n analyses\n were\n performed\n using\nonly\n quantitative\n data\n that\n could\n not\n be\n linked\n to\n any\n particular\nsubject.\n3.\n Results\n3.1.\n Vaccination\n rate\n and\n time\n of\n exposure\n to\n vaccines\nThe\n vaccination\n rates\n in\n cases\n and\n controls\n were\n as\n follows:\nMMR,\n 24.9%\n of\n cases\n and\n 24.1%\n of\n controls;\n Measles,\n 66.7%\n and\n62.9%;\n Mumps,\n 58.2%\n and\n 49.1%;\n Rubella,\n 57.1%\n and\n 53.6%;\n DPT,\n97.9%\n and\n 97.8%;\n Polio,\n 97.4%\n and\n 98.7%;\n B-encephalitis,\n 88.4%\n and\n92.0%,\n and\n BCG\n 96.3%\n and\n 97.3%\n (Table\n 1).", "mimetype": "text/plain", "start_char_idx": 18965, "end_char_idx": 20215, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fe9b0c82-9b44-4f87-b4ca-45b78ed44eec": {"__data__": {"id_": "fe9b0c82-9b44-4f87-b4ca-45b78ed44eec", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4c848230-58af-4f84-8f15-627bbf357a63", "node_type": "1", "metadata": {}, "hash": "9e23e8ff4313d8aa412ffc8a4c4002f9e2ec9785c3cdb56458ed868b958f355c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0bbbc694-5a47-4aa9-a5e2-43c00e9111ca", "node_type": "1", "metadata": {}, "hash": "be102e9bb98240e7cd880e2bfe6455bc1721ee79a7a8ccc271aad87f56ec9578", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\n mean\n times\n of\n each\nvaccine\n injection\n in\n cases\n and\n controls\n were\n as\n follows:\n DPT,\n 3.8\ntimes\n of\n cases\n and\n 3.7\n times\n of\n controls;\n Polio,\n 1.9\n times\n and\n 2.0\ntimes;\n B-encephalitis,\n 1.7\n times\n and\n 1.8\n times\n (Table\n 2).\n3.2.\n Analysis\n3.2.1.\n Analysis\n 1\nFor\n each\n vaccination,\n the\n ORs\n of\n cases\n versus\n controls\n were\n as\nfollows\n (no\n signi\ufb01cant\n differences\n were\n found):\n MMR,\n 1.04\n (95%\nCI,\n 0.65\u20131.68);\n Measles,\n 1.18\n (95%\n CI,\n 0.77\u20131.80);\n Mumps,\n 1.44\n(95%\n CI,\n 0.96\u20132.17);\n Rubella,\n 1.16\n (95%\n CI,\n 0.77\u20131.74);\n DPT,\n 1.06\n(95%\n CI,\n 0.24\u20134.75);\n Polio,\n 0.50\n (95%\n CI,\n 0.09\u20132.43);\n B-encephalitis,\n0.66\n (95%\n CI,\n 0.33\u20131.34);\n and\n BCG,\n 0.72\n (95%\n CI,\n 0.21\u20132.42).\n Mater-\nnal\n hypertension\n as\n a\n prenatal\n factor\n had\n an\n OR\n of\n 2.42\n (95%\n CI,\n0.53\u201312.36),\n but\n no\n signi\ufb01cant\n difference\n was\n found\n between\n cases\nand\n controls.\n For\n the\n other\n factors\n as\n well,\n cases\n did\n not\n have\nTable\n 2\nThe\n comparison\n of\n the\n times\n of\n vaccine\n injection\n between\n cases\n and\n controls.", "mimetype": "text/plain", "start_char_idx": 20217, "end_char_idx": 21268, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0bbbc694-5a47-4aa9-a5e2-43c00e9111ca": {"__data__": {"id_": "0bbbc694-5a47-4aa9-a5e2-43c00e9111ca", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fe9b0c82-9b44-4f87-b4ca-45b78ed44eec", "node_type": "1", "metadata": {}, "hash": "8fba094ad4f97780540ba208433babdf912bee253a6575a7ef5c07707897a04a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3de153b9-08a1-44f3-b4c3-44403dac8f80", "node_type": "1", "metadata": {}, "hash": "6b05a9c1fddfe6d30c937106b2da7160e047ebdedd6b059bc8c89c00ef2181d0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For\n the\n other\n factors\n as\n well,\n cases\n did\n not\n have\nTable\n 2\nThe\n comparison\n of\n the\n times\n of\n vaccine\n injection\n between\n cases\n and\n controls.\nVaccines\n \nCases\n \nControls\n \np-Value\nMean\n (\u00b1SD)\nMean\n (\u00b1SD)\nDPT\n \n3.8\n (\u00b10.8)\n \n3.7\n (\u00b10.7)\n \n.78a\nPolio\n \n1.9\n (\u00b10.3)\n \n2.0\n (\u00b10.3)\n \n.34b\nB-encephalitis\n1.7\n (\u00b10.7)\n \n1.8\n (\u00b10.6)\n \n.06b\nDPT,\n diphtheria\u2013pertussis\u2013tetanus\n vaccines.\na Student\u2019s\n t-test.\nb Welch\u2019s\n t-test.\nsigni\ufb01cantly\n higher\n ORs\n than\n controls.\n As\n a\n perinatal\n and\n neona-\ntal\n factor,\n low\n Apgar\n score\n and\n obstetrical\n vacuum\n extraction\n or\nforceps\n delivery\n had\n an\n OR\n of\n 3.64\n (95%\n CI,\n 0.66\u201326.39)\n and\n 1.28\n(95%\n CI,\n 0.66\u20132.51),\n respectively,\n but\n no\n signi\ufb01cant\n difference\n was\nfound\n between\n cases\n and\n controls.\n No\n other\n perinatal\n and\n neonatal\nfactors\n showed\n signi\ufb01cant\n differences\n between\n cases\n and\n controls\n(Table\n 1).\nA\n t-test\n was\n performed\n on\n the\n mean\n values\n of\n the\n times\n of\n expo-\nsure\n to\n DPT,\n Polio,\n and\n B-encephalitis,\n birth\n weight\n and\n head\n and\nchest\n circumference\n between\n cases\n and\n controls,\n and\n no\n signi\ufb01-\ncant\n differences\n were\n found\n (p\n >\n 0.05\n for\n all).\n The\n minimum\n number\nof\n vaccine\n injections\n was\n 3,\n and\n the\n maximum\n was\n 13.", "mimetype": "text/plain", "start_char_idx": 21113, "end_char_idx": 22366, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3de153b9-08a1-44f3-b4c3-44403dac8f80": {"__data__": {"id_": "3de153b9-08a1-44f3-b4c3-44403dac8f80", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0bbbc694-5a47-4aa9-a5e2-43c00e9111ca", "node_type": "1", "metadata": {}, "hash": "be102e9bb98240e7cd880e2bfe6455bc1721ee79a7a8ccc271aad87f56ec9578", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9747d265-d890-4252-982e-eeecda1d86d3", "node_type": "1", "metadata": {}, "hash": "3f682de7461f0f4570123a300374c8719524f68d1cf879237b0b1b999fb7384c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\n minimum\n number\nof\n vaccine\n injections\n was\n 3,\n and\n the\n maximum\n was\n 13.\n The\n mean\n(standard\n deviation)\n number\n of\n vaccine\n injections\n of\n cases\n and\n con-\ntrols\n was\n 11.4\n (1.7)\n and\n 11.4\n (1.7),\n respectively,\n and\n there\n was\n no\nsigni\ufb01cant\n difference\n between\n cases\n and\n controls\n (t\n =\n 0.07,\n p\n =\n 0.94)\n(Tables\n 2\n and\n 3).\n3.2.2.\n Analysis\n 2\nMaternal\n hypertension,\n low\n Apgar\n score,\n and\n obstetrical\n vac-\nuum\n extraction\n or\n forceps\n delivery,\n which\n had\n higher\n ORs\n in\n the\nresults\n of\n Analysis\n 1,\n were\n investigated\n as\n confounding\n factors\n using\na\n conditional\n multiple\n regression\n model.\n With\n regard\n to\n the\n pres-\nence\n of\n ASD,\n MMR\n had\n an\n OR\n of\n 1.10\n (95%\n CI,\n 0.64\u20131.90),\n and\nmaternal\n hypertension,\n low\n Apgar\n score,\n and\n obstetrical\n vacuum\nextraction\n or\n forceps\n delivery\n had\n ORs\n of\n 4.19\n (95%\n CI,\n 0.46\u201338.57),\n2.06\n (95%\n CI,\n 0.18\u201322.12)\n and\n 0.98\n (95%\n CI,\n 0.50\u20131.92),\n respectively.\nThere\n were\n no\n signi\ufb01cant\n differences\n (Table\n 4).\nTable\n 3\nThe\n comparison\n of\n quantitative\n variables\n between\n cases\n and\n controls.", "mimetype": "text/plain", "start_char_idx": 22284, "end_char_idx": 23391, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9747d265-d890-4252-982e-eeecda1d86d3": {"__data__": {"id_": "9747d265-d890-4252-982e-eeecda1d86d3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3de153b9-08a1-44f3-b4c3-44403dac8f80", "node_type": "1", "metadata": {}, "hash": "6b05a9c1fddfe6d30c937106b2da7160e047ebdedd6b059bc8c89c00ef2181d0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e865cdb3-5993-4174-89ce-86726dbb290e", "node_type": "1", "metadata": {}, "hash": "d897b863cb78f52c459dc1a319fa0906373e35d37641e59aea7ebf6272e71b4c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "There\n were\n no\n signi\ufb01cant\n differences\n (Table\n 4).\nTable\n 3\nThe\n comparison\n of\n quantitative\n variables\n between\n cases\n and\n controls.\nVariables\n \nCases\n \nControls\n \np-Value\nMean\n (\u00b1SD)\n \nMean\n (\u00b1SD)\nBirth\n weight\n (g)\n \n3085.7\n (\u00b1454.1)\n \n3109.4\n (\u00b1479.0)\n \n.62a\nHead\n circumference\n (cm)\n33.5\n (\u00b12.3)\n \n33.6\n (\u00b13.0)\n \n.88b\nChest\n circumference\n (cm)\n \n32.3\n (\u00b12.2)\n \n32.3\n (\u00b12.7)\n \n.90a\nThe\n number\n of\n vaccine\ninjections\n (shots)\n11.4\n (\u00b11.7)\n \n11.4\n (\u00b11.7)\n \n.94a\na Student\u2019s\n t-test.\nb Welch\u2019s\n t-test.\n4296\nY.\n Uno\n et\n al.\n /\n Vaccine\n 30 (2012) 4292\u2013\n 4298\nTable 4\nOdds\n ratios\n and\n 95%\n con\ufb01dence\n intervals\n of\n MMR\n vaccination\n injection\n analyzed\nwith\n a\n conditional\n logistic\n model.\nFactor\nORs\n (95%\n CI)\np-Value\nMMR\n vaccination\n injection\n \n(\u2212)\n \n1\n(+)\n1.10\n (0.64\u20131.90)\n \n.72\nMaternal\n hypertension\n \n(\u2212)\n \n1\n(+)\n \n4.19\n (0.46\u201338.57)\n \n.21\nLow  Apgar\n score\n \n(\u2212)\n \n1\n(+)\n2.06\n (0.18\u201322.12)\n.57\nObstetrical\n vacuum\nextraction\n or\n forceps\ndelivery\n(\u2212)\n \n1\n(+)\n \n0.98\n (0.50\u20131.92)\n \n.96\nASD,\n autism\n spectrum\n disorder;\n MMR,\n measles\u2013mumps\u2013rubella\n vaccines;\n ORs,\n odds\nratios;\n 95%\n CI,\n 95%\n con\ufb01dence\n intervals.\n3.2.3.", "mimetype": "text/plain", "start_char_idx": 23252, "end_char_idx": 24402, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e865cdb3-5993-4174-89ce-86726dbb290e": {"__data__": {"id_": "e865cdb3-5993-4174-89ce-86726dbb290e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9747d265-d890-4252-982e-eeecda1d86d3", "node_type": "1", "metadata": {}, "hash": "3f682de7461f0f4570123a300374c8719524f68d1cf879237b0b1b999fb7384c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7b337b74-e084-41ad-8579-18c9983d9283", "node_type": "1", "metadata": {}, "hash": "398d6a83573195a1ed8021dcb11146830377a12d0d7d747a9f1a15651cf96dda", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3.2.3.\n Analysis\n 3\nThe\n number\n of\n vaccine\n injections\n had\n an\n OR\n of\n 1.10\n (95%\n CI,\n0.95\u20131.26)\n in\n a\n conditional\n multiple\n regression\n model\n using\n the\nsame\n confounding\n factors\n as\n for\n Analysis\n 2,\n maternal\n hyperten-\nsion\n (OR\n =\n 3.63,\n 95%\n CI,\n 0.40\u201333.19),\n low\n Apgar\n score\n (OR\n =\n 2.14,\n95%\n CI,\n 0.19\u201323.78),\n and\n obstetrical\n vacuum\n extraction\n or\n forceps\ndelivery\n (OR\n =\n 1.02,\n 95%\n CI,\n 0.52\u20131.99),\n and\n there\n was\n no\n signi\ufb01cant\ndifference\n between\n cases\n and\n controls\n (Table\n 5).\n3.2.4.\n Power\n analysis\nRegarding\n power\n analysis\n for\n chi\n square\n statistics\n and\n t-test,\nwhen\n effect\n size\n is\n set\n to\n medium\n (in\n accordance\n to\n Cohen\u2019s\n crite-\nria),\n both\n samples\n that\n are\n characterized\n in\n our\n research\n had\n more\nthan\n 80%\n power\n for\n detecting\n association,\n respectively.\n However,\nin\n case,\n size\n effect\n is\n set\n to\n small,\n calculated\n power\n were\n 52%\n at\n chi\nsquare\n statistics\n and\n 53%\n at\n t-test.\n Similarly,\n regarding\n a\n conditional\nmultiple\n regression\n model,\n our\n sample\n had\n more\n than\n 80%\n of\n power\nfor\n detecting\n association\n in\n case\n of\n medium\n effect\n size.\n However\n in\ncase,\n size\n effect\n is\n set\n to\n small,\n calculated\n power\n was\n 56%.\n4.\n Discussion\nThe\n three\n previous\n case\u2013control\n studies\n focused\n on\n the\n rela-\ntionship\n between\n ASD\n and\n MMR.\n Speci\ufb01cally,\n the\n investigation\n of\nDeStefano\n et\n al.", "mimetype": "text/plain", "start_char_idx": 24396, "end_char_idx": 25802, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7b337b74-e084-41ad-8579-18c9983d9283": {"__data__": {"id_": "7b337b74-e084-41ad-8579-18c9983d9283", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e865cdb3-5993-4174-89ce-86726dbb290e", "node_type": "1", "metadata": {}, "hash": "d897b863cb78f52c459dc1a319fa0906373e35d37641e59aea7ebf6272e71b4c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cab4667c-04ef-400d-bb83-67649ee0f937", "node_type": "1", "metadata": {}, "hash": "2737f1f224ebdfb8c050f7d1301cf7f65530d10fd4e338f9ee8240cc4b46109f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Speci\ufb01cally,\n the\n investigation\n of\nDeStefano\n et\n al.\n was\n based\n on\n the\n Metropolitan\n Atlanta\n Develop-\nmental\n Disabilities\n Surveillance\n Program\n [31];\n Smeeth\n et\n al.\n used\ndata\n from\n the\n UK\n General\n Practice\n Research\n Database\n [32];\n and\nDeWilde\n et\n al.\n examined\n the\n association\n using\n the\n UK\n Doctors\u2019\nIndependent\n Network\n Database\n [33].\n The\n aforementioned\n studies\nTable\n 5\nOdds\n ratios\n of\n one\n measure\n and\n 95%\n con\ufb01dence\n intervals\n of\n the\n number\n of\n vaccine\ninjections\n analyzed\n with\n a\n conditional\n logistic\n model.\nFactor\n \nORs\n (95%\n CI)\n \np-Value\nThe\n number\n of\n vaccine\ninjections\n(\u2212)\n \n1\n(+) \n1.10a (0.95\u20131.26)\n \n.19\nMaternal\n hypertension\n(\u2212)\n \n1\n(+)\n \n3.63\n (0.40\u201333.19)\n \n.25\nLow  Apgar\n score\n(\u2212) \n1\n(+)\n \n2.14\n (0.19\u201323.78)\n \n.54\nObstetrical\n vacuum\nextraction\n or\n forceps\ndelivery\n(\u2212)\n \n1\n(+)\n1.02\n (0.52\u20131.99)\n \n.96\nASD,\n autism\n spectrum\n disorder;\n ORs,\n odds\n ratios;\n 95%\n CI,\n 95%\n con\ufb01dence\n intervals.\na OR\n of\n the\n number\n of\n vaccine\n injections\n means\n OR\n of\n increasing\n one\n injection\n of\nvaccine.\nprovided\n no\n epidemiological\n evidence\n for\n a\n causal\n association.\n The\npresent\n study\n is\n the\n \ufb01rst\n case\u2013control\n study\n in\n Asia\n investigating\nthe\n relationship\n between\n a\n variety\n of\n vaccines\n including\n MMR\n and\nthe\n risk\n of\n ASD\n onset.\nThese\n previous\n studies\n were\n conducted\n using\n relatively\n het-\nerogeneous\n samples\n in\n terms\n of\n genetic\n makeup.", "mimetype": "text/plain", "start_char_idx": 25747, "end_char_idx": 27185, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cab4667c-04ef-400d-bb83-67649ee0f937": {"__data__": {"id_": "cab4667c-04ef-400d-bb83-67649ee0f937", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7b337b74-e084-41ad-8579-18c9983d9283", "node_type": "1", "metadata": {}, "hash": "398d6a83573195a1ed8021dcb11146830377a12d0d7d747a9f1a15651cf96dda", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "94e39d20-fc08-4e86-8638-3123a29b7b30", "node_type": "1", "metadata": {}, "hash": "0371ff0986ba147ad3a49603098056fa493b47bf4bd0428d0b91ae6d6287b010", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "These\n previous\n studies\n were\n conducted\n using\n relatively\n het-\nerogeneous\n samples\n in\n terms\n of\n genetic\n makeup.\n Conversely,\n the\nJapanese\n population\n is\n thought\n to\n be\n highly\n homogenous\n on\n the\ngenetic\n level\n (which\n gives\n us\n the\n opportunity\n to\n minimize\n the\n effect\nof\n population-speci\ufb01c\n risk\n factors\n that\n might\n interact\n with\n envi-\nronmental\n exposures\n (i.e.\n immunization)),\n and\n almost\n all\n Japanese\nparents\n have\n an\n MCH\n handbook.\n The\n fact\n that\n highly\n reliable\n infor-\nmation\n concerning\n the\n pregnancy,\n perinatal,\n and\n neonatal\n periods\nis\n collected\n in\n the\n handbook\n was\n advantageous\n for\n conducting\n this\nresearch.\nIn\n this\n study,\n we  could\n not\n \ufb01nd\n the\n evidence\n that\n MMR\n vac-\ncination\n increases\n the\n risk\n of\n ASD\n onset.\n The\n present\n results\nsupport\n the\n \ufb01ndings\n from\n the\n previous\n case\u2013control\n studies\n con-\nducted\n in\n Caucasian\n populations.\n Furthermore,\n we\n could\n not\n \ufb01nd\nany\n evidences\n that\n other\n types\n of\n vaccines\n or\n a combined\n effect\nof\n multiple\n vaccines\n was\n associated\n with\n ASD\n onset.\n Therefore,\nthis\n study\n did\n not\n support\n the\n theory\n that\n vaccinations\n should\nbe\n avoided\n to\n reduce\n the\n risk\n of\n ASD\n onset.\n We  should\n be\nmore\n concerned\n about\n acquiring\n infectious\n diseases\n by\n avoiding\nvaccinations.\nIn\n the\n results\n of\n this\n study,\n the\n 95%\n CIs\n of\n vaccinations,\n espe-\ncially\n DPT,\n Polio,\n and\n BCG\n had\n a\n wide\n range\n because\n of\n small\n power.\nThe\n sample\n size\n was\n not\n large\n enough\n to\n absolutely\n exclude\n the\npossibility\n that\n DPT,\n Polio,\n and\n BCG\n vaccinations\n increased\n the\nrisk\n of\n ASD\n onset.", "mimetype": "text/plain", "start_char_idx": 27066, "end_char_idx": 28709, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "94e39d20-fc08-4e86-8638-3123a29b7b30": {"__data__": {"id_": "94e39d20-fc08-4e86-8638-3123a29b7b30", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cab4667c-04ef-400d-bb83-67649ee0f937", "node_type": "1", "metadata": {}, "hash": "2737f1f224ebdfb8c050f7d1301cf7f65530d10fd4e338f9ee8240cc4b46109f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1d13d7b6-69d7-4297-a9e7-3403e3534496", "node_type": "1", "metadata": {}, "hash": "e9bf979b53aba1bbb96f82d6cbd530b45217675ce603fadc48c68ad15aeafc25", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Additionally,\n there\n were\n no\n theories\n about\n an\nincrease\n in\n the\n risk\n of\n ASD\n onset\n concerns\n with\n any\n single\n types\nof\n vaccine\n injection\n that\n were\n included\n in\n this\n study,\n other\n than\nthe\n MMR\n vaccine.\n Then\n a\n conditional\n logistic\n model\n was\n applied\nnot\n to\n DPT,\n Polio,\n and\n BCG,\n but\n to\n MMR\n which\n was\n more\n con-\ncerned\n with\n the\n risk\n of\n ASD\n onset.\n This\n study\n was\n limited\n to\n data\nfrom\n the\n MCH\n handbook,\n which\n from\n the\n viewpoint\n of\n conduct-\ning\n an\n investigation\n is\n a\n highly\n reliable\n vaccination\n data\n source.\n On\none\n hand\n we  believe\n we  have\n obtained\n very\n reliable\n results.\n How-\never,\n on\n the\n other\n hand,\n the\n information\n in\n this\n handbook\n does\n not\ninclude\n several\n factors\n which\n were\n known\n to\n increase\n the\n risk\n of\nASD\n onset,\n such\n as\n parental\n age\n at\n birth,\n bleeding,\n birth\n order,\n pre-\nvious\n fetal\n loss,\n maternal\n prenatal\n medication\n use\n exclusively\n for\nhypertension\n and\n maternal\n toxaemia\n which\n were\n included\n in\n this\nstudy\n [49], and\n coexisting\n conditions\n that\n may\n in\ufb02uence\n vaccina-\ntions\n received,\n for\n example\n cardiovascular\n disease,\n other\n physical\ndiseases\n or\n anomaly,\n epilepsy,\n or\n allergy.\n We  were\n not\n able\n to\ninvestigate\n such\n conditions\n in\n controls\n because\n of\n the\n nature\n of\nthe\n data\n collection\n procedure,\n which\n involved\n community-based\nsampling.\n Moreover,\n the\n relationship\n is\n unclear\n between\n the\n time\nperiods\n when\n ASD\n was\n diagnosed\n and\n when\n the\n child\n was\n vacci-\nnated.", "mimetype": "text/plain", "start_char_idx": 28711, "end_char_idx": 30251, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1d13d7b6-69d7-4297-a9e7-3403e3534496": {"__data__": {"id_": "1d13d7b6-69d7-4297-a9e7-3403e3534496", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "94e39d20-fc08-4e86-8638-3123a29b7b30", "node_type": "1", "metadata": {}, "hash": "0371ff0986ba147ad3a49603098056fa493b47bf4bd0428d0b91ae6d6287b010", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "20b55d25-d125-42b8-80b0-db7781694664", "node_type": "1", "metadata": {}, "hash": "707d4e412163d1fb2d4134c9a3ef439c3cc0a0a93e18f1e9c20a0acd23e861d3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Moreover,\n the\n relationship\n is\n unclear\n between\n the\n time\nperiods\n when\n ASD\n was\n diagnosed\n and\n when\n the\n child\n was\n vacci-\nnated.\n It\n has\n been\n hypothesized\n that\n early\n exposure\n to\n thimerosal\nand\n immune\n globulin\n preparations\n in\ufb02uence\n neuropsychological\nde\ufb01cits\n in\n children\n include\n ASD\n [16,50]. Additionally,\n it\n is\n possi-\nble\n that\n parents\n lost\n motivation\n regarding\n vaccination\n before\n ASD\nwas\n diagnosed\n because\n of\n problems\n such\n as\n the\n child\u2019s\n inability\nto\n sit\n still\n or\n frequent\n tantrums.\n Even\n so,\n both\n groups\n showed\n a\nhigh\n vaccination\n rate\n for\n each\n of\n the\n vaccines,\n and\n because\n the\nmain\n topic\n of\n this\n study\n was\n to\n investigate\n whether\n vaccination\nincreases\n the\n risk\n of\n ASD\n onset,\n we\n believe\n these\n effects\n can\n be\nignored.\nIn\n future\n studies\n on\n vaccination\n and\n ASD,\n investigations\n with\nlarger\n sample\n sizes\n are\n expected,\n and\n we\n anticipate\n examining\n fac-\ntors\n which\n were\n known\n to\n increase\n the\n risk\n of\n ASD\n onset,\n coexisting\nconditions\n that\n may\n in\ufb02uence\n vaccination,\n such\n as\n cardiovascular\ndisease,\n other\n physical\n diseases\n or\n anomaly,\n epilepsy,\n or\n aller-\ngies,\n the\n age\n at\n ASD\n diagnosis\n and\n vaccines\n injection,\n and\n reasons\nwhy vaccinations\n were\n not\n performed.\n We  also\n look\n forward\n to\nY.\n Uno\n et\n al.\n /\n Vaccine\n 30 (2012) 4292\u2013\n 4298\n4297\nprospective\n studies\n that\n include\n pregnancy,\n delivery,\n or\n even\n pre-\nconception\n factors\n that\n may\n be\n associated\n with\n ASD.", "mimetype": "text/plain", "start_char_idx": 30112, "end_char_idx": 31623, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "20b55d25-d125-42b8-80b0-db7781694664": {"__data__": {"id_": "20b55d25-d125-42b8-80b0-db7781694664", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1d13d7b6-69d7-4297-a9e7-3403e3534496", "node_type": "1", "metadata": {}, "hash": "e9bf979b53aba1bbb96f82d6cbd530b45217675ce603fadc48c68ad15aeafc25", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "211dbb4c-78ba-437a-847c-5c153dbe7181", "node_type": "1", "metadata": {}, "hash": "4a354318362beb5c5c2e11307d14c36bd6a8a6c0171e0bb6da8cf7dbaf3d08ec", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In\n this\n study,\n we\n could\n not\n \ufb01nd\n any\n convincing\n evidence\n that\nMMR\n vaccination\n and\n increasing\n the\n number\n of\n vaccine\n injections\nwere\n associated\n with\n an\n increased\n risk\n of\n ASD\n in\n a\n genetically\nhomogeneous\n population.\n If\n such\n an\n association\n exists,\n it\n is\n so\n rare\nthat\n it\n could\n not\n be\n identi\ufb01ed\n in\n this\n large\n regional\n sample.\n There-\nfore,\n our\n \ufb01ndings\n indicate\n there\n is\n no\n basis\n for\n avoiding\n vaccination\nout\n of\n concern\n for\n ASD.\n This\n study\n investigated\n the\n link\n between\nvaccination\n and\n the\n risk\n of\n ASD,\n but\n it\n does\n not\n guarantee\n the\n safety\nor\n ef\ufb01cacy\n of\n the\n vaccines.\n Adverse\n reactions\n from\n vaccines\n other\nthan\n a\n link\n with\n ASD\n exist.\n Such\n adverse\n reactions\n must\n be\n studied,\nand\n safer\n and\n more\n effective\n vaccines\n must\n be\n developed.\n At\n one\ntime\n in\n Japan,\n mumps\n vaccine\n in\n the\n MMR\n vaccine\n caused\n several\ncases\n of\n aseptic\n meningitis.\n We  should\n continue\n to\n investigate\n the\nsafety\n and\n ef\ufb01cacy\n of\n vaccines\n carefully\n and\n the\n biological\n features\nof\n ASD\n in\n greater\n depth\n to\n improve\n outcomes\n related\n to\n long-term\nfunction\n and\n quality\n of\n life.\nAcknowledgments\nA\n part\n of\n this\n study\n is\n the\n result\n of\n research\n grants\n from\n the\n Min-\nistry\n of\n Health,\n Labor\n and\n Welfare\n of\n Japan,\n and\n \u201cIntegrated\n research\non\n neuropsychiatric\n disorders\u201d\n carried\n out\n under\n the\n Strategic\nResearch\n Program\n for\n Brain\n Sciences\n by\n the\n Ministry\n of\n Educa-\ntion,\n Culture,\n Sports,\n Science\n and\n Technology\n of\n Japan.", "mimetype": "text/plain", "start_char_idx": 31624, "end_char_idx": 33180, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "211dbb4c-78ba-437a-847c-5c153dbe7181": {"__data__": {"id_": "211dbb4c-78ba-437a-847c-5c153dbe7181", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "20b55d25-d125-42b8-80b0-db7781694664", "node_type": "1", "metadata": {}, "hash": "707d4e412163d1fb2d4134c9a3ef439c3cc0a0a93e18f1e9c20a0acd23e861d3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "86a9bd09-5c1a-48e4-9ce6-532b5c61a8dd", "node_type": "1", "metadata": {}, "hash": "96d5dfbaaecb69ccdefd8cd247f4cb14bdcad9339ab155985dd46d9099ce2101", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\n authors\nwould\n like\n to\n warmly\n thank\n all\n the\n students\n who\n took\n part\n in\n this\nresearch\n and\n their\n parents\n and\n teachers.\n They\n are\n grateful\n to\n Profes-\nsor\n Nobuyuki\n Hamajima\n and\n Professor\n Yutaka\n Inaba\n for\n advice\n and\nfor\n checking\n the\n statistical\n analyses.\n Special\n thanks\n are\n expressed\n to\nToru\n Yoshikawa,\n Hiroshi\n Fujioka,\n Yuko\n Yoshida,\n and\n Yuriko\n Hachiya\nfor\n their\n assistance.\nReferences\n[1]\n Lotter\n \nV.\n \nChildhood\n \nautism\n \nin\n \nAfrica.\n \nJ \nChild\n \nPsychol\n \nPsychiatry\n1978;19:231\u201344.\n[2]\n Wing\n L.\n Autistic\n spectrum\n disorders.\n BMJ\n 1996;312:327\u20138.\n[3]\n Wing\n L.\n The\n autistic\n spectrum.\n Lancet\n 1997;350:1761\u20136.\n[4]\n Baird\n G,\n Simonoff\n E,\n Pickles\n A,\n Chandler\n S,\n Loucas\n T,\n Meldrum\n D,\n et\n al.\n Prevalence\nof disorders\n of\n the\n autism\n spectrum\n in\n a population\n cohort\n of\n children\n in\n South\nThames:\n the\n Special\n Needs\n and\n Autism\n Project\n (SNAP).\n Lancet\n 2006;368:210\u20135.\n[5]  Brugha\n TS,\n McManus\n S,\n Bankart\n J, Scott\n F,\n Purdon\n S,\n Smith\n J,\n et\n al.\n Epidemiology\nof\n autism\n spectrum\n disorders\n in\n adults\n in\n the\n community\n in\n England.\n Arch\n Gen\nPsychiatry\n 2011;68:459\u201365.\n[6]\n Kim\n YS,\n Leventhal\n BL,\n Koh\n YJ,\n Fombonne\n E,\n Laska\n E,\n Lim\n EC,\n et\n al.\n Prevalence\n of\nautism\n spectrum\n disorders\n in\n a\n total\n population\n sample.\n Am\n J Psychiatry\n 2011.", "mimetype": "text/plain", "start_char_idx": 33182, "end_char_idx": 34533, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "86a9bd09-5c1a-48e4-9ce6-532b5c61a8dd": {"__data__": {"id_": "86a9bd09-5c1a-48e4-9ce6-532b5c61a8dd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "211dbb4c-78ba-437a-847c-5c153dbe7181", "node_type": "1", "metadata": {}, "hash": "4a354318362beb5c5c2e11307d14c36bd6a8a6c0171e0bb6da8cf7dbaf3d08ec", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6befac3e-2acb-4f0b-a964-4991d85ee0c4", "node_type": "1", "metadata": {}, "hash": "cee1c4977ab23473589ebb483cd6afbb4870e09e9884c2f43e150a4c5ee0f492", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Prevalence\n of\nautism\n spectrum\n disorders\n in\n a\n total\n population\n sample.\n Am\n J Psychiatry\n 2011.\n[7]\n Levy\n SE,\n Mandell\n DS,\n Schultz\n RT.\n Autism.\n Lancet\n 2009;374:1627\u201338.\n[8] Hallmayer\n J, Cleveland\n S,\n Torres\n A,\n Phillips\n J, Cohen\n B,\n Torigoe\n T,\n et\n al.\n Genetic\nheritability\n and\n shared\n environmental\n factors\n among\n twin\n pairs\n with\n autism.\nArch\n Gen\n Psychiatry\n 2011;68:1095\u2013102.\n[9]\n Lichtenstein\n P,\n Carlstrom\n E,\n Rastam\n M,  Gillberg\n C,\n Anckarsater\n H.\n The\n genet-\nics of\n autism\n spectrum\n disorders\n and\n related\n neuropsychiatric\n disorders\n in\nchildhood.\n Am\n J Psychiatry\n 2010;167:1357\u201363.\n[10]\n Wake\ufb01eld\n AJ,\n Murch\n SH,\n Anthony\n A,\n Linnell\n J, Casson\n DM,\n Malik\n M,\n et\n al.\nIleal-lymphoid-nodular\n hyperplasia,\n non-speci\ufb01c\n colitis,\n and\n pervasive\n devel-\nopmental\n disorder\n in\n children.\n Lancet\n 1998;351:637\u201341.\n[11]\n Lancet\n TEOT.\n Retraction-Ileal-lymphoid-nodular\n hyperplasia,\n non-speci\ufb01c\n col-\nitis, and\n pervasive\n developmental\n disorder\n in\n children.\n Lancet\n 2010;375:445.\n[12] Kawashima\n H,\n Mori\n T,\n Kashiwagi\n Y,\n Takekuma\n K,\n Hoshika\n A,\n Wake\ufb01eld\n A.\nDetection\n and\n sequencing\n of\n measles\n virus\n from\n peripheral\n mononuclear\ncells\n from\n patients\n with\n in\ufb02ammatory\n bowel\n disease\n and\n autism.\n Dig\n Dis\n Sci\n2000;45:723\u20139.", "mimetype": "text/plain", "start_char_idx": 34431, "end_char_idx": 35731, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6befac3e-2acb-4f0b-a964-4991d85ee0c4": {"__data__": {"id_": "6befac3e-2acb-4f0b-a964-4991d85ee0c4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "86a9bd09-5c1a-48e4-9ce6-532b5c61a8dd", "node_type": "1", "metadata": {}, "hash": "96d5dfbaaecb69ccdefd8cd247f4cb14bdcad9339ab155985dd46d9099ce2101", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1e6dc7ec-7455-4cf7-a018-40ba55cfca40", "node_type": "1", "metadata": {}, "hash": "caf311c7e599509c8aceb5551e4a7f8fc93eb45fd8ff2fc0b604dec882e7318b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Dig\n Dis\n Sci\n2000;45:723\u20139.\n[13] Uhlmann\n V,\n Martin\n CM,\n Sheils\n O,\n Pilkington\n L,\n Silva\n I,\n Killalea\n A,\n et\n al.\n Potential\nviral\n pathogenic\n mechanism\n for\n new\n variant\n in\ufb02ammatory\n bowel\n disease.\n Mol\nPathol\n 2002;55:84\u201390.\n[14]\n Delong\n G.\n A\n positive\n association\n found\n between\n autism\n prevalence\n and\n child-\nhood\n vaccination\n uptake\n across\n the\n U.S.\n population.\n J Toxicol\n Environ\n Health\n A\n2011;74:903\u201316.\n[15]\n Joint\n statement\n of\n the\n American\n Academy\n of\n Pediatrics\n (AAP)\n and\n the\n United\nStates\n Public\n Health\n Service\n (USPHS).\n Pediatrics\n 1999;104:568\u20139.\n[16]\n Bernard\n S,\n Enayati\n A,\n Redwood\n L,\n Roger\n H,\n Binstock\n T.\n Autism:\n a novel\n form\n of\nmercury\n poisoning.\n Med\n Hypotheses\n 2001;56:462\u201371.\n[17] Of\ufb01t\n PA.\n Vaccines\n and\n autism\n revisited\u2014the\n Hannah\n Poling\n case.\n N\n Engl\n J Med\n2008;358:2089\u201391.\n[18]\n Farrington\n CP,\n Miller\n E,\n Taylor\n B.\n MMR\n and\n autism:\n further\n evidence\n against\n a\ncausal\n association.\n Vaccine\n 2001;19:3632\u20135.\n[19]\n del\n Kaye\n JA,\n Mar\n Melero-Montes\n M,  Jick\n H.\n Mumps,\n measles,\n and\n rubella\n vaccine\nand\n the\n incidence\n of\n autism\n recorded\n by\n general\n practitioners:\n a\n time\n trend\nanalysis.\n BMJ\n 2001;322:460\u20133.\n[20]\n Dales\n L,\n Hammer\n SJ,\n Smith\n NJ.\n Time\n trends\n in\n autism\n and\n in\n MMR\n immunization\ncoverage\n in\n California.\n JAMA\n 2001;285:1183\u20135.", "mimetype": "text/plain", "start_char_idx": 35703, "end_char_idx": 37064, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1e6dc7ec-7455-4cf7-a018-40ba55cfca40": {"__data__": {"id_": "1e6dc7ec-7455-4cf7-a018-40ba55cfca40", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6befac3e-2acb-4f0b-a964-4991d85ee0c4", "node_type": "1", "metadata": {}, "hash": "cee1c4977ab23473589ebb483cd6afbb4870e09e9884c2f43e150a4c5ee0f492", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "312abb4d-20cc-4d5f-a37e-18115cba86eb", "node_type": "1", "metadata": {}, "hash": "b160d143aad39ef142a84ee698e5c664a6ed410df9c0f1ca7f38d19d652ad51d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Time\n trends\n in\n autism\n and\n in\n MMR\n immunization\ncoverage\n in\n California.\n JAMA\n 2001;285:1183\u20135.\n[21] Fombonne\n \nE,\n \nChakrabarti\n \nS.\n \nNo\n \nevidence\n \nfor\n \na\n \nnew\n \nvariant\n \nof\nmeasles\u2013mumps\u2013rubella-induced\n autism.\n Pediatrics\n 2001;108:E58.\n[22] Makela\n A,\n Nuorti\n JP,\n Peltola\n H.\n Neurologic\n disorders\n after\n measles\u2013mumps\u2013\nrubella\n vaccination.\n Pediatrics\n 2002;110:957\u201363.\n[23] Taylor\n B,\n Lingam\n R,\n Simmons\n A,\n Stowe\n J,\n Miller\n E,\n Andrews\n N.\n Autism\n and\nMMR\n vaccination\n in\n North\n London;\n no\n causal\n relationship.\n Mol\n Psychiatry\n2002;7(Suppl.\n 2):S7\u20138.\n[24]\n Madsen\n KM,\n Hviid\n A,\n Vestergaard\n M,\n Schendel\n D,\n Wohlfahrt\n J,\n Thorsen\n P,\net\n al.\n A\n population\n based\n study\n of\n MMR\n vaccination\n and\n autism.\n New\n Engl\n J\n2002;347:1477\u201382.\n[25] Chen\n W,\n Landau\n S,\n Sham\n P,\n Fombonne\n E.\n No\n evidence\n for\n links\n between\n autism,\nMMR\n and\n measles\n virus.\n Psychol\n Med\n 2004;34:543\u201353.\n[26] Richler\n J,\n Luyster\n R,\n Risi\n S,\n Hsu\n WL,\n Dawson\n G,\n Bernier\n R,\n et\n al.\n Is\nthere\n a\n \u2018regressive\n phenotype\u2019\n of\n autism\n spectrum\n disorder\n associated\n with\nthe\n measles\u2013mumps\u2013rubella\n vaccine?\n A\n CPEA\n Study.\n J\n Autism\n Dev\n Disord\n2006;36:299\u2013316.\n[27]\n Taylor\n B,\n Miller\n E,\n Farrington\n CP,\n Petropoulos\n MC,\n Favot-Mayaud\n I,\n Li\n J,\n et\n al.", "mimetype": "text/plain", "start_char_idx": 36962, "end_char_idx": 38260, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "312abb4d-20cc-4d5f-a37e-18115cba86eb": {"__data__": {"id_": "312abb4d-20cc-4d5f-a37e-18115cba86eb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1e6dc7ec-7455-4cf7-a018-40ba55cfca40", "node_type": "1", "metadata": {}, "hash": "caf311c7e599509c8aceb5551e4a7f8fc93eb45fd8ff2fc0b604dec882e7318b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fa81edf5-769e-4132-92c7-e3f82252530c", "node_type": "1", "metadata": {}, "hash": "151e3af00a557b787232c6decf41da6881026c9a36c118d7d36be7d348473294", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "[27]\n Taylor\n B,\n Miller\n E,\n Farrington\n CP,\n Petropoulos\n MC,\n Favot-Mayaud\n I,\n Li\n J,\n et\n al.\nAutism\n and\n measles,\n mumps,\n and\n rubella\n vaccine:\n no\n epidemiological\n evidence\nfor\n a causal\n association.\n Lancet\n 1999;353:2026\u20139.\n[28]\n Fombonne\n E,\n Zakarian\n R,\n Bennett\n A,\n Meng\n L,\n McLean-Heywood\n D.\n Pervasive\ndevelopmental\n disorders\n in\n Montreal,\n Quebec,\n Canada:\n prevalence\n and\n links\nwith\n immunizations.\n Pediatrics\n 2006;118:e139\u201350.\n[29]\n Honda\n H,\n Shimizu\n Y,\n Rutter\n M.\n No\n effect\n of\n MMR\n withdrawal\n on\n the\n inci-\ndence\n of\n autism:\n a total\n population\n study.\n J Child\n Psychol\n Psychiatry\n 2005;46:\n572\u20139.\n[30]\n Uchiyama\n T,\n Kurosawa\n M,\n Inaba\n Y.\n MMR-vaccine\n and\n regression\n in\n autism\n spec-\ntrum disorders:\n negative\n results\n presented\n from\n Japan.\n J Autism\n Dev\n Disord\n2007;37:210\u20137.\n[31] DeStefano\n F,\n Bhasin\n TK,\n Thompson\n WW,\n Yeargin-Allsopp\n M,\n Boyle\n C.\n Age\n at\n\ufb01rst  measles\u2013mumps\u2013rubella\n vaccination\n in\n children\n with\n autism\n and\n school-\nmatched\n control\n subjects:\n a population-based\n study\n in\n metropolitan\n Atlanta.\nPediatrics\n 2004;113:259\u201366.\n[32] Smeeth\n L,\n Cook\n C,\n Fombonne\n E,\n Heavey\n L,\n Rodrigues\n LC,\n Smith\n PG,\n et\n al.\n MMR\nvaccination\n and\n pervasive\n developmental\n disorders:\n a\n case\u2013control\n study.\nLancet\n 2004;364:963\u20139.\n[33]\n DeWilde\n S,\n Carey\n IM,\n Richards\n N,\n Hilton\n SR,\n Cook\n DG.", "mimetype": "text/plain", "start_char_idx": 38162, "end_char_idx": 39545, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fa81edf5-769e-4132-92c7-e3f82252530c": {"__data__": {"id_": "fa81edf5-769e-4132-92c7-e3f82252530c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "312abb4d-20cc-4d5f-a37e-18115cba86eb", "node_type": "1", "metadata": {}, "hash": "b160d143aad39ef142a84ee698e5c664a6ed410df9c0f1ca7f38d19d652ad51d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fea227ba-3e24-4421-b8cf-94d849198af5", "node_type": "1", "metadata": {}, "hash": "3fcf0206d6f0cc0338f4a1bc381c6f883f6050c11de069aaf19818a79b9f5ff2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Lancet\n 2004;364:963\u20139.\n[33]\n DeWilde\n S,\n Carey\n IM,\n Richards\n N,\n Hilton\n SR,\n Cook\n DG.\n Do\n children\n who\nbecome\n autistic\n consult\n more\n often\n after\n MMR\n vaccination.\n Br\n J Gen\n Pract\n2001;51:226\u20137.\n[34]\n Stephen\n D,\n Sugarman\n SD.\n Cases\n in\n vaccine\n court\u2014legal\n battles\n over\n vaccines\nand autism.\n N\n Engl\n J\n Med\n 2007;357:1275\u20137.\n[35] Casiday\n R,\n Cresswell\n T,\n Wilson\n D,\n Panter-Brick\n C.\n A\n survey\n of\n UK\n parental\nattitudes\n to\n the\n MMR\n vaccine\n and\n trust\n in\n medical\n authority.\n Vaccine\n2006;24:177\u201384.\n[36]\n Cassell\n JA,\n Leach\n M,  Poltorak\n MS,\n Mercer\n CH,\n Iversen\n A,\n Fairhead\n JR.\n Is\n the\n cul-\ntural\n context\n of\n MMR\n rejection\n a key\n to\n an\n effective\n public\n health\n discourse.\nPublic\n Health\n 2006;120:783\u201394.\n[37]\n Hilton\n \nS,\n \nHunt\n \nK,\n \nPetticrew\n \nM.\n \nMMR:\n \nmarginalised,\n \nmisrepresented\nand\n rejected?\n Autism:\n a\n focus\n group\n study.\n Arch\n Dis\n Child\n 2007;92:\n322\u20137.\n[38] Haga\n H,\n Yamada\n R,\n Ohnishi\n Y,\n Nakamura\n Y,\n Tanaka\n T.\n Gene-based\n SNP\n discovery\nas\n part\n of\n the\n Japanese\n Millennium\n Genome\n Project:\n identi\ufb01cation\n of\n 190,562\ngenetic\n variations\n in\n the\n human\n genome.\n Single-nucleotide\n polymorphism.\n J\nHum\n Genet\n 2002;47:605\u201310.\n[39]\n Kunugi\n H,\n Nanko\n S,\n Takei\n N,\n Saito\n K,\n Murray\n RM,\n Hirose\n T.\n Perinatal\n complica-\ntions\n and\n schizophrenia.", "mimetype": "text/plain", "start_char_idx": 39454, "end_char_idx": 40793, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fea227ba-3e24-4421-b8cf-94d849198af5": {"__data__": {"id_": "fea227ba-3e24-4421-b8cf-94d849198af5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fa81edf5-769e-4132-92c7-e3f82252530c", "node_type": "1", "metadata": {}, "hash": "151e3af00a557b787232c6decf41da6881026c9a36c118d7d36be7d348473294", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2b32d2b0-e89d-47a7-887c-ecedff8d9199", "node_type": "1", "metadata": {}, "hash": "0d216063908ac942a37580d5ba30470c84be64cd76aaa5be92d3108291c40a78", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "[39]\n Kunugi\n H,\n Nanko\n S,\n Takei\n N,\n Saito\n K,\n Murray\n RM,\n Hirose\n T.\n Perinatal\n complica-\ntions\n and\n schizophrenia.\n Data\n from\n the\n Maternal\n and\n Child\n Health\n Handbook\nin\n Japan.\n J Nerv\n Ment\n Dis\n 1996;184:542\u20136.\n[40] Ohara\n K,\n Tanabu\n S,\n Yoshida\n K,\n Sato\n Y,\n Shibuya\n H.\n Obstetric\n complications\nin\n siblings\n of\n Japanese\n schizophrenics:\n data\n from\n the\n Maternal\n and\n Child\nHealth\n Handbook.\n Prog\n Neuropsychopharmacol\n Biol\n Psychiatry\n 2005;29:\n617\u201320.\n[41]\n Wing\n \nL,\n \nLeekam\n \nSR,\n \nLibby\n \nSJ,\n \nGould\n \nJ, \nLarcombe\n \nM.  \nThe\n \ndiagnostic\ninterview\n for\n social\n and\n communication\n disorders:\n background,\n inter-\nrater \nreliability\n \nand\n \nclinical\n \nuse.\n \nJ \nChild\n \nPsychol\n \nPsychiatry\n \n2002;43:\n307\u201325.\n[42]\n Leekam\n SR,\n Libby\n SJ,\n Wing\n L,\n Gould\n J, Taylor\n C.\n The\n diagnostic\n interview\n for\nsocial and\n communication\n disorders:\n algorithms\n for\n ICD-10\n childhood\n autism\nand\n Wing\n and\n Gould\n autistic\n spectrum\n disorder.\n J Child\n Psychol\n Psychiatry\n2002;43:327\u201342.\n[43]\n Nygren\n G,\n Hagberg\n B,\n Billstedt\n E,\n Skoglund\n A,\n Gillberg\n C,\n Johansson\n M.\n The\nSwedish\n version\n of\n the\n Diagnostic\n Interview\n for\n Social\n and\n Communica-\ntion  Disorders\n (DISCO-10).\n Psychometric\n properties.\n J\n Autism\n Dev\n Disord\n2009;39:730\u201341.\n[44]\n Sugiura\n A,\n Yamada\n A.\n Aseptic\n meningitis\n as\n a\n complication\n of\n mumps\n vaccina-\ntion. Pediatr\n Infect\n Dis\n J 1991;10:209\u201313.", "mimetype": "text/plain", "start_char_idx": 40670, "end_char_idx": 42098, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2b32d2b0-e89d-47a7-887c-ecedff8d9199": {"__data__": {"id_": "2b32d2b0-e89d-47a7-887c-ecedff8d9199", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-2 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "0a199cd95bc6b3a528e3e5f1e5c7564edb12b1ff541dbd6a4aed7592e8723759", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fea227ba-3e24-4421-b8cf-94d849198af5", "node_type": "1", "metadata": {}, "hash": "3fcf0206d6f0cc0338f4a1bc381c6f883f6050c11de069aaf19818a79b9f5ff2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Pediatr\n Infect\n Dis\n J 1991;10:209\u201313.\n[45]\n Eaton\n WW,\n Mortensen\n PB,\n Thomsen\n PH,\n Frydenberg\n M.\n Obstetric\n complica-\ntions and\n risk\n for\n severe\n psychopathology\n in\n childhood.\n J\n Autism\n Dev\n Disord\n2001;31:279\u201385.\n[46] Hultman\n CM,\n Sparen\n P,\n Cnattingius\n S.\n Perinatal\n risk\n factors\n for\n infantile\n autism.\nEpidemiology\n 2002;13:417\u201323.\n4298\nY.\n Uno\n et\n al.\n /\n Vaccine\n 30 (2012) 4292\u2013\n 4298\n[47]\n Glasson\n EJ,\n Bower\n C,\n Petterson\n B,\n de\n Klerk\n N,\n Chaney\n G,\n Hallmayer\n JF.\n Perinatal\nfactors\n and\n the\n development\n of\n autism:\n a population\n study.\n Arch\n Gen\n Psychiatry\n2004;61:618\u201327.\n[48]\n Larsson\n HJ,\n Eaton\n WW,\n Madsen\n KM,\n Vestergaard\n M,  Olesen\n AV,\n Agerbo\n E,\net\n al.\n Risk\n factors\n for\n autism:\n perinatal\n factors,\n parental\n psychiatric\n history,\nand  socioeconomic\n status.\n Am\n J Epidemiol\n 2005;161:916\u201325,\n discussion\n 26\u20138.\n[49]\n Gardener\n H,\n Spiegelman\n D,\n Buka\n SL.\n Prenatal\n risk\n factors\n for\n autism:\n compre-\nhensive\n meta-analysis.\n Br\n J Psychiatry\n 2009;195:7\u201314.\n[50] Thompson\n WW,\n Price\n C,\n Goodson\n B,\n Shay\n DK,\n Benson\n P,\n Hinrichsen\n VL,\n et\n al.\nEarly\n thimerosal\n exposure\n and\n neuropsychological\n outcomes\n at\n 7\n to\n 10\n years.\nN  Engl\n J Med\n 2007;357:1281\u201392.", "mimetype": "text/plain", "start_char_idx": 42059, "end_char_idx": 43297, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2ad0d831-4f9f-4aa0-be5f-5f8b58f48d9f": {"__data__": {"id_": "2ad0d831-4f9f-4aa0-be5f-5f8b58f48d9f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "131283bb-14fd-4179-8b57-4c80d1930d66", "node_type": "1", "metadata": {}, "hash": "964a970975422226877088d93d3827131e797193829e524ff24c766de367cd1b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For many years it has been suspected that one or more viruses\nmight cause leukaemia in children. Kinlen (1988) suggested that\nchildhood leukaemia occurs as a rare response to a specific (and\ncommon) infectious agent, and that population influxes into rural\nareas favour epidemics of the infection and increases in leukaemia\nincidence. Greaves (1988) suggested that the risk of the common\nB-cell precursor subtype of acute lymphoblastic leukaemia (ALL)\nwas increased by delayed or diminished exposure to infections in\ninfancy. Supporting evidence for an infective origin of childhood\nleukaemia has come from descriptive, clustering and case-control\nstudies (Greaves and Alexander, 1993; Kinlen, 1996, 1997). The\nhypotheses need further testing in analytical studies (Neglia et al,\n1990). In this national, population-based case-control study, the\nhypotheses were: (1) that children infected with one or more\nspecific viruses are at increased risk of childhood leukaemia; and\n(2) that children with diminished or delayed exposure to common\ninfections in infancy are at increased risk of ALL.\n\ue00b\ue002\ue010\ue005\ue00e\ue008\ue002\ue00a\ue00f\ue000\ue002\ue00c\ue004\ue000\ue00b\ue005\ue010\ue007\ue00d\ue004\ue00f\nDetails of case ascertainment, pathology review, control selection\nand recruitment procedures have already been described (Dockerty\net al, 1998). The 131 eligible cases were newly diagnosed with\nchildhood leukaemia (ages 0\u201314 years) 1990\u20131993, and born and\nresident in New Zealand (NZ). Controls (matched 1:1 to cases on\nage \nand \nsex) \nwere \nselected \nrandomly \nfrom \nthe\nNZ-born and resident childhood population, using national birth\nrecords. Each control\u2019s birth was registered in the same quarter of\nthe same year as the matched case. Adopted children were not\neligible.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1687, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "131283bb-14fd-4179-8b57-4c80d1930d66": {"__data__": {"id_": "131283bb-14fd-4179-8b57-4c80d1930d66", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2ad0d831-4f9f-4aa0-be5f-5f8b58f48d9f", "node_type": "1", "metadata": {}, "hash": "d8282c79292d2dcf2641d54ccbf388950ccf435828023ee6af25f5505fbdcced", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5548bd02-b502-4808-9c9c-b10d27b1c448", "node_type": "1", "metadata": {}, "hash": "a7997d2f21e7f799f448b546213ebec813da63e3278a0745bcea8438909c4e85", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Each control\u2019s birth was registered in the same quarter of\nthe same year as the matched case. Adopted children were not\neligible.\nMaternal interviews were available for 121 children with\nleukaemia (92%); there were eight refusals, one notification by\ndeath certificate only (not contacted) and one questionnaire lost by\na courier. The age distribution of the 121 was: 69 aged 0\u20134 years,\n34 aged 5\u20139 years and 18 aged 10\u201314 years. Of the 121 matched\nfirst-choice controls, 89 (74%) took part; there were 11 refusals,\n19 not found, one mother with language difficulties and one\nmother was ill. Replacement controls were found for the 32 non-\nparticipants using the same methods.\nThe wider study also included 213 solid cancer cases with\nadditional age- and sex-matched controls (Dockerty et al, 1998),\ngiving a total of 303 available controls who could contribute to\nunconditional logistic regressions (see Analyses). Of all 303 first-\nchoice controls, the mothers of 209 (69%) were interviewed. The\n94 who did not take part included 46 not found, 46 refusals, one\nwith language difficulties, and one ill mother.\nThe mothers were interviewed in their homes during\n1991\u20131995, with identical standardized questionnaires for cases\nand controls. Neither parents nor interviewers were informed\nabout the hypotheses. The questionnaire was adapted from that of\nDrs Patricia McKinney and Eve Roman in the UK. Vaccination\nhistories were supplemented with information from parent-held\n\u2018Health and Development\u2019 records. A \u2018reference date\u2019 was used.\nFor a case, this was the date of diagnosis. For a control, it was the\ndate on which the child achieved the exact age the matched case\nwas at diagnosis. The child\u2019s social class (Office of Population\nCensuses and Surveys, 1991) was derived as the higher of the\nmother\u2019s and father\u2019s.", "mimetype": "text/plain", "start_char_idx": 1558, "end_char_idx": 3376, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5548bd02-b502-4808-9c9c-b10d27b1c448": {"__data__": {"id_": "5548bd02-b502-4808-9c9c-b10d27b1c448", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "131283bb-14fd-4179-8b57-4c80d1930d66", "node_type": "1", "metadata": {}, "hash": "964a970975422226877088d93d3827131e797193829e524ff24c766de367cd1b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7d698684-1436-4aa3-8449-b29c70a0d638", "node_type": "1", "metadata": {}, "hash": "948271d98997401c66cb314d8794f66e682bac0cc9a06e9a8a966e0fce84b48f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The child\u2019s social class (Office of Population\nCensuses and Surveys, 1991) was derived as the higher of the\nmother\u2019s and father\u2019s. \u2018Household density\u2019 was the average\n\ue008\ue01d\ue017\ue016\ue014\ue021\ue019\ue01e\ue01d\ue020\ue001\ue000\ue023\ue013\ue014\ue014\ue019\ue01d\ue013\ue021\ue019\ue01e\ue01d\ue020\ue001\ue000\ue013\ue01d\ue015\ue000\ue021\ue018\ue016\ue000\ue01f\ue019\ue020\ue01a\ue000\ue01e\ue017\ue000\ue014\ue018\ue019\ue01b\ue015\ue018\ue01e\ue01e\ue015\n\ue01b\ue016\ue022\ue01a\ue013\ue016\ue01c\ue019\ue013\nJD Dockerty1,2, DCG Skegg2, JM Elwood2, GP Herbison2, DMO Becroft3 and ME Lewis4\n1Childhood Cancer Research Group, University of Oxford, 57 Woodstock Road, Oxford OX2 6HJ, UK; 2Department of Preventive and Social Medicine,\nUniversity of Otago, PO Box 913, Dunedin, New Zealand; 3Department of Obstetrics and Gynaecology, University of Auckland, National Women\u2019s Hospital,\nClaude Road, Epsom, Auckland, New Zealand; 4Department of Paediatrics, Wellington School of Medicine, PO Box 7343, Wellington South, New Zealand\nSummary A nationwide case-control study was conducted in New Zealand, to test hypotheses about the role of infections in the aetiology of\nchildhood leukaemia. Children aged 0\u201314 years with leukaemia were matched on age and sex to controls selected from birth records. Case\nascertainment was virtually complete and 121 (92%) of 131 eligible case families took part. The participation rate among the 303 first-choice\neligible controls was 69%. Home interviews and serological tests were conducted. Adjusted relative risks were estimated by logistic\nregression.", "mimetype": "text/plain", "start_char_idx": 3246, "end_char_idx": 4550, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7d698684-1436-4aa3-8449-b29c70a0d638": {"__data__": {"id_": "7d698684-1436-4aa3-8449-b29c70a0d638", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5548bd02-b502-4808-9c9c-b10d27b1c448", "node_type": "1", "metadata": {}, "hash": "a7997d2f21e7f799f448b546213ebec813da63e3278a0745bcea8438909c4e85", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3d16adb7-901b-4d2a-b062-26aa6a10f038", "node_type": "1", "metadata": {}, "hash": "d2a782b81d905ed071b3f733b87eae6a3609213aeb7bce5f3d5ff12d665b0642", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The participation rate among the 303 first-choice\neligible controls was 69%. Home interviews and serological tests were conducted. Adjusted relative risks were estimated by logistic\nregression. There was an increased risk of leukaemia in relation to reported influenza infection of the child during the first year of life (adjusted\nodds ratio 6.8, 95% confidence interval 1.8\u201325.7). This could be a chance finding due to multiple comparisons, and it should be tested\nelsewhere. Some key variables relevant to Greaves\u2019 hypothesis were not associated with B-cell precursor acute lymphoblastic leukaemia\n(numbers of infections and vaccinations, firstborn status, attendance at preschool groups), although a small effect could not be ruled out with\na study of this size. Leukaemia risk was higher among children in poorer social circumstances, and this was true for all eligible children as well\nas for the participants.\nKeywords: epidemiology; leukaemia; infection; vaccination; case-control studies; influenza\n1483\nBritish Journal of Cancer (1999) 80(9), 1483\u20131489\n\u00a9 1999 Cancer Research Campaign\nArticle no. bjoc.1999.0548\nReceived 14 December 1998\nRevised 7 January 1999\nAccepted 12 January 1999\nCorrespondence to: JD Dockerty, Childhood Cancer Research Group,\nUniversity of Oxford, 57 Woodstock Road, Oxford OX2 6HJ, UK\nnumber of people per room in the house the child lived in at birth.\n\u2018Residential mobility\u2019 was the number of houses the child ever\nlived in up to the reference date.\nUndetected cancer could alter some exposures among cases\nbefore diagnosis. Because such changes in exposure would be a\nconsequence of the illness, it would be wrong to consider them in\nthe analyses. Thus, X-rays within 3 months of the reference date,\nand vaccinations in or after the calendar year of the diagnosis/\nreference date were not counted as exposures for cases or controls.\nWhere the exposure period of interest was the first 12 months of life\n(e.g. infections), children aged under 15 months on the reference\ndate were excluded. Specific vaccinations were counted only if the\nyear when they were given was known and was before the year of\nthe reference date.", "mimetype": "text/plain", "start_char_idx": 4357, "end_char_idx": 6513, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3d16adb7-901b-4d2a-b062-26aa6a10f038": {"__data__": {"id_": "3d16adb7-901b-4d2a-b062-26aa6a10f038", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7d698684-1436-4aa3-8449-b29c70a0d638", "node_type": "1", "metadata": {}, "hash": "948271d98997401c66cb314d8794f66e682bac0cc9a06e9a8a966e0fce84b48f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cafe85ce-b378-47ef-8b87-9da7ec981229", "node_type": "1", "metadata": {}, "hash": "df779a877b40b04f90ee4fd43fa129d083f375ae64e179f492e6356620944531", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "infections), children aged under 15 months on the reference\ndate were excluded. Specific vaccinations were counted only if the\nyear when they were given was known and was before the year of\nthe reference date. Children aged under n months on the reference\ndate were excluded from the analyses for a particular vaccination,\nwhere n was 3 months plus the youngest age when the vaccination\nwould be given.\nAnalyses\nAnalyses were conducted for combined leukaemias (121) and ALL\n(97 cases). Unconditional logistic regressions in SPSS included these\ncases and all 303 controls. Such an approach, in a study with\nmatching only on age and sex, should be valid given that the matched\nfactors were adjusted for (Rothman, 1986; Hamajima et al, 1994).\nWe checked whether there was any important bias towards a null\neffect (Breslow and Day, 1980) by repeating the ALL analyses with\nconditional logistic regression (97 matched pairs, EGRET software).\n1484\nJD Dockerty et al\nBritish Journal of Cancer (1999) 80(9), 1483\u20131489\n\u00a9 1999 Cancer Research Campaign \nTable 1\nOdds ratios for demographic factors and variables listed primarily as possible confounders. The odds ratios in this table are adjusted for age (in years)\nand sex\nChildhood leukaemias\nAcute lymphoblastic leukaemia\n95% CI\n95% CI\nNo. of\nNo. of\nOdds\nBounds\nNo. of\nNo.", "mimetype": "text/plain", "start_char_idx": 6304, "end_char_idx": 7618, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cafe85ce-b378-47ef-8b87-9da7ec981229": {"__data__": {"id_": "cafe85ce-b378-47ef-8b87-9da7ec981229", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3d16adb7-901b-4d2a-b062-26aa6a10f038", "node_type": "1", "metadata": {}, "hash": "d2a782b81d905ed071b3f733b87eae6a3609213aeb7bce5f3d5ff12d665b0642", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b308a02c-c053-4d7c-b3a7-fc34c2b74394", "node_type": "1", "metadata": {}, "hash": "145175fda20400183e2af9383d0aeb55602cfc439aa3a12f2a25a06a63d86dcf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "of\nNo. of\nOdds\nBounds\nNo. of\nNo. of\nOdds\nBounds\nCharacteristic or exposure\nCategories\ncases controls\nratio\nLower\nUpper\ncases\ncontrols\nratio\nLower Upper\nChild\u2019s social class\nI or II\n40\n145\n1.00\n34\n145\n1.00\n(highest of parents)\nIIIN or IIIM\n41\n90\n1.66\n0.98\n2.81\n35\n90\n1.65\n0.94\n2.91\nIV or V\n13\n32\n1.48\n0.69\n3.15\n8\n32\n1.04\n0.43\n2.52\nNo paid jobs \u2013 not\n26\n32\n3.00\n1.57\n5.71\n19\n32\n2.69\n1.32\n5.48\nclassifiable\nWas mother married at time\nNo\n47\n70\n1.00\n36\n70\n1.00\nof interview?\nYes\n74\n233\n0.44\n0.27\n0.70\n61\n233\n0.48\n0.29\n0.80\nChild\u2019s ethnic group\nNon-Maori\n104\n269\n1.00\n85\n269\n1.00\nMaori\n17\n33\n1.42\n0.74\n2.74\n12\n33\n1.23\n0.59\n2.58\nMother\u2019s highest educational\nNo qualifications\n45\n65\n1.00\n31\n65\n1.00\nqualification\nSchool Certificate\n15\n62\n0.28\n0.14\n0.57\n13\n62\n0.34\n0.16\n0.74\n6th form Cert to Scholarship\n15\n34\n0.59\n0.28\n1.25\n13\n34\n0.73\n0.32\n1.64\nPost-school non-University\n32\n115\n0.37\n0.21\n0.65\n27\n115\n0.44\n0.23\n0.83\nUniversity\n14\n27\n0.68\n0.31\n1.47\n13\n27\n0.87\n0.38\n1.99\nMother-home owner?", "mimetype": "text/plain", "start_char_idx": 7586, "end_char_idx": 8565, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b308a02c-c053-4d7c-b3a7-fc34c2b74394": {"__data__": {"id_": "b308a02c-c053-4d7c-b3a7-fc34c2b74394", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cafe85ce-b378-47ef-8b87-9da7ec981229", "node_type": "1", "metadata": {}, "hash": "df779a877b40b04f90ee4fd43fa129d083f375ae64e179f492e6356620944531", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0f8c0ba1-2f03-484e-b0b6-06bb6204518d", "node_type": "1", "metadata": {}, "hash": "5e24aed8d42bd9c4e71227b88669f7fee5b95127b258adda450aa3446abb0ac5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "No\n40\n77\n1.00\n29\n77\n1.00\nYes\n79\n226\n0.63\n0.39\n1.03\n66\n226\n0.74\n0.43\n1.27\nChild\u2019s gestational age\n40 weeks\n59\n138\n1.00\n50\n138\n1.00\n29\u201339 weeks\n35\n73\n0.99\n0.58\n1.67\n29\n73\n0.93\n0.53\n1.65\n41\u201345 weeks\n26\n92\n0.67\n0.39\n1.17\n18\n92\n0.53\n0.28\n0.99\nMother\u2019s age at birth of child\n15\u201334 yrs\n107\n279\n1.00\n84\n279\n1.00\n35\u201341 yrs\n14\n24\n1.56\n0.74\n3.29\n13\n24\n1.88\n0.86\n4.14\nChild\u2019s birth weight\n3000\u20133999 g\n84\n212\n1.00\n67\n212\n1.00\nunder 3000 g\n19\n52\n0.89\n0.49\n1.63\n16\n52\n0.93\n0.49\n1.78\n4000 g or more\n16\n36\n1.05\n0.53\n2.07\n12\n36\n0.90\n0.42\n1.91\nMother had any X-rays during\nNo\n103\n251\n1.00\n83\n251\n1.00\nindex pregnancy or 3 months\nYes\n13\n37\n0.87\n0.44\n1.74\n9\n37\n0.75\n0.34\n1.67\nbefore?\nMother had any abdominal or\nNo\n108\n273\n1.00\n87\n273\npelvic X-rays during pregnancy\nYes\n8\n15\n1.56\n0.62\n3.97\n5\n15\n1.24\n0.41\n3.69\nor 3 months before?", "mimetype": "text/plain", "start_char_idx": 8566, "end_char_idx": 9374, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0f8c0ba1-2f03-484e-b0b6-06bb6204518d": {"__data__": {"id_": "0f8c0ba1-2f03-484e-b0b6-06bb6204518d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b308a02c-c053-4d7c-b3a7-fc34c2b74394", "node_type": "1", "metadata": {}, "hash": "145175fda20400183e2af9383d0aeb55602cfc439aa3a12f2a25a06a63d86dcf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b96538d6-f042-4e19-9fa9-0b61651d8b18", "node_type": "1", "metadata": {}, "hash": "fcc6e63ae89e1468b00989f38ba8ae9250e14a20816074c4822ca5c2832a4378", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Child: any X-rays/ radiotherapy\nNo\n67\n178\n1.00\n55\n178\n1.00\nbefore reference date?a\nYes\n53\n123\n1.20\n0.76\n1.90\n42\n123\n1.15\n0.69\n1.89\nDid mother smoke cigarettes in\nNo\n71\n203\n1.00\n56\n203\n1.00\npregnancy or 3 months before?\nYes\n49\n99\n1.54\n0.97\n2.42\n40\n99\n1.66\n1.01\n2.74\nDid mother ever regularly smoke\nNo\n47\n140\n1.00\n37\n140\n1.00\ncigarettes (> 1 per day)?\nYes\n74\n163\n1.43\n0.92\n2.22\n60\n163\n1.50\n0.92\n2.43\naX-rays within 3 months of the reference date are excluded.\nInfections, vaccinations, and childhood leukaemia\n1485\nBritish Journal of Cancer (1999) 80(9), 1483\u20131489\n\u00a9 1999 Cancer Research Campaign \nTable 2\nOdds ratios for childhood leukaemias in relation to infections of the mother during her pregnancy with the child, or in the 3 months before the\npregnancy\nAdjusted for age in years\nAdjusted for age, sex, and\nand sex only\nother variablesc\nNo. of\nNo.", "mimetype": "text/plain", "start_char_idx": 9375, "end_char_idx": 10226, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b96538d6-f042-4e19-9fa9-0b61651d8b18": {"__data__": {"id_": "b96538d6-f042-4e19-9fa9-0b61651d8b18", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0f8c0ba1-2f03-484e-b0b6-06bb6204518d", "node_type": "1", "metadata": {}, "hash": "5e24aed8d42bd9c4e71227b88669f7fee5b95127b258adda450aa3446abb0ac5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a6bd9956-ba0b-4bd7-b6a9-2ab96bac9d84", "node_type": "1", "metadata": {}, "hash": "17a411c6baa3dc37cf4ce7fc3c2010d79e0bb657162e309ecb9a9b60af4e8b16", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "of\nNo. of\nOdds\n95% CI Bounds\nOdds\n95% CI Bounds\nInfectiona\nCategories\ncases controls\nratio\nLower\nUpper\nratio\nLower\nUpper\nInfluenza\nNo\n111\n271\n1.00\n1.00\nYes\n8\n27\n0.62\n0.27\n1.45\n0.58\n0.24\n1.41\nCystitis or kidney infection\nNo\n117\n287\n1.00\n1.00\nYes\n3\n13\n0.50\n0.14\n1.85\n0.56\n0.15\n2.16\nCold sores/oral herpes\nNo\n111\n278\n1.00\n1.00\nYes\n7\n17\n0.98\n0.38\n2.50\n0.70\n0.25\n1.99\nAny other infectionb\nNo\n110\n287\n1.00\n1.00\nYes\n9\n15\n1.45\n0.59\n3.57\n1.45\n0.55\n3.82\naSeveral other specific infections were asked about. For each of them, fewer than three mothers in the whole sample said they had the infection (rubella,\nmeasles, chicken pox, shingles, mumps, glandular fever, pneumonia, hepatitis B, malaria, and leptospirosis). b\u2019Other infections\u2019 are infections other than those\nin the Table or in (a) above. cThe other variables in the multivariate models were: child\u2019s social class, household crowding, mother\u2019s educational level.\nTable 3\nOdds ratios for childhood leukaemias in relation to certain infections of the child\nAdjusted for age in years\nAdjusted for age, sex, and\nand sex only\nother variablesc\nNo. of\nNo. of\nOdds\n95% CI Bounds\nOdds\n95% CI Bounds\nInfectiona\nCategories\ncases controls\nratio\nLower\nUpper\nratio\nLower\nUpper\nInfections of the child at any time prior to 3 months before the reference date\nGlandular fever\nNo\n119\n302\n1.00\n1.00\nYes\n2\n1\n6.75\n0.51\n88.72\n9.06\n0.60\n135.", "mimetype": "text/plain", "start_char_idx": 10220, "end_char_idx": 11588, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a6bd9956-ba0b-4bd7-b6a9-2ab96bac9d84": {"__data__": {"id_": "a6bd9956-ba0b-4bd7-b6a9-2ab96bac9d84", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b96538d6-f042-4e19-9fa9-0b61651d8b18", "node_type": "1", "metadata": {}, "hash": "fcc6e63ae89e1468b00989f38ba8ae9250e14a20816074c4822ca5c2832a4378", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "009400ab-a053-4db1-a608-dcfc1576e30d", "node_type": "1", "metadata": {}, "hash": "af40f05579b8b0d98821fe77d21f9a29304af7576e480a8804865b350570abcd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "00\n1.00\nYes\n2\n1\n6.75\n0.51\n88.72\n9.06\n0.60\n135.74\nCold sores\nNo\n115\n286\n1.00\n1.00\nYes\n5\n15\n0.86\n0.29\n2.51\n1.10\n0.34\n3.58\nGiardiasis\nNo\n120\n301\n1.00\n1.00\nYes\n1\n2\n1.05\n0.09\n12.53\n0.46\n0.03\n6.37\nInfections of the child in the first yr of lifeb\nWhooping cough\nNo\n114\n264\n1.00\n1.00\nYes\n2\n3\n1.48\n0.23\n9.45\n3.90\n0.43\n35.10\nMeasles\nNo\n111\n256\n1.00\n1.00\nYes\n5\n12\n1.13\n0.37\n3.43\n1.49\n0.41\n5.47\nRubella\nNo\n115\n264\n1.00\n1.00\nYes\n1\n4\n0.49\n0.05\n4.62\n0.77\n0.06\n9.52\nChicken pox\nNo\n109\n256\n1.00\n1.00\nYes\n7\n12\n1.69\n0.61\n4.71\n0.97\n0.27\n3.53\nMouth infection\nNo\n104\n246\n1.00\n1.00\nYes\n12\n22\n1.24\n0.58\n2.67\n1.12\n0.46\n2.72\nEye infection\nNo\n105\n238\n1.00\n1.00\nYes\n11\n30\n0.75\n0.35\n1.58\n0.56\n0.23\n1.39\nEar infection\nNo\n80\n192\n1.00\n1.00\nYes\n36\n76\n1.10\n0.67\n1.80\n1.05\n0.59\n1.85\nInfluenza\nNo\n107\n263\n1.00\n1.00\nYes\n9\n4\n5.58\n1.", "mimetype": "text/plain", "start_char_idx": 11542, "end_char_idx": 12336, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "009400ab-a053-4db1-a608-dcfc1576e30d": {"__data__": {"id_": "009400ab-a053-4db1-a608-dcfc1576e30d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a6bd9956-ba0b-4bd7-b6a9-2ab96bac9d84", "node_type": "1", "metadata": {}, "hash": "17a411c6baa3dc37cf4ce7fc3c2010d79e0bb657162e309ecb9a9b60af4e8b16", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c875a373-f9dc-4e48-b907-25a725734423", "node_type": "1", "metadata": {}, "hash": "37fcf5399851284d9f16baaf82e57e0bcc2c3f62ad733b4da4bb9be5ab67398e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "67\n1.80\n1.05\n0.59\n1.85\nInfluenza\nNo\n107\n263\n1.00\n1.00\nYes\n9\n4\n5.58\n1.57\n19.83\n6.80\n1.81\n25.66\nColds\nNo\n56\n137\n1.00\n1.00\nYes\n60\n131\n1.05\n0.66\n1.65\n1.10\n0.64\n1.89\nPersistent cough\nNo\n109\n251\n1.00\n1.00\nYes\n6\n17\n0.69\n0.26\n1.84\n0.80\n0.26\n2.45\nDiarrhoea and vomiting\nNo\n101\n222\n1.00\n1.00\nYes\n15\n46\n0.62\n0.33\n1.19\n0.53\n0.25\n1.12\n\u2018Other\u2019 infection\nNo\n99\n243\n1.00\n1.00\nYes\n17\n25\n1.54\n0.78\n3.01\n1.53\n0.69\n3.38\nNumber of above types of\nNone\n22\n70\n1.00\n1.00\ninfection in the first year of life\nOne\n38\n90\n1.25\n0.66\n2.34\n1.26\n0.61\n2.62\nTwo\n33\n60\n1.64\n0.84\n3.19\n1.33\n0.62\n2.84\nThree or more\n23\n48\n1.30\n0.63\n2.68\n1.30\n0.57\n2.96\nChild had any infection in\nNo\n22\n70\n1.00\n1.00\nthe first year of life\nYes\n94\n198\n1.37\n0.78\n2.41\n1.29\n0.68\n2.46\naSeveral other infections were asked about, but fewer than two mothers in the whole sample said the child had the infection (hepatitis B, poliomyelitis, and\ncytomegalovirus infection prior to 3 months before the reference date; and mumps in the first year of life).", "mimetype": "text/plain", "start_char_idx": 12267, "end_char_idx": 13254, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c875a373-f9dc-4e48-b907-25a725734423": {"__data__": {"id_": "c875a373-f9dc-4e48-b907-25a725734423", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "009400ab-a053-4db1-a608-dcfc1576e30d", "node_type": "1", "metadata": {}, "hash": "af40f05579b8b0d98821fe77d21f9a29304af7576e480a8804865b350570abcd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bdf8d3b1-068b-44c0-b839-f3519f7c727d", "node_type": "1", "metadata": {}, "hash": "fbaa10856c485d9a1d6d9aeecda7df77cb6033f521865312b52fc83b29118511", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "poliomyelitis, and\ncytomegalovirus infection prior to 3 months before the reference date; and mumps in the first year of life). bFor analyses of infections in the first year of life,\ncases and controls aged under 15 months on their reference dates were excluded. cThe other variables in the multivariate models were: child\u2019s social class,\nhousehold crowding, residential mobility, interview year and delay from reference date to interview.\nIn the unmatched analyses, age (in single years) and sex were\nalways adjusted for. Other potential confounders were listed for\neach exposure or group of exposures. They were then tested to see\nwhether they confounded the estimates for key variables chosen to\nrepresent each group of exposures. A potential confounder was\nadjusted for if adding it to the model (for any key variable)\nchanged the age- and sex-adjusted odds ratio for combined\nleukaemias by more than 10% (Maldonado and Greenland, 1993).\nInter-method reliability\nThe parents of 113 of the 121 cases (93%) and 111 of the 121\nmatched comparison children (92%) gave us permission to contact\ntheir general practitioners (GPs), who were sent brief standardized\nquestionnaires about selected exposures. These were completed by\nGPs of 93 cases (77%) and 87 matched controls (72%). The\ncomparison was restricted to the 124 (70 cases, 54 controls) whose\nGPs\u2019 records began before the children were aged 18 months.\nSerology\nIf consent was given, hospital workers took venipuncture or finger-\nprick samples from cases (if possible before treatment), and inter-\nviewers took finger-prick samples from controls. Sera were sent to\nthe NZ Communicable Disease Centre (NZCDC) for the following\nassays: measles immunoglobulin G (IgG), cytomegalovirus IgG,\nEpstein\u2013Barr virus capsid antigen (VCA) IgG, and poliomyelitis\nvirus (types 1\u20133) antibody titres. Analyses were based on pretreat-\nment results.", "mimetype": "text/plain", "start_char_idx": 13127, "end_char_idx": 15014, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bdf8d3b1-068b-44c0-b839-f3519f7c727d": {"__data__": {"id_": "bdf8d3b1-068b-44c0-b839-f3519f7c727d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c875a373-f9dc-4e48-b907-25a725734423", "node_type": "1", "metadata": {}, "hash": "37fcf5399851284d9f16baaf82e57e0bcc2c3f62ad733b4da4bb9be5ab67398e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5be868f9-874b-40fe-8248-caf280977b59", "node_type": "1", "metadata": {}, "hash": "bedea6d13c3d95e6765c67d7ee0c64e80ae9af57e25ece0a3d7e10b703044d9c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Analyses were based on pretreat-\nment results. Serological testing was conducted for 116 (96%) of\nthe 121 cases (but only 41 (34%) had pretreatment samples) and for\n127 (42%) of the 303 controls (interviewers had difficulties\nobtaining enough blood from controls). Antibody levels were cate-\ngorized as suggested a priori by the NZCDC. Measles, Epstein\u2013\nBarr virus and cytomegalovirus antibody results were reported as\nan index and categorized as: > 1.1 (positive), < 0.9 (negative) and\n0.9\u20131.1 (equivocal). Poliomyelitis antibody titres were categorized\nas: < 8 (no detectable antibodies), 8\u201332 (low antibody response),\n64\u2013256 (moderate) and 512 to > 1024 (high). Because there were\n1486\nJD Dockerty et al\nBritish Journal of Cancer (1999) 80(9), 1483\u20131489\n\u00a9 1999 Cancer Research Campaign \nTable 4\nOdds ratios for childhood leukaemias in relation to the child\u2019s vaccinations\nAdjusted for age in years\nAdjusted for age, sex, and\nand sex only\nother variablesb\nNo. of\nNo. of\nOdds\n95% CI Bounds\nOdds\n95% CI Bounds\nVaccination\nCategories\ncasesa controlsa ratio\nLower\nUpper\nratio\nLower\nUpper\nHad all usual immunizations?\nNo\n5\n25\n1.00\n1.00\n(if \u2018no\u2019 & due to cancer, excluded)\nYes\n94\n268\n2.10\n0.75\n5.83\n2.38\n0.73\n7.74\nHad any \u2018other\u2019 vaccinations before\nNo\n117\n291\n1.00\n1.00\nreference date?\nYes\n2\n6\n0.93\n0.18\n4.91\n0.63\n0.06\n6.26\nTriple vaccinec\nNo\n38\n88\n1.00\n1.00\nYes\n80\n197\n0.73\n0.44\n1.20\n1.01\n0.52\n1.95\nDouble vaccine\nNo\n57\n151\n1.00\n1.", "mimetype": "text/plain", "start_char_idx": 14968, "end_char_idx": 16397, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5be868f9-874b-40fe-8248-caf280977b59": {"__data__": {"id_": "5be868f9-874b-40fe-8248-caf280977b59", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bdf8d3b1-068b-44c0-b839-f3519f7c727d", "node_type": "1", "metadata": {}, "hash": "fbaa10856c485d9a1d6d9aeecda7df77cb6033f521865312b52fc83b29118511", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "936bf859-5e50-4ead-a66c-bbee5fb6b51e", "node_type": "1", "metadata": {}, "hash": "172f251bd46a7b7f6166ab2a117f49c2cfd79ba7bbbe4754a4597e6eda0473dc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "00\nYes\n80\n197\n0.73\n0.44\n1.20\n1.01\n0.52\n1.95\nDouble vaccine\nNo\n57\n151\n1.00\n1.00\nYes\n57\n132\n0.84\n0.52\n1.37\n0.82\n0.44\n1.54\nPolio sip\nNo\n37\n87\n1.00\n1.00\nYes\n80\n197\n0.74\n0.45\n1.23\n0.90\n0.47\n1.74\nHepatitis B vaccine\nNo\n52\n131\n1.00\n1.00\nYes\n62\n151\n0.69\n0.41\n1.17\n0.93\n0.49\n1.76\nMeasles vaccine\nNo\n55\n166\n1.00\n1.00\nYes\n58\n106\n1.52\n0.95\n2.45\n1.87\n1.00\n3.48\nMMR vaccine\nNo\n112\n270\n1.00\n1.00\nYes\n6\n15\n0.73\n0.27\n2.00\n0.80\n0.26\n2.42\nRubella (alone) vaccine\nNo \n114\n257\n1.00\n1.00\nYes\n1\n5\n0.78\n0.08\n7.71\n0.50\n0.03\n8.10\nBCG Mantoux testing\nNo\n118\n295\n1.00\n1.00\nYes\n2\n2\n2.08\n0.27\n15.95\n1.74\n0.19\n15.86\nPolio booster\nNo\n112\n279\n1.00\n1.00\nYes\n5\n12\n0.99\n0.32\n3.04\n0.97\n0.26\n3.59\nBCG vaccine\nNo\n112\n284\n1.00\n1.00\nYes\n8\n11\n1.55\n0.60\n4.05\n1.05\n0.33\n3.32\nOther vaccines\nNo\n117\n280\n1.00\n1.00\nYes\n2\n17\n0.20\n0.05\n0.92\n0.21\n0.", "mimetype": "text/plain", "start_char_idx": 16321, "end_char_idx": 17119, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "936bf859-5e50-4ead-a66c-bbee5fb6b51e": {"__data__": {"id_": "936bf859-5e50-4ead-a66c-bbee5fb6b51e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5be868f9-874b-40fe-8248-caf280977b59", "node_type": "1", "metadata": {}, "hash": "bedea6d13c3d95e6765c67d7ee0c64e80ae9af57e25ece0a3d7e10b703044d9c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "777bb992-5f3c-41ef-a932-b75aa7e0753b", "node_type": "1", "metadata": {}, "hash": "f46333d6b24302067d92ab2d21f642c458f911cb80df996f47bec715160501b4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "33\n3.32\nOther vaccines\nNo\n117\n280\n1.00\n1.00\nYes\n2\n17\n0.20\n0.05\n0.92\n0.21\n0.04\n1.12\nNo. of different vaccinationsc\nNone\n37\n78\n1.00\n1.00\nOne or two\n3\n19\n0.26\n0.07\n0.95\n0.52\n0.12\n2.23\nThree or four\n34\n111\n0.55\n0.30\n0.98\n0.57\n0.27\n1.21\nFive or more\n44\n79\n0.80\n0.44\n1.46\n0.99\n0.45\n2.18\nAny vaccinations?\nNo\n37\n78\n1.00\n1.00\nYes\n81\n209\n0.62\n0.37\n1.03\n0.71\n0.36\n1.38\naChildren aged under 3 months on the reference date were excluded from the analyses for: \u2018all usual immunizations\u2019, \u2018any other vaccinations\u2019, triple, double,\nhepatitis B, BCG and \u2018other\u2019 vaccines; and BCG Mantoux testing. Children aged under 6 months on the reference date were excluded from the analyses for\npolio sip and polio booster. Children under 9 months on the reference date were excluded from the analyses for measles and MMR vaccines, no. of vaccines,\nand \u2018any vaccinations\u2019. Children aged under 15 months on the reference date were excluded from the analyses for rubella (alone) vaccine. bThe other variables\nin the multivariate models were: child\u2019s social class, child\u2019s ethnic group, mother\u2019s marital status, mother\u2019s education, mother\u2019s home ownership, household\ncrowding, delay from reference date to interview, interview year. cSpecific vaccinations (triple, double, polio etc), including those contributing to the last two\nvariables in the table, were only counted if the year in which they were given was known and was before the reference year.\nfewer children in the serological analyses, a 20% cut-off was used\nto select confounders.", "mimetype": "text/plain", "start_char_idx": 17044, "end_char_idx": 18557, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "777bb992-5f3c-41ef-a932-b75aa7e0753b": {"__data__": {"id_": "777bb992-5f3c-41ef-a932-b75aa7e0753b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "936bf859-5e50-4ead-a66c-bbee5fb6b51e", "node_type": "1", "metadata": {}, "hash": "172f251bd46a7b7f6166ab2a117f49c2cfd79ba7bbbe4754a4597e6eda0473dc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f4e74f33-654b-4cb6-9321-3ceb85b4c678", "node_type": "1", "metadata": {}, "hash": "ef3ddd6f4e2c88cc0ba8ee28bfd12e4b0df1a7a7f3f4e0697b840e03c06a9e31", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "fewer children in the serological analyses, a 20% cut-off was used\nto select confounders.\n\ue00e\ue005\ue00f\ue011\ue00a\ue010\ue00f\nRisks of both combined leukaemias and ALL were significantly\nincreased among children from the \u2018no paid jobs\u2013not classifiable\u2019\nsocial class group, and significantly decreased among those whose\nmothers were married (Table 1). There were differences related to\nthe mother\u2019s education (P = 0.001); those whose mothers had no\nqualifications had the highest risks. For ALL, there was a signifi-\ncant decrease in risk associated with high gestational age, and a\nsignificant increase with maternal smoking in pregnancy.\nWe found no statistically significant associations of childhood\nleukaemia with maternal infections during the pregnancy or 3\nmonths before (Table 2), or with certain infections of the child at\nany time prior to 3 months before the reference date (Table 3). Risk\nwas significantly increased for reported influenza infection in the\nfirst year of life (adjusted odds ratio (OR) 6.8 (95% confidence\ninterval (CI) 1.8\u201325.7)). No associations were found with other\ninfections in the first year of life (Table 3), or with the number of\ndifferent types of infection. The findings for ALL (not shown)\nwere similar to those for combined leukaemias; for reported\ninfluenza the adjusted OR was 6.0 (1.4\u201326.2).\nMeasles vaccine (given alone) showed a raised leukaemia OR of\nborderline significance (1.9, 95% CI 1.0\u20133.5; Table 4). For\nInfections, vaccinations, and childhood leukaemia\n1487\nBritish Journal of Cancer (1999) 80(9), 1483\u20131489\n\u00a9 1999 Cancer Research Campaign \nTable 5\nOdds ratios for acute lymphoblastic leukaemia in relation to various factors indirectly related to exposure to infections\nAdjusted for age in years\nAdjusted for age, sex, and\nand sex only\nother variablesa\nNo. of\nNo.", "mimetype": "text/plain", "start_char_idx": 18468, "end_char_idx": 20260, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f4e74f33-654b-4cb6-9321-3ceb85b4c678": {"__data__": {"id_": "f4e74f33-654b-4cb6-9321-3ceb85b4c678", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "777bb992-5f3c-41ef-a932-b75aa7e0753b", "node_type": "1", "metadata": {}, "hash": "f46333d6b24302067d92ab2d21f642c458f911cb80df996f47bec715160501b4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "51029807-d168-4d24-ba8c-512fa3178f0b", "node_type": "1", "metadata": {}, "hash": "ce221f8eb2b399143a329209f6f5e77941a28e2b2f40b51c85cb0b9cf2fe04e0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "of\nNo. of\nOdds\n95% CI Bounds\nOdds\n95% CI Bounds\nFactor/exposure\nCategories\ncases controls\nratio\nLower\nUpper\nratio\nLower\nUpper\nHow many houses did child live \nNone or One\n32\n137\n1.00\n1.00\nin before reference date?\nTwo\n32\n92\n1.47\n0.82\n2.66\n1.48\n0.81\n2.72\nThree or more\n33\n74\n2.52\n1.31\n4.85\n2.36\n1.19\n4.67\nHousehold crowding: average \n\u22640.50\n18\n35\n1.00\n1.00\nno. of people per room in house \n>0.50 to 1.00\n60\n224\n0.49\n0.25\n0.97\n0.44\n0.21\n0.92\nchild lived in at birth\n>1.00\n16\n40\n0.87\n0.36\n2.06\n0.61\n0.22\n1.64\nDid child share a bedroom\nNo\n24\n105\n1.00\n1.00\nin house lived in at birth?\nYes\n70\n194\n1.36\n0.79\n2.35\n1.15\n0.65\n2.03\nWas index child the mother\u2019s \nNo\n60\n197\n1.00\n1.00\nfirstborn?\nYes\n37\n106\n1.09\n0.66\n1.80\n1.09\n0.66\n1.80\nDid mother live on farm during the \nNo\n84\n245\n1.00\n1.00\npregnancy or 3 months before?\nYes\n13\n58\n0.64\n0.32\n1.24\n0.77\n0.38\n1.55\nDid child ever live on a farm for more \nNo\n83\n231\n1.00\n1.00\nthan 1 month before reference date?", "mimetype": "text/plain", "start_char_idx": 20254, "end_char_idx": 21196, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "51029807-d168-4d24-ba8c-512fa3178f0b": {"__data__": {"id_": "51029807-d168-4d24-ba8c-512fa3178f0b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f4e74f33-654b-4cb6-9321-3ceb85b4c678", "node_type": "1", "metadata": {}, "hash": "ef3ddd6f4e2c88cc0ba8ee28bfd12e4b0df1a7a7f3f4e0697b840e03c06a9e31", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fc339b9b-e915-4135-b279-d26d722f96a3", "node_type": "1", "metadata": {}, "hash": "705b280454259dd95a6ce4850a046915b480998ac2cb3705c32db760ca467043", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Yes\n14\n68\n0.62\n0.32\n1.20\n0.75\n0.38\n1.48\nDid child have regular contact with \nNo\n39\n94\n1.00\n1.00\nother children from outside home at\n<12 monthsb\nYes\n51\n172\n0.67\n0.40\n1.12\n0.65\n0.36\n1.17\nDid mother breastfeed the child?\nNo\n8\n34\n1.00\n1.00\nYes\n89\n269\n1.10\n0.47\n2.56\n0.98\n0.39\n2.47\nAge child was when mother gave last\nChild not breastfed\n8\n34\n1.00\n1.00\nbreastfeed\n2 days to 6 months\n47\n123\n1.35\n0.56\n3.27\n1.24\n0.47\n3.23\n>6 months to 1 year\n25\n84\n0.88\n0.35\n2.25\n0.82\n0.29\n2.27\nover 1 year\n15\n62\n0.73\n0.27\n1.98\n0.47\n0.15\n1.43\nAge child was when solid food was\n4 months or younger\n44\n180\n1.00\n1.00\nfirst introduced\nolder than 4 months\n48\n122\n1.60\n0.98\n2.61\n1.25\n0.73\n2.12\nHow did mother sterilize child\u2019s\nDidn\u2019t sterilize them\n24\n82\n1.00\n1.00\nbottles/utensils?", "mimetype": "text/plain", "start_char_idx": 21197, "end_char_idx": 21949, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fc339b9b-e915-4135-b279-d26d722f96a3": {"__data__": {"id_": "fc339b9b-e915-4135-b279-d26d722f96a3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "51029807-d168-4d24-ba8c-512fa3178f0b", "node_type": "1", "metadata": {}, "hash": "ce221f8eb2b399143a329209f6f5e77941a28e2b2f40b51c85cb0b9cf2fe04e0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8cc5425e-44ad-4d5d-a800-a710e687d717", "node_type": "1", "metadata": {}, "hash": "8af2cdaa860fb294822d0b60f1856f454e5e50f57970c5a7d625eb9ab5bbc975", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Boiling\n38\n107\n1.39\n0.75\n2.57\n1.39\n0.75\n2.57\nSolution or tablets\n35\n108\n1.28\n0.69\n2.37\n1.28\n0.69\n2.37\nDid child ever have a blood \nNo\n94\n299\n1.00\n1.00\ntransfusion before reference date?c\nYes\n3\n3\n2.30\n0.42\n12.64\n2.54\n0.35\n18.30\naThe other variables in the multivariate models were as follows: \u2018residential mobility\u2019: mother\u2019s marital status, child\u2019s infection with influenza in the first year of\nlife; \u2018household crowding\u2019: child\u2019s social class, mother\u2019s marital status, mother\u2019s education, child\u2019s infection with influenza in the first year of life, age child was\nwhen solid food was first introduced; \u2018bedroom sharing\u2019: child\u2019s social class, mother\u2019s education; \u2018firstborn\u2019: no other variables; \u2018mother living on a farm in\npregnancy\u2019: child\u2019s social class, mother\u2019s marital status; for \u2018child living on a farm\u2019: child\u2019s social class; \u2018regular contact with other children\u2019: child\u2019s social class,\nmother\u2019s marital status, mother\u2019s educational level, mother\u2019s smoking during pregnancy, household crowding, residential mobility, and delay from reference date\nto interview; \u2018breastfeeding\u2019 and \u2018age stopped breastfeeding\u2019: child\u2019s social class, mother\u2019s education, household crowding, delay from reference date to\ninterview; \u2018age when solid food introduced\u2019: household crowding, delay from reference date to interview; \u2018method of sterilization of bottles/utensils\u2019: no other\nfactors; \u2018blood transfusion\u2019: child\u2019s social class, mother\u2019s home ownership, mother\u2019s education, delay from reference date to interview. bIn the analyses for\n\u2018regular contact with other children from outside the home at under 12 months of age\u2019, cases and controls who were aged less than 15 months on their\nreference dates were excluded. cTransfusions within 3 months of the reference date are excluded.\nMeasles/Mumps/Rubella (MMR), the OR was 0.8.", "mimetype": "text/plain", "start_char_idx": 21950, "end_char_idx": 23769, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8cc5425e-44ad-4d5d-a800-a710e687d717": {"__data__": {"id_": "8cc5425e-44ad-4d5d-a800-a710e687d717", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fc339b9b-e915-4135-b279-d26d722f96a3", "node_type": "1", "metadata": {}, "hash": "705b280454259dd95a6ce4850a046915b480998ac2cb3705c32db760ca467043", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2584f57c-437e-4bec-91ed-6b15b5f9c2ef", "node_type": "1", "metadata": {}, "hash": "00c0250ff494946bb6a2e634811f53f01b76a045758424f4e0323997bf1ff441", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cTransfusions within 3 months of the reference date are excluded.\nMeasles/Mumps/Rubella (MMR), the OR was 0.8. Although there\nwere some significant findings for intermediate categories of the\nnumber of different vaccinations of the child, the ORs moved\ntowards 1.0 and lost significance with adjustment for other\nconfounders. There was no significant trend with the number of\ndifferent vaccinations (P = 0.84). The ORs for ALL (not shown)\nwere similar.\nFor ALL there was a positive trend (P = 0.01) in relation to resi-\ndential mobility (Table 5). The OR for household crowding was\nsignificantly reduced for the middle category, but there was no\ntrend (P = 0.28). There was a trend in ALL risk with increasing\nduration of breastfeeding (P = 0.04); those breastfed for more than\na year had the lowest risk (OR 0.5). No significant associations\nwere found with attendance at particular types of preschool groups\nin the first year of life (results not shown). There were no signifi-\ncant associations between leukaemia and living with pets (dogs,\ncats, other furry animals or birds) during the pregnancy or the 3\nmonths before (mother), or before the reference date (child)-\nadjusted results, not shown.\nAdjusted ALL results from unconditional versus\nconditional logistic regression\nThe unmatched and matched analyses gave similar results for ALL\n(within the bounds of statistical variation). The confidence inter-\nvals from the matched were usually wider. Influenza in the first\nyear was associated with a non-significant increase in ALL risk in\nthe conditional logistic regression (OR 9.1, 95% CI 0.9\u201388.7).", "mimetype": "text/plain", "start_char_idx": 23659, "end_char_idx": 25265, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2584f57c-437e-4bec-91ed-6b15b5f9c2ef": {"__data__": {"id_": "2584f57c-437e-4bec-91ed-6b15b5f9c2ef", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8cc5425e-44ad-4d5d-a800-a710e687d717", "node_type": "1", "metadata": {}, "hash": "8af2cdaa860fb294822d0b60f1856f454e5e50f57970c5a7d625eb9ab5bbc975", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e7a70616-ea7e-4b21-b4c9-037bd31a27e0", "node_type": "1", "metadata": {}, "hash": "e4c1cc8517652217af81203bbf998b709e66ec9a3c76acc5d1ce279e91797fa2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Influenza in the first\nyear was associated with a non-significant increase in ALL risk in\nthe conditional logistic regression (OR 9.1, 95% CI 0.9\u201388.7). The\nvariables showing significant or borderline associations in the\nconditional logistic regression were eye infections in the first year\nof life (OR 0.2, 95% CI 0.1\u20130.7), residential mobility (highest\ncategory OR 2.3, 95% CI 1.0\u20134.9), household crowding (middle\ncategory OR 0.3, 95% CI 0.1\u20131.0; highest category OR 0.4, 95%\nCI 0.1\u20131.8), and age at which solids were introduced (> 4 vs \u22644\nmonths OR 1.9, 95% CI 1.0\u20133.5).\nComparison of information from mothers and GPs\nFor birth weight, MMR vaccination, measles infection and mouth\ninfection, the percentage agreement was 80% or more for both cases\nand controls. For measles vaccination, polio vaccination, ear infec-\ntion, upper respiratory tract infection and diarrhoea and vomiting,\nthe agreement was poor (below 80%) for controls and/or cases. For\neach variable, the percentage agreement did not differ significantly\nbetween cases and controls (\u03c72 with Yates\u2019 correction).\nSerology\nThe adjusted childhood leukaemia OR for poliovirus type 1\nserology (\u2018high\u2019 vs \u2018no or low\u2019 titres) was 14.6 (95% CI\n1.6\u2013136.1). The results for measles, Epstein\u2013Barr virus,\ncytomegalovirus and polioviruses types 2 and 3 showed no signif-\nicant associations. Further details are available elsewhere\n(Dockerty, 1997).\n\ue004\ue008\ue00f\ue003\ue011\ue00f\ue00f\ue008\ue00d\ue00c\nThere was little evidence of associations between childhood\nleukaemia and infections; the exception being a statistically signif-\nicant increase in risk with reported influenza in the first year of life\n(OR 6.8, 95% CI 1.8\u201325.7). This may be a chance association due\nto multiple comparisons.", "mimetype": "text/plain", "start_char_idx": 25113, "end_char_idx": 26818, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e7a70616-ea7e-4b21-b4c9-037bd31a27e0": {"__data__": {"id_": "e7a70616-ea7e-4b21-b4c9-037bd31a27e0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2584f57c-437e-4bec-91ed-6b15b5f9c2ef", "node_type": "1", "metadata": {}, "hash": "00c0250ff494946bb6a2e634811f53f01b76a045758424f4e0323997bf1ff441", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "66764eee-cd51-44b5-a758-34c31e317919", "node_type": "1", "metadata": {}, "hash": "4dd5e9e0cd9baa316a8e432900d6ef724448255440c0f4f43d18b6c520b74fc7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This may be a chance association due\nto multiple comparisons. \u2018Influenza\u2019 was specified on prompt\ncards used by the interviewers. It could be confused with other\nviruses or be asymptomatic, but such misclassification should be\nnon-differential, moving the OR towards 1.0. For seven of the nine\nexposed cases and three of the four exposed controls, the mothers\nreported that the GP was consulted. This high consultation rate is\nconsistent with the diagnosis. But even for GPs, diagnosis can be\ndifficult.\nWe checked for significant bias due to non-participation or\nrecall using two variables from the birth registrations: the parents\u2019\nmarital status (recording of date of marriage) and the paternal\noccupation (whether or not it was given; unemployed and retired\nwere counted as no occupation). Relevant information was avail-\nable for 129 of 131 eligible cases. There was no difference in the\npercentage married (68% of interviewed and 67% of eligible) or in\nthe percentage giving no paternal occupation (13% interviewed\nand 14% eligible). For the controls, the 94 non-interviewed first-\nchoice controls were compared with the 94 replacements (whose\nparents were interviewed). Significant differences were found. The\npercentages married were 65% (non-interviewed first-choice), and\n94% (interviewed replacement controls). The percentages with no\nlisted paternal occupation were 13% (non-interviewed first-\nchoice) and 3% (interviewed replacements). Logistic regressions\nwere conducted using the birth information from the eligible cases\n(129 with information) and the 303 eligible first-choice controls.\nIn the eligible population, the risk of leukaemia was decreased for\nchildren whose mothers were married (age- and sex-adjusted OR\n0.5, 95% CI 0.3\u20130.9); and increased for children whose birth\nrecords gave no paternal occupation (age- and sex-adjusted OR\n2.0, 95% CI 1.1\u20134.0). Each association was in the same direction\nas the associations found among the participants.\nThus, even when the bias due to non-participation was elimi-\nnated for these variables (and recall bias could not have occurred),\nthe same kinds of associations were found.", "mimetype": "text/plain", "start_char_idx": 26757, "end_char_idx": 28901, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "66764eee-cd51-44b5-a758-34c31e317919": {"__data__": {"id_": "66764eee-cd51-44b5-a758-34c31e317919", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e7a70616-ea7e-4b21-b4c9-037bd31a27e0", "node_type": "1", "metadata": {}, "hash": "e4c1cc8517652217af81203bbf998b709e66ec9a3c76acc5d1ce279e91797fa2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "16319c5d-e5cf-4fc6-a25b-113bdbe7c853", "node_type": "1", "metadata": {}, "hash": "01a2131be06fc399f8f1844cf0bbba1e25bff27dd2e5f38b8ead676af5e33646", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Thus, even when the bias due to non-participation was elimi-\nnated for these variables (and recall bias could not have occurred),\nthe same kinds of associations were found. This increases confi-\ndence in the main results for childhood leukaemia related to\nmarital status and social class. The differences between the\neligible population and the participants are unlikely to be impor-\ntant enough to account for the observed strong association with\ninfluenza, which persisted after controlling for confounders such\nas residential mobility and social class. However, confounding by\nan unknown strong risk factor cannot be ruled out. The association\nwith reported influenza was based on small numbers of exposed\nchildren and there were multiple comparisons, so it may be due to\nchance. It was not specific to leukaemias, because analyses\ncomparing children with combined solid cancers and the controls\nalso showed an association with reported influenza in the first\nyear of life (age- and sex-adjusted OR 4.0 (1.2\u201314.0); multiple\nvariable-adjusted OR 4.1 (1.1\u201315.2)). This could indicate a low\nestimate of the exposure prevalence in the control group, due to\nchance variation or bias. A causal interpretation may be less likely,\nbut cannot be ruled out.\nNo previous case-control or cohort studies have reported on\ninfluenza infections of the child. In a cohort study, Fedrick and\nAlberman (1972) found a strong positive association between\ninfluenza of the mother during the pregnancy and leukaemia or\nlymphoma of the child up to age 11 years (relative risk 9, P <\n0.001). In the Oxford Survey of Childhood Cancers, a case-control\nstudy, there was an increased risk of combined childhood cancers\nin relation to influenza in pregnancy (OR 1.5, 95% CI 1.1\u20132.1), but\nno association for leukaemias separately (Bithell et al, 1973).", "mimetype": "text/plain", "start_char_idx": 28729, "end_char_idx": 30553, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "16319c5d-e5cf-4fc6-a25b-113bdbe7c853": {"__data__": {"id_": "16319c5d-e5cf-4fc6-a25b-113bdbe7c853", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "66764eee-cd51-44b5-a758-34c31e317919", "node_type": "1", "metadata": {}, "hash": "4dd5e9e0cd9baa316a8e432900d6ef724448255440c0f4f43d18b6c520b74fc7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f95f3b4a-2370-4c4a-9477-536ce9754eff", "node_type": "1", "metadata": {}, "hash": "ace30c32d4a63747dc9c74207d6bc6bfa76b6b7c0a9ee48128d90d2cbda55d79", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\ncomparability of these with the current study depends on whether\n1488\nJD Dockerty et al\nBritish Journal of Cancer (1999) 80(9), 1483\u20131489\n\u00a9 1999 Cancer Research Campaign \ninfluenza infections in-utero and in early childhood could have\nsimilar effects. There are several mechanisms by which particular\nviruses can cause cancer (Dimmock and Primrose, 1994), but there\nis no more direct evidence of a carcinogenic potential of influenza\nviruses. The current finding for reported influenza needs further\ntesting in analytical studies elsewhere.\nThe small increase in leukaemia risk with measles vaccination is\nof borderline statistical significance (OR 1.9, 95% CI 1.0\u20133.5).\nThis is likely to be a chance finding because the odds ratios for\nMMR vaccination and measles serology were below 1.0.\nGreaves\u2019 hypothesis\nGreaves\u2019 (1988) hypothesis predicted an increased risk of B-cell\nprecursor ALL for those of higher socioeconomic level, firstborn\nchildren, and those with delayed or diminished exposure to\ncommon infections in infancy (Greaves, 1988; Neglia et al, 1990).\nProlonged breastfeeding, day-care attendance, crowding in houses\nand timely completion of early childhood immunizations were\npredicted to decrease the risk of B-precursor ALL (Greaves, 1988;\nNeglia et al, 1990; Greaves and Alexander, 1993). Greaves\u2019 (1988)\nhypothesis is not consistently supported by our results. In partic-\nular, the socioeconomic findings for ALL were in the opposite\ndirection to that predicted, even in the eligible population. There\nwas no association between ALL and firstborn status (OR 1.1),\nnumber of different infections in the first year of life (\u22653 infec-\ntions, OR 1.3) or attendance at preschool groups. The OR for \u2018any\nregular contact with children from outside the home\u2019 (0.7) was in\nthe direction predicted, but not statistically significant. The find-\nings for the highest categories of household crowding and duration\nof breastfeeding were in the direction predicted. There was no\nassociation with the number of vaccinations (\u22655 vaccinations,\nALL OR 1.1).", "mimetype": "text/plain", "start_char_idx": 30554, "end_char_idx": 32614, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f95f3b4a-2370-4c4a-9477-536ce9754eff": {"__data__": {"id_": "f95f3b4a-2370-4c4a-9477-536ce9754eff", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "16319c5d-e5cf-4fc6-a25b-113bdbe7c853", "node_type": "1", "metadata": {}, "hash": "01a2131be06fc399f8f1844cf0bbba1e25bff27dd2e5f38b8ead676af5e33646", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "653fec17-3a27-4c20-ae94-7d275575714d", "node_type": "1", "metadata": {}, "hash": "f35e04701ae4db3fa16caf5c2eaab75256f06ddc78ce851a3002b7504b48604b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The find-\nings for the highest categories of household crowding and duration\nof breastfeeding were in the direction predicted. There was no\nassociation with the number of vaccinations (\u22655 vaccinations,\nALL OR 1.1). Analyses restricted to the 87 cases with B-cell\nprecursor ALL showed very similar results (not shown). However,\na larger study would be needed to find a small effect or an effect\nlimited to certain subgroups.\nResidential mobility\nThere was a significant positive association with residential\nmobility. Of the 303 eligible first-choice controls, 46 (15%) did not\nparticipate because they could not be traced. They almost certainly\nmoved houses, and residential mobility among the controls would\nbe underestimated. Therefore, this association is probably\nspurious, and should not be regarded as evidence supporting\nKinlen\u2019s hypothesis.\nPoliovirus serology\nAlthough there was an increased risk of leukaemia in relation to\npoliovirus type 1 serology, there was no clear dose\u2013response and\nno association with oral poliomyelitis vaccine (questionnaire).\nLow percentages of cases and controls contributed serological\ninformation, and the smaller numbers meant that confounder\ncontrol was limited. The increased risk for poliovirus type 1 may\nbe due to residual confounding or chance variation.\n\ue003\ue00d\ue00c\ue003\ue00a\ue011\ue00f\ue008\ue00d\ue00c\nThis study gives little support to hypotheses of an infective aeti-\nology for childhood leukaemia. The raised odds ratio for reported\ninfluenza infection in the first year of life could be real, or due to\nchance variation. The questions about infectious exposures were\nbased on those of the large UK childhood cancer study, which\nshould soon produce results.", "mimetype": "text/plain", "start_char_idx": 32400, "end_char_idx": 34071, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "653fec17-3a27-4c20-ae94-7d275575714d": {"__data__": {"id_": "653fec17-3a27-4c20-ae94-7d275575714d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f95f3b4a-2370-4c4a-9477-536ce9754eff", "node_type": "1", "metadata": {}, "hash": "ace30c32d4a63747dc9c74207d6bc6bfa76b6b7c0a9ee48128d90d2cbda55d79", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a570ccc1-808d-4f46-8dd3-1414e6e726e7", "node_type": "1", "metadata": {}, "hash": "53d86c8411c72f9fd9df4f46bbc42645c340536b37faa6b7e50b2e3d8b2272ab", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The questions about infectious exposures were\nbased on those of the large UK childhood cancer study, which\nshould soon produce results.\n\ue002\ue003\ue009\ue00c\ue00d\ue012\ue00a\ue005\ue004\ue006\ue005\ue00b\ue005\ue00c\ue010\ue00f\nWe are grateful to all the families who took part, and to:\nInterviewers: J Adams-Schneider, P Babe, C Brown, P Carr, J\nCottrell, J Egan, V Leigh, J Ross, Jill Sye and Joan Sye;\nSecretaries and Research Assistants: E Andrews, S McCord, S\nPaulin, M Stevens and J Ward; NZCDC: J Miller and P Raynel;\nNZ Cancer Registry: J Fraser, L Mooney and B Wordsworth;\nPathologists: B Berkeley, Y Chan, B Synek and L Teague;\nClinicians: G Abbott, D Holdaway, S Macfarlane, D Mauger, B\nRobinson, J Skeen and teams; Others (for contributions or advice):\nJL Dockerty, Sir R Doll, P McKinney, C Manning, E Roman, K\nSharples, J Smeijers and G Spears. This study was funded by\nHealth Research Council of NZ, NZ Lottery Grants Board, A.B. de\nLautour Charitable Trust, Otago Medical School, Transpower NZ,\nCancer Society of NZ, Otago Medical Research Foundation and\nVariety Handcrafts.\nREFERENCES\nBithell JF, Draper GJ and Gorbach PD (1973) Association between malignant\ndisease in children and maternal virus infections. Br Med J 1: 706\u2013708\nBreslow NE and Day NE (1980) Statistical Methods in Cancer Research, Vol 1 \u2013 The\nAnalysis of Case-Control Studies. International Agency for Research on\nCancer: Lyon\nDimmock NJ and Primrose SB (1994) Introduction to Modern Virology, 4th edn.\nBlackwell Science: Oxford\nDockerty JD (1997) The epidemiology of childhood leukaemia in New Zealand,\nwith particular reference to hypotheses related to an infective cause. University\nof Otago, Dunedin, New Zealand. pp. 1\u2013535. Thesis for the degree of Doctor of\nPhilosophy.", "mimetype": "text/plain", "start_char_idx": 33936, "end_char_idx": 35621, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a570ccc1-808d-4f46-8dd3-1414e6e726e7": {"__data__": {"id_": "a570ccc1-808d-4f46-8dd3-1414e6e726e7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "653fec17-3a27-4c20-ae94-7d275575714d", "node_type": "1", "metadata": {}, "hash": "f35e04701ae4db3fa16caf5c2eaab75256f06ddc78ce851a3002b7504b48604b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cd09000f-1e4c-4243-9eec-ed38f3afe889", "node_type": "1", "metadata": {}, "hash": "d9801dd4d3e11eefb56b5bc864f050668b3c690440446c149ef5cfebf425efcb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "University\nof Otago, Dunedin, New Zealand. pp. 1\u2013535. Thesis for the degree of Doctor of\nPhilosophy.\nDockerty JD, Elwood JM, Skegg DCG and Herbison GP (1998) Electromagnetic\nfield exposures and childhood cancers in New Zealand. Cancer Causes Control\n9: 299\u2013309\nFedrick J and Alberman ED (1972) Reported influenza in pregnancy and subsequent\ncancer in the child. Br Med J 2: 485\u2013488\nGreaves MF (1988) Speculations on the cause of childhood acute lymphoblastic\nleukemia. Leukemia 2: 120\u2013125\nGreaves MF and Alexander FE (1993) An infectious etiology for common acute\nlymphoblastic leukaemia in childhood? Leukemia 7: 349\u2013360\nHamajima N, Hirose K, Inoue M, Takezaki T, Kuroishi T and Tajima K. (1994)\nCase-control studies: matched controls or all available controls? J. Clin.\nEpidemiol. 47: 971\u2013975.\nKinlen L (1988) Evidence for an infective cause of childhood leukaemia:\ncomparison of a Scottish new town with nuclear reprocessing sites in Britain.\nLancet ii: 1323\u20131327\nKinlen LJ (1996) Epidemiological evidence for an infective basis in childhood\nleukaemia. J. Roy. Soc. Health 116: 393\u2013399\nKinlen LJ (1997) High-contact paternal occupations, infection and childhood\nleukaemia: five studies of unusual population-mixing of adults. Br. J. Cancer\n76: 1539\u20131545\nMaldonado G and Greenland S. (1993) Simulation study of confounder-selection\nstrategies. Am. J. Epidemiol. 138: 923\u2013936.\nNeglia JP, Severson RK and Linet MS (1990) A reply to MF Greaves: toward a\ntestable etiology of childhood acute lymphoblastic leukemia. Leukemia 4:\n517\u2013521.\nOffice of Population Censuses and Surveys (1991) Standard Occupational\nClassification, Vol 3 \u2013 Social Classifications and Coding Methodology.", "mimetype": "text/plain", "start_char_idx": 35521, "end_char_idx": 37197, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cd09000f-1e4c-4243-9eec-ed38f3afe889": {"__data__": {"id_": "cd09000f-1e4c-4243-9eec-ed38f3afe889", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Dockerty (1999).pdf", "node_type": "4", "metadata": {}, "hash": "5805781fe0fccb4fad4e3556a61f8a420dfdb9d128a035e46a0b8221e8b4ee81", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a570ccc1-808d-4f46-8dd3-1414e6e726e7", "node_type": "1", "metadata": {}, "hash": "53d86c8411c72f9fd9df4f46bbc42645c340536b37faa6b7e50b2e3d8b2272ab", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Leukemia 4:\n517\u2013521.\nOffice of Population Censuses and Surveys (1991) Standard Occupational\nClassification, Vol 3 \u2013 Social Classifications and Coding Methodology. HMSO:\nLondon\nRothman KJ (1986) Modern Epidemiology. Little, Brown: Boston\nInfections, vaccinations, and childhood leukaemia\n1489\nBritish Journal of Cancer (1999) 80(9), 1483\u20131489\n\u00a9 1999 Cancer Research Campaign", "mimetype": "text/plain", "start_char_idx": 37035, "end_char_idx": 37408, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f5bf758f-8c8b-4a26-b87f-0a49a0d1b17f": {"__data__": {"id_": "f5bf758f-8c8b-4a26-b87f-0a49a0d1b17f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5b204e55-5058-4051-87f0-5201f4bdd5af", "node_type": "1", "metadata": {}, "hash": "30958a26eca0d5e4239d2890dcdbcc9f1cd59bc4e4ba983b56e9d37a2fde9ded", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "NEURO-EPIDEMIOLOGY\nA population-based case\u2013control study on viral infections\nand vaccinations and subsequent multiple sclerosis risk\nCecilia Ahlgren \u00c6 Kjell Tore\u00b4n \u00c6\nAnders Ode\u00b4n \u00c6 Oluf Andersen\nReceived: 16 January 2009 / Accepted: 25 June 2009 / Published online: 26 July 2009\n\u0001 Springer Science+Business Media B.V. 2009\nAbstract\nViral infections are probably involved in the\npathogenesis of multiple sclerosis (MS). A recent cohort\nstudy in the Gothenburg population revealed no change\nin MS incidence associated with the introduction of the\nSwedish measles, mumps and rubella vaccination pro-\ngrammes. The aim of the present study was to clarify\nwhether these infections or vaccinations, and two other\ninfections, varicella and infectious mononucleosis, in\ufb02u-\nence MS risk. We performed a population-based case\u2013\ncontrol study in Gothenburg that included 509 MS cases\nand 2,067 controls, born 1959\u20131986. Data on infections\nand vaccinations were obtained from questionnaires and\nfrom child health and school health records. We found no\nsigni\ufb01cant associations between measles, mumps, rubella\nor varicella and MS risk. These results were consistent\nbetween the two source materials. Infectious mononucle-\nosis was associated with signi\ufb01cantly higher MS risk (odds\nratio 2.03, 95% CI 1.52\u20132.73). Overall, there was no sig-\nni\ufb01cant\nassociation\nbetween\nmeasles-mumps-rubella\n(MMR) vaccination and MS risk, while those MMR vac-\ncinated before age ten only were at signi\ufb01cantly higher MS\nrisk (odds ratio 4.92, 95% CI 1.97\u201312.20). Those MMR\nvaccinated both before and after age ten had intermediate\nMS risk. Infection with measles, mumps, rubella and var-\nicella did not in\ufb02uence MS risk in contrast to infectious\nmononucleosis which conferred doubled MS risk.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1756, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5b204e55-5058-4051-87f0-5201f4bdd5af": {"__data__": {"id_": "5b204e55-5058-4051-87f0-5201f4bdd5af", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f5bf758f-8c8b-4a26-b87f-0a49a0d1b17f", "node_type": "1", "metadata": {}, "hash": "d589632fa5169cfdac2fb839e5ae87943e487f280ec8d5d1d8b0f209bf10a76b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "815e7035-fc0d-4701-adf6-73e6caf8b80b", "node_type": "1", "metadata": {}, "hash": "42359f4a931f48e93db39baa70c507fc003082f57ff20e06b803cb5afa97b338", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Infection with measles, mumps, rubella and var-\nicella did not in\ufb02uence MS risk in contrast to infectious\nmononucleosis which conferred doubled MS risk. The\nassociation with \u2018early\u2019 MMR vaccination only was an\nisolated \ufb01nding, limited by a small number of subjects and\nmultiple testing. Most likely this was a chance \ufb01nding.\nFuture studies could investigate it on an a priori basis.\nKeywords\nMultiple sclerosis \u0001 Viral infections \u0001\nVaccinations \u0001 Case\u2013control study \u0001 Gender\nAbbreviations\nCI\nCon\ufb01dence interval\nCIS\nClinically isolated syndrome\nCSF\nCerebrospinal \ufb02uid\nEBV\nEpstein\u2013Barr virus\nMMR\nMeasles-mumps-rubella\nMRI\nMagnetic resonance imaging\nMS\nMultiple sclerosis\nOR\nOdds ratio\nIntroduction\nMultiple sclerosis (MS) is a complex autoimmune disease\nprobably resulting from an interaction between genetic and\nenvironmental factors. Epidemiological \ufb01ndings suggest-\ning exogenous causative factors are a decreased risk of MS\nafter migration to a low-risk area before adult age [1\u20133]\nand a tendency to increased risk after late occurrence of\ncommon childhood infections [4\u20137].\nSerological studies of cerebrospinal \ufb02uid (CSF) show that\na majority of MS patients carry an intrathecal in\ufb02ammation\nC. Ahlgren (&) \u0001 O. Andersen\nInstitute of Clinical Neuroscience, Sahlgrenska University\nHospital, 413 45 Gothenburg, Sweden\ne-mail: cecilia.ahlgren@neuro.gu.se\nK. Tore\u00b4n\nInstitute of Occupational and Environmental Medicine,\nSahlgrenska University Hospital, Gothenburg, Sweden\nA. Ode\u00b4n\nDepartment of Mathematical Sciences, Chalmers University\nof Technology, Gothenburg, Sweden\n123\nEur J Epidemiol (2009) 24:541\u2013552\nDOI 10.1007/s10654-009-9367-2\nwith immunoreactivity to one or more of the viruses of the\nchildhood or adolescence infections measles, mumps,\nrubella, varicella zoster or Epstein\u2013Barr virus (EBV) [8\u201315].", "mimetype": "text/plain", "start_char_idx": 1604, "end_char_idx": 3414, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "815e7035-fc0d-4701-adf6-73e6caf8b80b": {"__data__": {"id_": "815e7035-fc0d-4701-adf6-73e6caf8b80b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5b204e55-5058-4051-87f0-5201f4bdd5af", "node_type": "1", "metadata": {}, "hash": "30958a26eca0d5e4239d2890dcdbcc9f1cd59bc4e4ba983b56e9d37a2fde9ded", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2884c249-5c5c-47c7-9b42-f3f7180fd711", "node_type": "1", "metadata": {}, "hash": "41297b8be67209d2b5f1817bec6121fa7c55a15b045647a09c4f06c6a33061f3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "However, viral antibodies may be an unspeci\ufb01c part of the\nautoimmune process, possibly the result of a polyclonal\nstimulation of B cells [16]. Case\u2013control studies on serum\nantibodies generally showed no differences concerning\nseropositivity to measles, mumps and rubella [5, 17, 18].\nGenes related to MS are generally expressed in the immune\nresponse, which supports the hypothesis that infections are\ninvolved in MS pathogenesis [19]. Experimentally, the risk\nof development of autoimmune disease differs in non-sterile\nversus sterile environments [20].\nThe underlying conditions in Sweden were unique for\nthe study of the possible in\ufb02uence of viral infections on the\nrisk of subsequent MS, as national mass vaccination pro-\ngrammes resulted in increasingly large numbers of people\nwithout a history of measles, mumps or rubella. Monova-\nlent vaccines were introduced against measles in 1971,\nmumps in 1973, and rubella in 1974 [21, 22]. In 1982, a\ncombined measles-mumps-rubella (MMR) vaccine for\nadministration at both 18 months and 12 years of age was\nintroduced in Sweden as the \ufb01rst country in the world [23].\nBefore the introduction of these vaccination programmes\nmore than 80% of Swedish children had a history of\nmeasles [24], and half of them a history of mumps and\nrubella [25, 26]. The percentage of children with a history\nof measles declined to 12.5% in children born in 1975 and\nfell further to 5.5% in children born in 1978 following mass\nvaccinations. The frequency of these three diseases drop-\nped to about 1% in children born in the 1980s (annual data\nfrom Child Health Centres, the Swedish Institute for\nInfectious\nDisease\nControl,\npersonal\ncommunication)\n(Fig. 1).\nA recent birth cohort and incidence cohort study was\ndesigned to analyse MS incidence during the period of\nimplementation of the Swedish national vaccination pro-\ngrammes. A baseline cohort represented the prevaccine era\nin inhabitants of Gothenburg born 1959\u20131961.", "mimetype": "text/plain", "start_char_idx": 3415, "end_char_idx": 5369, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2884c249-5c5c-47c7-9b42-f3f7180fd711": {"__data__": {"id_": "2884c249-5c5c-47c7-9b42-f3f7180fd711", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "815e7035-fc0d-4701-adf6-73e6caf8b80b", "node_type": "1", "metadata": {}, "hash": "42359f4a931f48e93db39baa70c507fc003082f57ff20e06b803cb5afa97b338", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "05a3e6da-7a24-43ad-a22a-f219213af2ce", "node_type": "1", "metadata": {}, "hash": "2523cc38056ba2d173c36d1fc8e3fcca2bdb6e253f8bb37000b01578269cf3cd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "A baseline cohort represented the prevaccine era\nin inhabitants of Gothenburg born 1959\u20131961. Four cohorts\nborn between 1962 and 1984 were selected to cover a sharp\nchange into each new vaccination programme. The MS\nincidence showed an age-related continuous increase\nthroughout the study period, but no stepwise increase from\nbaseline and previous cohorts to any of the cohorts selected\nto represent a new vaccination programme. Thus, there was\nno indication that the increasing MS incidence was related\nto the mass vaccination programmes [27]. However,\nalthough the vaccination programmes were coordinated\nnationwide, our cohorts were still relatively inhomoge-\nneous, and the power was limited. We therefore performed\na case\u2013control study which, based on a multiplex data set\non each individual, examines whether measles, mumps and\nrubella infections and vaccinations, and two other infec-\ntions, varicella and infectious mononucleosis, in\ufb02uence the\nrisk of developing MS.\nMaterials and methods\nCases\nMultiple sclerosis patients included in the study were resi-\ndents of the Greater Gothenburg region for one or more\nyears, were born in 1959\u20131986, and had disease onset at age\nten or later. The study area and the greater part of the patient\nmaterial were the same as in the recent cohort study which\nwas restricted to the age group 10\u201339 years, born 1959\u2013\n1990 [27]. The percentage of MS patients with disease onset\nwithin the study area was 81.9%. A smaller proportion of\nMS patients, who ful\ufb01lled the inclusion criteria regarding\nresidence of Gothenburg, but were older than 39 years at\nMS onset or had MS onset outside the study area were\nincluded in the present case\u2013control study. Eight patients\nwho were included in the cohort study were deceased, and\n13 patients had emigrated. We refrained from contacting 22\npatients for psychological reasons. Inclusion of cases and\ncontrols was restricted to adults aged 18 years or over at the\ntime of receiving the questionnaire (Fig. 2).", "mimetype": "text/plain", "start_char_idx": 5276, "end_char_idx": 7264, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "05a3e6da-7a24-43ad-a22a-f219213af2ce": {"__data__": {"id_": "05a3e6da-7a24-43ad-a22a-f219213af2ce", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2884c249-5c5c-47c7-9b42-f3f7180fd711", "node_type": "1", "metadata": {}, "hash": "41297b8be67209d2b5f1817bec6121fa7c55a15b045647a09c4f06c6a33061f3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1f63207a-e09b-4bce-ab61-2707f0de2aea", "node_type": "1", "metadata": {}, "hash": "0d835173db4ac45645e46ab46b139e2bd8450772edaaf2009950733140556c64", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We refrained from contacting 22\npatients for psychological reasons. Inclusion of cases and\ncontrols was restricted to adults aged 18 years or over at the\ntime of receiving the questionnaire (Fig. 2). Brie\ufb02y, we\n60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85\nYear of vaccine introduction\nAge\n>50%\n1971 Measles (monovalent vaccine) \n<7 y\n1973 Mumps (monovalent vaccine)\n>80% (girls)\n1974 Rubella (monovalent vaccine)\n12 y\n>90%\n1982 Measles-mumps-rubella (MMR)\n12 y\n>90%\n1982 Measles-mumps-rubella (MMR)\n18 m, 12 y\n60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85\nYear of birth\n1959\n1959\nFig. 1 The Swedish vaccination programmes. The target of the mass vaccinations was children born in certain years who had reached certain\nages. y years; m months\n542\nC. Ahlgren et al.\n123\nused several sources for obtaining the cases. In February to\nDecember 2004, we searched the administrative diagnosis\nregistries at Sahlgrenska University Hospital and the\nNational Patient Register of the National Board of Health\nand Welfare. Two of the authors (C.A., O.A.) reviewed all\nrecords with the diagnoses multiple sclerosis, demyelinat-\ning disorders in the central nervous system, acute transverse\nmyelitis, optic neuritis and retrobulbar neuritis, according to\nthe International Classi\ufb01cation of Diseases (ICD) 10, 9, and\n8. We reclassi\ufb01ed all cases according to both the Poser\ncriteria [28] with an added category of \u2018\u2018clinically isolated\nsyndromes\u2019\u2019 (CIS) [29] and the McDonald criteria [30].", "mimetype": "text/plain", "start_char_idx": 7065, "end_char_idx": 8603, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1f63207a-e09b-4bce-ab61-2707f0de2aea": {"__data__": {"id_": "1f63207a-e09b-4bce-ab61-2707f0de2aea", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "05a3e6da-7a24-43ad-a22a-f219213af2ce", "node_type": "1", "metadata": {}, "hash": "2523cc38056ba2d173c36d1fc8e3fcca2bdb6e253f8bb37000b01578269cf3cd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "726c5610-c1a5-4e84-a043-9a7259abc6ce", "node_type": "1", "metadata": {}, "hash": "35fbf50207b98cf5771063865536e79d5aee776f186aafe1f2fb5d6f41ae17d9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "According to the modi\ufb01ed Poser criteria, 23.2% of the total\npatient\nmaterial\n(N = 509)\nwere\npatients\nwith\nCIS;\naccording to the McDonald criteria, 21.8% were patients\nwith \u2018\u2018possible MS\u2019\u2019. Table 1 gives details of the propor-\ntions of patients in each subgroup of CIS. We included\nprimary progressive MS as a disease compatible with MS\npresenting as insidious progress from onset for at least\n1 year without remission and with subsequent development\nof additional foci (N = 19). Because of the uneven use of\nmagnetic resonance imaging (MRI) examinations through\nthe study period, we used the Poser criteria for our statistical\nanalyses.\nControls\nA total of 4,000 control subjects were randomly selected\nfrom the general population register in Gothenburg, Swe-\nden. Controls were born in the same years as the patients\n(1959\u20131986), and were residents of the study area on May\n13, 2004 when the selection was made (Table 2).\nStudy design\nA questionnaire was sent to 627 MS patients and 3,917\ncontrols who ful\ufb01lled the inclusion criteria (Fig. 2).\nSwedish children are regularly examined at child health\ncentres from birth to school entry, and within the school\nhealth care system from school entry at age 7 to at least age\n12. Childhood diseases and vaccinations are documented in\nthese records. We used this source of child health and\nschool health records in addition to the questionnaires.\nParticipants gave their consent to read their child health\nand school health records in their completed question-\nnaires. We selected the study participants who had attended\nthe sixth grade of school within the study area (N = 1,370;\n273 MS and 1,097 controls), as children received the \ufb01nal\nvaccination of the Swedish vaccination programme at age\n12 years, which usually coincided with the sixth grade of\nschool, and the records of these study participants were\nrelatively easily available (Fig. 2).", "mimetype": "text/plain", "start_char_idx": 8604, "end_char_idx": 10495, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "726c5610-c1a5-4e84-a043-9a7259abc6ce": {"__data__": {"id_": "726c5610-c1a5-4e84-a043-9a7259abc6ce", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1f63207a-e09b-4bce-ab61-2707f0de2aea", "node_type": "1", "metadata": {}, "hash": "0d835173db4ac45645e46ab46b139e2bd8450772edaaf2009950733140556c64", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "378a10ed-a4b2-4084-9484-4fb52f1af0dd", "node_type": "1", "metadata": {}, "hash": "2517e8addba678792d7a43197e1b896453d96139dc2479c743d5a72bf761d185", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2).\nAssessment of exposure\nQuestionnaires\nInformation about infections with measles, mumps, rubella,\nvaricella and infectious mononucleosis was obtained from\na self-administered questionnaire, together with the country\nSTUDY DESIGN\n688 MS\n4,000 C\nMS diagnosis according to Poser\nRandom selection from the population register\nMS onset  age 10\n6\n8\n9\n1\n-\n9\n5\n9\n1\n \nh\ntri\nb\n f\no\n \ns\nr\na\ne\nY\n6\n8\n9\n1\n-\n9\n5\n9\n1\n \nh\ntri\nb\n f\no\n \ns\nr\na\ne\nY\n \ng\nr\nu\nb\nn\ne\nh\nt\no\nG\n \nn\ni t\nn\ne\nd\ni\ns\ne\nR\ng\nr\nu\nb\nn\ne\nh\nt\no\nG\n \nn\ni t\nn\ne\nd\ni\ns\ne\nR\n8\nd\ne\ns\na\ne\nc\ne\nD\n13\nd\ne\nt\na\nr\ng\ni\nm\nE\n1\nd\ne\nt\na\nr\ng\ni\nm\nE\n3\ny\nc\ne\nr\nc\ne\nS\nUnknown place of residence\n15\nPsychological reasons\n22\n70\ny\nc\ne\nr\nc\ne\nS\nRe-assessed diagnoses\n15\nN a\n3\n8\n \n=\nN\n61\n \n=\n \n4,544 questionnaires sent \n627 MS\n3,917 C\n2,576 completed questionnaires received\n)\n%\n8\n.\n2\n5\n( \nC\n \n7\n6\n0\n,\n,\n2\n)\n%\n2\n.\n1\n8\n( \nS\nM\n \n9\n0\n5\nQuestionnaire data\n \nSelection of CHSH records\n1,751 (68.0%) \n1,370 (53.2% )\nof the total no.", "mimetype": "text/plain", "start_char_idx": 10492, "end_char_idx": 11438, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "378a10ed-a4b2-4084-9484-4fb52f1af0dd": {"__data__": {"id_": "378a10ed-a4b2-4084-9484-4fb52f1af0dd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "726c5610-c1a5-4e84-a043-9a7259abc6ce", "node_type": "1", "metadata": {}, "hash": "35fbf50207b98cf5771063865536e79d5aee776f186aafe1f2fb5d6f41ae17d9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5d2c9a84-b00d-4a30-8669-e32470848f7e", "node_type": "1", "metadata": {}, "hash": "4e916eddd268645f95b3769cb1a001c13b7b5aed329fa31514ae3dc6324c3697", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1\n8\n( \nS\nM\n \n9\n0\n5\nQuestionnaire data\n \nSelection of CHSH records\n1,751 (68.0%) \n1,370 (53.2% )\nof the total no. of questionnaire responders\nC\n \n7\n9\n0\n1\n   \nS\nM\n \n3\n7\n2\n \nf\no\n r\nu\no\nf ll\na\n \nn\no\n \"\no\nN\n\" r\no\n \"\ns\ne\nY\n\" \nd\ne\ntr\no\np\ne\nr\n    measles, mumps, rubella, varicella\n1,094 (79.9%) \n)\n%\n5\n.\n7\n6\n( \nC\n \n6\n9\n3\n,\n1\n)\n%\n7\n.\n9\n6\n( \nS\nM\n \n5\n5\n3\n206 MS (75.5%)\n                \n   888 C (80.9%)\nAvailable information on contracted infections\n in both questionnaire and CHSH recordb\n864 (33.5%) \nof the total no. of questionnaire responders\n)\n%\n1\n.\n3\n3\n( \nC\n \n5\n8\n6\n)\n%\n2\n.\n5\n3\n( \nS\nM\n \n9\n7\n1\nof the total no. of questionnaire responders\nCHSH records were obtained\nFig. 2 Study design. Flowchart\nshowing all MS patients and\ncontrols eligible for the present\nstudy. aOne person may be\nincluded in more than one\ncategory. bThe occurrence but\nnot the absence of speci\ufb01c\nchildhood diseases was\nregistered in the CHSH records.\nMS multiple sclerosis, C\ncontrols, CHSH child health and\nschool health\nA population-based case\u2013control study\n543\n123\nof birth of the participant and his or her parents. Swedish\norigin was de\ufb01ned as being born in Sweden with both\nparents born in Scandinavia. All infections were included,\nirrespective of the age at infection and irrespective of\nwhether this additional information was available.\nChild health and school health records\nInformation about infections with measles, mumps, rubella\nand varicella and vaccinations against these diseases was\ncollected from child health and school health records.", "mimetype": "text/plain", "start_char_idx": 11326, "end_char_idx": 12851, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5d2c9a84-b00d-4a30-8669-e32470848f7e": {"__data__": {"id_": "5d2c9a84-b00d-4a30-8669-e32470848f7e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "378a10ed-a4b2-4084-9484-4fb52f1af0dd", "node_type": "1", "metadata": {}, "hash": "2517e8addba678792d7a43197e1b896453d96139dc2479c743d5a72bf761d185", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d32283c2-b3ba-4aad-8c38-9c3d7fbe486e", "node_type": "1", "metadata": {}, "hash": "b126afa28221245c1a00a5124a2798332f6f4c5c65ae6ca7d9b8279243746f8c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Child health and school health records\nInformation about infections with measles, mumps, rubella\nand varicella and vaccinations against these diseases was\ncollected from child health and school health records.\nVaccination categories\nVaccines against measles, mumps, and rubella were\nadministered as vaccinations containing monovalent vac-\ncine strains or as vaccinations with the trivalent MMR\nvaccine, i.e. the combination of measles, mumps and rubella\nvaccine strains. Measles, mumps, and rubella vaccinations\nwere either \u2018\u2018early\u2019\u2019, i.e. before or at 10 years, or \u2018\u2018late\u2019\u2019, i.e.\nafter 10 years. The rationale for this division was that the\nmajority of the vaccinations were given around age\n12 years (90%), or at ages 1\u20138 years (54%). Less than 3%\nof the vaccinations were given at other ages (Table 3). The\n\ufb01rst analysis was performed on the entire study material of\nvaccinations with monovalent or combined measles, mumps\nand rubella vaccines. We de\ufb01ned three disjointed catego-\nries of vaccinations: \u2018No vaccination\u2019, \u2018Early vaccination\nonly\u2019, and \u2018Late vaccination\u2019. The group of individuals who\nreceived \u2018\u2018late\u2019\u2019 vaccination ([10 years of age) also inclu-\nded those who had received both a late and a prior early\nvaccination. The group of individuals vaccinated \u2018\u2018early\nonly\u2019\u2019 was restricted to those vaccinated below or at\n10 years of age. The major part of the entire material was\nMMR vaccinations. The second analysis was therefore\nrestricted to the subgroup of the MMR vaccinations. Four\ndisjointed vaccination categories: \u2018No MMR vaccination\u2019,\n\u2018Early MMR vaccination only\u2019, \u2018Late MMR vaccination\nonly\u2019, and \u2018Both an early and a late MMR vaccination\u2019 were\nde\ufb01ned. Comparisons were made within the group of MMR\nvaccinations.\nValidation\nThe proportion of MS patients for whom information about\ntheir history of measles, mumps, rubella and varicella\ninfections was available from both the questionnaire and\nfrom the child health and school health record was 35.2%\nof the total number of questionnaire responders.", "mimetype": "text/plain", "start_char_idx": 12642, "end_char_idx": 14662, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d32283c2-b3ba-4aad-8c38-9c3d7fbe486e": {"__data__": {"id_": "d32283c2-b3ba-4aad-8c38-9c3d7fbe486e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5d2c9a84-b00d-4a30-8669-e32470848f7e", "node_type": "1", "metadata": {}, "hash": "4e916eddd268645f95b3769cb1a001c13b7b5aed329fa31514ae3dc6324c3697", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8ad885d8-c67e-44ac-82df-b546f08ef7cd", "node_type": "1", "metadata": {}, "hash": "dced422d2ba3f71ab6cb19c9313481ffd66bff9249744e0c20260cca85e87bf8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The cor-\nresponding proportion for controls was 33.1% (Fig. 2).\nSensitivity and speci\ufb01city of questionnaire data was vali-\ndated by child health and school health records (Table 4).", "mimetype": "text/plain", "start_char_idx": 14663, "end_char_idx": 14844, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8ad885d8-c67e-44ac-82df-b546f08ef7cd": {"__data__": {"id_": "8ad885d8-c67e-44ac-82df-b546f08ef7cd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d32283c2-b3ba-4aad-8c38-9c3d7fbe486e", "node_type": "1", "metadata": {}, "hash": "b126afa28221245c1a00a5124a2798332f6f4c5c65ae6ca7d9b8279243746f8c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2a856edd-2b04-4f34-a0a9-83626305f597", "node_type": "1", "metadata": {}, "hash": "48331550e088eab59ddad26c21477a0088172821525af36b5e9118215df805af", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The cor-\nresponding proportion for controls was 33.1% (Fig. 2).\nSensitivity and speci\ufb01city of questionnaire data was vali-\ndated by child health and school health records (Table 4).\nTable 1 Clinical characteristics\nof MS patients\nMS multiple sclerosis, CIS\nclinically isolated syndrome,\nON optic neuritis, BS brain stem\nsyndrome, M myelitis, SD\nstandard deviation\nCharacteristic\nFemales\nMales\nTotal\nN\n%\nN\n%\nN\n%\nDiagnosis\nProbable and de\ufb01nite MS\n269\n75.4\n122\n80.3\n391\n76.8\nCIS\n88\n24.6\n30\n19.7\n118\n23.2\nCIS category\nON\n27\n30.7\n8\n26.7\n35\n29.7\nBS\n12\n13.6\n9\n30.0\n21\n17.8\nM\n22\n25.0\n7\n23.3\n29\n24.6\nLong tract or cerebral symptoms\n15\n17.0\n3\n10.0\n18\n15.3\nPolyfocal symptoms\n12\n13.6\n3\n10.0\n15\n12.7\nAge at onset of MS or CIS (years)\nMean \u00b1 SD\n26.5 \u00b1 6.6\n26.1 \u00b1 6.9\n26.4 \u00b1 6.7\nRange\n12\u201345\n10\u201343\n10\u201345\nMS or CIS onset in the study area\n285\n79.8\n132\n86.8\n417\n81.9\nTotal number of patients\n357\n100.0\n152\n100.0\n509\n100.0\nTable 2 Demographic characteristics of MS patients and controls\nCharacteristic\nMS patients\nControls\nN\n%\nN\n%\nFemale gender\n357\n70.1\n1,195\n57.8\nMale gender\n152\n29.9\n872\n42.2\nSwedish origina\n387\n76.0\n1,492\n72.2\nNon-Swedish origina\n110\n21.6\n547\n26.5\nMissing\n12\n2.4\n28\n1.3\nTotal\n509\n100.0\n2,067\n100.0\nMS multiple sclerosis\na Swedish origin was de\ufb01ned as being born in Sweden with both\nparents born in Scandinavia\n544\nC. Ahlgren et al.", "mimetype": "text/plain", "start_char_idx": 14663, "end_char_idx": 15997, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2a856edd-2b04-4f34-a0a9-83626305f597": {"__data__": {"id_": "2a856edd-2b04-4f34-a0a9-83626305f597", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8ad885d8-c67e-44ac-82df-b546f08ef7cd", "node_type": "1", "metadata": {}, "hash": "dced422d2ba3f71ab6cb19c9313481ffd66bff9249744e0c20260cca85e87bf8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "25e1dd38-e198-49ea-8dde-6f332a9f935e", "node_type": "1", "metadata": {}, "hash": "4d70011a9ef211d19b54c431b64c99621130e451e90e851b0fd893a45ae0d5c2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "123\nTable 3 Number of MS\npatients and controls in four\ndisjointed categories of different\nvaccinations with respect to age\nat \u2018Early\u2019 (B10 years), \u2018Late\u2019\n([10 years), and \u2018Both early\nand late\u2019 vaccination (N = 206\nMS patients, 888 controls)\nVaccination category\nNo. of MS patients\nNo.", "mimetype": "text/plain", "start_char_idx": 15998, "end_char_idx": 16282, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "25e1dd38-e198-49ea-8dde-6f332a9f935e": {"__data__": {"id_": "25e1dd38-e198-49ea-8dde-6f332a9f935e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2a856edd-2b04-4f34-a0a9-83626305f597", "node_type": "1", "metadata": {}, "hash": "48331550e088eab59ddad26c21477a0088172821525af36b5e9118215df805af", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cc2d5e59-f4e4-428f-a98e-fac7e610b47e", "node_type": "1", "metadata": {}, "hash": "a9c3dfd28ba26c394cc35b8f34c281a4331adda34aa07d2ed39c1c0dc149ca5b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "of MS patients\nNo. of controls\nTotal\nMonovalent or combined\nmeasles, mumps, rubella\nNo vaccination\n75\n230\n305\nEarly vaccination only\nAge\n\\3\n6\n36\n42\n3\u20138\n9\n10\n19\n9\u201310\n0\n0\n0\nTotal\n15\n46\n61\nLate vaccination only\nAge\n11\u201313\n68\n281\n349\n[13\n3\n8\n11\nTotal\n71\n289\n360\nBoth early and late vaccination\nAge\n\\3 and 11\u201313\n27\n265\n292\nOther ages\n17\n57\n74\nTotal\n44\n322\n366\nMissing information on age\n1\n1\n2\nCombined measles, mumps,\nrubella (MMR)\nNo vaccination\n125\n367\n492\nEarly vaccination only\nAge\n\\3\n5\n24\n29\n3\u20138\n3\n2\n5\n9\u201310\n0\n0\n0\nTotal\n8\n26\n34\nLate vaccination only\nAge\n11\u201313\n56\n294\n350\n[13\n1\n11\n12\nTotal\n57\n305\n362\nBoth early and late vaccination\nAge\n\\3 and 11\u201313\n12\n178\n190\nOther ages\n3\n12\n15\nTotal\n15\n190\n205\nMissing information on age\n1\n0\n1\nMonovalent measles\nNo vaccination\n166\n732\n898\nEarly vaccination only\nAge\n\\3\n19\n102\n121\n3\u20138\n19\n50\n69\n9\u201310\n0\n0\n0\nTotal\n38\n152\n190\nLate vaccination only\nAge\n11\u201313\n0\n0\n0\n[13\n0\n0\n0\nTotal\n0\n0\n0\nA population-based case\u2013control study\n545\n123\nParticipation\nWe performed a test to evaluate the possibility of bias due\nto uneven frequency of the questionnaire responses from\ndifferent study periods. The correlation between 4-year\nperiods of birth and participation in the study was tested\nwithin the MS group and within the controls by test for\ntrend in contingency table.", "mimetype": "text/plain", "start_char_idx": 16264, "end_char_idx": 17553, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cc2d5e59-f4e4-428f-a98e-fac7e610b47e": {"__data__": {"id_": "cc2d5e59-f4e4-428f-a98e-fac7e610b47e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "25e1dd38-e198-49ea-8dde-6f332a9f935e", "node_type": "1", "metadata": {}, "hash": "4d70011a9ef211d19b54c431b64c99621130e451e90e851b0fd893a45ae0d5c2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c0317ea4-25e4-4163-ab66-c3f03ef29ede", "node_type": "1", "metadata": {}, "hash": "b0098e97e4e315c573c562e65685f6d014b4f0b77ce2505195818b2777ff9abd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The correlation between 4-year\nperiods of birth and participation in the study was tested\nwithin the MS group and within the controls by test for\ntrend in contingency table. There was no signi\ufb01cant dif-\nference in the response rate between different periods (MS\npatients, P = 0.1844, controls, P = 0.6544).\nTable 3 continued\nVaccination category\nNo. of MS patients\nNo. of controls\nTotal\nBoth early and late vaccination\nAge\n\\3 and 11\u201313\n0\n1\n1\nOther ages\n0\n1\n1\nTotal\n0\n2\n2\nMissing information on age\n2\n2\n4\nMonovalent mumps\nNo vaccination\n202\n879\n1,081\nEarly vaccination only\nAge\n\\3\n0\n2\n2\n3\u20138\n4\n3\n7\n9\u201310\n0\n1\n1\nTotal\n4\n6\n10\nLate vaccination only\nAge\n11\u201313\n0\n2\n2\n[13\n0\n1\n1\nTotal\n0\n3\n3\nBoth early and late vaccination\nAge\n\\3 and 11\u201313\n0\n0\n0\nOther ages\n0\n0\n0\nTotal\n0\n0\n0\nMissing information on age\n0\n0\n0\nMonovalent rubella\nNo vaccination\n163\n774\n937\nEarly vaccination only\nAge\n\\3\n0\n1\n1\n3\u20138\n0\n1\n1\n9\u201310\n0\n0\n0\nTotal\n0\n2\n2\nLate vaccination only\nAge\n11\u201313\n41\n112\n153\n[13\n2\n0\n2\nTotal\n43\n112\n155\nBoth early and late vaccination\nAge\n\\3 and 11\u201313\n0\n0\n0\nOther ages\n0\n0\n0\nTotal\n0\n0\n0\nMissing information on age\n0\n0\n0\n546\nC. Ahlgren et al.\n123\nStatistical methods\nInfections\nLogistic regression analyses were applied to study the\nrelationship between infections and MS, age at infection\n(B10 or [10 years), and Swedish origin and MS.", "mimetype": "text/plain", "start_char_idx": 17380, "end_char_idx": 18694, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c0317ea4-25e4-4163-ab66-c3f03ef29ede": {"__data__": {"id_": "c0317ea4-25e4-4163-ab66-c3f03ef29ede", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cc2d5e59-f4e4-428f-a98e-fac7e610b47e", "node_type": "1", "metadata": {}, "hash": "a9c3dfd28ba26c394cc35b8f34c281a4331adda34aa07d2ed39c1c0dc149ca5b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "819f552d-19ff-4dd3-a429-e8ce7e73983a", "node_type": "1", "metadata": {}, "hash": "41eef922e8e69f64d7ccd5697cd1fd9c1f402a5b1afa3a5e3cfab3795ca58db9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "123\nStatistical methods\nInfections\nLogistic regression analyses were applied to study the\nrelationship between infections and MS, age at infection\n(B10 or [10 years), and Swedish origin and MS. Inde-\npendent variables were sex, year of birth, infection and\ninteraction between sex and infection. In order to take year\nof birth into account in a careful way we used spline\nfunctions of year of birth in the logistic regression analyses.\nThe results were expressed as odds ratios (OR). Two-tailed\nP-values \\0.05 were considered to be signi\ufb01cant.\nVaccinations\nORs were calculated in order to elucidate the effect on MS\nrisk of vaccinations at different ages before or at 10 years\nand after 10 years. Logistic models including sex and year of\nbirth (spline functions) were used with MS as the dependent\n0\u20131 variable. The analysis of \u2018\u2018Late vaccination versus none,\nor early only\u2019\u2019 (see \u2018\u2018Results\u2019\u2019) comprised a 0\u20131 variable\nattaining the value 1 if there was a late vaccination and 0\notherwise and another variable attaining the value 1 if there\nwas an early and no late vaccination and 0 otherwise. If b1\nand b2 are the beta coef\ufb01cients then exp(b2\u2013b1) gives the OR\nof early vaccination only versus late vaccination. The cor-\nresponding variance was calculated by use of the covariance\nbetween the beta coef\ufb01cients. The same method was applied\nfor the analysis restricted to the subgroup of MMR vacci-\nnations. All analyses of vaccinations were performed on data\nobtained from the child health and school health records.\nThis study was approved by the Regional Ethical\nReview Board in Gothenburg.\nResults\nRetrieved data\nThe questionnaire response rate was 81.2% in the MS\ngroup and 52.8% in the control group, providing a study\nmaterial of 509 patients and 2,067 controls. Child health\nand school health records of participants who had been in\nthe sixth grade of school within the study area were\nobtained for 206 MS patients and 888 controls, which\ncorresponds to 75.5% of the MS patients and 80.9% of the\ncontrols in this selection (Fig. 2).", "mimetype": "text/plain", "start_char_idx": 18501, "end_char_idx": 20541, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "819f552d-19ff-4dd3-a429-e8ce7e73983a": {"__data__": {"id_": "819f552d-19ff-4dd3-a429-e8ce7e73983a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c0317ea4-25e4-4163-ab66-c3f03ef29ede", "node_type": "1", "metadata": {}, "hash": "b0098e97e4e315c573c562e65685f6d014b4f0b77ce2505195818b2777ff9abd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4e8f5af4-8d35-4d07-973e-47c23c465733", "node_type": "1", "metadata": {}, "hash": "6bd35c0640bd22072b6e44e2f88fe0aefe7921fd1760ecf8cb1daabb26a5a9af", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2).\nGeneral demographic characteristics\nThe female-to-male ratio in the MS group was 2.35:1. The\npercentage of study participants of Swedish origin was\n76.0% in the MS group and 72.2% in the control group\n(Table 2).\nClinical characteristics\nTable 1 summarises the clinical characteristics of MS\n(N = 391) and CIS (N = 118) patients.\nOrigin\nThe risk of MS was signi\ufb01cantly higher in individuals\nof Swedish origin than in individuals of foreign origin\n(OR\n1.32,\n95%\ncon\ufb01dence\ninterval\n(CI)\n1.04\u20131.68,\nP = 0.0224).\nRecall of age at infection\nMultiple sclerosis patients seemed to recall age at infection\nbetter than controls. An analysis of measles infection and\nMS risk, including only infections which were reported\nwith age information, showed signi\ufb01cantly higher fre-\nquency of infections in the MS patient group than in the\ncontrol group (OR 1.34, 95% CI 1.05\u20131.70). Conversely,\nwhen only infections without age information were inclu-\nded, the frequency of infections was signi\ufb01cantly lower in\nthe MS patient group than in the control group (OR 0.70,\n95% CI 0.53\u20130.92).\nInfections\nThere were no signi\ufb01cant differences in the frequencies of\nmeasles, mumps, rubella or varicella reported in the ques-\ntionnaires between the MS group and the control group,\neither gender-speci\ufb01c or for both genders combined. The\nupper limits of the corresponding 95% CIs show that, if\nthere is a small effect, it is not likely to be higher than 30%\nfor measles, 50% for mumps and 20% for varicella.", "mimetype": "text/plain", "start_char_idx": 20538, "end_char_idx": 22020, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4e8f5af4-8d35-4d07-973e-47c23c465733": {"__data__": {"id_": "4e8f5af4-8d35-4d07-973e-47c23c465733", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "819f552d-19ff-4dd3-a429-e8ce7e73983a", "node_type": "1", "metadata": {}, "hash": "41eef922e8e69f64d7ccd5697cd1fd9c1f402a5b1afa3a5e3cfab3795ca58db9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "766be6f7-c70e-438a-a5ab-d8f6944718cf", "node_type": "1", "metadata": {}, "hash": "c17ea0ed3c0895e68623bf45363ac9efa9ee13f3773f51b95e98b0857fb1d0bd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\nreported frequency of infectious mononucleosis was sig-\nni\ufb01cantly higher in the MS group than in the control group\nfor both genders combined (OR 2.03, 95% CI 1.52\u20132.73)\nand for females (OR 2.27, 95% CI 1.61\u20133.22), but not for\nTable 4 Sensitivity and speci\ufb01city of questionnaire data validated by\nchild health and school health records\nInfection\nMS patients (N = 206)\nControls (N = 888)\nSensitivity\n(%)\nSpeci\ufb01city\n(%)\nSensitivity\n(%)\nSpeci\ufb01city\n(%)\nMeasles\n82.7\n92.3\n79.4\n91.4\nMumps\n72.0\n88.3\n68.0\n92.3\nRubella\n54.0\n85.2\n46.9\n89.3\nVaricella\n72.4\n80.0\n63.8\n74.4\nA population-based case\u2013control study\n547\n123\nmales (OR 1.55, 95% CI 0.88\u20132.71) (Table 5). However,\nthere was no signi\ufb01cant difference in MS risk associated\nwith infectious mononucleosis between women and men.\nWhen comparing the OR for women versus that for men the\ndifference between the two estimates was not signi\ufb01cant\n(P = 0.2576). Restricting the analysis of infections to\nprobable and de\ufb01nite MS patients, genders combined, did\nnot substantially alter the result (data not shown). There was\nno signi\ufb01cant difference between MS patients and controls\nwith respect to the frequencies of measles, mumps, rubella\nor varicella infections registered in the child health and\nschool health records (Table 6).\nInfections after the lowest age of MS onset\nIn the total material of patients and controls, none of the\nmeasles, mumps or rubella infections occurred above the\nage of 10 years in more than 5%, with 10 years being\nthe lowest age of MS onset in this study. Varicella\noccurred in approximately 13%, and infectious mononu-\ncleosis in approximately 10% above the age of 10.", "mimetype": "text/plain", "start_char_idx": 22021, "end_char_idx": 23659, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "766be6f7-c70e-438a-a5ab-d8f6944718cf": {"__data__": {"id_": "766be6f7-c70e-438a-a5ab-d8f6944718cf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4e8f5af4-8d35-4d07-973e-47c23c465733", "node_type": "1", "metadata": {}, "hash": "6bd35c0640bd22072b6e44e2f88fe0aefe7921fd1760ecf8cb1daabb26a5a9af", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "49c63b2f-6293-48d1-bc84-a54bfb486211", "node_type": "1", "metadata": {}, "hash": "18619e305c6dc478dee760a97018337717582eb4500e389cb14f0d85508add3d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Varicella\noccurred in approximately 13%, and infectious mononu-\ncleosis in approximately 10% above the age of 10. None\nof the MS patients reported measles or rubella after the\nonset of MS. Seven patients (1.4%) reported mumps or\nvaricella after the onset of MS. One MS patient reported\npossible infectious mononucleosis in the same year as the\nonset of MS.\nCombinations of infectious mononucleosis\nwith other infections\nThe OR for MS in individuals with a history of infectious\nmononucleosis and measles versus those with a history of\ninfectious mononucleosis only was 0.84 (95% CI 0.45\u2013\n1.58). Similar analyses were performed for ORs in indi-\nviduals with a history of infectious mononucleosis and\nmumps, rubella or varicella. No signi\ufb01cant changes in MS\nrisk were associated with any of these combinations\n(Table 7).\nVaccinations\nWe used data based exclusively on child health and school\nhealth records for the analyses of vaccinations and MS risk.\nThe \ufb01rst analysis was performed on the entire study\nmaterial including monovalent and combined measles,\nmumps and rubella vaccines. Simply having been vacci-\nnated against measles, mumps or rubella did not change the\nrisk of MS. \u2018Early vaccination only\u2019 (B10 years of age)\nwas associated with increased risk of MS (OR 2.46, 95%\nCI 1.27\u20134.76, P = 0.0075) in comparison to late, or both\nearly and late vaccination. \u2018Late vaccination\u2019 ([10 years of\nage) was associated with decreased risk (OR 0.64, 95% CI\n0.43\u20130.94, P = 0.0238) in comparison to no vaccination or\nTable 5 Odds ratios for MS in individuals with or without a history of each of \ufb01ve infections under study\nInfection\nNo. of MS patientsa\nNo. of controlsa\nFemales\nMales\nTotal\nOR\n95% CI\nOR\n95% CI\nOR\n95% CI\nMeasles\n432\n1,683\n1.21\n0.89\u20131.63\n0.66\n0.", "mimetype": "text/plain", "start_char_idx": 23546, "end_char_idx": 25301, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "49c63b2f-6293-48d1-bc84-a54bfb486211": {"__data__": {"id_": "49c63b2f-6293-48d1-bc84-a54bfb486211", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "766be6f7-c70e-438a-a5ab-d8f6944718cf", "node_type": "1", "metadata": {}, "hash": "c17ea0ed3c0895e68623bf45363ac9efa9ee13f3773f51b95e98b0857fb1d0bd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "be5c8ad4-ac53-47cf-8d35-420e7cee9e36", "node_type": "1", "metadata": {}, "hash": "7b7c26fa43b1c95e9fb8bd9e287531412c48f7827903d6fac506aba93a457a5c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "683\n1.21\n0.89\u20131.63\n0.66\n0.44\u20131.01\n1.00\n0.77\u20131.30\nMumps\n439\n1,739\n1.31\n1.00\u20131.73\n0.92\n0.62\u20131.36\n1.17\n0.93\u20131.48\nRubella\n410\n1,642\n0.95\n0.72\u20131.25\n0.51\n0.33\u20130.78\n0.79\n0.62\u20131.00\nVaricella\n470\n1,906\n0.80\n0.50\u20131.27\n0.90\n0.47\u20131.73\n0.83\n0.57\u20131.21\nInfectious mononucleosis\n442\n1,894\n2.27\n1.61\u20133.22\n1.55\n0.88\u20132.71\n2.03\n1.52\u20132.73\nData from questionnaires (N = 509 MS, 2,067 controls)\nMS multiple sclerosis, OR odds ratio, CI con\ufb01dence interval\na Number of MS patients and controls who responded \u2018\u2018Yes\u2019\u2019 or \u2018\u2018No\u2019\u2019\nTable 6 Odds ratios for MS in individuals with or without a history\nof each of four infections under study\nInfection\nOR\n95% CI\nMeasles\n1.00\n0.68\u20131.45\nMumps\n1.16\n0.83\u20131.62\nRubella\n1.16\n0.83\u20131.64\nVaricella\n1.30\n0.93\u20131.81\nData from child health and school health records (N = 206 MS, 888\ncontrols)\nMS multiple sclerosis, OR odds ratio, CI con\ufb01dence interval\nTable 7 Odds ratios for MS in individuals with a history of infec-\ntious mononucleosis and any other speci\ufb01c infection, versus indi-\nviduals with a history of infectious mononucleosis only\nInfection\nOR\n95% CI\nP-value\nMeasles\n0.84\n0.45\u20131.58\n0.5963\nMumps\n1.37\n0.75\u20132.49\n0.", "mimetype": "text/plain", "start_char_idx": 25275, "end_char_idx": 26401, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "be5c8ad4-ac53-47cf-8d35-420e7cee9e36": {"__data__": {"id_": "be5c8ad4-ac53-47cf-8d35-420e7cee9e36", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "49c63b2f-6293-48d1-bc84-a54bfb486211", "node_type": "1", "metadata": {}, "hash": "18619e305c6dc478dee760a97018337717582eb4500e389cb14f0d85508add3d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "47c29f19-b47f-482b-80b1-aee1db56f304", "node_type": "1", "metadata": {}, "hash": "5b26f6257031edc85bb834f8d717a49eab6e3e8d0810e0a11c9e08f55a3243ae", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "84\n0.45\u20131.58\n0.5963\nMumps\n1.37\n0.75\u20132.49\n0.3042\nRubella\n0.67\n0.36\u20131.23\n0.1935\nVaricella\n1.08\n0.32\u20133.64\n0.9074\nData from questionnaires (N = 509 MS, 2,067 controls)\nMS multiple sclerosis, OR odds ratio, CI con\ufb01dence interval\n548\nC. Ahlgren et al.\n123\nearly vaccination only. \u2018Late vaccination\u2019 and \u2018Early vac-\ncination only\u2019 were the two extreme groups. Those who\nhad received both an early and a late vaccination had an\nintermediate risk (Tables 3, 8). In order to study whether\nthe OR of 2.46 for early vaccination was an effect from the\nvaccination per se, or whether it was confounded by\ninfection, we calculated the MS risk in vaccinated indi-\nviduals with a history of measles versus vaccinated indi-\nviduals with no history of measles in the corresponding age\ngroup. There was no signi\ufb01cant in\ufb02uence on MS risk in\nmeasles vaccinated individuals depending on whether they\nhad a history of natural measles or not. Rather, the risk of\nMS associated with natural measles infection before or at\n10 years of age tended to be higher in the opposite direc-\ntion (OR 1.23, 95% CI 0.92\u20131.64) to that expected if the\nobserved higher MS risk associated with vaccination had\nbeen mediated by measles infection. The second analysis\nwas restricted to the subgroup of the MMR vaccinations.\nThe MS risk was not signi\ufb01cantly different in the MMR\nvaccinated group from that in the category of \u2018No MMR\nvaccination\u2019. \u2018Early MMR vaccination only\u2019 in comparison\nto late only, or both early and late vaccination was\nassociated with higher risk of MS (OR 4.92, 95% CI 1.97\u2013\n12.20, P = 0.0006). After adjusting for multiple compari-\nsons (the 25 similar comparisons possible to perform) using\nthe Bonferroni method, the P-value was 0.015.", "mimetype": "text/plain", "start_char_idx": 26358, "end_char_idx": 28076, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "47c29f19-b47f-482b-80b1-aee1db56f304": {"__data__": {"id_": "47c29f19-b47f-482b-80b1-aee1db56f304", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "be5c8ad4-ac53-47cf-8d35-420e7cee9e36", "node_type": "1", "metadata": {}, "hash": "7b7c26fa43b1c95e9fb8bd9e287531412c48f7827903d6fac506aba93a457a5c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5874c871-6835-4296-a620-7a3b7daad93f", "node_type": "1", "metadata": {}, "hash": "3ea635053f9606394cbffe7686086c271f91bc1d55d04402d7ba156b5ef522c7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "After adjusting for multiple compari-\nsons (the 25 similar comparisons possible to perform) using\nthe Bonferroni method, the P-value was 0.015. \u2018Late MMR\nvaccination only\u2019 in comparison to other MMR vaccina-\ntions was associated with decreased risk of MS (OR 0.40,\n95% CI 0.17\u20130.93, P = 0.0342). The category of \u2018Both an\nearly and a late MMR vaccination\u2019 was not associated with\nincreased MS risk (Tables 3, 9).\nDiscussion\nIn the present material, infection with measles, mumps,\nrubella or varicella did not in\ufb02uence subsequent MS risk,\nopposed to a signi\ufb01cant twofold higher MS risk related to a\nhistory of infectious mononucleosis. Restricting the anal-\nysis to probable and de\ufb01nite MS cases did not substantially\nTable 8 Odds ratios for MS associated with three disjointed categories of monovalent or combined measles, mumps, rubella vaccinations: \u2018No\nvaccination\u2019, \u2018Early vaccination only\u2019, and \u2018Late vaccination\u2019\nCompared groups\nOR\n95% CI\nP-value\nNo vaccination versus vaccination\n1.22\n0.77\u20131.92\n0.4101\nEarly vaccination onlya versus late vaccinationb\n2.46\n1.27\u20134.76\n0.0075\nLate vaccinationb versus none, or early only\n0.64\n0.43\u20130.94\n0.0238\nBoth an earlya and a late vaccinationb versus others\n1.02\n0.62\u20131.66\n0.9510\nData from child health and school health records (N = 206 MS, 888 controls).", "mimetype": "text/plain", "start_char_idx": 27933, "end_char_idx": 29230, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5874c871-6835-4296-a620-7a3b7daad93f": {"__data__": {"id_": "5874c871-6835-4296-a620-7a3b7daad93f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "47c29f19-b47f-482b-80b1-aee1db56f304", "node_type": "1", "metadata": {}, "hash": "5b26f6257031edc85bb834f8d717a49eab6e3e8d0810e0a11c9e08f55a3243ae", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "856f8351-ecfa-421d-92fb-ecdd9332f5fa", "node_type": "1", "metadata": {}, "hash": "f922321b3e3734de13169fac3a5abfaa95814aa4a9114deea3abf3b93cef08e5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The number of individuals in different categories is shown in\nTable 3\nMS multiple sclerosis, OR odds ratio, CI con\ufb01dence interval\na B10 years only\nb [10 years only, or both [10 and B10 years\nTable 9 Odds ratios for MS associated with four disjointed categories of measles, mumps, rubella (MMR) vaccinations: \u2018No MMR vaccina-\ntion\u2019, \u2018Early MMR vaccination only\u2019, \u2018Late MMR vaccination only\u2019, and \u2018Both an early and a late MMR vaccination\u2019\nCompared groups\nOR\n95% CI\nP-value\nNo MMR vaccinationa versus MMR vaccination\n1.13\n0.62\u20132.05\n0.6849\nEarly MMR vaccination onlyb versus othersc\n4.92\n1.97\u201312.20\n0.0006\nLate MMR vaccination onlyd versus othersc\n0.40\n0.17\u20130.93\n0.0342\nBoth an early and a late MMR vaccination versus othersc\n0.85\n0.38\u20131.92\n0.7017\nEarly MMR vaccination onlyb versus both an early and a late MMR vaccination\n3.99\n1.57\u201310.53\n0.0052\nLate MMR vaccination onlyd versus both an early and a late MMR vaccination\n0.95\n0.41\u20131.40\n0.9077\nData from child health and school health records (N = 206 MS, 888 controls). The number of individuals in different categories is shown in\nTable 3\nMS multiple sclerosis, OR odds ratio, CI con\ufb01dence interval\na MMR = combined measles, mumps, rubella\nb B10 years only\nc MMR vaccinations given at other ages\nd [10 years only\nA population-based case\u2013control study\n549\n123\nalter the \ufb01ndings. Vaccination with measles, mumps,\nrubella vaccines had no overall in\ufb02uence on the risk of later\nMS. We found early MMR vaccination to be associated\nwith a higher risk of subsequent MS than late MMR vac-\ncination. However, this result was an unexpected, isolated\n\ufb01nding, based on a small number of subjects and therefore,\nit provides relatively weak evidence.", "mimetype": "text/plain", "start_char_idx": 29231, "end_char_idx": 30915, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "856f8351-ecfa-421d-92fb-ecdd9332f5fa": {"__data__": {"id_": "856f8351-ecfa-421d-92fb-ecdd9332f5fa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5874c871-6835-4296-a620-7a3b7daad93f", "node_type": "1", "metadata": {}, "hash": "3ea635053f9606394cbffe7686086c271f91bc1d55d04402d7ba156b5ef522c7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "609c2577-db86-415f-aea2-bdda94c84725", "node_type": "1", "metadata": {}, "hash": "5ea6edfc4797c2afbc6ff81ccd1b645ab6d9e11479831c05d5598f48c978d1c3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "However, this result was an unexpected, isolated\n\ufb01nding, based on a small number of subjects and therefore,\nit provides relatively weak evidence.\nWe have used data not only from questionnaires, but\nalso from a source of more objective data in child health\nand school health records, where childhood infections were\ndocumented from birth to the teen years. The child health\nand school health records were produced many years in\nadvance of the present study in a uniform social system and\nMS was not an issue when these records were written. The\nfrequencies of infections may be underestimated in these\nrecords, but any such effect would probably be equal for\npatients and controls. The results for infections with mea-\nsles, mumps, rubella, varicella and MS risk based on the\nchild health and school health records con\ufb01rmed the cor-\nresponding results based on the questionnaires. There is\nalways a possibility that questionnaire responses are\naffected by recall bias, and this may have occurred in the\npresent study. The questionnaire response rate in the con-\ntrol group (52.8%) was lower than in the MS group\n(81.2%). Furthermore, since the permissions to retrieve the\nchild health and school health records were given in the\nquestionnaire responses, the difference in the questionnaire\nresponse rate, if biased, may have introduced a corre-\nsponding selection bias in the selection of the child health\nand school health records. However, there was no uneven\nfrequency of questionnaire responses from different study\nperiods. Therefore, the possibility that MS patients and\ncontrols decided to participate in the study depending on\ntheir experience of childhood infections and vaccinations,\nand that this affected the results, would be subtle.\nWe included all infections in our analyses, irrespective\nof age at infection and irrespective of whether age infor-\nmation was available. The reason for this was that the age\nat infection was not stated for a considerable number of the\nreported infections, and the MS patients tended to recall\nage at infection better than the controls, introducing\npotential bias in age-speci\ufb01c analyses. We had access to\ndata on age at infection in the child health and school\nhealth records, but the sample size did not allow age-\nspeci\ufb01c analyses.", "mimetype": "text/plain", "start_char_idx": 30770, "end_char_idx": 33050, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "609c2577-db86-415f-aea2-bdda94c84725": {"__data__": {"id_": "609c2577-db86-415f-aea2-bdda94c84725", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "856f8351-ecfa-421d-92fb-ecdd9332f5fa", "node_type": "1", "metadata": {}, "hash": "f922321b3e3734de13169fac3a5abfaa95814aa4a9114deea3abf3b93cef08e5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6bcc70bd-d454-45e4-a449-0ea29ab124fa", "node_type": "1", "metadata": {}, "hash": "c525bc6e7ad430e720cd378b034b89a370819a9245407f1343e2d8d9e28488f3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We had access to\ndata on age at infection in the child health and school\nhealth records, but the sample size did not allow age-\nspeci\ufb01c analyses. Therefore, we used \u2018\u2018Yes\u2019\u2019 or \u2018\u2018No\u2019\u2019\nresponses without using the additional information on age\nat infection in the analyses of frequency of infection in MS\npatients and controls. However, we used the information on\nage at infection for a simpli\ufb01ed analysis on measles before\nor after age 10, the age limit which was used in the anal-\nyses on vaccinations. The data material on age at vacci-\nnation was larger, and had a wider distribution than age at\ninfection, and was easily divisible into two age groups.\nSeveral studies were focused on age at childhood\ninfection rather than frequency of these infections in MS\npatients and controls [4, 6]. Studies based on interviews or\nquestionnaires found no signi\ufb01cant differences in fre-\nquency of infections [31, 32]. However, the interview or\nquestionnaire technique often entails problems with recall\nbias. Population-based case\u2013control studies with stronger\nstudy designs using more objective and less biased data\nsuch as serology [5], pre-symptomatic questionnaire data\n[7] or prospective registries [33], still found no signi\ufb01cant\ndifferences between MS patients and controls in the fre-\nquencies of preceding common viral childhood infections.\nThe results of a large population-based case\u2013control study\nin the Netherlands showed signi\ufb01cant differences, but these\nwere reported to be eliminated when a correction was\napplied for an estimated recall bias [34]. Our \ufb01ndings of\nequal frequency of infections in MS patients and controls,\nand of a twofold higher MS risk associated with infectious\nmononucleosis agree with the \ufb01ndings in other studies\n[35, 36].\nWe have shown, at \ufb01rst in a cohort analysis [27] and\nnow in a case\u2013control study that infection with measles,\nmumps or rubella does not signi\ufb01cantly in\ufb02uence the\nindividual risk of developing MS. We used data from the\nchild health and school health records here in an analysis of\nthe risk of subsequent MS in individuals exposed to dif-\nferent vaccinations, taking sex and the year of birth into\naccount.", "mimetype": "text/plain", "start_char_idx": 32905, "end_char_idx": 35061, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6bcc70bd-d454-45e4-a449-0ea29ab124fa": {"__data__": {"id_": "6bcc70bd-d454-45e4-a449-0ea29ab124fa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "609c2577-db86-415f-aea2-bdda94c84725", "node_type": "1", "metadata": {}, "hash": "5ea6edfc4797c2afbc6ff81ccd1b645ab6d9e11479831c05d5598f48c978d1c3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ab44d843-5e28-4039-a127-b5971bb1f0c8", "node_type": "1", "metadata": {}, "hash": "937ac6852f7fa69ea76e762bcfb35f7fe30ecd1df923295e664f21281e73f2ed", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We used data from the\nchild health and school health records here in an analysis of\nthe risk of subsequent MS in individuals exposed to dif-\nferent vaccinations, taking sex and the year of birth into\naccount. The chosen cut-off at 10 years isolates a distinct\ngroup of late vaccinations at about 12 years of age (90%)\nfrom the group of early vaccinations at age 1\u20138 years of\nage (54%). Less than 3% of the vaccinated participants\nwere vaccinated at other ages. From an immunological\npoint of view, however, the age limit is arbitrary. An\nanalysis of the entire study material of vaccinations with\nmonovalent or combined measles, mumps, and rubella\nvaccines showed no signi\ufb01cant difference in the risk of MS\nbetween vaccinated and unvaccinated individuals. The risk\nof MS was higher in individuals vaccinated before or at\n10 years only than in those vaccinated after that age, or\nboth before and after. The effect of vaccination seemed to\nbe independent of natural infection, since the risk of MS in\nthe measles vaccinated individuals was not in\ufb02uenced by\ntheir history of measles infection. The analysis of the\nsubgroup of MMR vaccinations showed similar results to\nthe analysis of the entire material. There was no overall\nsigni\ufb01cant change in MS risk depending on whether or not\nindividuals were MMR vaccinated. Among MMR vacci-\nnated individuals, the risk of MS was higher in those who\nhad received early vaccination only. A late vaccination was\nassociated with lower MS risk. Further analyses of MMR\nvaccinations revealed that the combination of an early and\nlate vaccination showed approximately the same risk as a\nlate vaccination only, suggesting that a late vaccination\n550\nC. Ahlgren et al.\n123\nmay neutralise the risk of MS in individuals who had\nreceived early vaccination only.\nA number of questions concerning a possible \u2018\u2018suscep-\ntibility age\u2019\u2019 are raised by these results. One possible\nexplanation may be that T cell tolerance to myelin is age\ndependent [37]. However, our unexpected \ufb01nding that early\nMMR vaccination was associated with higher risk of MS\nthan late MMR vaccination may be the result of chance and\nshould be treated with caution.", "mimetype": "text/plain", "start_char_idx": 34853, "end_char_idx": 37013, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ab44d843-5e28-4039-a127-b5971bb1f0c8": {"__data__": {"id_": "ab44d843-5e28-4039-a127-b5971bb1f0c8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6bcc70bd-d454-45e4-a449-0ea29ab124fa", "node_type": "1", "metadata": {}, "hash": "c525bc6e7ad430e720cd378b034b89a370819a9245407f1343e2d8d9e28488f3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f24eae03-b18b-4eb4-a1aa-566a828d0350", "node_type": "1", "metadata": {}, "hash": "f9e8cdc4698608b40c6750e8723d62e589586591a85dfa15b58abb6d56057a06", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "However, our unexpected \ufb01nding that early\nMMR vaccination was associated with higher risk of MS\nthan late MMR vaccination may be the result of chance and\nshould be treated with caution. The group of study partici-\npants who had received early vaccinations only was small\n(N = 61), less than 10% of the vaccinated individuals with\navailable child health and school health records. Eight MS\npatients and 26 controls were MMR vaccinated at a young\nage only. Although signi\ufb01cant in the present Gothenburg\nmaterial, the association with \u2018early MMR vaccination\nonly\u2019 was an isolated \ufb01nding, which was based on a small\nnumber of subjects and only provides relatively weak evi-\ndence. There have been no studies published which con-\nsidered age at measles, mumps, rubella vaccination and the\nsubsequent risk of MS. Thus, the possible importance of age\nat vaccination needs to be con\ufb01rmed or refuted in other\nstudy material. We con\ufb01rmed the result obtained by a pre-\nvious large population-based case\u2013control study showing\nthat ever having been vaccinated against measles, mumps or\nrubella does not increase the risk of MS [38].\nIn summary, infectious mononucleosis increased the risk\nof subsequent MS, while there was no indication that\ninfection with measles, mumps, rubella or varicella, alone\nor as a group, explains the development of MS. Any effect\non the risk of developing MS from these infections must be\nsmall. Furthermore, there was no indication that infectious\nmononucleosis augments the signi\ufb01cance of other infec-\ntions. The possible bene\ufb01t of including a vaccine against\nEBV in the vaccination programme should be investigated.\nConclusions\nThe strength of this study is that it exploited the large\ndifferences between the numbers of exposed and unex-\nposed individuals that occurred during the mass vaccina-\ntion campaigns against measles, mumps and rubella.\nFurthermore, we used information from two sources,\nquestionnaire data and data from the more objective child\nhealth and school health records, and these two sources\ngave very similar results.", "mimetype": "text/plain", "start_char_idx": 36828, "end_char_idx": 38885, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f24eae03-b18b-4eb4-a1aa-566a828d0350": {"__data__": {"id_": "f24eae03-b18b-4eb4-a1aa-566a828d0350", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ab44d843-5e28-4039-a127-b5971bb1f0c8", "node_type": "1", "metadata": {}, "hash": "937ac6852f7fa69ea76e762bcfb35f7fe30ecd1df923295e664f21281e73f2ed", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3dcd8adf-07aa-4eed-85c4-e96748424ba7", "node_type": "1", "metadata": {}, "hash": "491d988b23869bdb302884d8e858f6c43dad1d0ef68f79a0e9c716c5d3305d8e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Furthermore, we used information from two sources,\nquestionnaire data and data from the more objective child\nhealth and school health records, and these two sources\ngave very similar results. In the same patients and with the\nsame methods, we have shown that measles, mumps,\nrubella and varicella infections do not in\ufb02uence the risk of\nsubsequent MS. We con\ufb01rmed that the risk of MS is\nincreased by a factor of two following infectious mono-\nnucleosis. There was no overall effect of the measles,\nmumps and rubella vaccinations on MS risk. The most\nlikely explanation for the unexpected \ufb01nding that age at\nvaccination is of signi\ufb01cance for the risk of MS is that it is\na chance \ufb01nding, but future studies could investigate it on\nan a priori basis.\nAcknowledgments\nWe wish to thank Professor Lars Frise\u00b4n for\ngenerous help in providing records of optic neuritis at the Neuro-\nophthalmological Clinic, Sahlgrenska University Hospital; senior\nconsultant Victoria Romanus for providing vaccination data from the\nSwedish Institute for Infectious Disease Control; Malte Nordqvist for\ntechnical assistance; and the Research Foundation of the Multiple\nSclerosis Society of Gothenburg, Sweden, and the foundation of Anna-\nLisa and Bror Bjo\u00a8rnsson, Gothenburg, Sweden for \ufb01nancial support.\nReferences\n1. Dean G, Kurtzke JF. On the risk of multiple sclerosis according\nto age at immigration to South Africa. Br Med J. 1971;3(5777):\n725\u20139.\n2. Kurtzke JF, Beebe GW, Norman JE Jr. Epidemiology of multiple\nsclerosis in US veterans: III. Migration and the risk of MS.\nNeurology. 1985;35(5):672\u20138.\n3. Elian M, Nightingale S, Dean G. Multiple sclerosis among United\nKingdom-born children of immigrants from the Indian subcon-\ntinent, Africa and the West Indies. J Neurol Neurosurg Psychia-\ntry. 1990;53(10):906\u201311.\n4.", "mimetype": "text/plain", "start_char_idx": 38694, "end_char_idx": 40494, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3dcd8adf-07aa-4eed-85c4-e96748424ba7": {"__data__": {"id_": "3dcd8adf-07aa-4eed-85c4-e96748424ba7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f24eae03-b18b-4eb4-a1aa-566a828d0350", "node_type": "1", "metadata": {}, "hash": "f9e8cdc4698608b40c6750e8723d62e589586591a85dfa15b58abb6d56057a06", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ef6edcdf-b8a1-4bb1-b835-5be16ba75336", "node_type": "1", "metadata": {}, "hash": "d4e5fdafede083906648055240ac1cf1587e3d01513c8a6103c0ab399faafaf5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "J Neurol Neurosurg Psychia-\ntry. 1990;53(10):906\u201311.\n4. Sullivan CB, Visscher BR, Detels R. Multiple sclerosis and age at\nexposure to childhood diseases and animals: cases and their\nfriends. Neurology. 1984;34(9):1144\u20138.\n5. Compston DA, Vakarelis BN, Paul E, McDonald WI, Batchelor\nJR, Mims CA. Viral infection in patients with multiple sclerosis\nand HLA-DR matched controls. Brain. 1986;109(Pt 2):325\u201344.\n6. Bachmann S, Kesselring J. Multiple sclerosis and infectious\nchildhood diseases. Neuroepidemiology. 1998;17(3):154\u201360.\n7. Hernan MA, Zhang SM, Lipworth L, Olek MJ, Ascherio A.\nMultiple sclerosis and age at infection with common viruses.\nEpidemiology. 2001;12(3):301\u20136.\n8. Vandvik B, Norrby E, Nordal HJ. Optic neuritis: local synthesis\nin the central nervous system of oligoclonal antibodies to mea-\nsles, mumps, rubella, and herpes simplex viruses. Acta Neurol\nScand. 1979;60(4):204\u201313.\n9. Salmi A, Reunanen M, Ilonen J, Panelius M. Intrathecal antibody\nsynthesis to virus antigens in multiple sclerosis. Clin Exp\nImmunol. 1983;52(2):241\u20139.\n10. Bray PF, Luka J, Culp KW, Schlight JP. Antibodies against\nEpstein\u2013Barr nuclear antigen (EBNA) in multiple sclerosis CSF,\nand two pentapeptide sequence identities between EBNA and\nmyelin basic protein. Neurology. 1992;42(9):1798\u2013804.\n11. Frederiksen JL, Sindic CJ. Intrathecal synthesis of virus-speci\ufb01c\noligoclonal IgG, and of free kappa and free lambda oligoclonal\nbands in acute monosymptomatic optic neuritis. Comparison with\nbrain MRI.", "mimetype": "text/plain", "start_char_idx": 40439, "end_char_idx": 41932, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ef6edcdf-b8a1-4bb1-b835-5be16ba75336": {"__data__": {"id_": "ef6edcdf-b8a1-4bb1-b835-5be16ba75336", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3dcd8adf-07aa-4eed-85c4-e96748424ba7", "node_type": "1", "metadata": {}, "hash": "491d988b23869bdb302884d8e858f6c43dad1d0ef68f79a0e9c716c5d3305d8e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e1364a3c-55b2-4f49-86de-b6b5645f1641", "node_type": "1", "metadata": {}, "hash": "76d2150f946f9ca3bee02f64f136585b173036f811ecda2ba252e1181487ae95", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Comparison with\nbrain MRI. Mult Scler. 1998;4(1):22\u20136.\n12. Reiber H, Ungefehr S, Jacobi C. The intrathecal, polyspeci\ufb01c and\noligoclonal immune response in multiple sclerosis. Mult Scler.\n1998;4(3):111\u20137.\n13. Rand KH, Houck H, Denslow ND, Heilman KM. Epstein\u2013Barr\nvirus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in\npatients with multiple sclerosis. J Neurol Sci. 2000;173(1):32\u20139.\n14. Bednarova J, Stourac P, Adam P. Relevance of immunological\nvariables in neuroborreliosis and multiple sclerosis. Acta Neurol\nScand. 2005;112(2):97\u2013102.\n15. Petereit HF, Reske D. Expansion of antibody reactivity in the\ncerebrospinal \ufb02uid of multiple sclerosis patients-follow-up and\nclinical implications. Cerebrospinal Fluid Res. 2005;2:3.\nA population-based case\u2013control study\n551\n123\n16. Owens GP, Bennett JL, Gilden DH, Burgoon MP. The B cell\nresponse in multiple sclerosis. Neurol Res. 2006;28(3):236\u201344.\n17. Poskanzer DC, Sever JL, Sheridan JL, Prenney LB. Multiple\nsclerosis in the Orkney and Shetland Islands. IV: viral antibody\ntitres and viral infections. J Epidemiol Community Health.\n1980;34(4):258\u201364.\n18. Sundstrom P, Juto P, Wadell G, Hallmans G, Svenningsson A,\nNystrom L, et al. An altered immune response to Epstein\u2013Barr\nvirus in multiple sclerosis: a prospective study. Neurology.\n2004;62(12):2277\u201382.\n19. Ha\ufb02er DA, Compston A, Sawcer S, Lander ES, Daly MJ, De\nJager PL, et al.", "mimetype": "text/plain", "start_char_idx": 41906, "end_char_idx": 43299, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e1364a3c-55b2-4f49-86de-b6b5645f1641": {"__data__": {"id_": "e1364a3c-55b2-4f49-86de-b6b5645f1641", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ef6edcdf-b8a1-4bb1-b835-5be16ba75336", "node_type": "1", "metadata": {}, "hash": "d4e5fdafede083906648055240ac1cf1587e3d01513c8a6103c0ab399faafaf5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "95f4b75d-e118-4dc9-86df-dfd9f29a4101", "node_type": "1", "metadata": {}, "hash": "de2fda66a2807676ac3a482063bf5ea5cde70d428681ec8acdac93a4c2741fdf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2004;62(12):2277\u201382.\n19. Ha\ufb02er DA, Compston A, Sawcer S, Lander ES, Daly MJ, De\nJager PL, et al. Risk alleles for multiple sclerosis identi\ufb01ed by a\ngenomewide study. N Engl J Med. 2007;357(9):851\u201362.\n20. Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller\nDM. Transgenic mice that express a myelin basic protein-speci\ufb01c\nT cell receptor develop spontaneous autoimmunity. Cell. 1993;\n72(4):551\u201360.\n21. Bjorvatn B, Skoldenberg B. [Meningitis in mumps and orchitis in\nStockholm during 1955\u20131976\u2014an epidemiological background\nfor a vaccination policy] In Swedish. Lakartidningen. 1978;\n75(23):2295\u20138.\n22. Christenson B, Bottiger M. Changes of the immunological pat-\nterns against measles, mumps and rubella. A vaccination pro-\ngramme studied 3 to 7 years after the introduction of a two-dose\nschedule. Vaccine. 1991;9(5):326\u20139.\n23. Taranger J. Vaccination programme for eradication of measles,\nmumps, and rubella. Lancet. 1982;1(8277):915\u20136.\n24. Strom J. Social development and declining incidence of some\ncommon epidemic diseases in children. A study of the incidence\nin different age groups in Stockholm. Acta Paediatr Scand.\n1967;56(2):159\u201363.\n25. Strom J. [On the incidence of common epidemics of infectious\ndiseases in the light of conditions in Stockholm.] In Swedish. Soc\nMed Tidskr. 1959;36:347\u201354.\n26. Lundstrom R, Svedmyr A, Hagbard L, Kaijser K. Rubella\nimmunity as related to age and history of overt disease. Acta\nPaediatr Scand. 1967;56(3):279\u201385.\n27.", "mimetype": "text/plain", "start_char_idx": 43203, "end_char_idx": 44668, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "95f4b75d-e118-4dc9-86df-dfd9f29a4101": {"__data__": {"id_": "95f4b75d-e118-4dc9-86df-dfd9f29a4101", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e1364a3c-55b2-4f49-86de-b6b5645f1641", "node_type": "1", "metadata": {}, "hash": "76d2150f946f9ca3bee02f64f136585b173036f811ecda2ba252e1181487ae95", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dac560a0-05b7-4e0d-8ee3-2b754e989e60", "node_type": "1", "metadata": {}, "hash": "6c61fd67b7abf4b5d17c20dc471d96f35331fa45a4ceecde99582e80c627d9da", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Acta\nPaediatr Scand. 1967;56(3):279\u201385.\n27. Ahlgren C, Oden A, Toren K, Andersen O. Multiple sclerosis\nincidence in the era of measles-mumps-rubella mass vaccina-\ntions. Acta Neurol Scand. 2009;119(5):313\u201320.\n28. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA,\nEbers GC, et al. New diagnostic criteria for multiple sclerosis:\nguidelines for research protocols. Ann Neurol. 1983;13(3):227\u2013\n31.\n29. Brex PA, Ciccarelli O, O\u2019Riordan JI, Sailer M, Thompson AJ,\nMiller DH. A longitudinal study of abnormalities on MRI and\ndisability from multiple sclerosis. N Engl J Med. 2002;346(3):\n158\u201364.\n30. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP,\nLublin FD, et al. Recommended diagnostic criteria for multiple\nsclerosis: guidelines from the International Panel on the diagnosis\nof multiple sclerosis. Ann Neurol. 2001;50(1):121\u20137.\n31. Italian Multiple Sclerosis Study Group. Migration and infectious\ndiseases in etiology of multiple sclerosis: a case\u2013control study.\nIn: Battaglia M, editor. Multiple sclerosis research : proceedings\nof the international multiple sclerosis conference: an update\non multiple sclerosis (1989) 15\u201317 Sep 1988. Rome Excerpta\nMedica; 1989. p. 147\u201358.\n32. Gronning M, Riise T, Kvale G, Albrektsen G, Midgard R, Nyland\nH. Infections in childhood and adolescence in multiple sclerosis.\nA case\u2013control study. Neuroepidemiology. 1993;12(2):61\u20139.\n33. Bager P, Nielsen NM, Bihrmann K, Frisch M, Hjalgrim H,\nWohlfart J, et al. Childhood infections and risk of multiple\nsclerosis. Brain. 2004;127(Pt 11):2491\u20137.\n34.", "mimetype": "text/plain", "start_char_idx": 44625, "end_char_idx": 46168, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dac560a0-05b7-4e0d-8ee3-2b754e989e60": {"__data__": {"id_": "dac560a0-05b7-4e0d-8ee3-2b754e989e60", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Ahlgren (2009).pdf", "node_type": "4", "metadata": {}, "hash": "e5081f35df2c21f5872d1d59950f9fe873e95c0053d57ba603fb90b46715b048", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "95f4b75d-e118-4dc9-86df-dfd9f29a4101", "node_type": "1", "metadata": {}, "hash": "de2fda66a2807676ac3a482063bf5ea5cde70d428681ec8acdac93a4c2741fdf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Childhood infections and risk of multiple\nsclerosis. Brain. 2004;127(Pt 11):2491\u20137.\n34. Zaadstra BM, Chorus AM, van Buuren S, Kalsbeek H, van Noort\nJM. Selective association of multiple sclerosis with infectious\nmononucleosis. Mult Scler. 2008;14(3):307\u201313.\n35. Thacker EL, Mirzaei F, Ascherio A. Infectious mononucleosis\nand risk for multiple sclerosis: a meta-analysis. Ann Neurol.\n2006;59(3):499\u2013503.\n36. Nielsen TR, Rostgaard K, Nielsen NM, Koch-Henriksen N, Ha-\nahr S, Sorensen PS, et al. Multiple sclerosis after infectious\nmononucleosis. Arch Neurol. 2007;64(1):72\u20135.\n37. Huseby ES, Sather B, Huseby PG, Goverman J. Age-dependent T\ncell tolerance and autoimmunity to myelin basic protein. Immu-\nnity. 2001;14(4):471\u201381.\n38. DeStefano F, Verstraeten T, Jackson LA, Okoro CA, Benson P,\nBlack SB, et al. Vaccinations and risk of central nervous system\ndemyelinating diseases in adults. Arch Neurol. 2003;60(4):504\u20139.\n552\nC. Ahlgren et al.\n123", "mimetype": "text/plain", "start_char_idx": 46081, "end_char_idx": 47027, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "67897cfa-1086-4124-9198-fd87a04e1c1e": {"__data__": {"id_": "67897cfa-1086-4124-9198-fd87a04e1c1e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bbc46158-6629-43e9-86be-d39d7419eb99", "node_type": "1", "metadata": {}, "hash": "53d41a3fae2cecbfc8bef14cf2f83303736d047c4173a8ab7f4e9ab332f296d3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ORIGINAL ARTICLE\nTiming of routine immunisations and subsequent hay\nfever risk\nS A Bremner, I M Carey, S DeWilde, N Richards, W C Maier, S R Hilton, D P Strachan, D G Cook\n. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .\nSee end of article for\nauthors\u2019 affiliations\n. . . . . . . . . . . . . . . . . . . . . . .\nCorrespondence to:\nProf. D G Cook, Professor\nof Epidemiology,\nDepartment of Community\nHealth Sciences, St\nGeorge\u2019s Hospital Medical\nSchool, Cranmer Terrace,\nLondon SW17 0RE, UK;\nd.cook@sghms.ac.uk\nAccepted 6 July 2004\n. . . . . . . . . . . . . . . . . . . . . . .\nArch Dis Child 2005;90:567\u2013573.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 812, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bbc46158-6629-43e9-86be-d39d7419eb99": {"__data__": {"id_": "bbc46158-6629-43e9-86be-d39d7419eb99", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "67897cfa-1086-4124-9198-fd87a04e1c1e", "node_type": "1", "metadata": {}, "hash": "083c31be3080379067770e0befe03ccc9ca6f3b976a8c8303f71bd893f563653", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "de6a0703-ed14-478f-b0ed-87f56ebcf0dc", "node_type": "1", "metadata": {}, "hash": "2f477406088b92e328ed89d77973531ecc014e592eec17a7ca95cf3d9acd20b5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": ". . . . . . . . . . . . . . . . . .\nArch Dis Child 2005;90:567\u2013573. doi: 10.1136/adc.2004.051714\nBackground: Suggestions that immunisation influences allergic disease risk, either positively (pertussis) or\nnegatively (BCG) are of concern for vaccination policy.\nAims: To determine whether DTP, MMR, and BCG vaccination in infancy influenced hay fever risk.\nMethods: Case-control study of 7098 hay fever cases and controls, within two primary care databases.\nOne control per case was matched for practice, age, and sex. Odds ratios (OR) were derived using\nconditional logistic regression.\nResults: Compared to those completing in month 5 (base group) (39.3%), DTP unvaccinated children\n(4.3%) had a similar risk of hay fever (OR = 0.94, 95% CI 0.73 to 1.23). However, those completing after\n12 months (4.2%) had a reduced risk (OR = 0.60, 95% CI 0.45 to 0.76) compared to the base group.\nCompared to those vaccinated in month 14 (base group) (29.5%), MMR unvaccinated children (2.3%) had\nan OR of 0.79 (95% CI 0.58 to 1.08). Completion of MMR after two years was associated with reduced\nhay fever risk (OR = 0.62, 95% CI 0.48 to 0.80) compared to the base group. The effects of late\nimmunisation with DTP and MMR were independent. Those vaccinated with BCG by age 2 (2.4%) had an\nodds ratio of 1.28 (95% CI 0.96 to 1.70). Adjustment for consulting behaviour, social factors, or sibship\nsize did not alter these associations.\nConclusions: Immunisation against DTP or MMR does not increase the risk of hay fever. The lower\nconfidence limit for BCG vaccination contradicts the hypothesised protective effect.", "mimetype": "text/plain", "start_char_idx": 745, "end_char_idx": 2349, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "de6a0703-ed14-478f-b0ed-87f56ebcf0dc": {"__data__": {"id_": "de6a0703-ed14-478f-b0ed-87f56ebcf0dc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bbc46158-6629-43e9-86be-d39d7419eb99", "node_type": "1", "metadata": {}, "hash": "53d41a3fae2cecbfc8bef14cf2f83303736d047c4173a8ab7f4e9ab332f296d3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bae0e601-b2c3-4bf8-a641-5651b2854747", "node_type": "1", "metadata": {}, "hash": "8fcbfdc8fe996daba4e5cb3ffb8440867991c05ea18e82d67a5e03f412bcde0d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Conclusions: Immunisation against DTP or MMR does not increase the risk of hay fever. The lower\nconfidence limit for BCG vaccination contradicts the hypothesised protective effect. The reduced risk of hay\nfever among children immunised late may be explained by a third factor causing both postponement and\nreduced risk such as intercurrent febrile illnesses.\nA\nrise in the prevalence of atopic diseases such as allergic\nrhinitis during recent decades has been widely reported\nfrom developed countries.1\u20133 One postulated explana-\ntion is the reduction in childhood infections due to successful\nvaccination programmes. Without the challenge of poten-\ntially serious infection to trigger a Th1 immune response, a\nTh2 response could predominate in the developing immune\nsystem, predisposing to atopy and allergic diseases. The\nliterature on infections and atopic disease is equivocal.4\u20137\nHowever, vaccines themselves may influence the infantile\nimmune system by shifting expression in favour of either Th1\nor Th2 cytokine profiles.8 9 The relevant epidemiological\nevidence\nis\ninconsistent.9\nAlthough\none\nrecent\nreview\nconcluded that the evidence did not support vaccines causing\nallergic diseases, it focussed primarily on studies where the\noutcome was asthma, a disease which has both atopic and\nnon-atopic\ncomponents,\nparticularly\nin\nearly\ninfancy.10\nStudies focusing on allergic rhinitis provide a more specific\ntest of the hypothesis.\nDTP vaccination (against diphtheria, tetanus, and pertus-\nsis) has been considered as a possible inducer of immuno-\nglobulin E production through the whole cell pertussis\ncomponent. While positive associations have been reported\nwith atopic disease,11 allergy related respiratory symptoms,12\nand allergic illnesses,13 other studies have found no associa-\ntion between DTP vaccination and allergic diseases,14 hay\nfever,15 or atopy assessed by skin prick tests.16 17\nThe triple vaccine against mumps, measles, and rubella\n(MMR) has also been hypothesised as a risk factor for atopy,\nmainly due to the measles component, but again the evidence\nis inconsistent.", "mimetype": "text/plain", "start_char_idx": 2169, "end_char_idx": 4262, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bae0e601-b2c3-4bf8-a641-5651b2854747": {"__data__": {"id_": "bae0e601-b2c3-4bf8-a641-5651b2854747", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "de6a0703-ed14-478f-b0ed-87f56ebcf0dc", "node_type": "1", "metadata": {}, "hash": "2f477406088b92e328ed89d77973531ecc014e592eec17a7ca95cf3d9acd20b5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a0ea5a75-3f72-49a0-8b7e-73cd505e2518", "node_type": "1", "metadata": {}, "hash": "78aa05b089547b63029751e5322ed22036abddf7a2b4e10e72363ec4ca7b8257", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Wild measles infection was associated with a\nlower prevalence of allergic sensitisation in a study set in\nGuinea Bissau,18 while a Finnish study found that children\ninfected with wild measles were at an increased risk of later\nallergic\nrhinitis.19\nNot\nreceiving\nMMR\nvaccination\nwas\nprotective of atopy in a study set in Steiner schools in\nSweden.20 The Guinean and Swedish studies have been\ncriticised for uncontrolled confounding. However, a recent\nstudy of vaccinations and early onset hay fever using the\nWest Midlands section of the General Practice Research\nDatabase showed that, after controlling for consultation\nbehaviour, the apparent protective effect against hay fever of\nvaccination with MMR mostly disappeared.14 A study set in\nfive German cities found a negative dose-response relation\nbetween number of vaccine doses (MMR and DTP among\nothers) and allergic sensitisation.21 Finally, in one national\nBritish birth cohort, an inverse association between hay fever\nand measles immunisation and/or infection was apparently\nconfined to those with many older siblings.22\nBeing a live mycobacterial vaccine, BCG (bacillus Calmette-\nGue\u00b4rin) activates a strong Th1 response. Following the\nobservation that tuberculin reactivity was strongly inversely\nrelated to IgE levels23it has been suggested that this may\nprotect against a later atopic response, and BCG has been\nassociated with lower risk of subsequent atopy in some\nstudies,24 25 but not in others.26\u201330\nTo clarify the epidemiological evidence, we conducted\nnested case-control studies in two large UK databases of\nprimary care consultations (the General Practice Research\nDatabase (GPRD) and the Doctors\u2019 Independent Network\n(DIN)) to test the hypotheses that: (1) immunisation with\nDTP in the first year of life increases subsequent hay fever\nrisk; (2) receipt of MMR vaccine in the first two years of life\nincreases subsequent hay fever risk; and (3) BCG vaccination\nbefore age 2 years protects against subsequent hay fever. We\npaid particular attention to the timing of each vaccination in\norder to identify any critical period for long term immuno-\nlogical programming.\n567\nwww.archdischild.com\nby copyright.", "mimetype": "text/plain", "start_char_idx": 4263, "end_char_idx": 6440, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a0ea5a75-3f72-49a0-8b7e-73cd505e2518": {"__data__": {"id_": "a0ea5a75-3f72-49a0-8b7e-73cd505e2518", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bae0e601-b2c3-4bf8-a641-5651b2854747", "node_type": "1", "metadata": {}, "hash": "8fcbfdc8fe996daba4e5cb3ffb8440867991c05ea18e82d67a5e03f412bcde0d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2e12124b-5709-441b-94ab-344732117f40", "node_type": "1", "metadata": {}, "hash": "57612288448ab280f3edc961865aec4cd1cc4589d398b062caa3b0a792814a16", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We\npaid particular attention to the timing of each vaccination in\norder to identify any critical period for long term immuno-\nlogical programming.\n567\nwww.archdischild.com\nby copyright.\n on January 9, 2025 at Assistance Publique Hopitaux de Paris. Protected\nhttp://adc.bmj.com/\nArch Dis Child: first published as 10.1136/adc.2004.051714 on 20 May 2005. Downloaded from \nMETHODS\nA detailed description of our methodology has\nbeen published previously.31 In summary, we\nconducted nested case-control studies within a\nGPRD cohort of 76 310 children born between\n1989 and 1993 from 464 general practices, and\nwithin a DIN cohort of 40 183 children born\nbetween 1989 and 1997 from 141 general prac-\ntices. All children were registered with a con-\ntributing practice within three months of birth\nand had at least five years of continuous follow up\nwith that practice. Practices were located primarily\nin England and Wales but Scotland and Northern\nIreland were also represented.\nWe aimed to be consistent across the two\ndatabases in our case definition of hay fever and\nselection of relevant drugs, despite the various\ncoding systems used. Only codes synonymous\nwith \u2018\u2018allergic rhinitis\u2019\u2019 and with seasonal varia-\ntion in recording were permitted. To assess case-\nness, sequential diagnoses of hay fever and/or\nspecific medications were sought. Subjects who\nonly ever had a hay fever diagnosis before age 2, or\nnon-specific allergic rhinitis diagnoses which did\nnot exhibit a seasonal pattern were excluded from\nbeing cases or controls. All cases were required to\nhave at least one diagnosis of hay fever. For each\ncase of hay fever we selected one control child,\nmatched for general practice, sex, and birth month\nwho had continuous follow up until at least the\ndate of diagnosis of the index case.31 Cases and\ncontrols were thus followed up for similar lengths\nof time: 7.42 and 7.43 years respectively in GPRD\nand 8.22 and 8.24 years in DIN.", "mimetype": "text/plain", "start_char_idx": 6255, "end_char_idx": 8193, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2e12124b-5709-441b-94ab-344732117f40": {"__data__": {"id_": "2e12124b-5709-441b-94ab-344732117f40", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a0ea5a75-3f72-49a0-8b7e-73cd505e2518", "node_type": "1", "metadata": {}, "hash": "78aa05b089547b63029751e5322ed22036abddf7a2b4e10e72363ec4ca7b8257", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a933cb49-76c8-4830-b37a-eab925d0b487", "node_type": "1", "metadata": {}, "hash": "ec9d4178abbb551d09b35efa29f3210d2dddd89e471bad1c185f041b4e2eff27", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Records of cases and controls from GPRD (4196\npairs) and DIN (2902 pairs) were searched for the\nfirst occurrence of 3rd DTP immunisation (DTP3\nwith or without Haemophilus influenzae type b\nand/or poliomyelitis) or if absent, any other\nentries for DTP or pertussis. We chose 3rd DTP\nfor the main exposure as some general prac-\ntices\ndid\nnot\nroutinely\nrecord\n1st\nand\n2nd\ndoses. We also identified first entries for MMR\nimmunisation.\nThe sensitivity of any relation between hay fever\nand DTP, MMR, and BCG was assessed by\ncontrolling for consultation frequency in the first\nfive years of life, determined by categorising\nthe number of consultations during that time,\nexcluding\ndays\non\nwhich\nvaccinations\nwere\nadministered.\nIn the UK during the 1990s, DTP (whole cell\npertussis) vaccine was normally administered\nadsorbed\nonto\na\nmineral\ncompound.\nIt\nwas\nroutinely given as three separate injections at 8,\n12, and 16 weeks.32 It is usually administered at\nthe same time as an oral live poliomyelitis vaccine\nand can also be given in combination with\nHaemophilus influenzae type B vaccine (HiB).\nOn its introduction, MMR-II was recommended in\nyear 2 and subsequently in months 12\u201315. BCG\nvaccination is not routine during infancy, but is\ngenerally reserved for neonates at high risk of\ntuberculosis.\nAt\nthe\ntime\nof\nour\nstudy,\nthe\nCopenhagen substrain 1077 of BCG, given intra-\ndermally in a dose of 0.05 ml (to infants under\n3 months of age) or 0.1 ml was recommended.\nFor the principal analyses, timing of DTP3 was\ncategorised as 1st\u20134th month, 5th, 6th, 7th\u20139th,", "mimetype": "text/plain", "start_char_idx": 8194, "end_char_idx": 9752, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a933cb49-76c8-4830-b37a-eab925d0b487": {"__data__": {"id_": "a933cb49-76c8-4830-b37a-eab925d0b487", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2e12124b-5709-441b-94ab-344732117f40", "node_type": "1", "metadata": {}, "hash": "57612288448ab280f3edc961865aec4cd1cc4589d398b062caa3b0a792814a16", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "76e27594-9ba4-4bb8-9b5c-291678859916", "node_type": "1", "metadata": {}, "hash": "79955bf747f108617b197825cf10f4cb314e3d12a2456e09c56b4b32582dee51", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For the principal analyses, timing of DTP3 was\ncategorised as 1st\u20134th month, 5th, 6th, 7th\u20139th,\nTable 1\nCase-control study (GPRD) of hay fever and vaccinations\nVaccine\nMonth(s) of life\nCounts (%) cases + controls\nUnadjusted*\nAdjusted\u0001\nAdjusted`\nOR\n95% CI\np value\nOR\n95% CI\np value\nOR\n95% CI\np value\n8392 (100)\nDTP\nDTP3 1st\u20134th\n1087(13.0)\n0.91\n0.78 to 1.06\n0.22\n0.94\n0.78 to 1.12\n0.48\n0.90\n0.75 to 1.08\n0.26\nDTP3 5th\n2786 (33.2)\n1\n1\n1\nDTP3 6th\n1178 (14.0)\n1.01\n0.87 to 1.17\n0.88\n1.06\n0.89 to 1.27\n0.50\n1.10\n0.92 to 1.31\n0.31\nDTP3 7th\u20139th\n1163 (13.9)\n0.78\n0.66 to 0.92\n0.004\n0.73\n0.59 to 0.91\n0.004\n0.80\n0.64 to 0.99\n0.04\nDTP3 10th\u201312th\n1165 (13.9)\n0.75\n0.60 to 0.94\n0.01\n0.85\n0.64 to 1.13\n0.27\n0.93\n0.70 to 1.24\n0.63\nDTP3 13th +\n482 (5.7)\n0.53\n0.40 to 0.69\n,0.0001\n0.58\n0.41 to 0.81\n0.002\n0.64\n0.45 to 0.90\n0.01\nOther DTP\n183 (2.2)\n0.81\n0.57 to 1.15\n0.23\n0.83\n0.54 to 1.", "mimetype": "text/plain", "start_char_idx": 9657, "end_char_idx": 10526, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "76e27594-9ba4-4bb8-9b5c-291678859916": {"__data__": {"id_": "76e27594-9ba4-4bb8-9b5c-291678859916", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a933cb49-76c8-4830-b37a-eab925d0b487", "node_type": "1", "metadata": {}, "hash": "ec9d4178abbb551d09b35efa29f3210d2dddd89e471bad1c185f041b4e2eff27", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "17416c11-a704-4c5e-a2dd-34d5dfa75987", "node_type": "1", "metadata": {}, "hash": "febd4a35f526f295207bd9832fb85cfcda7b89842fea983df65a165f3be2d98b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "45 to 0.90\n0.01\nOther DTP\n183 (2.2)\n0.81\n0.57 to 1.15\n0.23\n0.83\n0.54 to 1.27\n0.39\n0.86\n0.55 to 1.33\n0.49\nNo DTP\n346 (4.1)\n0.90\n0.70 to 1.16\n0.42\n0.91\n0.66 to 1.26\n0.56\n1.01\n0.73 to 1.33\n0.95\nMMR\n1st\u201313th\n1688 (20.1)\n1.00\n0.86 to 1.16\n0.97\n0.98\n0.82 to 1.18\n0.84\n0.97\n0.81 to 1.16\n0.74\n14th\n2311 (27.5)\n1\n1\n1\n15th\n1638 (19.5)\n0.84\n0.73 to 0.97\n0.02\n0.88\n0.74 to 1.04\n0.13\n0.89\n0.75 to 1.06\n0.19\n16th\n1183 (14.1)\n0.92\n0.77 to 1.09\n0.34\n0.93\n0.76 to 1.15\n0.50\n0.93\n0.75 to 1.14\n0.48\n17th\n510 (6.1)\n0.96\n0.76 to 1.20\n0.69\n0.94\n0.72 to 1.23\n0.64\n0.96\n0.73 to 1.25\n0.75\n18th\u201324th\n618 (7.4)\n0.78\n0.64 to 0.95\n0.01\n0.86\n0.68 to 1.10\n0.23\n0.89\n0.70 to 1.14\n0.37\n25th+\n234 (2.8)\n0.69\n0.52 to 0.92\n0.01\n0.77\n0.54 to 1.08\n0.13\n0.83\n0.", "mimetype": "text/plain", "start_char_idx": 10452, "end_char_idx": 11174, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "17416c11-a704-4c5e-a2dd-34d5dfa75987": {"__data__": {"id_": "17416c11-a704-4c5e-a2dd-34d5dfa75987", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "76e27594-9ba4-4bb8-9b5c-291678859916", "node_type": "1", "metadata": {}, "hash": "79955bf747f108617b197825cf10f4cb314e3d12a2456e09c56b4b32582dee51", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "44fddeea-7f77-47a2-8831-b47652414413", "node_type": "1", "metadata": {}, "hash": "21d530c5a976f77923609994be2cc228ea57631c839865088d8158a98296f5d7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "8)\n0.69\n0.52 to 0.92\n0.01\n0.77\n0.54 to 1.08\n0.13\n0.83\n0.58 to 1.18\n0.29\nNo MMR\n210 (2.5)\n0.59\n0.42 to 0.82\n0.002\n0.77\n0.50 to 1.17\n0.22\n0.81\n0.53 to 1.24\n0.33\nBCG\nBCG ,2 y\n198 (2.4)\n1.39\n0.99 to 1.95\n0.06\n1.25\n0.85 to 1.85\n0.26\n1.36\n0.91 to 2.05\n0.14\nNo BCG/.2 y\n8180 (97.6)\n1\n1\n1\nOR, odds ratio; 95% CI, 95% confidence interval.\n*Unadjusted matched pairs analysis (4196 pairs for DTP and MMR, 4189 pairs for BCG).\n\u0001Adjusted for consultation frequency and restricted to pairs with non-ghost controls (3859 pairs for DTP and MMR, 3852 pairs for BCG).\n`Further adjusted for numbers of older and younger sibs and multiple births (3859 pairs for DTP and MMR, 3453 pairs for BCG).\nTests for trend (non-ghost control pairs and adjusted for consultation frequency).\nDTP: 0.92 (0.87, 0.97), p = 0.003; MMR: 0.96 (0.92, 0.99), p = 0.02.\n568\nBremner, Carey, DeWilde, et al\nwww.archdischild.com\nby copyright.\n on January 9, 2025 at Assistance Publique Hopitaux de Paris. Protected\nhttp://adc.bmj.com/\nArch Dis Child: first published as 10.1136/adc.2004.051714 on 20 May 2005. Downloaded from \n10th\u201312th, 13th or later, DTP other than 3rd,\npertussis (single vaccination) (DIN only), and\nunvaccinated against pertussis.", "mimetype": "text/plain", "start_char_idx": 11118, "end_char_idx": 12324, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "44fddeea-7f77-47a2-8831-b47652414413": {"__data__": {"id_": "44fddeea-7f77-47a2-8831-b47652414413", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "17416c11-a704-4c5e-a2dd-34d5dfa75987", "node_type": "1", "metadata": {}, "hash": "febd4a35f526f295207bd9832fb85cfcda7b89842fea983df65a165f3be2d98b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "36f0f793-eb0f-4d3f-86ff-06d5c8e9f56c", "node_type": "1", "metadata": {}, "hash": "93a08c1cbe96a830d46591c55a19a370d60d77b5e5280812056c73c983254363", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Downloaded from \n10th\u201312th, 13th or later, DTP other than 3rd,\npertussis (single vaccination) (DIN only), and\nunvaccinated against pertussis. MMR was cate-\ngorised into the time bands: 1st\u201313th month,\n14th, 15th, 16th, 17th, 18th\u201324th, and 25th\nmonth or later. Odds ratios are reported with\nthose vaccinated \u2018\u2018on time\u2019\u2019 (modal group)\nforming the reference group (month 5 for\nDTP3 and month 14 for MMR).\nFinally, records of BCG vaccination were\nsought in birth cohort members during their\nfirst two years of follow up. Our main exposure\nperiod of interest was BCG by the age of 2 years.\nThose vaccinated with BCG after the age of 2\nwere classed as unvaccinated for the purpose of\nthis analysis. Case-control pairs where either\nmember had a record of tuberculosis at any age\nwere excluded.\nStatistical analysis\nOur analyses are based on conditional multiple\nlogistic regression models, with the matched\npairs forming separate strata, using proc phreg in\nSAS (version 8.1 for SunOS).33\nWithin each database we adjusted for con-\nsultation frequency and examined the effect of\nexcluding potential \u2018\u2018ghost\u2019\u2019 controls.\nThese\nwere children who had no record of a general\npractitioner\nconsultation\nin\nthe\nperiod\nsix\nmonths before the case diagnosis date or at\nany time after. The true disease and exposure\nstatus of such controls would be unknown but\nwe might expect some of them to be misclassi-\nfied cases. We also investigated the possible\nconfounding influence of socioeconomic cir-\ncumstances measured at the small area level\nby ACORN classification in DIN34 and sibship\nstructure based on the family identifier in\nGPRD.", "mimetype": "text/plain", "start_char_idx": 12183, "end_char_idx": 13799, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "36f0f793-eb0f-4d3f-86ff-06d5c8e9f56c": {"__data__": {"id_": "36f0f793-eb0f-4d3f-86ff-06d5c8e9f56c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "44fddeea-7f77-47a2-8831-b47652414413", "node_type": "1", "metadata": {}, "hash": "21d530c5a976f77923609994be2cc228ea57631c839865088d8158a98296f5d7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f4f35c9d-c364-452a-ae27-f92d76e874b7", "node_type": "1", "metadata": {}, "hash": "d634387819caf9c35dd71dc26dc935a1684e1a80c19ccc9ed2fa19c6956eb8ab", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We also investigated the possible\nconfounding influence of socioeconomic cir-\ncumstances measured at the small area level\nby ACORN classification in DIN34 and sibship\nstructure based on the family identifier in\nGPRD.\nThe odds ratio estimates from the two case-\ncontrol\nstudies\nexcluding\npotential\n\u2018\u2018ghost\u2019\u2019\ncontrols and adjusted for consultation fre-\nquency were pooled using a fixed effects model\nby way of the meta command in Stata (version\n5.0 for Windows).35 36 In pooled, fixed effects\nmodels, we explored whether the effects of DTP/\nMMR were independent of each other and\nwhether there was any evidence of a trend\nacross categories of timing of vaccination.\nRESULTS\nDTP\nIn GPRD, 93.7% of cases plus controls were fully\nvaccinated with DTP, while only 4.1% were\nentirely unvaccinated (table 1). In DIN, 92.8%\nwere fully DTP vaccinated and only 1.1% were\nentirely\nunvaccinated,\nwith\n3.5%\nreceiving\npertussis only (table 2).\nIn both databases the DTP unvaccinated (also\npertussis unvaccinated in DIN) group were at\nvery similar risk of subsequent hay fever to\nthose vaccinated \u2018\u2018on time\u2019\u2019 with unadjusted\nodds ratios of 0.90 in GPRD (table 1) and 0.86 in\nDIN (table 2). Children identified as having\nincomplete or non-specific DTP records were\nsmall in number and there was no evidence of\nan excess or a deficit risk in this group.\nHowever, later/delayed vaccination with DTP3\nwas associated with decreased risk of hay fever,\nTable 2\nCase-control study (DIN) of hay fever and vaccinations\nVaccine\nMonth(s) of life\nCounts (%)cases + controls\nUnadjusted*\nAdjusted\u0001\nAdjusted`\nOR\n95% CI\np value\nOR\n95% CI\np value\nOR\n95% CI\np value\n5804 (100)\nDTP\nDTP3 1st\u20134th\n716 (12.3)\n1.15\n0.95 to 1.39\n0.15\n1.21\n0.93 to 1.58\n0.", "mimetype": "text/plain", "start_char_idx": 13583, "end_char_idx": 15295, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f4f35c9d-c364-452a-ae27-f92d76e874b7": {"__data__": {"id_": "f4f35c9d-c364-452a-ae27-f92d76e874b7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "36f0f793-eb0f-4d3f-86ff-06d5c8e9f56c", "node_type": "1", "metadata": {}, "hash": "93a08c1cbe96a830d46591c55a19a370d60d77b5e5280812056c73c983254363", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8905277d-48cf-4250-9ed6-a3a4fbe6ff58", "node_type": "1", "metadata": {}, "hash": "69b88c12fb95d8900cf4eae20933d734399b2a5a478438eee315ccf5e7e5b5e8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3)\n1.15\n0.95 to 1.39\n0.15\n1.21\n0.93 to 1.58\n0.15\n1.19\n0.91 to 1.55\n0.21\nDTP3 5th\n2813 (48.5)\n1\n1\n1\nDTP3 6th\n1055 (18.2)\n0.96\n0.82 to 1.11\n0.54\n1.01\n0.82 to 1.23\n0.96\n1.01\n0.82 to 1.23\n0.95\nDTP3 7th\u20139th\n470 (8.1)\n0.88\n0.71 to 1.09\n0.23\n0.99\n0.74 to 1.31\n0.92\n0.99\n0.74 to 1.31\n0.92\nDTP3 10th\u201312th\n207 (3.6)\n0.65\n0.43 to 0.96\n0.03\n0.51\n0.30 to 0.87\n0.01\n0.52\n0.30 to 0.88\n0.01\nDTP3 13th+\n119 (2.1)\n0.71\n0.49 to 1.05\n0.09\n0.64\n0.38 to 1.10\n0.10\n0.67\n0.39 to 1.14\n0.14\nOther DTP\n158 (2.7)\n0.94\n0.63 to 1.40\n0.75\n1.04\n0.60 to 1.81\n0.90\n1.02\n0.59 to 1.78\n0.94\nSome pertussis\n203 (3.5)\n1.55\n0.60 to 4.00\n0.37\n1.22\n0.30 to 4.97\n0.79\n1.24\n0.30 to 5.08\n0.77\nNo pertussis\n63 (1.1)\n0.86\n0.52 to 1.43\n0.57\n1.65\n0.83 to 3.28\n0.15\n1.67\n0.", "mimetype": "text/plain", "start_char_idx": 15249, "end_char_idx": 15972, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8905277d-48cf-4250-9ed6-a3a4fbe6ff58": {"__data__": {"id_": "8905277d-48cf-4250-9ed6-a3a4fbe6ff58", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f4f35c9d-c364-452a-ae27-f92d76e874b7", "node_type": "1", "metadata": {}, "hash": "d634387819caf9c35dd71dc26dc935a1684e1a80c19ccc9ed2fa19c6956eb8ab", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dbec8102-e036-4a27-8fad-587ae906d2cd", "node_type": "1", "metadata": {}, "hash": "1897823a70249312affecdd78a1f537c257e3f3b0587fe1edc1f996d8dec633e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1)\n0.86\n0.52 to 1.43\n0.57\n1.65\n0.83 to 3.28\n0.15\n1.67\n0.84 to 3.33\n0.14\nMMR\n1st\u201313th\n1128 (19.4)\n0.89\n0.74 to 1.06\n0.18\n0.90\n0.71 to 1.16\n0.43\n0.92\n0.72 to 1.18\n0.51\n14th\n1769 (30.5)\n1\n1\n1\n15th\n1192 (20.5)\n1.06\n0.91 to 1.25\n0.44\n1.24\n1.00 to 1.53\n0.05\n1.24\n1.00 to 1.54\n0.05\n16th\n772 (13.3)\n0.87\n0.71 to 1.06\n0.16\n0.96\n0.73 to 1.39\n0.79\n0.97\n0.73 to 1.28\n0.81\n17th\n335 (5.8)\n0.92\n0.71 to 1.21\n0.56\n1.00\n0.69 to 1.45\n0.99\n1.01\n0.70 to 1.47\n0.95\n18th\u201324th\n379 (6.5)\n0.78\n0.62 to 0.99\n0.04\n1.01\n0.73 to 1.28\n0.96\n1.01\n0.73 to 1.39\n0.96\n25th +\n119 (2.1)\n0.55\n0.37 to 0.82\n0.003\n0.54\n0.31 to 0.95\n0.03\n0.57\n0.32 to 0.99\n0.05\nNo MMR\n110 (1.9)\n0.72\n0.47 to 1.09\n0.12\n0.82\n0.45 to 1.50\n0.51\n0.81\n0.44 to 1.48\n0.50\nBCG\nBCG ,", "mimetype": "text/plain", "start_char_idx": 15916, "end_char_idx": 16631, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dbec8102-e036-4a27-8fad-587ae906d2cd": {"__data__": {"id_": "dbec8102-e036-4a27-8fad-587ae906d2cd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8905277d-48cf-4250-9ed6-a3a4fbe6ff58", "node_type": "1", "metadata": {}, "hash": "69b88c12fb95d8900cf4eae20933d734399b2a5a478438eee315ccf5e7e5b5e8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "571845a8-8109-449d-85d1-dc60dc2e3b88", "node_type": "1", "metadata": {}, "hash": "76b903c6b0f182d3ec83b8f20b75bbab759912b92e92a7d839aab62b08b12051", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "09\n0.12\n0.82\n0.45 to 1.50\n0.51\n0.81\n0.44 to 1.48\n0.50\nBCG\nBCG ,2 y\n144 (2.5)\n1.29\n0.89 to 1.88\n0.18\n1.31\n0.86 to 2.00\n0.21\n1.25\n0.79 to 1.96\n0.34\nNo BCG/.2 y\n5654 (97.5)\n1\n1\n1\nOR, odds ratio; 95% CI, 95% confidence interval.\n*Unadjusted matched pairs analysis (2902 pairs for DTP and MMR; 2899 pairs for BCG).\n\u0001Adjusted for consultation frequency and restricted to pairs with non-ghost controls (2611 pairs for DTP and MMR; 2602 pairs for BCG).\n`Further adjusted for ACORN socioeconomic category (1845 pairs for DTP and MMR; 1843 pairs for BCG).\nTests for trend (non-ghost control pairs and adjusted for consultation frequency).\nDTP: 0.90 (0.84, 0.96), p = 0.002; MMR: 0.95 (0.90, 0.99), p = 0.02.\nImmunisations and hay fever risk\n569\nwww.archdischild.com\nby copyright.\n on January 9, 2025 at Assistance Publique Hopitaux de Paris. Protected\nhttp://adc.bmj.com/\nArch Dis Child: first published as 10.1136/adc.2004.051714 on 20 May 2005. Downloaded from \nand the trend was significant in both databases. In both\ndatabases adjusting for consultation frequency and restrict-\ning to non-ghost controls had little effect on the odds ratio\nestimated, save for the \u2018\u2018no pertussis\u2019\u2019 group in DIN. In GPRD,\nthe number of older sibs was inversely related to hay fever\nrisk such that for each additional older sib, the odds of hay\nfever reduced by 17.3% (12.9\u201321.4%).", "mimetype": "text/plain", "start_char_idx": 16568, "end_char_idx": 17924, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "571845a8-8109-449d-85d1-dc60dc2e3b88": {"__data__": {"id_": "571845a8-8109-449d-85d1-dc60dc2e3b88", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dbec8102-e036-4a27-8fad-587ae906d2cd", "node_type": "1", "metadata": {}, "hash": "1897823a70249312affecdd78a1f537c257e3f3b0587fe1edc1f996d8dec633e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9834e6b4-e6b4-409e-b944-0a4af604bebe", "node_type": "1", "metadata": {}, "hash": "839f9204f4d88a6d14dc0e8a2ea02c1097d839d47b1b146e5e464f4996c99179", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Further adjustment for\nsibship structure was possible for 90% of case-control pairs in\nGPRD, but had little impact on the odds ratios (table 1). In\nDIN, the ACORN index was not significantly associated with\nhay fever risk: the odds ratio of hay fever was 0.99 (0.80\u2013\n1.22) in the thriving ACORN group compared to the striving\ngroup. Not surprisingly, further adjustment for the ACORN\nsocioeconomic\nindex\nhad\nlittle\nimpact\n(table\n2).\nThe\nsimilarity of the trends in the two databases with late DTP3\nvaccination is apparent in fig 1.\nMMR\nIn GPRD, 97.5% of cases plus controls were vaccinated with\nMMR, with 87.3% being vaccinated by 18 months, a further\n7.4% by age 2 years, and 2.8% after age 2; 2.5% had no record\nof vaccination (table 1). In DIN, 98.1% of cases plus controls\nreceived MMR; 89.5% by 18 months, a further 6.5% by age\n2 years, and 1.9% after age 2; 1.9% had no record of\nvaccination (table 2).\nFor MMR, the unvaccinated group were at lower risk of\nhay fever than those vaccinated on time: odds ratios of 0.59\nin GPRD (table 1) and 0.72 in DIN (table 2). Again there was\na decline in risk associated with later age of vaccination\nwhich was significant in both databases and the odds ratios\nfor the unvaccinated\nwere similar to those for those\nvaccinated with MMR after 18 months. Adjustment for\nconsultation frequency and restricting to non-ghost controls\nhad no major impact, but the odds ratio for the unvaccinated\ngroup in GPRD was less extreme after these adjustments\n(OR = 0.77).\nFurther\nadjustment\nfor\nsibship\nstructure\n(table 1) and ACORN socioeconomic score (table 2) made\nno impact on the odds ratios. The similarity of the results for\nthe two databases is shown in fig 2.", "mimetype": "text/plain", "start_char_idx": 17925, "end_char_idx": 19620, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9834e6b4-e6b4-409e-b944-0a4af604bebe": {"__data__": {"id_": "9834e6b4-e6b4-409e-b944-0a4af604bebe", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "571845a8-8109-449d-85d1-dc60dc2e3b88", "node_type": "1", "metadata": {}, "hash": "76b903c6b0f182d3ec83b8f20b75bbab759912b92e92a7d839aab62b08b12051", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "375c018f-5983-4f5a-b29f-29998e46dfdc", "node_type": "1", "metadata": {}, "hash": "c3e271794574639be1466bcf4ed5d69cb4f310e065177fad0676a6d3e16bce11", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The similarity of the results for\nthe two databases is shown in fig 2.\nBecause the results are so similar for both GPRD and DIN,\nfurther analyses to assess the independence of the trends\nwith delayed vaccination for the two triple vaccines were\nbased on pooling estimates from the two databases (table 3).\nIt is apparent that the trends are largely independent with\nthe inverse association between hay fever and postponement\nbeing\nsignificant\nfor\nboth DTP (p = 0.001)\nand MMR\n(p = 0.04).\nBCG\nThe percentage of cases and controls vaccinated with BCG\nwas almost identical in each database: 2.4% of GPRD and\n2.5% of DIN had a record of vaccination by age 2, 83% of\nthese within the first three months of life (tables 1 and 2). A\nfurther 0.2% in each database were vaccinated by age 5 years.\nIn both databases immunisation with BCG by age 2 was\nassociated with an increased risk of hay fever. The pooled\nestimate was 1.34 (95% CI 1.05 to 1.73; p = 0.02) which\nreduced to 1.28 (95% CI 0.96 to 1.73; p = 0.09) after adjusting\nfor consultation frequency and restriction to non-ghost\ncontrols.\nDISCUSSION\nIn our large scale investigation we have found that infants\nimmunised\nagainst\nDTP\nor\nMMR\nin\naccordance\nwith\nvaccination schedules are at no greater or lesser risk of hay\nfever than those who do not receive these immunisations.\nThis is reassuring in relation to the impact of routine\nvaccinations on atopic sensitisation, and concurs with the\nresults of an international comparison of the prevalence of\nallergic diseases and vaccine coverage.37\nThe finding of a protective effect of late immunisation was\nunexpected, but was consistent in the two databases; a\npowerful indication that the findings are not artefacts of a\nspecific method of recording. Moreover the odds of hay fever\nfall steadily with increasing lateness of vaccination for both\nDTP and MMR (figs 1 and 2) and the tests for trend are\nsignificant. The associations are therefore likely to be real,\nalthough not necessarily causal.", "mimetype": "text/plain", "start_char_idx": 19550, "end_char_idx": 21541, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "375c018f-5983-4f5a-b29f-29998e46dfdc": {"__data__": {"id_": "375c018f-5983-4f5a-b29f-29998e46dfdc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9834e6b4-e6b4-409e-b944-0a4af604bebe", "node_type": "1", "metadata": {}, "hash": "839f9204f4d88a6d14dc0e8a2ea02c1097d839d47b1b146e5e464f4996c99179", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "08a21e80-31bb-4403-8296-0626ebfaed80", "node_type": "1", "metadata": {}, "hash": "ee294603d4e7534ac4c89a6ad31261fe05e15996192768d05d18e7f0b52ca4f8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The associations are therefore likely to be real,\nalthough not necessarily causal. We consider potential\nexplanations under three headings: artefact, family factors,\nand childhood factors.\n1.8\n1.7\n1.6\n1.5\n1.4\n1.3\n1.2\n1.1\n1\n0.9\n0.8\n0.7\n0.6\n0.5\n0.4\n0.3\nMonth of life at vaccination\nGPRD\nDIN\nOdds ratio (log scale)\n<5\n5\n6\n7\u20139\n10\u201312\n13+\nNone\nFigure 1\nOdds of hay fever by age (in months) at 3rd DTP. Estimated odds ratios with 95% CI. Arrow represents upper confidence limit off scale.\nVaccination in month 5 is base group. None represents unvaccinated.\n570\nBremner, Carey, DeWilde, et al\nwww.archdischild.com\nby copyright.\n on January 9, 2025 at Assistance Publique Hopitaux de Paris. Protected\nhttp://adc.bmj.com/\nArch Dis Child: first published as 10.1136/adc.2004.051714 on 20 May 2005. Downloaded from \nArtefact\nThis is by far the largest and most comprehensive study to\ndate of the association between immunisation history and\nsubsequent allergic disease. Although delayed vaccinations\nwere uncommon, the size of our study detects trends with\nhigh levels of statistical significance.\nRestriction of potential \u2018\u2018ghost\u2019\u2019 controls had no important\nimpact on our results.\nIt is theoretically possible that families who consult their\nGP less often would be less likely to attend for routine\nvaccination and less likely to present their child with hay\nfever\nsymptoms.\nHowever,\nadjustment\nfor\nconsultation\nfrequency made little difference and there was no reduction\nin hay fever risk among DTP unvaccinated children, which\nmakes this explanation unlikely.\nFamily factors\nIn GPRD, the numbers of older and younger sibs were\navailable for 90% of case-control pairs.", "mimetype": "text/plain", "start_char_idx": 21459, "end_char_idx": 23117, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "08a21e80-31bb-4403-8296-0626ebfaed80": {"__data__": {"id_": "08a21e80-31bb-4403-8296-0626ebfaed80", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "375c018f-5983-4f5a-b29f-29998e46dfdc", "node_type": "1", "metadata": {}, "hash": "c3e271794574639be1466bcf4ed5d69cb4f310e065177fad0676a6d3e16bce11", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "080a38f5-4bbc-475c-8e0f-f1ad2c7fb849", "node_type": "1", "metadata": {}, "hash": "7a63697a5a0dd04d1febba90bd98cb5275d268df1e34cf276080781062bee685", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Family factors\nIn GPRD, the numbers of older and younger sibs were\navailable for 90% of case-control pairs. As consistently found\nelsewhere, children from larger families were less likely to\ncomplete vaccination on time, and having more older or\nyounger sibs was strongly protective of hay fever.38 However,\nadjusting for sibship structure had no effect on the relation\nbetween hay fever and timing of vaccination (table 1).\nFor both triple vaccines in DIN, we found a lower\npercentage\nimmunised\non\ntime\nin\nthe\nmore\ndeprived\nACORN groups and a greater percentage not immunised or\nimmunised late. However, in regression models, ACORN was\nfound not to confound the relation between exposure timing\nand later hay fever (table 2).\nChild factors\nAllergic children may differ from other children in several\nways. Their more frequent contacts with their GP may mean\nthey are also more likely to complete vaccinations. However,\nwhile consultation frequency was strongly positively related\nto the risk of hay fever, adjusting for it did not alter the odds\nratios for hay fever by age at immunisation.\n1.7\n1.8\n1.6\n1.5\n1.4\n1.3\n1.2\n1.1\n1\n0.9\n0.8\n0.7\n0.6\n0.5\n0.4\n0.3\nMonth of life at vaccination\nOdds ratio (log scale)\n1\u201313\n14\n15\n16\n17\n18\u201324\n25+\nNone\nGPRD\nDIN\nFigure 2\nOdds of hay fever by age (in months) at MMR. Estimated odds ratios with 95% CI. Vaccination in month 14 is base group. None represents\nunvaccinated.\nTable 3\nPooled (fixed effects) results for GPRD and DIN\nVaccine\nMonth(s) of life\nDTP and MMR modelled independently\nDTP and MMR modelled jointly\nOR\n95% CI\np value\nOR\n95% CI\np value\nAge at DTP3\nDTP3 1st\u20134th\n1.02\n0.90 to 1.17\n0.74\n1.02\n0.89 to 1.", "mimetype": "text/plain", "start_char_idx": 23010, "end_char_idx": 24659, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "080a38f5-4bbc-475c-8e0f-f1ad2c7fb849": {"__data__": {"id_": "080a38f5-4bbc-475c-8e0f-f1ad2c7fb849", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "08a21e80-31bb-4403-8296-0626ebfaed80", "node_type": "1", "metadata": {}, "hash": "ee294603d4e7534ac4c89a6ad31261fe05e15996192768d05d18e7f0b52ca4f8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2b47c8a3-7739-42e5-ac58-1b886a12e0af", "node_type": "1", "metadata": {}, "hash": "ba5b564540e405c4ebce13c2d26bf743d721de7407fec865496c922641c7d62b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "02\n0.90 to 1.17\n0.74\n1.02\n0.89 to 1.17\n0.78\nDTP3 5th\n1\n1\nDTP3 6th\n0.99\n0.88 to 1.12\n0.92\n1.00\n0.89 to 1.13\n0.996\nDTP3 7th\u20139th\n0.80\n0.69 to 0.94\n0.005\n0.83\n0.71 to 0.97\n0.02\nDTP3 10th\u201312th\n0.72\n0.58 to 0.90\n0.005\n0.75\n0.60 to 0.94\n0.01\nDTP3 13th +\n0.60\n0.45 to 0.76\n,0.001\n0.66\n0.50 to 0.86\n0.002\nOther DTP\n0.88\n0.65 to 1.20\n0.41\n0.94\n0.68 to 1.28\n0.69\nNo pertussis\n0.94\n0.73 to 1.23\n0.65\n0.99\n0.76 to 1.28\n0.92\nAge at 1st MMR\n1st\u201313th\n0.94\n0.83 to 1.07\n0.36\n0.92\n0.81 to 1.05\n0.24\n14th\n1\n1\n15th\n0.96\n0.85 to 1.08\n0.48\n0.97\n0.86 to 1.10\n0.62\n16th\n0.89\n0.76 to 1.04\n0.13\n0.91\n0.79 to 1.06\n0.24\n17th\n0.90\n0.74 to 1.10\n0.31\n0.94\n0.77 to 1.15\n0.56\n18th\u201324th\n0.80\n0.67 to 0.95\n0.01\n0.85\n0.71 to 1.01\n0.07\n25th +\n0.62\n0.48 to 0.", "mimetype": "text/plain", "start_char_idx": 24623, "end_char_idx": 25344, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2b47c8a3-7739-42e5-ac58-1b886a12e0af": {"__data__": {"id_": "2b47c8a3-7739-42e5-ac58-1b886a12e0af", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "080a38f5-4bbc-475c-8e0f-f1ad2c7fb849", "node_type": "1", "metadata": {}, "hash": "7a63697a5a0dd04d1febba90bd98cb5275d268df1e34cf276080781062bee685", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "13ff4ca8-fcda-4487-9cc7-919f56ffccf5", "node_type": "1", "metadata": {}, "hash": "7d7f1b77d815a4fa2d17243f26ed3d308572b1b7151a265f85a1f3442227b61b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "80\n0.67 to 0.95\n0.01\n0.85\n0.71 to 1.01\n0.07\n25th +\n0.62\n0.48 to 0.80\n,0.001\n0.67\n0.52 to 0.90\n0.007\nNo MMR\n0.79\n0.58 to 1.08\n0.13\n0.82\n0.59 to 1.12\n0.21\nAll of the analyses are based on non-ghost control pairs only and are adjusted for consultation frequency.\nOR, odds ratio; 95% CI, 95% confidence interval.\nImmunisations and hay fever risk\n571\nwww.archdischild.com\nby copyright.\n on January 9, 2025 at Assistance Publique Hopitaux de Paris. Protected\nhttp://adc.bmj.com/\nArch Dis Child: first published as 10.1136/adc.2004.051714 on 20 May 2005. Downloaded from \nA more plausible explanation for postponing immunisation\nwould\nbe\npresentation\nwith\na\nfever\nat\nthe\ntime\nan\nimmunisation was due. If this was as a result of infection\nwith a virus or bacterium which protected against subsequent\ndevelopment\nof\nhay\nfever,\nthen\npostponement\nwould\nindirectly be associated with lower risk. We propose that\nthis is the most plausible explanation for our observation, but\nit will require further exploration and independent confirma-\ntion as details of reasons for postponing vaccinations were\nnot recorded routinely on either database. A simple analysis\nof mean infection rate on a month-by-month basis in years 1\nand 2 did not show a graded relation with vaccination delay.\nThis is the subject of ongoing research.\nHowever, it would be premature to suggest changes to\nvaccination policy on the basis of our findings. MMR and\nDTP protect against potentially fatal diseases and recent\nmedia scares in the UK may have contributed to a reduction\nin immunisation uptake in recent years.39\nFinally, our finding that the small group of infants\nvaccinated with BCG in early life were at a small increased\nrisk of hay fever was contrary to expectations.", "mimetype": "text/plain", "start_char_idx": 25278, "end_char_idx": 27016, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "13ff4ca8-fcda-4487-9cc7-919f56ffccf5": {"__data__": {"id_": "13ff4ca8-fcda-4487-9cc7-919f56ffccf5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2b47c8a3-7739-42e5-ac58-1b886a12e0af", "node_type": "1", "metadata": {}, "hash": "ba5b564540e405c4ebce13c2d26bf743d721de7407fec865496c922641c7d62b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "762c6422-b5a0-4463-ada4-e8032aaca145", "node_type": "1", "metadata": {}, "hash": "c9a29fcf9e95c5efec6a957d4ba7ebfad596549e72a8805045c5faa5dbe1a301", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Again, this\nresult was not explained in any way by confounding due to\nACORN category or sibship structure. While the small\nincreased risk of hay fever associated with BCG is not\nimportant,\ncompared\nto\nthe\nprotection\noffered\nagainst\ntuberculosis, our results, with narrow confidence intervals,\neffectively rule out the hypothesised protective effect of BCG\non subsequent risk of allergic disease.\nConclusions\nIn summary, this study shows that infants vaccinated with\nDTP and MMR are at no greater or lesser risk of developing\nhay fever than unvaccinated children. This should reassure\nparents and clinicians and no opportunity should be missed\nto immunise. Postponement of routine immunisation in early\nlife is associated with a reduction in hay fever risk. This is a\nnovel and potentially important observation which deserves\nto be further investigated.\nThere is an increasing risk of a measles epidemic.40\nDelaying vaccination would further increase the number of\nsusceptible subjects at younger ages and almost certainly\nincrease the number of children not completing their\nimmunisations.\nWe believe that the most likely explanation is that\ninfections associated with fever both lead to postponement\nof immunisation and protect against development of atopy. If\nthis interpretation is correct, it implies that common and\nrelatively mild intercurrent illnesses which may not be\npresented to the GP, rather than serious infections, may\nunderlie the \u2018\u2018hygiene hypothesis\u2019\u2019 for allergic disease.38 41\nAuthors\u2019 affiliations\n. . . . . . . . . . . . . . . . . . . . .\nS A Bremner, I M Carey, S DeWilde, S R Hilton, D P Strachan, D G Cook,\nDepartment of Community Health Sciences, St George\u2019s Hospital\nMedical School, London, UK\nN Richards, CompuFile Limited, Send, Surrey, UK\nW C Maier, Worldwide Epidemiology Group, GlaxoSmithKline,\nGreenford, Middlesex, UK\nFunding: Wellcome Trust grant 065177/Z/01/Z\nCompeting interests: Nicky Richards is a director of CompuFile Ltd which\nmarkets DIN data to pharmaceutical companies.\nREFERENCES\n1 Burney P. The changing prevalence of asthma?", "mimetype": "text/plain", "start_char_idx": 27017, "end_char_idx": 29090, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "762c6422-b5a0-4463-ada4-e8032aaca145": {"__data__": {"id_": "762c6422-b5a0-4463-ada4-e8032aaca145", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "13ff4ca8-fcda-4487-9cc7-919f56ffccf5", "node_type": "1", "metadata": {}, "hash": "7d7f1b77d815a4fa2d17243f26ed3d308572b1b7151a265f85a1f3442227b61b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c1e95909-09d5-4a4e-9dd8-d36c5674da61", "node_type": "1", "metadata": {}, "hash": "e3bc99357aeccea2eeebbe2bae2fb76faa6db4e45c74fa589437aba288e35e45", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "REFERENCES\n1 Burney P. The changing prevalence of asthma? Thorax 2002;57:II36\u20139.\n2 Hopkin JM. The rise of atopy and links to infection. Allergy 2002;57:5\u20139.\n3 Upton MN, McConnachie A, McSharry C, et al. Intergenerational 20 year\ntrends in the prevalence of asthma and hay fever in adults: the Midspan family\nstudy surveys of parents and offspring. BMJ 2000;321:88.\n4 Benn CS, Melbye M, Wohlfahrt J, et al. Cohort study of sibling effect,\ninfectious diseases, and risk of atopic dermatitis during first 18 months of life.\nBMJ 2004;328:1223.\n5 McKeever TM, Lewis SA, Smith C, et al. Early exposure to infections and\nantibiotics and the incidence of allergic disease: a birth cohort study with the\nWest Midlands General Practice Research Database. J Allergy Clin Immunol\n2002;109:43\u201350.\n6 Matricardi PM, Ronchetti R. Are infections protecting from atopy? Curr Opin\nAllergy Clin Immunol 2001;1:413\u201319.\n7 Matricardi PM, Rosmini F, Panetta V, et al. Hay fever and asthma in relation to\nmarkers of infection in the United States. J Allergy Clin Immunol\n2002;110:381\u20137.\n8 Gru\u00a8ber C, Nilsson L, Bjo\u00a8rkste\u00b4n B. Do early childhood immunizations influence\nthe development of atopy and do they cause allergic reactions? Pediatr Allergy\nImmunol 2001;12:296\u2013311.\n9 Pershagen G. Can immunization affect the development of allergy? Pediatr\nAllergy Immunol 2000;11(suppl 13):26\u20138.\n10 Offit PA, Hackett CJ. Addressing parents\u2019 concerns: do vaccines cause allergic\nor autoimmune diseases? Pediatrics 2003;111:653\u20139.\n11 Farooqi IS, Hopkin JM. Early childhood infection and atopic disorder. Thorax\n1998;53:927\u201332.", "mimetype": "text/plain", "start_char_idx": 29033, "end_char_idx": 30624, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c1e95909-09d5-4a4e-9dd8-d36c5674da61": {"__data__": {"id_": "c1e95909-09d5-4a4e-9dd8-d36c5674da61", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "762c6422-b5a0-4463-ada4-e8032aaca145", "node_type": "1", "metadata": {}, "hash": "c9a29fcf9e95c5efec6a957d4ba7ebfad596549e72a8805045c5faa5dbe1a301", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "43935815-0253-4ff1-9ca5-b8c401d0ecef", "node_type": "1", "metadata": {}, "hash": "bacaf2106b85066639dbea8d68fef983d5265c6345aa3b2adf509e8307e90442", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Pediatrics 2003;111:653\u20139.\n11 Farooqi IS, Hopkin JM. Early childhood infection and atopic disorder. Thorax\n1998;53:927\u201332.\n12 Hurwitz EL, Morgenstern H. Effects of diphtheria-tetanus-pertussis or tetanus\nvaccination on allergies and allergy-related respiratory symptoms among\nchildren and adolescents in the United States. J Manipulative Physiol Ther\n2000;23:81\u201390.\n13 Kemp T, Pearce N, Fitzharris P, et al. Is infant immunization a risk factor for\nchildhood asthma or allergy? Epidemiology 1997;8:678\u201380.\n14 McKeever TM. A birth cohort study of the aetiology of allergic disease in\nchildren using the West Midlands General Practice Research Database. PhD\nthesis. University of Nottingham, 2002.\n15 Wjst M, Dold S, Reitmeir P, et al. Pertussis infection and allergic sensitization.\nAnn Allergy 1994;73:450\u20134.\n16 Maitra A, Sherriff A, Griffiths M, et al. Pertussis vaccination in infancy and\nasthma or allergy in later childhood: birth cohort study. BMJ\n2004;328:925\u20136.\n17 Nilsson L, Kjellman NI, Bjo\u00a8rkste\u00b4n B. Allergic disease at the age of 7 years after\npertussis vaccination in infancy: results from the follow-up of a randomized\ncontrolled trial of 3 vaccines. Arch Pediatr Adolesc Med 2003;157:1184\u20139.\n18 Shaheen SO, Aaby P, Hall AJ, et al. Measles and atopy in Guinea-Bissau.\nLancet 1996;347:1792\u20136.\n19 Paunio M, Heinonen OP, Virtanen M, et al. Measles history and atopic\ndiseases: a population-based cross-sectional study. JAMA 2000;283:343\u20136.\n20 Alm JS, Swartz J, Lilja G, et al. Atopy in children of families with an\nanthroposophic lifestyle.", "mimetype": "text/plain", "start_char_idx": 30502, "end_char_idx": 32053, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "43935815-0253-4ff1-9ca5-b8c401d0ecef": {"__data__": {"id_": "43935815-0253-4ff1-9ca5-b8c401d0ecef", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c1e95909-09d5-4a4e-9dd8-d36c5674da61", "node_type": "1", "metadata": {}, "hash": "e3bc99357aeccea2eeebbe2bae2fb76faa6db4e45c74fa589437aba288e35e45", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "57de5bbe-353b-491a-a0b8-262076531c0a", "node_type": "1", "metadata": {}, "hash": "42e064d48d6d6fb022cb9bfe14745e76873b297d28bc1769e3a323d2ccd4482d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "JAMA 2000;283:343\u20136.\n20 Alm JS, Swartz J, Lilja G, et al. Atopy in children of families with an\nanthroposophic lifestyle. Lancet 1999;353:1485\u20138.\n21 Gru\u00a8ber C, Illi S, Lau S, et al. Transient suppression of atopy in early childhood\nis associated with high vaccination coverage. Pediatrics 2003;111:E282\u20138.\n22 Lewis SA, Britton JR. Measles infection, measles vaccination and the effect of\nbirth order in the aetiology of hay fever. Clin Exp Allergy\n1998;28:1493\u2013500.\n23 Shirakawa T, Enomoto T, Shimazu S, et al. The inverse association between\ntuberculin responses and atopic disorder. Science 1997;275:77\u20139.\n24 Aaby P, Shaheen SO, Heyes CB, et al. Early BCG vaccination and reduction\nin atopy in Guinea-Bissau. Clin Exp Allergy 2000;30:644\u201350.\nWhat is already known on this topic\nN Routine vaccinations in early life offer essential\nprotection against potentially fatal diseases\nN Evidence for associations between atopic disease and\nthe pertussis component of DTP and the measles\ncomponent of MMR is inconclusive\nWhat this study adds\nN Children vaccinated with DTP or MMR are at no\ngreater risk of developing hay fever than those\nunvaccinated\nN Late vaccinees are at a reduced risk of developing hay\nfever. This is not explained by measured social or\nbehavioural indicators\nN BCG vaccinated children are at a slightly increased risk\nof developing hay fever. This is contrary to expecta-\ntions\nN These findings are consistent in two large, independent\nsamples in the UK\n572\nBremner, Carey, DeWilde, et al\nwww.archdischild.com\nby copyright.\n on January 9, 2025 at Assistance Publique Hopitaux de Paris. Protected\nhttp://adc.bmj.com/\nArch Dis Child: first published as 10.1136/adc.2004.051714 on 20 May 2005.", "mimetype": "text/plain", "start_char_idx": 31932, "end_char_idx": 33638, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "57de5bbe-353b-491a-a0b8-262076531c0a": {"__data__": {"id_": "57de5bbe-353b-491a-a0b8-262076531c0a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "43935815-0253-4ff1-9ca5-b8c401d0ecef", "node_type": "1", "metadata": {}, "hash": "bacaf2106b85066639dbea8d68fef983d5265c6345aa3b2adf509e8307e90442", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "63537c09-11f1-4208-82a9-50ac9022e8c6", "node_type": "1", "metadata": {}, "hash": "2376e7bf8ba03ea0b0246d216b7a2d0127513c0cdc3364ae4c5f47ac86dec242", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Protected\nhttp://adc.bmj.com/\nArch Dis Child: first published as 10.1136/adc.2004.051714 on 20 May 2005. Downloaded from \n25 Gru\u00a8ber C, Meinlschmidt G, Bergmann R, et al. Is early BCG vaccination\nassociated with less atopic disease? An epidemiological study in German\npreschool children with different ethnic backgrounds. Pediatr Allergy Immunol\n2002;13:177\u201381.\n26 Krause TG, Hviid A, Koch A, et al. BCG vaccination and risk of atopy. JAMA\n2003;289:1012\u201315.\n27 Wong GW, Hui DS, Tam CM, et al. Asthma, atopy and tuberculin responses\nin Chinese schoolchildren in Hong Kong. Thorax 2001;56:770\u20133.\n28 Alm JS, Lilja G, Pershagen G, et al. Early BCG vaccination and development\nof atopy. Lancet 1997;350:400\u20133.\n29 Strannega\u02dard IL, Larsson LO, Wennergren G, et al. Prevalence of allergy in\nchildren in relation to prior BCG vaccination and infection with atypical\nmycobacteria. Allergy 1998;53:249\u201354.\n30 Gru\u00a8ber C, Kulig M, Bergmann R, et al. Delayed hypersensitivity to tuberculin,\ntotal immunoglobulin E, specific sensitization, and atopic manifestation in\nlongitudinally followed early bacille Calmette-Guerin-vaccinated and\nnonvaccinated children. Pediatrics 2001;107:e36.\n31 Bremner SA, Carey IM, DeWilde S, et al. Early-life exposure to antibacterials\nand the subsequent development of hayfever in childhood in the UK: case-\ncontrol studies using the General Practice Research Database and the Doctors\u2019\nIndependent Network. Clin Exp Allergy 2003;33:1518\u201325.\n32 Department of Health, Welsh Office, Scottish Home and Health Department.\nImmunisation against infectious disease 1990. London: HMSO, 1990.\n33 SAS System for SunOS, version 8.1.", "mimetype": "text/plain", "start_char_idx": 33534, "end_char_idx": 35171, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "63537c09-11f1-4208-82a9-50ac9022e8c6": {"__data__": {"id_": "63537c09-11f1-4208-82a9-50ac9022e8c6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2005).pdf", "node_type": "4", "metadata": {}, "hash": "9794abeb516aee12777770a91eb1ca113e24d9caa57373ca47f2842efe961fe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "57de5bbe-353b-491a-a0b8-262076531c0a", "node_type": "1", "metadata": {}, "hash": "42e064d48d6d6fb022cb9bfe14745e76873b297d28bc1769e3a323d2ccd4482d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "32 Department of Health, Welsh Office, Scottish Home and Health Department.\nImmunisation against infectious disease 1990. London: HMSO, 1990.\n33 SAS System for SunOS, version 8.1. Cary, NC: SAS Institute Inc, 1999.\n34 DeWilde S, Carey IM, Bremner SA, et al. Evolution of statin prescribing 1994\u2013\n2001: a case of agism but not of sexism? Heart 2003;89:417\u201321.\n35 Statacorp. Stata Statistical Software: release 5.0. 1997. College Station, TX:\nStata Corporation.\n36 Sharp S, Sterne J. sbe16: Meta-analysis. Stata Technical Bulletin\n1997;38:9\u201314.\n37 Anderson HR, Poloniecki JD, Strachan DP, et al. Immunization and symptoms\nof atopic disease in children: results from the International Study of Asthma\nand Allergies in Childhood. Am J Public Health 2001;91:1126\u20139.\n38 Strachan DP. Family size, infection and atopy: the first decade of the \u2018\u2018hygiene\nhypothesis\u2019\u2019. Thorax 2000;55(suppl 1):S2\u201310.\n39 Completed primary courses at two years of age England and Wales, 1966\u2013\n1977, England only 1978 onwards. http://www.hpa.org.uk/infections/\ntopics_az/vaccination/cover.htm (accessed 26 May 2004).\n40 Jansen VAA, Stollenwerk N, Jensen HJ, et al. Measles outbreaks in a\npopulation of declining vaccine uptake. Science 2003;301:804.\n41 Strachan DP. Hay fever, hygiene, and household size. BMJ\n1989;299:1259\u201360.\nImmunisations and hay fever risk\n573\nwww.archdischild.com\nby copyright.\n on January 9, 2025 at Assistance Publique Hopitaux de Paris. Protected\nhttp://adc.bmj.com/\nArch Dis Child: first published as 10.1136/adc.2004.051714 on 20 May 2005. Downloaded from", "mimetype": "text/plain", "start_char_idx": 34992, "end_char_idx": 36544, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "77b59b22-68db-4add-b504-4f8a356d45db": {"__data__": {"id_": "77b59b22-68db-4add-b504-4f8a356d45db", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1802f041-f25d-4d95-bf4b-c1d1d8e541c0", "node_type": "1", "metadata": {}, "hash": "7534fbd8c634c13eac51049e9cdef08c44e3c8228a0c57a7fbdcc35f383d47ac", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine\n 33\n (2015)\n 2511\u20132516\nContents\n lists\n available\n at\n ScienceDirect\nVaccine\nj\n our\n na\n l ho\n me\n page:\n www.elsevier.com/locate/vaccine\nEarly\n exposure\n to\n the\n combined\n measles\u2013mumps\u2013rubella\n vaccine\n and\nthimerosal-containing\n vaccines\n and\n risk\n of\n autism\n spectrum\n disorder\nYota\n Uno a,b,\u2217, Tokio\n Uchiyama b,c, Michiko\n Kurosawa d,  Branko\n Aleksic e, Norio\n Ozaki a,e\na Department\n of\n Child\n and\n Adolescent\n Psychiatry,\n Nagoya\n University\n Graduate\n School\n of\n Medicine,\n Tsurumai-cho\n 65,\n Showa-ku,\n Nagoya,\n Aichi\n 466-8550,\nJapan\nb Department\n of\n Psychiatry,\n Yokohama\n Psycho-Developmental\n Clinic,\n Chigasaki\n chuo\n 7-7-2F,\n Tsuzuki-ku,\n Yokohama,\n Kanagawa\n 224-0032,\n Japan\nc Department\n of\n Faculty\n of\n Human\n Development,\n Fukushima\n University\n Graduate\n School,\n Kanayagawa\n 1,\n Fukushima,\n Fukushima\n 960-1248,\n Japan\nd Department\n of\n Epidemiology\n and\n Environmental\n Health,\n Juntendo\n University\n Graduate\n School\n of\n Medicine,\n Hongo\n 2-1-1,\n Bunkyo-ku,\n Tokyo\n 113-8421,\nJapan\ne Department\n of\n Psychiatry,\n Nagoya\n University\n Graduate\n School\n of\n Medicine,\n Tsurumai-cho\n 65,\n Showa-ku,\n Nagoya,\n Aichi\n 466-8550,", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1163, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1802f041-f25d-4d95-bf4b-c1d1d8e541c0": {"__data__": {"id_": "1802f041-f25d-4d95-bf4b-c1d1d8e541c0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "77b59b22-68db-4add-b504-4f8a356d45db", "node_type": "1", "metadata": {}, "hash": "05dcd26294729ebd130e97f7e255a10b05eb6c76abcff4bbce6026e92a64fc2f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cb1c02d1-a79b-4c4f-ad69-e44270927751", "node_type": "1", "metadata": {}, "hash": "7abb33ee8c33a90f40fb74132f28ec1fc431cb07a2583f3eedb36d138d76c6e8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Nagoya\n University\n Graduate\n School\n of\n Medicine,\n Tsurumai-cho\n 65,\n Showa-ku,\n Nagoya,\n Aichi\n 466-8550,\n Japan\na\n r\n t  i  c  l  e  \ni  n\n f  o\nArticle\n history:\nReceived\n 17\n September\n 2014\nReceived\n in\n revised\n form\n12\n December\n 2014\nAccepted\n 16\n December\n 2014\nAvailable\n online\n 3\n January\n 2015\nKeywords:\nAutism\n Spectrum\n Disorder\nRisk\n factor\nMeasles\u2013Mumps\u2013Rubella\n vaccine\nThimerosal\nCase\u2013control\n study\nEnvironmental\n factors\na\n b\n s  t  r\n a  c  t\nObjective:\n This  case\u2013control\n study  investigated\n the relationship\n between\n the  risk\n of Autism  Spectrum\nDisorder\n (ASD)  onset,  and  early  exposure\n to  the combined\n Measles\u2013Mumps\u2013Rubella\n (MMR)\n vaccine  and\nthimerosal\n consumption\n measured\n from  vaccinations\n in  the\n highly\n genetically\n homogenous\n Japanese\npopulation.\nMethods:\n Vaccination\n histories\n at  1,  3,  6,  12,  18, 24,  and  36 months\n from  birth\n were investigated\n in  ASD\ncases\n (189  samples),\n and  controls\n (224  samples)\n matching\n age  and  sex  in  each  case.  Crude\n odds  ratios\n(ORs)\n and  95%  con\ufb01dence\n intervals\n (95%\n CIs)  were  calculated\n to  determine\n relationship\n between\n MMR\nvaccination\n and ASD.  The  differences\n in  mean  values\n of the  thimerosal\n dosage\n between\n cases\n and\n controls\nwere\n analyzed\n using\n an  unpaired\n t-test.\n MMR  vaccination\n and  thimerosal\n dosage\n were  also\n investigated\nusing\n a  conditional\n multiple-regression\n model.", "mimetype": "text/plain", "start_char_idx": 1055, "end_char_idx": 2488, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cb1c02d1-a79b-4c4f-ad69-e44270927751": {"__data__": {"id_": "cb1c02d1-a79b-4c4f-ad69-e44270927751", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1802f041-f25d-4d95-bf4b-c1d1d8e541c0", "node_type": "1", "metadata": {}, "hash": "7534fbd8c634c13eac51049e9cdef08c44e3c8228a0c57a7fbdcc35f383d47ac", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "775c4247-f24f-46d7-81c8-93681dbcfc7f", "node_type": "1", "metadata": {}, "hash": "751728a192c51530a0146d518895a6375c638dfc507afa72bc680d6ae97091f6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MMR  vaccination\n and  thimerosal\n dosage\n were  also\n investigated\nusing\n a  conditional\n multiple-regression\n model.\nResults:\n There  were  no  signi\ufb01cant\n differences\n in  MMR  vaccination\n and  thimerosal\n dosage\n between\n cases\nand\n controls\n at  any  age.  Furthermore,\n the  ORs  (95%\n CIs)  of  MMR  vaccination\n and  thimerosal\n dosage\nassociated\n with  ASD  in  the  conditional\n multiple\n regression\n model  were,  respectively,\n 0.875 (0.345\u20132.222)\nand\n 1.205\n (0.862\u20131.683)\n at  age 18  months,\n 0.724\n (0.421\u20131.243)\n and  1.343 (0.997\u20131.808)\n at  24  months,\n and\n1.040\n (0.648\u20131.668)\n and  0.844  (0.632\u20131.128)\n at  36  months.\n Thus,  there\n were  no  signi\ufb01cant\n differences.\nConclusions:\n No  convincing\n evidence\n was\n found\n in  this  study  that  MMR  vaccination\n and  increasing\nthimerosal\n dose  were  associated\n with  an  increased\n risk  of ASD  onset.\n\u00a9  2014  Elsevier\n Ltd. All  rights\n reserved.\n1.\n Introduction\nAutism\n Spectrum\n Disorder\n (ASD)\n is\n a\n type\n of\n neurodevelop-\nmental\n disorder\n that\n signi\ufb01cantly\n affects\n patients\u2019\n social\n functions\nfor\n their\n lifetime.\n The\n etiology\n and\n pathology\n of\n this\n disorder\n are\nAbbreviations:\n \nASD,\n Autism\n Spectrum\n Disorder;\n MMR,\n measles\u2013mumps\u2013\nrubella;\n \nTCV,\n \nthimerosal-containing\n \nvaccine;\n \nYPDC,\n \nYokohama\n \nPsycho-\nDevelopmental\n Clinic;\n MCH\n handbook,\n Maternal\n and\n Child\n Health\n handbook;\nDPT,\n diphtheria\u2013pertussis\u2013tetanus.", "mimetype": "text/plain", "start_char_idx": 2370, "end_char_idx": 3802, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "775c4247-f24f-46d7-81c8-93681dbcfc7f": {"__data__": {"id_": "775c4247-f24f-46d7-81c8-93681dbcfc7f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cb1c02d1-a79b-4c4f-ad69-e44270927751", "node_type": "1", "metadata": {}, "hash": "7abb33ee8c33a90f40fb74132f28ec1fc431cb07a2583f3eedb36d138d76c6e8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "20cee29a-f767-4faa-8a01-97e28709cb8e", "node_type": "1", "metadata": {}, "hash": "bc31be740c21f89f9c605d08cc4074aac700e06735754c6c28a1c24685584140", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2217Corresponding\n author\n at:\n Yota\n Uno,\n Department\n of\n Child\n and\n Adolescent\n Psychi-\natry,\n Nagoya\n University\n Graduate\n School\n of\n Medicine,\n Tsurumai-cho\n 65,\n Showa-ku,\nNagoya,\n Aichi\n 466-8550,\n Japan.\n Tel.:\n +81\n 52\n 744\n 2282;\n fax:\n +81\n 52\n 744\n 2293.\nE-mail\n addresses:\n yota\n u@ypdc.net\n (Y.\n Uno),\n tokiouch@ca2.so-net.ne.jp\n(T.\n Uchiyama),\n mic@med.juntendo.ac.jp\n (M.\n Kurosawa),\nbranko@med.nagoya-u.ac.jp\n (B.\n Aleksic),\n ozaki-n@med.nagoya-u.ac.jp\n (N.\n Ozaki).\nstill\n predominantly\n unknown.\n It\n has\n been\n indicated\n that\n there\n is\n a\nstrong\n association\n with\n genetic\n factors,\n and\n the\n relative\n risk\n among\nsiblings\n is\n known\n to\n be\n greater\n than\n 20\n with\n heritability\n estimated\nto\n be\n as\n high\n as\n 50\u201380%\n [1\u20134]. In\n contrast,\n the\n concordance\n rate\n of\nidentical\n twins\n is\n not\n 100%,\n indicating\n that\n environmental\n factors\nalso\n play\n an\n important\n role\n in\n the\n onset\n of\n ASD\n [1,4,5]. One\n of\n the\nconcepts\n that\n has\n been\n discussed\n is\n whether\n vaccinations\n increase\nthe\n risk\n of\n ASD\n onset.\nThe\n view\n that\n vaccinations\n and\n ASD\n are\n related\n dates\n back\nto\n \nWake\ufb01eld\n \net\n \nal.\u2019s\n \narticle\n \n[6]; \nhowever,\n \nthe\n \npaper\n \nwas\nretracted\n in\n 2010\n because\n of\n ethical\n and\n methodological\n prob-\nlems\n [7].", "mimetype": "text/plain", "start_char_idx": 3803, "end_char_idx": 5076, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "20cee29a-f767-4faa-8a01-97e28709cb8e": {"__data__": {"id_": "20cee29a-f767-4faa-8a01-97e28709cb8e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "775c4247-f24f-46d7-81c8-93681dbcfc7f", "node_type": "1", "metadata": {}, "hash": "751728a192c51530a0146d518895a6375c638dfc507afa72bc680d6ae97091f6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d2dd06ff-478a-4681-b746-c7090c88a933", "node_type": "1", "metadata": {}, "hash": "bfebe31a1c4958dec7f0e6aadd085f7cc2c6271f0d789d7afcdbeb8c5cb7a187", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Thereafter,\n other\n studies\n suggested\n a\n link\n between\n the\nmeasles\u2013mumps\u2013rubella\n vaccine\n (MMR)\n and\n ASD\n [8,9], and\n con-\ncerns\n emerged\n that\n thimerosal\n (49.6%\n ethyl\n mercury\n by\n weight)\nincluded\n in\n other\n vaccines\n as\n a\n preservative\n might\n increase\n the\n ASD\nrisk\n [10\u201312].\n On\n the\n other\n hand,\n three\n case\u2013control\n studies,\n which\nhttp://dx.doi.org/10.1016/j.vaccine.2014.12.036\n0264-410X/\u00a9\n 2014\n Elsevier\n Ltd.\n All\n rights\n reserved.\n2512\n \nY.\n Uno\n et\n al.\n / Vaccine\n 33\n (2015)\n 2511\u20132516\nused\n the\n Metropolitan\n Atlanta\n Developmental\n Disabilities\n Surveil-\nlance\n Program\n [13], the\n UK\n General\n Practice\n Research\n Database\n [14],\nor\n the\n UK\n Doctors\u2019\n Independent\n Network\n Database\n [15], were\n con-\nducted\n in\n Western\n countries\n and\n demonstrated\n no\n link\n between\nMMR\n vaccination\n and\n ASD.\n In\n addition,\n another\n case\u2013control\n study\nthat\n utilized\n the\n Centers\n for\n Disease\n Control\n and\n Prevention\u2019s\n Vac-\ncine\n Safety\n Datalink\n also\n did\n not\n show\n signi\ufb01cant\n differences\n in\nthe\n amount\n of\n exposure\n to\n thimerosal\n between\n ASD\n and\n non-ASD\ngroups\n at\n various\n months\n following\n birth\n [16]. Moreover,\n accord-\ning\n to\n two\n meta-analytic\n articles,\n published\n in\n 2014,\n there\n were\nno\n associations\n between\n exposure\n to\n MMR\n vaccine/thimerosal\n and\nASD\n onset\n [17,18]. However,\n most\n studies\n have\n not\n considered\n vac-\ncinations\n timing\n and\n the\n subject\u2019s\n racial\n heterogeneity\n even\n though\ngenetic\n factors\n are\n known\n to\n be\n strongly\n involved\n in\n ASD\n onset.", "mimetype": "text/plain", "start_char_idx": 5078, "end_char_idx": 6616, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d2dd06ff-478a-4681-b746-c7090c88a933": {"__data__": {"id_": "d2dd06ff-478a-4681-b746-c7090c88a933", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "20cee29a-f767-4faa-8a01-97e28709cb8e", "node_type": "1", "metadata": {}, "hash": "bc31be740c21f89f9c605d08cc4074aac700e06735754c6c28a1c24685584140", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "79117fb5-95e0-47cf-9dc4-6f4ebb24537d", "node_type": "1", "metadata": {}, "hash": "18adbf57c9d22e814fd746622f2a18dcf2addf3cc9861b87ff23d8d9478e245d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "As\nan\n investigation\n that\n speci\ufb01ed\n the\n race\n of\n the\n study\n participants,\nwe\n conducted\n a\n case\u2013control\n study\n from\n the\n Japanese\n popula-\ntion\n [19].\n Japanese\n people\n were\n proven\n to\n be\n highly\n genetically\nhomogenous\n according\n to\n the\n genotyping\n results\n of\n 140,387\n sin-\ngle\n nucleotide\n polymorphisms\n [20]. In\n our\n previous\n study,\n there\nwas\n not\n any\n convincing\n evidence\n that\n MMR\n vaccination\n was\n asso-\nciated\n with\n an\n increased\n risk\n of\n ASD\n in\n Japanese\n people.\n However,\nthe\n effects\n due\n to\n the\n differences\n in\n vaccinations\n timing\n and\n the\namount\n of\n exposure\n to\n thimerosal\n were\n not\n accounted\n for\n in\n this\nstudy.\nThe\n risks\n related\n to\n ASD\n onset\n and\n vaccinations\n are\n still\n debated\n[21]\n and\n many\n parents\n and\n guardians\n avoid\n vaccinations\n due\n to\n fear\nof\n their\n children\n developing\n ASD\n [22\u201327], despite\n the\n existence\n of\nthese\n studies.\n Therefore,\n we\n conducted\n a\n case\u2013control\n study\n with\nJapanese\n subjects,\n who\n are\n highly\n genetically\n homogenous,\n to\n fur-\nther\n investigate\n whether\n exposure\n to\n MMR\n vaccine/thimerosal\n is\nrelated\n to\n ASD\n onset\n in\n greater\n detail.\n We  also\n accounted\n for\n tem-\nporal\n factors\n from\n birth\n to\n vaccinations.\n The\n present\n study\n involves\nthe\n same\n study\n population\n as\n our\n previous\n study\n [19], and\n consists\nof\n a\n more\n in-depth\n investigation\n of\n the\n vaccine\n data.\n2.\n Materials\n and\n methods\n2.1.\n Study\n population\n2.1.1.\n Cases\n (Fig.\n 1)\nCase\n \ndata\n \nfrom\n \npatients\n \nof\n \nthe\n \nYokohama\n \nPsycho-\nDevelopmental\n Clinic\n (YPDC)\n were\n used\n in\n this\n study.", "mimetype": "text/plain", "start_char_idx": 6618, "end_char_idx": 8222, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "79117fb5-95e0-47cf-9dc4-6f4ebb24537d": {"__data__": {"id_": "79117fb5-95e0-47cf-9dc4-6f4ebb24537d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d2dd06ff-478a-4681-b746-c7090c88a933", "node_type": "1", "metadata": {}, "hash": "bfebe31a1c4958dec7f0e6aadd085f7cc2c6271f0d789d7afcdbeb8c5cb7a187", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9b6f722d-cf2c-4ce7-9dcd-43a3901d2b18", "node_type": "1", "metadata": {}, "hash": "f964d37eca2b99d149c63c1d4c8557f614fed00649f9f3c815e352e51d052eb8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Cases\n (Fig.\n 1)\nCase\n \ndata\n \nfrom\n \npatients\n \nof\n \nthe\n \nYokohama\n \nPsycho-\nDevelopmental\n Clinic\n (YPDC)\n were\n used\n in\n this\n study.\n The\nYPDC\n opened\n in\n April\n 1997\n and\n is\n located\n in\n the\n Kanto\n area\n of\nJapan.\n It\n only\n accepts\n patients\n with\n suspected\n neurodevelopmental\ndisorders.\n Of\n the\n patients\n who\n initially\n consulted\n the\n YPDC\n from\nApril\n 1997\n until\n March\n 2011,\n eligible\n case\n subjects:\n (1)\n were\ndiagnosed\n with\n ASD,\n and\n (2)\n had\n been\n born\n between\n April\n 1,\n 1986\nand\n April\n 30,\n 1992,\n the\n possible\n time\n period\n for\n MMR\n vaccination.\n2.1.2.\n Diagnosis\n of\n ASD\nTo\n consider\n diagnoses,\n the\n developmental\n history\n and\n the\npresent\n illness\n of\n patients\n were\n obtained\n through\n the\n use\n of\nthe\n Diagnostic\n Interview\n for\n Social\n and\n Communication\n Disorder,\nversion\n 10\n (DISCO).\n This\n diagnostic\n interview,\n the\n DISCO\n is\n a\n semi-\nstructured\n interview\n form\n for\n diagnosing\n ASD.\n It\n is\n recognized\n as\none\n of\n the\n best\n ways\n to\n obtain\n a\n reliable\n and\n valid\n diagnosis\n of\n ASD\n[28\u201330].\n Patients\n were\n diagnosed\n based\n on\n the\n application\n of\n the\nASD\n algorithm\n of\n the\n Diagnostic\n and\n Statistical\n Manual,\n 5th\n edition,\nusing\n the\n DISCO\n data.\n2.1.3.\n Period\n of\n birth\nMMR\n vaccination\n in\n Japan\n was\n conducted\n under\n speci\ufb01c\n cir-\ncumstances\n and\n for\n only\n a\n short\n period\n of\n time.\n A\n combined\nMMR vaccination\n program\n commenced\n from\n April\n 1989,\n and\n only\none\n vaccination\n using\n MMR\n was\n included\n in\n the\n immunization\nschedule.", "mimetype": "text/plain", "start_char_idx": 8084, "end_char_idx": 9619, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9b6f722d-cf2c-4ce7-9dcd-43a3901d2b18": {"__data__": {"id_": "9b6f722d-cf2c-4ce7-9dcd-43a3901d2b18", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "79117fb5-95e0-47cf-9dc4-6f4ebb24537d", "node_type": "1", "metadata": {}, "hash": "18adbf57c9d22e814fd746622f2a18dcf2addf3cc9861b87ff23d8d9478e245d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fc98050d-9005-4eda-801a-d3190e96d7d8", "node_type": "1", "metadata": {}, "hash": "f1f5007caefaf772df9b5fdb7da460a237a08e7675d07c28be2b535d4b9643d3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "A\n combined\nMMR vaccination\n program\n commenced\n from\n April\n 1989,\n and\n only\none\n vaccination\n using\n MMR\n was\n included\n in\n the\n immunization\nschedule.\n The\n monovalent\n mumps,\n measles,\n and\n rubella\n vaccines\nremained\n the\n optimal\n choice\n of\n vaccine\n for\n those\n who\n did\n not\nparticipate\n in\n the\n MMR\n program.\n However,\n soon\n after\n the\n immu-\nnization\n program\n had\n started,\n there\n were\n several\n cases\n of\n aseptic\nmeningitis,\n which\n may\n have\n been\n caused\n by\n the\n mumps\n vaccine\n[31]. As\n a\n result,\n in\n April\n 1993,\n the\n Government\n ceased\n extensive\ninoculation\n with\n MMR.\n Therefore,\n children\n who\n were\n born\n from\nApril\n 1984\n to\n April\n 1992\n could\n receive\n MMR\n vaccination.\n How-\never,\n children\n who\n were\n born\n between\n April\n 1984\n and\n March\n 1986\nwere\n able\n to\n receive\n it\n after\n the\n age\n of\n three.\n Therefore,\n they\n were\nexcluded\n from\n the\n samples,\n because\n autism\n features\n always\n appear\nbefore\n the\n age\n of\n three.\n As\n a\n result,\n children\n who\n were\n born\n from\nApril\n 1986\n to\n April\n 1992\n were\n included\n in\n the\n present\n study.\n2.1.4.\n Controls\n (Fig.\n 1)\nControl\n subjects\n were\n recruited\n as\n volunteers\n from\n general\nschools\n in\n the\n Kanto\n area\n which\n is\n the\n same\n area\n where\n YPDC\npatients\n reside.\n There\n were\n 450\n students\n who\n were\n born\n from\nApril\n 1986\n to\n April\n 1992\n in\n these\n schools.\n Students\n who\n had\n pre-\nviously\n been\n recognized\n as\n having\n developmental\n problems\n and\nwere\n already\n receiving\n care\n were\n excluded.", "mimetype": "text/plain", "start_char_idx": 9464, "end_char_idx": 10980, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fc98050d-9005-4eda-801a-d3190e96d7d8": {"__data__": {"id_": "fc98050d-9005-4eda-801a-d3190e96d7d8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9b6f722d-cf2c-4ce7-9dcd-43a3901d2b18", "node_type": "1", "metadata": {}, "hash": "f964d37eca2b99d149c63c1d4c8557f614fed00649f9f3c815e352e51d052eb8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "260842f7-5d98-4a58-8685-4110e0712e0b", "node_type": "1", "metadata": {}, "hash": "4c8bd7dfc7ed61adddac74d780f8b93bf0dad8ff8066e2affae3a3207b83fb90", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Students\n who\n had\n pre-\nviously\n been\n recognized\n as\n having\n developmental\n problems\n and\nwere\n already\n receiving\n care\n were\n excluded.\n We  obtained\n informed\nconsent\n from\n 252\n students\n (56.0%).\n2.2.\n MCH\n handbook\n and\n source\n of\n data\nThe\n vaccination\n records,\n such\n as\n the\n type\n of\n vaccine,\n dose,\nmanufacturer,\n lot\n number,\n medical\n institution,\n and\n date\n of\n prior\nvaccinations\n were\n obtained\n from\n the\n Maternal\n and\n Child\n Health\n(MCH)\n handbook,\n which\n is\n a\n record\n provided\n to\n all\n mothers\n by\nthe\n relevant\n Japanese\n health\n system\n institution.\n It\n is\n a\n highly\n reli-\nable\n data\n record\n of\n early\n development,\n health,\n and\n immunization,\nand\n the\n data\n are\n record\n by\n health\n professionals\n (e.g.,\n public\n health\nnurses,\n obstetricians,\n and\n pediatricians)\n [32,33].\nFrom\n \nthis\n \nhandbook,\n \nwe  \nassessed\n \nthe\n \ntype\n \nof\n \nvaccine,\nfrequency,\n dose,\n timing,\n manufacturer,\n and\n lot\n number\n of\n vac-\ncinations\n that\n were\n given\n by\n 36\n months\n of\n age\n when\n ASD\nfeatures\n become\n apparent.\n The\n targeted\n vaccines\n were\n the\n MMR\nand\n the\n thimerosal-containing\n vaccines\n (TCVs)\n such\n as\n the\ndiphtheria\u2013pertussis\u2013tetanus\n vaccine\n (DPT);\n the\n polio\n vaccine;\n the\nJapanese\n B\n encephalitis\n vaccine;\n the\n \ufb02u\n vaccine;\n and\n the\n hepati-\ntis\n B\n vaccine.\n Case\n and\n control\n subjects\n whose\n records\n in\n the\n MCH\nhandbook\n were\n missing\n or\n illegible\n and\n those\n who\n were\n vaccinated\noutside\n Japan\n were\n excluded.\n2.3.", "mimetype": "text/plain", "start_char_idx": 10840, "end_char_idx": 12329, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "260842f7-5d98-4a58-8685-4110e0712e0b": {"__data__": {"id_": "260842f7-5d98-4a58-8685-4110e0712e0b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fc98050d-9005-4eda-801a-d3190e96d7d8", "node_type": "1", "metadata": {}, "hash": "f1f5007caefaf772df9b5fdb7da460a237a08e7675d07c28be2b535d4b9643d3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ea798cc5-5ed3-4f00-9e00-4ef84fd1daf2", "node_type": "1", "metadata": {}, "hash": "023d0ff909a345c44a44b1268132c6123f760ac935e49df2499cbf85b3a12da1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2.3.\n Selection\n of\n case\n children\n and\n matched\n control\n children\nAmong\n the\n patients\n who\n initially\n consulted\n the\n clinic\n between\nApril\n 1997\n and\n March\n 2011,\n 1875\n cases\n of\n ASD\n were\n identi\ufb01ed.\nOf\n these,\n 89\n cases\n were\n excluded\n because\n the\n MCH\n handbook\n was\nmissing\n or\n the\n vaccination\n record\n in\n the\n handbook\n could\n not\n be\nread,\n and\n three\n were\n excluded\n because\n they\n had\n received\n vaccina-\ntions\n outside\n Japan.\n Of\n the\n remaining\n 1783\n cases,\n 354\n cases\n (males:\nn\n =\n 286,\n 80.8%)\n were\n born\n between\n April\n 1986\n and\n April\n 1992,\n the\ntime\n period\n when\n MMR\n vaccinations\n were\n administered\n to\n children\nless\n than\n 3\n years\n old.\nFor\n the\n control\n group,\n 252\n subjects\n from\n the\n general\n school\n pop-\nulation\n were\n recruited\n into\n the\n present\n study.\n Of\n these,\n 28\n cases\nwere\n subsequently\n excluded\n because\n the\n MCH\n handbook\n was\n miss-\ning\n or\n the\n vaccination\n record\n could\n not\n be\n read.\n The\n goal\n was\n to\nhave\n a\n matched\n control\n for\n each\n case.\n However,\n since\n there\n were\nnot\n enough\n controls\n to\n match\n to\n all\n cases,\n 189\n subjects\n were\n cho-\nsen\n randomly\n from\n the\n ASD\n group\n as\n the\n case\n group.\n The\n controls\nwere\n individually\n matched\n to\n cases\n by\n age\n and\n sex.\n There\n were\n 189\ncases,\n mean\n age\n 22.6\n years\n (SD\n 2.2),\n and\n 224\n controls,\n mean\n age\n22.6\n years\n (SD\n 2.2),\n with\n case-to-control\n ratios\n ranging\n from\n 1:1\n to\n1:2\n (Fig.\n 1).\nY.\n Uno\n et\n al.", "mimetype": "text/plain", "start_char_idx": 12325, "end_char_idx": 13795, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ea798cc5-5ed3-4f00-9e00-4ef84fd1daf2": {"__data__": {"id_": "ea798cc5-5ed3-4f00-9e00-4ef84fd1daf2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "260842f7-5d98-4a58-8685-4110e0712e0b", "node_type": "1", "metadata": {}, "hash": "4c8bd7dfc7ed61adddac74d780f8b93bf0dad8ff8066e2affae3a3207b83fb90", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6ece4a43-7555-4408-b0e7-50396b962b6e", "node_type": "1", "metadata": {}, "hash": "a67551fb8ef82cbc62bafb7244982b7d634f28adb9b322cdeee72ea2907340b4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1).\nY.\n Uno\n et\n al.\n /\n Vaccine\n 33\n (2015)\n 2511\u20132516\n \n2513\nFig.\n 1.\n Flow\n chart\n of\n cases\n and\n controls\n identi\ufb01ed,\n excluded,\n and\n included\n in\n the\n analysis.\n2.4.\n Statistical\n analysis\n2.4.1.\n MMR\nThe\n number\n of\n individuals\n who\n received\n MMR\n vaccination\n by\n 1,\n3,\n 6,\n 12,\n 18,\n 24,\n and\n 36\n months\n of\n age\n were\n determined\n in\n both\n case\nand\n control\n groups,\n and\n the\n differences\n of\n whether\n or\n not\n an\n indi-\nvidual\n received\n the\n vaccinations\n at\n each\n age\n were\n investigated\n with\n\u00022 test.\n In\n addition,\n the\n crude\n odds\n ratios\n (ORs)\n and\n 95%\n con\ufb01dence\nintervals\n (CIs)\n of\n MMR\n vaccination-induced\n ASD\n were\n calculated.\n2.4.2.\n TCVs\nThe\n thimerosal\n content\n in\n each\n vaccine\n was\n calculated\n from\nthe\n manufacturer,\n lot\n number,\n and\n vaccination\n dose\n of\n the\n vac-\ncine\n recorded\n in\n the\n MCH\n handbook.\n The\n amount\n of\n exposure\n to\nthimerosal\n was\n determined\n in\n both\n case\n and\n control\n groups\n at\n 1,\n 3,\n6,\n 12,\n 18,\n 24,\n and\n 36\n months\n of\n age.\n In\n addition,\n the\n differences\n in\nthimerosal\n exposure\n at\n each\n age\n were\n investigated\n in\n the\n case\n and\ncontrol\n groups\n with\n F-test\n and\n unpaired\n t-test.\n According\n to\n the\nresults\n of\n the\n F-test,\n Student\u2019s\n t-test\n or\n Welch\u2019s\n t-test\n was\n chosen.\n2.4.3.", "mimetype": "text/plain", "start_char_idx": 13775, "end_char_idx": 15059, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6ece4a43-7555-4408-b0e7-50396b962b6e": {"__data__": {"id_": "6ece4a43-7555-4408-b0e7-50396b962b6e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ea798cc5-5ed3-4f00-9e00-4ef84fd1daf2", "node_type": "1", "metadata": {}, "hash": "023d0ff909a345c44a44b1268132c6123f760ac935e49df2499cbf85b3a12da1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "200a5689-4ac5-4338-94d0-d99fcdb0d19a", "node_type": "1", "metadata": {}, "hash": "222416d3f4fae9e7e82bc224a14455fd1fa92fb8937aa74be55be75724b88c56", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "According\n to\n the\nresults\n of\n the\n F-test,\n Student\u2019s\n t-test\n or\n Welch\u2019s\n t-test\n was\n chosen.\n2.4.3.\n Conditional\n multiple\n logistic\n model\nThe\n effects\n of\n both\n MMR\n vaccination\n and\n thimerosal\n dosage\n on\nASD\n onset\n were\n investigated\n by\n calculating\n the\n odds\n ratios\n and\ntheir\n 95%\n CIs\n using\n a\n conditional\n multiple\n logistic\n model\n with\n MMR\nvaccination\n and\n thimerosal\n dosage\n as\n explanatory\n variables.\n2.4.4.\n Power\n analysis\nTo\n calculate\n power\n levels\n of\n the\n present\n study,\n we\n conducted\npower\n analyses\n in\n accordance\n to\n a\n general\n power\n calculation\n model\nfor\n the\n \u00022 test,\n t-test,\n and\n the\n conditional\n multiple\n regression\nmodel.\n In\n brief,\n calculations\n of\n the\n power\n level\n were\n based\n on\n an\nalpha\n level\n of\n 0.05,\n two\n tails,\n and\n a\n medium\n effect\n size\n (w\n =\n 0.30\n for\nthe\n \u00022 test,\n d\n =\n 0.50\n for\n the\n t-test,\n and\n f2 =\n 0.15\n for\n the\n conditional\nmultiple\n regression\n model,\n in\n accordance\n with\n Cohen\u2019s\n criteria),\nwhich\n we  consider\n to\n be\n clinically\n meaningful.\nORs\n were\n considered\n signi\ufb01cant\n when\n the\n lower\n 95%\n CI\nexceeded\n 1.0.\n The\n t-tests\n were\n two-sided,\n and\n signi\ufb01cance\n was\nde\ufb01ned\n as\n p\n <\n 0.05.\n For\n power\n calculation,\n G*power\n v3.1\n was\n used.\n2.5.", "mimetype": "text/plain", "start_char_idx": 14954, "end_char_idx": 16211, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "200a5689-4ac5-4338-94d0-d99fcdb0d19a": {"__data__": {"id_": "200a5689-4ac5-4338-94d0-d99fcdb0d19a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6ece4a43-7555-4408-b0e7-50396b962b6e", "node_type": "1", "metadata": {}, "hash": "a67551fb8ef82cbc62bafb7244982b7d634f28adb9b322cdeee72ea2907340b4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "085be720-af62-4ff3-82f2-ae98f0cb350f", "node_type": "1", "metadata": {}, "hash": "a7682e144ff5f377b228e955d3f0ee4c7afb0d56b7bbfbb87b51889b03bf11c0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For\n power\n calculation,\n G*power\n v3.1\n was\n used.\n2.5.\n Ethical\n considerations\nThe\n protocol\n of\n this\n study\n was\n approved\n by\n the\n Ethics\n Commit-\ntees\n of\n the\n Nagoya\n University\n Graduate\n School\n of\n Medicine,\n and\n the\nstudy\n itself\n was\n conducted\n in\n conformity\n with\n the\n established\n eth-\nical\n standards\n of\n all\n institutions.\n The\n study\n was\n explained\n to\n the\nparticipants\n both\n verbally\n and\n in\n writing,\n and\n written\n consent\n was\nobtained\n from\n all\n participants.\n3.\n Results\n3.1.\n MMR\nNone\n of\n the\n individuals\n in\n the\n case\n group\n received\n MMR\n vacci-\nnations\n by\n 12\n months\n of\n age.\n Subsequently,\n the\n MMR\n vaccination\nrate\n gradually\n began\n to\n increase.\n For\n the\n control\n group,\n one\n indi-\nvidual\n (0.4%)\n received\n the\n MMR\n vaccination\n by\n 6\n months\n of\n age.\nHowever,\n there\n was\n no\n subject\n who\n received\n the\n MMR\n vaccina-\ntion\n from\n 6\n months\n to\n 12\n months.\n The\n rate\n gradually\n began\n to\nincrease\n after\n 12\n months.\n Eventually,\n the\n rates\n of\n cases\n and\n con-\ntrols\n at\n 36\n months\n were\n 24.9%\n and\n 24.1%,\n respectively.\n The\n OR\n of\nMMR\n vaccination\n causing\n ASD\n at\n 36\n months\n was\n 1.04\n (0.65\u20131.68).\nFurthermore,\n regarding\n each\n timing\n by\n 36\n months,\n the\n ORs\n were:\n0.81\n (95%\n CI:\n 0.31\u20132.09)\n at\n 18\n months\n and\n 0.93\n (0.55\u20131.57)\n at\n 24\nmonths.\n These\n results\n demonstrated\n that\n statistical\n differences\n in\n2514\n \nY.\n Uno\n et\n al.", "mimetype": "text/plain", "start_char_idx": 16155, "end_char_idx": 17576, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "085be720-af62-4ff3-82f2-ae98f0cb350f": {"__data__": {"id_": "085be720-af62-4ff3-82f2-ae98f0cb350f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "200a5689-4ac5-4338-94d0-d99fcdb0d19a", "node_type": "1", "metadata": {}, "hash": "222416d3f4fae9e7e82bc224a14455fd1fa92fb8937aa74be55be75724b88c56", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8a347705-d70f-4e0f-b39a-c3c15f382418", "node_type": "1", "metadata": {}, "hash": "2a54d425a35f405857e8393610ffa2bd1fb6756567df5e018ce1a96b1518d6d0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "These\n results\n demonstrated\n that\n statistical\n differences\n in\n2514\n \nY.\n Uno\n et\n al.\n / Vaccine\n 33\n (2015)\n 2511\u20132516\nTable\n 1\nCase\n and\n control\n children\n who\n received\n MMR\n vaccinations.\nAge\n (months)\n \nn (%)\n \np-value\n \nORs\n (95%\n CIs)\nCases\n (n\n =\n 189)\n \nControls\n (n\n = 224)\n1\n \n0 (0)\n \n0\n (0)\n \n1\n \n\u2013\n3\n \n0 (0)\n \n0\n (0)\n \n1\n \n\u2013\n6\n \n0 (0)\n1\n (0.4)\n0.36\n0\n (0\u2013\u221e)\n12\n \n0 (0)\n \n1\n (0.4)\n \n0.36\n \n0\n (0\u2013\u221e)\n18\n \n9\n (4.8)\n \n13\n (5.8)\n \n0.64\n \n0.81\n (0.31\u20132.09)\n24\n \n35\n (18.5)\n \n44\n (19.6)\n \n0.77\n \n0.93\n (0.55\u20131.57)\n36\n \n47\n (24.9)\n \n54\n (24.1)\n \n0.86\n \n1.04\n (0.65\u20131.68)\nOR,\n odds\n ratios;\n CI,\n con\ufb01dence\n interval.\n The\n case\n group\n involved\n 189\n samples,\n and\n the\n control\n group\n involved\n 224\n samples\n at\n each\n months\n from\n birth.\nTable\n 2\nCumulative\n exposure\n to\n thimerosal\n according\n to\n exposure\n period.", "mimetype": "text/plain", "start_char_idx": 17488, "end_char_idx": 18318, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8a347705-d70f-4e0f-b39a-c3c15f382418": {"__data__": {"id_": "8a347705-d70f-4e0f-b39a-c3c15f382418", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "085be720-af62-4ff3-82f2-ae98f0cb350f", "node_type": "1", "metadata": {}, "hash": "a7682e144ff5f377b228e955d3f0ee4c7afb0d56b7bbfbb87b51889b03bf11c0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "12a5a5e4-3380-43f6-803b-c92dcd23f2d6", "node_type": "1", "metadata": {}, "hash": "1d2981e0baedb9170fe561766fee278e3cb868beca3b3793dbf3d35f5b022594", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Table\n 2\nCumulative\n exposure\n to\n thimerosal\n according\n to\n exposure\n period.\nAge\n (months)\n \nCumulative\n exposure\n amount,\n \u0002g\np-value\nCases\n (n\n = 189)\n \nControls\n (n\n =\n 224)\nMean\n (SD)\n \nMin\u2013Max\n \nMean\n (SD)\n \nMin\u2013Max\n1\n \n1.3\n (18.2)\n0\u2013250\n0\n (0)\n0\u20130\n \n0.28a\n3\n \n1.3\n (18.2)\n \n0\u2013250\n \n2.2\n (33.4)\n \n0\u2013500\n \n0.73b\n6\n \n10.6\n (84.9)\n \n0\u2013750\n \n16.7\n (120.7)\n \n0\u20131500\n \n0.54b\n12\n \n172.0\n (457.1)\n \n0\u20132250\n \n112.1\n (372.8)\n \n0\u20131600\n \n0.15b\n18\n \n412.7\n (627.1)\n \n0\u20132250\n \n348.7\n (605.2)\n \n0\u20132100\n \n0.29a\n24\n \n804.2\n (741.6)\n \n0\u20132250\n \n676.8\n (719.5)\n \n0\u20132250\n \n0.08a\n36\n \n1314.8\n (796.5)\n \n0\u20132750\n \n1389.3\n (583.5)\n \n0\u20132750\n \n0.29b\nSD,\n standard\n deviation;\n Min\u2013Max,\n the\n minimum\n and\n maximum\n amounts\n of\n thimerosal\n cumulative\n exposure.\n The\n case\n group\n involved\n 189\n samples,\n and\n the\n control\n group\ninvolved\n 224\n samples\n at\n each\n month\n from\n birth.\nThere\n is\n 495.5\n \u0002g\n of\n mercury\n for\n every\n 1000\n \u0002g\n of\n thimerosal.\na Student\u2019s\n t-test,\nb Welch\u2019s\n t-test.\nAccording\n to\n the\n results\n of\n the\n F-test,\n Student\u2019s\n t-test\n or\n Welch\u2019s\n t-test\n was\n chosen.", "mimetype": "text/plain", "start_char_idx": 18239, "end_char_idx": 19317, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "12a5a5e4-3380-43f6-803b-c92dcd23f2d6": {"__data__": {"id_": "12a5a5e4-3380-43f6-803b-c92dcd23f2d6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8a347705-d70f-4e0f-b39a-c3c15f382418", "node_type": "1", "metadata": {}, "hash": "2a54d425a35f405857e8393610ffa2bd1fb6756567df5e018ce1a96b1518d6d0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aa8296bb-8cc6-49fb-8fe6-7f495712fd47", "node_type": "1", "metadata": {}, "hash": "de9a46abfdd2d6f74b6ce045c1e18091c74d41ab7be4469f27f6bdd3b09685fa", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "a Student\u2019s\n t-test,\nb Welch\u2019s\n t-test.\nAccording\n to\n the\n results\n of\n the\n F-test,\n Student\u2019s\n t-test\n or\n Welch\u2019s\n t-test\n was\n chosen.\nThe\n article\n has\n been\n modi\ufb01ed\n following\n feedback\n and\n the\n data\n in\n Table\n 2\n updated.\nthe\n rate\n of\n vaccinations\n could\n not\n be\n detected\n between\n the\n two\ngroups\n at\n each\n age\n (Table\n 1).\n3.2.\n TCVs\nIn\n the\n case\n group,\n there\n was\n one\n individual\n who\n received\n a\nhepatitis\n B\n vaccinations\n immediately\n after\n birth\n due\n to\n maternal\nhepatitis\n B,\n and\n thus\n the\n mean\n amount\n of\n exposure\n to\n thimerosal\nat\n 1\n month\n of\n age\n was\n 1.3\n \u0002g\n (SD:\n \u00b118.2).\n Subsequently,\n the\n amount\nof\n exposure\n to\n thimerosal\n gradually\n began\n to\n increase\n in\n this\n group\nat\n 6\n months\n in\n accordance\n with\n DPT\n and\n other\n vaccinations,\n and\nwas\n 1314.8\n \u0002g\n (\u00b1796.5)\n by\n 36\n months.\n In\n the\n control\n group,\n while\nthere\n were\n no\n individuals\n who\n were\n vaccinated\n with\n TCVs\n by\n 1\nmonth,\n one\n individual\n received\n a\n DPT\n vaccination\n by\n 3\n months\n and\nthe\n mean\n amount\n of\n exposure\n to\n thimerosal\n was\n therefore\n 2.2\n \u0002g\n(\u00b133.4).\n As\n a\n result,\n the\n amount\n of\n exposure\n to\n thimerosal\n gradu-\nally\n began\n to\n increase\n from\n 6\n months,\n and\n was\n 1389.3\n \u0002g\n (\u00b1583.5)\nby\n 36\n months.", "mimetype": "text/plain", "start_char_idx": 19178, "end_char_idx": 20439, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aa8296bb-8cc6-49fb-8fe6-7f495712fd47": {"__data__": {"id_": "aa8296bb-8cc6-49fb-8fe6-7f495712fd47", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "12a5a5e4-3380-43f6-803b-c92dcd23f2d6", "node_type": "1", "metadata": {}, "hash": "1d2981e0baedb9170fe561766fee278e3cb868beca3b3793dbf3d35f5b022594", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c99bda0d-a23f-4935-a869-dc80c3a652ca", "node_type": "1", "metadata": {}, "hash": "d3ca31c12117773480d0fe925ccb071a663e8cd2847eea399a5a6029ace5675f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\n mean\n amount\n of\n exposure\n to\n thimerosal\n was\ncompared\n between\n the\n case\n and\n control\n groups\n at\n 36\n months\n using\nan\n unpaired\n t-test,\n but\n statistically\n signi\ufb01cant\n difference\n was\n not\nobserved.\n Moreover,\n the\n mean\n amount\n of\n exposure\n of\n thimerosal\nat\n 1,\n 3,\n 6,\n 12,\n 18,\n and\n 24\n months\n were\n also\n compared,\n but\n there\nwere\n no\n statistically\n signi\ufb01cant\n differences\n between\n the\n cases\n and\ncontrols\n at\n any\n age\n (Table\n 2).\n3.3.\n Conditional\n multiple\n logistic\n model\nIn\n the\n conditional\n multiple\n logistic\n model,\n the\n ORs\n of\n 1\n \u0002g\nthimerosal\n exposure\n and\n MMR\n vaccination\n causing\n ASD\n were\n 1.205\n(95%\n CI:\n 0.862\u20131.683)\n and\n 0.875\n (0.345\u20132.222)\n at\n 18\n months,\n 1.343\n(0.997\u20131.808)\n and\n 0.724\n (0.421\u20131.243)\n at\n 24\n months,\n and\n 0.844\n(0.632\u20131.128)\n and\n 1.040\n (0.648\u20131.668),\n at\n 36\n months,\n respectively.\nThere\n were\n no\n signi\ufb01cant\n differences\n between\n cases\n and\n controls\nin\n MMR\n vaccination\n and\n thimerosal\n exposure\n at\n any\n age\n (Table\n 3).\n3.4.\n Power\n analysis\nWe  conducted\n \u00022 tests\n considering\n MMR\n vaccinations,\n t-tests\nfor\n thimerosal\n exposure,\n and\n a\n conditional\n multiple\n regression\nmodel\n for\n both\n MMR\n vaccinations\n and\n thimerosal\n exposure.\n Each\ntest\n had\n almost\n 100%\n power\n to\n detect\n medium\n size\n differences\n in\nCohen\u2019s\n criteria,\n which\n we\n consider\n to\n be\n clinically\n meaningful.\n4.", "mimetype": "text/plain", "start_char_idx": 20441, "end_char_idx": 21831, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c99bda0d-a23f-4935-a869-dc80c3a652ca": {"__data__": {"id_": "c99bda0d-a23f-4935-a869-dc80c3a652ca", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aa8296bb-8cc6-49fb-8fe6-7f495712fd47", "node_type": "1", "metadata": {}, "hash": "de9a46abfdd2d6f74b6ce045c1e18091c74d41ab7be4469f27f6bdd3b09685fa", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "81e16349-8057-4a80-b110-3bdc958a1a3c", "node_type": "1", "metadata": {}, "hash": "e90fb2f9c074a4c9f274bc168c8cb5aa2389b9c63642f7cea11dce81eaf88cf4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Each\ntest\n had\n almost\n 100%\n power\n to\n detect\n medium\n size\n differences\n in\nCohen\u2019s\n criteria,\n which\n we\n consider\n to\n be\n clinically\n meaningful.\n4.\n Discussion\nIn\n this\n study,\n we  conducted\n a\n case\u2013control\n study\n to\n assess\n the\nrate\n of\n MMR\n vaccination\n and\n amount\n of\n exposure\n to\n thimerosal\n at\n1,\n 3,\n 6,\n 12,\n 18,\n 24,\n and\n 36\n months\n of\n age\n with\n the\n objective\n to\n deter-\nmine\n the\n risk\n of\n ASD\n onset\n due\n to\n early\n exposure\n to\n MMR\n vaccine/\nTable\n 3\nOdds\n ratios\n and\n 95%\n con\ufb01dence\n intervals\n of\n cumulative\n exposure\n amount\n of\nthimerosal\n and\n MMR\n vaccination.\nAge\n (months)\n \nFactors\n \nORs\n \n95%\n CIs\n18\nMMR  (\u2212)\n \n1\nMMR\n (+)\n \n0.875\n \n0.345\u20132.222\nThimerosal\n \n1.205\n \n0.862\u20131.683\n24\nMMR\n (\u2212)\n \n1\nMMR\n (+)\n \n0.724\n \n0.421\u20131.243\nThimerosal\n \n1.343\n \n0.997\u20131.808\n36\nMMR\n (\u2212)\n \n1\nMMR\n (+)\n \n1.040\n \n0.648\u20131.668\nThimerosal\n \n0.844\n \n0.632\u20131.128\nOR,\n odds\n ratios;\n CIs,\n con\ufb01dence\n intervals;\n MMR,\n measles,\n mumps,\n rubella\n vaccine.\nThe\n case\n group\n involved\n 189\n samples,\n and\n the\n control\n group\n involved\n 224\n samples\nat\n each\n month\n from\n birth.\nOdds\n ratios\n and\n 95%\n con\ufb01dence\n intervals\n of\n thimerosal\n and\n MMR\n vaccinations\n cumu-\nlative\n exposure\n in\n each\n month\n from\n birth\n were\n analyzed\n with\n a\n conditional\n multiple\nlogistic\n model.", "mimetype": "text/plain", "start_char_idx": 21677, "end_char_idx": 22978, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "81e16349-8057-4a80-b110-3bdc958a1a3c": {"__data__": {"id_": "81e16349-8057-4a80-b110-3bdc958a1a3c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c99bda0d-a23f-4935-a869-dc80c3a652ca", "node_type": "1", "metadata": {}, "hash": "d3ca31c12117773480d0fe925ccb071a663e8cd2847eea399a5a6029ace5675f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ca6ab770-a78f-492c-88ee-129ea16262d3", "node_type": "1", "metadata": {}, "hash": "3ae6e507a0d9e256e7c477a61aeb89247658984c485a214bdf4155a5006c7d2b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Odds\n ratio\n for\n thimerosal\n is\n for\n a\n 1\n \u0002g\n increase\n in\n thimerosal\n exposure.\nThere\n is\n 495.5\n \u0002g\n of\n mercury\n for\n every\n 1000\n \u0002g\n of\n thimerosal.\nY.\n Uno\n et\n al.\n /\n Vaccine\n 33\n (2015)\n 2511\u20132516\n \n2515\nAge  (mon ths) \n3      \n \n  6        12    \n \n  24        36    \n \n  48    \n \n  60    \n \n  72 \nMMR \nPolio \nDPT \nI \nII \nJapane\n \nse B en cephali\n \ntis \nFlu \nHepa\n \ntitis B \nFig.\n 2.\n The\n MMR\n and\n TCVs\n vaccinations\n schedule\n for\n Japan\n during\n the\n duration\nof\n the\n study.\n The\n recommended\n ages\n of\n the\n vaccinations\n are\n illustrated\n by\n the\ndarker-shaded\n areas.\n The\n lighter-shaded\n areas\n show\n ages\n that\n they\n could\n receive\nthe\n vaccinations.\n \u201cI\u201d\n represents\n the\n \ufb01rst\n DPT\n vaccination,\n and\n \u201cII\u201d\n represents\n the\nsecond\n DPT\n vaccination.\nTCVs.\n We  also\n conducted\n conditional\n multiple\n logistic\n model\n anal-\nyses\n to\n comprehensively\n investigate\n these\n \ufb01ndings.\n Our\n results\nshowed\n that\n the\n rate\n of\n MMR\n vaccination\n and\n amount\n of\n exposure\nto\n thimerosal\n were\n not\n statistically\n signi\ufb01cantly\n different\n between\nthe\n ASD\n and\n non-ASD\n groups.\n These\n results\n therefore\n indicated\n that\nMMR\n vaccination\n and\n increased\n amount\n of\n exposure\n to\n thimerosal\ndo\n not\n elevate\n the\n risk\n for\n ASD\n onset.", "mimetype": "text/plain", "start_char_idx": 22980, "end_char_idx": 24242, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ca6ab770-a78f-492c-88ee-129ea16262d3": {"__data__": {"id_": "ca6ab770-a78f-492c-88ee-129ea16262d3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "81e16349-8057-4a80-b110-3bdc958a1a3c", "node_type": "1", "metadata": {}, "hash": "e90fb2f9c074a4c9f274bc168c8cb5aa2389b9c63642f7cea11dce81eaf88cf4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c6695782-74cd-4512-a00a-06bb558ec445", "node_type": "1", "metadata": {}, "hash": "53b3dc073f5f3016e98ae759fcec65e5c083e71ca46db6fa9e6d005b2f3f431f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "These\n results\n therefore\n indicated\n that\nMMR\n vaccination\n and\n increased\n amount\n of\n exposure\n to\n thimerosal\ndo\n not\n elevate\n the\n risk\n for\n ASD\n onset.\n Our\n results\n are\n consistent\nwith\n the\n \ufb01ndings\n from\n previous\n case\u2013control\n studies\n [13\u201316]\n that\ninvestigated\n the\n rate\n of\n MMR\n vaccination\n or\n the\n amount\n of\n expo-\nsure\n to\n thimerosal\n during\n the\n prenatal\n and\n infant\n periods.\n One\n of\n the\nsigni\ufb01cant\n \ufb01ndings\n of\n this\n study\n is\n that\n there\n were\n no\n differences\nbetween\n the\n case\n and\n control\n groups\n in\n receiving\n MMR\n vaccination\nor\n the\n amount\n of\n exposure\n to\n thimerosal\n at\n 1,\n 3,\n 6,\n 12,\n 18,\n 24,\n and\n 36\nmonths,\n and\n ASD\n features\n become\n apparent\n by\n 36\n months\n so\n these\ndata\n indicate\n that\n early\n vaccinations\n do\n not\n become\n risks\n for\n ASD\nonset.\nThe\n strengths\n of\n our\n study\n were:\n the\n study\n population\n consisted\nof\n individuals\n other\n than\n Caucasians;\n the\n study\n included\n Japanese\npeople,\n considered\n to\n be\n highly\n homogenous\n on\n the\n genetic\nlevel,\n which\n gave\n us\n the\n opportunity\n to\n minimize\n the\n effect\n of\npopulation-speci\ufb01c\n risk\n factors\n that\n might\n interact\n with\n environ-\nmental\n exposures\n (i.e.,\n immunization);\n the\n study\n used\n the\n MCH\nhandbook,\n a\n highly\n reliable\n data\n source;\n and\n the\n study\n was\n car-\nried\n out\n using\n ASD\n diagnoses\n that\n were\n made\n with\n high\n reliability\nand\n validity.\nIn\n Japan,\n the\n prevalence\n of\n ASD\n has\n not\n decreased\n even\nafter\n MMR\n vaccine\n were\n discontinued\n [34,35].", "mimetype": "text/plain", "start_char_idx": 24083, "end_char_idx": 25602, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c6695782-74cd-4512-a00a-06bb558ec445": {"__data__": {"id_": "c6695782-74cd-4512-a00a-06bb558ec445", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ca6ab770-a78f-492c-88ee-129ea16262d3", "node_type": "1", "metadata": {}, "hash": "3ae6e507a0d9e256e7c477a61aeb89247658984c485a214bdf4155a5006c7d2b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b8be6716-f8ea-43ec-b438-0321dc8896da", "node_type": "1", "metadata": {}, "hash": "d63afb38c44683aaa00ba7409bf4a7848680f8cf59dcaf7944f2704d08f7b976", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In\n Japan,\n the\n prevalence\n of\n ASD\n has\n not\n decreased\n even\nafter\n MMR\n vaccine\n were\n discontinued\n [34,35].\n Internationally,\n the\nprevalence\n of\n ASD\n remains\n high\n in\n spite\n of\n the\n increased\n usage\nof\n thimerosal-free\n vaccines\n [36\u201338]. Our\n results\n also\n corroborate\nthese\n current\n epidemiological\n situations.\nNonetheless,\n the\n present\n study\n does\n not\n guarantee\n the\n safety\nof\n the\n vaccines.\n There\n are\n numerous\n potential\n side\n effects\n that\n can\noccur\n as\n a\n result\n of\n being\n vaccinated,\n and\n because\n the\n actual\n circum-\nstance\n differs\n depending\n on\n the\n individual,\n it\n is\n clearly\n essential\n to\nassess\n and\n consider\n advantages\n and\n disadvantages\n for\n each\n indi-\nvidual.\n Moreover,\n the\n development\n of\n vaccines\n with\n reduced\n risks\nor\n potential\n risks\n other\n than\n ASD\n onset\n are\n also\n desired.\nMMR\n vaccinations\n prior\n to\n 12\n months\n of\n age\n and\n TCV\n vacci-\nnations\n prior\n to\n 6\n months\n of\n age\n are\n rare\n in\n Japan\n compared\n to\nother\n countries.\n This\n tendency\n might\n be\n because\n of\n the\n vaccination\nschedule\n in\n Japan\n (Fig.\n 2).\n MMR\n vaccinations\n were\n recommended\nfor\n children\n over\n 12\n months\n of\n age,\n and\n certain\n TCVs\n were\n recom-\nmended\n for\n those\n over\n 36\n months,\n in\n the\n past.\n Additionally,\n there\nwas\n no\n data\n of\n body\n weight\n when\n samples\n received\n TCV\n vacci-\nnations.\n We  could\n not\n calculate\n dosages\n of\n thimerosal\n exposure\nper\n kilogram.\n These\n factors\n hampered\n the\n study\n of\n the\n effects\n of\nvaccinations\n in\n infants\n immediately\n after\n birth,\n using\n a\n retrospec-\ntive\n study\n design.", "mimetype": "text/plain", "start_char_idx": 25489, "end_char_idx": 27090, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b8be6716-f8ea-43ec-b438-0321dc8896da": {"__data__": {"id_": "b8be6716-f8ea-43ec-b438-0321dc8896da", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c6695782-74cd-4512-a00a-06bb558ec445", "node_type": "1", "metadata": {}, "hash": "53b3dc073f5f3016e98ae759fcec65e5c083e71ca46db6fa9e6d005b2f3f431f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "de48dbda-c980-4a31-96bf-6df837fd486d", "node_type": "1", "metadata": {}, "hash": "2415a333358157e7465a1cb5bf0f856291b85f40d0065a12465790827a72a79c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "These\n factors\n hampered\n the\n study\n of\n the\n effects\n of\nvaccinations\n in\n infants\n immediately\n after\n birth,\n using\n a\n retrospec-\ntive\n study\n design.\n It\n is\n unclear\n whether\n early\n vaccinations\n are\n more\nharmful\n or\n not.\n It\n may\n be\n necessary\n to\n conduct\n a\n prospective\n study\nthat\n follows\n subjects\n who\n were\n vaccinated\n very\n early\n in\n life.\nMoreover,\n various\n genetic\n and\n environmental\n factors\n have\n been\nelucidated\n as\n potential\n risks\n involved\n in\n the\n onset\n of\n ASD\n [1]. In\n par-\nticular,\n several\n studies\n have\n been\n discussed\n that\n address\n whether\nASD\n cases\n who\n are\n apparently\n associated\n with\n vaccinations\n have\nhad\n their\n own\n health\n problems\n prior\n to\n vaccinations\n or\n have\n a\n fam-\nily\n history\n of\n autoimmune\n diseases\n [39]. While\n the\n present\n study\ninvestigated\n MMR\n and\n TCVs\n as\n environmental\n factors,\n it\n did\n not\ninclude\n a\n variety\n of\n other\n factors,\n such\n as\n maternal\n psychiatric\nstate\n and\n medications\n during\n pregnancy,\n infections,\n air\n pollution,\nor\n metals,\n which\n may\n be\n related\n to\n the\n onset\n of\n ASD\n and\n infant\nneurodevelopment\n [40\u201348]. Future\n studies\n should\n be\n conducted\nincluding\n these\n other\n factors.\n Nonetheless,\n it\n is\n presumable\n that\nmultiple\n factors\n affecting\n the\n onset\n of\n ASD\n exist\n and\n that\n the\n size\nof\n their\n effects\n may\n not\n be\n large\n [49]. Thus,\n it\n is\n essential\n to\n further\nincrease\n the\n sample\n size\n to\n compositely\n investigate\n these\n factors.\nFurthermore,\n we\n could\n utilize\n highly\n reliable\n data\n in\n the\n present\nstudy\n by\n using\n vaccine\n records\n from\n the\n MCH\n handbook.", "mimetype": "text/plain", "start_char_idx": 26935, "end_char_idx": 28556, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "de48dbda-c980-4a31-96bf-6df837fd486d": {"__data__": {"id_": "de48dbda-c980-4a31-96bf-6df837fd486d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b8be6716-f8ea-43ec-b438-0321dc8896da", "node_type": "1", "metadata": {}, "hash": "d63afb38c44683aaa00ba7409bf4a7848680f8cf59dcaf7944f2704d08f7b976", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3cc37b5e-f905-4d21-82bd-25c4f5ed3540", "node_type": "1", "metadata": {}, "hash": "ccfd79c56edd6d52e4b74504920f38dd69cded7523822a182d603443813f1439", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Furthermore,\n we\n could\n utilize\n highly\n reliable\n data\n in\n the\n present\nstudy\n by\n using\n vaccine\n records\n from\n the\n MCH\n handbook.\n On\n the\nother\n hand,\n this\n study\n did\n not\n account\n for\n the\n reasons\n why\n vaccines\nwere\n not\n given\n to\n certain\n individuals.\n ASD\n is\n known\n to\n exhibit\n var-\nious\n comorbidities\n such\n as\n epilepsy\n and\n malformations\n as\n well\n as\nhyperkinesia\n and\n temper\n tantrums.\n These\n may\n be\n the\n reasons\n why\nparents\n and\n guardians\n avoid\n vaccinations,\n and\n may\n have\n potentially\naffected\n their\n decisions\n in\n consenting\n to\n the\n vaccinations.\n There-\nfore,\n it\n may\n be\n desirable\n to\n investigate\n the\n reasons\n for\n avoiding\n the\nvaccinations.\n A\n prospective\n study\n that\n follows\n women\n from\n their\npre-pregnancy\n or\n prenatal\n stages\n in\n the\n general\n population\n in\n order\nto\n study\n other\n environmental\n factors\n affecting\n their\n children\n may\nalso\n be\n desirable\n in\n the\n future.\nWe\n believe\n it\n is\n necessary\n to\n explore\n genetic\n factors\n as\n well\n as\nconduct\n research\n that\n accounts\n for\n environmental\n factors\n in\n order\nelucidate\n the\n pathology\n of\n ASD.\n These\n may\n lead\n to\n early\n diagnosis\n of\nASD\n or\n the\n development\n of\n a\n biomarker\n to\n identify\n high-risk\n groups,\nwhich\n may,\n in\n turn,\n contribute\n to\n improved\n quality\n of\n life\n for\n ASD\npatients\n and\n their\n families.\nMMR\n vaccination\n and\n increased\n thimerosal\n exposure\n did\n not\nelevate\n the\n risk\n for\n ASD\n onset\n in\n this\n Japanese\n population.\n There-\nfore,\n there\n is\n no\n need\n to\n avoid\n these\n vaccinations\n due\n to\n concern\nof\n inducing\n ASD.", "mimetype": "text/plain", "start_char_idx": 28420, "end_char_idx": 30017, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3cc37b5e-f905-4d21-82bd-25c4f5ed3540": {"__data__": {"id_": "3cc37b5e-f905-4d21-82bd-25c4f5ed3540", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "de48dbda-c980-4a31-96bf-6df837fd486d", "node_type": "1", "metadata": {}, "hash": "2415a333358157e7465a1cb5bf0f856291b85f40d0065a12465790827a72a79c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "971ca21e-adec-4b42-b22c-ac5fb62b809e", "node_type": "1", "metadata": {}, "hash": "df7dc9dcd36c8dd52dc84b2bf30659317a43dd12035a025c4d7ab8013a6bb4a1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "There-\nfore,\n there\n is\n no\n need\n to\n avoid\n these\n vaccinations\n due\n to\n concern\nof\n inducing\n ASD.\n Nonetheless,\n many\n facts\n regarding\n the\n pathology\nof\n ASD\n remain\n unknown,\n and\n further\n elucidation\n in\n the\n future\n is\nanticipated.\nCon\ufb02ict\n of\n interest\nThe\n authors\n have\n no\n con\ufb02icts\n of\n interest\n to\n declare.\nAcknowledgments\nThe\n authors\n are\n grateful\n to\n Associate\n Professor\n Masahiko\nAndo,\n Nagoya\n University\n Hospital,\n for\n his\n advice\n and\n check-\ning\n of\n statistical\n analyses.\n This\n study\n is\n the\n result\n of\n research\ngrants\n from\n the\n Ministry\n of\n Health,\n Labor\n and\n Welfare\n of\n Japan\n(H22-Psychiatry-General-016),\n and\n \u201cIntegrated\n research\n on\n neu-\nropsychiatric\n disorders\u201d\n carried\n out\n under\n the\n Strategic\n Research\nProgram\n for\n Brain\n Sciences\n by\n the\n Ministry\n of\n Education,\n Culture,\nSports,\n Science\n and\n Technology\n of\n Japan.\nReferences\n[1]\n Hallmayer\n J, Cleveland\n S,\n Torres\n A,\n Phillips\n J, Cohen\n B,\n Torigoe\n T,\n et\n al.\n Genetic\nheritability\n and\n shared\n environmental\n factors\n among\n twin\n pairs\n with\n autism.\nArch Gen\n Psychiatry\n 2011;68:1095\u2013102.\n[2]\n Levy\n SE,\n Mandell\n DS,\n Schultz\n RT.\n Autism.\n Lancet\n 2009;374:1627\u201338.\n2516\n \nY.\n Uno\n et\n al.\n / Vaccine\n 33\n (2015)\n 2511\u20132516\n[3]\n Lichtenstein\n P,\n Carlstrom\n E,\n Rastam\n M,\n Gillberg\n C,\n Anckarsater\n H.\n The\n genet-\nics  of\n autism\n spectrum\n disorders\n and\n related\n neuropsychiatric\n disorders\n in\nchildhood.\n Am\n J Psychiatry\n 2010;167:1357\u201363.", "mimetype": "text/plain", "start_char_idx": 29915, "end_char_idx": 31398, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "971ca21e-adec-4b42-b22c-ac5fb62b809e": {"__data__": {"id_": "971ca21e-adec-4b42-b22c-ac5fb62b809e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3cc37b5e-f905-4d21-82bd-25c4f5ed3540", "node_type": "1", "metadata": {}, "hash": "ccfd79c56edd6d52e4b74504920f38dd69cded7523822a182d603443813f1439", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "87837c79-bdfd-439e-902e-4e7ec399a964", "node_type": "1", "metadata": {}, "hash": "04314c582f59f08ad7459a1e91dd24ab43226b425ef1e8cf3d0ff5e2e4b3b9df", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Am\n J Psychiatry\n 2010;167:1357\u201363.\n[4]\n Sandin\n S,\n Lichtenstein\n P,\n Kuja-Halkola\n R,\n Larsson\n H,\n Hultman\n CM,\n Reichenberg\nA.\n The\n familial\n risk\n of\n autism.\n JAMA\n 2014;311:1770\u20137.\n[5]\n Lai\n MC,\n Lombardo\n MV,\n Baron-Cohen\n S.\n Autism.\n Lancet\n 2014;383:896\u2013910.\n[6]\n Wake\ufb01eld\n AJ,\n Murch\n SH,\n Anthony\n A,\n Linnell\n J,\n Casson\n DM,\n Malik\n M,  et\n al.\nIleal-lymphoid-nodular\n hyperplasia,\n non-speci\ufb01c\n colitis,\n and\n pervasive\n devel-\nopmental\n disorder\n in\n children.\n Lancet\n 1998;351:637\u201341.\n[7]\n The\n Editors\n of\n The\n Lancet.\n Retraction-Ileal-lymphoid-nodular\n hyperplasia,\n non-\nspeci\ufb01c\n colitis,\n and\n pervasive\n developmental\n disorder\n in\n children.\n Lancet\n2010;375:445.\n[8]\n Kawashima\n H,\n Mori\n T,\n Kashiwagi\n Y,\n Takekuma\n K,\n Hoshika\n A,\n Wake\ufb01eld\n A.\nDetection\n and\n sequencing\n of\n measles\n virus\n from\n peripheral\n mononuclear\ncells\n from\n patients\n with\n in\ufb02ammatory\n bowel\n disease\n and\n autism.\n Dig\n Dis\n Sci\n2000;45:723\u20139.\n[9]\n Uhlmann\n V,\n Martin\n CM,\n Sheils\n O,\n Pilkington\n L,\n Silva\n I,\n Killalea\n A,\n et\n al.\n Potential\nviral\n pathogenic\n mechanism\n for\n new\n variant\n in\ufb02ammatory\n bowel\n disease.\n Mol\nPathol\n 2002;55:84\u201390.\n[10]\n Bernard\n S,\n Enayati\n A,\n Redwood\n L,\n Roger\n H,\n Binstock\n T.\n Autism:\n a\n novel\n form\n of\nmercury\n poisoning.", "mimetype": "text/plain", "start_char_idx": 31363, "end_char_idx": 32645, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "87837c79-bdfd-439e-902e-4e7ec399a964": {"__data__": {"id_": "87837c79-bdfd-439e-902e-4e7ec399a964", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "971ca21e-adec-4b42-b22c-ac5fb62b809e", "node_type": "1", "metadata": {}, "hash": "df7dc9dcd36c8dd52dc84b2bf30659317a43dd12035a025c4d7ab8013a6bb4a1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c0d608ae-e619-4b8d-af9b-157b451137b9", "node_type": "1", "metadata": {}, "hash": "dc1d91745cd5c175d5248f71eef43ee3aab16df05fb24daaa76c0091db3f0426", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "[10]\n Bernard\n S,\n Enayati\n A,\n Redwood\n L,\n Roger\n H,\n Binstock\n T.\n Autism:\n a\n novel\n form\n of\nmercury\n poisoning.\n Med\n Hypotheses\n 2001;56:462\u201371.\n[11]\n Of\ufb01t\n PA.\n Vaccines\n and\n autism\n revisited\n \u2013\n the\n Hannah\n Poling\n case.\n N\n Engl\n J Med\n2008;358:2089\u201391.\n[12]\n The\n American\n Academy\n of\n Pediatrics\n and\n The\n United\n States\n Public\n Health\nService\n Joint\n statement\n of\n the\n American\n Academy\n of\n Pediatrics\n (AAP)\nand\n the\n United\n States\n Public\n Health\n Service\n (USPHS).\n Pediatrics\n 1999;104:\n568\u20139.\n[13]\n DeStefano\n F,\n Bhasin\n TK,\n Thompson\n WW,\n Yeargin-Allsopp\n M,\n Boyle\n C.\n Age\n at\n\ufb01rst measles\u2013mumps\u2013rubella\n vaccination\n in\n children\n with\n autism\n and\n school-\nmatched\n control\n subjects:\n a\n population-based\n study\n in\n metropolitan\n atlanta.\nPediatrics\n 2004;113:259\u201366.\n[14]\n Smeeth\n L,\n Cook\n C,\n Fombonne\n E,\n Heavey\n L,\n Rodrigues\n LC,\n Smith\n PG,\n et\n al.\n MMR\nvaccination\n and\n pervasive\n developmental\n disorders:\n a\n case\u2013control\n study.\nLancet\n 2004;364:963\u20139.\n[15]\n DeWilde\n S,\n Carey\n IM,\n Richards\n N,\n Hilton\n SR,\n Cook\n DG.\n Do\n children\n who\nbecome\n autistic\n consult\n more\n often\n after\n MMR\n vaccination.\n Br\n J Gen\n Pract\n2001;51:226\u20137.\n[16]\n Price\n CS,\n Thompson\n WW,\n Goodson\n B,\n Weintraub\n ES,\n Croen\n LA,\n Hinrichsen\nVL,\n et\n al.\n Prenatal\n and\n infant\n exposure\n to\n thimerosal\n from\n vaccines\n and\nimmunoglobulins\n and\n risk\n of\n autism.", "mimetype": "text/plain", "start_char_idx": 32528, "end_char_idx": 33924, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c0d608ae-e619-4b8d-af9b-157b451137b9": {"__data__": {"id_": "c0d608ae-e619-4b8d-af9b-157b451137b9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "87837c79-bdfd-439e-902e-4e7ec399a964", "node_type": "1", "metadata": {}, "hash": "04314c582f59f08ad7459a1e91dd24ab43226b425ef1e8cf3d0ff5e2e4b3b9df", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6e437bc5-2d9a-4054-9d48-9223d9b7c470", "node_type": "1", "metadata": {}, "hash": "db3701fe7ed26ac0a34ef812ca87d3013fb8b55a9c647ad5bccc5cd6709e41ca", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Prenatal\n and\n infant\n exposure\n to\n thimerosal\n from\n vaccines\n and\nimmunoglobulins\n and\n risk\n of\n autism.\n Pediatrics\n 2010;126:656\u201364.\n[17]\n Taylor\n LE,\n Swerdfeger\n AL,\n Eslick\n GD.\n Vaccines\n are\n not\n associated\n with\n autism:\nan\n evidence-based\n meta-analysis\n of\n case\u2013control\n and\n cohort\n studies.\n Vaccine\n2014;32:3623\u20139.\n[18]\n Yoshimasu\n K,\n Kiyohara\n C,\n Takemura\n S,\n Nakai\n K.\n A\n meta-analysis\n of\n the\n evidence\non\n the\n impact\n of\n prenatal\n and\n early\n infancy\n exposures\n to\n mercury\n on\n autism\nand attention\n de\ufb01cit/hyperactivity\n disorder\n in\n the\n childhood.\n Neurotoxicology\n2014;44C:121\u201331.\n[19]\n Uno\n Y,\n Uchiyama\n T,\n Kurosawa\n M,  Aleksic\n B,\n Ozaki\n N.\n The\n combined\n measles,\nmumps,\n and\n rubella\n vaccines\n and\n the\n total\n number\n of\n vaccines\n are\n not\n asso-\nciated\n with\n development\n of\n autism\n spectrum\n disorder:\n the\n \ufb01rst\n case\u2013control\nstudy\n in\n Asia.\n Vaccine\n 2012;30:4292\u20138.\n[20]\n Yamaguchi-Kabata\n Y,\n Nakazono\n K,\n Takahashi\n A,\n Saito\n S,\n Hosono\n N,\n Kubo\n M,\n et\n al.\nJapanese\n population\n structure,\n based\n on\n SNP\n genotypes\n from\n 7003\n individ-\nuals\n compared\n to\n other\n ethnic\n groups:\n effects\n on\n population-based\n association\nstudies.\n Am\n J\n Hum\n Genet\n 2008;83:445\u201356.\n[21]\n Siva\n N.\n Thiomersal\n vaccines\n debate\n continues\n ahead\n of\n UN\n meeting.\n Lancet\n2012;379:2328.", "mimetype": "text/plain", "start_char_idx": 33816, "end_char_idx": 35154, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6e437bc5-2d9a-4054-9d48-9223d9b7c470": {"__data__": {"id_": "6e437bc5-2d9a-4054-9d48-9223d9b7c470", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c0d608ae-e619-4b8d-af9b-157b451137b9", "node_type": "1", "metadata": {}, "hash": "dc1d91745cd5c175d5248f71eef43ee3aab16df05fb24daaa76c0091db3f0426", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f7fec461-dc6e-4a24-913f-a1e37c68eb60", "node_type": "1", "metadata": {}, "hash": "3029d693e6bd970f3520b16d51dbab539cb2b4018499918024f72ec27ed4f689", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "[21]\n Siva\n N.\n Thiomersal\n vaccines\n debate\n continues\n ahead\n of\n UN\n meeting.\n Lancet\n2012;379:2328.\n[22]\n Brown\n KF,\n Long\n SJ,\n Ramsay\n M,\n Hudson\n MJ,\n Green\n J,\n Vincent\n CA,\n et\n al.\n U.K.\nparents\u2019\n decision-making\n about\n measles\u2013mumps\u2013rubella\n (MMR)\n vaccine\n 10\nyears\n after\n the\n MMR-autism\n controversy:\n a\n qualitative\n analysis.\n Vaccine\n2012;30:1855\u201364.\n[23]\n Casiday\n R,\n Cresswell\n T,\n Wilson\n D,\n Panter-Brick\n C.\n A\n survey\n of\n UK\n parental\nattitudes\n to\n the\n MMR\n vaccine\n and\n trust\n in\n medical\n authority.\n Vaccine\n2006;24:177\u201384.\n[24]\n Cassell\n JA,\n Leach\n M,\n Poltorak\n MS,\n Mercer\n CH,\n Iversen\n A,\n Fairhead\n JR.\n Is\n the\n cul-\ntural\n context\n of\n MMR\n rejection\n a\n key\n to\n an\n effective\n public\n health\n discourse.\nPublic\n Health\n 2006;120:783\u201394.\n[25]\n Hilton\n S,\n Hunt\n K,\n Petticrew\n M.\n MMR:\n marginalised,\n misrepresented\n and\nrejected?\n Autism:\n a\n focus\n group\n study.\n Arch\n Dis\n Child\n 2007;92:322\u20137.\n[26]\n Of\ufb01t\n PA,\n Cof\ufb01n\n SE.\n Communicating\n science\n to\n the\n public:\n MMR\n vaccine\n and\nautism.\n Vaccine\n 2003;22:1\u20136.\n[27]\n Stephen\n D,\n Sugarman\n SD.\n Cases\n in\n vaccine\n court\n \u2013\n legal\n battles\n over\n vaccines\nand\n autism.\n N\n Engl\n J\n Med\n 2007;357:1275\u20137.", "mimetype": "text/plain", "start_char_idx": 35051, "end_char_idx": 36256, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f7fec461-dc6e-4a24-913f-a1e37c68eb60": {"__data__": {"id_": "f7fec461-dc6e-4a24-913f-a1e37c68eb60", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6e437bc5-2d9a-4054-9d48-9223d9b7c470", "node_type": "1", "metadata": {}, "hash": "db3701fe7ed26ac0a34ef812ca87d3013fb8b55a9c647ad5bccc5cd6709e41ca", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a46ce135-3b82-40e3-9705-87789283acee", "node_type": "1", "metadata": {}, "hash": "c2565c699f67a651049a1b6c3aef7b20dc5910ea3c62415890f7347354e28971", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Cases\n in\n vaccine\n court\n \u2013\n legal\n battles\n over\n vaccines\nand\n autism.\n N\n Engl\n J\n Med\n 2007;357:1275\u20137.\n[28]\n Wing\n L,\n Leekam\n SR,\n Libby\n SJ,\n Gould\n J,\n Larcombe\n M.\n The\n Diagnostic\n Interview\n for\nSocial\n and\n Communication\n Disorders:\n background,\n inter-rater\n reliability\n and\nclinical\n use.\n J Child\n Psychol\n Psychiatry\n 2002;43:307\u201325.\n[29]\n Leekam\n SR,\n Libby\n SJ,\n Wing\n L,\n Gould\n J,\n Taylor\n C.\n The\n Diagnostic\n Interview\n for\nSocial\n and\n Communication\n Disorders:\n algorithms\n for\n ICD-10\n childhood\n autism\nand Wing\n and\n Gould\n autistic\n spectrum\n disorder.\n J Child\n Psychol\n Psychiatry\n2002;43:327\u201342.\n[30]\n Kent\n RG,\n Carrington\n SJ,\n Le\n Couteur\n A,\n Gould\n J, Wing\n L,\n Maljaars\n J,\n et\n al.\n Diagnosing\nAutism\n Spectrum\n Disorder:\n who\n will\n get\n a\n DSM-5\n diagnosis?\n J\n Child\n Psychol\nPsychiatry\n 2013;54:1242\u201350.\n[31]\n Sugiura\n A,\n Yamada\n A.\n Aseptic\n meningitis\n as\n a\n complication\n of\n mumps\n vaccina-\ntion. Pediatr\n Infect\n Dis\n J 1991;10:209\u201313.\n[32]\n Kunugi\n H,\n Nanko\n S,\n Takei\n N,\n Saito\n K,\n Murray\n RM,\n Hirose\n T.\n Perinatal\n complica-\ntions and\n schizophrenia.\n Data\n from\n the\n Maternal\n and\n Child\n Health\n Handbook\nin\n Japan.\n J Nerv\n Ment\n Dis\n 1996;184:542\u20136.\n[33]\n Ohara\n K,\n Tanabu\n S,\n Yoshida\n K,\n Sato\n Y,\n Shibuya\n H.\n Obstetric\n complications\n in\nsiblings\n of\n Japanese\n schizophrenics:\n data\n from\n the\n Maternal\n and\n Child\n Health\nHandbook.", "mimetype": "text/plain", "start_char_idx": 36148, "end_char_idx": 37552, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a46ce135-3b82-40e3-9705-87789283acee": {"__data__": {"id_": "a46ce135-3b82-40e3-9705-87789283acee", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f7fec461-dc6e-4a24-913f-a1e37c68eb60", "node_type": "1", "metadata": {}, "hash": "3029d693e6bd970f3520b16d51dbab539cb2b4018499918024f72ec27ed4f689", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e0094cdc-4771-4633-b97a-db6a817bfdc4", "node_type": "1", "metadata": {}, "hash": "f41403b21504218f1162ba5a73c6656e4965c335af659e22aec91e902be2b86c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Prog\n Neuropsychopharmacol\n Biol\n Psychiatry\n 2005;29:617\u201320.\n[34]\n Honda\n H,\n Shimizu\n Y,\n Rutter\n M.\n No\n effect\n of\n MMR\n withdrawal\n on\n the\n incidence\nof\n autism:\n a\n total\n population\n study.\n J\n Child\n Psychol\n Psychiatry\n 2005;46:572\u20139.\n[35]\n Uchiyama\n T,\n Kurosawa\n M,\n Inaba\n Y.\n MMR-vaccine\n and\n regression\n in\n autism\n spec-\ntrum\n disorders:\n negative\n results\n presented\n from\n Japan.\n J Autism\n Dev\n Disord\n2007;37:210\u20137.\n[36]\n Brugha\n TS,\n McManus\n S,\n Bankart\n J,\n Scott\n F,\n Purdon\n S,\n Smith\n J, et\n al.\n Epidemiology\nof\n autism\n spectrum\n disorders\n in\n adults\n in\n the\n community\n in\n England.\n Arch\n Gen\nPsychiatry\n 2011;68:459\u201365.\n[37]\n Kim\n YS,\n Leventhal\n BL,\n Koh\n YJ,\n Fombonne\n E,\n Laska\n E,\n Lim\n EC,\n et\n al.\n Prevalence\nof Autism\n Spectrum\n Disorders\n in\n a\n total\n population\n sample.\n Am\n J Psychiatry\n2011;168:904\u201312.\n[38]\n Taylor\n B,\n Jick\n H,\n Maclaughlin\n D.\n Prevalence\n and\n incidence\n rates\n of\n autism\nin\n the\n UK:\n time\n trend\n from\n 2004\u20132010\n in\n children\n aged\n 8 years.\n BMJ\n Open\n2013;3:e003219.\n[39]\n Vastag\n B.\n Congressional\n autism\n hearings\n continue:\n no\n evidence\n MMR\n vaccine\ncauses\n disorder.\n JAMA\n 2001;285:2567\u20139.\n[40]\n Christensen\n J, Gronborg\n TK,\n Sorensen\n MJ,\n Schendel\n D,\n Parner\n ET,\n Pedersen\n LH,\net\n al.\n Prenatal\n valproate\n exposure\n and\n risk\n of\n autism\n spectrum\n disorders\n and\nchildhood\n autism.", "mimetype": "text/plain", "start_char_idx": 37554, "end_char_idx": 38927, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e0094cdc-4771-4633-b97a-db6a817bfdc4": {"__data__": {"id_": "e0094cdc-4771-4633-b97a-db6a817bfdc4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a46ce135-3b82-40e3-9705-87789283acee", "node_type": "1", "metadata": {}, "hash": "c2565c699f67a651049a1b6c3aef7b20dc5910ea3c62415890f7347354e28971", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c895db56-1d2b-4d25-9de9-4ec7c7813279", "node_type": "1", "metadata": {}, "hash": "03c7c0ef1c950eb6f58a93877e167aa20d3199498ad3ae00b11375e3e52eeff9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Prenatal\n valproate\n exposure\n and\n risk\n of\n autism\n spectrum\n disorders\n and\nchildhood\n autism.\n JAMA\n 2013;309:1696\u2013703.\n[41]\n Ciesielski\n T,\n Weuve\n J,\n Bellinger\n DC,\n Schwartz\n J,\n Lanphear\n B,\n Wright\n RO.\n Cadmium\nexposure\n and\n neurodevelopmental\n outcomes\n in\n U.S.\n children.\n Environ\n Health\nPerspect\n 2012;120:758\u201363.\n[42]\n Gardener\n H,\n Spiegelman\n D,\n Buka\n SL.\n Prenatal\n risk\n factors\n for\n autism:\n compre-\nhensive\n meta-analysis.\n Br\n J\n Psychiatry\n 2009;195:7\u201314.\n[43]\n Guinchat\n V,\n Thorsen\n P,\n Laurent\n C,\n Cans\n C,\n Bodeau\n N,\n Cohen\n D.\n Pre-,\n peri-\n and\nneonatal\n risk\n factors\n for\n autism.\n Acta\n Obstet\n Gynecol\n Scand\n 2012;91:287\u2013300.\n[44]\n Ho\n M,  Garnett\n SP,\n Baur\n L,\n Burrows\n T,\n Stewart\n L,\n Neve\n M,  et\n al.\n Effectiveness\n of\nlifestyle\n interventions\n in\n child\n obesity:\n systematic\n review\n with\n meta-analysis.\nPediatrics\n 2012;130:e1647\u201371.\n[45]\n Rai\n D,\n Lee\n BK,\n Dalman\n C,\n Golding\n J,\n Lewis\n G,\n Magnusson\n C.\n Parental\n depression,\nmaternal\n antidepressant\n use\n during\n pregnancy,\n and\n risk\n of\n autism\n spectrum\ndisorders:\n population\n based\n case\u2013control\n study.\n BMJ\n 2013;346:f2059.\n[46]\n Volk\n HE,\n Lurmann\n F,\n Penfold\n B,\n Hertz-Picciotto\n I,\n McConnell\n R.\n Traf\ufb01c-related\nair\n pollution,\n particulate\n matter,\n and\n autism.\n JAMA\n Psychiatry\n 2013;70:71\u20137.", "mimetype": "text/plain", "start_char_idx": 38830, "end_char_idx": 40150, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c895db56-1d2b-4d25-9de9-4ec7c7813279": {"__data__": {"id_": "c895db56-1d2b-4d25-9de9-4ec7c7813279", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Uno-1 (2012).pdf", "node_type": "4", "metadata": {}, "hash": "ed4ad7f232e4ee2608db2f8582b0e97550f2289b2ecb5dc4759e6cab0bf328b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e0094cdc-4771-4633-b97a-db6a817bfdc4", "node_type": "1", "metadata": {}, "hash": "f41403b21504218f1162ba5a73c6656e4965c335af659e22aec91e902be2b86c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "JAMA\n Psychiatry\n 2013;70:71\u20137.\n[47]\n Zerbo\n O,\n Iosif\n AM,\n Walker\n C,\n Ozonoff\n S,\n Hansen\n RL,\n Hertz-Picciotto\n I.\n Is\n maternal\nin\ufb02uenza\n or\n fever\n during\n pregnancy\n associated\n with\n autism\n or\n developmental\ndelays?\n Results\n from\n the\n CHARGE\n (CHildhood\n Autism\n Risks\n from\n Genetics\n and\nEnvironment)\n study.\n J\n Autism\n Dev\n Disord\n 2013;43:25\u201333.\n[48]\n Zerbo\n O,\n Qian\n Y,\n Yoshida\n C,\n Grether\n JK,\n Van\n de\n Water\n J,\n Croen\n LA.\n Maternal\ninfection\n during\n pregnancy\n and\n autism\n spectrum\n disorders.\n J Autism\n Dev\n Disord\n2013,\n http://dx.doi.org/10.1007/s10803-013-2016-3.\n[49]\n State\n MW,\n Levitt\n P.\n The\n conundrums\n of\n understanding\n genetic\n risks\n for\n autism\nspectrum\n disorders.\n Nat\n Neurosci\n 2011;14:1499\u2013506.", "mimetype": "text/plain", "start_char_idx": 40119, "end_char_idx": 40863, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ac45745a-4213-4f9e-8e88-52cbe41c5938": {"__data__": {"id_": "ac45745a-4213-4f9e-8e88-52cbe41c5938", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9ce94375-b60d-495d-8bfe-d5b965f40ccf", "node_type": "1", "metadata": {}, "hash": "ff619cf273a068f27bb2f77f002e996a73dd0677b091793ac4fae5edb86e298b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Association between Drug and Vaccine\nUse and Acute Immune Thrombocytopenia\nin Childhood\nA Case-Control Study in Italy\nFederica Bertuola,1 Carla Morando,1 Francesca Menniti-Ippolito,2 Roberto Da Cas,2\nAnnalisa Capuano,3 Giorgio Perilongo1 and Liviana Da Dalt1\n1\nDepartment of Pediatrics, University of Padua, Padua, Italy\n2\nNational Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health,\nRome, Italy\n3\nDepartment of Experimental Medicine, Section of Pharmacology \u2018\u2018L. Donatelli\u2019\u2019, Second University\nof Naples, Naples, Italy\nAbstract\nBackground: Immune thrombocytopenic purpura (ITP) is an immuno-\nmediated disease characterized by a decrease in platelet count and, in its more\nsevere forms, by bleeding symptoms. Many drugs have been implicated in the\npathogenesis of drug-induced thrombocytopenia in adults; only limited data\non drug-related ITP in children have been published.\nObjective: Our study was set up to evaluate the consistency of the association\nbetween drug and vaccine use and ITP in children.\nStudy Design: This study is part of an Italian multicentre study on adverse\ndrug reactions in children, coordinated by the Italian National Institute of\nHealth, which was started in November 1999 and is ongoing.\nPatients or Other Participants: The study was conducted by enrolling\nall children aged more than 1 month who were hospitalized through the\npaediatric emergency department for the following conditions: thrombo-\ncytopenia\n(platelet\ncount\n<100 \u00b7 103/L);\nacute\nneurological\ndisorders;\nnon-infectious mucocutaneous diseases and vasculitis; and endoscopically\nconfirmed gastroduodenal lesions and/or clinically defined haematemesis and\nmelaena. Children with chronic pathologies or concomitant diagnoses of\ncancer or immunodeficiency were not included in our study.\nMain Outcome Measure: During hospital admission, a physician interviewed\nparents using a structured questionnaire. The main aim of the interview was\nto collect information on drug exposure in a time period of 3 weeks and\nvaccine exposure in a period of 6 weeks preceding hospitalization.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2102, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9ce94375-b60d-495d-8bfe-d5b965f40ccf": {"__data__": {"id_": "9ce94375-b60d-495d-8bfe-d5b965f40ccf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ac45745a-4213-4f9e-8e88-52cbe41c5938", "node_type": "1", "metadata": {}, "hash": "6f5b7ecda7c47140428b9421973653a08deded0b9c001ade7b7157654724fcf6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "31568e6b-b0d7-4c9b-9559-3ce21298dff0", "node_type": "1", "metadata": {}, "hash": "4b7ce2f1ed55016584ea545dca301741ce6fe9deb8f673c44bc49b159ce5ad4e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The main aim of the interview was\nto collect information on drug exposure in a time period of 3 weeks and\nvaccine exposure in a period of 6 weeks preceding hospitalization. Using a\ncase-control study design, exposure of children with thrombocytopenia\n(cases) to drugs and vaccines was compared with similar exposure of children\nORIGINAL RESEARCH ARTICLE\nDrug Saf 2010; 33 (1): 65-72\n0114-5916/10/0001-0065/$49.95/0\n\u00aa 2010 Adis Data Information BV. All rights reserved.\nwith gastroduodenal lesions and neurological disorders (controls); this\nallowed us to estimate the odds ratios (ORs) of the occurrence of thrombo-\ncytopenia associated with the use of drugs or vaccines.\nResults: Up to December 2007, the study population included 387 cases of\nthrombocytopenia and 1924 controls. Despite the low platelet count, ITP was\ngenerally a mild disease, without serious bleeding in the majority of cases and\nassociated with a short length of hospital stay. After adjusting for concurrent\nuse of other drugs, use of the antibacterials was associated with a more than\n2-fold increase in the risk of developing ITP (OR 2.4; 95% CI 1.8, 3.1). Mu-\ncolytics and NSAIDs were associated with an OR of 1.9; 95% CI 1.2, 2.9 and\n1.5; 95% CI 1.0, 2.1 respectively, while paracetamol (acetaminophen) was\nassociated with an OR of 1.5; 95% CI 1.2, 2.0. MMR vaccination was asso-\nciated with an increased risk of developing ITP (OR 2.4; 95% CI 1.2, 4.7).\nConclusions: The results of this study provide evidence for an association\nbetween ITP and exposure to selected antibacterials, NSAIDs, paracetamol,\nmucolytics and MMR vaccination.", "mimetype": "text/plain", "start_char_idx": 1930, "end_char_idx": 3542, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "31568e6b-b0d7-4c9b-9559-3ce21298dff0": {"__data__": {"id_": "31568e6b-b0d7-4c9b-9559-3ce21298dff0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9ce94375-b60d-495d-8bfe-d5b965f40ccf", "node_type": "1", "metadata": {}, "hash": "ff619cf273a068f27bb2f77f002e996a73dd0677b091793ac4fae5edb86e298b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e6f62207-4b02-44fe-819d-5b07c55e073d", "node_type": "1", "metadata": {}, "hash": "0fbdc47b2270ae7eef4366e66495eb7efd7929eaac7c070df5f806184d2effff", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Conclusions: The results of this study provide evidence for an association\nbetween ITP and exposure to selected antibacterials, NSAIDs, paracetamol,\nmucolytics and MMR vaccination.\nBackground\nImmune thrombocytopenic purpura (ITP) is\nan immunomediated disease characterized by a\ndecrease in platelet count and, in its more severe\nforms, by bleeding symptoms.[1] Although ITP\nhas been known for many years, many unresolved\nissues regarding its clinical definition, pathogenic\nmechanism, epidemiology, diagnosis and man-\nagement still remain.[1]\nSome studies have reported an incidence of\nITP of five cases/100 000 children per year and a\nprevalence of 4.6/100 000.[2-4] The aetiology of\nITP can be primary (idiopathic) or secondary to\ndifferent causal agents (drugs, pathologies such\nas systemic lupus erythematosus, and viral and\nbacterial infections).[5,6]\nDrugs may be involved in the development of\nthrombocytopenia, either through a direct toxic\neffect on the bone marrow, resulting in decreased\nplatelet production, or through immune-medi-\nated mechanisms, resulting in increased platelet\ndestruction.[7] Many drugs have been implicated\nin the pathogenesis of drug-induced thromobo-\ncytopenia in adults; those most frequently reported\nas possible causes are heparin, antibacterials,\nNSAIDs, cinchona alkaloid derivatives (quinine,\nquinidine), sulfonamide antibacterials, anticonvul-\nsants, disease-modifying antirheumatic drugs,\ndiuretics and tuberculostatics.[7-12]\nOn the contrary, limited data on drug-related\nITP in children have been published.[13]\nIn children, ITP has also been described in\nassociation with vaccinations; the majority of the\ncases are attributable to live virus vaccines,\nmainly the measles, mumps and rubella (MMR)\nvaccine. The absolute risk of developing ITP after\nMMR vaccine is estimated to be approximately\n1 in 21 000\u2013100000 inoculations.", "mimetype": "text/plain", "start_char_idx": 3362, "end_char_idx": 5234, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e6f62207-4b02-44fe-819d-5b07c55e073d": {"__data__": {"id_": "e6f62207-4b02-44fe-819d-5b07c55e073d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "31568e6b-b0d7-4c9b-9559-3ce21298dff0", "node_type": "1", "metadata": {}, "hash": "4b7ce2f1ed55016584ea545dca301741ce6fe9deb8f673c44bc49b159ce5ad4e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dc1cd5ce-6071-4527-98dd-6ebf7ff37a41", "node_type": "1", "metadata": {}, "hash": "4e15d0e61b3346ae23d74e59808d2bdbe4631e2bb18bf6ca12118e1757768fec", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The absolute risk of developing ITP after\nMMR vaccine is estimated to be approximately\n1 in 21 000\u2013100000 inoculations.[14-18] ITP associ-\nated with vaccination is generally a mild disease,\nwith few serious bleeding episodes or long-term\nsequelae, despite the low platelet count found in\nmany of the children.[16,18]\nThe aim of the study was to estimate, using a\ncase-control design, the consistency of the asso-\nciation between ITP and exposure to drugs and\nvaccines in childhood.\nPatients and Methods\nThis study is part of an Italian multicentre study\non adverse drug reactions in children, started in\nNovember 1999 and still ongoing, coordinated\nby the Italian National Institute of Health and\ninvolving four paediatric hospitals \u2013 Department\n66\nBertuola et al.\n\u00aa 2010 Adis Data Information BV. All rights reserved.\nDrug Saf 2010; 33 (1)\nof Paediatrics, University of Padua; Giannina\nGaslini Paediatric Hospital, Genova; Bambino\nGesu`\nHospital, Rome; and the Santobono-\nPausilipon Paediatric Hospital, Naples. The\nstudy was set up with the aim of investigating the\nassociation between drugs and vaccines and\nthe occurrence of selected medical conditions,\nusing case-control methodology.\nAll children hospitalized through the paedia-\ntric emergency department for the following\nconditions were included in the study: thrombo-\ncytopenia (platelet count <100 \u00b7 103/L); acute\nneurological disorders (convulsions were in-\ncluded only when not associated with fever); non-\ninfectious mucocutaneous diseases and vasculitis;\nand endoscopically confirmed gastroduodenal\nlesions (and/or clinically defined haematemesis\nand melaena). Exclusion criteria were age <1 month\nand >18 years, and the presence of the following\nconcomitant pathologies: cancer, immunodefici-\nency, and chronic renal and hepatic failure.\nFurthermore, children presenting with acute\nevents related to a reactivation of an underlying\nchronic disease or a congenital anomaly were not\nincluded.\nDuring hospital admission, a physician inter-\nviewed the parents using a structured ques-\ntionnaire.", "mimetype": "text/plain", "start_char_idx": 5115, "end_char_idx": 7172, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dc1cd5ce-6071-4527-98dd-6ebf7ff37a41": {"__data__": {"id_": "dc1cd5ce-6071-4527-98dd-6ebf7ff37a41", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e6f62207-4b02-44fe-819d-5b07c55e073d", "node_type": "1", "metadata": {}, "hash": "0fbdc47b2270ae7eef4366e66495eb7efd7929eaac7c070df5f806184d2effff", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5e870399-ced2-441f-b3b3-840cc2accdb1", "node_type": "1", "metadata": {}, "hash": "4c3db3575d323819fd315379dd61112f357d0697ba9b6f64808956961ea7fcda", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "During hospital admission, a physician inter-\nviewed the parents using a structured ques-\ntionnaire. The main aim of the interview was to\ncollect information on drug exposure in a time\nperiod of 3 weeks (6 weeks for vaccines) preced-\ning hospitalization. We investigated the exposure\nto all drugs, including herbal remedies and\nhomeopathic products. Data on drug use, such as\nindication, dose, duration of treatment, pre-\nscriber (physician- or self-medication) and other\nindividual data (age, sex, weight, height, chronic\ndiseases and parents\u2019 education) were also col-\nlected. Parents were asked for febrile infections\nthat occurred in the 3 weeks before hospital\nadmission. The information on the reason for\nadmission came from the paediatric emergency\ndepartment records, whereas the final diagnosis\nwas retrieved from the clinical records after dis-\ncharge. Informed consent for utilization of data\nfor research purposes was obtained.\nUsing a case-control study design, drug or\nvaccine exposure of children with one of the se-\nlected conditions (cases) was compared with that\nof children with the remaining conditions (con-\ntrols); this allowed us to estimate the odds ratio\n(OR) of the occurrence of each condition and the\nuse of drugs or vaccines.\nIn this study, we present only the results re-\nlated to ITP and its association with exposure to\ndrugs and vaccines from the beginning of the\nstudy in November 1999 to December 2007.\nIn order to calculate the OR, drug or vaccine\nexposure of children with thrombocytopenia\n(cases) was compared with that of children with\ngastrointestinal lesions and neurological dis-\norders (controls). Children with mucocutaneous\ndiseases were excluded from the control group\nbecause the drugs more frequently used by this\ngroup\nof\nchildren\n(i.e.\nantibacterials\nand\nNSAIDs) are also used by children presenting\nwith ITP, thus their inclusion could result in an\nunderestimation of the risks. Multiple logistic\nregression was used to adjust for potential con-\nfounding factors. SPSS (version 15.0, Chicago,\nIL, USA) was used for data analysis.\nResults\nDuring the study period, 4042 children sa-\ntisfied the inclusion criteria.", "mimetype": "text/plain", "start_char_idx": 7072, "end_char_idx": 9235, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5e870399-ced2-441f-b3b3-840cc2accdb1": {"__data__": {"id_": "5e870399-ced2-441f-b3b3-840cc2accdb1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dc1cd5ce-6071-4527-98dd-6ebf7ff37a41", "node_type": "1", "metadata": {}, "hash": "4e15d0e61b3346ae23d74e59808d2bdbe4631e2bb18bf6ca12118e1757768fec", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "99d21b6f-6ea8-41f6-b93c-8c443d44d730", "node_type": "1", "metadata": {}, "hash": "2c7abcd5c1c11cf33040f03f8418bbd699ae04db258bb2811855ecf9d4028e68", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "SPSS (version 15.0, Chicago,\nIL, USA) was used for data analysis.\nResults\nDuring the study period, 4042 children sa-\ntisfied the inclusion criteria. They included 387\npatients with ITP and 3655 patients with other\nconditions (1573 with neurological disorders, 351\nwith gastrointestinal lesions and 1731 with mu-\ncocutaneous diseases). Children with mucocuta-\nneous diseases were subsequently excluded from\nthe control group for the reasons described in the\nmethods section (figure 1).\nThe main characteristics of cases and controls\nare reported in table I.\nThe mean age at diagnosis of patients with ITP\nwas 4.9 years and there was an equal distribution\nbetween sexes. Most cases had very low platelet\ncount (mean platelet count was 10 \u00b7 103/L). The\nonset of ITP in our study population was char-\nacterized in 79.3% of cases by bruising and pe-\ntechiae. Less frequently, patients presented with\nepistaxis, with or without bruising (7.2%). In\n10.3% of cases, the finding of a low platelet count\nwas occasional, without clinical signs or symptoms,\nemerging during laboratory examinations pre-\nscribed by their family paediatrician or performed\nDrugs, Vaccines and Acute Thrombocytopenia in Children\n67\n\u00aa 2010 Adis Data Information BV. All rights reserved.\nDrug Saf 2010; 33 (1)\nin the paediatric emergency department for other\nindications different from ITP. None of the chil-\ndren with bleeding were haemodynamically un-\nstable, no child with ITP developed intracranial\nhaemorrhage and no child died (table II).\nFifty-nine percent of ITP patients were ex-\nposed to drugs during a period of 3 weeks before\nhospital admission. The most frequent indica-\ntions for the use of drugs were upper respiratory\ntract infections, fever, otitis and pain/headache.\nIn total, 181 children (46.8%) with ITP had an\ninfection in the 3 weeks preceding the hospitali-\nzation. The main diagnoses were upper re-\nspiratory tract infections (35%), fever (27%), flu\n(11%), gastroenteritis (6%) and otitis (3%).", "mimetype": "text/plain", "start_char_idx": 9087, "end_char_idx": 11072, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "99d21b6f-6ea8-41f6-b93c-8c443d44d730": {"__data__": {"id_": "99d21b6f-6ea8-41f6-b93c-8c443d44d730", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5e870399-ced2-441f-b3b3-840cc2accdb1", "node_type": "1", "metadata": {}, "hash": "4c3db3575d323819fd315379dd61112f357d0697ba9b6f64808956961ea7fcda", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "518ffb4d-1525-4bbc-b685-397960c377b6", "node_type": "1", "metadata": {}, "hash": "c7d2bcff2b4ad075533c0fe83c400efce783851e959feb549e7a756dbc89c9d4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The main diagnoses were upper re-\nspiratory tract infections (35%), fever (27%), flu\n(11%), gastroenteritis (6%) and otitis (3%). Fifty-\nfive percent of control patients were exposed to\ndrugs for the same indications as the cases.\nIn the case-control analysis, we focussed on\nthe classes of drugs with at least ten exposed cases\n(table III). The use of antibacterials, paracetamol\n(acetaminophen), mucolytics and anti-inflammatory\ndrugs was associated with an increased risk of\nthrombocytopenia, while corticosteroids were not.\nAfter adjusting for potential confounding factors\ndue to concurrent use of other drugs, the use of\nantibacterials was associated with a more than\n2-fold increase (OR 2.4; 95% CI 1.8, 3.1). In\nparticular, penicillin use had an OR of 1.9; 95%\nCI 1.3, 2.7, cephalosporin, 2.3; 95% CI 1.6, 3.4\nand macrolides, 2.6; 95% CI 1.6, 4.2. Mucolytic\nuse was associated with an almost 2-fold increase\nin risk (OR 1.9; 95% CI 1.2, 2.9). An increased\nrisk of thrombocytopenia was associated with\nNSAID (OR 1.5; 95% CI 1.0, 2.1) and para-\ncetamol (OR of 1.5; 95% CI 1.2, 2.0) use, but not\nwith corticosteroid use (OR 0.8; 95% CI 0.5, 1.3)\n(table III).\nTable IV reports the specific drugs more fre-\nquently used in our population, with at least ten\nusers among ITP patients.\nEleven percent of cases and 10% of controls\nwere vaccinated in the 6 weeks preceding hospital\nadmission.", "mimetype": "text/plain", "start_char_idx": 10943, "end_char_idx": 12333, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "518ffb4d-1525-4bbc-b685-397960c377b6": {"__data__": {"id_": "518ffb4d-1525-4bbc-b685-397960c377b6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "99d21b6f-6ea8-41f6-b93c-8c443d44d730", "node_type": "1", "metadata": {}, "hash": "2c7abcd5c1c11cf33040f03f8418bbd699ae04db258bb2811855ecf9d4028e68", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "002890c6-abbc-434a-ba48-fcc509802680", "node_type": "1", "metadata": {}, "hash": "98e484c726b50c9fc03772ce0984da5a117d6b4da27c997c8ce789a189093966", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Eleven percent of cases and 10% of controls\nwere vaccinated in the 6 weeks preceding hospital\nadmission. The OR estimated for ITP within\n6 weeks after vaccination was 0.9; 95% CI 0.6, 1.3\nfor all vaccines, and 2.4; 95% CI 1.2, 4.7 for the\nMMR vaccination (table V).\nDiscussion\nAll epidemiological studies performed on\nthrombocytopenia in childhood differ from each\nother largely in methodology used, inclusion and\nexclusion criteria, and duration. In our study, the\nmean age at presentation of ITP was 4.9 years.\nStudies by Kuhne et al.[19] and Watts[20] reported\nthat the mean age of acute ITP was 5.1 and\n5.2 years, respectively.\nWe observed that both sexes were equally\naffected. This finding was, in part, confirmed by\nKuhne and colleagues[21] who described an equal\nChildren enrolled\n(n = 4042)\nMucocutaneous\n(n = 1731)\nNeurological\n(n = 1573)\nGastrointestinal\n(n = 351)\nImmune\nthrombocytopenic purpura\n(n = 387)\nControls\n(n = 1924)\nExcluded\n(n = 1731)\nCases\n(n = 387)\nFig. 1. Selection of cases and controls.\nTable I. Characteristics of the study population\nCharacteristic\nCases\nControls\nNumber\n387\n1924\nMean age [y (SD)]\n4.9 (3.5)\n5.7 (4.9)\nFemales (%)\n46.2\n45.7\nMean length of hospital stay (days)\n5.5\n3.6\nChildren exposed to drugs (%)\n58.9\n55.2\nChildren exposed to vaccines (%)\n11.1\n10.4\n68\nBertuola et al.\n\u00aa 2010 Adis Data Information BV. All rights reserved.\nDrug Saf 2010; 33 (1)\ndistribution between sexes in children older than\n1 year of age, whereas in small children they ob-\nserved a predominance of boys. Other authors\ndescribed a predominance of boys among chil-\ndren under 10 years of age.", "mimetype": "text/plain", "start_char_idx": 12229, "end_char_idx": 13838, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "002890c6-abbc-434a-ba48-fcc509802680": {"__data__": {"id_": "002890c6-abbc-434a-ba48-fcc509802680", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "518ffb4d-1525-4bbc-b685-397960c377b6", "node_type": "1", "metadata": {}, "hash": "c7d2bcff2b4ad075533c0fe83c400efce783851e959feb549e7a756dbc89c9d4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "359d8f48-b9ed-4886-9d41-cdec548c9a69", "node_type": "1", "metadata": {}, "hash": "6db86165ab1017123b7602699d73dc1c401a1c3f3f90320374469175df06644b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Other authors\ndescribed a predominance of boys among chil-\ndren under 10 years of age.[22-24]\nIn our population, the onset of ITP was gen-\nerally acute \u2013 patients presented with bruising\nand petechiae in 79% of cases and, less frequently,\nepistaxis (7%). Only 10% of cases presented with\na low platelet count without clinical signs or\nsymptoms. For different authors, in most cases\nphysical examination at presentation was remark-\nable for the cutaneous manifestations of severe\nthrombocytopenia (bruising and petechial rash).\nMucosal bleeding occurred less frequently.[4,20,23,25]\nIn children with acute ITP, the key laboratory\nfinding was an isolated and often severe throm-\nbocytopenia. In our patients, the mean platelet\ncount was 10 \u00b7 103/L. Other studies reported that\nin more than 50% of cases, platelet count at pre-\nsentation was <20 \u00b7 103/L.[4,19,20,24-26]\nAccording to the literature,[2-4] despite the low\nplatelet count, ITP was generally a mild disease in\nthe majority of cases, without serious bleeding\nand with a short-lasting course (the mean length\nof hospital stay was about 5 days).\nThe purpose of this study was to evaluate the\nconsistency of the association between drug and\nvaccine use and ITP requiring hospitalization in\nchildren. In order to provide risk estimates, data\nwere analysed according to a case-control study\ndesign.\nDrug or vaccine exposure of children with one\nof the selected conditions was compared with that\nof children with the remaining conditions. This\ndesign was used to ensure that case and control\npatients, all of whom were hospitalized, were as\ncomparable as possible with regard to their drug\nexposure ascertainment. In fact, one of the limits\nof case-control studies is the so-called recall bias,\na difference in the accuracy of recall between\ncases and controls with regard to their drug ex-\nposure history. For this reason, it was decided not\nto select controls from the general population.\nWe are confident that children included in the\ncontrol population provided a valid estimate of\nthe source population of our cases.", "mimetype": "text/plain", "start_char_idx": 13752, "end_char_idx": 15825, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "359d8f48-b9ed-4886-9d41-cdec548c9a69": {"__data__": {"id_": "359d8f48-b9ed-4886-9d41-cdec548c9a69", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "002890c6-abbc-434a-ba48-fcc509802680", "node_type": "1", "metadata": {}, "hash": "98e484c726b50c9fc03772ce0984da5a117d6b4da27c997c8ce789a189093966", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f4fdcf86-7afc-4c71-914e-d368ed96436f", "node_type": "1", "metadata": {}, "hash": "c16297c6e10977639c0d77eaad46370b67ad3f39b05f5baac0025f43be84b96b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For this reason, it was decided not\nto select controls from the general population.\nWe are confident that children included in the\ncontrol population provided a valid estimate of\nthe source population of our cases. This is be-\ncause they represented children with acute con-\nditions, admitted through the same Paediatric\nEmergency Departments, whose histories were\ntaken in a similar way. Considering how the in-\nformation on previous drug use was gathered, the\npossibility of a differential recall bias is very low.\nAs this study was conducted in the Paediatric\nEmergency Department, it was not possible to\ninvestigate the pathogenetic role of drugs in ITP\ndevelopment.\nTable III. Drug class exposure (with at least ten users in immune thrombocytopenic purpura [ITP] patients) and estimated odds ratio for ITP\nDrug\nCases (n = 387)\nControls (n = 1924)\nCrude OR (95% CI)\nAdjusted ORa (95% CI)\nAntibacterials\n107\n286\n1.5 (2.0, 2.7)\n2.4 (1.8, 3.1)\npenicillin\n43\n120\n1.3 (1.9, 2.9)\n1.9 (1.3, 2.7)\ncephalosporin\n43\n98\n1.6 (2.4, 3.6)\n2.3 (1.6, 3.4)\nmacrolides\n27\n53\n1.7 (2.9, 4.9)\n2.6 (1.6, 4.2)\nMucolytics\n30\n80\n1.3 (2.2, 3.5)\n1.9 (1.2, 2.9)\nNSAIDs\n50\n174\n1.1 (1.5, 2.2)\n1.5 (1.0, 2.1)\nParacetamol (acetaminophen)\n86\n296\n1.6 (1.2, 2.2)\n1.5 (1.2, 2.0)\nCorticosteroids\n28\n157\n0.6 (0.96, 1.5)\n0.8 (0.5, 1.3)\na\nOR adjusted for the concomitant use of other drugs.", "mimetype": "text/plain", "start_char_idx": 15611, "end_char_idx": 16964, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f4fdcf86-7afc-4c71-914e-d368ed96436f": {"__data__": {"id_": "f4fdcf86-7afc-4c71-914e-d368ed96436f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "359d8f48-b9ed-4886-9d41-cdec548c9a69", "node_type": "1", "metadata": {}, "hash": "6db86165ab1017123b7602699d73dc1c401a1c3f3f90320374469175df06644b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3065b60e-c26f-4587-ad0b-c79a11623407", "node_type": "1", "metadata": {}, "hash": "4f46cd7931c02fa0e080275ba8355c6be4fdc26a5a5d08d76171493ac1176e35", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "OR = odds ratio.\nTable II. Most common signs and symptoms at presentationa\nClinical signs and symptoms at presentation\nNo. (%)\nBruising, purpura or petechiae\n307 (79.3)\nEpistaxis (with or without bruising)\n28 (7.2)\nOccasional finding without signs or symptoms\n40 (10.3)\nOther\n12 (3.2)\na\nMean platelet count (25th\u201375th percentile) was 10 \u00b7 103/L\n(5\u201321 \u00b7 103/L).\nDrugs, Vaccines and Acute Thrombocytopenia in Children\n69\n\u00aa 2010 Adis Data Information BV. All rights reserved.\nDrug Saf 2010; 33 (1)\nWe found that the use of antibacterials, mu-\ncolytics and NSAIDs during the 3 weeks before\nhospital admission for ITP was associated with\nan increased risk of thrombocytopenia. After\nadjusting for concurrent use of other drugs, the\nuse of antibacterials such as penicillin, cephalos-\nporin and macrolides, was associated with an al-\nmost\n2-fold\nincrease\nwith\nsmall\ndifferences\namong these classes.\nLiterature reports refer to several drug classes\nimplicated in the pathogenesis of drug-induced\nthrombocytopenia in adults.[7-12] Most of these\nare not frequently used in the paediatric popula-\ntion. NSAIDs and antibacterials are used in both\nadults and children, even if different drug classes\nhave a different prevalence of use in these popu-\nlations. For example, cotrimoxazole, which is\nfrequently prescribed in adults, is now not com-\nmonly used in children and for this reason we\ncould not provide an estimation of its risk. Apart\nfrom these considerations, the role of such drugs\nin the development of ITP remains unclear.\nIn our population, about half of the cases were\npreceded by an infectious illness, especially upper\nrespiratory tract infections. In a minority of\ncases, children affected by ITP had specific viral\nillnesses (chickenpox, mumps, rubella, infectious\nmononucleosis, etc.) in the previous 3 weeks.", "mimetype": "text/plain", "start_char_idx": 16965, "end_char_idx": 18781, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3065b60e-c26f-4587-ad0b-c79a11623407": {"__data__": {"id_": "3065b60e-c26f-4587-ad0b-c79a11623407", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f4fdcf86-7afc-4c71-914e-d368ed96436f", "node_type": "1", "metadata": {}, "hash": "c16297c6e10977639c0d77eaad46370b67ad3f39b05f5baac0025f43be84b96b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dec1f9c9-a590-4e6a-a8ad-2ee2a4048d83", "node_type": "1", "metadata": {}, "hash": "efdfbdd0b9c5922f888f5a1147545689ded06a721610a0ca4da952f62dd11fed", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In a minority of\ncases, children affected by ITP had specific viral\nillnesses (chickenpox, mumps, rubella, infectious\nmononucleosis, etc.) in the previous 3 weeks. This\nfinding of infectious illness preceding the diagno-\nsis of ITP is within the range of other European\nstudies.[22]\nThe drugs we found associated with ITP de-\nvelopment are widely used to treat infections in\nchildren. It has to be considered that the indica-\ntion for use (viral infections, upper respiratory\ntract infections, etc.) may represent an alternative\nexplanation to the occurrence of ITP. Never-\ntheless, when drugs or drug categories have the\nsame indications for use, confounding by indica-\ntion should not influence the comparison of the\ndifferent risk estimates.\nAn association between MMR vaccination\nand ITP has been widely described in the litera-\nture. In our study, the OR of developing ITP\nduring the 6 weeks following MMR vaccination\nwas 2.4; 95% CI 1.2, 4.7. Other studies evaluating\nthe risk of developing ITP after MMR vac-\ncine[16,17] have found a relative risk of 6.3; 95% CI\n1.3, 30.1 and a relative incidence of 3.27; 95% CI\n1.49, 7.16, respectively.\nWe did not estimate the incidence of develop-\ning ITP after MMR; in other studies, it resulted in\napproximately 1 in 21 000\u201340 000 inoculations,\nwith two of three cases being attributable to the\nvaccine.[14-17] This is considerably less than the\nrisk of developing ITP after natural measles (which\nis common), rubella (estimated to be about 1 in\n3000 cases) or mumps (which is rare).[17]\nConcerning follow-up, this study did not\nevaluate sequelae or recurrence of ITP after sub-\nsequent vaccinations or after the administration\nof the second dose of MMR. In the literature,\nrecurrence is a rare event.", "mimetype": "text/plain", "start_char_idx": 18618, "end_char_idx": 20366, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dec1f9c9-a590-4e6a-a8ad-2ee2a4048d83": {"__data__": {"id_": "dec1f9c9-a590-4e6a-a8ad-2ee2a4048d83", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3065b60e-c26f-4587-ad0b-c79a11623407", "node_type": "1", "metadata": {}, "hash": "4f46cd7931c02fa0e080275ba8355c6be4fdc26a5a5d08d76171493ac1176e35", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "106387c6-c05e-4b28-bf93-0efa90ac862d", "node_type": "1", "metadata": {}, "hash": "73ad0b013096ef9c3fbb94def622a0fa0c6808404f0afe3758680dee75798ac5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In the literature,\nrecurrence is a rare event.[17,26] Furthermore,\nsome studies provide clear evidence that children\nwith a history of ITP prior to the first dose\nof MMR vaccination are not at an increased\nrisk for a vaccine-associated episode and that\nTable IV. Drugs frequently used in our population (with at least ten\nusers in immune thrombocytopenic purpura patients)\nDrug\nCases (%)\n[n = 387]\nControls (%)\n[n = 1924]\nParacetamol (acetaminophen)\n86 (22.2)\n296 (15.4)\nAmoxycillin and clavulanic acid\n29 (6.9)\n80 (4.2)\nClarithromycin\n18 (4.3)\n32 (1.7)\nNiflumic acid\n17 (4.1)\n30 (1.6)\nCefaclor\n14 (3.3)\n35 (1.9)\nAmoxycillin\n14 (3.3)\n37 (2.0)\nBetamethasone\n11 (2.6)\n89 (4.7)\nBeclometasone\n11 (2.6)\n80 (4.2)\nCefixime\n11 (2.6)\n23 (1.2)\nIbuprofen\n11 (2.6)\n34 (1.8)\nAmbroxol\n11 (2.6)\n33 (1.8)\nTable V. Vaccination exposure and estimated odds ratio for immune\nthrombocytopenic purpura after vaccinations\nVaccine\nCases\n(n = 387)\nControls\n(n = 1924)\nAdjusted ORa\n(95% CI)\nAll vaccines\n43\n197\n0.9 (0.6, 1.3)\nMeasles, mumps\nand rubella\n14\n27\n2.4 (1.2, 4.7)\nOther vaccines\n29\n170\n0.7 (0.5, 1.1)\na\nOR adjusted for age and use of drugs.\nOR = odds ratio.\n70\nBertuola et al.\n\u00aa 2010 Adis Data Information BV. All rights reserved.\nDrug Saf 2010; 33 (1)\nvaccine-associated cases tend to be milder than\nothers.", "mimetype": "text/plain", "start_char_idx": 20320, "end_char_idx": 21612, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "106387c6-c05e-4b28-bf93-0efa90ac862d": {"__data__": {"id_": "106387c6-c05e-4b28-bf93-0efa90ac862d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dec1f9c9-a590-4e6a-a8ad-2ee2a4048d83", "node_type": "1", "metadata": {}, "hash": "efdfbdd0b9c5922f888f5a1147545689ded06a721610a0ca4da952f62dd11fed", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "65658d3a-af0e-4054-b333-de7b5b8158d0", "node_type": "1", "metadata": {}, "hash": "56349c4683314da4a9f8945e41a2c3d86c252cc22441aae4d7742ea2284a85ee", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "70\nBertuola et al.\n\u00aa 2010 Adis Data Information BV. All rights reserved.\nDrug Saf 2010; 33 (1)\nvaccine-associated cases tend to be milder than\nothers.[14-17]\nConclusions\nThis is the first study that aims at estimating\nthe risk of developing ITP following exposure to\ncommon drugs or vaccines in the paediatric\npopulation using a case-control design. Other\nstrengths of the study are its size and multicentre\nnature, with the opportunity to study a large\npopulation of children affected by a rare disease.\nThe results of this study provide evidence for\nan increased risk of developing ITP following\nexposure to antibacterials, NSAIDs, paracetamol\nand mucolytics, underlining the importance of a\ncareful evaluation of risks and benefits for a more\nrational use of drugs in children. In interpreting\nthese findings, we have to consider that the pre-\nsence of infectious illness in half of our patients\ncould represent a source of bias and that we have\nnot investigated the pathogenetic role of drugs in\nITP development. It is important in developing a\nmore rational use of drugs in children, to further\nevaluate carefully the risks and benefits of their\nuse.\nWe also confirmed an increased association\nbetween MMR vaccination and ITP, as described\nin the literature. As the risk of ITP after vacci-\nnation is smaller than the one after natural infec-\ntions with these viruses, it is clear that the benefits\nof vaccination programmes greatly exceed the sig-\nnificance of this possible adverse effect. Although\nthrombocytopenia is initially severe, the subsequent\ncourse is generally benign and short-lasting.\nFurther studies are required to increase know-\nledge on this topic; whereas several studies have\nbeen performed in the adult population, in chil-\ndren they are still lacking.\nAcknowledgements\nThis study has been supported by a research fund of the\nItalian Medicines Agency. None of the authors have any\nconflicts of interest relevant to the content of this study.\nThe authors would like to thank all the medical specialists\nof the paediatric hospitals who entered patients into the study\nand carefully reported the necessary data. Furthermore, we\nthank the staff members of the National Centre for Epide-\nmiology, Surveillance and Health Promotion, who have un-\ndertaken data processing.", "mimetype": "text/plain", "start_char_idx": 21462, "end_char_idx": 23754, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "65658d3a-af0e-4054-b333-de7b5b8158d0": {"__data__": {"id_": "65658d3a-af0e-4054-b333-de7b5b8158d0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "106387c6-c05e-4b28-bf93-0efa90ac862d", "node_type": "1", "metadata": {}, "hash": "73ad0b013096ef9c3fbb94def622a0fa0c6808404f0afe3758680dee75798ac5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "99cbd9fa-eef1-4136-a47b-5c400bfc5e45", "node_type": "1", "metadata": {}, "hash": "3a069991928a86ded48fe26bfd781a70577282a28d18be1c346e66efcadc879c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Furthermore, we\nthank the staff members of the National Centre for Epide-\nmiology, Surveillance and Health Promotion, who have un-\ndertaken data processing.\nWe are grateful to the following: Dott.ssa Monica Bolli,\nNational Centre for Epidemiology, Surveillance and Health\nPromotion, National Institute of Health, Rome; Dott.ssa\nFrancesca\nRovere,\nBurlo-Garofolo\nPaediatric\nHospital,\nTrieste; Dott.ssa Elena Falcon, Dott.ssa Anna Capretta,\nDott.ssa Francesca Intini, Department of Paediatrics, Uni-\nversity of Padua, Padua; Dott.ssa Rossella Rossi, Dott.ssa\nChiara Francesca Intra, Dott. Salvatore Renna, Giannina\nGaslini Paediatric Hospital, Genova; Dott. Nicola Pirozzi,\nDott. Umberto Raucci, Dott. Antonino Reale, Bambino Gesu`\nHospital, Rome; Dott. Vincenzo Tipo, Santobono-Pausilipon\nPaediatric Hospital, Naples; Dott.ssa Carmela Santuccio,\nItalian Medicines Agency, Rome.\nReferences\n1. Ruggeri M, Fortuna S, Rodeghiero F. Heterogeneity of\nterminology and clinical definitions in adult idiopathic\nthrombocytopenic purpura: a critical appraisal from a\nsystematic review of the literature. Haematologica 2008\nJan; 93 (1): 98-103\n2. Psaila B, Bussel JB. Immune thrombocytopenic purpura.\nHematol Oncol Clin North Am 2007 Aug; 21 (4): 743-59\n3. Fogarty PF, Segal JB. The epidemiology of immune\nthrombocytopenic purpura. Curr Opin Hematol 2007 Sep;\n14 (15): 515-9\n4. Rosth\u00f8j S, Hedlund-Treutiger I, Rajantie J, et al., on behalf\nof the NOPHO ITP Working Group and five national\nstudy groups.", "mimetype": "text/plain", "start_char_idx": 23598, "end_char_idx": 25086, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "99cbd9fa-eef1-4136-a47b-5c400bfc5e45": {"__data__": {"id_": "99cbd9fa-eef1-4136-a47b-5c400bfc5e45", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "65658d3a-af0e-4054-b333-de7b5b8158d0", "node_type": "1", "metadata": {}, "hash": "56349c4683314da4a9f8945e41a2c3d86c252cc22441aae4d7742ea2284a85ee", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d83d39bb-760b-4fe6-b481-2618a5d3c517", "node_type": "1", "metadata": {}, "hash": "b0d4a5b799be7c8c36e02dc310f0b766956781be1129caa77da3fc3ed7bb7ce2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Rosth\u00f8j S, Hedlund-Treutiger I, Rajantie J, et al., on behalf\nof the NOPHO ITP Working Group and five national\nstudy groups. Duration and morbidity of newly diagnosed\nidiopathic thrombocytopenic purpura in children: a pro-\nspective Nordic study of an unselected cohort. J Pediatr\n2003 Sep; 143 (3): 302-7\n5. Chong\nBH,\nHo\nSJ.\nAutoimmune\nthrombocytopenia.\nJ Thromb Haemost 2005 Aug; 3 (8): 1763-72\n6. Isoyama K, Yamada K. Previous mycoplasma pneumoniae\ninfection causing severe thrombocytopenic purpura. Am J\nHematol 1994 Nov; 47 (3): 252-3\n7. Van den Bemt P, Meyboom R, Egberts A. Drug-induced\nimmune thrombocytopenia. Drug Saf 2004; 27 (15):\n1243-52\n8. Visentin GP, Liu CY. Drug-induced thrombocytopenia.\nHematol Oncol Clin 2007 Aug; 21 (4): 685-96\n9. Ten Berg MJ, Huisman A, Souverein PC, et al. Drug-induced\nthrombocytopenia: a population study. Drug Saf 2006;\n29 (8): 713-21\n10. Aster RH, Bougie DW. Drug-induced immune thrombocy-\ntopenia. N Engl J Med 2007 Aug; 357 (6): 580-7\n11. Swisher KK, Li X, Vesely SK, et al. Drug-induced throm-\nbocytopenia: an updated systematic review, 2008. Drug Saf\n2009; 32 (1): 85-6\n12. Huerta C, Garcia Rodriguez LA. Risk of clinical blood\ndyscrasia in a cohort of antibiotic users. Pharmacotherapy\n2002 May; 22 (5): 630-6\n13.", "mimetype": "text/plain", "start_char_idx": 24962, "end_char_idx": 26224, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d83d39bb-760b-4fe6-b481-2618a5d3c517": {"__data__": {"id_": "d83d39bb-760b-4fe6-b481-2618a5d3c517", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "99cbd9fa-eef1-4136-a47b-5c400bfc5e45", "node_type": "1", "metadata": {}, "hash": "3a069991928a86ded48fe26bfd781a70577282a28d18be1c346e66efcadc879c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b5b18356-2f76-4b6c-8b9a-ce593ef02176", "node_type": "1", "metadata": {}, "hash": "f5be054f743a6d0bd0bd056b5fc748c216795a66d252959b826d57b7c5f7fc50", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Huerta C, Garcia Rodriguez LA. Risk of clinical blood\ndyscrasia in a cohort of antibiotic users. Pharmacotherapy\n2002 May; 22 (5): 630-6\n13. Risch L, Huber AR, Schmugge M. Diagnosis and treatment\nof heparin-induced thrombocytopenia in neonates and\nchildren. Thromb Res 2006; 118: 123-5\nDrugs, Vaccines and Acute Thrombocytopenia in Children\n71\n\u00aa 2010 Adis Data Information BV. All rights reserved.\nDrug Saf 2010; 33 (1)\n14. France EK, Glanz J, Xu S, et al. Risk of immune thrombo-\ncytopenic purpura after measles-mumps-rubella immuniza-\ntion in children. Vaccine Safety Datalink Team. Pediatrics\n2008 Mar; 121 (3): e687-92\n15. Rajantie J, Zeller B, Treutiger I, et al. Vaccination associated\nthrombocytopenic purpura in children. NOPHO ITP\nWorking Group and five national study groups. Vaccine\n2007 Feb 26; 25 (10): 1838-40\n16. Black C, Kaye JA, Jick H. MMR vaccine and idiopathic\nthrombocytopaenic purpura. Br J Clin Pharmacol 2003\nJan; 55 (1): 107-11\n17. Miller E, Waight P, Farrington CP, et al. Idiopathic\nthrombocytopenic purpura and MMR vaccine. Arch Dis\nChild 2001 Mar; 84 (3): 227-9\n18. Jonville-Bera AP, Autert E, Galy-Eyraud C, et al. Thrombo-\ncytopenic purpura after measles, mumps and rubella\nvaccination: a retrospective survey by the French regional\npharmacovigilance centres and pasteur-merieux serums et\nvaccins. Pediatr Infect Dis J 1996 Jan; 15 (1): 44-8\n19.", "mimetype": "text/plain", "start_char_idx": 26084, "end_char_idx": 27460, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b5b18356-2f76-4b6c-8b9a-ce593ef02176": {"__data__": {"id_": "b5b18356-2f76-4b6c-8b9a-ce593ef02176", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d83d39bb-760b-4fe6-b481-2618a5d3c517", "node_type": "1", "metadata": {}, "hash": "b0d4a5b799be7c8c36e02dc310f0b766956781be1129caa77da3fc3ed7bb7ce2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "828cec01-6372-4bfa-8c0c-2259e42e6484", "node_type": "1", "metadata": {}, "hash": "ae46597d809d8ec74bede2f0472d49ba9339dd14afea8558b31d7c2aa89e8b9f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Pediatr Infect Dis J 1996 Jan; 15 (1): 44-8\n19. Khune T, Imbach P, Bolton-Maggs PH, et al., for the In-\ntercontinental Childhood ITP Study Group. Newly diag-\nnosed idiopathic thrombocytopenic purpura in childhood:\nan observational study. Lancet 2001 Dec; 358 (9299): 2122-5\n20. Watts RG. Idiopathic thrombocytopenic purpura: a 10-year\nnatural history study at the childrens hospital of Alabama.\nClin Pediatr 2004 Oct; 43 (8): 691-702\n21. Khune T, Buchanan GR, Zimmerman S, et al., for the\nIntercontinental childhood ITP study group. A prospective\ncomparative study of 2540 infants and children with newly\ndiagnosed idiopathic thrombocytopenic purpura (ITP)\nfrom the intercontinental childhood ITP study group.\nJ Pediatr 2003 Nov; 143 (5): 605-8\n22. Blanchette V, Bolton-Maggs P. Childhood immune thrombo-\ncytopenic purpura: diagnosis and management. Pediatr\nClin North Am 2008 Apr; 55 (2): 393-420\n23. Bolton-Maggs PHB, Moon I. Assessment of UK practice for\nmanagement of acute childhood idiopathic thrombocyto-\npenic purpura against published guidelines. Lancet 1997\nAug; 350 (30): 620-3\n24. Sutor AH, Harms A, Kaufmehl K. Acute immune thrombo-\ncytopenia (ITP) in childhood: retrospective and prospec-\ntive survey in Germany. Semin Thromb Hemost 2001 Jun;\n27 (3): 253-67\n25. Zeller B, Helgestad J, Hellebostad M, et al. Immune\nthrombocytopenic purpura (ITP) in childhood in Norway:\na prospective, population based registration. Pediatr He-\nmatol Oncol 2000 Oct-Nov; 17 (7): 551-8\n26.", "mimetype": "text/plain", "start_char_idx": 27413, "end_char_idx": 28897, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "828cec01-6372-4bfa-8c0c-2259e42e6484": {"__data__": {"id_": "828cec01-6372-4bfa-8c0c-2259e42e6484", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bertuola (2010).pdf", "node_type": "4", "metadata": {}, "hash": "35f421aa71892d2f76e1dab2379cf16bae4ad5d0a455f0a40e279141c242a213", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b5b18356-2f76-4b6c-8b9a-ce593ef02176", "node_type": "1", "metadata": {}, "hash": "f5be054f743a6d0bd0bd056b5fc748c216795a66d252959b826d57b7c5f7fc50", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Pediatr He-\nmatol Oncol 2000 Oct-Nov; 17 (7): 551-8\n26. Stowe J. ITP and the second dose of MMR. Arch Dis Child\n2008 Feb; 93 (2): 182\nCorrespondence: Prof.ssa Liviana Da Dalt, Department of\nPediatrics, University of Padua, Via Giustiniani 3, 35128\nPadova, Italy.\nE-mail: liviana.dadalt@unipd.it\n72\nBertuola et al.\n\u00aa 2010 Adis Data Information BV. All rights reserved.\nDrug Saf 2010; 33 (1)", "mimetype": "text/plain", "start_char_idx": 28842, "end_char_idx": 29231, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fa82595c-0044-4c8d-b0bc-28b326d718c3": {"__data__": {"id_": "fa82595c-0044-4c8d-b0bc-28b326d718c3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "30a1cd42-0618-4468-98c3-89f29cc4e455", "node_type": "1", "metadata": {}, "hash": "558bf694b1a9dcf71e175ae8896e152e63c9cbeb09c8923c6b9d41d03228eed7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine\n 32 (2014) 369\u2013\n 374\nContents\n lists\n available\n at\n ScienceDirect\nVaccine\njou\n rn\n al\n hom\n ep\n age:\n www.elsevier.com/locat\n e/vaccine\nMumps\n vaccine\n effectiveness\n and\n risk\n factors\n for\n disease\nin\n households\n during\n an\n outbreak\n in\n New\n York\n City\nKara\n A.\n Livingston a,\u2217, Jennifer\n B.  Rosen b, Jane\n R.  Zucker b,c,  Christopher\n M.\n Zimmerman b\na Centers\n for\n Disease\n Control/Council\n of\n State\n and\n Territorial\n Epidemiologists\n Applied\n Epidemiology\n Fellowship,\n Atlanta,\n GA,\n USA\nb Bureau\n of\n Immunization,\n New\n York\n City\n Department\n of\n Health\n and\n Mental\n Hygiene,\n New\n York,\n NY,\n USA\nc Immunization\n Services\n Division/National\n Center\n for\n Immunization\n and\n Respiratory\n Diseases/Centers\n for\n Disease\n Control\n &\n Prevention,\n Atlanta,\n GA,\n USA\na  r\n t i  c  l  e  \ni  n  f\n o\nArticle\n history:\nReceived\n 22\n July\n 2013\nReceived\n in\n revised\n form\n 11\n October\n 2013\nAccepted\n 6\n November\n 2013\nAvailable online 16 November 2013\nKeywords:\nMumps\nOutbreaks\nVaccine\n effectiveness\nHouseholds\nRisk\n factors\na  b  s  t\n r\n a  c  t\nBackground\n and  objectives:\n Mumps\n outbreaks\n have\n been\n reported\n among\n vaccinated\n populations,\n and\ndeclining\n mumps\n vaccine\n effectiveness\n (VE)\n has  been  suggested\n as one  possible\n cause. During  a large\nmumps\n outbreak\n in  New  York  City,  we  assessed:\n (1)  VE of measles-mumps-rubella\n vaccine  (MMR)\n against\nmumps\n and  (2)  risk  factors\n for acquiring\n mumps\n in  households.\nMethods:\n Cases\n of  mumps  were  investigated\n using  standard\n methods.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1545, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "30a1cd42-0618-4468-98c3-89f29cc4e455": {"__data__": {"id_": "30a1cd42-0618-4468-98c3-89f29cc4e455", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fa82595c-0044-4c8d-b0bc-28b326d718c3", "node_type": "1", "metadata": {}, "hash": "e2cdfe3a65b938222da849f7a0f130aea0c2d62bd8661c81c580f216ddf23f7a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4a1b4a39-7d67-4252-8ea9-8bf5f0894487", "node_type": "1", "metadata": {}, "hash": "c305945b2343f168f5bfc5838441c6d86fbbfca53caca1d975cea2d4af26ccf7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Methods:\n Cases\n of  mumps  were  investigated\n using  standard\n methods.\n Additional\n information\n on disease\nand\n vaccination\n status  of  household\n contacts\n was  collected.\n Case  households\n completed\n follow-up\n phone\ninterviews\n 78\u2013198  days  after  initial  investigation\n to ascertain\n additional\n cases.\n Mumps\n cases  meeting\n the\nstudy\n case  de\ufb01nition\n were  included\n in  the  analysis.\n Risk  factors\n for  mumps\n were  assessed,\n and  VE  was\ncalculated\n using  secondary\n household\n attack\n rates.\nResults:\n Three  hundred\n and  eleven\n households\n with  2176\n residents\n were  included  in  the  analysis.\n The\nmedian\n age of  residents\n was  13 years\n (range  <1\u201385),\n and  462\n (21.2%)  residents\n met  the  study\n mumps\ncase\n de\ufb01nition.\n Among  7\u201317  year  olds,  89.7%  received\n one  or  more\n doses\n of MMR vaccine,\n with  76.7%\nreceiving\n two  doses.\n Young\n adults  aged  10\u201314\n years  (OR  =  2.4,  CI  =  1.3\u20134.7)  and  15\u201319 years  (OR  =  2.5,\nCI\n =  1.3\u20135.0)  were  at  highest  risk  of mumps.\n The  overall\n 2-dose\n VE  for  secondary\n contacts\n aged\n \ufb01ve and\nolder\n was  86.3%  (CI  63.3\u201394.9).\nConclusions:\n The  two-dose\n effectiveness\n of MMR  vaccine  against\n mumps\n was  86.3%,  consistent\n with\nother\n published\n mumps\n VE  estimates.\n Many\n factors  likely  contributed\n to  this  outbreak.", "mimetype": "text/plain", "start_char_idx": 1472, "end_char_idx": 2805, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4a1b4a39-7d67-4252-8ea9-8bf5f0894487": {"__data__": {"id_": "4a1b4a39-7d67-4252-8ea9-8bf5f0894487", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "30a1cd42-0618-4468-98c3-89f29cc4e455", "node_type": "1", "metadata": {}, "hash": "558bf694b1a9dcf71e175ae8896e152e63c9cbeb09c8923c6b9d41d03228eed7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "601950e8-2efe-443e-aa19-1b1c8389fe39", "node_type": "1", "metadata": {}, "hash": "60b8be003a525a9a71b91f37a69e0de0e9861f0de3357de93acfa323a366c4e7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Many\n factors  likely  contributed\n to  this  outbreak.\n Suboptimal\n MMR\ncoverage\n in  the affected\n population\n combined\n with  VE  may\n not  have\n conferred\n adequate\n immunity\n to\nprevent\n transmission\n and may  have  contributed\n to  this  outbreak.\n Achieving\n high  MMR  coverage\n remains\nthe\n best\n available\n strategy\n for  prevention\n of  mumps\n outbreaks.\n\u00a9 2013 Elsevier Ltd. All rights reserved.\n1.\n Introduction\nMumps\n is\n a\n viral\n infection\n that\n commonly\n presents\n with\n fever\nand\n parotid\n gland\n swelling.\n An\n estimated\n 20\u201330%\n of\n infections\n may\nbe\n asymptomatic\n [1,2].\n Complications\n may\n include\n orchitis,\n aseptic\nmeningitis\n and,\n rarely,\n deafness\n or\n encephalitis\n [3].\nMumps\n vaccine\n was\n \ufb01rst\n licensed\n in\n 1967\n and\n recommended\nfor\n routine\n use\n in\n children\n in\n 1977\n [4];\n by\n 1998,\n the\n number\n of\nreported\n cases\n in\n the\n United\n States\n had\n declined\n by\n over\n 99%\n [5,6].\nIn\n the\n United\n States,\n mumps\n vaccine\n is\n manufactured\n using\n the\nJeryl-Lynn\n strain\n and\n administered\n via\n subcutaneous\n injection\n as\n\u2217Corresponding\n author\n at:\n Jean\n Meyer\n USDA\n Human\n Nutrition\n Research\n Center\non\n Aging\n at\n Tufts\n University,\n 711\n Washington\n Street,\n Boston,\n MA  02111,\n USA.\nTel.:\n +1\n 617\n 556\n 3354.\nE-mail\n address:\n kara.livingston@tufts.edu\n (K.A.\n Livingston).\na\n combination\n measles-mumps-rubella\n vaccine\n (MMR)\n [7].\n A\n \ufb01rst\ndose\n is\n recommended\n for\n children\n at\n 12\u201315\n months\n of\n age,\n followed\nby\n a\n second\n dose\n at\n 4\u20136\n years\n of\n age.", "mimetype": "text/plain", "start_char_idx": 2750, "end_char_idx": 4268, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "601950e8-2efe-443e-aa19-1b1c8389fe39": {"__data__": {"id_": "601950e8-2efe-443e-aa19-1b1c8389fe39", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4a1b4a39-7d67-4252-8ea9-8bf5f0894487", "node_type": "1", "metadata": {}, "hash": "c305945b2343f168f5bfc5838441c6d86fbbfca53caca1d975cea2d4af26ccf7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7f6ed2c9-007d-48b5-962e-f655e418b78e", "node_type": "1", "metadata": {}, "hash": "56ed599c377e1337b354476034fbc8e246305ee20bd48b0b87e8d64a62953fd4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In\n spite\n of\n the\n dramatic\n post-vaccine\n era\n declines\n in\n mumps\ncases,\n occasional\n outbreaks\n have\n been\n reported\n among\n vacci-\nnated\n populations\n [6,8\u201310].\n A\n number\n of\n hypotheses\n have\n been\nraised\n to\n explain\n these\n outbreaks\n including\n waning\n immunity,\ncrowding,\n differences\n between\n the\n mumps\n vaccine\n strain\n and\n circu-\nlating\n wild\n strains,\n diminished\n mumps\n vaccine\n effectiveness\n (VE),\nand\n population\n immunity\n below\n the\n herd\n immunity\n threshold\n[11\u201313].\nDuring\n 2009\u20132010,\n a\n large,\n multi-state\n outbreak\n of\n mumps\noccurred\n among\n Orthodox\n Jewish\n communities\n in\n the\n Northeastern\nUnited\n States.\n New\n York\n City\n (NYC)\n has\n the\n largest\n Orthodox\n Jewish\ncommunity\n in\n the\n United\n States\n and\n identi\ufb01ed\n the\n largest\n number\nof\n mumps\n cases\n during\n the\n outbreak\n [14,15].\n The\n outbreak\n pre-\nsented\n an\n opportunity\n to\n assess\n risk\n factors\n associated\n with\n clinical\nmumps\n infection\n and\n VE.\n0264-410X/$\n \u2013\n see\n front\n matter \u00a9\n \n 2013 Elsevier Ltd. All rights reserved.\nhttp://dx.doi.org/10.1016/j.vaccine.2013.11.021\n370\nK.A.\n Livingston\n et\n al.\n / Vaccine\n 32 (2014) 369\u2013\n 374\n2.\n Methods\nThe\n NYC\n Department\n of\n Health\n and\n Mental\n Hygiene\n (DOHMH)\nconducts\n mumps\n surveillance\n via\n standard\n methods\n [1].\n Cases\n are\nclassi\ufb01ed\n according\n to\n the\n 2007\n Council\n of\n State\n and\n Territorial\n Epi-\ndemiologists\n (CSTE)\n de\ufb01nition.", "mimetype": "text/plain", "start_char_idx": 4269, "end_char_idx": 5674, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7f6ed2c9-007d-48b5-962e-f655e418b78e": {"__data__": {"id_": "7f6ed2c9-007d-48b5-962e-f655e418b78e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "601950e8-2efe-443e-aa19-1b1c8389fe39", "node_type": "1", "metadata": {}, "hash": "60b8be003a525a9a71b91f37a69e0de0e9861f0de3357de93acfa323a366c4e7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "08b2d910-5eb6-401d-8170-c3267ad3063e", "node_type": "1", "metadata": {}, "hash": "e9a47a75137482041aacba37ecb88f4b6026e670cbd97cd4c90fbc01362190c9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Cases\n are\nclassi\ufb01ed\n according\n to\n the\n 2007\n Council\n of\n State\n and\n Territorial\n Epi-\ndemiologists\n (CSTE)\n de\ufb01nition.\n The\n clinical\n case\n de\ufb01nition\n is\n acute\nonset\n of\n unilateral\n or\n bilateral\n swelling\n of\n the\n parotid\n or\n other\n sali-\nvary\n glands,\n lasting\n 2\n or\n more\n days,\n and\n without\n other\n apparent\ncause\n [16].\n Index\n cases\n in\n households\n were\n identi\ufb01ed\n through\n man-\ndated\n electronic\n reporting\n of\n positive\n test\n results\n by\n laboratories,\nor\n clinical\n reports\n of\n suspect\n disease\n by\n providers\n [17].\nBetween\n 2/5/2010\n and\n 4/8/2010,\n 473\n index\n households\n were\ncontacted\n for\n follow-up.\n Data\n was\n collected\n using\n a\n standard\n script.\nAn\n interviewer\n requested\n to\n speak\n with\n an\n adult,\n who\n provided\ninformation\n on\n each\n household\n member.\n A\n minimum\n of\n three\n call\nattempts,\n including\n at\n least\n one\n evening\n attempt,\n were\n made\n to\neach\n household.\n During\n calls,\n informants\n were\n asked:\n (1)\n whether\neach\n household\n contact\n slept\n in\n the\n home,\n on\n average,\n at\n least\n 5\nnights\n per\n week;\n (2)\n total\n number\n of\n bedrooms\n in\n the\n household\nand;\n (3)\n for\n each\n household\n contact:\n birth\n date,\n vaccination\n status,\nand\n whether\n they\n had\n been\n sick\n with\n either\n cheek\n swelling\n that\nlasted\n for\n at\n least\n two\n days\n or\n a\n doctor\n diagnosed\n case\n of\n mumps\nsince\n September\n 2009.\n We  de\ufb01ned\n an\n af\ufb01rmative\n answer\n as\n com-\npatible\n with\n the\n CSTE\n clinical\n case\n de\ufb01nition.", "mimetype": "text/plain", "start_char_idx": 5551, "end_char_idx": 7021, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "08b2d910-5eb6-401d-8170-c3267ad3063e": {"__data__": {"id_": "08b2d910-5eb6-401d-8170-c3267ad3063e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7f6ed2c9-007d-48b5-962e-f655e418b78e", "node_type": "1", "metadata": {}, "hash": "56ed599c377e1337b354476034fbc8e246305ee20bd48b0b87e8d64a62953fd4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a5080844-04dd-4638-8972-365a03917376", "node_type": "1", "metadata": {}, "hash": "4189ada4470801adcf62cfd96d24b7b2685b45ab892fec6cc1ebb7ec3de0e2c6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We  de\ufb01ned\n an\n af\ufb01rmative\n answer\n as\n com-\npatible\n with\n the\n CSTE\n clinical\n case\n de\ufb01nition.\n Informants\n reporting\ncases\n of\n mumps\n in\n their\n household\n were\n prompted\n to\n look\n at\n a\ncalendar\n and\n report\n date\n of\n onset,\n if\n possible.\nHouseholds\n with\n index\n cases\n identi\ufb01ed\n through\n surveillance\nfrom\n 9/1/2009\n to\n 12/31/2009\n were\n eligible\n for\n study\n inclusion.\n Case\nhouseholds\n were\n excluded\n if:\n (1)\n the\n index\n case\n lived\n alone;\n (2)\n the\nindex\n case\n did\n not\n live\n in\n the\n household\n (e.g.,\n lived\n in\n a\n dormitory);\n(3)\n the\n index\n case\n did\n not\n sleep\n in\n the\n home,\n on\n average,\n at\n least\n\ufb01ve\n nights\n per\n week;\n (4)\n there\n was\n not\n an\n English-speaking\n adult\nin\n the\n household;\n (5)\n an\n adult\n in\n the\n household\n was\n not\n able\n to\nbe\n contacted;\n or\n (6)\n an\n adult\n in\n the\n household\n refused\n to\n provide\ninformation\n on\n household\n contacts\n or\n provided\n incomplete\n infor-\nmation.\nFor\n this\n study,\n a\n case\n of\n mumps\n was\n de\ufb01ned\n as\n one\n meeting\nthe\n CSTE\n surveillance\n case\n de\ufb01nition\n or\n a\n compatible\n case\n identi-\n\ufb01ed\n via\n the\n phone\n interview\n [16].\n An\n index\n case\n was\n de\ufb01ned\n as\nthe\n \ufb01rst\n case\n in\n a\n household\n to\n be\n reported\n to\n DOHMH.\n Primary\ncases\n were\n those\n with\n the\n earliest\n onset\n of\n mumps\n in\n the\n house-\nhold.", "mimetype": "text/plain", "start_char_idx": 6924, "end_char_idx": 8234, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a5080844-04dd-4638-8972-365a03917376": {"__data__": {"id_": "a5080844-04dd-4638-8972-365a03917376", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "08b2d910-5eb6-401d-8170-c3267ad3063e", "node_type": "1", "metadata": {}, "hash": "e9a47a75137482041aacba37ecb88f4b6026e670cbd97cd4c90fbc01362190c9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2bcdda16-bc7a-429f-97df-0615d181750c", "node_type": "1", "metadata": {}, "hash": "201c3fa6713b1ca99d867903ad2118fb18f8b38fac4d9fadfa0078e01e8a5364", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Primary\ncases\n were\n those\n with\n the\n earliest\n onset\n of\n mumps\n in\n the\n house-\nhold.\n We\n de\ufb01ned\n household\n members\n as\n being\n exposed\n two\n days\nbefore\n parotitis\n onset\n of\n the\n primary\n case,\n which\n is\n the\n \ufb01rst\n day\nthat\n the\n primary\n case\n was\n infectious.\n We  de\ufb01ned\n co-primary\n cases\nas\n those\n with\n onset\n within\n nine\n days\n after\n the\n primary\n case\u2019s\n symp-\ntom\n onset.\n Secondary\n cases\n were\n de\ufb01ned\n as\n those\n reporting\n onset\nof\n mumps\n 10\u201325\n days\n after\n the\n primary\n case.\n Non-secondary\n cases\nwere\n de\ufb01ned\n as\n those\n occurring\n more\n than\n one\n incubation\n period\n(>25\n days)\n after\n the\n primary\n case.\nMumps\n vaccination\n status\n was\n based\n on\n documented,\n valid\nMMR\n doses.\n Acceptable\n documentation\n included\n MMR\n doses\nrecorded\n in\n the\n NYC\n Citywide\n Immunization\n Registry\n (CIR)\n [18]\nor\n those\n obtained\n directly\n from\n an\n individual\u2019s\n medical\n provider.\nCIR,\n an\n immunization\n information\n system\n sentinel\n site\n for\n the\n CDC,\nmaintains\n high\n quality\n completeness\n and\n timeliness\n for\n which\n 92%\nof\n immunizations\n are\n reported\n within\n one\n month\n and\n to\n which\n89.5%\n of\n providers\n regularly\n report\n [19].\n In\n 2009,\n CIR\n contained\ninformation\n on\n at\n least\n 85%\n of\n children,\n from\n birth\n to\n age\n 18,\n in\nNYC\n [20].", "mimetype": "text/plain", "start_char_idx": 8146, "end_char_idx": 9434, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2bcdda16-bc7a-429f-97df-0615d181750c": {"__data__": {"id_": "2bcdda16-bc7a-429f-97df-0615d181750c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a5080844-04dd-4638-8972-365a03917376", "node_type": "1", "metadata": {}, "hash": "4189ada4470801adcf62cfd96d24b7b2685b45ab892fec6cc1ebb7ec3de0e2c6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0663c540-22b5-4e1d-9672-24c0e9a7ea5a", "node_type": "1", "metadata": {}, "hash": "0c96b4b9e5348aac49061cd8ab6b1d3b20575845c4cc2751de96f112e6bd3b1e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In\n 2009,\n CIR\n contained\ninformation\n on\n at\n least\n 85%\n of\n children,\n from\n birth\n to\n age\n 18,\n in\nNYC\n [20].\n In\n order\n to\n be\n valid,\n doses\n had\n to\n be\n administered\n in\naccordance\n with\n the\n recommended\n vaccination\n schedule\n guide-\nlines,\n meaning\n the\n \ufb01rst\n dose\n had\n to\n be\n administered\n no\n earlier\nthan\n 4\n days\n before\n the\n \ufb01rst\n birthday\n and\n subsequent\n doses\n at\n least\n28\n days\n after\n a\n previous\n MMR\n dose\n [7].\n Individuals\n lacking\n MMR\ndocumentation\n from\n a\n medical\n provider\n and\n with\n a\n record\n in\n CIR\nwith\n at\n least\n one\n reported\n vaccination,\n but\n no\n recorded\n MMR\n doses,\nwere\n considered\n unvaccinated\n with\n MMR.\n Individuals\n with\n a\n valid\nprovider\n recorder\n with\n no\n recorded\n MMR\n doses\n were\n also\n consid-\nered\n unvaccinated.\n Individuals\n lacking\n MMR\n documentation\n from\na\n medical\n provider\n and\n with\n no\n recorded\n vaccinations\n in\n CIR\n were\nconsidered\n to\n have\n unknown\n MMR\n vaccination\n status.\nFrequencies\n were\n calculated\n to\n characterize\n households\n and\nindividuals\n living\n in\n households.\n Overall\n attack\n rate\n (AR)\n was\nde\ufb01ned\n as\n the\n number\n sick\n divided\n by\n the\n total\n number\n of\n indi-\nviduals\n in\n households.\n Household-level\n ARs\n were\n de\ufb01ned\n as\n total\nnumber\n sick\n in\n a\n household\n divided\n by\n total\n number\n living\n in\n that\nhousehold.\n Household\n density\n was\n de\ufb01ned\n as\n total\n number\n of\n peo-\nple\n divided\n by\n total\n number\n of\n bedrooms\n in\n a\n household.", "mimetype": "text/plain", "start_char_idx": 9320, "end_char_idx": 10780, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0663c540-22b5-4e1d-9672-24c0e9a7ea5a": {"__data__": {"id_": "0663c540-22b5-4e1d-9672-24c0e9a7ea5a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2bcdda16-bc7a-429f-97df-0615d181750c", "node_type": "1", "metadata": {}, "hash": "201c3fa6713b1ca99d867903ad2118fb18f8b38fac4d9fadfa0078e01e8a5364", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1bc8405c-3491-4d7e-ab88-2560594cb44e", "node_type": "1", "metadata": {}, "hash": "55acca52771cee3820a44176a503b8b4a8dca6ea53df54a77134230eefe65843", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Household\n density\n was\n de\ufb01ned\n as\n total\n number\n of\n peo-\nple\n divided\n by\n total\n number\n of\n bedrooms\n in\n a\n household.\n VE\n and\n 95%\ncon\ufb01dence\n intervals\n (CI)\n were\n calculated\n using\n secondary\n house-\nhold\n attack\n rates\n (SARs)\n following\n standard\n methods\n to\n examine\nthe\n percent\n reduction\n in\n risk\n among\n vaccinated\n relative\n to\n unvac-\ncinated\n individuals\n [21].\n We  similarly\n examined\n reduction\n in\n risk\namong\n those\n with\n unknown\n vaccination\n status\n relative\n to\n those\nunvaccinated.\nHousehold\n members\n under\n 5\n years\n of\n age\n (n\n =\n 348)\n were\nexcluded\n from\n the\n VE\n calculation\n because\n many\n had\n not\n yet\nreceived\n two\n doses\n of\n MMR,\n and\n clinical\n mumps\n is\n less\n common\namong\n this\n age\n group\n [22].\n The\n following\n were\n excluded\n from\n the\nVE\n calculation:\n household\n members\n with\n unknown\n age\n (n\n =\n 101);\ntwo\n households,\n totaling\n 6\n cases\n and\n 15\n non-cases,\n with\n insuf\ufb01cient\ninformation\n to\n identify\n the\n primary\n case;\n and\n cases\n for\n which\n the\ndate\n of\n illness\n onset\n could\n not\n be\n exactly\n determined\n (n\n =\n 25).\n MMR\ndoses\n administered\n within\n 25\n days\n (one\n incubation\n period)\n prior\nto\n illness\n onset\n of\n the\n primary\n case\n were\n not\n counted,\n in\n order\n to\nexclude\n doses\n potentially\n administered\n post-exposure\n (n\n =\n 3).\n Non-\nsecondary\n cases\n with\n onset\n after\n 25\n days\n (n\n =\n 40)\n were\n classi\ufb01ed\n as\nnon-cases\n for\n the\n purpose\n of\n calculating\n SARs.", "mimetype": "text/plain", "start_char_idx": 10655, "end_char_idx": 12108, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1bc8405c-3491-4d7e-ab88-2560594cb44e": {"__data__": {"id_": "1bc8405c-3491-4d7e-ab88-2560594cb44e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0663c540-22b5-4e1d-9672-24c0e9a7ea5a", "node_type": "1", "metadata": {}, "hash": "0c96b4b9e5348aac49061cd8ab6b1d3b20575845c4cc2751de96f112e6bd3b1e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a7fe8a93-03bd-40df-a9eb-15d95aee6a5e", "node_type": "1", "metadata": {}, "hash": "fcfe634df7a1069893fe6b82c059d61370149bbcc7d75cb448ddc62eb97cc06e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Generalized\n estimating\n equations\n (GEE)\n were\n used\n to\n exam-\nine\n risk\n factors\n for\n mumps\n among\n non-primary\n cases\n and\n non-sick\nhousehold\n contacts.\n Risk\n factors\n examined\n were\n age\n group,\n num-\nber\n of\n MMR\n doses\n received,\n time\n from\n last\n MMR\n dose\n (years),\n and\nhousehold\n density.\n GEE\n were\n used\n to\n account\n for\n potential\n cor-\nrelation\n between\n household\n members\n [23].\n Covariates\n signi\ufb01cant\nat\n p\n <\n 0.2\n in\n a\n univariate\n analysis\n were\n included\n in\n a\n multivariate\nmodel.\n Stepwise\n regression\n was\n used\n to\n create\n the\n most\n parsimo-\nnious\n multivariate\n model\n by\n eliminating\n covariates\n not\n signi\ufb01cant\nat\n p\n <\n 0.05.\n Among\n the\n VE\n analysis\n cohort,\n GEE\n were\n similarly\n used\nto\n examine\n two-dose\n VE\n adjusted\n for\n age\n group,\n time\n from\n last\nMMR\n dose,\n and\n household\n density.\n All\n analyses\n were\n performed\nin\n SAS\n 9.2\n (SAS\n Institute,\n Cary,\n NC).\nData\n was\n collected\n as\n a\n part\n of\n routine\n public\n health\n surveillance\nand\n outbreak\n response\n conducted\n by\n NYC\n DOHMH,\n and\n household\ninformants\n were\n asked\n to\n verbally\n consent\n to\n answering\n additional\nquestions\n during\n follow-up\n phone\n interviews.\n3.\n Results\nFive-hundred-\ufb01fty-one\n cases\n of\n mumps\n residing\n in\n 473\n house-\nholds\n were\n identi\ufb01ed\n by\n DOHMH\n surveillance\n during\n the\n study\nperiod.\n Three-hundred-forty-six\n (73.2%)\n households\n completed\nfollow-up\n interviews\n between\n 78\n and\n 219\n days\n after\n illness\n onset\n of\nthe\n primary\n case\n in\n the\n household\n (Fig.\n 1).", "mimetype": "text/plain", "start_char_idx": 12109, "end_char_idx": 13632, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a7fe8a93-03bd-40df-a9eb-15d95aee6a5e": {"__data__": {"id_": "a7fe8a93-03bd-40df-a9eb-15d95aee6a5e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1bc8405c-3491-4d7e-ab88-2560594cb44e", "node_type": "1", "metadata": {}, "hash": "55acca52771cee3820a44176a503b8b4a8dca6ea53df54a77134230eefe65843", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1bead9d1-a802-4a72-9862-4a2447ebcdf4", "node_type": "1", "metadata": {}, "hash": "2a3f279ce66bd4b176adbf328c964d82bb5e404008326141e14dbe271ecab6cb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1).\n Three-hundred-eleven\nhouseholds\n (66%)\n containing\n 2176\n individuals\n were\n successfully\nreached\n for\n follow-up\n and\n met\n inclusion\n criteria.\nHouseholds\n had\n a\n median\n of\n 7\n (range\n 2\u201316)\n residents\n and\n 4\n(range\n 1\u20138)\n bedrooms.\n Median\n household\n density\n was\n 2\n people\n per\nbedroom\n (range\n 0.5\u201311.0).\n Median\n age\n of\n all\n household\n residents\nwas\n 13\n years\n [range\n 0\u201385,\n interquartile\n range\n = 15.0],\n with\n 33.8%\naged\n 10\u201319\n years\n and\n 16.7%\n under\n 5\n years.\nAmong\n all\n 2176\n household\n residents,\n 462\n met\n our\n de\ufb01nition\nof\n mumps\n resulting\n in\n an\n overall\n attack\n rate\n (AR)\n of\n 21.2%.\n ARs\nranged\n from\n 6.7%-100%\n per\n household.\n The\n mean\n number\n of\n cases\nK.A.\n Livingston\n et\n al.\n / Vaccine\n 32 (2014) 369\u2013\n 374\n371\n2,446 total people (cases + contacts) \nresiding in 346 households that were reachable at both \ninitial and fo llow-up interviews \n256 excluded because primary \ncase did not sleep in home  \n14 secondary contacts excluded \nbecause did not sleep in home  \n2,176 total people  \nresiding in 311 households  \n449 people excluded for age: \n     348 less than 5 years of age  \n     101 with unknown age  \n351 cases excluded: \n309 primary \n21 co-primary \n6 cases and 15 non-sick contacts \nin households where primary \ncase unable to be identified \n3 people excluded because MMR \nadministered \n \n\u226425 days before onset of \nprimary case \nTotal el\n \nigib\n \nle for VE study: 1,348 people \nVaccine effectiveness study sample \n25 people excluded because generation \nof spread unknown \nFig.\n 1.\n Household\n residents\n included\n in\n overall\n study\n sample\n and\n vaccine\n effectiveness\n study\n sample.", "mimetype": "text/plain", "start_char_idx": 13629, "end_char_idx": 15273, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1bead9d1-a802-4a72-9862-4a2447ebcdf4": {"__data__": {"id_": "1bead9d1-a802-4a72-9862-4a2447ebcdf4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a7fe8a93-03bd-40df-a9eb-15d95aee6a5e", "node_type": "1", "metadata": {}, "hash": "fcfe634df7a1069893fe6b82c059d61370149bbcc7d75cb448ddc62eb97cc06e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8658329d-3cd8-4ef2-a6a5-e74e0db692a5", "node_type": "1", "metadata": {}, "hash": "3414a676589a44de3a42ba1f25ec8e92ab8f0c0ee3449edc22215cf8da96e654", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1.\n Household\n residents\n included\n in\n overall\n study\n sample\n and\n vaccine\n effectiveness\n study\n sample.\nper\n household\n was\n 1.5\n (median\n =\n 1,\n range\n 1\u20137).\n Sixty-seven\n percent\nof\n all\n cases\n were\n primary,\n 4.5%\n were\n co-primary,\n 10%\n were\n sec-\nondary,\n 10%\n occurred\n later,\n and\n 8%\n had\n undetermined\n onset\n date.\nMedian\n age\n was\n 15\n years\n for\n primary\n cases,\n 14\n years\n for\n co-primary\ncases,\n and\n 15\n years\n for\n secondary\n cases.\n Over\n 95%\n of\n both\n primary\nand\n co-primary\n cases\n and\n 85.4%\n of\n secondary\n cases\n were\n reported\nvia\n surveillance\n and\n con\ufb01rmed\n by\n case\n investigation\n (Table\n 1).\nAmong\n all\n non-index\n cases,\n 47%\n had\n been\n previously\n identi\ufb01ed\nTable\n 1\nCharacteristics\n of\n individuals\n living\n in\n study\n households\n (n\n =\n 2176).\nTotal\n n\n (%)\n \nPrimary\ncases\n n\n (%)\nCo-primary\ncases\n n\n (%)\nCases\n with\nundetermined\nonset\n date\n n\n (%)\nSecondary\ncases\n n\n (%)\nLater\n onset\ncases\n n\n (%)\nHousehold\ncontacts\n without\nillness\n n\n (%)\nTotal\n \n2176\n (100.0)\n \n309\n (14.2)\n \n21\n (1.0)\n \n37\n (1.7)\n \n48\n (2.2)\n \n47\n (2.1)\n \n1714\n (78.8)\nVaccination\n statusa\n0\n dose\n \n134\n (6.2)\n \n12\n (3.9)\n \n3\n (14.3)\n \n2\n (5.4)\n \n5\n (10.4)\n \n4\n (8.5)\n \n108\n (6.3)\n1\n dose\n \n362\n (16.6)\n \n34\n (11.0)\n \n0 (0.0)\n \n4\n (10.8)\n \n6\n (12.5)\n \n9\n (19.", "mimetype": "text/plain", "start_char_idx": 15166, "end_char_idx": 16446, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8658329d-3cd8-4ef2-a6a5-e74e0db692a5": {"__data__": {"id_": "8658329d-3cd8-4ef2-a6a5-e74e0db692a5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1bead9d1-a802-4a72-9862-4a2447ebcdf4", "node_type": "1", "metadata": {}, "hash": "2a3f279ce66bd4b176adbf328c964d82bb5e404008326141e14dbe271ecab6cb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "de439c8d-f2de-4e3b-843f-d5f758469f39", "node_type": "1", "metadata": {}, "hash": "7ad3a7e6f0817f9fd0b063441038baef690324d7a15bae2502e6fdce27d879a6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3)\n1\n dose\n \n362\n (16.6)\n \n34\n (11.0)\n \n0 (0.0)\n \n4\n (10.8)\n \n6\n (12.5)\n \n9\n (19.2)\n \n309\n (18.0)\n2\n dose\n \n921\n (42.3)\n \n164\n (53.1)\n \n10\n (47.6)\n \n11\n (29.7)\n \n19\n (39.6)\n \n23\n (48.9)\n \n694\n (40.5)\nUnknown\n \n759\n (34.9)\n \n99\n (32.0)\n \n8\n (38.1)\n \n20\n (54.1)\n \n18\n (37.5)\n \n11\n (23.4)\n \n603\n (35.2)\nAge\n group\n (years)\n0\u20134\n \n363\n (16.7)\n \n12\n (3.9)\n \n1\n (4.8)\n \n8\n (21.6)\n \n4\n (8.3)\n \n6\n (12.8)\n \n332\n (19.4)\n5\u20139\n \n377\n (17.3)\n \n31\n (10.0)\n \n3\n (14.3)\n \n3\n (8.1)\n \n6\n (12.5)\n \n7\n (14.9)\n \n327\n (19.1)\n10\u201314\n \n410\n (18.8)\n \n87\n (28.2)\n \n8\n (38.1)\n \n4\n (10.8)\n \n12\n (25.0)\n \n17\n (36.2)\n \n282\n (16.5)\n15\u201319\n \n326\n (15.0)\n \n86\n (27.8)\n \n6\n (28.6)\n \n7\n (18.9)\n \n12\n (25.0)\n \n8\n (17.0)\n \n207\n (12.1)\n20+\n \n599\n (27.5)\n \n93\n (30.1)\n \n3\n (14.3)\n \n15\n (40.5)\n \n14\n (29.2)\n \n8\n (17.0)\n \n466\n (27.2)\nUnknown\n \n101\n (4.6)\n \n0 (0.0)\n \n0 (0.0)\n \n0\n (0.", "mimetype": "text/plain", "start_char_idx": 16365, "end_char_idx": 17204, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "de439c8d-f2de-4e3b-843f-d5f758469f39": {"__data__": {"id_": "de439c8d-f2de-4e3b-843f-d5f758469f39", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8658329d-3cd8-4ef2-a6a5-e74e0db692a5", "node_type": "1", "metadata": {}, "hash": "3414a676589a44de3a42ba1f25ec8e92ab8f0c0ee3449edc22215cf8da96e654", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "464b332b-ee09-455a-981f-a837a5f962b6", "node_type": "1", "metadata": {}, "hash": "b850dc20af43d2da683f17cfbffe9236d1f9fceef3335aa9794b4da47e582f7a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2)\n \n8\n (17.0)\n \n466\n (27.2)\nUnknown\n \n101\n (4.6)\n \n0 (0.0)\n \n0 (0.0)\n \n0\n (0.0)\n \n0\n (0.0)\n \n1\n (2.1)\n \n100\n (5.8)\nMedian\n (range)\n13\n (0\u201385)\n15\n (0\u201384)\n \n14\n (3\u201353)\n \n18\n (0\u201347)\n \n15\n (0\u201345)\n \n12\n (0\u201346)\n \n12\n (0\u201385)\nMean\n \u00b1\n std.devb\n17\n \u00b1\n 15\n \n19\n \u00b1\n 12\n \n15\n \u00b1\n 10\n \n19\n \u00b1\n 13\n \n19\n \u00b1\n 12\n \n15\n \u00b1\n 12\n \n17\n \u00b1\n 15\nMethod\n of\n report\n (n\n =\n 462\n cases)\nReported\n via\n surveillance\n \n386\n (83.5)\n \n304\n (98.4)\n \n20\n (95.2)\n \n3\n (8.1)\n \n41\n (85.4)\n \n18\n (38.3)\n \n0 (0.0)\nSelf-reported\n at\n follow-up\n \n76\n (16.5)\n \n5\n (1.6)\n \n1\n (4.8)\n \n34\n (91.9)\n \n7\n (14.6)\n \n29\n (61.7)\n \n0 (0.0)\na Only\n valid\n doses\n considered.\nb Standard\n deviation.\n372\nK.A.\n Livingston\n et\n al.\n / Vaccine\n 32 (2014) 369\u2013\n 374\nTable\n 2\nHousehold\n residents\n by\n vaccination\n status\n and\n age\n group\n (n\n =\n 2075).", "mimetype": "text/plain", "start_char_idx": 17126, "end_char_idx": 17917, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "464b332b-ee09-455a-981f-a837a5f962b6": {"__data__": {"id_": "464b332b-ee09-455a-981f-a837a5f962b6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "de439c8d-f2de-4e3b-843f-d5f758469f39", "node_type": "1", "metadata": {}, "hash": "7ad3a7e6f0817f9fd0b063441038baef690324d7a15bae2502e6fdce27d879a6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f4a29f19-582c-4ce8-aae9-882c95f979bd", "node_type": "1", "metadata": {}, "hash": "2e281b75514d00d3708175ede07d2b097b125668f6e08465bb217d674705eccd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "/ Vaccine\n 32 (2014) 369\u2013\n 374\nTable\n 2\nHousehold\n residents\n by\n vaccination\n status\n and\n age\n group\n (n\n =\n 2075).\nAge\n group\n (years)\n n\n (%)\nValid\n MMR\n doses\n \n<1\n \n1\u20133\n \n4\u20136\n \n7\u201312\n \n13\u201317\n \n18+\n \nTotal\n0\n \n64\n (92.8)\n \n38\n (17.0)\n \n6\n (2.8)\n \n10\n (2.2)\n \n8\n (1.9)\n \n6\n (0.9)\n \n132\n (6.4)\n1\n \n1\n (1.4)\n174\n (77.7)\n54\n (25.4)\n \n59\n (12.8)\n \n54\n (13.1)\n \n19\n (2.7)\n \n361\n (17.4)\n2\n \n0 (0.0)\n \n2\n (0.9)\n \n145\n (68.1)\n \n365\n (79.4)\n \n305\n (73.9)\n \n97\n (13.9)\n \n914\n (44.1)\nUnknown\n \n4\n (5.8)\n \n10\n (4.5)\n \n8\n (3.8)\n \n26\n (5.6)\n \n46\n (11.1)\n \n574\n (82.5)\n \n668\n (32.2)\nvia\n DOHMH\n surveillance,\n while\n 53%\n were\n identi\ufb01ed\n via\n follow-up\ninterview.\n Thirty-nine\n (12.5%)\n households\n had\n a\n secondary\n case.\nNon-primary\n cases\n with\n known\n onset\n occurred\n between\n 10\n and\n145\n days\n (median\n =\n 25\n days)\n after\n the\n onset\n of\n symptoms\n of\n the\nprimary\n case.\nAmong\n those\n in\n the\n study\n 7\u201317\n years\n of\n age,\n 89.7%\n had\n received\none\n or\n more\n doses\n of\n MMR\n vaccine\n with\n 76.7%\n receiving\n 2\n doses.", "mimetype": "text/plain", "start_char_idx": 17800, "end_char_idx": 18817, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f4a29f19-582c-4ce8-aae9-882c95f979bd": {"__data__": {"id_": "f4a29f19-582c-4ce8-aae9-882c95f979bd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "464b332b-ee09-455a-981f-a837a5f962b6", "node_type": "1", "metadata": {}, "hash": "b850dc20af43d2da683f17cfbffe9236d1f9fceef3335aa9794b4da47e582f7a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "76d1b04c-c3b1-4a78-bf19-a4df63a1c621", "node_type": "1", "metadata": {}, "hash": "ae4c8969ca62ed5ff7276316e1bd8d66bcdf446f23d7c9d85a80f6ed8fb71894", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Immunization\n history\n was\n not\n available\n for\n 6.8%\n of\n household\n resi-\ndents\n less\n than\n 18\n years\n of\n age\n and\n 82.5%\n of\n those\n 18\n years\n and\n older\n(Table\n 2).\nAmong\n 126\n non-primary\n cases,\n age\n group\n was\n the\n only\nsigni\ufb01cant\n risk\n factor\n for\n mumps.\n Household\n residents\n 10\u201314\nyears\n (OR\n =\n 2.4,\n 95%\n CI\n =\n 1.3\u20134.7)\n and\n 15\u201319\n years\n (OR\n =\n 2.5,\n 95%\nCI\n =\n 1.3\u20135.0)\n had\n the\n highest\n odds\n of\n mumps\n compared\n to\n the\nyoungest\n age\n group.\n Number\n of\n MMR\n doses\n (p\n =\n 0.856)\n and\n house-\nhold\n density\n (p\n =\n 0.495)\n were\n not\n signi\ufb01cantly\n associated\n with\nmumps\n illness\n in\n univariate\n models.\n Time\n from\n last\n MMR\n dose\nwas\n signi\ufb01cantly\n associated\n with\n illness\n in\n a\n univariate\n model\n (esti-\nmate\n \u00b1\n SE\n =\n 0.073\n \u00b1\n 0.021,\n p\n =\n 0.0007)\n but\n was\n no\n longer\n signi\ufb01cant\nwhen\n included\n in\n a\n multivariate\n model\n with\n age\n (p\n =\n 0.791).\nVE\n was\n assessed\n among\n 44\n secondary\n cases\n and\n 1304\n non-sick\nhousehold\n contacts.\n One\n and\n two-dose\n VE\n was\n 82.9%\n (CI\n 37.1\u201395.4)\nand\n 86.3%\n (CI\n 63.3\u201394.9),\n respectively.\n Individuals\n with\n unknown\nvaccination\n status\n experienced\n an\n 83.7%\n (55.9\u201393.9)\n reduction\n in\ndisease\n compared\n to\n unvaccinated\n individuals.", "mimetype": "text/plain", "start_char_idx": 18818, "end_char_idx": 20049, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "76d1b04c-c3b1-4a78-bf19-a4df63a1c621": {"__data__": {"id_": "76d1b04c-c3b1-4a78-bf19-a4df63a1c621", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f4a29f19-582c-4ce8-aae9-882c95f979bd", "node_type": "1", "metadata": {}, "hash": "2e281b75514d00d3708175ede07d2b097b125668f6e08465bb217d674705eccd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "314db8d3-38dc-45dd-8f6c-7184e251946e", "node_type": "1", "metadata": {}, "hash": "ffb83f2a7fe7cf76772a9877790d06edf1f55ab2e2b92667c4794e0ba4b345f7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Individuals\n with\n unknown\nvaccination\n status\n experienced\n an\n 83.7%\n (55.9\u201393.9)\n reduction\n in\ndisease\n compared\n to\n unvaccinated\n individuals.\n GEE\n modeling\n failed\nto\n show\n an\n effect\n of\n age,\n time\n from\n vaccination,\n or\n household\n den-\nsity\n on\n VE\n (Table\n 3).\n4.\n Discussion\nA  large\n outbreak\n of\n mumps\n provided\n an\n opportunity\n to\n assess\nmumps\n VE\n and\n explore\n reasons\n for\n outbreaks\n among\n vaccinated\npopulations.\n While\n a\n majority\n of\n cases\n were\n vaccinated,\n our\n esti-\nmate\n of\n two-dose\n VE\n of\n 86.3%\n supports\n the\n substantial\n bene\ufb01t\n of\nmumps\n vaccination.\nThe\n 45-year\n history\n of\n mumps\n vaccine\n has\n provided\n multiple\nopportunities\n to\n assess\n VE\n over\n time.\n The\n vaccine\n ef\ufb01cacy\n of\n mono-\nvalent\n mumps\n vaccine,\n measured\n shortly\n after\n administration,\n was\n95%\n in\n the\n initial\n clinical\n trial\n [24].\n One-dose\n VE\n estimates\n obtained\nin\n the\n United\n States\n from\n 1973\n to\n 1989\n ranged\n from\n 75%\n to\n 91%\n[25].\n Recent\n point\n estimates,\n obtained\n from\n 2005\n to\n 2010,\n have\nTable\n 3\nMumps\n vaccine\n effectiveness\n (VE)\n among\n secondary\n household\n contacts\n 5\n years\n of\nage\n and\n older\n by\n number\n of\n valid\n MMR\n doses\n (n\n =\n 1348).", "mimetype": "text/plain", "start_char_idx": 19901, "end_char_idx": 21104, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "314db8d3-38dc-45dd-8f6c-7184e251946e": {"__data__": {"id_": "314db8d3-38dc-45dd-8f6c-7184e251946e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "76d1b04c-c3b1-4a78-bf19-a4df63a1c621", "node_type": "1", "metadata": {}, "hash": "ae4c8969ca62ed5ff7276316e1bd8d66bcdf446f23d7c9d85a80f6ed8fb71894", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6fb635f7-767d-49e5-8312-d5ff88e5342e", "node_type": "1", "metadata": {}, "hash": "261df7255c6edb2b761944df58b5ea12d179954cb574843a4dfd06726d666dda", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Valid\n MMR\n doses\n \nSick\n \nNot\n sick\n \nTotal\n \nVE\n (95%\n CI)\n0\n \n4\n \n16\n \n20\n \n\u2013\n1\n \n4\n \n113\n \n117\n \n82.9\n (37.1\u201395.4)\n2a\n19\n \n672\n \n691\n \n86.3\n (63.3\u201394.9)\nUnknown\n \n17\n \n503\n \n520\n \n83.7\n (55.9\u201393.9)b\n> =\n 1\n \n23\n \n785\n \n808\n \n85.8\n (62.7\u201394.6)\na Adjusted\n for\n age\n category\n VE\n =\n 86.3\n (52.4\u201396.0),\n adjusted\n for\n household\n density\nVE\n =\n 86.3\n (52.4\u201396.0),\n adjusted\n for\n years\n from\n last\n MMR\n using\n 1\n dose\n as\n reference\ngroup\n VE\n =\n 12.8\n (0\u201369.6).\nb Reduction\n in\n disease\n in\n individuals\n with\n unknown\n vaccination\n status\n compared\nto\n unvaccinated.\nranged\n from\n 64%\n to\n 88%\n for\n one-dose\n VE\n and\n 83%\n to\n 92%\n for\n two-\ndose\n VE\n [10,13,26\u201329].\n Our\n estimates\n of\n one\n (82.9%)\n and\n two-dose\n(86.3%)\n VE\n are\n within\n the\n con\ufb01dence\n intervals\n of\n other\n published\nestimates\n obtained\n in\n both\n the\n United\n States\n and\n other\n countries\n[13,26\u201330].\n Some\n published\n literature\n has\n suggested\n that\n vaccine-\ninduced\n immunity\n may\n wane,\n for\n example\n due\n to\n less\n endemic\ndisease\n boosting\n immunity\n among\n vaccinated\n populations\n [13,31].\nHowever,\n our\n VE\n is\n in\n the\n range\n of\n published\n estimates,\n suggesting\nthat\n waning\n immunity\n was\n not\n likely\n driving\n the\n outbreak.\nLow\n MMR\n vaccination\n coverage\n alone\n could\n account\n for\n this\nmumps\n outbreak.", "mimetype": "text/plain", "start_char_idx": 21105, "end_char_idx": 22411, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6fb635f7-767d-49e5-8312-d5ff88e5342e": {"__data__": {"id_": "6fb635f7-767d-49e5-8312-d5ff88e5342e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "314db8d3-38dc-45dd-8f6c-7184e251946e", "node_type": "1", "metadata": {}, "hash": "ffb83f2a7fe7cf76772a9877790d06edf1f55ab2e2b92667c4794e0ba4b345f7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c21b6d4c-aca5-4d71-9b53-53789ddf4b5f", "node_type": "1", "metadata": {}, "hash": "20a068318501aec0cf9fdb31032c6e64b079fa926a12b1af0132329695970ba2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Low\n MMR\n vaccination\n coverage\n alone\n could\n account\n for\n this\nmumps\n outbreak.\n In\n addition,\n differences\n in\n coverage\n between\n the\naffected\n community\n and\n the\n surrounding\n population\n might\n account\nfor\n the\n limited\n transmission\n outside\n of\n the\n community,\n even\n in\n such\na\n densely\n populated\n urban\n area\n [14].\n Among\n those\n 13\u201317\n years\n of\nage\n in\n our\n study,\n 73.9%\n received\n two\n doses\n of\n MMR\n vaccine.\n By\n com-\nparison,\n results\n from\n the\n 2010\n National\n Immunization\n Survey\n show\nthat\n 94.5%\n (95%\n CI\n 90.6\u201396.8%)\n of\n adolescents\n 13\u201317\n years\n of\n age\nin\n NYC\n received\n 2\n or\n more\n doses\n of\n MMR\n [32].\n New\n York\n State\n law\nmandates\n at\n least\n one\n dose\n of\n mumps-containing\n vaccine\n for\n school\nattendance\n [33].\n Among\n NYC\u2019s\n approximately\n 1.1\n million\n public\nschool\n children,\n compliance\n with\n immunization\n requirements\n is\nhigh,\n with\n 98.8%\n being\n fully\n vaccinated\n by\n the\n end\n of\n the\n term\n in\n the\nlast\n several\n years\n (DOHMH\n internal\n data).\n However,\n most\n children\nin\n the\n Orthodox\n Jewish\n community\n attend\n private\n religious\n schools\nwhere\n compliance\n with\n immunization\n requirements\n appears\n to\n be\nlower.\nThe\n estimated\n herd\n immunity\n threshold\n for\n mumps\n vaccination\nis\n 75\u201386%\n [34].\n Mumps\n VE\n less\n than\n 90%\n combined\n with\n vaccina-\ntion\n coverage\n at\n the\n herd\n immunity\n threshold,\n speci\ufb01cally\n two-dose\ncoverage\n less\n than\n 80%\n among\n children\n and\n adolescents,\n could\n cre-\nate\n a\n synergy\n in\n which\n herd\n immunity\n was\n not\n adequate\n to\n prevent\ntransmission.", "mimetype": "text/plain", "start_char_idx": 22329, "end_char_idx": 23891, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c21b6d4c-aca5-4d71-9b53-53789ddf4b5f": {"__data__": {"id_": "c21b6d4c-aca5-4d71-9b53-53789ddf4b5f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6fb635f7-767d-49e5-8312-d5ff88e5342e", "node_type": "1", "metadata": {}, "hash": "261df7255c6edb2b761944df58b5ea12d179954cb574843a4dfd06726d666dda", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8b13f4bd-acab-44ab-a6ef-1d299a8052e2", "node_type": "1", "metadata": {}, "hash": "413e386cf293abb9299c4085fe45104d4246ea0d7af40773ca1e157a5db0be11", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Mathematical\n modeling\n has\n suggested\n that\n VE\n would\nneed\n to\n be\n >80%\n to\n prevent\n the\n transmission\n of\n mumps\n in\n a\n highly\nvaccinated\n population\n [35].\n While\n our\n estimates\n of\n VE\n are\n above\nthis\n theoretical\n threshold,\n estimates\n are\n very\n close\n to\n the\n thresh-\nold,\n and\n our\n con\ufb01dence\n intervals\n are\n broad\n suggesting\n that\n these\ntwo\n factors\n may\n have\n been\n suf\ufb01cient\n to\n account\n for\n our\n outbreak.\nOther\n factors\n have\n been\n proposed\n to\n explain\n the\n occurrence\n of\nmumps\n outbreaks.\n Serological\n and\n observational\n studies\n have\n sug-\ngested\n that\n mumps\n immunity\n may\n wane\n over\n time\n resulting\n in\ndiminished\n vaccine\n effectiveness\n [12,13,31,36\u201338],\n but\n no\n associ-\nation\n between\n time\n from\n vaccination\n and\n mumps\n was\n observed\n in\nour\n analysis.\n Diminished\n VE\n of\n MMR\n vaccine\n due\n to\n antigenic\n differ-\nences\n between\n the\n strains\n causing\n outbreaks\n and\n the\n vaccine\n strain\nhas\n also\n been\n proposed\n as\n a\n reason\n for\n occurrence\n of\n outbreaks\n [38].\nHowever,\n the\n mumps\n viruses\n associated\n with\n the\n outbreak\n were\nall\n genotype\n G.\n In\n a\n laboratory\n study,\n antibodies\n against\n the\n Jeryl\nLynn\n mumps\n virus\n vaccine\n strain\n effectively\n neutralized\n wild-type\ngenotype\n G\n virus\n [39].\nCrowding\n and\n intensity\n of\n exposure\n have\n also\n been\n proposed\nas\n risk\n factors\n for\n mumps\n transmission\n [11].\n Other\n factors\n relat-\ning\n to\n intensity\n of\n exposure,\n which\n we\n did\n not\n measure,\n may\nhave\n also\n played\n a\n role\n in\n driving\n this\n outbreak.\n We  did\n not\n\ufb01nd\n an\n association\n between\n household\n density\n and\n transmis-\nsion.", "mimetype": "text/plain", "start_char_idx": 23893, "end_char_idx": 25514, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8b13f4bd-acab-44ab-a6ef-1d299a8052e2": {"__data__": {"id_": "8b13f4bd-acab-44ab-a6ef-1d299a8052e2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c21b6d4c-aca5-4d71-9b53-53789ddf4b5f", "node_type": "1", "metadata": {}, "hash": "20a068318501aec0cf9fdb31032c6e64b079fa926a12b1af0132329695970ba2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8a00169c-2683-49a3-8669-ccb34c630ecb", "node_type": "1", "metadata": {}, "hash": "98d5eb5353d7fad96c08b76c834f1daf77a5ad6e85ec7bce8cc0caf4294c4083", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We  did\n not\n\ufb01nd\n an\n association\n between\n household\n density\n and\n transmis-\nsion.\n However,\n the\n communities\n affected\n by\n the\n outbreak\n engage\nin\n frequent\n gatherings\n among\n themselves\n for\n religious\n holidays\nK.A.\n Livingston\n et\n al.\n / Vaccine\n 32 (2014) 369\u2013\n 374\n373\nand\n celebrations\n that\n may\n have\n contributed\n to\n a\n higher\n inten-\nsity\n of\n exposure\n to\n mumps.\n In\n addition,\n the\n majority\n of\n children\nin\n these\n communities\n attend\n religious\n schools\n separated\n by\n gen-\nder.\n The\n schools\n are\n crowded,\n and\n children,\n especially\n adolescent\nboys,\n spend\n long\n hours\n studying\n in\n close\n contact.\n While\n inten-\nsity\n of\n exposure\n may\n have\n played\n some\n role\n in\n this\n outbreak,\n our\nhousehold\n study\n does\n not\n provide\n any\n evidence\n in\n support\n of\n this\nhypothesis.\nA\n number\n of\n limitations\n to\n our\n study\n should\n be\n considered\nwhen\n interpreting\n our\n \ufb01ndings.\n Among\n secondary\n cases,\n 15%\n were\nreported\n by\n the\n head-of-household.\n These\n cases\n were\n not\n con-\n\ufb01rmed\n by\n investigation\n or\n medical\n record\n review\n and\n may\n not\nhave\n ful\ufb01lled\n the\n CSTE\n case\n de\ufb01nition.\n The\n time\n between\n the\n index\ncase\n onset\n and\n the\n follow-up\n interview\n may\n have\n led\n to\n cases\nbeing\n missed\n due\n to\n poor\n recall.\n Vaccination\n coverage\n estimates\nare\n exclusive\n to\n households\n with\n known\n mumps\n disease,\n and\n cov-\nerage\n in\n the\n overall\n Orthodox\n Jewish\n community\n may\n differ.\n In\naddition,\n the\n study\n was\n conducted\n during\n a\n community-wide\n out-\nbreak,\n so\n exposure\n to\n mumps\n may\n have\n occurred\n in\n other\n settings\nbesides\n the\n home.", "mimetype": "text/plain", "start_char_idx": 25430, "end_char_idx": 27041, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8a00169c-2683-49a3-8669-ccb34c630ecb": {"__data__": {"id_": "8a00169c-2683-49a3-8669-ccb34c630ecb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8b13f4bd-acab-44ab-a6ef-1d299a8052e2", "node_type": "1", "metadata": {}, "hash": "413e386cf293abb9299c4085fe45104d4246ea0d7af40773ca1e157a5db0be11", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ffffe5fb-cda7-4cc3-9b0d-f5bf72d78cc8", "node_type": "1", "metadata": {}, "hash": "6e7d53afa95b3535b07a6d68e267447ed054f78a015532725ef59c2c390deb48", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We  did\n not\n investigate\n speci\ufb01c\n exposures\n dur-\ning\n religious\n holidays\n and\n community\n celebrations\n when\n members\nof\n the\n affected\n community\n may\n have\n had\n close\n contact.\n Further-\nmore,\n the\n de\ufb01nition\n of\n household\n density,\n based\n on\n number\n of\nbedrooms\n and\n total\n people,\n may\n not\n have\n been\n suf\ufb01ciently\n pre-\ncise\n to\n detect\n an\n effect.\n Our\n examination\n of\n mumps\n in\n relation\nto\n time\n from\n MMR\n may\n have\n been\n limited\n by\n little\n variability\n in\nthe\n number\n of\n years\n from\n last\n MMR\n dose.\n Most\n cases\n in\n the\n over-\nall\n outbreak\n were\n male,\n but\n the\n gender\n of\n mumps\n cases\n identi\ufb01ed\nat\n follow-up\n in\n this\n study\n was\n not\n ascertained\n [14].\n However,\n the\ngender\n difference\n in\n the\n overall\n outbreak\n may\n suggest\n that\n there\nwas\n not\n equal\n exposure\n to\n disease\n among\n all\n members\n of\n the\n study\nhouseholds.\nWith\n respect\n to\n vaccination\n status,\n we\n required\n documentation\nof\n vaccination,\n and\n those\n lacking\n documentation\n were\n classi\ufb01ed\nas\n unknown.\n Misclassi\ufb01cation\n of\n vaccinated\n and\n unvaccinated\n per-\nsons\n into\n the\n unknown\n group\n may\n have\n limited\n the\n precision\n of\n our\nVE\n estimate\n by\n excluding\n those\n who\n lacked\n documentation\n because\nthey\n had\n never\n been\n vaccinated,\n as\n well\n as\n decreased\n our\n estimate\nof\n the\n proportion\n of\n those\n who\n were\n fully\n vaccinated.\n However,\n the\nfact\n that\n individuals\n with\n unknown\n vaccination\n status\n experienced\nan\n 83.7%\n (55.9\u201393.9)\n reduction\n in\n disease\n suggests\n that\n they\n were\nlikely\n vaccinated.\nIn\n addition,\n this\n study\n only\n assessed\n VE\n for\n clinical\n disease.", "mimetype": "text/plain", "start_char_idx": 27043, "end_char_idx": 28666, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ffffe5fb-cda7-4cc3-9b0d-f5bf72d78cc8": {"__data__": {"id_": "ffffe5fb-cda7-4cc3-9b0d-f5bf72d78cc8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8a00169c-2683-49a3-8669-ccb34c630ecb", "node_type": "1", "metadata": {}, "hash": "98d5eb5353d7fad96c08b76c834f1daf77a5ad6e85ec7bce8cc0caf4294c4083", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a3d2ca21-81e4-46eb-a691-eec68d0f2358", "node_type": "1", "metadata": {}, "hash": "a396aebf4c78fa9a21f000739c8cae87a954043d53cd93e96eaf9dd100f1b8c3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In\n addition,\n this\n study\n only\n assessed\n VE\n for\n clinical\n disease.\n Given\nthat\n asymptomatic\n disease\n is\n common,\n our\n VE\n estimates\n may\n be\noverestimates\n with\n respect\n to\n MMR\n vaccine\n preventing\n infection.\nThere\n was\n not\n a\n signi\ufb01cant\n difference\n between\n our\n one-dose\n and\ntwo-dose\n mumps\n VE\n estimates;\n however,\n this\n may\n have\n been\n due\nto\n insuf\ufb01cient\n statistical\n power\n to\n detect\n any\n incremental\n increase\nin\n protection\n from\n a\n second\n dose.\n In\n spite\n of\n the\n limitations\n of\n our\nstudy,\n our\n results\n for\n one\n and\n two-dose\n VE\n were\n consistent\n with\nestimates\n previously\n described\n in\n the\n literature.\nWhile\n outbreaks\n of\n mumps\n have\n occurred\n in\n vaccinated\n popu-\nlations,\n mumps\n has\n declined\n dramatically\n since\n the\n introduction\nof\n mumps\n vaccination\n in\n the\n United\n States\n [2,4].\n In\n the\n US,\n high\nMMR\n vaccination\n coverage\n levels\n have\n been\n achieved;\n over\n 90%\nof\n adolescents\n have\n received\n two\n doses\n of\n MMR\n [32].\n The\n high\nmumps\n vaccination\n coverage\n in\n the\n broader\n NYC\n population\n may\nhave\n limited\n the\n scope\n of\n this\n outbreak.\n In\n order\n to\n achieve\n mumps\nelimination\n in\n the\n U.S.,\n a\n better\n understanding\n of\n factors\n leading\nto\n mumps\n outbreaks\n in\n vaccinated\n populations\n and\n measures\n to\ncontrol\n such\n outbreaks\n is\n required.\n Better\n measures\n of\n serologic\ncorrelates\n of\n mumps\n immunity\n and\n the\n impact\n of\n waning\n immunity\nneed\n to\n be\n explored.\n Promotion\n of\n mumps\n vaccination\n in\n accor-\ndance\n with\n recommendations\n from\n the\n Advisory\n Committee\n on\nImmunization\n Practices\n remains\n the\n most\n effective\n strategy\n for\ncontrolling\n mumps\n [40].", "mimetype": "text/plain", "start_char_idx": 28595, "end_char_idx": 30265, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a3d2ca21-81e4-46eb-a691-eec68d0f2358": {"__data__": {"id_": "a3d2ca21-81e4-46eb-a691-eec68d0f2358", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ffffe5fb-cda7-4cc3-9b0d-f5bf72d78cc8", "node_type": "1", "metadata": {}, "hash": "6e7d53afa95b3535b07a6d68e267447ed054f78a015532725ef59c2c390deb48", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dd4c0257-c3a8-4583-a27f-e4b20ca59e47", "node_type": "1", "metadata": {}, "hash": "b168c4ce21801a5611c3f40592037ce395543f197cd7ad30040e80cfe1181fb0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Acknowledgments\nThe\n authors\n would\n like\n to\n thank\n Mekete\n Asfaw,\n Luis\n Baez,\n and\nthe\n NYC\n DOHMH\n Vaccine-Preventable\n Disease\n Surveillance\n Unit\n for\ntheir\n assistance\n with\n data\n collection;\n Kisha\n Cummings\n and\n Mar-\ngaret\n Doll\n for\n their\n feedback;\n Carlos\n Espada,\n Richard\n Cumberbatch,\nand\n agents\n at\n the\n New\n York\n City\n Call\n Center\n for\n their\n assistance\n in\ncollecting\n follow-up\n data;\n Joseph\n Egger\n for\n consulting\n on\n data\n anal-\nyses;\n James\n Hadler\n and\n Gregory\n Armstrong\n for\n feedback\n on\n study\ndesign\n and\n analyses.\nContributors:\n All\n authors\n contributed\n to\n the\n conception\n and\ndesign\n of\n the\n study,\n analysis\n design,\n and\n interpretation\n of\n data;\n KAL\nperformed\n the\n statistical\n analysis\n and\n drafted\n the\n manuscript;\n all\nauthors\n were\n involved\n in\n critical\n revision\n and\n had\n \ufb01nal\n approval\n of\nthe\n manuscript.\n Con\ufb02ict\n of\n interest\n statement:\n The\n authors\n declare\nno\n con\ufb02icts\n of\n interest.\n Funding:\n This\n work\n was\n supported\n in\n part\n by\nan\n appointment\n to\n the\n Applied\n Epidemiology\n Fellowship\n Program\nadministered\n by\n the\n Council\n of\n State\n and\n Territorial\n Epidemiologists\n(CSTE)\n and\n funded\n by\n the\n Centers\n for\n Disease\n Control\n and\n Preven-\ntion\n (CDC)\n [Cooperative\n Agreement\n Number\n 5U38HM000414].\nReferences\n[1]\n Centers\n for\n Disease\n Control\n and\n Prevention.\n Manual\n for\n the\n surveillance\n of\nvaccine-preventable\n diseases.\n Atlanta,\n GA:\n Centers\n for\n Disease\n Control\n and\nPrevention;\n 2008.\n[2]\n Centers\n for\n Disease\n Control\n and\n Prevention.\n Mumps\n Epidemic\n \u2013\n Iowa,\n 2006.\nMMWR\n Morb\n Mortal\n Wkly\n Rep\n 2006;55:1\u20133.", "mimetype": "text/plain", "start_char_idx": 30266, "end_char_idx": 31894, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dd4c0257-c3a8-4583-a27f-e4b20ca59e47": {"__data__": {"id_": "dd4c0257-c3a8-4583-a27f-e4b20ca59e47", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a3d2ca21-81e4-46eb-a691-eec68d0f2358", "node_type": "1", "metadata": {}, "hash": "a396aebf4c78fa9a21f000739c8cae87a954043d53cd93e96eaf9dd100f1b8c3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "96f9758a-c81d-4b4e-84e6-ada94e519d00", "node_type": "1", "metadata": {}, "hash": "4760b7a7582d0eefc4121362c48ac709ce8159d3d35152ae3288d15849716fe1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Mumps\n Epidemic\n \u2013\n Iowa,\n 2006.\nMMWR\n Morb\n Mortal\n Wkly\n Rep\n 2006;55:1\u20133.\n[3]\n Hviid\n A,\n Rubin\n S,\n Muhlemann\n K.\n Mumps.\n Lancet\n 2008;371:932\u201344.\n[4]\n Centers\n for\n Disease\n Control\n and\n Prevention.\n Current\n trends\n mumps\n \u2013\n United\nStates,\n 1985\u20131988.\n MMWR\n Morb\n Mortal\n Wkly\n Rep\n 1989;38:101\u20135.\n[5]\n Centers\n for\n Disease\n Control\n and\n Prevention.\n Achievements\n in\n public\n health,\n1900\u20131999:\n impact\n of\n vaccines\n universally\n recommended\n for\n children\n \u2013\n United\nStates,\n 1990\u20131998.\n MMWR\n Morb\n Mortal\n Wkly\n Rep\n 1999;48:243\u20138.\n[6]\n Dayan\n GH,\n Quinlisk\n MP,\n Parker\n AA,\n Barskey\n AE,\n Harris\n ML,\n Schwartz\n JMH,\net\n al.\n Recent\n resurgence\n of\n mumps\n in\n the\n United\n States.\n N\n Engl\n J Med\n2008;358:1580\u20139.\n[7]\n Prevention\n of\n measles,\n rubella,\n congenital\n rubella\n syndrome,\n and\n mumps,\n 2013:\nsummary\n recommendations\n of\n the\n Advisory\n Committee\n on\n Immunization\n Prac-\ntices\n (ACIP).\n MMWR\n Morb\n Mortal\n Wkly\n Rep\n 2013;62(4):1\u201334.\n[8]\n Barskey\n AE,\n Glasser\n JW,\n LeBaron\n CW.\n Mumps\n resurgences\n in\n the\n United\n States:\na\n historical\n perspective\n on\n unexpected\n elements.\n Vaccine\n 2009;27:6186\u201395.\n[9]\n Carde\u02dcnosa\n N,\n Dom\u00b4\u0131nguez\n A,\n Camps\n N,\n Mart\u00b4\u0131nez\n A,\n Torner\n N,\n Navas\n E,\n et\n al.\n Non-\npreventable\n mumps\n outbreaks\n in\n schoolchildren\n in\n Catalonia.", "mimetype": "text/plain", "start_char_idx": 31818, "end_char_idx": 33126, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "96f9758a-c81d-4b4e-84e6-ada94e519d00": {"__data__": {"id_": "96f9758a-c81d-4b4e-84e6-ada94e519d00", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dd4c0257-c3a8-4583-a27f-e4b20ca59e47", "node_type": "1", "metadata": {}, "hash": "b168c4ce21801a5611c3f40592037ce395543f197cd7ad30040e80cfe1181fb0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2efc6e76-ad95-42f7-9cd1-c7cf9659a411", "node_type": "1", "metadata": {}, "hash": "2ce1555883449b9a2c4caa9a9b99a0770d6451edbf1adb4646deb01ad3917ace", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Non-\npreventable\n mumps\n outbreaks\n in\n schoolchildren\n in\n Catalonia.\n Scand\n J\n Infect\n Dis\n2006;38:671\u20134.\n[10]\n Castilla\n J,\n Cenoz\n MG,\n Arriazu\n M,  Fern\u00b4andez-Alonso\n M,  Mart\u00b4\u0131nez-Artola\n V,\n Etxe-\nberria\n J,\n et\n al.\n Effectiveness\n of\n Jeryl\n Lynn-containing\n vaccine\n in\n Spanish\n children.\nVaccine\n 2009;27:2089\u201393.\n[11]\n Quinlisk\n PM.\n Mumps\n control\n today.\n J Infect\n Dis\n 2010;202:655\u20136.\n[12]\n Levine\n H,\n Ankol\n OE,\n Rozhavski\n V,\n Davidovitch\n N,\n Aboudy\n Y,\n Zarka\n S,\n et\n al.\n Sub-\noptimal\n prevalence\n of\n mumps\n antibodies\n in\n a population\n based\n study\n of\n young\nadults\n in\n Israel\n after\n 20\n years\n of\n two\n dose\n universal\n vaccination\n policy.\n Vaccine\n2011;29:2785\u201390.\n[13]\n Cohen\n C,\n White\n JM,\n Savage\n EJ,\n Glynn\n JR,\n Choi\n Y,\n Andrews\n N,\n et\n al.\n Vaccine\n effec-\ntiveness\n estimates,\n 2004\u20132005\n mumps\n outbreak,\n England.\n Emerg\n Infect\n Dis\n2007;13:12\u20137.\n[14]\n Centers\n for\n Disease\n Control\n and\n Prevention.\n Mumps\n outbreak\n \u2013\n New\n York,\n New\nJersey,\n Quebec,\n 2009.\n MMWR\n Morb\n Mortal\n Wkly\n Rep\n 2009;58:1\u20135.\n[15]\n Barskey\n AE,\n Schulte\n C,\n Rosen\n JB,\n Handschur\n EF,\n Rausch-Phung\n E,\n Doll\n MK,\n et\n al.\nMumps\n outbreak\n in\n Orthodox\n Jewish\n communities\n in\n the\n United\n States.\n N\n Engl\nJ\n Med\n 2012;367(18):1704\u201313.\n[16]\n Council\n for\n State\n and\n Territorial\n Epidemiologists.", "mimetype": "text/plain", "start_char_idx": 33056, "end_char_idx": 34387, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2efc6e76-ad95-42f7-9cd1-c7cf9659a411": {"__data__": {"id_": "2efc6e76-ad95-42f7-9cd1-c7cf9659a411", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "96f9758a-c81d-4b4e-84e6-ada94e519d00", "node_type": "1", "metadata": {}, "hash": "4760b7a7582d0eefc4121362c48ac709ce8159d3d35152ae3288d15849716fe1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f3e1433f-f9c2-4509-acc4-603639271d03", "node_type": "1", "metadata": {}, "hash": "56ab52c02bb5bde20b645428290952480b82e93176bf2fd8797a6f5f627a84cc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "N\n Engl\nJ\n Med\n 2012;367(18):1704\u201313.\n[16]\n Council\n for\n State\n and\n Territorial\n Epidemiologists.\n Revision\n of\n the\n surveillance\ncase\n de\ufb01nition\n for\n mumps.\n Position\n Statement\n 2007;\n 2013.\n Available\n at:\nhttp://www.cste.org/dnn/AnnualConference/PositionStatements/tabid/191/\nDefault.aspx\n [accessed\n 04.10.12].\n[17]\n Nguyen\n TQ,\n Thorpe\n L,\n Makki\n HA,\n Mostashari\n F.\n Bene\ufb01ts\n and\n barriers\n to\n elec-\ntronic\n laboratory\n results\n reporting\n for\n noti\ufb01able\n diseases:\n the\n New\n York\n City\nDepartment\n of\n Health\n and\n Mental\n Hygiene\n experience.\n Am\n J\n Public\n Health\n2007;97(S1):S142\u20135.\n[18]\n Metroka\n AE,\n Hansen\n MA,\n Papadouka\n V,\n Zucker\n JR.\n Using\n an\n immunization\n infor-\nmation\n system\n to\n improve\n accountability\n for\n vaccines\n distributed\n through\n the\nvaccines\n for\n children\n program\n in\n New\n York\n City,\n 2005\u20132008.\n J Public\n Health\nManag\n 2009;15:E13\u201321.\n[19]\n New\n York\n City\n Department\n of\n Health\n and\n Mental\n Hygiene.\n Immunization\n Infor-\nmation\n System\n Annual\n Report\n 2012.\n Atlanta,\n GA:\n Program\n Operations\n Branch,\nImmunization\n Services\n Division,\n Centers\n for\n Disease\n Control\n and\n Prevention;\n2013.\n[20]\n New\n York\n City\n Department\n of\n Health\n and\n Mental\n Hygiene.\n Immunization\n Infor-\nmation\n System\n Annual\n Report\n 2009.\n Atlanta,\n GA:\n Program\n Operations\n Branch,\n374\nK.A.\n Livingston\n et\n al.\n / Vaccine\n 32 (2014) 369\u2013\n 374\nImmunization\n Services\n Division,\n Centers\n for\n Disease\n Control\n and\n Prevention;\n2010.", "mimetype": "text/plain", "start_char_idx": 34288, "end_char_idx": 35766, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f3e1433f-f9c2-4509-acc4-603639271d03": {"__data__": {"id_": "f3e1433f-f9c2-4509-acc4-603639271d03", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2efc6e76-ad95-42f7-9cd1-c7cf9659a411", "node_type": "1", "metadata": {}, "hash": "2ce1555883449b9a2c4caa9a9b99a0770d6451edbf1adb4646deb01ad3917ace", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d2963986-3c37-45e4-a0b3-c80e3177ce6b", "node_type": "1", "metadata": {}, "hash": "331a3ca3d12c4913b572a79d1a0bb61a93e4334266e8264d0debc506c1f1db0c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Livingston\n et\n al.\n / Vaccine\n 32 (2014) 369\u2013\n 374\nImmunization\n Services\n Division,\n Centers\n for\n Disease\n Control\n and\n Prevention;\n2010.\n[21]\n Orenstein\n WA,\n Bernier\n RH,\n Dondero\n TJ,\n Hinman\n AR,\n Marks\n JS,\n Bart\n KJ,\net\n al.\n Field\n evaluation\n of\n vaccine\n ef\ufb01cacy.\n Bull\n World\n Health\n Organ\n 1985;63:\n1055\u201368.\n[22]\n Harris\n RW,\n Turnbull\n CD,\n Isacson\n P,\n Karzon\n DT,\n Winkelstein\n Jr\n W.\n Mumps\n in\n a\nnortheast\n metropolitan\n community.\n Am\n J Epidemiol\n 1968;88:224\u201333.\n[23]\n Allison\n PD.\n Logistic\n regression\n using\n the\n SAS\n system:\n theory\n and\n application.\nCary,\n NC:\n SAS\n Institute\n Incorporate;\n 1999.\n[24]\n Hilleman\n MR,\n Buynak\n EB,\n Weibel\n RE,\n Stokes\n J.\n Live,\n attenuated\n mumps-virus\nvaccine.  N\n Engl\n J\n Med\n 1968;278:227\u201332.\n[25]\n Atkinson\n W,  Wolfe\n S,\n Hamborsky\n J,\n McIntyre\n L,\n editors.\n Centers\n for\n Disease\nControl\n and\n Prevention.\n Epidemiology\n and\n prevention\n of\n vaccine-preventable\ndiseases.\n 11th\n ed.\n Washington\n DC:\n Public\n Health\n Foundation;\n 2009.\n[26]\n Marin\n M,  Quinlisk\n P,\n Shimabukuro\n T,\n Sawhney\n C,\n Brown\n C,\n Lebaron\n CW.\n Mumps\nvaccination\n coverage\n and\n vaccine\n effectiveness\n in\n a\n large\n outbreak\n among\n col-\nlege\n students\n \u2013\n Iowa,\n 2006.\n Vaccine\n 2008;26:3601\u20137.", "mimetype": "text/plain", "start_char_idx": 35625, "end_char_idx": 36874, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d2963986-3c37-45e4-a0b3-c80e3177ce6b": {"__data__": {"id_": "d2963986-3c37-45e4-a0b3-c80e3177ce6b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f3e1433f-f9c2-4509-acc4-603639271d03", "node_type": "1", "metadata": {}, "hash": "56ab52c02bb5bde20b645428290952480b82e93176bf2fd8797a6f5f627a84cc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ff371d50-0bf7-462d-9011-71e5c1fbbdc9", "node_type": "1", "metadata": {}, "hash": "d3426395b5986414c1703c8f509b7b03833f5f738dc4a382fd89f17726faad9d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine\n 2008;26:3601\u20137.\n[27]\n Harling\n R,\n White\n JM,\n Ramsay\n ME,\n Macsween\n KF,\n van\n den\n Bosch\n C.\n The\n effec-\ntiveness\n of\n the\n mumps\n component\n of\n the\n MMR\n vaccine:\n a\n case\n control\n study.\nVaccine\n 2005;23(31):4070\u20134.\n[28]\n Schaffzin\n JK,\n Pollock\n L,\n Schulte\n C,\n Henry\n K,\n Dayan\n G,\n Blog\n D,\n et\n al.\n Effectiveness\nof\n previous\n mumps\n vaccination\n during\n a\n summer\n camp\n outbreak.\n Pediatrics\n2007;120:862\u20138.\n[29]\n Dom\u00b4\u0131nguez\n A,\n Torner\n N,\n Castilla\n J,\n Batalla\n J,\n Godoy\n P,\n Guevara\n M,  et\n al.\nMumps\n vaccine\n effectiveness\n in\n highly\n immunized\n populations.\n Vaccine\n2010;28:3567\u201370.\n[30]\n Lopez\n Hernandez\n B,\n Martin\n Velez\n RM,\n Roman\n Garcia\n C,\n Sanchez\n Penalver\n I,\nLopez\n Rosique\n JA.\n An\n epidemic\n outbreak\n of\n mumps.\n A\n study\n of\n vaccinal\n ef\ufb01cacy.\nAten\n Primaria\n 2000;25(3):148\u201352,\n 27.\n[31]\n Cortese\n MM,\n Jordan\n HT,\n Curns\n AT,\n Quinlan\n PA,\n Ens\n KA,\n Denning\n PM,\n et\n al.\n Mumps\nvaccine\n performance\n among\n university\n students\n during\n a\n mumps\n outbreak.\nClin\n Infect\n Dis\n 2008;46:1172\u201380.\n[32]\n Centers\n for\n Disease\n Control\n and\n Prevention.\n Statistics\n and\n surveillance:\n2010 \nNIS-Teen\n \nVaccination\n \nCoverage\n \nTable\n \nData;\n \n2013.\n \nAvailable\n \nat:\nhttp://www.cdc.gov/vaccines/stats-surv/nisteen/data/tables\n 2010.htm\n[accessed\n 06.12.11].", "mimetype": "text/plain", "start_char_idx": 36850, "end_char_idx": 38159, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ff371d50-0bf7-462d-9011-71e5c1fbbdc9": {"__data__": {"id_": "ff371d50-0bf7-462d-9011-71e5c1fbbdc9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d2963986-3c37-45e4-a0b3-c80e3177ce6b", "node_type": "1", "metadata": {}, "hash": "331a3ca3d12c4913b572a79d1a0bb61a93e4334266e8264d0debc506c1f1db0c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e60a2f6a-89d9-47fc-bf46-43338d19b50b", "node_type": "1", "metadata": {}, "hash": "111096cd191bff4b0a386a3bd289d826f5a03aafdd23d67e1665e181a4a1be74", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Available\n \nat:\nhttp://www.cdc.gov/vaccines/stats-surv/nisteen/data/tables\n 2010.htm\n[accessed\n 06.12.11].\n[33]\n Available\n \nat:\n \nhttp://public.leginfo.state.ny.us/LAWSSEAF.cgi?QUERYTYPE=\nLAWS+&QUERYDATA=$$PBH2164$$@TXPBH02164+&LIST=LAW+\n&BROWSER=BROWSER+&TOKEN=04771095+&TARGET=VIEW\n \n[accessed\n20.12.11]\n New\n York\n State.\n Laws\n of\n New\n York.\n Public\n Health\n Law:\n Article\n 21,\nTitle\n 6,\n Law\n \u00a72164;\n 2013.\n[34]\n Fine\n PM.\n Community\n immunity.\n In:\n Vaccines.\n 4th\n ed.\n Philadelphia,\n PA:\n Elsevier;\n2004.\n p.\n 1443\u201361.\n[35]\n Anderson\n RM,\n May\n RM.\n Vaccination\n and\n herd\n immunity\n to\n infectious\n diseases.\nNature\n 1985;318:323\u20139.\n[36]\n Briss\n PA,\n Fehrs\n LJ,\n Parker\n RA,\n Wright\n PF,\n Sannella\n EC,\n Hutcheson\n RH,\n et\n al.\n Sus-\ntained\n transmission\n of\n mumps\n in\n a\n highly\n vaccinated\n population:\n assessment\nof\n primary\n vaccine\n failure\n and\n waning\n vaccine-induced\n immunity.\n J\n Infect\n Dis\n1994;169:77\u201382.\n[37]\n Nojd\n J,\n Tecle\n T,\n Samuelsson\n A,\n Orvell\n C.\n Mumps\n virus\n neutralizing\n antibodies\ndo\n not\n protect\n against\n reinfection\n with\n a\n heterologous\n mumps\n virus\n genotype.\nVaccine\n 2001;19:1727\u201331.\n[38]\n Date\n AA,\n Kyaw\n MH,\n Rue\n AM,\n Klahn\n J, Obrecht\n L,\n Krohn\n T,\n et\n al.", "mimetype": "text/plain", "start_char_idx": 38053, "end_char_idx": 39271, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e60a2f6a-89d9-47fc-bf46-43338d19b50b": {"__data__": {"id_": "e60a2f6a-89d9-47fc-bf46-43338d19b50b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Livingston (2013).pdf", "node_type": "4", "metadata": {}, "hash": "9fd62e0f4c221a3d044772f6b99dfc07ebe77b92b0bf7ab184373025b2694405", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ff371d50-0bf7-462d-9011-71e5c1fbbdc9", "node_type": "1", "metadata": {}, "hash": "d3426395b5986414c1703c8f509b7b03833f5f738dc4a382fd89f17726faad9d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "[38]\n Date\n AA,\n Kyaw\n MH,\n Rue\n AM,\n Klahn\n J, Obrecht\n L,\n Krohn\n T,\n et\n al.\n Long-term\n per-\nsistence\n of\n mumps\n antibody\n after\n receipt\n of\n 2\n Measles-Mumps-Rubella\n (MMR)\nvaccinations\n and\n antibody\n response\n after\n a third\n MMR\n vaccination\n among\n a\nuniversity\n population.\n J\n Infect\n Dis\n 2008;197:1662\u20138.\n[39]\n Rubin\n SA,\n Qi\n L,\n Audet\n SA,\n Sullivan\n B,\n Carbone\n KM,\n Bellini\n WJ,\n et\n al.\nAntibody\n induced\n by\n immunization\n with\n the\n Jeryl\n Lynn\n mumps\n vac-\ncine\n \nstrain\n \neffectively\n \nneutralizes\n \na\n \nheterologous\n \nwild-type\n \nmumps\nvirus\n \nassociated\n \nwith\n \na\n \nlarge\n \noutbreak.\n \nJ \nInfect\n \nDis\n \n2008;198:\n508\u201315.\n[40]\n Centers\n for\n Disease\n Control\n and\n Prevention.\n Measles\n prevention:\n recommenda-\ntions\n of\n the\n immunization\n practices\n advisory\n committee\n (ACIP).\n MMWR\n Morb\nMortal\n Wkly\n Rep\n 1989;38(S-9):1\u201318.", "mimetype": "text/plain", "start_char_idx": 39192, "end_char_idx": 40051, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b2669964-82f2-4fa7-8359-92ba8691f651": {"__data__": {"id_": "b2669964-82f2-4fa7-8359-92ba8691f651", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Freeman (1993).pdf", "node_type": "4", "metadata": {}, "hash": "0966563a8070e16d9e85a565d3f0b68a3cacfadcc0c13eac515c817af23df087", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b9467b42-bfd2-498f-a1c4-d177f294e63f", "node_type": "1", "metadata": {}, "hash": "68346f9bd4060e9f1adc9f366fcff23889ee37487def0d0042deed014ebe9e48", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ORIGINAL RESEARCH * NOUVEAUTES EN RECHERCHE\nIllness after measles-mumps-rubella vaccination\nThomas R. Freeman, MD, CCFP; Moira A. Stewart, PhD; Linda Turner, MEd\nObjectives: To provide accurate information on the common sequelae of measles-mumps-\nrubella (MMR) vaccination and to compare postvaccine symptoms in children vaccinated\nat 13 and 15 months.\nDesign: Prospective cluster randomized controlled trial.\nSetting: Twenty-two family practices in southwestem Ontario.\nPatients: All 376 infants who were due to receive MMR vaccine in the next year; 253\n(67.3%) successfully completed the study.\nIntervention: MMR vaccine administered at 13 months by half of the family physicians and\nat 15 months by the remaining half.\nOutcome measures: Family physician's physical findings in children 7 days and 30 days af-\nter vaccine; reported illnesses by mothers in a daily diary in the month before and after vacci-\nnation and medical records of visits to family physicians and hospital admissions in the\nmonth before and after vaccination.\nResults: Compared with the incidence rates in the corresponding weeks before vaccination,\nthe rates of lymphadenopathy (23.8%) and fever (16.8%) were higher 1 week afterward and\nthe rate of rash (26.9%) was higher 7 to 14 days afterward. Fewer health problems were re-\nported in the third and fourth weeks after vaccination than in the corresponding weeks be-\nforehand. Hospital admissions after vaccination were no more frequent than those before\nonce cause and time of admission were taken into account. The two age groups did not differ\nin any of the outcomes.\nConclusions: Mothers should be informed about the possibility of increased physical find-\nings in the weeks after MMR vaccination, especially lymphadenopathy, nasal discharge and\nrash. Since the occurrence of sequelae does not seem to differ significantly between 13-\nmonth-old recipients and 15-month-old recipients, it should not influence the decision of\nwhen to administer the vaccine.\nObjectifs: Renseigner de facon precise sur les suites courantes de la vaccination rou-\ngeole-oreillons-rubeole (ROR) et comparer les sympt6mes apres la vaccination chez les en-\nfants vaccines 'a 13 et a 15 mois.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2199, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b9467b42-bfd2-498f-a1c4-d177f294e63f": {"__data__": {"id_": "b9467b42-bfd2-498f-a1c4-d177f294e63f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Freeman (1993).pdf", "node_type": "4", "metadata": {}, "hash": "0966563a8070e16d9e85a565d3f0b68a3cacfadcc0c13eac515c817af23df087", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b2669964-82f2-4fa7-8359-92ba8691f651", "node_type": "1", "metadata": {}, "hash": "c0d20f23a91126045669f27da5ee1ecc57bcd8795fabf575becb780b76c8a856", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b8d1b3af-00d3-447a-9f98-a02df4a064de", "node_type": "1", "metadata": {}, "hash": "081410a7efba9186d411734e2b463d81162420293899d5a7aacf4748cce6d21f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Conception : Etude clinique prospective randomisee et contr6lee et en grappes.\nContexte: Vingt-deux cliniques de m6decine familiale du sud-ouest de l'Ontario.\nPatients: Les 376 enfants qui devaient recevoir leur vaccin ROR au cours de l'annee;\n1'etude complete a porte sur 253 (67,3 %) des sujets.\nIntervention: La moitie des medecins a administre le vaccin ROR 'a 13 mois et l'autre 'a 15\nmois.\nMesures des resultats: Symptomes physiques observes par les medecins de famille chez les\nenfants de 7 a 30 jours apres la vaccination; maladies notees par les meres dans un carnet, sur\nune periode allant d'un mois avant a un mois apres la vaccination, et visites au medecin de\nfamille et admissions hospitalieres consignees aux dossiers medicaux pour la meme periode.\nResultats: Par comparaison avec le taux d'incidence au cours des semaines correspondantes\nFrom the departments ofFamilv Medicine and ofEpidemiology and Biostatistics, University of Western Ontario, London, Ont.\nReprint requests to: Dr. Thomas R. Freeman, Byron Fanmily Medical Centre, 1228 Commissioner Rd. W, London, ON N6K IC7\n<-- For prescribing information see page 1732\nCAN MED ASSOC J 1993,149 (I 1)\n1669\nprecedant la vaccination, on a constate une augmentation d'adenopathie (22,5 %) et de fievre\n(16,8 %) une semaine apres, et de d'eruptions cutanees (26,9 %) de 7 'a 14 jours apres. On a\nsignale moins de problemes de sante au cours des troisieme et quatrieme semaines apres la\nvaccination qu'au cours des semaines correspondantes avant la vaccination. Il n'y avait pas\nplus d'admissions hospitalieres apres qu'avant la vaccination, une fois pris en compte les\ncauses et le moment de l'admission.", "mimetype": "text/plain", "start_char_idx": 2200, "end_char_idx": 3869, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b8d1b3af-00d3-447a-9f98-a02df4a064de": {"__data__": {"id_": "b8d1b3af-00d3-447a-9f98-a02df4a064de", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Freeman (1993).pdf", "node_type": "4", "metadata": {}, "hash": "0966563a8070e16d9e85a565d3f0b68a3cacfadcc0c13eac515c817af23df087", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b9467b42-bfd2-498f-a1c4-d177f294e63f", "node_type": "1", "metadata": {}, "hash": "68346f9bd4060e9f1adc9f366fcff23889ee37487def0d0042deed014ebe9e48", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "25390829-26cf-4cec-9bb3-5907124d5284", "node_type": "1", "metadata": {}, "hash": "73fdc21cf676b1b6e26f9a411c4971ad538489e39fc2da44ce35bc03a1f78651", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Il n'y avait pas\nplus d'admissions hospitalieres apres qu'avant la vaccination, une fois pris en compte les\ncauses et le moment de l'admission. I1 n'y avait pas de diff6rence de resultats entre les deux\ngroupes d'age.\nConclusions: On devrait informer les meres de la possibilite que des symptomes physiques\nse manifestent en plus grand nombre pendant les semaines suivant la vaccination ROR, parti-\nculierement l'adenopathie, l'ecoulement nasal et les eruptions cutanees. L'age ne devrait pas\ninfluencer la decision de vacciner, puisqu'il ne semble pas y avoir de difference symptoma-\ntique sensible chez les receveurs de 13 et de 15 mois.\nT\nhere has been a significant increase in the number\nof measles outbreaks in the United States and\nCanada over the past 10 years.',2 This may be due\nto inadequate vaccination coverage, an issue causing\nconsiderable concern,3 or to the improper timing of vac-\ncination. Recommendations that guidelines be developed\nfor health care professionals have been made so that in-\nformation on the measles-mumps-rubella (MMR) vac-\ncine, with its concomitant risks and benefits, can be\nprovided to patients or their parents.4'5 However, the\ncommon sequelae of MMR vaccination are not well\nknown and may lead to unnecessary treatment.6\nThe purpose of this study was to (a) provide accu-\nrate information on the common sequelae of MMR vac-\ncination and (b) compare postvaccine symptoms in\nchildren vaccinated at 13 and 15 months.", "mimetype": "text/plain", "start_char_idx": 3726, "end_char_idx": 5182, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "25390829-26cf-4cec-9bb3-5907124d5284": {"__data__": {"id_": "25390829-26cf-4cec-9bb3-5907124d5284", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Freeman (1993).pdf", "node_type": "4", "metadata": {}, "hash": "0966563a8070e16d9e85a565d3f0b68a3cacfadcc0c13eac515c817af23df087", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b8d1b3af-00d3-447a-9f98-a02df4a064de", "node_type": "1", "metadata": {}, "hash": "081410a7efba9186d411734e2b463d81162420293899d5a7aacf4748cce6d21f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "26db15ea-7b22-4151-a16c-2b1fc55921b7", "node_type": "1", "metadata": {}, "hash": "17246f1a0bc5e472057dc8fb825615e6e020cde26a157d9735e03039dd2dfeae", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The existing information on adverse effects of\nMMR vaccine in Canada comes from the manufacturer's\nlist of such effects obtained through premarketing stud-\nies,7 a study of a recently introduced MMR vaccine\n(Trivirix)8 and two retrospective family-practice-based\nstudies.9\"0 However, all of these studies have limitations:\nthe manufacturer's list included occurrences of unspeci-\nfied frequency, the Trivirix study relied on a single ex-\namination by a nurse 10 days after vaccination and did\nnot specify the criteria for an adverse reaction, and the\nretrospective studies included only problems sufficiently\nserious in the parent's mind to bring the child back to the\ndoctor's office.\nThe possible adverse effects listed by the manufac-\nturer are malaise, sore throat, headache, fever, rash, ery-\nthema, induration, regional lymphadenopathy, parotitis,\norchitis, thrombocytopenia and purpura. Allergic reac-\ntions such as urticaria, arthritis, arthralgia and polyneuri-\ntis have also been reported. Encephalitis is reported to\noccur in one case per million doses of all live vaccines\nadministered, 1000 times less frequent than the inci-\ndence of encephalitis with natural measles infection.7\nThe Trivirix study found that the principal problems af-\nter vaccination were tonsillitis (in 56.7% of cases), cer-\nvical adenopathy (in 43.3%) and parotitis (in 20%).8 The\nretrospective studies showed an increase in the number\nof physician visits for conjunctivitis, otitis media and up-\nper and lower respiratory tract infections.9\"0\nA double-blind placebo-controlled crossover study\nof reactions to MMR vaccine in 581 pairs of twins was\nconducted in Finland.\" The incidence rates of symptoms\nsuch as cough, runny nose, nausea and vomiting,\nrecorded by the mothers over 1 month after vaccination,\nwere lower in the vaccinated group than in the placebo\ngroup after the second week; this suggests a \"protective\neffect\" of the vaccine, perhaps owing to the induction of\ninterferon.", "mimetype": "text/plain", "start_char_idx": 5183, "end_char_idx": 7157, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "26db15ea-7b22-4151-a16c-2b1fc55921b7": {"__data__": {"id_": "26db15ea-7b22-4151-a16c-2b1fc55921b7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Freeman (1993).pdf", "node_type": "4", "metadata": {}, "hash": "0966563a8070e16d9e85a565d3f0b68a3cacfadcc0c13eac515c817af23df087", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "25390829-26cf-4cec-9bb3-5907124d5284", "node_type": "1", "metadata": {}, "hash": "73fdc21cf676b1b6e26f9a411c4971ad538489e39fc2da44ce35bc03a1f78651", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8a9a7cf7-9878-484b-a324-c686482f77a6", "node_type": "1", "metadata": {}, "hash": "761a237a0c18210b204eb010e2fcf05e536d39513bb67000c4f64fdc76a054d1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Because of the involvement of twins in that\ntrial, subtraction of the incidence of a given symptom in\nthe twin receiving the placebo from the incidence of the\nsame symptom in the vaccinated twin revealed a true ad-\nverse reaction rate for each of 15 signs and symptoms.\nThese rates were much lower than generally reported.\nThe authors attributed this to the frequent occurrence of\nsymptoms in children in general and suggested that\nMMR vaccine is safer than currently recognized. The\nstudy had the weakness of relying only on the observa-\ntions of the mothers; the investigators were unable to\ncomment on the incidence of otitis media, tonsillitis and\nlymphadenopathy, which require the examination by an\nobjective, medically trained observer.\nOur second goal, to compare postvaccine illnesses\nin children vaccinated at different ages, will add to the\ndebate about the optimum time to vaccinate children.\nThe manufacturer and the National Advisory Committee\non Immunization recommend vaccination after 12\nmonths to avoid interference with the immunogenic re-\nsponse by maternal antibodies.7\"2 However, other author-\nities have asked that the vaccine not be given until 15\nmonths, because 12-month-old recipients had a lower\nseroconversion rate than 15-month-old recipients.2 The\nattack rate in measles outbreaks in the United States and\nCanada has been two to three times higher in children\nvaccinated at 12 to 13 months of age than in those vacci-\nnated at 15 months.'3\nMethods\nThe study was conducted by 22 family physicians\nin Oxford and Middlesex counties and the Waterloo re-\ngion of southwestern Ontario. The design was a prospec-\ntive cluster randomized controlled study in which half of\nthe family physicians were randomly assigned to admin-\nister the MMR vaccine (M-M-R II; Merck Sharp &\nDohme Canada, Kirkland, Que.) at 13 months and the\n1670\nCAN MED ASSOC J 1993; 149 (11)\nLE 1ler DECEMBRE 1993\nother half at 15 months. Thirteen months was chosen in-\nstead of 12 months to ensure that vaccination occurred\nafter the twelfth month, to comply with current recom-\nmendations. All babies were identified in each practice\nwho were due to receive MMR vaccine in the next year.", "mimetype": "text/plain", "start_char_idx": 7158, "end_char_idx": 9339, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8a9a7cf7-9878-484b-a324-c686482f77a6": {"__data__": {"id_": "8a9a7cf7-9878-484b-a324-c686482f77a6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Freeman (1993).pdf", "node_type": "4", "metadata": {}, "hash": "0966563a8070e16d9e85a565d3f0b68a3cacfadcc0c13eac515c817af23df087", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "26db15ea-7b22-4151-a16c-2b1fc55921b7", "node_type": "1", "metadata": {}, "hash": "17246f1a0bc5e472057dc8fb825615e6e020cde26a157d9735e03039dd2dfeae", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e7583468-e34b-4f13-ad38-ead763c36800", "node_type": "1", "metadata": {}, "hash": "f9da0a9486553e172e08f4a6caf6d6b71dbf3e76f8df031e61373e9f0902d57e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All babies were identified in each practice\nwho were due to receive MMR vaccine in the next year.\nThe mothers were asked to consent to the study and to\nvisit the doctor's office 1 month before vaccination.\nThe data on illnesses were collected from three\nsources: (a) results of examination by the family phys-\nician of each child at vaccination and 7 and 30 days af-\nterward, (b) a standardized close-ended diary kept daily\nby each mother for the 4 weeks before and the 4 weeks\nafter vaccination and (c) medical records of the family\nphysicians indicating any illness resulting in patient-\ninitiated visit or admission to hospital during the month\nbefore and the month after vaccination.\nFamily physician's examination\nAt each of the three study visits to the physician's\noffice the following were examined and any positive\nfindings noted: eyes (conjunctiva); ears (tympanic mem-\nbranes, particularly for light reflex, retraction, radial ery-\nthema, inflammation and bulging); mouth (for en-\nanthema and Koplik's spots) and throat (tonsils and\nparotid gland); anterior triangle and posterior triangle,\nincluding postauricular nodes and occipital nodes (for\nsigns of lymphadenopathy); lungs (for rales or rhonchi);\nabdomen (for tenderness and signs of organic disease);\ngenitourinary tract (for testicular swelling); central ner-\nvous system (for alertness); skin (for rash, erythema,\nmacules, papules and vesicules); and temperature.\nPhysicians attended two workshops to ensure con-\nsistency in the criteria for positive findings. No formal\nassessment was made of the interobserver agreement.\nHowever, the same physician examined a child on each\nof the three occasions, and each physician entered ap-\nproximately equal numbers of children into the study.\nThese strategies were implemented to reduce interob-\nserver bias.\nSymptom diary\nThe daily diary was designed to overcome prob-\nlems of recall, which hamper alternative methods such\nas weekly and monthly interviews.\"'-6 It was pilot tested\nfor clarity and mothers' compliance. The diary included\nthe following four questions, with responses recorded on\na 5-point scale (1 poor, 3 average, 5 good).\n* What sort of day has this been for your child?\n* How do you rate your child's eating today?", "mimetype": "text/plain", "start_char_idx": 9242, "end_char_idx": 11487, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e7583468-e34b-4f13-ad38-ead763c36800": {"__data__": {"id_": "e7583468-e34b-4f13-ad38-ead763c36800", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Freeman (1993).pdf", "node_type": "4", "metadata": {}, "hash": "0966563a8070e16d9e85a565d3f0b68a3cacfadcc0c13eac515c817af23df087", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8a9a7cf7-9878-484b-a324-c686482f77a6", "node_type": "1", "metadata": {}, "hash": "761a237a0c18210b204eb010e2fcf05e536d39513bb67000c4f64fdc76a054d1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cca18bfe-3779-4f9f-b533-d9b9d73efbd9", "node_type": "1", "metadata": {}, "hash": "ffbaf6e928c5d93542345a05782651f001c5c339a9071066d54ea27f32f9b97c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "* What sort of day has this been for your child?\n* How do you rate your child's eating today?\n* How do you rate your child's sleeping pattern to-\nday?\n* Did your child have any health problems today?\nIf Yes, did you (a) talk with a friend or relative, (b) use\nover-the-counter medicine or (c) use medicine pre-\nscribed by doctors? Were the following problems bother-\ning your child today: rash, swollen glands, runny nose,\nrunny eyes, cold sores, cough, sore throat, fever?\nTwo variables reflecting the child's illness were\ncreated from the daily diary. First, the variable days with\nhealth problems was ascertained from the responses to\nthe question Did your child have any health problems to-\nday? Second, each day in the month before and the\nmonth after vaccination was classified as to whether or\nnot the child was sick. The variable sick day referred to a\nday during which the mother identified a health problem\nas a symptom rather than some other concern (e.g., in-\ngoing foot) and during which at least one of the follow-\ning applied: a poorer eating or sleeping rating than that\nfor the previous day, or the use of medications (over the\ncounter or prescribed).\nThe number of days with health problems and the\nnumber of sick days in each of the 4 weeks after vacci-\nnation were compared between the two groups of chil-\ndren. The unpaired t-test was used to compare\ndifferences. The statistical power of the study to detect a\ndifference of 2 sick days between the 13-month and 15-\nmonth age groups, at an a value of 0.05, was 0.80. To\ncompare illness rates before and after vaccination we\nconducted paired t-tests on the number of days with\nhealth problems per week for the corresponding weeks\nbefore and after vaccination.\nResults\nThere were 376 eligible children, of whom 253\n(67.3%) successfully completed the study (this in-\ncluded their mother keeping the diary for the 2 months\nand the necessary follow-up appointments).", "mimetype": "text/plain", "start_char_idx": 11394, "end_char_idx": 13326, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cca18bfe-3779-4f9f-b533-d9b9d73efbd9": {"__data__": {"id_": "cca18bfe-3779-4f9f-b533-d9b9d73efbd9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Freeman (1993).pdf", "node_type": "4", "metadata": {}, "hash": "0966563a8070e16d9e85a565d3f0b68a3cacfadcc0c13eac515c817af23df087", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e7583468-e34b-4f13-ad38-ead763c36800", "node_type": "1", "metadata": {}, "hash": "f9da0a9486553e172e08f4a6caf6d6b71dbf3e76f8df031e61373e9f0902d57e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a7248631-d7cf-486a-b3d3-c665d9eaab06", "node_type": "1", "metadata": {}, "hash": "7af35cb8ca93319e8c2edb14496a549ddf2515ffdd6db231d5c6e68e24316744", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Results\nThere were 376 eligible children, of whom 253\n(67.3%) successfully completed the study (this in-\ncluded their mother keeping the diary for the 2 months\nand the necessary follow-up appointments). Of the 123\nremaining children 45 had mothers who refused to par-\nticipate, 24 were taken out out of the study, 23 were not\nincluded in the results because of incomplete data (e.g.,\na diary with more than 14 days missing or a missed\nvisit on day 7), and 31 were missed or already had re-\nceived the vaccine.\nOf the 253 children who completed the study 126\nwere randomly assigned to be vaccinated at 13\nmonths and 127 at 15 months. Some vaccinations\nwere delayed as much as a week to allow a child to\nrecover from an illness. Boys represented 55.4% of\nthe total number of children. This proportion did not\ndiffer significantly between the two groups, nor did\nbirth weight, gestational age at birth, weight at vacci-\nnation, mother's age, mother's educational level,\nchild-care arrangements, number of preschool and\nschool-aged children in the household, birth order and\nnumber of hours in child care. The father's educa-\ntional level was significantly higher in the 15-month\ngroup than in the 13-month group; this likely reflected\nthe cluster randomized design, in which similar par-\nents would choose the same physician, and was not\nthought to significantly differentiate the two groups of\nchildren.\nCAN MED ASSOC J 1993; 149 (I1)\n1671\nDECEMBER 1, 1993\nsymptoms became apparent 5 days after vaccination.22\nThe number of days with health problems did not\ndiffer significantly between the two age groups (Table\n1). Overall, the children had a health problem approx-\nimately 2 days each week (Table 1). Also not signifi-\ncantly different between the two groups were the\nnumber of sick days and the physical findings at exami-\nnation 7 days after vaccination. Both groups exhibited\non average close to one positive finding per child (0.89\nin the 13-month group and 0.93 in the 15-month group).", "mimetype": "text/plain", "start_char_idx": 13124, "end_char_idx": 15115, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a7248631-d7cf-486a-b3d3-c665d9eaab06": {"__data__": {"id_": "a7248631-d7cf-486a-b3d3-c665d9eaab06", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Freeman (1993).pdf", "node_type": "4", "metadata": {}, "hash": "0966563a8070e16d9e85a565d3f0b68a3cacfadcc0c13eac515c817af23df087", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cca18bfe-3779-4f9f-b533-d9b9d73efbd9", "node_type": "1", "metadata": {}, "hash": "ffbaf6e928c5d93542345a05782651f001c5c339a9071066d54ea27f32f9b97c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9739e15e-4138-48cd-ad46-b796ddb1b3d0", "node_type": "1", "metadata": {}, "hash": "6b6a3e73070a3f4ae8a85fe8b303fbffacce7b578e62137a5818294c1944462d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Both groups exhibited\non average close to one positive finding per child (0.89\nin the 13-month group and 0.93 in the 15-month group).\nThe medical records indicated that the number of\nvisits on average to the family physician in the month af-\nter vaccination (omitting the visit at 7 days required by\nthe study) did not differ significantly between the 13-\nmonth group and the 15-month group (0.75 v. 0.79 re-\nspectively).\nSix children were admitted to hospital. Four in the\n13-month group were admitted because of dehydration,\nearache and fever (on day 19), pneumonia (on day 25),\ndehydration, diarrhea and anorexia (on day 25) and\nburns (on day 28); two in the 15-month group were ad-\nmitted because of fever, anorexia and bruising (on day\n10) and red throat, fever and leukocytes in urine (on day\n11). The case of fever, anorexia and bruising was diag-\nnosed as immune thrombocytopenia, which has previ-\nously been reported after vaccination.'7-2' In this case the\nWeek after\nvaccination\nAge group; mean duration\nof health problems, d*\n13mo\n15mo\nFirst\n2.1\n(n = 120)\n2.1\n(n = 122)\nSecond\n2.6 (n = 122)\n2.4 (n = 124)\nThird\n2.1\n(n = 124)\n2.0 (n = 122)\nFourth\n1.9 (n = 109)\n2.1 (n=110)\n*TI number of mothers who completed the diary for each of the\n7 days varied slightly from week to week.\nIllness before and after vaccination\nUnexpectedly, the mean number of days with re-\nported health problems was not significantly higher in\nthe weeks after MMR vaccination than in the weeks\nbeforehand (Table 2). On the contrary, in the third and\nfourth weeks after vaccination, there were significantly\nfewer days with health problems than in the corre-\nsponding weeks before vaccination. We analysed the\nsame data stratified by time of year to control for the\neffects of seasons of frequent illness (e.g., spring and\nautumn).", "mimetype": "text/plain", "start_char_idx": 14982, "end_char_idx": 16795, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9739e15e-4138-48cd-ad46-b796ddb1b3d0": {"__data__": {"id_": "9739e15e-4138-48cd-ad46-b796ddb1b3d0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Freeman (1993).pdf", "node_type": "4", "metadata": {}, "hash": "0966563a8070e16d9e85a565d3f0b68a3cacfadcc0c13eac515c817af23df087", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a7248631-d7cf-486a-b3d3-c665d9eaab06", "node_type": "1", "metadata": {}, "hash": "7af35cb8ca93319e8c2edb14496a549ddf2515ffdd6db231d5c6e68e24316744", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "33500868-a951-470f-85e8-2ed001c76714", "node_type": "1", "metadata": {}, "hash": "197d77ac05b387c8665d240380437eebbb048903fc2efe3ed267ac70350afcb5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We analysed the\nsame data stratified by time of year to control for the\neffects of seasons of frequent illness (e.g., spring and\nautumn). Although the number of days with health\nproblems was greater for children vaccinated in Octo-\nber, November, March and April than for those vacci-\nnated in the rest of the year, the difference in health\nproblems before and after vaccination was identical to\nthe results seen in Table 2.\nWe examined data on particular symptoms reported\nby the mothers (Table 3) and found that runny nose was\nless common after MMR vaccination than before. Fever,\non the other hand, was significantly more common in the\nfirst week after vaccination than in the week before.\nHowever, fever was significantly less frequent by the\nthird week after vaccination than the third week before-\nhand. Rash was the only symptom consistently more fre-\nquent after vaccination. Rashes were twice as frequent in\nthe second week and also significantly more frequent in\nthe third week after vaccination than in the correspond-\ning weeks beforehand.\nThree infants were admitted to hospital in the\nmonth before vaccination, as compared with the six ad-\nmitted in the month afterward (three of whom were ad-\nmitted on or after day 25).\nThe mean number of physical findings in the phys-\nicians' examinations of the children were compared. On\naverage the physicians found 0.5 noteworthy physical\nfindings on the day the MMR vaccine was administered,\nas compared with 0.91 on day 7 after vaccination (paired\nt = 5.68, p < 0.001).", "mimetype": "text/plain", "start_char_idx": 16658, "end_char_idx": 18184, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "33500868-a951-470f-85e8-2ed001c76714": {"__data__": {"id_": "33500868-a951-470f-85e8-2ed001c76714", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Freeman (1993).pdf", "node_type": "4", "metadata": {}, "hash": "0966563a8070e16d9e85a565d3f0b68a3cacfadcc0c13eac515c817af23df087", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9739e15e-4138-48cd-ad46-b796ddb1b3d0", "node_type": "1", "metadata": {}, "hash": "6b6a3e73070a3f4ae8a85fe8b303fbffacce7b578e62137a5818294c1944462d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3bc083cc-3028-49ec-9c6b-05af9633877a", "node_type": "1", "metadata": {}, "hash": "b52e1f3434cd2cfaab22ecd4c6c9517883b8e6738e26e6c7a7ed16b8c515a0e7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Compared with the 7-day findings,\n0.75 were noted 30 days after vaccination (paired t =\nMean duration\nof health problems, d\nWeek before and\nBefore\nAfter\nafter vaccination*\nvaccination\nvaccination\npvaluet\nFirst (n = 239)\n2.2\n2.1\nNS\nSecond (n = 241)\n2.7\n2.5\nNS\nThird (n = 237)\n2.5\n2.0\n< 0.05\nFourth (n-=192)\n2.5\n2.0\n<0.05\n*The number of mothers Wo completed the diary for each of the 7 days varied\nslightly from week to week\ntNS = not signfficant; paired test was usW to determine the p values.\n1672\nCAN MED ASSOC J 1993; 149 (11)\nIllness after vaccination\nLE I er DECEMBRE 1993\n2.42, p < 0.02). Table 4 shows the proportion of children\n2.42, p < 0.02). Table 4 shows the proportion.of children\nwho had physical findings 7 days after vaccination.\nTiming ofsymptoms\nWe calculated the proportion of children with\nsymptoms on each of the 15 days after vaccination.\nRunny nose was most common 5 days after vaccination.\nCough occurred in 10.0% to 15.0% of the children from\nday 4 to day 10 and then decreased in frequency. The\ntime when fever was most likely to occur was approx-\nimately 10 days after vaccination, and it was reported in\n10.2% of the children. Rash was similar to fever in that\n12.0% of the children had a rash around 10 days after\nvaccination. Runny eyes and swollen glands were not\ncommon at any time during the 15 days examined. The\ndaily proportion of children given over-the-counter med-\nications was 14.0% until the 10th and 11th day, when it\nwas 17.1% and 18.1% respectively; it dropped to 10.5%\non day 12.", "mimetype": "text/plain", "start_char_idx": 18185, "end_char_idx": 19708, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3bc083cc-3028-49ec-9c6b-05af9633877a": {"__data__": {"id_": "3bc083cc-3028-49ec-9c6b-05af9633877a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Freeman (1993).pdf", "node_type": "4", "metadata": {}, "hash": "0966563a8070e16d9e85a565d3f0b68a3cacfadcc0c13eac515c817af23df087", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "33500868-a951-470f-85e8-2ed001c76714", "node_type": "1", "metadata": {}, "hash": "197d77ac05b387c8665d240380437eebbb048903fc2efe3ed267ac70350afcb5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ed799ce4-b737-42cf-af97-4f78f60900a3", "node_type": "1", "metadata": {}, "hash": "4dc6385429129a67fc68b13f05e9ccef9deecacbb68747cb599ef7880badd5df", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In contrast, prescription medicine was given\nto 5.0% of the children until the 8th day, when the pro-\nportion rose to 9.7% and remained there.\nDiscussion\nWe found that the morbidity after MMR vaccina-\ntion did not differ significantly between the 13-month\nand 15-month groups. It seems that issues of postvaccine\nmorbidity need not enter into the decision of when to\ngive the vaccine.\nA strength of this study is that it was conducted in\nthe family practice setting and used observations from\nthree- sources; these features permitted a fairly complete\npicture to be drawn about the childrens' health problems.\nThe mothers' observations in the diaries gave daily in-\nformation. The physicians' log provided more objective\ndata on physical findings at the seventh day after vacci-\nnation such as the status of the child's ear drums and\ntonsils. Finally, a review of office records and hospital\ncharts provided information on postvaccine conditions\nserious enough to necessitate medical or hospital care.\nThe limitations of this study are generalizability\nand observation bias. The population was limited to rural\nand urban children in southwestern Ontario, whose par-\nents were educated at a level typical of the region and\nwere compliant with guidelines for vaccinating their\nchildren at 1 year of age.\nObservation bias may have resulted in the mothers\nbeing especially vigilant shortly after vaccination and\nbecoming less so toward the end of the study period.\nSuch bias did not affect the validity of the comparison\nbetween the two age groups. However, it may explain\ndifferences in morbidity before and after vaccination.\nWe used more than one source of data: although it can\nbe argued that the mothers were subject to observation\nbias, the same would likely not be true for the phys-\nicians' findings, since the reported symptoms and signs\n(e.g., lymphadenopathy and nasal discharge) have been\nlinked to the MMR vaccine in the product literature.\nLess vigilant observations by participants who keep di-\naries has been reported,'4 but not at the 6-week mark,\nwhen we noted a decrease in the number of symptoms.\nOvercoming observation bias so that the vaccine,\ncan be isolated as the cause of the children's illness re-\nquires a placebo-controlled trial, which we did not think\nwas ethically justifiable.", "mimetype": "text/plain", "start_char_idx": 19709, "end_char_idx": 22014, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ed799ce4-b737-42cf-af97-4f78f60900a3": {"__data__": {"id_": "ed799ce4-b737-42cf-af97-4f78f60900a3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Freeman (1993).pdf", "node_type": "4", "metadata": {}, "hash": "0966563a8070e16d9e85a565d3f0b68a3cacfadcc0c13eac515c817af23df087", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3bc083cc-3028-49ec-9c6b-05af9633877a", "node_type": "1", "metadata": {}, "hash": "b52e1f3434cd2cfaab22ecd4c6c9517883b8e6738e26e6c7a7ed16b8c515a0e7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "66c1d50a-1c71-4f8b-8833-f8868c9dc5ee", "node_type": "1", "metadata": {}, "hash": "cd37e393431289d5ac1c103e0a8e533922ed1a96414109c77b1e10a110d14fb9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Overcoming observation bias so that the vaccine,\ncan be isolated as the cause of the children's illness re-\nquires a placebo-controlled trial, which we did not think\nwas ethically justifiable. Such a trial was conducted in\nFinland\" and showed some findings similar to ours.\nWhen comparing the mothers' observations with\nthose of the physicians on the same day, we found wide\ndifferences. For example, on the seventh day after vacci-\nnation runny nose was reported by mothers in approx-\nNo. (and %)\nof children\nFinding\n(n = 240)\nLymphadenopathy\n57 (23.8)\nNasal discharge\n15\n(6.3)\nRash\n11\n(4.6)\nAbnormal tympanic membrane\n(otitis media)\n8\n-(3.3)\nConjunctival abnormality\n8\n(3.3)\nAbnormal tonsils\n2\n(0.8)\nWeek; %\u00b0 of patients with symptom\n- First\nSecond\nThird\nFourth\nSymptom\nBefore\nAfter\nBefore\nAfter\nBefore\nAfter\nBefore\nAfter\nCough\n19.7\n;21.8\n22.3\n24.1\n26.0\n19.7\n27.1\n20.7\nFever\n7.2\n16&8t\n.\n17.9\n19.2\n14.5\n7.9*.\n0.-0\n9.2\nRash\n11.2\n13.2\n138\n26.9t\n12.4.\n17.1*\n11.3\n13.8\nRunny eyes\n6.0\n-: 5.8\n9.5\n7.3\n9.3\n5.4\n-\n10.9\n6.9\nRunny nose\n29.7\n32.9\n39.3\n37A.1\n38.Q\n29.2*\n37.6\n26.3\nSwollen glands\n0.1\n0.1\n0.1\n4.9\n2.0\n1.7\n2.4\n0.9\n*p c 0.05, paired t-test comparing values before and after.\ntp< 0.01, paired Htest comparing values before And after.", "mimetype": "text/plain", "start_char_idx": 21822, "end_char_idx": 23054, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "66c1d50a-1c71-4f8b-8833-f8868c9dc5ee": {"__data__": {"id_": "66c1d50a-1c71-4f8b-8833-f8868c9dc5ee", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Freeman (1993).pdf", "node_type": "4", "metadata": {}, "hash": "0966563a8070e16d9e85a565d3f0b68a3cacfadcc0c13eac515c817af23df087", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ed799ce4-b737-42cf-af97-4f78f60900a3", "node_type": "1", "metadata": {}, "hash": "4dc6385429129a67fc68b13f05e9ccef9deecacbb68747cb599ef7880badd5df", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7e9e024f-6259-4614-8867-26865766040c", "node_type": "1", "metadata": {}, "hash": "54f7d6d84068fe00ddba8931550296a61beec75e05683c9d1eb1aba09ef8f00e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tp< 0.01, paired Htest comparing values before And after.\nCAN MED ASSOC J 1993; 149 (11)\n1673\nDECEMBER 1, 1993\nimately 20% of the children, whereas the physicians,\nviewing the children on that day (and asked specifically\nto comment on this symptom) recorded it in only 6.3%.\nThis discrepancy has implications for other studies of\nthis type. If physicians and other health care profession-\nals involved in vaccine trials consistently underreport\nsymptoms or if patients overreport, the results of studies\nthat rely solely on one source may be misleading.\nA comparison of our findings with those of another\nCanadian study8 provides some interesting contrasts.\nAmong the 120 children in that study who received the\nM-M-R II vaccine the incidence rate of conjunctivitis\nwas 4.2% at day 10, which was similar to our rate of\n3.3% at day 7 and is consistent with findings by others.\"\nThe remainder of the findings in the 1986 report were\nmuch higher than our corresponding figures (e.g., tonsil-\nlitis 56.7% v. 0.8% respectively, cervical adenopathy\n43.3% v. 23.8%). Most surprising, the incidence rate of\nparotid swelling in the other report was 20.0%; in our\nstudy there was not one instance of parotid swelling\nnoted by a physician. Our findings are consistent with\nother studies of vaccine side effects in this age group.\"\nOne possible explanation for the high rate of the side-\neffects in the other study8 is an unusually high rate of\n\"background\" illness at the time of observation. A sec-\nond possibility is that their diagnostic criteria were dif-\nferent from the conventional ones used by us and the\nother investigators.\nOur finding that prescription drug use increased ap-\nproximately 7 days after vaccination supports the obser-\nvation that physicians may be unaware of the common\nsequelae of MMR vaccination. Although the symptom\ndiaries did not show an increase in symptoms around the\nseventh day, the physicians' reports on day 7 did show a\nchange from the day of vaccination. These findings pre-\nsumably account for the reported increased use of pre-\nscription drugs.", "mimetype": "text/plain", "start_char_idx": 22997, "end_char_idx": 25072, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7e9e024f-6259-4614-8867-26865766040c": {"__data__": {"id_": "7e9e024f-6259-4614-8867-26865766040c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Freeman (1993).pdf", "node_type": "4", "metadata": {}, "hash": "0966563a8070e16d9e85a565d3f0b68a3cacfadcc0c13eac515c817af23df087", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "66c1d50a-1c71-4f8b-8833-f8868c9dc5ee", "node_type": "1", "metadata": {}, "hash": "cd37e393431289d5ac1c103e0a8e533922ed1a96414109c77b1e10a110d14fb9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6f9b48a3-30ed-47c5-91fb-8d35dc38cbf6", "node_type": "1", "metadata": {}, "hash": "19e427f12d8e5cb7823419c275c63c00ccb2336a09089d03ac33a718afdbc2e9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "These findings pre-\nsumably account for the reported increased use of pre-\nscription drugs. This is perhaps understandable, since the\nsymptoms and signs that were found are not mentioned\nin the product literature as being vaccine related. As the\nevidence about the common illness patterns after routine\nMMR vaccination accumulates, it may be important to\ninclude this information in the product literature so that\nunnecessary treatment is avoided and parents are pro-\nvided with more accurate information about what to ex-\npect in their children.\nIn conclusion, family physicians should tell parents\nof children receiving MMR vaccine to watch for fever,\ncough and runny nose in the first week after vaccination\nand rash in the second and third week.\nOur study was successful in showing that commu-\nnity-based surveillance of adverse reactions to a vac-\ncine can be carried out in family physicians' offices. It\ncan serve as a prototype for further studies of reac-\ntions, especially given the increased interest in vac-\ncines and their possible side effects as well as the\nproliferation of new vaccines expected to be intro-\nduced in the near future.\nWe thank Drs. Carol Buck and Martin Bass for their ideas on\nthe design of this project and Dr. Ian McWhinney for his\ncomments on the paper. We also thank the 22 family phys-\nicians in southwestern Ontario who participated in the study.\nThis research was supported by grant 6606-3028-43 from\nthe National Health Research and Development Program. The\npilot study of the symptom diary was funded by a sustaining\ngrant from the College of Family Physicians of Canada.\nDr. Stewart was the recipient of a Career Scientist Award\nfrom the Health Research Personnel Development Program,\nOntario Ministry of Health.\nReferences\n1. Statement on recommended use of measles vaccine in Canada.\nCan Dis Wkly Rep 1990; 16: 7-10\n2. Measles prevention: recommendations of the Immunization Prac-\ntices Advisory Committee (ACIP). MMWR 1989; 38: 1-17\n3. Rayner C: Mass communication media in health education. In\nDoxiadis S (ed): Ethical Dilemmas in Health Promotion, Wiley,\nNew York, 1987: 213-220\n4.", "mimetype": "text/plain", "start_char_idx": 24981, "end_char_idx": 27111, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6f9b48a3-30ed-47c5-91fb-8d35dc38cbf6": {"__data__": {"id_": "6f9b48a3-30ed-47c5-91fb-8d35dc38cbf6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Freeman (1993).pdf", "node_type": "4", "metadata": {}, "hash": "0966563a8070e16d9e85a565d3f0b68a3cacfadcc0c13eac515c817af23df087", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7e9e024f-6259-4614-8867-26865766040c", "node_type": "1", "metadata": {}, "hash": "54f7d6d84068fe00ddba8931550296a61beec75e05683c9d1eb1aba09ef8f00e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2b8834dc-140d-41ff-8c64-ece4c1eef6f0", "node_type": "1", "metadata": {}, "hash": "5f184cd1538116c185ed332caf6cbc74bccef300b81f02aff501daeb77c91d9d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Rayner C: Mass communication media in health education. In\nDoxiadis S (ed): Ethical Dilemmas in Health Promotion, Wiley,\nNew York, 1987: 213-220\n4. Bill 98, An Act to amend the Health Promotion and Protection\nAct, 1983, SO, 1987, c 32\n5. Immunization: Benefits, Risks and Reportable Events. A Guide for\nOntario Physicians, College of Physicians and Surgeons of On-\ntario, Toronto, 1988\n6. Freeman T: Erythema multiforme in children taking amoxicillin\nafter vaccination [C]. Can Med Assoc J 1982; 127: 818-820\n7. M-M-R II (product monogr), Merck Sharp & Dohme, Kirkland,\nQue.\n8. Clinical trial of Trivirix for measles, mumps and rubella vaccina-\ntion. Can Dis Wkly Rep 1986; 12: 85-88\n9. Evers S, McCracken E, Stewart M: Illness following MMR im-\nmunization in Indian and non-Indian children. Can Fam Phys-\nician 1983; 29: 1445-1450\n10. Freeman TR: A reprospective study of MMR vaccine. Proceed-\nings of the North American Primary Care Research Group, Apr\n17-20, 1983, Banff, Alta.\n11. Peltola H, Heinonen OP: Frequency of true adverse reactions to\nmeasles-mumps-rubella vaccine. Lancet 1986; 1: 939-942\n12. National Advisory Committee on Immunization: Canadian Immu-\nnization Guide, 3rd ed (cat H49-8/1989E), Dept of National\nHealth and Welfare, Ottawa, 1989\n13. Orenstein WA, Markowitz LE, Preblud SR et al: Appropriate age\nfor measles immunization in the United States. Dev Biol Stand\n1986; 65: 13-21\n14. Freer CB: Self-care: a Health Diary Study (master's thesis), U of\nWestern Ontario, London, 1978\n15.", "mimetype": "text/plain", "start_char_idx": 26964, "end_char_idx": 28470, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2b8834dc-140d-41ff-8c64-ece4c1eef6f0": {"__data__": {"id_": "2b8834dc-140d-41ff-8c64-ece4c1eef6f0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Freeman (1993).pdf", "node_type": "4", "metadata": {}, "hash": "0966563a8070e16d9e85a565d3f0b68a3cacfadcc0c13eac515c817af23df087", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6f9b48a3-30ed-47c5-91fb-8d35dc38cbf6", "node_type": "1", "metadata": {}, "hash": "19e427f12d8e5cb7823419c275c63c00ccb2336a09089d03ac33a718afdbc2e9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Dev Biol Stand\n1986; 65: 13-21\n14. Freer CB: Self-care: a Health Diary Study (master's thesis), U of\nWestern Ontario, London, 1978\n15. Roghman KJ, Haggerty RG: The diary as a research instrument in\nthe study of health and illness behavior. Med Care 1972; 10:\n143-163\n16. Pridham KF, Hansen MF, Bradley ME et al: Issues of concern to\nmothers of new babies. JFam Pract 1982; 14: 1079-1085\n17. Kelton JG: Vaccination associated relapse of immune thrombocy-\ntopenia. JAMA 1981; 245: 369-370\n18. Bartos HG: Thrombocytopenia associated with rubella vaccina-\ntion, New York State. J Med 1972; 72: 499\n19. Sharma ON: Thromboctyopenia following measles-mumps-rubella\nvaccination in a one-year-old infant. Clin Pediatr 1973; 12: 315\n20. Forrest JM, Honeyman MC, Louric VA: Rubella vaccination and\nthrombocytopenia, Australia, NZ. J Med 1974; 4: 352-355\n21. Neiderud J: Thrombocytopenia purpura after a combined vaccine\nagainst morbilli, parotitis and rubella. Acta Paediatr Scand 1983;\n72: 613-614\n22. Hook K: Proceedings of Research Day in Family Medicine, U of\nWestern Ontario, London, Oct 6, 1987\n1674\nCAN MED ASSOC J 1993; 149 ( 11)\nLE\nI er DECEMBRE 1993", "mimetype": "text/plain", "start_char_idx": 28336, "end_char_idx": 29484, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "eb4dba73-ef55-4202-a43c-483554f62f5f": {"__data__": {"id_": "eb4dba73-ef55-4202-a43c-483554f62f5f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "45ac5908-816f-488a-b9ac-cbb5796d040e", "node_type": "1", "metadata": {}, "hash": "05283343faf5eacde56d9dc8aefe450f39684e71a72a19aee665f5334652f4d6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "N Engl J Med, Vol. 344, No. 13\n \n\u00b7\n \nMarch 29, 2001\n \n\u00b7\n \nwww.nejm.org\n \n\u00b7\n \n955\n \nTHE EFFECTIVENESS OF THE VARICELLA VACCINE IN CLINICAL PRACTICE\n \nTHE EFFECTIVENESS OF THE VARICELLA VACCINE IN CLINICAL PRACTICE\n \nM\n \nARIETTA\n \n V\n \n\u00c1ZQUEZ\n \n, M.D., P\n \nHILLIP\n \n S. L\n \nA\n \nR\n \nUSSA\n \n, M.D., A\n \nNNE\n \n A. G\n \nERSHON\n \n, M.D., S\n \nHARON\n \n P. S\n \nTEINBERG\n \n, \nK\n \nIMBERLY\n \n F\n \nREUDIGMAN\n \n, P\n \nH\n \n.D., \n \nAND\n \n E\n \nUGENE\n \n D. S\n \nHAPIRO\n \n, M.D.\n \nA\n \nBSTRACT\n \nBackground\n \nA live attenuated varicella vaccine\nwas approved for use in the United States in March\n1995 and is recommended for all susceptible persons\n12 months of age or older.\n \nMethods\n \nTo assess the effectiveness of the varicel-\nla vaccine, we conducted a case\u2013control study with\ntwo controls per child with chickenpox, matched ac-\ncording to both age and pediatric practice. Children\nwith potential cases of chickenpox were identified by\nactive surveillance of pediatric practices in the New\nHaven, Connecticut, area. Research assistants visited\nthe children on day 3, 4, or 5 of the illness, assessed\nthe severity of the illness, and collected samples from\nlesions to test for varicella\u2013zoster virus by the poly-\nmerase chain reaction (PCR).\n \nResults\n \nFrom March 1997 through November 2000,\ndata collection was completed for 330 potential cas-\nes, of which 243 (74 percent) were in children who had\npositive PCR tests for varicella\u2013zoster virus. Of the 56\nvaccinated children with chickenpox, 86 percent had\nmild disease, whereas only 48 percent of the 187 un-\nvaccinated children with chickenpox had mild disease\n(P<0.001).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1606, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "45ac5908-816f-488a-b9ac-cbb5796d040e": {"__data__": {"id_": "45ac5908-816f-488a-b9ac-cbb5796d040e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eb4dba73-ef55-4202-a43c-483554f62f5f", "node_type": "1", "metadata": {}, "hash": "ea007b74c8fad014cba9c632fe367ac17220ebb5d9fd540ef025e340318f7696", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "724611ac-747c-4330-bef6-d157579a12a3", "node_type": "1", "metadata": {}, "hash": "be67f5bca191c2d077a31bad43e7d4561d5b784c244626982534f87b3d6d7bed", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Among the 202 children with PCR-con-\nfirmed varicella\u2013zoster virus and their 389 matched\ncontrols, 23 percent of the children with chickenpox\nand 61 percent of the matched controls had received\nthe vaccine (vaccine effectiveness, 85 percent; 95 per-\ncent confidence interval, 78 to 90 percent; P<0.001).\nAgainst moderately severe and severe disease the vac-\ncine was 97 percent effective (95 percent confidence\ninterval, 93 to 99 percent). The effectiveness of the\nvaccine was virtually unchanged (87 percent) after\nadjustment for potential confounders by means of\nconditional logistic regression.\n \nConclusions\n \nVaricella vaccine is highly effective\nas used in clinical practice. (N Engl J Med 2001;344:\n955-60.)\n \nCopyright \u00a9 2001 Massachusetts Medical Society.\n \nFrom the Departments of Pediatrics (M.V., E.D.S.) and Epidemiology\nand Public Health (E.D.S.) and the Children\u2019s Clinical Research Center\n(E.D.S.), Yale University School of Medicine, New Haven, Conn.; and the\nDepartment of Pediatrics, Columbia University College of Physicians and\nSurgeons, New York (P.S.L., A.A.G., K.F., S.P.S.). Address reprint requests\nto Dr. Shapiro at the Department of Pediatrics, Yale University School of\nMedicine, P.O. Box 208064, New Haven, CT 06520-8064.\n \nVARICELLA vaccine containing live at-\ntenuated virus (Oka strain) was developed\nin Japan in the early 1970s.\n \n1\n \n In the United\nStates, the vaccine was approved by the\nFood and Drug Administration in 1995 and is rec-\nommended for persons 12 months of age or older\nwho are susceptible to chickenpox.\n \n2\n \nThere have been numerous questions about both\nthe use and the effectiveness of varicella vaccine.\n \n3\n \n The\nefficacy of a vaccine as it is used in clinical practice\nmay be different from its efficacy in a clinical trial.", "mimetype": "text/plain", "start_char_idx": 1607, "end_char_idx": 3389, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "724611ac-747c-4330-bef6-d157579a12a3": {"__data__": {"id_": "724611ac-747c-4330-bef6-d157579a12a3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "45ac5908-816f-488a-b9ac-cbb5796d040e", "node_type": "1", "metadata": {}, "hash": "05283343faf5eacde56d9dc8aefe450f39684e71a72a19aee665f5334652f4d6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "314242a5-f537-44ba-8564-dcdf3a7320c0", "node_type": "1", "metadata": {}, "hash": "eb7105b488a05c8d4edb375108171614401cdbcca2637ee6585cfdcff82a1fec", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3\n \n The\nefficacy of a vaccine as it is used in clinical practice\nmay be different from its efficacy in a clinical trial.\n \n4\n \nMuch of the evidence on which the licensure of var-\nicella vaccine was based came from a clinical trial that\nassessed a vaccine with a substantially higher con-\nA\n \ncentration of virus (17,000 plaque-forming units per\ndose) than is contained in the licensed vaccine (3000\nto 9000 plaque-forming units per dose).\n \n5\n \n Further-\nmore, the live attenuated virus is thermolabile, so the\nvaccine must be kept frozen and its concentration of\nvirus diminishes over time. The duration of effec-\ntiveness is a critical issue, yet the clinical trials con-\nducted in normal children assessed the effectiveness of\nthe vaccine for only two years after immunization (or\nfor three years in immunocompromised children).\n \n6-8\n \nLonger-term follow-up studies in vaccinated persons\nhave been reported.\n \n9,10\n \n The protective concentrations\nof antibody among vaccinated persons in Japan have\npersisted for more than 20 years after immunization,\n \n11\n \nbut this persistence may be due in part to a booster\neffect from exposure to persons with chickenpox in\na country where the vaccine is not used widely\n \n12\n \n and\nwhere the incidence of chickenpox remains high. We\nare conducting an ongoing case\u2013control study to as-\nsess the effectiveness of the vaccine as it is used in ac-\ntual practice in the United States.\n \nMETHODS\n \nEligibility Requirements\n \nSubjects were healthy children between 13 months and 16 years\nof age. Children for whom the vaccine is not routinely recom-\nmended \u2014 those who were immunocompromised because of an\nunderlying illness (e.g., leukemia) or medications (e.g., prednisone)\n\u2014 were excluded. Children with a history of chickenpox were ex-\ncluded, since varicella vaccine is not recommended for such children.\nChildren who had received the vaccine within the preceding\nfour weeks were excluded from the study, since it takes two to four\nweeks for antibodies to develop and about 7 percent of vaccinated\npersons have a vaccine-associated rash (characterized by a mild\nexanthem of 6 to 10 lesions that lasts for two to three days) in\nthe first month after vaccination.", "mimetype": "text/plain", "start_char_idx": 3268, "end_char_idx": 5472, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "314242a5-f537-44ba-8564-dcdf3a7320c0": {"__data__": {"id_": "314242a5-f537-44ba-8564-dcdf3a7320c0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "724611ac-747c-4330-bef6-d157579a12a3", "node_type": "1", "metadata": {}, "hash": "be67f5bca191c2d077a31bad43e7d4561d5b784c244626982534f87b3d6d7bed", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "86fc3426-945e-4ed7-ae57-1ceb5820d405", "node_type": "1", "metadata": {}, "hash": "8dd999ea2c68e736c935ea8699fd85bcde67e90d92fc36314571b7e509c904b4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2\n \n We were interested in assessing\nthe effectiveness of the vaccine against chickenpox and did not wish\nto include as children with chickenpox children who merely had\nminor side effects of the vaccine. Similarly, if chickenpox had been\nincubating at the time of vaccination, disease would have devel-\noped within four weeks.\nThe study was approved by the Human Investigations Commit-\ntee at Yale University School of Medicine.\n \nIdentification, Evaluation, and Classification \nof Potential Cases\n \nThe case group consisted of children in whom chickenpox was\nsuspected who received medical care at the 15 participating pedi-\natric practices in greater New Haven, Connecticut. Potential cases\nThe New England Journal of Medicine is produced by NEJM Group, a division of the Massachusetts Medical Society.\nDownloaded from nejm.org at AP HP-Assistance Publique Hopitaux de Paris on January 9, 2025. For personal use only. \n No other uses without permission. Copyright \u00a9 2001 Massachusetts Medical Society. All rights reserved.\n \n956\n \n\u00b7\n \nN Engl J Med, Vol. 344, No. 13\n \n\u00b7\n \nMarch 29, 2001\n \n\u00b7\n \nwww.nejm.org\n \nThe New England Journal of Medicine\n \nwere identified by means of active surveillance. Investigators were\nnotified of all potential cases, regardless of severity, including many\ncases in children whose illness was managed over the telephone\nwithout being evaluated in person by a clinician.\nThe parents of eligible children were invited to participate in\nthe study, and written informed consent was obtained from a par-\nent, as well as oral consent from the child, when appropriate. A re-\nsearch assistant (who was unaware of the vaccination status of the\nchild) visited the home of each patient with possible chickenpox\n(ideally on day 3 of the illness, but as late as day 5 when necessary).\nA parent was interviewed, and the severity of the illness was as-\nsessed according to a modified version of a scale used in earlier\nclinical trials (Table 1).\n \n7\n \nIn addition, a lesion was unroofed with use of a nonheparin-\nized capillary tube in which vesicular fluid was collected to test\nfor the presence of varicella\u2013zoster virus by the polymerase chain\nreaction (PCR).", "mimetype": "text/plain", "start_char_idx": 5475, "end_char_idx": 7653, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "86fc3426-945e-4ed7-ae57-1ceb5820d405": {"__data__": {"id_": "86fc3426-945e-4ed7-ae57-1ceb5820d405", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "314242a5-f537-44ba-8564-dcdf3a7320c0", "node_type": "1", "metadata": {}, "hash": "eb7105b488a05c8d4edb375108171614401cdbcca2637ee6585cfdcff82a1fec", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "335d0851-a6ff-485c-b6a4-ca66afc72b77", "node_type": "1", "metadata": {}, "hash": "16d0a14f1df6fc28e5d6e9e79536ccfb20b9769e73f73f6701fc4dc8e28b3d8f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The base of the lesion was rubbed with a cotton-\ntipped swab, which was then rubbed on a slide for testing with a\ndirect fluorescent-antibody assay. Material from the swab was an-\nalyzed by PCR if vesicular fluid was not available.\nA PCR assay specific for varicella\u2013zoster virus was used to de-\ntect the virus and to differentiate the strain contained in the vaccine\nfrom wild-type strains.\n \n13\n \n In addition, to assess the adequacy of the\nspecimen (since varicella\u2013zoster virus is found in association with\ncells), all samples that were negative for varicella\u2013zoster virus were\ntested for a 268-bp region of the \n \nb\n \n-globin gene that is present in\nall human cells; a positive result indicated the presence of cellular\nmaterial in the specimen.\n \n13\n \nThe investigators who performed the PCR and direct fluores-\ncent-antibody tests and interpreted the results were unaware of each\nchild\u2019s vaccination status. The PCR assay was considered positive\nif the specimen was positive for varicella\u2013zoster virus DNA and\nall negative controls in the batch were negative. It was considered\nnegative if the specimen was negative for varicella\u2013zoster virus\nDNA, all positive controls in the batch were positive, and the spec-\nimen was positive for \n \nb\n \n-globin (indicating the presence of amplifi-\nable DNA). The result was considered indeterminate if the specimen\nwas negative for both varicella\u2013zoster virus DNA and \n \nb\n \n-globin.\nThe results of the direct fluorescent-antibody assay were interpret-\ned as recommended by the manufacturer (Merifluor varicella\u2013\nzoster virus, Meridian Diagnostics, Cincinnati): specimens with two\nor more epithelial cells in the smear that exhibited typical apple-\ngreen fluorescence were considered positive for varicella\u2013zoster\nvirus. Specimens that were negative but that had less than one cell\nper high-power (\u00ac400) field were considered to be inadequate spec-\nimens. Specimens with an adequate number of cells but with few-\ner than two cells that exhibited immunofluorescence were consid-\nered negative. Potential cases of chickenpox were classified on the\nbasis of the PCR results.", "mimetype": "text/plain", "start_char_idx": 7654, "end_char_idx": 9770, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "335d0851-a6ff-485c-b6a4-ca66afc72b77": {"__data__": {"id_": "335d0851-a6ff-485c-b6a4-ca66afc72b77", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "86fc3426-945e-4ed7-ae57-1ceb5820d405", "node_type": "1", "metadata": {}, "hash": "8dd999ea2c68e736c935ea8699fd85bcde67e90d92fc36314571b7e509c904b4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cb97391b-079e-4f22-927e-b4ac2543df1d", "node_type": "1", "metadata": {}, "hash": "e1ef37f216a6d1084fe680dc06c98870a150c578b9661c0bd056e48083cb716d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Specimens with an adequate number of cells but with few-\ner than two cells that exhibited immunofluorescence were consid-\nered negative. Potential cases of chickenpox were classified on the\nbasis of the PCR results.\n \nSelection of Controls\n \nFor each child with a potential case of chickenpox, two controls,\nmatched according to date of birth (within one month) and pe-\ndiatric practice, were selected. A list of potential controls was gen-\nerated from the computerized data base of the practice; it con-\nsisted of all patients in the practice born between 30 days before\nand 30 days after the birth of the child with the potential case of\nchickenpox. A table of random numbers was used to select the\norder in which potential controls and their parents were contacted,\nscreened for eligibility, and if eligible, invited to enroll in the study.\n \nCollection of Data and Ascertainment of Vaccinations\n \nThe medical records of all the children (from all sources of care)\nwere reviewed to obtain information about all previous immuni-\nzations. Children for whom there was written documentation that\nthey had received varicella vaccine four weeks or more before the\n\u201cfocal time\u201d \u2014 the date of onset of chickenpox or, for the con-\ntrols, the date of onset in the matched children with chickenpox\n\u2014 were classified as vaccinated. As per current recommendations,\nchildren with potential cases of chickenpox and their matched con-\ntrols who were 13 years of age or older were considered to have\nbeen vaccinated if they had received two doses of vaccine at least\nfour weeks before the focal time.\n \nStatistical Analysis\n \nMatched odds ratios for vaccination, with both their associated\nP values (assessed with the Mantel\u2013Haenszel chi-square test for\nmatched data) and 95 percent confidence intervals, were calculated\nwith the use of True Epistat and SPSS statistical software.\n \n14-16\n \n The\neffectiveness of the vaccine was calculated as 1 minus the matched\nodds ratio. These estimates were adjusted for the effects of possible\nconfounders with the use of conditional logistic regression.\n \n17\n \n The\nstatistical significance of differences among unmatched dichotomous\nand continuous variables was determined by the Pearson chi-square\ntest and Student\u2019s t-test, respectively.\n \n15\n \n All P values are two-sided.", "mimetype": "text/plain", "start_char_idx": 9555, "end_char_idx": 11857, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cb97391b-079e-4f22-927e-b4ac2543df1d": {"__data__": {"id_": "cb97391b-079e-4f22-927e-b4ac2543df1d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "335d0851-a6ff-485c-b6a4-ca66afc72b77", "node_type": "1", "metadata": {}, "hash": "16d0a14f1df6fc28e5d6e9e79536ccfb20b9769e73f73f6701fc4dc8e28b3d8f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3fa27b8e-4603-4b09-9f22-242e1e163cb8", "node_type": "1", "metadata": {}, "hash": "631c8a7fbb047c1ca6399a4d21f6a429431f9ce546c79f5e9e305ddaffa32413", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "17\n \n The\nstatistical significance of differences among unmatched dichotomous\nand continuous variables was determined by the Pearson chi-square\ntest and Student\u2019s t-test, respectively.\n \n15\n \n All P values are two-sided.\nTo assess whether bias in the selection of controls might have\naffected the results, we compared the proportion of children with\nchickenpox who had received the measles, mumps, and rubella\n(MMR) vaccine with the proportion of controls who had received\nit. Since the MMR vaccine should have been administered at about\nthe same age as the varicella vaccine and the MMR vaccine should\nhave had no effect on the risk of chickenpox, we expected that there\nwould be no significant difference between the proportion of\nchildren with chickenpox and the proportion of controls who had\nreceived the MMR vaccine. If there were a significant difference, it\nwould suggest that there had been selection bias (e.g., bias due\nto differential use of medical care).\nWe also assessed the effectiveness of the vaccine among the\nchildren with potential cases of chickenpox whose PCR test results\nwere either negative for varicella\u2013zoster virus or indeterminate, since\nthe vaccine should not be effective for these patients. To provide\nadditional information to support the accuracy of the classification\nof potential cases according to the results of the PCR test, parents\nwere called at least 1 month after enrollment and asked whether\nthey knew of anyone in whom chickenpox had developed between\n10 and 21 days after having had close contact with the child with\na potential case of chickenpox.\n \nT\n \nABLE\n \n 1. \n \nS\n \nCALE\n \n U\n \nSED\n \n \n \nTO\n \n A\n \nSSESS\n \n \n \nTHE\n \n S\n \nEVERITY\n \n \n \nOF\n \n I\n \nLLNESS\n \n.\n \nV\n \nARIABLE\n \nN\n \nO\n \n.", "mimetype": "text/plain", "start_char_idx": 11637, "end_char_idx": 13372, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3fa27b8e-4603-4b09-9f22-242e1e163cb8": {"__data__": {"id_": "3fa27b8e-4603-4b09-9f22-242e1e163cb8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cb97391b-079e-4f22-927e-b4ac2543df1d", "node_type": "1", "metadata": {}, "hash": "e1ef37f216a6d1084fe680dc06c98870a150c578b9661c0bd056e48083cb716d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1166e94e-e6d9-4576-bcb8-6b8c21c79340", "node_type": "1", "metadata": {}, "hash": "d401a2ce52ef2f803a01c43788912f14df6a565c8b329db05b3998f2326c64c9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "S\n \nCALE\n \n U\n \nSED\n \n \n \nTO\n \n A\n \nSSESS\n \n \n \nTHE\n \n S\n \nEVERITY\n \n \n \nOF\n \n I\n \nLLNESS\n \n.\n \nV\n \nARIABLE\n \nN\n \nO\n \n. \n \nOF\n \n P\n \nOINTS\n \nRash\nNumber of lesions\n1\u201350\n51\u2013100\n101\u2013500\n>500\n1\n2\n4\n6\nCharacter of lesions\nMacular or papular\nMostly vesicular\nHemorrhagic\n2\n4\n4\nFever\nTemperature, 38.8\u201339.9\u00b0C (102\u2013103.9\u00b0F)\nTemperature, \u00bb40\u00b0C (104\u00b0F)\n1\n3\nSystemic signs\nPain in back or abdomen\nInterstitial pneumonia\nEncephalitis\n4\n5\n5\nSubjective assessment (by research assistant)\nDoes not appear ill\nAppears moderately ill\nAppears severely ill\n0\n2\n5\nSeverity (total score)\nMild disease\nModerately severe disease\nSevere disease\n\u00ab7\n8\u201315\n\u00bb16\nThe New England Journal of Medicine is produced by NEJM Group, a division of the Massachusetts Medical Society.\nDownloaded from nejm.org at AP HP-Assistance Publique Hopitaux de Paris on January 9, 2025. For personal use only. \n No other uses without permission. Copyright \u00a9 2001 Massachusetts Medical Society. All rights reserved.\n \nTHE EFFECTIVENESS OF THE VARICELLA VACCINE IN CLINICAL PRACTICE\n \nN Engl J Med, Vol. 344, No. 13\n \n\u00b7\n \nMarch 29, 2001\n \n\u00b7\n \nwww.nejm.org\n \n\u00b7\n \n957\n \nRESULTS\n \nBetween March 1997 and November 2000, 461\nchildren with suspected cases of chickenpox were\nidentified. Of these, 118 were excluded: a sample from\na skin lesion could not be obtained from 10 chil-\ndren; 13 children were identified more than five days\nafter the onset of the rash; 19 had been vaccinated\nless than four weeks before the onset of the illness;\n24 could not be contacted; and 52 children or their\nparents declined to participate. In addition, com-\nplete data were not available for 13 children with po-\ntential cases of chickenpox. We enrolled 500 matched\ncontrols.", "mimetype": "text/plain", "start_char_idx": 13253, "end_char_idx": 14956, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1166e94e-e6d9-4576-bcb8-6b8c21c79340": {"__data__": {"id_": "1166e94e-e6d9-4576-bcb8-6b8c21c79340", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3fa27b8e-4603-4b09-9f22-242e1e163cb8", "node_type": "1", "metadata": {}, "hash": "631c8a7fbb047c1ca6399a4d21f6a429431f9ce546c79f5e9e305ddaffa32413", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "469b2088-2087-44da-808f-bb4cf8f46886", "node_type": "1", "metadata": {}, "hash": "f1811739f36a1003e3f531dc8e92123f4869bf3e9d1828e891e5560b7ddbb7ae", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In addition, com-\nplete data were not available for 13 children with po-\ntential cases of chickenpox. We enrolled 500 matched\ncontrols. Another 675 potential controls were not\neligible because they had had chickenpox before the\nfocal time; we were unable to reach the parents of\n526 potential controls; and 33 whom we did reach\ndeclined to participate.\nThere were 330 children with potential cases of\nchickenpox for whom complete data were available.\nOf these, only 35 percent were seen by a nurse-prac-\ntitioner or physician. The diagnosis was made over the\ntelephone for the other 65 percent. The results of the\nPCR tests and the direct fluorescent-antibody assays\nfor the suspected cases of chickenpox are shown in\nTable 2 (the first 53 potential cases were not included\nin this comparison because the research assistants were\nlearning the proper techniques for obtaining the sam-\nples and preparing the slides for the direct fluores-\ncent-antibody assays). Clinically useful results (either\npositive or negative) were obtained more frequently\nwith the PCR test (258 of 277 [93 percent]) than\nwith the direct fluorescent-antibody assay (203 of 277\n[73 percent], P<0.001). The first 100 samples with\npositive results on the PCR test and the samples from\nall vaccinated children with chickenpox and a posi-\ntive PCR result were analyzed to determine the type\nof varicella\u2013zoster virus. All were wild-type virus.\nOverall, the PCR test was positive in 243 of the\n330 children with potential cases of chickenpox (74\npercent). Characteristics of these 243 children are\nshown in Table 3. The illness was substantially less\nsevere among the children who had received the var-\nicella vaccine. Children with chickenpox who had not\nreceived the vaccine were more likely to have a fever\nand to be treated with an antipyretic (usually aceta-\nminophen).\nComplete data were available for one or both of\nthe matched controls for 202 of the 243 children\nwith positive results on PCR; estimation of the effec-\ntiveness of the varicella vaccine was based on these\n202 cases and their 389 controls (Table 4).", "mimetype": "text/plain", "start_char_idx": 14821, "end_char_idx": 16912, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "469b2088-2087-44da-808f-bb4cf8f46886": {"__data__": {"id_": "469b2088-2087-44da-808f-bb4cf8f46886", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1166e94e-e6d9-4576-bcb8-6b8c21c79340", "node_type": "1", "metadata": {}, "hash": "d401a2ce52ef2f803a01c43788912f14df6a565c8b329db05b3998f2326c64c9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0a2be063-d5cf-4d5a-b33e-246049f88c2e", "node_type": "1", "metadata": {}, "hash": "9e785065e17a48de49951f0a2b01bbb32c19d5cc73d9f2b8bcb02fecae11e948", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The chil-\ndren with chickenpox were substantially less likely than\nthe controls to have received the varicella vaccine (23\npercent vs. 61 percent), but there was no difference\nin the proportions that had received the MMR vac-\ncine (100 percent in both groups). The overall effec-\ntiveness of the varicella vaccine is shown in Table 5.\nThe vaccine was 85 percent effective (95 percent con-\nfidence interval, 78 to 90 percent; P<0.001). The\nvaccine was 97 percent effective (95 percent confi-\ndence interval; 93 to 99 percent; P<0.001) against\nmoderately severe and severe disease. The vaccine\u2019s\neffectiveness for children younger than 5 years of age\nwas 79 percent (95 percent confidence interval, 61\nto 89 percent; P<0.001); for children 5 to 10 years\nof age, it was 89 percent (95 percent confidence in-\n \nT\n \nABLE\n \n 2. \n \nC\n \nOMPARISON\n \n \n \nOF\n \n \n \nTHE\n \n R\n \nESULTS\n \n \n \nOF\n \n PCR \n \nAND\n \n D\n \nIRECT\n \n F\n \nLUORESCENT\n \n-A\n \nNTIBODY\n \n A\n \nSSAY\n \n \n \nFOR\n \n 277 S\n \nUSPECTED\n \n C\n \nASES\n \n \n \nOF\n \n C\n \nHICKENPOX\n \n.\n \nD\n \nIRECT\n \nF\n \nLUORESCENT\n \n-A\n \nNTIBODY\n \n \nA\n \nSSAY\n \nPCR\n \nPOSITIVE\nNEGATIVE\nINDETERMINATE\n \nno. (%)\n \nPositive\n153 (55)\n1 (<1)\n0\nNegative\n16 (6)\n29 (10)\n4 (1)\nIndeterminate\n29 (10)\n30 (11)\n15 (5)\n \n*The scale used to assign the severity score is presented in Table 1. A score\nof 7 or lower indicates mild disease; a score of 8 to 15 indicates moderately\nsevere disease; and a score of 16 or higher indicates severe disease.\n \nT\n \nABLE\n \n 3. \n \nC\n \nHARACTERISTICS\n \n \n \nOF\n \n A\n \nLL\n \n C\n \nHILDREN\n \n \n \nWITH\n \n PCR-P\n \nOSITIVE\n \n C\n \nASES\n \n \n \nOF\n \n C\n \nHICKENPOX\n \n.", "mimetype": "text/plain", "start_char_idx": 16913, "end_char_idx": 18513, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0a2be063-d5cf-4d5a-b33e-246049f88c2e": {"__data__": {"id_": "0a2be063-d5cf-4d5a-b33e-246049f88c2e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "469b2088-2087-44da-808f-bb4cf8f46886", "node_type": "1", "metadata": {}, "hash": "f1811739f36a1003e3f531dc8e92123f4869bf3e9d1828e891e5560b7ddbb7ae", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "98e06273-cf66-407b-9433-d1c6b808e571", "node_type": "1", "metadata": {}, "hash": "ad461941c86420e0b6337f8f3222cf96f2ca0c3802ee44dea59ca303dddf3dce", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "C\n \nHARACTERISTICS\n \n \n \nOF\n \n A\n \nLL\n \n C\n \nHILDREN\n \n \n \nWITH\n \n PCR-P\n \nOSITIVE\n \n C\n \nASES\n \n \n \nOF\n \n C\n \nHICKENPOX\n \n.\n \nV\n \nARIABLE\n \nV\n \nACCINATED\n \n(N=56)\nU\n \nNVACCINATED\n \n(N=187)\nP V\n \nALUE\n \nAge (mo)\nMean\nMedian\nRange\n66\n61\n21\u2013170\n75\n70\n15\u2013189\n0.08\nFemale sex \u2014 no. (%)\n25 (45)\n102 (55)\n0.22\nWhite race \u2014 no. (%)\n44 (79)\n159 (85)\n0.30\nWeekday location \u2014 no. (%)\nSchool\nDay-care center\nHome\n46 (82)\n6 (11)\n4 (7)\n138 (74)\n27 (14)\n22 (12)\n0.22\n0.48\n0.46\nKnown exposure to varicella\n\u2014 no. (%)\nHousehold\nDay-care center\nCasual\nClassroom\n42 (75)\n5 (9)\n14 (25)\n7 (12)\n16 (29)\n144 (77)\n40 (21)\n25 (13)\n24 (13)\n55 (29)\n0.72\nNo recognized exposure \u2014 no. (%)\n14 (25)\n43 (23)\nFever (temperature \u00bb38.8\u00b0C [102\u00b0F])\n\u2014 no. (%)\n6 (11)\n45 (24)\n0.03\nMedications \u2014 no. (%)\nAcyclovir\nAntipyretic\n0 \n22 (39)\n6 (3)\n120 (64)\n0.34\n<0.001\nSeverity of illness*\nMean score\nMedian score\nRange\nMild \u2014 no. (%)\nModerate or severe \u2014 no. (%)\n4 \n3 \n3\u201312\n48 (86)\n8 (14)\n7\n8\n3\u201316\n89 (48)\n98 (52)\n<0.001\n<0.001\n<0.001\nThe New England Journal of Medicine is produced by NEJM Group, a division of the Massachusetts Medical Society.\nDownloaded from nejm.org at AP HP-Assistance Publique Hopitaux de Paris on January 9, 2025. For personal use only. \n No other uses without permission. Copyright \u00a9 2001 Massachusetts Medical Society.", "mimetype": "text/plain", "start_char_idx": 18389, "end_char_idx": 19690, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "98e06273-cf66-407b-9433-d1c6b808e571": {"__data__": {"id_": "98e06273-cf66-407b-9433-d1c6b808e571", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0a2be063-d5cf-4d5a-b33e-246049f88c2e", "node_type": "1", "metadata": {}, "hash": "9e785065e17a48de49951f0a2b01bbb32c19d5cc73d9f2b8bcb02fecae11e948", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3da51b5f-7b44-46f6-b0c5-41f6a99c2018", "node_type": "1", "metadata": {}, "hash": "7bf7a719611b6c3c33d2259792aaf6bec4e5ad762790d5a6749ad1d367dca55d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For personal use only. \n No other uses without permission. Copyright \u00a9 2001 Massachusetts Medical Society. All rights reserved.\n \n958\n \n\u00b7\n \nN Engl J Med, Vol. 344, No. 13\n \n\u00b7\n \nMarch 29, 2001\n \n\u00b7\n \nwww.nejm.org\n \nThe New England Journal of Medicine\n \nterval, 80 to 94 percent; P<0.001); and for children\nolder than 10 years of age, it was 92 percent (95 per-\ncent confidence interval, 45 to 99 percent; P=0.03).\nInformation about one or two matched controls\nwas available for 40 children with suspected cases of\nchickenpox whose PCR result was negative and for 19\nof those whose PCR result was indeterminate. Among\nthe groups containing a child with chickenpox-like\nillness but negative PCR results, 29 of 40 children\nwith the suspected cases (72 percent) and 48 of their\n74 matched controls (65 percent) had received the\nvaricella vaccine (P=0.53); among the groups con-\ntaining a child with chickenpox-like illness and inde-\nterminate PCR results, 14 of 19 children with the sus-\npected cases (74 percent) and 23 of their 37 matched\ncontrols (62 percent) had received the varicella vac-\ncine (P=0.55). Thus, the vaccine was not effective in\npreventing illness associated with either negative or\nindeterminate results on a PCR assay for varicella\u2013\nzoster virus.\nAccording to the available reports of the parents,\nchickenpox developed within 10 to 21 days in at least\none person who had had close contact with a child\nwith chickenpox-like illness in 30 percent (58 of 195)\nof the PCR-positive cases (including 7 of 43 PCR-\npositive cases in vaccinated children). By contrast, no\nparents of any of the 71 children with chickenpox-\nlike illness and negative or indeterminate results on\nPCR reported any contacts in whom varicella subse-\nquently developed (P<0.001).", "mimetype": "text/plain", "start_char_idx": 19584, "end_char_idx": 21347, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3da51b5f-7b44-46f6-b0c5-41f6a99c2018": {"__data__": {"id_": "3da51b5f-7b44-46f6-b0c5-41f6a99c2018", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "98e06273-cf66-407b-9433-d1c6b808e571", "node_type": "1", "metadata": {}, "hash": "ad461941c86420e0b6337f8f3222cf96f2ca0c3802ee44dea59ca303dddf3dce", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "05d6d891-6047-44b0-aeec-c96d893c106b", "node_type": "1", "metadata": {}, "hash": "be51793c8f798b897edf4aa1d4031919eb3a872e218d18d1ec95295208fa71cd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Similarly, children with\nchickenpox-like illness and positive results on PCR\nwere more likely to have had known exposure to\nsomeone with chickenpox (187 of 243 [77 percent])\nthan were children with chickenpox-like illness whose\nPCR result was either negative or indeterminate (22\nof 87 [25 percent]; odds ratio, 9.9; P<0.001).\n \nDISCUSSION\n \nThese results indicate that the effectiveness of the\nvaricella vaccine as it is used in actual practice is ex-\ncellent, at least in the short term. Virtually all the vac-\ncinated children in whom chickenpox subsequently\ndeveloped (all of whom were infected with wild-\ntype virus) had very mild disease. These findings are\nconsistent with those of a study by the Centers for\nDisease Control and Prevention that show a marked\ndecline in the incidence of chickenpox in areas where\nthe vaccine is widely used,\n \n18\n \n as well as with reports\nof the effectiveness of the vaccine after outbreaks in\nday-care centers.\n \n19-21\n \nIt may be too soon to assess the duration of vaccine-\ninduced immunity to chickenpox. Varicella\u2013zoster\nvirus is still circulating in the population, so boost-\ning of vaccine-induced immunity may still occur com-\nmonly. However, as the incidence of chickenpox de-\n \n*One of the 5 vaccinated children with chickenpox with no vaccinated controls had only 1 matched\ncontrol, as did 4 of the 40 unvaccinated children with chickenpox with no vaccinated controls.\n\u2020Three of the 19 vaccinated children with chickenpox with 1 vaccinated control had only 1\nmatched control, as did 7 of the 57 unvaccinated children with chickenpox with 1 vaccinated control.\n\u2021CI denotes confidence interval. The odds ratio represents the odds of having received the vaccine\namong children with chickenpox as compared with controls.\n\u00a7The vaccine\u2019s effectiveness was 85 percent (95 percent confidence interval, 78 to 90 percent;\nP<0.001); after adjustment with conditional logistic regression for the effects of differences in sex,\nrace, and attendance at group day care, the effectiveness was 87 percent (95 percent confidence in-\nterval, 78 to 92 percent; P<0.001).\n \nT\n \nABLE\n \n 5.", "mimetype": "text/plain", "start_char_idx": 21348, "end_char_idx": 23466, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "05d6d891-6047-44b0-aeec-c96d893c106b": {"__data__": {"id_": "05d6d891-6047-44b0-aeec-c96d893c106b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3da51b5f-7b44-46f6-b0c5-41f6a99c2018", "node_type": "1", "metadata": {}, "hash": "7bf7a719611b6c3c33d2259792aaf6bec4e5ad762790d5a6749ad1d367dca55d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a743d653-e23f-4c37-9cef-d54c91f12f2a", "node_type": "1", "metadata": {}, "hash": "b714bb69d4089ab1b96696fe44dec6c9ddc4f0dde5f536f1e78a584bc5b8ecaa", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "T\n \nABLE\n \n 5. \n \nE\n \nFFECTIVENESS\n \n \n \nOF\n \n \n \nTHE\n \n V\n \nACCINE\n \n.\n \nC\n \nHILD\n \n \n \nWITH\n \nC\n \nHICKENPOX\n \nN\n \nO\n \n. \n \nWITH\n \n N\n \nO\n \n \nV\n \nACCINATED\n \nC\n \nONTROLS\n \n*\nN\n \nO\n \n. \n \nWITH\n \n 1\nV\n \nACCINATED\n \nC\n \nONTROL\u2020\nNO. WITH 2\nVACCINATED\nCONTROLS\nMATCHED ODDS RATIO\n(95% CI)\u2021\nVaccinated\n5 \n19 \n22\n0.15 (0.10\u20130.22)\u00a7\nNot vaccinated\n40 \n57 \n59\n*MMR denotes measles, mumps, and rubella.\nTABLE 4. CHARACTERISTICS OF CHILDREN WITH CHICKENPOX \nAND CONTROLS.\nCHARACTERISTIC\nCHILDREN WITH\nCHICKENPOX\n(N=202)\nCONTROLS\n(N=389)\nP VALUE\nAge (mo)\nMean\nMedian\nRange\n69\n65\n15\u2013189\n68\n64\n15\u2013189\n0.72\nFemale sex \u2014 no. (%)\n107 (53)\n207 (53)\n0.99\nWhite race \u2014 no. (%)\n168 (83)\n331 (85)\n0.55\nWeekday location \u2014 no. (%)\nSchool\nDay-care center\nHome\n152 (75)\n29 (14)\n21 (10)\n301 (77)\n35 (9)\n53 (14)\n0.61\n0.05\n0.30\nReceived MMR vaccine \u2014 no. (%)*\n202 (100)\n389 (100)\n1.0\nReceived varicella vaccine \u2014 no. (%)\n46 (23)\n237 (61)\n<0.001\nThe New England Journal of Medicine is produced by NEJM Group, a division of the Massachusetts Medical Society.\nDownloaded from nejm.org at AP HP-Assistance Publique Hopitaux de Paris on January 9, 2025. For personal use only. \n No other uses without permission. Copyright \u00a9 2001 Massachusetts Medical Society. All rights reserved.\nTHE EFFECTIVENESS OF THE VARICELLA VACCINE IN CLINICAL PRACTICE\nN Engl J Med, Vol. 344, No.", "mimetype": "text/plain", "start_char_idx": 23452, "end_char_idx": 24791, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a743d653-e23f-4c37-9cef-d54c91f12f2a": {"__data__": {"id_": "a743d653-e23f-4c37-9cef-d54c91f12f2a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "05d6d891-6047-44b0-aeec-c96d893c106b", "node_type": "1", "metadata": {}, "hash": "be51793c8f798b897edf4aa1d4031919eb3a872e218d18d1ec95295208fa71cd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "30478ce1-585b-4290-b790-92a5b233d6ac", "node_type": "1", "metadata": {}, "hash": "06fd46742415753fbb45c3729dcba7c467e63641d94c31a9122b833e9da8fe22", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Copyright \u00a9 2001 Massachusetts Medical Society. All rights reserved.\nTHE EFFECTIVENESS OF THE VARICELLA VACCINE IN CLINICAL PRACTICE\nN Engl J Med, Vol. 344, No. 13 \u00b7 March 29, 2001 \u00b7 www.nejm.org \u00b7 959\nclines, such natural boosting of immunity will become\nincreasingly rare. Because ours is an ongoing study,\nwe expect that, over time, we will be able to detect\nany waning of immunity that occurs.\nBy the PCR test, 19 percent of the samples from\nchildren in whom chickenpox was suspected were neg-\native and nearly 7 percent had indeterminate results.\nThe hypothesis that these samples were from chil-\ndren who did not truly have chickenpox is supported\nby the fact that a substantially lower proportion of\nthese children than of the children with PCR-posi-\ntive cases had had recent exposure to someone with\nchickenpox. Similarly, none of these children had con-\ntacts in whom chickenpox developed within 10 to 21\ndays of their illnesses (as compared with 30 percent\nof the children with PCR-positive cases). Most chil-\ndren (65 percent) in whom chickenpox was suspect-\ned were given the diagnosis over the telephone and\nwere never seen by a clinician. This information has\nimportant public health implications because if these\nchildren had not participated in the study, some of\nthem would be believed erroneously to have a histo-\nry of chickenpox and so would not be given the var-\nicella vaccine even though they remain susceptible to\nchickenpox.\nBecause case\u2013control studies like ours are obser-\nvational rather than experimental, they are especially\nsusceptible to bias. We found that although a much\nhigher proportion of controls than of children with\nchickenpox had received the varicella vaccine, all the\nchildren in the study had received the MMR vaccine,\nsuggesting that selection bias related to the likeli-\nhood of vaccination was not an important factor in\nthe study. Far fewer children with PCR-positive cases\nof chickenpox than their matched controls had re-\nceived the varicella vaccine.", "mimetype": "text/plain", "start_char_idx": 24631, "end_char_idx": 26635, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "30478ce1-585b-4290-b790-92a5b233d6ac": {"__data__": {"id_": "30478ce1-585b-4290-b790-92a5b233d6ac", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a743d653-e23f-4c37-9cef-d54c91f12f2a", "node_type": "1", "metadata": {}, "hash": "b714bb69d4089ab1b96696fe44dec6c9ddc4f0dde5f536f1e78a584bc5b8ecaa", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5d33927e-00c7-4919-aac5-507bfd9f0f08", "node_type": "1", "metadata": {}, "hash": "3161b68dace4a84a70c1cb5893f4ca270c957ba74cd9989167425b0358112933", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Far fewer children with PCR-positive cases\nof chickenpox than their matched controls had re-\nceived the varicella vaccine. If this difference (which\nresulted in an estimate of vaccine effectiveness of 85\npercent) were due to bias, a similar difference should\nalso have been observed between the children with\ncases that were negative or indeterminate by PCR and\ntheir matched controls. Such a difference would have\nindicated that the vaccine was also effective against\nillnesses associated with negative and indeterminate\nresults on a PCR assay for varicella\u2013zoster virus. How-\never, as expected, the vaccine was not effective against\nthese illnesses.\nThere was some risk that matching according to\npediatric practice might bias the results toward the\nnull hypothesis because of overmatching. However,\nthe effectiveness that we found, as well as the substan-\ntial variation in the proportion of controls from each\npractice who had been vaccinated, suggests that pos-\nsible overmatching did not have a substantial effect.\nIn summary, the effectiveness of the vaccine was\nexcellent. The great majority of breakthrough cases of\nchickenpox among vaccinated children were mild. We\nconclude that, thus far, the varicella vaccine, as it is\nused in clinical practice, is highly effective.\nSupported by a Robert Wood Johnson Foundation Minority Medical\nFaculty Development Award (to Dr. V\u00e1zquez), by grants from the National\nInstitutes of Health (RO1-AI41608, RO1-AI24021, and K24-AI01703),\nand by a grant to the Yale Children\u2019s Clinical Research Center from the\nGeneral Clinical Research Centers Program of the National Center for Re-\nsearch Resources (MO1-RR06022).\nWe are indebted to Nancy Holabird, Amy Margolis, and Valerie\nParcells for obtaining the data; to Dr.", "mimetype": "text/plain", "start_char_idx": 26513, "end_char_idx": 28272, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5d33927e-00c7-4919-aac5-507bfd9f0f08": {"__data__": {"id_": "5d33927e-00c7-4919-aac5-507bfd9f0f08", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "30478ce1-585b-4290-b790-92a5b233d6ac", "node_type": "1", "metadata": {}, "hash": "06fd46742415753fbb45c3729dcba7c467e63641d94c31a9122b833e9da8fe22", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "04134b00-3801-42d4-a448-1d97b3a6e38c", "node_type": "1", "metadata": {}, "hash": "26340829327cc898f7f150b065a286af75c36a0e4663280e9578a1279753e7b3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We are indebted to Nancy Holabird, Amy Margolis, and Valerie\nParcells for obtaining the data; to Dr. John Leventhal for his critique\nof the manuscript; and to the practitioners who participated in the\nstudy and allowed their patients to participate in it: P. Alvino, F.\nAnderson, R. Anderson, R. Angoff, B. Balch, G. Bogacki, E. Borsuk,\nK. Bradford, M. Brochin, N. Brown, C. Butler, C. Canny, M. Car-\njulo, J. Carlson, J. Cooley-Jacobs, N. Czarkowski, P. Davis, M. Dil-\nlaway, C. Dorfman, R. Dorr, G. Draper, D. Durante, O. Ehrlich,\nT. Etkin, D. Fahey, K. Fearn, B. Freeman, M. Gad, J. Geiger, V.\nGerdon, G. Germain, B. Giserman, L. Glassman, E. Gleich, L.\nGould, R. Halperin, J. Harper, J. Harwin, A. Hoefer, F. Holmes, J.\nHoogstra, C. Keana, K. Kennedy, K. Krieser, E. Lawrence, R. Leb-\novitz, D. Listman, M.C. Longo, A. Lustbader, C. Mann, F. McKee,\nA. Meyers, J. Morgan, J. Murphy, P. Murtagh, R. Nolfo, B. Parker,\nS. Perkins, A. Polletta, M. Porter, D.E. Rana, E. Rice, M. Robert,\nT. Rose, P. Ryan-Krause, M. Sanyal, R. Seligson, L. Semeraro, E.\nSmith, E. Springhorn, J. Stein, D. Sullivan, C. Summers, D. Torres,\nL. Waldman, M. Wakeman, G. Wanerka, C. Wechsler, R. Whelan,\nE. Wiesner, and J. Zelson.\nREFERENCES\n1.", "mimetype": "text/plain", "start_char_idx": 28172, "end_char_idx": 29391, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "04134b00-3801-42d4-a448-1d97b3a6e38c": {"__data__": {"id_": "04134b00-3801-42d4-a448-1d97b3a6e38c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5d33927e-00c7-4919-aac5-507bfd9f0f08", "node_type": "1", "metadata": {}, "hash": "3161b68dace4a84a70c1cb5893f4ca270c957ba74cd9989167425b0358112933", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ed869e31-0b34-4b2c-943c-fb4b3b4c0597", "node_type": "1", "metadata": {}, "hash": "abc2f6b60ddb3cd18c10288ec5ab44d320e3a5f9c79ae7f4659679665c0ded56", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "REFERENCES\n1. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. Live vaccine used \nto prevent the spread of varicella in children in hospital. Lancet 1974;2:\n1288-90.\n2. Prevention of varicella: recommendations of the Advisory Committee \non Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep \n1996;45(RR-11):1-36.\n3. Schaffer SJ, Bruno S. Varicella immunization practices and the factors \nthat influence them. Arch Pediatr Adolesc Med 1999;153:357-62.\n4. Clemens JD, Shapiro ED. Resolving the pneumococcal vaccine contro-\nversy: are there alternatives to randomized clinical trials? Rev Infect Dis \n1984;6:589-600.\n5. Weibel RE, Neff BJ, Kuter BJ, et al. Live attenuated varicella virus\nvaccine: efficacy trial in healthy children. N Engl J Med 1984;310:1409-\n15.\n6. Weibel RE, Kuter BJ, Neff BJ, et al. Live Oka/Merck varicella vaccine \nin healthy children: further clinical and laboratory assessment. JAMA 1985;\n245:2435-9.\n7. Gershon AA, Steinberg SP, Gelb L, et al. Live attenuated varicella vac-\ncine: efficacy for children with leukemia in remission. JAMA 1984;252:\n355-62.\n8. Johnson CE, Stancin T, Fattlar D, Rome LP, Kumar ML. A long-term \nprospective study of varicella vaccine in healthy children. Pediatrics 1997;\n100:761-6.\n9. Kuter BJ, Weibel RE, Guess HA, et al. Oka/Merck varicella vaccine in \nhealthy children: final report of a 2-year efficacy study and 7-year follow-\nup studies. Vaccine 1991;9:643-7.\n10. Clements DA, Armstrong CB, Ursano AM, Moggio MM, Walter EB, \nWilfert CM.", "mimetype": "text/plain", "start_char_idx": 29378, "end_char_idx": 30882, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ed869e31-0b34-4b2c-943c-fb4b3b4c0597": {"__data__": {"id_": "ed869e31-0b34-4b2c-943c-fb4b3b4c0597", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "04134b00-3801-42d4-a448-1d97b3a6e38c", "node_type": "1", "metadata": {}, "hash": "26340829327cc898f7f150b065a286af75c36a0e4663280e9578a1279753e7b3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8b890c95-f78b-40bd-a1a8-e61454397a84", "node_type": "1", "metadata": {}, "hash": "8644debf6d9ba059d8630d1e001fc077794991f8ce71c65b3bc025853baf0060", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine 1991;9:643-7.\n10. Clements DA, Armstrong CB, Ursano AM, Moggio MM, Walter EB, \nWilfert CM. Over five-year follow-up of Oka/Merck varicella vaccine \nrecipients in 465 infants and adolescents. Pediatr Infect Dis J 1995;14:\n874-9.\n11. Asano Y, Suga S, Yoshikawa T, et al. Experience and reason: twenty-\nyear follow-up of protective immunity of the Oka strain live varicella vac-\ncine. Pediatrics 1994;94:524-6.\n12. Asano Y. Varicella vaccine: the Japanese experience. J Infect Dis 1996;\n174:Suppl 3:S310-S313.\n13. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, Silverstein S. \nRestriction fragment length polymorphism of polymerase chain reaction \nproducts from vaccine and wild-type varicella-zoster virus isolates. J Virol \n1992;66:1016-20.\n14. Gustafson TL. TRUE EPISTAT manual. 5th ed. Richardson, Tex.: \nEpistat Services, 1994.\n15. Selvin S. Statistical analysis of epidemiologic data. 2nd ed. Vol. 25 of \nMonographs in epidemiology and biostatistics. New York: Oxford Univer-\nsity Press, 1996.\n16. SPSS for Windows, release 10.0: user\u2019s guide. Chicago: SPSS, 1999.\n17. EGRET for Windows: software for the analysis of biomedical and ep-\nidemiological studies: user manual. Cambridge, Mass.: Cytel Software, \n1999.\nThe New England Journal of Medicine is produced by NEJM Group, a division of the Massachusetts Medical Society.\nDownloaded from nejm.org at AP HP-Assistance Publique Hopitaux de Paris on January 9, 2025. For personal use only. \n No other uses without permission. Copyright \u00a9 2001 Massachusetts Medical Society. All rights reserved.\n960 \u00b7 N Engl J Med, Vol. 344, No.", "mimetype": "text/plain", "start_char_idx": 30784, "end_char_idx": 32380, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8b890c95-f78b-40bd-a1a8-e61454397a84": {"__data__": {"id_": "8b890c95-f78b-40bd-a1a8-e61454397a84", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Vazquez (2001).pdf", "node_type": "4", "metadata": {}, "hash": "8cb09345519bb5d5af51fd9fe6f9255d2057b46abf8b313c2f810025fadbcf1a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ed869e31-0b34-4b2c-943c-fb4b3b4c0597", "node_type": "1", "metadata": {}, "hash": "abc2f6b60ddb3cd18c10288ec5ab44d320e3a5f9c79ae7f4659679665c0ded56", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For personal use only. \n No other uses without permission. Copyright \u00a9 2001 Massachusetts Medical Society. All rights reserved.\n960 \u00b7 N Engl J Med, Vol. 344, No. 13 \u00b7 March 29, 2001 \u00b7 www.nejm.org\nThe New England Journal of Medicine\n18. Seward J, Peterson C, Mascola L, et al. Decline in varicella disease: \nevidence of vaccine impact. Pediatr Res 2000;47:Suppl:276A. abstract.\n19. Izurieta HS, Strebel PM, Blake P. Postlicensure effectiveness of varicella \nvaccine during an outbreak in a child care center. JAMA 1997;278:1495-9.\n20. Buchholz U, Moolenaar R, Peterson C, Mascola L. Varicella outbreaks \nafter vaccine licensure: should they make you chicken? Pediatrics 1999;104:\n561-3.\n21. Clements DA, Moreira SP, Coplan PM, Bland CL, Walter EB. Postli-\ncensure study of varicella vaccine effectiveness in a day-care setting. Pediatr \nInfect Dis J 1999;18:1047-50.\nCopyright \u00a9 2001 Massachusetts Medical Society.\nThe New England Journal of Medicine is produced by NEJM Group, a division of the Massachusetts Medical Society.\nDownloaded from nejm.org at AP HP-Assistance Publique Hopitaux de Paris on January 9, 2025. For personal use only. \n No other uses without permission. Copyright \u00a9 2001 Massachusetts Medical Society. All rights reserved.", "mimetype": "text/plain", "start_char_idx": 32219, "end_char_idx": 33465, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3fb243b1-f5ae-488f-8704-ba092792b9ac": {"__data__": {"id_": "3fb243b1-f5ae-488f-8704-ba092792b9ac", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aa1668da-e3ff-4486-abf8-942919b0be53", "node_type": "1", "metadata": {}, "hash": "0e6317b7a329ef86a1ac944f794bfccc51790d2b9a8eeef3b4d4587fb72e1edf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "998\u2002 |\u2002 www.pidj.com\t\nThe Pediatric Infectious Disease Journal\u2002 \u2022\u2002 Volume 32, Number 9, September 2013\nVaccine Reports\nBackground: Effectiveness of 1 dose of varicella vaccination was esti-\nmated to be 85\u201388% against clinical varicella of any severity in case-control \nstudies in non-European countries, but lower effectiveness has been dem-\nonstrated in outbreaks.\nMethods: A prospective, age- and practice-matched case-control study \nwas conducted in Germany to assess the effectiveness of 1 dose of OKA/\nGSK varicella vaccine (derived from the OKA strain, a Japanese clinical \nisolate) and of any varicella vaccine (including OKA/GSK, OKA/Merck \nand MMR-OKA/GSK) against polymerase chain reaction (PCR)-confirmed \nvaricella under conditions of routine use.\nResults: The cohort included 432 PCR-confirmed cases and 432 matched \ncontrols (1\u20137 years old). Varicella vaccination was reported for 13.2% \n(57/432) of cases and 45.1% (195/432) of controls. Median time since vac-\ncination was 28 and 25 months, respectively. Vaccinated cases experienced \nmilder disease (P < 0.0001) and shorter duration of disease (P = 0.004) \ncompared with unvaccinated cases. After adjusting for gender and school/\nday-care attendance, vaccine effectiveness of 1 dose of OKA/GSK against \nPCR-confirmed varicella of any severity was 71.5% (95% confidence inter-\nval [CI]: 49.1\u201384.0) and 94.7% (95% CI: 77.8\u201398.7) against PCR-con-\nfirmed moderate or severe varicella. Adjusted effectiveness for any varicella \nvaccine was 86.4% (95% CI: 77.3\u201391.8) against any severity and 97.7% \n(95% CI: 90.5\u201399.4) against moderate or severe varicella.\nConclusions: One dose of varicella vaccine provided high protection \nagainst moderate and severe varicella disease for a period of up to 5 years \nafter vaccination.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1782, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aa1668da-e3ff-4486-abf8-942919b0be53": {"__data__": {"id_": "aa1668da-e3ff-4486-abf8-942919b0be53", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3fb243b1-f5ae-488f-8704-ba092792b9ac", "node_type": "1", "metadata": {}, "hash": "2927486485646a1bc8d95150a198fee10e6aa1e080ddfe6ef1f7346a38bbac3f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9f164277-2729-4702-80a4-6f2f28278e0b", "node_type": "1", "metadata": {}, "hash": "069a36ce35cfaa46507c9f5784f85b60903bf3e718a4725fc72076a04e26a6a5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Conclusions: One dose of varicella vaccine provided high protection \nagainst moderate and severe varicella disease for a period of up to 5 years \nafter vaccination. However, further effectiveness data are needed to assess \nlong-term protection.\nKey Words: varicella, vaccination, Germany, children\n(Pediatr Infect Dis J 2013;32:998\u20131004)\nV\naricella, or chickenpox, is caused by the varicella-zoster virus \n(VZV), a highly communicable herpes virus with a secondary \nattack rate of up to 90% among susceptible household contacts. In \nunvaccinated populations, approximately 90% of varicella infec-\ntions occur in children between 1 and 14 years of age.1,2 Immu-\nnity after varicella disease is generally long lasting, but the virus \nremains latent in human nerve tissue and can reactivate, resulting \nin herpes zoster, particularly in individuals older than 50 years.3\nBefore the introduction of routine varicella vaccination in \nGermany, 62.5% of children had already been infected by varicella \nby the age of 5 years and 94.2% by 10\u201311 years of age.4 There were \nan estimated 14.1 varicella hospitalizations per 100,000 children in \nGermany.5 This was in the mid-range observed in other studies from \nEurope and the United States, with 0.9\u201329.4 hospitalizations per \n100,000 children.5 The most common varicella-associated compli-\ncations in hospitalized children in Germany were neurologic, skin \ninfection and gastrointestinal tract complications, with permanent \nsequelae reported in 1.7%.5,6 The estimated annual varicella-associ-\nated mortality rate before implementation of routine varicella vac-\ncination was 0.4/1,000,000 children <17 years of age in Germany7 \nand 0.65/1,000,000 children <20 years of age in the United States.8\nAlthough varicella vaccines are licensed in many countries, \nroutine childhood varicella vaccination is only implemented in Aus-\ntralia, Canada, Costa Rica, Ecuador, Germany, Greece, Italy (7 of 21 \nregions), Israel, Latvia, Luxembourg, Oman, Panama, Qatar, Saudi \nArabia,", "mimetype": "text/plain", "start_char_idx": 1618, "end_char_idx": 3628, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9f164277-2729-4702-80a4-6f2f28278e0b": {"__data__": {"id_": "9f164277-2729-4702-80a4-6f2f28278e0b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aa1668da-e3ff-4486-abf8-942919b0be53", "node_type": "1", "metadata": {}, "hash": "0e6317b7a329ef86a1ac944f794bfccc51790d2b9a8eeef3b4d4587fb72e1edf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6a46f61a-6fc4-4711-8847-0c393981a35f", "node_type": "1", "metadata": {}, "hash": "739fc0ef8f5f605e30e5352be25e1841359abe2013cc0e8dccd8debcbdf4dcdd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Canada, Costa Rica, Ecuador, Germany, Greece, Italy (7 of 21 \nregions), Israel, Latvia, Luxembourg, Oman, Panama, Qatar, Saudi \nArabia, South Korea, Spain (2 of 17 regions), Taiwan, the United \nArab Emirates, Uruguay and the United States.9\u201315 As the first coun-\ntry in Europe, Germany introduced routine varicella vaccination in \nJuly 2004, with 1 dose for all infants and children between 11 and \n14 months of age.16 In 2006, vaccination coverage for 1 dose of vari-\ncella vaccine among children 18\u201336 months was 38% in the area of \nMunich, increasing to 51% in 2007, to 53% in 2008 and 2009 and \nto 66% in 201017 (also Streng et al, unpublished data). Extrapolated \nnationwide coverage for Germany among 24-month-old children was \nestimated as 38% in 2006, 63% in 2007 and 78% in 2008.18 In 2009, \na 2-dose schedule was recommended for all ages, with both doses \napplied in the second year of life for all licensed varicella vaccines.19\nThe monovalent OKA/Merck vaccine (Varivax\u00ae; Merck, \nWhitehouse Station, NJ) was licensed in the United States in 1995, \nresulting in impressive decline of varicella incidence, hospitaliza-\ntions and mortality after implementation of the 1-dose vaccination \nCopyright \u00a9 2013 by Lippincott Williams & Wilkins\nISSN: 0891-3668/13/3209-0998\nDOI: 10.1097/INF.0b013e31829ae263\nThe Effectiveness of Varicella Vaccination in  \nChildren in Germany\nA Case-control Study\nJohannes G. Liese, MD,*\u2020 Carine Cohen, PhD,\u2021 Anita Rack, MD,\u2020 Kerstin Pirzer, MD,\u2020 Stefan Eber, MD,\u00a7 \nMaxim Blum, MSc,\u2021 Michael Greenberg, MD,\u2021\u00b6 and Andrea Streng, PhD*\u2020\nAccepted for publication April 1, 2013.", "mimetype": "text/plain", "start_char_idx": 3493, "end_char_idx": 5101, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6a46f61a-6fc4-4711-8847-0c393981a35f": {"__data__": {"id_": "6a46f61a-6fc4-4711-8847-0c393981a35f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9f164277-2729-4702-80a4-6f2f28278e0b", "node_type": "1", "metadata": {}, "hash": "069a36ce35cfaa46507c9f5784f85b60903bf3e718a4725fc72076a04e26a6a5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "97ae60aa-dc55-4532-a0bf-67dd155cfde9", "node_type": "1", "metadata": {}, "hash": "37690ebdf620bcdecfcdd53e0c0bbe27a1b068eebb89693b7d623a96ef23cb43", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "From the *Department of Paediatrics, University Hospital, W\u00fcrzburg; \u2020Depart-\nment of Paediatrics, University Hospital, Munich, Germany; \u2021GlaxoSmith-\nKline Vaccines, Wavre, Belgium; \u00a7Technical University Hospital, Munich, \nGermany; and \u00b6Sanofi Pasteur, Lyon, France.\nThe trial registration number was ClinicalTrials.gov NCT00679796.\nGlaxoSmithKline Biologicals SA (GSK) was the funding source and was involved \nin all stages of the study conduct and analysis. The investigators are indepen-\ndent from GSK. GSK also took responsibility for all costs associated with the \ndevelopment and publishing of the present article. The scientific writer was \npaid by GSK. All authors have completed the journal\u2019s Authorship Respon-\nsibility, Financial Disclosures, and Copyright Transfer form, and declare the \nfollowing: C.C. and M.B. are employees of GlaxoSmithKline group of com-\npanies, M.G. was employed by GlaxoSmithKline group of companies at the \ntime the study was performed, C.C. and M.G. own stock options in GSK, \nJ.G.L. and A.S. received a research grant for the submitted study from GSK \nand unconditional research grants for various epidemiological studies, J.G.L. \nreceived honoraria as consultant from GSK and Astra Zeneca, as well as for \nlectures from GSK, Astra Zeneca, Abbott and Wyeth, and received financial \nsupport from GSK Vaccines, Sanofi Pasteur and Wyeth for participation on \ncongresses, A.S. received an honorary as consultant from Sanofi Pasteur \nMSD and financial support from GSK for participation on congresses, A.R. \nand K.P. were employed as study physicians from the research grant for the \nsubmitted study, J.G.L., A.S. and A.R. received honoraria for presentations on \nthe study investigator meeting and A.R. has received a grant from CSL Beh-\nring and has received financial support from CSL Behring for participation on \nmeeting. The authors have no other funding or conflicts of interest to disclose.", "mimetype": "text/plain", "start_char_idx": 5103, "end_char_idx": 7034, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "97ae60aa-dc55-4532-a0bf-67dd155cfde9": {"__data__": {"id_": "97ae60aa-dc55-4532-a0bf-67dd155cfde9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6a46f61a-6fc4-4711-8847-0c393981a35f", "node_type": "1", "metadata": {}, "hash": "739fc0ef8f5f605e30e5352be25e1841359abe2013cc0e8dccd8debcbdf4dcdd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "43754de9-f9ee-4b76-adda-8ed45fed841d", "node_type": "1", "metadata": {}, "hash": "31029ad6f17dee6bc3d40b5e173a787f058df7b26de5bdde23a58d601ff54b4c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "has received a grant from CSL Beh-\nring and has received financial support from CSL Behring for participation on \nmeeting. The authors have no other funding or conflicts of interest to disclose.\nAddress for correspondence: Johannes G. Liese, MD, University Children\u2019s Hos-\npital, Pediatric Infectious Diseases and Immunology, Josef-Schneider-Str. 2, \nD-97080 W\u00fcrzburg, Germany. E-mail: Liese_j@klinik.uni-wuerzburg.de.\nSupplemental digital content is available for this article. Direct URL citations \nappear in the printed text and are provided in the HTML and PDF versions of \nthis article on the journal\u2019s website (www.pidj.com).", "mimetype": "text/plain", "start_char_idx": 6840, "end_char_idx": 7471, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "43754de9-f9ee-4b76-adda-8ed45fed841d": {"__data__": {"id_": "43754de9-f9ee-4b76-adda-8ed45fed841d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "97ae60aa-dc55-4532-a0bf-67dd155cfde9", "node_type": "1", "metadata": {}, "hash": "37690ebdf620bcdecfcdd53e0c0bbe27a1b068eebb89693b7d623a96ef23cb43", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c2a49a5e-cad7-4ccb-815c-384866dc694a", "node_type": "1", "metadata": {}, "hash": "1c87a6388364a5ae6d611ad7f1330276af7b16036a81c89d26de345ebbfa1cae", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Supplemental digital content is available for this article. Direct URL citations \nappear in the printed text and are provided in the HTML and PDF versions of \nthis article on the journal\u2019s website (www.pidj.com).\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8KKGKV0Ymy+78= on 01/09/2025\nThe Pediatric Infectious Disease Journal\u2002 \u2022\u2002 Volume 32, Number 9, September 2013\t\nVaricella Vaccination\n\u00a9 2013 Lippincott Williams & Wilkins\b\nwww.pidj.com\u2002 |\u2002999\nprogram.8,20\u201322 In case-control studies, OKA/Merck showed a \n1-dose vaccine effectiveness of 85% [95% confidence interval \n(CI): 78\u201390]23 and 87% (95% CI: 81\u201391)24 against varicella of any \nseverity and of 97% (95% CI: 93\u201399) against moderate or severe \ninfection,23 whereas the effectiveness of 2 doses was 98% (95% CI: \n84\u2013100) against varicella of any severity.25 Nevertheless, even in \nhighly vaccinated populations in the United States, varicella out-\nbreaks occurred frequently.26,27 Case-control studies from Israel \nand China on OKA/GSK (Varilrix\u00ae; GlaxoSmithKline, Wavre, Bel-\ngium) estimated the effectiveness of 88% (95% CI: 77\u201394) against \nclinical varicella of any severity and 100% against moderate or \nsevere illness,28 and 86% (95% CI: 73\u201393) against clinical vari-\ncella, respectively.29 None of the previously published OKA/GSK \ncase-control studies used laboratory-confirmed cases of varicella. \nFurthermore, no effectiveness data from case-control studies on \nvaricella vaccines are available from Europe thus far.", "mimetype": "text/plain", "start_char_idx": 7259, "end_char_idx": 8840, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c2a49a5e-cad7-4ccb-815c-384866dc694a": {"__data__": {"id_": "c2a49a5e-cad7-4ccb-815c-384866dc694a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "43754de9-f9ee-4b76-adda-8ed45fed841d", "node_type": "1", "metadata": {}, "hash": "31029ad6f17dee6bc3d40b5e173a787f058df7b26de5bdde23a58d601ff54b4c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dfb0a5fc-7f48-4fe5-a9e7-1eb9a0b75876", "node_type": "1", "metadata": {}, "hash": "f4f7d6f59e79d40f3afe9a776a99c0ea36e1e91ca701ebb5eb6fc4fd123cfd48", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Furthermore, no effectiveness data from case-control studies on \nvaricella vaccines are available from Europe thus far. The objective \nof the present case-control study was to assess the effectiveness of \n1 dose of OKA/GSK and of any marketed varicella vaccines (OKA/\nGSK, OKA/Merck and MMR-OKA/GSK) against varicella under \nconditions of routine use in pediatric practices in Germany.\nMATERIALS AND METHODS\nStudy Setting and Objectives\nFrom February 2008 to October 2010, a prospective, age- \nand practice-matched case-control study was conducted in 35 pedi-\natric practices caring for approximately one quarter of the pediatric \npopulation from the Munich (Bavaria) area and its adjacent districts. \nIn this area, there was an average annual pediatric population of \napproximately 238,000 children <17 years of age and 78,000 chil-\ndren <5 years of age during the years 2005 to 2010.30 The primary \nobjectives of the study were to assess the effectiveness of 1 dose \nof OKA/GSK against polymerase chain reaction (PCR)-confirmed \nvaricella of any severity. The effectiveness of 1 dose of any available \nvaricella vaccines, including OKA/GSK, OKA/Merck and MMR-\nOKA/GSK, was also studied, as well as the effectiveness against \nclinical varicella (ie, irrespective of laboratory confirmation).\nSample Size for Vaccine Effectiveness for 1 Dose \nof OKA/GSK\nSample size was estimated for the main objective of the \nstudy, that is, to measure vaccine effectiveness for 1 dose of \nOKA/GSK vaccine, under the following assumptions: vaccina-\ntion coverage of 25%, vaccine effectiveness of 80%, OKA/GSK \nrepresenting 60% of varicella vaccine used and 15% exclusion of \nPCR-confirmed cases due to absence of age-matched controls or \nto vaccination within a 28-day window. Under these assumptions, \nto provide 80% power that the lower limit of the 95% CI of vac-\ncine effectiveness would be >50%, enrollment was planned for at \nleast 420 PCR-confirmed varicella cases and an equal number of \nmatched controls.", "mimetype": "text/plain", "start_char_idx": 8721, "end_char_idx": 10719, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dfb0a5fc-7f48-4fe5-a9e7-1eb9a0b75876": {"__data__": {"id_": "dfb0a5fc-7f48-4fe5-a9e7-1eb9a0b75876", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c2a49a5e-cad7-4ccb-815c-384866dc694a", "node_type": "1", "metadata": {}, "hash": "1c87a6388364a5ae6d611ad7f1330276af7b16036a81c89d26de345ebbfa1cae", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d80df529-199f-4c74-b482-82f105128887", "node_type": "1", "metadata": {}, "hash": "f101a8a3a639156205689aa4d0b57ddf437240cc7e0d7545ac4058cfb5946460", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Inclusion and Exclusion Criteria\nChildren at least 1 year of age, born on or after July 1, \n2003, who had their residence in Germany, at least 1 previous \nwell-child visit to the practice, and for whom written informed \nconsent was provided, were eligible to participate as cases if they \nhad suspected clinical varicella disease at the time of study entry. \nChildren matched by age and pediatric practice, fulfilling the same \ncriteria as cases but without history or present clinical diagnosis of \nvaricella, were eligible to be included as controls. Children were \nexcluded from participating as a case or control if they had any \nhistory of hypersensitivity to any component of the varicella vac-\ncines, a congenital or acquired immunodeficiency, were receiving \ntreatment with immunosuppressive therapy, had a previous history \nof varicella by physician records or parental report or had a lack of \ndocumented vaccination history.\nStudy Recruitment and Procedures\nFor all potential varicella cases, the child\u2019s pediatrician \ninformed the study physician. After the parents or guardians pro-\nvided informed consent, the study physician visited the child at \nhome, preferably within 5 days of varicella onset. Up to 3 sam-\nples were obtained per child for PCR confirmation of varicella. \nClinical information including the date of onset of rash, number of \nlesions, type of lesions, presence of fever or other symptoms and \nan assessment of severity of disease were recorded. The study phy-\nsician was blinded to the child\u2019s varicella vaccination status until \nclinical assessment was completed. At the end of the home visit, \nthe vaccination status was documented according to the child\u2019s vac-\ncination card. The child\u2019s pediatrician collected data from medical \nrecords including demographic data, the child\u2019s medical history and \nvaccination status [for varicella and for measles-mumps-rubella \n(MMR)] as documented in the patient chart. Follow-up data on dis-\nease outcome and complications were obtained by phone call with \nthe parent or guardian 2\u20134 weeks after study visit.\nOne age- and practice-matched control child per case child \nwas recruited after a standardized procedure by identifying the \nchild closest in date of birth to the case child from the practice \nrecords.", "mimetype": "text/plain", "start_char_idx": 10720, "end_char_idx": 13005, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d80df529-199f-4c74-b482-82f105128887": {"__data__": {"id_": "d80df529-199f-4c74-b482-82f105128887", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dfb0a5fc-7f48-4fe5-a9e7-1eb9a0b75876", "node_type": "1", "metadata": {}, "hash": "f4f7d6f59e79d40f3afe9a776a99c0ea36e1e91ca701ebb5eb6fc4fd123cfd48", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3d6fece6-cdbf-4630-8fd2-56d244f229b5", "node_type": "1", "metadata": {}, "hash": "293c11540f18fbe8467524afc2b96652c842938d2afe3da3716b97a0385e6341", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "One age- and practice-matched control child per case child \nwas recruited after a standardized procedure by identifying the \nchild closest in date of birth to the case child from the practice \nrecords. In case this child did not fulfill the inclusion criteria for \ncontrols, or if the parent/guardian could not be contacted within an \ninterval of 2 days with at least 3 attempts, the child with the next \nclosest date of birth was identified. Once a control was eligible and \nwritten consent had been provided, the child\u2019s medical history and \nvaccination status were obtained from the practice medical records. \nThe pediatrician verified these data and supplemented demographic \ndata by calling the parents or guardians by phone.\nCases were classified as vaccinated varicella cases if they \nhad received OKA/GSK, OKA/Merck or the combined MMR-\nOKA/GSK vaccine at least 28 days before varicella onset. Con-\ntrols were classified as vaccinated if they had received OKA/GSK, \nOKA/Merck or MMR-OKA/GSK vaccine at least 28 days before \nvaricella onset in the matched case. Severity assessment of vari-\ncella disease was based on a clinical scale as used in a previous \nstudy.23 A severity score of \u22647 was classified as mild, 8\u201315 was \nclassified as moderate, and a score of \u226516 was classified as severe \nvaricella disease.\nThe study protocol, any amendments, the informed consent \nand other information that required preapproval were reviewed \nand approved by regional and investigational center Institutional  \nEthics Committee or Institutional Review Board, Ethical Commit-\ntee of the Medical Faculty of the University of Munich and the \nEthical Committee of the Bavarian Medical Association.\nLaboratory Analysis\nSpecimens from skin lesions were collected by unroof-\ning a fluid-filled vesicle, scabs or crusts with a sterile needle. If \nvesicular fluid was not sufficient or lesions were dry, samples \nwere collected by gently rubbing the base of the lesions. Speci-\nmens were stored and transported at \u221220\u00b0C and, after shipment \nto the central laboratory (GlaxoSmithKline Vaccines), varicella \ninfection was confirmed by the detection of VZV DNA through \nquantitative PCR (qPCR).", "mimetype": "text/plain", "start_char_idx": 12804, "end_char_idx": 14983, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3d6fece6-cdbf-4630-8fd2-56d244f229b5": {"__data__": {"id_": "3d6fece6-cdbf-4630-8fd2-56d244f229b5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d80df529-199f-4c74-b482-82f105128887", "node_type": "1", "metadata": {}, "hash": "f101a8a3a639156205689aa4d0b57ddf437240cc7e0d7545ac4058cfb5946460", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1a371629-4354-45ad-8953-46cdbb9be0f0", "node_type": "1", "metadata": {}, "hash": "2e7e798637a77874c353d8e5602f3ce1e88be3b5e3e227ebb46a5152810d6d89", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This qPCR VZV technique was used \nto amplify a VZV open reading frame 62 region.31 Samples were \nconsidered positive for VZV DNA if the qPCR signal exceeded \nthe copy number limit of detection determined by VZV DNA \nstandard curve. To confirm DNA integrity for samples that were \nVZV DNA negative, qPCR for the housekeeping gene, actin, was  \nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8KKGKV0Ymy+78= on 01/09/2025\nLiese et al\t\nThe Pediatric Infectious Disease Journal\u2002 \u2022\u2002 Volume 32, Number 9, September 2013\n1000\u2002 |\u2002 www.pidj.com\b\n\u00a9 2013 Lippincott Williams & Wilkins\nperformed. If a sample was VZV DNA and actin negative, it was \nconsidered an invalid (indeterminate) result. Primer and probe sets \nspecific for VZV (forward: 5\u2032 gtggccctcgagaggtgg 3\u2032, reverse: 5\u2032 \ncaaaggtgcgcgacgatg 3\u2032, probe: 5\u2032 FAM-ccgggccgtgtttgcatcg-BHQ \n3\u2032) and actin (forward: 5\u2032 ctggaacggtgaaggtgaca 3\u2032, reverse: 5\u2032 ggc-\ncacattgtgaactttg 3\u2032, probe: 5\u2032 FAM-cagtcggttggagcgagcatccc-EDQ \n3\u2032) were used in the following PCR program: uracil DNA glycosy-\nlase, activation 50\u00b0C/2 minutes, 95\u00b0C for 10 minutes followed by \n40 cycles of 95\u00b0C/15 seconds (denaturation) and 60\u00b0C/60 seconds \n(annealing/extension). In cases with >1 laboratory result per child, \nat least 1 positive result was considered positive for varicella.", "mimetype": "text/plain", "start_char_idx": 14984, "end_char_idx": 16376, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1a371629-4354-45ad-8953-46cdbb9be0f0": {"__data__": {"id_": "1a371629-4354-45ad-8953-46cdbb9be0f0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3d6fece6-cdbf-4630-8fd2-56d244f229b5", "node_type": "1", "metadata": {}, "hash": "293c11540f18fbe8467524afc2b96652c842938d2afe3da3716b97a0385e6341", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "554c24d8-15a9-4846-8298-e9243702e39f", "node_type": "1", "metadata": {}, "hash": "2f8fecfbbe82fb9ae5552be983956675c04b8dadca0490cab98bdc623e16326d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In cases with >1 laboratory result per child, \nat least 1 positive result was considered positive for varicella. The \nlaboratory personnel analyzing the specimens were not aware of \nthe participant\u2019s vaccination status.\nStatistical Analysis\nStatistical analyses were conducted using the \u201caccording to \nprotocol\u201d (ATP)-confirmed cases cohort and their matched controls \n(Fig., Supplemental Digital Content 1, http://links.lww.com/INF/\nB579). Analysis of vaccine effectiveness for clinical varicella was \nperformed on the ATP-enrolled cases and ATP-matched control \ncohort, including additional varicella cases with negative or inde-\nterminate PCR results and their matched controls. Fisher\u2019s exact \ntest was used for statistical comparison of categorical variables. \nWilcoxon rank-sum test was used to assess statistical significance \nbetween groups for continuous variables. All P values were 2-sided, \nand results were considered statistically significant if the 2-tailed P \nvalue was <0.05.\nMultiple logistic regression was used to model the relation-\nship between the probability of having varicella and varicella vac-\ncination, adjusting for possible confounders. Model building was \nperformed through a forward selection strategy combined with prior \nknowledge of possible confounders.23,29 Selection started from the \nbasic model (varicella vaccination) and, based on the literature, also \nincluded gender and school or day-care attendance. Other variables \n[treatment with steroids or other immunosuppressants, presence of \nasthma, country of birth (Germany or other), receipt of varicella vac-\ncine within 28 days of receiving MMR vaccine, preexisting medical \nconditions, type of health insurance (social/private), total number of \nwell-baby visits and number of sick-child visits over the preceding \n12 months] were introduced individually and were retained in the \nmodel if they were statistically significant at the P = 0.05 level.\nVaccine effectiveness was calculated as 1 minus the matched \nodds ratio multiplied by 100%. The matched odds ratio for vaccina-\ntion was calculated using conditional logistic regression, with asso-\nciated P values and 95% CIs. To estimate the effect of time since \nvaccination, a dummy variable was created for each possible year \nduring which vaccinated children could have developed the disease.", "mimetype": "text/plain", "start_char_idx": 16264, "end_char_idx": 18605, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "554c24d8-15a9-4846-8298-e9243702e39f": {"__data__": {"id_": "554c24d8-15a9-4846-8298-e9243702e39f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1a371629-4354-45ad-8953-46cdbb9be0f0", "node_type": "1", "metadata": {}, "hash": "2e7e798637a77874c353d8e5602f3ce1e88be3b5e3e227ebb46a5152810d6d89", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "46ace99f-2cd4-4b71-ae88-8cf6f3176c87", "node_type": "1", "metadata": {}, "hash": "d92f7648d08d3f295fee59481970aef8d9c7af0e7199afa0622e9b1854b3aea2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "To estimate the effect of time since \nvaccination, a dummy variable was created for each possible year \nduring which vaccinated children could have developed the disease. \nStatistical analyses were performed using SAS version 9.2 (SAS \nInstitute Inc., Cary, NC).\nRESULTS\nRecruitment\nBetween February 2008 and June 2010, 35 pediatric prac-\ntices reported 908 clinically suspected varicella cases; 81.8% of \nthese potential cases were seen in the practice, 17.4% diagnosed \nby phone and 0.8% identified otherwise. Ultimately, 480 cases and \ntheir matched controls met the criteria for inclusion in the ATP-\nenrolled cohort (Fig., Supplemental Digital Content 1, http://links.\nlww.com/INF/B579). Ninety percent (432/480) of cases had posi-\ntive PCR results and 10% (48/480) had negative or indeterminate \nPCR results, resulting in an ATP-confirmed cohort of 432 cases and \n432 matched controls.\nGeneral Characteristics of Cases and Controls\nGeneral characteristics of the 432 cases and their matched \ncontrols are shown in Table\u00a01. Demographic characteristics of cases \nand controls were similar, except that cases had attended day care \nfor a median of 17 days during the month before the onset of vari-\ncella compared with 20 days in the controls (P < 0.0001; Table\u00a01).\nRegarding the vaccination status of the 432 varicella cases, \n375 (86.8%) were not vaccinated against varicella, 55 (12.7%) had \nreceived 1 dose of any varicella vaccine and 2 (0.5%) had received \n2 doses of any varicella vaccine (Table\u00a01). Of the 55 cases vac-\ncinated with 1 dose, 35 (63.6%) had received OKA/GSK and 19 \n(34.5%) either OKA/Merck [15 (27.3%)] or MMR-OKA/GSK \n[4 (7.3%)]; vaccine type was unknown in 1 case (1.8%; Table\u00a01). \nThe mean age at the time of the first dose of any varicella vac-\ncine was 1.1 years (standard deviation 0.7) among vaccinated con-\nfirmed cases.", "mimetype": "text/plain", "start_char_idx": 18435, "end_char_idx": 20290, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "46ace99f-2cd4-4b71-ae88-8cf6f3176c87": {"__data__": {"id_": "46ace99f-2cd4-4b71-ae88-8cf6f3176c87", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "554c24d8-15a9-4846-8298-e9243702e39f", "node_type": "1", "metadata": {}, "hash": "2f8fecfbbe82fb9ae5552be983956675c04b8dadca0490cab98bdc623e16326d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "022a0787-3714-44c1-b284-e2232bbfe814", "node_type": "1", "metadata": {}, "hash": "ba1f8a130f2e9edced783baf82133cc3ff82bec51a0098d01961feadd4b2c33d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The mean age at the time of the first dose of any varicella vac-\ncine was 1.1 years (standard deviation 0.7) among vaccinated con-\nfirmed cases. The median time since vaccination was 28 months \n(range: 5\u201357; interquartile range: 20; Q1: 18; Q3: 38). A total of \n343 (79.4%) cases had received at least 1 dose of an MMR vac-\ncine (with any available MMR vaccine or MMR-OKA/GSK). Of \nthese, 337 (98.3%) received solely MMR vaccine (80.5% received \n2 doses, 17.8% received 1 dose).\nA higher proportion of controls had received varicella vac-\ncination compared with cases (45.1% versus 13.2%, P < 0.0001; \nTable\u00a0 1). Among the controls, 237 (54.9%) were unvaccinated \nagainst varicella, 153 (35.4%) had received 1 dose of any vari-\ncella vaccine and 42 (9.7%) had received 2 doses of any varicella \nvaccine. Of the 153 controls vaccinated with 1 dose, 63 (41.2%) \nhad received OKA/GSK and 87 (56.9%) either OKA/Merck [73 \n(47.7%)] or MMR-OKA/GSK [14 (9.2%)]; vaccine type was \nunknown for 3 controls (2.0%; Table\u00a01). The mean age at the time \nof the first dose of any varicella vaccine was 1.3 years (standard \ndeviation 1.1) among vaccinated controls. The median time since \nvaccination was 25 months (range: 1\u201354; interquartile range: 22). \nThe proportion of children receiving any MMR vaccination (any \nMMR vaccine or MMR-OKA/GSK) was not different among cases \nand controls (Table\u00a01).", "mimetype": "text/plain", "start_char_idx": 20146, "end_char_idx": 21530, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "022a0787-3714-44c1-b284-e2232bbfe814": {"__data__": {"id_": "022a0787-3714-44c1-b284-e2232bbfe814", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "46ace99f-2cd4-4b71-ae88-8cf6f3176c87", "node_type": "1", "metadata": {}, "hash": "d92f7648d08d3f295fee59481970aef8d9c7af0e7199afa0622e9b1854b3aea2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b262be08-ebc5-434d-b893-302028f4998b", "node_type": "1", "metadata": {}, "hash": "8d5f7eea313adf3856365ad9d0e771f4d8672458a8bdd2645f1f933c2e715751", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The proportion of children receiving any MMR vaccination (any \nMMR vaccine or MMR-OKA/GSK) was not different among cases \nand controls (Table\u00a01).\nComparison of Vaccinated and Unvaccinated \nCases\nOnset of varicella, both in the 57 vaccinated and 375 unvac-\ncinated confirmed cases, varied by season, first usually with an \nincrease in November and peaking in spring (Fig., Supplemental \nDigital Content 2, http://links.lww.com/INF/B580). A comparison \nof the vaccinated and unvaccinated cases is given in Table\u00a0 2. A \ngreater proportion of unvaccinated versus vaccinated cases expe-\nrienced fever after the onset of varicella (61.0% versus 35.7%). \nUnvaccinated cases also had a higher median severity of disease \nscore (8 versus 5, P < 0.0001) and more lesions compared with \nvaccinated cases (12.3% of unvaccinated cases had 1\u201350 lesions \nversus 61.4% of vaccinated cases, P < 0.0001). Median duration \nof varicella was 1 day longer in unvaccinated compared with vac-\ncinated cases (9 versus 8 days, P = 0.0041).\nSystemic signs after the onset of varicella were reported for \n1 of the 57 vaccinated cases (1.8%) and for 37 of the 375 unvac-\ncinated cases (9.9%). The majority of systemic signs were pain in \nthe back or abdomen (in 1 vaccinated case and in 35 unvaccinated \ncases); 1 unvaccinated case presented with interstitial pneumonia. \nOverall, 43 vaccinated cases (75.4%) and 353 of unvaccinated cases \n(94.1%) reported medical treatment during the illness. The most \nfrequently reported medication was antipyretic, reported for 3 vac-\ncinated cases and 48 unvaccinated cases. Eleven (19.3%) of 57 vac-\ncinated case patients needed an additional physician consultation for \nvaricella treatment.", "mimetype": "text/plain", "start_char_idx": 21385, "end_char_idx": 23087, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b262be08-ebc5-434d-b893-302028f4998b": {"__data__": {"id_": "b262be08-ebc5-434d-b893-302028f4998b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "022a0787-3714-44c1-b284-e2232bbfe814", "node_type": "1", "metadata": {}, "hash": "ba1f8a130f2e9edced783baf82133cc3ff82bec51a0098d01961feadd4b2c33d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cd0efde0-268f-402f-827c-ebb0639968f0", "node_type": "1", "metadata": {}, "hash": "e1bc154922f9b77ad3e673a511a50da84a982a3ca86c04e854e76d489dbe5c02", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Eleven (19.3%) of 57 vac-\ncinated case patients needed an additional physician consultation for \nvaricella treatment. In comparison, 64 (17.1%) of 375 unvaccinated \ncase patients needed a medical visit; of these, 61 needed physician \nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8KKGKV0Ymy+78= on 01/09/2025\nThe Pediatric Infectious Disease Journal\u2002 \u2022\u2002 Volume 32, Number 9, September 2013\t\nVaricella Vaccination\n\u00a9 2013 Lippincott Williams & Wilkins\b\nwww.pidj.com\u2002 |\u20021001\nconsultations and 3 emergency room visits; 1 child was hospitalized \ndue to pneumonia. None of the vaccinated cases but 24 (6.4%) of the \nunvaccinated cases reported sequelae of permanent scars.\nMultiple Logistic Regression Analyses\nAll vaccine effectiveness models were adjusted for gender \nand school or day-care attendance; all other variables were excluded \nfrom the model during the modeling process as they were not sta-\ntistically significant (at P = 0.05 level). Unadjusted and adjusted \nvalues for vaccine effectiveness were very similar for all estimates \n(Table\u00a03). The primary outcomes were an adjusted effectiveness of \n1 dose against PCR-confirmed varicella of any severity of 71.5% \n(95% CI: 49.1\u201384.0) for OKA/GSK and 86.4% (95% CI: 77.3\u2013\n91.8) for any varicella vaccine, including OKA/GSK (Table\u00a03). The \nadjusted effectiveness against PCR-confirmed moderate or severe \nvaricella was 94.7% (95% CI: 77.8\u201398.7) for OKA/GSK and \n97.7% (95% CI: 90.5\u201399.4) for any varicella vaccine (including \nOKA/GSK).", "mimetype": "text/plain", "start_char_idx": 22970, "end_char_idx": 24556, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cd0efde0-268f-402f-827c-ebb0639968f0": {"__data__": {"id_": "cd0efde0-268f-402f-827c-ebb0639968f0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b262be08-ebc5-434d-b893-302028f4998b", "node_type": "1", "metadata": {}, "hash": "8d5f7eea313adf3856365ad9d0e771f4d8672458a8bdd2645f1f933c2e715751", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c38e94b8-7b10-4c5a-9ab8-c12845d0952a", "node_type": "1", "metadata": {}, "hash": "eb75cf0501652540e098a3c4f9b9fd13d922d9c80c64722cd71579ddc30d8660", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The effectiveness of 1 dose of any varicella vaccine \n(including OKA/GSK) against clinical varicella of any severity \n(including 48 cases with negative or indeterminate PCR results) \nwas 81.1% (95% CI: 71.0\u201387.7; unadjusted) and 81.2% (95% CI: \n71.2\u201387.8; adjusted). The effectiveness of 2 doses of any varicella \nvaccine (including OKA/GSK) against PCR-confirmed varicella \nof any severity was high in both the unadjusted (94.3%, 95% CI: \n76.2\u201398.6) and the adjusted (94.3%, 95% CI: 76.4\u201398.6) model. \nAge at vaccination (<15 months or \u226515 months) did not have an \neffect on vaccine effectiveness, neither as a main effect nor in inter-\naction with time since vaccination. The effectiveness of 1 dose of \nOKA/GSK or any varicella vaccine against PCR-confirmed severe \nvaricella could not be evaluated due to the low number of severe \ncases (no vaccinated and only 3 unvaccinated severe cases).\nThe effectiveness of 1 dose of OKA/GSK was 84.6% \n(95% CI: 31.8\u201396.5) up to 1 year after vaccination, 41.9% (95%  \nCI: \u221252.6 to 77.9) during the second year after vaccination and \n75.9% (95% CI: \u221220.8 to 95.2) 4\u20135 years after vaccination. With \nany varicella vaccine, it was 94.5% (95% CI: 76.9\u201398.7) up to 1 \nyear after vaccination, 81.5% (95% 56.8\u201392.1) in the second year \nafter vaccination and 73.2% (95% CI: 9.1\u201392.1) 4\u20135 years after \nvaccination (Fig.\u00a01).", "mimetype": "text/plain", "start_char_idx": 24557, "end_char_idx": 25913, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c38e94b8-7b10-4c5a-9ab8-c12845d0952a": {"__data__": {"id_": "c38e94b8-7b10-4c5a-9ab8-c12845d0952a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cd0efde0-268f-402f-827c-ebb0639968f0", "node_type": "1", "metadata": {}, "hash": "e1bc154922f9b77ad3e673a511a50da84a982a3ca86c04e854e76d489dbe5c02", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a3893a42-362e-4c76-9e89-03d5d98c38ce", "node_type": "1", "metadata": {}, "hash": "a768cbc55ba3c9989843521a273296a0beec9db34fe9ae77b11610bf3535e9f4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The difference in effectiveness over the entire \nperiod was not statistically significant, with a global P value for \nequality test between all years of 0.543 for OKA/GSK and 0.235 \nfor any varicella vaccine (including OKA/GSK).\nDISCUSSION\nPrincipal Findings\nThis is the first case-control epidemiological study of the \neffectiveness of 1-dose varicella vaccination under conditions of \nroutine use in Europe. Children with varicella in this study were \nbetween 1 and 6 years of age; 87% were unvaccinated. Vaccinated \ncases had received the vaccine at a median time of 28 months before \nthe onset of disease. As seen previously,20 breakthrough cases in var-\nicella-vaccinated children had a significantly milder clinical course \nwhen compared with cases among unvaccinated children, with fewer \nlesions and a shorter duration of disease. The adjusted effectiveness \nof 1 dose of OKA/GSK against PCR-confirmed varicella disease of \nany severity was 71.5% (95% CI: 49.1\u201384.0), and for all investigated \nvaricella vaccines (including OKA/GSK, OKA/Merck and MMR-\nOKA/GSK), the effectiveness was 86.4% (95% CI: 77.3\u201391.8). With \nregard to moderate or severe PCR-confirmed varicella, the effective-\nness of OKA/GSK was 94.7% (95% CI: 77.8\u201398.7), similar to the \n97.7% (95% CI: 90.5\u201399.4) effectiveness for any varicella vaccine.\nTABLE 1.\u2003 Comparison of Demographics and Vaccination History of Confirmed Varicella Cases and Matched Controls \n(ATP Cohort for Confirmed Cases and Matched Controls)\nCases  \n(N = 432)\nControls  \n(N = 432)\nP\nAge, yr\n\u2003 \u0007Median\n\u2003 \u0007Range\n3.0\n1\u20136\n4.0\n1\u20137\n0.3148\nMale gender\n217 (50.2%)\n220 (50.9%)\n0.8918\nMedian number of previous well-child visits\n8.0\n8.0\n0.", "mimetype": "text/plain", "start_char_idx": 25914, "end_char_idx": 27592, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a3893a42-362e-4c76-9e89-03d5d98c38ce": {"__data__": {"id_": "a3893a42-362e-4c76-9e89-03d5d98c38ce", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c38e94b8-7b10-4c5a-9ab8-c12845d0952a", "node_type": "1", "metadata": {}, "hash": "eb75cf0501652540e098a3c4f9b9fd13d922d9c80c64722cd71579ddc30d8660", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7f2bee7d-1f6f-4da2-a4e4-3befd79ef5c2", "node_type": "1", "metadata": {}, "hash": "ec1fa1f73d2c43e3cd611a948bfc01b9390546099cc3d657ce04883cbb948239", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3148\nMale gender\n217 (50.2%)\n220 (50.9%)\n0.8918\nMedian number of previous well-child visits\n8.0\n8.0\n0.1517\nPreexisting medical condition\n78 (18.1%)\n100 (23.1%)\n0.0771\nDay-care attendance\n363 (84.0%)\n351 (81.3%)\n0.3232\nMedian number of days in day care (per month)\n17.0\n20.0\n<0.0001\nSchool attendance\n7 (1.6%)\n6 (1.4%)\n1.000\nHealth insurance\n\u2003 \u0007Statutory\n\u2003 \u0007Private\n295 (68.3%)\n137 (31.7%)\n282 (65.3%)\n150 (34.7%)\n0.3861\nReceived any MMR vaccination (MMR or MMR vaccine)\n343 (79.4%)\n357 (82.6%)\n0.2594\nReceived any varicella vaccination\n57 (13.2%)\n195 (45.1%)\n<0.0001\nAmong vaccinated cases/controls only\n(n = 57)\n(n = 195)\nNumber of doses of varicella vaccine administered more than 28 days before onset/ \nfocal time*\n0.0011\n\u2003 \u00071\n55 (96.5%)\n153 (78.5%)\n\u2003 \u00072\n2 (3.5%)\n42 (21.5%)\nAge of first vaccination is <12 mo\n8 (14.0%)\n38 (19.5%)\n0.4372\nAge of first vaccination is <15 mo\n41 (71.9%)\n114 (58.5%)\n0.0882\nType of varicella vaccine for doses >28 days before onset/focal time\n<0.0001\n\u2003 \u0007OKA/GSK (1 dose)\n35 (61.4%)\n63 (32.3%)\n\u2003 \u0007OKA/GSK (2 doses)\n0 (0.0%)\n6 (3.1%)\n\u2003 \u0007Other than OKA/GSK (1 dose)\u2020\n19 (33.3%)\n87 (44.6%)\n\u2003 \u0007Other than OKA/GSK (2 doses)\u2020\n2 (3.", "mimetype": "text/plain", "start_char_idx": 27490, "end_char_idx": 28646, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7f2bee7d-1f6f-4da2-a4e4-3befd79ef5c2": {"__data__": {"id_": "7f2bee7d-1f6f-4da2-a4e4-3befd79ef5c2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a3893a42-362e-4c76-9e89-03d5d98c38ce", "node_type": "1", "metadata": {}, "hash": "a768cbc55ba3c9989843521a273296a0beec9db34fe9ae77b11610bf3535e9f4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8615f1ba-dda7-4301-b254-1ec63028c748", "node_type": "1", "metadata": {}, "hash": "c223e17a872faefa44811381e7d7fae4fd07e241e5a8a9186c12e566798d9294", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3%)\n87 (44.6%)\n\u2003 \u0007Other than OKA/GSK (2 doses)\u2020\n2 (3.5%)\n25 (12.8%)\n\u2003 \u00071 dose of OKA/GSK and 1 dose of other (2 doses)\u2020\n0 (0.0%)\n11 (5.6%)\n\u2003 \u0007Unknown (1 dose)\n1 (1.8%)\n3 (1.5%)\n*Missing data: varicella vaccination dose number was missing for 1 control participant.\n\u2020\u201cOther than OKA/GSK\u201d includes OKA/Merck and MMR-OKA/GSK.\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8KKGKV0Ymy+78= on 01/09/2025\nLiese et al\t\nThe Pediatric Infectious Disease Journal\u2002 \u2022\u2002 Volume 32, Number 9, September 2013\n1002\u2002 |\u2002 www.pidj.com\b\n\u00a9 2013 Lippincott Williams & Wilkins\nExploratory analyses of vaccine effectiveness over time were \nnot powered to measure a potential decrease in effectiveness accord-\ning to time since vaccination. The difference in effectiveness by year \nwas not statistically significant. The apparent decrease in vaccine \neffectiveness according to time since vaccination after 1 dose vari-\ncella vaccination should be interpreted with caution. Other authors \nhave suggested that this could potentially reflect waning immunity, \nand/or the age-specific incidence of varicella, which peaks around \n4\u20135 years of age in countries that do not vaccinate routinely, and at \nan older age if vaccination coverage increases.27,32 The vaccine effec-\ntiveness per year follows the same pattern as reported by Fu et al,29 \nwith the highest vaccine effectiveness during the first year after vac-\ncination and the lowest in the second year after vaccination.", "mimetype": "text/plain", "start_char_idx": 28593, "end_char_idx": 30136, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8615f1ba-dda7-4301-b254-1ec63028c748": {"__data__": {"id_": "8615f1ba-dda7-4301-b254-1ec63028c748", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7f2bee7d-1f6f-4da2-a4e4-3befd79ef5c2", "node_type": "1", "metadata": {}, "hash": "ec1fa1f73d2c43e3cd611a948bfc01b9390546099cc3d657ce04883cbb948239", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "78b494ca-ca34-4f58-b9b5-05bc7b2530a6", "node_type": "1", "metadata": {}, "hash": "15c469c4a7ab52c566f6c3457176a3394d24f0868edc4fbb4fd6e3d7ab555bdd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The drop \nin effectiveness in the second year after vaccination followed by an \nincrease in the following year observed in both studies may be due \nto the effect of age corresponding to the entry to child-care units \nor school.32,33 Frequent outbreaks after vaccination with 1 dose,26 \nthought to be mainly due to primary vaccine failure34 and partly due \nto waning immunity,32 resulted in the recommendation of a second \ndose of varicella vaccine in childhood vaccination programs both \nin the United States in 200735,36 and in Germany in 2009.19 In the \npresent study, the effectiveness of 2 doses of any varicella vaccine \n(94.3%, 95% CI: 76.4\u201398.6) was similar to what was found in a US-\nbased study of 2 doses of OKA/Merck (98.3%, 95% CI: 83.5\u2013100).25\nStrengths and Limitations\nStrengths of our study were the prospective design with \npredefined case definitions, including PCR confirmation of cases, \nand assessment of the clinical status and severity of disease for all \nenrolled cases by a trained study physician. Due to the restriction to \na specific geographic area, the study population was homogenous; \nin the enrolled cohort, there was no indication of bias.33,37 Both \ncases and controls were routine clients of the participating practices \nwith similar frequencies of well- and sick-child visits, and vaccina-\ntion status according to practice record and vaccination cards of the \ncases were in good accordance, suggesting that misclassifications \nTABLE 2.\u2003 Comparison of Vaccinated and Unvaccinated Confirmed Varicella Cases (ATP \nCohort for Confirmed Cases)\nVaccinated\n(N = 57)\nUnvaccinated\n(N = 375)\nP\nAge, yr\n\u2003 \u0007Median\n\u2003 \u0007Range\n3.0\n1\u20136\n3.0\n1\u20136\n0.7298\nMale gender\n34 (59.6%)\n183 (48.8%)\n0.1550\nDay-care attendance\n54 (94.7%)\n309 (82.4%)\n0.0184\nMedian number of days in day care\n17.0\n17.0\n0.9684\nPreexisting medical condition*\n9 (15.8%)\n69 (18.", "mimetype": "text/plain", "start_char_idx": 30137, "end_char_idx": 31999, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "78b494ca-ca34-4f58-b9b5-05bc7b2530a6": {"__data__": {"id_": "78b494ca-ca34-4f58-b9b5-05bc7b2530a6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8615f1ba-dda7-4301-b254-1ec63028c748", "node_type": "1", "metadata": {}, "hash": "c223e17a872faefa44811381e7d7fae4fd07e241e5a8a9186c12e566798d9294", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "df098aee-87ef-4a64-8d09-05a908a03ffd", "node_type": "1", "metadata": {}, "hash": "a35a1db22fafecf5b319509371be262be356a1f0938af4b500a66e44d600f81f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "4%)\n0.0184\nMedian number of days in day care\n17.0\n17.0\n0.9684\nPreexisting medical condition*\n9 (15.8%)\n69 (18.4%)\n0.7147\nExposure to varicella or zoster in previous 3 wk*\n49 (90.7%)\n308 (94.8%)\n0.2204\nFever after the onset of varicella*\n20 (35.7%)\n225 (61.0%)\n0.0005\nSeverity of disease*\n\u2003 \u0007Median severity score\n5\n8\n<0.0001\n\u2003 \u0007Mild\n49 (87.5%)\n113 (31.7%)\n<0.0001\n\u2003 \u0007Moderate\n7 (12.5%)\n235 (66.0%)\n\u2003 \u0007Severe\n0 (0.0%)\n8 (2.2%)\nEstimated number of lesions\n<0.0001\n\u2003 \u00071\u201350\n35 (61.4%)\n46 (12.3%)\n\u2003 \u000751\u2013100\n17 (29.8%)\n112 (29.9%)\n\u2003 \u0007101\u2013500\n5 (8.8%)\n187 (49.9%)\n\u2003 \u0007>500\n0 (0.0%)\n30 (8.0%)\nNeeded second medical visit\n11 (19.3%)\n64 (17.1%)\n0.7076\nVaricella disease complications\n0 (0.0%)\n6 (1.6%)\n1.000\nOutcome\n0.0522\n\u2003 \u0007Recovered\n57 (100.0%)\n342 (91.2%)\n\u2003 \u0007Recovered with sequelae\n0 (0.0%)\n26 (6.9%)\n\u2003 \u0007Recovering\n0 (0.0%)\n7 (1.9%)\nDuration\u2014median number of days\n8\n9\n0.0041\n*Missing data: preexisting condition listed \u201cunknown\u201d for 1 unvaccinated confirmed case, severity score missing for 1 vaccinated case and 19 \nunvaccinated cases, varicella exposure missing for 3 vaccinated cases and 50 unvaccinated cases,", "mimetype": "text/plain", "start_char_idx": 31889, "end_char_idx": 32996, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "df098aee-87ef-4a64-8d09-05a908a03ffd": {"__data__": {"id_": "df098aee-87ef-4a64-8d09-05a908a03ffd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "78b494ca-ca34-4f58-b9b5-05bc7b2530a6", "node_type": "1", "metadata": {}, "hash": "15c469c4a7ab52c566f6c3457176a3394d24f0868edc4fbb4fd6e3d7ab555bdd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c1f57c9a-4d8b-49b0-a708-4960594e2abd", "node_type": "1", "metadata": {}, "hash": "fe8801d2b9d781629b7d4c5cbb11a06e3217c6297120dc8255db4ca484459b32", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "severity score missing for 1 vaccinated case and 19 \nunvaccinated cases, varicella exposure missing for 3 vaccinated cases and 50 unvaccinated cases, fever after onset unknown for 1 vaccinated case \nand 6 unvaccinated cases. Proportions were calculated excluding missing data.\nTABLE 3.\u2003 Varicella Vaccine Effectiveness Results (ATP Cohort for Confirmed Cases and Matched Controls)\nUnadjusted  \nVaccine  \nEffectiveness  \n(95% CI)\nAdjusted*  \nVaccine  \nEffectiveness  \n(95% CI)\nEffectiveness of 1 dose of OKA/GSK against PCR-confirmed varicella (any severity)\n70.6% (47.7\u201383.5)\n71.5% (49.1\u201384.0)\u2020\nEffectiveness of 1 dose of any varicella vaccine against PCR-confirmed varicella (any severity)\u2021\n86.1% (76.9\u201391.7)\n86.4% (77.3\u201391.8)\u00a7\nEffectiveness of 1 dose of OKA/GSK against PCR-confirmed varicella (moderate or severe)\n94.1% (75.5\u201398.6)\n94.7% (77.8\u201398.7)\nEffectiveness of 1 dose of any varicella vaccine against PCR-confirmed varicella (moderate or severe)\u2021\n97.6% (90.1\u201399.4)\n97.7% (90.5\u201399.4)\n*Adjusted for gender and school or day-care attendance.\n\u2020Effectiveness in children vaccinated at 15 months or older was not statistically significantly different from those vaccinated before 15 months (71.7% vs. 75.2%, P = 0.644).\n\u2021\u201cAny varicella vaccine\u201d includes OKA/GSK, OKA/Merck and MMR-OKA/GSK.\n\u00a7Effectiveness in children vaccinated at 15 months or older was not statistically significantly different from those vaccinated before 15 months (86.4% vs. 87.0%, P = 0.822).", "mimetype": "text/plain", "start_char_idx": 32847, "end_char_idx": 34314, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c1f57c9a-4d8b-49b0-a708-4960594e2abd": {"__data__": {"id_": "c1f57c9a-4d8b-49b0-a708-4960594e2abd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "df098aee-87ef-4a64-8d09-05a908a03ffd", "node_type": "1", "metadata": {}, "hash": "a35a1db22fafecf5b319509371be262be356a1f0938af4b500a66e44d600f81f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "df34f173-8d46-4b83-9daa-9455e83e4eab", "node_type": "1", "metadata": {}, "hash": "747e9ecb7571eb17f967f910ddcc686a1cf13627f0f9fa0e208daa2aa93ebcf5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u00a7Effectiveness in children vaccinated at 15 months or older was not statistically significantly different from those vaccinated before 15 months (86.4% vs. 87.0%, P = 0.822).\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8KKGKV0Ymy+78= on 01/09/2025\nThe Pediatric Infectious Disease Journal\u2002 \u2022\u2002 Volume 32, Number 9, September 2013\t\nVaricella Vaccination\n\u00a9 2013 Lippincott Williams & Wilkins\b\nwww.pidj.com\u2002 |\u20021003\nof vaccination status in controls were minimal. There was also no \nindication for selection bias related to parents\u2019 acceptance of child-\nhood vaccinations23,37 when we compared the receipt of trivalent \nMMR vaccination (93% of participants) between cases and con-\ntrols, based on the assumption that receipt of an MMR vaccination \ndoes not influence the likelihood of varicella disease.\nThe point estimates on vaccine effectiveness for any varicella \nvaccine were higher than the point estimates for OKA/GSK vaccine \nduring the first 4 years after vaccination. However, this study was not \ndesigned or powered to evaluate the difference between vaccines, \nand therefore, any statistical comparison would not be appropriate. \nAnother limitation of this study is that the investigated population \nmay not be fully representative for other areas of Germany where \nvaricella vaccination coverage might be slightly higher.18 It has been \nshown that high levels of vaccination coverage typically lead to high \nlevels of herd protection, as in the United States and Uruguay.13,38 \nHerd protection in our study population is estimated to be limited \nbecause varicella vaccination coverage among controls, who reflect \nthe general population from which the cases arose, was 47.5%.", "mimetype": "text/plain", "start_char_idx": 34140, "end_char_idx": 35922, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "df34f173-8d46-4b83-9daa-9455e83e4eab": {"__data__": {"id_": "df34f173-8d46-4b83-9daa-9455e83e4eab", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c1f57c9a-4d8b-49b0-a708-4960594e2abd", "node_type": "1", "metadata": {}, "hash": "fe8801d2b9d781629b7d4c5cbb11a06e3217c6297120dc8255db4ca484459b32", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "59a15939-27a8-48a1-8d31-19ea0d83cfe7", "node_type": "1", "metadata": {}, "hash": "97f821a0cb3eb4729248bb57b64363dc3407f073380830167ff77fe6f647c181", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Fre-\nquent exposure to wild-type virus, as in our study, may have resulted \nin an increased risk of varicella breakthrough disease, especially in \nchildren vaccinated with 1 dose and, therefore, in a decreased esti-\nmate of vaccine effectiveness. Nevertheless, we could show that even \nunder real-life conditions with low vaccination coverage, varicella \nvaccines were very effective. It should also be noted that vaccine \neffectiveness was investigated only up to 5 years after vaccination, \nand therefore long-term effectiveness could not be assessed. Finally, \nthe small proportion of children who had received more than 1 dose \nof a varicella vaccine restricted our ability to examine the effect of \nthe 2 doses recommended in Germany since 2009.\nRelation to Other Studies\nThe results of the study are in agreement with previous esti-\nmates of vaccine efficacy from prelicensure randomized clinical \ntrials (from 72% to 100% for 1 dose),39 as well as with vaccine \neffectiveness results from retrospective data analysis40 and out-\nbreak investigations,41\u201343 including a meta-analysis of outbreaks \n(73% overall effectiveness after 1 dose).27 The results were also in \naccordance with previous publications on the impact of vaccination \nin Germany,44,45 where effectiveness of 1 dose of varicella vaccina-\ntion was reported as 71%, with nonsignificant vaccine-specific dif-\nferences (OKA/GSK: 56%, OKA/Merck: 86%, MMR-OKA/GSK: \n55%).45 However, this outbreak investigation had several methodo-\nlogical limitations, for example, the fact that different outbreaks \nwere pooled and there was no laboratory confirmation of varicella \ndisease.46 Effectiveness of 1 dose of any varicella vaccine against \nPCR-confirmed varicella infection of any severity and against PCR-\nconfirmed moderate or severe varicella was similar to the case-\ncontrol study in the United States by V\u00e1zquez et al23 [86.1% (95% \nCI: 76.9\u201391.7) versus 85% (95% CI: 78\u201390) and 97.6% (95% CI: \n90.1\u201399.4) versus 97% (95% CI: 93\u201399), respectively; unadjusted], \nwho investigated the effectiveness of OKA/Merck.", "mimetype": "text/plain", "start_char_idx": 35923, "end_char_idx": 38000, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "59a15939-27a8-48a1-8d31-19ea0d83cfe7": {"__data__": {"id_": "59a15939-27a8-48a1-8d31-19ea0d83cfe7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "df34f173-8d46-4b83-9daa-9455e83e4eab", "node_type": "1", "metadata": {}, "hash": "747e9ecb7571eb17f967f910ddcc686a1cf13627f0f9fa0e208daa2aa93ebcf5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dbedbd08-9e8b-4e24-9123-e1567c1b436c", "node_type": "1", "metadata": {}, "hash": "2f5a47f97ea01eb57593435f96807f523aaf831bf2f3b18ec7a142e1779fea12", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In our study, \nthe effectiveness of OKA/GSK against any varicella disease was \nlower [70.6% (95% CI: 47.7\u201383.5)], but the effectiveness against \nmoderate or severe varicella was comparably high [94.1% (95% CI: \n75.5\u201398.6)]. In case-control studies from Israel and China based \non parent interviews of children clinically diagnosed with varicella \n(no laboratory confirmation) during a period of still very low cover-\nage, the effectiveness data of OKA/GSK were slightly higher, 88% \n(95% CI: 77\u201394) and 86% (95% CI: 73\u201393), respectively, than what \nwe found in our setting against laboratory-confirmed varicella.28,29 \nThis may indicate that in our study the identification of nontypical \nmild cases of varicella in vaccinated children (with a small number \nof lesions) was facilitated when compared with other studies.\nVaricella vaccination at an early age had been associated \nwith lower vaccine effectiveness in some studies,24,47 although \nother studies could not confirm that difference.28,41,48 In contrast to \nV\u00e1zquez et al,24 varicella vaccine effectiveness in our study was not \nlower in children vaccinated at <15 months of age.\nMeaning of the Study\nThe first epidemiological case-control study of the effective-\nness of varicella vaccination in a routine setting in Europe provides \nvaluable information on the effectiveness of 1-dose varicella vaccina-\ntion during a period of up to 5 years after vaccination in a population \nwith vaccination coverage of about 50%. In agreement with the litera-\nture, the effectiveness against moderate or severe varicella was high, \nallowing for the control of severe varicella disease and complications.\nUnanswered Questions and Future Research\nAdditional research is necessary to assess the long-term vac-\ncine effectiveness of 1 or 2 doses of licensed varicella vaccines in \nEurope.\nTRADEMARKS\nVarilrix (OKA/GSK) and Priorix Tetra (MMR-OKA/GSK) \nare registered trademarks of the GlaxoSmithKline group of com-\npanies. Varivax (OKA/Merck) is a registered trademark of Merck, \nSanofi Pasteur MSD.", "mimetype": "text/plain", "start_char_idx": 38001, "end_char_idx": 40044, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dbedbd08-9e8b-4e24-9123-e1567c1b436c": {"__data__": {"id_": "dbedbd08-9e8b-4e24-9123-e1567c1b436c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "59a15939-27a8-48a1-8d31-19ea0d83cfe7", "node_type": "1", "metadata": {}, "hash": "97f821a0cb3eb4729248bb57b64363dc3407f073380830167ff77fe6f647c181", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bdbf7a3b-5d63-4ec0-8a6c-33d511b19e4b", "node_type": "1", "metadata": {}, "hash": "7ff7feef985ba23288fb31413e97a68133b58b09755b5eda64184d42979d6887", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Varivax (OKA/Merck) is a registered trademark of Merck, \nSanofi Pasteur MSD. For pharmaceutical details of each of the vac-\ncines, we refer to the respective manufacturer\u2019s product information.\nACKNOWLEDGMENTS\nThe authors thank all families consenting to participate in the \nstudy, as well as all pediatricians contributing data: Drs. Baukhage, \nFIGURE 1.\u2002 Varicella vaccine effectiveness (1 dose) over time \nagainst PCR-confirmed varicella of any severity (ATP cohort \nfor confirmed cases and matched controls). Bars represent \n95% CIs. Global P value for equality test between all years \nwas 0.543 for OKA/GSK and 0.235 for any varicella vaccine \n(includes OKA/GSK, OKA/Merck, MMR-OKA/GSK).\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8KKGKV0Ymy+78= on 01/09/2025\nLiese et al\t\nThe Pediatric Infectious Disease Journal\u2002 \u2022\u2002 Volume 32, Number 9, September 2013\n1004\u2002 |\u2002 www.pidj.com\b\n\u00a9 2013 Lippincott Williams & Wilkins\nBergner, Bienert, B\u00f6rzs\u00f6nyi, B\u00f6se O\u00b4Reilly, Eidenschink, Feiereisen, \nFendel, Groethuysen, Haas, Haus, Intemann, Joiko, Krandick, Kron\u00ad\nwitter, Linder, Mrach, Oenaldi, Pauli, Praun, Rinker, Sch\u00e4ffler, Schatz, \nSchuhb\u00f6ck, Schwick, Simon, Sturm, Thilemann, Tichmann-Schumann, \nValentin, Vogel, Wittermann and W\u00f6mle. They also thank Lyn-Julia \nKohl and Nicola Henrich from Munich University Children\u2019s Hospi\u00ad\ntal for their contributions as study physicians.", "mimetype": "text/plain", "start_char_idx": 39968, "end_char_idx": 41441, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bdbf7a3b-5d63-4ec0-8a6c-33d511b19e4b": {"__data__": {"id_": "bdbf7a3b-5d63-4ec0-8a6c-33d511b19e4b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dbedbd08-9e8b-4e24-9123-e1567c1b436c", "node_type": "1", "metadata": {}, "hash": "2f5a47f97ea01eb57593435f96807f523aaf831bf2f3b18ec7a142e1779fea12", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1aae36e4-da49-4dbb-8a76-f61b25fdf6c1", "node_type": "1", "metadata": {}, "hash": "5971785f55c9394b8d37cff2b9f5e6c1a3dd7228b65407fe3889318ea30d0a35", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "They also thank Lyn-Julia \nKohl and Nicola Henrich from Munich University Children\u2019s Hospi\u00ad\ntal for their contributions as study physicians. The authors gratefully \nacknowledge the support of Alexandra Fritsch and Regina Krim\u00ad\nmer (GlaxoSmithKline, Munich) for local study organization. From \nGlaxoSmithKline Vaccines (Rixensart), they thank Carine Maggetto \n(data management), Emilie Balian (laboratory analyses) and Pascale \nSchrauben (statistical programming). V\u00e9ronique Duquenne (Glaxo\u00ad\nSmithKline Vaccines), Luise Kalbe (GlaxoSmithKline Vaccines) and \nMyriam Wilbaux (XPE Pharma and Science on behalf of GlaxoSmith\u00ad\nKline Vaccines) provided editorial assistance and coordinated draft\u00ad\ning of the article, and Jan Brissinck (GlaxoSmithKline Vaccines) and \nAnna Dow (Freelance) provided scientific writing support.\nREFERENCES\n\t 1.\t Heininger U, Seward JF. Varicella. Lancet. 2006;368:1365\u20131376.\n\t 2.\t Wharton M. The epidemiology of varicella-zoster virus infections. Infect \nDis Clin North Am. 1996;10:571\u2013581.\n\t 3.\t Weinberg JM. Herpes zoster: epidemiology, natural history, and common \ncomplications. J Am Acad Dermatol. 2007;57(suppl 6):S130\u2013S135.\n\t 4.\t Wutzler P, F\u00e4rber I, Wagenpfeil S, et al. Seroprevalence of varicella-zoster \nvirus in the German population. Vaccine. 2001;20:121\u2013124.\n\t 5.\t Liese JG, Grote V, Rosenfeld E, et al.; ESPED Varicella Study Group. The \nburden of varicella complications before the introduction of routine vari-\ncella vaccination in Germany. Pediatr Infect Dis J. 2008;27:119\u2013124.\n\t 6.\t Rack AL, Grote V, Streng A, et al.", "mimetype": "text/plain", "start_char_idx": 41301, "end_char_idx": 42861, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1aae36e4-da49-4dbb-8a76-f61b25fdf6c1": {"__data__": {"id_": "1aae36e4-da49-4dbb-8a76-f61b25fdf6c1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bdbf7a3b-5d63-4ec0-8a6c-33d511b19e4b", "node_type": "1", "metadata": {}, "hash": "7ff7feef985ba23288fb31413e97a68133b58b09755b5eda64184d42979d6887", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "55417efd-558f-40d3-b881-f0979d8610bf", "node_type": "1", "metadata": {}, "hash": "88481b3a6067502750ec5510d4e43385443fc20fc288748040c42deb06bdc257", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Pediatr Infect Dis J. 2008;27:119\u2013124.\n\t 6.\t Rack AL, Grote V, Streng A, et al. Neurologic varicella complications before \nroutine immunization in Germany. Pediatr Neurol. 2010;42:40\u201348.\n\t 7.\t Grote V, von Kries R, Springer W, et al. Varicella-related deaths in children \nand adolescents--Germany 2003\u20132004. Acta Paediatr. 2008;97:187\u2013192.\n\t 8.\t Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the US \nafter implementation of the vaccination program. Pediatrics. 2011;128:214\u2013220.\n\t 9.\t Calendrier Vaccinal Recommand\u00e9 au Luxembourg. Available at: http://www.\nsante.public.lu/fr/rester-bonne-sante/120-vaccinations/calendrier-vaccinal/\nindex.html. Accessed March 6, 2012.\n\t10.\t Boletin Epidemiol\u00f3gico de la Comunidad de Madrid. Varicela en la \nComunidad de Madrid, A\u00f1os 2001 a 2009. 2010; 16:3\u201322.\n\t11.\t Alfonsi V, D\u2019Ancona F, Giambi C, et al.; Regional Coordinators for \nInfectious Diseases and Vaccinations. Current immunization policies for \npneumococcal, meningococcal C, varicella and rotavirus vaccinations in \nItaly. Health Policy. 2011;103:176\u2013183.\n\t12.\t Bonanni P, Breuer J, Gershon A, et al. Varicella vaccination in Europe - tak-\ning the practical approach. BMC Med. 2009;7:26.\n\t13.\t Quian J, R\u00fcttimann R, Romero C, et al. Impact of universal varicella vaccina-\ntion on 1-year-olds in Uruguay: 1997-2005. Arch Dis Child. 2008;93:845\u2013850.\n\t14.\t Reuss AM, Feig M, Kappelmayer L, et al.", "mimetype": "text/plain", "start_char_idx": 42782, "end_char_idx": 44197, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "55417efd-558f-40d3-b881-f0979d8610bf": {"__data__": {"id_": "55417efd-558f-40d3-b881-f0979d8610bf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1aae36e4-da49-4dbb-8a76-f61b25fdf6c1", "node_type": "1", "metadata": {}, "hash": "5971785f55c9394b8d37cff2b9f5e6c1a3dd7228b65407fe3889318ea30d0a35", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "855b6a76-5fa7-497e-b988-b1f8b9b3ed00", "node_type": "1", "metadata": {}, "hash": "90ae7170b833aef9bc16268b6c1072679982d90d72d4c7264ebb339aa0513c92", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Arch Dis Child. 2008;93:845\u2013850.\n\t14.\t Reuss AM, Feig M, Kappelmayer L, et al. Varicella vaccination cover-\nage of children under two years of age in Germany. BMC Public Health. \n2010;10:502.\n\t15.\t Gavrielov-Yusim N, Battat E, Neumann L, et al. Birth order and private volun-\ntary immunization\u2013a study of 110,902 children. Vaccine. 2012;30:442\u2013447.\n\t16.\t Robert Koch Institut. Empfehlungen der St\u00e4ndigen Impfkommission \n(STIKO) am Robert Koch Institut/Stand: Juli 2004. Epidemiol Bull. \n2004;30:235\u2013250.\n\t17.\t Streng A, Seeger K, Grote V, et al. Varicella vaccination coverage in \nBavaria (Germany) after general vaccine recommendation in 2004. Vaccine. \n2010;28:5738\u20135745.\n\t18.\t Hohle M, Siedler A, Bader HM, et al. Assessment of varicella vac-\ncine effectiveness in Germany: a time-series approach. Epidemiol Infect. \n2011;139:1710\u20131719.\n\t19.\t Robert Koch Institut. Empfehlungen der St\u00e4ndigen Impfkommission \n(STIKO) am Robert Koch Institut/Stand: Juli 2009. Epidemiol Bull. \n2009;30:279\u2013298.\n\t20.\t Chaves SS, Zhang J, Civen R, et al. Varicella disease among vaccinated per-\nsons: clinical and epidemiological characteristics, 1997\u20132005. J Infect Dis. \n2008;197(suppl 2):S127\u2013S131.\n\t21.\t Guris D, Jumaan AO, Mascola L, et al. Changing varicella epidemiol-\nogy in active surveillance sites--United States, 1995\u20132005. J Infect Dis. \n2008;197(suppl 2):S71\u2013S75.\n\t22.\t Shah SS, Wood SM, Luan X, et al.", "mimetype": "text/plain", "start_char_idx": 44119, "end_char_idx": 45517, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "855b6a76-5fa7-497e-b988-b1f8b9b3ed00": {"__data__": {"id_": "855b6a76-5fa7-497e-b988-b1f8b9b3ed00", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "55417efd-558f-40d3-b881-f0979d8610bf", "node_type": "1", "metadata": {}, "hash": "88481b3a6067502750ec5510d4e43385443fc20fc288748040c42deb06bdc257", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c1b151ff-275c-41c9-a899-014221999c53", "node_type": "1", "metadata": {}, "hash": "9200e25bc0c79dc9ad4a1e14416219ec9fe02f520fcf57f1fcf155749f89106c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "J Infect Dis. \n2008;197(suppl 2):S71\u2013S75.\n\t22.\t Shah SS, Wood SM, Luan X, et al. Decline in varicella-related ambulatory \nvisits and hospitalizations in the United States since routine immunization \nagainst varicella. Pediatr Infect Dis J. 2010;29:199\u2013204.\n\t23.\t V\u00e1zquez M, LaRussa PS, Gershon AA, et al. The effectiveness of the vari-\ncella vaccine in clinical practice. N Engl J Med. 2001;344:955\u2013960.\n\t24.\t V\u00e1zquez M, LaRussa PS, Gershon AA, et al. Effectiveness over time of \nvaricella vaccine. JAMA. 2004;291:851\u2013855.\n\t25.\t Shapiro ED, Vazquez M, Esposito D, et al. Effectiveness of 2 doses of vari-\ncella vaccine in children. J Infect Dis. 2011;203:312\u2013315.\n\t26.\t Seward JF, Marin M, V\u00e1zquez M. Varicella vaccine effectiveness in the US \nvaccination program: a review. J Infect Dis. 2008;197(suppl 2):S82\u2013S89.\n\t27.\t Bayer O, Heininger U, Heiligensetzer C, et al. Metaanalysis of vaccine \neffectiveness in varicella outbreaks. Vaccine. 2007;25:6655\u20136660.\n\t28.\t Sheffer R, Segal D, Rahamani S, et al. Effectiveness of the Oka/GSK attenu-\nated varicella vaccine for the prevention of chickenpox in clinical practice in \nIsrael. Pediatr Infect Dis J. 2005;24:434\u2013437.\n\t29.\t Fu C, Wang M, Liang J, et al. The effectiveness of varicella vaccine in \nChina. Pediatr Infect Dis J. 2010;29:690\u2013693.\n\t30.\t Bavarian Statistical Office. Available at: https://www.statistik.bayem.de. \nAccessed March 6, 2012.\n\t31.", "mimetype": "text/plain", "start_char_idx": 45437, "end_char_idx": 46842, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c1b151ff-275c-41c9-a899-014221999c53": {"__data__": {"id_": "c1b151ff-275c-41c9-a899-014221999c53", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "855b6a76-5fa7-497e-b988-b1f8b9b3ed00", "node_type": "1", "metadata": {}, "hash": "90ae7170b833aef9bc16268b6c1072679982d90d72d4c7264ebb339aa0513c92", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ef3cb886-76b3-4014-96e8-484f2752c8fb", "node_type": "1", "metadata": {}, "hash": "a3cd8069fc6a1b4e1a49b17928fe6684bb15a461b70871a422f1ce5cb6e07490", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2010;29:690\u2013693.\n\t30.\t Bavarian Statistical Office. Available at: https://www.statistik.bayem.de. \nAccessed March 6, 2012.\n\t31.\t Mols JF, Ledent E, Heineman TC. Sampling of herpes zoster skin lesion types \nand the impact on viral DNA detection. J Virol Methods. 2013;188:145\u2013147.\n\t32.\t Chaves SS, Gargiullo P, Zhang JX, et al. Loss of vaccine-induced immunity \nto varicella over time. N Engl J Med. 2007;356:1121\u20131129.\n\t33.\t Niccolai LM, Ogden LG, Muehlenbein CE, et al. Methodological issues in \ndesign and analysis of a matched case-control study of a vaccine\u2019s effective-\nness. J Clin Epidemiol. 2007;60:1127\u20131131.\n\t34.\t Michalik DE, Steinberg SP, LaRussa PS, et al. Primary vaccine failure after 1 \ndose of varicella vaccine in healthy children. J Infect Dis. 2008;197:944\u2013949.\n\t35.\t Marin M, G\u00fcris D, Chaves SS, et al.; Advisory Committee on Immunization \nPractices, Centers for Disease Control and Prevention (CDC). Prevention of \nvaricella: recommendations of the Advisory Committee on Immunization \nPractices (ACIP). MMWR Recomm Rep. 2007;56(RR-4):1\u201340.\n\t36.\t Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: \na review of successes and challenges. Pediatrics. 2008;122:e744\u2013e751.\n\t37.\t Shapiro ED. Case-control studies of the effectiveness of vaccines: validity \nand assessment of potential bias. Pediatr Infect Dis J. 2004;23:127\u2013131.\n\t38.\t Chaves SS, Lopez AS, Watson TL, et al. Varicella in infants after  \nimplementation of the US varicella vaccination program. Pediatrics. \n2011;128:1071\u20131077.\n\t39.\t Skull SA, Wang EE.", "mimetype": "text/plain", "start_char_idx": 46715, "end_char_idx": 48273, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ef3cb886-76b3-4014-96e8-484f2752c8fb": {"__data__": {"id_": "ef3cb886-76b3-4014-96e8-484f2752c8fb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c1b151ff-275c-41c9-a899-014221999c53", "node_type": "1", "metadata": {}, "hash": "9200e25bc0c79dc9ad4a1e14416219ec9fe02f520fcf57f1fcf155749f89106c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c7a689c6-71c4-4fff-8e5b-0a70f1c69b8d", "node_type": "1", "metadata": {}, "hash": "42d3b99a0adec1c9381360539ab3c7cc793da02b48f007391371267d8c44b8fe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Varicella in infants after  \nimplementation of the US varicella vaccination program. Pediatrics. \n2011;128:1071\u20131077.\n\t39.\t Skull SA, Wang EE. Varicella vaccination\u2013a critical review of the evidence. \nArch Dis Child. 2001;85:83\u201390.\n\t40.\t Passwell JH, Hemo B, Levi Y, et al. Use of a computerized database to study \nthe effectiveness of an attenuated varicella vaccine. Pediatr Infect Dis J. \n2004;23:221\u2013226.\n\t41.\t Arnedo-Pena A, Puig-Barber\u00e0 J, Aznar-Orenga MA, et al. Varicella vac-\ncine effectiveness during an outbreak in a partially vaccinated population in \nSpain. Pediatr Infect Dis J. 2006;25:774\u2013778.\n\t42.\t Miron D, Lavi I, Kitov R, et al. Vaccine effectiveness and severity of varicella \namong previously vaccinated children during outbreaks in day-care centers \nwith low vaccination coverage. Pediatr Infect Dis J. 2005;24:233\u2013236.\n\t43.\t Quian RJ, Protasio PA, Dall\u2019orso VP, et al. Varicella outbreak in a village in \nUruguay. Rev Chilena Infectol. 2010;27:47\u201351.\n\t44.\t Siedler A, Arndt U. Impact of the routine varicella vaccination programme \non varicella epidemiology in Germany. Euro Surveill. 2010;15:19530.\n\t45.\t Spackova M, Wiese-Posselt M, Dehnert M, et al. Comparative vari-\ncella vaccine effectiveness during outbreaks in day-care centres. Vaccine. \n2010;28:686\u2013691.\n\t46.\t Marchetti F, Cuccia M. The effectiveness of Varivax and Varilrix vaccines. \nVaccine. 2010;28:4859\u20134860.\n\t47.\t Verstraeten T, Jumaan AO, Mullooly JP, et al.; Vaccine Safety Datalink \nResearch Group.", "mimetype": "text/plain", "start_char_idx": 48131, "end_char_idx": 49622, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c7a689c6-71c4-4fff-8e5b-0a70f1c69b8d": {"__data__": {"id_": "c7a689c6-71c4-4fff-8e5b-0a70f1c69b8d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Liese (2013).pdf", "node_type": "4", "metadata": {}, "hash": "8a81aebd46ba88483322ef6577ab1ebc846750a4f5f173e4d67ec0f772d12466", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ef3cb886-76b3-4014-96e8-484f2752c8fb", "node_type": "1", "metadata": {}, "hash": "a3cd8069fc6a1b4e1a49b17928fe6684bb15a461b70871a422f1ce5cb6e07490", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine. 2010;28:4859\u20134860.\n\t47.\t Verstraeten T, Jumaan AO, Mullooly JP, et al.; Vaccine Safety Datalink \nResearch Group. A retrospective cohort study of the association of varicella \nvaccine failure with asthma, steroid use, age at vaccination, and measles-\nmumps-rubella vaccination. Pediatrics. 2003;112:e98\u2013103.\n\t48.\t Outbreak of varicella among vaccinated children--Michigan, 2003. MMWR \nMorb Mortal Wkly Rep. 2004;53:389\u2013392.\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8KKGKV0Ymy+78= on 01/09/2025", "mimetype": "text/plain", "start_char_idx": 49501, "end_char_idx": 50104, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a79a2dc0-943e-4f80-8ada-748dcef1262f": {"__data__": {"id_": "a79a2dc0-943e-4f80-8ada-748dcef1262f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Mackenzie (2006).pdf", "node_type": "4", "metadata": {}, "hash": "0596be92d702d2163e403a71751e6f2c9df359f025c1790dec41b2d53410ade7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "96c9871d-5215-45c7-826c-4d18b6126a2f", "node_type": "1", "metadata": {}, "hash": "4923284963f661fd8c476fe9f760f5596b07ec160c0601ca6b390cad9b7aabff", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Mumps in a boarding school:\ndescription of an outbreak\nand control measures\nABSTRACT\nBackground\nThe number of cases of mumps in the UK has\nincreased during 2004\u20132005. Understanding why\nsome people are more susceptible to mumps\ninfection will help target vaccination and other\ncontrol measures in the future. This paper describes\na mumps outbreak in a boarding school in Scotland\n(October to November 2004).\nObjectives\nTo describe the characteristics of cases in a mumps\noutbreak; and to conduct a case-control study looking\nat the effect of previous measles-mumps-rubella\n(MMR) vaccination.\nDesign\nDescriptive epidemiology.\nData sources\nClinical, laboratory and surveillance data.\nSetting\nA private school with 600 boarding and day pupils.\nResults\nFifty cases were notified to the public health\ndepartment as having mumps. Twenty of the cases\n(40%) were confirmed virologically, all born between\n1987\u20131991. A matched case-control study was\nconducted to explore the effect of prior MMR\nvaccination. Compared to no vaccine, MMR\nprotected against mumps (odds ratio = 0.7), two\ndoses offering best protection (odds ratio = 0.5), but\nthe study was not large enough to detect a\nstatistically significant difference.\nConclusion\nSome children and young people in the UK are\ncurrently incompletely vaccinated. This outbreak\nillustrates the potential of a mumps outbreak to\ndisrupt the medical, educational and social life of a\nschool. All children should be vaccinated with two\ndoses of MMR vaccine before school entry. Children\nand young people born between 1979\u20131991 should\nbe given the necessary additional dose(s) of MMR\nvaccine.\nKeywords\nmeasles-mumps-rubella vaccine; mumps infection;\noutbreaks.\nINTRODUCTION\nMumps is caused by a paramyxovirus. Symptoms\nare typically mild and include fever, malaise and a\ncharacteristic\nparotid\nswelling.\nComplications\ninclude aseptic meningitis, pancreatitis, orchitis and\noophritis.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1915, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "96c9871d-5215-45c7-826c-4d18b6126a2f": {"__data__": {"id_": "96c9871d-5215-45c7-826c-4d18b6126a2f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Mackenzie (2006).pdf", "node_type": "4", "metadata": {}, "hash": "0596be92d702d2163e403a71751e6f2c9df359f025c1790dec41b2d53410ade7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a79a2dc0-943e-4f80-8ada-748dcef1262f", "node_type": "1", "metadata": {}, "hash": "0f46935298e8c359c386e92e67fb6890d5eff26a7c46434f62e053ad980b0e61", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "557e54de-3f51-4487-884f-df706bbe4720", "node_type": "1", "metadata": {}, "hash": "a077838aece1f95526cb581f8d9d79f7ee17aaed3f8299b01fc04ddc6259b82e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Symptoms\nare typically mild and include fever, malaise and a\ncharacteristic\nparotid\nswelling.\nComplications\ninclude aseptic meningitis, pancreatitis, orchitis and\noophritis. Some cases may, however, be subclinical\nor have an atypical presentation.1 The virus is spread\nby airborne droplets and the incubation period is\n14\u201321 days, with an infectious period from 2 days\nbefore onset of parotitis to 9 days afterwards.\nIn the UK mumps was a relatively common\nchildhood infection until the introduction of the\nmeasles-mumps-rubella (MMR) vaccine in 1988.\nThere were 3095 notifications in 1989 falling to 155\nnotifications in 2001.2 Recently, however, there has\nbeen an increase in the number of cases of mumps\nin Scotland, from 182 (2003) to 3592 (2004).3\nThe rise in cases has included outbreaks in\nschools and colleges of further education across\nScotland and the rest of the UK.4 This increase in\ncases has a number of possible explanations.\nMMR vaccination was introduced in a single dose\nin 1988, with a second dose offering increased\nprotection\nintroduced\nin\n1996.\nPeople\nborn\nbetween 1979 and 1991 may be incompletely\nvaccinated and may not have come into contact\nwith the wild mumps strain and could therefore be\nat particular risk of mumps infection. Secondly,\ndiscredited scientific papers published in the late\n1990s5 led to poor uptake of MMR vaccine in some\nDouglas G Mackenzie, George Craig, Nicholas F Hallam, Janelle Moore and Janet Stevenson\nDG Mackenzie, BSc, MRCP, MPH, MFPH, specialist registrar,\nPublic Health Department, NHS Fife; G Craig, MRCP,\nMRCGP, GP at the school; NF Hallam, MA, MBChB, PhD,\nFRCPath, consultant virologist, NHS Lothian \u2013 University\nHospitals Division; JE Moore, RGN, BSc(Hons), school\nnursing sister; J Stevenson, MA, MBBS, FFPH, consultant,\nPublic Health Department, Lothian NHS Board.", "mimetype": "text/plain", "start_char_idx": 1742, "end_char_idx": 3570, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "557e54de-3f51-4487-884f-df706bbe4720": {"__data__": {"id_": "557e54de-3f51-4487-884f-df706bbe4720", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Mackenzie (2006).pdf", "node_type": "4", "metadata": {}, "hash": "0596be92d702d2163e403a71751e6f2c9df359f025c1790dec41b2d53410ade7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "96c9871d-5215-45c7-826c-4d18b6126a2f", "node_type": "1", "metadata": {}, "hash": "4923284963f661fd8c476fe9f760f5596b07ec160c0601ca6b390cad9b7aabff", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "47341b9f-e3bb-4a7c-aa08-231889991fa2", "node_type": "1", "metadata": {}, "hash": "f5dfc6e7c418ec3e9ee7d3a6a9a5542b39ef8ea93e462dbf70b85849fa901a7d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Address for correspondence\nDr DG Mackenzie, Specialist registrar, Public Health\nDepartment, Cameron House, Windygates, Leven, Fife,\nKY8 5RG. E-mail: gm@nhs.net\nSubmitted: 28 June 2005; Editor\u2019s response:\n1 September 2005; final acceptance: 12 January 2006.\n\u00a9British Journal of General Practice 2006; 56: 526\u2013529.\nBritish Journal of General Practice, Ju\nDG Mackenzie, G Craig, NF Hallam, et al\n526\nBritish Journal of General Practice, July 2006\ncommunities.\nUptake\nof\nMMR\nvaries\ninternationally.6\nThis report describes an outbreak of mumps in a\nco-educational private school in Lothian, Scotland\nwith a large number of international pupils. The\nschool takes around 600 boarding and day pupils\naged 7\u201318 years and has a well-resourced medical\ncentre. The school is split into a number of \u2018houses\u2019\nthat operate independently for much of the school\nday although pupils come together at assembly and\nmealtimes. The aim of the study was to describe the\ngroups at risk of mumps infection so that these\ngroups can be given the MMR vaccine to reduce the\nchances of further outbreak of mumps elsewhere.\nAdditionally, a case-control study was conducted to\nexplore the effect of previous MMR vaccination.\nMETHOD\nFour outbreak control team meetings were held in\nthe school to discuss the epidemiology and control\nof the outbreak. Participants included school medical\nand nursing staff, senior teaching staff, a consultant\nvirologist and members of the local public health\ndepartment. A number of control measures were put\nin place following the first outbreak control team\nmeeting. Vaccination was planned in conjunction\nwith the Health Protection Team of the public health\ndepartment, but the administration of vaccine was\ndelayed for some pupils because of questions and\nconcerns\nfrom\nparents\nabout\nMMR\nvaccine.\nMovement between school houses was restricted\nand social and sporting functions with other schools\nwere also cancelled. Patients with mumps were not\nallowed to return to school for 10 days following\nonset of parotid swelling, and were asked to either\nreturn home or stay in the school medical centre\nduring the period of recovery.", "mimetype": "text/plain", "start_char_idx": 3571, "end_char_idx": 5702, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "47341b9f-e3bb-4a7c-aa08-231889991fa2": {"__data__": {"id_": "47341b9f-e3bb-4a7c-aa08-231889991fa2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Mackenzie (2006).pdf", "node_type": "4", "metadata": {}, "hash": "0596be92d702d2163e403a71751e6f2c9df359f025c1790dec41b2d53410ade7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "557e54de-3f51-4487-884f-df706bbe4720", "node_type": "1", "metadata": {}, "hash": "a077838aece1f95526cb581f8d9d79f7ee17aaed3f8299b01fc04ddc6259b82e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2591e22b-be26-41c4-af66-27d6cd6ef983", "node_type": "1", "metadata": {}, "hash": "cf7f976d76120d3f03ea8596eb978e947a2661e24852e1db3ef8f04ac505774c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Patients with mumps were not\nallowed to return to school for 10 days following\nonset of parotid swelling, and were asked to either\nreturn home or stay in the school medical centre\nduring the period of recovery.\nParticipants were all suspected cases of mumps\n(n = 50) from a single boarding school notified to the\nconsultant in public health medicine (October to\nNovember 2004). Data were collected by clinical staff\ninvolved in the management of the outbreak,\nsupplemented subsequently with laboratory and\nsurveillance data. The agreed case definition was\nparotid swelling, viral illness and no other reasonable\ncause. Virology results were available from the local\nvirology laboratory and the national reference\nlaboratory. Acute cases of mumps were identified\nusing a combination of parotid swab, acute and\nconvalescent\nsera,\nurine\nor\nsalivary\ntesting.\nVirologically confirmed cases (n = 20) met the case\ndefinition and had one or more positive tests on\nvirological testing. Clinical cases (n = 30) met the\ncase definition but without virological testing or with\nonly negative results.\nData about vaccination status were available from\na number of sources, including pupil medical notes\nheld\nin\nthe\nschool,\ntelephone\nand\nemail\ncommunication with parents and, for local pupils, the\nScottish Immunisation Recall System.\nA case-control study was conducted using pre-\noutbreak vaccination status from controls matched\nto controls for age, sex, residential status and\nwhether they were a UK or international student. Two\ncontrols were selected for each case. Controls had\nno record of previous mumps infection. Day pupils\nwere less likely to have had virological testing so no\nfurther analysis based on residential status or usual\ncountry of residence has been attempted beyond the\ncase-control study.\nData collection was performed by school nursing\nand medical staff and the principal author. Data\nanalysis was performed in Microsoft Excel\u00ae. Sample\nsize calculations for the case control study were\nestimated for statistical power 0.8 and statistical\nsignificance 0.05 using published equations.7\nRESULTS\nThere were 50 cases notified as having mumps (30\nclinical with 20 virologically confirmed).", "mimetype": "text/plain", "start_char_idx": 5492, "end_char_idx": 7686, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2591e22b-be26-41c4-af66-27d6cd6ef983": {"__data__": {"id_": "2591e22b-be26-41c4-af66-27d6cd6ef983", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Mackenzie (2006).pdf", "node_type": "4", "metadata": {}, "hash": "0596be92d702d2163e403a71751e6f2c9df359f025c1790dec41b2d53410ade7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "47341b9f-e3bb-4a7c-aa08-231889991fa2", "node_type": "1", "metadata": {}, "hash": "f5dfc6e7c418ec3e9ee7d3a6a9a5542b39ef8ea93e462dbf70b85849fa901a7d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4c7b8f27-3ff5-4842-8b1b-dd0713893ee6", "node_type": "1", "metadata": {}, "hash": "d720b8f4a1c119f745fcd8b37b9d1f6545200b46e23326734fc22667667e2fa2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The mumps\nvirus genotype identified was G2, identical to a\ncurrently circulating wild-type strain (L Jin, personal\ncommunication, 2005). Virologically confirmed cases\n(n = 20) were all born between 1987\u20131991 and in\ntotal 48/50 (96%) notified cases were in this age\ngroup. There were 18 boarding pupils and two day\npupils with virologically confirmed mumps. There\nwere equal numbers of students from the UK (n = 10)\nand\nother\ncountries\n(n = 10)\nwith\nvirologically\nconfirmed mumps. None of the cases required\nadmission to hospital and none of the cases had\ncomplications of mumps.\nThe outbreak curve is shown in Figure 1. The index\ncase became ill on day 1, with secondary cases\nstarting on day 18. The number of cases peaked on\nday 21. Following the second wave of cases, all but\nHow this fits in\nChildren and young people born between 1979\nand 1991 who have not received both doses of\nMMR may be at particular risk of mumps\ninfection. All virologically confirmed cases of\nmumps in this outbreak were born between 1987\nand 1991, and were therefore in the age group\nthought to be most at risk. Prior MMR vaccination\n(particularly two doses of MMR) appeared to offer\nprotection against mumps infection in this\noutbreak. Children and young people should have\nadditional doses of MMR if they are incompletely\nvaccinated or unvaccinated.\nOriginal Papers\n527\nDG Mackenzie, G Craig, NF Hallam, et al\nBritish Journal of General Practice, Ju\n528\none of the subsequent cases were clinical, without\nvirological confirmation. There have been no further\ncases of mumps in the school (to November 2005).\nThe timing of the first outbreak control team\nmeeting, vaccinations and half-term holiday are also\nshown in Figure 1. Control measures were put in\nplace at the outbreak control team meeting.\nTable 1 shows the results of the case-control\nstudy.", "mimetype": "text/plain", "start_char_idx": 7687, "end_char_idx": 9519, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4c7b8f27-3ff5-4842-8b1b-dd0713893ee6": {"__data__": {"id_": "4c7b8f27-3ff5-4842-8b1b-dd0713893ee6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Mackenzie (2006).pdf", "node_type": "4", "metadata": {}, "hash": "0596be92d702d2163e403a71751e6f2c9df359f025c1790dec41b2d53410ade7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2591e22b-be26-41c4-af66-27d6cd6ef983", "node_type": "1", "metadata": {}, "hash": "cf7f976d76120d3f03ea8596eb978e947a2661e24852e1db3ef8f04ac505774c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b5a0d3af-b355-4088-806c-e7f2ee70087d", "node_type": "1", "metadata": {}, "hash": "c95d653eef8c4af82ee55ac91a6f39cf3f96cf106c5df5e18496d5d0efb24b42", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Control measures were put in\nplace at the outbreak control team meeting.\nTable 1 shows the results of the case-control\nstudy. Compared to no vaccine, MMR vaccine\nappeared to protect against mumps (odds ratio =\n0.7; 95% confidence interval (CI) = 0.2 to 2.0) and\ntwo doses of MMR vaccine offered best protection\n(odds ratio = 0.5; 95% CI = 0.1 to 3.2).\nDISCUSSION\nSummary of main findings\nThere were 50 clinical cases of mumps in this\noutbreak and 20 were virologically confirmed. All the\nconfirmed cases were in patients in their teenage\nyears (born between 1987\u20131991). This outbreak\nincluded day and boarding pupils and UK and\ninternational pupils.\nMMR vaccination prior to the outbreak appeared\nto be protective against mumps infection, particularly\ntwo doses of MMR vaccine. However the case-\ncontrol study was not large enough to detect a\nstatistically significant difference. Using the odds\nratio comparing no MMR vaccine with two doses of\nMMR, the number of cases of mumps required to\nidentify a statistically significant difference would\nhave been 378.\nOther public health measures taken to limit the\nspread of infection included restriction in movement\nof pupils in the school, cancellation of school events,\nand exclusion for 10 days. These control measures\nmay have limited the spread of mumps infection, but\nthe half-term holiday may also have limited the\nnumber of cases. The control measures resulted in\nconsiderable disruption to staff, parents and pupils\nat the school and school medical centre, impacting\non educational, social and sporting activities at the\nschool.\nStrengths and limitations of the study\nThis study has described the epidemiology of a\nmumps outbreak in a UK boarding school. The study\nhas used clinical data provided by pupils, parents,\nand medical staff, and virology data from the\nstandard laboratory tests recommended during the\noutbreak. The findings are therefore particularly\nrelevant to clinical practice.\nThe reliance on clinical information has, however,\nresulted in important limitations to this study. Only\n40% of notified cases were virologically confirmed as\nmany cases were incompletely investigated.", "mimetype": "text/plain", "start_char_idx": 9394, "end_char_idx": 11542, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b5a0d3af-b355-4088-806c-e7f2ee70087d": {"__data__": {"id_": "b5a0d3af-b355-4088-806c-e7f2ee70087d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Mackenzie (2006).pdf", "node_type": "4", "metadata": {}, "hash": "0596be92d702d2163e403a71751e6f2c9df359f025c1790dec41b2d53410ade7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4c7b8f27-3ff5-4842-8b1b-dd0713893ee6", "node_type": "1", "metadata": {}, "hash": "d720b8f4a1c119f745fcd8b37b9d1f6545200b46e23326734fc22667667e2fa2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "29c02703-206d-48c9-b6eb-8de89140447f", "node_type": "1", "metadata": {}, "hash": "20f9b9b48097b1a2e98f4bdbe6df0efb04ee8759ec59851ed142ddcb638269d7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The reliance on clinical information has, however,\nresulted in important limitations to this study. Only\n40% of notified cases were virologically confirmed as\nmany cases were incompletely investigated. Day\npupils were less likely to have had virological testing,\nparticularly if they attended their own doctor rather\nthan the school medical centre. While the under-\nsampling is unfortunate from an epidemiological\nperspective, this is not unexpected as there were\nother clinical priorities during the outbreak. Controls\nin the case-control study had not had virological\ntesting, and it is possible therefore that some\ncontrols were infected during the outbreak but\nremained asymptomatic or had atypical symptoms,\nand it is possible that some controls had been\ninfected previously.\nThere were also questions about the accuracy of\nthe reported vaccination status of some children.\nChildren and parents were frequently not aware of\nOdds ratios (and 95% CIs)\nNo MMR\nOne dose of\nTwo doses of\nNo vaccine\nNo vaccine versus\nOne dose of MMR\nvaccine\nMMR vaccine\nMMR vaccine\nversus any MMR\ntwo doses of MMR\nversus two doses of MMR\nCases\n9\n9\n2\n0.66\n0.52\n0.74\n(n = 20)\n(0.22 to 2.00)\n(0.09 to 3.16)\n(0.12 to 4.40)\nControls\n14\n20\n6\n\u2013\n\u2013\n\u2013\n(n = 40)\nTable 1. Results of case-control study (n = 60, 20 virologically confirmed cases, 40 controls without signs\nor symptoms of mumps). Two controls were matched to each virologically confirmed case, matched for\nage, sex, residential status and whether UK or international student.\n0\n2\n4\n6\n8\n10\n12\n14\n16\nClinical\nConfirmed\n \n53\n49\n45\n41\n37\n33\n29\n25\n21\n17\n13\n9\n5\n1\nDay of outbreak\nNumber of cases\nFirst OCT \nmeeting\nVaccination\nHalf-term holiday\nFigure 1. Outbreak curve\n(date of onset not known\nfor one participant, so\nn = 58).\nOCT = outbreak control team.", "mimetype": "text/plain", "start_char_idx": 11341, "end_char_idx": 13125, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "29c02703-206d-48c9-b6eb-8de89140447f": {"__data__": {"id_": "29c02703-206d-48c9-b6eb-8de89140447f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Mackenzie (2006).pdf", "node_type": "4", "metadata": {}, "hash": "0596be92d702d2163e403a71751e6f2c9df359f025c1790dec41b2d53410ade7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b5a0d3af-b355-4088-806c-e7f2ee70087d", "node_type": "1", "metadata": {}, "hash": "c95d653eef8c4af82ee55ac91a6f39cf3f96cf106c5df5e18496d5d0efb24b42", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b9eaf0b8-50a4-403b-a3bd-34ce57e46564", "node_type": "1", "metadata": {}, "hash": "74a64bc2a2fde306a2b93b3e9df43f74af242b947a3226d0a5acb040cc129527", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Outbreak curve\n(date of onset not known\nfor one participant, so\nn = 58).\nOCT = outbreak control team.\nOriginal Papers\nwhich vaccines had been given in the past, with\nconfusion about single vaccines, the measles-rubella\nvaccine given in the early 1990s and MMR. These\nconcerns about the accuracy of diagnosis, recording\nof previous infection, and recording of vaccination\nstatus were important sources of potential bias in the\ncase-control study.\nComparison with existing literature\nThe age group affected by this mumps outbreak\n(those born between 1987\u20131991) was the age group\nexpected to be at highest risk of mumps infection\nbecause of the 8-year period between introducing\nthe first and second doses of MMR in the UK. This\nfinding is consistent with other UK studies.4 This\nobservation is also consistent with recommendations\nfrom the Chief Medical Officer in Scotland who\nrecommended opportunistic vaccination of children\nand young people born between 1979\u20131991 (August\n2004).8\nImplications for future research and clinical\npractice\nThe findings have relevance for primary care staff\nand Health Protection Teams across the UK. This\noutbreak occurred in a private boarding school, but\nthe findings may also be relevant to colleges of\nfurther education and universities, many of which\nhave residential students. The findings also reinforce\nthe continuing concern that some parents have\nabout MMR vaccination. This suggests that there is\nstill more work to be done in educating parents about\nthe safety of MMR vaccine and the wide-ranging\neffects that can result from mumps outbreaks as a\nconsequence of inadequate levels of vaccination.\nMany teenagers and young adults are at risk of\nmumps infection because they are incompletely\nvaccinated with MMR vaccine and have not been\nexposed to infection in the past. With suboptimal\nlevels of vaccination in the UK outbreaks are now\nrelatively common. In this outbreak children born\nbetween 1987\u20131991 were at particular risk, with\nboarding and day pupils both affected. There was\nwidespread disruption to pupils, parents and staff\nbeyond\nthe\neffects\non\nhealth.\nIncompletely\nvaccinated or unvaccinated children and young\npeople MMR should receive full vaccination (two\ndoses of MMR).", "mimetype": "text/plain", "start_char_idx": 13024, "end_char_idx": 15251, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b9eaf0b8-50a4-403b-a3bd-34ce57e46564": {"__data__": {"id_": "b9eaf0b8-50a4-403b-a3bd-34ce57e46564", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Mackenzie (2006).pdf", "node_type": "4", "metadata": {}, "hash": "0596be92d702d2163e403a71751e6f2c9df359f025c1790dec41b2d53410ade7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "29c02703-206d-48c9-b6eb-8de89140447f", "node_type": "1", "metadata": {}, "hash": "20f9b9b48097b1a2e98f4bdbe6df0efb04ee8759ec59851ed142ddcb638269d7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "892478ff-0dba-4146-a64d-e6e490872a0a", "node_type": "1", "metadata": {}, "hash": "1d72a997816f204c6acfdbcc98bebb02ef7536bf10d7a68e6695a73cf0ffd985", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Incompletely\nvaccinated or unvaccinated children and young\npeople MMR should receive full vaccination (two\ndoses of MMR). There should also be better\nassessment and recording of vaccination status at\nentry into schools and colleges.\nFunding body\nThis study required no additional funding\nEthics committee\nThe data were collected as part of the Public Health\nmanagement of the outbreak. This collection of data was\ndiscussed with the local Caldicott Guardian, Acting Director\nof Public Health, who also agreed to the submission of the\nfindings for publication. Staff at the school medical centre\nparticipated fully at all stages of the outbreak and\nsubsequently in the analysis and preparation of this paper\nCompeting interests\nThe authors have stated that there are none\nAcknowledgements\nThe authors would like to thank the staff at the Specialist\nVirology Centre, Edinburgh Royal Infirmary, and the staff and\npupils at the boarding school for their input to this outbreak\nand Dr Claire Cameron and Dr John Cowden, Health\nProtection Scotland, for their advice about conducting a\ncase-control study.\nREFERENCES\n1.\nRamsay ME, Brown DW, Eastcott HR, Begg NT. Saliva antibody\ntesting and vaccination in a mumps outbreak. CDR 1991; 1:\nR96\u2013R98.\n2.\nScottish Health on the Web. Mumps. www.show.scot.nhs.uk/\nscieh/Surveillance/mumps.htm (accessed 16 Feb 2005).\n3.\nCameron C. Mumps update. Health Protection Scotland Weekly\nReport 2005; 39: 4.\n4.\nPugh RN, Akinosi B, Pooransingh S, et al. An outbreak of mumps\nin the metropolitan area of Walsall, UK. Int J Infect Dis 2002; 6:\n283\u2013287.\n5.\nJackson T. TV Programme raises fresh allegations about MMR\ndoctor: BMJ 2004; 329: 1254.\n6.\nFleck F. UK and Italy have low MMR uptake. BMJ 2003; 327: 1124.\n7.\nKirkwood BR, Sterne JAC. Essential medical statistics. 2nd edn.\nOxford: Blackwell Sciences, 2003.\n8.\nChief Medical Officer Letter.", "mimetype": "text/plain", "start_char_idx": 15130, "end_char_idx": 16997, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "892478ff-0dba-4146-a64d-e6e490872a0a": {"__data__": {"id_": "892478ff-0dba-4146-a64d-e6e490872a0a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Mackenzie (2006).pdf", "node_type": "4", "metadata": {}, "hash": "0596be92d702d2163e403a71751e6f2c9df359f025c1790dec41b2d53410ade7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b9eaf0b8-50a4-403b-a3bd-34ce57e46564", "node_type": "1", "metadata": {}, "hash": "74a64bc2a2fde306a2b93b3e9df43f74af242b947a3226d0a5acb040cc129527", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "7.\nKirkwood BR, Sterne JAC. Essential medical statistics. 2nd edn.\nOxford: Blackwell Sciences, 2003.\n8.\nChief Medical Officer Letter. Mumps outbreaks in Scotland: offer\nof MMR to high risk individuals in high risk settings\nhttp://www.show.scot.nhs.uk/sehd/cmo/DC20040804mumps.pdf\n(accessed 5 Jun 2006).\nBritish Journal of General Practice, July 2006\n529", "mimetype": "text/plain", "start_char_idx": 16864, "end_char_idx": 17217, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7fe3b69d-8721-4171-ab41-2f819925f9e0": {"__data__": {"id_": "7fe3b69d-8721-4171-ab41-2f819925f9e0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Bhuniya (2013).pdf", "node_type": "4", "metadata": {}, "hash": "099c2d3f05ad82ff3e959990ce37038e91411de67782b71f82e7f03ab495d105", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e4bfe047-e804-424f-b782-bbd0ec482b9c", "node_type": "1", "metadata": {}, "hash": "2628d7dafe56c94aaf5c569835cc853a692b945220c6870cc743112a1c8ebaab", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Indian Journal of Public Health, Volume 57, Issue 4, October-December, 2013\nMeasles Outbreak among the Dukpa Tribe of Buxa Hills in West \nBengal, India: Epidemiology and Vaccine Efficacy\nSatinath Bhuniya1, *Dipankar Maji2, Debasis Mandal3, Nilanjan Mondal4\n1Epidemiologist, Integrated Disease Surveillance Project (IDSP), 3Dy. CMOH-II & District Surveillance Of\ufb01 cer, Department of Health & Family \nWelfare, Jalpaiguri, 2DADHS & Nodal Of\ufb01 cer, IDSP, Department of Health & Family Welfare, Government of West Bengal, \n4Ex. BMOH, Uttar Latabari BPHC, Jalpaiguri, West Bengal, India\nSummary\nAlthough measles is a vaccine preventable disease, its occurrence and outbreaks are common in India. Four remote \nand inaccessible hamlets, inhabited by the Dukpa tribe, at Buxa Hills under Kalchini Block of Jalpaiguri District, West \nBengal experienced a measles outbreak during the months of April-June, 2011. The authors conducted an investigation \nto assess vaccine coverage, vaccine ef\ufb01 cacy (VE) and to describe the patterns of measles outbreaks in this community. \nThe over-all attack rate was 14.3%; that among males and females were 12.6% and 16.0% respectively (P = 0.189). \nAttack rate was highest (40%) in 0 to <5 years followed by that in the 5 to <15 years (36.5%). VE was 66.3% (95% \nof the con\ufb01 dence interval 46.9-78.6%). There is an urgent need to increase the vaccination coverage through special \ntactics for reaching the unreached.\nKeywords:\nKeywords: Attack rate, Measles outbreak, Measles vaccine, Vaccine ef\ufb01 cacy\nMeasles is still a major cause of childhood morbidity and \nmortality in India in-spite of Universal Immunization \nprogram being in place since 1985.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1674, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e4bfe047-e804-424f-b782-bbd0ec482b9c": {"__data__": {"id_": "e4bfe047-e804-424f-b782-bbd0ec482b9c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Bhuniya (2013).pdf", "node_type": "4", "metadata": {}, "hash": "099c2d3f05ad82ff3e959990ce37038e91411de67782b71f82e7f03ab495d105", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7fe3b69d-8721-4171-ab41-2f819925f9e0", "node_type": "1", "metadata": {}, "hash": "fcd4f0decc55e175e9926365b3519af961ec38cb6d0f3509a53e32ad21c2a3e7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4e95fd08-60f2-4209-a6ad-6feed0dd0a14", "node_type": "1", "metadata": {}, "hash": "b142e93433e61c4a4719caa25625c6da72f17ecda4bb0f6ba8d0af6274e703bc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "A number of measles \noutbreaks (281) were noti\ufb01 ed during 2008-2011 under \nintegrated disease surveillance project, Ministry of health \nand family welfare, Government of India.5 The ongoing \nevaluation of vaccine programs is an important strategy \nto get insight into the effectiveness of the program and \nprovide necessary feedback. Studies are revealed that \nmeasles outbreaks occurs mainly due to low vaccine \ncoverage or low vaccine ef\ufb01 cacy (VE) or both.1,2,4.\n*Corresponding Author: Dr. Dipankar Maji,\nDADHS & Nodal Of\ufb01 cer, 1/1 N.K. Chatterjee Street, \nP.O. Belgharia (Landmark: Near Old Building of Mahakali Girls\u2019 \nHigh School), Kolkata - 700 056, West Bengal, India.\nE-mail: maji.dipankar@gmail.com\nBrief Research Article\nAccess this article online\nAccess this article online\nWebsite:\nWebsite: www.ijph.in\nQuick Response Code:\nDOI:\nDOI: 10.4103/0019-557X.123273  \nPMID:\nPMID: ***\nA measles outbreak occurred at four high altitude \nvillages of Buxa Hills in Jalpaiguri District over a \n12 week period in April-June 2011. These villages had \npoor accessibility to modern health care system; a non-\ngovernment organization alone has been providing the \nbasic maternal and child health services with logistic \nsupport from health and family welfare Department since \n2007 in that area. The four village namely viz. Lepchakha \n(2800 ft), Onchulom (2700 ft), Lalbanglow (2000 ft), \nTashigaon (2300 ft) in Jalpaiguri District of West Bengal, \nIndia are inhabited by the Dukpa tribe. Total population \nof the four villages was 793 (males-52%, females-48%).\nThe District Surveillance unit conducted a study in order \nto determine the time, place and person characteristics of \nthe outbreak as well as the VE in the outbreak affected \narea with prior permission from the respective authority \nof the Directorate of Health Services, Government of \nWest Bengal. Ethical clearance was also taken.", "mimetype": "text/plain", "start_char_idx": 1675, "end_char_idx": 3568, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4e95fd08-60f2-4209-a6ad-6feed0dd0a14": {"__data__": {"id_": "4e95fd08-60f2-4209-a6ad-6feed0dd0a14", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Bhuniya (2013).pdf", "node_type": "4", "metadata": {}, "hash": "099c2d3f05ad82ff3e959990ce37038e91411de67782b71f82e7f03ab495d105", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e4bfe047-e804-424f-b782-bbd0ec482b9c", "node_type": "1", "metadata": {}, "hash": "2628d7dafe56c94aaf5c569835cc853a692b945220c6870cc743112a1c8ebaab", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "09365b1b-f2df-45c9-8de2-242fce505a35", "node_type": "1", "metadata": {}, "hash": "75555c72aa4539c22783a24e67e117153c96d2143f02d628c61b7f5ad6e43c44", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Ethical clearance was also taken. Clinical \nmeasles cases which had occurred during last 3 months \nwere found and line listed through the house to house \nsearch in the affected villages in the 1st week of July \n2011 by using a semi-structured questionnaire. Measles \nvaccination status was determined from immunization \ncards. If immunization card was not available, vaccination \nDownloaded from http://journals.lww.com/ijph by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\n273\nBhuniya, et al.: Measles Outbreak Among the Dukpa Tribe\nIndian Journal of Public Health, Volume 57, Issue 4, October-December, 2013\nstatus was recorded as unknown. We followed World \nHealth Organization de\ufb01 nitions of clinical and con\ufb01 rmed \nmeasles. A clinical case of measles is de\ufb01 ned as fever \nwith maculo-papular rash and either conjunctivitis or \ncough or coryza. A con\ufb01 rmed case of measles is de\ufb01 ned \nas a clinical case who is positive for anti-measles virus \nnucleoprotein immunoglobulin M (IgM) antibodies in \nserological tests but has not been vaccinated against \nmeasles during last 1 month.3 Six blood samples were \ncollected from selected cases, who were within 5th-15th \nday of illness from the onset of rash, for IgM enzyme-\nlinked immunosorbent assay test.\nA retrospective cohort study was conducted to estimate \nVE. There was no system of measles vaccination service \nin Buxa Hills area before 2007. Since then, vaccination \nprogram was going on having a coverage rate of 74% until \nJune 2011. Hence, children above 5 years in this region \nwere mostly unimmunized.", "mimetype": "text/plain", "start_char_idx": 3535, "end_char_idx": 5175, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "09365b1b-f2df-45c9-8de2-242fce505a35": {"__data__": {"id_": "09365b1b-f2df-45c9-8de2-242fce505a35", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Bhuniya (2013).pdf", "node_type": "4", "metadata": {}, "hash": "099c2d3f05ad82ff3e959990ce37038e91411de67782b71f82e7f03ab495d105", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4e95fd08-60f2-4209-a6ad-6feed0dd0a14", "node_type": "1", "metadata": {}, "hash": "b142e93433e61c4a4719caa25625c6da72f17ecda4bb0f6ba8d0af6274e703bc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f00f5055-636a-4b87-a529-5199081c901c", "node_type": "1", "metadata": {}, "hash": "b9efb79d822bf7c5e991c38ba123dc0fae25fc2c83274fccd8c2164689bb4c7e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Since then, vaccination \nprogram was going on having a coverage rate of 74% until \nJune 2011. Hence, children above 5 years in this region \nwere mostly unimmunized. Hence, we considered only the \nchildren of 9-59 months (as on 30 June 2011) as the cohort \nfor the study. There was no reported history of measles \nwithin the cohort prior to the outbreak. The exposure \nvariable as measles vaccination before the outbreak and \nthe outcome variable was an attack of clinical measles. We \nused the formula: VE (%)9 = (1 \u2013 relative risk) \u00d7 100. As \nwe included all children in the above-mentioned age group \nin the study, there is no need to calculate any sample size. \nData analysis was done by using a statistical test calculator \nand relative risk calculator.\nThe outbreak was con\ufb01 rmed as measles as \ufb01 ve of six \nserum samples tested positive for measles IgM. The total \nnumber of measles cases was 113. No death was reported. \nThe epi-curvet [Figure 1] shows that the outbreak started \nfrom the 1st week of April and continued until last week of \nJune, i.e., the early monsoon. Peak of the outbreak was in \n6th week. Maximum number of cases occurred in between \n4th and 8th week of the episode. No further cases were \nreported in the village in next 6 weeks following the last \ncase reported in June 2011. There is not much variation \nin gender wise time distribution of the occurrence of \nmeasles cases.\nTable 1 shows that among the cases, 52 (46%) were male \nand 61 (54%) were female. The youngest case was aged \nonly 3 months. The mother of that the child was also \naffected. The upper limit of the age range was 31 years, \nthe median being 10 years. The over-all attack rate was \n14.3% (113/793; 95% of the con\ufb01 dence interval [CI] \n11.8-6.7%). Attack rates among males and females were \nnot signi\ufb01 cantly different (52/412 [12.6%] vs. 61/381 \n[16.0%]; P = 0.189).", "mimetype": "text/plain", "start_char_idx": 5011, "end_char_idx": 6879, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f00f5055-636a-4b87-a529-5199081c901c": {"__data__": {"id_": "f00f5055-636a-4b87-a529-5199081c901c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Bhuniya (2013).pdf", "node_type": "4", "metadata": {}, "hash": "099c2d3f05ad82ff3e959990ce37038e91411de67782b71f82e7f03ab495d105", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "09365b1b-f2df-45c9-8de2-242fce505a35", "node_type": "1", "metadata": {}, "hash": "75555c72aa4539c22783a24e67e117153c96d2143f02d628c61b7f5ad6e43c44", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e3a8e410-eaea-4708-8847-ca1ff8afefd3", "node_type": "1", "metadata": {}, "hash": "883479fa5b5824eabc9a2ccc067c65475233fb2d20960bbf1f9ac070bb317d36", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Attack rates among males and females were \nnot signi\ufb01 cantly different (52/412 [12.6%] vs. 61/381 \n[16.0%]; P = 0.189). Of the 113 clinical cases, 89 (78.8%) \nwere children (0 to <15 years). The attack rate among \nchildren was signi\ufb01 cantly higher than that in adults (\u226515 \nyears) (89/236 [37.7%] vs. 24/557 [4.3%]; Chi-square = \n151.36, P < 0.001). Attack rate was highest in the under \n5 years age group.\nAmong 113 clinical cases, only 18 (15.9%) were \nvaccinated before the outbreak. Vaccination status of \nTable 1: Attack rate of measles by age and sex\nAge group \n(years)\nNo. of the population \nby sex\nNo. of persons \ndeveloped measles\nAttack \nrate (%)\nMale\nFemale\nTotal\nMale Female Total\n0 to <5\n47\n33\n80\n19\n13\n32\n40.0\n5 to <15\n81\n75\n156\n21\n36\n57\n36.5\n15 to <25\n116\n106\n222\n9\n10\n19\n8.6\n25 and above\n168\n167\n335\n3\n2\n5\n1.5\nTotal\n412\n381\n793\n52\n61\n113\n14.3\nAttack rate (%)\n12.6\n16.0\n14.3\nFigure 1: Epi-curve showing gender-wise time distribution of measles cases (n = 113)\nDownloaded from http://journals.lww.com/ijph by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\n274\nBhuniya, et al.", "mimetype": "text/plain", "start_char_idx": 6760, "end_char_idx": 7926, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e3a8e410-eaea-4708-8847-ca1ff8afefd3": {"__data__": {"id_": "e3a8e410-eaea-4708-8847-ca1ff8afefd3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Bhuniya (2013).pdf", "node_type": "4", "metadata": {}, "hash": "099c2d3f05ad82ff3e959990ce37038e91411de67782b71f82e7f03ab495d105", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f00f5055-636a-4b87-a529-5199081c901c", "node_type": "1", "metadata": {}, "hash": "b9efb79d822bf7c5e991c38ba123dc0fae25fc2c83274fccd8c2164689bb4c7e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "901d9370-70f6-42fc-b3e3-8b9bf0315e8d", "node_type": "1", "metadata": {}, "hash": "9e5da6e3ae889af1c7d2fc6611613ffcbd0968dfe2a259ffef61c9194e87b3ea", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": ": Measles Outbreak Among the Dukpa Tribe\nIndian Journal of Public Health, Volume 57, Issue 4, October-December, 2013\n42 (37.2%) was unknown. Remaining 53 (46.9%) cases \nwere unvaccinated.\nThe cohort size of children of 9-59 months for calculation \nof VE was 68. Among them 50 were vaccinated and the \nrest were unvaccinated on retrospective observation. \nAttack rates among the vaccinated and the unvaccinated \nwere 30.0% and 88.9% respectively. Our study estimated \nthe VE to be 66.3% (95% CI: 46.9-78.6%). VE by \nage at vaccination within 9-59 months children shows \na marginal difference between the two groups viz.: \nVaccinated between 9 and 12 months (VE = 66.59%) \nversus vaccinated after 12 months of age (VE = 65.38%).\nWe suspect that measles was transmitted from outsider \ntourists at Buxa Fort to the local Dukpa children, \nbecause no measles case was reported in Buxa Hills \nin last 1 year before the outbreak. Most of the earlier \nstudies revealed that the respective measles outbreaks \nwere attributable either to low measles vaccine coverage \nor low VE or both.1,2,4,6,7,8 Our study among Drukpa \ntribe of Buxa Hills determined the both to be the \ncause(s). Mostly the children below 15 years were \naffected during the outbreak. There were several \nreasons for the predominance of measles in that age \ngroup in the community. Children over 5 years of age \nwere not protected by measles vaccine earlier. Being \nin an isolated community, the herd immunity of the \n5 to <15 year age group owing to exposure to natural \nmeasles was likely to be low too. A good proportion of \nchildren of 1-5 years were also unvaccinated. Moreover, \nVE was far below (66.3%) the expected standard \n(85%).", "mimetype": "text/plain", "start_char_idx": 7926, "end_char_idx": 9623, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "901d9370-70f6-42fc-b3e3-8b9bf0315e8d": {"__data__": {"id_": "901d9370-70f6-42fc-b3e3-8b9bf0315e8d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Bhuniya (2013).pdf", "node_type": "4", "metadata": {}, "hash": "099c2d3f05ad82ff3e959990ce37038e91411de67782b71f82e7f03ab495d105", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e3a8e410-eaea-4708-8847-ca1ff8afefd3", "node_type": "1", "metadata": {}, "hash": "883479fa5b5824eabc9a2ccc067c65475233fb2d20960bbf1f9ac070bb317d36", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1a51ab27-7480-44b9-93ac-27cdf0a87cd9", "node_type": "1", "metadata": {}, "hash": "04a51ca23dcbba9e03f51b04801bcd91fcadf3524061ceb1231c6d359566022f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "A good proportion of \nchildren of 1-5 years were also unvaccinated. Moreover, \nVE was far below (66.3%) the expected standard \n(85%). Almost similar low VE was also found in a \nstudy at Nutandih village of Purulia District of West \nBengal.8 In our case, the unvaccinated children below \n5 years were given a dose of measles immunization \nduring the outbreak. We have considered those children \nto be unvaccinated ones so far VE estimation was \nconcerned, although the said dose of vaccine might have \ndeveloped some immunity in the vaccines within the \ntime period of the outbreak. This could have resulted \nin an underestimation of the VE. However, out of \nthese children only two remained to be affected with \nmeasles. Considering the much larger cohort size with \nrespect to this, we can say that the underestimation \nwould be only a little. Unlike some earlier measles \noutbreaks in other areas, there was no death in the \npresent outbreak and the attack rate in females was not \nsigni\ufb01 cantly higher than that in the males.2,3,6,7,8 It is \nrecommended that measles immunization program in \nthe Buxa Hills area be reviewed to \ufb01 nd out the reason \nof low VE. The vaccination point on the hills is 23 km \naway from the vaccine store and it requires an uphill \nwalk of about 8 km to reach there. Hence, vaccine cold \nchain is potentially vulnerable and needs to be specially \nmonitored. However, over-all vaccine coverage among \nthe under-five population was below the expected \nlevel of achievement, which needs to be addressed. \nFurthermore, the second opportunity vaccination should \nbe arranged as per the revised guideline10 (2010) of the \nMinistry of health and family welfare, Government of \nIndia.\nThis study has its own limitations; i.e., (a) the VE \nestimation had to be done with only a small population \nthereby reducing the precision of the estimate and (b) the \nresults might not be externally valid as the study subjects \nbelonged to a special isolated community.\nInadequate vaccine coverage, low VE and possibly \nlow herd immunity due to geographical separation \nfrom measles endemic areas contributed to causation \nof the outbreak.", "mimetype": "text/plain", "start_char_idx": 9490, "end_char_idx": 11639, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1a51ab27-7480-44b9-93ac-27cdf0a87cd9": {"__data__": {"id_": "1a51ab27-7480-44b9-93ac-27cdf0a87cd9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Bhuniya (2013).pdf", "node_type": "4", "metadata": {}, "hash": "099c2d3f05ad82ff3e959990ce37038e91411de67782b71f82e7f03ab495d105", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "901d9370-70f6-42fc-b3e3-8b9bf0315e8d", "node_type": "1", "metadata": {}, "hash": "9e5da6e3ae889af1c7d2fc6611613ffcbd0968dfe2a259ffef61c9194e87b3ea", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "56167494-277c-4aa9-8264-1626d8a21133", "node_type": "1", "metadata": {}, "hash": "f155989157d575d6f1f54530f667be0c709dcb4feeab8d18cd2d6dfe289a22b4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Inadequate vaccine coverage, low VE and possibly \nlow herd immunity due to geographical separation \nfrom measles endemic areas contributed to causation \nof the outbreak. Emphasis needs to be given to \nattain the program goal of primary measles vaccine \ncoverage within the stipulated age as well as the \nsecond dose vaccination as per the current national \nguideline.\nAcknowledgment\nWe do acknowledge the co-operation extended by the Family \nPlanning Association of India, Kalchini Branch during the \nstudy. We are grateful to the State Surveillance Unit, Public \nHealth Branch, Directorate of Health Services, Government. \nof West Bengal for their kind permission to conduct the \nstudy. Last but not the least, we are thankful to the people of \nLepchakha, Onchloom, Lalbangla and Tashigaon who were \nalways cooperative with us.\nReferences\n1. \nMis hra A, Mishra S, Lahariya C, Jain P, Bhadoriya \nRS, Shrivastav D, et al. Practical observations from an \nepidemiological investigation of a measles outbreak in a \ndistrict of India. Indian J Community Med 2009;34:117-21.\n2. \nGupta BP, Sharma S. Measles outbreak in a rural area near \nShimla. Indian J Community Med 2006;31:106-8.\n3. \nSniadack DH, Moscoso B, Aguilar R, Heath J, Bellini W, \nChiu MC. Measles epidemiology and outbreak response \nimmunization in a rural community in Peru. Bull World Health \nOrgan 1999;77:545-52.\nDownloaded from http://journals.lww.com/ijph by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\n275\nBhuniya, et al.", "mimetype": "text/plain", "start_char_idx": 11470, "end_char_idx": 13036, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "56167494-277c-4aa9-8264-1626d8a21133": {"__data__": {"id_": "56167494-277c-4aa9-8264-1626d8a21133", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Bhuniya (2013).pdf", "node_type": "4", "metadata": {}, "hash": "099c2d3f05ad82ff3e959990ce37038e91411de67782b71f82e7f03ab495d105", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1a51ab27-7480-44b9-93ac-27cdf0a87cd9", "node_type": "1", "metadata": {}, "hash": "04a51ca23dcbba9e03f51b04801bcd91fcadf3524061ceb1231c6d359566022f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6a037f3e-6123-481b-8353-0091850379e3", "node_type": "1", "metadata": {}, "hash": "240d590ed944131ea798bb0a0b8457168fba11cf96a2bbb93deec8f37383401b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": ": Measles Outbreak Among the Dukpa Tribe\nIndian Journal of Public Health, Volume 57, Issue 4, October-December, 2013\nAvailable from: http://www.nie.gov.in/images/leftcontent_\nattach/MAE_Achievements. Last accessed on May, 2013.\n9. \nDesai VK, Kapadia SJ, Kumar P, Nirupam S. Study of measles \nincidence and vaccination coverage in slums of Surat City. \nIndian J Community Med 2003;28:10-4.\n10. Government of India, Ministry of Health and Family Welfare. \nMeasles Catch-Up Immunization Campaign \u2014 Guideline for \nPlanning and Implementation: MoHFW, Govt. of India; 2010. \nAvailable from: http://www.unicef.org/india/Operational_\nguideline_for_Measles_catch_up_immunization_campaign__\nMoHFW_GoI. Last accessed on May, 2013.\n4. \nThakur JS, Ratho RK, Bhatia SP, Grover R, Issaivanan M, \nAhmed B, et al. Measles outbreak in a Periurban area of \nChandigarh: Need for improving vaccine coverage and \nstrengthening surveillance. Indian J Pediatr 2002;69:33-7.\n5. \nGovernment of India, Ministry of Health and Family \nWelfare, Integrated Disease Surveillance Project. Outbreak \nSurveillance, Central Surveillance Unit, IDSP, 2011. Available \nfrom: http://www.idsp.nic.in/idsp/IDSP/Outbreaks.ppt. Last \naccessed on May, 2013.\n6. \nBharti B, Bharti S. Measles in a hilly hamlet of northern India. \nIndian J Pediatr 2002;69:1033-5.\n7. \nRajapaksa L. A case control study to assess the efficacy of \nmeasles vaccine. Ceylon Med J 1993;38:178-80.\n8. \nDas PK. Poor vaccine coverage continues to cause measles \noutbreak in Purulia District, West Bengal, India, 2006.", "mimetype": "text/plain", "start_char_idx": 13036, "end_char_idx": 14580, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6a037f3e-6123-481b-8353-0091850379e3": {"__data__": {"id_": "6a037f3e-6123-481b-8353-0091850379e3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Bhuniya (2013).pdf", "node_type": "4", "metadata": {}, "hash": "099c2d3f05ad82ff3e959990ce37038e91411de67782b71f82e7f03ab495d105", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "56167494-277c-4aa9-8264-1626d8a21133", "node_type": "1", "metadata": {}, "hash": "f155989157d575d6f1f54530f667be0c709dcb4feeab8d18cd2d6dfe289a22b4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Ceylon Med J 1993;38:178-80.\n8. \nDas PK. Poor vaccine coverage continues to cause measles \noutbreak in Purulia District, West Bengal, India, 2006. \nCite this article as: Bhuniya S, Maji D, Mandal D, Mondal N. Measles outbreak \namong the Dukpa tribe of Buxa hills in West Bengal, India: Epidemiology and \nvaccine ef\ufb01 cacy. Indian J Public Health 2013;57:272-5.\nSource of Support: Nil. Con\ufb02 ict of Interest: None declared.\nDownloaded from http://journals.lww.com/ijph by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025", "mimetype": "text/plain", "start_char_idx": 14434, "end_char_idx": 15026, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9abc49aa-d7fd-4204-8a0b-ef95d68d50d4": {"__data__": {"id_": "9abc49aa-d7fd-4204-8a0b-ef95d68d50d4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf", "node_type": "4", "metadata": {}, "hash": "8c8a35f2ca80e741162a3ac5fe702b2ad5a3159a2a2247afd7e40309da3a0b18", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7858b58e-8c8d-4ded-b420-a2e9ce5bf117", "node_type": "1", "metadata": {}, "hash": "2f8bd0ae12e1b96907110efb9ca530b8dd102f250abe03068716b674398b9893", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ORIGINAL STUDIES\nLack of Association Between Measles-Mumps-Rubella\nVaccination and Autism in Children\nA Case-Control Study\nDorota Mroz\u02d9ek-Budzyn, PhD, Agnieszka Kie\u0142tyka, PhD, and Renata Majewska, MSc\nObjective: The \ufb01rst objective of the study was to determine whether there\nis a relationship between the measles-mumps-rubella (MMR) vaccination\nand autism in children. The second objective was to examine whether the\nrisk of autism differs between use of MMR and the single measles vaccine.\nDesign: Case-control study.\nStudy Population: The 96 cases with childhood or atypical autism, aged\n2 to 15, were included into the study group. Controls consisted of 192\nchildren individually matched to cases by year of birth, sex, and general\npractitioners.\nMethods: Data on autism diagnosis and vaccination history were from\nphysicians. Data on the other probable autism risk factors were collected\nfrom mothers. Logistic conditional regression was used to assess the risk of\nautism resulting from vaccination. Assessment was made for children\nvaccinated (1) Before diagnosis of autism, and (2) Before \ufb01rst symptoms\nof autism onset. Odds ratios were adjusted to mother\u2019s age, medication\nduring pregnancy, gestation time, perinatal injury and Apgar score.\nResults: For children vaccinated before diagnosis, autism risk was lower in\nchildren vaccinated with MMR than in the nonvaccinated (OR: 0.17, 95%\nCI: 0.06\u20130.52) as well as to vaccinated with single measles vaccine (OR:\n0.44, 95% CI: 0.22\u20130.91). The risk for vaccinated versus nonvaccinated\n(independent of vaccine type) was 0.28 (95% CI: 0.10\u20130.76). The risk\nconnected with being vaccinated before onset of \ufb01rst symptoms was\nsigni\ufb01cantly lower only for MMR versus single vaccine (OR: 0.47, 95%\nCI: 0.22\u20130.99).\nConclusions: The study provides evidence against the association of\nautism with either MMR or a single measles vaccine.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1877, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7858b58e-8c8d-4ded-b420-a2e9ce5bf117": {"__data__": {"id_": "7858b58e-8c8d-4ded-b420-a2e9ce5bf117", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf", "node_type": "4", "metadata": {}, "hash": "8c8a35f2ca80e741162a3ac5fe702b2ad5a3159a2a2247afd7e40309da3a0b18", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9abc49aa-d7fd-4204-8a0b-ef95d68d50d4", "node_type": "1", "metadata": {}, "hash": "bd70bc95176afd531f2c1798c215e8b293ecce887833889880530ad83b467020", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "531e4ff5-2072-4ca9-ba21-cd15216e598b", "node_type": "1", "metadata": {}, "hash": "1fd7430bae8ee6a1b39ec0e9c5da4675217aaf570c3915c3959b02fd3917b702", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Conclusions: The study provides evidence against the association of\nautism with either MMR or a single measles vaccine.\nKey Words: MMR vaccine, autism, children\n(Pediatr Infect Dis J 2010;29: 397\u2013400)\nA\ngreat deal of speculation exists concerning the possible\nassociations of certain vaccines, particularly the measles-\nmumps-rubella (MMR) vaccine, with autism. Wake\ufb01eld et al1\nwere the \ufb01rst to propose that the MMR vaccine might be causally\nlinked to autism. It was suggested that gastrointestinal and devel-\nopmental symptoms constituted a syndrome that might be trig-\ngered by this vaccine. Their study was widely criticized but\ngenerated immense media attention, leading to a fall in MMR\ncoverage in some European countries.2\u20135 Since that report, a\nnumber of other studies have found no evidence to support a link\nbetween MMR vaccination and autism.6\u20139\nAlthough Poland continues to report high MMR vaccination\ncoverage, questions concerning the safety of this vaccine, boosted\nby periodic antivaccination campaigns, persist. The MMR vaccine\nwas introduced in Poland later than in most other European\ncountries. For the past 10 years, the MMR vaccine has been\ngradually replacing the single-antigen measles variety. When it\nwas \ufb01rst introduced, MMR was not covered by the national health\nservice of Poland. Parents who wished to vaccinate their children\nwith MMR, as opposed to the single mandatory measles vaccine,\nhad to pay extra. For this reason, few children were immunized\nwith MMR. The Polish mandatory vaccinations schedule did not\ninclude MMR for all children until 2004. Since then, already high\nlevels of immunization against measles have slightly grown.10\nPoland\u2019s heterogeneous population (ie, vaccinated with MMR,\nvaccinated against measles only, nonvaccinated) serves as a\nunique sample group for studying the debated association of\nthese vaccines with autism in children. Although a wide variety\nof published studies fail to \ufb01nd any such in\ufb02uence or relation-\nship, the association between MMR and autism remains in the\nminds of some medical workers and parents.", "mimetype": "text/plain", "start_char_idx": 1758, "end_char_idx": 3839, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "531e4ff5-2072-4ca9-ba21-cd15216e598b": {"__data__": {"id_": "531e4ff5-2072-4ca9-ba21-cd15216e598b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf", "node_type": "4", "metadata": {}, "hash": "8c8a35f2ca80e741162a3ac5fe702b2ad5a3159a2a2247afd7e40309da3a0b18", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7858b58e-8c8d-4ded-b420-a2e9ce5bf117", "node_type": "1", "metadata": {}, "hash": "2f8bd0ae12e1b96907110efb9ca530b8dd102f250abe03068716b674398b9893", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7f314f68-e111-4932-87ab-657b5affac0d", "node_type": "1", "metadata": {}, "hash": "b5a7637f444f52a738ea7571232d91c4ec13d9262718a2fce93c5d918ffaf729", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Although a wide variety\nof published studies fail to \ufb01nd any such in\ufb02uence or relation-\nship, the association between MMR and autism remains in the\nminds of some medical workers and parents. This way of\nthinking threatens to undermine the implementation of measles\nelimination programs.11\u201313\nThe \ufb01rst objective of this study was to determine whether a\nrelationship exists between MMR vaccination and autism in chil-\ndren. The second objective was to examine whether the risk of\nautism differs between MMR and the single measles vaccine.\nMATERIALS AND METHODS\nStudy Population\nSubjects were identi\ufb01ed using general practitioner records\nin the Lesser Poland (Ma\u0142opolska) Voivodeship in Poland. The\nsample population of this study included children aged 2 to 15\nyears diagnosed with childhood or atypical autism, classi\ufb01ed\naccording to ICD 10-criteria as F84.0 or F84.1, respectively. Every\ndiagnosis of autism was made by child psychiatrist. Dates of these\ndiagnoses were recorded in general practitioners \ufb01les. Cases with\nuncertain diagnosis of autism, secondary to disease state or trauma,\nwere excluded. Two controls were selected for each affected child,\nindividually matched by year of birth, gender, and physician\u2019s\npractice. The \ufb01rst 2 children visited the physician after the time of\nthe autistic child visit who met entry criteria served as controls.\nQuestionnaire to the Parents of Affected Children\nand Controls\nParents were interviewed by trained nurses using a stan-\ndardized questionnaire. Questions for all children included infor-\nmation about prenatal and postnatal development, mental and\nphysical development, chronic diseases, malformations and inju-\nries, history of bowel disturbances, birth order, family size, and\nparents\u2019 socioeconomic status.\nParents of children with autism were additionally asked\nabout the date of onset of symptom, the period when parents \ufb01rst\nAccepted for publication October 1, 2009.\nFrom the Department of Epidemiology and Preventive Medicine, Jagiellonian\nUniversity, Collegium Medicum, Krakow, Poland.", "mimetype": "text/plain", "start_char_idx": 3649, "end_char_idx": 5699, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7f314f68-e111-4932-87ab-657b5affac0d": {"__data__": {"id_": "7f314f68-e111-4932-87ab-657b5affac0d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf", "node_type": "4", "metadata": {}, "hash": "8c8a35f2ca80e741162a3ac5fe702b2ad5a3159a2a2247afd7e40309da3a0b18", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "531e4ff5-2072-4ca9-ba21-cd15216e598b", "node_type": "1", "metadata": {}, "hash": "1fd7430bae8ee6a1b39ec0e9c5da4675217aaf570c3915c3959b02fd3917b702", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "50077128-90c5-4e65-b1fb-4ad35c0165ea", "node_type": "1", "metadata": {}, "hash": "6c80823b665adcc3001f19822dbcdc9eab064ab964aae4e37241849cdafbfa13", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "From the Department of Epidemiology and Preventive Medicine, Jagiellonian\nUniversity, Collegium Medicum, Krakow, Poland.\nAddress for correspondence: Dorota Mroz\u02d9ek-Budzyn, PhD, Chair of Epidemi-\nology and Preventive Medicine UJ CM, Kopernika 7A, 31\u2013034 Krako\u00b4w,\nPoland. E-mail: dorotamrozek@tlen.pl.\nCopyright \u00a9 2010 by Lippincott Williams & Wilkins\nISSN: 0891-3668/10/2905-0397\nDOI: 10.1097/INF.0b013e3181c40a8a\nThe Pediatric Infectious Disease Journal \u2022 Volume 29, Number 5, May 2010\nwww.pidj.com\n| 397\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\nsuspected their child\u2019s symptoms might be related to autism, and\ntheir knowledge and beliefs regarding the cause of autism. This\nquestionnaire did not contain any questions concerning the child\u2019s\nvaccination history so as to not bias the parent\u2019s answers (ie,\ninsinuate a relationship with autism).\nAutism Diagnosis and Vaccination History\nThe date of the child\u2019s autism diagnosis as well as his or her\nvaccination history was extracted directly from the physician\u2019s\nrecords.\nData Analysis\nCases of autism were considered as vaccinated if vaccina-\ntion preceded the onset of symptoms. Controls were considered\nvaccinated if they received their vaccination before age of symp-\ntoms onset of their matched case subject. Conditional logistic\nregression analysis was used to examine the association between\nMMR vaccination and autism in the matched case-control analysis.\nThe odds ratios were calculated for vaccinated versus nonvacci-\nnated children, vaccinated with the single measles vaccine versus\nnonvaccinated, vaccinated with MMR versus nonvaccinated, and\nvaccinated with MMR versus the single measles vaccine.", "mimetype": "text/plain", "start_char_idx": 5579, "end_char_idx": 7369, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "50077128-90c5-4e65-b1fb-4ad35c0165ea": {"__data__": {"id_": "50077128-90c5-4e65-b1fb-4ad35c0165ea", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf", "node_type": "4", "metadata": {}, "hash": "8c8a35f2ca80e741162a3ac5fe702b2ad5a3159a2a2247afd7e40309da3a0b18", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7f314f68-e111-4932-87ab-657b5affac0d", "node_type": "1", "metadata": {}, "hash": "b5a7637f444f52a738ea7571232d91c4ec13d9262718a2fce93c5d918ffaf729", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8d5d92ac-dd75-4db9-950f-64f931768fc0", "node_type": "1", "metadata": {}, "hash": "0c78b4e44a52055fd5c82b2c0a676d7d49dc5620a6ee33073cda99fb3b4c0569", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This\nprocedure was repeated for vaccination preceding the time of\nautism diagnosis.\nOther potential risk factors of autism (mother\u2019s age, moth-\ner\u2019s education, gestation time, medication during pregnancy, peri-\nnatal injury, and Apgar scale score) were examined and those that\nappeared to be associated with autism (P \u0001 0.2) were carried\nforward into multivariate models. The statistical signi\ufb01cance was\nde\ufb01ned as P \u0001 0.05. Statistical analyses were performed using\nSTATA 8.0.\nRESULTS\nThe study population consisted of 96 cases and 192 con-\ntrols, with a mean age 7.5 \u0002 2.6 years, 81.2% boys and 19.8%\ngirls. Approximately 13% of case-group mothers were aged \u000135\nyears at time of delivery compared with 7.2% of control-group\nmothers. This represented a statistically signi\ufb01cant difference (Ta-\nble 1). Gestation time \u000238 weeks was also signi\ufb01cantly more\nfrequent in cases than controls. The mothers of autistic children\nsigni\ufb01cantly more often took medication during pregnancy\n(mostly antibiotics and antihypertensive drugs). Case-group\nsubjects signi\ufb01cantly more often suffered from some form of\nperinatal injury. Although the difference was not signi\ufb01cant,\n5-minute Apgar scores were often less than 9 in autistic chil-\ndren. These 5 factors were taken as potential confounders and\nincluded in multivariate analysis.\nCase-group parents recognized abnormal behavior by age 1\nyear in 40% of their children. This number rose to 69.8% by age\n2 years. A diagnosis of autism was con\ufb01rmed in 45.8% of children\nby age 2 years, in 22.9% by age 3 years, 21.9% by age 4 years, and\n9.4% were diagnosed at age \u00034 years.\nMost children (64.6% of cases and 76.6% of controls) were\nvaccinated at age 12 to 18 months. Across both groups, there were\n9 children not vaccinated against measles (Table 2).", "mimetype": "text/plain", "start_char_idx": 7370, "end_char_idx": 9155, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8d5d92ac-dd75-4db9-950f-64f931768fc0": {"__data__": {"id_": "8d5d92ac-dd75-4db9-950f-64f931768fc0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf", "node_type": "4", "metadata": {}, "hash": "8c8a35f2ca80e741162a3ac5fe702b2ad5a3159a2a2247afd7e40309da3a0b18", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "50077128-90c5-4e65-b1fb-4ad35c0165ea", "node_type": "1", "metadata": {}, "hash": "6c80823b665adcc3001f19822dbcdc9eab064ab964aae4e37241849cdafbfa13", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fe15bde7-7f1a-4e07-9ded-5b958a0db54e", "node_type": "1", "metadata": {}, "hash": "9038557459d8c94ec97b0ec7fbf757dca2afb1474be908265a36f9bf84011e29", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Across both groups, there were\n9 children not vaccinated against measles (Table 2). The percent-\nage of nonvaccinated children was signi\ufb01cantly higher (P \u0004 0.001)\nin cases than in controls. The MMR vaccine was used in 44.3% of\nvaccinated cases and 55.0% of vaccinated controls. This difference\nwas not statistically signi\ufb01cant.\nOdds ratios of having autism, based on vaccination status\nand type of vaccine used, are presented in Table 3. Using logistic\nunivariate regression modeling, no positive association was found\nTABLE 2.\nVaccination Practices, Before the Diagnosis\nof Autism, and Before Onset of Symptoms\nStatus\nChildren\nWith\nAutism\nControl\nGroup\nN\n%\nN\n%\nVaccinated before symptom onset*\nNo\n26\n27.1\n44\n22.9\nMonovalent vaccine\n39\n40.6\n61\n31.8\nMMR\n31\n32.3\n87\n45.3\nVaccinated before diagnosis\u2020\nNo\n17\n17.7\n9\n4.7\nMonovalent vaccine\n45\n46.9\n81\n42.2\nMMR\n34\n35.4\n102\n53.1\nEver vaccinated\nNo\n8\n8.3\n1\n0.5\nMonovalent vaccine\n49\n51.0\n86\n44.8\nMMR\n39\n40.6\n105\n54.7\nFor the control group:\n*Vaccinated before age of symptom onset of their matched case-group subject.\n\u2020Vaccinated before age of autism diagnosis of their matched case-group subject.\nTABLE 3.\nAssociation Between Single Measles and\nMMR Vaccination Before the Diagnosis of Autism and\nBefore Onset of Symptoms, Based on Univariate\nModeling\nStatus\nOR\n95% CI\nStatistical\nSignificance\nVaccinated (independent of\nvaccine type) vs.\nnonvaccinated\nVaccinated before symptom onset\n0.56\n0.24\u20131.30\nns\nVaccinated before\ndiagnosis\n0.23\n0.09\u20130.57\nP \u0004 0.001\nSingle and MMR vaccination vs.", "mimetype": "text/plain", "start_char_idx": 9072, "end_char_idx": 10598, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fe15bde7-7f1a-4e07-9ded-5b958a0db54e": {"__data__": {"id_": "fe15bde7-7f1a-4e07-9ded-5b958a0db54e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf", "node_type": "4", "metadata": {}, "hash": "8c8a35f2ca80e741162a3ac5fe702b2ad5a3159a2a2247afd7e40309da3a0b18", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8d5d92ac-dd75-4db9-950f-64f931768fc0", "node_type": "1", "metadata": {}, "hash": "0c78b4e44a52055fd5c82b2c0a676d7d49dc5620a6ee33073cda99fb3b4c0569", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4de7dbfa-a22d-4899-8259-8c6d16884033", "node_type": "1", "metadata": {}, "hash": "62dc113fcfe5b7cbb94b6f590474fb4948c39d9ddcd13382047de4a64872c530", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nonvaccinated\nVaccinated before symptom onset*\nSingle vaccine\n0.73\n0.30\u20131.73\nns\nMMR\n0.39\n0.16\u20130.98\nP \u0004 0.045\nVaccinated before diagnosis\u2020\nSingle vaccine\n0.29\n0.12\u20130.73\nP \u0004 0.008\nMMR\n0.16\n0.07\u20130.41\nP \u0001 0.001\nMMR vs. single vaccine\nVaccinated before symptom onset\n0.53\n0.28\u20131.02\nP \u0004 0.059\nVaccinated before diagnosis\n0.53\n0.29\u20130.97\nP \u0004 0.040\nFor the control group:\n*Vaccinated before age of symptom onset of their matched case-group subject.\n\u2020Vaccinated before age of autism diagnosis of their matched case-group subject.\nns indicates not significant.\nTABLE 1.", "mimetype": "text/plain", "start_char_idx": 10599, "end_char_idx": 11157, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4de7dbfa-a22d-4899-8259-8c6d16884033": {"__data__": {"id_": "4de7dbfa-a22d-4899-8259-8c6d16884033", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf", "node_type": "4", "metadata": {}, "hash": "8c8a35f2ca80e741162a3ac5fe702b2ad5a3159a2a2247afd7e40309da3a0b18", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fe15bde7-7f1a-4e07-9ded-5b958a0db54e", "node_type": "1", "metadata": {}, "hash": "9038557459d8c94ec97b0ec7fbf757dca2afb1474be908265a36f9bf84011e29", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c38e6b79-2d89-4361-b064-38240a634980", "node_type": "1", "metadata": {}, "hash": "2bca579f96e1de23db0ee2144f22659615a6f40bb7d6dcb0b44f62872951b9ee", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2020Vaccinated before age of autism diagnosis of their matched case-group subject.\nns indicates not significant.\nTABLE 1.\nCase- and Control-Group Characteristics\nCharacteristic\nCases\n(n \u0004 96)\nControls\n(n \u0004 192)\nStatistical\nSignificance\nN\n%\nN\n%\nMother aged \u000135 yr\n12\n12.9\n14\n7.3\n0.013\nMother completed\nuniversity\neducation\n29\n30.5\n68\n35.6\n0.43\nGestation time\n\u000238 wk\n21\n21.9\n21\n11.0\n0.021\nMedication during\npregnancy\n43\n44.8\n50\n26.0\n0.002\nPerinatal injury\n13\n13.5\n9\n4.7\n0.016\n5-min Apgar scale\nscore \u00019\n17\n17.7\n20\n10.4\n0.094\nMroz\u02d9ek-Budzyn et al\nThe Pediatric Infectious Disease Journal \u2022 Volume 29, Number 5, May 2010\n\u00a9 2010 Lippincott Williams & Wilkins\n398\n|\nwww.pidj.com\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\nbetween measles vaccination and autism: all relative risks were\nbelow 1 and showed that vaccinated children, especially those with\nMMR, had a smaller risk of autism. Analyzing vaccination status\nbefore diagnosis demonstrated a very low odds ratio for vaccinated\nversus nonvaccinated. This tendency was slightly stronger for\nthose vaccinated with MMR versus nonvaccinated, then the single\nmeasles variety versus nonvaccinated. Also, children vaccinated\nwith MMR had a risk equal to half of those vaccinated with the\nsingle measles variety.", "mimetype": "text/plain", "start_char_idx": 11039, "end_char_idx": 12419, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c38e6b79-2d89-4361-b064-38240a634980": {"__data__": {"id_": "c38e6b79-2d89-4361-b064-38240a634980", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf", "node_type": "4", "metadata": {}, "hash": "8c8a35f2ca80e741162a3ac5fe702b2ad5a3159a2a2247afd7e40309da3a0b18", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4de7dbfa-a22d-4899-8259-8c6d16884033", "node_type": "1", "metadata": {}, "hash": "62dc113fcfe5b7cbb94b6f590474fb4948c39d9ddcd13382047de4a64872c530", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "be94d891-14df-42c0-8b6c-244257671464", "node_type": "1", "metadata": {}, "hash": "28b351589a5ffcbbf1d286717a0334681881c93322ef4cc500399b9ca0377c0c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Also, children vaccinated\nwith MMR had a risk equal to half of those vaccinated with the\nsingle measles variety. The only signi\ufb01cant association for being\nvaccinated before the onset of symptoms was found for the\ndifference between MMR vaccination and nonvaccination.\nOdds ratios did not change substantially after adjusting for\npotential confounders (eg, mother\u2019s age, medication during preg-\nnancy, gestation time, perinatal injury, and 5-minute Apgar scale\nscores) (Table 4). Vaccination before diagnosis, regardless of\nvaccine variety used, signi\ufb01cantly decreased the probability of\nbeing diagnosed with autism. Children vaccinated with MMR had\na lower odds ratio of having autism than nonvaccinated children as\nwell as those vaccinated with the single measles vaccine. After\nadjusting for potential confounders, the association between being\nvaccinated before the onset of symptoms and type of vaccine used\nbecame signi\ufb01cant. The risk of having autism in children vacci-\nnated with MMR was only 44% comparing to children vaccinated\nonly against measles.\nAll models \ufb01t the data (likelihood ratio \u00032, P values mostly\n\u00010.0001, the larger one equals 0.0013).\nDISCUSSION\nOur study revealed that MMR vaccination was not signi\ufb01-\ncantly associated with an increased risk of autism in children. In a\nseparate analysis, a similar result was achieved for the single-\nantigen measles vaccine. An unexpected \ufb01nding was that odds\nratios associated with MMR were lower than with the single\nmeasles vaccine.\nOur results argue against the Wake\ufb01eld et al hypothesis,1\nwhich suggested that developmental symptoms in children with\nautism may be triggered by the presence of the measles virus in the\nbowels of children vaccinated with MMR. He stated that the\nsimultaneous administration of 3 types of live viruses in the MMR\nvaccine was too great a burden for a child\u2019s immunologic system,\nincreasing the chance of measles virus persistence, subsequently\nleading to the development of autistic symptoms. Therefore in\nmany countries, the increased incidence of childhood autism was\ninitially linked with the launching of MMR vaccination cam-\npaigns.", "mimetype": "text/plain", "start_char_idx": 12307, "end_char_idx": 14439, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "be94d891-14df-42c0-8b6c-244257671464": {"__data__": {"id_": "be94d891-14df-42c0-8b6c-244257671464", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf", "node_type": "4", "metadata": {}, "hash": "8c8a35f2ca80e741162a3ac5fe702b2ad5a3159a2a2247afd7e40309da3a0b18", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c38e6b79-2d89-4361-b064-38240a634980", "node_type": "1", "metadata": {}, "hash": "2bca579f96e1de23db0ee2144f22659615a6f40bb7d6dcb0b44f62872951b9ee", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "af49053f-7243-4cfa-b72e-934be6f1c7bd", "node_type": "1", "metadata": {}, "hash": "96bddb604245d827f493edafcf889cc58d080914c01fb2a80903d30ee64bac62", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Therefore in\nmany countries, the increased incidence of childhood autism was\ninitially linked with the launching of MMR vaccination cam-\npaigns. This study was unable to con\ufb01rm the Wake\ufb01eld et al\nhypothesis, \ufb01nding a lower risk of developing autism for\nchildren vaccinated against measles, with the lowest risk being\nfound for children vaccinated with MMR. Our study partici-\npants were not evaluated for the presence of the measles virus\nin their gastrointestinal tracts. Other previously published study\nfound strong evidence against the association of autism with\npersistent measles virus RNA in gastrointestinal tracts exposed\nto the MMR vaccine.14\nThe \ufb01ndings of our study concerning the single-antigen\nmeasles vaccine cannot be compared with other reports, as no\nsimilar study has been previously published. Other studies exam-\nined sample populations vaccinated exclusively with MMR, as the\ntriple vaccine program was launched much earlier in those coun-\ntries, than in Poland. Yet this study was still able to reach\nconclusions similar to previously published studies, con\ufb01rming\nthat MMR is not associated with an increased risk of autism. Odds\nratios obtained in this study were similar to those obtained by other\nauthors.15\u201317\nThe decreased risk of autism among vaccinated children\nmay be due to some other confounding factors in their health\nstatus. For example, healthcare workers or parents may have\nnoticed signs of developmental delay or disease before the actual\nautism diagnosis and for this reason have avoided vaccination.\nA heterogeneous population of children vaccinated with\nMMR or exclusively against measles is a strength of our study.\nFirst, such a study population offers the opportunity to evaluate\nthose vaccinated with MMR and the single measles variety for the\nrisk of autism. Second, it allowed for examining whether the risk\nof being diagnosed with autism differed between these 2 vaccines.\nParticipants\u2019 vaccination histories were taken directly from\nphysician\u2019s records, eliminating the potential for recall bias. Be-\ncause they are surveyed by independent public health workers at\nleast twice per year, Polish vaccination records are very reliable.\nIntroducing the MMR vaccine as a replacement for the\nsingle-antigen measles vaccine in the mandatory vaccination\nschedule improved vaccination coverage against measles in Po-\nland.", "mimetype": "text/plain", "start_char_idx": 14295, "end_char_idx": 16659, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "af49053f-7243-4cfa-b72e-934be6f1c7bd": {"__data__": {"id_": "af49053f-7243-4cfa-b72e-934be6f1c7bd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf", "node_type": "4", "metadata": {}, "hash": "8c8a35f2ca80e741162a3ac5fe702b2ad5a3159a2a2247afd7e40309da3a0b18", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "be94d891-14df-42c0-8b6c-244257671464", "node_type": "1", "metadata": {}, "hash": "28b351589a5ffcbbf1d286717a0334681881c93322ef4cc500399b9ca0377c0c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "87e8f3cf-7efc-415f-9488-34252726521a", "node_type": "1", "metadata": {}, "hash": "94af71f6d75cc7acd83ee63429f82f04728265baf969b2f85f2f885305da370f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Introducing the MMR vaccine as a replacement for the\nsingle-antigen measles vaccine in the mandatory vaccination\nschedule improved vaccination coverage against measles in Po-\nland. This serves as evidence that, despite extensive media cover-\nage of the debated association between MMR and autism, public\nacceptance of this vaccine remains very high. The situation in\nPoland is different to that of many European countries, where\nMMR vaccinations by age 2 years fell more than 10% and were\nfollowed by measles outbreaks. In this time, Poland\u2019s already high\nrate of measles immunization even slightly increased.10\nWe were able to control many potential confounding fac-\ntors, known to be associated with vaccination practices and pos-\nsibly serving as risk factors for autism. We included 2 index dates\nto assess previous vaccination: the onset of symptoms and of\ndiagnosis of autism. Parental concern in regards to symptoms and\nsymptom etiology, reported retrospectively, can be biased by\nconfounding factors. Date of diagnosis based on physician\u2019s\nrecords is not affected by recall bias, serving as a better index date\nthan the onset of symptoms.\nOne limitation of this study included omitting other perva-\nsive developmental disorders. The decision was made to restrict\nthe study population to cases of autism in the interest of better\nTABLE 4.\nAssociation Between Single Measles and\nMMR Vaccination Before the Diagnosis of Autism and\nBefore Onset of Symptoms, Based on Multivariate\nModeling\nStatus\nOR*\n95% CI\nStatistical\nSignificance\nVaccinated (independent of vaccine\ntype) vs. nonvaccinated\nVaccinated before symptom onset\n0.65\n0.26\u20131.63\nns\nVaccinated before diagnosis\n0.28\n0.10\u20130.76\nP \u0004 0.012\nSingle and MMR vaccines vs.", "mimetype": "text/plain", "start_char_idx": 16479, "end_char_idx": 18204, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "87e8f3cf-7efc-415f-9488-34252726521a": {"__data__": {"id_": "87e8f3cf-7efc-415f-9488-34252726521a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf", "node_type": "4", "metadata": {}, "hash": "8c8a35f2ca80e741162a3ac5fe702b2ad5a3159a2a2247afd7e40309da3a0b18", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "af49053f-7243-4cfa-b72e-934be6f1c7bd", "node_type": "1", "metadata": {}, "hash": "96bddb604245d827f493edafcf889cc58d080914c01fb2a80903d30ee64bac62", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9db18719-12a8-4520-8cb2-74068ab3c8a1", "node_type": "1", "metadata": {}, "hash": "7b57f5e09b17e3109bc1c83a47919333ec7357ac2ad16f89ccaec46fdb316852", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nonvaccinated\nVaccinated before symptom onset\u2020\nSingle vaccine\n0.86\n0.33\u20132.23\nns\nMMR\n0.42\n0.15\u20131.16\nns\nVaccinated before diagnosis\u2021\nSingle vaccine\n0.36\n0.13\u20131.00\nP \u0004 0.050\nMMR\n0.17\n0.06\u20130.52\nP \u0004 0.002\nMMR vs. single vaccine\nVaccinated before symptom onset\n0.47\n0.22\u20130.99\nP \u0004 0.046\nVaccinated before diagnosis\n0.44\n0.22\u20130.91\nP \u0004 0.026\n*Adjusted for mother\u2019s age (15\u201335, 36\u201344 years), medication during pregnancy,\ngestation time (36\u201337, 38\u201343 weeks), perinatal injury, 5-minute Apgar scale score\n(3\u20138, 9\u201310).\nFor the control group:\n\u2020Vaccinated before age of symptom onset of their matched case-group subject.\n\u2021Vaccinated before age of autism diagnosis of their matched case-group subject.\nns indicates not significant.\nThe Pediatric Infectious Disease Journal \u2022 Volume 29, Number 5, May 2010\nMMR Vaccine and Autism\n\u00a9 2010 Lippincott Williams & Wilkins\nwww.pidj.com\n| 399\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025\nexamining possible associations connected only with this disease,\nthe most severe of all autistic spectrum disorders.", "mimetype": "text/plain", "start_char_idx": 18205, "end_char_idx": 19362, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9db18719-12a8-4520-8cb2-74068ab3c8a1": {"__data__": {"id_": "9db18719-12a8-4520-8cb2-74068ab3c8a1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf", "node_type": "4", "metadata": {}, "hash": "8c8a35f2ca80e741162a3ac5fe702b2ad5a3159a2a2247afd7e40309da3a0b18", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "87e8f3cf-7efc-415f-9488-34252726521a", "node_type": "1", "metadata": {}, "hash": "94af71f6d75cc7acd83ee63429f82f04728265baf969b2f85f2f885305da370f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fc6041ce-5bdf-4b8e-a087-0ba5d878d77f", "node_type": "1", "metadata": {}, "hash": "527cebc86f807eaea25f47a1a8defc602a227e5fcaf06078a524320a6469ed96", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Still, this study\nhad the possibility of comparing its \ufb01ndings with the results of\nother authors, who assessed the risk of autism in addition to other\nautistic spectrum disorders.18\u201320\nThe \ufb01ndings in this study may be useful in discussing the\npotential risks and bene\ufb01ts of vaccination programs which use the\nsingle versus triple MMR vaccine. These \ufb01ndings suggest that both\nvaccines are characterized by a similar level of safety with respect\nto the risk of autism in children.\nREFERENCES\n1. Wake\ufb01eld A, Murch S, Anthony A, et al. Ileal-lymphoid-nodular hyper-\nplasia, non-speci\ufb01c colitis, and pervasive developmental disorder in chil-\ndren. Lancet. 1998;351:637\u2013641.\n2. Berger A. The third degree MMR: can you decide? Br Med J. 2003;327:\n628.\n3. Jackson T. MMR: more scrutiny, please. Br Med J. 2003;326:1272\u20131273.\n4. Casiday R, Cresswel T, Wilson D, et al. A survey of UK parental attitudes\nto the MMR vaccine and trust in medical authority. Vaccine. 2006;24:177\u2013\n184.\n5. Madsen K, Hviid A, Vestergaard M, et al. A population based study of\nmeasles, mumps, and rubella vaccination and autism. N Engl J Med.\n2002;347:1477\u20131485.\n6. Hendrickson B, Turner J. MMR vaccination, ileal lymphoid nodular hy-\nperplasia, and pervasive developmental disorder. Lancet. 2002;359:2052\u2013\n2053.\n7. Maldonado Y. Current controversies in vaccination: vaccine safety. JAMA.\n2002;288:3155\u20133158.\n8. Wilson K, Mills E, Ross C, et al. Association of autistic spectrum disorder\nand the measles, mumps, and rubella vaccine: a systematic review of\ncurrent epidemiological evidence. Arch Pediatr Adolesc Med. 2003;157:\n628\u2013635.\n9.", "mimetype": "text/plain", "start_char_idx": 19363, "end_char_idx": 20967, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fc6041ce-5bdf-4b8e-a087-0ba5d878d77f": {"__data__": {"id_": "fc6041ce-5bdf-4b8e-a087-0ba5d878d77f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf", "node_type": "4", "metadata": {}, "hash": "8c8a35f2ca80e741162a3ac5fe702b2ad5a3159a2a2247afd7e40309da3a0b18", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9db18719-12a8-4520-8cb2-74068ab3c8a1", "node_type": "1", "metadata": {}, "hash": "7b57f5e09b17e3109bc1c83a47919333ec7357ac2ad16f89ccaec46fdb316852", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "92fb437a-8b3d-405f-8154-c4b5c6ed952f", "node_type": "1", "metadata": {}, "hash": "c6f6cb4677e3b64399bb09045012c98e36de61929bfb29b8d058e32c50e6c832", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Association of autistic spectrum disorder\nand the measles, mumps, and rubella vaccine: a systematic review of\ncurrent epidemiological evidence. Arch Pediatr Adolesc Med. 2003;157:\n628\u2013635.\n9. DeStefano F, Karapurkar T, Thompson W, et al. Age of \ufb01rst measles-\nmumps-rubella vaccination in children with autism and school-matched\ncontrol subjects: a population-based study in metropolitan Atlanta. Pediat-\nrics. 2004;111:259\u2013266.\n10. Mroz\u02d9ek-Budzyn D, Kie\u0142tyka A. The relationship between MMR vaccina-\ntion level and the number of new cases of autism in children \u0005in Polish\u0006.\nPrzegl Epidemiol. 2008;62:597\u2013604.\n11. Mayor S. Researcher from study alleging link between MMR and autism\nwarns of measles epidemic. Br Med J. 2003;327:1069.\n12. DeStefano F, Thompson W. MMR vaccine and autism: an update of the\nscienti\ufb01c evidence. Expert Rev Vaccines. 2004;3:19\u201322.\n13. Andrews N, Miller E, Taylor B, et al. Recall bias, MMR and autism. Arch\nDis Child. 2002;87:493\u2013495.\n14. Horning M, Briese T, Buise T, et al. Lack of association between measles\nvirus vaccine and autism with enteropathy: a case-control study. PLoS One.\n2008;3:e3140.\n15. Klein K, Diehl E. Relationship between MMR vaccine and autism. Ann\nPharmacother. 2004;38:1297\u20131300.\n16. Chen W, Landau S, Sham P, et al. No evidence for links between autism,\nMMR and measles virus. Psychol Med. 2004;34:543\u2013553.\n17. Uchigama T, Kurosawa M, Inaba Y. MMR-vaccine and regression in\nautism spectrum disorders: negative results presented from Japan. J Autism\nDev Disord. 2007;37:210\u2013217.\n18.", "mimetype": "text/plain", "start_char_idx": 20776, "end_char_idx": 22310, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "92fb437a-8b3d-405f-8154-c4b5c6ed952f": {"__data__": {"id_": "92fb437a-8b3d-405f-8154-c4b5c6ed952f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf", "node_type": "4", "metadata": {}, "hash": "8c8a35f2ca80e741162a3ac5fe702b2ad5a3159a2a2247afd7e40309da3a0b18", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fc6041ce-5bdf-4b8e-a087-0ba5d878d77f", "node_type": "1", "metadata": {}, "hash": "527cebc86f807eaea25f47a1a8defc602a227e5fcaf06078a524320a6469ed96", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bd0e5e2a-e2a3-4d5e-aea9-63c8449ba15d", "node_type": "1", "metadata": {}, "hash": "5d2bac4931956389efa1f5af82695b735146bc7a1528f33fff288b74ba48d41f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "J Autism\nDev Disord. 2007;37:210\u2013217.\n18. Smeeth L, Cook C, Fombonne E, et al. MMR vaccination and pervasive\ndevelopmental disorders: a case-control study. Lancet. 2004;364:963\u2013970.\n19. Honda H, Shimizu Y, Rutter M. No effect of MMR withdrawal on the\nincidence of autism: a total population study. J Child Psychol Psychiatry.\n2005;46:572\u2013579.\n20. Hopkins Tanne J. MMR vaccine is not linked with autism, says Danish\nstudy. Br Med J. 2002;325:1134\u20131140.\nCURRENT ABSTRACTS\nEdited by: Robert J. Leggiadro, MD\nImported Case of Marburg Hemorrhagic Fever\u2014Colorado, 2008\nCenters for Disease Control and Prevention. MMWR. 2009;58:1377\u20131380.\nA 44-year-old woman was hospitalized with an unexpected febrile illness\nin Colorado in January 2008 after returning to the United States from a\n2-week safari in Uganda. Her hospital course was characterized by hepa-\ntitis, renal failure, pancytopenia, coagulopathy, myositis, pancreatitis, and\nencephalopathy. Testing was negative for leptospirosis, viral hepatitis,\nmalaria, arboviral infection, acute schistosomiasis, rickettsial infection, and\nviral hemorrhagic fevers (VHF), including Ebola and Marburg hemor-\nrhagic fever (MHF).\nIn July 2008, the patient requested repeat testing after she learned of\nthe fatal case of MHF in a Dutch tourist who recently had visited the same cave\nshe had visited in Uganda, the Python Cave. Serum collected 6 months after the\nColorado patient\u2019s illness tested positive for anti-Marburg virus IgG by ELISA,\nprompting additional testing of archived day 10 serum. Nested RT-PCR con\ufb01rmed\nthe presence of Marburg virus RNA fragments in the day 10 sample.\nComment: Before the case described in this report, the only\nhuman cases of VHF imported into the US were single cases of Lassa\nfever in Chicago in 1989, and in Trenton in 2004.", "mimetype": "text/plain", "start_char_idx": 22269, "end_char_idx": 24066, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bd0e5e2a-e2a3-4d5e-aea9-63c8449ba15d": {"__data__": {"id_": "bd0e5e2a-e2a3-4d5e-aea9-63c8449ba15d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf", "node_type": "4", "metadata": {}, "hash": "8c8a35f2ca80e741162a3ac5fe702b2ad5a3159a2a2247afd7e40309da3a0b18", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "92fb437a-8b3d-405f-8154-c4b5c6ed952f", "node_type": "1", "metadata": {}, "hash": "c6f6cb4677e3b64399bb09045012c98e36de61929bfb29b8d058e32c50e6c832", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Comment: Before the case described in this report, the only\nhuman cases of VHF imported into the US were single cases of Lassa\nfever in Chicago in 1989, and in Trenton in 2004. No previous cases of\nimported \ufb01lovirus (Marburg or Ebola virus) have been reported in the\nUS, making this the \ufb01rst imported case of a \ufb01loviral hemorrhagic fever\nin the US.\nGrowing evidence demonstrates that fruit bats are the natural\nreservoir of Marburg virus. The patient may have acquired Marburg virus\ninfection through exposure to bat secretions or excretions while visiting the\nPython Cave. Although the Python Cave is closed and no additional MHF\ncases have been reported, travelers should be aware of the risk for\nacquiring MHF in endemic areas in Africa and should avoid entering caves\nor mines inhabited by bats in these areas.\nHealth-care providers should have a low threshold of suspicion for\nVHF among travelers returning from endemic areas, promptly implement\nappropriate infection control measures, and rapidly report suspected cases,\nwhich are nationally noti\ufb01able.\nCurrent Abstracts\nThe Pediatric Infectious Disease Journal \u2022 Volume 29, Number 5, May 2010\n\u00a9 2010 Lippincott Williams & Wilkins\n400\n|\nwww.pidj.com\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 01/09/2025", "mimetype": "text/plain", "start_char_idx": 23890, "end_char_idx": 25267, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1c5bcba6-b696-4efa-bcbe-495a5b0fd3ad": {"__data__": {"id_": "1c5bcba6-b696-4efa-bcbe-495a5b0fd3ad", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Cenoz (2013).pdf", "node_type": "4", "metadata": {}, "hash": "96c21deefc8663e7dc0e19f0e5157a2ed0138d274d92ec5c4ed6ef7df85780fb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "79f1a250-c48b-4bf1-9ba0-900bd351de9c", "node_type": "1", "metadata": {}, "hash": "194b0ff6ccdbbcf2bba1cd94f6cc1b28ed2f719bb532cc5fc21cfacd16dbf08e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Human Vaccines & Immunotherapeutics\nISSN: 2164-5515 (Print) 2164-554X (Online) Journal homepage: www.tandfonline.com/journals/khvi20\nE\ufb00ectiveness of one and two doses of varicella\nvaccine in preventing laboratory-con\ufb01rmed cases\nin children in Navarre, Spain\nManuel Garc\u00eda Cenoz, V\u00edctor Mart\u00ednez-Artola, Marcela Guevara, Carmen\nEzpeleta, Aurelio Barricarte & Jes\u00fas Castilla\nTo cite this article: Manuel Garc\u00eda Cenoz, V\u00edctor Mart\u00ednez-Artola, Marcela Guevara, Carmen\nEzpeleta, Aurelio Barricarte & Jes\u00fas Castilla (2013) E\ufb00ectiveness of one and two doses of\nvaricella vaccine in preventing laboratory-con\ufb01rmed cases in children in Navarre, Spain,\nHuman Vaccines & Immunotherapeutics, 9:5, 1172-1176, DOI: 10.4161/hv.23451\nTo link to this article:  https://doi.org/10.4161/hv.23451\nPublished online: 16 Jan 2013.\nSubmit your article to this journal \nArticle views: 1309\nView related articles \nCiting articles: 9 View citing articles \nFull Terms & Conditions of access and use can be found at\nhttps://www.tandfonline.com/action/journalInformation?journalCode=khvi20\n\u00a92013 Landes Bioscience. Do not distribute.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1103, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "79f1a250-c48b-4bf1-9ba0-900bd351de9c": {"__data__": {"id_": "79f1a250-c48b-4bf1-9ba0-900bd351de9c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Cenoz (2013).pdf", "node_type": "4", "metadata": {}, "hash": "96c21deefc8663e7dc0e19f0e5157a2ed0138d274d92ec5c4ed6ef7df85780fb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1c5bcba6-b696-4efa-bcbe-495a5b0fd3ad", "node_type": "1", "metadata": {}, "hash": "4fc3cc9a6f6aeccef10929c06ce0a5b936011aa1327f3aa26a6b9d3bdad6a004", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fc5b7164-4a6b-4f07-ad62-d84fb553a122", "node_type": "1", "metadata": {}, "hash": "7dde7d21a1c6a5bb43e1537bd1d6609167460cd44e388a8d511262e0c51d4119", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Do not distribute.\nHuman Vaccines & Immunotherapeutics 9:5, 1172\u20131176; May 2013; \u00a9 2013 Landes Bioscience\n Short Report\n1172\t\nHuman Vaccines & Immunotherapeutics\t\nVolume 9 Issue 5\n*Correspondence to: Jes\u00fas Castilla; Email: jcastilc@navarra.es\nSubmitted: 10/12/12; Revised: 12/17/12; Accepted: 12/31/12\nhttp://dx.doi.org/10.4161/hv.23451\nIntroduction\nIn the absence of vaccination, varicella virus circulates widely and \ninfects most people during childhood.1 In 1995 the first varicella \nvaccine was introduced in the US childhood vaccination sched-\nule with one dose. Subsequent years have seen a reduction in the \ncases of varicella.2,3 This vaccine showed good short-term efficacy \nin clinical trials,4 and in the first observational studies.5-7 Over \ntime, however, continued outbreaks in highly vaccinated popula-\ntions and an increasing number vaccine failures3,8-11 led to the \nrecommendation of a second dose.12,13 Higher antibody titers are \nachieved with a second dose of varicella vaccine,14 which suggests \ngreater and longer lasting protection. Vaccination schedules with \none and two doses currently coexist, but few studies have evalu-\nated the effectiveness of vaccination with two doses in preventing \nconfirmed cases of varicella.15-17\nIn Navarre, Spain, varicella vaccine had been marketed since \n2004. Initially, a single dose at 15 mo was recommended by pedi-\natricians,18 and parents could choose to have their children vac-\ncinated if they paid for it. Coverage increased to 19% of children \naged 1 to 5 y in 2006. In 2007, universal varicella vaccination \nwas introduced into the childhood vaccination schedule with one \ndose of Varivax\u00ae (Oka/Merck) applied at 15 mo, and beginning \nin 2009 the second dose was added at 3 y of age. In the period \n2009\u20132011 vaccination coverage was around 95% for the first \ndose and over 89% for the second dose.", "mimetype": "text/plain", "start_char_idx": 1085, "end_char_idx": 2955, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fc5b7164-4a6b-4f07-ad62-d84fb553a122": {"__data__": {"id_": "fc5b7164-4a6b-4f07-ad62-d84fb553a122", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Cenoz (2013).pdf", "node_type": "4", "metadata": {}, "hash": "96c21deefc8663e7dc0e19f0e5157a2ed0138d274d92ec5c4ed6ef7df85780fb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "79f1a250-c48b-4bf1-9ba0-900bd351de9c", "node_type": "1", "metadata": {}, "hash": "194b0ff6ccdbbcf2bba1cd94f6cc1b28ed2f719bb532cc5fc21cfacd16dbf08e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5eb39918-e3eb-47db-a622-c71effa6c5b2", "node_type": "1", "metadata": {}, "hash": "456eafe08a5cdcd7aaf2626a68f60494e80adcc8f537aa7c1bdbacb305f53c9f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In the period \n2009\u20132011 vaccination coverage was around 95% for the first \ndose and over 89% for the second dose. Children not previously \nvaccinated who had not had varicella were also offered vaccina-\ntion at 3 y and 10 y of age.19\nVaricella vaccine effectiveness was evaluated in a case-control study in Navarre, Spain, in 2010\u20132012. The cases were 54 \nchildren aged 15 months to 10 years with a diagnosis of varicella confirmed by polymerase-chain-reaction. Each case was \nmatched with eight controls by pediatric practice, district of residence and date of birth. The effectiveness was 87% (95% \nconfidence interval: 60% to 97%) for one dose of vaccine and 97% (80% to 100%) for two doses. A single dose was 93% \n(34% to 100%) effective in the first year, which declined to 61% (95% CI: -64% to 94%) after the third year. In conclusion, \nvaricella vaccine is highly effective in preventing confirmed cases, although this effect declines over time since the first \ndose. A second dose helps to reestablish very high levels of effectiveness and to reduce the risk of breakthrough varicella.\nEffectiveness of one and two doses of varicella \nvaccine in preventing laboratory-confirmed cases \nin children in Navarre, Spain\nManuel Garc\u00eda Cenoz,1,2 V\u00edctor Mart\u00ednez-Artola,3 Marcela Guevara,1,2 Carmen Ezpeleta,3 Aurelio Barricarte1,2 \nand Jes\u00fas Castilla1,2,*\n1Instituto de Salud P\u00fablica de Navarra; Pamplona, Spain; 2CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP); Pamplona, Spain; 3Servicio de Microbiolog\u00eda;  \nComplejo Hospitalario de Navarra; Pamplona, Spain\nKeywords: varicella, varicella-zoster virus, varicella vaccine, vaccine effectiveness, breakthrough varicella\nThe objective of this study was to evaluate the effectiveness of \nvaricella vaccine in preventing confirmed cases by comparing the \none- and two-dose schedules.", "mimetype": "text/plain", "start_char_idx": 2841, "end_char_idx": 4672, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5eb39918-e3eb-47db-a622-c71effa6c5b2": {"__data__": {"id_": "5eb39918-e3eb-47db-a622-c71effa6c5b2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Cenoz (2013).pdf", "node_type": "4", "metadata": {}, "hash": "96c21deefc8663e7dc0e19f0e5157a2ed0138d274d92ec5c4ed6ef7df85780fb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fc5b7164-4a6b-4f07-ad62-d84fb553a122", "node_type": "1", "metadata": {}, "hash": "7dde7d21a1c6a5bb43e1537bd1d6609167460cd44e388a8d511262e0c51d4119", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d8586f51-3e71-4910-a40b-a102a332398a", "node_type": "1", "metadata": {}, "hash": "4c078c4aca2e48e93b58d8fcebd323be5facd66f57cf8515b9b5dd394a35f981", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Results\nDuring the study period, the participating pediatricians reported \n70 clinical cases of varicella in children aged 15 mo to 10 y, which \nwere tested by real-time polymerase chain reaction (PCR), and \n54 (77%) of them were confirmed for varicella virus. No cases \nrequired hospitalization or presented complications of varicella. \nThere were no differences among positive and negative patients \nin the characteristics evaluated, apart from the varicella vaccina-\ntion status. Among unvaccinated children, 89% were confirmed \nfor varicella virus as compared with 38% of vaccinated children \n(p < 0.001).\nEach confirmed case was matched by pediatric practice, dis-\ntrict of residence and date of birth (\u00b1 1 y) with eight controls. \nCases (n = 54) and controls (n = 432) were distributed almost \nequally in terms of age and birth year. No differences were found \nby sex or by history of any major chronic condition. Visits to \nthe pediatrician in the previous 12 mo and having migrant par-\nents were somewhat more frequent among cases, therefore it was \ndecided to adjust for these two variables in the multivariate mod-\nels (Table 1).\nSome 26% of controls had received one dose of varicella vac-\ncine and 15% had received two doses, compared with 9% and \n2% of cases, respectively (p < 0.001). However, cases and controls \n\u00a92013 Landes Bioscience. Do not distribute.\nwww.landesbioscience.com\t\nHuman Vaccines & Immunotherapeutics\t\n1173\n Short Report\nShort Report\nfailure with two doses occurred in a child with no major chronic \nconditions who had received the second dose of vaccine 48 weeks \nbefore being diagnosed with varicella.\nIn the conditional logistic regression analysis the effectiveness \nof any dose of vaccine was 92% (95% CI: 77% to 97%). Having \nreceived a single dose of vaccine showed an effectiveness of 87% \n(95% CI: 60% to 97%), and the effectiveness of two doses was \n97% (95% CI: 80% to 100%). Similar findings were found in \nthe analysis restricted to children aged 3 y or more (Table 2).", "mimetype": "text/plain", "start_char_idx": 4673, "end_char_idx": 6688, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d8586f51-3e71-4910-a40b-a102a332398a": {"__data__": {"id_": "d8586f51-3e71-4910-a40b-a102a332398a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Cenoz (2013).pdf", "node_type": "4", "metadata": {}, "hash": "96c21deefc8663e7dc0e19f0e5157a2ed0138d274d92ec5c4ed6ef7df85780fb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5eb39918-e3eb-47db-a622-c71effa6c5b2", "node_type": "1", "metadata": {}, "hash": "456eafe08a5cdcd7aaf2626a68f60494e80adcc8f537aa7c1bdbacb305f53c9f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8804bce7-1c1c-49a0-9790-b8c33c53efef", "node_type": "1", "metadata": {}, "hash": "c0f274ba5564700f32280a12f3d37121986713b7e38e32872d80bbc723484ffe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Similar findings were found in \nthe analysis restricted to children aged 3 y or more (Table 2). \nTwo doses conferred an incremental protection of 74% (95% CI: \n-115% to 100%; p = 0.231) as compared with one dose, although \nthis result was not statistically significant.\nAmong those vaccinated with a single dose, the effectiveness \nwas 93% (95% CI: 34% to 100%) in the first 12 mo after vac-\ncination, 95% (95% CI: 62% to 100%) between 12 and 35 mo \nafter vaccination, and 61% (95% CI: -64% to 94%) after 35 mo \n(Table 2). The time after vaccination as a continuous variable \nin years was associated with an increased risk of breakthrough \nvaricella among children who had received a dose of vaccine (OR \n= 2.07, 95% CI: 1.13\u20133.80, p = 0.019) (Table 3).\nDiscussion\nThe results of this study show that the varicella vaccine is effec-\ntive in preventing confirmed cases of varicella, although the \neffect of this vaccine depends on the number of doses and the \ntime since the last dose. Vaccine effectiveness was 87% for one \ndose and 97% for two doses. The results suggest that the second \ndose of vaccine increases the effectiveness with respect to the first \ndose, although this result did not reach statistical significance. \nThese findings are similar to those of other authors. In a litera-\nture review, Seward et al. found a mean effectiveness for one dose \nof vaccine of 84.5%, with a range of 44% to 100%.3 Shapiro et \nal. estimated a 98.3% effectiveness for two doses of vaccine in \npreventing laboratory-confirmed cases.15 Our estimation of the \nincremental effect of the second dose as compared with the first \nis also within the range of what other authors have found;15-17 \nhowever, the large differences found among these studies show \nthat the incremental effect of the second dose is a relative measure \nthat may vary depending on the situation in which it is evaluated.", "mimetype": "text/plain", "start_char_idx": 6593, "end_char_idx": 8478, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8804bce7-1c1c-49a0-9790-b8c33c53efef": {"__data__": {"id_": "8804bce7-1c1c-49a0-9790-b8c33c53efef", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Cenoz (2013).pdf", "node_type": "4", "metadata": {}, "hash": "96c21deefc8663e7dc0e19f0e5157a2ed0138d274d92ec5c4ed6ef7df85780fb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d8586f51-3e71-4910-a40b-a102a332398a", "node_type": "1", "metadata": {}, "hash": "4c078c4aca2e48e93b58d8fcebd323be5facd66f57cf8515b9b5dd394a35f981", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2b346bfc-c74a-43e6-840f-1065859f3bd8", "node_type": "1", "metadata": {}, "hash": "7445ac4a70de8070e2c6d948a1544edccdc01e3cc8ab7ab17507b6fa37e25aab", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The effectiveness of a single dose of varicella vaccine was very \nhigh during the first three years (> 90%) and fell in children who \nhad been vaccinated more than three years previously (61%), \nwhich supports the role of waning immunity as an explanation \nof the suboptimal effectiveness of a single dose of varicella vac-\ncine.8,20 In Navarre the loss of effectiveness was more pronounced \nthan in other studies,8 although the wide confidence intervals \nmean that no conclusions can be drawn in this respect. This loss \nof effectiveness may have been facilitated by the fact that circula-\ntion of the varicella-zoster virus also declined considerably during \nthe study period,19 with the consequent reduction of the booster \neffect from repeated exposure to wild virus.\nMost children with two doses of varicella vaccine had received \nthe last dose recently, and only one clinical case with two doses \nwas confirmed by the laboratory, which made it impossible to \ndetermine if there is an important loss of effectiveness over time. \ndid not differ in coverage with one and two doses of MMR vac-\ncine (p = 0.766) (Table 1).\nVaccination status varied with age. A total of 75% of controls \nyounger than 3 y had been vaccinated, 80% of those aged 3\u20134 \ny, 49% of those aged 5\u20136 y and 23% of children aged 7 or older. \nThe median time since vaccination was 22 mo among the con-\ntrols who had received one dose of vaccine and 17 mo in those \nwho had received two doses.\nSix vaccine failures were confirmed by PCR, and one of them \nhad received two doses of vaccine. The time between the last \ndose and diagnosis of varicella ranged between 35 weeks and 6 y, \nand the age at diagnosis between 2 and 8 y. Only one person had \nbeen diagnosed with a major chronic condition. The only vaccine \nTable\u00a01.", "mimetype": "text/plain", "start_char_idx": 8479, "end_char_idx": 10270, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2b346bfc-c74a-43e6-840f-1065859f3bd8": {"__data__": {"id_": "2b346bfc-c74a-43e6-840f-1065859f3bd8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Cenoz (2013).pdf", "node_type": "4", "metadata": {}, "hash": "96c21deefc8663e7dc0e19f0e5157a2ed0138d274d92ec5c4ed6ef7df85780fb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8804bce7-1c1c-49a0-9790-b8c33c53efef", "node_type": "1", "metadata": {}, "hash": "c0f274ba5564700f32280a12f3d37121986713b7e38e32872d80bbc723484ffe", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8c134f85-7fd9-44f4-8d10-cae0a3818cb4", "node_type": "1", "metadata": {}, "hash": "55fa40462b07cde07cc4a27ff68f9312b1960cd88afaee59a844411e68a6c7b8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The only vaccine \nTable\u00a01. Characteristics of cases and controls\nCases\nControls\np-value\nN (%)\nN (%)\nSex\n0.067\nMale\n21 (39%)\n225 (52%)\nFemale\n33 (61%)\n207 (48%)\nAge\n0.998\n15\u201324 mo\n6 (11%)\n48 (11%)\n3\u20134 y\n7 (13%)\n59 (14%)\n5\u20136 y\n9 (17%)\n67 (16%)\n7\u20138 y\n26 (48%)\n214 (50%)\n9\u201310 y\n6 (11%)\n44 (10%)\nMajor chronic condition\n0.487\nNo\n47 (87%)\n360 (83%)\nYes\n7 (13%)\n72 (17%)\nOther persons in the house-\nhold\n0.124\n1\n4 (7%)\n41 (9%)\n2\n5 (9%)\n96 (22%)\n3\n24 (44%)\n164 (38%)\n4+\n21 (39%)\n131 (30%)\nMigrant parents\n0.019\nNo\n42 (78%)\n384 (89%)\nYes\n12 (22%)\n48 (11%)\nVisits to the pediatrician\n0.050\n0\n3 (6%)\n73 (17%)\n1\u20135\n30 (56%)\n239 (55%)\n6+\n21 (39%)\n120 (28%)\nDoses of varicella vaccine\n< 0.001\n0\n48 (89%)\n257 (59%)\n1\n5 (9%)\n112 (26%)\n2\n1 (2%)\n63 (15%)\nDoses of measles-mumps-\nrubella vaccine\n0.766\n0\n2 (4%)\n26 (6%)\n1\n14 (26%)\n103 (24%)\n2\n38 (70%)\n303 (70%)\nTotal\n54 (100%)\n432 (100%)\n\u00a92013 Landes Bioscience. Do not distribute.\n1174\t\nHuman Vaccines & Immunotherapeutics\t\nVolume 9 Issue 5\nwere excluded from the study. Although the sensitivity of PCR \nis high, we cannot totally rule out a bias for the exclusion of \nfalse-negative results for varicella virus.", "mimetype": "text/plain", "start_char_idx": 10244, "end_char_idx": 11387, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8c134f85-7fd9-44f4-8d10-cae0a3818cb4": {"__data__": {"id_": "8c134f85-7fd9-44f4-8d10-cae0a3818cb4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Cenoz (2013).pdf", "node_type": "4", "metadata": {}, "hash": "96c21deefc8663e7dc0e19f0e5157a2ed0138d274d92ec5c4ed6ef7df85780fb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2b346bfc-c74a-43e6-840f-1065859f3bd8", "node_type": "1", "metadata": {}, "hash": "7445ac4a70de8070e2c6d948a1544edccdc01e3cc8ab7ab17507b6fa37e25aab", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "01430f57-e2cb-4562-b33c-b53432329299", "node_type": "1", "metadata": {}, "hash": "ec97eb4065bb752fa62b9040b6d33e55a82cf94be87bb04014e8f1853164d9f6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Although the sensitivity of PCR \nis high, we cannot totally rule out a bias for the exclusion of \nfalse-negative results for varicella virus. In the matched analysis, \nonly case-control pairs discordant for vaccination status provide \ninformation. To improve the power of the study we included \neight controls per case, which provided more opportunities to \nhave case-control pairs that contributed to the estimation of \nvaccine effectiveness.\nCase-control studies may be subject to bias in the selection \nof controls. Coverage of MMR vaccine was similar in cases and \ncontrols, which seems to rule out this bias, given that both the \nMMR and varicella vaccines are administered to children at simi-\nlar ages.\nVaccine failures occurred in children with both one and two \ndoses of vaccine. Cases of breakthrough varicella are usually \nmild, with few lesions; therefore they can be confused with other \ncauses. In a context of universal vaccination and low incidence, \nvirological confirmation is essential to avoid including false cases \nwhich would lead to an underestimate of vaccine effectiveness.\nIn conclusion, varicella vaccine is highly effective in prevent-\ning confirmed cases, although this effect declines over time since \nthe first dose. The administration of a second dose helps to rees-\ntablish very high levels of effectiveness and to reduce the risk of \nbreakthrough varicella. However, it is desirable to continue mon-\nitoring the duration of the effectiveness of two doses of varicella \nvaccine over time.\nMoreover, the incremental effect of the second dose may be over-\nestimated, given that the average time since the last dose was lon-\nger in children who had received only one dose of vaccine than \nin those who had received two, therefore the latter had less time \nto develop waning immunity. The same phenomenon may have \naffected other studies that have evaluated the incremental effect \nof the second dose of vaccine.15,16 The effectiveness that we found \nfor the second dose is similar to that observed in the two years \nfollowing the administration of the first dose, which suggests the \nusefulness of continued monitoring of the effectiveness of the \nsecond dose over the longer term.", "mimetype": "text/plain", "start_char_idx": 11246, "end_char_idx": 13458, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "01430f57-e2cb-4562-b33c-b53432329299": {"__data__": {"id_": "01430f57-e2cb-4562-b33c-b53432329299", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Cenoz (2013).pdf", "node_type": "4", "metadata": {}, "hash": "96c21deefc8663e7dc0e19f0e5157a2ed0138d274d92ec5c4ed6ef7df85780fb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8c134f85-7fd9-44f4-8d10-cae0a3818cb4", "node_type": "1", "metadata": {}, "hash": "55fa40462b07cde07cc4a27ff68f9312b1960cd88afaee59a844411e68a6c7b8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9539f2ab-a8a3-4492-ad2b-01392e1f2319", "node_type": "1", "metadata": {}, "hash": "28a9cc18a792a56b74ffc99ef17f2da85316df2d14ba2248d401395306535d3c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Among the strengths of this study are the restriction to lab-\noratory-confirmed cases, since the proportion of PCR-negative \ncases was higher among vaccinated children, and the fact that \nit was performed during the period the vaccine was being intro-\nduced, when there were large proportions of both vaccinated \nand unvaccinated children of different ages. However, it also \nhas several limitations. The number of study subjects was small \nand the confidence intervals of the estimates were wide due to \nthe major decline in incidence after the introduction of vac-\ncination with two doses.19 Accordingly, all the results should \nbe viewed with caution. Not all pediatricians participated in \ntaking samples for laboratory confirmation of cases, although \nthose who did took samples from all patients with clinical \nsigns of varicella, which avoids selection bias due to vaccina-\ntion status. Clinical cases that were negative for varicella virus \nTable\u00a02. Estimates of the effectiveness of varicella vaccine in different analyses\nVaricella vaccine status\nCases/ controls\nCrude vaccine effectiveness (95% CI)*\nAdjusted vaccine effectiveness (95% CI)#\np-value\nUnvaccinated\n48/257\n-\n-\nVaccinated (any dose)\n6/175\n90% (73%; 96%)\n92% (77%; 97%)\n< 0.001\nUnvaccinated\n48/257\n-\n-\nOne dose\n5/112\n84% (53%; 95%)\n87% (60%; 97%)\n< 0.001\nTwo doses\n1/63\n97% (79%; 100%)\n97% (80%; 100%)\n< 0.001\nChildren aged < 3 y\nUnvaccinated\n5/12\n-\n-\nOne dose\n1/36\n93% (31%; 100%)\n84% (-58%; 100%)\n0.119\nChildren aged \u2265 3 y\nUnvaccinated\n43/245\n-\n-\nOne dose\n4/76\n78% (30%; 95%)\n80% (37%; 95%)\n0.003\nTwo doses\n1/63\n96% (78%; 100%)\n97% (79%; 100%)\n< 0.001\n* Result of the unadjusted conditional logistic regression model.", "mimetype": "text/plain", "start_char_idx": 13459, "end_char_idx": 15150, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9539f2ab-a8a3-4492-ad2b-01392e1f2319": {"__data__": {"id_": "9539f2ab-a8a3-4492-ad2b-01392e1f2319", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Cenoz (2013).pdf", "node_type": "4", "metadata": {}, "hash": "96c21deefc8663e7dc0e19f0e5157a2ed0138d274d92ec5c4ed6ef7df85780fb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "01430f57-e2cb-4562-b33c-b53432329299", "node_type": "1", "metadata": {}, "hash": "ec97eb4065bb752fa62b9040b6d33e55a82cf94be87bb04014e8f1853164d9f6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "42848b44-0486-4429-8fce-5a5db5ceff37", "node_type": "1", "metadata": {}, "hash": "c995377c239938c7cbc5a43abfd2673d3905be5ff6eb617db359f84b65002c34", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "#Result of the exact conditional logistic regression adjusted for migrant parents and \nvisits to the pediatrician in the previous 12 mo.\nTable\u00a03. Estimates of the effectiveness of one dose of varicella vaccine according to time since vaccination\nVaricella vaccine status\nCases/controls\nCrude vaccine effectiveness (95% CI)*\nAdjusted vaccine effectiveness (95% CI)#\np-value\nUnvaccinated\n48/257\n-\n-\n< 12 mo after vaccination\n1/30\n89% (4%; 100%)\n93% (34%; 100%)\n0.011\n12\u201335 mo after vaccination\n1/47\n93% (51%; 100%)\n95% (62%; 100%)\n< 0.001\n\u2265 36 mo after vaccination\n3/35\n64% (-42%; 94%)\n61% (-64%; 94%)\n0.271\n*Result of the unadjusted conditional logistic regression model. #Result of the exact conditional logistic regression adjusted for migrant parents and \nvisits to the pediatrician in the previous 12 mo.\n\u00a92013 Landes Bioscience. Do not distribute.\nwww.landesbioscience.com\t\nHuman Vaccines & Immunotherapeutics\t\n1175\nand the number of visits to the pediatrician in the previous 12 \nmo. These last two variables were included as indicators of health \ncare seeking behaviors. Varicella cases occurring more than 42 d \nafter administration of a dose of varicella vaccine were considered \nvaccine failures or breakthrough varicella.\nWe evaluated the effect of having received any dose of vari-\ncella vaccine and also of having received specifically one or two \ndoses. After excluding children who had received two doses of \nvaccine, we evaluated the effect of one dose, according to time \nsince vaccination as a categorical and as a continuous variable.\nUnmatched dichotomous variables were compared by \u03c72. \nMatched odds ratio (OR) for vaccination, with their 95% con-\nfidence interval (CI), was calculated with conventional or exact \nconditional logistic regression models adjusted for potential con-\nfounding. Vaccine effectiveness was estimated as a percentage: \n(1-OR) \u00d7 100.\nThe Navarre Ethical Committee for Medical Research \napproved the study protocol.\nDisclosure of Potential Conflicts of Interest\nNo potential conflicts of interest were disclosed.", "mimetype": "text/plain", "start_char_idx": 15151, "end_char_idx": 17207, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "42848b44-0486-4429-8fce-5a5db5ceff37": {"__data__": {"id_": "42848b44-0486-4429-8fce-5a5db5ceff37", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Cenoz (2013).pdf", "node_type": "4", "metadata": {}, "hash": "96c21deefc8663e7dc0e19f0e5157a2ed0138d274d92ec5c4ed6ef7df85780fb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9539f2ab-a8a3-4492-ad2b-01392e1f2319", "node_type": "1", "metadata": {}, "hash": "28a9cc18a792a56b74ffc99ef17f2da85316df2d14ba2248d401395306535d3c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4ec51779-3da5-4aeb-ac1d-ea7e2930445b", "node_type": "1", "metadata": {}, "hash": "f27315e6a42154ae0831eb6718258f2589011220feac855a1c62dc81451b36a4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The Navarre Ethical Committee for Medical Research \napproved the study protocol.\nDisclosure of Potential Conflicts of Interest\nNo potential conflicts of interest were disclosed.\nAcknowledgments\nThis work has been funded by the Health Department of the \nRegional Government of Navarre (Project 77/09) and by the \nSpanish Ministry of Health and Social Services (EC11\u2013308). The \nmembers of the Network of Primary Health Care Paediatricians \nof Navarre are: S. Urcelay, B. Compains, T. Molins, M. Cano, \nM.A. Huarte, M.S. Galardi, M. Elizalde, A. Diaz Alfaro, M. de \nMiguel, L. Marin, M.T. Virto, B. Rodriguez P\u00e9rez, I. Hualde, V. \nLanda, A. Barbadillo, M. Grochowich, C. Zabalza, J.M. Vizcay, \nB. Go\u00f1i, J.C. Rold\u00e1n, B.E. Fernandez, G. Poignon, J. Palau, R. \nRevert, T. Bandr\u00e9s, M.A. Zabalza, F. Satrustegui, A. Go\u00f1i, F.J. \nGil Saenz and L.A. Rodriguez.\nMaterials and Methods\nThe present matched case-control study was conducted in \nNavarre, Spain, using information from health care computerized \ndatabases. Varicella surveillance is based on automatic reporting \nof all clinical cases from the clinical records databases of hospitals \nand primary health care. Since May 2010, varicella surveillance \nhas incorporated a protocol for laboratory confirmation of cases. \nTwenty-nine primary care pediatricians agreed to adhere to this \nprotocol by taking a vesicle swab from all cases of varicella, after \nreceiving parental consent. Samples were collected with a polyes-\nter swab, placed in transport medium and maintained at ambient \ntemperature until delivery to the laboratory. DNA was extracted \nfrom clinical samples using an automated platform (Biorobot \nEZ1-Qiagen). Real time polymerase-chain-reaction assay was \nperformed in Smart Cycler, and Smart varicella-zoster virus reac-\ntive (Cepheid) was used for DNA detection.", "mimetype": "text/plain", "start_char_idx": 17030, "end_char_idx": 18854, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4ec51779-3da5-4aeb-ac1d-ea7e2930445b": {"__data__": {"id_": "4ec51779-3da5-4aeb-ac1d-ea7e2930445b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Cenoz (2013).pdf", "node_type": "4", "metadata": {}, "hash": "96c21deefc8663e7dc0e19f0e5157a2ed0138d274d92ec5c4ed6ef7df85780fb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "42848b44-0486-4429-8fce-5a5db5ceff37", "node_type": "1", "metadata": {}, "hash": "c995377c239938c7cbc5a43abfd2673d3905be5ff6eb617db359f84b65002c34", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f55e3477-1036-44f2-9b38-644455849215", "node_type": "1", "metadata": {}, "hash": "704c3fcb69a0ed056325cee4c0a1b00ddbe1e57942421bcfa2c522719f72e381", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Real time polymerase-chain-reaction assay was \nperformed in Smart Cycler, and Smart varicella-zoster virus reac-\ntive (Cepheid) was used for DNA detection.\nIn this study, the cases were children aged 15 mo to 10 y who \nwere diagnosed with varicella confirmed by PCR between May 1, \n2010 and June 30, 2012. From the primary care database of clini-\ncal records, eight anonymous controls were selected for each case \nfrom children with no previous diagnosis of varicella, matched \nwith the cases by pediatric practice, district of residence and date \nof birth (\u00b1 1 y). From all controls who met these eligibility crite-\nria, we consecutively selected those whose date of birth was clos-\nest to that of the case, preferably among those born in the same \ncalendar year. The number of doses and date of administration of \nthe varicella and measles-mumps-rubella (MMR) vaccines were \ntaken from the Navarre vaccination registry for both the cases \nand controls. From the clinical documentation of cases and con-\ntrols we obtained information on the sex, date of birth, pedia-\ntrician, district and municipality of residence, major chronic \nconditions (cardiovascular disease, respiratory disease, diabetes, \nneurological disease, renal disease or cancer), migrant parents \nReferences\n1.\t\nHeininger U, Seward JF. Varicella. Lancet 2006; \n368:1365-76; \nPMID:17046469; \nhttp://dx.doi.\norg/10.1016/S0140-6736(06)69561-5.\n2.\t\nSeward JF, Watson BM, Peterson CL, Mascola L, Pelosi \nJW, Zhang JX, et al. Varicella disease after introduction \nof varicella vaccine in the United States, 1995-2000. \nJAMA 2002; 287:606-11; PMID:11829699; http://\ndx.doi.org/10.1001/jama.287.5.606.\n3.\t\nSeward JF, Marin M, V\u00e1zquez M. Varicella vac-\ncine effectiveness in the US vaccination program: \na review.", "mimetype": "text/plain", "start_char_idx": 18699, "end_char_idx": 20472, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f55e3477-1036-44f2-9b38-644455849215": {"__data__": {"id_": "f55e3477-1036-44f2-9b38-644455849215", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Cenoz (2013).pdf", "node_type": "4", "metadata": {}, "hash": "96c21deefc8663e7dc0e19f0e5157a2ed0138d274d92ec5c4ed6ef7df85780fb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4ec51779-3da5-4aeb-ac1d-ea7e2930445b", "node_type": "1", "metadata": {}, "hash": "f27315e6a42154ae0831eb6718258f2589011220feac855a1c62dc81451b36a4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1b13d24b-2914-4162-b45c-e367990f6a17", "node_type": "1", "metadata": {}, "hash": "702275d682efe1aa989f9409ba853e2e3563e1e1b33a43273b8f00df2ec1dc34", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3.\t\nSeward JF, Marin M, V\u00e1zquez M. Varicella vac-\ncine effectiveness in the US vaccination program: \na review. J Infect Dis 2008; 197(Suppl 2):S82-9; \nPMID:18419415; http://dx.doi.org/10.1086/522145.\n4.\t\nWeibel RE, Neff BJ, Kuter BJ, Guess HA, Rothenberger \nCA, Fitzgerald AJ, et al. Live attenuated varicella virus \nvaccine. Efficacy trial in healthy children. N Engl J \nMed 1984; 310:1409-15; PMID:6325909; http://\ndx.doi.org/10.1056/NEJM198405313102201.\n5.\t\nV\u00e1zquez M, LaRussa PS, Gershon AA, Steinberg SP, \nFreudigman K, Shapiro ED. The effectiveness of the \nvaricella vaccine in clinical practice. N Engl J Med \n2001; 344:955-60; PMID:11274621; http://dx.doi.\norg/10.1056/NEJM200103293441302.\n6.\t\nVaris T, Vesikari T. Efficacy of high-titer live attenuated \nvaricella vaccine in healthy young children. J Infect Dis \n1996; 174(Suppl 3):S330-4; PMID:8896541; http://\ndx.doi.org/10.1093/infdis/174.Supplement_3.S330.\n7.\t\nFu C, Wang M, Liang J, Xu J, Wang C, Bialek S. The \neffectiveness of varicella vaccine in China. Pediatr Infect \nDis J 2010; 29:690-3; PMID:20216242; http://dx.doi.\norg/10.1097/INF.0b013e3181d7380e.\n8.\t\nV\u00e1zquez M, LaRussa PS, Gershon AA, Niccolai LM, \nMuehlenbein CE, Steinberg SP, et al. Effectiveness \nover time of varicella vaccine.", "mimetype": "text/plain", "start_char_idx": 20362, "end_char_idx": 21621, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1b13d24b-2914-4162-b45c-e367990f6a17": {"__data__": {"id_": "1b13d24b-2914-4162-b45c-e367990f6a17", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Cenoz (2013).pdf", "node_type": "4", "metadata": {}, "hash": "96c21deefc8663e7dc0e19f0e5157a2ed0138d274d92ec5c4ed6ef7df85780fb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f55e3477-1036-44f2-9b38-644455849215", "node_type": "1", "metadata": {}, "hash": "704c3fcb69a0ed056325cee4c0a1b00ddbe1e57942421bcfa2c522719f72e381", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "470af235-e630-45ba-935e-bb0c19340244", "node_type": "1", "metadata": {}, "hash": "039253ed8d115e2a12e9211ab4e773149e37c2d614b448f20ff05abcb7215d4d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "V\u00e1zquez M, LaRussa PS, Gershon AA, Niccolai LM, \nMuehlenbein CE, Steinberg SP, et al. Effectiveness \nover time of varicella vaccine. JAMA 2004; 291:851-\n5; \nPMID:14970064; \nhttp://dx.doi.org/10.1001/\njama.291.7.851.\n9.\t\nMichalik DE, Steinberg SP, Larussa PS, Edwards KM, \nWright PF, Arvin AM, et al. Primary vaccine failure \nafter 1 dose of varicella vaccine in healthy children. J \nInfect Dis 2008; 197:944-9; PMID:18419532; http://\ndx.doi.org/10.1086/529043.\n10.\t Huang WC, Huang LM, Chang IS, Tsai FY, Chang \nLY. Varicella breakthrough infection and vaccine \neffectiveness in Taiwan. Vaccine 2011; 29:2756-60; \nPMID:21315697; http://dx.doi.org/10.1016/j.vac-\ncine.2011.01.092.\n11.\t Lu L, Suo L, Li J, Zhai L, Zheng Q, Pang X, et \nal. A varicella outbreak in a school with high one-\ndose vaccination coverage, Beijing, China. Vaccine \n2012; 30:5094-8; PMID:22687763; http://dx.doi.\norg/10.1016/j.vaccine.2012.05.072.\n12.\t Marin M, G\u00fcris D, Chaves SS, Schmid S, Seward \nJF; Advisory Committee on Immunization Practices, \nCenters for Disease Control and Prevention (CDC). \nPrevention of varicella: recommendations of the \nAdvisory Committee on Immunization Practices \n(ACIP). MMWR Recomm Rep 2007; 56(RR-4):1-40; \nPMID:17585291.\n13.\t Bernaola Iturbe E, Gim\u00e9nez S\u00e1nchez F, Baca Cots M, \nde Juan Mart\u00edn F, D\u00edez Domingo J, Garc\u00e9s S\u00e1nchez M, \net al.", "mimetype": "text/plain", "start_char_idx": 21489, "end_char_idx": 22834, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "470af235-e630-45ba-935e-bb0c19340244": {"__data__": {"id_": "470af235-e630-45ba-935e-bb0c19340244", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Cenoz (2013).pdf", "node_type": "4", "metadata": {}, "hash": "96c21deefc8663e7dc0e19f0e5157a2ed0138d274d92ec5c4ed6ef7df85780fb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1b13d24b-2914-4162-b45c-e367990f6a17", "node_type": "1", "metadata": {}, "hash": "702275d682efe1aa989f9409ba853e2e3563e1e1b33a43273b8f00df2ec1dc34", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fb4d89a4-3de5-4f9c-a300-14c6fb5140b0", "node_type": "1", "metadata": {}, "hash": "df9ff264cef4dc078d0fd50ebfe92a80f78842139b02e95dbbd3d873e66cc67f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "13.\t Bernaola Iturbe E, Gim\u00e9nez S\u00e1nchez F, Baca Cots M, \nde Juan Mart\u00edn F, D\u00edez Domingo J, Garc\u00e9s S\u00e1nchez M, \net al.; Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Calendario vac-\nunal de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda: recomen-\ndaciones 2008. [Immunization schedule of the Spanish \nAssociation of Pediatrics: recommendations 2008]. \nAn Pediatr (Barc) 2008; 68:63-9; PMID:18194631; \nhttp://dx.doi.org/10.1157/13114474.\n14.\t Kuter B, Matthews H, Shinefield H, Black S, Dennehy \nP, Watson B, et al.; Study Group for Varivax. Ten year \nfollow-up of healthy children who received one or \ntwo injections of varicella vaccine. Pediatr Infect Dis \nJ 2004; 23:132-7; PMID:14872179; http://dx.doi.\norg/10.1097/01.inf.0000109287.97518.67.\n15.\t Shapiro ED, Vazquez M, Esposito D, Holabird \nN, Steinberg SP, Dziura J, et al. Effectiveness of 2 \ndoses of varicella vaccine in children. J Infect Dis \n2011; 203:312-5; PMID:21208922; http://dx.doi.\norg/10.1093/infdis/jiq052.\n\u00a92013 Landes Bioscience. Do not distribute.\n1176\t\nHuman Vaccines & Immunotherapeutics\t\nVolume 9 Issue 5\n20.\t Chaves SS, Gargiullo P, Zhang JX, Civen R, Guris D, \nMascola L, et al. Loss of vaccine-induced immunity to \nvaricella over time. N Engl J Med 2007; 356:1121-\n9; \nPMID:17360990; \nhttp://dx.doi.org/10.1056/\nNEJMoa064040.\n18.\t Comit\u00e9 Asesor de Vacunas de la Asociaci\u00f3n Espa\u00f1ola \nde Pediatr\u00eda.", "mimetype": "text/plain", "start_char_idx": 22718, "end_char_idx": 24070, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fb4d89a4-3de5-4f9c-a300-14c6fb5140b0": {"__data__": {"id_": "fb4d89a4-3de5-4f9c-a300-14c6fb5140b0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Cenoz (2013).pdf", "node_type": "4", "metadata": {}, "hash": "96c21deefc8663e7dc0e19f0e5157a2ed0138d274d92ec5c4ed6ef7df85780fb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "470af235-e630-45ba-935e-bb0c19340244", "node_type": "1", "metadata": {}, "hash": "039253ed8d115e2a12e9211ab4e773149e37c2d614b448f20ff05abcb7215d4d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "18.\t Comit\u00e9 Asesor de Vacunas de la Asociaci\u00f3n Espa\u00f1ola \nde Pediatr\u00eda. Calendario vacunal de la Asociaci\u00f3n \nEspa\u00f1ola de Pediatr\u00eda: recomendaciones 2004. \n[Vaccination schedule of the Spanish Association of \nPediatrics: recommendations 2004]. An Pediatr (Barc) \n2004; 60:468-72; PMID:15105003; http://dx.doi.\norg/10.1157/13059651.\n19.\t Cenoz MG, Catal\u00e1n JC, Zamarbide FI, Berastegui \nMA, Gurrea AB. Impacto de la vacunaci\u00f3n universal \nfrente a la varicela en Navarra, 2006-2010. [Impact of \nuniversal vaccination against chicken pox in Navarre, \n2006-2010]. An Sist Sanit Navar 2011; 34:193-202; \nPMID:21904402; http://dx.doi.org/10.4321/S1137-\n66272011000200006.\n16.\t Gould PL, Leung J, Scott C, Schmid DS, Deng \nH, Lopez A, et al. An outbreak of varicella in ele-\nmentary school children with two-dose varicella vac-\ncine recipients--Arkansas, 2006. Pediatr Infect Dis \nJ 2009; 28:678-81; PMID:19593254; http://dx.doi.\norg/10.1097/INF.0b013e31819c1041.\n17.\t Nguyen MD, Perella D, Watson B, Marin M, Renwick \nM, Spain CV. Incremental effectiveness of second dose \nvaricella vaccination for outbreak control at an elemen-\ntary school in Philadelphia, pennsylvania, 2006. Pediatr \nInfect Dis J 2010; 29:685-9; PMID:20354463; http://\ndx.doi.org/10.1097/INF.0b013e3181d9f657.", "mimetype": "text/plain", "start_char_idx": 24000, "end_char_idx": 25271, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c800a5a8-5887-4726-a9d2-e050a6e84f9e": {"__data__": {"id_": "c800a5a8-5887-4726-a9d2-e050a6e84f9e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "89364d7e-2288-41b5-aa50-2e683b8a55a4", "node_type": "1", "metadata": {}, "hash": "93320fb8d6ec684cf26b8039f90e1d894db76f34f1a6272d4bfb890a11a70de7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Articles\nwww.thelancet.com   Vol 383   April 12, 2014\t\n1313\nProtection against varicella with two doses of combined \nmeasles-mumps-rubella-varicella vaccine versus one dose of \nmonovalent varicella vaccine: a multicentre, observer-blind, \nrandomised, controlled trial\nRoman Prymula, Marianne Riise Bergsaker, Susanna Esposito, Leif Gothefors, Sorin Man, Nadezhda Snegova, M\u00e1ria \u0160tefkovi\u010dova, \nVytautas Usonis, Jacek Wysocki, Martine Douha, Ventzislav Vassilev, Ouzama Nicholson, Bruce L Innis, Paul Willems\nSummary\nBackground Rates of varicella have decreased substantially in countries implementing routine varicella vaccination. \nImmunisation is possible with monovalent varicella vaccine or a combined measles-mumps-rubella-varicella vaccine \n(MMRV). We assessed protection against varicella in naive children administered one dose of varicella vaccine or two \ndoses of MMRV.\nMethods This study was done in ten European countries with endemic varicella. Healthy children aged 12\u201322 months \nwere randomised (3:3:1 ratio, by computer-generated randomisation list, with block size seven) to receive 42 days apart \n(1) two doses of MMRV (MMRV group), or (2) MMR at dose one and monovalent varicella vaccine at dose two (MMR+V \ngroup), or (3) two doses of MMR (MMR group; control). Participants and their parents or guardians, individuals \ninvolved in assessment of any outcome, and sponsor staff involved in review or analysis of data were masked to \ntreatment assignment. The primary efficacy endpoint was occurrence of confirmed varicella (by detection of varicella \nzoster virus DNA or epidemiological link) from 42 days after the second vaccine dose to the end of the first phase of the \ntrial. Cases were graded for severity. Efficacy analyses were per protocol. Safety analyses included all participants who \nreceived at least one vaccine dose. This trial is registered with ClinicalTrials.gov, number NCT00226499.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1919, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "89364d7e-2288-41b5-aa50-2e683b8a55a4": {"__data__": {"id_": "89364d7e-2288-41b5-aa50-2e683b8a55a4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c800a5a8-5887-4726-a9d2-e050a6e84f9e", "node_type": "1", "metadata": {}, "hash": "6b82f9f894843f2b8b1cd69c4dd43243cfdd83f86a48feea3884c1f6411f9033", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "112e92fb-0a63-49c3-8ef8-6d9d3c092c68", "node_type": "1", "metadata": {}, "hash": "eefc388d3e982663f9d07fcd8f9b64ca98a9ce6b04a63a0bb3ff2f4b48e88520", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Cases were graded for severity. Efficacy analyses were per protocol. Safety analyses included all participants who \nreceived at least one vaccine dose. This trial is registered with ClinicalTrials.gov, number NCT00226499.\nFindings Between Sept 1, 2005, and May 10, 2006, 5803 children (mean age 14\u00b72 months, SD 2\u00b75) were vaccinated. In \nthe efficacy cohort of 5285 children, the mean duration of follow-up in the MMRV group was 36 months (SD 8\u00b78), in \nthe MMR+V group was 36 months (8\u00b75) and in the MMR group was 35 months (8\u00b79). Varicella cases were confirmed \nfor 37 participants in the MMRV group (two moderate to severe), 243 in the MMR+V group, and 201 in the MMR \ngroup. Second cases occurred for three participants (all in the MMR+V group). Varicella cases were moderate to severe \nfor two participants in the MMRV group, 37 in the MMR+V group (one being a second case that followed a mild first \ncase); and 117 in the MMR group. Efficacy of two-dose MMRV against all varicella was 94\u00b79% (97\u00b75% CI 92\u00b74\u201396\u00b76), \nand against moderate to severe varicella was 99\u00b75% (97\u00b75\u201399\u00b79). Efficacy of one-dose varicella vaccine against all \nvaricella was 65\u00b74% (57\u00b72\u201372\u00b71), and against moderate to severe varicella (post hoc) was 90\u00b77% (85\u00b79\u201393\u00b79). The most \ncommon adverse event in all groups was injection-site redness (up to 25% of participants). Within 15 days after dose \none, 57\u00b74% (95% CI 53\u00b79\u201360\u00b79) of participants in the MMRV group reported fever of 38\u00b0C or more, by contrast with \n44\u00b75% (41\u00b70\u201348\u00b71) with MMR+V, and 39\u00b78% (33\u00b78\u201346\u00b71) with MMR.", "mimetype": "text/plain", "start_char_idx": 1698, "end_char_idx": 3243, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "112e92fb-0a63-49c3-8ef8-6d9d3c092c68": {"__data__": {"id_": "112e92fb-0a63-49c3-8ef8-6d9d3c092c68", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "89364d7e-2288-41b5-aa50-2e683b8a55a4", "node_type": "1", "metadata": {}, "hash": "93320fb8d6ec684cf26b8039f90e1d894db76f34f1a6272d4bfb890a11a70de7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bb4e2bc2-e312-498d-aad2-15a53a94c04b", "node_type": "1", "metadata": {}, "hash": "97639c88f01f6b730b8852282275182dac26ab18f2197a56318087287306e3c5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Eight serious adverse events were deemed \nrelated to vaccination (three MMRV, four MMR+V, one MMR). All resolved within the study period.\nInterpretation These results support the implementation of two-dose varicella vaccination on a short course, to ensure \noptimum protection from all forms of varicella disease.\nFunding GlaxoSmithKline Vaccines.\nIntroduction\nVaricella is a highly contagious disease caused by the \nvaricella zoster virus (VZV). Universal vaccination with \nlive-attenuated varicella vaccine in the USA since 1995, \nand Uruguay since 1999, has substantially reduced the \nincidence of varicella and related admissions to hospital \nand deaths.1\u20133 However, breakthrough varicella occurs in \nchildren vaccinated with one dose.4 In 2007, a two-dose \nlive varicella-vaccine schedule was recommended by \nthe USA\u2019s Advisory Committee on Immunization \nPractices.5 This schedule could include a live monovalent \nvaricella vaccine, or a combination measles-mumps-\nrubella-varicella vaccine (MMRV).5\nCountries considering implementation of universal \nvaricella immunisation must decide whether to offer one \nor two doses, the timing of a second dose, and whether to \nuse MMRV as a potential way to enhance compliance.6,7 \nMMRV vaccines have been licensed with two-dose \nschedules in most European countries on the basis of \ncomparative immunogenicity to monovalent varicella \nvaccines only.6 No differences in anti-VZV immuno\u00ad\ngenicity have been identified between MMRV and \nLancet 2014; 383: 1313\u201324\nPublished Online \nJanuary 29, 2014 \nhttp://dx.doi.org/10.1016/\nS0140-6736(12)61461-5\nThis online publication has \nbeen corrected.", "mimetype": "text/plain", "start_char_idx": 3244, "end_char_idx": 4879, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bb4e2bc2-e312-498d-aad2-15a53a94c04b": {"__data__": {"id_": "bb4e2bc2-e312-498d-aad2-15a53a94c04b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "112e92fb-0a63-49c3-8ef8-6d9d3c092c68", "node_type": "1", "metadata": {}, "hash": "eefc388d3e982663f9d07fcd8f9b64ca98a9ce6b04a63a0bb3ff2f4b48e88520", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "34cf3a1f-c68c-4e96-9176-206fd39045a2", "node_type": "1", "metadata": {}, "hash": "2327981dd88069f116753cdb82819c6a5b13db653df9b77f357faae7a5ff6ca9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The corrected \nversion first appeared at \nthelancet.com on \nJanuary 23, 2020\nSee Comment page 1276\nUniversity Hospital, Hradec \nKralove, Czech Republic \n(Prof R Prymula MD); \nDepartment of Vaccines, \nNorwegian Institute of Public \nHealth, Oslo, Norway \n(M Riise Bergsaker MD); Pediatric \nHighly Intensive Care Unit, \nUniversity of Milan, Fondazione \nIRCCS Ca\u2019 Granda Ospedale \nMaggiore Policlinico, Milan, \nItaly (S Esposito MD); Swedish \nInstitute for Communicable \nDisease Control, Stockholm, \nSweden (Prof L Gothefors MD); \nDepartment of Clinical Sciences \nPediatrics, Ume\u00e5 University, \nUme\u00e5, Sweden \n(Prof L Gothefors); University of \nMedicine and Pharmacy Iuliu \nHa\u0163ieganu, Cluj-Napoca, \nRomania (S Man MD); Institute \nof Immunology, Moscow, Russia \n(N Snegova MD); Department of \nEpidemiology, Regional Office \nof Public Health, Trenc\u00edn, Slovak \nRepublic (M \u0160tefkovi\u010dova MD); \nVilnius University, Clinic of \nPaediatrics, Vilnius, Lithuania \n(Prof V Usonis MD); University \nSchool of Medical Sciences, \nPoznan, Poland \n(Prof J Wysocki MD); Regional \nMedical Center for Mother and \nChild, Poznan, Poland \n(Prof J Wysocki); \nGlaxoSmithKline Vaccines, \nKing of Prussia, PA, USA \n(O Nicholson MD, B L Innis MD); \nand GlaxoSmithKline Vaccines, \nWavre, Belgium (M Douha MSc, \nV Vassilev PhD, P Willems MD) \nArticles\n1314\t\nwww.thelancet.com   Vol 383   April 12, 2014\nmonovalent varicella vaccine administered con\u00adcomitantly \nwith MMR.8\u201311 Never\u00adtheless, MMRV\u2019s efficacy for \nprevention of vari\u00adcella has not been confirmed.\nWe did a randomised clinical trial to assess the pro\u00ad\ntection against varicella afforded by administration of \ntwo doses of MMRV or one dose of monovalent varicella \nvaccine.", "mimetype": "text/plain", "start_char_idx": 4880, "end_char_idx": 6577, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "34cf3a1f-c68c-4e96-9176-206fd39045a2": {"__data__": {"id_": "34cf3a1f-c68c-4e96-9176-206fd39045a2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bb4e2bc2-e312-498d-aad2-15a53a94c04b", "node_type": "1", "metadata": {}, "hash": "97639c88f01f6b730b8852282275182dac26ab18f2197a56318087287306e3c5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6ffcfcf5-7fd8-4d3c-9e32-0d26ea6b86b3", "node_type": "1", "metadata": {}, "hash": "e2224367c3f69bdf908bc6e5b18f8040309952fe71615c3a5403601cc95a4a43", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We did a randomised clinical trial to assess the pro\u00ad\ntection against varicella afforded by administration of \ntwo doses of MMRV or one dose of monovalent varicella \nvaccine. To achieve more robust efficacy estimates than \nin previous multiyear live varicella-vaccine trials,12\u201315 \nthe first phase of this trial (reported here) was observer-\nblind and used a concurrent control group, active sur\u00ad\nveillance for varicella, and rigorous case confirmation \nand severity-grading procedures. This trial was initiated \nin countries with endemic varicella among children aged \n12\u201322 months, permitting a stringent test of vaccine \nefficacy. We also assessed immunogenicity and safety of \nthe vaccine regimens.\nMethods\nStudy design and participants\nThis study is the first phase (Sept 1, 2005, to June 29, \n2009) of an observer-blind, randomised, controlled trial. \nThe study was done in 111 study centres in Europe: Czech \nRepublic (22), Greece (11), Italy (nine), Lithuania (nine), \nNorway (five), Poland (ten), Romania (nine), Russia (14), \nSlovakia (17), and Sweden (five).\nAn eligible participant was a healthy child aged \n12\u201322 months at the time of the first vaccination; had a \nnegative history of varicella, mumps, measles, and rubella \ndiseases and vaccinations; and was either (1) at home \nwith at least one sibling (with negative history of varicella \ndisease and vaccination), or (2) attending a childminder \n(where at least one child was without a known positive \nhistory of varicella disease and vac\u00adcination), or (3) playing \nfor more than 5 min weekly with children without a \nknown positive history of varicella disease and vaccination, \nor (4) registered to attend a daycare centre from 24 months \nof age. An eligible participant\u2019s parents or guardians had \ndirect access to a telephone and were deemed by the \ninvestigator of being capable of complying with the \nrequirements of the trial protocol.\nThe trial was approved by Research Ethics Committees \nof all participating countries.", "mimetype": "text/plain", "start_char_idx": 6403, "end_char_idx": 8399, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6ffcfcf5-7fd8-4d3c-9e32-0d26ea6b86b3": {"__data__": {"id_": "6ffcfcf5-7fd8-4d3c-9e32-0d26ea6b86b3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "34cf3a1f-c68c-4e96-9176-206fd39045a2", "node_type": "1", "metadata": {}, "hash": "2327981dd88069f116753cdb82819c6a5b13db653df9b77f357faae7a5ff6ca9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7d9686fb-303a-4643-8a3c-1f16fb367ba4", "node_type": "1", "metadata": {}, "hash": "a8198831a099f657cbfb0ed47fb30b6f0c1905ac7e841cace497cfd74d602441", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The trial was approved by Research Ethics Committees \nof all participating countries. In the Czech Republic, \nGreece, Italy, Lithuania, Norway, Romania, Russia, \nSlovakia, and Sweden the trial was done in accordance \nwith the Declaration of Helsinki and good clinical \npractice guidelines. Written informed consent was \nobtained from the parents or guardians of all children \nbefore trial entry. An Independent Data Monitoring \nCommittee (IDMC) monitored the study and classified \nsuspected varicella cases. Deviations from good clinical \npractice guidelines in Poland were investigated by GSK \nVaccines. The findings of GSK Vaccines\u2019 investigation \nare shown at the end of the Methods. \nProcedures\nEligible participants were randomly allocated (3:3:1 ratio) \nto one of three treatment groups: group MMRV, in which \nMMRV (Priorix-Tetra, GlaxoSmithKline Vaccines [GSK], \nRixenstart, Belgium) was administered at doses one and \ntwo; group MMR+V, in which MMR was administered at \ndose one (Priorix, GSK) and monovalent varicella vaccine \n(Varilrix, GSK) at dose two; or group MMR, in which \nMMR (Priorix) was administered at doses one and two. \nDoses were admin\u00adistered 42 days apart (day 0 and day 42). \nAfter completion of this first phase of the clinical trial, \ngroup MMR+V participants were offered the second dose \nof MMR in accordance with the immunisation schedule \nof their respective country.\n200 participants per country were included in a subset \nused for additional immunogenicity and reactogenicity \nanalyses. According to the country, this subset consisted \nof either the first 200 participants enrolled irrespective \nof the study centre, or 200 participants enrolled at \nselected centres.\nAll study vaccines were lyophilised and refrigerator-\nstable, to be reconstituted before injection with supplied \ndiluent. Three lots each of MMRV and of monovalent \nvaricella vaccine and one lot of MMR were used \n(appendix p 1). All vaccines were administered sub\u00ad\ncutaneously in the deltoid region of the left arm.", "mimetype": "text/plain", "start_char_idx": 8314, "end_char_idx": 10333, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7d9686fb-303a-4643-8a3c-1f16fb367ba4": {"__data__": {"id_": "7d9686fb-303a-4643-8a3c-1f16fb367ba4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6ffcfcf5-7fd8-4d3c-9e32-0d26ea6b86b3", "node_type": "1", "metadata": {}, "hash": "e2224367c3f69bdf908bc6e5b18f8040309952fe71615c3a5403601cc95a4a43", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bdb0d9e5-4aab-4c2f-b23c-6fa98e7eb88c", "node_type": "1", "metadata": {}, "hash": "6c3918c1142af0ce488da314c784224d709809d8e817a241545301395e746d65", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All vaccines were administered sub\u00ad\ncutaneously in the deltoid region of the left arm.\nThe primary efficacy endpoint was the occurrence \nof confirmed varicella from 42 days after the second \nvaccine dose to the end of the first phase of the trial. \nThe secondary efficacy endpoint was the occurrence of \nconfirmed varicella graded by severity over the same time \nperiod. Other secondary endpoints were anti-VZV \nantibody concentrations at day 0, day 42, day 84, year 1, \nand year 2; occurrence of solicited injection-site symp\u00ad\ntoms within 4 days after each dose; occurrence of solicited \nfever within 15 days and 43 days after each dose and other \nsolicited general symptoms within 43 days after each \ndose; and occurrence of herpes zoster and of any serious \nadverse event to the end of the first phase of the trial. \nThree immunogenicity secondary endpoints and three \nhealth-economics \nsecondary \nendpoints \nwere \nnot \nconsidered in this Article and will be presented \nelsewhere; these endpoints were measles, mumps, and \nrubella antibody titres in a subset of patients at day 0, day \n84, year 1, and year 2; and for the varicella cases during \nthe study, the time lost from work by parents or guardians \nto provide care; the attendance time lost to day care, \nchildminder, or school or any extra-curricular activities; \nand the time spent by a paid caregiver to provide care. \nParents or guardians of participants were requested \nto seek assessment of their child for any rash illness \nsuggestive of varicella or herpes zoster and to report such \nrash illnesses of others in the household. These requests \nwere repeated through monthly contact after the child \ncompleted vaccination.", "mimetype": "text/plain", "start_char_idx": 10247, "end_char_idx": 11935, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bdb0d9e5-4aab-4c2f-b23c-6fa98e7eb88c": {"__data__": {"id_": "bdb0d9e5-4aab-4c2f-b23c-6fa98e7eb88c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7d9686fb-303a-4643-8a3c-1f16fb367ba4", "node_type": "1", "metadata": {}, "hash": "a8198831a099f657cbfb0ed47fb30b6f0c1905ac7e841cace497cfd74d602441", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6c8138f2-1838-411d-914f-982c47ce5bfd", "node_type": "1", "metadata": {}, "hash": "ddde1cdf931cdaa9acba6a0d8ea83cc74913e2d1a6f05ea328f594d39702e254", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "These requests \nwere repeated through monthly contact after the child \ncompleted vaccination. For participants with a rash \nillness, a detailed description of the case was recorded \nwith type of rash (including photographs), duration of \nrash, intensity of rash, presence of fever during the rash \nevent, disease complications, and (to identify an epi\u00ad\ndemiological link) information about contact with, and \nSee Online for appendix\nCorrespondence to: \nDr Ouzama Nicholson, \nGlaxoSmithKline Vaccines, \nKing of Prussia, PA 19406-2772, \nUSA \nouzama.n.henry@gsk.com\nArticles\nwww.thelancet.com   Vol 383   April 12, 2014\t\n1315\ncharacterisation of, potential index cases. Vesicular \ndermal lesions were sampled by un\u00adroofing the lesion and \ncollecting the fluid by capillary action. Dry lesions \n(papules or crusts) were sampled by unroofing and \nswabbing, or by collecting scabs or crusts from lesions. \nVZV DNA was detected and determined by restriction \nfragment length polymorphism (RFLP) analysis of the \nPCR amplified product. PCR detection of \u03b2-globin DNA \nserved as a positive control for adequate lesion sampling.16 \nAll cases of varicella-like rash17,18 assessed by the \ninvestigator were referred to the IDMC for final blinded \nclassification (figure 1). The IDMC\u2019s assessment of \nclinical criteria and of disease severity was done without \nknowledge of the VZV-PCR/RFLP result or of the history \nof an epidemiological link (ie, exposure to a valid varicella \nindex case within 30 days of rash onset). A varicella case \nwas confirmed when the VZV-PCR/RFLP result was \npositive or when the case met clinical criteria and had an \nepidemiological link. Varicella severity grading was based \non the scoring system of V\u00e1zquez and colleagues19 with \nmodifications: mild disease, 7 points or fewer; moderately \nsevere disease, 8\u201315 points; severe disease, 16 points or \nmore.", "mimetype": "text/plain", "start_char_idx": 11842, "end_char_idx": 13716, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6c8138f2-1838-411d-914f-982c47ce5bfd": {"__data__": {"id_": "6c8138f2-1838-411d-914f-982c47ce5bfd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bdb0d9e5-4aab-4c2f-b23c-6fa98e7eb88c", "node_type": "1", "metadata": {}, "hash": "6c3918c1142af0ce488da314c784224d709809d8e817a241545301395e746d65", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "72e7103f-f60c-4751-b404-87ac33170c3f", "node_type": "1", "metadata": {}, "hash": "d2abff1401ef202a3ae749e8bead2181db5d4b973964b211904a4bce27d30be2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The modifications were that more than 500 lesions \nwas attributed 8 points; both interstitial pneumonia and \nencephalitis were attributed 10 points, macular and \npapular lesions were scored separately, each at 2 points; \nand pain in the back or abdomen was not scored.\nAnti-VZV antibody concentrations were established in \nblood samples by ELISA (Enzygnost; Siemens, Marburg, \nGermany; appendix p 3). A seronegative participant had \nan \nanti-VZV \nantibody \nconcentration \nless \nthan \n25 mIU/mL. A seroresponse was defined as a post-\nvaccination antibody concentration 50 mIU/mL or more \nin a particpant who was seronegative before vaccination.\nFor participants in the reactogenicity subset of the total \nvaccinated cohort and after each dose, injection-site \nreactions (pain, redness, and swelling) were solicited \ndaily for 4 days and general symptoms (fever [rectal \ntemperature \u226538\u00b70\u00b0C or axillary temperature \u226537\u00b75\u00b0C], \nrash, parotid or salivary gland swelling, and any signs of \nmeningism [including febrile seizures]) were solicited for \n43 days. Unsolicited adverse events were also recorded for \n43 days (appendix p 4). For all participants, any serious \nadverse event (which included an adverse event that \nresulted in persistent or substantial incapacity, admission \nto hospital, or death) or any with\u00addrawal attributed to \nadverse events were recorded in detail during the whole \nstudy period. All solicited local symptoms were deemed \ncausally related to vaccination. Causality of solicited \ngeneral symptoms, unsolicited symptoms, and serious \nadverse events was assessed by the investigator.\nRandomisation and masking\nA randomisation list with a block size of seven was \ngenerated at GSK with SAS software (version 8.2) and was \nused to ascribe a unique treatment number for the two-\nvaccine dose regimen with a blocking scheme respecting \nthe 3:3:1 treatment allocation ratio. The blocking scheme \nalso took into account the three vaccine lots used for \nMMRV and monovalent varicella vaccine. The blocking \nscheme was respected in the distribution of vaccine \ntreatments to each study centre.", "mimetype": "text/plain", "start_char_idx": 13717, "end_char_idx": 15824, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "72e7103f-f60c-4751-b404-87ac33170c3f": {"__data__": {"id_": "72e7103f-f60c-4751-b404-87ac33170c3f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6c8138f2-1838-411d-914f-982c47ce5bfd", "node_type": "1", "metadata": {}, "hash": "ddde1cdf931cdaa9acba6a0d8ea83cc74913e2d1a6f05ea328f594d39702e254", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "38b141f7-097f-4293-8b3d-04bb207a7cf1", "node_type": "1", "metadata": {}, "hash": "285460a8ab9d124f0f1629acebc58b3137658730c101417ae9e6dc3ac8f8433d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The blocking scheme \nalso took into account the three vaccine lots used for \nMMRV and monovalent varicella vaccine. The blocking \nscheme was respected in the distribution of vaccine \ntreatments to each study centre. Each eligible participant \nwas allocated (via the internet at the study centre) a unique \ntreatment number, with a minimisation algo\u00adrithm \naccounting for study centre and containing a random \ncomponent. The vaccine was prepared out of view of the \nparticipants\u2019 parents or guardians and of the individuals \nwho were responsible for assessing and recording the \nreactogenicity of the vaccines. All indi\u00adviduals involved in \nthe assessment of any outcome after vaccination (whether \nefficacy or safety) were unaware of the treatment \nadministered. Sponsor staff involved in review or analysis \nof data were also unaware of the treatment assignments.\nStatistical analysis\nStatistical power calculations (with PASS software \n[version 2000], one-sided proportion) were based on \nvaccine efficacy being determined as a proportion, \nFigure 1: Schematic description of the procedure followed to confirm varicella cases\nIDMC=Independent Data Monitoring Committee. EDL=epidemiological link. PCR+ indicates a case for which \nVZV-PCR/RFLP is positive and \u03b2-globin-PCR is positive. PCR\u2013 encompasses one of three case outcomes: \nVZV-PCR/RFLP negative and \u03b2-globin-PCR positive; VZV-PCR/RFLP negative and \u03b2-globin-PCR negative \n(ie, PCR result invalid); or missing sample.\nReport skin \nrash or eruptions\nDocument clinical symptoms,\nphotograph rashes, collect PCR\nsamples, and identify index cases\nReview PCR and \nEDL data\nReview PCR data\nVaricella-like\nrash?\nNo case\n(PCR\u2013)\nNo case\n(PCR\u2013/EDL\u2013)\nNo case\n(PCR+)\nCon\ufb01rmed\n(PCR\u2013/EDL+)\nCon\ufb01rmed\nYes\nYes\nNo\nNo\nNo\nYes\nNo\nNo\nYes\nYes\nParent or guardian\nInvestigator\nIDMC\nMeet clinical\ncriteria?\nPCR+?\nPCR+?\nEDL+?", "mimetype": "text/plain", "start_char_idx": 15609, "end_char_idx": 17463, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "38b141f7-097f-4293-8b3d-04bb207a7cf1": {"__data__": {"id_": "38b141f7-097f-4293-8b3d-04bb207a7cf1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "72e7103f-f60c-4751-b404-87ac33170c3f", "node_type": "1", "metadata": {}, "hash": "d2abff1401ef202a3ae749e8bead2181db5d4b973964b211904a4bce27d30be2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2025d05e-25b2-4df6-af1c-c91cc2f1265d", "node_type": "1", "metadata": {}, "hash": "22f623a7d88f03f70ddbfdefb42fbd4c78a5813e452df318e5ceb36f59263f20", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "PCR+?\nPCR+?\nEDL+?\nArticles\n1316\t\nwww.thelancet.com   Vol 383   April 12, 2014\ncalculated as 1\u2013(the proportion of cases in the test group \n[either MMRV or MMR+V] divided by the proportion of \ncases in the control group [MMR]). In view of the \n3:3:1 ran\u00addomisation and assuming live varicella vaccine \nefficacies of 0\u00b78 (ie, 80%) in both MMRV and MMR+V \ngroups, 144 confirmed varicella cases in the entire cohort \n(39[MMRV]+39[MMR+V]+66[MMR]) was calculated to \nprovide 89% power to reject at least one of the null \nhypotheses with a one-sided test (ie, H0: vaccine efficacy \n<60%) and a Bonferonni correction for multiple com\u00ad\nparisons giving a type I error of 1\u00b725%. In view of this \noutcome and assuming a 2 year follow-up, exclusion of \n20% of participants from the per-protocol analysis, and a \nconservative annual attack rate of 5% for children in the \nMMR control group, the number of eligible participants \nto be enrolled was calculated to be 5754.\nFigure 2: Allocation and elimination of participants during course of study\nSeropositive participants were excluded from the per-protocol cohorts. Numbers in parentheses correspond to the subsets used to analyse unsolicited and solicited \nadverse events up to 43 days after each vaccine dose (as part of the total vaccinated cohort), and to analyse anti-varicella-zoster-virus responses at day 42 (as part \nof the per-protocol immunogenicity cohort). No enrolled participant was excluded from the vaccination cohort. Exclusion criteria are listed in appendix p 2. \nMMRV=measles-mumps-rubella-varicella combined vaccine. MMR+V=measles-mumps-rubella combined vaccine plus monovalent varicella vaccine. \nMMR=measles-mumps-rubella combined vaccine only.\n5803 participants enrolled and randomised \n2487 assigned MMR+V (812 in adverse \n \nevent and anti-VZV subset)\n827 assigned MMR (268 in adverse event \n \nand anti-VZV subset", "mimetype": "text/plain", "start_char_idx": 17446, "end_char_idx": 19321, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2025d05e-25b2-4df6-af1c-c91cc2f1265d": {"__data__": {"id_": "2025d05e-25b2-4df6-af1c-c91cc2f1265d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "38b141f7-097f-4293-8b3d-04bb207a7cf1", "node_type": "1", "metadata": {}, "hash": "285460a8ab9d124f0f1629acebc58b3137658730c101417ae9e6dc3ac8f8433d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a59e25e7-2299-4b2c-af81-1e9fb5801de9", "node_type": "1", "metadata": {}, "hash": "2a8d85e27d63127a2a70f42d83e290d0f504648edd90108abd21d67256b4425d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "5803 participants enrolled and randomised \n2487 assigned MMR+V (812 in adverse \n \nevent and anti-VZV subset)\n827 assigned MMR (268 in adverse event \n \nand anti-VZV subset immunogenicity \n \ncohort)\n2489 assigned MMRV (807 in adverse \n \nevent and anti-VZV subset)\n2245 (704) included in per-protocol\n \nimmunogenicity cohort\n244 (103) excluded from \n \nimmunogenicity cohort\n \n 3 (3) administration of other \n \n \n vaccine\n \n 2 (0) randomisation code \n \n \n broken\n \n 10 (4) study vaccine not\n \n \n administered per protocol\n \n 3 (0) protocol violation\n \n 56 (13) initially seropositive or\n \n \n antibody status unknown\n \n 5 (2) administration of \n \n \n forbidden drug\n \n 2 (1) underlying medical \n \n \n condition\n \n 25 (10) non-compliance with \n \n \n vaccine schedule\n \n 7 (4) non-compliance with \n \n \n blood sampling\n \n 130 (65) essential serological \n \n \n data missing\n \n \n \n210 excluded from e\ufb03cacy cohort\n \n 10 study vaccine not\n \n \n administered per protocol\n \n 3 protocol violation\n \n 2 underlying medical \n \n \n condition\n \n 7 varicella disease before \n \n \n day 84\n \n 73 no follow-up after day 84\n \n 115 initially seropositive or\n \n \n antibody status unknown\n224 excluded from e\ufb03cacy cohort\n \n 18 study vaccine not \n \n \n administered per protocol\n \n 6 protocol violation\n \n 3 underlying medical \n \n \n condition\n \n 28 varicella disease before \n \n \n day 84\n \n 56 no follow-up after day 84\n \n 110 initially seropositive or\n \n \n antibody status unknown\n \n 3 other\n84 excluded from e\ufb03cacy cohort\n \n 1 study vaccine not \n \n  administered per protocol\n \n 1 protocol violation\n \n 9 varicella disease before \n \n  day 84\n \n 30 no follow-up after day 84\n \n 42 initially seropositive or\n \n  antibody status unknown\n \n 1 other\n239 (101) excluded from", "mimetype": "text/plain", "start_char_idx": 19151, "end_char_idx": 20884, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a59e25e7-2299-4b2c-af81-1e9fb5801de9": {"__data__": {"id_": "a59e25e7-2299-4b2c-af81-1e9fb5801de9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2025d05e-25b2-4df6-af1c-c91cc2f1265d", "node_type": "1", "metadata": {}, "hash": "22f623a7d88f03f70ddbfdefb42fbd4c78a5813e452df318e5ceb36f59263f20", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ec56494a-2cd5-4882-93ab-defaf4b74a1b", "node_type": "1", "metadata": {}, "hash": "0e16af6bad672f9b11a359a935294bafdc55bbcd86c52124cd40714ff9f97143", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "disease before \n \n  day 84\n \n 30 no follow-up after day 84\n \n 42 initially seropositive or\n \n  antibody status unknown\n \n 1 other\n239 (101) excluded from \n \nimmunogenicity cohort\n \n 2 (2) administration of other \n \n \n vaccine\n \n 7 (4) randomisation code \n \n \n broken\n \n 18 (5) study vaccine not\n \n \n administered per protocol\n \n 6 (2) protocol violation\n \n 54 (11) initially seropositive or\n \n \n antibody status unknown\n \n 8 (6) administration of \n \n \n forbidden drug\n \n 2 (0) underlying medical\n \n \n condition\n \n 17 (9) non-compliance with\n \n \n vaccine schedule\n \n 18 (9) non-compliance with \n \n \n blood sampling\n \n 102 (48) essential serological \n \n \n data missing\n \n 3 (3) incoherence, or\n \n \n abnormality, or error in data\n \n 2 (2) other\n85 (36) excluded from\n \nimmunogenicity cohort\n \n 3 (0) randomisation code \n \n \n broken\n \n 1 (0) study vaccine not\n \n \n administered per protocol\n \n 1 (0) protocol violation\n \n 20 (5) initially seropositive or\n \n \n antibody status unknown\n \n 5 (3) administration of \n \n \n forbidden drug\n \n 4 (1) non-compliance with\n \n \n vaccine schedule\n \n 3 (1) non-compliance with \n \n \n blood sampling\n \n 46 (25) essential serological \n \n \n data missing\n \n 1 (1) incoherence, or\n \n \n abnormality, or error in data\n \n 1 (0) other\n2248 (711) included in per-protocol\n \nimmunogenicity cohort\n742 (232) included in per-protocol\n \nimmunogenicity cohort\n2279 included in per-protocol\n \ne\ufb03cacy cohort\n2263 included in per-protocol\n \ne\ufb03cacy cohort\n743 included in per-protocol\n \ne\ufb03cacy cohort\n1 (1) incoherence, abnormality, \nor error in data\nArticles\nwww.thelancet.com   Vol 383   April 12, 2014\t\n1317\nVaccine efficacies against confirmed varicella,", "mimetype": "text/plain", "start_char_idx": 20731, "end_char_idx": 22400, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ec56494a-2cd5-4882-93ab-defaf4b74a1b": {"__data__": {"id_": "ec56494a-2cd5-4882-93ab-defaf4b74a1b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a59e25e7-2299-4b2c-af81-1e9fb5801de9", "node_type": "1", "metadata": {}, "hash": "2a8d85e27d63127a2a70f42d83e290d0f504648edd90108abd21d67256b4425d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8c26f933-c200-4104-807f-0d728c1a4b5b", "node_type": "1", "metadata": {}, "hash": "0278ff2a7ef14bdab7a049e5525cf2ed0b0c723cf03a91b839cecfd040f6c512", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "abnormality, \nor error in data\nArticles\nwww.thelancet.com   Vol 383   April 12, 2014\t\n1317\nVaccine efficacies against confirmed varicella, from \n42 days after dose two until the end of the study period, \nwere estimated in the per-protocol efficacy cohort. The \nprimary objective for one dose of varicella vaccine or two \ndoses of MMRV was to exclude a lower limit of the two-\nsided 97\u00b75% CI for vaccine efficacy against all grades of \nvaricella that was less than 60%. The secondary objective \nfor one dose of varicella vaccine or two doses of MMRV \nwas to exclude a lower limit of the two-sided 97\u00b75% CI \nfor vaccine efficacy against moderate varicella that \nwas less than 70% and against severe varicella that was \nless than 80%. Vaccine efficacy was calculated as \n100\u00d7(1\u2013hazard ratio [HR]). HRs and CIs were estimated \nwith a Cox regression model in which the treatment \ngroup was the only regressor. 97\u00b75% CIs were used \nbecause a Bonferroni correction was applied giving a \nnominal one-sided type I error of 1\u00b725%. To control the \neffect of multiple objectives on the type I error rate, the \nsecondary objective was assessed in a confirmatory \nmanner when the primary objective was reached for the \ngiven vaccine. 95% CIs were used for the exploratory \nanalysis of vaccine efficacy by country.\nAnti-VZV antibody responses were analysed in the per-\nprotocol immunogenicity cohort (figure 2). The analysis \nof safety was done on the total vaccinated cohort for \nserious adverse events and on the reactogenicity subset \nfor solicited and unsolicited adverse events within \n42 days after each dose. Computation of the exact 95% CI \nfor proportions within a treatment group assumed \nindependence between doses.20 Computation of 95% CIs \nfor the geometric mean concentrations (GMCs) used an \nANOVA model on log10 transformed data assumed to be \nnormally distributed with unknown variance. SAS \n(version 9.2, including Proc-StatXact, version 8.1 module) \nwas used for all computations.", "mimetype": "text/plain", "start_char_idx": 22262, "end_char_idx": 24246, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8c26f933-c200-4104-807f-0d728c1a4b5b": {"__data__": {"id_": "8c26f933-c200-4104-807f-0d728c1a4b5b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ec56494a-2cd5-4882-93ab-defaf4b74a1b", "node_type": "1", "metadata": {}, "hash": "0e16af6bad672f9b11a359a935294bafdc55bbcd86c52124cd40714ff9f97143", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "13bbdb23-df50-4103-8648-eabc0e5524cd", "node_type": "1", "metadata": {}, "hash": "b03ce6e72dfd46c40df822291c779eaba2a1fa730a0c1315956c289b920861c6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "SAS \n(version 9.2, including Proc-StatXact, version 8.1 module) \nwas used for all computations. This trial is registered \nwith ClinicalTrials.gov, number NCT00226499.\nDeviations from good clinical practice guidelines\nOn May 31, 2012, GSK Vaccines (the Sponsor) was made \naware of deviations from good clinical practice guidelines \naffecting GSK Vaccines studies done in Poland between \n2005 and 2011. The Sponsor submitted a report on their \ninvestigation into the present study to The Lancet on \nOct 22, 2013. Deviations from good clinical practice \nguidelines, other notable findings, and corrective actions \ntaken after the investigation are described below. The \nclinical trial is planned to follow-up participants for \n10 years and is therefore ongoing.\nAn addendum to the informed consent form (ICF; for a \nsubset of participants [dated Oct 3, 2005] and for all \nparticipants [dated Jan 6, 2006]) was implemented at sites \nbefore Ethics Committee and Regulatory Authority \napproval. The ICF addendum was implemented to correct \nthe requirements for temperature recording. The original \nICF incorrectly stated that temperature recording should \nbegin on day 4. This was not consistent with the protocol \nwhich required temperature recording to begin on day 0. \nSince the addendum did not involve an emergency safety \nupdate, it should not have been implemented before the \nappropriate approvals. The Sponsor has notified the \nEthics Committee and Regulatory Authority of this \ndeviation. The Sponsor has also undertaken additional \ntraining to ensure that investigators are aware that \nchanges to ICFs should not be implemented before the \nappropriate approval unless there is a need to inform and \nprotect participants from probable harm on the basis of \nthe availability of new safety information.\nTen sites in Poland lacked monitoring visit reports for at \nleast one on-site monitoring visit undertaken by local \nrepresentatives of the Sponsor. Because of the lack of \nmonitoring visit reports for some visits, the Sponsor could \nnot, upon study conclusion, verify the validity of all the \ndata collected at these sites. As a result, all sites in Poland \nwere remonitored by the Sponsor between November, \n2012, and June, 2013. This re-monitoring included review \nof ICFs, eligibility criteria, documentation", "mimetype": "text/plain", "start_char_idx": 24151, "end_char_idx": 26467, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "13bbdb23-df50-4103-8648-eabc0e5524cd": {"__data__": {"id_": "13bbdb23-df50-4103-8648-eabc0e5524cd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8c26f933-c200-4104-807f-0d728c1a4b5b", "node_type": "1", "metadata": {}, "hash": "0278ff2a7ef14bdab7a049e5525cf2ed0b0c723cf03a91b839cecfd040f6c512", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "124fd7b4-616d-4a87-907a-440e65d0354f", "node_type": "1", "metadata": {}, "hash": "6348c1a4588b1dd13dcc3e831f7cef4c021746f3555026bb2c58292084201dae", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "As a result, all sites in Poland \nwere remonitored by the Sponsor between November, \n2012, and June, 2013. This re-monitoring included review \nof ICFs, eligibility criteria, documentation of serious \nMMRV \nN=2279\nMMR+V \nN=2263\nMMR  \nN=743\nTotal  \nN=5285\nAge (months)\n14\u00b72 (2\u00b75)\n14\u00b72 (2\u00b74)\n14\u00b72 (2\u00b75)\n14\u00b72 (2\u00b75)\nSex\nGirls\n1057 (46\u00b74%)\n1109 (49\u00b70%)\n359 (48\u00b73%)\n2525 (47\u00b78%)\nBoys\n1222 (53\u00b76%)\n1154 (51\u00b70%)\n384 (51\u00b77%)\n2760 (52\u00b72%)\nRace\nWhite\n2227 (97\u00b77%)\n2225 (98\u00b73%)\n736 (99\u00b71%)\n5188 (98\u00b72%)\nBlack\n8 (0\u00b74)\n7 (0\u00b73%)\n1 (0\u00b71%)\n16 (0\u00b73%)\nArabic/north African\n21 (0\u00b79%)\n7 (0\u00b73%)\n2 (0\u00b73%)\n30 (0\u00b76%)\nEast/southeast Asian\n7 (0\u00b73%)\n6 (0\u00b73%)\n1 (0\u00b71%)\n14 (0\u00b73%)\nSouth Asian\n2 (0\u00b71%)\n2 (0\u00b71%)\n0\n4 (0\u00b71%)\nAmerican Hispanic\n1 (<0\u00b71%)\n5 (0\u00b72%)\n2 (0\u00b73%)\n8 (0\u00b72%)\nJapanese\n1 (<0\u00b71%)\n0\n0\n1 (<0\u00b71%)\nOther\n12 (0\u00b75%)\n11 (0\u00b75%)\n1 (0\u00b71%)\n24 (0\u00b75%)\nCountry\nCzech Republic\n525 (23\u00b70%)\n516 (22\u00b78%)\n171 (23\u00b70%)\n1212 (22\u00b79%)\nGreece\n115 (5\u00b70%)\n111 (4\u00b79%)\n31 (4\u00b72%)\n257 (4\u00b79%)\nItaly\n106 (4\u00b77%)\n108 (4\u00b78%)\n35", "mimetype": "text/plain", "start_char_idx": 26280, "end_char_idx": 27255, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "124fd7b4-616d-4a87-907a-440e65d0354f": {"__data__": {"id_": "124fd7b4-616d-4a87-907a-440e65d0354f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "13bbdb23-df50-4103-8648-eabc0e5524cd", "node_type": "1", "metadata": {}, "hash": "b03ce6e72dfd46c40df822291c779eaba2a1fa730a0c1315956c289b920861c6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fdf2b368-df0b-4e91-8b67-327fc75872bb", "node_type": "1", "metadata": {}, "hash": "4ce593d54a648121a7780823f1248ea4f0f101ab677e825c2f32801501f9ccf2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "(5\u00b70%)\n111 (4\u00b79%)\n31 (4\u00b72%)\n257 (4\u00b79%)\nItaly\n106 (4\u00b77%)\n108 (4\u00b78%)\n35 (4\u00b77%)\n249 (4\u00b77%)\nLithuania\n256 (11\u00b72%)\n255 (11\u00b73%)\n86 (11\u00b76%)\n597 (11\u00b73%)\nNorway\n74 (3\u00b72%)\n76 (3\u00b74%)\n25 (3\u00b74%)\n175 (3\u00b73%)\nPoland\n385 (16\u00b79%)\n368 (16\u00b73%)\n116 (15\u00b76%)\n869 (16\u00b74%)\nRomania\n121 (5\u00b73%)\n126 (5\u00b76%)\n42 (5\u00b77%)\n289 (5\u00b75%)\nRussia\n378 (16\u00b76)\n392 (17\u00b73%)\n130 (17\u00b75%)\n900 (17\u00b70%)\nSlovakia\n199 (8\u00b77%)\n195 (8\u00b76%)\n68 (9\u00b72%)\n462 (8\u00b77%)\nSweden\n120 (5\u00b73%)\n116 (5\u00b71%)\n39 (5\u00b72%)\n275 (5\u00b72%)\nCare type at enrolment\nAt least one sibling at home\n655 (28\u00b77%)\n591 (26\u00b71%)\n191 (25\u00b77%)\n1437 (27\u00b72%)\nAttending day care centre\n525 (23\u00b70%)\n546 (24\u00b71%)\n187 (25\u00b72%)\n1258 (23\u00b78%)\nAttending a child minder\n148 (6\u00b75%)\n154 (6\u00b78%)\n57 (7\u00b77%)\n359 (6\u00b78%)\nAt least once a week contact*\n2051 (90\u00b70%)\n2052 (90\u00b77%)\n679 (91\u00b74%)\n4782 (90\u00b75%)\nData are n (%) or mean (SD). MMRV=measles-mumps-rubella-varicella combined vaccine. MMR+V=measles-mumps-\nrubella combined vaccine plus monovalent varicella vaccine. MMR=measles-mumps-rubella combined vaccine only. \n*With other children without a known positive history of varicella disease or vaccination.", "mimetype": "text/plain", "start_char_idx": 27186, "end_char_idx": 28271, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fdf2b368-df0b-4e91-8b67-327fc75872bb": {"__data__": {"id_": "fdf2b368-df0b-4e91-8b67-327fc75872bb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "124fd7b4-616d-4a87-907a-440e65d0354f", "node_type": "1", "metadata": {}, "hash": "6348c1a4588b1dd13dcc3e831f7cef4c021746f3555026bb2c58292084201dae", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "059691ec-b286-408d-8399-91cc26358c6e", "node_type": "1", "metadata": {}, "hash": "c1e0b968ea82b18be5e22259fe4df58a6a0c2b75894abac0c551a827ec189725", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MMR=measles-mumps-rubella combined vaccine only. \n*With other children without a known positive history of varicella disease or vaccination.\nTable 1: Demographic characteristics of the per-protocol cohort\nArticles\n1318\t\nwww.thelancet.com   Vol 383   April 12, 2014\nadverse events, and review of data collected for \ndocumentation of clinical varicella cases for all participants. \nAdditionally, at nine of the ten sites, full source data \nverification for 20% of participants was done; at one of the \nten sites, full source data verification was not done because \nthe site had already been closed. All ICFs for this site were \nchecked and deemed valid. The re-monitoring effort at the \nnine sites that were still open showed that the ICFs for all \nparticipants were valid and that all participants met the \nrequired eligibility criteria. Full source data verification of \nthe sample of 20% of participants was deemed acceptable. \nHowever, it was identified that some serious adverse \nevents were not reported within 24 h after notification to \nthe investigator, as stipulated in the protocol. The issue of \nlate reporting of serious adverse events is covered below. \nAdditionally, for one site, most suspected clinical varicella \ncases (15 of 21) had no photograph associated with the case \nas stipulated in the protocol. Although this restricted the \ninformation \navailable \nto \nthe \nstudy\u2019s \nadjudication \ncommittee tasked with reviewing clinical information, \nincluding photographs, to confirm suspected cases of \nvaricella, most of those cases (ten of 15) had a skin lesion \nsample available for confirmation by polymerase chain \nreaction (PCR). Sites were re-trained on the need to report \nserious adverse events in a timely fashion and the need to \nphotograph skin lesions when children presented with \nsuspected cases of varicella. The Sponsor has informed the \nRegulatory Authority and Ethics Committee of these issues \nregarding monitoring oversight of the study at these ten \nsites and has also submitted the results of site re-\nmonitoring to the Regulatory Authorities and Ethics \nCommittee.\nThe Sponsor requires that investigators report serious \nadverse events to the company within 24 h of their \nnotification.", "mimetype": "text/plain", "start_char_idx": 28131, "end_char_idx": 30354, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "059691ec-b286-408d-8399-91cc26358c6e": {"__data__": {"id_": "059691ec-b286-408d-8399-91cc26358c6e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fdf2b368-df0b-4e91-8b67-327fc75872bb", "node_type": "1", "metadata": {}, "hash": "4ce593d54a648121a7780823f1248ea4f0f101ab677e825c2f32801501f9ccf2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "54bf8267-ffd9-47de-84ae-39044aba0549", "node_type": "1", "metadata": {}, "hash": "adb310735b172e3ed26ea3f6dbab4486067a0b7fa33ecc5c536d778454c80589", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The Sponsor requires that investigators report serious \nadverse events to the company within 24 h of their \nnotification. During this investigation, three sites in \nPoland were identified as having failed to report serious \nadverse events within the required 24 h period. Five \nserious adverse events in three participants occurred \nbefore the end of enrolment and were reported more \nthan 24 h after the investigator was notified: otitis media \nand gastroenteritis (reported 10 months after investigator \nnotification), and gastroenterocolitis, rhinopharyngitis, \nand laryngitis (reported within 3\u201312 days of notification). \nThe investigators did not deem any of these events to be \nrelated to the study vaccines. The Sponsor believes that \nmore timely reporting of these common paediatric \ninfections, which are not deemed to be new safety signals \nfor the vaccines administered in the trial, would not have \naffected the informed consent information. Therefore \nthe delayed reporting would not have affected a parent\u2019s \nwillingness to enrol a child in the study. The Sponsor has \nre-trained investigators on the timely reporting of serious \nadverse events.\nStudy participants were given gifts at visits that occurred \nafter the end of the vaccination phase of the study starting \nat visit 3 (day 84). These gifts included one of the following \nat each visit: a skipping rope, a ball, a children\u2019s \nencyclopaedia, bubble bath and sponge, a puzzle, a game, \nor a book. Each study participant received a total of five \ngifts. Study ICFs included information about these gifts, \nand these documents were approved by the Ethics \nCommittee and Regulatory Authority. This practice was \nperceived as possibly in conflict with local laws in Poland \nwhich forbids financial inducements in clinical trials. \nFurthermore, while internal Sponsor policies at the start \nof the study did not preclude the distribution of such \nnominal gifts, policies that took effect during the course \nof the study prohibit gift giving to clinical trial participants. \nThe practice of gift giving was halted in the context of the \ngood clinical practice compliance issues that were \ndetected during the investigation. By the end of 2013, the \nparents of study participants were notified that children \nwould no longer receive gifts at subsequent study visits.", "mimetype": "text/plain", "start_char_idx": 30233, "end_char_idx": 32565, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "54bf8267-ffd9-47de-84ae-39044aba0549": {"__data__": {"id_": "54bf8267-ffd9-47de-84ae-39044aba0549", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "059691ec-b286-408d-8399-91cc26358c6e", "node_type": "1", "metadata": {}, "hash": "c1e0b968ea82b18be5e22259fe4df58a6a0c2b75894abac0c551a827ec189725", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5198105c-23a3-4b92-b585-bd167ed1e39e", "node_type": "1", "metadata": {}, "hash": "9d465329bc083f5a923bea5824e10d4593ab853f896ec8b0838b6af8bf600c66", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "By the end of 2013, the \nparents of study participants were notified that children \nwould no longer receive gifts at subsequent study visits. \nIn view of the low value of the items provided, the \nSponsor does not believe that the items are likely to have \nresulted in inappropriate inducement. The practice and \nits suspension have been reported to the relevant Ethics \nCommittee and Regulatory Authority.\nIn Poland, annual progress reports were not routinely \ngenerated by local representatives of the Sponsor and \ntherefore were not submitted to the Ethics Committee or \nRegulatory Authority throughout the duration of the \nstudy as required by International Conference on \nHarmonisation good clinical practice 8.3.19.\nThe Sponsor informed the Ethics Committee and \nRegulatory Authority in Poland of this issue on Nov 12, \nn/N\nTotal time \nto event \n(years)\nAttack rate \n(97\u00b75% CI) per \n100 person years\nVaccine efficacy \n(97\u00b75% CI)\np value\nH0\nMMRV\nAll\n37/2279\n6690\n0\u00b76 (0\u00b74\u20130\u00b78)\n94\u00b79 (92\u00b74\u201396\u00b76)\n<0\u00b70001\nVacccine \nefficacy <60%\nModerate \nto severe\n2/2279\n6740\n0\u00b70 (0\u00b70\u20130\u00b71)\n99\u00b75 (97\u00b75\u201399\u00b79)\n<0\u00b70001\nVacccine \nefficacy <80%\nMMR+V\nAll\n243/2263\n6455\n3\u00b78 (3\u00b73\u20134\u00b73)\n65\u00b74 (57\u00b72\u201372\u00b71)\n0\u00b71265\nVacccine \nefficacy <60%\nModerate \nto severe\n37/2263\n6698\n0\u00b76 (0\u00b74\u20130\u00b78)\n90\u00b77 (85\u00b79\u201393\u00b79)\n\u00b7\u00b7\nVacccine \nefficacy <70%\nMMR\nAll\n201/743\n1934\n10\u00b74 (9\u00b71\u201311\u00b79)\n\u00b7\u00b7\n\u00b7\u00b7\n\u00b7\u00b7\nModerate \nto severe\n117/743\n2047\n5\u00b77 (4\u00b78\u20136\u00b79)\n\u00b7\u00b7\n\u00b7\u00b7\n\u00b7\u00b7\nThe time to event was the time from 42 days after dose two to the time of the event\u2019s first occurrence.", "mimetype": "text/plain", "start_char_idx": 32424, "end_char_idx": 33931, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5198105c-23a3-4b92-b585-bd167ed1e39e": {"__data__": {"id_": "5198105c-23a3-4b92-b585-bd167ed1e39e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "54bf8267-ffd9-47de-84ae-39044aba0549", "node_type": "1", "metadata": {}, "hash": "adb310735b172e3ed26ea3f6dbab4486067a0b7fa33ecc5c536d778454c80589", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "163bb8b0-fa69-4fff-ad6c-6ac1f81f1dc9", "node_type": "1", "metadata": {}, "hash": "acb171f8525faeb522f20edf6fd9b04a63cff24453f0490787fe73e35574284a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In the two \nvaccine efficacy calculations, the event was either any (all) varicella grades or only moderate to severe varicella, \nrespectively. When there was no varicella event, time to event was censored at the end of the first phase of the trial \n(June 29, 2009) or at the last visit (if the participant withdrew). The date of the varicella case was the date of (in order of \npreference for available data) rash onset (the appearance of the first lesion), telephone contact to the investigator, or \ninvestigator\u2019s ascertainment visit. Testing the null hypothesis (H0) for vaccine efficacy against moderate to severe \ndisease (secondary objective) was conditional on the rejection of the null hypothesis (H0) for vaccine efficacy against all \ndisease (primary objective). Therefore the p value is not shown for MMR+V efficacy against moderate to severe disease. \nMMRV=measles-mumps-rubella-varicella combined vaccine. MMR+V=measles-mumps-rubella combined vaccine plus \nmonovalent varicella vaccine. MMR=measles-mumps-rubella combined vaccine only.\nTable 2: Vaccine efficacy against varicella in the per-protocol efficacy cohort\nArticles\nwww.thelancet.com   Vol 383   April 12, 2014\t\n1319\n2012. Thereafter, the annual progress reports for the \nmost recent years were submitted on Feb 4, 2013. It \nshould be noted that while annual progress reports were \nnot submitted, annual safety reports had been provided \nand submitted to the Ethics Committee and Regulatory \nAuthority throughout the study. The Sponsor has \nimplemented corrective actions to ensure timely \nsubmission of annual progress reports to the appropriate \nRegulatory Authority and Ethics Committee.\nRole of the funding source\nThe trial was sponsored and designed by GSK but \namended with input from an IDMC consisting of \nrelevant experts. Investigators generated and reported \nthe data for analysis by GSK statisticians according to a \nprespecified analysis plan. All authors had complete \naccess to the analysed data (without compromising \nthe trial blinding), participated in the drafting and \nreviewing of the report, and vouch for the accuracy and \ncompleteness of this report.", "mimetype": "text/plain", "start_char_idx": 33932, "end_char_idx": 36079, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "163bb8b0-fa69-4fff-ad6c-6ac1f81f1dc9": {"__data__": {"id_": "163bb8b0-fa69-4fff-ad6c-6ac1f81f1dc9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5198105c-23a3-4b92-b585-bd167ed1e39e", "node_type": "1", "metadata": {}, "hash": "9d465329bc083f5a923bea5824e10d4593ab853f896ec8b0838b6af8bf600c66", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fe9a13ee-c36e-4b5d-b452-aa430ad1cc4e", "node_type": "1", "metadata": {}, "hash": "528922ed1ef93e6c57f1c663a16ba5c421cfa5342f73fa31dbb16102c8be682c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All authors had complete \naccess to the analysed data (without compromising \nthe trial blinding), participated in the drafting and \nreviewing of the report, and vouch for the accuracy and \ncompleteness of this report. RP, SE, VU, LG, JW, ON, \nand PW had final responsibility for the decision to \nsubmit for publication. GSK covered the costs associated \nwith the development and publishing of the manuscript, \nincluding writing assistance.\nResults\nBetween Sept 1, 2005, and May 10, 2006, 5803 partici\u00ad\npants were enrolled (figure 2). Most (56\u00b74%) of the \n5285 participants in the efficacy cohort were from the \nCzech Republic, Poland, and Russia (table 1). The overall \nmean age was 14\u00b72 months (range 11\u201322 months) at the \ntime of enrolment. 98\u00b72% were white with a male to \nfemale ratio of 1\u00b70 to 0\u00b79. The three treatment groups \nwere much the same in terms of age, race, and sex, and \nof the proportion of children with different levels of \ncontact based on care type.\nIn the per-protocol efficacy cohort (5285 children), the \nmean duration of follow-up in the MMRV group was \n36 months (SD 8\u00b78), in the MMR+V group was \n36 months (8\u00b75) and in the MMR group was 35 months \n(8\u00b79). The percentage of participants with a reported \ncontact with varicella or zoster disease, or both, was \nFigure 3: Varicella case grading and seasonal rates of infection in the \nper-protocol cohort for efficacy\n(A) Varicella case rate (per 100 person years) for each treatment group for the \nmonths starting January, 2006, and ending June, 2009. (B) Mean severity scores \nfor each treatment group during blocks of 6 months over course of study. Error \nbars are SD. (C) Overall grading for varicella with respect to the percentage of \nconfirmed cases within a treatment group, and the grading within some of the \ncategories.", "mimetype": "text/plain", "start_char_idx": 35862, "end_char_idx": 37667, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fe9a13ee-c36e-4b5d-b452-aa430ad1cc4e": {"__data__": {"id_": "fe9a13ee-c36e-4b5d-b452-aa430ad1cc4e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "163bb8b0-fa69-4fff-ad6c-6ac1f81f1dc9", "node_type": "1", "metadata": {}, "hash": "acb171f8525faeb522f20edf6fd9b04a63cff24453f0490787fe73e35574284a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "67fc1903-5ea5-4253-9296-49cdc05fe8d3", "node_type": "1", "metadata": {}, "hash": "6b2f6488cdd4f7bae0c483123ba8f8843741fd74812bdfad37e73d1d49441bc4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Error \nbars are SD. (C) Overall grading for varicella with respect to the percentage of \nconfirmed cases within a treatment group, and the grading within some of the \ncategories. An overall score was determined from the following illness attributes \n(individual scores given in parentheses): rash, number of lesions, 1\u20135 (1), \n51\u2013100 (2), 101\u2013500 (4), and >500 (8); the character of most lesions, macular \n(2), papular (2), vesicular (4), and haemorrhagic (10); fever, 38\u00b78\u00b0C\u201339\u00b79\u00b0C (1), \nand \u226540\u00b0C (3); interstitial pneumonia (10); encephalitis (10); and a subjective \nassessment by the investigator, participant does not seem ill (0), participant \nseems moderately ill (2), and participant seems severely ill (5). Disease gradings \nwere: mild disease, \u22647 points; moderately severe disease, 8\u201315 points; and severe \ndisease, \u226516 points. Graph bars within a treatment group from right to left and \nwith progressively more shading follow increases in grading. Error bars are \n95% CI. Note, all values and assessments refer to the first-varicella case only, \nbecause three participants (all in the MMR+V group) had second cases of \nvaricella. MMRV=measles-mumps-rubella-varicella combined vaccine. \nMMR+V=measles-mumps-rubella combined vaccine plus monovalent varicella \nvaccine. MMR=measles-mumps-rubella combined vaccine only.", "mimetype": "text/plain", "start_char_idx": 37489, "end_char_idx": 38815, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "67fc1903-5ea5-4253-9296-49cdc05fe8d3": {"__data__": {"id_": "67fc1903-5ea5-4253-9296-49cdc05fe8d3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fe9a13ee-c36e-4b5d-b452-aa430ad1cc4e", "node_type": "1", "metadata": {}, "hash": "528922ed1ef93e6c57f1c663a16ba5c421cfa5342f73fa31dbb16102c8be682c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "62760ccb-8578-4851-b3c1-4cb49b0d2b80", "node_type": "1", "metadata": {}, "hash": "f304bf629e0253493c88ba03d74431724a985030899cce19f1fdd24aa48ee4b0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MMR+V=measles-mumps-rubella combined vaccine plus monovalent varicella \nvaccine. MMR=measles-mumps-rubella combined vaccine only.\n0\n20\n40\n60\n80\n100\nCases (%)\nOverall grade\nC\nA\nB\nFever\nMMRV\nMMR+V\nMMR\nInvestigator assessment\n0\n20\n40\n60\n80\n100\nCases (%)\n0\n20\n40\n60\n80\n100\nCases (%)\nNumber of lesions\nPredominant type of lesion\nMMRV\nMMR+V\nMMR\nDuration\n1\u201350\n51\u2013100\n100\u2013500\n>500\nMild\nModerate \nto severe\nSevere\nMacul\nPapul\nVesic\nHemor\nNone\n38\u00b78\u201339\u00b79\u00baC\n\u226540\u00baC\n1\u20135 days\n6\u201310 days\n11\u201315 days\n>15 days\nNot ill\nModerately ill\nSeverely ill\n1 (January) 12\n24\n36\n42\n0\n10\n20\n30\nVaricella cases per 100 person-years\nMonth\nMMR\nMMR+V\nMMRV\n0\u20136\n6\u201312\n12\u201318\n18\u201324\n24\u201330\n30\u201336\n>36\n0\n2\n4\n6\n8\n10\n12\n14\nSeverity scores (SD)\nPeriod (months)\nMMRV\nMMR+V\nMMR\nArticles\n1320\t\nwww.thelancet.com   Vol 383   April 12, 2014\n19\u00b74% (144 of 743) in the MMR group, 20\u00b79% (474 of \n2263) in the MMR+V group, and 23\u00b71% (527 of 2279) in \nthe MMRV group. In the MMR (control) group, \n201 participants had varicella cases, giving an incidence \nof 10\u00b74 per 100 person years (table 2); of these, more than \nhalf were graded as moderately severe or severe.", "mimetype": "text/plain", "start_char_idx": 38686, "end_char_idx": 39793, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "62760ccb-8578-4851-b3c1-4cb49b0d2b80": {"__data__": {"id_": "62760ccb-8578-4851-b3c1-4cb49b0d2b80", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "67fc1903-5ea5-4253-9296-49cdc05fe8d3", "node_type": "1", "metadata": {}, "hash": "6b2f6488cdd4f7bae0c483123ba8f8843741fd74812bdfad37e73d1d49441bc4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "58f04a92-1494-44ac-a8e1-f85c8a027577", "node_type": "1", "metadata": {}, "hash": "658c82d45b7cd4d5964cd3e4f36101f17231ff4722ddcf487c48c53c4b89a702", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In the \nMMR+V group (one-dose live varicella vaccine), \n243 participants had varicella cases, giving an incidence \nof 3\u00b78 per 100 person years. In the MMRV group (two-\ndose live varicella vaccine), 37 participants had vari\u00adcella \ncases, giving an incidence of 0\u00b76 per 100 person years. \nNotably, most live varicella vaccine recipients had first \ncases that were mild (MMR+V group, 207 of 243; MMRV \ngroup, 35 of 37) compared with the MMR control group \n(84 of 201). Three participants had second cases of \nvaricella (all in the MMR+V group). For one participant, \nthe first case was mild and the second case was moderate. \nFor the two other participants, all the cases were mild. \nThe mean varicella severity grades of all cases were 5\u00b75 \n(SD 2\u00b71) in the MMR+V group and 4\u00b78 (1\u00b75) in the \nMMRV group, and were also indicative of mild disease, \nby contrast with 8\u00b71 (2\u00b79) in MMR control group, \nindicative of moderately severe disease. Efficacy of two-\ndose vaccination against all varicella was 94\u00b79% and \nagainst moderate to severe varicella was 99\u00b75%. For one-\ndose, efficacy was 65\u00b74% against all varicella and 90\u00b77% \nagainst moderate to severe disease (table 2). Hence, risk \nof breakthrough varicella was 6\u00b79 times (95% CI 4\u00b79\u20139\u00b78) \nless likely with two doses of live varicella vaccine (MMRV \ngroup) than with one dose (MMR+V group). We \nidentified no evidence that vaccine efficacy estimates \nwere different in the individual par\u00adticipating countries \nfrom the overall estimates (appen\u00addix p 5). Two doses of \nlive varicella vac\u00adcine also seemed to substantially reduce \nthe \nseasonal \nfluctuations \nin \nvaricella \nincidence \n(figure 3A).", "mimetype": "text/plain", "start_char_idx": 39794, "end_char_idx": 41438, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "58f04a92-1494-44ac-a8e1-f85c8a027577": {"__data__": {"id_": "58f04a92-1494-44ac-a8e1-f85c8a027577", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "62760ccb-8578-4851-b3c1-4cb49b0d2b80", "node_type": "1", "metadata": {}, "hash": "f304bf629e0253493c88ba03d74431724a985030899cce19f1fdd24aa48ee4b0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a24958b9-8ead-4430-b21d-3de059e33ebd", "node_type": "1", "metadata": {}, "hash": "66ed7a5abe6a018c811fd32e3dd2ba1903e675f33678034c32c49f70de8f1cce", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Two doses of \nlive varicella vac\u00adcine also seemed to substantially reduce \nthe \nseasonal \nfluctuations \nin \nvaricella \nincidence \n(figure 3A). For one or two doses of live varicella vaccine, \nwe noted no evidence that the respective degrees of \nprotection against varicella changed during the follow-up \nperiod (appendix p 6). Moreover, we recorded no obvious \nincrease in mean severity scores in either of the live \nvaricella vaccine groups compared with the MMR group \n(figure 3B).\nThe difference in disease severity grading was apparent \nin many of the contributing grading categories, including \nfever, number and predominant type of lesions, and the \ninvestigator\u2019s assessment (figure 3C). Moreover, many \nvaricella cases (16 of 37, 43\u00b72%) in the MMRV group were \nconfirmed by epidemiological link, by contrast with only \n9\u00b75% (23 of 243) of (first) cases in the MMR+V group and \n6\u00b75% (13 of 201) of cases in the MMR group. Confirmation \nby epidemiological link, in addition to direct VZV-DNA \ndetection, was used to increase sensitivity of case finding, \nespecially in mild breakthrough cases in which lesions \nwould be more difficult to sample and in which viral DNA \nmight be reduced in quantity or cleared more rapidly. \nNotably, for 15 of 16 cases in the MMRV group and 12 of \n23 cases in MMR+V group confirmed by epidemiological \nlink, no VZV-DNA was detected in lesion samples, whereas \nno VZV-DNA was detected for only two of 13 cases from \nthe MMR group (although sample quality was adequate \nbecause \u03b2-globin DNA was detected). Besides the 29 VZV-\nDNA negative cases con\u00adfirmed by epidemiological link, we \nrecorded 20 cases without a sample (one MMRV; nine \nMMR+V; ten MMR) and three cases with inadequate \nsample quality (two MMR+V; one MMR).", "mimetype": "text/plain", "start_char_idx": 41296, "end_char_idx": 43055, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a24958b9-8ead-4430-b21d-3de059e33ebd": {"__data__": {"id_": "a24958b9-8ead-4430-b21d-3de059e33ebd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "58f04a92-1494-44ac-a8e1-f85c8a027577", "node_type": "1", "metadata": {}, "hash": "658c82d45b7cd4d5964cd3e4f36101f17231ff4722ddcf487c48c53c4b89a702", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c4ae90ec-6d86-4400-bc3a-fb1ec1003238", "node_type": "1", "metadata": {}, "hash": "cde1f28b45b6b7bebb0d73ddcdac11696123d499528c10ec0311758746b58a47", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Anti-VZV responses 42 days after one or two doses \nof live varicella vaccines were broadly distributed, yet \nseemed to be different, suggested by the rightward \nincremental shifts in the reverse cummulative curves in \naccordance with the number of live varicella-vaccine \ndoses (figure 4A). Distribution of anti-VZV responses, \nand seroresponse rates and GMCs, seemed to be much \nthe same after one dose of MMRV or monovalent \nvaricella vaccines (figure 4). Moreover, 42 days after dose \nFigure 4: Anti-VZV antibody responses to vaccination\n(A) Reverse cumulative curves describing the percentage of particpants with \nrespect to anti-VZV antibody concentrations, 42 days after dose 2 (day 84) in the \nMMR and MMR+V groups and after dose 1 and dose 2 in the MMRV group. Vertical \ndashed line shows the seroresponse cutoff of 50 mIU/mL. (B) Percentage of \nparticpants with seroresponses to vaccination (vertical bars, left axes) and \ngeometric mean concentrations (GMCs; symbols, right axes) in the three \ntreatment groups at day 42, day 84, year 1 and year 2. Error bars are 95% CI and for \nGMCs are masked by the size of the symbols. Data at day 42 come from the subset \nof the per-protocol cohort for immunogenicity. Data at day 84, year 1, and year 2 \ncome from the entire per-protocol cohort for immunogenicity. VZV=varicella \nzoster virus. MMRV=measles-mumps-rubella-varicella combined vaccine. \nMMR+V=measles-mumps-rubella combined vaccine plus monovalent varicella \nvaccine. MMR=measles-mumps-rubella combined vaccine only. D=day. Y=year.", "mimetype": "text/plain", "start_char_idx": 43056, "end_char_idx": 44600, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c4ae90ec-6d86-4400-bc3a-fb1ec1003238": {"__data__": {"id_": "c4ae90ec-6d86-4400-bc3a-fb1ec1003238", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a24958b9-8ead-4430-b21d-3de059e33ebd", "node_type": "1", "metadata": {}, "hash": "66ed7a5abe6a018c811fd32e3dd2ba1903e675f33678034c32c49f70de8f1cce", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ffc2c2b5-ba57-4d3d-9f09-57fbe2d03823", "node_type": "1", "metadata": {}, "hash": "7dc850861ed02cc2bca7d8047b11bb3089c2da98e6838152bb4fff98f21c9a0b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MMR=measles-mumps-rubella combined vaccine only. D=day. Y=year.\n10\n100\n1000\n10 000\n0\n20\n40\n60\n80\n100\nA\nB\nParticipants (%)\nAnti-VZV antibody (mIU/mL)\nMMR\nMMR+V\nMMRV D1\nMMRV D2\nD42\nD84\nY1\nY2\n0\n20\n10\n100\n1000\n10 000\n40\n60\n80\n100\nParticipants with seroresponse (%)\nGMC mIU/mL\nTime\nMMRV\nMMR+V\nMMR\nArticles\nwww.thelancet.com   Vol 383   April 12, 2014\t\n1321\ntwo of MMRV, the anti-VZV antibody GMC was about \n18 times higher (1839 vs 97 mIU/mL) and the sero\u00ad\nresponse rate was higher (99\u00b76% vs 79\u00b72%) than 42 days \nafter dose one (see figure 4B). Although reduced at \n2 years, the apparent improved immunogenicity of two \nlive varicella-vaccine doses compared with one dose \npersisted, such that the occurrence of seroresponse for \ntwo doses versus one dose was 96\u00b71% (95% CI 95\u00b71\u201396\u00b79) \nversus 78\u00b72% (76\u00b72\u201380\u00b70) and the anti-VZV antibody \nGMCs were 414 mIU/mL (95% CI 392\u2013438) versus \n169 mIU/mL (157\u2013182). After 2 years, the percentage of \nseropositive participants in the control group (who were \nseronegative before vaccination) was 26\u00b76% (95% CI \n23\u00b72\u201330\u00b72).\nRedness was the most frequently reported solicited \ninjection-site symptom in each group and after each dose \n(table 3). After dose two, 24\u00b78% of participants who \nreceived MMRV reported redness by contrast with 13\u00b77% \nof those who received monovalent varicella vac\u00adcine and \n9\u00b73% of those who received MMR.", "mimetype": "text/plain", "start_char_idx": 44537, "end_char_idx": 45901, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ffc2c2b5-ba57-4d3d-9f09-57fbe2d03823": {"__data__": {"id_": "ffc2c2b5-ba57-4d3d-9f09-57fbe2d03823", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c4ae90ec-6d86-4400-bc3a-fb1ec1003238", "node_type": "1", "metadata": {}, "hash": "cde1f28b45b6b7bebb0d73ddcdac11696123d499528c10ec0311758746b58a47", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "85ea9e8d-9d21-42d6-b570-5454e89e91d5", "node_type": "1", "metadata": {}, "hash": "b39df352c838896c7946300391ff2db1aca64e58a0612d543a52b4b4360971c0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Percentages of \nparticipants reporting fever (\u226538\u00b0C) in all groups peaked \nat day 9 after dose one; 31% (248 of 807) after receiving \nMMRV and 23% (184 of 812) and 17% (45 of 268) and \nafter receiving MMR in the other two groups (appendix \np 7). During the 15 day period after dose one, fever was \nreported by 57\u00b74% of participants after MMRV, by \ncontrast with 44\u00b75% and 39\u00b78% after MMR (table 3). \nGrade 3 fever was reported by 12\u00b79% of participants after \nMMRV, by contrast with 6\u00b73% and 7\u00b73% after MMR. \nDuring 15 days after dose two, fever was reported by \n24\u00b79% (MMRV), 26\u00b70% (movovalent varicella vaccine), \nand 22\u00b73% (MMR) of participants. The percentage of \nparticipants reporting at least one unsolicited symptom \nafter the first or second dose ranged between 31 and 37% \nacross the three groups. The nature of these unsolicited \nsymptoms seemed much the same in each group (data \nnot shown).\nThe occurrence of serious adverse events was 17\u00b79% \n(148 of 827) in the MMR group, 19\u00b73% (481 of 2487) in the \nMMR+V, and 19\u00b70% (474 of 2489) in the MMRV group. \nOccurrence of serious adverse events attributed a causal \nlink to vaccination were 0\u00b71% in the MMR (one of 827), \n0\u00b72% (four of 2487), and 0\u00b71% (three of 2489) in the \nMMRV group. All these serious adverse events were \nreported as recovered or resolved (table 4). 13 febrile \nseizures were reported as serious adverse events up to \nday 84 in the total vaccination cohort. Four were \nattributed as having a causal link to vaccination, and \noccurred 8\u20139 days after dose one; three were reported \nafter MMRV and one was reported after MMR (table 4).", "mimetype": "text/plain", "start_char_idx": 45902, "end_char_idx": 47513, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "85ea9e8d-9d21-42d6-b570-5454e89e91d5": {"__data__": {"id_": "85ea9e8d-9d21-42d6-b570-5454e89e91d5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ffc2c2b5-ba57-4d3d-9f09-57fbe2d03823", "node_type": "1", "metadata": {}, "hash": "7dc850861ed02cc2bca7d8047b11bb3089c2da98e6838152bb4fff98f21c9a0b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ba12e42b-d335-4b8b-abd2-e65348210076", "node_type": "1", "metadata": {}, "hash": "9b1a058587186bd6a65eb20efaa2a276cd5bc9f1a2067f934fd6d1c0fdcfbc41", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Four were \nattributed as having a causal link to vaccination, and \noccurred 8\u20139 days after dose one; three were reported \nafter MMRV and one was reported after MMR (table 4). \nThese 13 febrile seizures included two that were solicited \nN \n(local)\nN \n(fever)\nParticipants (% [exact 95% CI])\nAll grades\nGrade 3\nRedness (day 0\u20133)\nPain (day 0\u20133)\nSwelling (day 0\u20133)\nFever (day 0\u201314)\nRedness (day 0\u20133)\nPain (day 0\u20133)\nSwelling (day 0\u20133)\nFever (day 0\u201314)\nDose 1\nMMRV\n782\n784\n17\u00b75% (14\u00b79\u201320\u00b74)\n9\u00b75% (7\u00b75\u201311\u00b77)\n4\u00b79% (3\u00b75\u20136\u00b76)\n57\u00b74% (53\u00b79\u201360\u00b79)\n0\u00b74% (0\u00b71\u20131\u00b71)\n0\u00b71% (0\u00b70\u20130\u00b77)\n0\u00b74% (0\u00b71\u20131\u00b71)\n12\u00b79% (10\u00b76\u201315\u00b74)\nMMR+V*\n796\n795\n19\u00b73% (16\u00b77\u201322\u00b73)\n10\u00b74% (8\u00b74\u201312\u00b78)\n4\u00b76% (3\u00b73\u20136\u00b74)\n44\u00b75% (41\u00b70\u201348\u00b71)\n0\u00b74% (0\u00b71\u20131\u00b71)\n0\u00b73% (0\u00b70\u20130\u00b79)\n0\u00b70% (0\u00b70\u20130\u00b75)\n7\u00b73% (5\u00b76\u20139\u00b73)\nMMR\n256\n256\n14\u00b71% (10\u00b70\u201318\u00b79)\n7\u00b78% (4\u00b78\u201311\u00b78)\n2\u00b73% (0\u00b79\u20135\u00b70)\n39\u00b78% (33\u00b78\u201346\u00b71)\n0\u00b70% (0\u00b70\u20131\u00b74)\n0\u00b70% (0\u00b70\u20131\u00b74)\n0\u00b70% (0\u00b70\u20131\u00b74)\n6\u00b73% (3\u00b76\u201310.", "mimetype": "text/plain", "start_char_idx": 47339, "end_char_idx": 48216, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ba12e42b-d335-4b8b-abd2-e65348210076": {"__data__": {"id_": "ba12e42b-d335-4b8b-abd2-e65348210076", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "85ea9e8d-9d21-42d6-b570-5454e89e91d5", "node_type": "1", "metadata": {}, "hash": "b39df352c838896c7946300391ff2db1aca64e58a0612d543a52b4b4360971c0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1b5bafec-d74b-49ff-93d9-029beea4d359", "node_type": "1", "metadata": {}, "hash": "337d22a8b1253e0442beb4e9f0f0cc2815904993375b9e9eb85600376cd18863", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "0)\nDose 2\nMMRV\n758\n758\n24\u00b78% (21\u00b78\u201328.0)\n12\u00b70% (9\u00b78\u201314\u00b75)\n9\u00b75% (7\u00b75\u201311\u00b78)\n24\u00b79% (21\u00b79\u201328\u00b72)\n3\u00b74% (2\u00b73\u20135\u00b70)\n0\u00b70% (0\u00b70\u20130\u00b75)\n0\u00b75% (0\u00b71\u20131\u00b73)\n3\u00b77% (2\u00b75\u20135\u00b73)\nMMR+V*\n774\n773\n13\u00b77% (11\u00b74\u201316\u00b73)\n8\u00b71% (6\u00b73\u201310\u00b73)\n4\u00b70% (2\u00b77\u20135\u00b76)\n26\u00b70% (22\u00b79\u201329\u00b72)\n0\u00b74% (0\u00b71\u20131\u00b71)\n0\u00b71% (0\u00b70\u20130\u00b77)\n0\u00b70% (0\u00b70\u20130\u00b75)\n4\u00b75% (3\u00b72\u20136\u00b72)\nMMR\n247\n247\n9\u00b73% (6\u00b70\u201313\u00b76)\n6\u00b75% (3\u00b77\u201310\u00b73)\n1\u00b72% (0\u00b73\u20133\u00b75)\n22\u00b73% (17\u00b72\u201328\u00b70)\n0\u00b70% (0\u00b70\u20131\u00b75)\n0\u00b74% (0\u00b70\u20132\u00b72)\n0\u00b70% (0\u00b70\u20131\u00b75)\n5\u00b77% (3\u00b71\u20139\u00b73)\nReactogenicity subset (N) consists of participants with at least one documented dose. Redness (up to 25% of participants in any group) was the most common solicited injection-site symptom in all three \ngroups and after both doses. Occurrence of redness and swelling only increased after the second dose in the MMRV group. MMRV=measles-mumps-rubella-varicella combined vaccine. \nMMR+V=measles-mumps-rubella combined vaccine plus monovalent varicella vaccine. MMR=measles-mumps-rubella combined vaccine only.", "mimetype": "text/plain", "start_char_idx": 48216, "end_char_idx": 49153, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1b5bafec-d74b-49ff-93d9-029beea4d359": {"__data__": {"id_": "1b5bafec-d74b-49ff-93d9-029beea4d359", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ba12e42b-d335-4b8b-abd2-e65348210076", "node_type": "1", "metadata": {}, "hash": "9b1a058587186bd6a65eb20efaa2a276cd5bc9f1a2067f934fd6d1c0fdcfbc41", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bedbdc48-a4e1-4fbd-9a8a-5bc47cccff55", "node_type": "1", "metadata": {}, "hash": "1338e7a49eca154db2e00614407ba932f14f6be2d8dc222fe3fd6ace9d596924", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MMR+V=measles-mumps-rubella combined vaccine plus monovalent varicella vaccine. MMR=measles-mumps-rubella combined vaccine only. *In the MMR+V group, reactions after dose 1 were to MMR and \nreactions after dose two were to V.\nTable 3: Participants reporting solicited injection-site (local) symptoms up to 4 days after each dose and of fever up to 15 days after each dose in the reactogenicity subset\nMedDRA system organ \nclass21\nAge \n(months)\nSex\nDose\nOnset \n(days \nafter \ndose)\nDuration \n(days)\nIntensity \n(grade)\nMMRV\nFebrile convulsion\nNervous system disorders\n14\nM\n1\n8\n1\n3\nFebrile convulsion\nNervous system disorders\n17\nF\n1\n9\n1\n3\nFebrile convulsion\nNervous system disorders\n13\nM\n1\n8\n1\n2\nMMR+V\nHerpes zoster*\nInfections and infestations\n17\nF\n1\n24\n36\n1\nRash papular\nSkin and subcutaneous \ntissue disorders\n15\nF\n1\n16\n10\n1\nBacterial infection\nInfections and infestations\n17\nF\n2\n3\n13\n2\nPeritonsillar abscess\nInfections and infestations\n18\nM\n2\n6\n21\n3\nMMR\nFebrile convulsion\nNervous system disorders\n15\nM\n1\n8\n1\n3\nSerious adverse events were recorded during the entire study period. MMRV=measles-mumps-rubella-varicella combined \nvaccine. MMR+V=measles-mumps-rubella combined vaccine plus monovalent varicella vaccine. MMR=measles-mumps-\nrubella combined vaccine only. *This case was considered by IDMC but was not confirmed as herpes zoster.", "mimetype": "text/plain", "start_char_idx": 49025, "end_char_idx": 50364, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bedbdc48-a4e1-4fbd-9a8a-5bc47cccff55": {"__data__": {"id_": "bedbdc48-a4e1-4fbd-9a8a-5bc47cccff55", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1b5bafec-d74b-49ff-93d9-029beea4d359", "node_type": "1", "metadata": {}, "hash": "337d22a8b1253e0442beb4e9f0f0cc2815904993375b9e9eb85600376cd18863", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "14135fa3-2c79-4606-aace-410478184e63", "node_type": "1", "metadata": {}, "hash": "690b86379ce668ca0d1509d1db3a3c9cac774d202d431b2e878ca4084ffad9e8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MMR=measles-mumps-\nrubella combined vaccine only. *This case was considered by IDMC but was not confirmed as herpes zoster.\nTable 4: Serious adverse events deemed by the investigator to be related to vaccination in the total \nvaccinated cohort\nArticles\n1322\t\nwww.thelancet.com   Vol 383   April 12, 2014\nfrom the reactogenicity subset; one from a participant \n9 days after the first dose of MMRV (and related to \nvaccination), and another from a par\u00adticipant 20 days after \nmonovalent varicella vaccine (at dose two and not related \nto vaccination).\nDiscussion\nIn this study of more than 5000 children, efficacy of two-\ndose MMRV against all varicella was almost 95%, and \nagainst moderate to severe varicella was more than 99%. \nThis protection was greater than for one-dose varicella \nvaccine, which had efficacy against all varicella of about \n65%, and against moderate to severe varicella of roughly \n91%. Redness was the most frequently reported solicited \ninjection-site symptom in each group and after each dose \n(up to 25% of participants). More participants in the \nMMRV group (about 57%) reported fever of 38\u00b0C or more \nwithin 15 days of dose one than in the other groups \n(40\u201345%). Occurrence of serious adverse events deemed \nrelated to vaccination was three in the MMRV group, four \nin the MMR+V group, and one in the MMR group.\nAs far as we are aware, this is the first study to assess \nvaccine efficacy of one and two doses of live varicella \nvaccines in comparison with a control vaccine, and in a \nuniform age cohort living in a setting of endemic VZV \ntransmission (panel).7 We used a randomised, observer-\nblind, parallel group design with active case ascertainment \nthat deemed even mild rash to be illnesses. These results \ndescribe the first 3 years of follow-up, but more data for \nlonger term protection are anticipated with the analysis of \n10 years of follow-up in the same study cohort.", "mimetype": "text/plain", "start_char_idx": 50241, "end_char_idx": 52154, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "14135fa3-2c79-4606-aace-410478184e63": {"__data__": {"id_": "14135fa3-2c79-4606-aace-410478184e63", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bedbdc48-a4e1-4fbd-9a8a-5bc47cccff55", "node_type": "1", "metadata": {}, "hash": "1338e7a49eca154db2e00614407ba932f14f6be2d8dc222fe3fd6ace9d596924", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c5cf9988-3284-4624-b8e4-4893ebbb1a35", "node_type": "1", "metadata": {}, "hash": "eb35303cdbc0ab6499e1dbe5ad40a811798a56133eb6ebb6d54bffac5e54ea34", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "These results \ndescribe the first 3 years of follow-up, but more data for \nlonger term protection are anticipated with the analysis of \n10 years of follow-up in the same study cohort.\nOne dose of live varicella vaccine was 90\u00b77% efficacious \nat prevention of moderate to severe disease but only \n65\u00b74% efficacious at prevention of all breakthrough \nvaricella. Most breakthrough varicella was mild in line \nwith other findings.3,14 Because mild breakthrough \ndisease is associated with less VZV transmission than \nmore severe disease,22 one dose of live varicella vaccine is \nlikely to reduce the risk of VZV transmission. It is also \nlikely to be effective in prevention of varicella compli\u00ad\ncations and many of the associated costs (eg, admissions \nto hospital),1,3 especially with a rapid implementation of \nuniversal vaccination, as noted in Uruguay.2 The 10 year \nanalysis of the MMR+V cohort might address whether a \none-dose schedule offers long-term protection or defers \nthe appearance of moderate or severe disease to a later \nage. In Uruguay, 8 years after implementation of uni\u00ad\nversal vaccination, rates of varicella-related admissions to \nhospital are estimated to have remained at about 90% \nlower than before implementation.2,23\nThe short two-dose schedule of live varicella vac\u00adcination \nwas 94\u00b79% efficacious at prevention of break\u00adthrough \nvaricella. This two-dose schedule is in line with recom\u00ad\nmendations for combining monovalent varicella vaccine \nwith MMR vaccination, with the first dose being admin\u00ad\nistered in the second year of life and with the second dose \nshortly after (at least one month).5,7 The short schedule \ncould also be implemented with MMR+V as first dose and \nMMRV as second dose to minimise the risk of febrile \nseizures.24 Administration of the second dose soon after \nthe first and before the child enters into day care or school \nshould also minimise the risk of breakthrough varicella.", "mimetype": "text/plain", "start_char_idx": 51971, "end_char_idx": 53902, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c5cf9988-3284-4624-b8e4-4893ebbb1a35": {"__data__": {"id_": "c5cf9988-3284-4624-b8e4-4893ebbb1a35", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "14135fa3-2c79-4606-aace-410478184e63", "node_type": "1", "metadata": {}, "hash": "690b86379ce668ca0d1509d1db3a3c9cac774d202d431b2e878ca4084ffad9e8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "14601df2-22dd-4e36-b4ca-b3e7b812d287", "node_type": "1", "metadata": {}, "hash": "ccc4d94675cbfb4368ec0614201a2136cde36a3f7b9bbf2b30eff99770eb0a94", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "By preventing even mild disease, two-dose live varicella \nvaccination is also likely to be better than one dose in \nfurther reducing the risk of VZV transmission.22\nWe identified no evidence that the protection afforded \nby one or two doses of live varicella vaccine was \ndiminished over 3 years in the face of highly endemic \ndisease. The relatively greater protection against even \nmild varicella afforded by the short two-dose (MMRV) \nschedule compared with the one-dose (monovalent \nvaricella vaccine) schedule was associated with an \nincreased anti-VZV GMC and seropositivity rate at all \ntimepoints after full vaccination, in line with earlier \nstudies.8,11,25\u201329 VZV exposure (including subclinical in\u00ad\nfections) after day 84 might have boosted the anti-VZV \nantibody responses at later timepoints, but this effect, if \nsubstantial, should have narrowed the difference between \nMMRV and MMR+V groups and that was not noted.\nReactogenicity and safety variables were in line with \nother studies,8,11,25\u201327,29\u201333 including the findings that in \nMMRV recipients com\u00adpared with MMR recipients, fever \nwithin 15 days after the first dose was more frequent, \nespecially at day 9; and injection-site redness within 4 days \nafter the second dose was more frequent.8,11,25,31,33 An \nincreased risk of febrile seizure 7\u201310 days after the first \ndose of MMRV (ProQuad, Merck & Co, Whitehouse \nStation, NJ, USA) has been reported elsewhere in an \nanalysis of vaccine surveillance data from 459\u2009000 infants.24 \nAlthough three of the four febrile seizures related to \nvaccination in our study were reported after the first dose \nof MMRV, a substantially larger study would be required to \nestablish whether the relative risk of febrile seizure differs \nPanel: Research in context\nSystematic review\nWe searched PubMed with the terms \u201cvaricella\u201d, \u201cvaccine\u201d, \u201cefficacy\u201d, and \u201ceffectiveness\u201d \nfor articles published in English up to June 12, 2012.", "mimetype": "text/plain", "start_char_idx": 53904, "end_char_idx": 55839, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "14601df2-22dd-4e36-b4ca-b3e7b812d287": {"__data__": {"id_": "14601df2-22dd-4e36-b4ca-b3e7b812d287", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c5cf9988-3284-4624-b8e4-4893ebbb1a35", "node_type": "1", "metadata": {}, "hash": "eb35303cdbc0ab6499e1dbe5ad40a811798a56133eb6ebb6d54bffac5e54ea34", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1e730da3-d39e-4ceb-b4a0-4ea134ea93f9", "node_type": "1", "metadata": {}, "hash": "3bcb8e3e74aa579c6c3880e89d7190c55f01b0f3e9cdd770affb138d2b270c3a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The relevance of papers was further \nconsidered (with the additional search term \u201cclinical trial\u201d) on the basis that they reported \na clinical efficacy or effectiveness trial of currently licensed live-attenuated varicella \nvaccines, or a meta-analysis or review of these trials.\nInterpretation\nAs far as we are aware, this study is the first randomised concurrently controlled trial in \nhealthy children aged 12\u201322 months, assessing the multiyear efficacy of a live varicella \nvaccine, formulated either as a monovalent vaccine or combined with MMR vaccine, on \nthe basis of active surveillance for rash illness of any intensity with rigorous case \nconfirmation. The results from this study confirm the highly efficacious protection \nafforded by two doses of MMRV given over 6 weeks against varicella of any intensity. They \nalso support the highly efficacious protection afforded by one dose of monovalent varicella \nvaccine against typical varicella disease (moderate to severe), although prevention of mild \nbreakthrough varicella was not as high as that afforded by two doses of MMRV.\nArticles\nwww.thelancet.com   Vol 383   April 12, 2014\t\n1323\nfrom that assessed for ProQuad. Overall, no new clinically \nimportant safety signals were identified and the results are \nsupportive of an acceptable safety profile of the MMRV, \nmonovalent varicella vaccine, and MMR schedules in \nhealthy children during their second year of life.\nThe strengths of this study compared with previous \nassessments of VZV vaccine efficacy were its use of a \nrandomised control group, active surveillance, and \nstringent procedures for case confirmation. All these \nmeasures were designed to achieve a robust estimate \nof vaccine efficacy, including against even mild break\u00ad\nthrough disease. Case confirmation by epidemiological \nlink afforded increased sensitivity for case detection in \nsituations where the VZV-PCR result was negative or \nunobtainable. The greater reliance on an epidemiological \nlink for confirming cases in the MMRV group most \nprobably resulted from the mildness of the disease.", "mimetype": "text/plain", "start_char_idx": 55840, "end_char_idx": 57921, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1e730da3-d39e-4ceb-b4a0-4ea134ea93f9": {"__data__": {"id_": "1e730da3-d39e-4ceb-b4a0-4ea134ea93f9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "14601df2-22dd-4e36-b4ca-b3e7b812d287", "node_type": "1", "metadata": {}, "hash": "ccc4d94675cbfb4368ec0614201a2136cde36a3f7b9bbf2b30eff99770eb0a94", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c175bca9-2774-4d34-b6d7-a8f751b822c2", "node_type": "1", "metadata": {}, "hash": "5fc481d7f00b36ba2f643d22aea1fd985f0bef7cf1f0e5762b4651fdf34d9ca4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The greater reliance on an epidemiological \nlink for confirming cases in the MMRV group most \nprobably resulted from the mildness of the disease. In \nmild disease, failure to detect VZV-DNA might have \nbeen attributable to its true absence, implying another \ncause, or to difficulties in sampling such as inadequate \nunroofing of the papule, or because of VZV being cleared \nbefore sampling. Some cases might have been falsely \nconfirmed by epidemiological link; if this occurred more \noften among varicella vaccine recipients than controls, \nthen vaccine efficacies could have been underestimated.\nThe one-dose efficacy of 65\u00b74% for monovalent varicella \nvaccine was less than the previous estimate of 88% \n(95% CI 72\u201396) for GSK\u2019s vaccine of similar potency.13 In \nthe previous study, done in Finland, case confirmation \nmight have been less rigorous and biased in favour of \ndetecting cases in the control group. Case confirmation re\u00ad\nquired a four-times difference between anti-VZV titres in \nacute and conva\u00adlescence samples, which might have been \nless likely with seropositive vaccine recipients than with \nseronegative control participants. Furthermore, case \nidentification through epidemiological link to index cases \nwas not considered. Moreover, the measures used in the \npresent study to avoid overestimation of vaccine efficacy \nmight explain differences in comparison with other \nprevious long-term studies done in the USA. In those \nstudies, one-dose vaccine efficacy was estimated in the \nrange of 88\u00b79%\u201394\u00b74%12,14,15 and two-dose vaccine efficacy \nwas estimated at 98\u00b73%14 (in children aged up to 612 or \n1214,15 years). These studies did not include control groups \nand parents were aware that their children were vaccinated \nagainst VZV: this knowledge might have biased parents \nagainst reporting rashes. Moreover, vaccine efficacies \nwere potentially overestimated because they were based \non historic attack rates from the pre-1995 universal live \nvaricella vaccination era in the USA,12,14,15 and yet the \nsurveillance periods extended well beyond 1995\u20132003.", "mimetype": "text/plain", "start_char_idx": 57776, "end_char_idx": 59858, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c175bca9-2774-4d34-b6d7-a8f751b822c2": {"__data__": {"id_": "c175bca9-2774-4d34-b6d7-a8f751b822c2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1e730da3-d39e-4ceb-b4a0-4ea134ea93f9", "node_type": "1", "metadata": {}, "hash": "3bcb8e3e74aa579c6c3880e89d7190c55f01b0f3e9cdd770affb138d2b270c3a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "83d0c219-5137-46df-8d9c-ed71f80f3968", "node_type": "1", "metadata": {}, "hash": "c2d47ffbf8de13fbbd10e9b753204a0f8b6147ea71211abcf36431dc08009dbf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Although vaccine effectiveness studies are not as \nrigorously controlled as efficacy studies and would not \nuse systematic procedures for case follow-up, the 65\u00b74% \nefficacy estimate of one-dose monovalent varicella vaccine \nis in line with the effectiveness estimate of 72% (95% CI \n68\u201376) from a meta-analysis of 14 studies of varicella \noutbreaks.34 However, this efficacy estimate seems lower \nthan the median effectiveness estimate of 84\u00b75% from \nnumerous effectiveness studies of mono\u00advalent varicella \nvaccine (Varivax) or MMRV (ProQuad) in the USA,35 and \nlower than effectiveness estimates in case controlled \nstudies, such as 88% (95% CI 77\u201394) in Israel,36 86% \n(73\u201393) in China,37 and 85% (95% CI 78\u201390) in the USA.19 \nThe 94\u00b79% efficacy of two doses of MMRV is in line with \nthe study of outbreaks at German daycare centres, in \nwhich MMRV (PriorixTetra) effectiveness was estimated \nat 91% (95% CI 65\u201398) and in which two doses were \nestimated to be more effective than one.38 The efficacy of \ntwo doses of MMRV is also in line with estimates of two \ndoses of monovalent varicella vaccine, such as 98% \n(95% CI 84\u2013100).39\nThe design and multinational nature of the present \nstudy provide a robust estimate of vaccine efficacy and \nsupport the generalisability of the study conclusions to \nregions or countries with high rates of VZV transmis\u00ad\nsion. During 3 years of active follow-up in settings where \nvaricella is endemic, one dose of live varicella vaccine \nprovided strong protection against moderate to severe \nforms of varicella, whereas two doses of live varicella \nvaccine provided high rates of protection against all \nforms of varicella disease. These results support the \nimplementation of two-dose varicella vaccination on a \nshort course, to ensure optimum protection from all \nforms of varicella disease.\nContributors\nPW and BI conceived the trial, designed the trial, and obtained research \nfunding.", "mimetype": "text/plain", "start_char_idx": 59859, "end_char_idx": 61787, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "83d0c219-5137-46df-8d9c-ed71f80f3968": {"__data__": {"id_": "83d0c219-5137-46df-8d9c-ed71f80f3968", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c175bca9-2774-4d34-b6d7-a8f751b822c2", "node_type": "1", "metadata": {}, "hash": "5fc481d7f00b36ba2f643d22aea1fd985f0bef7cf1f0e5762b4651fdf34d9ca4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7c0cc80d-33a8-48ad-87c4-ceb8c4762322", "node_type": "1", "metadata": {}, "hash": "b8fa7c236e1b687bcae38c8a9be707897c53074d6e56cfc00c0e17750e678bb3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Contributors\nPW and BI conceived the trial, designed the trial, and obtained research \nfunding. MD provided statistical advice on trial design and drafted the \nanalysis plan which was approved by PW and BI. VV designed the \nlaboratory testing for case confirmation. All authors contributed to the \nacquisition and review of the data. RP, MRB, SE, LG, SM, NS, MS, VU, \nand JW recruited patients. MD analysed the data. All authors contributed \nto the interpretation of data and the drafting of the report. They revised \nit critically for important intellectual content and approved the version to \nbe published.\nConflicts of interest\nMD, BI, ON, and VV are employees of GlaxoSmithKline [GSK] Vaccines. \nPW was an employee of GSK Vaccines when the trial was ongoing. \nBI and PW have stock options in GSK Vaccines. RP, VU, SM, and SE \nhave received grants from GSK Vaccines. RP, VU, and LG have received \nconsulting fees from GSK Vaccines. VU, SM, and JW have received \ntravel grants from GSK Vaccines to attend scientific meetings. SM has \nreceived fees for lectures including service on speakers\u2019 bureaus from \nGSK Vaccines. MRB, NS, and MS have not received any consulting fees \nand declare that they have no conflicts of interest.\nAcknowledgments\nWe thank the parents, guardians, and children for their participation in \nthis clinical study. We thank the investigators, the nurses, and other staff \nmembers involved. We also thank the IDMC members; Alan Arbeter, \nJacques Senterre, Ulrich Heininger, Luigi Notarangelo, and \nJavier Diez-Domingo. We thank Michael Povey for statistical support. \nWriting assistance was provided by Matthew Morgan (4Clinics, Waterloo, \nBelgium), was funded by GSK, and was used in all stages of the report\u2019s \ndevelopment. V\u00e9ronique Duquenne (Cromsource, Kraainem, Belgium) \nand Luise Kalbe (GlaxoSmtihKline) coordinated the report\u2019s development.", "mimetype": "text/plain", "start_char_idx": 61692, "end_char_idx": 63567, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7c0cc80d-33a8-48ad-87c4-ceb8c4762322": {"__data__": {"id_": "7c0cc80d-33a8-48ad-87c4-ceb8c4762322", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "83d0c219-5137-46df-8d9c-ed71f80f3968", "node_type": "1", "metadata": {}, "hash": "c2d47ffbf8de13fbbd10e9b753204a0f8b6147ea71211abcf36431dc08009dbf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6f7a92b6-c4e0-46ce-b837-5a00ec35d649", "node_type": "1", "metadata": {}, "hash": "7acfa1c0618033b0c21423a133e1fe84dcd9a0b0ee885e6e5d03a163a49076a2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "V\u00e9ronique Duquenne (Cromsource, Kraainem, Belgium) \nand Luise Kalbe (GlaxoSmtihKline) coordinated the report\u2019s development.\nReferences\n1\t\nLopez AS, Zhang J, Brown C, Bialek S. Varicella-related \nhospitalizations in the United States, 2000\u20132006: the 1-dose \nvaricella vaccination era. Pediatrics 2011; 127: 238\u201345.\nArticles\n1324\t\nwww.thelancet.com   Vol 383   April 12, 2014\n2\t\nQuian J, R\u00fcttimann R, Romero C, et al. Impact of universal \nvaricella vaccination on 1-year-olds in Uruguay: 1997\u20132005. \nArch Dis Child 2008; 93: 845\u201350.\n3\t\nMarin M, Meissner HC, Seward JF. Varicella prevention in the \nUnited States: a review of successes and challenges. Pediatrics 2008; \n122: e744\u201351.\n4\t\nLee BR, Feaver SL, Miller CA, Hedberg CW, Ehresmann KR. \nAn elementary school outbreak of varicella attributed to vaccine \nfailure: policy implications. J Infect Dis 2004; 190: 477\u201383.\n5\t\nMarin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of \nvaricella: recommendations of the Advisory Committee on \nImmunization Practices (ACIP). MMWR Recomm Rep 2007; 56: 1\u201340.\n6\t\nWutzler P, Knuf M, Liese J. Varicella: efficacy of two-dose \nvaccination in childhood. Dtsch Arztebl Int 2008; 105: 567\u201372.\n7\t\nBonanni P, Breuer J, Gershon A, et al. Varicella vaccination in \nEurope\u2014taking the practical approach. BMC Med 2009; 7: 26.\n8\t\nGoh P, Lim FS, Han HH, Willems P. Safety and immunogenicity of \nearly vaccination with two doses of tetravalent measles-mumps-\nrubella-varicella (MMRV) vaccine in healthy children from \n9 months of age.", "mimetype": "text/plain", "start_char_idx": 63444, "end_char_idx": 64960, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6f7a92b6-c4e0-46ce-b837-5a00ec35d649": {"__data__": {"id_": "6f7a92b6-c4e0-46ce-b837-5a00ec35d649", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7c0cc80d-33a8-48ad-87c4-ceb8c4762322", "node_type": "1", "metadata": {}, "hash": "b8fa7c236e1b687bcae38c8a9be707897c53074d6e56cfc00c0e17750e678bb3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b148c180-2136-4627-a27f-5deabcd93cb6", "node_type": "1", "metadata": {}, "hash": "90849c0452ba7b7dad8820402fe974b084a7a443bf873a93890e9697f0ae8fc9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Infection 2007; 35: 326\u201333.\n9\t\nLieberman JM, Williams WR, Miller JM, et al. The safety and \nimmunogenicity of a quadrivalent measles, mumps, rubella and \nvaricella vaccine in healthy children: a study of manufacturing \nconsistency and persistence of antibody. Pediatr Infect Dis J 2006; \n25: 615\u201322.\n10\t\nShinefield H, Black S, Digilio L, et al. Evaluation of a quadrivalent \nmeasles, mumps, rubella and varicella vaccine in healthy children. \nPediatr Infect Dis J 2005; 24: 665\u201369.\n11\t\nKnuf M, Habermehl P, Zepp F, et al. Immunogenicity and safety of \ntwo doses of tetravalent measles-mumps-rubella-varicella vaccine in \nhealthy children. Pediatr Infect Dis J 2006; 25: 12\u201318.\n12\t\nShinefield HR, Black SB, Staehle BO, et al. Vaccination with \nmeasles, mumps and rubella vaccine and varicella vaccine: safety, \ntolerability, immunogenicity, persistence of antibody and duration \nof protection against varicella in healthy children. Pediatr Infect Dis J \n2002; 21: 555\u201361.\n13\t\nVaris T, Vesikari T. Efficacy of high-titer live attenuated varicella \nvaccine in healthy young children. J Infect Dis 1996; \n174 (suppl 3): S330\u201334.\n14\t\nKuter B, Matthews H, Shinefield H, et al. Ten year follow-up of \nhealthy children who received one or two injections of varicella \nvaccine. Pediatr Infect Dis J 2004; 23: 132\u201337.\n15\t\nVessey SJ, Chan CY, Kuter BJ, et al. Childhood vaccination against \nvaricella: persistence of antibody, duration of protection, \nand vaccine efficacy. J Pediatr 2001; 139: 297\u2013304.", "mimetype": "text/plain", "start_char_idx": 64961, "end_char_idx": 66453, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b148c180-2136-4627-a27f-5deabcd93cb6": {"__data__": {"id_": "b148c180-2136-4627-a27f-5deabcd93cb6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6f7a92b6-c4e0-46ce-b837-5a00ec35d649", "node_type": "1", "metadata": {}, "hash": "7acfa1c0618033b0c21423a133e1fe84dcd9a0b0ee885e6e5d03a163a49076a2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "10895ccf-cfae-4c69-b8b8-747c86df97ee", "node_type": "1", "metadata": {}, "hash": "c22fbc46dc35ab362ac4a88335ed5c37d7f3b6125f805c09fca8b011c2644ef0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Childhood vaccination against \nvaricella: persistence of antibody, duration of protection, \nand vaccine efficacy. J Pediatr 2001; 139: 297\u2013304.\n16\t\nLaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, \nSilverstein S. Restriction fragment length polymorphism of \npolymerase chain reaction products from vaccine and wild-type \nvaricella-zoster virus isolates. J Virol 1992; 66: 1016\u201320.\n17\t\nJumaan A, Hughes H, Schmid S, et al. Varicella. \nVaccine-preventable disease surveillance manual. 3rd edn. Atlanta, \nGA, USA: Centers for Disease Control, 2002: 1\u201321.\n18\t\nCenters for Disease Control. Epidemiology and prevention of \nvaccine-preventable diseases. In: Atkinson W, Wolfe S, \nHamborsky J, McIntyre L, eds. The pink book. 11th edn. \nWashington DC: Public Health Foundation, 2002.\n19\t\nV\u00e1zquez M, Larussa PS, Gershon AA, Steinberg SP, Freudigman K, \nShapiro ED. The effectiveness of the varicella vaccine in clinical \npractice. N Engl J Med 2001; 344: 955\u201360.\n20\t Clopper CJ, Pearson ES. The use of confidence or fiducial limits \nillustrated in the case of the binomial. Bimetrika 1934; 26: 404\u201313.\n21\t\nMedDRA. Medical Dictionary for Regulatory Activities, version 12.0. \nMcClean: MedDRA MSSO, 2009. \n22\t Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO. \nContagiousness of varicella in vaccinated cases: a household contact \nstudy. JAMA 2004; 292: 704\u201308.\n23\t Quian J, R\u00fcttimann R, Protasio A, Dall\u2019Orso P, Romero C, Mas M. \nReduction in hospitalizations and ambulatory visits eight years after \nintroduction of universal mass vaccination against varicella in \nUruguayan children.", "mimetype": "text/plain", "start_char_idx": 66310, "end_char_idx": 67894, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "10895ccf-cfae-4c69-b8b8-747c86df97ee": {"__data__": {"id_": "10895ccf-cfae-4c69-b8b8-747c86df97ee", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b148c180-2136-4627-a27f-5deabcd93cb6", "node_type": "1", "metadata": {}, "hash": "90849c0452ba7b7dad8820402fe974b084a7a443bf873a93890e9697f0ae8fc9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5ccec8f6-b0fd-4386-b622-9ec41d8c7a72", "node_type": "1", "metadata": {}, "hash": "076caa3a03d49b3b83b854cdc6b8fc8c468f2d54a98abfd3879ec13be10673a5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "http://www.kenes.com/espid09/abstracts/\npdf/870.pdf (accessed June 12, 2012).\n24\t\nKlein NP, Fireman B, Yih WK, et al. Measles-mumps-rubella-\nvaricella combination vaccine and the risk of febrile seizures. \nPediatrics 2010; 126: e1\u20138.\n25\t Czajka H, Schuster V, Zepp F, Esposito S, Douha M, Willems P. \nA combined measles, mumps, rubella and varicella vaccine \n(Priorix-Tetra): immunogenicity and safety profile. Vaccine 2009; \n27: 6504\u201311.\n26\t Gillet Y, Steri GC, Behre U, et al. Immunogenicity and safety of \nmeasles-mumps-rubella-varicella (MMRV) vaccine followed by one \ndose of varicella vaccine in children aged 15 months\u20132 years or \n2\u20136 years primed with measles-mumps-rubella (MMR) vaccine. \nVaccine 2009; 27: 446\u201353.\n27\t\nKreth HW, Lee BW, Kosuwon P, et al. Sixteen years of global \nexperience with the first refrigerator-stable varicella vaccine \n(Varilrix). BioDrugs 2008; 22: 387\u2013402.\n28\t Li S, Chan IS, Matthews H, et al. Inverse relationship between \nsix week postvaccination varicella antibody response to vaccine and \nlikelihood of long term breakthrough infection. Pediatr Infect Dis J \n2002; 21: 337\u201342.\n29\t Schuster V, Otto W, Maurer L, et al. Immunogenicity and safety \nassessments after one and two doses of a refrigerator-stable \ntetravalent measles-mumps-rubella-varicella vaccine in healthy \nchildren during the second year of life. Pediatr Infect Dis J 2008; \n27: 724\u201330.\n30\t Dhillon S, Curran MP. Live attenuated measles, mumps, rubella, \nand varicella zoster virus vaccine (Priorix-Tetra).", "mimetype": "text/plain", "start_char_idx": 67895, "end_char_idx": 69408, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5ccec8f6-b0fd-4386-b622-9ec41d8c7a72": {"__data__": {"id_": "5ccec8f6-b0fd-4386-b622-9ec41d8c7a72", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "10895ccf-cfae-4c69-b8b8-747c86df97ee", "node_type": "1", "metadata": {}, "hash": "c22fbc46dc35ab362ac4a88335ed5c37d7f3b6125f805c09fca8b011c2644ef0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "450ff60f-73f3-44d4-a882-b6009a590807", "node_type": "1", "metadata": {}, "hash": "bee100de83ff3263ae511b0d04d9b07ab063178ca31d923a6de092fa4059903b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "30\t Dhillon S, Curran MP. Live attenuated measles, mumps, rubella, \nand varicella zoster virus vaccine (Priorix-Tetra). Paediatr Drugs \n2008; 10: 337\u201347.\n31\t\nNolan T, McIntyre P, Roberton D, Descamps D. Reactogenicity and \nimmunogenicity of a live attenuated tetravalent measles-mumps-\nrubella-varicella (MMRV) vaccine. Vaccine 2002; 21: 281\u201389.\n32\t Halperin SA, Ferrera G, Scheifele D, et al. Safety and \nimmunogenicity of a measles-mumps-rubella-varicella vaccine \ngiven as a second dose in children up to six years of age. Vaccine \n2009; 27: 2701\u201306.\n33\t R\u00fcmke HC, Loch HP, Hoppenbrouwers K, et al. Immunogenicity \nand safety of a measles-mumps-rubella-varicella vaccine following \na 4-week or a 12-month interval between two doses. Vaccine 2011; \n29: 3842\u201349.\n34\t\nBayer O, Heininger U, Heiligensetzer C, von Kries R. Metaanalysis \nof vaccine effectiveness in varicella outbreaks. Vaccine 2007; \n25: 6655\u201360.\n35\t Seward JF, Marin M, V\u00e1zquez M. Varicella vaccine effectiveness in \nthe US vaccination program: a review. J Infect Dis 2008; \n197 (suppl 2): S82\u201389.\n36\t Sheffer R, Segal D, Rahamani S, et al. Effectiveness of the Oka/GSK \nattenuated varicella vaccine for the prevention of chickenpox in \nclinical practice in Israel. Pediatr Infect Dis J 2005; 24: 434\u201347.\n37\t\nFu C, Wang M, Liang J, Xu J, Wang C, Bialek S. The effectiveness of \nvaricella vaccine in China. Pediatr Infect Dis J 2010; 29: 690\u201393.", "mimetype": "text/plain", "start_char_idx": 69289, "end_char_idx": 70699, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "450ff60f-73f3-44d4-a882-b6009a590807": {"__data__": {"id_": "450ff60f-73f3-44d4-a882-b6009a590807", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa\u2010Prymula (2014).pdf", "node_type": "4", "metadata": {}, "hash": "a99e9317facb02b5acc57d960a6ad22d1f751c7dfb44cd9e536463302df24add", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5ccec8f6-b0fd-4386-b622-9ec41d8c7a72", "node_type": "1", "metadata": {}, "hash": "076caa3a03d49b3b83b854cdc6b8fc8c468f2d54a98abfd3879ec13be10673a5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Pediatr Infect Dis J 2010; 29: 690\u201393.\n38\t Spackova M, Wiese-Posselt M, Dehnert M, Matysiak-Klose D, \nHeininger U, Siedler A. Comparative varicella vaccine effectiveness \nduring outbreaks in day-care centres. Vaccine 2010; 28: 686\u201391.\n39\t Shapiro ED, Vazquez M, Esposito D, et al. Effectiveness of 2 doses \nof varicella vaccine in children. J Infect Dis 2011; 203: 312\u201315.", "mimetype": "text/plain", "start_char_idx": 70661, "end_char_idx": 71033, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "af884ecd-239d-4a7f-aef8-ae545251bf69": {"__data__": {"id_": "af884ecd-239d-4a7f-aef8-ae545251bf69", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7594fab0-d929-463a-bd62-486512aa707e", "node_type": "1", "metadata": {}, "hash": "82524518423e6397c6df694f82f7a32f78aa90e70fcc9cf85007f967f14c7d6c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "One or two doses of live varicella virus-containing vaccines: Ef\ufb01cacy,\npersistence of immune responses, and safety six years after\nadministration in healthy children during their second year of life q\nOuzama Henry a, Jerzy Brzostek b, Hanna Czajka c, Giedra Leviniene d, Olga Reshetko e, Roberto Gasparini f,\nPetr Pazdiora g, Doina Plesca h, Maria Giuseppina Desole i, Rimantas Kevalas d, Giovanni Gabutti j,\nMichael Povey k,\u21d1, Bruce Innis a\na Vaccine Discovery and Development, GSK, Philadelphia, United States\nb Poradnia Chor\u00f3b Zakaz\u00b4nych ZOZ De\u02dbbica, De\u02dbbica, Poland\nc Infectious Diseases Outpatient Clinic, The St.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 618, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7594fab0-d929-463a-bd62-486512aa707e": {"__data__": {"id_": "7594fab0-d929-463a-bd62-486512aa707e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "af884ecd-239d-4a7f-aef8-ae545251bf69", "node_type": "1", "metadata": {}, "hash": "1a8fdb533d9ebcc97bfa48b1693e9303e883080d9ca7f2ad56d0de4f1d4023a2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "84fc3ae0-ff29-4c01-9c2f-c457dac8c20c", "node_type": "1", "metadata": {}, "hash": "984dd90205ddde5dc6ca9067cbf69825d2a62275df0cafc2b17171b71d21069a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Luis Provincial Specialist Children\u2019s Hospital, Cracow, Poland\nd Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania\ne Pharmacology, Saratov Medical University, Saratov, Russia\nf Department of Health Sciences, Genoa University, Genoa, Italy\ng Department of Epidemiology, Medical Faculty Pilsen of Charles University, Czech Republic\nh Pediatrics, University of Medicine and Pharmacy, Bucharest, Romania\ni Servizio di Igiene Pubblica, ASL Sassari, Italy\nj Department of Medical Sciences, University of Ferrara, Ferrara, Italy\nk Biostatistics, GSK, Wavre, Belgium\na r t i c l e\ni n f o\nArticle history:\nReceived 30 June 2017\nReceived in revised form 29 November 2017\nAccepted 30 November 2017\nAvailable online 7 December 2017\nKeywords:\nVaccine\nEf\ufb01cacy\nLong-term follow-up\nVaricella-zoster virus\nMeasles-mumps-rubella\na b s t r a c t\nBackground: This phase III B follow-up of an initial multicenter study (NCT00226499) will evaluate the\nten-year ef\ufb01cacy of two doses of the combined measles-mumps-rubella-varicella vaccine (MMRV) and\none dose of the live attenuated varicella vaccine (V) versus a measles-mumps-rubella control group\n(MMR) for the prevention of clinical varicella disease. Here we present ef\ufb01cacy results for six years\npost-vaccination.\nMethods: In phase A of the study, healthy children aged 12\u201322 months from ten European countries were\nrandomized (3:3:1) and received either two doses of MMRV, or one dose of combined MMR and one dose\nof monovalent varicella vaccine (MMR+V), or two doses of the MMR vaccine (control), 42 days apart.\nVaccine ef\ufb01cacy against all and against moderate or severe varicella (con\ufb01rmed by detection of viral\nDNA or epidemiological link) was assessed from six weeks up to six years post-dose 2 for the MMRV\nand MMR+V groups, and was calculated with 95% con\ufb01dence intervals (CI).", "mimetype": "text/plain", "start_char_idx": 619, "end_char_idx": 2464, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "84fc3ae0-ff29-4c01-9c2f-c457dac8c20c": {"__data__": {"id_": "84fc3ae0-ff29-4c01-9c2f-c457dac8c20c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7594fab0-d929-463a-bd62-486512aa707e", "node_type": "1", "metadata": {}, "hash": "82524518423e6397c6df694f82f7a32f78aa90e70fcc9cf85007f967f14c7d6c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dcd2c745-c2bb-4ae7-9187-1a82dc074f12", "node_type": "1", "metadata": {}, "hash": "cb852e91120e7a429811555f6c700564d4250a79a044624b4a493b0ce1b53ec5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The severity of varicella\nwas calculated using the modi\ufb01ed V\u00e1zquez scale (mild \u0001 7; moderately severe = 8\u201315; severe \u0003 16).\nHerpes zoster cases were also recorded.\nResults: 5289 children (MMRV = 2279, mean age = 14.2, standard deviation [SD] = 2.5; MMR+V = 2266,\nmean age = 14.2, SD = 2.4; MMR = 744, mean age = 14.2, SD = 2.5 months) were included in the ef\ufb01cacy\ncohort. 815 varicella cases were con\ufb01rmed. Ef\ufb01cacy of two doses of MMRV against all and against mod-\nerate or severe varicella was 95.0% (95% CI: 93.6\u201396.2) and 99.0% (95% CI: 97.7\u201399.6), respectively.\nEf\ufb01cacy of one dose of varicella vaccine against all and against moderate or severe varicella was 67.0%\n(95% CI: 61.8\u201371.4) and 90.3% (95% CI: 86.9\u201392.8), respectively. There were four con\ufb01rmed herpes zoster\ncases (MMR+V = 2, MMR = 2), all were mild and three tested positive for the wild-type virus.\nhttps://doi.org/10.1016/j.vaccine.2017.11.081\n0264-410X/\u0001 2017 GlaxoSmithKline SA. Published by Elsevier Ltd.\nThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).", "mimetype": "text/plain", "start_char_idx": 2465, "end_char_idx": 3543, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dcd2c745-c2bb-4ae7-9187-1a82dc074f12": {"__data__": {"id_": "dcd2c745-c2bb-4ae7-9187-1a82dc074f12", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "84fc3ae0-ff29-4c01-9c2f-c457dac8c20c", "node_type": "1", "metadata": {}, "hash": "984dd90205ddde5dc6ca9067cbf69825d2a62275df0cafc2b17171b71d21069a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "99e674af-33a4-4afa-8720-f070a89b29ea", "node_type": "1", "metadata": {}, "hash": "00b3cda274c2af883059990b0615507b372510257d08a8408a294f6f8994ab98", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Published by Elsevier Ltd.\nThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).\nAbbreviations: VZV, varicella-zoster virus; MMR, measles-mumps-rubella; MMRV, measles-mumps-rubella-varicella; CI, con\ufb01dence interval; SAE, serious adverse event;\nHZ, herpes zoster; VE, vaccine ef\ufb01cacy; ATP, according-to-protocol; CDC, Centers for Disease Control and Prevention; PCR, polymerase chain reaction; IDMC, Independent\nData Monitoring Committee; ELISA, enzyme-linked immunosorbent assay; GMC, geometric mean concentration; TVC, total vaccinated cohort; HR, hazard ratio; LL, lower\nlimit; UL, upper limit.\nq Previous congress activities, if any: Partial data were presented as an abstract and presentation at the 33rd European Society for Paediatric Infectious Diseases\nConference (May 2015, Leipzig, Germany).\n\u21d1Corresponding author at: GSK, Avenue Fleming 20, 1300 Wavre, Belgium.\nE-mail addresses: ouzama.n.henry@gsk.com (O. Henry), jerzy_br@poczta.onet.pl (J. Brzostek), hanna.czajka@onet.pl (H. Czajka), giedralev@gmail.com (G. Leviniene),\nreshetko@yandex.ru (O. Reshetko), gasparini@unige.it (R. Gasparini), PAZDIORA@fnplzen.cz (P. Pazdiora), doinaplesca@yahoo.com (D. Plesca), madesole@aslsassari.it (M.G.\nDesole), rimantas.kevalas@kaunoklinikos.lt (R. Kevalas), giovanni.gabutti@unife.it (G. Gabutti), michael.x.povey@gsk.com (M. Povey), innisb00@gmail.com (B. Innis).", "mimetype": "text/plain", "start_char_idx": 3415, "end_char_idx": 4829, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "99e674af-33a4-4afa-8720-f070a89b29ea": {"__data__": {"id_": "99e674af-33a4-4afa-8720-f070a89b29ea", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dcd2c745-c2bb-4ae7-9187-1a82dc074f12", "node_type": "1", "metadata": {}, "hash": "cb852e91120e7a429811555f6c700564d4250a79a044624b4a493b0ce1b53ec5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "32dfb671-5c82-4f01-ae1b-30cb27ba9fc6", "node_type": "1", "metadata": {}, "hash": "5fc4b3b189c212b90b02d5579805ced2f7cedcd66e5786dea21a382ea00adc0e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine 36 (2018) 381\u2013387\nContents lists available at ScienceDirect\nVaccine\njournal homepage: www.elsevier.com/locate/vaccine\ni\nAn update to this article is included at the end\nConclusions: Two doses of the MMRV vaccine and one dose of the varicella vaccine remain ef\ufb01cacious\nthrough six years post-vaccination.\n\u0001 2017 GlaxoSmithKline SA. Published by Elsevier Ltd. This is an open access article under the CC BY license\n(http://creativecommons.org/licenses/by/4.0/).\n1. Introduction\nVaricella (chickenpox), caused by the varicella-zoster virus\n(VZV), is a highly contagious vaccine-preventable disease, respon-\nsible for 4.2 million hospitalizations and 4200 deaths annually,\nworldwide [1]. In countries where universal vaccination was intro-\nduced, the incidence of varicella cases, including hospitalizations\nand deaths, has substantially declined [2\u20135].\nAn important aspect in the design of universal immunization\nprograms against varicella is the number of doses. While one-\ndose schedules were shown to be effective against the disease,\nbreakthrough cases were still reported [2\u20136]. Out of the 33 coun-\ntries that recommended varicella containing vaccines, 14 recom-\nmended a two-dose schedule. Another important aspect is the\nchoice of vaccine, i.e. monovalent or combined varicella vaccine.\nImproved\nuptake\nrates\nmight\nbe\nachieved\nby\nthe\nco-\nadministration of varicella-containing vaccines with routine child-\nhood vaccines or with the use of combined varicella-containing\nvaccines [7].\nGSK\u2019s trivalent measles-mumps-rubella vaccine (MMR; Priorix)\nand the monovalent live attenuated varicella vaccine (V; Varilrix)\nare licensed in many countries worldwide. Both vaccines are indi-\ncated for active immunization of children at least 9 months of age,\nand can be given concomitantly, but at separate injection sites\n[8,9].", "mimetype": "text/plain", "start_char_idx": 4830, "end_char_idx": 6657, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "32dfb671-5c82-4f01-ae1b-30cb27ba9fc6": {"__data__": {"id_": "32dfb671-5c82-4f01-ae1b-30cb27ba9fc6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "99e674af-33a4-4afa-8720-f070a89b29ea", "node_type": "1", "metadata": {}, "hash": "00b3cda274c2af883059990b0615507b372510257d08a8408a294f6f8994ab98", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7c556ca9-451a-4b79-8a56-148c332262f5", "node_type": "1", "metadata": {}, "hash": "d9013470c1c7eef641071bde5500a63d03f355db99f52fcf609599e4f52c3476", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Both vaccines are indi-\ncated for active immunization of children at least 9 months of age,\nand can be given concomitantly, but at separate injection sites\n[8,9].\nGSK has developed a combined tetravalent measles-mumps-\nrubella-varicella vaccine (MMRV; Priorix-Tetra) that offers conve-\nnience for parents and medical practitioners by combining the\nbene\ufb01ts of measles-mumps-rubella and varicella vaccination in a\nsingle injection, and would therefore improve the vaccine coverage\nboth against chickenpox and against measles, mumps and rubella.\nMoreover, meningococcal vaccines could be co-administered with\nMMRV at the same clinical visit [10]. The immunogenicity and\nsafety of the combined MMRV have been demonstrated in clinical\ntrials; MMRV was licensed based on comparative immunogenicity\ntrials versus monovalent varicella vaccines [11\u201313].\nPhase A of this phase III, observer-blinded, randomized, con-\ntrolled, multicenter study (NCT00226499) assessed protection\nagainst varicella in naive children who received two doses of\nMMRV or one dose of monovalent varicella vaccine at 12\u201322\nmonths of age. After a mean follow-up of approximately three\nyears, ef\ufb01cacy of two doses of MMRV against all varicella was\n94.9% (97.5% con\ufb01dence interval [CI]: 92.4\u201396.6), and against mod-\nerate to severe varicella was 99.5% (97.5% CI: 97.5\u201399.9). Ef\ufb01cacy of\none-dose varicella vaccine was 65.4% (97.5% CI: 57.2\u201372.1) against\nall varicella and 90.7% (97.5% CI: 85.9\u201393.9) against moderate to\nsevere varicella [14].\nWe report the ef\ufb01cacy, antibody persistence and safety data up\nto six years after the second vaccine dose. Long term follow-up is\nongoing and will extend up to ten years post-vaccination.\n2. Methods\n2.1.", "mimetype": "text/plain", "start_char_idx": 6495, "end_char_idx": 8202, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7c556ca9-451a-4b79-8a56-148c332262f5": {"__data__": {"id_": "7c556ca9-451a-4b79-8a56-148c332262f5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "32dfb671-5c82-4f01-ae1b-30cb27ba9fc6", "node_type": "1", "metadata": {}, "hash": "5fc4b3b189c212b90b02d5579805ced2f7cedcd66e5786dea21a382ea00adc0e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1d1eedda-d70c-4178-82d4-397e172de1a6", "node_type": "1", "metadata": {}, "hash": "861dd183a67169f2b9e72e6a4dedcf6b5a3c1ebfeb150fa3e50284e66fcf7326", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Long term follow-up is\nongoing and will extend up to ten years post-vaccination.\n2. Methods\n2.1. Study design and participants\nThe study design was previously described [14]. Brie\ufb02y, this\nstudy is a follow-up of the phase A, observer-blind, controlled,\nstudy conducted in Czech Republic, Greece, Italy, Lithuania, Nor-\nway, Poland, Romania, Russian Federation, Slovakia and Sweden\nbetween 2009 and 2015, in accordance with the Declaration of Hel-\nsinki and International Conference on Harmonization Good Clinical\nPractice guidelines [15,16]. The study protocol was reviewed and\napproved by independent ethics committees. Protocol deviations\nwere presented elsewhere [14].\nIn phase A of the study, healthy children aged 12\u201322 months\nfrom\nthe\nten\ncountries\nmentioned\nabove\nwere\nrandomized\n(3:3:1) to one of the three treatment groups, and received either\ntwo doses of MMRV (Priorix-Tetra, GSK) at Day 0 and Day 42\n(MMRV group), or one dose of MMR (Priorix, GSK) at Day 0 and\none dose of monovalent varicella vaccine (Varilrix, GSK) at Day\n42 (MMR+V group), or two doses of the MMR (Priorix, GSK) vaccine\n(control) at Day 0 and Day 42 (MMR group).\nStudy population (with inclusion and exclusion criteria), ran-\ndomization and blinding, as well as vaccine composition and\nadministration route, were previously described [14].\nFor phase B, the study remained observer-blind for all groups\nwith the exception of the MMR+V group in countries where the\nnational vaccination schedules included a second dose of MMR\nvaccination at 4\u20138 years of age (Italy, Lithuania, Romania, Russian\nFederation, Sweden). Independent Data Monitoring Committee\n(IDMC) members also remained blinded to the study treatment\ngroup when assessing varicella cases.\nThe objectives of this phase B study were secondary and\ndescriptive, i.e.", "mimetype": "text/plain", "start_char_idx": 8106, "end_char_idx": 9910, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1d1eedda-d70c-4178-82d4-397e172de1a6": {"__data__": {"id_": "1d1eedda-d70c-4178-82d4-397e172de1a6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7c556ca9-451a-4b79-8a56-148c332262f5", "node_type": "1", "metadata": {}, "hash": "d9013470c1c7eef641071bde5500a63d03f355db99f52fcf609599e4f52c3476", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4b9abe0d-81a2-4206-84e9-927b3830fe39", "node_type": "1", "metadata": {}, "hash": "4ff79328e853ca38b4e8cc1db9f6588a92644ea0623cd54fc9e34d21c2f73592", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Independent Data Monitoring Committee\n(IDMC) members also remained blinded to the study treatment\ngroup when assessing varicella cases.\nThe objectives of this phase B study were secondary and\ndescriptive, i.e. to assess: the long-term ef\ufb01cacy of one dose of\nmonovalent varicella vaccine or two doses of MMRV in preventing\nprobable and con\ufb01rmed varicella cases after vaccination, the ef\ufb01-\ncacy of the study vaccines according to the severity of varicella\ncases and the occurrence of complicated varicella cases reported\nas serious adverse events (SAEs) (ef\ufb01cacy objectives). The varicella\nimmune response in terms of varicella seropositivity rates and geo-\nmetric mean antibody concentrations (GMCs) in all children four\nand six years post-vaccination (immunogenicity objectives) were\nalso assessed. The safety of the study vaccines was evaluated in\nterms of occurrence of SAEs and by description of occurred herpes\nzoster (HZ) cases, in all children following vaccination (safety\nobjectives).\nThe current analysis was designed to monitor the severity of\nvaricella in vaccinated and unvaccinated children, and to deter-\nmine whether or not susceptible individuals remained in the con-\ntrol group and to assess the bene\ufb01t of two doses or one dose of\nvaricella vaccination versus control.\n2.2. Ef\ufb01cacy assessment\nThe main analysis of vaccine ef\ufb01cacy (VE) was based on the\naccording-to-protocol (ATP) cohort for ef\ufb01cacy in phase A + B and\nchildren were followed up for a median duration of 6.4 years. VE\nwas also evaluated for phase B alone. All children\u2019s parents/-\nguardians were provided with diary cards to record maximum\ninformation related to varicella/zoster case(s) to aid grading of\nseverity.\nCase ascertainment and con\ufb01rmation have been described pre-\nviously [14]. Brie\ufb02y, the study followed a varicella case de\ufb01nition\nused by the Centers for Disease Control and Prevention (CDC) with\nslight modi\ufb01cations.", "mimetype": "text/plain", "start_char_idx": 9701, "end_char_idx": 11613, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4b9abe0d-81a2-4206-84e9-927b3830fe39": {"__data__": {"id_": "4b9abe0d-81a2-4206-84e9-927b3830fe39", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1d1eedda-d70c-4178-82d4-397e172de1a6", "node_type": "1", "metadata": {}, "hash": "861dd183a67169f2b9e72e6a4dedcf6b5a3c1ebfeb150fa3e50284e66fcf7326", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0432e6b8-04d3-45af-b59c-2c4651c2077f", "node_type": "1", "metadata": {}, "hash": "e165db17af64941cfd56ab7cb51ced76046cfcaabb9cb7fe789aac1050576ae3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Brie\ufb02y, the study followed a varicella case de\ufb01nition\nused by the Centers for Disease Control and Prevention (CDC) with\nslight modi\ufb01cations. A varicella case was con\ufb01rmed when it met\nthe clinical case de\ufb01nition and the polymerase chain reaction\n382\nO. Henry et al. / Vaccine 36 (2018) 381\u2013387\n(PCR) result was positive, or when it met the clinical de\ufb01nition,\nwas con\ufb01rmed by the IDMC and was epidemiologically linked to\na valid index case.\nThe severity of varicella/zoster was assessed using the modi\ufb01ed\nV\u00e1zquez scale [17]. These modi\ufb01cations were described previously\n[14].\nTo optimize the reporting procedures of suspected varicella/-\nzoster cases and to ensure that the maximum number of cases\nwere promptly identi\ufb01ed and reported to the study sites, all chil-\ndren\u2019s parents/guardians were contacted by telephone between\nstudy visits (once every six months during phase B) to remind\nthem to report to the investigator/study site any skin eruption that\nmight be indicative of varicella/zoster their child may have.\n2.3. Assessment of antibody persistence\nA blood sample (4 mL) was collected from all children four and\nsix years post-vaccination for determination of VZV antibodies and\nresults were analyzed in comparison to antibody responses evalu-\nated in phase A of the study (at Day 42, Day 84, Year 1 and Year 2).\nThe evaluation of antibody persistence at Year 6 was based on\nthe adapted ATP cohort for persistence, i.e. excluding the serology\nresults of children who did not respect the visit intervals for that\nspeci\ufb01c phase. A child who did not respect the interval from Visit\n3 to Year 2 but respected the interval from Visit 3 to Year 6 was\nexcluded from the adapted cohort for Years 1 and 2 (phase A)\nbut was included for Years 4 and 6 analyses (phase B). The data\nlock point for the Year 6 immunogenicity analysis was 17 Decem-\nber 2015.", "mimetype": "text/plain", "start_char_idx": 11473, "end_char_idx": 13325, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0432e6b8-04d3-45af-b59c-2c4651c2077f": {"__data__": {"id_": "0432e6b8-04d3-45af-b59c-2c4651c2077f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4b9abe0d-81a2-4206-84e9-927b3830fe39", "node_type": "1", "metadata": {}, "hash": "4ff79328e853ca38b4e8cc1db9f6588a92644ea0623cd54fc9e34d21c2f73592", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1ccf0c49-7f3b-476f-8be8-3ecf0ba299e6", "node_type": "1", "metadata": {}, "hash": "d6924eddfea9d7a71491a68757519ca0519abf102746a4a83d2b49ea3d420cf4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The data\nlock point for the Year 6 immunogenicity analysis was 17 Decem-\nber 2015.\nSerum was analyzed by enzyme-linked immunosorbent assay\n(ELISA), with assay cut-off: 25 mIU/mL for antibodies against\nVZV, and dermal lesions and/or throat swabs were analyzed using\nPCR for all children.\nA child seropositive for VZV had to have an antibody concentra-\ntion greater than or equal to the cut-off value of 25 mIU/mL.\nGMCs were calculated by taking the anti-log of the mean of the\nlog concentrations for the assay. Antibody concentrations below\nthe cut-off were given an arbitrary value of half the cut-off for\nthe purpose of GMC calculations. Additionally, all concentrations\nbetween 25 mIU/mL and 40 mIU/mL were given a value of 25\nmIU/mL prior to log-transformation. Values below 25 mIU/mL\nwere given an arbitrary value of 12.5 mIU/mL.\nThe identi\ufb01cation and characterization of VZV DNA for qualita-\ntive (+/\u0004) and strain identi\ufb01cation (wild type/vaccine strain) was\ndone using PCR-Restriction Fragment Length Polymorphism (RFLP)\n[18].\n2.4. Safety assessment\nThe primary safety analyses were part of phase A. In phase B,\nonly SAEs were recorded in the total vaccinated cohort (TVC),\nthroughout the study (from 01 July 2009 until 17 December\n2015). All complications of varicella/zoster cases (secondary bacte-\nrial infection of the skin, cerebellar ataxia, encephalitis, pneumo-\nnia, hepatitis, appendicitis, arthritis, glomerulonephritis, orchitis,\npericarditis) were to be considered SAEs. The intensity and causal-\nity of each SAE was assessed and reported by the investigators.\n2.5. Statistical analyses\nStatistical analyses were previously described in detail [14]. The\nstatistical analyses were descriptive and were done using SAS Drug\nDevelopment version 3. The exact 95% CIs for a proportion within a\ngroup were calculated in SAS using the method of Clopper [19].", "mimetype": "text/plain", "start_char_idx": 13243, "end_char_idx": 15111, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1ccf0c49-7f3b-476f-8be8-3ecf0ba299e6": {"__data__": {"id_": "1ccf0c49-7f3b-476f-8be8-3ecf0ba299e6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0432e6b8-04d3-45af-b59c-2c4651c2077f", "node_type": "1", "metadata": {}, "hash": "e165db17af64941cfd56ab7cb51ced76046cfcaabb9cb7fe789aac1050576ae3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6d67bcea-9c99-49e4-8e39-88c4b5abecc7", "node_type": "1", "metadata": {}, "hash": "831ea8c6a4c489fdeca4db03299123fbb0771406e99a23b748088d9e5c05c95c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\nstatistical analyses were descriptive and were done using SAS Drug\nDevelopment version 3. The exact 95% CIs for a proportion within a\ngroup were calculated in SAS using the method of Clopper [19].\nThe VE computation was based on the hazard ratio (HR) esti-\nmated with the Cox proportional hazards regression model, which\ntakes into account the individual follow-up time of each child and\ncensored data [20], using the formula VE = 100 \u0005 (1 \u0004 HR). Ef\ufb01cacy\nwas assessed in the ATP cohort for ef\ufb01cacy, which included all chil-\ndren who completed their vaccinations and respected the protocol\nrequirements.\nThe TVC included all children who received at least one dose of\nstudy vaccine during phase A.\n3. Results\n3.1. Study population\nOf the 5803 children enrolled and vaccinated (TVC) in phase A,\n4580 were included in the TVC in phase B, and 3829 (66%) com-\npleted the study up to Year 6; 5289 and 3791 were included in\nthe ATP cohort for ef\ufb01cacy in phase A + B and phase B, respectively\n(Fig. 1).\nThe three treatment groups were well-balanced with regard to\ndemographic characteristics and to the proportion of children with\ndifferent levels of contact based on care type. The mean age at \ufb01rst\nvaccine dose and the other demographic characteristics for the ATP\ncohort for ef\ufb01cacy were similar in phase A + B and phase B\n(Table 1).\n3.2. Vaccine ef\ufb01cacy\nDuring the median 6.4 years of follow-up in phase A + B, the\nnumber (percentage) of children with a reported contact with vari-\ncella and/or zoster disease was 764 (33.5% [95% CI: 31.6\u201335.5]) in\nthe MMRV group, 730 (32.2% [95% CI: 30.3\u201334.2]) in the MMR+V\ngroup and 211 (28.4% [95% CI: 25.1\u201331.7]) in the MMR control\ngroup.", "mimetype": "text/plain", "start_char_idx": 14911, "end_char_idx": 16588, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6d67bcea-9c99-49e4-8e39-88c4b5abecc7": {"__data__": {"id_": "6d67bcea-9c99-49e4-8e39-88c4b5abecc7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1ccf0c49-7f3b-476f-8be8-3ecf0ba299e6", "node_type": "1", "metadata": {}, "hash": "d6924eddfea9d7a71491a68757519ca0519abf102746a4a83d2b49ea3d420cf4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "14d0f3d1-58ba-4fc3-9aef-d8e707748e28", "node_type": "1", "metadata": {}, "hash": "23a2cf6ed9e3860f8ebd310d07404c4d68417802d50b31d8d2f9e141cf08c6f3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The VE of two doses of MMRV against all and against mod-\nerate or severe varicella was 95.0% (95% CI: 93.6\u201396.2) and 99.0%\n(95% CI: 97.7\u201399.6), respectively. Ef\ufb01cacy of one dose of varicella\nvaccine (MMR+V) against all and against moderate or severe vari-\ncella was 67.0% (95% CI: 61.8\u201371.4) and 90.3% (95% CI: 86.9\u201392.8),\nrespectively. After a median follow-up of 3.3 years, similar ef\ufb01cacy\nwas observed in phase B alone (Table 2).\nNo severe con\ufb01rmed varicella was reported in the MMRV group\n(receiving 2 doses of varicella vaccine) and one case was reported\nin the MMR+V group (receiving 1 dose of varicella vaccine) as com-\npared to six cases in the MMR control group (receiving no varicella\nvaccine). The majority of con\ufb01rmed \ufb01rst varicella cases were mild\nin the MMRV and MMR+V groups (91.5% [95% CI: 82.5\u201396.8] and\n87.1% [95% CI: 83.5\u201390.2], respectively); more than half of the\ncases in the MMR control group were moderately severe or severe\n(Table 3).\nAmong the children who developed a breakthrough case of vari-\ncella in the MMRV and MMR+V groups during the follow-up per-\niod, the majority (87.3% [95% CI: 77.3\u201394.0] and 76.6% [95% CI:\n72.3\u201380.6], respectively) had \u000150 lesions.", "mimetype": "text/plain", "start_char_idx": 16589, "end_char_idx": 17778, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "14d0f3d1-58ba-4fc3-9aef-d8e707748e28": {"__data__": {"id_": "14d0f3d1-58ba-4fc3-9aef-d8e707748e28", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6d67bcea-9c99-49e4-8e39-88c4b5abecc7", "node_type": "1", "metadata": {}, "hash": "831ea8c6a4c489fdeca4db03299123fbb0771406e99a23b748088d9e5c05c95c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "022b209b-2a85-4821-ab1d-f05c184541c3", "node_type": "1", "metadata": {}, "hash": "c80c0ee719b174ea5d75f5f4b39fee2b8a966771dd81b5d5129a3be9e60a66c3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "33.8% [95% CI: 28.7\u2013\n39.3] of those with con\ufb01rmed varicella disease in the MMR control\ngroup exhibited 1\u201350 lesions and the majority had >50 lesions\n(32.6% [95% CI: 27.5\u201338.0] with 51\u2013100 lesions, 29.5% [95% CI:\n24.6\u201334.8] with 101\u2013500 lesions and 3.7% [95% CI: 1.9\u20136.4] with\n>500\nlesions).\nWithin\neach\ngroup,\nsimilar\ndistribution\nwas\nobserved by severity or by number of lesions in phase B compared\nto phase A + B (Table 3).\nIn phase A + B, the majority of \ufb01rst con\ufb01rmed varicella cases\nthat exhibited predominantly vesicular lesions ranged from 46.5%\n(95% CI: 34.5\u201358.7) in the MMRV group to 70.8% (95% CI: 65.5\u2013\n75.7) (Table 3). In phase B, most \ufb01rst con\ufb01rmed varicella cases\nexhibited predominantly papular lesions in the MMRV (45.0 [95%\nCI: 29.3\u201361.5]) and MMR+V (50.8 [95% CI: 43.4\u201358.2]) groups,\nO. Henry et al. / Vaccine 36 (2018) 381\u2013387\n383\nwhile in the MMR group the majority of cases (51.2 [95% CI: 42.1\u2013\n60.2]) exhibited vesicular lesions (Table 3).\nThe highest rates of con\ufb01rmed varicella cases over time were\nrecorded from October to June in the MMR group.\nThere were three con\ufb01rmed HZ cases (one in MMR+V group and\ntwo in MMR group); all were mild and all children had a previous\nPCR-con\ufb01rmed varicella case; all con\ufb01rmed HZ cases tested posi-\ntive for the wild-type virus.", "mimetype": "text/plain", "start_char_idx": 17779, "end_char_idx": 19068, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "022b209b-2a85-4821-ab1d-f05c184541c3": {"__data__": {"id_": "022b209b-2a85-4821-ab1d-f05c184541c3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "14d0f3d1-58ba-4fc3-9aef-d8e707748e28", "node_type": "1", "metadata": {}, "hash": "23a2cf6ed9e3860f8ebd310d07404c4d68417802d50b31d8d2f9e141cf08c6f3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "932873de-b58e-4e0c-a797-f60b1d74cce1", "node_type": "1", "metadata": {}, "hash": "a74e39fd15db7cd1ba4eb2ea5ee53264d51d42a9530a058e5b555a9c2f8e566f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The interval between the onset of pri-\nTable 1\nDemographic characteristics of the children in phase A + B and phase B of the study (ATP cohort for ef\ufb01cacy).\nCharacteristic\nPhase A + B\nPhase B\nMMRV\nMMR+V\nControl\nMMRV\nMMR+V\nControl\n(N = 2279)\n(N = 2266)\n(N = 744)\n(N = 1802)\n(N = 1593)\n(N = 396)\nMean age (months) at \ufb01rst vaccine dose \u00b1 SD\n14.2 \u00b1 2.5\n14.2 \u00b1 2.4\n14.3 \u00b1 2.5\n14.3 \u00b1 2.4\n14.2 \u00b1 2.5\n14.1 \u00b1 2.4\nGender\nFemale, n (%)\n1057 (46.4)\n1109 (48.9)\n360 (48.4)\n826 (45.8)\n793 (49.8)\n186 (47.0)\nEthnicity\nWhite \u2013 Caucasian heritage, n (%)\n2227 (97.7)\n2227 (98.3)\n737 (99.1)\n1763 (97.8)\n1573 (98.7)\n393 (99.2)\nArabic/North African heritage, n (%)\n21 (0.9)\n7 (0.3)\n2 (0.3)\n14 (0.8)\n2 (0.1)\n1 (0.3)\nOther, n (%)\n31 (1.4)\n32 (1.4)\n5 (0.6)\n25 (1.4)\n18 (1.2)\n2 (0.5)\nCountry\nCzech Republic, n (%)\n525 (23.0)\n516 (22.8)\n171 (23.0)\n507 (28.1)\n412 (25.9)\n82 (20.7)\nGreece, n (%)\n115 (5.0)\n113 (5.0)\n32 (4.3)\n\u2013\n\u2013\n\u2013\nItaly, n (%)\n106 (4.7)\n109 (4.8)\n35 (4.7)\n89 (4.9)\n82 (5.1)\n16 (4.0)\nLithuania, n (%)\n256 (11.2)\n255 (11.3)\n86 (11.6)\n241 (13.4)\n218 (13.", "mimetype": "text/plain", "start_char_idx": 19069, "end_char_idx": 20109, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "932873de-b58e-4e0c-a797-f60b1d74cce1": {"__data__": {"id_": "932873de-b58e-4e0c-a797-f60b1d74cce1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "022b209b-2a85-4821-ab1d-f05c184541c3", "node_type": "1", "metadata": {}, "hash": "c80c0ee719b174ea5d75f5f4b39fee2b8a966771dd81b5d5129a3be9e60a66c3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "89257aff-5380-433c-9826-af5c536d653f", "node_type": "1", "metadata": {}, "hash": "650043c429f7fcf58674930a25f04eef4012520cfbc2817121fe5c4b2b03bb37", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "9)\n82 (5.1)\n16 (4.0)\nLithuania, n (%)\n256 (11.2)\n255 (11.3)\n86 (11.6)\n241 (13.4)\n218 (13.7)\n65 (16.4)\nNorway, n (%)\n74 (3.2)\n76 (3.4)\n25 (3.4)\n65 (3.6)\n57 (3.6)\n10 (2.5)\nPoland, n (%)\n385 (16.9)\n368 (16.2)\n116 (15.6)\n350 (19.4)\n320 (20.1)\n89 (22.5)\nRomania, n (%)\n121 (5.3)\n126 (5.6)\n42 (5.6)\n81 (4.5)\n75 (4.7)\n24 (6.1)\nRussia, n (%)\n378 (16.6)\n392 (17.3)\n130 (17.5)\n181 (10.0)\n185 (11.6)\n49 (12.4)\nSlovakia, n (%)\n199 (8.7)\n195 (8.6)\n68 (9.1)\n191 (10.6)\n173 (10.9)\n46 (11.6)\nSweden, n (%)\n120 (5.3)\n116 (5.1)\n39 (5.2)\n97 (5.4)\n71 (4.5)\n15 (3.8)\nCare type\nAt least one sibling at home, n (%)\n655 (28.7)\n592 (26.1)\n192 (25.8)\n528 (29.3)\n397 (24.9)\n93 (23.5)\nAttending day care center, n (%)\n525 (23.0)\n546 (24.1)\n187 (25.1)\n356 (19.8)\n320 (20.1)\n78 (19.7)\nAttending a childminder, n (%)\n148 (6.5)\n155 (6.8)\n57 (7.7)\n106 (5.9)\n94 (5.9)\n25 (6.3)\nAt least once a week contact,a n (%)\n2051 (90.0)\n2055 (90.7)\n680 (91.4)\n1618 (89.8)\n1449 (91.0)\n363 (91.7)\nATP, according-to-protocol; N,", "mimetype": "text/plain", "start_char_idx": 20020, "end_char_idx": 21000, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "89257aff-5380-433c-9826-af5c536d653f": {"__data__": {"id_": "89257aff-5380-433c-9826-af5c536d653f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "932873de-b58e-4e0c-a797-f60b1d74cce1", "node_type": "1", "metadata": {}, "hash": "a74e39fd15db7cd1ba4eb2ea5ee53264d51d42a9530a058e5b555a9c2f8e566f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e339712a-495d-4f2a-921a-802e2815b390", "node_type": "1", "metadata": {}, "hash": "47744498ebe065c2b0e64c7eaa7ddf3d88049612695e1124301b066db53463cc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "0)\n2055 (90.7)\n680 (91.4)\n1618 (89.8)\n1449 (91.0)\n363 (91.7)\nATP, according-to-protocol; N, total number of children in the respective phase; SD, standard deviation; n (%), number (percentage) of children in a given category; other,\nBlack, East/South East Asian, American Hispanic, Japanese and other heritage.\nNote: demographic characteristics for phase A have previously been presented.\na With other children without a known positive history of varicella disease or vaccination.\nFig. 1. Flow chart of children in the study with reasons for elimination from according-to-protocol analyses. N, number of children in each group/cohort; ATP, according-to-\nprotocol; MMRV, children who received two doses of the combined measles-mumps-rubella-varicella vaccine (at Day 0 and Day 42); MMR+V, children who received one dose\nof MMR (at Day 0) and one dose of monovalent varicella vaccine (at Day 42); MMR, children who received two doses of the measles-mumps-rubella vaccine (active control, at\nDay 0 and Day 42).\n384\nO. Henry et al. / Vaccine 36 (2018) 381\u2013387\nmary disease and the onset of HZ was between 15 and 57 months.\nTwo cases (one in MMR+V and one in MMR group) had papular and\none (MMR group) had vesicular lesions.\n3.3. Antibody persistence\nTwo doses of MMRV and one dose of MMR+V induced antibody\nresponses against VZV that persisted for up to 6 years after vacci-\nnation, with GMCs at least 5-fold greater than the seroconversion\nthreshold at all time points assessed, with and without censoring\nof post-infection data. Compared to Year 2, anti-VZV concentra-\ntions also increased in the MMR group at Year 4 and Year 6, with\na value 3.6-fold greater than the threshold being observed at Year\n6 (Fig. 2).", "mimetype": "text/plain", "start_char_idx": 20909, "end_char_idx": 22619, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e339712a-495d-4f2a-921a-802e2815b390": {"__data__": {"id_": "e339712a-495d-4f2a-921a-802e2815b390", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "89257aff-5380-433c-9826-af5c536d653f", "node_type": "1", "metadata": {}, "hash": "650043c429f7fcf58674930a25f04eef4012520cfbc2817121fe5c4b2b03bb37", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7dfb43b1-c99e-4a84-88f9-f0abed1a0aba", "node_type": "1", "metadata": {}, "hash": "d8c8802f3ac43bc59f5f3b528691d2678d8825373ed585f6ca36325a7198beb9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2). The percentage of seronegative children in the control\ngroup decreased from 97.8% (95% CI: 95.0\u201399.3) (at Day 42) to\n44.9% (95% CI: 37.4\u201352.6) (at Year 6). By country (except Greece,\nwhere centers were closed prior to the start of Phase B due to\nimplementation of varicella vaccination program), at year 6, the\nproportion of seronegative children varied from 0% (95% CI: 0\u2013\n28.5) in Romania to 80% (95% CI: 28.4\u201399.5) in Sweden.\n3.4. Safety\nFrom the start of phase B to Year 6, a total of 570 SAEs were\nreported for 422 children; none of the SAEs were fatal or consid-\nered vaccine-related by the investigator.\nFour children reported SAEs (leukemia, rhabdomyosarcoma,\nlymphadenopathy, and thrombocytopenia) that resulted in with-\ndrawal from the study.\n4. Discussion\nThis is, to our knowledge, the \ufb01rst study to assess the\nVE of one- or two-dose varicella vaccination, in the presence\nof a control group, over a period of approximately 6 years.\nData on longer term protection (10 years) is currently being\ncollected.\nAfter a follow-up of 6 years (median: 6.4 years), the ef\ufb01cacy of\ntwo doses of MMRV against all varicella and against moderate to\nsevere varicella was >95%. This protection was greater than that\nprovided by one dose of MMR+V, which had an ef\ufb01cacy against\nall varicella of 67.0%, and against moderate to severe varicella of\n>90.0%. Compared to Year 3 data [14] it can be observed that pro-\ntection against varicella was sustained for up to 6 years post-\nvaccination, as there was no diminution of VE.", "mimetype": "text/plain", "start_char_idx": 22616, "end_char_idx": 24135, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7dfb43b1-c99e-4a84-88f9-f0abed1a0aba": {"__data__": {"id_": "7dfb43b1-c99e-4a84-88f9-f0abed1a0aba", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e339712a-495d-4f2a-921a-802e2815b390", "node_type": "1", "metadata": {}, "hash": "47744498ebe065c2b0e64c7eaa7ddf3d88049612695e1124301b066db53463cc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "96ca1451-2e10-4bfd-a3e3-90ebeb8db844", "node_type": "1", "metadata": {}, "hash": "07543161405d35382157f95ecdac0a8a318208ec07c3d815b4d509e468bd644b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Compared to Year 3 data [14] it can be observed that pro-\ntection against varicella was sustained for up to 6 years post-\nvaccination, as there was no diminution of VE. It is also notable\nthat the vast majority of breakthrough varicella cases in the MMRV\nand MMR+V groups (87.3% and 76.6%, respectively) were mild (<50\nlesions). In the control group varicella cases with <50 lesions\noccurred in only 33.8% of the children. The incidence of HZ in the\ncontrol group is too low to comment on the impact of vaccination\non this disease although it can be noted that there were no\nreported cases in the MMRV group.\nTable 2\nVaccine ef\ufb01cacy against all, moderate and severe, and severe con\ufb01rmed varicella cases (A) from six weeks after dose 2, or (B) from the beginning of phase B until data lock point\nfor the Year 6 analysis (ATP cohort for ef\ufb01cacy).", "mimetype": "text/plain", "start_char_idx": 23967, "end_char_idx": 24811, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "96ca1451-2e10-4bfd-a3e3-90ebeb8db844": {"__data__": {"id_": "96ca1451-2e10-4bfd-a3e3-90ebeb8db844", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7dfb43b1-c99e-4a84-88f9-f0abed1a0aba", "node_type": "1", "metadata": {}, "hash": "d8c8802f3ac43bc59f5f3b528691d2678d8825373ed585f6ca36325a7198beb9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8509db5f-77a6-4649-8925-0ae1116beb27", "node_type": "1", "metadata": {}, "hash": "7333df93224e0b5bd9ba1010bc2069b8a2dfb85f795f086ae7002395b78c7ac7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Disease severity\nStudy group\nPhase A + B\nPhase B\nn/N\nVaccine ef\ufb01cacy (95% CI)\nn/N\nVaccine ef\ufb01cacy (95% CI)\nAll varicella cases\nMMRV\n71/2279\n95.0 (93.6\u201396.2)\n33/1800\n95.3 (93.1\u201396.8)\nMMR+V\n419/2266\n67.0 (61.8\u201371.4)\n176/1592\n69.5 (61.5\u201375.8)\nModerate or severe varicella cases\nMMRV\n6/2279\n99.0 (97.7\u201399.6)\n4/1800\n98.4 (95.5\u201399.4)\nMMR+V\n58/2266\n90.3 (86.9\u201392.8)\n18/1592\n91.8 (85.9\u201395.2)\nSevere varicella cases\nMMRV\n0/2279\n100 (unde\ufb01ned)\n0/1800\n100 (unde\ufb01ned)\nMMR+V\n1/2266\n94.6 (55.3\u201399.4)\n0/1592\n100 (unde\ufb01ned)\nCon\ufb01rmed varicella case, a case that met the clinical case de\ufb01nition and the PCR result was positive, or met the clinical de\ufb01nition, was con\ufb01rmed by the Independent Data\nMonitoring Committee and was epidemiologically linked to a valid index case [14]; ATP, according-to-protocol; MMRV, children who received two doses of the combined\nmeasles-mumps-rubella-varicella vaccine (at Day 0 and Day 42); MMR+V, children who received one dose of MMR (at Day 0) and one dose of monovalent varicella vaccine (at\nDay 42); N, number of children included in each group (without missing values); n, number of children reporting at least one event in each group; CI, con\ufb01dence interval.\nTable 3\nDisease severity and number of lesions for the \ufb01rst con\ufb01rmed varicella cases (ATP cohort for ef\ufb01cacy).", "mimetype": "text/plain", "start_char_idx": 24812, "end_char_idx": 26102, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8509db5f-77a6-4649-8925-0ae1116beb27": {"__data__": {"id_": "8509db5f-77a6-4649-8925-0ae1116beb27", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "96ca1451-2e10-4bfd-a3e3-90ebeb8db844", "node_type": "1", "metadata": {}, "hash": "07543161405d35382157f95ecdac0a8a318208ec07c3d815b4d509e468bd644b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aca3613b-2e60-4eee-b439-ab69b9ed740b", "node_type": "1", "metadata": {}, "hash": "e8c3afc728d5792c241566bf93a8676fc8f8051aeb2ab0412ef16d421650faae", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Table 3\nDisease severity and number of lesions for the \ufb01rst con\ufb01rmed varicella cases (ATP cohort for ef\ufb01cacy).\nPhase A + B\nPhase B\nPercentage of all cases (95% CI)\nPercentage of all cases (95% CI)\nMMRV\nN = 71\nMMR+V\nN = 419\nMMR\nN = 325\nMMRV\nN = 40\nMMR+V\nN = 185\nMMR\nN = 125\nSeverity\nAccording to disease severity\nMild\n91.5 (82.5\u201396.8)\n87.1 (83.5\u201390.2)\n48.9 (43.4\u201354.5)\n90.0 (76.3\u201397.2)\n90.3 (85.1\u201394.1)\n59.2 (50.1\u201367.9)\nModerately severe\n8.5 (3.2\u201317.5)\n12.9 (9.8\u201316.5)\n49.2 (43.7\u201354.8)\n10.0 (2.8\u201323.7)\n9.7 (5.9\u201314.9)\n37.6 (29.1\u201346.7)\nSevere\n0.0 (0.0\u20135.1)\n0.0 (0.0\u20130.9)\n1.8 (0.7\u20134.0)\n0.0 (0.0\u20138.8)\n0.0 (0.0\u20132.0)\n3.2 (0.9\u20138.0)\nNumber of lesions\nAccording to number of lesions\n1\u201350\n87.3 (77.3\u201394.0)\n76.6 (72.3\u201380.6)\n33.8 (28.7\u201339.3)\n80.0 (64.4\u201390.9)\n79.5 (72.9\u201385.0)\n48.8 (39.8\u201357.9)\n51\u2013100\n11.3 (5.0\u201321.0)\n16.7 (13.3\u201320.6)\n32.6 (27.5\u201338.0)\n17.5 (7.3\u201332.8)\n14.1 (9.4\u201319.9)\n26.4 (18.9\u201335.", "mimetype": "text/plain", "start_char_idx": 25992, "end_char_idx": 26875, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aca3613b-2e60-4eee-b439-ab69b9ed740b": {"__data__": {"id_": "aca3613b-2e60-4eee-b439-ab69b9ed740b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8509db5f-77a6-4649-8925-0ae1116beb27", "node_type": "1", "metadata": {}, "hash": "7333df93224e0b5bd9ba1010bc2069b8a2dfb85f795f086ae7002395b78c7ac7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "68a7b4b4-e8e2-4938-a35c-f86b4b650d4b", "node_type": "1", "metadata": {}, "hash": "56e2008336b672e63b31aadae0dd3e9034083c6e7b02fa64612011700b0240cc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "6)\n32.6 (27.5\u201338.0)\n17.5 (7.3\u201332.8)\n14.1 (9.4\u201319.9)\n26.4 (18.9\u201335.0)\n101\u2013500\n1.4 (0.0\u20137.6)\n5.7 (3.7\u20138.4)\n29.5 (24.6\u201334.8)\n2.5 (0.1\u201313.2)\n5.4 (2.6\u20139.7)\n20.0 (13.4\u201328.1)\n\u0003501\n0.0 (0.0\u20135.1)\n0.2 (0.0\u20131.3)\n3.7 (1.9\u20136.4)\n0.0 (0.0\u20138.8)\n0.0 (0.0\u20132.0)\n4.8 (1.8\u201310.2)\nPredominant type of lesions\nAccording to predominant type of lesions\nMacular\n8.5 (3.2\u201317.5)\n2.1 (1.0\u20134.0)\n0.0 (0.0\u20131.1)\n10.0 (2.8\u201323.7)\n3.2 (1.2\u20136.9)\n0.8 (0.0\u20134.4)\nPapular\n42.3 (30.6\u201354.6)\n45.1 (40.3\u201350.0)\n26.5 (21.7\u201331.6)\n45.0 (29.3\u201361.5)\n50.8 (43.4\u201358.2)\n45.6 (36.7\u201354.7)\nVesicular\n46.5 (34.5\u201358.7)\n51.1 (46.2\u201356.0)\n70.8 (65.5\u201375.7)\n40.0 (24.9\u201356.7)\n42.2 (35.0\u201349.6)\n51.2 (42.1\u201360.2)\nHemorrhagic\n2.8 (0.3\u20139.8)\n1.0 (0.3\u20132.4)\n2.5 (1.1\u20134.8)\n5.0 (0.6\u201316.9)\n2.2 (0.6\u20135.4)\n2.", "mimetype": "text/plain", "start_char_idx": 26809, "end_char_idx": 27538, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "68a7b4b4-e8e2-4938-a35c-f86b4b650d4b": {"__data__": {"id_": "68a7b4b4-e8e2-4938-a35c-f86b4b650d4b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aca3613b-2e60-4eee-b439-ab69b9ed740b", "node_type": "1", "metadata": {}, "hash": "e8c3afc728d5792c241566bf93a8676fc8f8051aeb2ab0412ef16d421650faae", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "021d82cc-c6f3-4443-9d9f-1072049b3722", "node_type": "1", "metadata": {}, "hash": "2674997d1cf54a7fb0bf165b136e7f0ef0df5bec6afabb658dcad608171f0b3f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "0 (0.3\u20132.4)\n2.5 (1.1\u20134.8)\n5.0 (0.6\u201316.9)\n2.2 (0.6\u20135.4)\n2.4 (0.5\u20136.9)\nATP, according-to-protocol; MMRV, children who received two doses of the combined measles-mumps-rubella-varicella vaccine (at Day 0 and Day 42); MMR+V, children who\nreceived one dose of MMR (at Day 0) and one dose of monovalent varicella vaccine (at Day 42); MMR, children who received two doses of the measles-mumps-rubella vaccine\n(active control, at Day 0 and Day 42); N, number of children with varicella cases in each group. Disease severity was: mild disease (\u00017 points); moderately severe disease (8\u2013\n15 points); severe disease (\u000316 points) scored by Independent Data Monitoring Committee using the modi\ufb01ed V\u00e1zquez scale [17].\nO. Henry et al. / Vaccine 36 (2018) 381\u2013387\n385\nIn the control group, at year 6, there were still 79 children\n(44.9%) seronegative for anti-VZV antibodies and these children\nremaining susceptible to VZV infection/disease. The increase in\nGMC overtime in the control group despite post-infection data\nbeing considered missing indicates that there is a degree of under-\nreporting of varicella cases or subjects are experiencing subclinical\nvaricella infection. If this proportion is generalized to the entire\nremaining control group, an ef\ufb01cacy estimate at 10 years is\nexpected to be informative.\nFrom 3 to 6 years post-vaccination no safety concerns were\nidenti\ufb01ed, with none of the SAEs being assessed by the investiga-\ntors as vaccine-related. These results support the vaccines\u2019 known\nclinically acceptable safety pro\ufb01les [21].\nThe strengths of this trial, conferring it robustness, are its\nmultinational and multiyear design, the inclusion of a control\ngroup, its rigorous case con\ufb01rmation procedures, and the fact\nthat it was not conducted in countries with UMV against vari-\ncella.", "mimetype": "text/plain", "start_char_idx": 27481, "end_char_idx": 29270, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "021d82cc-c6f3-4443-9d9f-1072049b3722": {"__data__": {"id_": "021d82cc-c6f3-4443-9d9f-1072049b3722", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "68a7b4b4-e8e2-4938-a35c-f86b4b650d4b", "node_type": "1", "metadata": {}, "hash": "56e2008336b672e63b31aadae0dd3e9034083c6e7b02fa64612011700b0240cc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7be29463-6861-4ab3-8c9a-1bf2d8f47141", "node_type": "1", "metadata": {}, "hash": "14a97416d3649c783f3c1f095877f2c8d666419c0b411d8be09651724a70cd3c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The fact that active surveillance was done to identify vari-\ncella cases and that a blinded adjudication committee was used\nto assess suspected cases are also strong points. Some of its\nlimitations include loss to follow-up over the cohort\u2019s periods,\nracial homogeneity of the children, not all cases being presented\n(and even when presented no systematic picture record) and\nunblinding of some children in the MMR+V group (could be\nbiased if parents brought children with rash illness to medical\nattention).\nOur data suggest that implementation of two-dose varicella\nvaccination in children during their second year of life ensures\noptimum protection against all forms of varicella disease.\n5. Conclusions\nThe ef\ufb01cacy of two doses of MMRV and one dose of MMR+V per-\nsisted through >6 years post-vaccination, with two doses of MMRV\nbeing highly ef\ufb01cacious against varicella of any severity and one\ndose of MMR+V being highly ef\ufb01cacious against moderate/severe\ndisease with moderate protection against milder disease. No safety\nissues were identi\ufb01ed.\nTrademark statement\nVarilrix, Priorix and Priorix-Tetra are trademarks of the GSK\ngroup of companies.\nFunding\nGlaxoSmithKline Biologicals SA was the funding source and was\ninvolved\nin\nall\nstages\nof\nthe\nstudy\nconduct\nand\nanalysis.\nGlaxoSmithKline Biologicals SA also took responsibility for all costs\nassociated with the development and publishing of the present\nmanuscript.\nAuthor\u2019s contribution\nOH and BI contributed to the conception, design and planning of\nthe study. MP contributed as statistician to the method and selec-\ntion development, the statistical data analysis, the reporting of\ndata and the assessment of robustness of this manuscript. All\nauthors contributed to the acquisition and review of the data. JB,\nHC, GL, OR, RG, PP, DP, MGD, RK and GG recruited patients. All\nauthors contributed to the interpretation of data and the drafting\nof the report. They revised it critically for important intellectual\ncontent and approved the version to be published.", "mimetype": "text/plain", "start_char_idx": 29271, "end_char_idx": 31291, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7be29463-6861-4ab3-8c9a-1bf2d8f47141": {"__data__": {"id_": "7be29463-6861-4ab3-8c9a-1bf2d8f47141", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "021d82cc-c6f3-4443-9d9f-1072049b3722", "node_type": "1", "metadata": {}, "hash": "2674997d1cf54a7fb0bf165b136e7f0ef0df5bec6afabb658dcad608171f0b3f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "882a92c5-0a84-4013-bcda-a6de97d78293", "node_type": "1", "metadata": {}, "hash": "53ab38d592317ec9cafbee4996f27f7a95bdeb9831d82c7dfa98cd3397a8f3b0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All\nauthors contributed to the interpretation of data and the drafting\nof the report. They revised it critically for important intellectual\ncontent and approved the version to be published.\nCon\ufb02ict of interest\nAll authors have completed the ICMJE uniform disclosure form\nat www.icmje.org/coi_disclosure.pdf and declare: Ouzama Henry\nand Michael Povey are employed by the GSK group of companies.\nBruce Innis was employed by the GSK group of companies at the\ntime of the study and is now an employee of PATH. Bruce Innis\nand Ouzama Henry hold shares in the GSK group of companies\nas part of their employee remuneration. Giovanni Gabutti\u2019s\nprevious institute (LHU4 \u2018\u2018Chiavarese\u201d, Liguria Region) received\npayment for his participation as a principal investigator in the trial;\nhe has received payment from the GSK group of companies, Sano\ufb01\nPasteur, MSD Italy and Sequirus for participation as a board\nFig. 2. Anti-VZV GMCs and seroresponse to varicella vaccination in initially seronegative children with post-infection data considered missing (adapted persistence cohort).\nGMC, geometric mean concentration; CI, con\ufb01dence interval; VZV, varicella zoster virus; MMRV, children who received two doses of the combined measles-mumps-rubella-\nvaricella vaccine (at Day 0 and Day 42); MMR+V, children who received one dose of MMR (at Day 0) and one dose of monovalent varicella vaccine (at Day 42); MMR, children\nwho received two doses of the measles-mumps-rubella vaccine (active control, at Day 0 and Day 42); N, number of children with available results; %, percentage of children\nwith anti-VZV concentration \u0003 25 mIU/mL. Error bars depict 95% CIs.\n386\nO. Henry et al. / Vaccine 36 (2018) 381\u2013387\nmember, and received consulting and lecture fees from the GSK\ngroup of companies, Novartis, Sano\ufb01Pasteur MSD, and P\ufb01zer.\nHanna Czajka received payment for her participation as a principal\ninvestigator in this trial.", "mimetype": "text/plain", "start_char_idx": 31102, "end_char_idx": 33009, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "882a92c5-0a84-4013-bcda-a6de97d78293": {"__data__": {"id_": "882a92c5-0a84-4013-bcda-a6de97d78293", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7be29463-6861-4ab3-8c9a-1bf2d8f47141", "node_type": "1", "metadata": {}, "hash": "14a97416d3649c783f3c1f095877f2c8d666419c0b411d8be09651724a70cd3c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3acb2c33-0ba9-462b-a85a-44844c2fdd72", "node_type": "1", "metadata": {}, "hash": "f7fe3c1b46c413b0ae755d62092177a5c711d22b51d9dace1abd7ac0d74e295f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Hanna Czajka received payment for her participation as a principal\ninvestigator in this trial. All other authors declare no potential con-\n\ufb02ict of interest.\nAcknowledgments\nThe authors thank the children who participated in the study\nand their parents/guardians. The authors also thank the Adjudica-\ntion Committee, Adrian Kremer (XPE Pharma & Science, Belgium c/\no GSK) for publication management, and Lucia Adina Truta and\nAlp\u00e1r P\u00f6llnitz (XPE Pharma & Science c/o GSK) for drafting the\nmanuscript.\nReferences\n[1] WHO. Varicella and herpes zoster vaccines: WHO position paper. Wkly\nEpidemiol Rec 2014;89:265\u201388.\n[2] Lopez AS, Guris D, Zimmerman L, Gladden L, Moore T, Haselow DT, et al. One\ndose of varicella vaccine does not prevent school outbreaks: is it time for a\nsecond dose? Pediatrics 2006;117:e1070\u20137.\n[3] Leung J, Harpaz R. Impact of the maturing varicella vaccination program on\nvaricella and related outcomes in the United States: 1994\u20132012. J Ped Infect\nDis Soc 2016;5:395\u2013402.\n[4] Lopez AS, Zhang J, Brown C, Bialek S. Varicella-related hospitalizations in the\nUnited States, 2000\u20132006: the 1-dose varicella vaccination era. Pediatrics\n2011;127:238\u201345.\n[5] Papaloukas O, Giannouli G, Papaevangelou V. Successes and challenges in\nvaricella vaccine. Ther Adv Vaccines 2014;2:39\u201355.\n[6] Quian J, Ruttimann R, Romero C, Dall\u2019Orso P, Cerisola A, Breuer T, et al. Impact\nof universal varicella vaccination on 1-year-olds in Uruguay: 1997\u20132005. Arch\nDis Child 2008;93:845\u201350.\n[7] Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V,\net al.", "mimetype": "text/plain", "start_char_idx": 32915, "end_char_idx": 34483, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3acb2c33-0ba9-462b-a85a-44844c2fdd72": {"__data__": {"id_": "3acb2c33-0ba9-462b-a85a-44844c2fdd72", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "882a92c5-0a84-4013-bcda-a6de97d78293", "node_type": "1", "metadata": {}, "hash": "53ab38d592317ec9cafbee4996f27f7a95bdeb9831d82c7dfa98cd3397a8f3b0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6836d020-1f7b-4a2e-8d6e-68a010f0e520", "node_type": "1", "metadata": {}, "hash": "8f28987f07a5e1c048bb86cc4279f7988c017b7a4b81ab3d7e9fab445d4af204", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "[7] Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V,\net al. Varicella vaccination in Europe \u2013 taking the practical approach. BMC Med\n2009;7:26.\n[8] EMA. Priorix \u2013 summary of product characteristics. Available at <http://www.\nema.europa.eu/docs/en_GB/document_library/Referrals_document/Priorix_\n30/WC500124199.pdf> [accessed Feb 2017].\n[9] Varilrix.\nProduct\ninformation.\nAvailable\nat\n<https://au.gsk.com/media/\n265139/varilrix_pi_008_approved.pdf> [accessed Feb 2017].\n[10] Durando P, Esposito S, Bona G, Cuccia M, Desole MG, Ferrera G, et al. The\nimmunogenicity and safety of a tetravalent measles-mumps-rubella-varicella\nvaccine when co-administered with conjugated meningococcal C vaccine to\nhealthy children: a phase IIIb, randomized, multi-center study in Italy. Vaccine\n2016;34:4278\u201384.\n[11] Goh P, Lim FS, Han HH, Willems P. Safety and immunogenicity of early\nvaccination with two doses of tetravalent measles-mumps-rubella-varicella\n(MMRV) vaccine in healthy children from 9 months of age. Infection\n2007;35:326\u201333.\n[12] Knuf M, Habermehl P, Zepp F, Mannhardt W, Kuttnig M, Muttonen P, et al.\nImmunogenicity and safety of two doses of tetravalent measles-mumps-\nrubella-varicella vaccine in healthy children. Pediatr Infect Dis J 2006;25:12\u20138.\n[13] Lalwani S, Chatterjee S, Balasubramanian S, Bavdekar A, Mehta S, Datta S, et al.\nImmunogenicity and safety of early vaccination with two doses of a combined\nmeasles-mumps-rubella-varicella vaccine in healthy Indian children from 9\nmonths of age: a phase III, randomised, non-inferiority trial.", "mimetype": "text/plain", "start_char_idx": 34399, "end_char_idx": 35974, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6836d020-1f7b-4a2e-8d6e-68a010f0e520": {"__data__": {"id_": "6836d020-1f7b-4a2e-8d6e-68a010f0e520", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3acb2c33-0ba9-462b-a85a-44844c2fdd72", "node_type": "1", "metadata": {}, "hash": "f7fe3c1b46c413b0ae755d62092177a5c711d22b51d9dace1abd7ac0d74e295f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c765c0e7-d52b-455b-9a0c-ff60e064c3c1", "node_type": "1", "metadata": {}, "hash": "374943fd99b64e5db8d3a2b9be7070737fb1e5679e5dc4625f57e68cbaa60549", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BMJ Open 2015;5:\ne007202.\n[14] Prymula R, Bergsaker MR, Esposito S, Gothefors L, Man S, Snegova N, et al.\nProtection against varicella with two doses of combined measles-mumps-\nrubella-varicella vaccine versus one dose of monovalent varicella vaccine: a\nmulticentre,\nobserver-blind,\nrandomised,\ncontrolled\ntrial.\nThe\nLancet\n2014;383:1313\u201324.\n[15] World Medical Association Declaration of Helsinki. Ethical principles for\nmedical research involving human subjects. JAMA 2013;310:2191\u20134.\n[16] ICH.\nGuideline\nfor\ngood\nclinical\npractice;\n1996.\n<https://www.ich.\norg/\ufb01leadmin/Public_Web_Site/ICH_Products/Guidelines/Ef\ufb01cacy/E6/E6_R1_\nGuideline.pdf> [accessed Feb 2017].\n[17] V\u00e1zquez M, LaRussa PS, Gershon AA, Steinberg SP, Freudigman K, Shapiro ED.\nThe effectiveness of the varicella vaccine in clinical practice. New Engl J Med\n2001;344:955\u201360.\n[18] LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, Silverstein S. Restriction\nfragment length polymorphism of polymerase chain reaction products from\nvaccine and wild-type varicella-zoster virus isolates. J Virol 1992;66:1016\u201320.\n[19] Clopper CJ, Pearson ES. The use of con\ufb01dence or \ufb01ducial limits illustrated in\nthe case of the binomial. Biometrika 1934;26:404\u201313.\n[20] Cox\nDR.\nRegression\nmodels\nand\nlife-tables.\nJ\nRoy\nStat\nSoc\nB\nMet\n1972;34:187\u2013220.\n[21] Leung JH, Hirai HW, Tsoi KK. Immunogenicity and reactogenicity of tetravalent\nvaccine for measles, mumps, rubella and varicella (MMRV) in healthy children:\na\nmeta-analysis\nof\nrandomized\ncontrolled\ntrials.", "mimetype": "text/plain", "start_char_idx": 35975, "end_char_idx": 37486, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c765c0e7-d52b-455b-9a0c-ff60e064c3c1": {"__data__": {"id_": "c765c0e7-d52b-455b-9a0c-ff60e064c3c1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6836d020-1f7b-4a2e-8d6e-68a010f0e520", "node_type": "1", "metadata": {}, "hash": "8f28987f07a5e1c048bb86cc4279f7988c017b7a4b81ab3d7e9fab445d4af204", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ddf8cb74-3b72-4304-b445-850fe6a4ca99", "node_type": "1", "metadata": {}, "hash": "029c57dca0d6693ec13228082896f7683065e87ff90fde84bb60c84d92add14e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Expert\nRev\nVaccines\n2015;14:1149\u201357.\nO. Henry et al. / Vaccine 36 (2018) 381\u2013387\n387\nUpdate\nVaccine\nVolume 36, Issue 45, 29 October 2018, Page 6894\n https://doi.org/10.1016/j.vaccine.2018.09.022\nDOI:\nCorrigendum\nCorrigendum to \u2018\u2018One or two doses of live varicella virus-containing\nvaccines: Ef\ufb01cacy, persistence of immune responses, and safety six years\nafter administration in healthy children during their second year of life\u201d\n[Vaccine 36 (2018) 381\u2013387] q\nOuzama Henry a, Jerzy Brzostek b, Hanna Czajka c, Giedra Leviniene d, Olga Reshetko e, Roberto Gasparini f,\nPetr Pazdiora g, Doina Plesca h, Maria Giuseppina Desole i, Rimantas Kevalas d, Giovanni Gabutti j,\nMichael Povey k,\u21d1, Bruce Innis a\na Vaccine Discovery and Development, GSK, Philadelphia, United States\nb Poradnia Chor\u00f3b Zakaz\u00b4nych ZOZ De\u02dbbica, De\u02dbbica, Poland\nc Infectious Diseases Outpatient Clinic, The St.", "mimetype": "text/plain", "start_char_idx": 37487, "end_char_idx": 38363, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ddf8cb74-3b72-4304-b445-850fe6a4ca99": {"__data__": {"id_": "ddf8cb74-3b72-4304-b445-850fe6a4ca99", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c765c0e7-d52b-455b-9a0c-ff60e064c3c1", "node_type": "1", "metadata": {}, "hash": "374943fd99b64e5db8d3a2b9be7070737fb1e5679e5dc4625f57e68cbaa60549", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ac23e213-8735-4477-8133-1e048571dd7d", "node_type": "1", "metadata": {}, "hash": "0365fc49ebfd517ee08a746a0819849e3f7cac11a6327ae456d2ee947b08e7bc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Luis Provincial Specialist Children\u2019s Hospital, Cracow, Poland\nd Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania\ne Pharmacology, Saratov Medical University, Saratov, Russia\nf Department of Health Sciences, Genoa University, Genoa, Italy\ng Department of Epidemiology, Medical Faculty Pilsen of Charles University, Czech Republic\nh Pediatrics, University of Medicine and Pharmacy, Bucharest, Romania\ni Servizio di Igiene Pubblica, ASL Sassari, Italy\nj Department of Medical Sciences, University of Ferrara, Ferrara, Italy\nk Biostatistics, GSK, Wavre, Belgium\nThe authors regret to inform that in the last paragraph of the\nSection 3.2. describing the vaccine ef\ufb01cacy the section:\n\u2018\u2018There were three con\ufb01rmed HZ cases (one in MMR + V group\nand two in MMR group); all were mild and all children had a pre-\nvious PCR-con\ufb01rmed varicella case; three con\ufb01rmed HZ cases\ntested positive for the wild-type virus. The interval between the\nonset of primary disease and the onset of HZ was between 15\nand 57 months. Two cases (one in MMR + V and one in MMR\ngroup) had papular and one (MMR group) had vesicular lesions.\u201d\nis incorrect due to a mistake in the number of con\ufb01rmed HZ cases\nreported. The correct section is:\n\u2018\u2018There were four con\ufb01rmed HZ cases (two in MMR + V group\nand two in MMR group); all were mild and all children had a pre-\nvious PCR-con\ufb01rmed varicella case; three con\ufb01rmed HZ cases\ntested positive for the wild-type virus. The interval between the\nonset of primary disease and the onset of HZ was between 15\nand 57 months.", "mimetype": "text/plain", "start_char_idx": 38364, "end_char_idx": 39920, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ac23e213-8735-4477-8133-1e048571dd7d": {"__data__": {"id_": "ac23e213-8735-4477-8133-1e048571dd7d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ddf8cb74-3b72-4304-b445-850fe6a4ca99", "node_type": "1", "metadata": {}, "hash": "029c57dca0d6693ec13228082896f7683065e87ff90fde84bb60c84d92add14e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "25b25392-2296-4d44-ae31-5e5f6645ca0b", "node_type": "1", "metadata": {}, "hash": "d96ad002cf1c8c10884a90855019633f4baa5430afdbf81778e374988ff0a472", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The interval between the\nonset of primary disease and the onset of HZ was between 15\nand 57 months. Two cases (one in MMR + V and one in MMR\ngroup) had papular and two cases (one in MMR + V and one in\nMMR group) had vesicular lesions.\u201d\nWhile this does not impact neither the results of the study and\nits signi\ufb01cance nor the conclusion, we thought that was important\nto notify it in order to be aligned with what is mentioned in the\nconclusion of the abstract.\nThe authors would like to apologise for any inconvenience\ncaused.\nhttps://doi.org/10.1016/j.vaccine.2018.09.022\n0264-410X/\u0001 2018 GlaxoSmithKline SA. Published by Elsevier Ltd.\nThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).\nDOI of original article: https://doi.org/10.1016/j.vaccine.2017.11.081\nq Previous congress activities, if any: Partial data were presented as an abstract and presentation at the 33rd European Society for Paediatric Infectious Diseases\nConference (May 2015, Leipzig, Germany).\n\u21d1Corresponding author at: GSK, Avenue Fleming 20, 1300 Wavre, Belgium.\nE-mail addresses: ouzama.n.henry@gsk.com (O. Henry), jerzy_br@poczta.onet.pl (J. Brzostek), hanna.czajka@onet.pl (H. Czajka), giedralev@gmail.com (G. Leviniene),\nreshetko@yandex.ru (O. Reshetko), gasparini@unige.it (R. Gasparini), PAZDIORA@fnplzen.cz (P. Pazdiora), doinaplesca@yahoo.com (D. Plesca), madesole@aslsassari.it\n(M.G. Desole), rimantas.kevalas@kaunoklinikos.lt (R. Kevalas), giovanni.gabutti@unife.it (G. Gabutti), michael.x.povey@gsk.com (M. Povey), innisb00@gmail.com (B. Innis).", "mimetype": "text/plain", "start_char_idx": 39821, "end_char_idx": 41399, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "25b25392-2296-4d44-ae31-5e5f6645ca0b": {"__data__": {"id_": "25b25392-2296-4d44-ae31-5e5f6645ca0b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Henry (2018).pdf", "node_type": "4", "metadata": {}, "hash": "d6109a77235e55e42c1316e088417da7f2e4d55d5be4cfd1d5fdd309144fc99c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ac23e213-8735-4477-8133-1e048571dd7d", "node_type": "1", "metadata": {}, "hash": "0365fc49ebfd517ee08a746a0819849e3f7cac11a6327ae456d2ee947b08e7bc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine 36 (2018) 6894\nContents lists available at ScienceDirect\nVaccine\njournal homepage: www.elsevier.com/locate/vaccine", "mimetype": "text/plain", "start_char_idx": 41400, "end_char_idx": 41522, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "28d7e561-d3fa-4493-8beb-11f9a0aff374": {"__data__": {"id_": "28d7e561-d3fa-4493-8beb-11f9a0aff374", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2007).pdf", "node_type": "4", "metadata": {}, "hash": "3022dc13eee58127d843c2bcef4e4e36c4ea0ad9fb5c14eff80154a1e9d6f51f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "30439b62-bcdf-43d0-9264-c637c6eba573", "node_type": "1", "metadata": {}, "hash": "171c95c2a37e79bb2f9bb2d13c5e0f057dd8be9e70acc7f768ba27ea00b8b69e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ORIGINAL PAPER\nVaccinations, infections and antibacterials in the first grass pollen season of\nlife and risk of later hayfever\nS. A. Bremner\u0001, I. M. Carey\u0001, S. DeWilde\u0001, N. Richardsw, W. C. Maierz, S. R. Hilton\u0001, D. P. Strachan\u0001 and D. G. Cook\u0001\n\u0001Division of Community Health Sciences, St George\u2019s, University of London, London, UK, wCegedim Strategic Data, Send, Surrey, UK and zElan Pharma Ltd, Stevenage,\nHerts, UK\nClinical and\nExperimental\nAllergy\nCorrespondence:\nDerek G. Cook, Division of Community\nHealth Sciences, St George\u2019s, University\nof London, Cranmer Terrace, London\nSW17 0RE, UK.\nE-mail: d.cook@sgul.ac.uk\nSummary\nBackground It has been hypothesized that early-life exposure to vaccinations, infections or\nantibacterials in\ufb02uence allergic disease development. Concurrent exposure to grass pollens\nmay alter any effect.\nObjective To test the hypothesis that exposure to antibacterials, vaccinations (DTP or MMR) or\nspeci\ufb01c infections during the \ufb01rst grass pollen seasons of life in\ufb02uences the risk of hayfever\nmore than at any other time of the year.\nMethods Nested case\u2013control studies were based on birth cohorts within two large databases\nof computerized patient records from UK general practices: the General Practice Research\nDatabase (GPRD) and Doctors\u2019 Independent Network (DIN). Seven thousand ninety-eight\nhayfever cases, diagnosed after age 2, were matched to controls for practice, age, sex and\nfollow-up of control to case ascertainment date. Conditional logistic regression was used to\ncompare exposure by age 1 (age 2 for MMR) inside vs. outside the grass pollen season\n(May, June, July). Odds ratios (ORs) were pooled across databases.\nResults There were no associations in either database between MMR during vs. outside the\ngrass pollen season and later hayfever. Of 23 infections studied, none were statistically\nsigni\ufb01cant; although analyses for the less common conditions were limited by low statistical\npower.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1942, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "30439b62-bcdf-43d0-9264-c637c6eba573": {"__data__": {"id_": "30439b62-bcdf-43d0-9264-c637c6eba573", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2007).pdf", "node_type": "4", "metadata": {}, "hash": "3022dc13eee58127d843c2bcef4e4e36c4ea0ad9fb5c14eff80154a1e9d6f51f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "28d7e561-d3fa-4493-8beb-11f9a0aff374", "node_type": "1", "metadata": {}, "hash": "88ea4907c7f243cfccbf39c65c10902b82a173995f8a0eb2b809d7b1a32155c6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bda59f27-7081-41b5-be79-07d7160ac046", "node_type": "1", "metadata": {}, "hash": "2a0a12999f45e618362b55f6b70108a3ad9a4b1353ec8fd44c7cea016436b91a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "outside the\ngrass pollen season and later hayfever. Of 23 infections studied, none were statistically\nsigni\ufb01cant; although analyses for the less common conditions were limited by low statistical\npower. The pooled OR for hayfever comparing exposure to antibacterials only in the grass\npollen season with only outside it was 1.20 (95% CI 0.98\u20131.47) and for DTP was 0.84 (95% CI\n0.72\u20130.98).\nConclusion Although an interaction between early exposure to microbial agents and\nconcurrent grass pollen exposure on hayfever risk seemed plausible, there was little\nevidence to support it across a range of analyses. However, the effect of DTP though weak\ndeserves further study.\nKeywords antibacterial, grass pollen allergy, infection, primary care databases, vaccination\nSubmitted 1 November 2006; revised 15 December 2006; accepted 7 February 2007\nIntroduction\nThe earliest grass pollen seasons of a child\u2019s life are\npotentially critical periods for the initiation and develop-\nment of pollen sensitization and hayfever. Previous epide-\nmiological studies have explored this by investigating\nvariations in the prevalence of pollen allergy by month\nof birth, but the results have been inconsistent [1\u20137]. In\n755 Japanese schoolchildren, the prevalence of allergic\nrhinitis (AR) was signi\ufb01cantly higher in those who were\nborn between August and October [4]. In 6535 10-year-\nolds in Munich and Bavaria, those born in May had a 50%\nincreased risk of hayfever whereas those born in Novem-\nber were protected (40% reduced risk) [5]. In a study of\nDerbyshire schoolchildren, there was no signi\ufb01cant asso-\nciation between month of birth and hayfever prevalence,\nalthough prevalence was the lowest for June and July\nbirths [7]. More speci\ufb01cally, it has been hypothesized that\nconcurrent challenge to the immune system by pollens\nand microbial agents early in life may inhibit proliferation\nof T-helper type 2 (Th2) cell clones and thereby prevent\nallergy [8].", "mimetype": "text/plain", "start_char_idx": 1741, "end_char_idx": 3684, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bda59f27-7081-41b5-be79-07d7160ac046": {"__data__": {"id_": "bda59f27-7081-41b5-be79-07d7160ac046", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2007).pdf", "node_type": "4", "metadata": {}, "hash": "3022dc13eee58127d843c2bcef4e4e36c4ea0ad9fb5c14eff80154a1e9d6f51f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "30439b62-bcdf-43d0-9264-c637c6eba573", "node_type": "1", "metadata": {}, "hash": "171c95c2a37e79bb2f9bb2d13c5e0f057dd8be9e70acc7f768ba27ea00b8b69e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3141b514-dbc1-4ccd-bd08-4b74a1af9d71", "node_type": "1", "metadata": {}, "hash": "4bb492ffc8e76908ac149b6addfa527a2924b8fe9573171df04d7559ba77dc48", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In the only study to test this hypothesis\nClinical and Experimental Allergy, 37, 512\u2013517\n\u0001c 2007 The Authors\nJournal compilation \u0001c 2007 Blackwell Publishing Ltd\nepidemiologically, Strachan et al. [6] studied 11 765 ado-\nlescent children in Shef\ufb01eld, UK, and found no relation-\nship between infection in month 1 and the prevalence of\nlater hayfever in 960 June births.\nPreviously, we and others have exploited the potential\nof large primary care databases to examine the role of\nfactors operating in the \ufb01rst year of life on the risk of\ndeveloping hayfever and asthma. The roles of routine\nvaccination [9, 10], infectious illnesses [11] and antibac-\nterials [11, 12] have been examined. Overall, the \ufb01ndings\nhave been negative; however, the possibility exists that\nexposure to these agents during the grass pollen season\nmay induce different effects from exposure outside the\ngrass pollen season.\nWe therefore hypothesized that: (i) routine vaccination,\n(ii) infectious illnesses presenting during the grass pollen\nseason or (iii) exposure to antibacterials during the grass\npollen season, indicating infectious illness at the time of\nearly allergen exposure, reduce the risk of subsequent\nhayfever. We investigate these hypotheses using two large\nUK-based primary care databases (PCDs): the General Prac-\ntice Research Database (GPRD) and the Doctors\u2019 Indepen-\ndent Network (DIN) [13, 14]. The advantage of using these is\nthat the exposures and outcome are reliably recorded, the\nresults apply to the general population and the analyses are\nbased on large numbers of subjects. The latter is particularly\nimportant when examining the interaction between micro-\nbial agents and the grass pollen season.\nMethods\nWe conducted nested case\u2013control studies within a GPRD\ncohort of 76 310 children born between 1989 and 1993\nfrom 464 practices and within a DIN cohort of 40183\nchildren born between 1989 and 1997 from 141 general\npractices. All children had at least 5 years of follow-up\nfrom birth and had been registered with the practice\nwithin 3 months of birth.", "mimetype": "text/plain", "start_char_idx": 3685, "end_char_idx": 5744, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3141b514-dbc1-4ccd-bd08-4b74a1af9d71": {"__data__": {"id_": "3141b514-dbc1-4ccd-bd08-4b74a1af9d71", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2007).pdf", "node_type": "4", "metadata": {}, "hash": "3022dc13eee58127d843c2bcef4e4e36c4ea0ad9fb5c14eff80154a1e9d6f51f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bda59f27-7081-41b5-be79-07d7160ac046", "node_type": "1", "metadata": {}, "hash": "2a0a12999f45e618362b55f6b70108a3ad9a4b1353ec8fd44c7cea016436b91a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bbec1a35-d6d9-422b-99ea-f784eaee9f55", "node_type": "1", "metadata": {}, "hash": "e6c3c7e92c9fdd7fb0c4a4159fbe28a84ca6de472ad88227d4ef1d1aaf8b338d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All children had at least 5 years of follow-up\nfrom birth and had been registered with the practice\nwithin 3 months of birth. Background information on the\nDIN database and the birth cohorts de\ufb01ned in GPRD and\nDIN are published elsewhere [13, 14].\nFor each case of hayfever diagnosed, we selected\none control child, matched for general practice, sex,\nbirth month and follow-up of control to at least date\nof diagnosis of case. A more detailed account can be\nfound in Bremner et al. [12]. Cases of hayfever were those\nwho had diagnostic codes and/or treatment for hayfever,\nafter 2 years of age. Children who were only diagnosed\nbefore age 2 and not subsequently con\ufb01rmed, or who only\never had non-speci\ufb01c AR codes that did not exhibit\na seasonal pattern were excluded from being cases or\ncontrols.\nThe advantages of using the two separate databases\nwere: (i) we could assess the consistency of results across\ndatabases and (ii) pooling data from both databases\nincreased power. Pragmatically, we de\ufb01ned the grass\npollen season as May, June and July, although we recog-\nnize that this varies according to location and annual\nweather \ufb02uctuations [15]. May, June and July births are\nlikely to be exposed to two partial grass pollen seasons\nin year 1.\nWe carried out three different matched case\u2013control\nanalyses, all analysed by conditional logistic regression\nusing proc phreg in SAS version 8.1 [16]. In the \ufb01rst, we\nconsidered: (i) only those pairs where both infants were\nfully vaccinated to third DTP by month 12, exposure being\nat least one dose within the grass pollen season vs. no\ndoses within the grass pollen season; (ii) only those\ncase\u2013control pairs with both members vaccinated with\nMMR by 24 months, with exposure being MMR within\nvs. outside a pollen season. We excluded pairs where the\ncase and/or control were not exposed because such\nnon-exposed subjects may differ from those exposed in\nimportant respects such as consultation behaviour, social\ncircumstances or family size.", "mimetype": "text/plain", "start_char_idx": 5619, "end_char_idx": 7610, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bbec1a35-d6d9-422b-99ea-f784eaee9f55": {"__data__": {"id_": "bbec1a35-d6d9-422b-99ea-f784eaee9f55", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2007).pdf", "node_type": "4", "metadata": {}, "hash": "3022dc13eee58127d843c2bcef4e4e36c4ea0ad9fb5c14eff80154a1e9d6f51f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3141b514-dbc1-4ccd-bd08-4b74a1af9d71", "node_type": "1", "metadata": {}, "hash": "4bb492ffc8e76908ac149b6addfa527a2924b8fe9573171df04d7559ba77dc48", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aa14ee17-5cc9-4d9b-9e93-c4aa4f5ca061", "node_type": "1", "metadata": {}, "hash": "f96bb794713995570dc915c186dc0b9e69742215bf22e8eb3549cfb3c92ec395", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "outside a pollen season. We excluded pairs where the\ncase and/or control were not exposed because such\nnon-exposed subjects may differ from those exposed in\nimportant respects such as consultation behaviour, social\ncircumstances or family size.\nIn the second analysis, we explored a wide variety of\ninfections ranging from common, such as diarrhoea and\nvomiting, to rare, such as threadworms, as de\ufb01ned in\nDeWilde et al. [17]. As a control condition, we also\nincluded behavioural problems in our selection, as these\nare not uncommon and could not feasibly be related to the\nrisk of developing hayfever. We were interested in com-\nparing the effect upon hayfever of infection only in a\ngrass pollen season vs. the same infection only outside a\ngrass pollen season. However, for many of the case\u2013\ncontrol pairs where one child fell into one of these two\nexposure groups, the other would either not be exposed at\nall or be exposed in both periods. For example those\ncase\u2013control pairs where one was exposed in the pollen\nseason and the other was not exposed at all provide an\nestimate of pollen season exposure vs. no exposure.\nEqually, other pairs where one was exposed outside the\npollen season and the other was not exposed provide an\nestimate of non-pollen season exposure vs. no exposure.\nPutting both estimates together gives an estimate of\npollen vs. non-pollen season exposure. Excluding all such\npairs would exclude the majority of subjects for certain\nconditions, severely compromising statistical power. For\ninfections, we therefore based the analysis on all case\u2013\ncontrol pairs.\nIn the third analysis, exposures to antibacterials in these\nmonths were \ufb02agged. We then de\ufb01ned variables to code\nexposure only in the grass pollen season, only outside it,\nin both periods and in neither period of the \ufb01rst 12 months\nof life. As with immunizations, the analysis was limited to\nthose case\u2013control pairs where both were exposed to\nantibacterials during the \ufb01rst year of life.\nOdds ratios (ORs) were pooled across databases using a\n\ufb01xed-effect model. This was carried out using the meta-\nanalysis command available for Stata [18, 19].", "mimetype": "text/plain", "start_char_idx": 7366, "end_char_idx": 9500, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aa14ee17-5cc9-4d9b-9e93-c4aa4f5ca061": {"__data__": {"id_": "aa14ee17-5cc9-4d9b-9e93-c4aa4f5ca061", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2007).pdf", "node_type": "4", "metadata": {}, "hash": "3022dc13eee58127d843c2bcef4e4e36c4ea0ad9fb5c14eff80154a1e9d6f51f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bbec1a35-d6d9-422b-99ea-f784eaee9f55", "node_type": "1", "metadata": {}, "hash": "e6c3c7e92c9fdd7fb0c4a4159fbe28a84ca6de472ad88227d4ef1d1aaf8b338d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "61fd618e-a7df-4bda-820b-9d3ad9af3aba", "node_type": "1", "metadata": {}, "hash": "951549b71a50687b8cfdbd2689657d599563b7d43fcb2c1c97694d687445f646", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Odds ratios (ORs) were pooled across databases using a\n\ufb01xed-effect model. This was carried out using the meta-\nanalysis command available for Stata [18, 19]. GPRD\u2019s\n\u0001c 2007 The Authors\nJournal compilation \u0001c 2007 Blackwell Publishing Ltd, Clinical and Experimental Allergy, 37 : 512\u2013517\nVaccinations, infections, antibacterials, grass pollen and risk of hayfever 513\n 13652222, 2007, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2222.2007.02697.x by Assistance Publique Hopitaux De Paris Ap-Hp, Wiley Online Library on [09/01/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nScienti\ufb01c and Ethics Advisory Group (SEAG) gave ethical\napproval for our study.\nResults\nThe cumulative incidence of hayfever in GPRD was 5.6%\nand 7.3% in DIN. In GPRD, the cases were followed up for\na mean of 7.4 years, and the mean age of \ufb01rst diagnosis of\nhayfever was 4.6 years. The corresponding \ufb01gures in DIN\nwere 8.2 years of follow-up and a mean age of 5.1 years\nat \ufb01rst diagnosis. Further details are available in Bremner\net al. [12]. In both our GPRD and our DIN cohorts, the\nhighest percentages of hayfever cases had been born in\nMarch, April, May and June (around 9\u201310% in each of\nthese months). It should be noted that season of birth is\ncontrolled for in our study design by matching of controls\nto cases for date of birth.", "mimetype": "text/plain", "start_char_idx": 9343, "end_char_idx": 10831, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "61fd618e-a7df-4bda-820b-9d3ad9af3aba": {"__data__": {"id_": "61fd618e-a7df-4bda-820b-9d3ad9af3aba", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2007).pdf", "node_type": "4", "metadata": {}, "hash": "3022dc13eee58127d843c2bcef4e4e36c4ea0ad9fb5c14eff80154a1e9d6f51f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aa14ee17-5cc9-4d9b-9e93-c4aa4f5ca061", "node_type": "1", "metadata": {}, "hash": "f96bb794713995570dc915c186dc0b9e69742215bf22e8eb3549cfb3c92ec395", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d31dc2d7-8b50-446e-9f06-1b203d7d884e", "node_type": "1", "metadata": {}, "hash": "3db8acbf75319deb31063808e97773cb343e32856ee9a139e20be5ede676f0bf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "It should be noted that season of birth is\ncontrolled for in our study design by matching of controls\nto cases for date of birth.\nTo illustrate the level of exposure to the different\nmicrobial agents by season, we give the total number of\ncases plus controls in both cohorts (ignoring matching): (i)\nnot exposed, (ii) exposed only outside the grass pollen\nseason, (iii) exposed only within the grass pollen season\nand (iv) exposed both in and outside the grass pollen\nseason as well as the percentage of cases plus controls\nexposed (Table 1).\nVaccinations\nIn GPRD, 83.7% of case\u2013control pairs received their third\nDTP before age 1 and 94.7% received their MMR before\nTable 1. Odds ratios of hay fever given exposure to antibacterials, DTP or infection (by 12 months) or MMR (by 24 months) in a grass pollen season vs.\noutside one\nExposure\nTotals (cases1controls)\nExposed (%)\nPooled across GPRD and DIN\nNot\u0001\nout\nin\nboth\nOR\n95% CI\nP-value\nDTPw by 12 months\n2 018\n6126\n6 052\nN/A\n85.8\n0.84\n(0.72, 0.98)\n0.02\nMMRz by 24 months\n673\n9 690\n3 833\nN/A\n95.3\n1.05\n(0.94, 1.18)\n0.38\nInfectionz by 12 months\nUpper respiratory tract\n7 510\n4 667\n799\n1 220\n47.1\n1.02\n(0.88, 1.19)\n0.78\nConjunctivitis\n9 676\n3156\n870\n494\n31.8\n1.04\n(0.89, 1.20)\n0.65\nDiarrhoea and vomiting\n10 034\n3 077\n695\n390\n29.3\n1.01\n(0.86, 1.20)\n0.86\nAcute otitis media\n11091\n2 334\n463\n308\n21.9\n0.95\n(0.78, 1.17)\n0.", "mimetype": "text/plain", "start_char_idx": 10702, "end_char_idx": 12068, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d31dc2d7-8b50-446e-9f06-1b203d7d884e": {"__data__": {"id_": "d31dc2d7-8b50-446e-9f06-1b203d7d884e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2007).pdf", "node_type": "4", "metadata": {}, "hash": "3022dc13eee58127d843c2bcef4e4e36c4ea0ad9fb5c14eff80154a1e9d6f51f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "61fd618e-a7df-4bda-820b-9d3ad9af3aba", "node_type": "1", "metadata": {}, "hash": "951549b71a50687b8cfdbd2689657d599563b7d43fcb2c1c97694d687445f646", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "25afd740-88f3-4381-b8dd-b0ed1c49d658", "node_type": "1", "metadata": {}, "hash": "26588ee85dc4c667b2ae3d4c280cf93f1cdba49fd2705f60d88879de8b4f3af6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "86, 1.20)\n0.86\nAcute otitis media\n11091\n2 334\n463\n308\n21.9\n0.95\n(0.78, 1.17)\n0.65\nBronchitis and chest infection\n12 018\n1 668\n302\n188\n15.2\n1.17\n(0.91, 1.49)\n0.22\nCandidiasis\n11 783\n1 660\n604\n149\n17.0\n1.02\n(0.84, 1.23)\n0.84\nViral illness\n13175\n737\n242\n42\n7.2\n0.97\n(0.72, 1.30)\n0.83\nFever/pyrexia\n13 233\n630\n269\n64\n6.8\n1.05\n(0.78, 1.41)\n0.73\nSore throat\n13 438\n553\n171\n34\n5.3\n0.88\n(0.66, 1.17)\n0.38\nBronchiolitis\n13 329\n767\n69\n31\n6.1\n0.86\n(0.52, 1.42)\n0.56\nLaryngitis and croup\n13 688\n403\n93\n12\n3.6\n1.10\n(0.70, 1.74)\n0.67\nChickenpox\n13 757\n314\n123\n2\n3.1\n1.14\n(0.74, 1.75)\n0.55\nOther viral rash\n13 938\n171\n82\n5\n1.8\n0.91\n(0.54, 1.53)\n0.72\nImpetigo\n14 016\n128\n47\n5\n1.3\n1.64\n(0.75, 3.59)\n0.22\nOtitis externa\n14 069\n87\n37\n3\n0.9\n0.50\n(0.22, 1.10)\n0.09\nChronic otitis media\n14 076\n95\n24\n1\n0.8\n0.74\n(0.30, 1.84)\n0.", "mimetype": "text/plain", "start_char_idx": 11989, "end_char_idx": 12793, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "25afd740-88f3-4381-b8dd-b0ed1c49d658": {"__data__": {"id_": "25afd740-88f3-4381-b8dd-b0ed1c49d658", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2007).pdf", "node_type": "4", "metadata": {}, "hash": "3022dc13eee58127d843c2bcef4e4e36c4ea0ad9fb5c14eff80154a1e9d6f51f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d31dc2d7-8b50-446e-9f06-1b203d7d884e", "node_type": "1", "metadata": {}, "hash": "3db8acbf75319deb31063808e97773cb343e32856ee9a139e20be5ede676f0bf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0577dd9b-883b-4800-aa74-08ccfe26d749", "node_type": "1", "metadata": {}, "hash": "6dd361af16742314791bb7405ea308d082f7b1b7e3f0ff8f9f43acafe4445a2a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "22, 1.10)\n0.09\nChronic otitis media\n14 076\n95\n24\n1\n0.8\n0.74\n(0.30, 1.84)\n0.52\nMeasles\n14 058\n105\n33\n0\n1.0\n1.71\n(0.76, 3.84)\n0.20\nRubella\n14 047\n103\n45\n1\n1.0\n0.67\n(0.33, 1.36)\n0.26\nUrinary tract infections\n14 039\n111\n35\n11\n1.1\n0.69\n(0.35, 1.38)\n0.30\nThreadworms\n14119\n58\n19\n0\n0.5\n1.03\n(0.36, 2.96)\n0.96\nIn\ufb02uenza\n14 060\n121\n14\n1\n1.0\n0.83\n(0.27, 2.58)\n0.75\nDermatophytosis\n14120\n60\n15\n1\n0.5\n0.56\n(0.16, 1.98)\n0.37\nAbscess/boil/nail infection\n14135\n40\n19\n2\n0.4\n2.18\n(0.65, 7.37)\n0.21\nControl condition\nBehavioural problems\n13 616\n412\n145\n23\n4.1\n1.03\n(0.70, 1.51)\n0.88\nAntibacterialsz by 12 months\n5491\n5618\n740\n2347\n61.3\n1.20\n(0.98, 1.47)\n0.07\nFor the vaccinations and antibacterials, case-control pairs were restricted to those where both had been exposed.\n\u0001\u2018\u2018Not\u2019\u2019 exposed to antibacterials and vaccinations were not analysed but are presented for completeness.\nwAny DTP dose in grass pollen season vs. none in grass pollen season.\nzIn grass pollen season versus outside grass pollen season only.", "mimetype": "text/plain", "start_char_idx": 12718, "end_char_idx": 13712, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0577dd9b-883b-4800-aa74-08ccfe26d749": {"__data__": {"id_": "0577dd9b-883b-4800-aa74-08ccfe26d749", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2007).pdf", "node_type": "4", "metadata": {}, "hash": "3022dc13eee58127d843c2bcef4e4e36c4ea0ad9fb5c14eff80154a1e9d6f51f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "25afd740-88f3-4381-b8dd-b0ed1c49d658", "node_type": "1", "metadata": {}, "hash": "26588ee85dc4c667b2ae3d4c280cf93f1cdba49fd2705f60d88879de8b4f3af6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b06fc4bf-c7b7-4bbb-a630-006e8c65b729", "node_type": "1", "metadata": {}, "hash": "cf89b612c44f200fa977bda545dd3dee5584052c66b28a22faa2de0f33235b19", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "wAny DTP dose in grass pollen season vs. none in grass pollen season.\nzIn grass pollen season versus outside grass pollen season only.\nTotals (cases1controls) = across GPRD and DIN; number in each exposure category, ignoring matching none = unexposed; out = exposed only outside\ngrass pollen season; in = exposed only inside grass pollen season; both = exposed both out- and inside grass pollen season.\nGPRD, General Practice Research Database; DIN, Doctors\u2019 Independent Network; OR, odds ratio; CI, con\ufb01dence interval, N/A, not applicable.\n\u0001c 2007 The Authors\nJournal compilation \u0001c 2007 Blackwell Publishing Ltd, Clinical and Experimental Allergy, 37 : 512\u2013517\n514 S. A. Bremner et al\n 13652222, 2007, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2222.2007.02697.x by Assistance Publique Hopitaux De Paris Ap-Hp, Wiley Online Library on [09/01/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nage 2. In DIN, the percentages were 88.8% and 96.1%. Our\nanalyses were restricted to the case\u2013control pairs where\nboth received vaccination in the relevant time period.\nHaving any dose of DTP during the grass pollen season\n(compared with DTP outside the grass pollen season) was\nassociated with a small reduction in the OR of hayfever\nin both GPRD [OR = 0.87, 95% con\ufb01dence interval (CI)\n0.72\u20131.06] and in DIN (OR = 0.79, 95% CI 0.62\u20131.00) (Fig.\n1) The \ufb01xed-effects pooled estimate was 0.84 (95% CI\n0.72\u20130.98) (Table 1).\nReceipt of MMR in a grass pollen season by age 24\nmonths was associated with an increased OR of hayfever\nin the GPRD (1.11) and a reduced OR in DIN (0.97) (Fig. 1).", "mimetype": "text/plain", "start_char_idx": 13578, "end_char_idx": 15335, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b06fc4bf-c7b7-4bbb-a630-006e8c65b729": {"__data__": {"id_": "b06fc4bf-c7b7-4bbb-a630-006e8c65b729", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2007).pdf", "node_type": "4", "metadata": {}, "hash": "3022dc13eee58127d843c2bcef4e4e36c4ea0ad9fb5c14eff80154a1e9d6f51f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0577dd9b-883b-4800-aa74-08ccfe26d749", "node_type": "1", "metadata": {}, "hash": "6dd361af16742314791bb7405ea308d082f7b1b7e3f0ff8f9f43acafe4445a2a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e44dce7c-2d1a-42a4-a630-6912b901d23c", "node_type": "1", "metadata": {}, "hash": "50323d29ea9ac8a268d23794ebf4618746eec39ef3734a7a43917641749bcb25", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1).\nBoth the CI estimates included 1 and the \ufb01xed-effects\nFigure 1. Risk of later hayfever, given exposure to vaccinations, infections and antibacterials (inside vs. outside the grass pollen season): (G)= General Practice\nResearch Database (D)= Doctors\u2019 Independent Network odds ratio (log10 scale) of hayfever, given exposure to vaccinations, infections and antibacterials.\n\u0001c 2007 The Authors\nJournal compilation \u0001c 2007 Blackwell Publishing Ltd, Clinical and Experimental Allergy, 37 : 512\u2013517\nVaccinations, infections, antibacterials, grass pollen and risk of hayfever 515\n 13652222, 2007, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2222.2007.02697.x by Assistance Publique Hopitaux De Paris Ap-Hp, Wiley Online Library on [09/01/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nmodel gave a combined estimate of 1.05, which was not\nstatistically signi\ufb01cant (Table 1).\nInfections\nThe prevalence of infections among all case\u2013control pairs\nranges from 47% for URT to 0.4% for abscesses (Table 1).\nAs a result, the power for contrasting risk of exposure\nwithin to outside the groups is limited for a number of the\ninfections. This is re\ufb02ected in wider con\ufb01dence limits for\nthe estimated ORs, particularly when analysing the two\ndatabases separately (Fig. 1).\nFor some conditions, there was substantial variability\nbetween the GPRD and DIN results (Fig. 1). For most\nconditions, however, the overlap between the CIs was\nlarge and, of the 23 infections plus behavioural problems\ncomparable in this way, in only seven instances did the\nestimate from one database not lie within the 95% CI of\nthe other database. In 14 comparisons, one database\nestimate was negative (OR o 1) and the other positive\n(OR 4 1).", "mimetype": "text/plain", "start_char_idx": 15332, "end_char_idx": 17216, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e44dce7c-2d1a-42a4-a630-6912b901d23c": {"__data__": {"id_": "e44dce7c-2d1a-42a4-a630-6912b901d23c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2007).pdf", "node_type": "4", "metadata": {}, "hash": "3022dc13eee58127d843c2bcef4e4e36c4ea0ad9fb5c14eff80154a1e9d6f51f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b06fc4bf-c7b7-4bbb-a630-006e8c65b729", "node_type": "1", "metadata": {}, "hash": "cf89b612c44f200fa977bda545dd3dee5584052c66b28a22faa2de0f33235b19", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f2bc1ece-2d34-49b5-8473-bb5208cf59b0", "node_type": "1", "metadata": {}, "hash": "07e261833f086fd785e36a0f091f24ea75f0492b31c17effd421194db4e86d99", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In 14 comparisons, one database\nestimate was negative (OR o 1) and the other positive\n(OR 4 1). There was no tendency for one database to\nconsistently report higher ORs than the other (Fig. 1).\nOn pooling, most of the ORs were close to 1 (Table 1).\nThe CIs were wide for many of the conditions, even after\npooling. The only border line signi\ufb01cant association with\nhayfever was for otitis externa within compared with\noutside the grass pollen season (pooled OR 0.50, 95% CI\n0.22\u20131.10, P = 0.09).\nAntibacterials\nIn GPRD, for cases and controls combined, 5.1% of\nchildren were exposed to antibacterials only in a grass\npollen season, 17.9% were exposed both within and out-\nwith a grass pollen season, 40.3% were exposed only\noutside and 36.7% were not exposed. In DIN, the percen-\ntages were 5.4%, 14.5%, 38.6% and 41.5%.\nOur analyses were restricted to the case\u2013control pairs\nwhere both members had received antibacterials in year 1\n(43.6% in GPRD and 36.6% in DIN). The OR for exposure\nwithin compared with outside the grass pollen season was\n1.19, 95% CI 0.91\u20131.54) in GPRD and 1.22 (95% CI\n0.89\u20131.67) in DIN (Fig. 1). The pooled OR was 1.20 (95%\nCI 0.98\u20131.47) (Table 1).\nDiscussion\nIn two population-based birth cohorts, we have not\ndemonstrated any signi\ufb01cant relationship between hayf-\never and vaccination with MMR, with infections or use of\nantibacterials relative to the grass pollen season. The\nsigni\ufb01cant effect of DTP may be a chance \ufb01nding, given\nthe large number of comparisons made, but given its\npolicy relevance it deserves further study.", "mimetype": "text/plain", "start_char_idx": 17121, "end_char_idx": 18674, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f2bc1ece-2d34-49b5-8473-bb5208cf59b0": {"__data__": {"id_": "f2bc1ece-2d34-49b5-8473-bb5208cf59b0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2007).pdf", "node_type": "4", "metadata": {}, "hash": "3022dc13eee58127d843c2bcef4e4e36c4ea0ad9fb5c14eff80154a1e9d6f51f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e44dce7c-2d1a-42a4-a630-6912b901d23c", "node_type": "1", "metadata": {}, "hash": "50323d29ea9ac8a268d23794ebf4618746eec39ef3734a7a43917641749bcb25", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "26a37c1d-46de-4754-a492-e84cdd5de950", "node_type": "1", "metadata": {}, "hash": "1b044b6a192cc0b20b570218cfc57bfb75ded57f816df59f9b33afb936234b9b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\nsigni\ufb01cant effect of DTP may be a chance \ufb01nding, given\nthe large number of comparisons made, but given its\npolicy relevance it deserves further study.\nIn investigating exposure to early-life infections and\nrisk of subsequent atopic disease, some authors have\nconsidered the total burden of infection [20\u201323]. We\ndecided not to de\ufb01ne the total burden as we were\ninvestigating such a broad range of conditions and\nbecause of the dif\ufb01culty of distinguishing new disease\nepisodes. While incident infections are easy to identify in\nPCDs, recurrent diagnostic codes may not re\ufb02ect new\ndisease occurrences.\nDespite differences in coding conventions and data\nstructure, the two databases revealed similar results, instil-\nling greater con\ufb01dence in the generalizability of our\nconclusions. Compared with our earlier publications,\nwhich examined the effect of exposure to antibacterials\nor immunizations at any time in the \ufb01rst year of life vs.\nnot, the analyses presented here are less likely to be\nconfounded [10, 12]. This is because, unlike our earlier\nstudies, we are not comparing subjects exposed or not\nexposed to a particular microbial agent, which may be\nconfounded with individual and family characteristics,\nsuch as consultation behaviour. Rather, we are comparing\nthose exposed in different seasons. Such differences are\nunlikely to be confounded by individual or family char-\nacteristics.\nWe considered hayfever to be a suitable outcome to\ninvestigate as it is undeniably atopic and the relevant\nallergen exposure is con\ufb01ned to the spring and summer\nmonths. Further, the crucial development period of the\nimmune system investigated here (largely year 1) and the\ndiagnosis of hayfever have substantial temporal separa-\ntion. We carefully de\ufb01ned treated hayfever using speci\ufb01c\ntherapies and seasonal presentation, and believe the vast\nmajority of our cases to have hayfever. Criticism could be\nlevelled at our de\ufb01nition of the pollen season; some grass\npollens are still being released in August, a month that we\ndid not include in our de\ufb01nition of the pollen season, but\nthese are at much lower levels than in May, June and July\n[24].", "mimetype": "text/plain", "start_char_idx": 18520, "end_char_idx": 20661, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "26a37c1d-46de-4754-a492-e84cdd5de950": {"__data__": {"id_": "26a37c1d-46de-4754-a492-e84cdd5de950", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2007).pdf", "node_type": "4", "metadata": {}, "hash": "3022dc13eee58127d843c2bcef4e4e36c4ea0ad9fb5c14eff80154a1e9d6f51f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f2bc1ece-2d34-49b5-8473-bb5208cf59b0", "node_type": "1", "metadata": {}, "hash": "07e261833f086fd785e36a0f091f24ea75f0492b31c17effd421194db4e86d99", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e8560f9b-399a-4855-b61e-6ff14e62996e", "node_type": "1", "metadata": {}, "hash": "c4d537de56c4880ffc7b72370b4111cd93bc24147ce006f61aa10f2f48b71380", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The effect of this would be a reduction in power to\ndetect an OR different to 1 for the comparison \u2018exposed\nonly in the grass pollen season\u2019 vs. \u2018exposed only outside\nthe grass pollen season\u2019.\nOur study posed a well-de\ufb01ned question, with minimal\nconfounding, across a range of exposures that are central\nto the \u2018hygiene hypothesis\u2019. While previous studies have\ninvestigated early exposure to the agents we describe in\nrelation to hayfever, only one has addressed this interac-\ntion with the pollen season [6]; few others would have had\nsuf\ufb01cient statistical power to do so. Although the notion\nof an interaction between microbial agents and the grass\npollen season on hayfever risk seemed plausible, there was\nlittle evidence to support it across a range of analyses. We\nconclude that previous studies that considered only all-\nyear exposures were not misleading. However, given its\npolicy relevance, the borderline effect of DTP deserves\nfurther study.\n\u0001c 2007 The Authors\nJournal compilation \u0001c 2007 Blackwell Publishing Ltd, Clinical and Experimental Allergy, 37 : 512\u2013517\n516 S. A. Bremner et al\n 13652222, 2007, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2222.2007.02697.x by Assistance Publique Hopitaux De Paris Ap-Hp, Wiley Online Library on [09/01/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nAcknowledgements\nThis work was funded by Wellcome Trust Grant 065177/\nZ/01/Z.\nCon\ufb02ict of interest: N. R. is director of Cegedim Strate-\ngic Data Ltd which markets DIN data to pharmaceutical\ncompanies.\nReferences\n1 Aberg N. Birth season variation in asthma and allergic rhinitis.\nClin Exp Allergy 1989; 19:643\u20138.\n2 Schafer T, Przybilla B, Ring J, Kunz B, Greif A, Uberla K.\nManifestation of atopy is not related to patient\u2019s month of birth.", "mimetype": "text/plain", "start_char_idx": 20662, "end_char_idx": 22586, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e8560f9b-399a-4855-b61e-6ff14e62996e": {"__data__": {"id_": "e8560f9b-399a-4855-b61e-6ff14e62996e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2007).pdf", "node_type": "4", "metadata": {}, "hash": "3022dc13eee58127d843c2bcef4e4e36c4ea0ad9fb5c14eff80154a1e9d6f51f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "26a37c1d-46de-4754-a492-e84cdd5de950", "node_type": "1", "metadata": {}, "hash": "1b044b6a192cc0b20b570218cfc57bfb75ded57f816df59f9b33afb936234b9b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e6ee1549-7422-434f-9a4d-903dc6401306", "node_type": "1", "metadata": {}, "hash": "7cecc60ff266ab4d3e2c58eacf695431c7c0b0f65da1ed2627482f65b92af5f9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2 Schafer T, Przybilla B, Ring J, Kunz B, Greif A, Uberla K.\nManifestation of atopy is not related to patient\u2019s month of birth.\nAllergy 1993; 48:291\u20134.\n3 Sibbald B, Rink E. Birth month variation in atopic and non-\natopic rhinitis. Clin Exp Allergy 1990; 20:285\u20138.\n4 Saitoh Y, Dake Y, Shimazu S et al. Month of birth, atopic disease,\nand atopic sensitization. J Invest Allergol Clin Immunol 2001;\n11:183\u20137.\n5 Wjst M, Dold S, Reitmeir P, Stiepel E, von Mutius E. Month of\nbirth and allergic disease at the age of 10. Clin Exp Allergy 1992;\n22:1026\u201331.\n6 Strachan DP, Taylor EM, Carpenter RG. Family structure, neona-\ntal infection, and hay fever in adolescence. Arch Dis Child 1996;\n74:422\u20136.\n7 Anderson HR, Bailey PA, Bland JM. The effect of birth month on\nasthma, eczema, hayfever, respiratory symptoms, lung function,\nand hospital admissions for asthma. Int J of Epidemiol 1981;\n10:45\u201351.\n8 Martinez FD. Role of viral infections in the inception of asthma\nand allergies during childhood: could they be protective? Thorax\n1994; 49:1189\u201391.\n9 McKeever TM, Lewis SA, Smith C, Hubbard R. Vaccination and\nallergic disease: a birth cohort study. Am J Public Health 2004;\n94:985\u20139.\n10 Bremner SA, Carey IM, DeWilde S et al. Timing of routine\nimmunisations and subsequent hay fever risk. Arch Dis Child\n2005; 90:567\u201373.\n11 McKeever TM, Lewis SA, Smith C et al. Early exposure\nto infections and antibiotics and the incidence of allergic\ndisease: a birth cohort study with the West Midlands General\nPractice Research Database. J Allergy Clin Immunol 2002; 109:\n43\u201350.\n12 Bremner SA, Carey IM, DeWilde S et al.", "mimetype": "text/plain", "start_char_idx": 22459, "end_char_idx": 24059, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e6ee1549-7422-434f-9a4d-903dc6401306": {"__data__": {"id_": "e6ee1549-7422-434f-9a4d-903dc6401306", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2007).pdf", "node_type": "4", "metadata": {}, "hash": "3022dc13eee58127d843c2bcef4e4e36c4ea0ad9fb5c14eff80154a1e9d6f51f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e8560f9b-399a-4855-b61e-6ff14e62996e", "node_type": "1", "metadata": {}, "hash": "c4d537de56c4880ffc7b72370b4111cd93bc24147ce006f61aa10f2f48b71380", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f1fe7710-9297-4819-85d7-f2a45dca1e44", "node_type": "1", "metadata": {}, "hash": "54fd978f3a90fce2ed56c72b2d209ba7854e0283b815fb3dbd0014f5cba55cd2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "J Allergy Clin Immunol 2002; 109:\n43\u201350.\n12 Bremner SA, Carey IM, DeWilde S et al. Early-life exposure to\nantibacterials and the subsequent development of hayfever in\nchildhood in the UK: case\u2013control studies using the General\nPractice Research Database and the Doctors\u2019 Independent Net-\nwork. Clin Exp Allergy 2003; 33:1518\u201325.\n13 Carey IM, Cook DG, DeWilde S et al. Developing a large\nelectronic primary care database (Doctors\u2019 Independent Network)\nfor research. Int J Med Inform 2004; 73:443\u201353.\n14 Carey I, Cook D, DeWilde S et al. Implications of the problem\norientated medical record (POMR) for research using electronic\nGP databases: a comparison of the Doctors Independent Network\nDatabase (DIN) and the General Practice Research Database\n(GPRD). BMC Family Practice 2003; 4:14.\n15 Emberlin J, Mullins J, Corden J et al. Regional variations in grass\npollen seasons in the UK, long-term trends and forecast models.\nClin Exp Allergy 1999; 29:347\u201356.\n16 SAS Institute Inc. SAS System for SunOS, version 8.1. Cary, NC,\nUSA: SAS Institute Inc, 1999.\n17 DeWilde S, Carey IM, Bremner SA et al. A comparison of the\nrecording of 30 common childhood conditions in the Doctors\u2019\nindependent network and the general practice research data-\nbases. Health Stat Quart 2004; 22:21\u201330.\n18 Stata Corporation. Stata for Windows, version 8.0. College\nStation, TX, USA: Stata Corporation, 1985-2003.\n19 Sharp S, Sterne J. Sbe16: meta-analysis. Stata Techn Bull 1997;\n38:9\u201314.\n20 Bager P, Westergaard T, Rostgaard K, Hjalgrim H, Melbye M. Age\nat childhood infections and risk of atopy. Thorax 2002;\n57:379\u201382.", "mimetype": "text/plain", "start_char_idx": 23977, "end_char_idx": 25571, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f1fe7710-9297-4819-85d7-f2a45dca1e44": {"__data__": {"id_": "f1fe7710-9297-4819-85d7-f2a45dca1e44", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Bremner (2007).pdf", "node_type": "4", "metadata": {}, "hash": "3022dc13eee58127d843c2bcef4e4e36c4ea0ad9fb5c14eff80154a1e9d6f51f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e6ee1549-7422-434f-9a4d-903dc6401306", "node_type": "1", "metadata": {}, "hash": "7cecc60ff266ab4d3e2c58eacf695431c7c0b0f65da1ed2627482f65b92af5f9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "20 Bager P, Westergaard T, Rostgaard K, Hjalgrim H, Melbye M. Age\nat childhood infections and risk of atopy. Thorax 2002;\n57:379\u201382.\n21 Benn CS, Melbye M, Wohlfahrt J, Bjorksten B, Aaby P. Cohort\nstudy of sibling effect, infectious diseases, and risk of atopic\ndermatitis during \ufb01rst 18 months of life. BMJ 2004; 328:1223.\n22 Cullinan P, Harris JM, Taylor AJN et al. Can early infection\nexplain the sibling effect in adult atopy? Eur Respir J 2003;\n22:956\u201361.\n23 Paunio M, Peltola H, Virtanen M, Leinikki P, Makela A, Heinonen\nOP. Acute infections, infection pressure, and atopy. Clin Exp\nAllergy 2006; 36:634\u20139.\n24 Emberlin J, Savage M, Jones S. Annual variations in grass pollen\nseasons in London 1961\u20131990: trends and forecast models. Clin\nExp Allergy 1993; 23:911\u20138.\n\u0001c 2007 The Authors\nJournal compilation \u0001c 2007 Blackwell Publishing Ltd, Clinical and Experimental Allergy, 37 : 512\u2013517\nVaccinations, infections, antibacterials, grass pollen and risk of hayfever 517\n 13652222, 2007, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2222.2007.02697.x by Assistance Publique Hopitaux De Paris Ap-Hp, Wiley Online Library on [09/01/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License", "mimetype": "text/plain", "start_char_idx": 25439, "end_char_idx": 26796, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1100bea9-7e88-4ce7-a920-1ed56b391dc6": {"__data__": {"id_": "1100bea9-7e88-4ce7-a920-1ed56b391dc6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Black (2003).pdf", "node_type": "4", "metadata": {}, "hash": "d876a78863a46423ca0c4cd2b9afe3abc0390934a1b75de73e0cc6c1c46c3425", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f3b1375b-8110-44c1-818f-0d83155e59b5", "node_type": "1", "metadata": {}, "hash": "832a7eb3ad3811919dd3d5a7cc9a6c99dc9009cfdffd5cb69a9aff52bf625f1d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u00a9 2003 Blackwell Science Ltd Br J Clin Pharmacol, 55, 107\u2013111\n107\nBlackwell Science, LtdOxford, UKBCPBritish Journal of Clinical Pharmacology0306-5251Blackwell Publishing 200355Short ReportMMR vaccine and idiopathic thrombocytopaenic purpuraC. Black \net al.\nCorrespondence: Dr Corri Black, Department of Public Health, Aberdeen\nUniversity, Polwarth Building, Forrester Hill, Aberdeen AB25 2ZD, UK Fax:\n+44 1224 662994; E-mail: corri.black@abdn.ac.uk\nReceived 17 April 2002, accepted 13 August 2002.\nMMR vaccine and idiopathic thrombocytopaenic purpura\nCorri Black,1,2 James A. Kaye,2 Hershel Jick2\n1Department of Public Health, Aberdeen University, Aberdeen, UK; \n2Boston Collaborative Drug Surveillance Program, Boston University School of \nMedicine, Muzzey Street, Lexington, USA\nAims To estimate the relationship between idiopathic thrombocytopaenic purpura\n(ITP) and the measles, mumps and rubella (MMR) vaccination in children; calcu-\nlating the relative risk estimate for ITP with in 6 weeks after MMR vaccination\nand the attributable risk of ITP within 6 weeks after MMR vaccination.\nMethods Using the General Practice Research Database we identi\ufb01ed children with\na \ufb01rst-time diagnosis of ITP from a base population of children aged less than 6 years\nbetween January 1988 and December 1999. After describing the characteristics of\nall the children identi\ufb01ed with ITP, we focused on cases aged 13\u201324 months to\nperform a population-based, case\u2013control analysis to estimate the relative risk of\ndeveloping ITP within 6 weeks after MMR vaccination. We also calculated the risk\nof ITP attributable to the MMR vaccination.\nResults Sixty-three children with a \ufb01rst time diagnosis of ITP were identi\ufb01ed; 23\ncases were between 13 and 24 months old.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1746, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f3b1375b-8110-44c1-818f-0d83155e59b5": {"__data__": {"id_": "f3b1375b-8110-44c1-818f-0d83155e59b5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Black (2003).pdf", "node_type": "4", "metadata": {}, "hash": "d876a78863a46423ca0c4cd2b9afe3abc0390934a1b75de73e0cc6c1c46c3425", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1100bea9-7e88-4ce7-a920-1ed56b391dc6", "node_type": "1", "metadata": {}, "hash": "f7119f6a8cacc88b2b40418512534ef42b6ab5729189e984a1ca5a752c36b6c9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aa8fbc69-a5d5-4c30-be60-dfd792fbef3f", "node_type": "1", "metadata": {}, "hash": "7901a269c952c02b831326f4166c59f26b058c8cd67f8089a88ec94ae65f836e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Results Sixty-three children with a \ufb01rst time diagnosis of ITP were identi\ufb01ed; 23\ncases were between 13 and 24 months old. The relative risk estimate for ITP within\n6 weeks after MMR vaccination, compared to the combined group of unvaccinated\nchildren and children vaccinated with MMR more than 26 weeks previously was\n6.3 (95% CI 1.3\u201330.1). The attributable risk of developing ITP within 6 weeks after\nMMR vaccination was estimated to be 1 in 25 000 vaccinations (95% con\ufb01dence\ninterval 21 300, 89 400).\nConclusion This study con\ufb01rms the increased risk of ITP within 6 weeks after\nMMR vaccination. However, the attributable risk of ITP within 6 weeks after\nMMR vaccination is low.\nKeywords: idiopathic thrombocytopaenic purpura, MMR vaccine \nIntroduction\nIdiopathic thrombocytopaenic purpura (ITP) is an\nautoimmune condition resulting in increased platelet\ndestruction. The incidence of ITP among children in\nthe UK is reported to be around 4 per 100 000 per year\nand is usually self-limiting, although occasional deaths\nhave occurred [1]. ITP has been associated with viral\ninfections and with a variety of vaccinations during\nchildhood [2, 3]. Case reports describe ITP in close time\nassociation with the measles, mumps and rubella (MMR)\nvaccination; in particular, within 6 weeks of vaccination\n[4\u20137].\nMiller et al. [8] recently studied hospital admissions of\n1-year-old children with a diagnosis of ITP in\nseven health board regions in England, and used record\nlinkage to regional child health registries in order to\nestablish the vaccination history of potential cases. The\nauthors identi\ufb01ed a peak in the number of cases of ITP\nwithin 6 weeks after MMR vaccination (so-called\n\u2018vaccine-related\u2019 ITP). Thirteen children developed ITP\nduring this time period [relative incidence 3.27; 95%\ncon\ufb01dence interval (CI)1.5, 7.1].", "mimetype": "text/plain", "start_char_idx": 1624, "end_char_idx": 3450, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aa8fbc69-a5d5-4c30-be60-dfd792fbef3f": {"__data__": {"id_": "aa8fbc69-a5d5-4c30-be60-dfd792fbef3f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Black (2003).pdf", "node_type": "4", "metadata": {}, "hash": "d876a78863a46423ca0c4cd2b9afe3abc0390934a1b75de73e0cc6c1c46c3425", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f3b1375b-8110-44c1-818f-0d83155e59b5", "node_type": "1", "metadata": {}, "hash": "832a7eb3ad3811919dd3d5a7cc9a6c99dc9009cfdffd5cb69a9aff52bf625f1d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7d88bc7c-6735-4d77-8f7f-32e8b82330f1", "node_type": "1", "metadata": {}, "hash": "a708f66f9f6ba8e5fcafb5e063fca95f455f1a679d0cdcf1e4049d3329ab2caa", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Thirteen children developed ITP\nduring this time period [relative incidence 3.27; 95%\ncon\ufb01dence interval (CI)1.5, 7.1]. They estimated the\nattributable risk of ITP within 6 weeks of MMR vacci-\nnation to be 1 in 32 300 vaccinations [8].\nThe aim of this study was to evaluate the relationship\nbetween ITP and MMR vaccination in children regis-\ntered with the UK General Practice Research Database\n(GPRD) using a case\u2013control study design, and to pro-\nvide an estimate of the background risk of nonvaccine-\nrelated ITP among children.\nMethods\nThe GPRD has been described in several previous pub-\nlications [9, 10]. The quality and completeness of the data\ncollection is regularly assessed and validation studies have\nbeen published [11, 12]. Practices not meeting the nec-\nessary standards of data collection for research have been\nC. Black et al.\n108\n\u00a9 2003 Blackwell Science Ltd Br J Clin Pharmacol, 55, 107\u2013111\nexcluded. The recording of vaccine data, in particular, is\nvirtually complete [13, 14]. Two hundred and eighty-\neight general practices contributing to data collection\nbetween 1988 and 1999 were included in this study.\nAll data is anonymized with regard to patient and GP\nidenti\ufb01cation.\nFor the current study we identi\ufb01ed a base population\nof all children aged less than 6 years old, enrolled in the\nGPRD within 4 months of birth, and born between 1\nJanuary 1988 and 31 December 1999. As an initial broad\nsearch, we identi\ufb01ed children with a \ufb01rst-time diagnosis\nof thrombocytopaenia (International Classi\ufb01cation of\nDisease 287.1) from the base population.\nReview of the computer records by two investigators,\nblinded to the MMR vaccination status, enabled\nexclusion of children with illnesses predisposing to\nthrombocytopaenia or purpura (i.e. not idiopathic\nthrombocytopaenic purpura).", "mimetype": "text/plain", "start_char_idx": 3331, "end_char_idx": 5128, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7d88bc7c-6735-4d77-8f7f-32e8b82330f1": {"__data__": {"id_": "7d88bc7c-6735-4d77-8f7f-32e8b82330f1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Black (2003).pdf", "node_type": "4", "metadata": {}, "hash": "d876a78863a46423ca0c4cd2b9afe3abc0390934a1b75de73e0cc6c1c46c3425", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aa8fbc69-a5d5-4c30-be60-dfd792fbef3f", "node_type": "1", "metadata": {}, "hash": "7901a269c952c02b831326f4166c59f26b058c8cd67f8089a88ec94ae65f836e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "39efb49f-bce6-4d02-a8c5-5ee9b8c5edbb", "node_type": "1", "metadata": {}, "hash": "b9b1ae073f922265521a5217eb276c9ff80bdcd16628679aed11860dbff09625", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "not idiopathic\nthrombocytopaenic purpura). These included bone mar-\nrow failure, congenital thrombocytopaenia, severe malab-\nsorption, severe sepsis and neonatal thrombocytopaenia.\nSixty-\ufb01ve children were considered to have a \ufb01rst-time\ndiagnosis of idiopathic thrombocytopaenic purpura\nrecorded in their computer records. Further anonymized\nmedical records regarding the diagnosis were requested.\nThe date of the \ufb01rst recorded diagnosis of ITP in the\ncomputer record was assigned as the index date.\nCase\u2013control study\nFor the case\u2013control study, we focused on some 165 000\nchildren aged 13\u201324 months. Greater than 90% of chil-\ndren at risk of developing \u2018possible MMR vaccine-\nrelated\u2019 ITP (i.e. children within 6 weeks after \ufb01rst\nMMR vaccination) were within this age group. The\nmedian age of \ufb01rst MMR vaccination among children\nregistered with the GPRD is 13 months.\nTo each case aged 13\u201324 months we matched up to\nsix controls by age at index date (within 1 month), prac-\ntice and sex. The index date for each case was assigned\nas the index date for the matched controls and the same\nexclusion criteria were applied.\nExposure to MMR vaccine was noted, and the time\ninterval between vaccination and the index date deter-\nmined from the computer records. We referred to ITP\ncases that occurred within 6 weeks after an MMR\nvaccine as \u2018possible vaccine-related\u2019 cases because Miller\net al. found an association between MMR exposure and\nITP during the 6 weeks after MMR vaccination [8], and\nbecause this is a plausible period of risk related to a\nprimary immune response [12]. We also evaluated the\nrisk of ITP during a longer period after MMR vaccina-\ntion (7\u201326 weeks). For calculation of relative risks, the\nreference exposure group was a combination of children\nwho had not yet received MMR vaccination before their\nindex date and children who had received MMR vacci-\nnation more than 26 weeks before their index date.", "mimetype": "text/plain", "start_char_idx": 5086, "end_char_idx": 7006, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "39efb49f-bce6-4d02-a8c5-5ee9b8c5edbb": {"__data__": {"id_": "39efb49f-bce6-4d02-a8c5-5ee9b8c5edbb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Black (2003).pdf", "node_type": "4", "metadata": {}, "hash": "d876a78863a46423ca0c4cd2b9afe3abc0390934a1b75de73e0cc6c1c46c3425", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7d88bc7c-6735-4d77-8f7f-32e8b82330f1", "node_type": "1", "metadata": {}, "hash": "a708f66f9f6ba8e5fcafb5e063fca95f455f1a679d0cdcf1e4049d3329ab2caa", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b2db4a03-45e4-4d2b-886c-797ccff3efd2", "node_type": "1", "metadata": {}, "hash": "9e92340eb7a87c1a0831dfa84fca73b0487d7ef2ba415f19dded6debba30d45e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We conducted a nested case\u2013control analysis to evalu-\nate whether there was any relationship between recent\nMMR vaccination and the risk of ITP. Because the data\nwere sparse, we grouped case\u2013control sets by 3-month\nage bands (13\u201315 months, 16\u201318 months, and so on). In\naddition, we included boys and girls in sets together\nbecause childhood ITP is reported to occur with equal\nfrequency among both sexes [13, 14], and because pre-\nliminary analysis of our data showed no evidence for a\npredominance of cases among either sex. The relative risk\nof ITP during the speci\ufb01ed time periods after MMR\nvaccination was estimated as the odds ratio using condi-\ntional logistic regression. (PHREG procedure; SAS ver-\nsion 8; SAS Institute Inc., Cary, NC, USA).\nIncidence of ITP among 13- to 24-month-old children\nWe estimated the absolute and attributable risks of ITP\nduring the 6 weeks after MMR vaccination. \nThe attributable risk of ITP in relationship to MMR\nvaccination was estimated by the formula\n AR  =  (RR-1)/RR\nwhere \u2018RR\u2019 is the relative risk for the relevant time\nperiod. Using Poisson regression, we assessed the trend\nin yearly incidence of ITP among children aged 13\u2013\n24 months over the 11-year period of the study (Stata,\nversion 7.0; Stata Corporation, College Park, TX, USA)\nand calculated the \u2018background\u2019 risk of ITP among this\nage group.\nResults\nCharacteristics of ITP and relationship to MMR in base \npopulation\nSixty-\ufb01ve children were identi\ufb01ed as potential cases of\nITP from the computer records. Medical records were\navailable for 41/65 (63%) children. The diagnosis of\nthrombocytopaenia recorded in the computer record was\ncon\ufb01rmed to be ITP in 39/41 (95%) children after med-\nical record review. Two children, in whom ITP was not\ncon\ufb01rmed, were excluded from further analysis.", "mimetype": "text/plain", "start_char_idx": 7007, "end_char_idx": 8800, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b2db4a03-45e4-4d2b-886c-797ccff3efd2": {"__data__": {"id_": "b2db4a03-45e4-4d2b-886c-797ccff3efd2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Black (2003).pdf", "node_type": "4", "metadata": {}, "hash": "d876a78863a46423ca0c4cd2b9afe3abc0390934a1b75de73e0cc6c1c46c3425", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "39efb49f-bce6-4d02-a8c5-5ee9b8c5edbb", "node_type": "1", "metadata": {}, "hash": "b9b1ae073f922265521a5217eb276c9ff80bdcd16628679aed11860dbff09625", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f47e8133-47a1-47f9-9d68-b70a2c6c1c44", "node_type": "1", "metadata": {}, "hash": "9c75f24fdc18059399ed6bdb6d11935fb8601a43cd291283ac282b5b56ce525c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Two children, in whom ITP was not\ncon\ufb01rmed, were excluded from further analysis. Medical\nrecords were unobtainable for 24 children either because\nhe child had transferred out of the practice or the prac-\ntice chose not to provide additional medical records for\nresearch purposes any longer. These children were con-\nsidered to be \u2018probable\u2019 cases.\nTherefore, 63 children less than 6 years old were con-\nsidered as having a \ufb01rst-time diagnosis of ITP. Fifty-two\nof these children (82.5%) had received an MMR vacci-\nnation before their index date. Characteristics of the 63\n 13652125, 2003, 1, Downloaded from https://bpspubs.onlinelibrary.wiley.com/doi/10.1046/j.1365-2125.2003.01790.x by Assistance Publique Hopitaux De Paris Ap-Hp, Wiley Online Library on [09/01/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nMMR vaccine and idiopathic thrombocytopaenic purpura\n\u00a9 2003 Blackwell Science Ltd Br J Clin Pharmacol, 55, 107\u2013111\n109\nchildren with ITP in the base population are listed in\nTable 1. ITP occurred with similar frequency in boys and\ngirls. Fifty children (79%) had mild disease with no\ncomplications. None of the 13 children with bleeding\nwere haemodynamically unstable or required blood trans-\nfusion, and no child with ITP died. Although most\nchildren with ITP were referred to hospital, 11/63\n(17.5%) were managed as outpatients, with no hospital\nadmission.\nAmong the 52 children who developed ITP at some\ntime after having MMR vaccination, only three had\nrecurrences of ITP, and these recurrences were unrelated\nto any subsequent MMR vaccination. Eleven children\ndeveloped ITP without having a previous MMR vacci-\nnation; seven were subsequently vaccinated with MMR\nand none developed a recurrence of ITP.", "mimetype": "text/plain", "start_char_idx": 8720, "end_char_idx": 10592, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f47e8133-47a1-47f9-9d68-b70a2c6c1c44": {"__data__": {"id_": "f47e8133-47a1-47f9-9d68-b70a2c6c1c44", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Black (2003).pdf", "node_type": "4", "metadata": {}, "hash": "d876a78863a46423ca0c4cd2b9afe3abc0390934a1b75de73e0cc6c1c46c3425", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b2db4a03-45e4-4d2b-886c-797ccff3efd2", "node_type": "1", "metadata": {}, "hash": "9e92340eb7a87c1a0831dfa84fca73b0487d7ef2ba415f19dded6debba30d45e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7bbd786b-a3b7-4173-8e9b-f1cfd162d7df", "node_type": "1", "metadata": {}, "hash": "767fd67ea77290f38bddaceaf6cc1d5d86cab67b6d137a939605b18591d67ee2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Eleven children\ndeveloped ITP without having a previous MMR vacci-\nnation; seven were subsequently vaccinated with MMR\nand none developed a recurrence of ITP.\nCase\u2013control study\nTwenty-three children aged 13\u201324 months developed\nITP. Eight of the 23 children in this age range developed\nITP within 6 weeks after receiving their \ufb01rst MMR\nvaccination (\u2018possible vaccine-related\u2019 ITP). Seven of\nthese events occurred between day 7 and day 28 after\nvaccination.\nThe 23 cases were matched, by age (within 1 month),\nsex, practice and index date, to 116 controls. For calcu-\nlation of relative risks, we used a combined reference\nexposure group of children who had not received MMR\nvaccination before their index date and children who had\nreceived MMR vaccination more than 26 weeks before\ntheir index date (Table 2). The estimated relative risk of\n13\u201324-month-old children developing ITP during the\nperiod within 6 weeks after MMR vaccination, com-\npared to the reference group, was 6.3 (95% CI 1.3, 30.1).\nIn contrast, the estimated relative risk during the period\nfrom 7 to 26 weeks after MMR vaccination was not\nsigni\ufb01cantly elevated. Estimating the relative risk (RR),\nexcluding \u2018probable cases\u2019 where medical records were\nnot available to con\ufb01rm the diagnosis of ITP, did not\nmaterially change the relative risk estimate.\nReview of computer records and additional documents\nof the eight children with vaccine-related ITP showed\nno evidence of infection, other illness, or other drug\nexposure during the month before MMR vaccination,\nnor during the weeks between vaccination and the\ndiagnosis of ITP. Although two of the eight children\nwith vaccine-related ITP subsequently received a second\nMMR vaccination, neither experienced a recurrence of\nITP.\nTable 1 Characteristics of children with ITP.\nOutcomes\nNo.", "mimetype": "text/plain", "start_char_idx": 10434, "end_char_idx": 12239, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7bbd786b-a3b7-4173-8e9b-f1cfd162d7df": {"__data__": {"id_": "7bbd786b-a3b7-4173-8e9b-f1cfd162d7df", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Black (2003).pdf", "node_type": "4", "metadata": {}, "hash": "d876a78863a46423ca0c4cd2b9afe3abc0390934a1b75de73e0cc6c1c46c3425", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f47e8133-47a1-47f9-9d68-b70a2c6c1c44", "node_type": "1", "metadata": {}, "hash": "9c75f24fdc18059399ed6bdb6d11935fb8601a43cd291283ac282b5b56ce525c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9151a37c-6dfd-4652-aec7-4e8c8e574d4c", "node_type": "1", "metadata": {}, "hash": "81eb033470cb3418efb3530ef66dd30fb56950c8212c27a4e7b3026cec138754", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Although two of the eight children\nwith vaccine-related ITP subsequently received a second\nMMR vaccination, neither experienced a recurrence of\nITP.\nTable 1 Characteristics of children with ITP.\nOutcomes\nNo. of cases (n = 63)\nAge (at diagnosis)\n0\u201312 months\n6\n13\u201324 months\n23\n25\u201336 months\n10\n37\u201348 months\n9\n49\u201360 months\n7\n61\u201372 months\n8\nSex\nMale\n35\nFemale\n28\nPlatelet count\nPlatelets <20\n29\nPlatelets 20\u2013100\n10\nUnknown\n24\nManagement\nHospitalized\n33\nOutpatient\n11\nUnknown\n19\nTreatment\nNone\n18\nImmunoglobulin\n13*\nSteroids\n11\nUnknown\n23\nComplications\nActive bleeding**\n13\nSerious complications\n0\nRecurrence\nYes\n3\nNo\n60\n*Two children received both steroids and immunoglobulins.\n**Includes epistaxsis(5), mouth blisters(2), gastrointestinal bleeding(2),\nother(4).\nTable 2 Vaccination exposure and estimated relative risk of ITP after MMR vaccination among 13\u201324-month-old children.\nVaccination exposure\nCases (n = 23)\nControls (n = 116)\nRelative risk\n95% CI\nReference group [unexposed to MMR\nor > 26 weeks after MMR]\n9 (39.1%)\n65 (56.0%)\nReference\n\u2013\n6 weeks or less after MMR vaccination\n8 (34.8%)\n19 (16.4%)\n6.3\n1.3, 30.1\n7 to 26 weeks after MMR\n6 (26.1%)\n32 (27.6%)\n1.5\n0.4, 4.8\n 13652125, 2003, 1, Downloaded from https://bpspubs.onlinelibrary.wiley.com/doi/10.1046/j.1365-2125.2003.01790.x by Assistance Publique Hopitaux De Paris Ap-Hp, Wiley Online Library on [09/01/2025].", "mimetype": "text/plain", "start_char_idx": 12032, "end_char_idx": 13405, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9151a37c-6dfd-4652-aec7-4e8c8e574d4c": {"__data__": {"id_": "9151a37c-6dfd-4652-aec7-4e8c8e574d4c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Black (2003).pdf", "node_type": "4", "metadata": {}, "hash": "d876a78863a46423ca0c4cd2b9afe3abc0390934a1b75de73e0cc6c1c46c3425", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7bbd786b-a3b7-4173-8e9b-f1cfd162d7df", "node_type": "1", "metadata": {}, "hash": "767fd67ea77290f38bddaceaf6cc1d5d86cab67b6d137a939605b18591d67ee2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9e3c84e5-124a-4c25-8faa-959cb414f1be", "node_type": "1", "metadata": {}, "hash": "9950fa947dc115af423890753b29ed610b6cfc900b252a967ca36f21dc4a7836", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nC. Black et al.\n110\n\u00a9 2003 Blackwell Science Ltd Br J Clin Pharmacol, 55, 107\u2013111\nIncidence of ITP among 13- to 24-month-old children\nThe estimated absolute risk of developing ITP during\nthe 6 weeks after MMR vaccination was 1 in 21 000\n(95% CI 10 500, 47 800) vaccine doses. The estimated\nattributable risk of developing ITP during the 6 weeks\nafter MMR vaccination was 1 in 25 000 (95% CI 21 300,\n89 400) vaccine doses.\nNo trend was detected in the yearly incidence rate of\nITP among 13\u201324-month-olds over the 11 years of the\nstudy (Table 3).\nFifteen of the 23 cases of ITP among 13\u201324 month-\nolds occurred in children who had not received MMR\nvaccination or who received MMR vaccination more\nthan 6 weeks before their index date. The estimated\n\u2018background\u2019 rate of ITP (unrelated to MMR vaccina-\ntion) among children aged 13\u201324 months was 0.9 per\n10 000 person-years (95% CI 0.5, 1.5).\nDiscussion\nWe estimated the background rate of ITP among 13\u201324-\nmonth-old children to be 0.9 in 10 000 person-years. We\nfound an approximately six-fold increase in risk of ITP\nin 13\u201324-month-old children during the 6 weeks follow-\ning MMR vaccination. Seven of the eight vaccine-related\ncases of ITP occurred between week 2 and week 4 after\nvaccination. The risk of developing ITP during the\n6 weeks after MMR vaccination attributable to the vac-\ncine was estimated to be 1 in 25 000 vaccine doses. (The\nattributable risk is calculated for a 6-week time period\nand should not be compared directly to the background\nincidence rate for ITP, which is the estimated average\nrisk over the 1-year age period under study in the\nabsence of recent MMR vaccination.)", "mimetype": "text/plain", "start_char_idx": 13406, "end_char_idx": 15245, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9e3c84e5-124a-4c25-8faa-959cb414f1be": {"__data__": {"id_": "9e3c84e5-124a-4c25-8faa-959cb414f1be", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Black (2003).pdf", "node_type": "4", "metadata": {}, "hash": "d876a78863a46423ca0c4cd2b9afe3abc0390934a1b75de73e0cc6c1c46c3425", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9151a37c-6dfd-4652-aec7-4e8c8e574d4c", "node_type": "1", "metadata": {}, "hash": "81eb033470cb3418efb3530ef66dd30fb56950c8212c27a4e7b3026cec138754", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "330eb42a-766b-48b8-b0f5-316ebc8e76ab", "node_type": "1", "metadata": {}, "hash": "f1732aebe81c8980053931f311f677e160243ab51252f18e37f73ac7af4640bf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The estimated RR\nduring the period from 7 to 26 weeks after MMR vac-\ncination was not signi\ufb01cantly elevated [RR 1.5 (95% CI\n0.4, 4.8)] but with broad con\ufb01dence intervals, the data\nare compatible with a longer risk period.\nLike the study by Miller et al. [8], our study provides\nadditional evidence of the association between ITP and\nMMR vaccination. We found a higher relative and attrib-\nutable point estimate risk of ITP within 6 weeks of\nMMR vaccination than Miller et al., although the con-\n\ufb01dence intervals are wide and overlapping. While there\nis no statistically signi\ufb01cant difference, two aspects in the\nstudy design may have contributed to a difference in\nrelative and attributable risk. Miller et al. relied only on\nhospital admission data, but by using the GPRD, we\nwere able to identify children managed as outpatients.\nMiller et al. also found only 67% of the children admitted\nto hospital with ITP could be linked to a vaccination\nhistory in the child health registry. The GPRD has been\nfound to have virtually complete recording of vaccine\nhistories and a consistently high proportion of children\nregistered to practices contributing to the GPRD have\nbeen found to be vaccinated with MMR [14]. By\nrestricting our study to children registered with a GP\nwithin 4 months of birth we are con\ufb01dent that we have\ncomplete vaccine histories for all of the cases and controls\nin this study.\nIn an attempt to reduce bias, the identi\ufb01cation of cases\nand controls was carried out by two reviewers blinded\nto the vaccine exposure of the subjects, who indepen-\ndently assessed the computer records and available case\nrecords for children with potential ITP. The diagnosis\ncode for ITP in the computer records were con\ufb01rmed\nby hospital discharge letter in 95% of available case\nrecords, again con\ufb01rming the high quality of data record-\ning by GPs contributing the GPRD.\nDuring the study period of 1988\u201399 the vaccination\nrate among children registered with the GPRD has been\nconstant around 94% [14].", "mimetype": "text/plain", "start_char_idx": 15246, "end_char_idx": 17246, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "330eb42a-766b-48b8-b0f5-316ebc8e76ab": {"__data__": {"id_": "330eb42a-766b-48b8-b0f5-316ebc8e76ab", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Black (2003).pdf", "node_type": "4", "metadata": {}, "hash": "d876a78863a46423ca0c4cd2b9afe3abc0390934a1b75de73e0cc6c1c46c3425", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9e3c84e5-124a-4c25-8faa-959cb414f1be", "node_type": "1", "metadata": {}, "hash": "9950fa947dc115af423890753b29ed610b6cfc900b252a967ca36f21dc4a7836", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ff62dbf0-1a65-4d00-b5bd-f9748630a3ea", "node_type": "1", "metadata": {}, "hash": "d71f3583047fca1757478c858e997dc25890349b4a54fd81521f7a8fc5490d83", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "During the study period of 1988\u201399 the vaccination\nrate among children registered with the GPRD has been\nconstant around 94% [14]. Similarly, no statistically sig-\nni\ufb01cant trend in the rate of ITP among 13\u201324-month-\nold children was found during this time period. This\ncontrasts to the time trend analysis, published by our\ngroup, regarding autism and MMR vaccination over a\nsimilar time period. The incidence of autism was shown\nto increase steeply over time while MMR vaccination\nrates were virtually constant [14].\nThis study con\ufb01rms that ITP below the age of 6 years\nold is generally a mild disease, with few serious bleeding\nepisodes or long-term sequele, despite the low platelet\ncounts found in many of the children. Most children\npresented with bruising and petechiae. Five had minor\nepistaxis and two had minor gastrointestinal bleeds but\nnone were haemodynamically compromised or required\nblood transfusion. Recurrence of ITP among the chil-\ndren studied was uncommon. Of the 11 children who\nTable 3 Yearly incidence of ITP among 13\u201324-month-old \nchildren.", "mimetype": "text/plain", "start_char_idx": 17116, "end_char_idx": 18182, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ff62dbf0-1a65-4d00-b5bd-f9748630a3ea": {"__data__": {"id_": "ff62dbf0-1a65-4d00-b5bd-f9748630a3ea", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Black (2003).pdf", "node_type": "4", "metadata": {}, "hash": "d876a78863a46423ca0c4cd2b9afe3abc0390934a1b75de73e0cc6c1c46c3425", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "330eb42a-766b-48b8-b0f5-316ebc8e76ab", "node_type": "1", "metadata": {}, "hash": "f1732aebe81c8980053931f311f677e160243ab51252f18e37f73ac7af4640bf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d1cda7b2-fcb6-409d-a467-f790aa7ff127", "node_type": "1", "metadata": {}, "hash": "96e90fc584b74bb7885a776e58e24a28864d75c8a308034c6b9616a15cd2998c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Recurrence of ITP among the chil-\ndren studied was uncommon. Of the 11 children who\nTable 3 Yearly incidence of ITP among 13\u201324-month-old \nchildren.\nYear\nCases\nPerson-time\nYearly incidence rate\n(per 10 000) and\ncon\ufb01dence interval\n1989\n0\n6 378\n0 (0, 5.8)\n1990\n0\n14 530\n0 (0, 2.5)\n1991\n2\n16 772\n1.2 (0.1, 4.3)\n1992\n5\n20 829\n2.4 (0.8, 5.6)\n1993\n5\n19 745\n2.5 (0.8, 5.9)\n1994\n0\n20 521\n0 (0, 1.8)\n1995\n4\n19 252\n2.1 (0.6, 5.3)\n1996\n4\n15 612\n2.6 (0.7, 6.6)\n1997\n2\n10 822\n1.8 (0.2, 6.7)\n1998\n1\n8 307\n1.2 (0, 6.7)\n1999\n0\n1 918\n0 (0, 19)\n*95% two-sided con\ufb01dence interval or 97.5% one-sided con\ufb01dence\ninterval (for years in which there were no cases).\n 13652125, 2003, 1, Downloaded from https://bpspubs.onlinelibrary.wiley.com/doi/10.1046/j.1365-2125.2003.01790.x by Assistance Publique Hopitaux De Paris Ap-Hp, Wiley Online Library on [09/01/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nMMR vaccine and idiopathic thrombocytopaenic purpura\n\u00a9 2003 Blackwell Science Ltd Br J Clin Pharmacol, 55, 107\u2013111\n111\ndeveloped ITP prior to MMR vaccination, none devel-\noped a recurrence after subsequent vaccination.", "mimetype": "text/plain", "start_char_idx": 18034, "end_char_idx": 19286, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d1cda7b2-fcb6-409d-a467-f790aa7ff127": {"__data__": {"id_": "d1cda7b2-fcb6-409d-a467-f790aa7ff127", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Black (2003).pdf", "node_type": "4", "metadata": {}, "hash": "d876a78863a46423ca0c4cd2b9afe3abc0390934a1b75de73e0cc6c1c46c3425", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ff62dbf0-1a65-4d00-b5bd-f9748630a3ea", "node_type": "1", "metadata": {}, "hash": "d71f3583047fca1757478c858e997dc25890349b4a54fd81521f7a8fc5490d83", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "063bd937-826a-4cf9-ab3d-1f6f19322e15", "node_type": "1", "metadata": {}, "hash": "c37e3a4ec20d753f10b569112b1c94ecf28ecd7607f3073dcce2d0cb1a2e19e9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Of the eight children with MMR vaccine associated\nITP, two went on to receive a second MMR vaccination\nwithout recurrence.\nConclusion\nAlthough ITP is one of the most frequently diagnosed\nhaematological disorders among young children, it is an\nuncommon condition. The risk of ITP occurring within\nthe 6 weeks after vaccination with MMR is signi\ufb01cantly\nincreased. However the attributable risk of ITP within\n6 weeks after MMR vaccination remains low at 1 in\n25 000 vaccinated children. Complications or long-term\nconsequences of ITP in this age group are rare. For the\nmajority of children less than 6 years of age, the illness\nis self-limiting.\nWe thank the general practitioners who contribute data to the\nGPRD for their continued participation and excellent patient care.\nThe Boston Collaborative Drug Surveillance Program is supported\nin part by grants from AstraZeneca, Berlex Laboratories, Bristol-\nMyers Squibb Pharmaceutical Research Institute,GlaxoSmithKline,\nHoffmann-La Roche, Ingenix Pharmaceutical Services, Johnson &\nJohnson Pharmaceutical Research & Development, L.L.C.,\nPharmacia Corporation and Novartis Farmac\u00e9utica. This study was\nnot funded.\nReferences\n1\nBolton-Maggs PHB. Idiopathic thrombocytopenic purpura. \nArch Dis Child  2000; 83: 220\u2013222.\n2\nRonchi F, Cecchi P, Falcioni F et al. Thrombicytopenic \npurpura as adverse reaction to recombinant hepatitis B \nvaccine. Arch Dis Child  1998; 78: 273\u2013274.\n3\nWiniarski J. Mechanisms in childhood idiopathic \nthrombocytopenic purpura (ITP). Acta Paediatr Suppl  1998; \n424: 54\u201356.\n4\nValcha V, Forman E, Miron D, Georges P. Recurrent \nthrobocytopenic purpura after repeated measles, mumps and \nrubella vaccination. Pediatrics 1996; 97: 738\u2013739.", "mimetype": "text/plain", "start_char_idx": 19287, "end_char_idx": 20994, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "063bd937-826a-4cf9-ab3d-1f6f19322e15": {"__data__": {"id_": "063bd937-826a-4cf9-ab3d-1f6f19322e15", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Black (2003).pdf", "node_type": "4", "metadata": {}, "hash": "d876a78863a46423ca0c4cd2b9afe3abc0390934a1b75de73e0cc6c1c46c3425", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d1cda7b2-fcb6-409d-a467-f790aa7ff127", "node_type": "1", "metadata": {}, "hash": "96e90fc584b74bb7885a776e58e24a28864d75c8a308034c6b9616a15cd2998c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "89575e18-210d-431a-bbbd-59340052d7ae", "node_type": "1", "metadata": {}, "hash": "cb03ce307ed8f174a1fe06ec3f5cf4396db762405d50c1650fb0594329d057a6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Pediatrics 1996; 97: 738\u2013739.\n5\nChang SK, Farrell DL, Dougan K, Kobayashi B. Acute \nidiopathic thrombocytopenic purpura following combined \nvaccination against measles, mumps and rubella. J Am Board \nFam Pract  1996; 9: 53\u201355.\n6\nBeeler J, Varrichio F, Wise R. Thrombocytopenia after \nimmunization with measles vaccines. Pediatr Infect Dis J  1996; \n15: 88\u201390.\n7\nJonville-Bera A, Autret E, Galy-Eyraud C, Hessel L. \nThrombocytopenic purpura after measles, mumps and rubella \nvaccination. Pediatr Infect Dis J  1996; 15: 44\u201348.\n8\nMiller E, Waight P, Farrington P, Andrews N, Stowe J, \nTaylor B. Idiopathic thrombocytopenic purpura and MMR \nvaccine. Arch Dis Child  2001; 84: 227\u2013229.\n9\nJick HA. Database worth saving. Lancet 1997; 350: 1045\u20131046 \n[Letter].\n10\nLawson DH, Sherman V, Hollowell J. General Prac Res \nDatabase QJM  1998; 91: 445\u2013452.\n11\nJick H, Terris BZ, Derby LE, Jick SS. Further validation of \ninformation recorded on a general practitioner based \ncomputerised data resource in the United Kingdom. \nPharmicoepidemiol Drug Saf  1992; 1: 347\u2013343.\n12\nJick H, Jick SS, Derby LE. Validation of information recorded \non general practitioner based computerised data resource in \nthe United Kingdom. BMJ 1991; 302: 766\u2013768.\n13\nJick H, Withers JM, Dean AD. Haemophilus influenza  vaccine. \nBr J Gen Pract  1995; 45: 107 [Letter].", "mimetype": "text/plain", "start_char_idx": 20965, "end_char_idx": 22299, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "89575e18-210d-431a-bbbd-59340052d7ae": {"__data__": {"id_": "89575e18-210d-431a-bbbd-59340052d7ae", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Black (2003).pdf", "node_type": "4", "metadata": {}, "hash": "d876a78863a46423ca0c4cd2b9afe3abc0390934a1b75de73e0cc6c1c46c3425", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "063bd937-826a-4cf9-ab3d-1f6f19322e15", "node_type": "1", "metadata": {}, "hash": "c37e3a4ec20d753f10b569112b1c94ecf28ecd7607f3073dcce2d0cb1a2e19e9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "13\nJick H, Withers JM, Dean AD. Haemophilus influenza  vaccine. \nBr J Gen Pract  1995; 45: 107 [Letter].\n14\nKaye JA, Melero-Montes M, Jick H. Mumps, measles and \nrubella vaccine, and the incidence of autism recorded by \ngeneral practitioners. BMJ 2001; 322: 460\u2013463.\n 13652125, 2003, 1, Downloaded from https://bpspubs.onlinelibrary.wiley.com/doi/10.1046/j.1365-2125.2003.01790.x by Assistance Publique Hopitaux De Paris Ap-Hp, Wiley Online Library on [09/01/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License", "mimetype": "text/plain", "start_char_idx": 22195, "end_char_idx": 22854, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9df0c3f4-afe9-461c-b510-d446e9a1d4a6": {"__data__": {"id_": "9df0c3f4-afe9-461c-b510-d446e9a1d4a6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Edees (1991).pdf", "node_type": "4", "metadata": {}, "hash": "b0d22391c371d3964df4f641ae48ef33f2bc669b479936966d7b4fffd3eb40dd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "40e9346a-c98d-4f78-bfad-8412ee39923a", "node_type": "1", "metadata": {}, "hash": "242e21068064fc66849c2e6bc89a7a8db0b83395bf1909ceff83e1ab3fe4fbf9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Public\" Health (1991), 105, 91-97 \n\u00a9 The Society of Public Health, 1991 \nA Randomised Single Blind Trial of a Combined \nMumps Measles Rubella Vaccine to Evaluate \nSerological Response and Reactions in the UK \nPopulation \nS. Edees*, C. R. Pullan and D. Hull \nDepartment of Child Hea/th, University Hospital, Queen \"s Medica/ Centre, \nNottingham \nFour hundred and twenty children were randomly assigned to receive either mumps \nmeasles rubella (MMR) vaccine (207) or measles vaccine (213) in a single blind study, to \ninvestigate the reactogenicity and serology of the MMR vaccine. There was no \nsignificant difference between the number of children developing symptoms after MM R \nvaccination to those developing symptoms after measles vaccination. Both vaccines are \nassociated with a rash, temperature and restlessness five to thirteen days after vaccina- \ntion. The serological response to measles vaccine was similar in both groups with 92-6% \nseroconverting with MMR, and 96-8% with measles. Seroconvertion against mumps \nand rubella with the MMR vaccine was 88% and 96% respectively. This study confirms \nthe safety and efficacy of the MMR vaccine in a UK population. \nIntroduction \nThe mumps measles rubella (MMR) vaccine was introduced into the UK vaccination \nschedule in October 1988. ~ \nIt is hoped that this change in immunisation policy will boost vaccination rates against \nmeasles towards the 90% uptake target for 1990 suggested by the WHO and lead ultimately \nto the erradication of measles, mumps and rubella. \nThe MMR vaccine has been available in America since the 1970s, and Scandinavia since \n1982. 2 There are many data from these countries concerning the vaccine. The majority of \nthese studies used vaccines containing Jeryl Lynn (mumps) and Moraten (measles) virus \nstrains. 3'4's In the UK we are also using Urabe AM/9 (mumps) Schwarz (measles) \ncombination. This combination has been compared to Jeryl Lynn-Moraten vaccine, and \nfound to be at least equally immunogenic and reactogenic.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2013, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "40e9346a-c98d-4f78-bfad-8412ee39923a": {"__data__": {"id_": "40e9346a-c98d-4f78-bfad-8412ee39923a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Edees (1991).pdf", "node_type": "4", "metadata": {}, "hash": "b0d22391c371d3964df4f641ae48ef33f2bc669b479936966d7b4fffd3eb40dd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9df0c3f4-afe9-461c-b510-d446e9a1d4a6", "node_type": "1", "metadata": {}, "hash": "768bb70429fa4a1e33cd784344b8a199b5c65616a8af9304483e144d94141e4e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b23943fc-d734-4362-8277-1b585de6acec", "node_type": "1", "metadata": {}, "hash": "2ae0633539a8328cdef2b997308d93859797832d970488fad73072689c281304", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This combination has been compared to Jeryl Lynn-Moraten vaccine, and \nfound to be at least equally immunogenic and reactogenic. 6 Some workers have suggested \nthe immunogenicity and reactogenicity of the Urabe AM/9 Schwarz combination to be \ngreater. 7,8 \nIt is important we define the benefits and the risks of the vaccine in the UK population if \nwe are to counsel parents appropriately and strive to achieve the 90% uptake target. \nThis is a report of the results of a single blind randomized control trial, evaluating the \nserological response, and reactogenicity of a MMR vaccine, Trimovax (Schwarz \n1000TCIDs0, Urabe AM/9 5000 TCID~0, rubella RA 27/3 1000 TCIDso) using a measles \nvaccine, Rouvax (Schwarz 100 TCID~0 ) as control, under routine conditions in the UK. \n* To whom correspondence should be sent. \n92 \nS. Edees et al. \nTable I \nExclusion criteria \n1. Infants aged less than 12 months or over 48 months \n2. \nInfants with malignant disease \n3. \nInfants who were immunocomprised \n4. \nInfants with a history of convulsions* \n5. \nInfants with a history of anaphylactic reaction to eggs, neomycin or \nkanomycin \n6. \nInfants with a history of measles or mumps (not rubella because of \nthe inaccuracy of the diagnosis) \n* Infants who had suffered from convulsions were excluded from the study because of \nthe limited licence of the MMR vaccination at the time of the study. \nMethod \nThe study was based in two areas of Nottingham (Rushcliffe and Broxtowe) and was \ncarried out over a 12 month period. The names of children who would be eligible for \nmeasles vaccination at this time (age 13-15 months) were obtained from health visitors' \nbirth books. Parents were approached by letter. If they expressed an interest in the study \nthey were visited by a doctor (SE), the study was explained in detail and written consent \nwas obtained. \nChildren who fell into any of the categories in Table ! were excluded from the study.", "mimetype": "text/plain", "start_char_idx": 1885, "end_char_idx": 3818, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b23943fc-d734-4362-8277-1b585de6acec": {"__data__": {"id_": "b23943fc-d734-4362-8277-1b585de6acec", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Edees (1991).pdf", "node_type": "4", "metadata": {}, "hash": "b0d22391c371d3964df4f641ae48ef33f2bc669b479936966d7b4fffd3eb40dd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "40e9346a-c98d-4f78-bfad-8412ee39923a", "node_type": "1", "metadata": {}, "hash": "242e21068064fc66849c2e6bc89a7a8db0b83395bf1909ceff83e1ab3fe4fbf9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7e0c15e9-5de4-4dc0-a83d-dab4425ce902", "node_type": "1", "metadata": {}, "hash": "53db4dd6c9e364edc467e0a95445f7b8d28752aa526e3ec6a858595a236dc5af", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Children who fell into any of the categories in Table ! were excluded from the study. \nVaccination was deferred in any child who had been in contact with measles, mumps or \nrubella in the previous three weeks, had a febrile illness, had received gamma globulin in the \nprevious three months or had received a vaccine in the previous month. \nThe child was randomly assigned to receive MMR vaccine or measles vaccine by a system \nof sealed number envelopes, the numbers corresponding to the child's study number. \nRandomization occurred at the time of vaccination in the Child Health Clinic. \nThe vaccination was given in the upper arm, unless the parents objected in which case it \nwas given in the upper leg. Prior to vaccination 1.5 ml of venous blood was taken into a dry \ntube. Parents were given a diary and asked to record any symptoms in the child, whether or \nnot they thought them attributable to the vaccination. The diary asked specifically if the \nchild had: anything to see at the injection site, sore arm, pain anywhere, a rash, a fever, or if \nthey had received medication. There was also a space to record if the child was different \nfrom usual and in what way. The diary was completed daily for three weeks. The parents \nwere asked to continue to monitor their child for a further three weeks and record any \nsymptoms weekly in the diary. After six weeks the diaries were collected and any symptoms \ndiscussed with the parents. A second blood sample was taken at this time for serology. The \ntrial code was broken and the parents informed which vaccine the child had received. If the \nchild had received only measles vaccine they were offered mumps (Immovax) and rubella \n(Rudivax) vaccinations. \nThe information from the diaries was categorised into symptom groups: \n1. Local symptoms: erythema, induration, pain. \n2. General specific symptoms; rash, parotitis, testicular swelling, arthralgia, arthritis, \nconjunctival inflammation, convulsion. \n3. General non-specific symptoms; fever, adenopathy, nasopharyngeal inflammation, \ndigestive disorders, restlessness.", "mimetype": "text/plain", "start_char_idx": 3733, "end_char_idx": 5814, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7e0c15e9-5de4-4dc0-a83d-dab4425ce902": {"__data__": {"id_": "7e0c15e9-5de4-4dc0-a83d-dab4425ce902", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Edees (1991).pdf", "node_type": "4", "metadata": {}, "hash": "b0d22391c371d3964df4f641ae48ef33f2bc669b479936966d7b4fffd3eb40dd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b23943fc-d734-4362-8277-1b585de6acec", "node_type": "1", "metadata": {}, "hash": "2ae0633539a8328cdef2b997308d93859797832d970488fad73072689c281304", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "04a63fb2-2891-448b-b010-eec64514cb89", "node_type": "1", "metadata": {}, "hash": "9a4c0175bfe01cdbfc38b821879584dcb79323260f1457994a505d012858bf9b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3. General non-specific symptoms; fever, adenopathy, nasopharyngeal inflammation, \ndigestive disorders, restlessness. \nRestlessness is the term we have used to describe a non-specifically unwell child; it covers \nsuch terms as irritable, miserable, tearful, clingy, not sleeping, noted by the parents. \nSerological response and reactions in the UK Population \n93 \nThe blood for serology was separated and the serum frozen at - 20\u00b0C. It was transported \non dry ice to the laboratories of Institute Merieux, Lyon, France, where analysis was \nperformed. \nMeasles and rubella antibody levels were determined using Haem-agglutination \ninhibition; the mumps antibody titres were determined using the neutralisation test. 9 \nImmunity to measles and rubella was assumed if the antibody titre was greater than 20, \nand to mumps if the antibody titre was greater than 120. In cases where there was an \ninsufficient sample for full analysis, titres were estimated in the priority measles, mumps, \nrubella. The Study was approved by the local ethical committee. \nResults \nFour hundred and twenty children were enrolled into the study: 213 were assigned to the \nmeasles group and 207 to the MMR group. Completed diaries were received for 196 (9:2%) \nchildren in the measles group and for 198 (95.6%) in the MMR group. Completed diaries \nwere unavailable for the remainder, either because the parents did not wish further contact \nwith the study (19), or failed to complete the diary but did attend for follow-up (6), or \nmoved from the area during the study period (1). \nPaired blood samples were obtained for 308 (73 %) subjects. The mean age of vaccination \nof children in the measles group was 14.5 months (SD 2.5 months), and in the MMR group \n14.7 months (SD 1.5 months). \nThe symptoms observed are shown in Table II. Only 8 children in the measles group and \n11 in the MMR group recorded no symptoms. There was no difference in the frequency of \nTable I!", "mimetype": "text/plain", "start_char_idx": 5697, "end_char_idx": 7644, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "04a63fb2-2891-448b-b010-eec64514cb89": {"__data__": {"id_": "04a63fb2-2891-448b-b010-eec64514cb89", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Edees (1991).pdf", "node_type": "4", "metadata": {}, "hash": "b0d22391c371d3964df4f641ae48ef33f2bc669b479936966d7b4fffd3eb40dd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7e0c15e9-5de4-4dc0-a83d-dab4425ce902", "node_type": "1", "metadata": {}, "hash": "53db4dd6c9e364edc467e0a95445f7b8d28752aa526e3ec6a858595a236dc5af", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c213f53c-e004-47e9-98d0-c1237f6629b2", "node_type": "1", "metadata": {}, "hash": "4f912ca3cfed42e699c7e1275eb5f994c52336b0fe1b25a80e1d6bf0ba1f9218", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The symptoms observed are shown in Table II. Only 8 children in the measles group and \n11 in the MMR group recorded no symptoms. There was no difference in the frequency of \nTable I! Percentage of children who developed symptoms \nMMR \nMeasles \n% \n% \n(n = 198) \n(n = 196) \nLocal symptoms \nerythema \n9.1 \n8.2* \ninduration \n0.5 \n0 \npain \n4.5 \n7.1 * \nGeneral symptoms (specific): \nrash \n43.9 \n51.0\" \nparotitis \n2.5 \n0 \nconjunctivitis \n8.6 \n10.7\" \ntesticular swelling \n0 \n0 \narthralgia \n0 \n0 \narthritis \n0 \n0 \nconvulsion \n0 \n0 \nGeneral symptoms (non-specific): \nfever \n38.3 \n37.8* \nadenopathy \n1.0 \n1.5 \nnasopharyngeal disorders \n57.1 \n58.7* \ngastrointestinal disorders \n41.9 \n37.8* \nrestlesness \n62.6 \n75.0* \n* No difference in frequency of symptoms between the two groups, \nusing )~2 test. P = > 0.05 \n94 \nS. Edees et al. \nasterised symptoms between the two vaccine groups, using the chi-square test (P> 0.05). \nLocal symptoms of vaccination were rarely noted and tended to occur within the first two \ndays. Three general symptoms, fever, restlessness and rash, were clustered, and had a peak \nincidence on days 5 to 13 after vaccination (Figure 1). The incidence of gastro-intestinal \ndisorders, conjunctivitis, and nasopharyngeal inflammation, varied throughout the six \nweeks in both groups and had no relationship to the vaccination. The rates were 2-60 \n5 15 % and 0-3 % respectively. Parotitis was observed in five children who had received the \n20- \n0 \nE \n~\" lO \n03 \n\"6 \n0 \nFever \n-G- M.M.R.", "mimetype": "text/plain", "start_char_idx": 7462, "end_char_idx": 8957, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c213f53c-e004-47e9-98d0-c1237f6629b2": {"__data__": {"id_": "c213f53c-e004-47e9-98d0-c1237f6629b2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Edees (1991).pdf", "node_type": "4", "metadata": {}, "hash": "b0d22391c371d3964df4f641ae48ef33f2bc669b479936966d7b4fffd3eb40dd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "04a63fb2-2891-448b-b010-eec64514cb89", "node_type": "1", "metadata": {}, "hash": "9a4c0175bfe01cdbfc38b821879584dcb79323260f1457994a505d012858bf9b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d7c54a47-6187-4e8f-ab8b-7f7ad1f0271b", "node_type": "1", "metadata": {}, "hash": "2e82497df5b53fc24b274cf4cf039b0ed8af991034aa4a55cda88aa5cbf98649", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Parotitis was observed in five children who had received the \n20- \n0 \nE \n~\" lO \n03 \n\"6 \n0 \nFever \n-G- M.M.R. Vaccination \n-~- Measles Vaccination \n10 \n20 \n30 \n40 \nRestlessness \n\u00a3 \nQ. \nE \n\"6 \n30 \n20 \n10 \n10 \n20 \n30 \n40 \nRash \nO \nF~ \n03 \n~6 \nom \n30\" \n20. \n10. \n0 \n0 \n10 \n20 \n30 \n40 \nDays after vaccination \nFigure 1 Clustering of symptoms occurring post-vaccination. \nFigure 2 \nSerological response and reactions in the UK Population \nMeasles vaccine \n\u00b0\u00b0L \n'iiL \n80 \n80 \noo \n60 \n\"~ 4o \n4o \n\u00b0~\u00a3 20 \n20 \n0 \n0 \n<20 \n30-120 150-> \n<120 180-480 >720 \n<20 \n30-120 150-> \n64O \n64O \nMeasles antibody titre \nMumps antibody titre \nRubella antibody titre \nMMR Vaccine \nioo[i \n100[ \nlO0[i \n60 \n60 \n60 \n\u00a2..) \n40 \n40 \n40 \n20 \n20 \n20 \n0 \n0 \n0 \n<20 \n30-120 150--> \n<120 180-480 >720 \n<20 \n30-120 150-> \n640 \n640 \nMeasles antibody titre \nMumps antibody titre \nRubella antibody titre \nAntibody titres pre- and post-vaccination (I, pre-vaccination; [], post-vaccination). \n95 \nMMR vaccine. It developed between 21 and 42 days after vaccination and it was present for \nan average of eight days. Three cases of mumps, confirmed by antibody titres, were noted in \nschool-age siblings of children who had received the MMR vaccine occurring between 20 \nand 25 days post-vaccination. \nThe antibody distributions pre- and post-vaccination are shown in Figure 2. The \nseroconversion rates obtained from paired sere for non-immune children are demonstrated \nin Table III.", "mimetype": "text/plain", "start_char_idx": 8849, "end_char_idx": 10290, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d7c54a47-6187-4e8f-ab8b-7f7ad1f0271b": {"__data__": {"id_": "d7c54a47-6187-4e8f-ab8b-7f7ad1f0271b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Edees (1991).pdf", "node_type": "4", "metadata": {}, "hash": "b0d22391c371d3964df4f641ae48ef33f2bc669b479936966d7b4fffd3eb40dd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c213f53c-e004-47e9-98d0-c1237f6629b2", "node_type": "1", "metadata": {}, "hash": "4f912ca3cfed42e699c7e1275eb5f994c52336b0fe1b25a80e1d6bf0ba1f9218", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7dcff453-0ba8-4ca9-9d44-3fa3190183e8", "node_type": "1", "metadata": {}, "hash": "a1ebb15582dba25c3d4fc13e9827027e285b274a96eb1a7bff28bfe70db75254", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The antibody distributions pre- and post-vaccination are shown in Figure 2. The \nseroconversion rates obtained from paired sere for non-immune children are demonstrated \nin Table III. \nOnly one child failed to respond to all the components of the MMR vaccine, two did not \ndevelop immunity to both mumps and measles, whilst several did not respond to individual \ncomponents (measles 8, mumps 12, rubella 4). \nWe looked more closely at those children who had developed a fever, rash and \nrestlessness between days 5 and 13 after the vaccination. Two hundred and forty three \n(60%) of the children had one of the symptoms in this time, 41 (10%) had all of the \nsymptoms. We looked for a relationship between antibody response and symptomatology. \nOf the children who had one sympton in the period, 120 had a measles titre of greater than \n150, and 29 of the children who had all three symptoms had a high antibody response to \none component of the vaccine. (Measles greater than 150, mumps greater than 720, rubella \ngreater than 150.) \nTable III Seroconversion on paired sere from non-immune children pre-vaccination \nMeasles vaccine \nMMR vaccine \nPre- \nPost- \nSero- \nPre- \nPost- \nSero- \nvaccination \nvaccination \nconversion \nvaccination \nvaccination \nconversion \nnon-immune \nimmune \n(%) \nnon-immune \nimmune \n(%) \nchildren \nchildren \nchildren \nchildren \nMeasles \n157 \n152 \n96.8 \n149 \n138 \n92.6 \nMumps \n133 \n4 \n3.0 \n122 \n107 \n87.7 \nRubella \n133 \n4 \n3.0 \n125 \n120 \n96.0 \n96 \nS. Edees et al. \nDiscussion \nIt is essential that when a vaccine is introduced into a community, its effects in that \ncommunity are defined. Two earlier studies in the UK looked at the serological response to \nthe MMR vaccine, but the open nature of the study made it difficult to interpret \nreactogenicity. 10.~l \nIn this study, to minimise bias of symptom reporting, the parents were not informed \nwhich vaccine their child had received.", "mimetype": "text/plain", "start_char_idx": 10107, "end_char_idx": 12018, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7dcff453-0ba8-4ca9-9d44-3fa3190183e8": {"__data__": {"id_": "7dcff453-0ba8-4ca9-9d44-3fa3190183e8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Edees (1991).pdf", "node_type": "4", "metadata": {}, "hash": "b0d22391c371d3964df4f641ae48ef33f2bc669b479936966d7b4fffd3eb40dd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d7c54a47-6187-4e8f-ab8b-7f7ad1f0271b", "node_type": "1", "metadata": {}, "hash": "2e82497df5b53fc24b274cf4cf039b0ed8af991034aa4a55cda88aa5cbf98649", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d69033a1-e1ff-4a44-ba05-f9c54da58de9", "node_type": "1", "metadata": {}, "hash": "8d292d2d6003ef688356298f0b17b0cfa13858831c8479347a360faf0d61e7ce", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "10.~l \nIn this study, to minimise bias of symptom reporting, the parents were not informed \nwhich vaccine their child had received. Ideally one would use a placebo control group but \nwe felt it unethical to do so in an invasive study, and opted to compare the new vaccine \n(MMR) with the one it has replaced (measles). \nMany parents reported their children to have symptoms. This high illness level occurred \nthroughout the six-week period, and involved nasopharyngeal and gastrointestinal \nsymptoms. There was no temporal relationship to vaccination. This probably represents \nbackground illness and is in agreement with the findings of Vesikari et al. 6 \nA symptom complex of rash, fever and restlessness in the second week of vaccination is a \nwell-recognised reaction to measles vaccination. Sixty per cent of our study were affected by \none of these symptoms: this is quite high, but is in accordance with other workers who have \nshown between 30 and 40% to be affected by fever following measles vaccination. 6J'~\u00b0 A \nmore accurate assessment of true adverse reaction is thought to be that of Petola and \nHeinonen in their study using a placebo group. 3 As far as possible we tried to create the \nconditions of the routine use of the vaccine. However, although parental anxiety may well \nbe higher in study conditions, it is our impression that most parents will observe their child \nclosely following vaccination. Thus, though the rate of adverse reaction we report may not \nbe the true reaction rate, it is the rate perceived by parents. We have found this rate to be \nsimilar for both MMR and measles vaccination. Health workers should be aware that mild \nand self-limiting reactions are common after most vaccinations so that parents are fully \ninformed and can be adequately reassured. The reactions are similar to those after the \nmeasles vaccine alone. \nParotitis associated with mumps vaccination occurred in 2.5% of our study. This is \nhigher than has previously been reported in the majority of other studies using Jeryl Lynn \nmumps vaccine. The Oxford study ~r (using the same vaccine as this study) reported an \nincidence of 1%. In view of the low incidence and small numbers of the studies, the \ndifferences observed in rates are probably not significant.", "mimetype": "text/plain", "start_char_idx": 11887, "end_char_idx": 14161, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d69033a1-e1ff-4a44-ba05-f9c54da58de9": {"__data__": {"id_": "d69033a1-e1ff-4a44-ba05-f9c54da58de9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Edees (1991).pdf", "node_type": "4", "metadata": {}, "hash": "b0d22391c371d3964df4f641ae48ef33f2bc669b479936966d7b4fffd3eb40dd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7dcff453-0ba8-4ca9-9d44-3fa3190183e8", "node_type": "1", "metadata": {}, "hash": "a1ebb15582dba25c3d4fc13e9827027e285b274a96eb1a7bff28bfe70db75254", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "79a6d93b-02b1-478a-b246-33d22f6bff0b", "node_type": "1", "metadata": {}, "hash": "6a2e71a1013a781b3a243f71abe13ec2fe9ed5efc06aa7c219a32c4ae3f60e84", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The Oxford study ~r (using the same vaccine as this study) reported an \nincidence of 1%. In view of the low incidence and small numbers of the studies, the \ndifferences observed in rates are probably not significant. \nIt has been suggested that Urabe AM/9, which produces a higher incidence of \npost-vaccination symptoms than Jeryl Lynn, is also more immunogenic. We have not \nfound evidence to support this claim. The seroconversion rate for mumps was relatively \nlow. The mumps antibody was analysed using the neutralization test, which has been \nreported to be the most reliable and sensitive method. ~2 Most studies use the ELISA \nmethod. The comparatively low seroconversion rate may be attributable to the high \npre-vaccination mumps immunity (13%) in our sample, a reflection of the prevalence of \nwild mumps at the time of the study. American researchers found 3% of 18-month olds \nwere seropositive for mumps. ~2 If a given percentage of the population are non-responders \nto either wild mumps or vaccine strains then the proportion of these within the \nnon-immune group will increase with exposure. Thus the greater the exposure to wild \nmumps the more likely it will be that the vaccination conversion rate is falsely low. \nThe circulation of wild mumps at the time of the study could also explain the three cases \nof mumps observed in siblings. Further surveillance of this reaction is required. Mumps \nvirus has been isolated from throat swabs of symptomatic vaccinees--this could have \nimplications when vaccinating selected groups within closed communities, for example \nresidential schools. \nSerological response and reactions in the UK Population \n97 \nSome consider that a marked reaction to a vaccine in an individual would be associated \nwith a high antibody response. This has not been shown in these results. The study supports \nthe safety and efficacy of the MMR vaccine and provides data for informed advice to \nparents on the reactogenicity of the vaccine. \nAcknowledgement \nDr S. Edees was sponsored by a grant from Merieux UK Ltd. \nReferences \n1. Department of Health and Social Security. (1988). Immunisation against Infectious Disease. \nLondon: HMSO. \n2.", "mimetype": "text/plain", "start_char_idx": 13945, "end_char_idx": 16127, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "79a6d93b-02b1-478a-b246-33d22f6bff0b": {"__data__": {"id_": "79a6d93b-02b1-478a-b246-33d22f6bff0b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Edees (1991).pdf", "node_type": "4", "metadata": {}, "hash": "b0d22391c371d3964df4f641ae48ef33f2bc669b479936966d7b4fffd3eb40dd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d69033a1-e1ff-4a44-ba05-f9c54da58de9", "node_type": "1", "metadata": {}, "hash": "8d292d2d6003ef688356298f0b17b0cfa13858831c8479347a360faf0d61e7ce", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "25e3c987-ab2c-483a-8865-00f8a2230531", "node_type": "1", "metadata": {}, "hash": "d6982fd75d9d1a71d2bc0ba0f4a2f8fe79f3614b6357b56c992d835f6ef8d05f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "References \n1. Department of Health and Social Security. (1988). Immunisation against Infectious Disease. \nLondon: HMSO. \n2. Petola, H., Karanko, V., Kikri, T. et al. (1986). Rapid effect on endemic measles, mumps and \nrubella of a nationwide vaccination programme in Finland. Lancet, i, 137-139, \n3. Petola, H. & Heinonen, O. (1986). Frequency of true adverse reactions to measles mumps rubella \nvaccine. Lancet, i, 939-942. \n4. Christenson, B., Bottiger, M. & Heller, L. (1983). Mass vaccination programme aimed at \neradicating measles, mumps and rubella in Sweden: First experience. British Medical Journal, \n287, 389-391. \n5. Brunell, P. A., Weigle, K. & Murphy, M. D. (1983). Antibody response following measles mumps \nrubella vaccine under conditions of customary use. JAMA, 250, 1409-1411. \n6. Vesikari, T., Ala-Laurila, E. L., Heikkinen, A,, Terho, A., D'Hondt, E. & Andre, F. E. (1984). \nClinical trial of a new trivalent measles mumps rubella vaccine in young children. AJDA, 138, \n843-847. \n7. Vesikari, T., Andre, F. E., Simoen, E. et al. (1983). Comparison of the Urabe Amn Schwarz and \nJeryl Lynn-Moraten combination of mumps measles vaccines in young children. Acta Paediatric \nScandinavica, 72, 41-46. \n8. Popau-Kraupp, T., Kundi, M., Ambrosch, F., Vanura, H. & Launz, C. (1986). A controlled trial \nfor evaluting two live attenuated mumps-measles vaccines (UAS+JUM) in young children.", "mimetype": "text/plain", "start_char_idx": 16003, "end_char_idx": 17404, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "25e3c987-ab2c-483a-8865-00f8a2230531": {"__data__": {"id_": "25e3c987-ab2c-483a-8865-00f8a2230531", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab\u2010Edees (1991).pdf", "node_type": "4", "metadata": {}, "hash": "b0d22391c371d3964df4f641ae48ef33f2bc669b479936966d7b4fffd3eb40dd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "79a6d93b-02b1-478a-b246-33d22f6bff0b", "node_type": "1", "metadata": {}, "hash": "6a2e71a1013a781b3a243f71abe13ec2fe9ed5efc06aa7c219a32c4ae3f60e84", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "& Launz, C. (1986). A controlled trial \nfor evaluting two live attenuated mumps-measles vaccines (UAS+JUM) in young children. \nJournal of Medical Virology, 18, 69-79. \n9. Sato, H., Alvrecht, P., Hicks, J. T., Myer, B. L. & Enwis, F. A. (1987). Sensitive neutralisation \ntest for mumps antibody. Archives of Virology, 58, 301-305. \n10. Dunlop, J. M., Choudhury, R. K., Roberts, J. St. C. & Bryett, K. A. (1989). An evaluation of \nmeasles, mumps and rubella vaccine in a population of Yorkshire infants. Public ltealth, 103, \n331-335. \nI I. Robertson, C. M., Bennet, V. J., Jefferson, N. et aL (1988). Serological evaluation of a measles \nmumps and rubella vaccine. Archives of Disease in ChiMhood. 63, 612-616. \n12. Christenson, B. & Bottiger, M. (1985). Vaccination against measles mumps rubella; A compari- \nson between the antibody responses at the ages of 18 months and 12 years and between different \nmethods of antibody titration. Journal of Biological Standardisation, 13, 167-172.", "mimetype": "text/plain", "start_char_idx": 17279, "end_char_idx": 18266, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8cb9aaad-b7fc-4cf6-b9a3-2492314ab51e": {"__data__": {"id_": "8cb9aaad-b7fc-4cf6-b9a3-2492314ab51e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dd1f8b49-cec6-4394-898e-080918d0e7b0", "node_type": "1", "metadata": {}, "hash": "501dfcfa73bf22c07b77d3926bd6690902a95154e29d6d73e8cb892f53b2c932", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccines and the risk of acute disseminated encephalomyelitis\nYong Chen a,1,\u21d1, Fubao Ma a, Yuanling Xu b, Xuhua Chu c, Jinlin Zhang a\na Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, China\nb Department of Neurology, Nanjing Brain Hospital, China\nc Department of Neurology, Jiangsu Provincial People\u2019s Hospital, China\na r t i c l e\ni n f o\nArticle history:\nReceived 15 January 2018\nReceived in revised form 12 May 2018\nAccepted 14 May 2018\nAvailable online 18 May 2018\nKeywords:\nVaccines\nAcute disseminated encephalomyelitis\na b s t r a c t\nBackground: It is important to examine the risk of Acute disseminated encephalomyelitis (ADEM) after\nvaccination.\nMethods: We conducted a nested case\u2013control study between January 2011 and December 2015. Four\ncontrols per case were matched for age, gender, address. An independent expert committee validated\nthe diagnoses of cases and controls. Data on vaccinations were obtained from computerized vaccination\nrecords. The analyses were conducted with the use of conditional logistic regression.\nResults: The analyses include 272 cases of ADEM and 1096 controls. No increase in the risk of ADEM was\nobserved for vaccination against hepatitis B, in\ufb02uenza, polio(live), diphtheria, pertuss(acellular), tetanu-\nsis, measles, mumps, rubella, Japanese Encephalitis, meningitis, hepatitis A, varicella and rabies vaccines.\nVaccine was associated with a statistically signi\ufb01cant increase in risk in the 31\u201360-day exposure interval\n(OR, 4.04 [95% CI, 1.07\u201312.69]), but not the 0\u201330 and 61\u2013180-day interval. There was no association\nbetween vaccine received and the recurrence of ADEM.\nConclusions: Findings from the present study do not demonstrate an association of vaccines with an\nincreased risk of ADEM and its recurrence among either paediatric (\u000118 years) or adult (>18 years) indi-\nviduals within the 180 days after vaccinations.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1931, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dd1f8b49-cec6-4394-898e-080918d0e7b0": {"__data__": {"id_": "dd1f8b49-cec6-4394-898e-080918d0e7b0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8cb9aaad-b7fc-4cf6-b9a3-2492314ab51e", "node_type": "1", "metadata": {}, "hash": "3dca14312f3d1c41170de7130fa795d2999e63e0be506f553bff15ae77605912", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3976c430-341e-4970-a98a-81b2093afe0c", "node_type": "1", "metadata": {}, "hash": "5dae22ea89d758af30735ae7b1d2f938c6bb9f45d86a787b2c76ba5ddd4c4858", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The \ufb01nding in children in the 31\u201360 day risk interval is\nlikely coincidental and was not con\ufb01rmed in separate self-control analyses.\n\u0001 2018 Elsevier Ltd. All rights reserved.\n1. Introduction\nAcute disseminated encephalomyelitis (ADEM) is an immune-\nmediated central nervous system disorder, characterized by an\nacute encephalopathy with polyfocal neurological de\ufb01cits [1].\nThe pathogenesis of ADEM is not known clearly, but adhesion\nmolecules, chemokines, matrix metalloproteinase, and other cell\nfactors are thought to be important in its occurrence and develop-\nment [2].\nIn addition to a known association with infections, vaccinations\nalso have been suggested to induce a small increased risk of ADEM\n[3]. In an American study, vaccination was found to precede ADEM\nin about 5% (2/42) of cases [4]. Several cases of young females pre-\nsenting with onset of ADEM approximately 1 month following the\nadministration of human papillomavirus (HPV) vaccine have been\nreported [5,6]. In Langer-Gould et al, a higher risk of CNS demyeli-\nnating disease was only observed in those less than 50 years at \ufb01rst\n14 and 30 days, but not further longer period, following any vacci-\nnation (a \u2018\u2018temporal shift\u201d phenomenon) [7].\nIn recent years, the Expanded Program on Immunization (EPI)\nhas been carried out in China. The type and number of vaccines\nadministered to residents increased. The probability of having a\nsevere abnormal reaction such as ADEM to vaccines is small, but\nthe onset of such reactions usually cause widespread public con-\ncern. This may reduce public con\ufb01dence in vaccines [8]. Vaccines\navailable for use in Jiangsu Province was presented in Supplemen-\ntary material Table 1.\nThe purpose of this study was to examine in more detail the\nassociation between the risk of ADEM including disease recurrence\nand vaccines.\n2. Materials and methods\n2.1. Setting\nIn China, most people get medical technology and specialized\nneurological care from public hospitals.", "mimetype": "text/plain", "start_char_idx": 1932, "end_char_idx": 3898, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3976c430-341e-4970-a98a-81b2093afe0c": {"__data__": {"id_": "3976c430-341e-4970-a98a-81b2093afe0c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dd1f8b49-cec6-4394-898e-080918d0e7b0", "node_type": "1", "metadata": {}, "hash": "501dfcfa73bf22c07b77d3926bd6690902a95154e29d6d73e8cb892f53b2c932", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5f617676-81f3-4984-9b6a-865d3d3804ec", "node_type": "1", "metadata": {}, "hash": "745b0c8c7ddde92008aa9758e47f497b2f42fe0fee1d64127ffb26b1d7a5ac61", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2. Materials and methods\n2.1. Setting\nIn China, most people get medical technology and specialized\nneurological care from public hospitals. Generally, patients who\nhttps://doi.org/10.1016/j.vaccine.2018.05.063\n0264-410X/\u0001 2018 Elsevier Ltd. All rights reserved.\n\u21d1Corresponding author at: Jiangsu Provincial Center for Disease Control and\nPrevention, 172 Street Jiangsu, Nanjing, Jiangsu Province 210009, China.\nE-mail addresses: chenyong12345678@163.com (Y. Chen), 13948520@qq.com\n(Y. Xu), 16006819@qq.com (X. Chu), jinlinzhang@yeah.net (J. Zhang).\n1 Statistical Analysis conducted by Yong Chen, MD, Jiangsu Provincial Center for\nDisease Control and Prevention.\nVaccine 36 (2018) 3733\u20133739\nContents lists available at ScienceDirect\nVaccine\njournal homepage: www.elsevier.com/locate/vaccine\nget suspected ADEM are admitted in hospital as emergencies, and\nsoon after, a neurologist will be invited to take care of them.\nPatients no more than 16 years old who are affected by neurolog-\nical diseases are usually taken in pediatric hospitals.\nThe province of Jiangsu is located in the east of China. It covers a\nsurface of 107.2 thousand km2 and the mean population density is\n767 inhabitants/km2. Nantong, Yancheng and Xuzhou, which are\nthree cities in Jiangsu province, were involved in this study. Totally,\n74 hospitals were involved, 21 in Nantong, 20 in Yancheng and 33\nin Xuzhou, and they all provided inpatient services. In these hospi-\ntals, any departments that might have received patients meeting\nthe case de\ufb01nition were involved, including neurology, internal\nmedicine, pediatrics, and inpatient wards. The research was\napproved by the institutional review board of the Jiangsu Provin-\ncial Center for Disease Control and Prevention (JSCDC). Informed\nconsent was waived because this was a medical records review\nstudy without direct patient contact.\n2.2.", "mimetype": "text/plain", "start_char_idx": 3759, "end_char_idx": 5621, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5f617676-81f3-4984-9b6a-865d3d3804ec": {"__data__": {"id_": "5f617676-81f3-4984-9b6a-865d3d3804ec", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3976c430-341e-4970-a98a-81b2093afe0c", "node_type": "1", "metadata": {}, "hash": "5dae22ea89d758af30735ae7b1d2f938c6bb9f45d86a787b2c76ba5ddd4c4858", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "76695f1a-8798-458a-a797-be3fbbda8f85", "node_type": "1", "metadata": {}, "hash": "4819753dc6b54fdfb8abc82846e7d2aaa802e70b60c94e850c7ea3ebf1cedb86", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Informed\nconsent was waived because this was a medical records review\nstudy without direct patient contact.\n2.2. Case identi\ufb01cation\nWe searched the Hospital Information Systems (HIS) for \ufb01rst\nmention of International Classi\ufb01cation of Diseases, Tenth Revision\n(ICD-10), diagnostic codes (G04.001, G04.002, G04.051, G04.903,\nand G04.912) for ADEM from January 1, 2011, to December 31,\n2015, for persons of any age.\nDiagnoses were con\ufb01rmed by neurologists from clinical data,\nsuch as clinical manifestations, computed tomography (CT), elec-\ntroencephalograph (EEG), cerebrospinal \ufb02uid (CSF) and magnetic\nresonance imaging (MRI) examinations. The consensus de\ufb01nitions\nof ADEM that were updated by the International Pediatric MS\nStudy Group in 2013 were used [9]. The emergence of either new\nor old neurologic symptoms lasting more than 24 h, which stabi-\nlized or resolved either partially or completely, or lesions on MRI\nwas de\ufb01ned as a relapse if it occurred >3 months after disease\nonset, and as a \ufb02are if it occurred \u00013 months after disease onset\n[10].\n2.3. Control selection\nFor each ADEM case, 4 control individuals randomly selected\nfrom the same hospital with no history of ADEM were matched\nto the case according to year of birth (within 1 year), gender, and\nzip code (a surrogate measure for socioeconomic status) during\nthe same period. The control participants were assigned the same\nindex date as their matched case (symptom onset date). Controls\nwere patients referred for headache (except trigeminal neuralgia),\nmigraine, vascular or other diseases which were thought not to\nmodify the probability of vaccination. Patients with chronic severe\nneurological diseases or autoimmune diseases were excluded.\n2.4. Vaccination records\nInformation on vaccinations was obtained from Information\nManagement System for Immunization Programming, in which\nanyone who received vaccinations would be registered, matched\nwith ID number and veri\ufb01ed by paper vaccination records. Any\nvaccination was considered to be an exposure.", "mimetype": "text/plain", "start_char_idx": 5509, "end_char_idx": 7532, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "76695f1a-8798-458a-a797-be3fbbda8f85": {"__data__": {"id_": "76695f1a-8798-458a-a797-be3fbbda8f85", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5f617676-81f3-4984-9b6a-865d3d3804ec", "node_type": "1", "metadata": {}, "hash": "745b0c8c7ddde92008aa9758e47f497b2f42fe0fee1d64127ffb26b1d7a5ac61", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "68c7e3ce-e5ac-441e-bd36-fc1f8f95109e", "node_type": "1", "metadata": {}, "hash": "ce80a5337fc5aec0c4511a790bf86801d3d3aea0a26359873617beb1deb380e8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Any\nvaccination was considered to be an exposure. We collected infor-\nmation on all vaccinations received within 180 days.\n2.5. Covariates\nOther data obtained included nationality (Han and others),\noccupation, marital status (married and single), allergy, familial\ndiseases, comorbid chronic diseases, and history of infectious dis-\neases. Comorbid chronic diseases and history of infectious diseases\nwere within 6 months before the index date.\n2.6. Statistical analysis\nConditional logistic regression following univariable analysis\nwas used to estimate the matched odds ratio (OR) and its corre-\nsponding 95% two-sided CI for the association between ADEM\nand vaccination. For each case, the index date was the date of onset\nof the \ufb01rst symptoms of the CNS demyelinating event. For the con-\ntrols, we assigned the time of the onset of ADEM in the individual\nwith whom the control was matched. The models were adjusted\nfor nationality, occupation, marital status, allergy, familial diseases,\ncomorbid chronic diseases, and history of infectious diseases\nwithin 6 months before the index date, and all variables with a P\nvalue less than 0.20 were included in the regression model [11].\nTo examine both the immediate and long-term effects of vaccina-\ntion on ADEM, the exposure was restricted to the following differ-\nent time frames before the index date: 14 days, 30 days, 60 days,\n90 days, and 180 days. Additional analyses were strati\ufb01ed by\nsubintervals 0\u201314, 15\u201330, 31\u201360, 61\u201390, and 91\u2013180 days. To\ndetermine whether\nthe paediatric was\nassociated\nwith any\nvaccine-associated ADEM, the study population was strati\ufb01ed\naccording to age (\u000118 years and >18 years) at the index date.\nTo examine whether or not each case was vaccinated in the 31\u2013\n60 interval or the remainder of the 1 to 180 post-vaccination time\ninterval, self-controlled case series (SCCS) analyses were used. To\navoid the confounding by infection, we looked at cases without a\nhistory of infection in the prior 6 months separately.", "mimetype": "text/plain", "start_char_idx": 7483, "end_char_idx": 9481, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "68c7e3ce-e5ac-441e-bd36-fc1f8f95109e": {"__data__": {"id_": "68c7e3ce-e5ac-441e-bd36-fc1f8f95109e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "76695f1a-8798-458a-a797-be3fbbda8f85", "node_type": "1", "metadata": {}, "hash": "4819753dc6b54fdfb8abc82846e7d2aaa802e70b60c94e850c7ea3ebf1cedb86", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d211cd0b-1839-4017-81c3-db17934b9210", "node_type": "1", "metadata": {}, "hash": "a2571f7cf3fcb70f030438ac54abadbc7b835c0438e11f36b9657774a5a71b01", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "To\navoid the confounding by infection, we looked at cases without a\nhistory of infection in the prior 6 months separately. The risk inter-\nval was the 31\u201360 day interval and the comparisons interval\nincluded the remainder of the 1 to 180 post-vaccination time inter-\nval. We do the analysis for receipt of any vaccine and as many\nspeci\ufb01c vaccines as possible. We also conducted separate analyses\nfor children and adults.\nThe means (SDs) of normally distributed variables were com-\npared using 2-sample t tests; for binary or categorical variables,\nv2 analysis with the Fisher exact test was used. We de\ufb01ned a P\nvalue less than 0.05 as statistically signi\ufb01cant. All analyses were\nconducted in 2017.\n3. Results\nTotally,\n272 patients\nwith newly\ndiagnosed\nADEM\nwere\nincluded in the study after an independent diagnosis of two neu-\nrologists (Fig. 1). A summary of selected characteristics of the cases\n(272) with ADEM and the controls (1096) is presented in Table 1.\n272 cases selected \n340 cases identified \n24 excluded: \n\u201315 diagnosed before January 1, 2011 \n\u20139 did not have ADEM \n264 cases matched \nwith 4 controls each \n8 cases matched \nwith 5 controls each \n316 cases \n\u201344 cases short of MRI result \nFig. 1. Case classi\ufb01cation \ufb02ow.\n3734\nY. Chen et al. / Vaccine 36 (2018) 3733\u20133739\nBecause of matching, cases and controls had similar distributions\nof sex and age (Table 1). Cases and controls also had similar levels\nof nationality, marital status, place of residence, allergy history,\nfamily history of demyelinating diseases or other autoimmune dis-\neases, and comorbid chronic diseases. Compared with controls, the\ncases were more likely to have had a visit for an infectious illness\nin the 6 months before symptom onset (P < 0.05), and 88.36% cases\nand 79.34% controls were upper respiratory tract infections.\nThe analyses of the association between any vaccination and\nthe risk of ADEM by age and time since vaccination are presented\nin Table 2.", "mimetype": "text/plain", "start_char_idx": 9359, "end_char_idx": 11310, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d211cd0b-1839-4017-81c3-db17934b9210": {"__data__": {"id_": "d211cd0b-1839-4017-81c3-db17934b9210", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "68c7e3ce-e5ac-441e-bd36-fc1f8f95109e", "node_type": "1", "metadata": {}, "hash": "ce80a5337fc5aec0c4511a790bf86801d3d3aea0a26359873617beb1deb380e8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "13ca1353-2e60-42e6-a5e6-ef8ab6ec1d85", "node_type": "1", "metadata": {}, "hash": "e6eff39baa49bdfcbfc9916635f1a2de2dddbcd49b05bd80e43a6604ec56d223", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The analyses of the association between any vaccination and\nthe risk of ADEM by age and time since vaccination are presented\nin Table 2. Among paediatric population (\u000118 years), the adjusted\nOR of ADEM for cases as compared with controls within 180 days\nbefore the index date was 1.19 (95% CI, 0.78\u20131.74). Vaccine was\nassociated with a statistically signi\ufb01cant increase in risk in the\n31\u201360-day exposure interval (OR, 4.04 [95% CI, 1.07\u201312.69]), but\nnot the 0\u201330 and 61\u2013180-day interval. Among adult population\n(>18 years), the corresponding OR was 1.22 (95% CI, 0.23\u20134.76).\nWhen the data were pooled, the adjusted OR for cases as compared\nwith controls was not statistically signi\ufb01cant.\nNo increase in the risk of ADEM was observed for vaccination\nagainst hepatitis B, in\ufb02uenza, polio(live), diphtheria, pertuss(acel-\nlular), tetanusis, measles, mumps, rubella, Japanese Encephalitis,\nmeningitis, hepatitis A, varicella and rabies vaccines (Table 3).\nThe number of Japanese Encephalitis vaccinated individuals 180\ndays before symptom onset for the cases was too low to draw\nany conclusions. The adjusted ORs for cases as compared with con-\ntrols did not materially change when additional analyses were\nstrati\ufb01ed by subintervals 0\u201314, 15\u201330, 31\u201360, 61\u201390, and 91\u2013\n180 days (Supplementary material Table 2). There were no statisti-\ncally signi\ufb01cant interactions by sex for any of the associations\nbetween speci\ufb01c vaccines and ADEM, indicating that the results\nwere not different between male and female (Supplementary\nmaterial Table 3).\n23 cases without a history of infection in the prior 6 months\nwere included in the SCCS analyses. Tables 4 show the results of\nthe SCCS analyses using the 31\u201360 day exposure interval. There\nwas no statistically signi\ufb01cant increased risk of any vaccination\nor speci\ufb01c vaccines, and also in either children or adults.", "mimetype": "text/plain", "start_char_idx": 11174, "end_char_idx": 13025, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "13ca1353-2e60-42e6-a5e6-ef8ab6ec1d85": {"__data__": {"id_": "13ca1353-2e60-42e6-a5e6-ef8ab6ec1d85", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d211cd0b-1839-4017-81c3-db17934b9210", "node_type": "1", "metadata": {}, "hash": "a2571f7cf3fcb70f030438ac54abadbc7b835c0438e11f36b9657774a5a71b01", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "787ed6b9-31cf-4f82-99a2-b8f59c1ed440", "node_type": "1", "metadata": {}, "hash": "0966276f0b39e9fc11001a94a2429942dfd99506d4d1609225e28e4541b64037", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "There\nwas no statistically signi\ufb01cant increased risk of any vaccination\nor speci\ufb01c vaccines, and also in either children or adults.\nThirty-nine patients (21 \u0001 18 year-old vs 18 >18 year-old) have\nexperienced at least once relapse. Follow-up was a median of 25\nmonths (25th\u201375th percentile 8\u201367), 26 months (25th\u201375th per-\ncentile 9\u201372) in children and 23 months (25th\u201375th percentile\n5\u201366) in adults, P = 0.59. Rate of relapse was not signi\ufb01cantly lower\nin patients >18 year-old than \u000118 year-old (13.43% vs 15.21%, P =\n0.68). Among both paediatric patients (\u000118 years) and adult\npatients, the ORs (95% CI) of the association with ADEM recurrence\nwere not statistically signi\ufb01cant (Table 5).\n4. Discussion\nIn this nested case-control study, we found that the risk of\nADEM was not signi\ufb01cantly increased within the 180 days after\nvaccinations. We found that any vaccines are not associated with\nan increased risk of ADEM among either paediatric (\u000118 years)\nor adult (>18 years) individuals except for the 31\u201360-day exposure\ninterval among paediatric population (\u000118 years). The \ufb01nding in\nchildren in the 31\u201360 day risk interval is likely coincidental, per-\nhaps from multiple comparisons. The \ufb01nding is inconsistent\nbetween children and adults and in the vaccine-speci\ufb01c analysis,\nit does not appear speci\ufb01c to a particular vaccine, and there was\nTable 2\nAssociation between any vaccination and ADEM by age and time since vaccination.\nTime of vaccination\nbefore index date\nAge \u000118 y\nAge >18 y\nNo. (%) of\ncases\nNo. (%) of\ncontrols\nOR (95% CI)\nAdjusted OR\n(95% CI)\nNo. (%) of\ncases\nNo. (%) of\ncontrols\nOR (95% CI)\nAdjusted OR\n(95% CI)\na\n14 d\n4(2.90)\n16(2.88)\n1.01(0.", "mimetype": "text/plain", "start_char_idx": 12894, "end_char_idx": 14557, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "787ed6b9-31cf-4f82-99a2-b8f59c1ed440": {"__data__": {"id_": "787ed6b9-31cf-4f82-99a2-b8f59c1ed440", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "13ca1353-2e60-42e6-a5e6-ef8ab6ec1d85", "node_type": "1", "metadata": {}, "hash": "e6eff39baa49bdfcbfc9916635f1a2de2dddbcd49b05bd80e43a6604ec56d223", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "269903f8-4576-4aa8-9da4-08b11faa69e9", "node_type": "1", "metadata": {}, "hash": "0e905430c53ed11fe5bb9794cf8367448e1551c9f366d3ef44779c2110305626", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "(%) of\ncontrols\nOR (95% CI)\nAdjusted OR\n(95% CI)\na\n14 d\n4(2.90)\n16(2.88)\n1.01(0.33\u20133.06)\n1.03(0.35\u20133.07)\n3(2.24)\n9(1.67)\n1.35(0.36\u20135.06)\n1.32(0.33\u20134.95)\n30 d\n7(5.07)\n40(7.19)\n0.69(0.30\u20131.57)\n0.68(0.29\u20131.54)\n5(3.73)\n22(4.07)\n0.91(0.34\u20132.46)\n0.95(0.36\u20132.49)\n60 d\n20(14.49)\n53(9.53)\n1.61(0.93\u20132.79)\n1.59(0.90\u20132.76)\n11(8.21)\n38(7.04)\n1.18(0.59\u20132.38)\n1.15(0.55\u20132.30)\n90 d\n30(21.74)\n91(16.37)\n1.42(0.89\u20132.26)\n1.40(0.85\u20132.24)\n18(13.43)\n59(10.93)\n1.27(0.72\u20132.23)\n1.24(0.69\u20132.20)\n180 d\n56(40.58)\n201(36.15)\n1.21(0.82\u20131.77)\n1.19(0.78\u20131.74)\n24(17.91)\n106(19.63)\n0.89(0.55\u20131.46)\n0.93(0.59\u20131.55)\nb\n0\u201314 d\n4(2.90)\n16(2.88)\n1.01(0.33\u20133.06)\n1.08(0.39\u20133.16)\n3(2.24)\n9(1.67)\n1.35(0.36\u20135.06)\n1.24(0.26\u20136.06)\n15\u201330 d\n3(2.17)\n24(4.31)\n0.49(0.15\u20131.66)\n0.65(0.", "mimetype": "text/plain", "start_char_idx": 14477, "end_char_idx": 15214, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "269903f8-4576-4aa8-9da4-08b11faa69e9": {"__data__": {"id_": "269903f8-4576-4aa8-9da4-08b11faa69e9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "787ed6b9-31cf-4f82-99a2-b8f59c1ed440", "node_type": "1", "metadata": {}, "hash": "0966276f0b39e9fc11001a94a2429942dfd99506d4d1609225e28e4541b64037", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "beb36809-5a60-41f3-b472-94b0860898b2", "node_type": "1", "metadata": {}, "hash": "041f943b331e64defaf107756c35b306ae7d9a214e31cd6a7bf48eedfdeb3a02", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "06)\n1.24(0.26\u20136.06)\n15\u201330 d\n3(2.17)\n24(4.31)\n0.49(0.15\u20131.66)\n0.65(0.35\u20131.86)\n2(1.50)\n13(2.40)\n0.61(0.14\u20132.72)\n0.71(0.23\u20133.72)\n31\u201360 d\n13(9.42)\n13(2.34)\n4.34(1.97\u20139.60)\n4.04(1.07\u201312.69)\n6(4.48)\n16(2.97)\n1.52(0.52\u20133.96)\n1.22(0.23\u20134.76)\n61\u201390 d\n10(7.25)\n38(6.84)\n1.07(0.52\u20132.19)\n1.10(0.32\u20132.59)\n7(5.22)\n21(3.89)\n1.35(0.56\u20133.24)\n1.25(0.26\u20134.24)\n91\u2013180 d\n26(18.84)\n110(19.78)\n0.94(0.59\u20131.51)\n0.84(0.39\u20131.41)\n6(4.48)\n47(8.70)\n0.49(0.20\u20131.16)\n0.56(0.25\u20133.19)\nOdds ratio (95% con\ufb01dence interval) from conditional logistic regression models adjusted for occupation, familial diseases, comorbid chronic diseases, and history of\ninfectious diseases.\nTable 1\nDistribution of baseline characteristics between cases and controls.\nCharacteristic\nNo.", "mimetype": "text/plain", "start_char_idx": 15146, "end_char_idx": 15880, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "beb36809-5a60-41f3-b472-94b0860898b2": {"__data__": {"id_": "beb36809-5a60-41f3-b472-94b0860898b2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "269903f8-4576-4aa8-9da4-08b11faa69e9", "node_type": "1", "metadata": {}, "hash": "0e905430c53ed11fe5bb9794cf8367448e1551c9f366d3ef44779c2110305626", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "28f25062-2a41-466b-b0a8-7e0dd47b48ce", "node_type": "1", "metadata": {}, "hash": "e73b1b5ea998f19500e465707b4219d5816e02dba3c8137df2c385de4d020ce2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "familial diseases, comorbid chronic diseases, and history of\ninfectious diseases.\nTable 1\nDistribution of baseline characteristics between cases and controls.\nCharacteristic\nNo. (%)\nP value\nCases (n = 272)\nControls (n = 1096)\nAge at onset\n0\u201320 years\n138(50.74)\n556(50.73)\n1.00\n21\u201340 years\n44(16.18)\n177(16.15)\n41\u201360 years\n63(23.16)\n254(23.18)\n>61 years\n27(9.92)\n109(9.94)\nMean (range)\n15.42(2.00\u201386.00)\n15.43(2.00\u201386.00)\nSex\nMale\n149(54.78)\n599(54.65)\n0.97\nFemale\n123(45.22)\n497(45.35)\nNationality\nHan\n269(98.90)\n1076(98.18)\n0.41\nOthers\n3(1.10)\n20(1.82)\nMarital status\nMarried\n177(65.07)\n693(63.23)\n0.57\nSingle\n95(34.93)\n403(36.77)\nPlace of residence\nUrban\n62(22.79)\n304(27.74)\n0.09\nRural\n210(77.21)\n792(72.26)\nAllergy history\nNo\n260(95.59)\n1024(93.43)\n0.19\nYes\n12(4.41)\n72(6.57)\nFamily history\nNo\n264(97.06)\n1037(94.62)\n0.10\nYes\n8(2.94)\n59(5.38)\nComorbid chronic diseases\nNo\n220(80.88)\n884(80.66)\n0.93\nYes\n52(19.12)\n212(19.34)\nHistory of infectious diseases within 6 months before the index date\nNo\n40(14.71)\n573(52.28)\n0.00\nYes\n232(85.29)\n523(47.72)\nY. Chen et al. / Vaccine 36 (2018) 3733\u20133739\n3735\nTable 3\nAssociation between different vaccines and ADEM by time since vaccination.", "mimetype": "text/plain", "start_char_idx": 15703, "end_char_idx": 16887, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "28f25062-2a41-466b-b0a8-7e0dd47b48ce": {"__data__": {"id_": "28f25062-2a41-466b-b0a8-7e0dd47b48ce", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "beb36809-5a60-41f3-b472-94b0860898b2", "node_type": "1", "metadata": {}, "hash": "041f943b331e64defaf107756c35b306ae7d9a214e31cd6a7bf48eedfdeb3a02", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f473b478-5509-4d2c-aac5-ae89da349883", "node_type": "1", "metadata": {}, "hash": "5824b69326d13f4a7213ac1687389ac7bc523c4409446e6d9e5406d838241048", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "/ Vaccine 36 (2018) 3733\u20133739\n3735\nTable 3\nAssociation between different vaccines and ADEM by time since vaccination.\nVaccines\nVaccinated \u000114 d before index date\nVaccinated \u000130 d before index date\nNo. (%) of cases\nNo. (%) of controls\nOR (95% CI)\nAdjusted OR (95% CI)\nNo. (%) of cases\nNo. (%) of controls\nOR (95% CI)\nAdjusted OR (95% CI)\nHepatitis B\n4(1.47)\n20(1.82)\n0.80(0.27\u20132.37)\n0.75(0.17\u20133.39)\n8(2.94)\n38(3.47)\n0.84(0.39\u20131.83)\n0.82(0.35\u20131.78)\nIn\ufb02uenza\n4(1.47)\n17(1.55)\n0.95(0.32\u20132.84)\n0.92(0.38\u20132.54)\n9(3.31)\n52(4.74)\n0.69(0.33\u20131.41)\n0.72(0.35\u20131.48)\nPolio(live)\n0(0.00)\n0(0.00)\nNA\nNA\n0(0.00)\n0(0.00)\nNA\nNA\nDiphtheria, pertuss(acellular), tetanusis\n0(0.00)\n0(0.00)\nNA\nNA\n0(0.00)\n1(0.09)\nNA\nNA\nMeasles, mumps, rubella\n0(0.00)\n0(0.00)\nNA\nNA\n1(0.37)\n3(0.27)\nNA\nNA\nJapanese Encephalitis\n0(0.00)\n0(0.00)\nNA\nNA\n0(0.00)\n1(0.09)\nNA\nNA\nMeningitis(A/C/Y/W135)\n0(0.00)\n1(0.09)\nNA\nNA\n0(0.00)\n2(0.18)\nNA\nNA\nHepatitis A\n0(0.00)\n0(0.00)\nNA\nNA\n0(0.00)\n1(0.", "mimetype": "text/plain", "start_char_idx": 16770, "end_char_idx": 17713, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f473b478-5509-4d2c-aac5-ae89da349883": {"__data__": {"id_": "f473b478-5509-4d2c-aac5-ae89da349883", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "28f25062-2a41-466b-b0a8-7e0dd47b48ce", "node_type": "1", "metadata": {}, "hash": "e73b1b5ea998f19500e465707b4219d5816e02dba3c8137df2c385de4d020ce2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d2595d05-dda3-45ee-a0cc-7a129fad3c7c", "node_type": "1", "metadata": {}, "hash": "40c0cd3f74f35c3a6af1073640b7b59651696a8b42054965c2a3fc3cea7a7c3c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "00)\n2(0.18)\nNA\nNA\nHepatitis A\n0(0.00)\n0(0.00)\nNA\nNA\n0(0.00)\n1(0.09)\nNA\nNA\nVaricella\n1(0.37)\n3(0.27)\nNA\nNA\n1(0.37)\n5(0.46)\nNA\nNA\nRabies\n0(0.00)\n2(0.18)\nNA\nNA\n1(0.37)\n5(0.46)\nNA\nNA\nVaccines\nVaccinated \u000160 d before index date\nVaccinated \u000190 d before index date\nNo. (%) of cases\nNo. (%) of controls\nOR (95% CI)\nAdjusted OR (95% CI)\nNo. (%) of cases\nNo. (%) of controls\nOR (95% CI)\nAdjusted OR (95% CI)\nHepatitis B\n13(8.46)\n51(6.48)\n1.03(0.55\u20131.93)\n1.05(0.57\u20131.96)\n31(11.40)\n117(10.68)\n1.08(0.71\u20131.64)\n1.11(0.82\u20132.64)\nIn\ufb02uenza\n19(6.99)\n85(7.76)\n0.89(0.53\u20131.50)\n0.88(0.52\u20131.48)\n27(9.93)\n122(11.13)\n0.88(0.57\u20131.37)\n0.98(0.67\u20131.57)\nPolio(live)\n2(0.74)\n15(1.37)\n0.53(0.12\u20132.35)\n0.555(0.14\u20132.37)\n5(1.84)\n23(2.10)\n0.87(0.33\u20132.32)\n0.77(0.30\u20132.52)\nDiphtheria, pertuss(acellular), tetanusis\n3(1.10)\n11(1.00)\n1.10(0.31\u20133.97)\n1.15(0.38\u20133.46)\n7(2.57)\n32(2.92)\n0.88(0.38\u20132.", "mimetype": "text/plain", "start_char_idx": 17649, "end_char_idx": 18504, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d2595d05-dda3-45ee-a0cc-7a129fad3c7c": {"__data__": {"id_": "d2595d05-dda3-45ee-a0cc-7a129fad3c7c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f473b478-5509-4d2c-aac5-ae89da349883", "node_type": "1", "metadata": {}, "hash": "5824b69326d13f4a7213ac1687389ac7bc523c4409446e6d9e5406d838241048", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ec2a71b0-4cdf-4d37-a1b7-636690f59441", "node_type": "1", "metadata": {}, "hash": "072d438e2f0e74e0c14c91906d04169f9bf1993d927f22e9218b59af69077d3f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "00)\n1.10(0.31\u20133.97)\n1.15(0.38\u20133.46)\n7(2.57)\n32(2.92)\n0.88(0.38\u20132.01)\n0.82(0.30\u20132.21)\nMeasles, mumps, rubella\n3(1.10)\n15(1.37)\n0.80(0.23\u20132.80)\n0.85(0.28\u20132.85)\n5(1.84)\n27(2.46)\n0.74(0.28\u20131.94)\n0.72(0.38\u20131.84)\nJapanese Encephalitis\n0(0.00)\n1(0.09)\nNA\nNA\n1(0.37)\n5(0.46)\nNA\nNA\nMeningitis(A/C/Y/W135)\n1(0.37)\n3(0.27)\nNA\nNA\n3(1.10)\n8(0.73)\n1.52(0.40\u20135.76)\n1.55(0.45\u20135.78)\nHepatitis A\n2(0.74)\n10(0.91)\n0.80(0.18\u20133.69)\n0.83(0.21\u20133.72)\n7(2.57)\n35(3.19)\n0.80(0.35\u20131.82)\n0.85(0.38\u20131.86)\nVaricella\n3(1.10)\n8(0.73)\n1.52(0.40\u20135.76)\n1.49(0.38\u20135.74)\n7(2.57)\n25(2.28)\n1.13(0.48\u20132.65)\n1.15(0.49\u20132.68)\nRabies\n2(0.74)\n7(0.64)\nNA\nNA\n6(2.21)\n28(2.55)\n0.86(0.35\u20132.10)\n0.88(0.33\u20132.18)\nVaccines\nVaccinated \u0001180 d before index date\nNo. (%) of cases\nNo.", "mimetype": "text/plain", "start_char_idx": 18439, "end_char_idx": 19165, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ec2a71b0-4cdf-4d37-a1b7-636690f59441": {"__data__": {"id_": "ec2a71b0-4cdf-4d37-a1b7-636690f59441", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d2595d05-dda3-45ee-a0cc-7a129fad3c7c", "node_type": "1", "metadata": {}, "hash": "40c0cd3f74f35c3a6af1073640b7b59651696a8b42054965c2a3fc3cea7a7c3c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b8d641ac-25c7-4eff-ab34-240510d1ca3a", "node_type": "1", "metadata": {}, "hash": "fe2905d5365e616944e77ecd96f6b17b19eb5bc931c4ebedb927f5a8cda53e6c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "86(0.35\u20132.10)\n0.88(0.33\u20132.18)\nVaccines\nVaccinated \u0001180 d before index date\nNo. (%) of cases\nNo. (%) of controls\nOR (95% CI)\nAdjusted OR (95% CI)\nHepatitis B\n61(22.43)\n255(23.27)\n0.95(0.64\u20131.31)\n0.93(0.56\u20131.35)\nIn\ufb02uenza\n38(13.97)\n149(13.59)\n1.03(0.70\u20131.52)\n1.05(0.79\u20131.55)\nPolio(live)\n9(3.31)\n28(2.55)\n1.31(0.61\u20132.80)\n1.35(0.65\u20132.89)\nDiphtheria, pertuss(acellular), tetanusis\n14(5.15)\n45(4.11)\n1.27(0.69\u20132.34)\n1.41(0.55\u20133.38)\nMeasles, mumps, rubella\n11(4.04)\n36(3.28)\n1.24(0.62\u20132.47)\n1.03(0.68\u20133.75)\nJapanese Encephalitis\n1(0.37)\n6(0.55)\nNA\nNA\nMeningitis(A/C/Y/W135)\n6(2.21)\n15(1.37)\n1.63(0.63\u20134.23)\n1.56(0.55\u20135.38)\nHepatitis A\n18(6.62)\n65(5.93)\n1.12(0.66\u20131.93)\n1.44(0.85\u20132.98)\nVaricella\n17(6.25)\n82(7.48)\n0.82(0.48\u20131.42)\n0.88(0.43\u20131.67)\nRabies\n11(4.04)\n35(3.19)\n1.28(0.64\u20132.55)\n1.26(0.63\u20132.58)\nOdds ratio (95% con\ufb01dence interval) from conditional logistic regression models adjusted for occupation, marital status, allergy, comorbid chronic diseases, and history of infectious diseases.", "mimetype": "text/plain", "start_char_idx": 19070, "end_char_idx": 20056, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b8d641ac-25c7-4eff-ab34-240510d1ca3a": {"__data__": {"id_": "b8d641ac-25c7-4eff-ab34-240510d1ca3a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ec2a71b0-4cdf-4d37-a1b7-636690f59441", "node_type": "1", "metadata": {}, "hash": "072d438e2f0e74e0c14c91906d04169f9bf1993d927f22e9218b59af69077d3f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d9be7f00-07c6-4925-9b79-fbb28d1476e1", "node_type": "1", "metadata": {}, "hash": "18aa71d715c3d6e62b43c6901c454a34baf58f38bcdd637afb8b2b884e1af8f4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3736\nY. Chen et al. / Vaccine 36 (2018) 3733\u20133739\nno statistically signi\ufb01cant increased risk in the SCCS analyses. The\nresult could be due to residual confounding with the use of hospi-\ntalized controls, especially with the large differences in infectious\ndiseases between the cases and controls.\nHepatitis B has been the vaccine about which there has been the\ngreatest\ncontroversy\nregarding\na\npossible\nassociation\nwith\ndemyelinating diseases. We found no increased risk with HepB-\ncontaining vaccine and the risk of ADEM 180 days following vacci-\nnation, which consistents with the results from most previous\nHepB vaccine and ADEM risk studies [7,12\u201314]. However, as in\nthe previous French study [15], an association between pediatric\nacute CNS in\ufb02ammatory demyelination and Engerix B vaccine\nwas reported only 3 years after vaccination (OR, 2.8; 95% CI, 1.2\u2013\n6.4). This \ufb01nding is dif\ufb01cult to interpret because the study failed\nto \ufb01nd associations for other HepB vaccine brands. Our results\nare also different from another analysis conducted in France which\nfound that the number of noti\ufb01ed cases that occurred within 2\nmonths after HepB vaccination was higher than expected [16].\nThere have been some case reports of central nervous system\ndemyelination within a few weeks after the HepB vaccination,\nbut as their authors recognize, these reports cannot demonstrate\na causal or triggering association [17,18].\nIn\ufb02uenza vaccine is another commonly administered to people.\nThe null result that we found in this investigation is consistent\nwith the recent observation that there was no increase in the risk\nof neurological disorders after the pandemic in\ufb02uenza A(H1N1)\nvaccination of more than one million people in Sweden [19].\nFor the other vaccines, individual cases with demyelinating dis-\neases that followed shortly after a vaccination were reported [20\u2013\n28]. Based on 2 exposed cases, the odds ratio for Tdap exposure 5\u2013\n28 days prior to ADEM onset was 15.8 (95% CI, 1.2\u2013471.6) [29].", "mimetype": "text/plain", "start_char_idx": 20057, "end_char_idx": 22046, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d9be7f00-07c6-4925-9b79-fbb28d1476e1": {"__data__": {"id_": "d9be7f00-07c6-4925-9b79-fbb28d1476e1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b8d641ac-25c7-4eff-ab34-240510d1ca3a", "node_type": "1", "metadata": {}, "hash": "fe2905d5365e616944e77ecd96f6b17b19eb5bc931c4ebedb927f5a8cda53e6c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "abfd97c7-212c-49a6-aefa-47fd3c0c5c04", "node_type": "1", "metadata": {}, "hash": "ed19d95fb2fa33bb65fd46ad0290076d722ceb167705d1188557048213e78f1f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Based on 2 exposed cases, the odds ratio for Tdap exposure 5\u2013\n28 days prior to ADEM onset was 15.8 (95% CI, 1.2\u2013471.6) [29].\nHowever, it is dif\ufb01cult to interpret these associations because it\nis not possible to distinguish whether the observed event was cau-\nsal or coincidental. Our study evaluated several vaccines, and the\nresults indicate that the observations in the published case reports\nprobably represent coincidental temporal associations rather than\ncausal associations. Another epidemiologic study about central\nnervous system demyelinating diseases after the adult vaccines\nalso suggested that the \ufb01ndings may be due to chance [12].\nRecurrence after an initial ADEM diagnosis was in about 14% of\npatients in our study, which is higher than reported in Argentina\n(10%, follow up 80 months)[30], and lower than in France (18%, fol-\nlow up 65 months)[31], Italy (30.5%, follow up 69 months)[32] and\nUnited States (24%, follow up 24 months)[10]. Children and adults\nexperienced demyelinating relapses in similar proportions in our\nstudy, consistent with prior research [10]. We did not \ufb01nd any sig-\nni\ufb01cant association between ADEM recurrence and vaccination.\nMany identi\ufb01able infections are well known risk factors for\nADEM [33]. Most cases (85.29%) in our study had signs of infection\n6 months prior to the neurologic symptoms. It is likely that the\ninfectious agents trigger an autoimmune response against the\nCNS antigens, which leads to the CNS pathology. In theory, vaccines\ncould increase the risk of ADEM through mechanisms similar to\nthose induced by infections. However, even in animal models,\nthese mechanisms are complex and depend on the timing of expo-\nsure, antigen type, genetic background, and coadministration of\nadjuvants [34]. The hypothesis was that the vaccine could cause\nan acute autoimmune reaction in susceptible persons soon after\nadministration [35]. This hypothesis may seem plausible given\nwhat we know about adverse reactions to other drugs, but its\nappropriateness to ADEM is questionable.\nOur study was a large population-based case-control study that\nincluded both male and female.", "mimetype": "text/plain", "start_char_idx": 21922, "end_char_idx": 24046, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "abfd97c7-212c-49a6-aefa-47fd3c0c5c04": {"__data__": {"id_": "abfd97c7-212c-49a6-aefa-47fd3c0c5c04", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d9be7f00-07c6-4925-9b79-fbb28d1476e1", "node_type": "1", "metadata": {}, "hash": "18aa71d715c3d6e62b43c6901c454a34baf58f38bcdd637afb8b2b884e1af8f4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c1f1de9c-a6ff-462e-beed-4f4c2c20427f", "node_type": "1", "metadata": {}, "hash": "e96cf63922450670c346ed9431e69bd4faa77638126a2002a0d2e37bc40d50cb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This hypothesis may seem plausible given\nwhat we know about adverse reactions to other drugs, but its\nappropriateness to ADEM is questionable.\nOur study was a large population-based case-control study that\nincluded both male and female. It adds to existing knowledge by\nproviding information on several vaccines that had not previously\nbeen studied. The retrospective nature of the case-control design\nmay be subject to recall bias, but recall bias was avoided through\nthe use of computerized vaccination records.\nOur study has several limitations. We could not evaluate the\nassociation between ADEM and HPV vaccine, because no HPV vac-\ncine is available in Jiangsu, although it has been reported that sev-\neral young females presented with fulminant onset of ADEM 2 to 4\nweeks following administration of HPV vaccine [5,6]. We could not\nTable 4\nRelative risk of ADEM in the 31\u201360 day risk interval following vaccines, compared to remainder of the 180 days after vaccination.\nExposure interval\nNonexposure interval\nIRR\n95% CI\nVaccines\nHepatitis B\n2\n7\n1.64\n0.43\u201310.59\nIn\ufb02uenza\n1\n5\n1.78\n0.38\u201321.56\nPolio(live)\n0\n1\nNA\nNA\nDiphtheria, pertuss(acellular), tetanusis\n0\n2\nNA\nNA\nMeasles, mumps, rubella\n0\n2\nNA\nNA\nJapanese Encephalitis\n0\n0\nNA\nNA\nMeningitis(A/C/Y/W135)\n0\n1\nNA\nNA\nHepatitis A\n1\n2\n2.38\n0.28\u201339.42\nVaricella\n0\n3\nNA\nNA\nRabies\n0\n2\nNA\nNA\nAny\n4\n19\n1.32\n0.64\u20135.62\nAge\n\u000118y\n3\n13\n0.93\n0.57\u20136.42\n>18y\n1\n6\n0.86\n0.35\u201319.38\nTable 5\nAssociation between any vaccination and relapse of ADEM by age.\nAge \u000118 y\nAge >18 y\nNo. (%) of\nvaccinated\nNo.", "mimetype": "text/plain", "start_char_idx": 23810, "end_char_idx": 25343, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c1f1de9c-a6ff-462e-beed-4f4c2c20427f": {"__data__": {"id_": "c1f1de9c-a6ff-462e-beed-4f4c2c20427f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "abfd97c7-212c-49a6-aefa-47fd3c0c5c04", "node_type": "1", "metadata": {}, "hash": "ed19d95fb2fa33bb65fd46ad0290076d722ceb167705d1188557048213e78f1f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eb4fe5a3-bc16-41ea-9793-47d8766f7e89", "node_type": "1", "metadata": {}, "hash": "ce58e26b210e980b5bae3f1d661308ab0764540bd340ac35bb6afaba234e7d66", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Age \u000118 y\nAge >18 y\nNo. (%) of\nvaccinated\nNo. (%) of\nnonvaccinated\nOR (95% CI)\nAdjusted OR\n(95% CI)\nNo. (%) of\nvaccinated\nNo. (%) of\nnonvaccinated\nOR (95% CI)\nAdjusted OR\n(95% CI)\nRelapse\n8(38.10)\n13(61.90)\n0.89(0.34\u20132.30)\n095\n5(27.78)\n13(72.22)\n1.96(0.63\u20136.16)\n1.32\nRelapse-free\n48(41.03)\n69(58.97)\n(0.52\u20131.68)\n19(16.38)\n97(83.62)\n(0.35\u20135.43)\nTotal\n56(40.58)\n82(59.42)\n24(17.91)\n110(82.09)\nOdds ratio (95% con\ufb01dence interval) from conditional logistic regression models adjusted for occupation, allergy, familial diseases, comorbid chronic diseases, and history of\ninfectious diseases.\nY. Chen et al. / Vaccine 36 (2018) 3733\u20133739\n3737\ndetect associations with small select subgroups (symptom onset\nwithin 14 days following Rabies vaccine, etc). Lack of association\nof vaccines with ADEM in our study is also probably because there\nare not enough numbers of subjects regarding a rare event. Studies\nwith larger sample size are required to further validate the results.\nWe could not examine the potential in\ufb02uence of vaccine preserva-\ntives and adjuvants. Further studies are needed to completely rule\nout an effect. Residual confounding(s) may be another limitation.\nWe collected only information on vaccinations received within\n180 days, instead of vaccinations beyond the risk period. Other-\nwise, use of \u2018\u2018case-only\u201d analysis (e.g., self-controlled case series/\ninterval or case-crossover) could eliminate measured and unmea-\nsured \ufb01xed confounding.\n5.", "mimetype": "text/plain", "start_char_idx": 25298, "end_char_idx": 26754, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "eb4fe5a3-bc16-41ea-9793-47d8766f7e89": {"__data__": {"id_": "eb4fe5a3-bc16-41ea-9793-47d8766f7e89", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c1f1de9c-a6ff-462e-beed-4f4c2c20427f", "node_type": "1", "metadata": {}, "hash": "e96cf63922450670c346ed9431e69bd4faa77638126a2002a0d2e37bc40d50cb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8b201d2d-e611-4d7f-9d55-112065fcba80", "node_type": "1", "metadata": {}, "hash": "82e8dcabf991db9a46d295e022975d129ccfbc7952bee01c047cdec2bdd85500", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Other-\nwise, use of \u2018\u2018case-only\u201d analysis (e.g., self-controlled case series/\ninterval or case-crossover) could eliminate measured and unmea-\nsured \ufb01xed confounding.\n5. Conclusions\nIn summary, \ufb01ndings from the present study do not demon-\nstrate an association of vaccines with an increased risk of ADEM\nand its recurrence among either paediatric (\u000118 years) or adult\n(>18 years) individuals within the 180 days after vaccinations\nexcept for the 31\u201360-day exposure interval among paediatric pop-\nulation (\u000118 years). The \ufb01nding in children in the 31\u201360 day risk\ninterval is likely coincidental and was not con\ufb01rmed in separate\nself-control analyses. We found no association between HepB vac-\ncination and an increased risk of ADEM up to 180 days after vacci-\nnation, which is reassuring. Our results also indicate that previous\ncase reports of ADEM shortly after administration of several other\nvaccines probably represent coincidental temporal associations\nand not true causal associations.\nAcknowledgments\nThe authors greatly appreciated the \ufb01eldwork of the following\ninstitutions: Nantong CDC, Yancheng CDC, and Xuzhou CDC.\nFunding\nThis work was supported by Science Project of the Jiangsu\nProvincial Commission of Health and Family Planning [grant num-\nbers H201515] and the Science-Education Project of the Jiangsu\nCenter for Disease Control and Prevention (CDC) [grant number\nJKRC2011023].\nDisclosure of con\ufb02ict of interest\nNone.\nAuthor contributions\nYong Chen, study concept and design, analysis and interpreta-\ntion of data.\nFubao Ma, study concept and design, study supervision.\nYuanling Xu, acquisition of data, interpretation of data.\nXuhua Chu, acquisition of data, interpretation of data.\nJinlin Zhang, study concept and design, acquisition of data.\nAppendix A. Supplementary material\nSupplementary data associated with this article can be found, in\nthe online version, at https://doi.org/10.1016/j.vaccine.2018.05.\n063.\nReferences\n[1] Hara T. Acute disseminated encephalomyelitis (ADEM): its diagnostic criteria\nand therapy.", "mimetype": "text/plain", "start_char_idx": 26586, "end_char_idx": 28623, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8b201d2d-e611-4d7f-9d55-112065fcba80": {"__data__": {"id_": "8b201d2d-e611-4d7f-9d55-112065fcba80", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eb4fe5a3-bc16-41ea-9793-47d8766f7e89", "node_type": "1", "metadata": {}, "hash": "ce58e26b210e980b5bae3f1d661308ab0764540bd340ac35bb6afaba234e7d66", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "79144015-d1b4-4b0d-93c7-967f8a5d57ca", "node_type": "1", "metadata": {}, "hash": "fe9fb0cc42543dc324aa4c5c63209f7f0cf1c651209aa2db48ead9c5cb892e63", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "063.\nReferences\n[1] Hara T. Acute disseminated encephalomyelitis (ADEM): its diagnostic criteria\nand therapy. Nihon rinsho Jpn J Clin Med 2013;71:887\u201392.\n[2] Zhuoya MCL, Jianxiang L. Advances in molecular pathogenesis of acute\ndisseminated encephalomyelitis. Chin J Neuroimmun Neurol. 2008;15:106\u20138.\n[3] Tenembaum\nS,\nChitnis\nT,\nNess\nJ,\nHahn\nJS.\nAcute\ndisseminated\nencephalomyelitis. Neurology 2007;68:S23\u201336.\n[4] Leake JA, Albani S, Kao AS, Senac MO, Billman GF, Nespeca MP, et al. Acute\ndisseminated encephalomyelitis in childhood: epidemiologic, clinical and\nlaboratory features. Pediat Inf Dis J 2004;23:756\u201364.\n[5] Wildemann\nB,\nJarius\nS,\nHartmann\nM,\nRegula\nJU,\nHametner\nC.\nAcute\ndisseminated\nencephalomyelitis\nfollowing\nvaccination\nagainst\nhuman\npapilloma virus. Neurology 2009;72:2132\u20133.\n[6] Bomprezzi R, Wildemann B. Acute disseminated encephalomyelitis following\nvaccination against human papilloma virus. Neurology 2010;74:864. author\nreply -5.\n[7] Langer-Gould A, Qian L, Tartof SY, Brara SM, Jacobsen SJ, Beaber BE, et al.\nVaccines and the risk of multiple sclerosis and other central nervous system\ndemyelinating diseases. JAMA Neurol 2014;71:1506\u201313.\n[8] Hall A, Kane M, Roure C, Meheus A. Multiple sclerosis and hepatitis B vaccine?\nVaccine 1999;17:2473\u20135.\n[9] Marin\nSE,\nCallen\nDJ.", "mimetype": "text/plain", "start_char_idx": 28514, "end_char_idx": 29808, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "79144015-d1b4-4b0d-93c7-967f8a5d57ca": {"__data__": {"id_": "79144015-d1b4-4b0d-93c7-967f8a5d57ca", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8b201d2d-e611-4d7f-9d55-112065fcba80", "node_type": "1", "metadata": {}, "hash": "82e8dcabf991db9a46d295e022975d129ccfbc7952bee01c047cdec2bdd85500", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "22edc40a-1e8c-4d05-85bf-7b82e40569c5", "node_type": "1", "metadata": {}, "hash": "a2bcfb076ea7512e400b16dfe9af64a3ae6f8740610416f724e8aed88362c084", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "[8] Hall A, Kane M, Roure C, Meheus A. Multiple sclerosis and hepatitis B vaccine?\nVaccine 1999;17:2473\u20135.\n[9] Marin\nSE,\nCallen\nDJ.\nThe\nmagnetic\nresonance\nimaging\nappearance\nof\nmonophasic\nacute\ndisseminated\nencephalomyelitis:\nan\nupdate\npost\napplication\nof\nthe\n2007\nconsensus\ncriteria.\nNeuroimag\nClin\nN\nA\n2013;23:245\u201366.\n[10] Koelman DL, Chahin S, Mar SS, Venkatesan A, Hoganson GM, Yeshokumar AK,\net al. Acute disseminated encephalomyelitis in 228 patients: a retrospective,\nmulticenter US study. Neurology 2016;86:2085\u201393.\n[11] Maldonado\nG,\nGreenland\nS.\nSimulation\nstudy\nof\nconfounder-selection\nstrategies. Am J Epidemiol 1993;138:923\u201336.\n[12] DeStefano F, Verstraeten T, Jackson LA, Okoro CA, Benson P, Black SB, et al.\nVaccinations and risk of central nervous system demyelinating diseases in\nadults. Arch Neurol 2003;60:504\u20139.\n[13] Touze E, Fourrier A, Rue-Fenouche C, Ronde-Oustau V, Jeantaud I, Begaud B,\net al. Hepatitis B vaccination and \ufb01rst central nervous system demyelinating\nevent: a case-control study. Neuroepidemiology 2002;21:180\u20136.\n[14] Zipp F, Weil JG, Einhaupl KM. No increase in demyelinating diseases after\nhepatitis B vaccination. Nat Med 1999;5:964\u20135.\n[15] Mikaeloff Y, Caridade G, Suissa S, Tardieu M. Hepatitis B vaccine and the risk of\nCNS in\ufb02ammatory demyelination in childhood. Neurology 2009;72:873\u201380.", "mimetype": "text/plain", "start_char_idx": 29677, "end_char_idx": 31009, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "22edc40a-1e8c-4d05-85bf-7b82e40569c5": {"__data__": {"id_": "22edc40a-1e8c-4d05-85bf-7b82e40569c5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "79144015-d1b4-4b0d-93c7-967f8a5d57ca", "node_type": "1", "metadata": {}, "hash": "fe9fb0cc42543dc324aa4c5c63209f7f0cf1c651209aa2db48ead9c5cb892e63", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f2f2182e-ee2f-4ccf-859d-35af46e21330", "node_type": "1", "metadata": {}, "hash": "9c534561997b89fc95901705d898d9190dda7a1c5a73359ca122940c0639e939", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Neurology 2009;72:873\u201380.\n[16] Fourrier A, Begaud B, Alperovitch A, Verdier-Taillefer MH, Touze E, Decker N,\net al. Hepatitis B vaccine and \ufb01rst episodes of central nervous system\ndemyelinating disorders: a comparison between reported and expected\nnumber of cases. Brit J Clin Pharmacol 2001;51:489\u201390.\n[17] Kaplanski G, Retornaz F, Durand J, Soubeyrand J. Central nervous system\ndemyelination after vaccination against hepatitis B and HLA haplotype. J\nNeurol Neurosurg Psychiatr 1995;58:758\u20139.\n[18] Herroelen L, de Keyser J, Ebinger G. Central-nervous-system demyelination\nafter\nimmunisation\nwith\nrecombinant\nhepatitis\nB\nvaccine.\nLancet\n1991;338:1174\u20135.\n[19] Bardage C, Persson I, Ortqvist A, Bergman U, Ludvigsson JF, Granath F.\nNeurological and autoimmune disorders after vaccination against pandemic\nin\ufb02uenza A (H1N1) with a monovalent adjuvanted vaccine: population based\ncohort study in Stockholm, Sweden. Bmj 2011;343:d5956.\n[20] Poser CM. Neurological complications of swine in\ufb02uenza vaccination. Acta\nNeurol Scand 1982;66:413\u201331.\n[21] Bakshi R, Mazziotta JC. Acute transverse myelitis after in\ufb02uenza vaccination:\nmagnetic resonance imaging \ufb01ndings. J Neuroimag: Off J Am Soc Neuroimag\n1996;6:248\u201350.\n[22] Rabin\nJ.\nHazard\nof\nin\ufb02uenza\nvaccine\nin\nneurologic\npatients.\nJama\n1973;225:63\u20134.\n[23] Rosenberg GA. Meningoencephalitis following an in\ufb02uenza vaccination. The\nNew Engl J Med 1970;283:1209.\n[24] Behan PO.", "mimetype": "text/plain", "start_char_idx": 30984, "end_char_idx": 32400, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f2f2182e-ee2f-4ccf-859d-35af46e21330": {"__data__": {"id_": "f2f2182e-ee2f-4ccf-859d-35af46e21330", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "22edc40a-1e8c-4d05-85bf-7b82e40569c5", "node_type": "1", "metadata": {}, "hash": "a2bcfb076ea7512e400b16dfe9af64a3ae6f8740610416f724e8aed88362c084", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "64a55bf2-d438-4960-8b89-d349c417c271", "node_type": "1", "metadata": {}, "hash": "198cc5cd8ccc54ec396bda5046b30255b273222a228501f8a5f82961a4d79260", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "[23] Rosenberg GA. Meningoencephalitis following an in\ufb02uenza vaccination. The\nNew Engl J Med 1970;283:1209.\n[24] Behan PO. Diffuse myelitis associated with rubella vaccination. Brit Med J\n1977;1:166.\n[25] Holt S, Hudgins D, Krishnan KR, Critchley EM. Diffuse myelitis associated with\nrubella vaccination. Brit Med J 1976;2:1037\u20138.\n[26] Huber S, Kappos L, Fuhr P, Wetzel S, Steck AJ. Combined acute disseminated\nencephalomyelitis and acute motor axonal neuropathy after vaccination for\nhepatitis\nA\nand\ninfection\nwith\nCampylobacter\njejuni.\nJ\nNeurol\n1999;246:1204\u20136.\n[27] Joyce KA, Rees JE. Transverse myelitis after measles, mumps, and rubella\nvaccine. Bmj 1995;311:422.\n[28] Mancini J, Chabrol B, Moulene E, Pinsard N. Relapsing acute encephalopathy: a\ncomplication of diphtheria-tetanus-poliomyelitis immunization in a young\nboy. Eur J Pediatr 1996;155:136\u20138.\n[29] Baxter R, Lewis E, Goddard K, Fireman B, Bakshi N, DeStefano F, et al. Acute\ndemyelinating events following vaccines: a case-centered analysis. Clin Inf\nDis: Off Publ Inf Dis Soc Am 2016;63:1456\u201362.\n[30] Tenembaum\nS,\nChamoles\nN,\nFejerman\nN.\nAcute\ndisseminated\nencephalomyelitis: a long-term follow-up study of 84 pediatric patients.\nNeurology 2002;59:1224\u201331.\n[31] Mikaeloff Y, Caridade G, Husson B, Suissa S, Tardieu M. Neuropediatric\nKSGotFNS.", "mimetype": "text/plain", "start_char_idx": 32278, "end_char_idx": 33588, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "64a55bf2-d438-4960-8b89-d349c417c271": {"__data__": {"id_": "64a55bf2-d438-4960-8b89-d349c417c271", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Chen (2018).pdf", "node_type": "4", "metadata": {}, "hash": "edc62dcc67d99574a2af4681f47d3b82881d9e259f1fece6328ef8756e821b09", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f2f2182e-ee2f-4ccf-859d-35af46e21330", "node_type": "1", "metadata": {}, "hash": "9c534561997b89fc95901705d898d9190dda7a1c5a73359ca122940c0639e939", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "[31] Mikaeloff Y, Caridade G, Husson B, Suissa S, Tardieu M. Neuropediatric\nKSGotFNS. Acute disseminated encephalomyelitis cohort study: prognostic\n3738\nY. Chen et al. / Vaccine 36 (2018) 3733\u20133739\nfactors for relapse. European journal of paediatric neurology. EJPN: Off J Eur\nPaediatr Neurol Soc 2007;11:90\u20135.\n[32] Marchioni E, Ravaglia S, Montomoli C, Tavazzi E, Minoli L, Baldanti F, et al.\nPostinfectious neurologic syndromes: a prospective cohort study. Neurology\n2013;80:882\u20139.\n[33] Javed A, Khan O. Acute disseminated encephalomyelitis. Handbook Clin Neurol\n2014;123:705\u201317.\n[34] Munz C, Lunemann JD, Getts MT, Miller SD. Antiviral immune responses:\ntriggers of or triggered by autoimmunity? Nat Rev Immunol 2009;9:246\u201358.\n[35] Tourbah A, Gout O, Liblau R, Lyon-Caen O, Bougniot C, Iba-Zizen MT, et al.\nEncephalitis after hepatitis B vaccination: recurrent disseminated encephalitis\nor MS? Neurology 1999;53:396\u2013401.\nY. Chen et al. / Vaccine 36 (2018) 3733\u20133739\n3739", "mimetype": "text/plain", "start_char_idx": 33503, "end_char_idx": 34476, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b9b6779f-48f2-4062-ac6d-1e5a09d6605c": {"__data__": {"id_": "b9b6779f-48f2-4062-ac6d-1e5a09d6605c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "89885db5-31ce-4f82-ae00-1927e2f72cb1", "node_type": "1", "metadata": {}, "hash": "9d490d1c01a400551342b41620be19a742d051289dde778135d18796b29c1eac", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Articles\nIntroduction\nIn 1998, it was suggested that measles-mumps-rubella\n(MMR) vaccination might cause autism, on the basis of\na study of 12 children with pervasive developmental\ndisorder referred to a paediatric gastroenterology unit,\nwith no comparison group.1 In a subsequent larger\ncase series, the condition postulated to be associated\nwith MMR vaccination was referred to as autistic\nenterocolitis.2 These studies, and the \ufb01ndings of gut\nepithelial damage in children with autism,3 led the\nresearchers to suggest that MMR vaccination could act\nas a trigger for a particular phenotype of autism.4\nFragments of measles virus genome were reported in\nthe intestinal tissue of children with autism and\nassociated gut disease more frequently than in a\ncomparison group of children, some of whom had gut\ndisease but all of whom were developmentally normal.5\nThe origin of the fragments of measles virus genome\nin \nthese \nchildren \nhas \nnot \nbeen \nestablished.\nFurthermore, whether the presence of the fragments\nwas speci\ufb01c to this subgroup of children, or whether\nthey were due to intestinal disease rather than a cause\nof it, is unknown.6\nSubsequent epidemiological studies did not con\ufb01rm\nan association between MMR vaccination and\nautism,7\u20139 but these \ufb01ndings failed to reassure the\npublic.10\u201312 The coverage of MMR vaccine by the age of\n2 years in England fell from 92% in 1995\u201396 to 82% in\n2002\u201303,13 and was followed by measles outbreaks.14,15\nIn the light of continuing concern, we did a large case-\ncontrol study to assess the risk of autism and other\npervasive developmental disorders (PDDs) associated\nwith MMR vaccination, by use of the UK General\nPractice Research Database (GPRD).\nMethods\nThe study methods have been described in detail\nelsewhere.16 In brief, we did a case-control study to\ninvestigate whether MMR vaccination was associated\nwith an increased risk of autism or other PDDs. Data\nwere abstracted from the GPRD, a database that includes\npatients\u2019 records of vaccination and diagnoses of autism\nor other PDDs.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2035, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "89885db5-31ce-4f82-ae00-1927e2f72cb1": {"__data__": {"id_": "89885db5-31ce-4f82-ae00-1927e2f72cb1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b9b6779f-48f2-4062-ac6d-1e5a09d6605c", "node_type": "1", "metadata": {}, "hash": "dc28c6a18321ef2a423cb7f52df84d497c4f38a11cd68e94897a4011b31cbd34", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ec95059d-2800-4536-81ee-b6232f13b315", "node_type": "1", "metadata": {}, "hash": "deb03e47b308e4754722cac5a2e42e0a20b26df2840d3a8ad73a077b30d7ca58", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Data\nwere abstracted from the GPRD, a database that includes\npatients\u2019 records of vaccination and diagnoses of autism\nor other PDDs. The GPRD was set up in 1987, under the\nname of VAMP (Value Added Medical Products)\nResearch Bank.17 The database consists of the electronic\nclinical records of patients registered with contributing\ngeneral \npractices. \nThe \npractices \nare \nbroadly\nrepresentative of all practices in England and Wales in\nterms of geographical distribution, practice size, and the\nage and sex of registered patients.18 The GPRD aims\nto\ninclude complete prescribing and diagnostic\ninformation for every registered patient. Data are\nanonymised. The quality of the information in the\ndatabase has been found to be high in independent\nvalidation studies.17 Two studies have assessed the\ncompleteness of recording of diagnoses made in medical\nfacilities outside the practice, and found recording rates\nin excess of 90%.19,20 There is excellent agreement\nbetween prescribing data from the GPRD and national\ndata from the Prescription Pricing Authority.21 For\npatients who were not registered with a practice in the\nGPRD from birth, information on previous vaccinations\nand diagnoses should be entered into their electronic\nrecord when they transfer into the practice.", "mimetype": "text/plain", "start_char_idx": 1903, "end_char_idx": 3179, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ec95059d-2800-4536-81ee-b6232f13b315": {"__data__": {"id_": "ec95059d-2800-4536-81ee-b6232f13b315", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "89885db5-31ce-4f82-ae00-1927e2f72cb1", "node_type": "1", "metadata": {}, "hash": "9d490d1c01a400551342b41620be19a742d051289dde778135d18796b29c1eac", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8c0c90f9-aabc-45b9-9a6d-d822e9264f58", "node_type": "1", "metadata": {}, "hash": "b0ab1597a3aaa7b3158bb9c62b80ef00931c7ac29134289008b10a862fa8e80a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The number\nLancet 2004; 364: 963\u201369\nDepartment of Epidemiology\nand Population Health\n(Liam Smeeth MRCGP);\nDepartment of Infectious and\nTropical Diseases (C Cook MSc,\nProf L C Rodrigues PhD,\nProf P G Smith DSc,\nProf A J Hall FRCP); London\nSchool of Hygiene and Tropical\nMedicine, London, UK;\nDepartment of Psychiatry,\nMcGill University, Montreal\nChildren\u2019s Hospital, Canada\n(Prof E Fombonne FRCPsych);\nand Institute of Psychiatry,\nKings College, London, UK\n(L Heavey PhD)\nCorrespondence to: \nDr Liam Smeeth, Department of\nEpidemiology and Population\nHealth, London School of\nHygiene and Tropical Medicine,\nLondon WC1E 7HT, UK\nautism@lshtm.ac.uk\nwww.thelancet.com Vol 364   September 11, 2004 \n963\nMMR vaccination and pervasive developmental disorders: a\ncase-control study\nLiam Smeeth, Claire Cook, Eric Fombonne, Lisa Heavey, Laura C Rodrigues, Peter G Smith, Andrew J Hall\nSummary \nBackground Concern that measles-mumps-rubella (MMR) vaccination might cause autism has led to a fall in\nvaccine coverage. We investigated whether MMR vaccination is associated with an increased risk of autism or other\npervasive developmental disorders.\nMethods We did a matched case-control study using the UK General Practice Research Database. Cases were people\nborn in 1973 or later who had \ufb01rst recorded diagnosis of pervasive developmental disorder while registered with a\ncontributing general practice between 1987 and 2001. Controls were matched on age, sex, and general practice.\nFindings 1294 cases and 4469 controls were included. 1010 cases (78\u00b71%) had MMR vaccination recorded before\ndiagnosis, compared with 3671 controls (82\u00b71%) before the age at which their matched case was diagnosed. After\nadjustment for age at joining the database, the odds ratio for association between MMR and pervasive\ndevelopmental disorder was 0\u00b786 (95% CI 0\u00b768\u20131\u00b709).", "mimetype": "text/plain", "start_char_idx": 3180, "end_char_idx": 5022, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8c0c90f9-aabc-45b9-9a6d-d822e9264f58": {"__data__": {"id_": "8c0c90f9-aabc-45b9-9a6d-d822e9264f58", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ec95059d-2800-4536-81ee-b6232f13b315", "node_type": "1", "metadata": {}, "hash": "deb03e47b308e4754722cac5a2e42e0a20b26df2840d3a8ad73a077b30d7ca58", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1a1f1f4c-19e2-45ff-a22f-550a1651322c", "node_type": "1", "metadata": {}, "hash": "6148355b4a68727f0a60467e4fe58045a3029c8c00759b82b4cf1ffa304b29de", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "After\nadjustment for age at joining the database, the odds ratio for association between MMR and pervasive\ndevelopmental disorder was 0\u00b786 (95% CI 0\u00b768\u20131\u00b709). Findings were similar when restricted to children with a\ndiagnosis of autism, to those vaccinated with MMR before the third birthday, or to the period before media\ncoverage of the hypothesis linking MMR with autism.\nInterpretation Our \ufb01ndings suggest that MMR vaccination is not associated with an increased risk of pervasive\ndevelopmental disorders.\nArticles\nof practices included in the GPRD varied during the\nstudy period, rising from 34 in 1988 to 557 in 1996, then\nfalling to 380 by 2001. \nStudy population\nThe study population consisted of all people who were\nregistered in the GPRD at any time between June 1, 1987\n(when the database was started), and Dec 31, 2001, and\nwho were born in 1973 or later, to ensure that virtually\nall individuals eligible for MMR vaccination were\nincluded. Cases were de\ufb01ned as children with a \ufb01rst\ndiagnosis of a PDD during the study period while\nregistered with a practice contributing to the GPRD.\nThey were found by searching the electronic records for\nclinical codes indicating a diagnosis of PDD (codes used\nare available on request). Those who were \ufb01rst\ndiagnosed outside the study period were excluded from\nthe study and were not eligible to be selected as controls.\nThose with autistic disorders and similar presentations\nwere classi\ufb01ed as having \u201cautism\u201d and those with other\ndescriptions (such as Asperger\u2019s syndrome) were\nclassi\ufb01ed as having \u201cother PDD\u201d. Patients who had more\nthan one PDD diagnostic code recorded at different\ntimes (for example, autism and then Asperger\u2019s\nsyndrome) were classi\ufb01ed as having the most speci\ufb01c\ndiagnosis (in this example Asperger\u2019s syndrome).\nHowever, the date of the \ufb01rst diagnosis with a PDD was\ntaken as the date of diagnosis.", "mimetype": "text/plain", "start_char_idx": 4864, "end_char_idx": 6734, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1a1f1f4c-19e2-45ff-a22f-550a1651322c": {"__data__": {"id_": "1a1f1f4c-19e2-45ff-a22f-550a1651322c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8c0c90f9-aabc-45b9-9a6d-d822e9264f58", "node_type": "1", "metadata": {}, "hash": "b0ab1597a3aaa7b3158bb9c62b80ef00931c7ac29134289008b10a862fa8e80a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ffa9822f-08fe-4e49-a180-e0162c32067d", "node_type": "1", "metadata": {}, "hash": "0b3c65b62993ef4bdf2c4448b9ec200ee57436dab6d016087e8c1e1488334c5d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "However, the date of the \ufb01rst diagnosis with a PDD was\ntaken as the date of diagnosis. \nWe aimed to select \ufb01ve controls for every case from\namong individuals in the study population who had no\ndiagnosis of PDD recorded in their general practice\nrecord and who were alive and registered with a\nparticipating practice on the date of the PDD diagnosis\nin the case. Controls were individually matched to cases\nby year of birth (up to 1 year older or younger), sex, and\ngeneral practice. For each of 300 cases, \ufb01ve controls\ncould be identi\ufb01ed who met all the matching criteria.\nFor the remaining 994, one or more controls was\nexcluded (\ufb01gure 1). \nIn 1988, MMR vaccination was introduced in the UK\nfor all children aged 12\u201315 months. During 1988 to\n1991, in a catch-up campaign, MMR vaccine was also\noffered to all children up until the age of school entry\n(4\u20135 years). A second dose at school entry was\nintroduced in 1996, with a further catch-up campaign\nfor children born on or after January 1, 1990, who had\nnot previously received two doses of a vaccine\ncontaining \nmeasles. \nMMR \nvaccination \nis \nalso\nrecommended for non-immune adults, especially those\nin residential care or those starting college, and for\nnon-immune contacts during a measles outbreak. A\ncatch-up campaign for children aged 5\u201316 years was\nlaunched in 1994, but measles-rubella vaccination was\nused, not MMR.\nAn algorithm to identify children in the GPRD with\nrecorded MMR vaccination was developed. The case-\ncontrol status of individuals was concealed during\nassessment of exposure status. After the introduction of\nMMR vaccine in 1988, a single clinical code for MMR\nvaccination was not implemented immediately in all\nGPRD practices. In some practices the individual\nvaccine components were coded separately for several\nyears.", "mimetype": "text/plain", "start_char_idx": 6648, "end_char_idx": 8446, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ffa9822f-08fe-4e49-a180-e0162c32067d": {"__data__": {"id_": "ffa9822f-08fe-4e49-a180-e0162c32067d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1a1f1f4c-19e2-45ff-a22f-550a1651322c", "node_type": "1", "metadata": {}, "hash": "6148355b4a68727f0a60467e4fe58045a3029c8c00759b82b4cf1ffa304b29de", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7892dc11-3fdd-4b8b-97aa-654c3bbc57a2", "node_type": "1", "metadata": {}, "hash": "baa77d2f3edf5cb8a15da48471a69e449b7b673d816d00e88250763a47f09c7b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In some practices the individual\nvaccine components were coded separately for several\nyears. Therefore, when measles, mumps, and rubella\nvaccinations were all coded as having been given on the\nsame day or within a 21-day period, the vaccination was\nclassi\ufb01ed as representing MMR vaccination (because\nlive vaccines are recommended to be separated by a\nperiod of at least 21 days).22\nFor each case, information on MMR vaccination was\nabstracted from the GPRD records from their date of\nbirth up until their date of diagnosis with a PDD. For\ncontrols, vaccination data were abstracted from their\ndate of birth up to their index date\u2014de\ufb01ned as the date\nwhen they were the same age (to the nearest month) as\ntheir matched case at the time the case was \ufb01rst\ndiagnosed with a PDD. Month of birth was available for\n82% of cases. For cases without month of birth recorded\nin the GPRD record, the month of birth was retrieved\nfrom case notes, questionnaires, or GPRD event records\nrelating to birth, where available. Month of birth was\navailable for 79% of controls. Where month of birth was\nunknown for cases or controls the birth date was taken\nas June 30 of the year of birth.", "mimetype": "text/plain", "start_char_idx": 8354, "end_char_idx": 9523, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7892dc11-3fdd-4b8b-97aa-654c3bbc57a2": {"__data__": {"id_": "7892dc11-3fdd-4b8b-97aa-654c3bbc57a2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ffa9822f-08fe-4e49-a180-e0162c32067d", "node_type": "1", "metadata": {}, "hash": "0b3c65b62993ef4bdf2c4448b9ec200ee57436dab6d016087e8c1e1488334c5d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4a1a6deb-2010-4f64-b37e-3cc5f9dc7b5e", "node_type": "1", "metadata": {}, "hash": "584be10ff42e46011e36ce2aed98157eee136893101f17b0ab12e6dbc634524a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Month of birth was\navailable for 79% of controls. Where month of birth was\nunknown for cases or controls the birth date was taken\nas June 30 of the year of birth. \n964\nwww.thelancet.com Vol 364   September 11, 2004 \n1410 identified with \n            a first recorded \n            diagnosis of PDD \n            in the study period\n6465 potential controls \n            identified \n116 excluded:\n     1 PDD was the only\n         entry in electronic \n        record\n  96 no entry in  \n        electronic \n        record for \n       12 months \n        before diagnosis \n        of PDD\n  19 insufficient \n        evidence to \n        support PDD\n        in review \n        of records\n1294 cases included \n           in analysis \n4469 controls included \n            in analysis\n300 cases had 5 controls each\n400 cases had 4 controls each\n303 cases had 3 controls each\n194 cases had 2 controls each\n  72 cases had 1 controls each\n  25 cases had 0 controls each\n1996 excluded:\n1096 not registered \n           with GPRD on\n           index date\n   750 no entry in \n            GPRD record \n            for 12 months \n            before index date\n      59 no clinical data in \n            GPRD record\n      73 cases sampled \n            as controls\n     18 selected twice\nFigure 1: Numbers of potential cases and controls identi\ufb01ed, excluded, and\nincluded in study\nArticles\nAnalyses\nData were analysed with conditional logistic regression.23\nThe primary analysis assessed the relation between\nMMR vaccination and the odds of being diagnosed with\na PDD. We repeated this analysis excluding children\nwho had received a dose of measles vaccine before\nMMR. Secondary analyses examined the risks associated\nwith MMR vaccination administered before or after a\nchild\u2019s third birthday and before or after the age of\n18 months, to assess exposure at ages before the\nprobable onset of symptoms.24 We also separately\nanalysed cases classi\ufb01ed as having autism, excluding\nthose with other PDDs. Potential confounding factors\nwere introduced individually into the model and were\nretained if the odds ratio for MMR vaccination changed\nby 10% or more.", "mimetype": "text/plain", "start_char_idx": 9361, "end_char_idx": 11486, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4a1a6deb-2010-4f64-b37e-3cc5f9dc7b5e": {"__data__": {"id_": "4a1a6deb-2010-4f64-b37e-3cc5f9dc7b5e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7892dc11-3fdd-4b8b-97aa-654c3bbc57a2", "node_type": "1", "metadata": {}, "hash": "baa77d2f3edf5cb8a15da48471a69e449b7b673d816d00e88250763a47f09c7b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7486f986-b16c-4043-a8f3-b79682e8cfc7", "node_type": "1", "metadata": {}, "hash": "8c829a5e5838fd8f176021a50d97296e15dd43f9ba646b1ccfad4f8b27d39437", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Potential confounding factors\nwere introduced individually into the model and were\nretained if the odds ratio for MMR vaccination changed\nby 10% or more. \nAge at \ufb01rst registration with a general practice\ncontributing to the GPRD was judged to be a potential\nconfounding factor because, on average, cases were \ufb01rst\nregistered at an older age than controls (table 1), and\nevidence suggested that those who moved into the\nGPRD at older ages were less likely to have MMR\nvaccination recorded in the database, presumably\nbecause \nof \nincomplete \nascertainment \nof \npast\nvaccinations when they joined the GPRD. For controls\nborn in 1988 or later who \ufb01rst registered with a\nparticipating practice before their \ufb01rst birthday, 95\u00b76%\n(2129 of 2227) had one or more doses of MMR\nvaccination recorded before the age at diagnosis of their\nmatched case, compared with 87\u00b72% (1012 of 1160) of\ncontrols \ufb01rst registered after their \ufb01rst birthday. The\ncorresponding values for cases were 96\u00b79% (538 of 555)\nand 83\u00b73% (345 of 414). For analysis, age at \ufb01rst\nregistration was classi\ufb01ed as before \ufb01rst birthday (thus\nregistered with the GPRD from before the age at which\nthey were \ufb01rst eligible for MMR vaccination), aged\n1\u20134 years, 5\u20139 years, or older than 10 years. We also\nregarded as potential confounding variables the length\nof time a child was registered with a practice in the\nGPRD before the index date (in quintiles derived from\ncases and controls combined), and the frequency of\nconsultation with the general practitioner (number of\nconsultations during the time registered with the GPRD\nbefore the index date divided by the time registered\nbefore the index date). Interaction terms were\nintroduced and likelihood ratio tests were used to assess\ntheir statistical signi\ufb01cance. \nThe study was approved by the scienti\ufb01c and ethics\nadvisory group of the GPRD and by the ethics committee\nof the London School of Hygiene and Tropical Medicine.", "mimetype": "text/plain", "start_char_idx": 11333, "end_char_idx": 13261, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7486f986-b16c-4043-a8f3-b79682e8cfc7": {"__data__": {"id_": "7486f986-b16c-4043-a8f3-b79682e8cfc7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4a1a6deb-2010-4f64-b37e-3cc5f9dc7b5e", "node_type": "1", "metadata": {}, "hash": "584be10ff42e46011e36ce2aed98157eee136893101f17b0ab12e6dbc634524a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5a5ab1d5-346a-47df-9cf5-58225285cdc5", "node_type": "1", "metadata": {}, "hash": "163270f19c31f6b93e7bc626f8e4fed4824d5f0fa3119961d6e3b6660e8ef974", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The study was approved by the scienti\ufb01c and ethics\nadvisory group of the GPRD and by the ethics committee\nof the London School of Hygiene and Tropical Medicine.\nRole of the funding source\nThe sponsor of the study reviewed the initial study\nprotocol but had no role in the study design, collection,\nanalysis or interpretation of data, writing of the report,\nor the decision to submit the paper for publication.\nResults\nThe numbers of cases and controls initially identi\ufb01ed,\nreasons for exclusion, and numbers included in the\nanalyses are shown in \ufb01gure 1. When there were no\nentries in the GPRD record for 12 months before the\ndiagnosis or index date, or no clinical data recorded at all\n(apart from the PDD diagnosis for cases), cases and\ncontrols were excluded because of concerns about the\ncompleteness of the clinical data recorded. All cases\nwere registered with a practice contributing to the GPRD\non their diagnosis date. Controls were excluded if they\nwere not registered with a practice contributing to the\nGPRD on their index date. Duplicate records for a small\nnumber of controls who were sampled twice were\nexcluded from the control group, as were cases who were\nsampled as controls.  \nSome of the general practices contributing data to the\nGPRD were willing to provide anonymised copies of\nhospital letters and specialist reports on individual\npatients. Of all patients with a recorded diagnosis of PDD\nin the GPRD, including diagnoses made before\nregistration with a practice participating in the GPRD,\n446 were registered with 203 general practices willing to\nprovide this service. For 80 of these individuals, medical\nrecords were not available because the patient was no\nwww.thelancet.com Vol 364   September 11,", "mimetype": "text/plain", "start_char_idx": 13101, "end_char_idx": 14829, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5a5ab1d5-346a-47df-9cf5-58225285cdc5": {"__data__": {"id_": "5a5ab1d5-346a-47df-9cf5-58225285cdc5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7486f986-b16c-4043-a8f3-b79682e8cfc7", "node_type": "1", "metadata": {}, "hash": "8c829a5e5838fd8f176021a50d97296e15dd43f9ba646b1ccfad4f8b27d39437", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "57626620-a440-491d-a101-23dcf27f3302", "node_type": "1", "metadata": {}, "hash": "7b1620fe6e4b0c1c65233de4835f08e18ae8c1dc4ee584cecfa3ff490e39861b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For 80 of these individuals, medical\nrecords were not available because the patient was no\nwww.thelancet.com Vol 364   September 11, 2004  \n965\nCases (n=1294)\nControls (n=4469)\nNumber female (%)*\n222 (17\u00b72%)\n768 (17\u00b72%)\nAge at diagnosis*\u2020\nMedian age in years (IQR)\n5\u00b74 (3\u00b76\u20139\u00b77)\n4\u00b79 (3\u00b75\u20138\u00b78)\nAge in years (%)\n1\u20132\n181 (14\u00b70%)\n695 (15\u00b75%)\n3\u20134\n414 (32\u00b70%)\n1581 (35\u00b74%)\n5\u20139\n396 (30\u00b76%)\n1292 (28\u00b79%)\n\u000210\n303 (23\u00b74%)\n901 (20\u00b72%)\nBirthyear (%)\n1973\u201387\n316 (24\u00b74%)\n1021 (22\u00b79%)\n1988\u201395\n798 (61\u00b77%)\n2811 (62\u00b79%)\n1996\u201399\n180 (13\u00b79%)\n637 (14\u00b72%)\nAge joined GPRD (%)\n0 years\n561 (43\u00b74%)\n2254 (50\u00b74%)\n1\u20134 years\n416 (32\u00b71%)\n1267 (28\u00b73%)\n5\u20139 years\n166 (12\u00b78%)\n485 (10\u00b79%)\n\u000210 years\n125 (9\u00b77%)\n298 (6\u00b77%)\nMissing\n26 (2\u00b70%)\n165 (3\u00b77%) \nMedian time in GPRD in years (IQR)\n3\u00b73 (1\u00b78\u20135\u00b72)\n3\u00b74 (2\u00b72\u20135\u00b72)\nMedian number of consultations with\n5\u00b74 (3\u00b72\u20139\u00b70)\n4\u00b70 (2\u00b72\u20136\u00b75)\ngeneral practice per year,", "mimetype": "text/plain", "start_char_idx": 14697, "end_char_idx": 15570, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "57626620-a440-491d-a101-23dcf27f3302": {"__data__": {"id_": "57626620-a440-491d-a101-23dcf27f3302", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5a5ab1d5-346a-47df-9cf5-58225285cdc5", "node_type": "1", "metadata": {}, "hash": "163270f19c31f6b93e7bc626f8e4fed4824d5f0fa3119961d6e3b6660e8ef974", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3bf723be-d664-4668-95c2-2a0a88275e01", "node_type": "1", "metadata": {}, "hash": "defd989e58e4b4b0ae2a419c015bbcb55692fee986e4fc167ec10b233c981731", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "before PDD\ndiagnosis or index date (IQR)\nMMR vaccination before PDD diagnosis or index date\nAt any age (%)\n1010 (78\u00b71%)\n3671 (82\u00b71%)\nBefore third birthday (%)\n909 (70\u00b73%)\n3287 (73\u00b76%)\nBefore age 18 months (%)\n805 (62\u00b72%)\n2908 (65\u00b71%)\nMedian age in years at \ufb01rst MMR \n1\u00b72 (1\u00b71\u20131\u00b74)\n1\u00b72 (1\u00b71\u20131\u00b74)\nvaccination (IQR)\nDiagnostic category\nAutism (%)\n991 (76\u00b76%)\nN/A\nOther PDD (%)\n303 (23\u00b74%)\nN/A\n*Matching variables. \u2020For controls, selection was to year of birth (to within 1 year):\nthese are the data shown in the table. In the analysis of vaccination history, matching\nwas to age at diagnosis to the nearest month.\nTable 1: Characteristics of cases and controls\nArticles\nlonger registered with the general practitioner. We\nobtained complete case records including copies of\nhospital clinic letters and specialist reports for 318 (87%)\nof the remaining 366 patients. These records were\nreviewed by a psychologist (LH), and a random sample of\n50 records was also reviewed by a child psychiatrist (EF),\nboth of whom have long experience in the specialty of\nautism. They judged that a PDD was probably present in\n294 children (92\u00b75%).25 Of the 318 patients for whom\nspecialist reports were obtained, 211 were \ufb01rst diagnosed\nwith a PDD after they entered the GPRD and therefore\nwere included in this case-control study. A diagnosis of\nPDD was con\ufb01rmed for 193 of the 211 (91\u00b75%). For the\nremaining 18, the symptoms and clinical features\nrecorded were not suf\ufb01cient to con\ufb01rm a diagnosis of\nPDD; these cases were excluded from the analysis. One\nfurther case was excluded because the general practice\nreported that the diagnosis was a coding error. \nDetails of the cases and controls included are shown in\ntable 1.", "mimetype": "text/plain", "start_char_idx": 15571, "end_char_idx": 17274, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3bf723be-d664-4668-95c2-2a0a88275e01": {"__data__": {"id_": "3bf723be-d664-4668-95c2-2a0a88275e01", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "57626620-a440-491d-a101-23dcf27f3302", "node_type": "1", "metadata": {}, "hash": "7b1620fe6e4b0c1c65233de4835f08e18ae8c1dc4ee584cecfa3ff490e39861b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7de8fef1-2d33-48bb-ab43-05b16068d4b2", "node_type": "1", "metadata": {}, "hash": "f94b1f6d9de6d71453d708ca13e66ed4f9398ee6585f22a25e81bf4b37dc4296", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "One\nfurther case was excluded because the general practice\nreported that the diagnosis was a coding error. \nDetails of the cases and controls included are shown in\ntable 1. The median age of cases at the \ufb01rst recorded\ndiagnosis of PDD was 5\u00b74 years; the average within-set\ndifference in date of birth between cases and their\nmatched controls was zero (IQR \u2013181 to 122 days). On\naverage, cases joined practices contributing to the GPRD\nat older ages than controls, and therefore had shorter\nperiods of registration before the index date. Cases were\nless likely than controls to have a record of MMR\nvaccination before the index date. Just over three\nquarters of cases were classi\ufb01ed as having autism, and\nthe remainder as having another PDD.\nThe unadjusted matched odds ratio for the association\nbetween MMR vaccination before the index date and a\ndiagnosis of PDD was 0\u00b773 (95% CI 0\u00b759\u20130\u00b791; table 2).\nAfter adjustment for the age at which participants joined\nthe GPRD, the odds ratio increased to 0\u00b786 (0\u00b768\u20131\u00b709).\nFurther adjustment for duration of period in the GPRD\nand for consultation rate had no substantial effect on the\nodds ratio. The adjusted odds ratio associated with MMR\nvaccination after the third birthday was lower than that\nfor before the third birthday, but not signi\ufb01cantly so. The\nresults were very similar when re-analysed with an age\ncutoff of 18 months to de\ufb01ne MMR exposure. Re-\nanalysis excluding children who had received measles\nvaccine before MMR (4\u00b74% of cases and 5\u00b72% of\ncontrols) had no substantial effect on these results.\nWe repeated the analysis restricted to 553 cases and\n2126 controls whose index date was before Jan 1, 1998\n(the hypothesis that MMR vaccination increased the risk\nof autism \ufb01rst received widespread media coverage in\nFebruary, 1998). After adjustment for the age at which\nparticipants joined the GPRD, the odds ratio was 0\u00b791\n(95% CI 0\u00b762\u20131\u00b733), similar to the overall results.", "mimetype": "text/plain", "start_char_idx": 17102, "end_char_idx": 19035, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7de8fef1-2d33-48bb-ab43-05b16068d4b2": {"__data__": {"id_": "7de8fef1-2d33-48bb-ab43-05b16068d4b2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3bf723be-d664-4668-95c2-2a0a88275e01", "node_type": "1", "metadata": {}, "hash": "defd989e58e4b4b0ae2a419c015bbcb55692fee986e4fc167ec10b233c981731", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "617226ab-148a-4322-8762-7db2bbe8e389", "node_type": "1", "metadata": {}, "hash": "26b61e6e4687eb5c960493b560c4a7409c85a9843c7e1c8afe18cb24fa376799", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "After adjustment for the age at which\nparticipants joined the GPRD, the odds ratio was 0\u00b791\n(95% CI 0\u00b762\u20131\u00b733), similar to the overall results. \nWe repeated the analysis restricted to participants for\nwhom we had month of birth recorded: 82% of cases\n(1059) and 79% of controls (3524). The adjusted odds\nratio was 0\u00b794 (95% CI 0\u00b772\u20131\u00b723).\nWe assessed whether the odds ratio associated with\nMMR vaccination varied according to the age at which\nparticipants joined a contributing general practice. The\nadjusted odds ratios for the association between MMR\nvaccination before the index date were 1\u00b747 (95% CI\n0\u00b784\u20132\u00b757) for participants who joined the GPRD before\ntheir \n\ufb01rst \nbirthday, \nand \n0\u00b775 \n(0\u00b757\u20130\u00b797) \nfor\nparticipants who joined after their \ufb01rst birthday (p=0\u00b703\nfor difference between the odds ratios). Restriction of\nthis analysis to those with a month of birth recorded\nproduced odds ratios that were slightly closer to 1\n(p=0\u00b709). Table 3 shows results of the analyses done\nseparately for the 991 cases classi\ufb01ed as having autism\nand the 303 cases classi\ufb01ed as having another PDD. The\nresults for the two subgroups were similar. \nDiscussion\nWe found that MMR vaccination was not associated\nwith an increased risk of subsequently being\ndiagnosed with a PDD. The \ufb01ndings were similar\nwhen analysis was restricted to children classi\ufb01ed as\nhaving autism, or to children who had MMR\nvaccination before age 3 years. \nAn unexpected \ufb01nding was that the odds ratio\nassociated with MMR vaccination varied according to the\nage at which a person joined the GPRD. In particular, the\nodds ratio associated with MMR vaccination was higher\namong children who joined the GPRD at birth or before\ntheir \ufb01rst birthday than among children who joined at a\nlater age; however, the con\ufb01dence intervals were wide\nand the excess risk was not signi\ufb01cant.", "mimetype": "text/plain", "start_char_idx": 18892, "end_char_idx": 20730, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "617226ab-148a-4322-8762-7db2bbe8e389": {"__data__": {"id_": "617226ab-148a-4322-8762-7db2bbe8e389", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7de8fef1-2d33-48bb-ab43-05b16068d4b2", "node_type": "1", "metadata": {}, "hash": "f94b1f6d9de6d71453d708ca13e66ed4f9398ee6585f22a25e81bf4b37dc4296", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "85e65315-3369-43d9-8cd2-7ab97358b775", "node_type": "1", "metadata": {}, "hash": "ff3ed237e9b9b494239fbae38cc0309c7c5cc6f5b91622153ebc2c0f340d91c3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This \ufb01nding\n966\nwww.thelancet.com Vol 364   September 11, 2004 \nUnadjusted OR (95% CI) Adjusted OR (95% CI)*\np (for adjusted OR)\nMMR vaccination before index date\nAt any age\nNo MMR vaccination\n(1\u00b70)\nVaccinated with MMR\n0\u00b773 (0\u00b759\u20130\u00b791)\n0\u00b786 (0\u00b768\u20131\u00b709)\n0\u00b721\nBefore and after third birthday\nNo MMR vaccination\n(1\u00b70)\nMMR vaccination before third birthday 0\u00b775 (0\u00b760\u20130\u00b795)\n0\u00b790 (0\u00b770\u20131\u00b715)\n0\u00b739\nMMR vaccination after third birthday\n0\u00b768 (0\u00b750\u20130\u00b794)\n0\u00b777 (0\u00b755\u20131\u00b708)\n0\u00b713\nBefore and after age 18 months\nNo MMR vaccination\n(1\u00b70)\nMMR vaccination before 18 months\n0\u00b776 (0\u00b760\u20130\u00b796)\n0\u00b790 (0\u00b770\u20131\u00b715)\n0\u00b739\nMMR vaccination after 18 months\n0\u00b769 (0\u00b754\u20130\u00b789)\n0\u00b780 (0\u00b761\u20131\u00b705)\n0\u00b711\nOR=odds ratio. *Adjusted for age joined GPRD.\nTable 2: Association between PDD and MMR vaccination before index date, before and after third\nbirthday, and before and after age 18 months\nUnadjusted OR (95% CI)\nAdjusted OR (95% CI)*\np (for adjusted OR)\nMMR vaccination before index date\nAutism only\nNo MMR vaccination\n(1\u00b70) \nVaccinated with MMR\n0\u00b777 (0\u00b760\u20130\u00b798)\n0\u00b788 (0\u00b767\u20131\u00b715)\n0\u00b735\nOther PDDs only\nNo MMR vaccination\n(1\u00b70) \nVaccinated with MMR\n0\u00b760 (0\u00b739\u20130\u00b792)\n0\u00b775 (0\u00b746\u20131\u00b723)\n0\u00b725\nOR=odds ratio. *Adjusted for age joined GPRD.", "mimetype": "text/plain", "start_char_idx": 20731, "end_char_idx": 21926, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "85e65315-3369-43d9-8cd2-7ab97358b775": {"__data__": {"id_": "85e65315-3369-43d9-8cd2-7ab97358b775", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "617226ab-148a-4322-8762-7db2bbe8e389", "node_type": "1", "metadata": {}, "hash": "26b61e6e4687eb5c960493b560c4a7409c85a9843c7e1c8afe18cb24fa376799", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ced813cd-8deb-47ae-8ac1-e4f712701b78", "node_type": "1", "metadata": {}, "hash": "0954c2c858cab10b2e43f22440e037d52c09cc93f2e1663d0788f0fe4446dca4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "*Adjusted for age joined GPRD.\nTable 3: Association between diagnosis of autism or other PDD and MMR vaccination\nArticles\ncould have been due to selection bias, or could have been\na chance result due to multiple statistical testing.\nStrengths of our study included the large size and\npopulation-based data. We included more than\n1000 cases with a diagnosis of PDD. With 82% MMR\ncoverage among controls, we were able to detect an odds\nratio of 1\u00b73 or greater with 90% power at the 5%\nsigni\ufb01cance level. Vaccination was recorded before the\ndate of diagnosis so there was no scope for recall bias,\nand we were able to separately examine the data\nrecorded before the hypothesis that MMR vaccination\nincreased the risk of autism had been proposed. A\nrecorded diagnosis of PDD had a high positive predictive\nvalue,25 with 91\u00b75% of a sample of cases having a\ndiagnosis of PDD con\ufb01rmed. A limitation of the study\nwas that when children joined participating general\npractices after the date of MMR vaccination, their\nprevious \nvaccination \nhistory \nwas \nrecorded\nretrospectively. Our \ufb01ndings suggest that such recording\nmight have been incomplete, and the completeness of\nrecording was related to the age at which people\nregistered with a contributing practice. Additionally,\ncases joined practices contributing to the GPRD at a later\nage than controls; therefore, we adjusted for the age at\nwhich people joined the database. However, there was\nsome evidence that the odds ratio associated with MMR\nvaccination varied according to the age at which a child\njoined the GPRD. It is possible that the incomplete\nascertainment of vaccination history for children who\njoined the GPRD at later ages affected cases and controls\ndifferentially, though it is unclear why this should occur.\nWe were not able to measure or control for some\npotential confounding factors such as birth order within\nfamilies and social class, both of which are known to be\nassociated with vaccination and might be risk factors for\nautism. For the index date, to assess previous\nvaccination, we used date of recorded diagnosis, not\nonset of symptoms.", "mimetype": "text/plain", "start_char_idx": 21896, "end_char_idx": 24005, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ced813cd-8deb-47ae-8ac1-e4f712701b78": {"__data__": {"id_": "ced813cd-8deb-47ae-8ac1-e4f712701b78", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "85e65315-3369-43d9-8cd2-7ab97358b775", "node_type": "1", "metadata": {}, "hash": "ff3ed237e9b9b494239fbae38cc0309c7c5cc6f5b91622153ebc2c0f340d91c3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f59dd4b5-a2f0-48e8-b476-c758b7810311", "node_type": "1", "metadata": {}, "hash": "0e06346fc2274a10b022d3fb889108fcda3136a8349d2b9f4094a7d03cbcdb96", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For the index date, to assess previous\nvaccination, we used date of recorded diagnosis, not\nonset of symptoms. It is possible that parents might\nhave noticed signs of PDD before the diagnosis of PDD,\nand avoided MMR vaccination because of these signs.\nThe ability of uncontrolled confounding to produce\napparent protective effects of vaccination has been\nexplored in detail elsewhere.26 It is important to note that\nrestriction of the analysis to cases and controls whose\nindex date was before the widespread media coverage of\nthe hypothesis that MMR vaccination increased the risk\nof autism gave results similar to the overall results. We\nwere not able to separately identify the subgroup of cases\nwith regressive symptoms to investigate the hypothesis\nthat only some children are vulnerable to MMR-induced\ndisease and that this is always regressive.27 However, two\nrecent studies have argued against the existence of a\ndistinct MMR-induced regressive type of autism.28,29\nWe did a systematic review of published studies that\nassessed the risk of PDD in individuals who received\nMMR vaccine and those not vaccinated. Relevant studies\nwere sought without language restriction by searches of\nPubMed and EMBASE with key terms autism, autistic,\npervasive developmental disorder, regression, and\nmeasles, mumps, rubella alone or in combination, and\nvariants of the abbreviation MMR. Reference lists of\nretrieved articles were scanned and recent reviews\nconsulted.9; 30-33 Studies were eligible if an effect measure\n(with a standard error or con\ufb01dence interval) for the\nassociation between exposure to MMR vaccine and\nsubsequent PDD could be obtained from the report or by\ncontacting the study authors. Two investigators extracted\ndata, with any discrepancies resolved by discussion. The\nDerSimonian and Laird Q test was used to evaluate\nheterogeneity of effect between studies. The summary\nodds ratio and 95% CI were calculated with the Mantel-\nHaenszel \ufb01xed effect34 and DerSimonian and Laird\nrandom effects35 models. \nIn the systematic review, we identi\ufb01ed three other\nstudies that had directly assessed the risk of autism or\nother PDDs associated with MMR vaccination.8,36-38 The\nresults from a Danish cohort study8 were very similar to\nthe results we obtained.", "mimetype": "text/plain", "start_char_idx": 23895, "end_char_idx": 26155, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f59dd4b5-a2f0-48e8-b476-c758b7810311": {"__data__": {"id_": "f59dd4b5-a2f0-48e8-b476-c758b7810311", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ced813cd-8deb-47ae-8ac1-e4f712701b78", "node_type": "1", "metadata": {}, "hash": "0954c2c858cab10b2e43f22440e037d52c09cc93f2e1663d0788f0fe4446dca4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d3ce73a7-95f9-4d8b-a2ff-0fbf0ce9ad14", "node_type": "1", "metadata": {}, "hash": "bef2f4cbd2332f2a36869d214e227e0ee57372f4d9e0e4b67f54d176036e44b2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The Danish study was from a\ncohort sample, which lends itself to reporting results\non the relative risk scale and not the odds ratio scale\nused in this study. Information provided was\ninsuf\ufb01cient for conversion to the odds ratio scale, but\nassuming a baseline incidence of autism of less than\none per thousand, and a risk ratio closer to unity than\n0\u00b78, the two scales are approximately equal with an\nerror of less than 0\u00b702%, calculated with the formula\n(baseline odds)\u0003(1\u2013relative risk)\u0003100%. Unpublished\ndata were supplied by the authors of a study by Jick and\ncolleagues.36,37 Of the 122 cases included, 118 (96\u00b77%)\nhad received MMR vaccine before the date of diagnosis,\nwww.thelancet.com Vol 364   September 11, 2004  \n967\nDecreased risk\nIncreased risk\nEffect\n0\u00b750\n0\u00b775\n1\u00b700\n1\u00b725\n1\u00b750\n2\u00b700\n0\u00b787 (0\u00b776\u20131\u00b7001)\u00a7\n0\u00b786 (0\u00b768\u20131\u00b709)\u2021\n0\u00b793 (0\u00b766\u20131\u00b730)\u2020\n0\u00b783 (0\u00b765\u20131\u00b707)*\n0\u00b792 (0\u00b768\u20131\u00b724)*\nEffect size (95% Cl)\nMadsen et al (autism)8\nMadsen et al (ASD)8\nDeSteano et al33\nPresent\nCombined\nFigure 2: Meta-analysis of studies that compared risk of autism or other PDDs among vaccinated and\nunvaccinated individuals\nASD=other autistic spectrum disorders. Shaded boxes and horizontal lines correspond to effect size ratios and\n95% CIs. Size of shaded box proportional to reciprocal of square of standard error of effect. *Rate ratio, adjusted for\nage, calendar period, sex, birth weight, gestational age, mother\u2019s education and socioeconomic status. \u2020Odds ratio,\ncases and controls matched on age, sex, and school, adjusted for birth weight, multiple gestation, maternal age,\nand maternal education. \u2021Odds ratio, cases and controls matched on age, sex, and general practice, adjusted for age\nregistered with general practice. \u00a7Pooled relative risk.", "mimetype": "text/plain", "start_char_idx": 26156, "end_char_idx": 27895, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d3ce73a7-95f9-4d8b-a2ff-0fbf0ce9ad14": {"__data__": {"id_": "d3ce73a7-95f9-4d8b-a2ff-0fbf0ce9ad14", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f59dd4b5-a2f0-48e8-b476-c758b7810311", "node_type": "1", "metadata": {}, "hash": "0e06346fc2274a10b022d3fb889108fcda3136a8349d2b9f4094a7d03cbcdb96", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bed4e3b3-d714-41d6-af8e-952c6759044a", "node_type": "1", "metadata": {}, "hash": "b3191538baf52ce9a8378583fbbceacc5ab9c0dbf3aaaa16ed85c749ff331f1c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2021Odds ratio, cases and controls matched on age, sex, and general practice, adjusted for age\nregistered with general practice. \u00a7Pooled relative risk.\nArticles\ncompared with 569 of 587 controls (96\u00b79%). Ignoring\nany effect matching might have had, these data gave an\nodds ratio of 0\u00b793 (95% CI 0\u00b730\u20133\u00b786). The cases\nincluded in the study by Jick and colleagues36,37 were a\nsubsample of the cases included in our study and were\ntherefore not included in the pooled estimate. In a\nstudy by DeStefano and colleagues,38 the adjusted odds\nratio in the subsample for whom more detailed\ninformation was available (\ufb01gure 2) was closer to unity\nthan the unadjusted odds ratio in the whole sample\n(1\u00b712, 95% CI 0\u00b791\u20131\u00b738). We used the subsample\nresult because there was evidence of confounding in\nthe unadjusted result. \nThe results for the studies included in our meta-\nanalysis and the pooled estimate are presented in\n\ufb01gure 2. We noted no evidence of heterogeneity\n(p=0\u00b794). The pooled relative risk was 0\u00b787 (95% CI\n0\u00b776\u20131\u00b7001). The Dersimonian and Laird estimate of\nthe between study variance was zero, hence the results\nof the \ufb01xed and random effects models were identical.\nHence, the \ufb01ndings of the three studies we identi\ufb01ed\nby systematic review were in accord with those of our\ncase-control study. Our \ufb01nding of no increased risk of\nPDD in individuals who received MMR vaccine\ncompared with those not vaccinated was consistent\nwith previous studies that showed no temporal relation\nbetween MMR vaccination and the development of\nPDD within individuals,7,28,29,39-42\nand the negative\n\ufb01ndings from studies that compared incidence rates of\nPDD with MMR vaccine coverage.7,28,29,43\u201347\nWe have found no convincing evidence that MMR\nvaccination increases the risk of autism or other PDDs.\nNo signi\ufb01cant association has been found in rigorous\nstudies in a range of different settings.", "mimetype": "text/plain", "start_char_idx": 27747, "end_char_idx": 29621, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bed4e3b3-d714-41d6-af8e-952c6759044a": {"__data__": {"id_": "bed4e3b3-d714-41d6-af8e-952c6759044a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d3ce73a7-95f9-4d8b-a2ff-0fbf0ce9ad14", "node_type": "1", "metadata": {}, "hash": "bef2f4cbd2332f2a36869d214e227e0ee57372f4d9e0e4b67f54d176036e44b2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fb968f96-11a0-437d-bd06-962f0a4e944d", "node_type": "1", "metadata": {}, "hash": "a972e856dff6782a91d81f8791512459b831f93761b17f8828fd77b3684d855f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "No signi\ufb01cant association has been found in rigorous\nstudies in a range of different settings. These are severe\ndiseases for which very little is known about causation;\nthis \nabsence \nof \nknowledge \nitself \nmight \nhave\ncontributed to the misplaced emphasis on MMR as a\ncause. Research into the real origins of autism is\nurgently needed. \nContributors\nL Smeeth, A J Hall, E Fombonne, L C Rodrigues, and P G Smith designed\nthe study. L Heavey and E Fombonne undertook the validation of case\nreports. C Cook analysed the data. L Smeeth drafted the paper. All authors\ncommented on drafts and approved the \ufb01nal version of the paper.\nCon\ufb02ict of interest statement\nL Smeeth, C Cook, L Heavey, L C Rodrigues, and P G Smith have no\ncon\ufb02icts of interest. E Fombonne has provided advice on the\nepidemiology and clinical aspects of autism to scientists advising parents,\nto vaccine manufacturers (for a fee), and to several government\ncommittees. A J Hall received a \ufb01nancial contribution from Merck\ntowards research on hepatitis B vaccination in 1998. He is also a member\nof the Joint Committee on Vaccines and Immunisation (2002\u2013present).\nAcknowledgments\nWe thank Helen Weiss for checking the statistical analyses for errors;\nStephen Evans, Paddy Farrington, and Paul Fine for comments on the\nmanuscript; and Hershel Jick and James Kaye for providing additional\ndata. This statement does not imply that these people necessarily agree\nwith all parts of the paper. The study was funded by the UK Medical\nResearch Council. L Smeeth is supported by a Medical Research\nCouncil Clinician Scientist Fellowship.\n968\nwww.thelancet.com Vol 364   September 11, 2004 \nReferences\n1 \nWake\ufb01eld AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular\nhyperplasia, non-speci\ufb01c colitis, and pervasive developmental\ndisorder in children. Lancet 1998; 351: 637\u201341.\n2\nWake\ufb01eld AJ, Anthony A, Murch SH, et al.", "mimetype": "text/plain", "start_char_idx": 29527, "end_char_idx": 31403, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fb968f96-11a0-437d-bd06-962f0a4e944d": {"__data__": {"id_": "fb968f96-11a0-437d-bd06-962f0a4e944d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bed4e3b3-d714-41d6-af8e-952c6759044a", "node_type": "1", "metadata": {}, "hash": "b3191538baf52ce9a8378583fbbceacc5ab9c0dbf3aaaa16ed85c749ff331f1c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "746cbf4a-d692-4323-b145-7d84f98a57a8", "node_type": "1", "metadata": {}, "hash": "0f2db95fe996bbe7b621b7f09eb35213d7dd79792e9ce49e040f0632ff7d7850", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Lancet 1998; 351: 637\u201341.\n2\nWake\ufb01eld AJ, Anthony A, Murch SH, et al. Enterocolitis in children\nwith developmental disorders. Am J Gastroenterol 2000; 95: 2285\u201395.\n3\nFurlano RI, Anthony A, Day R, et al. Colonic CD8 and gamma delta\nT-cell in\ufb01ltration with epithelial damage in children with autism.\nJ Pediatr 2001; 138: 366\u201372.\n4\nWake\ufb01eld AJ, Montgomery SM. Measles, mumps, rubella vaccine:\nThrough a glass, darkly. Adverse Drug React Toxicol Rev 2001; 19:\n265\u201383.\n5\nUhlmann V, Martin CM, Sheils O, et al. Potential viral pathogenic\nmechanism for new variant in\ufb02ammatory bowel disease. Mol Pathol\n2002; 55: 84\u201390.\n6\nSmeeth L, Hall A, Rodrigues L, Cook C, Fombonne E. Autism,\nbowel in\ufb02ammation, and measles. Lancet 2002; 359: 2112\u201313.\n7\nTaylor B, Miller E, Farrington CP, et al. Autism and measles,\nmumps, and rubella vaccine: no epidemiological evidence for a\ncausal association. Lancet 1999; 353: 2026\u201329.\n8\nMadsen KM, Hviid A, Vestergaard M, et al. A population-based\nstudy of measles, mumps, and rubella vaccination and autism.\nN Engl J Med 2002; 347: 1477\u201382.\n9\nWilson K, Mills E, Ross C, McGowan J, Jadad A. Association of\nautistic spectrum disorder and the measles, mumps, and rubella\nvaccine: a systematic review of current epidemiological evidence.\nArch Pediatr Adolesc Med 2003; 157: 628\u201334.\n10\nLoff B, Cordner S. Australia\u2019s measles campaign challenged. Lancet\n1998; 352: 1368.\n11\nBurton D. Opening statement by the Chairman.", "mimetype": "text/plain", "start_char_idx": 31335, "end_char_idx": 32768, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "746cbf4a-d692-4323-b145-7d84f98a57a8": {"__data__": {"id_": "746cbf4a-d692-4323-b145-7d84f98a57a8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fb968f96-11a0-437d-bd06-962f0a4e944d", "node_type": "1", "metadata": {}, "hash": "a972e856dff6782a91d81f8791512459b831f93761b17f8828fd77b3684d855f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f87add3c-454a-4bfa-a0d1-be1b81cf1de7", "node_type": "1", "metadata": {}, "hash": "6bee0e918e00fee3b08664512ee30bf1f59990d57214d6b0f01aaed51dc18bbb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "10\nLoff B, Cordner S. Australia\u2019s measles campaign challenged. Lancet\n1998; 352: 1368.\n11\nBurton D. Opening statement by the Chairman. Government\nReform Committee United States House of Representatives.\nAutism: present challenges, future needs\u2014why the increased rates?\nWashington DC: Committee on Government Reform, 2000.\n12\nRamsay ME, Yarwood J, Lewis D, Campbell H, White JM. Parental\ncon\ufb01dence in measles, mumps and rubella vaccine: evidence from\nvaccine coverage and attitudinal surveys. Br J Gen Pract 2002; 52:\n912\u201316.\n13\nDepartment of Health. Statistical bulletin. NHS Immunisation\nStatistics, England. 2002\u201303. http://www.publications.doh.gov.uk/\npublic/sb0316.htm (accessed Aug 31, 2004).\n14\nReport from the Director of Public Health, NHS London Regional\nOf\ufb01ce. Measles in London: incidence and current action. London:\nGreater London Authority; 2002.\n15\nJansen VA, Stollenwerk N, Jensen HJ, Ramsay ME, Edmunds WJ,\nRhodes CJ. Measles outbreaks in a population with declining\nvaccine uptake. Science 2003; 301: 804.\n16\nSmeeth L, Hall AJ, Fombonne E, Rodrigues LC, Huang X,\nSmith PG. A case-control study of autism and mumps-measles-\nrubella vaccination using the general practice research database:\ndesign and methodology. BMC Public Health 2001; 1: 2.\n17\nWalley T, Mantgani A. The UK General Practice Research\nDatabase. Lancet 1997; 350: 1097\u201399.\n18\nOf\ufb01ce for National Statistics. Key health statistics from general\npractice 1996 (Series MB6 No. 1). London: Of\ufb01ce for National\nStatistics; 1998.\n19\nNazareth I, King M, Haines A, Rangel L, Myers S. Accuracy of\ndiagnosis of psychosis on a general practice computer system. BMJ\n1993; 307: 32\u201334.", "mimetype": "text/plain", "start_char_idx": 32634, "end_char_idx": 34284, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f87add3c-454a-4bfa-a0d1-be1b81cf1de7": {"__data__": {"id_": "f87add3c-454a-4bfa-a0d1-be1b81cf1de7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "746cbf4a-d692-4323-b145-7d84f98a57a8", "node_type": "1", "metadata": {}, "hash": "0f2db95fe996bbe7b621b7f09eb35213d7dd79792e9ce49e040f0632ff7d7850", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2b010ffb-92a8-4656-8756-17f252c23e6b", "node_type": "1", "metadata": {}, "hash": "964c057d824456ab9480043a6465d405d3ac8d7c9b56276b0d74104e2eec0041", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "19\nNazareth I, King M, Haines A, Rangel L, Myers S. Accuracy of\ndiagnosis of psychosis on a general practice computer system. BMJ\n1993; 307: 32\u201334.\n20\nvan Staa T, Abenhaim L. The quality of information recorded on a\nUK database of primary care records: a study of hospitalisations due\nto hypoglycaemia and other conditions. Pharmacoepid Drug Safety\n1994; 3: 15\u201321.\n21\nHollowell J. The General Practice Research Database: quality of\nmorbidity data. Popul Trends 1997: 36\u201340.\n22\nSalisbury DM, Begg NT. Immunisation against infectious disease.\nLondon: HM Stationery Of\ufb01ce; 1996.\n23\nClayton D, Hills M. Conditional logistic regression. Statistical\nmodels in epidemiology. Oxford: Oxford University Press; 1993:\n290\u201397.\n24\nRapin I. Autism. N Engl J Med 1997; 337: 97\u2013104.\n25\nFombonne E, Heavey L, Smeeth L, et al. Validation of the\ndiagnosis of autism in general practitioner records.\nBMC Public Health 2004; 4: 5. \nArticles\n26\nFine PE, Chen RT. Confounding in studies of adverse reactions to\nvaccines. Am J Epidemiol 1992; 136: 121\u201335.\n27\nSpitzer WO. Measles, mumps, and rubella vaccination and autism.\nN Engl J Med 2003; 348: 951\u201352.\n28\nFombonne E, Chakrabarti S. No evidence for a new variant of\nmeasles-mumps-rubella-induced autism. Pediatrics 2001; 108:\nE58.\n29\nTaylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J.\nMeasles, mumps, and rubella vaccination and bowel problems or\ndevelopmental regression in children with autism: population\nstudy. BMJ 2002; 324: 393\u201396.\n30\nMMR vaccine\u2014how effective and how safe? Drug Ther Bull 2003;\n41: 25\u201329.", "mimetype": "text/plain", "start_char_idx": 34137, "end_char_idx": 35687, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2b010ffb-92a8-4656-8756-17f252c23e6b": {"__data__": {"id_": "2b010ffb-92a8-4656-8756-17f252c23e6b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f87add3c-454a-4bfa-a0d1-be1b81cf1de7", "node_type": "1", "metadata": {}, "hash": "6bee0e918e00fee3b08664512ee30bf1f59990d57214d6b0f01aaed51dc18bbb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "62b6f08d-85a2-4fbe-9d9c-6c6260911d80", "node_type": "1", "metadata": {}, "hash": "0b002ed776afb225b2d2cc2bbc87a9bae18fdfcdd02fc62524445c0fa2a2693b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BMJ 2002; 324: 393\u201396.\n30\nMMR vaccine\u2014how effective and how safe? Drug Ther Bull 2003;\n41: 25\u201329.\n31\nJefferson T, Price D, Demicheli V, Bianco E. Unintended events\nfollowing immunization with MMR: a systematic review. Vaccine\n2003; 21: 3954\u201360.\n32\nMiller E. Measles-mumps-rubella vaccine and the development of\nautism. Semin Pediatr Infect Dis 2003; 14: 199\u2013206.\n33\nDeStefano F, Thompson WW. MMR vaccine and autism: an\nupdate of the scienti\ufb01c evidence. Expert Rev Vaccines 2004; 3:\n19\u201322.\n34\nMantel N, Haenszel W. Statistical aspects of the analysis of data\nfrom retrospective studies of disease. J Natl Cancer Inst 1959; 22:\n719\u201348.\n35\nDerSimonian R, Laird N. Meta-analysis in clinical trials.\nControlled Clin Trials 1986; 7: 177\u201388.\n36\nJick H, Kaye JA, Black C. Changes in risk of autism in the U.K. for\nbirth cohorts 1990\u20131998. Epidemiology 2003; 14: 630\u201332.\n37\nJick H, Kaye JA. Epidemiology and possible causes of autism.\nPharmacotherapy 2003; 23: 1524\u201330.\n38\nDeStefano F, Bhasin TK, Thompson WW, Yeargin-Allsopp M,\nBoyle C. Age at \ufb01rst measles-mumps-rubella vaccination in\nchildren with autism and school-matched control subjects: a\npopulation-based study in metropolitan atlanta. Pediatrics 2004;\n113: 259\u201366.\n39\nPatja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H. Serious\nadverse events after measles-mumps-rubella vaccination during a\nfourteen-year prospective follow-up. Pediatr Infect Dis J 2000; 19:\n1127\u201334.", "mimetype": "text/plain", "start_char_idx": 35590, "end_char_idx": 37018, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "62b6f08d-85a2-4fbe-9d9c-6c6260911d80": {"__data__": {"id_": "62b6f08d-85a2-4fbe-9d9c-6c6260911d80", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Smeeth (2004).pdf", "node_type": "4", "metadata": {}, "hash": "5a180d4c3e978b766aca21be301eb1eb47ceb7b04c8ac610fcf334246f3ab6a8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2b010ffb-92a8-4656-8756-17f252c23e6b", "node_type": "1", "metadata": {}, "hash": "964c057d824456ab9480043a6465d405d3ac8d7c9b56276b0d74104e2eec0041", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Pediatr Infect Dis J 2000; 19:\n1127\u201334.\n40\nFarrington CP, Miller E, Taylor B. MMR and autism: further\nevidence against a causal association. Vaccine 2001; 19: 3632\u201335.\n41\nDeWilde S, Carey IM, Richards N, Hilton SR, Cook DG. Do\nchildren who become autistic consult more often after MMR\nvaccination? Br J Gen Pract 2001; 51: 226\u201327.\n42\nMakela A, Nuorti JP, Peltola H. Neurologic disorders after measles-\nmumps-rubella vaccination. Pediatrics 2002; 110: 957\u201363.\n43\nGillberg C, Heijbel H. MMR and autism. Autism 1998; 2: 423\u201324.\n44\nDales L, Hammer SJ, Smith NJ. Time trends in autism and in\nMMR immunization coverage in California. JAMA 2001; 285:\n1183\u201385.\n45\nKaye JA, Mar Melero-Montes M, Jick H. Mumps, measles, and\nrubella vaccine and the incidence of autism recorded by general\npractitioners: a time trend analysis. BMJ 2001; 322: 460\u201363.\n46\nGeier DA, Geier MR. A comparative evaluation of the effects of\nMMR immunization and mercury doses from thimerosal-\ncontaining childhood vaccines on the population prevalence of\nautism. Med Sci Monit 2004; 10: I33\u2013I39.\n47\nChen W, Landau S, Sham P, Fombonne E. No evidence for links\nbetween autism, MMR and measles virus. Psychol Med 2004; 34:\n543\u201353.\nwww.thelancet.com Vol 364   September 11, 2004  \n969", "mimetype": "text/plain", "start_char_idx": 36979, "end_char_idx": 38223, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "99bd6e87-aa8c-41cb-b59f-3fc44eec5979": {"__data__": {"id_": "99bd6e87-aa8c-41cb-b59f-3fc44eec5979", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Arenz (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f9f4ad2a7801d3583e37a93eea3206bf6c9aa9cfb3c08c3a967a8c624a746266", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b7020cd3-e0ad-4da0-bd79-c796794e7c7e", "node_type": "1", "metadata": {}, "hash": "d20fc941b9725b41d24a15781c326d9c97ab2796bc2d1276cc54130d462facb7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ORIGINAL STUDIES\nEffectiveness of Measles Vaccination After Household\nExposure During a Measles Outbreak\nA Household Contact Study in Coburg, Bavaria\nStephan Arenz, MD, MPH, MSc,* Heinz-Josef Schmitt, MD,\u2020 Annedore Tischer, MD,\u2021\nand Ru\u00a8diger von Kries, MD, MSc\u00a7\nBackground: A measles outbreak was recently observed in Coburg,\nBavaria, in a population with vaccination rates of 76.5% in 5- to\n6-year-old children in the years preceding the outbreak. Only a small\nproportion of children had received 2 vaccinations against measles.\nVaccine effectiveness is estimated in a household contact study and\nalso by a screening method.\nMethods: A household contact study was conducted in families\nwith at least 1 measles case by standardized computer-assisted\ntelephone interviews to assess secondary attack rate and to estimate\nvaccine effectiveness. Vaccine effectiveness was also estimated with\nFarrington\u2019s screening method with information from school entry\nexaminations and from questionnaires of con\ufb01rmed measles cases in\nthe Coburg outbreak.\nResults: Thirty-eight children were primary cases. Of their contacts,\n20 children were included in the study as secondary cases (1\nvaccinated), and 23 children were contacts who did not develop\nmeasles (12 vaccinated once and 4 vaccinated twice), resulting in a\nvaccine effectiveness of 90% (95% con\ufb01dence interval, 35\u201397%) for\none vaccine dose. The proportion of the population vaccinated\nreached 81.5% during the outbreak and the proportion of the cases\nvaccinated was 10.9%, resulting in a vaccine effectiveness estimated\nusing the screening method of 97.2% (95% con\ufb01dence interval,\n95.7\u201398.3%).\nConclusions: With the use of 2 approaches to estimate the effec-\ntiveness of measles vaccination, a consistently high vaccine effec-\ntiveness of 90% or above was shown during a measles outbreak in\nWestern Europe.\nKey Words: measles, vaccine, effectiveness, outbreak\n(Pediatr Infect Dis J 2005;24: 697\u2013699)\nW\nith the elimination of measles imminent in many coun-\ntries, there will be few opportunities to assess the\neffectiveness of measles vaccines.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2088, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b7020cd3-e0ad-4da0-bd79-c796794e7c7e": {"__data__": {"id_": "b7020cd3-e0ad-4da0-bd79-c796794e7c7e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Arenz (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f9f4ad2a7801d3583e37a93eea3206bf6c9aa9cfb3c08c3a967a8c624a746266", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "99bd6e87-aa8c-41cb-b59f-3fc44eec5979", "node_type": "1", "metadata": {}, "hash": "528e9e50ef852780e0c0b8257665e123f085a753638d9074498da3963789f7d5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3f981c5c-cac4-40fd-a3cf-c9f65e7938d6", "node_type": "1", "metadata": {}, "hash": "cc54fa61efcbd3f2d48f1c9e30514ae1dc8fe0ed0fe7867510434b54d1029e96", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This, however, is still an\nissue because the effectiveness of 1 injection of measles\nvaccine is high, but not complete.1 The German Standing\nCommittee on Vaccination (Sta\u00a8ndige Impfkommission) rec-\nommends the \ufb01rst measles vaccination at the age of 11\u201314\nmonths and a second vaccination at the age of 15\u201323\nmonths.2 The average vaccination rate for at least 1 dose of\nmeasles vaccine in 5- to 6-year-old children in Germany was\n91.3% in 2000\u20132002.3 In Coburg, a measles outbreak with\n1191 reported cases was recently observed in a population\nwith vaccination rates of 76.5% in this age group in the years\npreceding the outbreak and only a small proportion of chil-\ndren vaccinated twice.4 This gave us the opportunity to\nestimate the measles vaccine effectiveness (VE) in a house-\nhold contact study (VEhousehold) and using the screening\nmethod (VEscreening).5\nMATERIALS AND METHODS\nHousehold Contact Study. According to the German \u201cinfec-\ntious diseases protection law,\u201d all cases of measles must be\nreported to the local public health authorities. During the\nmeasles outbreak in Coburg between November 2001 and\nJune 2002, local health authorities sent a questionnaire to the\nreporting families to con\ufb01rm measles by means of clinical\nsymptoms and to evaluate vaccination status. Additionally\nfamilies were asked to participate in a household contact\nstudy. The families\u2019 names, addresses and telephone numbers\nwere sent to the principle investigator (S.A.) if the families\ngave written informed consent. These families were given\nfurther details on the household contact study and were asked\nto provide certi\ufb01cates of vaccination for every family mem-\nber. Standardized computer-assisted telephone interviews\nwere conducted by trained interviewers. Household members\nwere interviewed regarding the onset and duration of measles\nsymptoms, history of measles, exposure to other measles\ncases in public institutions, existence of other diseases, med-\nications, breast-feeding, vaccination status and date of vacci-\nnation.\nCase De\ufb01nition.", "mimetype": "text/plain", "start_char_idx": 2089, "end_char_idx": 4126, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3f981c5c-cac4-40fd-a3cf-c9f65e7938d6": {"__data__": {"id_": "3f981c5c-cac4-40fd-a3cf-c9f65e7938d6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Arenz (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f9f4ad2a7801d3583e37a93eea3206bf6c9aa9cfb3c08c3a967a8c624a746266", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b7020cd3-e0ad-4da0-bd79-c796794e7c7e", "node_type": "1", "metadata": {}, "hash": "d20fc941b9725b41d24a15781c326d9c97ab2796bc2d1276cc54130d462facb7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9c6bde03-70ea-432a-8616-2945b6624aec", "node_type": "1", "metadata": {}, "hash": "f34a94f0289b13d366bd46833dc90663385d48e0762f3b8257548f5541e84a8a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Case De\ufb01nition. For this outbreak setting, the case de\ufb01nition\nfor measles required a generalized maculopapular rash with\nfever \u000138.4\u00b0C for \u00013 days and at least one of the following\nsigns: cough; coryza; Koplik spots; or conjunctivitis. A pri-\nmary case was the \ufb01rst household member who acquired\nmeasles. Coprimary cases were de\ufb01ned as measles patients\nwho developed a fever within 4 days after the onset of a rash\nin the primary case. Secondary cases were con\ufb01rmed measles\nAccepted for publication March 10, 2005.\nFrom the *Bavarian State Of\ufb01ce for Health and Food Safety, Oberschleis-\nsheim; the \u2020Department of Pediatrics, Johannes-Gutenberg-University\nMainz, Mainz; \u2021Robert-Koch-Institut, Berlin; and the \u00a7Institute for\nSocial Paediatrics and Adolescent Medicine, Ludwig-Maximilians-\nUniversity, Munich, Germany\nReprints not available.\nCopyright \u00a9 2005 by Lippincott Williams & Wilkins\nISSN: 0891-3668/05/2408-0697\nDOI: 10.1097/01.inf.0000172900.70430.c2\nThe Pediatric Infectious Disease Journal \u2022 Volume 24, Number 8, August 2005\n697\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdtwnfKZBYtws= on 01/09/2025\npatients who developed a fever within 5\u201325 days after the\nonset of a rash in the primary case. Contacts were all\nhousehold members who had contact with measles cases in\nthe household during their infectious period.\nInclusion Criteria.", "mimetype": "text/plain", "start_char_idx": 4111, "end_char_idx": 5555, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9c6bde03-70ea-432a-8616-2945b6624aec": {"__data__": {"id_": "9c6bde03-70ea-432a-8616-2945b6624aec", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Arenz (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f9f4ad2a7801d3583e37a93eea3206bf6c9aa9cfb3c08c3a967a8c624a746266", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3f981c5c-cac4-40fd-a3cf-c9f65e7938d6", "node_type": "1", "metadata": {}, "hash": "cc54fa61efcbd3f2d48f1c9e30514ae1dc8fe0ed0fe7867510434b54d1029e96", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "464f0591-1c4c-46e4-899b-c56cda9e9e91", "node_type": "1", "metadata": {}, "hash": "0a6cc03a5a8722032e79d6c5b1825c5ad37904b9114afa919edf781c9df86bf1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Contacts were all\nhousehold members who had contact with measles cases in\nthe household during their infectious period.\nInclusion Criteria. Household members were included in the\nstudy if they met the following inclusion criteria: contact with\nmeasles cases in their infectious period; younger than 19\nyears of age at the time of the onset of disease; and no\nimmunosuppression. Only secondary cases and contacts\nwithout a history of measles were included in the \ufb01nal\nanalysis of vaccine effectiveness.\nData Analysis. To reduce bias caused by different exposure\nof vaccinees and nonvaccinees to measles secondary attack\nrates were determined in families in a household contact\nstudy. In this setting, the exposure is generally uniform.6 The\ndata of the household contact study were used to estimate\nVEhousehold as follows: VEhousehold \u0002 (ARU \u0003 ARV)/\nARU*100, where ARU is the attack rate in unvaccinated\npersons and ARV is the attack rate in vaccinated persons,\nrespectively.6\nVEscreening was estimated by the screening method with\nthe formula VEscreening \u0002 1 \u0003 PCV/(1 \u0003 PCV) * (1 \u0003\nPPV)/PPV5.\nInformation about the proportion vaccinated (PCV) was\ntaken from the questionnaires of con\ufb01rmed measles patients\n5 years or older. We selected these age groups under the\nassumption that vaccination status was constant in older age\ngroups. The proportion of the population vaccinated (PPV)\nwas estimated from school entry examinations in Coburg\nbetween September 2001 and June 2002 in 5- to 6-year-old\nchildren. Con\ufb01dence intervals were calculated by the exact\nmethod of Katz. Statistical analyses were performed with\nSAS Software version 8.\nRESULTS\nHousehold Contact Study. During the Coburg outbreak, 1191\ncases of measles were reported. We requested the families of\n762 measles cases to send written consent to be contacted by\nthe principal investigator, and 86 parents agreed to participate\nin a telephone interview. Four of the families could not be\nreached by telephone, and 27 had fewer than 2 children living\nin the household, leaving 55 families with a total of 124\nchildren for the household contact study. All of these families\nparticipated.", "mimetype": "text/plain", "start_char_idx": 5416, "end_char_idx": 7560, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "464f0591-1c4c-46e4-899b-c56cda9e9e91": {"__data__": {"id_": "464f0591-1c4c-46e4-899b-c56cda9e9e91", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Arenz (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f9f4ad2a7801d3583e37a93eea3206bf6c9aa9cfb3c08c3a967a8c624a746266", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9c6bde03-70ea-432a-8616-2945b6624aec", "node_type": "1", "metadata": {}, "hash": "f34a94f0289b13d366bd46833dc90663385d48e0762f3b8257548f5541e84a8a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dd223dd4-3f70-48b0-806e-2373be6c6e83", "node_type": "1", "metadata": {}, "hash": "0cfb9ec600884dd6d83dbde5ce8d9d13025377965e7f0dee0c6eaae3f1d501ec", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All of these families\nparticipated. In these 55 families, 38 children (69%) ful\ufb01lled\nthe criteria of the clinical case de\ufb01nition for measles and were\nde\ufb01ned as primary cases. In most of the 17 excluded cases,\nthe reason for exclusion was that the duration of the rash was\n\u00044 days.\nForty-seven children were household members and had\ncontact with the primary cases during their infectious period.\nTwenty-three of them were contacts but did not acquire\nmeasles. Two of the contacts were vaccinated during the\nincubation period, 1 with the \ufb01rst vaccination and 1 with the\nsecond. These children were counted according to their\nformer vaccination status.6 Of the 24 potential secondary\ncases, 4 children were excluded because they did not meet the\ncase de\ufb01nition, leaving 20 children to be counted as second-\nary cases. Six secondary cases were younger than 2 years of\nage, of whom 3 were younger than 1 year. There were no\ncoprimary cases.\nOf the 43 exposed children included in the \ufb01nal anal-\nysis, 25 were female and 18 were male. Median age was 5\nyears 3 months in measles cases and 6 years 6 months in\ncontacts without measles. None of the included children had\na history of measles. Vaccinated participants had been im-\nmunized between 1984 and April 2002. Vaccination status of\nthe participants is shown in Table 1. ARV (1 vaccination)\nwas 8%, whereas ARU was 73%, resulting in a VEhousehold\nfor 1 vaccination of 90% \u000595% con\ufb01dence interval (95% CI),\n35\u201397%\u0006. VEhousehold for 1 or more vaccinations was 92%\n(95% CI 48% to 98%). No child with \u00011 vaccination con-\ntracted measles; therefore VEhousehold for 2 immunizations\nwas not calculated.\nScreening Method. In school entry examinations in Coburg\nduring 2001 and 2002, 1437 children 5\u20136 years of age were\nexamined.", "mimetype": "text/plain", "start_char_idx": 7525, "end_char_idx": 9293, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dd223dd4-3f70-48b0-806e-2373be6c6e83": {"__data__": {"id_": "dd223dd4-3f70-48b0-806e-2373be6c6e83", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Arenz (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f9f4ad2a7801d3583e37a93eea3206bf6c9aa9cfb3c08c3a967a8c624a746266", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "464f0591-1c4c-46e4-899b-c56cda9e9e91", "node_type": "1", "metadata": {}, "hash": "0a6cc03a5a8722032e79d6c5b1825c5ad37904b9114afa919edf781c9df86bf1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "efcef278-fdc8-4d61-937f-bd30b82c43ea", "node_type": "1", "metadata": {}, "hash": "6d986426410ca3210cf5ec0b4bc8ff4b0be8fae27946fa574fcbdcb7633b2386", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Screening Method. In school entry examinations in Coburg\nduring 2001 and 2002, 1437 children 5\u20136 years of age were\nexamined. Of those, 1368 presented certi\ufb01cates of vaccina-\ntion (95.2%), and 81.5% of these 1368 children had been\nvaccinated at least once (PPV). In the Coburg measles out-\nbreak, 229 persons had con\ufb01rmed measles and were 5 years\nor older. Twenty-\ufb01ve of them had been vaccinated, so that\nPCV was 10.9% resulting in a VEscreening of 97.2% (95% CI\n95.7\u201398.3).\nDISCUSSION\nThe measles outbreak in Coburg offered the rare op-\nportunity in an industrialized country in Western Europe to\nestimate the effectiveness of one measles vaccine injection\nduring an outbreak situation in a household contact study and\nto compare these \ufb01ndings to vaccine effectiveness estimates\nby a population-based screening method. Vaccine effective-\nness is often questioned by antivaccination lobbyists, citing\nthat measles is observed among vaccinated persons, espe-\ncially in outbreak settings. Both estimates calculated here\nshowed a high vaccine effectiveness with corresponding VE\nestimates of 90% or greater. We believe that this study is the\n\ufb01rst household contact study on effectiveness of measles\nvaccination during an outbreak in Europe.\nTo test the validity of our estimates, sensitivity analyses\nwere performed. Originally we con\ufb01ned our analyses to cases\naccording to a strict clinical case de\ufb01nition. In an outbreak\nsituation, however, it might be justi\ufb01ed to be less strict,\nbecause most presumed measles cases observed in the out-\nbreak are likely to be cases. Excluding the duration of rash\nfrom the case de\ufb01nition for measles resulted in 45 instead of\n38 primary cases, with 25 instead of 20 secondary cases (24\nTABLE 1.", "mimetype": "text/plain", "start_char_idx": 9169, "end_char_idx": 10896, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "efcef278-fdc8-4d61-937f-bd30b82c43ea": {"__data__": {"id_": "efcef278-fdc8-4d61-937f-bd30b82c43ea", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Arenz (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f9f4ad2a7801d3583e37a93eea3206bf6c9aa9cfb3c08c3a967a8c624a746266", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dd223dd4-3f70-48b0-806e-2373be6c6e83", "node_type": "1", "metadata": {}, "hash": "0cfb9ec600884dd6d83dbde5ce8d9d13025377965e7f0dee0c6eaae3f1d501ec", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1e0585d8-1ac3-46d2-a807-ed3b793d8402", "node_type": "1", "metadata": {}, "hash": "e47e6afa9f368ae950c785619d71a0a2b10d2ee296ab71495a0c0327cdf848c4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Excluding the duration of rash\nfrom the case de\ufb01nition for measles resulted in 45 instead of\n38 primary cases, with 25 instead of 20 secondary cases (24\nTABLE 1.\nVaccination Status of Participants\nVaccine Status\nMeasles\nNo Measles\nTotal\nAttack\nRate(%)\nNone\n19 (95)*\n7 (30)\n26 (60)\n73\n1 dose\u2020\n1 (5)\n12 (52)\n13 (30)\n8\n2 doses\n0 (0)\n4 (17)\n4 (9)\n0\nTotal\n20 (100)\n23 (100)\n43 (100)\n*Numbers in parentheses, percent.\n\u2020VEhousehold (for 1 dose only) \u0002 90% (95% CI 35\u201397%).\nArenz et al\nThe Pediatric Infectious Disease Journal \u2022 Volume 24, Number 8, August 2005\n\u00a9 2005 Lippincott Williams & Wilkins\n698\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdtwnfKZBYtws= on 01/09/2025\nnot vaccinated) and 28 instead of 23 contacts without measles\n(10 not vaccinated, 13 vaccinated once, 5 vaccinated twice).\nHowever, these changes did not alter the VEhousehold of 90%.\nCounting the 2 children vaccinated during the incubation\nperiod as vaccinated (assigned to their former vaccination\nstatus in accordance with the recommendations given by\nOrenstein et al6 in the base case calculations) did not change\nthe VEhousehold estimates (data not shown).\nIn a sensitivity analysis for the VE estimation using the\nscreening method, we also applied the PPV of the years\npreceding the outbreak (76.5% in the years 1998 and 1999 to\n2000 and 2001) to estimate VEscreening.", "mimetype": "text/plain", "start_char_idx": 10735, "end_char_idx": 12176, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1e0585d8-1ac3-46d2-a807-ed3b793d8402": {"__data__": {"id_": "1e0585d8-1ac3-46d2-a807-ed3b793d8402", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Arenz (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f9f4ad2a7801d3583e37a93eea3206bf6c9aa9cfb3c08c3a967a8c624a746266", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "efcef278-fdc8-4d61-937f-bd30b82c43ea", "node_type": "1", "metadata": {}, "hash": "6d986426410ca3210cf5ec0b4bc8ff4b0be8fae27946fa574fcbdcb7633b2386", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b7fe84a7-6607-4614-9f23-657b3dcaf70b", "node_type": "1", "metadata": {}, "hash": "84013b3cbe8b369b0ae339730b83e7381a5f6da1fdadac502ff91e0a27681476", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The estimate for the\nVEscreening was 96.3% which does not differ substantially\nfrom the estimate based on the post outbreak vaccination\ncoverage data (97.2%).\nOur data are in line with the results of other published\nhousehold contact studies from Australia, Palau and Korea,\nwhich estimated a VE between 86 and 92%.7\u20139 In comparison\nwith our study, those studies had smaller numbers of vacci-\nnated participants. In addition, only Guris et al8 strati\ufb01ed\nby number of vaccinations, whereas no information about the\nnumber of vaccinations was given in the other studies.\nThere are limitations of our study. Only 86 families of\n1191 cases (some of them were siblings) agreed to participate\nin the study. For reasons of data protection requirements in\nGermany, we could not recontact families who answered\nthe questionnaire but did not send back the written in-\nformed consent for the household contact study. It is\npossible that there was an overrepresentation of vaccina-\ntion critics who denied their children vaccinations in the\nnonparticipant group, whereas participants of the house-\nhold contact study may have been more likely to have their\nchildren vaccinated. This would likely result in underesti-\nmation of vaccine effectiveness. The con\ufb01dence interval\naround VEhousehold was wide because only one child with\nvaccination acquired measles.\nWe used a clinical case de\ufb01nition without serologic\ncon\ufb01rmation. However, Hutchins et al10 were able to show\nthat the positive predictive value of a clinical case de\ufb01ni-\ntion in a situation with a high incidence is 74%. In the\nCoburg outbreak, cumulative incidence was 882 cases/\n100,000 inhabitants.4\nOur data con\ufb01rm the effectiveness of either 1 or 2 doses\nof measles vaccine in an outbreak situation.\nREFERENCES\n1. Hersh BS, Markowitz LE, Hoffman RE, et al. A measles outbreak at a\ncollege with a prematriculation immunization requirement. Am J Public\nHealth. 1991;81:360\u2013364.\n2. Robert-Koch-Institut. Empfehlungen der Sta\u00a8ndigen Impfkommission\n(STIKO) am Robert Koch-Institut / Stand: July 2004.", "mimetype": "text/plain", "start_char_idx": 12177, "end_char_idx": 14223, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b7fe84a7-6607-4614-9f23-657b3dcaf70b": {"__data__": {"id_": "b7fe84a7-6607-4614-9f23-657b3dcaf70b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Arenz (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f9f4ad2a7801d3583e37a93eea3206bf6c9aa9cfb3c08c3a967a8c624a746266", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1e0585d8-1ac3-46d2-a807-ed3b793d8402", "node_type": "1", "metadata": {}, "hash": "e47e6afa9f368ae950c785619d71a0a2b10d2ee296ab71495a0c0327cdf848c4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "218b15e3-5b0a-45fe-8a69-e768faff6d4f", "node_type": "1", "metadata": {}, "hash": "f03b5c4bb30a109bc210dee97f6c26dbaef7fe8d0ee3da6ba3521001d039a7ae", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2. Robert-Koch-Institut. Empfehlungen der Sta\u00a8ndigen Impfkommission\n(STIKO) am Robert Koch-Institut / Stand: July 2004. Epidemiol Bull\n2004;30:235\u2013250.\n3. Robert-Koch-Institut. Schwerpunktbericht der Gesundheitsberichter-\nstattung des Bundes. 2004:172.\n4. Arenz S, Kalies H, Ludwig MS, et al. The outbreak of measles in\nCoburg: what lessons can we learn? Deuterzteblatt. 2003;100:3245\u2013\n3249.\n5. Farrington CP. Estimation of vaccine effectiveness using the screening\nmethod. Int J Epidemiol. 1993;22:742\u2013746.\n6. Orenstein WA, Bernier RH, Dondero TJ, et al. Field evaluation of\nvaccine ef\ufb01cacy. Bull World Health Organ. 1985;63:1055\u20131068.\n7. Jeremijenko AM, Kelly H, Patel M. The high morbidity associated with\na measles outbreak in a west Australian town. J Paediatr Child Health.\n1996;32:382\u2013385.\n8. Guris D, McCready J, Watson JC, et al. Measles vaccine effectiveness\nand duration of vaccine-induced immunity in the absence of boosting\nfrom exposure to measles virus. Pediatr Infect Dis J. 1996;15:1082\u2013\n1086.\n9. Kim SK, Son BK, Chung CY, et al. Ef\ufb01cacy of measles vaccine during\nthe 1993 measles epidemic in Korea. Pediatr Infect Dis J. 1995;14:346\u2013\n349.\n10. Hutchins SS, Papania MJ, Amler R, et al. Evaluation of the measles\nclinical case de\ufb01nition. J Infect Dis 2004;189(suppl 1):S153\u2013S159.", "mimetype": "text/plain", "start_char_idx": 14104, "end_char_idx": 15398, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "218b15e3-5b0a-45fe-8a69-e768faff6d4f": {"__data__": {"id_": "218b15e3-5b0a-45fe-8a69-e768faff6d4f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Arenz (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f9f4ad2a7801d3583e37a93eea3206bf6c9aa9cfb3c08c3a967a8c624a746266", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b7fe84a7-6607-4614-9f23-657b3dcaf70b", "node_type": "1", "metadata": {}, "hash": "84013b3cbe8b369b0ae339730b83e7381a5f6da1fdadac502ff91e0a27681476", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Evaluation of the measles\nclinical case de\ufb01nition. J Infect Dis 2004;189(suppl 1):S153\u2013S159.\nThe Pediatric Infectious Disease Journal \u2022 Volume 24, Number 8, August 2005\nMeasles Vaccine Effectiveness\n\u00a9 2005 Lippincott Williams & Wilkins\n699\nDownloaded from http://journals.lww.com/pidj by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW\nnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdtwnfKZBYtws= on 01/09/2025", "mimetype": "text/plain", "start_char_idx": 15306, "end_char_idx": 15717, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bf44dac5-4ebb-4605-9ca5-50e4fb922b93": {"__data__": {"id_": "bf44dac5-4ebb-4605-9ca5-50e4fb922b93", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Hungerford (2014).pdf", "node_type": "4", "metadata": {}, "hash": "c5aeac885288b565bb3d3860f3d7396560992264af88e6b0c4025a1ca361e195", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5dcf5578-a39a-4cb6-acf1-6cf1b2d736c9", "node_type": "1", "metadata": {}, "hash": "256beb689e4ee2a987490eebe72eb6444ef7e6ced2365aa4d208a58b7b439c60", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Risk factors for transmission of measles during an\noutbreak: matched caseecontrol study\nD. Hungerford a,*, P. Cleary a, S. Ghebrehewet b, A. Keenan b, R. Vivancos a\na Field Epidemiology Services North West, Public Health England, Liverpool, UK\nb Health Protection Team, Cheshire & Merseyside Public Health England Centre, Public Health England, Liverpool, UK\nA R T I C L E\nI N F O\nArticle history:\nReceived 25 April 2013\nAccepted 20 November 2013\nAvailable online 21 December\n2013\nKeywords:\nEpidemiology\nVaccination\nMeasles\nHospital infection\nInfection control\nS U M M A R Y\nBackground: In 2012, an outbreak of measles occurred in Merseyside, UK with 359\ncon\ufb01rmed cases by 30 June. Numerous cases reported visits to healthcare and social\nsettings.\nAim: To identify risk factors associated with measles transmission during the outbreak.\nMethods: In April 2012, a retrospective matched caseecontrol study was conducted. Fifty-\n\ufb01ve con\ufb01rmed cases and 55 community controls, matched 1:1 for age and geography, were\nselected at random. Data on exposures in the two weeks before illness, including atten-\ndance at a healthcare setting, were collected via telephone interview. Univariate and\nmulti-variate analyses were conducted and odds ratios were calculated.\nFindings: Forty-two cases and 42 matched controls were contacted successfully. Univar-\niate exact conditional logistic regression analysis identi\ufb01ed that cases were more likely to\nhave attended an emergency department, been admitted to hospital and be incompletely\nvaccinated (for age). Multi-variate analysis found three factors to be independently\nassociated with measles infection: incomplete/partial vaccination for age [adjusted odds\nratio (aOR) 22.1, 95% con\ufb01dence interval (CI) 3.8eN, P < 0.001], under age for routine\nvaccination (aOR 20.4, 95% CI 2.0eN, P \u00bc 0.009) and hospital admission (aOR 20.2, 95% CI\n1.4eN, P \u00bc 0.025).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1889, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5dcf5578-a39a-4cb6-acf1-6cf1b2d736c9": {"__data__": {"id_": "5dcf5578-a39a-4cb6-acf1-6cf1b2d736c9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Hungerford (2014).pdf", "node_type": "4", "metadata": {}, "hash": "c5aeac885288b565bb3d3860f3d7396560992264af88e6b0c4025a1ca361e195", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bf44dac5-4ebb-4605-9ca5-50e4fb922b93", "node_type": "1", "metadata": {}, "hash": "a4d5c00df8b48b9dbb2b290c22b52e9e69dd7f8dd7c444736743dc75ee0ecc32", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "56eeed07-6e02-4dad-8928-5fb8db76abbc", "node_type": "1", "metadata": {}, "hash": "a40e99b8dd6c6c467a5de945f34a05c823f6146f2c22b8398b6b5af8bfcdf276", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Conclusions: Incomplete/partial vaccination, under age for routine vaccination and hos-\npital admission were associated with measles infection. These \ufb01ndings highlight the\nimportance of timely vaccination of eligible individuals, early diagnosis, timely isolation of\ncases, and implementation of strict infection control measures.\n\u00aa 2013 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.\nIntroduction\nMeasles is a highly infectious systemic viral disease spread\nby airborne transmission. However, routine vaccination in\nmany developed countries has meant that measles has become\nrelatively uncommon. In England, prior to the introduction of\nmeasles vaccination (i.e. in the 1960s), there were an esti-\nmated 300,000 measles noti\ufb01cations per year and scores of\nassociated deaths.1 Following the introduction of the single-\ndose measles vaccine in 1968, the number of cases of mea-\nsles decreased signi\ufb01cantly, and the introduction of the com-\nbined measles mumps and rubella (MMR) vaccine in 1988\ncontinued this trend.1 Unfortunately, following a high-pro\ufb01le\npaper in 1998 linking the MMR vaccine to autism and the\ndevelopment of bowel disorders, vaccination coverage in En-\ngland declined, reaching as low as 80% in 2003/2004.2,3 The\n* Corresponding author. Address: Field Epidemiology Services North\nWest, Public Health England, 5th Floor, Rail House, Lord Nelson Street,\nLiverpool L11JF, UK. Tel.: \u00fe44 0844 225 1295; fax: \u00fe44 (0) 151 708\n9445.\nE-mail address: daniel.hungerford@phe.gov.uk (D. Hungerford).\nAvailable online at www.sciencedirect.com\nJournal of Hospital Infection\njournal homepage: www.elsevierhealth.com/journals/jhin\n0195-6701/$ e see front matter \u00aa 2013 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.", "mimetype": "text/plain", "start_char_idx": 1890, "end_char_idx": 3676, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "56eeed07-6e02-4dad-8928-5fb8db76abbc": {"__data__": {"id_": "56eeed07-6e02-4dad-8928-5fb8db76abbc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Hungerford (2014).pdf", "node_type": "4", "metadata": {}, "hash": "c5aeac885288b565bb3d3860f3d7396560992264af88e6b0c4025a1ca361e195", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5dcf5578-a39a-4cb6-acf1-6cf1b2d736c9", "node_type": "1", "metadata": {}, "hash": "256beb689e4ee2a987490eebe72eb6444ef7e6ced2365aa4d208a58b7b439c60", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "134513ea-b471-4d90-9124-72539314d3b2", "node_type": "1", "metadata": {}, "hash": "5dc78fd85ee13e0856b5c07d557b70d388b2e318eb397b031eb5abb2e3bb9944", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Published by Elsevier Ltd. All rights reserved.\nhttp://dx.doi.org/10.1016/j.jhin.2013.11.008\nJournal of Hospital Infection 86 (2014) 138e143\nclaims in the paper were later discredited and the paper was\nretracted by the publishers.4,5\nAt the start of the 21st Century, the number of con\ufb01rmed\nmeasles cases in England was as low as approximately 100 per\nyear. This number has since increased, reaching a peak of 1330\ncases in 2008; in 2011, there were 1067 cases (1.7 per 100,000\npopulation).6 During the last 10 years, there have been a\nnumber of small outbreaks across the country, particularly in\ntravelling communities. In recent years, vaccine coverage has\nincreased again (92% in 2011), but this has coincided with an\nincrease in the number of cases of measles.7\nThis caseecontrol study was initiated as part of the wider\npublic health investigation into the largest measles outbreak in\nMerseyside (North West England) since the introduction of the\nMMR vaccine in 1988. The \ufb01rst few cases were seen in January\n2012, and by the end of June, there had been 359 con\ufb01rmed\ncases of measles in the area.8 This compares with an average of\nnine con\ufb01rmed cases per year over the previous \ufb01ve years.9 As\nof the end of June 2012, over one-third of cases were children\naged under \ufb01ve years and 30% of cases were aged 15 years or\nolder.8 Cases were predominantly resident in Liverpool and\nSefton, and were mainly sporadic with a few outbreaks in\nnurseries and family clusters.", "mimetype": "text/plain", "start_char_idx": 3629, "end_char_idx": 5096, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "134513ea-b471-4d90-9124-72539314d3b2": {"__data__": {"id_": "134513ea-b471-4d90-9124-72539314d3b2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Hungerford (2014).pdf", "node_type": "4", "metadata": {}, "hash": "c5aeac885288b565bb3d3860f3d7396560992264af88e6b0c4025a1ca361e195", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "56eeed07-6e02-4dad-8928-5fb8db76abbc", "node_type": "1", "metadata": {}, "hash": "a40e99b8dd6c6c467a5de945f34a05c823f6146f2c22b8398b6b5af8bfcdf276", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "72fee3fd-8000-408b-b5cd-132e6b072d63", "node_type": "1", "metadata": {}, "hash": "a9bdc7f614808d770b042ff58799f7fabe56ff3ae181663ad7a16ed2551a0ff4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Interestingly, the strain identi-\n\ufb01ed in many of the cases was B3, the predominant strain found\non the African continent.10 The B3 strain has been identi\ufb01ed in\ncases from outbreaks in other European countries such as Spain\nin 2011, but it is distinct from strains identi\ufb01ed in other parts of\nEngland during the same time frame as the outbreak in\nMerseyside.8\nIn order to determine the relevant risk factors associated\nwith measles infection/transmission (including community\nsettings), a caseecontrol study was undertaken at an early\nstage of this outbreak. This paper reports the \ufb01ndings of the\ncaseecontrol study.\nMethods\nCase de\ufb01nition and identi\ufb01cation\nA case was de\ufb01ned as a person living in Merseyside with\nmicrobiological con\ufb01rmation of measles (oral \ufb02uid/blood test\nimmunoglobulin M positive or polymerase chain reaction pos-\nitive) between 1 January and 14 March 2012 with no history of\nvaccination within six weeks of diagnosis. Cases were identi-\n\ufb01ed with a computerized case management database, used by\nCheshire & Merseyside Health Protection Team (CMHPT). As\nthe assessment focused on possible transmission settings,\ncases were excluded from the study if they had travelled\noutside of the UK in the two months preceding the onset of\nillness. In total, there were 71 con\ufb01rmed cases of measles in\nMerseyside; one case was excluded from the study due to\ntravel outside of the UK, leaving 70 cases for random alloca-\ntion in the study.\nSelection of controls\nControls were de\ufb01ned as asymptomatic persons (no history\nof fever and rash) with no history of travel outside of the UK in\nthe two months preceding the onset of illness in the matched\ncase. The controls were selected at random, matched by\ngeneral medical practice and age (within one year). To ensure\nthat all cases were matched to an appropriate number of\ncontrols (see below), \ufb01ve potential controls were identi\ufb01ed for\neach case to allow for those who refused to participate or were\nuntraceable; if information could not be obtained for the\nselected control, another control was chosen according to the\nsame principles.", "mimetype": "text/plain", "start_char_idx": 5097, "end_char_idx": 7186, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "72fee3fd-8000-408b-b5cd-132e6b072d63": {"__data__": {"id_": "72fee3fd-8000-408b-b5cd-132e6b072d63", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Hungerford (2014).pdf", "node_type": "4", "metadata": {}, "hash": "c5aeac885288b565bb3d3860f3d7396560992264af88e6b0c4025a1ca361e195", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "134513ea-b471-4d90-9124-72539314d3b2", "node_type": "1", "metadata": {}, "hash": "5dc78fd85ee13e0856b5c07d557b70d388b2e318eb397b031eb5abb2e3bb9944", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bbd96f11-c650-427f-a176-8968ecfd6256", "node_type": "1", "metadata": {}, "hash": "fba9ca8f1db53387203db26965d897f5cb721b6bfb3baa108d52ceabc51b2cc6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Data collection\nAll cases and controls were sent a letter from the CMHPT and\nthe National Health Service (NHS) on behalf of their general\nmedical practitioner, informing them of the purpose of the\nstudy and that they would be contacted by the local public\nhealth team if they agreed to take part. Telephone interviews\nwere undertaken following acquisition of valid consent using an\nagreed script and a structured questionnaire. Information was\ncollected on demographics and vaccination history. Data were\nalso obtained on community and healthcare settings attended\nin the two weeks preceding the onset of illness in the matched\ncase. Therefore, any case participants that were hospital in-\npatients prior to onset were not admitted to hospital due to the\nmeasles virus. Information was collected on demographics,\nvaccination history, community settings visited and attendance\nat healthcare settings. The interviews were conducted with a\nparent or guardian if the case/control was under 16 years of\nage. Data were entered real-time into a con\ufb01dential secure\nweb-based survey tool and database.11\nSample size\nA sample size calculation was conducted to assess the\nnumber of cases and controls needed to achieve a minimum\ndetectable odds ratio of 4 (at 5% signi\ufb01cance level) for a\nmatched study with a caseecontrol ratio of 1:1. Assuming a 50%\nexposure level among controls, a sample size of 39 cases and 39\ncontrols was required to achieve 80% power. As such, 55 cases\nwere selected at random to allow for cases/controls that might\nbe untraceable or refuse to participate.\nStatistical analysis\nTo identify potential risk factors for measles infection,\nexact conditional logistic regression was used to calculate\nmatched crude odds ratios (mOR), 95% con\ufb01dence intervals\n(CIs) and P-values using the likelihood ratio test. Exact condi-\ntional logistic regression was identi\ufb01ed as the most appropriate\ntechnique for a small number of cases and controls. Variables\nthat were signi\ufb01cant at a level of P < 0.2 on univariate analysis\nand/or known to be associated with increased risk of measles\ninfection in the literature were selected for multi-variate\nregression.", "mimetype": "text/plain", "start_char_idx": 7187, "end_char_idx": 9343, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bbd96f11-c650-427f-a176-8968ecfd6256": {"__data__": {"id_": "bbd96f11-c650-427f-a176-8968ecfd6256", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Hungerford (2014).pdf", "node_type": "4", "metadata": {}, "hash": "c5aeac885288b565bb3d3860f3d7396560992264af88e6b0c4025a1ca361e195", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "72fee3fd-8000-408b-b5cd-132e6b072d63", "node_type": "1", "metadata": {}, "hash": "a9bdc7f614808d770b042ff58799f7fabe56ff3ae181663ad7a16ed2551a0ff4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "919f383b-0b84-41a3-a2ab-34ea9c85480f", "node_type": "1", "metadata": {}, "hash": "d66e0dc5127a1ecc84349259d087af8aafb4a9edb67e8d41e5f7b5e49f7417c1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The \ufb01nal model was selected by a forward step-\nwise procedure, and no interaction terms were considered in\nthe analysis because of the sample size and missing data for\nsome variables. Two-sided P-values of <0.05 were considered\nto indicate signi\ufb01cance, and 95% CIs were calculated. All sta-\ntistical analyses were performed using R Version 2.15.0 or\nSTATA Version 12.12,13\nEthics\nAs this study examined an outbreak that had a direct impact\non public health, no ethical approval was required. Cases and\nD. Hungerford et al. / Journal of Hospital Infection 86 (2014) 138e143\n139\ncontrols were contacted by trained health professionals who\nwere speci\ufb01cally aware of the organization\u2019s patient con\ufb01-\ndentially principles and data protection requirements. Valid\nconsent was sought from all participants.\nResults\nForty-two (78% at the time of study) cases and 42 matched\ncontrols were interviewed over a two-week period. It was not\npossible to contact 13 cases who had been allocated to the\nstudy (N \u00bc 55). No cases or controls refused to take part in the\nstudy. The demographic characteristics of cases and controls\nare shown in Table I. No signi\ufb01cant differences in demographic\ncharacteristics were seen between cases and controls.\nUnivariate analysis\nAll potential exposures and risk factors for measles infection\nidenti\ufb01ed through the interviews were investigated in univar-\niate analysis (Figure 1). Age >13 months and incomplete/par-\ntial vaccination for age were signi\ufb01cantly associated (mOR 6.3,\n95% CI 1.9e33.4, P < 0.001) with measles infection. Contact\nwith a measles case (mOR 32.68, 95% CI 5.8eN, P < 0.001) and\nmaternal history of measles (mOR 3.0, 95% CI 1.03e10.6,\nP \u00bc 0.04) were signi\ufb01cantly associated with measles infection.", "mimetype": "text/plain", "start_char_idx": 9344, "end_char_idx": 11081, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "919f383b-0b84-41a3-a2ab-34ea9c85480f": {"__data__": {"id_": "919f383b-0b84-41a3-a2ab-34ea9c85480f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Hungerford (2014).pdf", "node_type": "4", "metadata": {}, "hash": "c5aeac885288b565bb3d3860f3d7396560992264af88e6b0c4025a1ca361e195", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bbd96f11-c650-427f-a176-8968ecfd6256", "node_type": "1", "metadata": {}, "hash": "fba9ca8f1db53387203db26965d897f5cb721b6bfb3baa108d52ceabc51b2cc6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1d48c3f9-98c3-4f1c-b00f-82eaa3ec5c62", "node_type": "1", "metadata": {}, "hash": "0367b078e57c741cf250b29146ef65a8fd5b0601737d943698c43934c3379950", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In terms of the settings attended, attendance at an emergency\ndepartment (mOR 6.0, 95% CI 1.3e55.2, P \u00bc 0.01) and hospital\nadmission (mOR 8.2, 95% CI 1.2eN, P \u00bc 0.03) were signi\ufb01cantly\nassociated with measles infection. However, being under age\nfor vaccination (<14 months) was not signi\ufb01cantly associated\nwith measles infection, although the mOR was elevated.\nMulti-variate analysis\nNine exposures/risk factors were identi\ufb01ed for inclusion\n(P < 0.20) in the multi-variate analysis. Forward stepwise exact\nconditional logistic regression beginning with history of contact\nwith measles as the single predictor variable did not identify\nother variables with a signi\ufb01cant effect when added to the\nmodel. It was then excluded from further models as it was\nproviding a duplicate measure of setting contact and would\nmask any speci\ufb01c setting association. The \ufb01nal multi-variate\nmodel\nidenti\ufb01ed\nincomplete/partial\nvaccination\nfor\nage\n[adjusted odds ratio (aOR) 22.1, 95% CI 3.8eN, <0.001], under\nage for routine vaccination (aOR 20.4, 95% CI 2.0eN,\nP \u00bc 0.009) and hospital admission (aOR 20.2, 95% CI 1.4eN,\nP \u00bc 0.025) as signi\ufb01cant risk factors for measles infection. aORs\nare also shown in Figure 1.\nDiscussion\nThis matched caseecontrol study provides further strong\nevidence that eligible children and young adults who are un-\nimmunized/partially immunized and those who are too young\nto be vaccinated are at signi\ufb01cantly increased risk of measles\ninfection when measles virus is circulating.", "mimetype": "text/plain", "start_char_idx": 11082, "end_char_idx": 12570, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1d48c3f9-98c3-4f1c-b00f-82eaa3ec5c62": {"__data__": {"id_": "1d48c3f9-98c3-4f1c-b00f-82eaa3ec5c62", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Hungerford (2014).pdf", "node_type": "4", "metadata": {}, "hash": "c5aeac885288b565bb3d3860f3d7396560992264af88e6b0c4025a1ca361e195", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "919f383b-0b84-41a3-a2ab-34ea9c85480f", "node_type": "1", "metadata": {}, "hash": "d66e0dc5127a1ecc84349259d087af8aafb4a9edb67e8d41e5f7b5e49f7417c1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "42d785e8-085d-4345-baee-d02b9e4f1bb9", "node_type": "1", "metadata": {}, "hash": "07d7c4753fde113260b64bf84bcbe149facc640e771dd247c615fba316edc449", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "As supported by the\ndescriptive epidemiology of this outbreak, healthcare settings\nare likely to have played an important role in exposure to\nmeasles, transmission and spread, particularly in hospital\ninpatients.8\nAlthough there were a small number of measles outbreaks in\nnurseries and playgroups in Merseyside, these settings were not\nfound to be associated with increased risk of measles infec-\ntion/transmission.\nProtection against measles in those who are too young for\nvaccination is dependent on passive immunity from maternal\nantibodies and/or herd protection. This study found that being\ntoo young for vaccination increased the risk of measles infec-\ntion. The large number of cases in children who were too young\nfor routine vaccination could be explained by early waning of\nmaternal antibodies and lower MMR vaccination coverage in\nchildren and young adults.8,14 Waning of maternal antibodies,\nalthough more rapid in babies born to vaccinated mothers than\nbabies born to naturally immune mothers, is an issue for both\nTable I\nDemographic characteristics of measles cases and matched controls, Merseyside, UK, April 2012. Figures are N (%) (N \u00bc 84)\nCharacteristic\nNumber complete\nCases (N \u00bc 42)\nControls (N \u00bc 42)\nAge (months)\n84\nMedian\n16\n15.5\nLower quartile\n10\n10\nUpper quartile\n76\n77.5\nSex (male)\n84\n22 (52)\n15 (36)\nVaccination status\n83\nVaccinated appropriately for age\n5 (12)\n23 (56)\nIncompletely/partially vaccinated for age (>13 months)\n22 (52)\n6 (15)\nUnder age for vaccination (<14 months)\n15 (36)\n12 (29)\nHad contact with a measles case\n81\n26 (65)\n2 (5)\nNo. of children aged under \ufb01ve years in household\n84\nMedian\n1\n1\nLower quartile\n0\n0\nUpper quartile\n1\n1\nMaternal age\n79\nMedian\n30.8\n30.8\nLower quartile\n25.2\n26.2\nUpper quartile\n34.7\n38\nD. Hungerford et al. / Journal of Hospital Infection 86 (2014) 138e143\n140\ngroups.", "mimetype": "text/plain", "start_char_idx": 12571, "end_char_idx": 14408, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "42d785e8-085d-4345-baee-d02b9e4f1bb9": {"__data__": {"id_": "42d785e8-085d-4345-baee-d02b9e4f1bb9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Hungerford (2014).pdf", "node_type": "4", "metadata": {}, "hash": "c5aeac885288b565bb3d3860f3d7396560992264af88e6b0c4025a1ca361e195", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1d48c3f9-98c3-4f1c-b00f-82eaa3ec5c62", "node_type": "1", "metadata": {}, "hash": "0367b078e57c741cf250b29146ef65a8fd5b0601737d943698c43934c3379950", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5d3bfec2-5b71-4765-a2b0-c7ddcd62b72d", "node_type": "1", "metadata": {}, "hash": "54f34f3d829bb49f7e810c86f92c5475648a8072e9bb98c388a79ae22156c518", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "/ Journal of Hospital Infection 86 (2014) 138e143\n140\ngroups. A recent study showed that over 95% of infants in both\naforementioned groups had lost immunity by six months of\nage.14\nUnsurprisingly, in other outbreaks of measles reported in\nthe literature, the majority of cases were incompletely/\npartially vaccinated for age.15,16 The results from this casee\ncontrol study support this evidence, and show that although\nvaccination coverage in the caseecontrol study area was\nrelatively high, with 91% coverage for one dose at 24 months\nand 86% coverage for two doses at \ufb01ve years, it needs to be\nimproved and sustained.7 It should be noted that since the\noutbreak started, vaccination coverage in the study area has\nincreased to 96% for one dose at 24 months and 91% for two\ndoses at \ufb01ve years.7 This increase is likely to have been in\ufb02u-\nenced by greater vaccination efforts and media coverage of the\noutbreak.8 This, however, is still below the goal of 95%\ncoverage for two doses set by the World Health Organization\nEuropean Region to eradicate measles transmission by 2015.17\nIt is important to recognize that vaccination uptake does not\nconsider cohorts of children who may have missed vaccination\nin previous years; these cohorts continue to accumulate and\nform a large subsection of the population in areas as densely\npopulated as Merseyside. This study and descriptive epidemi-\nology of the outbreak show that a number of cases were in this\ncategory.8\nMost other studies looking at measles exposure in health-\ncare settings have implicated emergency departments as a risk\nfor outbreak spread.18e22 This study identi\ufb01ed an independent\nsigni\ufb01cant association between measles infection and hospital\nadmission.", "mimetype": "text/plain", "start_char_idx": 14347, "end_char_idx": 16061, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5d3bfec2-5b71-4765-a2b0-c7ddcd62b72d": {"__data__": {"id_": "5d3bfec2-5b71-4765-a2b0-c7ddcd62b72d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Hungerford (2014).pdf", "node_type": "4", "metadata": {}, "hash": "c5aeac885288b565bb3d3860f3d7396560992264af88e6b0c4025a1ca361e195", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "42d785e8-085d-4345-baee-d02b9e4f1bb9", "node_type": "1", "metadata": {}, "hash": "07d7c4753fde113260b64bf84bcbe149facc640e771dd247c615fba316edc449", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3804c975-701b-4618-8e08-551b81157a58", "node_type": "1", "metadata": {}, "hash": "6453a5f8ef41876ce94818fe4beadfafb46b04bc021e6a7ef8639b53acd22148", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The opportunity for the transmission of airborne\ndiseases such as measles is high in healthcare settings, and this\nrisk is increased as a highly infectious disease such as measles is\ndif\ufb01cult\nto\ndifferentiate\nclinically\nfrom\nother\nviral\nin-\nfections.8,20 Outbreaks reported in the literature, particularly\nin the USA, have highlighted that clinicians have limited\nexperience with measles due to high vaccination coverage and\nrarity of outbreaks, contributing to delays in diagnosis and\nappropriate isolation procedures.21,22 Measles cases are also\nuncommon in the UK, and it is possible that similar issues\noccurred during this outbreak.\nThis caseecontrol study found that hospital admission was\nindependently\nassociated\nwith\nmeasles\ninfection/trans-\nmission. However, it is dif\ufb01cult to distinguish between patients\nwho were exposed in emergency departments and patients\nwho were exposed in inpatient departments, as most in-\npatients are admitted through an emergency department.\nNevertheless, inpatients would have had a longer length of\nstay, providing a longer duration for exposure to a measles case\nand possibly more time to come into contact with an infected\nperson.\nAlthough targeted by routine vaccination, children under\n\ufb01ve years of age remain the highest risk group for measles\ninfection, and outbreaks continue to occur despite relatively\nhigh uptake of the MMR vaccine. However, these uptake rates\nare short of the 95% target recommended for attaining herd\nprotection. As this study implies, cohorts of unvaccinated/\npartially vaccinated children continue to accumulate, resulting\nin an increased risk of measles infection and outbreaks.\nConsequently, children too young for routine vaccination (<14\nmonths) do not have the protection afforded by herd immunity.\nAlthough appropriate in smaller contextual outbreaks, bringing\nforward the vaccination of children who were under age for the\n\ufb01rst dose of the MMR vaccine was not considered applicable in\nthis outbreak.8 Therefore, the continued concerted effort of\nhealthcare professionals and the media to promote immuni-\nzation is critical to reduce missed/avoided routine vaccination\nand meet the 95% target.", "mimetype": "text/plain", "start_char_idx": 16062, "end_char_idx": 18233, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3804c975-701b-4618-8e08-551b81157a58": {"__data__": {"id_": "3804c975-701b-4618-8e08-551b81157a58", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Hungerford (2014).pdf", "node_type": "4", "metadata": {}, "hash": "c5aeac885288b565bb3d3860f3d7396560992264af88e6b0c4025a1ca361e195", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5d3bfec2-5b71-4765-a2b0-c7ddcd62b72d", "node_type": "1", "metadata": {}, "hash": "54f34f3d829bb49f7e810c86f92c5475648a8072e9bb98c388a79ae22156c518", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "17b5a8b3-1598-4065-bcd3-763b96fc7967", "node_type": "1", "metadata": {}, "hash": "a41d5a75ccd0bb6c748e44c106f69e681969d6c743f1b0a3d9eef159ac2773dd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Catch-up MMR immunization cam-\npaigns in children between \ufb01ve and 18 years have had varied\nGender\nUnder age for vaccination (<14 months)\n>13 months incompletely/partially vaccinated for age\nContact with a measles case\nEmergency department\nClasses\nClub\nCollege\nGP\nHospital inpatient\nHospital outpatient\nInfant school\nJunior school\nLeisure centre\nNursery\nOut-of-hours GP\nParty\nPlace of worship\nPlay centre\nSecondary school\nSupermarket\nChildren centres\nUniversity\nWalk-in-centre\n0.1\n1.0\n10.0\n100.0\n200.0\n300.0\nMatched odds ratio\nPotential risk factor\nFigure 1. Univariate and multi-variate analysis of exposures/risk factors for measles infection. Adjusted OR (red line), adjusted odds\nratio; crude mOR (blue line), crude matched odds ratio; GP, general practitioner.\nD. Hungerford et al. / Journal of Hospital Infection 86 (2014) 138e143\n141\nsuccess, but lessons learned from previous campaigns should\nhelp to increase their success in the future.23e25 It is important\nthat these strategies, especially school MMR catch-up pro-\ngrammes, are given higher priority.\nHealthcare settings also contribute to measles transmission,\nas shown in this caseecontrol study. In order to reduce trans-\nmission, it is critical to increase measles awareness among\npractitioners to ensure rapid diagnosis, early isolation of cases,\nand implementation of enhanced infection control measures.\nAlthough not investigated in this caseecontrol study, other\nstudies have shown the importance of healthcare worker im-\nmunity in the reduction of transmission.20e22 The MMR vacci-\nnation status of front-line healthcare workers was also found to\nbe a signi\ufb01cant issue in the Merseyside outbreak covered by this\nstudy.26 It is recommended that evidence of immunity against\nmeasles/MMR\nvaccination\nstatus\nof\nfront-line\nhealthcare\nworkers should be identi\ufb01ed, recorded and accessible.\nStrengths and limitations\nAny selection bias was minimized as cases were selected at\nrandom, and over half of all con\ufb01rmed cases (42/71) at the\ntime of study took part with no refusals to participate. Controls\nwere matched by general medical practice and age.", "mimetype": "text/plain", "start_char_idx": 18234, "end_char_idx": 20346, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "17b5a8b3-1598-4065-bcd3-763b96fc7967": {"__data__": {"id_": "17b5a8b3-1598-4065-bcd3-763b96fc7967", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Hungerford (2014).pdf", "node_type": "4", "metadata": {}, "hash": "c5aeac885288b565bb3d3860f3d7396560992264af88e6b0c4025a1ca361e195", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3804c975-701b-4618-8e08-551b81157a58", "node_type": "1", "metadata": {}, "hash": "6453a5f8ef41876ce94818fe4beadfafb46b04bc021e6a7ef8639b53acd22148", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3e0f98b4-e9e0-4a2d-b10e-d9cc2e57c8e2", "node_type": "1", "metadata": {}, "hash": "cd69ff8f969228be174fbfa4c53310385ef1311f6fee0251cb34a1ebbbab20d1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Controls\nwere matched by general medical practice and age. General\nmedical practice was used as a proxy of a participant\u2019s area of\nresidence, and because it provided a method for rapid identi-\n\ufb01cation of age-matched controls. However, when using this\nmethod to match area of residence, it is possible that some\nparticipants may be registered with a general medical practice\nin another residential area, and therefore not be appropriately\nmatched in terms of area of residence. Analysis of the partic-\nipants\u2019 postcodes revealed that this was not an issue in this\nsample, and should not have affected the \ufb01nal analyses.\nData quality and completeness were high for both cases and\ncontrols, and this was helped by the fact that case de-\nmographics and travel status were already available through\nthe case management system. One participant had no recorded\nvaccination status; as such, they were excluded from the uni-\nvariate and multi-variate analyses that included this variable.\nUse of a retrospective interview method meant that recall\nbias could have been an issue, particularly for controls, as\nparticipants were asked to recall events which may have\nhappened up to three months prior to their interview. Attempts\nwere made to minimize recall bias by shortening the time be-\ntween presentation of illness and data collection as much as\npossible.\nAlthough the study sample size met the minimum de\ufb01ned by\nthe sample size calculation, it remains relatively small,\nexplaining the wide CIs presented. Therefore, when used in\nisolation, the outcomes of this study should be interpreted with\ncaution.", "mimetype": "text/plain", "start_char_idx": 20288, "end_char_idx": 21885, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3e0f98b4-e9e0-4a2d-b10e-d9cc2e57c8e2": {"__data__": {"id_": "3e0f98b4-e9e0-4a2d-b10e-d9cc2e57c8e2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Hungerford (2014).pdf", "node_type": "4", "metadata": {}, "hash": "c5aeac885288b565bb3d3860f3d7396560992264af88e6b0c4025a1ca361e195", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "17b5a8b3-1598-4065-bcd3-763b96fc7967", "node_type": "1", "metadata": {}, "hash": "a41d5a75ccd0bb6c748e44c106f69e681969d6c743f1b0a3d9eef159ac2773dd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fe384b07-e257-40c0-9b64-51b321179104", "node_type": "1", "metadata": {}, "hash": "e654c3daa5ba12ac7e318fcb1b05e09151471d9ac0dcd39eff42077dbb467112", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Therefore, when used in\nisolation, the outcomes of this study should be interpreted with\ncaution.\nAcknowledgements\nThe authors wish to thank all study participants, the in-\nterviewers (Kemi Adeyemi, Elspeth Anwar, Jennie Day, Akinlua\nJames, Sarah Kinsella, Rebecca Mason, Nancy Medley, Frank\nRugman, Wendy Storey, Helen Stubbs), NHS Central Operation\n(Mersey), Cheshire & Merseyside Health Protection Team\n(HPT), and all the other individuals and organizations involved\nin the outbreak: general practitioners in Merseyside; Rob\nBarnett (Liverpool LMC Secretary); Aintree University Hospital;\nAlder Hey Children\u2019s Hospital; Liverpool Community Health;\nLiverpool Women\u2019s Hospital; Royal Liverpool & Broadgreen\nUniversity Hospital; St Helens & Knowsley NHS Trust; Halton &\nSt Helens Primary Care Trust (PCT); Knowsley PCT; Liverpool\nPCT; Sefton PCT; Wirral PCT; North West Public Health\nTrainees; Cumbria & Lancashire HPT; Greater Manchester HPT;\nPHE Immunisation Division; PHE Laboratory Manchester; and\nPHE Field Epidemiology Services.\nCon\ufb02ict of interest statement\nNone declared.\nFunding source\nNone.\nReferences\n1. Health Protection Agency. Measles noti\ufb01cations and deaths in\nEngland\nand\nWales,\n1940e2008.\nLondon:\nHealth\nProtection\nAgency; 2010.\n2. Wake\ufb01eld AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular\nhyperplasia, non-speci\ufb01c colitis, and pervasive developmental\ndisorder in children. Lancet 1998;351:637e641.\n3. Health Protection Agency. Completed primary courses at two\nyears of age: England and Wales, 1966e1977, England only 1978\nonwards. London: Health Protection Agency; 2011.\n4. Farrington CP, Miller E, Taylor B. MMR and autism: further evi-\ndence against a causal association. Vaccine 2001;19:3632e3635.\n5. Retraction.", "mimetype": "text/plain", "start_char_idx": 21788, "end_char_idx": 23527, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fe384b07-e257-40c0-9b64-51b321179104": {"__data__": {"id_": "fe384b07-e257-40c0-9b64-51b321179104", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Hungerford (2014).pdf", "node_type": "4", "metadata": {}, "hash": "c5aeac885288b565bb3d3860f3d7396560992264af88e6b0c4025a1ca361e195", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3e0f98b4-e9e0-4a2d-b10e-d9cc2e57c8e2", "node_type": "1", "metadata": {}, "hash": "cd69ff8f969228be174fbfa4c53310385ef1311f6fee0251cb34a1ebbbab20d1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d15e755d-2f8a-4d76-960a-7cdfd366f768", "node_type": "1", "metadata": {}, "hash": "d6ee12d85551d4a0506c87b8645446a0bbb2a155ead2c14867179e20a895f28e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Farrington CP, Miller E, Taylor B. MMR and autism: further evi-\ndence against a causal association. Vaccine 2001;19:3632e3635.\n5. Retraction. Ileal-lymphoid-nodular hyperplasia, non-speci\ufb01c coli-\ntis, and pervasive developmental disorder in children. Lancet\n2010;375:445.\n6. Health Protection Agency. Con\ufb01rmed cases of measles by region\nand age: 1996e2011. London: Health Protection Agency; 2012.\n7. Health Protection Agency. Quarterly vaccine coverage data.\nLondon: Health Protection Agency; 2012.\n8. Vivancos R, Keenan A, Farmer S, et al. An ongoing large outbreak\nof measles in Merseyside, England, January to June 2012. Euro\nSurveill 2012;17, pii: 20226.\n9. Cheshire and Merseyside Health Protection Unit. Local surveil-\nlance data. Liverpool: Cheshire and Merseyside Health Protection\nUnit; 2012.\n10. World Health Organization. Measles virus nomenclature update:\n2012. Wkly Epidemiol Rec 2012;87:73e80.\n11. Classapps.SelectSurvey.Net.OverlandPark,Kansas:Classapps;2012.\n12. R Core Team. R: a language and environment for statistical\ncomputing. Vienna: R Foundation for Statistical Computing; 2012.\n13. StataCorp. Stata Statistical Software: Release 10. College Station,\nTexas: StataCorp; 2007.\n14. Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P.\nEarly waning of maternal measles antibodies in era of measles\nelimination: longitudinal study. BMJ 2010;340:c1626.\n15. Gee S, Cotter S, O\u2019Flanagan D. Spotlight on measles 2010: measles\noutbreak in Ireland 2009e2010. Euro Surveill 2010;15, pii: 19500.\n16.", "mimetype": "text/plain", "start_char_idx": 23386, "end_char_idx": 24903, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d15e755d-2f8a-4d76-960a-7cdfd366f768": {"__data__": {"id_": "d15e755d-2f8a-4d76-960a-7cdfd366f768", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Hungerford (2014).pdf", "node_type": "4", "metadata": {}, "hash": "c5aeac885288b565bb3d3860f3d7396560992264af88e6b0c4025a1ca361e195", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fe384b07-e257-40c0-9b64-51b321179104", "node_type": "1", "metadata": {}, "hash": "e654c3daa5ba12ac7e318fcb1b05e09151471d9ac0dcd39eff42077dbb467112", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "92239001-9bd2-4976-9234-ce57245bee53", "node_type": "1", "metadata": {}, "hash": "8c1062b0453670001bfe22764e439f1a77c17ce4e37a1b526661f2cef0d9ba0a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Euro Surveill 2010;15, pii: 19500.\n16. Tagarro Garc\u0131\u00b4a A, Jime\u00b4nez Bueno S, Herreros Ferna\u00b4ndez ML, et al.\nOutbreak of measles in the population of Spanish origin in North\nMadrid. An Pediatr (Barc) 2012;76:350e354.\n17. World Health Organization. Eliminating measles and rubella.\nFramework for the veri\ufb01cation process in the WHO European\nRegion. Copenhagen: WHO Regional Of\ufb01ce for Europe; 2012.\n18. Farizo KM, Stehr-Green PA, Simpson DM, Markowitz LE. Pediatric\nemergency room visits: a risk factor for acquiring measles. Pedi-\natrics 1991;87:74e79.\n19. Bowen AC, Ferson MJ, Palasanthiran P. Consequences of an un-\nrecognized measles exposure in an emergency department. Emerg\nMed Australas 2009;21:491e496.\nD. Hungerford et al. / Journal of Hospital Infection 86 (2014) 138e143\n142\n20. Weston KM, Dwyer DE, Ratnamohan M, et al. Nosocomial and\ncommunity transmission of measles virus genotype D8 imported by\na returning traveller from Nepal. Commun Dis Intell 2006;\n30:358e365.\n21. Chen SY, Anderson S, Kutty PK, et al. Health care-associated mea-\nsles outbreak in the United States after an importation: challenges\nand economic impact. J Infect Dis 2011;203:1517e1525.\n22. Centers for Disease Control and Prevention. Hospital-associated\nmeasles outbreak e Pennsylvania, MarcheApril 2009. MMWR Morb\nMortal Wkly Rep 2012;61:30e32.\n23. Roberts RJ, Sandifer QD, Evans MR, Nolan-Farrell MZ, Davis PM.\nReasons for non-uptake of measles, mumps, and rubella catch up\nimmunisation in a measles epidemic and side effects of the vac-\ncine. BMJ 1995;310:1629e1632.\n24. Health Protection Agency.", "mimetype": "text/plain", "start_char_idx": 24865, "end_char_idx": 26447, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "92239001-9bd2-4976-9234-ce57245bee53": {"__data__": {"id_": "92239001-9bd2-4976-9234-ce57245bee53", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Hungerford (2014).pdf", "node_type": "4", "metadata": {}, "hash": "c5aeac885288b565bb3d3860f3d7396560992264af88e6b0c4025a1ca361e195", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d15e755d-2f8a-4d76-960a-7cdfd366f768", "node_type": "1", "metadata": {}, "hash": "d6ee12d85551d4a0506c87b8645446a0bbb2a155ead2c14867179e20a895f28e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BMJ 1995;310:1629e1632.\n24. Health Protection Agency. CAPITAL CATCH-UP: MMR catch-up\nvaccination campaigns by London primary care trusts, winter\n2004e2005. Evaluation report of the Campaign Regional Technical\nPlanning Group. London: Health Protection Agency; 2007.\n25. Lashkari HP, El Bashir H. Immunisations among school leavers: is\nthere a place for measles-mumps-rubella vaccine? Euro Surveill\n2010;15, pii: 19555.\n26. Lamden K, Vivancos R, McCann R, Ghebrehewet S. Why is measles\nso dif\ufb01cult? Re: Measles epidemic exposes inadequate vaccination\ncoverage in Pakistan. BMJ 2013;346:f245.\nD. Hungerford et al. / Journal of Hospital Infection 86 (2014) 138e143\n143", "mimetype": "text/plain", "start_char_idx": 26394, "end_char_idx": 27058, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "89a3dc0c-a05e-4c99-a895-af0b483f0de4": {"__data__": {"id_": "89a3dc0c-a05e-4c99-a895-af0b483f0de4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "820ee6ce-6632-495e-9e65-51f2dca8bd47", "node_type": "1", "metadata": {}, "hash": "c1239054d9468bc90857c3cb5be79f34dc58adc1f886593ce1f9c38d263238f6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "www.thelancet.com/infection   Vol 19   March 2019\t\n287\nArticles\nProtection against varicella with two doses of combined \nmeasles-mumps-rubella-varicella vaccine or one dose of \nmonovalent varicella vaccine: 10-year follow-up of a \nphase 3 multicentre, observer-blind, randomised, \ncontrolled trial\nMichael Povey, Ouzama Henry, Marianne A Riise Bergsaker, Roman Chlibek, Susanna Esposito, Carl-Erik Flodmark, Leif Gothefors, Sorin Man, \nSven-Arne Silfverdal, M\u00e1ria \u0160tefkovi\u010dov\u00e1, Vytautas Usonis, Jacek Wysocki, Paul Gillard, Roman Prymula\nSummary\nBackground The duration of protection provided by varicella vaccines is unclear. We assessed the 10-year vaccine \nefficacy of two doses of a combined measles-mumps-rubella-varicella vaccine (MMRV), one live attenuated varicella \nvaccine (V) dose given after one measles-mumps-rubella vaccine (MMR) dose (MMR\u2009+\u2009V), versus two MMR doses \n(control vaccine) for the prevention of confirmed varicella.\nMethods This was a phase 3b follow-up of an observer-blinded, randomised, controlled trial. In phase a, children aged \n12\u201322 months (at first vaccination) from Czech Republic (Czechia), Greece, Italy, Lithuania, Norway, Poland, Romania, \nRussia, Slovakia, and Sweden were randomly assigned by computer-generated randomisation list (3:3:1) to receive \ntwo doses of MMRV, one dose of MMR and one dose of varicella vaccine, or two doses of MMR, 42 days apart. \nVaricella cases were confirmed by detection of viral DNA, or epidemiological link and clinical assessment, by an \nindependent data monitoring committee; disease severity was based on a modified V\u00e1zquez scale. Hazard ratios for \nMMRV and MMR\u2009+\u2009V versus MMR estimated in the per-protocol cohort using a Cox proportional hazards regression \nmodel were used to calculate vaccine efficacy and 95% CI. Serious adverse events were recorded throughout the study \nin all vaccinated children. Study objectives were secondary and descriptive.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1932, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "820ee6ce-6632-495e-9e65-51f2dca8bd47": {"__data__": {"id_": "820ee6ce-6632-495e-9e65-51f2dca8bd47", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "89a3dc0c-a05e-4c99-a895-af0b483f0de4", "node_type": "1", "metadata": {}, "hash": "169450305b365246fa207dad3cd9bf1a23184d2cc1dcdb4837389ad3be469e67", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "414314c9-27c0-4f37-afca-9781873930d7", "node_type": "1", "metadata": {}, "hash": "76e72accb346333c8089fc52d5f23dc26b78b329f56572524f887e349643647c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Serious adverse events were recorded throughout the study \nin all vaccinated children. Study objectives were secondary and descriptive. The trial is registered at ClinicalTrials.gov, \nnumber NCT00226499.\nFindings Between Sept 1, 2005, and May 10, 2006, 5803 children (mean age 14\u00b72 months, SD 2\u00b75) were vaccinated. \nThe per-protocol cohort included 2279 children from the MMRV group, 2266 from the MMR\u2009+\u2009V group, and 744 from \nthe MMR group. From baseline to a median follow-up of 9\u00b78 years, 76 (3%) children in the MMRV group, 469 (21%) \nin the MMR\u2009+\u2009V group, and 352 (47%) in the MMR group had varicella. Vaccine efficacy against all varicella was \n95\u00b74% (95% CI 94\u00b70\u201396\u00b74) for MMRV and 67\u00b72% (62\u00b73\u201371\u00b75) for MMR\u2009+\u2009V; vaccine efficacy against moderate or \nsevere varicella was 99\u00b71% (97\u00b79\u201399\u00b76) for MMRV and 89\u00b75% (86\u00b71\u201392\u00b71) for MMR\u2009+\u2009V. During phase b, \nserious adverse events were reported by 290 (15%) of 1961 children in the MMRV group, 317 (16%) of 1978 in the \nMMR\u2009+\u2009V group, and 93 (15%) of 641 in the MMR group. There were no treatment-related deaths.\nInterpretation The 10-years vaccine efficacy observed, suggests that a two-dose schedule of varicella vaccine provided \noptimum long-term protection for the prevention of varicella by offering individual protection against all severities of \ndisease and leading to a potential reduction in transmission, as observed in the US experience with universal mass \nvaccination.\nFunding GlaxoSmithKline Biologicals.\nCopyright \u00a9 2019 Elsevier Ltd. All rights reserved.", "mimetype": "text/plain", "start_char_idx": 1797, "end_char_idx": 3319, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "414314c9-27c0-4f37-afca-9781873930d7": {"__data__": {"id_": "414314c9-27c0-4f37-afca-9781873930d7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "820ee6ce-6632-495e-9e65-51f2dca8bd47", "node_type": "1", "metadata": {}, "hash": "c1239054d9468bc90857c3cb5be79f34dc58adc1f886593ce1f9c38d263238f6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "76711df1-632e-4048-97f1-545d4d5bf743", "node_type": "1", "metadata": {}, "hash": "6d9c2dd5ac725eb81c2c51aecdcfe3e2fa8912a0cdd0ad8e86f424d39c904a03", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Funding GlaxoSmithKline Biologicals.\nCopyright \u00a9 2019 Elsevier Ltd. All rights reserved.\nIntroduction\nAfter the introduction of universal vaccination of children \nagainst varicella using a one-dose schedule in the USA \nand other countries, the incidence of varicella cases and \nassociated admissions to hospital and deaths substantially \ndeclined.1\u20134 A two-dose live varicella vaccine schedule \nwas recommended by the USA\u2019s Advisory Committee \non Immunization Practices in 2007, for the active \nimmunisation of children aged 9 months or older, which \nfurther decreased the incidence of varicella.5 Vaccination \nschedules could include a monovalent live attenuated \nvaricella vaccine (V), or a combination measles-mumps-\nrubella-varicella vaccine (MMRV).5\u20137 Previous studies \nhave shown comparable antibody responses after \ndose two, whether this was administered 6\u201312 weeks or \n3\u20136 years after dose one.8 Although monovalent varicella \nvaccine can be given together with other childhood \nvaccines at separate injection sites, the use of a combined \nLancet Infect Dis 2019; \n19: 287\u201397\nPublished Online \nFebruary 11, 2019 \nhttp://dx.doi.org/10.1016/ \nS1473-3099(18)30716-3\nThis online publication has \nbeen corrected. The corrected \nversion first appeared at \nthelancet.com/infection on \nJanuary 29, 2020\nSee Comment page 222\nGlaxoSmithKline, Wavre, \nBelgium (M Povey MSc; \nP Gillard MD); GlaxoSmithKline, \nRockville, MD, USA \n(O Henry MD); Division of \nHealth Services, Department of \nGlobal Health, Norwegian \nInstitute of Public Health, \nOslo, Norway \n(M A Riise Bergsaker MD); \nUniversity of Defence, Faculty \nof Military Health Sciences, \nHradec Kralove, Czech Republic \n(Prof R Chlibek MD; \nProf R Prymula MD); Pediatric \nClinic, Department of Surgical \nand Biomedical Sciences, \nUniversit\u00e0 degli Studi di \nPerugia, Perugia, Italy \n(S Esposito MD); Department of \nPaediatrics, Sk\u00e5nes University \nHospital,", "mimetype": "text/plain", "start_char_idx": 3231, "end_char_idx": 5141, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "76711df1-632e-4048-97f1-545d4d5bf743": {"__data__": {"id_": "76711df1-632e-4048-97f1-545d4d5bf743", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "414314c9-27c0-4f37-afca-9781873930d7", "node_type": "1", "metadata": {}, "hash": "76e72accb346333c8089fc52d5f23dc26b78b329f56572524f887e349643647c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "22185fb8-05a9-4c9c-a06c-17bb9d01e683", "node_type": "1", "metadata": {}, "hash": "03ab31b6f69dcef72ba52c0090bb061148a082d1eea06491d695bf447efcee16", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Department of Surgical \nand Biomedical Sciences, \nUniversit\u00e0 degli Studi di \nPerugia, Perugia, Italy \n(S Esposito MD); Department of \nPaediatrics, Sk\u00e5nes University \nHospital, Malmo, Sweden \n(C-E Flodmark MD); The Public \nHealth Agency of Sweden and \nDepartment of Clinical \nSciences/Pediatrics, Ume\u00e5 \nUniversity, Ume\u00e5, Sweden \n(L Gothefors MD); 3rd Pediatric \nDepartment, Iuliu Ha\u021bieganu \nUniversity of Medicine and \nPharmacy, Cluj-Napoca, \nRomania (Prof S Man MD); \nClinical Sciences, Pediatrics, \nUme\u00e5 University, Ume\u00e5, \nSweden (S-A Silfverdal MD); \nFaculty of Health Care, \nAlexander Dub\u010dek University of \nTren\u010d\u00edn, Tren\u010d\u00edn, Slovakia \n(M \u0160tefkovi\u010dov\u00e1 MD); Clinic of \nChildren\u2019s Diseases, Institute of\nArticles\n288\t\nwww.thelancet.com/infection   Vol 19   March 2019\n Clinical Medicine, Faculty of \nMedicine, Vilnius University, \nVilnius, Lithuania \n(Prof V Usonis MD); Department \nof Preventive Medicine, Poznan \nUniversity of Medical Sciences, \nPoznan, Poland \n(Prof J Wysocki MD); and Charles \nUniversity, Faculty of Medicine \nin Hradec Kralove, Department \nof Social Medicine, Hradec \nKralove, Czech Republic \n(Prof R Prymula MD)\nCorrespondence to: \nMr Michael Povey, \nGlaxoSmithKline, Wavre 1300, \nBelgium \nmichael.x.povey@gsk.com\nMMRV reduces the number of injections and is reported \nto improve vaccine uptake.9,10\nIn a previously published phase 3a, randomised, \nobserver-blinded, multicentre study, 5803 children were \nvaccinated during the second year of life 42 days apart \nwith two doses of MMRV (MMRV group), or one dose of \nmeasles-mumps-rubella vaccine (MMR) then one dose \nof varicella vaccine (V; MMR\u2009+\u2009V group), or two doses of \nMMR control vaccine (MMR group).", "mimetype": "text/plain", "start_char_idx": 4966, "end_char_idx": 6646, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "22185fb8-05a9-4c9c-a06c-17bb9d01e683": {"__data__": {"id_": "22185fb8-05a9-4c9c-a06c-17bb9d01e683", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "76711df1-632e-4048-97f1-545d4d5bf743", "node_type": "1", "metadata": {}, "hash": "6d9c2dd5ac725eb81c2c51aecdcfe3e2fa8912a0cdd0ad8e86f424d39c904a03", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1bbc4280-b997-499d-bc46-d6d350230ee6", "node_type": "1", "metadata": {}, "hash": "a0e70099ff3c67a409d4230728ec9fca7833bd3de7f964d80d01898538d75c77", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MMR\u2009+\u2009V group), or two doses of \nMMR control vaccine (MMR group).11 The study was \ndone in countries with endemic varicella among children \naged 12\u201322 months, but without recommendation for the \nvaccination of children against varicella.\nDuring a mean follow-up of about 3 years, the attack \nrate in the control group was of 10\u00b74 per 100 person-years \n(201 events) and 0\u00b76 per 100 person-years (37 events) in \nthe MMRV group.11 The observed vaccine efficacy against \nvaricella of 94\u00b79% with two doses of MMRV was \nconsistent with previous estimates of vaccine efficacy \nwith two-dose schedules of MMRV (91%) or monovalent \nvaricella vaccine (98%).12,13 The varicella attack rate in the \nMMR\u2009+\u2009V group was 3\u00b78 per 100 person-years (243 events) \nand the observed vaccine efficacy of 65\u00b74% was consistent \nwith the effectiveness estimate of 72% from a meta-\nanalysis of one-dose monovalent varicella vaccines given \nduring a varicella outbreak.14\nAfter completing the 3-year follow-up in phase 3a, \nchildren entered phase 3b, which included assessments \nup to 10 years follow-up. At 6 years (median 6\u00b74 years), \nthe vaccine efficacy for two-dose MMRV was 95\u00b70% \nagainst all varicella and 99\u00b70% against moderate or \nsevere varicella, and for MMR\u2009+\u2009V was 67\u00b70% against all \nvaricella and 90\u00b73% against moderate or severe varicella. \nIn the majority of children, immune responses at 6 years \nagainst varicella zoster virus were above the threshold for \nseroconversion.15\nThe observed vaccine efficacy for protection against \nall varicella at years 3 and 6 follow-up supported the use \nof two-dose MMRV over one-dose MMR\u2009+\u2009V, although it \nwas not known whether the vaccines offered long-term \nprotection or deferred the appearance of moderate or \nsevere disease.", "mimetype": "text/plain", "start_char_idx": 6581, "end_char_idx": 8336, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1bbc4280-b997-499d-bc46-d6d350230ee6": {"__data__": {"id_": "1bbc4280-b997-499d-bc46-d6d350230ee6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "22185fb8-05a9-4c9c-a06c-17bb9d01e683", "node_type": "1", "metadata": {}, "hash": "03ab31b6f69dcef72ba52c0090bb061148a082d1eea06491d695bf447efcee16", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eb35fe5a-e72c-46af-a5a9-4609a133ecbc", "node_type": "1", "metadata": {}, "hash": "bc0d339014fc0601c2995f926911bf35903e122120af0388d6396f56ce8bd8ec", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In this report from phase b of the study, \nwe describe vaccine efficacy and antibody persistence \nResearch in context\nEvidence before this study\nSeveral countries recommend the universal vaccination of \nchildren against varicella using monovalent varicella \nvaccine (V), given together with other childhood vaccines at \nseparate injection sites, or as a combined \nmeasles-mumps-rubella-varicella vaccine (MMRV). A PubMed \nsearch on May 15, 2018, of \u201cMMRV\u201d identified three systematic \nreviews and meta-analyses, among which the most up-to-date \nwas a meta-analysis of the effectiveness, immunogenicity and \nsafety of one-dose versus two-dose varicella vaccination, based \non studies published between Jan 1, 1995, and June 30, 2017. \nThe meta-analysis showed that the two-dose varicella \nvaccination schedule was more immunogenic and more \neffective at preventing varicella disease than one dose of \nvaricella vaccine. For two doses versus one dose of varicella \nvaccine, vaccine effectiveness increased by 79% in randomised \ncontrolled trials (RCTs), 63% in cohort studies, and 81% in \ncase-control studies. Direct evidence for a protective effect was \nprovided by two RCTs that compared the vaccine efficacy of \none-dose and two-dose varicella vaccine schedules. The \nfirst RCT to compare the dosing schedules was done before \nvaricella vaccine was licensed in 1995, meaning that disease \nexposure and transmission was high. In the most recent RCT \nto provide efficacy data on varicella vaccines, children were \nenrolled and vaccinated between Sept 1, 2005, and \nMay 10, 2006, in countries with endemic varicella among \nchildren and with no recommendation for varicella vaccination.", "mimetype": "text/plain", "start_char_idx": 8337, "end_char_idx": 10021, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "eb35fe5a-e72c-46af-a5a9-4609a133ecbc": {"__data__": {"id_": "eb35fe5a-e72c-46af-a5a9-4609a133ecbc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1bbc4280-b997-499d-bc46-d6d350230ee6", "node_type": "1", "metadata": {}, "hash": "a0e70099ff3c67a409d4230728ec9fca7833bd3de7f964d80d01898538d75c77", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "19db6951-bdb0-47f2-a7ad-92ea1cdf72c5", "node_type": "1", "metadata": {}, "hash": "fa8d80035a3ff1761abbd04c569d3d5dc8d9d9ad6997a01f44ad9b33d92c21a9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This phase 3 RCT assessed two doses of MMRV or one dose of \nmeasles-mumps-rubella vaccine (MMR)\u2009+\u2009one dose of varicella \nvaccine (MMR+V) compared with two doses of MMR (control), \nand at the 3-year follow-up showed that, compared with \ncontrol vaccine, the efficacy of the two-dose MMRV schedule \nwas 94\u00b79%, the efficacy of the one-dose varicella vaccine \nschedule was 65\u00b74% against all varicella. The 6-year follow-up \nshowed that, compared with control vaccine, the efficacy of \ntwo doses of MMRV against all varicella was 95\u00b70%, and of \none dose was 67\u00b70%. These efficacy estimates support the use \nof two doses of MMRV over the one-dose varicella vaccine \nschedule for protection against varicella disease for up to \n6 years after vaccination in healthy children.\nAdded value of this study\nFurther to the analyses at years 3 and 6, this long-term \nfollow-up provides descriptive efficacy estimates for varicella \nvaccine in children aged 10\u201311 years. The vaccine efficacy \nestimates over 10 years showed that compared with control \nvaccine, for two-dose MMRV the efficacy against all varicella \nwas 95\u00b74%, and for one dose of varicella vaccine was 67\u00b72%. \nThat is, in a setting where varicella is endemic among children \nallowing for natural boosting, compared with control vaccine, \nthe two-dose MMRV schedule provided higher protection \nthroughout 10 years than one dose of varicella vaccine against \nall severities of varicella disease.\nImplications of all available evidence\nThe effectiveness of various varicella vaccines for protection \nagainst varicella disease in children has been widely established \nin countries which include varicella in routine childhood \nvaccination programmes. In addition, the benefits of combined \nMMRV over separate injections of MMR+V are well established, \nand include simpler delivery of vaccines, increased compliance, \nand reduced health-care costs. The clinical evidence shows \nthat a two-dose schedule of live varicella MMRV provides robust \nlong-term protection against varicella disease in young children.", "mimetype": "text/plain", "start_char_idx": 10023, "end_char_idx": 12076, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "19db6951-bdb0-47f2-a7ad-92ea1cdf72c5": {"__data__": {"id_": "19db6951-bdb0-47f2-a7ad-92ea1cdf72c5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eb35fe5a-e72c-46af-a5a9-4609a133ecbc", "node_type": "1", "metadata": {}, "hash": "bc0d339014fc0601c2995f926911bf35903e122120af0388d6396f56ce8bd8ec", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d81ee5c9-81a1-46a0-98bf-bc901a50a9ff", "node_type": "1", "metadata": {}, "hash": "e063b2c46f554b4e5100e8ac2d91b883def3bf0a7c31425ea44de8edef60b0fe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The clinical evidence shows \nthat a two-dose schedule of live varicella MMRV provides robust \nlong-term protection against varicella disease in young children.\nArticles\nwww.thelancet.com/infection   Vol 19   March 2019\t\n289\nSee Online for appendix\nFor the study protocol see www.\ngsk-clinicalstudyregister.com/\nstudy100388\nagainst varicella at a median follow-up of 9\u00b78 years after \ntwo doses of MMRV or one dose of MMR\u2009+\u2009one dose of \nvaricella vaccine versus two doses of MMR control. A \nsummary contextualising the outcomes of this study \nfor health-care professionals is presented in the \nappendix.\nMethods\nStudy design\nThis phase 3b study was an observer-blind, controlled, \nassessment of children aged 12\u201322 months who were \nrandomly assigned (3:3:1) to receive two doses of MMRV, \none dose of MMR followed by one dose of V, or two doses \nof MMR control vaccine, 42 days apart. The study \ncomprised two distinct surveillance periods: phase a and \nb. Phase a\u2009+\u2009b began 6 weeks after dose two and ended at \nthe last visit in phase b (year 10), covering the overall \n10 years of the study, whereas phase b started, on \naverage, 3 years after vaccination and ended at the last \nvisit in phase b. An overview of the study design is shown \nin the appendix.\nThe study was done in Czech Republic (Czechia), Italy, \nGreece, Lithuania, Norway, Poland, Romania, Russia, \nSlovakia, and Sweden (NCT00226499). A protocol \nsummary is available. The follow-ups at years 3 and 6 \nhave been previously published.11,15 Here we describe \nvaccine efficacy and varicella zoster virus antibody \npersistence up to 10 years after vaccination.", "mimetype": "text/plain", "start_char_idx": 11917, "end_char_idx": 13539, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d81ee5c9-81a1-46a0-98bf-bc901a50a9ff": {"__data__": {"id_": "d81ee5c9-81a1-46a0-98bf-bc901a50a9ff", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "19db6951-bdb0-47f2-a7ad-92ea1cdf72c5", "node_type": "1", "metadata": {}, "hash": "fa8d80035a3ff1761abbd04c569d3d5dc8d9d9ad6997a01f44ad9b33d92c21a9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e935b5e7-10d0-43f2-b425-7eb98d07abde", "node_type": "1", "metadata": {}, "hash": "3ae25d6226c303c199a0677b1d3c2e4bb8deedb1187e5a27270b583242b0d67e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The follow-ups at years 3 and 6 \nhave been previously published.11,15 Here we describe \nvaccine efficacy and varicella zoster virus antibody \npersistence up to 10 years after vaccination.\nParticipants\nChildren aged 12\u201322 months were eligible for inclusion if \nthey had not received MMR or varicella vaccines, or both, \nor had measles-mumps-rubella or varicella zoster or \nherpes zoster diseases, or both, and were at home with at \nleast one sibling with negative history of varicella disease \nand vaccination, at a child-minders where at least one child \nwas without a known positive history of varicella disease \nand vaccination, playing for more than 5 min/week with \nchildren without a known positive history of varicella \ndisease and vaccination, or registered to attend day care \nfrom 24 months. All parents and guardians gave informed \nwritten consent for participation.\nThe study was done in accordance with the Declaration \nof Helsinki and International Harmonization Good \nClinical Practice guidelines. The protocol was reviewed \nand approved by an independent ethics committees or \ninstitutional review board in all participating countries. \nProtocol deviations have been previously published.11\nRandomisation and masking\nThe vaccines assessed were MMRV (Priorix-Tetra, \nGlaxoSmithKline [GSK]), MMR (Priorix, GSK), and \nmonovalent varicella (V; Varilrix, GSK). Randomisation \nand blinding have been previously described.11 Briefly, \nchildren were randomly assigned (3:3:1) to receive \ntwo doses of MMRV at days 0 and 42 (MMRV group); \none dose of MMR at day 0 and one dose of varicella \nvaccine at day 42 (MMR\u2009+\u2009V group), or two doses of MMR \nvaccine as control at days 0 and 42.\nProcedures\nVaccines were administered subcutaneously in the \ndeltoid of the child\u2019s left arm. Three lots each of MMRV \nand monovalent varicella vaccine and one lot of \nMMR control vaccine were used.", "mimetype": "text/plain", "start_char_idx": 13352, "end_char_idx": 15240, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e935b5e7-10d0-43f2-b425-7eb98d07abde": {"__data__": {"id_": "e935b5e7-10d0-43f2-b425-7eb98d07abde", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d81ee5c9-81a1-46a0-98bf-bc901a50a9ff", "node_type": "1", "metadata": {}, "hash": "e063b2c46f554b4e5100e8ac2d91b883def3bf0a7c31425ea44de8edef60b0fe", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6643e548-cc27-4f37-b1f2-a3f7322dbbab", "node_type": "1", "metadata": {}, "hash": "845353830c8ef4d1b47d967bc3e66199cf198f9739a53a3a2ceb4aec43a58127", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Three lots each of MMRV \nand monovalent varicella vaccine and one lot of \nMMR control vaccine were used. During phase b, the \nstudy remained observer blind (including parents and \nguardians) for all groups except the MMR\u2009+\u2009V group in \ncountries where the national vaccination schedule \nincludes a second dose of MMR vaccination at age \n4\u20138 years (Czech Republic, Italy, Lithuania, Romania, \nRussia, and Sweden). The independent data monitoring \ncommittee remained masked to the study treatment \ngroup when assessing varicella cases.\nOutcomes\nThe outcomes for phase b were secondary and descriptive. \nThe efficacy outcomes were to assess vaccine efficacy of \ntwo doses of MMRV or one dose of MMR\u2009+\u2009one dose of \nvaricella vaccine versus two doses of MMR control vaccine \nagainst varicella at 10 years after vaccination, and vaccine \nefficacy of MMRV or MMR\u2009+\u2009V for the prevention of \nvaricella according to the severity of varicella cases. The \nimmunogenicity outcomes at 10 years were to assess the \nproportions of varicella zoster virus seropositivity, geo\u00ad\nmetric mean titres, and geometric mean concentrations \nof varicella zoster virus antibodies. Measles, mumps, and \nrubella antibody titres in a subset of children at years 4, 6, \n8, and 10 will be presented elsewhere. The long-term \nsafety outcome was to describe serious adverse events \nand cases of herpes zoster.\nThe burden of illness was assessed among parents \nand guardians who had a child with confirmed \nvaricella, including: time lost from work as a result of \ncaring for their child; time their child lost for daily \nactivities (attendance at daycare, child minders, school, \nextra-\u200bcurricular activities); time when assistance was \nneeded to care for their child with varicella (nurse, \nbabysitter, paid caregiver); and whether they would \nhave contacted or visited a physician to seek advice for \nvaricella if their child were not participating in the \ntrial.\nParents were asked to seek assessment if their child or \na member of their household had any rash or illness \nresembling varicella or herpes zoster, and a detailed \ndescription of the rash was recorded.", "mimetype": "text/plain", "start_char_idx": 15136, "end_char_idx": 17267, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6643e548-cc27-4f37-b1f2-a3f7322dbbab": {"__data__": {"id_": "6643e548-cc27-4f37-b1f2-a3f7322dbbab", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e935b5e7-10d0-43f2-b425-7eb98d07abde", "node_type": "1", "metadata": {}, "hash": "3ae25d6226c303c199a0677b1d3c2e4bb8deedb1187e5a27270b583242b0d67e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0b4a3aab-a887-4043-846d-cfb4d23753c9", "node_type": "1", "metadata": {}, "hash": "eaf56afd3f2bfbbd68ef0b446c85679942576844b195cd8360d0173dab6c09a2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Parents were asked to seek assessment if their child or \na member of their household had any rash or illness \nresembling varicella or herpes zoster, and a detailed \ndescription of the rash was recorded. The description \nincluded duration of rash episode; estimation of the daily \nnumber of lesions or vesicles, or both; measurement of \ndaily body temperature during the period of rash; and the \ndate when the illness ended (first day when the child \nresumed normal everyday activities as it was before the \nonset of varicella zoster). Vesicular dermal lesions were \nsampled by unroofing the lesion and collecting the fluid \nby capillary action. Dry lesions (papules or crusts) were \nsampled by unroofing and swabbing, or by collecting \nArticles\n290\t\nwww.thelancet.com/infection   Vol 19   March 2019\nscabs or crusts from lesions. The samples were used for \nthe laboratory identification and characterisation of \nvaricella zoster virus. DNA for qualitative and strain \nidentification (wild type or vaccine) was done using \nPCR-restriction fragment length polymorphism.\nParents and guardians were contacted by telephone once \nevery 6 months during phase b to remind them to report \nsuspicions of varicella or zoster infection in their child.\nDuring the case ascertainment visit, the investigator \nrecorded the date of the visit, examined the child to \n2489 assigned MMRV\n2279 included in phase a + b per-protocol e\ufb03cacy cohort\n210 excluded\n \n10 study vaccine not administered  per protocol \n \n3 protocol violation \n \n2 underlying medical condition\n \n7 varicella disease before day 84 \n \n73 no follow-up after day 84 \n \n115 initially seropositive or antibody status\n                  unknown\n318 excluded due to lost follow-up \n1961 included in phase b total  vaccinated cohort \n159 excluded\n \n6 study vaccine not administered according to\n                 protocol\n \n2 protocol violated for inclusion or exclusion\n                criteria\n \n4 underlying medical condition forbidden by\n                 protocol\n \n6 varicella disease before day 84\n \n86 initially seropositive or unknown antibody\n                 status for prevaccination  blood sample\n \n55 probable or con\ufb01rmed varicella disease\n                between day 84 and  June 30,", "mimetype": "text/plain", "start_char_idx": 17065, "end_char_idx": 19303, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0b4a3aab-a887-4043-846d-cfb4d23753c9": {"__data__": {"id_": "0b4a3aab-a887-4043-846d-cfb4d23753c9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6643e548-cc27-4f37-b1f2-a3f7322dbbab", "node_type": "1", "metadata": {}, "hash": "845353830c8ef4d1b47d967bc3e66199cf198f9739a53a3a2ceb4aec43a58127", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "30a904ed-8315-44b0-8102-b83596246498", "node_type": "1", "metadata": {}, "hash": "b77df6cedab068737b961e973bd09acad0275ddd40ddacf19eca727d9d8378e8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2009\n1802 included in phase b per-protocol e\ufb03cacy cohort\n676 excluded\n \n10 administration of any medication forbidden\n                  by the protocol\n \n79 non-compliance with blood sampling\n                  scheduling\n \n587 essential seriological data missing \n1415 completed the 10-year study (phase a + b)\n1285 included in phase b per-protocol cohort for\n           persistence at year 10\n1074 withdrawn\n \n8 serious adverse events\n \n2 non-serious adverse events\n \n1064  others\n2487 assigned MMR+V \n5803 participants enrolled and randomly assigned \n2266 included in phase a + b per-protocol e\ufb03cacy cohort\n221 excluded\n \n18 study vaccine not administered per protocol \n \n6 protocol violation \n \n3 underlying medical condition\n \n28 varicella disease before day 84 \n \n56 no follow-up after day 84 \n \n110 initially seropositive or antibody status\n                unknown\n288  excluded due to lost follow-up \n1978 included in phase b total vaccinated cohort \n385 excluded\n \n11 study vaccine not administered according\n                  to protocol\n \n5 protocol violated for inclusion or exclusion\n                  criteria\n \n3 underlying medical condition forbidden by\n                  protocol\n \n22 varicella disease before day 84\n \n90 initially seropositive or unknown antibody\n                  status for prevaccination blood sample\n \n254 probable or con\ufb01rmed varicella disease\n                  between day 84 and June 30,", "mimetype": "text/plain", "start_char_idx": 19304, "end_char_idx": 20732, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "30a904ed-8315-44b0-8102-b83596246498": {"__data__": {"id_": "30a904ed-8315-44b0-8102-b83596246498", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0b4a3aab-a887-4043-846d-cfb4d23753c9", "node_type": "1", "metadata": {}, "hash": "eaf56afd3f2bfbbd68ef0b446c85679942576844b195cd8360d0173dab6c09a2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "15c64ba2-1b8c-41ff-b8c3-5c91b8e54d02", "node_type": "1", "metadata": {}, "hash": "5128152a30e6987b43d3f61c31bf46986ffa751af8d02323880680340838ec29", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2009\n1593 included in phase b per-protocol e\ufb03cacy cohort\n692 excluded\n \n5 administration of any medication forbidden\n                  by the protocol\n \n73 non-compliance with blood sampling\n                  scheduling\n \n614 essential seriological data missing \n223 excluded\n \n1 administration of any medication forbidden\n                  by  the protocol\n \n1 underlying medical condition forbidden by\n                  the protocol\n \n29 non-compliance with blood sampling\n                  scheduling\n \n192 essential seriological data missing \n1415 completed the 10-year study (phase a + b)\n1286 included in phase b per-protocol cohort for\n           persistence at year 10\n1072 withdrawn\n \n3 serious adverse events\n \n3 non-serious adverse events\n \n1066  others\n827 assigned MMR\n744 included in phase a + b per-protocol e\ufb03cacy cohort\n83 excluded\n     \n1 study vaccine not administered per protocol \n     \n1 protocol violation \n     \n9 varicella disease before day 84 \n     30 no follow-up after day 84 \n     42 initially seropositive or antibody status\n              unknown\n103 excluded due to lost follow-up \n641 included in phase b total vaccinated cohort \n245 excluded\n \n1 study vaccine not administered according\n                   to protocol\n \n1 protocol violated for inclusion or exclusion\n                   criteria\n \n8 varicella disease before day 84\n \n32 initially seropositive or unknown antibody\n                   status for prevaccination blood sample\n \n203 probable or con\ufb01rmed varicella disease\n                   between day 84 and June 30, 2009\n396 included in phase b per-protocol e\ufb03cacy cohort\n468 completed the 10-year study (phase a + b)\n418 included in phase b per-protocol cohort for\n         persistence at year 10\n359 withdrawn\n \n3 serious adverse events\n \n356 others\nArticles\nwww.thelancet.com/infection   Vol 19   March 2019\t\n291\ndescribe the case in detail, and photographed the lesions \nto document their distribution and nature. Collection of \nbiological samples from the dermal lesions for viral \nidentification and recording the number and type of \nsamples were reported in the child\u2019s electronic case \nreport form.", "mimetype": "text/plain", "start_char_idx": 20733, "end_char_idx": 22886, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "15c64ba2-1b8c-41ff-b8c3-5c91b8e54d02": {"__data__": {"id_": "15c64ba2-1b8c-41ff-b8c3-5c91b8e54d02", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "30a904ed-8315-44b0-8102-b83596246498", "node_type": "1", "metadata": {}, "hash": "b77df6cedab068737b961e973bd09acad0275ddd40ddacf19eca727d9d8378e8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "138d72bb-e583-4bd3-b568-db5f4bf90183", "node_type": "1", "metadata": {}, "hash": "a24b770e43ebf2ba0e348d93b8fea755eb27a344c888e5062d9021464d574817", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "and photographed the lesions \nto document their distribution and nature. Collection of \nbiological samples from the dermal lesions for viral \nidentification and recording the number and type of \nsamples were reported in the child\u2019s electronic case \nreport form. The verification and transcription of diary \ncard (ie, a card given to the parents or guardians to record \ncharacteristics of the suspected varicella illness) data in \nthe child\u2019s electronic case report form included any \ntreatment given the child for varicella, any back or \nabdominal pain observed in the child, and the outcome \nof the disease when available. Herpes zoster cases were \nalso recorded.\nAll cases of varicella-like rash identified by the in-\u200b\nvestigator were referred to the independent data \nmonitoring committee for blinded classification using a \nmodified V\u00e1zquez scale (mild \u22647, moderately severe \n8\u201315, severe \u226516).15,16 The variables for assessing the \nseverity of illness were: rash (number and type of \nlesions), fever, pain back or abdomen complications, and \ninvestigator\u2019s subjective assessment of the illness. A \nvaricella case was confirmed when it met the clinical case \ndefinition and the PCR result was positive for a wild-type \nvaricella virus, or when it met the clinical definition, was \nconfirmed by independent data monitoring committee, \nand was epidemiologically linked to a valid index case.17,18 \nAssessments of antibody persistence and safety are \ndescribed in the appendix.\nStatistical analysis\nThe sample size and statistical power calculations \nfor vaccine efficacy in phase a have been previously \ndescribed.11 Vaccine efficacy estimates in the long-term \nfollow-up were descriptive. The hazard ratios (HRs) for \nMMRV and MMR\u2009+\u2009V versus MMR control were estimated \nby use of a Cox proportional hazards regression model, \naccounting for individual follow-up time of each child and \ncensored data. The proportional hazard assumptions were \nverified using Schoenfeld residual plots. Follow-up time \nfor the varicella cases was censored at the rash start date. \nVaccine efficacy was calculated as 100x(1\u2013HR), with a two-\nsided 95% CI. The phase a\u2009+\u2009b, and phase b per-protocol \ncohorts for vaccine efficacy included children who \ncompleted their vaccinations and fulfilled the protocol \nrequirements.", "mimetype": "text/plain", "start_char_idx": 22625, "end_char_idx": 24929, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "138d72bb-e583-4bd3-b568-db5f4bf90183": {"__data__": {"id_": "138d72bb-e583-4bd3-b568-db5f4bf90183", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "15c64ba2-1b8c-41ff-b8c3-5c91b8e54d02", "node_type": "1", "metadata": {}, "hash": "5128152a30e6987b43d3f61c31bf46986ffa751af8d02323880680340838ec29", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f208f906-3b05-4c46-baaa-57e87bc24eaa", "node_type": "1", "metadata": {}, "hash": "f14f0972e6d2362c401448ae4100bc58fcc23c6e22f73053b0b9dbd0f1ba834f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The phase a\u2009+\u2009b, and phase b per-protocol \ncohorts for vaccine efficacy included children who \ncompleted their vaccinations and fulfilled the protocol \nrequirements. Children with confirmed or probable \nvaricella disease in phase a were excluded from the phase \nb vaccine efficacy cohort.\nThe seropositivity proportions for varicella zoster virus \nantibodies at each timepoint was defined as the \nproportion of children with antibody titres of at least \n25 mIU/mL who were seronegative (titre <25 mIU/mL) \nprevaccination. Geometric mean concentrations were \ncalculated by taking the anti-log of the mean of the log \nconcentrations for each assay. Antibody titres below the \nassay cutoff were given an arbitrary value of half the cut-\noff for geometric mean concentration calculations. For \nthe varicella zoster virus antibody assay, all titres between \n25 mIU/mL and 40 mIU/mL were given a value of \n25 mIU/mL before log-transformation. Children with \nmissing or non-evaluable measurements were excluded \nfrom immunogenicity analyses. Antibody persistence \nwas assessed in the per-protocol cohort for persistence \nincluding children who completed their vaccinations, \nfulfilled the protocol requirements, and had a serum \nsample at the given timepoint.\nAll safety assessments were done in the total vaccinated \ncohort, including all children who received at least one \nFigure 1: Study flowchart\nChildren with confirmed or probable varicella disease in phase a were excluded \nfrom the phase b vaccine efficacy cohort. Phase a\u2009+\u2009b was from 6 weeks \npostvaccination to the final follow-up at year 10. Phase b was from 3 years \npostvaccination to the final follow-up at year 10. MMRV=measles-mumps-rubella-\nvaricella vaccine. MMR\u2009+\u2009V=live attenuated varicella vaccine after MMR. \nMMR=measles-mumps-rubella vaccine.", "mimetype": "text/plain", "start_char_idx": 24764, "end_char_idx": 26574, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f208f906-3b05-4c46-baaa-57e87bc24eaa": {"__data__": {"id_": "f208f906-3b05-4c46-baaa-57e87bc24eaa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "138d72bb-e583-4bd3-b568-db5f4bf90183", "node_type": "1", "metadata": {}, "hash": "a24b770e43ebf2ba0e348d93b8fea755eb27a344c888e5062d9021464d574817", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b9e6b753-9284-4930-bccc-4c4c0696a6bd", "node_type": "1", "metadata": {}, "hash": "ca7fa6543533aae6025983211f83764adad3fb9b4c05469de67e6a5080394c62", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MMR\u2009+\u2009V=live attenuated varicella vaccine after MMR. \nMMR=measles-mumps-rubella vaccine.\nMMRV \n(N=2279)\nMMR+V \n(N=2266)\nMMR (control; \nN=744)\nMean age at vaccine \ndose one\n14\u00b72 (2\u00b75)\n14\u00b72 (2\u00b74)\n14\u00b72 (2\u00b75)\nGirls\n1057 (46%)\n1109 (49%)\n360 (48%)\nBoys\n1222 (54%)\n1157 (51%)\n384 (52%)\nRace or ethnicity\nWhite\n2227 (98%)\n2227 (98%)\n737 (99%)\nArabic or north \nAfrican\n21 (1%)\n7 (<1%)\n2 (<1%)\nOther\n31 (1%)\n32 (1%)\n5 (1%)\nCountry\nCzechia\n525 (23%)\n516 (23%)\n171 (23%)\nGreece\n115 (5%)\n113 (5%)\n32 (4%)\nItaly\n106 (5%)\n109 (5%)\n35 (5%)\nLithuania\n256 (11%)\n255 (11%)\n86 (12%)\nNorway\n74 (3%)\n76 (3%)\n25 (3%)\nPoland\n385 (17%)\n368 (16%)\n116 (16%)\nRomania\n121 (5%)\n126 (6%)\n42 (6%)\nRussia\n378 (17%)\n392 (17%)\n130 (17%)\nSlovakia\n199 (9%)\n195 (9%)\n68 (9%)\nSweden\n120 (5%)\n116 (5%)\n39 (5%)\nType of care\nAt least one sibling \nat home\n655 (29%)\n592 (26%)\n192 (26%)\nAttending day-care \ncentre\n525 (23%)\n546 (24%)\n187 (25%)\nAttending a child \nminder\n148 (6%)\n155 (7%)\n57 (8%)\nAt least once a \nweek contact*\n2051 (90%)\n2055 (91%)\n680 (91%)\nData are months (SD) or n (%).", "mimetype": "text/plain", "start_char_idx": 26486, "end_char_idx": 27532, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b9e6b753-9284-4930-bccc-4c4c0696a6bd": {"__data__": {"id_": "b9e6b753-9284-4930-bccc-4c4c0696a6bd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f208f906-3b05-4c46-baaa-57e87bc24eaa", "node_type": "1", "metadata": {}, "hash": "f14f0972e6d2362c401448ae4100bc58fcc23c6e22f73053b0b9dbd0f1ba834f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "67f5848a-c0d4-4474-be54-040dea62f499", "node_type": "1", "metadata": {}, "hash": "4665da590806d4c49a190f70db83e95b30f9cd60e54facb466e58f6a1d9c3dc5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Phase a\u2009+\u2009b was from 6 weeks postvaccination to \nthe final follow-up at year 10. MMRV=measles-mumps-rubella-varicella vaccine. \nMMR+V=live attenuated varicella vaccine after MMR. \nMMR=measles-mumps-rubella vaccine. *With other children without a known \npositive history of varicella disease or vaccination.\nTable 1: Demographic characteristics in the per-protocol efficacy \ncohort (phase a\u2009+\u2009b)\nArticles\n292\t\nwww.thelancet.com/infection   Vol 19   March 2019\ndose of vaccine in phase a. Safety data were described as \nnumber and proportion of children reporting the event \nwith a two-sided 95% CI. SAS (version 9.3, including \nProc-StatXact, version 8.1 module) was used for all \ncomputations.\nThis trial is registered with ClinicalTrials.gov, number \nNCT00226499.\nRole of the funding source\nThe trial was sponsored and designed by GlaxoSmithKline \nBiologicals but amended with input from an independent \ndata monitoring committee consisting of relevant experts. \nInvestigators generated and reported the data for analysis \nby GSK statisticians according to a prespecified analysis \nplan. All authors had complete access to the analysed data \n(without compromising the trial blinding), participated in \nthe drafting and reviewing of the report, and vouch for \nthe accuracy and completeness of this report. MP, OH, \nMARB, RC, SE, C-EF, LG, SM, S-AS, MS, VU, JW, PG, \nand RP had final responsibility for the decision to submit \nfor publication. GlaxoSmithKline Biologicals covered the \ncosts associated with the development and publishing of \nthe manuscript, including writing assistance.\nResults\n5803 children were enrolled and vaccinated between \nSept 1, 2005, and May 10, 2006. Phase a was extended \nthrough the first half of 2009, so the median follow-up \nwas about 3 years. Phase b started on July 1, 2009, and the \nlast study visit was on Dec 15, 2016.", "mimetype": "text/plain", "start_char_idx": 27533, "end_char_idx": 29389, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "67f5848a-c0d4-4474-be54-040dea62f499": {"__data__": {"id_": "67f5848a-c0d4-4474-be54-040dea62f499", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b9e6b753-9284-4930-bccc-4c4c0696a6bd", "node_type": "1", "metadata": {}, "hash": "ca7fa6543533aae6025983211f83764adad3fb9b4c05469de67e6a5080394c62", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "27b564f2-d9b4-449f-a5f7-e2ff581be6bb", "node_type": "1", "metadata": {}, "hash": "5479e108fadb42f565395dde23afbbdf8f1b6df43cbf3749e5bd04f8f9294ba2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Phase b started on July 1, 2009, and the \nlast study visit was on Dec 15, 2016.\nIn phase a, the total vaccinated cohort comprised \n5803 children aged 12\u201322 months at enrolment, of which \n4580 children continued long-term follow-up in phase b. \nThe demographic characteristics of the total vaccinated \ncohort have been previously published.11 The per-protocol \nefficacy cohort (phase a\u2009+\u2009b) included 5289 children \n(91% of the total vaccinated cohort for phase a), and the \nper-protocol efficacy cohort (phase b) included a total of \n3791 children (83% of the total vaccinated cohort for \nphase b). During the 10-year follow-up, 2505 children in \nthe total vaccinated cohort were withdrawn from the \nstudy, including 14 that withdrew because of a serious \nadverse event and five because of a non-serious adverse \nevent (figure 1).\nThe main reasons for exclusion from the per-protocol \nefficacy cohort (phase a\u2009+\u2009b) were being seropositive or of \nunknown serostatus at baseline and being lost to follow-\nup 42 days after vaccination. In the efficacy cohorts, the \ndemographic characteristics and the level of varicella \nzoster virus exposure based on care type were balanced \nacross groups, and consistent with the total vaccinated \ncohort. In the per-protocol efficacy cohort (phase a\u2009+\u2009b) the \nmean age of children at enrolment was 14\u00b72 months, \n98% of children were white, and most were from \nCzech Republic (23%), Russia (17%), and Poland \n(16%, table 1). The per-protocol persistence cohort \nincluded 5235 children (90% of the total vaccinated cohort; \nappendix). The main reasons for exclusion from the \nper-protocol persistence cohort were blood sample \nmissing, unknown antibody status prevaccination, and \nbeing seropositive prevaccination.", "mimetype": "text/plain", "start_char_idx": 29310, "end_char_idx": 31057, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "27b564f2-d9b4-449f-a5f7-e2ff581be6bb": {"__data__": {"id_": "27b564f2-d9b4-449f-a5f7-e2ff581be6bb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "67f5848a-c0d4-4474-be54-040dea62f499", "node_type": "1", "metadata": {}, "hash": "4665da590806d4c49a190f70db83e95b30f9cd60e54facb466e58f6a1d9c3dc5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8094eb9b-2bd0-4fc0-91ad-74fbb59a638d", "node_type": "1", "metadata": {}, "hash": "b03574b218a7ee0f372a575422d45a2403fa12d92878bd66dfaf3fcefdb78a2d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The main reasons for exclusion from the \nper-protocol persistence cohort were blood sample \nmissing, unknown antibody status prevaccination, and \nbeing seropositive prevaccination.\nIn the per-protocol efficacy cohort (phase a\u2009+\u2009b), during \na median 9\u00b78 years of follow-up, contact with varicella or \nherpes zoster, or both, was reported in 825 (36%) children \nin the MMRV group, 789 (35%) children in the \nMMR\u2009+\u2009V group, and 224 (30%) children in the MMR \ncontrol group. Varicella cases were recorded in 76 (3%) \nchildren in the MMRV group, 469 (21%) in the \nMMR\u2009+\u2009V group, and 352 (47%) in the MMR control \ngroup. The vaccine efficacy of two doses of MMRV \nagainst all varicella cases was 95\u00b74% (95% CI 94\u00b70\u201396\u00b74) \nand against moderate or severe varicella was 99\u00b71% \n(97\u00b79\u201399\u00b76). The vaccine efficacy of one dose of varicella \nvaccine in the MMR\u2009+\u2009V group against all cases was \n67\u00b72% (62\u00b73\u201371\u00b75) and against moderate or severe \nvaricella was 89\u00b75% (86\u00b71\u201392\u00b71; table 2). A sensitivity \nanalysis done on the total vaccinated cohort revealed \nsimilar vaccine efficacy to that observed in the \nper-protocol efficacy cohort (data not shown). Over the \n10-year follow-up, annual vaccine efficacy remained more \nthan 91\u00b74% for MMRV and more than 59\u00b74% for \nMMR\u2009+\u2009V and were stable over time (figure 2). The mean \nseverity scores of the first confirmed varicella cases were \n4\u00b79 (SD 2\u00b70) in the MMRV group and 5\u00b74 (2\u00b73) in the \nMMR\u2009+\u2009V group. In the MMR control group, the mean \nNumber of \npatients (n/N)\nTotal time to \nevent (years)\nAttack rate (95% CI) \nper 100 person-years\nVaccine efficacy \n(95% CI)\nPhase", "mimetype": "text/plain", "start_char_idx": 30877, "end_char_idx": 32480, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8094eb9b-2bd0-4fc0-91ad-74fbb59a638d": {"__data__": {"id_": "8094eb9b-2bd0-4fc0-91ad-74fbb59a638d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "27b564f2-d9b4-449f-a5f7-e2ff581be6bb", "node_type": "1", "metadata": {}, "hash": "5479e108fadb42f565395dde23afbbdf8f1b6df43cbf3749e5bd04f8f9294ba2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "772b2b5b-0ee2-4839-a5b7-f3f2d3137e2e", "node_type": "1", "metadata": {}, "hash": "6bf5e92d93e5d50c57fbe7d757bbd5bef61ccb38982985db63bafcd02aad8629", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In the MMR control group, the mean \nNumber of \npatients (n/N)\nTotal time to \nevent (years)\nAttack rate (95% CI) \nper 100 person-years\nVaccine efficacy \n(95% CI)\nPhase a\u2009+\u2009b\nTwo-dose MMRV\nAll cases\n76/2279\n16\u2009971\n0\u00b74 (0\u00b74\u20130\u00b76)\n95\u00b74% (94\u00b70\u201396\u00b74)\nModerate or severe\n6/2279\n17\u2009376\n0\u00b70 (0\u00b70\u20130\u00b71)\n99\u00b71% (97\u00b79\u201399\u00b76)\nOne-dose MMR+V\nAll cases\n469/2266\n14\u2009567\n3\u00b72 (2\u00b79\u20133\u00b75)\n67\u00b72% (62\u00b73\u201371\u00b75)\nModerate or severe\n67/2266\n16\u2009918\n0\u00b74 (0\u00b73\u20130\u00b75)\n89\u00b75% (86\u00b71\u201392\u00b71)\nMMR (control)\nAll cases\n352/744\n3464\n10\u00b72 (9\u00b72\u201311\u00b73)\nNA\nModerate or severe\n176/744\n4492\n3\u00b79 (3\u00b74\u20134\u00b75)\nNA\nPhase b\nTwo-dose MMRV\nAll cases\n38/1800\n10\u2009080\n0\u00b74 (0\u00b73\u20130\u00b75)\n95\u00b79% (94\u00b71\u201397\u00b71)\nModerate or severe\n4/1800\n10\u2009237\n0\u00b70 (0\u00b70\u20130\u00b71)\n98\u00b77% (96\u00b74\u201399\u00b75)\nOne-dose MMR+V\nAll cases\n225/1591\n7961\n2\u00b78 (2\u00b75\u20133\u00b72)\n69\u00b78% (62\u00b78\u201375\u00b75)\nModerate or severe\n27/1592\n8862\n0\u00b73 (0\u00b72\u20130\u00b74)\n90\u00b70% (84\u00b72\u201393\u00b77)\nMMR (control)\nAll cases\n149/396\n1473\n10\u00b71 (8\u00b76\u201311\u00b79)\nNA\nModerate or severe\n59/396\n1880\n3\u00b71 (2\u00b74\u20134\u00b71)\nNA\nPhase", "mimetype": "text/plain", "start_char_idx": 32314, "end_char_idx": 33255, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "772b2b5b-0ee2-4839-a5b7-f3f2d3137e2e": {"__data__": {"id_": "772b2b5b-0ee2-4839-a5b7-f3f2d3137e2e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8094eb9b-2bd0-4fc0-91ad-74fbb59a638d", "node_type": "1", "metadata": {}, "hash": "b03574b218a7ee0f372a575422d45a2403fa12d92878bd66dfaf3fcefdb78a2d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3601d46b-fcea-452c-bd71-65c48f9597c8", "node_type": "1", "metadata": {}, "hash": "0c5512eac548e8fd6cf25696418e1afdf489022a307003f0f7f0d5ed3b2f72a8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cases\n149/396\n1473\n10\u00b71 (8\u00b76\u201311\u00b79)\nNA\nModerate or severe\n59/396\n1880\n3\u00b71 (2\u00b74\u20134\u00b71)\nNA\nPhase a\u2009+\u2009b was from 6 weeks postvaccination to the final follow-up at year 10, and phase b was from 3 years \npostvaccination to the final follow-up at year 10. MMRV=measles-mumps-rubella-varicella vaccine. MMR+V=live \nattenuated varicella vaccine after MMR. MMR=measles-mumps-rubella vaccine. NA=not applicable.\nTable 2: Descriptive vaccine efficacy estimates against confirmed varicella in the per-protocol efficacy cohorts\nArticles\nwww.thelancet.com/infection   Vol 19   March 2019\t\n293\nseverity score was 7\u00b77 (3\u00b71; appendix). No cases of severe \nconfirmed varicella were reported in the MMRV group, \none severe confirmed case in the MMR\u2009+\u2009V group (<1%), \nand six severe cases in the MMR control group (1%).\nAmong the children who developed varicella disease in \nthe MMRV and MMR\u2009+\u2009V groups during the follow-up \nperiod, the majority had 50 lesions or fewer (MMRV \n88%, MMR\u2009+\u2009V 76%). By comparison, 36% of those with \nconfirmed varicella disease in the MMR control group \nexhibited one to 50 lesions and the majority had more \nthan 50 lesions (32% with 51\u2013100 lesions, 28% with \n101\u2013500 lesions, and 4% with >500 lesions). The monthly \ndistribution of confirmed varicella cases showed higher \nproportions of varicella cases in the autumn, winter, and \nspring, compared with summer, with almost no cases \nreported in August. This seasonal distribution is clear in \nthe MMR control group and MMR\u2009+\u2009V group, but less so \nin the MMRV group because of the very low number of \nreported cases (appendix).", "mimetype": "text/plain", "start_char_idx": 33164, "end_char_idx": 34750, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3601d46b-fcea-452c-bd71-65c48f9597c8": {"__data__": {"id_": "3601d46b-fcea-452c-bd71-65c48f9597c8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "772b2b5b-0ee2-4839-a5b7-f3f2d3137e2e", "node_type": "1", "metadata": {}, "hash": "6bf5e92d93e5d50c57fbe7d757bbd5bef61ccb38982985db63bafcd02aad8629", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "574c1c82-5777-434f-8934-72f2ac04af9e", "node_type": "1", "metadata": {}, "hash": "dbe2eea8ce061198bb1a01f80ba906b585313e5fc67490f9ec9cde0e03e07f6e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This seasonal distribution is clear in \nthe MMR control group and MMR\u2009+\u2009V group, but less so \nin the MMRV group because of the very low number of \nreported cases (appendix).\nIn the per-protocol efficacy cohort (phase b), the median \nduration of follow-up was 6\u00b759 years in the MMRV group, \n6\u00b757 years in the MMR\u2009+\u2009V group, and 6\u00b755 years in the \nMMR group. Contact with varicella cases, herpes zoster \ncases, or both, was reported in 404 (22%) children in the \nMMRV group, 348 (22%) children in the MMR\u2009+\u2009V group, \nand 77 (19%) children in the MMR control group. \nConfirmed varicella cases were recorded in 38 (2%) \nchildren in the MMRV group, 225 (14%) in the \nMMR\u2009+\u2009V group, and 149 (38%) in the MMR control group. \nThe vaccine efficacy of two-dose MMRV against all varicella \nwas 95\u00b79% (95% CI 94\u00b71\u201397\u00b71) and against moderate or \nsevere varicella was 98\u00b77% (96\u00b74\u201399\u00b75). The vaccine \nefficacy of one-dose MMR\u2009+\u2009V against all varicella was \n69\u00b78% (62\u00b78\u201375\u00b75) and against moderate or severe \nvaricella was 90\u00b70% (84\u00b72\u201393\u00b77; table 2). For both groups, \nefficacy against probable varicella cases was similar to that \nobserved for confirmed cases (data not shown). The mean \nseverity scores of first confirmed varicella cases were \n5\u00b70 (SD 2\u00b74) in the MMRV group, 5\u00b71 (2\u00b72) in the \nMMR\u2009+\u2009V group, and 7\u00b72 (3\u00b72) in the MMR control group \n(appendix).", "mimetype": "text/plain", "start_char_idx": 34577, "end_char_idx": 35922, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "574c1c82-5777-434f-8934-72f2ac04af9e": {"__data__": {"id_": "574c1c82-5777-434f-8934-72f2ac04af9e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3601d46b-fcea-452c-bd71-65c48f9597c8", "node_type": "1", "metadata": {}, "hash": "0c5512eac548e8fd6cf25696418e1afdf489022a307003f0f7f0d5ed3b2f72a8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "312f4e06-d476-45ae-a3e2-9d69a46d327e", "node_type": "1", "metadata": {}, "hash": "dd7852d1c5b7d1d93d110965319e174353689c7c76c8f167d5c10a04778d1466", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In the per-protocol persistence cohort, two doses of \nMMRV, and one dose of MMR\u2009+\u2009V induced varicella \nzoster virus antibody responses that persisted for up \nto 10 years after vaccination, with geometric mean \nconcentrations at least five-times greater than the \nthreshold for seropositivity (25 mIU/mL) at all timepoints \nassessed, with and without censoring post-infection data. \nAt 10 years, the proportion of seropositive children was \n99\u00b76% in the two-dose MMRV groups and 98\u00b74% in the \none-dose MMR\u2009+\u2009V group (figure 3). In the MMRV and \nMMR\u2009+\u2009V groups, geometric mean concentrations for \nvaricella zoster virus antibodies increased gradually from \n1\u201310 years follow-up, and at 10 years, geometric mean \nconcentrations were similar in both groups, and greater \nthan 16-times higher than the threshold for seropositivity. \nIn the MMR control group, 8\u00b74% of children were \nseropositive for varicella zoster virus antibodies at 1 year; \ngeometric mean concentrations for varicella zoster virus \nantibodies increased at all timepoints from 1 year, and \nthe proportion of seropositive children at years 2, 4, 6, 8, \nand 10 were 13\u00b76%, 30\u00b72%, 55\u00b71%, 66\u00b77%, and 73\u00b70%, \nrespectively.\nIn the total vaccinated cohort during phase a\u2009+\u2009b, a total \nof 2694 serious adverse events were reported for \n1538 children, of which none were complicated varicella \ncases; eight serious adverse events were considered \nvaccine-related by the investigator (table 3).", "mimetype": "text/plain", "start_char_idx": 35923, "end_char_idx": 37372, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "312f4e06-d476-45ae-a3e2-9d69a46d327e": {"__data__": {"id_": "312f4e06-d476-45ae-a3e2-9d69a46d327e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "574c1c82-5777-434f-8934-72f2ac04af9e", "node_type": "1", "metadata": {}, "hash": "dbe2eea8ce061198bb1a01f80ba906b585313e5fc67490f9ec9cde0e03e07f6e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0006ca69-d207-425d-9be0-40f74536c40e", "node_type": "1", "metadata": {}, "hash": "707f80af871e8ca451ee8374236c2890d11bc6cecf13d3aacc505841e821cea9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In phase a, \n57% of children in the MMRV group, 45% in the \n0\nVaricella cases (%)\n25\n20\n15\n10\n5\nA\n0\nVaccine e\ufb03cacy (%)\n100\n90\n80\n70\n60\n50\n40\n30\n20\n10\nB\n10\n9\n8\n6\n7\n5\n4\n3\n2\n1\n0\nVaricella cases (n)\nStudy year\n120\n80\n100\n60\n40\n20\nC\nMMRV\nMMR+V\nMMR\nMMRV\nMMR+V\nMMR\nMMRV versus MMR\nMMR+V versus MMR\nFigure 2: Percentage of children with a confirmed varicella case (A), vaccine \nefficacy against all varicella (B), and number of varicella cases (C) by year in \nthe per-protocol cohort for efficacy\nMMRV=measles-mumps-rubella-varicella vaccine. MMR\u2009+\u2009V=live attenuated \nvaricella vaccine after MMR. MMR=measles-mumps-rubella vaccine.\nArticles\n294\t\nwww.thelancet.com/infection   Vol 19   March 2019\nMMR\u2009+\u2009V cohort, and 40% in the MMR cohort reported \nfever of at least 38\u00b0C within 15 days of the first dose. In \nphase a, two of the serious adverse events were fatal but \nnot considered vaccine-related by the investigator \n(one accidental death due to a fire, and one accidental \ndeath due to a television set [mechanical fault]). \nReactogenicity and safety during phase a has been \npreviously reported.11 In the total vaccinated cohort, \nduring phase b, at least one serious adverse event was \nreported by 290 (15%) children in the MMRV, 317 (16%) \nin the MMR\u2009+\u2009V group, and 93 (15%) in the MMR control \ngroup. During phase a+b, 14 children withdrew from the \nstudy because of a serious adverse event. None of the \nserious adverse events reported in phase b were \nconsidered vaccine-related by the investigator, and none \nwere fatal.", "mimetype": "text/plain", "start_char_idx": 37373, "end_char_idx": 38896, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0006ca69-d207-425d-9be0-40f74536c40e": {"__data__": {"id_": "0006ca69-d207-425d-9be0-40f74536c40e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "312f4e06-d476-45ae-a3e2-9d69a46d327e", "node_type": "1", "metadata": {}, "hash": "dd7852d1c5b7d1d93d110965319e174353689c7c76c8f167d5c10a04778d1466", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "721c97ba-e2ff-4957-bad4-2f335c5a82e8", "node_type": "1", "metadata": {}, "hash": "3557437e1df4e48e39ae11d4871a46dcc9cab0c955118ae677e1d925a31e7dee", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "During phase a+b, 14 children withdrew from the \nstudy because of a serious adverse event. None of the \nserious adverse events reported in phase b were \nconsidered vaccine-related by the investigator, and none \nwere fatal.\nIn the total vaccinated cohort during phase a\u2009+\u2009b, there \nwere six confirmed cases of herpes zoster (four children in \nthe MMR\u2009+\u2009V group and two children in the MMR group), \nall of which were mild. Five children tested positive for \nthe wild-type virus and the other was negative by PCR \n(appendix). Two children in the MMR\u2009+\u2009V group and one in \nMMR group had papular lesions. Two children in MMR\u2009+\u2009V \ngroup and one child in MMR group had vesicular lesions.\nAmong parents and guardians of children with \nconfirmed varicella infection, 41\u00b76% (95% CI 30\u00b74\u201353\u00b74), \nFigure 3: Varicella zoster virus antibody persistence in the per-protocol persistence cohort\nMMRV=measles-mumps-rubella-varicella vaccine. MMR\u2009+\u2009V=live attenuated varicella vaccine after MMR. MMR=measles-mumps-rubella vaccine. GMC=geometric \nmean antibody concentration.", "mimetype": "text/plain", "start_char_idx": 38674, "end_char_idx": 39729, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "721c97ba-e2ff-4957-bad4-2f335c5a82e8": {"__data__": {"id_": "721c97ba-e2ff-4957-bad4-2f335c5a82e8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0006ca69-d207-425d-9be0-40f74536c40e", "node_type": "1", "metadata": {}, "hash": "707f80af871e8ca451ee8374236c2890d11bc6cecf13d3aacc505841e821cea9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "44f156d0-51c8-4d16-ae43-4aace24b76e5", "node_type": "1", "metadata": {}, "hash": "d1d3dde90ee9d7acb76af93958516d23bd3579091cf7d0ac326bb818722ff6c6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MMR\u2009+\u2009V=live attenuated varicella vaccine after MMR. MMR=measles-mumps-rubella vaccine. GMC=geometric \nmean antibody concentration.\nSeropositivity\nMMRV\nMMR+V\nMMR\nN (%)\nN (%)\nN (%)\nN (%)\nN (%)\nN (%)\nN (%)\nN (%)\nDay 42\nDay 84\nYear 1\nYear 2\nYear 4\nYear 6\nYear 8\nYear 10\n1169\n831\n111\n(100%)\n(98%)\n(73%)\n1146\n828\n117\n(100%)\n(97%)\n(67%)\n1292\n1021\n176\n(100%)\n(97%)\n(55%)\n1342\n1142\n242\n(99%)\n(93%)\n(30%)\n1869\n1776\n522\n(99%)\n(92%)\n(14%)\n2019\n1970\n620\n(100%)\n(96%)\n(8%)\n2209\n2191\n727\n(100%)\n  (95%)\n    (5%)\n674\n677\n229\n(96%)\n(2%)\n(2%)\nTime point\n10\n10 000\nMMRV\nMMR+V\nMMR\n1000\n100\nGMC (95% CI;", "mimetype": "text/plain", "start_char_idx": 39598, "end_char_idx": 40181, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "44f156d0-51c8-4d16-ae43-4aace24b76e5": {"__data__": {"id_": "44f156d0-51c8-4d16-ae43-4aace24b76e5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "721c97ba-e2ff-4957-bad4-2f335c5a82e8", "node_type": "1", "metadata": {}, "hash": "3557437e1df4e48e39ae11d4871a46dcc9cab0c955118ae677e1d925a31e7dee", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c4b5515f-3098-423b-900f-ace51384fa19", "node_type": "1", "metadata": {}, "hash": "4b20b350041f30ab94610cf006a69b49d335fefb91adb6fe40c10f518e5bb78f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "log10)\nSex\nCountry\nRace\nAge at \nonset \n(years)\nVerbatim\nPreferred term\nPrimary System \nOrgan Class\nType of \nmedical \nattendance\nDose\nDay of \nonset\nDuration \n(days)\nOutcome\nMMRV\nFemale\nGreece\nWhite\n1\nFebrile convulsions\nFebrile convulsion\nNervous system \ndisorders\nHO\n1\n9\n1\nRecovered or resolved\nMMR+V\nFemale\nGreece\nWhite\n1\nPapular rash linear\nHerpes zoster\nInfections and \ninfestations\nMD\n1\n24\n36\nRecovered or resolved\nMMR+V\nFemale\nGreece\nWhite\n1\nPapular vesicular rash\nRash papular\nSkin and \nsubcutaneous tissue \ndisorders\nMD\n1\n16\n10\nRecovered or resolved\nMMR+V\nMale\nSweden\nWhite\n1\nPeritonsillar abscess\nPeritonsillar abscess\nInfections and \ninfestations\nHO\n2\n6\n21\nRecovered or resolved\nMMRV\nMale\nPoland\nWhite\n1\nFebrile convulsions\nFebrile convulsion\nNervous system \ndisorders\nHO\n1\n8\n1\nRecovered or resolved\nMMR+V\nFemale\nNorway\nWhite\n1\nSuspected secondary \nbacterial infection of \nvaricella lesion\nBacterial infection\nInfections and \ninfestations\nMD\n2\n3\n13\nRecovered or resolved\nMMRV\nMale\nSweden\nWhite\n1\nFever conculsion\nFebrile convulsion\nNervous system \ndisorders\nMD\n1\n8\n1\nRecovered or resolved\nMMR\nMale\nPoland\nWhite\n1\nFebrile seizures\nFebrile convulsion\nNervous system \ndisorders\nHO\n1\n8\n1\nRecovered or resolved\nMMRV=measles-mumps-rubella-varicella vaccine. MMR+V=live attenuated varicella vaccine after MMR. MMR=measles-mumps-rubella vaccine. HO=admitted to hospital. MD=medical personnel.", "mimetype": "text/plain", "start_char_idx": 40182, "end_char_idx": 41575, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c4b5515f-3098-423b-900f-ace51384fa19": {"__data__": {"id_": "c4b5515f-3098-423b-900f-ace51384fa19", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "44f156d0-51c8-4d16-ae43-4aace24b76e5", "node_type": "1", "metadata": {}, "hash": "d1d3dde90ee9d7acb76af93958516d23bd3579091cf7d0ac326bb818722ff6c6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3dfe8ff5-6622-4291-a249-f8b3e131fb9d", "node_type": "1", "metadata": {}, "hash": "bcc0e7131233559c6147a7cd55a8ff6cfd935848ff8ab4a3a03b1d3db50fc6de", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MMR+V=live attenuated varicella vaccine after MMR. MMR=measles-mumps-rubella vaccine. HO=admitted to hospital. MD=medical personnel.\nTable 3: Overview of serious adverse events related to vaccination in the total vaccinated cohort from day 0 to 10-years follow-up\nArticles\nwww.thelancet.com/infection   Vol 19   March 2019\t\n295\n40\u00b77% (36\u00b73\u201345\u00b73), and 44\u00b71% (38\u00b78\u201349\u00b74) of the \nMMRV, MMR\u2009+\u2009V, and MMR control groups reported \nlosing time from work as a result of their child\u2019s illness. \nThe median time lost from work was 27 h in the MMRV \ngroup, 40 h in the MMR\u2009+\u2009V group, and 48 h in the MMR \ncontrol group (appendix). The median time lost from \nplanned activities, such as nursery, school, or day care \nreported by parents of children with confirmed varicella \ninfection was 36 h in the MMRV group, 42 h in the \nMMR\u2009+\u2009V group, and 50 h in the MMR control group. \nThe proportion of parents who stated that they would \nhave contacted a physician regarding their child\u2019s illness \nhad they not been in a clinical trial was 69% in the \nMMRV group, 77% in the MMR\u2009+\u2009V group, and 82% in \nthe MMR control group.\nDiscussion\nIn this phase 3b, long-term follow-up of an observer-\nblind, controlled study of children randomly assigned \n(3:3:1) to receive two doses of MMRV, one dose of \nMMR\u2009+\u2009one dose of varicella vaccine, or two doses of \nMMR control during the second year of life, we describe \nthe long-term vaccine efficacy for the prevention of \nvaricella and the persistence of varicella zoster virus \nantibodies.", "mimetype": "text/plain", "start_char_idx": 41443, "end_char_idx": 42953, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3dfe8ff5-6622-4291-a249-f8b3e131fb9d": {"__data__": {"id_": "3dfe8ff5-6622-4291-a249-f8b3e131fb9d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c4b5515f-3098-423b-900f-ace51384fa19", "node_type": "1", "metadata": {}, "hash": "4b20b350041f30ab94610cf006a69b49d335fefb91adb6fe40c10f518e5bb78f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e9b2edeb-158e-4702-9878-3fc98d7b66e4", "node_type": "1", "metadata": {}, "hash": "064e038eb372ad4883e06453d055197bcd0f7985b8d244dd169e56a090abfa9a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "During a median 9\u00b78 years follow-up, the \nvaccine efficacy of two doses of MMRV against all \n(probable and confirmed) varicella cases was 95\u00b74% \ncompared with 67\u00b72% with one dose of varicella vaccine. \nThis is consistent with phase a of the study, where at \n3 years follow-up, the vaccine efficacy of two doses of \nMMRV against all varicella cases was 94\u00b79% and for \none dose of varicella vaccine was 65\u00b74%. Our 10-year \nvaccine efficacy estimates suggest that the short two-dose \nMMRV schedule provided optimum long-term protection \nfor the prevention of all varicella, although both the \nMMRV and MMR\u2009+\u2009V schedules were effective, with \nMMRV preventing moderate or severe varicella at 99\u00b71% \nand MMR+V at 89\u00b75%.\nIn phase a, the vaccine efficacy estimates supported the \nuse of the short two-dose MMRV schedule over the one-\ndose MMR\u2009+\u2009V schedule, although it was not known \nwhether the vaccines offered long-term protection or \ndelayed the appearance of moderate or severe disease. \nPrevious studies have shown that cases of varicella are \nmilder in severity for children who are vaccinated than \nfor those who are unvaccinated, although the incidence \nof varicella is reported to increase from 1 year to up to \n10 years post vaccination.19,20 In the MMRV and MMR\u2009+\u2009V \ngroups, respectively, during the first 3 years of follow-up, \nthe rates of varicella were 0\u00b76 per 100 person-years \nand 3\u00b78 per 100 person-years, and over the 10 years \nfollow-up period were 0\u00b74 per 100 person-years and \n3\u00b72 per 100 person-years.", "mimetype": "text/plain", "start_char_idx": 42954, "end_char_idx": 44471, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e9b2edeb-158e-4702-9878-3fc98d7b66e4": {"__data__": {"id_": "e9b2edeb-158e-4702-9878-3fc98d7b66e4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3dfe8ff5-6622-4291-a249-f8b3e131fb9d", "node_type": "1", "metadata": {}, "hash": "bcc0e7131233559c6147a7cd55a8ff6cfd935848ff8ab4a3a03b1d3db50fc6de", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a3c7c0a4-d715-4f9a-98c2-7706987d5ff7", "node_type": "1", "metadata": {}, "hash": "f22c2676c554d6546adf43615f03b33c5d58499e7491a2272ddf82f5d95f8d57", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In addition, in phase a, the \nmean severity scores for cases were indicative of mild \ndisease in the MMRV group at 4\u00b78 (SD 1\u00b75) and MMR\u2009+\u2009V \ngroup at 5\u00b75 (2\u00b71), compared with moderate or severe \ndisease in the MMR control group at 8\u00b71 (2\u00b79).11 In \nphase b, the mean severity scores indicated mild disease \nin the MMRV group at 5\u00b70 (2\u00b74) and MMR\u2009+\u2009V group at \n5\u00b71 (2\u00b72), and no severe cases were reported. In the \nMMR control group, four severe cases were reported, \nand the mean severity scores were indicative of moderate \ndisease at 7\u00b72 (3\u00b72). These results suggest that among \nchildren vaccinated against varicella in the second year of \nlife, cases were milder than cases in unvaccinated \nchildren, and that the rate and severity of varicella disease \ndid not increase with time since vaccination up to \n10 years follow-up.\nIn the per-protocol persistence cohort, antibody titres \nagainst varicella zoster virus persisted at 10 years, \nwith more than 98% of children in the MMRV and \nMMR\u2009+\u2009V \ngroups \nremaining \nseropositive. \nIn \nan \nenvironment with endemic varicella, some vaccinees \nmight experience subclinical disease in the early years \nafter vaccination, which might boost varicella zoster \nvirus-specific immune responses and re-establish \nprotection. This exogenous boosting was considered to \nhave contributed to the high vaccine effectiveness in the \nearly years after mass vaccination against varicella was \nimplemented in the USA.21 Seropositivity proportions at \nday 84 were 99\u00b78% in the MMRV group and 95\u00b70% in \nthe MMR\u2009+\u2009V group, with no change at 2 years (MMRV \n99\u00b74%, MMR\u2009+\u2009V 92\u00b73%), suggesting that natural \nexposure to varicella zoster virus had no exogenous \nboosting effect of humoral immune responses during \nthe 2 years after vaccination.", "mimetype": "text/plain", "start_char_idx": 44472, "end_char_idx": 46239, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a3c7c0a4-d715-4f9a-98c2-7706987d5ff7": {"__data__": {"id_": "a3c7c0a4-d715-4f9a-98c2-7706987d5ff7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e9b2edeb-158e-4702-9878-3fc98d7b66e4", "node_type": "1", "metadata": {}, "hash": "064e038eb372ad4883e06453d055197bcd0f7985b8d244dd169e56a090abfa9a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1e005c00-f3e2-4b13-a3f0-7d27b8779c58", "node_type": "1", "metadata": {}, "hash": "7d9c8277d85d5aa5785287ae53cc9690afbebeca8100b3bb2e3d643ef500681b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "At 10 years, the proportions \nof children who were seropositive for varicella zoster \nvirus (\u226525 mIU/mL) were 99\u00b76% in the MMRV group \nand 98\u00b74% and MMR\u2009+\u2009V group, and the proportions of \nchildren with varicella zoster virus titres of at least \n50 mIU/mL were 98\u00b70% and 93\u00b77%, respectively, \nsuggesting that long-term natural exposure to varicella \nzoster virus had a modest boosting effect in the one-dose \nMMR\u2009+\u2009V group.\nThe previously reported safety profiles of the vaccines \nduring the follow-up at 2 years were consistent with the \nestablished profile of combined MMRV and monovalent \nlive attenuated varicella vaccines.22\u201325 Within 15 days of \ndose one, fever of 38\u00b0C or more and grade 3 fever were \nmore frequent in the MMRV group than the other \nvaccine groups, which is in line with various studies that \nhave reported an increased risk of febrile seizures after \nthe first dose of MMRV compared with separate \nMMR\u2009+\u2009V, although the risk is relatively low.7,26\u201329 Our \nstudy was not powered to detect increased risk of febrile \nseizures. From the start of phase b to 10 years post \nvaccination, the proportions of serious adverse events \nwere similar between the vaccine groups (14\u00b75\u201316\u00b70%), \nand none of the serious adverse events were considered \nvaccine-related by the investigator. During phase a+b, \n14 children withdrew from the study because of a serious \nadverse event, including leukaemia, rhabdomyosarcoma, \nlymphadenopathy, and thrombocytopenia.", "mimetype": "text/plain", "start_char_idx": 46240, "end_char_idx": 47706, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1e005c00-f3e2-4b13-a3f0-7d27b8779c58": {"__data__": {"id_": "1e005c00-f3e2-4b13-a3f0-7d27b8779c58", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a3c7c0a4-d715-4f9a-98c2-7706987d5ff7", "node_type": "1", "metadata": {}, "hash": "f22c2676c554d6546adf43615f03b33c5d58499e7491a2272ddf82f5d95f8d57", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "95d1f976-44cb-4e4e-bb2c-5f3e6221bd42", "node_type": "1", "metadata": {}, "hash": "5fbae4636fab3395f91be4aaaa82af61c205dee741ad30a0e5e3948588cd978f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "During phase a+b, \n14 children withdrew from the study because of a serious \nadverse event, including leukaemia, rhabdomyosarcoma, \nlymphadenopathy, and thrombocytopenia. Over the \n10 years follow-up, no new safety concerns were identified \nArticles\n296\t\nwww.thelancet.com/infection   Vol 19   March 2019\namong children who received two doses of MMRV or \none dose of MMR\u2009+\u2009V.\nDuring the one-dose varicella vaccination era in the \nUSA (1996\u20132005), the incidence of varicella cases \ndecreased by about 90%, hospitalisation for varicella \ndisease by 88%, and deaths due to varicella disease \ndecreased by more than 65%, when compared with 1995. \nFurther declines in varicella incidence and related \nhospitalisations have been observed since switching to the \ntwo-dose schedule in 2006. The proportion of cases of \nvaricella reported in children with immunocompromising \nconditions also decreased significantly in the two-dose era \nwhen compared with the one-dose era.30 The rapid \nimplementation of vaccination against varicella in other \ncountries, including Uruguay, Australia, Canada, and \nGermany, has also shown a substantial decrease in the \nincidence and severity of varicella infections in children.1\u20133,31 \nHowever, because varicella is usually perceived as a mild \ndisease in children, vaccination is not a priority for many \nstate-funded programmes, even though mild cases \nrepresent an economic burden due to the disruption of a \nchild\u2019s activities, reduced work productivity among \nparents and guardians, and the use of health-care \nservices.31 In countries that have adopted vaccination \nagainst varicella, routine childhood vaccination is reported \nto be cost-effective from a health-care perspective and a \nsocietal perspective.31\nIn each of the vaccine groups in our study, about 40% of \nparents and guardians of children with confirmed \nvaricella reported losing time from work and about \n75% reported that their child missed regular activities \nsuch as nursery or school.", "mimetype": "text/plain", "start_char_idx": 47536, "end_char_idx": 49522, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "95d1f976-44cb-4e4e-bb2c-5f3e6221bd42": {"__data__": {"id_": "95d1f976-44cb-4e4e-bb2c-5f3e6221bd42", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1e005c00-f3e2-4b13-a3f0-7d27b8779c58", "node_type": "1", "metadata": {}, "hash": "7d9c8277d85d5aa5785287ae53cc9690afbebeca8100b3bb2e3d643ef500681b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b5a96e81-fd0f-48ce-9f9b-b6fd9493c809", "node_type": "1", "metadata": {}, "hash": "ce360564452e329d5a9c59ae6b6588cc4c60dc0f090c6a74fecc7fbe40658707", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In the MMRV and MMR\u2009+\u2009V \ngroups, respectively, parents and guardians lost a mean \nof 37 h and 42 h of work time, and in the MMR control \ngroup, a mean of 52 h were lost. Moreover, in each of \nthe vaccine groups, about two-thirds of parents and \nguardians said they would have contacted a physician \nhad they not been taking part in a clinical trial, suggesting \nthat varicella disease in children is a societal and health-\ncare burden. Given that the incidence of varicella cases \nacross European countries without universal varicella \nvaccination was recently estimated to be 5\u00b75 million \nper year, the economic burden of varicella disease is \nlikely to be substantial.32\nConcerns have been raised33 regarding the potential \neffect of vaccination against varicella on the epidemiology \nof herpes zoster; however, evidence for such an association \nis scarce.34 The possible under-reporting of contacts and \ncases was a limitation of the study. In phase b, for \nexample, the lowest contact rate was reported in the MMR \ncontrol group, which also had the highest proportion of \nvaricella cases, meaning that it is probable that some \nparents did not record contacts that resulted in cases. \nMoreover, varicella zoster virus seropositivity increased at \nall timepoints in the MMR control group, and among \nchildren who remained in the study until the end and \nreported no varicella case at any point, 73\u00b70% were \nseropositive for varicella zoster virus. This suggests that \nvaricella cases were either under-reported, or that \ninfections were subclinical. A further limitation was the \nrelatively high attrition rate in the per-protocol populations \nfor efficacy across the timepoints. However, to the best of \nour knowledge, this study was the first to compare \nvaricella vaccines with a control group in a cohort of \nchildren of a uniform age in a setting where varicella \nzoster virus transmission is endemic. Additional factors \nthat increase the generalisability of the outcomes were \nthe multicentre, international design and long-term \nfollow-up, active surveillance, rigorous case-confirmation \nprocedures, and the blinded adjudication of suspected \ncases.", "mimetype": "text/plain", "start_char_idx": 49523, "end_char_idx": 51684, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b5a96e81-fd0f-48ce-9f9b-b6fd9493c809": {"__data__": {"id_": "b5a96e81-fd0f-48ce-9f9b-b6fd9493c809", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "95d1f976-44cb-4e4e-bb2c-5f3e6221bd42", "node_type": "1", "metadata": {}, "hash": "5fbae4636fab3395f91be4aaaa82af61c205dee741ad30a0e5e3948588cd978f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dd5749fd-6293-4960-89a1-e571b7dbaa3c", "node_type": "1", "metadata": {}, "hash": "c3965384bd76dc2621d6d2033654a18b3eeae743baf04b6e7ddbc81ff444dfae", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Additional factors \nthat increase the generalisability of the outcomes were \nthe multicentre, international design and long-term \nfollow-up, active surveillance, rigorous case-confirmation \nprocedures, and the blinded adjudication of suspected \ncases.\nIn a setting where varicella zoster virus is endemic \namong children allowing for natural boosting, the \ntwo-dose MMRV schedule provided optimum protection \nagainst all severities of varicella disease at 10 years. This \nis consistent with the vaccine efficacy of two doses of \nMMRV and one dose of MMR\u2009+\u2009one dose of varicella \nvaccine at 2 years post vaccination.\nContributors\nOH contributed to the conception, design and planning of the study. \nMP contributed as statistician to the method and selection development, \nthe statistical data analysis, the reporting of data and the assessment of \nrobustness of this manuscript. All authors contributed to the acquisition \nand review of the data. MARB, RC, SE, C-EF, LG, SM, S-AS, MS, VU, \nJW, and RP recruited patients. All authors contributed to the \ninterpretation of data and the drafting of the manuscript. They revised it \ncritically for important intellectual content and approved the version to \nbe published.\nDeclaration of interests\nOH, MP, and PG are employed by the GSK group of companies. \nOH and PG also hold shares in the GSK group of companies as part of \ntheir employee remuneration. LG received personal fees from the GSK \ngroup of companies for his participation as principal investigator during \nthe study. SM received personal fees from the GSK group of companies \nfor his participation as principal investigator during the study and also \nspeaker fees. SE reports having received personal fees from the GSK \ngroup of companies, Sanofi Aventis, Merck, and Vifor outside the \nsubmitted work. Honorarium was paid by the GSK group of companies \nto S-AS\u2019s institution of employment for advisory board meetings. \nM\u0160 received personal fees from the GSK group of companies for her \nparticipation as a principal investigator during the study and also for \nconsultancy and scientific meeting attendance. JW received personal \nfees from the GSK group of companies for his participation as principal \ninvestigator during the study.", "mimetype": "text/plain", "start_char_idx": 51433, "end_char_idx": 53673, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dd5749fd-6293-4960-89a1-e571b7dbaa3c": {"__data__": {"id_": "dd5749fd-6293-4960-89a1-e571b7dbaa3c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b5a96e81-fd0f-48ce-9f9b-b6fd9493c809", "node_type": "1", "metadata": {}, "hash": "ce360564452e329d5a9c59ae6b6588cc4c60dc0f090c6a74fecc7fbe40658707", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "39b37a7c-7070-4149-adfc-225c8dbd2c03", "node_type": "1", "metadata": {}, "hash": "20bbd28389afbccbf1c13e554d2a106603499c37bf07098a45b5ad51bec06afc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "JW received personal \nfees from the GSK group of companies for his participation as principal \ninvestigator during the study. RP received grants from the GSK group of \ncompanies during the study and also grants from the GSK group of \ncompanies, Sanofi Pasteur, and Novartis outside the submitted work. \nAll other authors declare no potential competing interests.\nData sharing statement\nAnonymised individual participant data and study documents can be \nrequested for further research from www.clinicalstudydatarequest.com.\nAcknowledgments\nThe authors thank the children who participated in the study and their \nparents or guardians and the Adjudication Committee. The authors also \nthank Adrian Kremer (XPE Pharma & Science, Belgium c/o GSK) \nfor publication management, and Annick Moon (Freelancer for XPE \nPharma & Science c/o GSK) and the XPE writing platform for drafting \nthe manuscript.\nReferences\n1\t\nLopez AS, Zhang J, Brown C, Bialek S. Varicella-related \nhospitalizations in the United States, 2000\u20132006: the 1-dose \nvaricella vaccination era. Pediatrics 2011; 127: 238\u201345.\nArticles\nwww.thelancet.com/infection   Vol 19   March 2019\t\n297\n2\t\nMarin M, Meissner HC, Seward JF. Varicella prevention in the \nUnited States: a review of successes and challenges. Pediatrics 2008; \n122: e744\u201351.\n3\t\nQuian J, Ruttimann R, Romero C, et al. Impact of universal \nvaricella vaccination on 1-year-olds in Uruguay: 1997\u20132005. \nArch Dis Child 2008; 93: 845\u201350.\n4\t\nYin M, Xu X, Liang Y, Ni J. Effectiveness, immunogenicity and \nsafety of one vs. two-dose varicella vaccination: a meta-analysis. \nExpert Rev Vaccines 2018; 17: 351\u201362.\n5\t\nMarin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention \nof varicella: recommendations of the Advisory Committee on \nImmunization Practices (ACIP). MMWR Recomm Rep 2007; \n56: 1\u201340.", "mimetype": "text/plain", "start_char_idx": 53548, "end_char_idx": 55362, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "39b37a7c-7070-4149-adfc-225c8dbd2c03": {"__data__": {"id_": "39b37a7c-7070-4149-adfc-225c8dbd2c03", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dd5749fd-6293-4960-89a1-e571b7dbaa3c", "node_type": "1", "metadata": {}, "hash": "c3965384bd76dc2621d6d2033654a18b3eeae743baf04b6e7ddbc81ff444dfae", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5777a53d-6489-46d9-9239-9e116196a259", "node_type": "1", "metadata": {}, "hash": "56c96b3bdc0acdc762dae3b515387210e9ab08e1875c9939ba46a0dbb7072e73", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Prevention \nof varicella: recommendations of the Advisory Committee on \nImmunization Practices (ACIP). MMWR Recomm Rep 2007; \n56: 1\u201340.\n6\t\nMa SJ, Li X, Xiong YQ, Yao AL, Chen Q. Combination \nmeasles-mumps-rubella-varicella vaccine in healthy children: \na systematic review and meta-analysis of immunogenicity and \nsafety. Medicine 2015; 94: e1721.\n7\t\nMa SJ, Xiong YQ, Jiang LN, Chen Q. Risk of febrile seizure after \nmeasles-mumps-rubella-varicella vaccine: a systematic review and \nmeta-analysis. Vaccine 2015; 33: 3636\u201349.\n8\t\nEuropean Centre for Disease Prevention and Control. Varicella \nvaccination in the European Union. https://ecdc.europa.eu/sites/\nportal/files/media/en/publications/Publications/Varicella-\nGuidance-2015.pdf (accessed July 10, 2018).\n9\t\nPriorix summary of product characteristics. GlaxoSmithKline UK, \nStockley Park West, Uxbridge, Middlesex, UB11 1BT. 2017. \nhttps://www.medicines.org.uk/emc/medicine/2054 \n(accessed Aug 18, 2017).\n10\t\nVarilrix summary of product characteristics. GlaxoSmithKline UK, \nStockley Park West, Uxbridge, Middlesex, UB11 1BT. 2017. \nhttps://www.medicines.org.uk/emc/medicine/9787 \n(accessed Aug 18, 2017).\n11\t\nPrymula R, Bergsaker MR, Esposito S, et al. Protection against \nvaricella with two doses of combined measles-mumps-rubella-\nvaricella vaccine versus one dose of monovalent varicella vaccine: \na multicentre, observer-blind, randomised, controlled trial. \nLancet 2014; 383: 1313\u201324.\n12\t\nShapiro ED, Vazquez M, Esposito D, et al. Effectiveness of 2 doses \nof varicella vaccine in children. J Infect Dis 2011; 203: 312\u201315.", "mimetype": "text/plain", "start_char_idx": 55227, "end_char_idx": 56808, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5777a53d-6489-46d9-9239-9e116196a259": {"__data__": {"id_": "5777a53d-6489-46d9-9239-9e116196a259", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "39b37a7c-7070-4149-adfc-225c8dbd2c03", "node_type": "1", "metadata": {}, "hash": "20bbd28389afbccbf1c13e554d2a106603499c37bf07098a45b5ad51bec06afc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "647246f9-711e-424b-8675-b14f8ee040a4", "node_type": "1", "metadata": {}, "hash": "01f481fa400596e6dfe9f2127384fe1f0c7e6d0e415ea9a948822ad160f02a13", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Effectiveness of 2 doses \nof varicella vaccine in children. J Infect Dis 2011; 203: 312\u201315.\n13\t\nSpackova M, Wiese-Posselt M, Dehnert M, Matysiak-Klose D, \nHeininger U, Siedler A. Comparative varicella vaccine effectiveness \nduring outbreaks in day-care centres. Vaccine 2010; 28: 686\u201391.\n14\t\nBayer O, Heininger U, Heiligensetzer C, von Kries R. Metaanalysis \nof vaccine effectiveness in varicella outbreaks. Vaccine 2007; \n25: 6655\u201360.\n15\t\nHenry O, Brzostek J, Czajka H, et al. One or two doses of live \nvaricella virus-containing vaccines: Efficacy, persistence of immune \nresponses, and safety six years after administration in healthy \nchildren during their second year of life. Vaccine 2018; 36: 381\u201387.\n16\t\nVazquez M, LaRussa PS, Gershon AA, Steinberg SP, Freudigman K, \nShapiro ED. The effectiveness of the varicella vaccine in clinical \npractice. N Engl J Med 2001; 344: 955\u201360.\n17\t\nCenters for Disease Control and Prevention. Epidemiology and \nprevention of vaccine-preventable diseases. In: Atkinson W, \nWolfe S, Hamborsky J, McIntyre L, eds. The pink book. 11th edn. \nWashington DC: Public Health Foundation, 2002.\n18\t\nJumaan A, Hughes H, Schmid S, et al. Varicella vaccine-preventable \ndisease surveillance manual. 3rd edn. Atlanta, GA, USA: Centers \nfor Disease Control. 2002; 1\u201321.\n19\t\nZhang X, Yan Y, Liu F, et al. The epidemiology and risk factors for \nbreakthrough varicella in Beijing Fengtai district. Vaccine 2012; \n30: 6186\u201389.", "mimetype": "text/plain", "start_char_idx": 56717, "end_char_idx": 58164, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "647246f9-711e-424b-8675-b14f8ee040a4": {"__data__": {"id_": "647246f9-711e-424b-8675-b14f8ee040a4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5777a53d-6489-46d9-9239-9e116196a259", "node_type": "1", "metadata": {}, "hash": "56c96b3bdc0acdc762dae3b515387210e9ab08e1875c9939ba46a0dbb7072e73", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9861027e-8bd2-45b8-a02d-a7ddf35a2e7a", "node_type": "1", "metadata": {}, "hash": "fbaeb6bd66db6fca19f05b0d4d0cf4579d0d5065402afc77f0495127b97baf86", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The epidemiology and risk factors for \nbreakthrough varicella in Beijing Fengtai district. Vaccine 2012; \n30: 6186\u201389.\n20\t Kurugol Z, Halicioglu O, Koc F, Koturoglu G, Aksit S. Varicella \nrates among unvaccinated and one-dose vaccinated healthy children \nin Izmir, Turkey. Int J Infect Dis 2011; 15: e475\u201380.\n21\t\nGoldman GS. Universal varicella vaccination: efficacy trends and \neffect on herpes zoster. Int J Toxicol 2005; 24: 205\u201313.\n22\t Dhillon S, Curran MP. Live attenuated measles, mumps, rubella, \nand varicella zoster virus vaccine (Priorix-Tetra). Paediatr Drugs \n2008; 10: 337\u201347.\n23\t Goh P, Lim FS, Han HH, Willems P. Safety and immunogenicity of \nearly vaccination with two doses of tetravalent measles-mumps-\nrubella-varicella (MMRV) vaccine in healthy children from \n9 months of age. Infection 2007; 35: 326\u201333.\n24\t\nKnuf M, Habermehl P, Zepp F, et al. Immunogenicity and safety of \ntwo doses of tetravalent measles-mumps-rubella-varicella vaccine in \nhealthy children. Pediatr Infect Dis J 2006; 25: 12\u201318.\n25\t Kreth HW, Lee BW, Kosuwon P, et al. Sixteen years of global \nexperience with the first refrigerator-stable varicella vaccine \n(Varilrix). BioDrugs 2008; 22: 387\u2013402.\n26\t Bauchau V, Van Holle L, Cohen C. Modelling hospitalisation ratios \nfor febrile convulsions and severe varicella under combined \nmeasles, mumps, rubella, and varicella (MMRV-Priorix-Tetra) \ncompared to separate MMR\u2009+\u2009V vaccination. Drug Saf 2015; \n38: 1095\u2013102.\n27\t\nKlein NP, Fireman B, Yih WK, et al.", "mimetype": "text/plain", "start_char_idx": 58046, "end_char_idx": 59540, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9861027e-8bd2-45b8-a02d-a7ddf35a2e7a": {"__data__": {"id_": "9861027e-8bd2-45b8-a02d-a7ddf35a2e7a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa-Povey (2019).pdf", "node_type": "4", "metadata": {}, "hash": "37d9557baa6ed47004bf4488d3d4fea5d535fb6f84b10e3db7c0479dbb27a383", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "647246f9-711e-424b-8675-b14f8ee040a4", "node_type": "1", "metadata": {}, "hash": "01f481fa400596e6dfe9f2127384fe1f0c7e6d0e415ea9a948822ad160f02a13", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Drug Saf 2015; \n38: 1095\u2013102.\n27\t\nKlein NP, Fireman B, Yih WK, et al. Measles-mumps-rubella-\nvaricella combination vaccine and the risk of febrile seizures. \nPediatrics 2010; 126: e1\u20138.\n28\t Schink T, Holstiege J, Kowalzik F, Zepp F, Garbe E. Risk of febrile \nconvulsions after MMRV vaccination in comparison to MMR or \nMMR\u2009+\u2009V vaccination. Vaccine 2014; 32: 645\u201350.\n29\t Macartney K, Gidding HF, Trinh L, et al. Evaluation of combination \nmeasles-mumps-rubella-varicella vaccine introduction in Australia. \nJAMA Pediatr 2017; 171: 992\u201398.\n30\t Bialek SR, Perella D, Zhang J, et al. Impact of a routine two-dose \nvaricella vaccination program on varicella epidemiology. Pediatrics \n2013; 132: e1134\u201340.\n31\t\nWutzler P, Bonanni P, Burgess M, Gershon A, Safadi MA, \nCasabona G. Varicella vaccination\u2014the global experience. \nExpert Rev Vaccines 2017; 16: 833\u201343.\n32\t Riera-Montes M, Bollaerts K, Heininger U, et al. Estimation of the \nburden of varicella in Europe before the introduction of universal \nchildhood immunization. BMC Infect Dis 2017; 17: 353.\n33\t Gidding HF, Brisson M, Macintyre CR, Burgess MA. Modelling the \nimpact of vaccination on the epidemiology of varicella zoster virus \nin Australia. Aust N Z J Public Health 2005; 29: 544\u201351.\n34\t\nPapaloukas O, Giannouli G, Papaevangelou V. Successes and \nchallenges in varicella vaccine. Ther Adv Vaccines 2014; 2: 39\u201355.", "mimetype": "text/plain", "start_char_idx": 59471, "end_char_idx": 60844, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "565a0f89-7dca-44e3-9190-dd2f0ae3708c": {"__data__": {"id_": "565a0f89-7dca-44e3-9190-dd2f0ae3708c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c1f4ce2e-0d71-4329-a846-e4d4aa7b7c3c", "node_type": "1", "metadata": {}, "hash": "84ecbbd476c294889262eafaeb0a8db82b1677f8133183b0b61b1b9818e9ba59", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Human Vaccines & Immunotherapeutics\nISSN: 2164-5515 (Print) 2164-554X (Online) Journal homepage: www.tandfonline.com/journals/khvi20\nE\ufb00ectiveness of one dose of mumps vaccine\nagainst clinically diagnosed mumps in Guangzhou,\nChina, 2006\u20132012\nChuanxi Fu, Jianxiong Xu, Yuanjun Cai, Qing He, Chunhuan Zhang, Jian Chen,\nZhiqiang Dong, Wensui Hu, Hui Wang, Wei Zhu & Ming Wang\nTo cite this article: Chuanxi Fu, Jianxiong Xu, Yuanjun Cai, Qing He, Chunhuan Zhang, Jian\nChen, Zhiqiang Dong, Wensui Hu, Hui Wang, Wei Zhu & Ming Wang (2013) E\ufb00ectiveness of one\ndose of mumps vaccine against clinically diagnosed mumps in Guangzhou, China, 2006\u20132012,\nHuman Vaccines & Immunotherapeutics, 9:12, 2524-2528, DOI: 10.4161/hv.26113\nTo link to this article:  https://doi.org/10.4161/hv.26113\nPublished online: 16 Aug 2013.\nSubmit your article to this journal \nArticle views: 421\nView related articles \nFull Terms & Conditions of access and use can be found at\nhttps://www.tandfonline.com/action/journalInformation?journalCode=khvi20\n\u00a9 2013 Landes Bioscience. Do not distribute.\nHuman Vaccines & Immunotherapeutics 9:12, 2524\u20132528; December 2013; \u00a9 2013 Landes Bioscience\n Research Paper\n2524\t\nHuman Vaccines & Immunotherapeutics\t\nVolume 9 Issue 12\nIntroduction\nMumps virus causes an acute febrile illness with a nonspecific \nprodrome followed by painful swelling of the parotid and less \ncommonly, other salivary glands.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1404, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c1f4ce2e-0d71-4329-a846-e4d4aa7b7c3c": {"__data__": {"id_": "c1f4ce2e-0d71-4329-a846-e4d4aa7b7c3c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "565a0f89-7dca-44e3-9190-dd2f0ae3708c", "node_type": "1", "metadata": {}, "hash": "b210042237475d663d570a0b9637e8c8a60830fbf156c813e48993630a58c387", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5ef2dc49-ac1e-470e-97db-68baa3761b9e", "node_type": "1", "metadata": {}, "hash": "440f2873ff03366e0f30138c98b3428e148df095c87d09f4aa2b15af7c87ac73", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Complications of mumps \ninclude deafness, mastitis, aseptic meningitis, encephalitis, \nand, in postpubertal age groups, oophoritis and orchitis.1 The \nincubation period of mumps ranges from 12\u201325 d but parotitis \nmay develop 16\u201318 d post exposure.\nAlthough mumps-containing vaccines were introduced in \nChina in 1990s, mumps continues to be a public health concern \ndue to the lack of decline in reported mumps cases. A total of \n909 087 cases of mumps were reported accumulatively in China \nduring 2008\u20132010 with annual average incidence of 22.8 per \n100\u2009000. Up to 81.8% of the cases occurred in children aged 3\u201314 \ny and 97.0% of the outbreaks occurred in child care settings and \nschools, especially in the primary schools.2,3 Reported mumps \nincidence is not declining in China, but the increase or lack of \ndecrease may be due to improved surveillance in the country.\nLocated on the Tropic of Cancer, with a subtropical climate \nwith an average temperature of 22.9 \u00b0C, Guangzhou is the \nlargest metropolis in Southern China with a population over \n12.75 million in 2012. Mumps has been a notifiable disease since \n1990 in Guangzhou; 18\u2009072 mumps cases were reported during \n2004 to 2012 (Fig.\u00a01), with the peak period of May to August \neach year. The international measles-mumps-rubella (MMR) \nvaccine (Jeryl-Lynn and RIT4385) was introduced in 1990 in \nGuangzhou.", "mimetype": "text/plain", "start_char_idx": 1405, "end_char_idx": 2775, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5ef2dc49-ac1e-470e-97db-68baa3761b9e": {"__data__": {"id_": "5ef2dc49-ac1e-470e-97db-68baa3761b9e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c1f4ce2e-0d71-4329-a846-e4d4aa7b7c3c", "node_type": "1", "metadata": {}, "hash": "84ecbbd476c294889262eafaeb0a8db82b1677f8133183b0b61b1b9818e9ba59", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ee92081b-0fc2-4319-9a3a-0762d9a77df1", "node_type": "1", "metadata": {}, "hash": "de836daceba4b9594c5b54b5e6edcc0720dc2251468c648d63ee02f7568048c9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The international measles-mumps-rubella (MMR) \nvaccine (Jeryl-Lynn and RIT4385) was introduced in 1990 in \nGuangzhou. Since 1995, domestic live attenuated mumps vaccine \n(S79 and Wm84 strain, derived from Jery1-Lynn) has been in use \nin Guangzhou and is provided to children more than 8 mo of age.4 \nPrevious evaluations of the mumps vaccine effectiveness (VE) in \nGuangzhou during 2004\u20132005 showed a moderate protection of \n86.0% (95% CI, 77.2\u201391.5%) to children aged 8 mo to 12 y.4,5 \nSince 2008, MMR or MM (measles-mumps) vaccine has been \nadministered to children 18\u201324 mo of age as part of the national \nroutine vaccination schedule. To continue to assess the mumps \nVE in Guangzhou, China during 2006 to 2012, we performed a \n1:1 matched case-control study.\n*Correspondence to: Ming Wang; Email: wangming@gzcdc.org.cn\nSubmitted: 04/25/2013; Revised: 07/23/2013; Accepted: 08/12/2013\nhttp://dx.doi.org/10.4161/hv.26113\nEffectiveness of one dose of mumps vaccine \nagainst clinically diagnosed mumps \nin Guangzhou, China, 2006\u20132012\nChuanxi Fu\u2020, Jianxiong Xu\u2020, Yuanjun Cai, Qing He, Chunhuan Zhang, Jian Chen, Zhiqiang Dong, Wensui Hu, Hui Wang,  \nWei Zhu, and Ming Wang*\nGuangzhou Center for Disease Control and Prevention; Guangzhou, PR China\n\u2020These authors contributed equally to this work.\nKeywords: mumps, vaccine effectiveness, matched case-control studies, children, China\nAlthough mumps-containing vaccines were introduced in China in 1990s, mumps continues to be a public health \nconcern due to the lack of decline in reported mumps cases. To assess the mumps vaccine effectiveness (VE) in \nGuangzhou, China, we performed a 1:1 matched case-control study.", "mimetype": "text/plain", "start_char_idx": 2658, "end_char_idx": 4324, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ee92081b-0fc2-4319-9a3a-0762d9a77df1": {"__data__": {"id_": "ee92081b-0fc2-4319-9a3a-0762d9a77df1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5ef2dc49-ac1e-470e-97db-68baa3761b9e", "node_type": "1", "metadata": {}, "hash": "440f2873ff03366e0f30138c98b3428e148df095c87d09f4aa2b15af7c87ac73", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5b09f1d5-6a37-4ab1-9831-0dc9580b20bd", "node_type": "1", "metadata": {}, "hash": "72a497389e2232e3423c6a0bdf61a224afb4b6f826bb9ce385b14345af748d21", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "To assess the mumps vaccine effectiveness (VE) in \nGuangzhou, China, we performed a 1:1 matched case-control study. Among children in Guangzhou aged 8 mo to 12 y \nduring 2006 to 2012, we matched one healthy child to each child with clinically diagnosed mumps. Cases with clinically \ndiagnosed mumps were identified from surveillance sites system and healthy controls were randomly sampled from \nthe Children\u2019s Expanded Programmed Immunization Administrative Computerized System in Guangzhou. Conditional \nlogistic regression was used to calculate VE. We analyzed the vaccination information for 1983 mumps case subjects \nand 1983 matched controls and found that the overall VE for 1 dose of mumps vaccine, irrespective of the manufacture, \nwas 53.6% (95% confidence interval [CI], 41.0\u201363.5%) to children aged 8 mo to 12 y. This post-marketing mumps VE \nstudy found that immunization with one dose of the mumps vaccine confers partial protection against mumps disease. \nEvaluation of the VE for the current mumps vaccines, introduction of a second dose of mumps vaccine, and assessment \nof modifications to childhood immunization schedules is essential.\n\u00a9 2013 Landes Bioscience. Do not distribute.\nwww.landesbioscience.com\t\nHuman Vaccines & Immunotherapeutics\t\n2525\n Research Paper\nResearch Paper\nResults\nOf the 11\u2009579 reported mumps cases in Guangzhou between \nMay 1 and August 31, during 2006 to 2012, 4629 (40.0%) \nmumps case subjects were randomly sampled. A group of 1983 \ncase subjects (42.8%) and 1983 controls were finally included \nin our analysis. The remaining 57.2% of 4629 cases were not \nenrolled because they could not be identified in the Children EPI \nAdministrative Computerized System. The sampled cases did not \ndiffer from the included cases in respect to gender (3078 males \nvs. 1551 females 1.98:1, 1294 males vs.", "mimetype": "text/plain", "start_char_idx": 4209, "end_char_idx": 6046, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5b09f1d5-6a37-4ab1-9831-0dc9580b20bd": {"__data__": {"id_": "5b09f1d5-6a37-4ab1-9831-0dc9580b20bd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ee92081b-0fc2-4319-9a3a-0762d9a77df1", "node_type": "1", "metadata": {}, "hash": "de836daceba4b9594c5b54b5e6edcc0720dc2251468c648d63ee02f7568048c9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a090bae2-6e6b-479f-a252-8a00bfc85dc9", "node_type": "1", "metadata": {}, "hash": "1240f4b6312a274964fc8ca85d4fd8b08693fac3c9e8084316e4dc830c003e12", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The sampled cases did not \ndiffer from the included cases in respect to gender (3078 males \nvs. 1551 females 1.98:1, 1294 males vs. 689 females 1.88; \u03c72 = \n0.952, p = 0.329), but the sampled cases were older than included \ncases (5.36 \u00b1 2.55 y old, 4.53 \u00b1 2.42 y old; t = 12.233, p = 0.000).\nThe median age of case subjects at time of diagnosis was 4.53 \ny (range: 8 mo to 11.83 y). Among the 3966 study participants, \n2217 (55.9%) had received 1 dose of mumps vaccine. The \npercentage of vaccinated controls was higher than the percentage \nof vaccinated cases (62.7% vs. 49.1%)(Table 1).\nAfter adjusting for vaccination age, the overall VE of one dose \nof the mumps vaccine relative to no vaccination was 53.6% (95% \nCI, 41.0\u201363.5%) for the prevention of clinical mumps among \nchildren aged 8 mo to 12 y (Table 2). Mumps vaccination \nprovided a moderate protection for children aged 19 mo to 12 \ny old. And no protective effect was observed for children aged \n8 to 18 mo. The VE reached statistical significance during the \nfirst 8 y. The international vaccine provided 51.3% (95%CI, \n7.2\u201374.4%) protection for children, while no protective effect \nwas found for domestic vaccine.\nDiscussion\nWe analyzed the vaccination information for 1983 mumps \ncase subjects and 1983 matched controls aged 8 mo to 12 y from \n2006 to 2012 in Guangzhou, China. The overall VE for 1 dose \nof mumps vaccine, irrespective of the manufacture, was 53.6% \n(95% CI, 41.0\u201363.5%). This post-marketing mumps VE study \nfound that immunization with one dose of the mumps vaccine \nconfers partial protection against mumps disease. VE since \nnine years after vaccination was lack of statistical power and the \nsmall sample size (2 vaccinated cases) might be a contributing \nfactor.", "mimetype": "text/plain", "start_char_idx": 5915, "end_char_idx": 7668, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a090bae2-6e6b-479f-a252-8a00bfc85dc9": {"__data__": {"id_": "a090bae2-6e6b-479f-a252-8a00bfc85dc9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5b09f1d5-6a37-4ab1-9831-0dc9580b20bd", "node_type": "1", "metadata": {}, "hash": "72a497389e2232e3423c6a0bdf61a224afb4b6f826bb9ce385b14345af748d21", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1c17262d-58b2-4838-8717-46fe90a7c9d0", "node_type": "1", "metadata": {}, "hash": "4e4c0edebaf46c317b6f958e3ebabc0784b832e8dd359c396fc45a1b64186e20", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "VE since \nnine years after vaccination was lack of statistical power and the \nsmall sample size (2 vaccinated cases) might be a contributing \nfactor.\nMMR or MM vaccine has been included in the National \nImmunization Program in China in 2008. That is to say, eligible \nchildren aged 8\u201324 mo are able to mainly receive free domestic \nMMR or MM vaccine for preventing mumps. However, the \nvaccinations among children older than 2 y have to be paid by \ntheir guardians. Consequently, the mumps vaccination coverage \nmay increase dramatically since 2008 among children 8\u201324 mo. \nThe mumps incidence rate among children of 3\u201312 y old may be \nhigher than other age groups, since this cohort was not \u201celigible\u201d \nfor vaccination under the prior National Immunization Program. \nSome parents may choose international vaccines for their children \n(8\u201324 mo) even if the extra charges, because they would believe \nthat international vaccines may provide better protection than the \ndomestic vaccines. As a result, vaccine type is highly correlated \nwith age at vaccination, the younger children may be likely to \nreceive domestic vaccines rather than international vaccines, \nand the older children would receive both kind of vaccines. \nDue to the 63.7% missing of the manufacture information in \nthe electronic system, the small sample size in the study made it \nhard to conduct separately by vaccine type to address whether VE \nwanes over time, we only addressed it in general.\nThe 1 dose VE for Jeryl Lynn-containing mumps vaccine \nranges from 49\u201388% (median: 77%).6,7 There is dearth of \nstudies that have examined vaccine effectiveness exclusively \nfor mumps vaccines containing the RIT 4385 strain although \nthere are several published studies that include individuals who \nreceived the RIT 4385 strain mumps vaccine.8,9 The VE for the \nRIT 4385 strain is expected to be similar to the Jeryl-Lynn strain \nas it is a derivative of the Jery1-Lynn strain.", "mimetype": "text/plain", "start_char_idx": 7519, "end_char_idx": 9463, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1c17262d-58b2-4838-8717-46fe90a7c9d0": {"__data__": {"id_": "1c17262d-58b2-4838-8717-46fe90a7c9d0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a090bae2-6e6b-479f-a252-8a00bfc85dc9", "node_type": "1", "metadata": {}, "hash": "1240f4b6312a274964fc8ca85d4fd8b08693fac3c9e8084316e4dc830c003e12", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9bb79566-e4f4-4614-a454-84545d6a1493", "node_type": "1", "metadata": {}, "hash": "b77e8935074b3b6acece11d60cb81f7514f1e2be057ff2b0a558fbad7656d071", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Our VE estimate for 1 dose of mumps vaccine for the \ninternational mumps vaccine is similar to lower range Jery1 \nLynn-containing vaccine, ie, 49\u201366%6,8,10\u201313 and VE for \noutbreaks in Zhongshan, China in 2008 (65%).14 Different study \ndesigns, including case definition, and availability of vaccination \ninformation, may lead to the variable findings. Other possible \nfactors include the response to a mumps virus genotype. The \ndistribution of mumps virus genotypes (especially the small \nhydrophobic protein gene) varies extensively both temporally \nand geographically.15-17 However, we cannot compare the \nprevalent serotype with other areas because there is no such data \nin Guangzhou, even little is known on the presence of antibody \nFigure\u00a01. Mumps incidence in Guangzhou during 2004\u20132012 (per 100\u2009000).\n\u00a9 2013 Landes Bioscience. Do not distribute.\n2526\t\nHuman Vaccines & Immunotherapeutics\t\nVolume 9 Issue 12\nto mumps virus in Guangzhou. Future work should be taken to \nreveal the circulation of mumps virus in Guangzhou.\nThe difference between the VE for the domestic vaccine in \nour study and that from the controlled random clinical trials may \nbe related to the cold chain. Conditions in the cold chain may not \nbe as adequate as required.18 In addition, with a wide spectrum \nof vaccine recipients, it is possible that the observed impact of \nvaccination is lower than results from the controlled random \nclinical trials. Another possible reason is that this study has \nlonger follow-up than most clinical trials, which typically have \nvery short-term follow-up.19 Although there are no established \nimmunologic correlates of mumps protection in China, mumps \nVE estimates are usually based on serological studies, which \nhave shown to provide moderate protection to children. A \nmeta-analysis based on 23 studies on domestic or international \nmumps vaccines conducted from 1979 to 2011 showed that the \nhemagglutination inhibition antibody positive conversion rate \nwas 23.2\u201393.2%.20\nThere are several strengths to this study.", "mimetype": "text/plain", "start_char_idx": 9464, "end_char_idx": 11504, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9bb79566-e4f4-4614-a454-84545d6a1493": {"__data__": {"id_": "9bb79566-e4f4-4614-a454-84545d6a1493", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1c17262d-58b2-4838-8717-46fe90a7c9d0", "node_type": "1", "metadata": {}, "hash": "4e4c0edebaf46c317b6f958e3ebabc0784b832e8dd359c396fc45a1b64186e20", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "68e975fa-6982-401c-a7a6-9acf1366de01", "node_type": "1", "metadata": {}, "hash": "ea6ee459f9b5b2cbdb3fa7c3f0b4eead2eaf23772dab61bc0073e636f8bd4dea", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Above all, by using \ninformation about cases\u2019 clinical diagnoses from the surveillance \nsystem and vaccination records from the children\u2019s EPI \nAdministrative Computerized System, we eliminated the recall \nbias that is a common problem in traditional case-control studies. \nA second strength is that controls matched cases with respect \nto the street where cases lived, thus cases and controls may be \ncomparable to exposure to mumps, regardless of underlying \nmedical condition and family financial status, which improve \nthe validity of the results.\nOur study has several limitations. First, approximately \n60% of the case subjects were missing from the computerized \nsystem EPI system. It is possible that the exclusion of these \ncase subjects may reduce the generalizability of our findings. \nThis may be due to children from neighboring cities who seek \nmedical treatment in Guangzhou, or the floating children \nlived in Guangzhou. Missing vaccination records may be more \nfrequent among unvaccinated children, which can result in a \nnegative bias to the results. However, according to sample size \ncalculations, based on Schlesselman\u2019s equation for matched case-\ncontrol studies, the large sample size (especially in the 2011\u201312 \nseason) could be sufficient to provide insightful evidence on the \nmumps VE, our findings could provide insightful evidence on \nthe mumps VE. Second, the sample may not be representative \nof all mumps patients in that the cases in our study were not \nlaboratory confirmed and some of the controls may have been \nlatent or subclinical cases. Third, we did not collect and estimate \nother potential confounders, e.g., co-morbidity, socio-economic \nstatus, physical health status, and the severity of mumps cases. \nThe collection of these factors may have been important because \nthey may indicate children with underlying health problems and/\nor children who may be more likely to present to the hospital, \nwhich could result in positive or negative biases. Fourth, mumps \ncomplications such as deafness and orchitis were not investigated \namong the cases, which is also a shortcoming and thus we failed \nto calculate the VE against mumps complications. Finally, \ncompared with the prospective VE studies conducted in special \nhospitals (outpatient or inpatient), the retrospective case-control \nstudy may be less comparable in every subject (cases vs.", "mimetype": "text/plain", "start_char_idx": 11505, "end_char_idx": 13891, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "68e975fa-6982-401c-a7a6-9acf1366de01": {"__data__": {"id_": "68e975fa-6982-401c-a7a6-9acf1366de01", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9bb79566-e4f4-4614-a454-84545d6a1493", "node_type": "1", "metadata": {}, "hash": "b77e8935074b3b6acece11d60cb81f7514f1e2be057ff2b0a558fbad7656d071", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "252ec247-3290-4361-9688-3df0ae02c986", "node_type": "1", "metadata": {}, "hash": "e45f6bb2d73bddf12559f8693540450db0d6fe2950a021d320383e08e2dcd744", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Finally, \ncompared with the prospective VE studies conducted in special \nhospitals (outpatient or inpatient), the retrospective case-control \nstudy may be less comparable in every subject (cases vs. controls) \nwithin the same age category equally exposed to mumps virus.\nOur study indicates that one dose of mumps vaccine \nadministered between 19 mo to 12 y of age confers partial \nprotection against mumps but with the possibility of waning \nimmunity. With the increasing number of mumps cases in \nChina, we believe that mumps-containing vaccination should be \ncontinued. What\u2019s more, the mumps VE against complications \nin theory could be higher than against parotitis. Although the \nVE of longer time-periods since vaccination are mostly not \nstatistically significant, this study also suggests that mumps VE \nmay decline nine years after vaccination, and previous studies also \ndocumented increased risk of developing mumps with increasing \ntime after vaccination.9,21 The second dose of mumps-containing \nvaccination campaign should be added in the national schedule, \nmay be performed in ~11 y old. Otherwise, providing catch-up \nvaccination opportunities for older children who were not \neligible for the national vaccination schedule also would increase \nvaccination coverage in the age groups most affected by mumps. \nEfforts to explore modifications in the immunization schedule \nto optimize the performance of the current vaccine for mumps \ncontrol should be encouraged.\nTable\u00a01. Demographic characteristics of study subjects\nNumber of mumps \ncases/total (%)\nNumber of controls/total (%)\nP value\nGender\n1.000\nMale\n1294(65.3)\n1294(65.3)\nArea\n1.000\nUrban\n479(24.2)\n479(24.2)\nRural\n732(36.9)\n732(36.9)\nAge of onseta\n4.53 \u00b1 2.42\n4.54 \u00b1 2.43\n0.943\nVaccinatedb\n974(49.1)\n1243(62.7)\n0.000\nAge of vaccinationa,c\n1.60 \u00b1 0.76\n1.63 \u00b1 0.74\n0.262\naTwo-sample t-test was used to analyze group difference. Mean \u00b1 standard deviation. bVaccination vs. No vaccination.", "mimetype": "text/plain", "start_char_idx": 13693, "end_char_idx": 15654, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "252ec247-3290-4361-9688-3df0ae02c986": {"__data__": {"id_": "252ec247-3290-4361-9688-3df0ae02c986", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "68e975fa-6982-401c-a7a6-9acf1366de01", "node_type": "1", "metadata": {}, "hash": "ea6ee459f9b5b2cbdb3fa7c3f0b4eead2eaf23772dab61bc0073e636f8bd4dea", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "315e93d3-e8c1-4982-b3e4-411b20568e92", "node_type": "1", "metadata": {}, "hash": "2e04ba075965ca1283c112dad6e43c9b8eaadb14f1d456d54d505069fd2f50d3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Mean \u00b1 standard deviation. bVaccination vs. No vaccination. \u03c72 test was used to \nanalyze group differences. cOnly included children received mumps vaccines.\n\u00a9 2013 Landes Bioscience. Do not distribute.\nwww.landesbioscience.com\t\nHuman Vaccines & Immunotherapeutics\t\n2527\nMethods\nCase subjects, 8 mo to 12 y of age, were randomly selected from \ntwo electronic databases in Guangzhou: the Notifiable Disease \nReporting System and the Children\u2019s Expanded Programmed \nImmunization (EPI) Administrative Computerized System, \nwhich have been described in detail elsewhere.22 A mumps case \nwas defined as having acute onset of unilateral or bilateral tender \nswelling of the parotid of salivary gland lasting two or more \ndays without any other apparent cause.4 Bacterial infection was \nexcluded by the absence of an increase in the white blood cell \ncount. Because of the large number of cases reported each year, \nthe case subjects were selected by the simple random sampling \nmethod from May to August, the peak mumps reporting periods, \nduring 2006 to 2012.\nControls were randomly selected among children, aged 8 mo \nto 12 y, listed in the Children\u2019s EPI Administrative Computerized \nSystem, which was designed to manage the immunization records \nof children less than 7 y of age in Guangzhou in 1997. The EPI \nsystem allows health care workers to easily record, retrieve and \nanalyze all children\u2019s vaccination information; registration of \nvaccination information in the system is required.23,24 Controls \nwere accepted if they did not have prior history of mumps, as \nconfirmed by a phone call by physicians from the Guangzhou \nCenter for Disease Control and Prevention (GZCDC). A list of \npotential controls with sequence number for each case subject was \nthen created and matched by birth date, gender, and residence \n(living area, in the same community or village, and residence was \ncategorized into urban, rural, and rural-urban continuum area). \nA random number was used to select the potential control. If the \npotential control declined to participate and/or had prior history \nof mumps disease, a control candidate with the next closet date of \nbirth to the case subject was enrolled to participate.", "mimetype": "text/plain", "start_char_idx": 15595, "end_char_idx": 17802, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "315e93d3-e8c1-4982-b3e4-411b20568e92": {"__data__": {"id_": "315e93d3-e8c1-4982-b3e4-411b20568e92", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "252ec247-3290-4361-9688-3df0ae02c986", "node_type": "1", "metadata": {}, "hash": "e45f6bb2d73bddf12559f8693540450db0d6fe2950a021d320383e08e2dcd744", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a38ae011-abd5-448e-bf01-18afa421570f", "node_type": "1", "metadata": {}, "hash": "f7e7e15bce3d95c2c37cbc29b52f89f6a5ae4367b242c0654454af68783603c1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "If the \npotential control declined to participate and/or had prior history \nof mumps disease, a control candidate with the next closet date of \nbirth to the case subject was enrolled to participate.\nVE was calculated as one minus the odds ratio (OR) \u00d7 100%, \nwhere the odds of mumps among the vaccinated subjects was \ncompared with the odds of mumps among the unvaccinated \nsubjects as before.25 For cases, only mumps vaccinations received \nat least 30 d before the onset of mumps disease were considered \nvalid. For controls, we considered only doses administered up \nto 30 d before the date of symptom onset in the corresponding \ncase subject. The vaccines were categorized either as domestic \nor international based on (1) manufacture information in the \ndatabase and (2) the age of receipt of the vaccine. For example: If \nthe information of the manufacture was missing but the subject \ndid receive a vaccine when less than 12 mo of age then \u2018domestic\u2019 \nwas assigned to the manufacture.\nSPSS statistical software (version 16.0, SPSS, Inc.) was used \nfor data validation and statistical analysis. Vaccination age and \nvaccination status were included in the model. Using the methods \nby Niccolai LM to calculate VE for time since vaccination and \nage at the time of vaccination.26 p \u2264 0.05 was regarded as a \nTable\u00a02. Estimates of the effectiveness of one dose mumps vaccination in children 8 mo to 12 y old, multivariate conditional logistic regression analysis\nVaccinated case (%)\nVaccianted \ncontrol (%)\nVaccine effectiveness \n(95%CI),%\nP \nVaccination age (months)\n8\u201311\n95(75.4)\n96(76.2)\n98.5(-14734584.4,100.0)\n0.610\n12\u201318\n443(80.8)\n538(83.7)\n50.0(-451.4,95.5)\n0.571\n19\u201324\n315(76.3)\n447(86.0)\n75.0(33.4,90.6)\n0.006\n\u226525\n121(13.5)\n162(23.3)\n64.6(46.0,76.8)\n<0.0001\nTime since vaccination (year)\n< 1\n202(10.", "mimetype": "text/plain", "start_char_idx": 17604, "end_char_idx": 19415, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a38ae011-abd5-448e-bf01-18afa421570f": {"__data__": {"id_": "a38ae011-abd5-448e-bf01-18afa421570f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "315e93d3-e8c1-4982-b3e4-411b20568e92", "node_type": "1", "metadata": {}, "hash": "2e04ba075965ca1283c112dad6e43c9b8eaadb14f1d456d54d505069fd2f50d3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "362d480b-a168-4fc7-973c-bb3292d77dc5", "node_type": "1", "metadata": {}, "hash": "76d012e548fb1c3b0a094ad2f73fde90ecd7cd372f915c296a74b1dde2c6f86b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "006\n\u226525\n121(13.5)\n162(23.3)\n64.6(46.0,76.8)\n<0.0001\nTime since vaccination (year)\n< 1\n202(10.2)\n269(13.6)\n53.6 (37.8,65.4)\n<0.0001\n1\n221(11.1)\n260(13.1)\n49.0(28.7,63.5)\n<0.0001\n2\n150(7.6)\n196(9.9)\n54.5(34.0,68.6)\n<0.0001\n3\n101(5.1)\n132(6.7)\n52.0(27.0, 68.4)\n0.001\n4\n73(3.7)\n110(5.5)\n62.8(40.3,76.9)\n<0.0001\n5\n80(4.0)\n93(4.7)\n56.0(25.0,74.2)\n0.003\n6\n58(2.9)\n76(3.8)\n57.4(25.9,75.5)\n0.002\n7\n57(2.9)\n66(3.3)\n52.4(12.8,74.0)\n0.016\n8\n30(1.5)\n36(1.8)\n52.9(1.2,77.6)\n0.046\n\u22659\n2(0.1)\n5(0.3)\n87.7(-18.6,98.7)\n0.07\nManufacturer\nInternational\n112(5.6)\n145(7.3)\n51.3(7.2,74.4)\n0.029\nDomestic\n242(12.2)\n261(7.3)\n21.4(-54.2,59.9)\n0.484\nMissing\n620(31.3)\n837(42.2)\n57.8(42.1,69.3)\n<0.0001\nTotal\n974(49.1)\n1243(62.7)\n53.6(41.0,63.5)\n<0.0001\n\u00a9 2013 Landes Bioscience. Do not distribute.", "mimetype": "text/plain", "start_char_idx": 19322, "end_char_idx": 20091, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "362d480b-a168-4fc7-973c-bb3292d77dc5": {"__data__": {"id_": "362d480b-a168-4fc7-973c-bb3292d77dc5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a38ae011-abd5-448e-bf01-18afa421570f", "node_type": "1", "metadata": {}, "hash": "f7e7e15bce3d95c2c37cbc29b52f89f6a5ae4367b242c0654454af68783603c1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cb47377d-d18b-42d9-9df7-871b1d9fd4cf", "node_type": "1", "metadata": {}, "hash": "c654ff6ee58fc9cd26b3319098cbacf83795a36d39420dc9e78bd3d0832c50f9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1)\n1243(62.7)\n53.6(41.0,63.5)\n<0.0001\n\u00a9 2013 Landes Bioscience. Do not distribute.\n2528\t\nHuman Vaccines & Immunotherapeutics\t\nVolume 9 Issue 12\nstatistically significant difference. Study approval was obtained \nfrom the GZCDC ethics committee.\nDisclosure of Potential Conflicts of Interest\nThe authors have no other conflicts of interest or funding to \ndisclose.\nFunding\nThis work was supported by grants from the National Science \nand Technology Major Projects of China\uff08No. 2012ZX10004213-\n005\uff09, the Guangdong Provincial Department of Science and \nTechnology (2011B061300044 and 2012B091100045) and the \nDepartment of Guangzhou Science and Information Technology \n(2012J5100005). The funders had no role in the study design, \ndata collection or analysis, decision to publish, or preparation of \nthe manuscript.\nAcknowledgments\nWe would like to thank the healthcare personnel and staff \nwho collaborated in this study. We wish to also give thanks to Dr \nPreeta K Kutty, who provided her helpful comments during the \nmanuscript preparation process.\nReferences\n1.\t\nHviid A, Rubin S, M\u00fchlemann K. Mumps. Lancet \n2008; 371:932-44; PMID:18342688; http://dx.doi.\norg/10.1016/S0140-6736(08)60419-5\n2.\t\nFei F, Feng L, Xu Z, Feng Z. Epidemiology of mumps \nin China, 2008-2010. Dis Surveill 2011; 26:691-3\n3.\t\nYin D, Fan C, Cao L, Wang H, Zhou Y, Liang X. \nEpidemiological analysis of epidemic parotitis \nin China from 2004 to 2006. Dis Surveill 2007; \n22:310-1\n4.\t\nFu C, Liang J, Wang M. Matched case-control \nstudy of effectiveness of live, attenuated S79 mumps \nvirus vaccine against clinical mumps.", "mimetype": "text/plain", "start_char_idx": 20009, "end_char_idx": 21601, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cb47377d-d18b-42d9-9df7-871b1d9fd4cf": {"__data__": {"id_": "cb47377d-d18b-42d9-9df7-871b1d9fd4cf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "362d480b-a168-4fc7-973c-bb3292d77dc5", "node_type": "1", "metadata": {}, "hash": "76d012e548fb1c3b0a094ad2f73fde90ecd7cd372f915c296a74b1dde2c6f86b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7889789b-8ac8-4f0a-9195-61c9f89f5ba9", "node_type": "1", "metadata": {}, "hash": "37a0fb94413b34667ecabb512c02d140e30b2458a2fd8bec11a29db2aeb0176b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Fu C, Liang J, Wang M. Matched case-control \nstudy of effectiveness of live, attenuated S79 mumps \nvirus vaccine against clinical mumps. Clin Vaccine \nImmunol 2008; 15:1425-8; PMID:18667635; http://\ndx.doi.org/10.1128/CVI.00122-08\n5.\t\nFu CX, Nie J, Liang JH, Wang M. Evaluation of \nlive attenuated S79 mumps vaccine effectiveness in \nmumps outbreaks: a matched case-control study. Chin \nMed J (Engl) 2009; 122:307-10; PMID:19236809\n6.\t\nDeeks SL, Lim GH, Simpson MA, Gagn\u00e9 L, \nGubbay J, Kristjanson E, Fung C, Crowcroft NS. \nAn assessment of mumps vaccine effectiveness by \ndose during an outbreak in Canada. CMAJ 2011; \n183:1014-20; \nPMID:21576295; \nhttp://dx.doi.\norg/10.1503/cmaj.101371\n7.\t\nWorld \nHealth \nOrganization. \nImmunological \nbasis \nfor \nimmunization: \nMumps. \n24 \nNovember \n2010.http://whqlibdoc.who.int/\npublications/2010/9789241500661_eng.pdf.\n8.\t\nHarling R, White JM, Ramsay ME, Macsween KF, \nvan den Bosch C. The effectiveness of the mumps \ncomponent of the MMR vaccine: a case control study. \nVaccine 2005; 23:4070-4; PMID:15950329; http://\ndx.doi.org/10.1016/j.vaccine.2004.10.020\n9.\t\nCohen C, White JM, Savage EJ, Glynn JR, Choi \nY, Andrews N, Brown D, Ramsay ME. Vaccine \neffectiveness \nestimates, \n2004-2005 \nmumps \noutbreak, England. Emerg Infect Dis 2007; 13:12-7; \nPMID:17370510\n10.", "mimetype": "text/plain", "start_char_idx": 21465, "end_char_idx": 22772, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7889789b-8ac8-4f0a-9195-61c9f89f5ba9": {"__data__": {"id_": "7889789b-8ac8-4f0a-9195-61c9f89f5ba9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cb47377d-d18b-42d9-9df7-871b1d9fd4cf", "node_type": "1", "metadata": {}, "hash": "c654ff6ee58fc9cd26b3319098cbacf83795a36d39420dc9e78bd3d0832c50f9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f7eaa3e7-44d8-4489-a604-25a581d7c64a", "node_type": "1", "metadata": {}, "hash": "c90715fdf78c2e3d09ae9f8784c80b0e6060bfad3670e84ea0ed768e77cbeaf1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Emerg Infect Dis 2007; 13:12-7; \nPMID:17370510\n10.\t Castilla J, Garc\u00eda Cenoz M, Arriazu M, Fern\u00e1ndez-\nAlonso M, Mart\u00ednez-Artola V, Etxeberria J, Irisarri F, \nBarricarte A. Effectiveness of Jeryl Lynn-containing \nvaccine in Spanish children. Vaccine 2009; 27:2089-\n93; PMID:19356610; http://dx.doi.org/10.1016/j.\nvaccine.2009.02.001\n11.\t Sartorius B, Penttinen P, Nilsson J, Johansen K, \nJ\u00f6nsson K, Arneborn M, L\u00f6fdahl M, Giesecke J. An \noutbreak of mumps in Sweden, February-April 2004. \nEuro Surveill 2005; 10:191-3; PMID:16280614\n12.\t Chamot E, Toscani L, Egger P, Germann D, Bourquin \nC. [Estimation of the efficacy of three strains of \nmumps vaccines during an epidemic of mumps in the \nGeneva canton (Switzerland)]. Rev Epidemiol Sante \nPublique 1998; 46:100-7; PMID:9592852\n13.\t Toscani L, Batou M, Bouvier P, Schlaepfer A. \n[Comparison of the efficacy of various strains of \nmumps vaccine: a school survey]. Soz Praventivmed \n1996; 41:341-7; PMID:9027138; http://dx.doi.\norg/10.1007/BF01324283\n14.\t Man W, Jin-Kou Z, Tao W, Li-Xin H, Chao M, \nQi-Ru S, Hui-Ming L. Mumps-containing vaccine \neffectiveness during outbreaks in two schools in \nGuangdong, China, 2012. Western Pac Surveill \nResponse J 2012; 3:29-32; PMID:23908936; http://\ndx.doi.org/10.5365/wpsar.2012.3.4.012\n15.", "mimetype": "text/plain", "start_char_idx": 22722, "end_char_idx": 24005, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f7eaa3e7-44d8-4489-a604-25a581d7c64a": {"__data__": {"id_": "f7eaa3e7-44d8-4489-a604-25a581d7c64a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7889789b-8ac8-4f0a-9195-61c9f89f5ba9", "node_type": "1", "metadata": {}, "hash": "37a0fb94413b34667ecabb512c02d140e30b2458a2fd8bec11a29db2aeb0176b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3b9a86e9-005c-468b-a813-2cc627b41550", "node_type": "1", "metadata": {}, "hash": "517b562974d6233450fb1a221f1fa2de9ca5b904688ed506bda4c5fa8455e085", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Wang Y, Ma Y, Han Y, Guo JQ. [SH protein genetic \ncharacterization analysis of wild-type mumps virus \nisolated in Liaoning province from 2008 to 2011]. \nBing Du Xue Bao 2012; 28:506-10; PMID:23233924\n16.\t Zhang DY, Feng Y, Zhong SL, Lu YY, Zhuang FC, \nXu CP. [Comparative analysis on the complete \ngenome sequence of mumps epidemic strain and \nmumps vaccine strain S79 isolated in Zhejiang \nprovince, China between year 2005 and 2010]. \nZhonghua Yu Fang Yi Xue Za Zhi 2012; 46:252-7; \nPMID:22800598\n17.\t Carr MJ, Moss E, Waters A, Dean J, Jin L, Coughlan \nS, Connell J, Hall WW, Hassan J. Molecular \nepidemiological evaluation of the recent resurgence in \nmumps virus infections in Ireland. J Clin Microbiol \n2010; 48:3288-94; PMID:20660212; http://dx.doi.\norg/10.1128/JCM.00434-10\n18.\t Fu C, Wang M, Liang J, He T, Wang D, Xu J. \nEffectiveness of Lanzhou lamb rotavirus vaccine \nagainst \nrotavirus \ngastroenteritis \nrequiring \nhospitalization: a matched case-control study. \nVaccine 2007; 25:8756-61; PMID:18023510; http://\ndx.doi.org/10.1016/j.vaccine.2007.10.036\n19.\t Clemens J, Brenner R, Rao M, Tafari N, Lowe C. \nEvaluating new vaccines for developing countries. \nEfficacy or effectiveness? JAMA 1996; 275:390-\n7; \nPMID:8569019; \nhttp://dx.doi.org/10.1001/\njama.1996.03530290060038\n20.\t Xu W, Zhang G, Liang S, Wang Y, Shang Q, Teng X, \nLi D. Systematic review on immunology effect and \nprotective efficacy of mumps attenuated live vaccine.", "mimetype": "text/plain", "start_char_idx": 24007, "end_char_idx": 25453, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3b9a86e9-005c-468b-a813-2cc627b41550": {"__data__": {"id_": "3b9a86e9-005c-468b-a813-2cc627b41550", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f7eaa3e7-44d8-4489-a604-25a581d7c64a", "node_type": "1", "metadata": {}, "hash": "c90715fdf78c2e3d09ae9f8784c80b0e6060bfad3670e84ea0ed768e77cbeaf1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "64a7dc35-d954-4ce6-8fa3-30ecfa46c2f9", "node_type": "1", "metadata": {}, "hash": "c301baae8ccbbe6203548a4db5468004ba9a232455e4cab39879f778c1a69be2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Xu W, Zhang G, Liang S, Wang Y, Shang Q, Teng X, \nLi D. Systematic review on immunology effect and \nprotective efficacy of mumps attenuated live vaccine. \nChinese Journal of Vaccines and Immunization 2011; \n17:426-50\n21.\t Cortese MM, Jordan HT, Curns AT, Quinlan PA, \nEns KA, Denning PM, Dayan GH. Mumps vaccine \nperformance among university students during a \nmumps outbreak. Clin Infect Dis 2008; 46:1172-80; \nPMID:18444852; http://dx.doi.org/10.1086/529141\n22.\t Fu C, He Q, Xu J, Xie H, Ding P, Hu W, Dong Z, \nLiu X, Wang M. Effectiveness of the Lanzhou lamb \nrotavirus vaccine against gastroenteritis among \nchildren. Vaccine 2012; 31:154-8; PMID:23127516; \nhttp://dx.doi.org/10.1016/j.vaccine.2012.10.078\n23.\t Fu C, Xu J, He Q, Li Z, Liu F. Seasonal influenza \nvaccine effectiveness in children during 2010-\n2011 season: A case-cohort study. Hum Vaccin \nImmunother. \n9(5). \nForthcoming \n2013; \nPMID:23324620; \nhttp://dx.doi.org/10.4161/\nhv.23457\n24.\t He Q, Xu J, Chen X, Lu J, Li K, Li Z, Wang M, Yang \nQ, Dong Z, Liu X, et al. Effectiveness of seasonal \ninfluenza vaccine against clinically diagnosed \ninfluenza over two consecutive seasons in children \nin Guangzhou, China: A matched case-control \nstudy. Hum Vaccin Immunother. 9(5). Forthcoming \n2013; PMID:23733038; http://dx.doi.org/10.4161/\nhv.24980\n 25.\t Fu C, Wang M, Liang J, Xu J, Wang C, Bialek S. The \neffectiveness of varicella vaccine in China.", "mimetype": "text/plain", "start_char_idx": 25300, "end_char_idx": 26713, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "64a7dc35-d954-4ce6-8fa3-30ecfa46c2f9": {"__data__": {"id_": "64a7dc35-d954-4ce6-8fa3-30ecfa46c2f9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Fu (2013).pdf", "node_type": "4", "metadata": {}, "hash": "4fa560714484a6c5c924bd01fad4af0bf3522ba098f5fe566dc02c9736295cf1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3b9a86e9-005c-468b-a813-2cc627b41550", "node_type": "1", "metadata": {}, "hash": "517b562974d6233450fb1a221f1fa2de9ca5b904688ed506bda4c5fa8455e085", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Fu C, Wang M, Liang J, Xu J, Wang C, Bialek S. The \neffectiveness of varicella vaccine in China. Pediatr \nInfect Dis J 2010; 29:690-3; PMID:20216242; \nhttp://dx.doi.org/10.1097/INF.0b013e3181d7380e\n26.\t Niccolai LM, Ogden LG, Muehlenbein CE, Dziura \nJD, V\u00e1zquez M, Shapiro ED. Methodological issues \nin design and analysis of a matched case-control \nstudy of a vaccine\u2019s effectiveness. J Clin Epidemiol \n2007; 60:1127-31; PMID:17938054; http://dx.doi.\norg/10.1016/j.jclinepi.2007.02.009", "mimetype": "text/plain", "start_char_idx": 26617, "end_char_idx": 27103, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "336a2dff-f095-470d-918c-f80a901ddb0d": {"__data__": {"id_": "336a2dff-f095-470d-918c-f80a901ddb0d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e7112721-1998-4089-bd06-7153b55dbe0b", "node_type": "1", "metadata": {}, "hash": "ae611ca1a839ca7235ba9c764c50cae6ab8e82f8e656961acab15d5dd262e40d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue027\ue033\ue030\ue000\ue03b\ue03a\ue03e\ue03e\ue034\ue02d\ue037\ue030\ue000\ue02c\ue03e\ue03e\ue03a\ue02e\ue034\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue03a\ue031\ue000\ue034\ue039\ue031\ue02c\ue039\ue03f\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue03e\ue000\ue042\ue034\ue03f\ue033\ue000\ue03d\ue034\ue03e\ue036\ue000\ue03a\ue031\ue000\ue02e\ue033\ue034\ue037\ue02f\ue005\n\ue033\ue03a\ue03a\ue02f\ue000\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034\ue02c\ue000\ue033\ue02c\ue03e\ue000\ue02d\ue030\ue030\ue039\ue000\ue03a\ue031\ue000\ue034\ue039\ue03f\ue030\ue03d\ue030\ue03e\ue03f\ue000\ue031\ue03a\ue03d\ue000\ue038\ue03a\ue03d\ue030\ue000\ue03f\ue033\ue02c\ue039\ue000\ue00b\ue008\ue000\ue044\ue030\ue02c\ue03d\ue03e\ue006\ue000\ue01d\ue039\ue000\ue02c\n\ue03e\ue038\ue02c\ue037\ue037\ue000\ue033\ue03a\ue03e\ue03b\ue034\ue03f\ue02c\ue037\ue005\ue02d\ue02c\ue03e\ue030\ue02f\ue000\ue02e\ue02c\ue03e\ue030\ue005\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue000\ue03e\ue03f\ue040\ue02f\ue044", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 172, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e7112721-1998-4089-bd06-7153b55dbe0b": {"__data__": {"id_": "e7112721-1998-4089-bd06-7153b55dbe0b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "336a2dff-f095-470d-918c-f80a901ddb0d", "node_type": "1", "metadata": {}, "hash": "7898a204e748127524295831c45c9fd02be18b69786b9c00ac6176ca3cdd4b55", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "62ca3026-9bbf-41b0-aa62-caef9da8ff81", "node_type": "1", "metadata": {}, "hash": "683a9e2478b37173506e2fcd0ad933900667982dd86a2dc948fb77b99493272a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03e\ue030\ue005\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue03a\ue031\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034\ue02c\ue000\ue034\ue039\n\ue015\ue040\ue03e\ue03f\ue03d\ue02c\ue037\ue034\ue02c\ue004\ue000\ue02c\ue039\ue000\ue030\ue043\ue02e\ue030\ue03e\ue03e\ue000\ue03a\ue031\ue000\ue02f\ue034\ue03b\ue033\ue03f\ue033\ue030\ue03d\ue034\ue02c\ue004\ue000\ue03f\ue030\ue03f\ue02c\ue039\ue040\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue03b\ue030\ue03d\ue03f\ue040\ue03e\ue03e\ue034\ue03e\ue000\ue002\ue018\ue027\ue024\ue003\n\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue03e\ue000\ue042\ue02c\ue03e\ue000\ue03a\ue02d\ue03e\ue030\ue03d\ue041\ue030\ue02f\ue000\ue02c\ue038\ue03a\ue039\ue032\ue000\ue03f\ue033\ue030\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue002\ue01d\ue039\ue039\ue034\ue03e\ue004\ue000\ue009\ue011\ue00e\ue00d\ue003\ue006\n\ue026\ue040\ue02d\ue03e\ue030\ue03c\ue040\ue030", "mimetype": "text/plain", "start_char_idx": 156, "end_char_idx": 328, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "62ca3026-9bbf-41b0-aa62-caef9da8ff81": {"__data__": {"id_": "62ca3026-9bbf-41b0-aa62-caef9da8ff81", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e7112721-1998-4089-bd06-7153b55dbe0b", "node_type": "1", "metadata": {}, "hash": "ae611ca1a839ca7235ba9c764c50cae6ab8e82f8e656961acab15d5dd262e40d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b684e8a2-c8fb-4df2-8c71-d22fbf715ee4", "node_type": "1", "metadata": {}, "hash": "a514f7346646c06f0499a429bb70835c12e9626f5997259a8dac94df5a027cb3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue004\ue000\ue009\ue011\ue00e\ue00d\ue003\ue006\n\ue026\ue040\ue02d\ue03e\ue030\ue03c\ue040\ue030\ue039\ue03f\ue000\ue03e\ue03f\ue040\ue02f\ue034\ue030\ue03e\ue004\ue000\ue033\ue03a\ue042\ue030\ue041\ue030\ue03d\ue004\ue000\ue02f\ue034\ue02f\ue000\ue039\ue03a\ue03f\ue000\ue02e\ue03a\ue039\ue031\ue034\ue03d\ue038\ue000\ue03f\ue033\ue034\ue03e\ue000\ue031\ue034\ue039\ue02f\ue034\ue039\ue032\ue006\ue000\ue027\ue033\ue030\n\ue037\ue02c\ue03d\ue032\ue030\ue004\ue000\ue03b\ue03a\ue03b\ue040\ue037\ue02c\ue03f\ue034\ue03a\ue039\ue005\ue02d\ue02c\ue03e\ue030\ue02f\ue000\ue023\ue043\ue031\ue03a\ue03d\ue02f\ue000\ue026\ue040\ue03d\ue041\ue030\ue044\ue000\ue03a\ue031\ue000\ue017\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000\ue017\ue02c\ue039\ue02e\ue030\ue03d\n\ue03d\ue030\ue03b\ue03a\ue03d\ue03f\ue030\ue02f\ue000\ue03b\ue03d\ue03a\ue03f\ue030\ue02e\ue03f\ue034\ue041\ue030\ue000\ue030\ue031\ue031\ue030\ue02e\ue03f\ue03e\ue000\ue031\ue03d\ue03a\ue038\ue000\ue03e\ue038\ue02c\ue037\ue037\ue03b\ue03a\ue043\ue004", "mimetype": "text/plain", "start_char_idx": 311, "end_char_idx": 483, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b684e8a2-c8fb-4df2-8c71-d22fbf715ee4": {"__data__": {"id_": "b684e8a2-c8fb-4df2-8c71-d22fbf715ee4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "62ca3026-9bbf-41b0-aa62-caef9da8ff81", "node_type": "1", "metadata": {}, "hash": "683a9e2478b37173506e2fcd0ad933900667982dd86a2dc948fb77b99493272a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f395342a-cb76-4bb6-a0a9-c204e3487571", "node_type": "1", "metadata": {}, "hash": "85008d478b8420deb4a70e608cb400cff218ebf4c5719d6f2519c80c2da8c174", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03e\ue000\ue031\ue03d\ue03a\ue038\ue000\ue03e\ue038\ue02c\ue037\ue037\ue03b\ue03a\ue043\ue004\ue000\ue02f\ue034\ue03b\ue033\ue03f\ue033\ue030\ue03d\ue034\ue02c\ue004\ue000\ue03f\ue030\ue03f\ue02c\ue039\ue040\ue03e\ue004\n\ue03b\ue030\ue03d\ue03f\ue040\ue03e\ue03e\ue034\ue03e\ue004\ue000\ue038\ue030\ue02c\ue03e\ue037\ue030\ue03e\ue004\ue000\ue03d\ue040\ue02d\ue030\ue037\ue037\ue02c\ue004\ue000\ue03b\ue03a\ue037\ue034\ue03a\ue038\ue044\ue030\ue037\ue034\ue03f\ue034\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue02d\ue02c\ue02e\ue034\ue037\ue037\ue030\ue000\ue017\ue02c\ue037\ue038\ue030\ue03f\ue03f\ue030\ue005\n\ue01b\ue040\ue046\ue03d\ue034\ue039\ue000\ue002\ue016\ue017\ue01b\ue003\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue000\ue02c\ue038\ue03a\ue039\ue032\ue000\ue00d\ue00e\ue00b\ue00e\ue000\ue02e\ue033\ue034\ue037\ue02f\ue03d\ue030\ue039\ue000\ue042\ue034\ue03f\ue033\ue000\ue02c\ue037\ue037\ue000\ue031\ue03a\ue03d\ue038\ue03e\ue000\ue03a\ue031\n\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034\ue02c", "mimetype": "text/plain", "start_char_idx": 467, "end_char_idx": 639, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f395342a-cb76-4bb6-a0a9-c204e3487571": {"__data__": {"id_": "f395342a-cb76-4bb6-a0a9-c204e3487571", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b684e8a2-c8fb-4df2-8c71-d22fbf715ee4", "node_type": "1", "metadata": {}, "hash": "a514f7346646c06f0499a429bb70835c12e9626f5997259a8dac94df5a027cb3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "063ba50f-4c8b-4d5f-94db-e193735ae62c", "node_type": "1", "metadata": {}, "hash": "8f7f2524dfbb801e2573553d211e8a85b9b5f2b76aa592152f2cb03798808005", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03a\ue03d\ue038\ue03e\ue000\ue03a\ue031\n\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034\ue02c\ue000\ue002\ue01f\ue039\ue030\ue02c\ue037\ue030\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue010\ue00e\ue003\ue006\ue000\ue026\ue034\ue038\ue034\ue037\ue02c\ue03d\ue037\ue044\ue004\ue000\ue02c\ue000\ue02e\ue02c\ue03e\ue030\ue005\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue03a\ue031\n\ue016\ue03d\ue034\ue03f\ue034\ue03e\ue033\ue000\ue02e\ue033\ue034\ue037\ue02f\ue03d\ue030\ue039\ue000\ue042\ue034\ue03f\ue033\ue000\ue02c\ue037\ue037\ue000\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034\ue02c\ue03e\ue000\ue03d\ue030\ue03b\ue03a\ue03d\ue03f\ue030\ue02f\ue000\ue02c\ue000\ue03e\ue034\ue032\ue039\ue034\ue031\ue034\ue02e\ue02c\ue039\ue03f\ue037\ue044\n\ue03d\ue030\ue02f\ue040\ue02e\ue030\ue02f\ue000\ue03d\ue034\ue03e\ue036\ue000\ue03a\ue031\ue000\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034\ue02c\ue000\ue02c\ue038\ue03a\ue039\ue032\ue000\ue02e\ue033\ue034", "mimetype": "text/plain", "start_char_idx": 622, "end_char_idx": 794, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "063ba50f-4c8b-4d5f-94db-e193735ae62c": {"__data__": {"id_": "063ba50f-4c8b-4d5f-94db-e193735ae62c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f395342a-cb76-4bb6-a0a9-c204e3487571", "node_type": "1", "metadata": {}, "hash": "85008d478b8420deb4a70e608cb400cff218ebf4c5719d6f2519c80c2da8c174", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cac686cb-52c0-4fb2-9013-596c2381201b", "node_type": "1", "metadata": {}, "hash": "e6d5962c3cf83f6fa7373eaeb36a77d0cdcab360e8b56ad64339a9f9b0efec53", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue036\ue02c\ue030\ue038\ue034\ue02c\ue000\ue02c\ue038\ue03a\ue039\ue032\ue000\ue02e\ue033\ue034\ue037\ue02f\ue03d\ue030\ue039\ue000\ue042\ue033\ue03a\ue000\ue03d\ue030\ue02e\ue030\ue034\ue041\ue030\ue02f\ue000\ue03f\ue030\ue03f\ue02c\ue039\ue040\ue03e\ue004\n\ue02f\ue034\ue03b\ue033\ue03f\ue033\ue030\ue03d\ue034\ue02c\ue004\ue000\ue03b\ue030\ue03d\ue03f\ue040\ue03e\ue03e\ue034\ue03e\ue004\ue000\ue03e\ue038\ue02c\ue037\ue037\ue03b\ue03a\ue043\ue004\ue000\ue03b\ue03a\ue037\ue034\ue03a\ue000\ue02c\ue039\ue02f\ue007\ue03a\ue03d\ue000\ue038\ue030\ue02c\ue03e\ue037\ue030\ue03e\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\n\ue002\ue021\ue02e\ue01f\ue034\ue039\ue039\ue030\ue044\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue010\ue00f\ue003\ue006\ue000\ue015\ue037\ue03e\ue03a\ue004\ue000\ue02c\ue000\ue03e\ue038\ue02c\ue037\ue037\ue000\ue02e\ue02c\ue03e\ue030\ue005\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue03a\ue031\ue000\ue039\ue03a\ue039\ue005", "mimetype": "text/plain", "start_char_idx": 778, "end_char_idx": 949, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cac686cb-52c0-4fb2-9013-596c2381201b": {"__data__": {"id_": "cac686cb-52c0-4fb2-9013-596c2381201b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "063ba50f-4c8b-4d5f-94db-e193735ae62c", "node_type": "1", "metadata": {}, "hash": "8f7f2524dfbb801e2573553d211e8a85b9b5f2b76aa592152f2cb03798808005", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7f0a0007-f933-4723-b21c-7e54803771af", "node_type": "1", "metadata": {}, "hash": "670bc9c26a6431de8f683cdf11be51d932ae9f730369f7d16cb4b54c207b631d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03a\ue037\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue03a\ue031\ue000\ue039\ue03a\ue039\ue005\n\ue027\ue005\ue02e\ue030\ue037\ue037\ue000\ue02c\ue02e\ue040\ue03f\ue030\ue000\ue037\ue044\ue038\ue03b\ue033\ue03a\ue02d\ue037\ue02c\ue03e\ue03f\ue034\ue02e\ue000\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034\ue02c\ue000\ue002\ue015\ue020\ue020\ue003\ue000\ue034\ue039\ue000\ue01e\ue02c\ue03b\ue02c\ue039\ue000\ue03d\ue030\ue03b\ue03a\ue03d\ue03f\ue030\ue02f\n\ue03b\ue03d\ue03a\ue03f\ue030\ue02e\ue03f\ue034\ue041\ue030\ue000\ue030\ue031\ue031\ue030\ue02e\ue03f\ue03e\ue000\ue031\ue03a\ue03d\ue000\ue02d\ue03a\ue03f\ue033\ue000\ue016\ue017\ue01b\ue000\ue02c\ue039\ue02f\ue000\ue038\ue030\ue02c\ue03e\ue037\ue030\ue03e\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue002\ue022\ue034\ue03e\ue033\ue034\n\ue02c\ue039\ue02f\ue000\ue021\ue034\ue044\ue02c\ue036\ue030\ue004\ue000\ue009\ue011\ue010\ue011\ue003\ue004\ue000\ue042\ue033\ue030\ue03d\ue030\ue02c\ue03e\ue000\ue02c\ue000\ue03e\ue03f", "mimetype": "text/plain", "start_char_idx": 933, "end_char_idx": 1105, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7f0a0007-f933-4723-b21c-7e54803771af": {"__data__": {"id_": "7f0a0007-f933-4723-b21c-7e54803771af", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cac686cb-52c0-4fb2-9013-596c2381201b", "node_type": "1", "metadata": {}, "hash": "e6d5962c3cf83f6fa7373eaeb36a77d0cdcab360e8b56ad64339a9f9b0efec53", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8eb15c5b-ac89-48e2-ab04-d63a408c3300", "node_type": "1", "metadata": {}, "hash": "d351d8bc704351fc7306ff746f23dfebe2ff9add70e145721587836ea881be86", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue011\ue003\ue004\ue000\ue042\ue033\ue030\ue03d\ue030\ue02c\ue03e\ue000\ue02c\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue03a\ue031\ue000\ue02e\ue033\ue034\ue037\ue02f\ue03d\ue030\ue039\ue000\ue042\ue034\ue03f\ue033\ue000\ue02c\ue037\ue037\ue000\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034\ue02c\n\ue03f\ue044\ue03b\ue030\ue03e\ue000\ue034\ue039\ue000\ue01b\ue030\ue03d\ue038\ue02c\ue039\ue044\ue000\ue03d\ue030\ue03b\ue03a\ue03d\ue03f\ue030\ue02f\ue000\ue02c\ue000\ue03b\ue03d\ue03a\ue03f\ue030\ue02e\ue03f\ue034\ue041\ue030\ue000\ue030\ue031\ue031\ue030\ue02e\ue03f\ue000\ue03a\ue031\ue000\ue040\ue039\ue03e\ue03b\ue030\ue02e\ue034\ue031\ue034\ue030\ue02f\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue005\n\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue03e\ue000\ue002\ue01f\ue02c\ue02c\ue03f\ue03e\ue02e\ue033\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue011\ue00e\ue003\ue006\n\ue02a\ue030\ue000\ue02e\ue02c\ue03d\ue03d\ue034\ue030\ue02f\ue000\ue03a\ue040\ue03f\ue000\ue02c\ue000\ue037\ue02c\ue03d\ue032\ue030", "mimetype": "text/plain", "start_char_idx": 1089, "end_char_idx": 1261, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8eb15c5b-ac89-48e2-ab04-d63a408c3300": {"__data__": {"id_": "8eb15c5b-ac89-48e2-ab04-d63a408c3300", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7f0a0007-f933-4723-b21c-7e54803771af", "node_type": "1", "metadata": {}, "hash": "670bc9c26a6431de8f683cdf11be51d932ae9f730369f7d16cb4b54c207b631d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "750bd2e6-734c-4c49-889a-e856fbe1573f", "node_type": "1", "metadata": {}, "hash": "cffdef5186e496771561c887e7b51d5c9480c1d6b037a86b8af79a8fc22554b3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03d\ue034\ue030\ue02f\ue000\ue03a\ue040\ue03f\ue000\ue02c\ue000\ue037\ue02c\ue03d\ue032\ue030\ue000\ue02e\ue02c\ue03e\ue030\ue005\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue000\ue034\ue039\ue041\ue030\ue03e\ue03f\ue034\ue032\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue03a\ue031\ue000\ue03b\ue03a\ue03f\ue030\ue039\ue03f\ue034\ue02c\ue037\n\ue03d\ue034\ue03e\ue036\ue000\ue031\ue02c\ue02e\ue03f\ue03a\ue03d\ue03e\ue000\ue031\ue03a\ue03d\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000\ue015\ue020\ue020\ue000\ue02e\ue03a\ue039\ue02f\ue040\ue02e\ue03f\ue030\ue02f\ue000\ue02e\ue03a\ue037\ue037\ue02c\ue02d\ue03a\ue03d\ue02c\ue03f\ue034\ue041\ue030\ue037\ue044\ue000\ue02d\ue044\ue000\ue03f\ue033\ue030\n\ue022\ue02c\ue03f\ue034\ue03a\ue039\ue02c\ue037\ue000\ue017\ue02c\ue039\ue02e\ue030\ue03d\ue000\ue01d\ue039\ue03e\ue03f\ue034\ue03f\ue040\ue03f\ue030\ue000\ue002\ue022\ue017\ue01d\ue003\ue000\ue02c\ue039\ue02f\ue000\ue03f\ue033\ue030\ue000\ue017\ue033\ue034\ue037\ue02f\ue03d\ue030\ue039\ue049\ue03e\ue000", "mimetype": "text/plain", "start_char_idx": 1245, "end_char_idx": 1417, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "750bd2e6-734c-4c49-889a-e856fbe1573f": {"__data__": {"id_": "750bd2e6-734c-4c49-889a-e856fbe1573f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8eb15c5b-ac89-48e2-ab04-d63a408c3300", "node_type": "1", "metadata": {}, "hash": "d351d8bc704351fc7306ff746f23dfebe2ff9add70e145721587836ea881be86", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9cbf00fc-c3de-46ed-ac44-19de2fed978d", "node_type": "1", "metadata": {}, "hash": "113dc854f60ab4f885ece52a85d3bf553fb60a28de202e97802f41b7b945444a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue000\ue03f\ue033\ue030\ue000\ue017\ue033\ue034\ue037\ue02f\ue03d\ue030\ue039\ue049\ue03e\ue000\ue017\ue02c\ue039\ue02e\ue030\ue03d\ue000\ue01b\ue03d\ue03a\ue040\ue03b\n\ue002\ue017\ue017\ue01b\ue003\ue000\ue02c\ue038\ue03a\ue039\ue032\ue000\ue02e\ue033\ue034\ue037\ue02f\ue03d\ue030\ue039\ue000\ue02f\ue034\ue02c\ue032\ue039\ue03a\ue03e\ue030\ue02f\ue000\ue03b\ue03d\ue034\ue03a\ue03d\ue000\ue03f\ue03a\ue000\ue02c\ue032\ue030\ue000\ue009\ue00d\ue006\ue000\ue027\ue03a\ue000\ue034\ue039\ue041\ue030\ue03e\ue03f\ue034\ue032\ue02c\ue03f\ue030\n\ue03f\ue033\ue030\ue000\ue034\ue039\ue031\ue037\ue040\ue030\ue039\ue02e\ue030\ue000\ue03a\ue031\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue03a\ue039\ue000\ue015\ue020\ue020\ue000\ue03d\ue034\ue03e\ue036\ue004\ue000\ue042\ue030\ue000\ue030\ue041\ue02c\ue037\ue040\ue02c\ue03f\ue030\ue02f\ue000\ue03d\ue030\ue02e\ue03a\ue03d\ue02f\ue030\ue02f\n\ue034\ue039\ue031\ue03a\ue03d\ue038\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue031\ue03a\ue03d\ue000", "mimetype": "text/plain", "start_char_idx": 1401, "end_char_idx": 1573, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9cbf00fc-c3de-46ed-ac44-19de2fed978d": {"__data__": {"id_": "9cbf00fc-c3de-46ed-ac44-19de2fed978d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "750bd2e6-734c-4c49-889a-e856fbe1573f", "node_type": "1", "metadata": {}, "hash": "cffdef5186e496771561c887e7b51d5c9480c1d6b037a86b8af79a8fc22554b3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "76640b05-437d-4c5e-ad65-3459aa81188e", "node_type": "1", "metadata": {}, "hash": "feb145cb0334628d9697491b214703b7ab55d0717e0a02f08c0d5207d5bcf3dc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue034\ue039\ue031\ue03a\ue03d\ue038\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue031\ue03a\ue03d\ue000\ue02c\ue037\ue037\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue000\ue03d\ue030\ue02e\ue03a\ue038\ue038\ue030\ue039\ue02f\ue030\ue02f\ue000\ue031\ue03a\ue03d\ue000\ue03d\ue03a\ue040\ue03f\ue034\ue039\ue030\ue000\ue040\ue03e\ue030\ue000\ue034\ue039\n\ue034\ue039\ue031\ue02c\ue039\ue02e\ue044\ue000\ue02c\ue038\ue03a\ue039\ue032\ue000\ue00c\ue00b\ue011\ue000\ue015\ue020\ue020\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue02c\ue039\ue000\ue030\ue03c\ue040\ue02c\ue037\ue000\ue039\ue040\ue038\ue02d\ue030\ue03d\ue000\ue03a\ue031\ue000\ue038\ue02c\ue03f\ue02e\ue033\ue030\ue02f\n\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue000\ue034\ue039\ue000\ue039\ue034\ue039\ue030\ue000\ue021\ue034\ue02f\ue042\ue030\ue03e\ue03f\ue030\ue03d\ue039\ue000\ue02c\ue039\ue02f\ue000\ue021\ue034\ue02f\ue005\ue015\ue03f\ue037\ue02c\ue039\ue03f\ue034\ue02e\ue000\ue03e\ue03f\ue02c\ue03f\ue030\ue03e\ue000", "mimetype": "text/plain", "start_char_idx": 1557, "end_char_idx": 1728, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "76640b05-437d-4c5e-ad65-3459aa81188e": {"__data__": {"id_": "76640b05-437d-4c5e-ad65-3459aa81188e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9cbf00fc-c3de-46ed-ac44-19de2fed978d", "node_type": "1", "metadata": {}, "hash": "113dc854f60ab4f885ece52a85d3bf553fb60a28de202e97802f41b7b945444a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3299e4e9-3225-47c6-9555-8ebbcdf9d032", "node_type": "1", "metadata": {}, "hash": "365b9b85c5d09c87ea302a9806eab113782c09e982a44705713ae0379f905df2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue015\ue03f\ue037\ue02c\ue039\ue03f\ue034\ue02e\ue000\ue03e\ue03f\ue02c\ue03f\ue030\ue03e\ue000\ue034\ue039\ue000\ue03f\ue033\ue030\ue000\ue028\ue026\ue015\ue006\n\ue00a\ue004\ue00f\ue006\ue00c\ue003\ue00e\n\ue024\ue02c\ue03f\ue034\ue030\ue039\ue03f\ue03e\ue000\ue042\ue034\ue03f\ue033\ue000\ue015\ue020\ue020\ue000\ue02c\ue032\ue030\ue02f\ue000\ue008\ue047\ue009\ue00c\ue004\ue000\ue02f\ue034\ue02c\ue032\ue039\ue03a\ue03e\ue030\ue02f\ue000\ue02d\ue030\ue03f\ue042\ue030\ue030\ue039\ue000\ue009\ue011\ue010\ue011\ue000\ue02c\ue039\ue02f\ue000\ue009\ue011\ue011\ue00b\ue004\n\ue042\ue030\ue03d\ue030\ue000\ue030\ue039\ue03d\ue03a\ue037\ue037\ue030\ue02f\ue000\ue034\ue039\ue000\ue03f\ue033\ue030\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue002\ue01f\ue037\ue030\ue034\ue039\ue030\ue03d\ue038\ue02c\ue039\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue011\ue00f\ue003\ue006\ue000\ue026\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue03e\ue000\ue042\ue033\ue03a\n\ue03d\ue030\ue03e\ue034\ue02f\ue030\ue02f\ue000\ue034", "mimetype": "text/plain", "start_char_idx": 1712, "end_char_idx": 1885, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3299e4e9-3225-47c6-9555-8ebbcdf9d032": {"__data__": {"id_": "3299e4e9-3225-47c6-9555-8ebbcdf9d032", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "76640b05-437d-4c5e-ad65-3459aa81188e", "node_type": "1", "metadata": {}, "hash": "feb145cb0334628d9697491b214703b7ab55d0717e0a02f08c0d5207d5bcf3dc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "017508ae-7d25-4ebb-8909-e7503bf872fb", "node_type": "1", "metadata": {}, "hash": "a0759d3feeea6681b16d9caa278eb697ba885e0fb38118cefca401d104ef340e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue02e\ue03f\ue03e\ue000\ue042\ue033\ue03a\n\ue03d\ue030\ue03e\ue034\ue02f\ue030\ue02f\ue000\ue034\ue039\ue000\ue01d\ue037\ue037\ue034\ue039\ue03a\ue034\ue03e\ue004\ue000\ue01d\ue039\ue02f\ue034\ue02c\ue039\ue02c\ue004\ue000\ue01d\ue03a\ue042\ue02c\ue004\ue000\ue021\ue034\ue02e\ue033\ue034\ue032\ue02c\ue039\ue004\ue000\ue021\ue034\ue039\ue039\ue030\ue03e\ue03a\ue03f\ue02c\ue004\ue000\ue022\ue030\ue042\n\ue01e\ue030\ue03d\ue03e\ue030\ue044\ue004\ue000\ue023\ue033\ue034\ue03a\ue004\ue000\ue024\ue030\ue039\ue039\ue03e\ue044\ue037\ue041\ue02c\ue039\ue034\ue02c\ue004\ue000\ue03a\ue03d\ue000\ue02a\ue034\ue03e\ue02e\ue03a\ue039\ue03e\ue034\ue039\ue000\ue02c\ue03f\ue000\ue03f\ue033\ue030\ue000\ue03f\ue034\ue038\ue030\ue000\ue03a\ue031\ue000\ue02f\ue034\ue02c\ue032\ue039\ue03a\ue03e\ue034\ue03e\n\ue042\ue030\ue03d\ue030\ue000\ue030\ue037\ue034\ue032\ue034\ue02d\ue037\ue030\ue000\ue031\ue03a\ue03d\ue000\ue03f\ue033\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue02e\ue03a\ue038", "mimetype": "text/plain", "start_char_idx": 1868, "end_char_idx": 2040, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "017508ae-7d25-4ebb-8909-e7503bf872fb": {"__data__": {"id_": "017508ae-7d25-4ebb-8909-e7503bf872fb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3299e4e9-3225-47c6-9555-8ebbcdf9d032", "node_type": "1", "metadata": {}, "hash": "365b9b85c5d09c87ea302a9806eab113782c09e982a44705713ae0379f905df2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3f5e83a9-5cc6-48b5-80e0-9d5893fdd423", "node_type": "1", "metadata": {}, "hash": "3a45187e15b904db020bd0396d44b3909b951402fb46cae7da87c6f6b8e77129", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue02e\ue03a\ue038\ue03b\ue03a\ue039\ue030\ue039\ue03f\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue006\ue000\ue017\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\n\ue03e\ue030\ue037\ue030\ue02e\ue03f\ue030\ue02f\ue000\ue03f\ue033\ue03d\ue03a\ue040\ue032\ue033\ue000\ue03d\ue02c\ue039\ue02f\ue03a\ue038\ue005\ue02f\ue034\ue032\ue034\ue03f\ue000\ue02f\ue034\ue02c\ue037\ue034\ue039\ue032\ue000\ue002\ue025\ue03a\ue02d\ue034\ue03e\ue03a\ue039\ue000\ue02c\ue039\ue02f\ue000\ue018\ue02c\ue034\ue032\ue037\ue030\ue004\ue000\ue009\ue011\ue010\ue00c\ue003\n\ue042\ue030\ue03d\ue030\ue000\ue034\ue039\ue02f\ue034\ue041\ue034\ue02f\ue040\ue02c\ue037\ue037\ue044\ue000\ue038\ue02c\ue03f\ue02e\ue033\ue030\ue02f\ue000\ue03f\ue03a\ue000\ue03f\ue033\ue030\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue02d\ue044\ue000\ue02c\ue032\ue030\ue000\ue002\ue042\ue034\ue03f\ue033\ue034\ue039\ue000\ue00a\ue00d\ue001\ue000\ue03a\ue031\ue000", "mimetype": "text/plain", "start_char_idx": 2024, "end_char_idx": 2196, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3f5e83a9-5cc6-48b5-80e0-9d5893fdd423": {"__data__": {"id_": "3f5e83a9-5cc6-48b5-80e0-9d5893fdd423", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "017508ae-7d25-4ebb-8909-e7503bf872fb", "node_type": "1", "metadata": {}, "hash": "a0759d3feeea6681b16d9caa278eb697ba885e0fb38118cefca401d104ef340e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "005b2222-49ff-4b69-a0b8-974cef38001f", "node_type": "1", "metadata": {}, "hash": "ce2a610b90d5003f19b32429b523cac4796d2d1949039d04b392a5151f5f38f4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue000\ue002\ue042\ue034\ue03f\ue033\ue034\ue039\ue000\ue00a\ue00d\ue001\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\n\ue02e\ue03a\ue03d\ue03d\ue030\ue03e\ue03b\ue03a\ue039\ue02f\ue034\ue039\ue032\ue000\ue02e\ue02c\ue03e\ue030\ue049\ue03e\ue000\ue02c\ue032\ue030\ue000\ue02c\ue03f\ue000\ue02f\ue034\ue02c\ue032\ue039\ue03a\ue03e\ue034\ue03e\ue003\ue004\ue000\ue03f\ue033\ue030\ue000\ue031\ue034\ue03d\ue03e\ue03f\ue000\ue030\ue034\ue032\ue033\ue03f\ue000\ue02f\ue034\ue032\ue034\ue03f\ue03e\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\n\ue03f\ue030\ue037\ue030\ue03b\ue033\ue03a\ue039\ue030\ue000\ue039\ue040\ue038\ue02d\ue030\ue03d\ue004\ue000\ue02c\ue039\ue02f\ue000\ue03d\ue02c\ue02e\ue030\ue000\ue002\ue015\ue031\ue03d\ue034\ue02e\ue02c\ue039\ue005\ue015\ue038\ue030\ue03d\ue034\ue02e\ue02c\ue039\ue007\ue042\ue033\ue034\ue03f\ue030\ue007\ue03a\ue03f\ue033\ue030\ue03d\ue003\ue006\n\ue027\ue033\ue030\ue03d\ue030\ue000\ue042\ue030\ue03d\ue030\ue000\ue03f\ue033\ue03d\ue030\ue030\ue000\ue03e\ue030\ue03b\ue02c\ue03d\ue02c", "mimetype": "text/plain", "start_char_idx": 2180, "end_char_idx": 2352, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "005b2222-49ff-4b69-a0b8-974cef38001f": {"__data__": {"id_": "005b2222-49ff-4b69-a0b8-974cef38001f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3f5e83a9-5cc6-48b5-80e0-9d5893fdd423", "node_type": "1", "metadata": {}, "hash": "3a45187e15b904db020bd0396d44b3909b951402fb46cae7da87c6f6b8e77129", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a8072cee-8df3-4a9a-956e-770eb686fa3f", "node_type": "1", "metadata": {}, "hash": "9f888633b2b560d4af15ffbc84a57067a31ca128ddd4ca36cb02b2e1fb8fdf67", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue030\ue03d\ue030\ue000\ue03f\ue033\ue03d\ue030\ue030\ue000\ue03e\ue030\ue03b\ue02c\ue03d\ue02c\ue03f\ue030\ue000\ue02e\ue03a\ue038\ue03b\ue03a\ue039\ue030\ue039\ue03f\ue03e\ue000\ue03a\ue031\ue000\ue03f\ue033\ue034\ue03e\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue004\ue000\ue02c\ue03e\ue000\ue02f\ue030\ue03e\ue02e\ue03d\ue034\ue02d\ue030\ue02f\n\ue030\ue02c\ue03d\ue037\ue034\ue030\ue03d\ue000\ue002\ue01f\ue037\ue030\ue034\ue039\ue030\ue03d\ue038\ue02c\ue039\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue011\ue00f\ue003\ue006\ue000\ue021\ue03a\ue03f\ue033\ue030\ue03d\ue03e\ue000\ue03a\ue031\ue000\ue011\ue00e\ue001\ue000\ue03a\ue031\ue000\ue030\ue037\ue034\ue032\ue034\ue02d\ue037\ue030\ue000\ue02e\ue02c\ue03e\ue030\ue03e\n\ue02c\ue039\ue02f\ue000\ue00f\ue00d\ue001\ue000\ue03a\ue031\ue000\ue030\ue037\ue034\ue032\ue034\ue02d\ue037\ue030\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue000\ue031\ue03d\ue03a\ue038\ue000\ue03f\ue033\ue030\ue000\ue039\ue034\ue039\ue030\ue000\ue03e\ue03f\ue02c\ue03f", "mimetype": "text/plain", "start_char_idx": 2336, "end_char_idx": 2508, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a8072cee-8df3-4a9a-956e-770eb686fa3f": {"__data__": {"id_": "a8072cee-8df3-4a9a-956e-770eb686fa3f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "005b2222-49ff-4b69-a0b8-974cef38001f", "node_type": "1", "metadata": {}, "hash": "ce2a610b90d5003f19b32429b523cac4796d2d1949039d04b392a5151f5f38f4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a75922f5-2197-49db-beb7-6a9728804ec4", "node_type": "1", "metadata": {}, "hash": "4db0b32c0f541218ab75b4059d3cbfc31c4fb1a4f9c21cd0a1bbb1f64aa361c8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03a\ue038\ue000\ue03f\ue033\ue030\ue000\ue039\ue034\ue039\ue030\ue000\ue03e\ue03f\ue02c\ue03f\ue030\ue03e\ue000\ue02e\ue03a\ue038\ue03b\ue037\ue030\ue03f\ue030\ue02f\ue000\ue02c\ue039\n\ue034\ue039\ue034\ue03f\ue034\ue02c\ue037\ue000\ue03f\ue030\ue037\ue030\ue03b\ue033\ue03a\ue039\ue030\ue000\ue034\ue039\ue03f\ue030\ue03d\ue041\ue034\ue030\ue042\ue004\ue000\ue02c\ue039\ue02f\ue000\ue038\ue03a\ue03f\ue033\ue030\ue03d\ue03e\ue000\ue03a\ue031\ue000\ue00f\ue010\ue010\ue000\ue002\ue011\ue010\ue001\ue003\ue000\ue02c\ue039\ue02f\ue000\ue00e\ue011\ue011\n\ue002\ue011\ue00f\ue001\ue003\ue000\ue030\ue037\ue034\ue032\ue034\ue02d\ue037\ue030\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue004\ue000\ue03d\ue030\ue03e\ue03b\ue030\ue02e\ue03f\ue034\ue041\ue030\ue037\ue044\ue004\ue000\ue03b\ue02c\ue03d\ue03f\ue034\ue02e\ue034\ue03b\ue02c\ue03f\ue030\ue02f\ue000\ue034\ue039\ue000\ue02c\n\ue03e\ue040\ue02d\ue03e\ue030\ue03c\ue040\ue030\ue039\ue03f\ue000", "mimetype": "text/plain", "start_char_idx": 2492, "end_char_idx": 2664, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a75922f5-2197-49db-beb7-6a9728804ec4": {"__data__": {"id_": "a75922f5-2197-49db-beb7-6a9728804ec4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a8072cee-8df3-4a9a-956e-770eb686fa3f", "node_type": "1", "metadata": {}, "hash": "9f888633b2b560d4af15ffbc84a57067a31ca128ddd4ca36cb02b2e1fb8fdf67", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f26fbf1e-4334-4aff-8edf-89c057639c1e", "node_type": "1", "metadata": {}, "hash": "5f713b54cc6e179042f1e967049d615e43bf0d9bbfe9371a264d96d819e95db2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue000\ue034\ue039\ue000\ue02c\n\ue03e\ue040\ue02d\ue03e\ue030\ue03c\ue040\ue030\ue039\ue03f\ue000\ue034\ue039\ue005\ue03b\ue030\ue03d\ue03e\ue03a\ue039\ue000\ue034\ue039\ue03f\ue030\ue03d\ue041\ue034\ue030\ue042\ue006\ue000\ue01d\ue039\ue000\ue03f\ue033\ue030\ue000\ue03f\ue033\ue034\ue03d\ue02f\ue000\ue02e\ue03a\ue038\ue03b\ue03a\ue039\ue030\ue039\ue03f\ue004\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue005\n\ue03f\ue034\ue03a\ue039\ue000\ue02f\ue02c\ue03f\ue02c\ue000\ue042\ue030\ue03d\ue030\ue000\ue03b\ue03d\ue03a\ue041\ue034\ue02f\ue030\ue02f\ue000\ue02d\ue044\ue000\ue038\ue03a\ue03f\ue033\ue030\ue03d\ue03e\ue000\ue002\ue02d\ue02c\ue03e\ue030\ue02f\ue000\ue03a\ue039\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue03d\ue030\ue02e\ue03a\ue03d\ue02f\ue03e\n\ue031\ue03d\ue03a\ue038\ue000\ue03b\ue033\ue044\ue03e\ue034\ue02e\ue034\ue02c\ue039\ue03e\ue003\ue000\ue03a\ue03d\ue000\ue03a\ue02d\ue03f\ue02c\ue034\ue039\ue030\ue02f\ue000\ue02f\ue034\ue03d\ue030\ue02e\ue03f\ue037", "mimetype": "text/plain", "start_char_idx": 2647, "end_char_idx": 2819, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f26fbf1e-4334-4aff-8edf-89c057639c1e": {"__data__": {"id_": "f26fbf1e-4334-4aff-8edf-89c057639c1e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a75922f5-2197-49db-beb7-6a9728804ec4", "node_type": "1", "metadata": {}, "hash": "4db0b32c0f541218ab75b4059d3cbfc31c4fb1a4f9c21cd0a1bbb1f64aa361c8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9fe87c3b-34e0-4267-ac75-bca1be82f3ef", "node_type": "1", "metadata": {}, "hash": "51bd3e19dc8972051a10c7e1824a4bd7c1033ca4af3098c7c4a426d9c6cb7ba8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03a\ue02d\ue03f\ue02c\ue034\ue039\ue030\ue02f\ue000\ue02f\ue034\ue03d\ue030\ue02e\ue03f\ue037\ue044\ue000\ue031\ue03d\ue03a\ue038\ue000\ue03f\ue033\ue030\ue000\ue03b\ue033\ue044\ue03e\ue034\ue02e\ue034\ue02c\ue039\ue03e\ue000\ue03a\ue031\ue000\ue00e\ue00b\ue008\n\ue002\ue00f\ue011\ue006\ue011\ue001\ue003\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue00d\ue00d\ue008\ue000\ue002\ue00f\ue010\ue006\ue00f\ue001\ue003\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue004\ue000\ue03d\ue030\ue03b\ue03d\ue030\ue03e\ue030\ue039\ue03f\ue034\ue039\ue032\ue000\ue03a\ue041\ue030\ue03d\ue02c\ue037\ue037\n\ue03b\ue02c\ue03d\ue03f\ue034\ue02e\ue034\ue03b\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue03d\ue02c\ue03f\ue030\ue03e\ue000\ue03a\ue031\ue000\ue00f\ue008\ue006\ue009\ue001\ue000\ue031\ue03a\ue03d\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue00d\ue008\ue006\ue00c\ue001\ue000\ue031\ue03a\ue03d\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue006\n\ue027\ue033\ue030", "mimetype": "text/plain", "start_char_idx": 2803, "end_char_idx": 2975, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9fe87c3b-34e0-4267-ac75-bca1be82f3ef": {"__data__": {"id_": "9fe87c3b-34e0-4267-ac75-bca1be82f3ef", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f26fbf1e-4334-4aff-8edf-89c057639c1e", "node_type": "1", "metadata": {}, "hash": "5f713b54cc6e179042f1e967049d615e43bf0d9bbfe9371a264d96d819e95db2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fefc6bd8-9070-423d-98bd-5812948f31c3", "node_type": "1", "metadata": {}, "hash": "254efd47f0dee581eea23d63da46bc9677e2c1a92e0aa761e74f7875df82ccb8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue031\ue03a\ue03d\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue006\n\ue027\ue033\ue030\ue03d\ue030\ue000\ue042\ue030\ue03d\ue030\ue000\ue00c\ue00b\ue011\ue000\ue038\ue02c\ue03f\ue02e\ue033\ue030\ue02f\ue000\ue03b\ue02c\ue034\ue03d\ue03e\ue000\ue031\ue03a\ue03d\ue000\ue042\ue033\ue03a\ue038\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue02f\ue02c\ue03f\ue02c\ue000\ue042\ue030\ue03d\ue030\n\ue02e\ue03a\ue037\ue037\ue030\ue02e\ue03f\ue030\ue02f\ue006\n\ue018\ue02c\ue03f\ue02c\ue000\ue02e\ue03a\ue037\ue037\ue030\ue02e\ue03f\ue034\ue03a\ue039\ue000\ue031\ue03a\ue03d\ue038\ue03e\ue004\ue000\ue02e\ue03a\ue038\ue03b\ue037\ue030\ue03f\ue030\ue02f\ue000\ue02d\ue044\ue000\ue03f\ue033\ue030\ue000\ue038\ue03a\ue03f\ue033\ue030\ue03d\ue03e\ue000\ue040\ue03e\ue034\ue039\ue032\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue005\n\ue03f\ue034\ue03a\ue039\ue000\ue03d\ue030\ue02e\ue03a\ue03d\ue02f\ue03e\ue000\ue031\ue03d\ue03a\ue038\ue000\ue03b\ue033\ue044\ue03e\ue034\ue02e\ue034", "mimetype": "text/plain", "start_char_idx": 2958, "end_char_idx": 3131, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fefc6bd8-9070-423d-98bd-5812948f31c3": {"__data__": {"id_": "fefc6bd8-9070-423d-98bd-5812948f31c3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9fe87c3b-34e0-4267-ac75-bca1be82f3ef", "node_type": "1", "metadata": {}, "hash": "51bd3e19dc8972051a10c7e1824a4bd7c1033ca4af3098c7c4a426d9c6cb7ba8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1e128941-05a6-4b66-979c-aecd0e1fe41a", "node_type": "1", "metadata": {}, "hash": "b57911ea8a73b198aa024f42610e9586da404a58fe7ac530cc448a8a052e3522", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03d\ue02f\ue03e\ue000\ue031\ue03d\ue03a\ue038\ue000\ue03b\ue033\ue044\ue03e\ue034\ue02e\ue034\ue02c\ue039\ue03e\ue000\ue03a\ue03d\ue000\ue02d\ue044\ue000\ue03f\ue033\ue030\ue000\ue03b\ue033\ue044\ue03e\ue034\ue02e\ue034\ue02c\ue039\ue03e\ue000\ue03f\ue033\ue030\ue038\ue03e\ue030\ue037\ue041\ue030\ue03e\ue004\n\ue034\ue039\ue03c\ue040\ue034\ue03d\ue030\ue02f\ue000\ue042\ue033\ue030\ue03f\ue033\ue030\ue03d\ue000\ue02c\ue039\ue02f\ue000\ue042\ue033\ue030\ue039\ue000\ue03f\ue033\ue030\ue000\ue02e\ue033\ue034\ue037\ue02f\ue000\ue033\ue02c\ue02f\ue000\ue03d\ue030\ue02e\ue030\ue034\ue041\ue030\ue02f\ue000\ue03a\ue03d\ue02c\ue037\ue000\ue03a\ue03d\ue000\ue034\ue039\ue035\ue030\ue02e\ue03f\ue030\ue02f\n\ue007\ue01d\ue017\ue012\ue01d\ue022\ue000\ue024\ue012\ue014\ue014\ue019\ue01d\ue012\ue022\ue019\ue01e\ue01d\ue021\ue000\ue012\ue01d\ue015\ue000\ue020\ue019\ue021\ue01a\ue000\ue01e\ue017\ue000\ue014\ue018\ue019\ue01b\ue015\ue018\ue01e\ue01e\ue015\ue000\ue012\ue014\ue023\ue022\ue016\n\ue01b\ue025\ue01c\ue01f\ue018", "mimetype": "text/plain", "start_char_idx": 3115, "end_char_idx": 3287, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1e128941-05a6-4b66-979c-aecd0e1fe41a": {"__data__": {"id_": "1e128941-05a6-4b66-979c-aecd0e1fe41a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fefc6bd8-9070-423d-98bd-5812948f31c3", "node_type": "1", "metadata": {}, "hash": "254efd47f0dee581eea23d63da46bc9677e2c1a92e0aa761e74f7875df82ccb8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e94a0253-4e50-4245-bccf-c148e27e9272", "node_type": "1", "metadata": {}, "hash": "57c2fa41c02bde9f2a8c1c0abbbf0490c445f37aef68d705fdde59f2f14fb450", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue015\ue018\ue01e\ue01e\ue015\ue000\ue012\ue014\ue023\ue022\ue016\n\ue01b\ue025\ue01c\ue01f\ue018\ue01e\ue013\ue01b\ue012\ue021\ue022\ue019\ue014\ue000\ue01b\ue016\ue023\ue01a\ue012\ue016\ue01c\ue019\ue012\ue000\ue019\ue01d\ue000\ue022\ue018\ue016\ue000\ue010\ue00e\ue001\nFD Groves1, G Gridley1, S Wacholder1, XO Shu2, LL Robison2, JP Neglia2 and MS Linet1\n1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892-7244, USA, 2Department of Pediatrics, University of\nMinnesota Medical School, Minneapolis, Minnesota, USA\nSummary Previous studies have suggested that infant vaccinations may reduce the risk of subsequent childhood leukaemia. Vaccination\nhistories were compared in 439 children (ages 0\u201314) diagnosed with acute lymphoblastic leukaemia (ALL) in nine Midwestern and\nMid-Atlantic states (USA) between 1 January 1989 and 30 June 1993 and 439 controls selected by random-digit dialing and individually\nmatched to cases on age, race and telephone exchange. Among matched pairs, similar proportions of cases and controls had received at\nleast one dose of oral poliovirus (98%), diphtheria\u2013tetanus\u2013pertussis (97%), and measles\u2013mumps\u2013rubella (90%) vaccines. Only 47% of\ncases and 53% of controls had received any Haemophilus influenzae type b (Hib) vaccine (relative risk (RR) = 0.73; 95% confidence interval\n(CI) 0.50\u20131.06).", "mimetype": "text/plain", "start_char_idx": 3270, "end_char_idx": 4417, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e94a0253-4e50-4245-bccf-c148e27e9272": {"__data__": {"id_": "e94a0253-4e50-4245-bccf-c148e27e9272", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1e128941-05a6-4b66-979c-aecd0e1fe41a", "node_type": "1", "metadata": {}, "hash": "b57911ea8a73b198aa024f42610e9586da404a58fe7ac530cc448a8a052e3522", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bf99d17f-2b4d-4c76-aa8a-e741cc557fc6", "node_type": "1", "metadata": {}, "hash": "b0563cc6907e3e9ba69996b2d794a0fea12d793de4021b3694790709c745cffd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Although similar proportions of cases (12%) and controls (11%) received the polysaccharide Hib vaccine (RR = 1.13; 95% CI\n0.64\u20131.98), more controls (41%) than cases (35%) received the conjugate Hib vaccine (RR = 0.57; 95% CI 0.36\u20130.89). Although we found no\nrelationship between most infant vaccinations and subsequent risk of childhood ALL, our findings suggest that infants receiving the conjugate\nHib vaccine may be at reduced risk of subsequent childhood acute lymphoblastic leukemia. Further studies are needed to confirm this\nassociation and, if confirmed, to elucidate the underlying mechanism.\nKeywords: acute lymphoblastic leukaemia; Haemophilus influenzae; vaccination; children\n175\nBritish Journal of Cancer (1999) 81(1), 175\u2013178\n\u00a9 1999 Cancer Research Campaign\nArticle no. bjoc.1999.0668\nReceived 24 November 1998\nRevised 8 February 1999 \nAccepted 9 February 1999\nCorrespondence to: FD Groves, Descriptive Studies Section, Biostatistics\nBranch, Epidemiology and Biostatistics Program, Division of Cancer\nEpidemiology and Genetics, National Cancer Institute, Executive Plaza \u2013\nSouth, Room #8089, 6120 Executive Boulevard, MSC #7244, Bethesda, MD\n20892-7244, USA\n\ue03b\ue03a\ue037\ue034\ue03a\ue041\ue034\ue03d\ue040\ue03e\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue004\ue000\ue03f\ue03d\ue034\ue041\ue02c\ue037\ue030\ue039\ue03f\ue000\ue02f\ue034\ue03b\ue033\ue03f\ue033\ue030\ue03d\ue034\ue02c\ue047\ue03f\ue030\ue03f\ue02c\ue039\ue040\ue03e\ue047\ue03b\ue030\ue03d\ue03f\ue040\ue03e\ue03e\ue034\ue03e\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039", "mimetype": "text/plain", "start_char_idx": 4418, "end_char_idx": 5656, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bf99d17f-2b4d-4c76-aa8a-e741cc557fc6": {"__data__": {"id_": "bf99d17f-2b4d-4c76-aa8a-e741cc557fc6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e94a0253-4e50-4245-bccf-c148e27e9272", "node_type": "1", "metadata": {}, "hash": "57c2fa41c02bde9f2a8c1c0abbbf0490c445f37aef68d705fdde59f2f14fb450", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f9f16392-9d9d-4cea-9550-a212f171934d", "node_type": "1", "metadata": {}, "hash": "c346bf981be936ff0499531ee8a86cfe4128c3b9b1315bccb79a1ae24f26e780", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03b\ue030\ue03d\ue03f\ue040\ue03e\ue03e\ue034\ue03e\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue004\n\ue02d\ue034\ue041\ue02c\ue037\ue030\ue039\ue03f\ue000\ue02f\ue034\ue03b\ue033\ue03f\ue033\ue030\ue03d\ue034\ue02c\ue047\ue03f\ue030\ue03f\ue02c\ue039\ue040\ue03e\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue004\ue000\ue02d\ue034\ue041\ue02c\ue037\ue030\ue039\ue03f\ue000\ue03f\ue030\ue03f\ue02c\ue039\ue040\ue03e\ue047\ue02f\ue034\ue03b\ue033\ue03f\ue033\ue030\ue03d\ue034\ue02c\n\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue004\ue000\n\ue038\ue03a\ue039\ue03a\ue041\ue02c\ue037\ue030\ue039\ue03f\ue000\n\ue03f\ue030\ue03f\ue02c\ue039\ue040\ue03e\ue000\n\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue004\ue000\n\ue03f\ue03d\ue034\ue041\ue02c\ue037\ue030\ue039\ue03f\ue000\n\ue038\ue030\ue02c\ue03e\ue037\ue030\ue03e\ue047\n\ue038\ue040\ue038\ue03b\ue03e\ue047\ue03d\ue040\ue02d\ue030\ue037\ue037\ue02c\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue004\ue000Haemophilus influenzae \ue032\ue03d\ue03a", "mimetype": "text/plain", "start_char_idx": 5640, "end_char_idx": 5834, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f9f16392-9d9d-4cea-9550-a212f171934d": {"__data__": {"id_": "f9f16392-9d9d-4cea-9550-a212f171934d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bf99d17f-2b4d-4c76-aa8a-e741cc557fc6", "node_type": "1", "metadata": {}, "hash": "b0563cc6907e3e9ba69996b2d794a0fea12d793de4021b3694790709c745cffd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aeea1d91-69e2-49ca-89f0-9a79be8a02df", "node_type": "1", "metadata": {}, "hash": "c0c157df89c954f9e5897eb852e2f23b7d96abe895295dfd685012930f6b6947", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue004\ue000Haemophilus influenzae \ue032\ue03d\ue03a\ue040\ue03b\ue000\ue02d\ue000\ue002\ue01c\ue034\ue02d\ue003\n\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue004\ue000\ue033\ue030\ue03b\ue02c\ue03f\ue034\ue03f\ue034\ue03e\ue000\ue016\ue000\ue041\ue034\ue03d\ue040\ue03e\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue02c\ue039\ue02f\ue000\ue03a\ue03f\ue033\ue030\ue03d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue006\ue000\ue01a\ue03a\ue03d\ue000\ue00b\ue00a\ue011\n\ue002\ue00f\ue00d\ue001\ue003\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue00b\ue00b\ue00c\ue000\ue002\ue00f\ue00e\ue001\ue003\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue000\ue02c\ue038\ue03a\ue039\ue032\ue000\ue03f\ue033\ue030\ue000\ue00c\ue00b\ue011\n\ue038\ue02c\ue03f\ue02e\ue033\ue030\ue02f\ue000\ue03b\ue02c\ue034\ue03d\ue03e\ue004\ue000\ue03f\ue033\ue030", "mimetype": "text/plain", "start_char_idx": 5799, "end_char_idx": 5990, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aeea1d91-69e2-49ca-89f0-9a79be8a02df": {"__data__": {"id_": "aeea1d91-69e2-49ca-89f0-9a79be8a02df", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f9f16392-9d9d-4cea-9550-a212f171934d", "node_type": "1", "metadata": {}, "hash": "c346bf981be936ff0499531ee8a86cfe4128c3b9b1315bccb79a1ae24f26e780", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f17d2dfa-e141-4339-9e5a-16b555dda23f", "node_type": "1", "metadata": {}, "hash": "d10d9ddbb9b0c4f125ceaac880c49fbd66017cee4440e964c6b02bf7d7b93894", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03f\ue02e\ue033\ue030\ue02f\ue000\ue03b\ue02c\ue034\ue03d\ue03e\ue004\ue000\ue03f\ue033\ue030\ue000\ue038\ue03a\ue03f\ue033\ue030\ue03d\ue000\ue03b\ue03d\ue03a\ue041\ue034\ue02f\ue030\ue02f\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue03d\ue030\ue02e\ue03a\ue03d\ue02f\ue03e\ue004\ue000\ue02c\ue039\ue02f\ue000\ue03f\ue033\ue030\n\ue03b\ue033\ue044\ue03e\ue034\ue02e\ue034\ue02c\ue039\ue000\ue042\ue02c\ue03e\ue000\ue039\ue03a\ue03f\ue000\ue02e\ue03a\ue039\ue03f\ue02c\ue02e\ue03f\ue030\ue02f\ue006\ue000\ue02a\ue034\ue03f\ue033\ue000\ue03f\ue033\ue030\ue000\ue038\ue03a\ue03f\ue033\ue030\ue03d\ue049\ue03e\ue000\ue03b\ue030\ue03d\ue038\ue034\ue03e\ue03e\ue034\ue03a\ue039\ue004\ue000\ue02c\n\ue038\ue030\ue02f\ue034\ue02e\ue02c\ue037\ue005\ue03d\ue030\ue02e\ue03a\ue03d\ue02f\ue000\ue03d\ue030\ue03c\ue040\ue030\ue03e\ue03f\ue000\ue042\ue02c\ue03e\ue000\ue031\ue034\ue037\ue030\ue02f\ue000\ue042\ue034\ue03f\ue033\ue000\ue03f\ue033\ue030\ue000\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f", "mimetype": "text/plain", "start_char_idx": 5974, "end_char_idx": 6146, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f17d2dfa-e141-4339-9e5a-16b555dda23f": {"__data__": {"id_": "f17d2dfa-e141-4339-9e5a-16b555dda23f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aeea1d91-69e2-49ca-89f0-9a79be8a02df", "node_type": "1", "metadata": {}, "hash": "c0c157df89c954f9e5897eb852e2f23b7d96abe895295dfd685012930f6b6947", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cbf91903-648b-4d14-8767-95b0ed1f30fc", "node_type": "1", "metadata": {}, "hash": "33c69c0223363bbce3d5b2e45225f99d2ac4a79e45313729302561f718a95129", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue042\ue034\ue03f\ue033\ue000\ue03f\ue033\ue030\ue000\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue049\ue03e\ue000\ue03b\ue03d\ue034\ue038\ue02c\ue03d\ue044\ue000\ue03b\ue033\ue044\ue03e\ue034\ue005\n\ue02e\ue034\ue02c\ue039\ue004\ue000\ue03d\ue030\ue03c\ue040\ue030\ue03e\ue03f\ue034\ue039\ue032\ue000\ue02f\ue030\ue03f\ue02c\ue034\ue037\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue02f\ue02c\ue03f\ue030\ue03e\ue000\ue03a\ue031\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue031\ue03a\ue03d\ue000\ue03f\ue033\ue030\ue000\ue03d\ue030\ue038\ue02c\ue034\ue039\ue034\ue039\ue032\n\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue03e\ue006\n\ue029\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue02f\ue02c\ue03f\ue02c\ue000\ue042\ue030\ue03d\ue030\ue000\ue03e\ue03a\ue040\ue032\ue033\ue03f\ue000\ue02d\ue040\ue03f\ue000\ue039\ue03a\ue03f\ue000\ue03a\ue02d\ue03f\ue02c\ue034\ue039\ue030\ue02f\ue000\ue031\ue03d\ue03a\ue038\ue000\ue009\ue00d\ue010\ue000\ue03a\ue031\ue000\ue03f\ue033", "mimetype": "text/plain", "start_char_idx": 6130, "end_char_idx": 6302, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cbf91903-648b-4d14-8767-95b0ed1f30fc": {"__data__": {"id_": "cbf91903-648b-4d14-8767-95b0ed1f30fc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f17d2dfa-e141-4339-9e5a-16b555dda23f", "node_type": "1", "metadata": {}, "hash": "d10d9ddbb9b0c4f125ceaac880c49fbd66017cee4440e964c6b02bf7d7b93894", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6e54aa62-8012-4810-ac2e-9923970b0303", "node_type": "1", "metadata": {}, "hash": "79a7712af069ae7b105fcf55b0328033de2d7573629acc82831aa0969903f9b2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue02f\ue000\ue031\ue03d\ue03a\ue038\ue000\ue009\ue00d\ue010\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\n\ue00f\ue010\ue010\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue042\ue033\ue03a\ue03e\ue030\ue000\ue038\ue03a\ue03f\ue033\ue030\ue03d\ue03e\ue000\ue042\ue030\ue03d\ue030\ue000\ue034\ue039\ue03f\ue030\ue03d\ue041\ue034\ue030\ue042\ue030\ue02f\ue000\ue034\ue039\ue005\ue03b\ue030\ue03d\ue03e\ue03a\ue039\ue004\ue000\ue03a\ue031\ue000\ue042\ue033\ue03a\ue038\ue000\ue00e\ue00b\n\ue042\ue030\ue03d\ue030\ue000\ue02f\ue040\ue030\ue000\ue03f\ue03a\ue000\ue038\ue02c\ue03f\ue030\ue03d\ue039\ue02c\ue037\ue000\ue03d\ue030\ue031\ue040\ue03e\ue02c\ue037\ue004\ue000\ue02c\ue039\ue02f\ue000\ue011\ue00c\ue000\ue042\ue030\ue03d\ue030\ue000\ue02f\ue040\ue030\ue000\ue03f\ue03a\ue000\ue03b\ue033\ue044\ue03e\ue034\ue02e\ue034\ue02c\ue039\ue000\ue03d\ue030\ue031\ue040\ue03e\ue02c\ue037\n\ue03a\ue03d\ue000\ue039\ue03a\ue039\ue005\ue03d\ue030\ue03e\ue03b\ue03a\ue039\ue03e\ue030\ue006\ue000\ue020\ue034\ue036\ue030\ue042\ue034\ue03e", "mimetype": "text/plain", "start_char_idx": 6286, "end_char_idx": 6458, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6e54aa62-8012-4810-ac2e-9923970b0303": {"__data__": {"id_": "6e54aa62-8012-4810-ac2e-9923970b0303", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cbf91903-648b-4d14-8767-95b0ed1f30fc", "node_type": "1", "metadata": {}, "hash": "33c69c0223363bbce3d5b2e45225f99d2ac4a79e45313729302561f718a95129", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2e3696a3-945f-4702-a472-cba14f5a0386", "node_type": "1", "metadata": {}, "hash": "942a481a1dbfac0efefc521a5a54fa253dbd0af6dede836943270b358a7e4baf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue030\ue03e\ue03b\ue03a\ue039\ue03e\ue030\ue006\ue000\ue020\ue034\ue036\ue030\ue042\ue034\ue03e\ue030\ue004\ue000\ue010\ue00c\ue000\ue038\ue02c\ue03f\ue030\ue03d\ue039\ue02c\ue037\ue000\ue03d\ue030\ue031\ue040\ue03e\ue02c\ue037\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue00e\ue00b\ue000\ue03b\ue033\ue044\ue03e\ue034\ue02e\ue034\ue02c\ue039\n\ue03d\ue030\ue031\ue040\ue03e\ue02c\ue037\ue03e\ue000\ue03a\ue03d\ue000\ue039\ue03a\ue039\ue005\ue03d\ue030\ue03e\ue03b\ue03a\ue039\ue03e\ue030\ue03e\ue000\ue042\ue030\ue03d\ue030\ue000\ue03f\ue033\ue030\ue000\ue038\ue02c\ue034\ue039\ue000\ue03d\ue030\ue02c\ue03e\ue03a\ue039\ue03e\ue000\ue031\ue03a\ue03d\ue000\ue03f\ue033\ue030\ue000\ue009\ue00c\ue011\n\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue000\ue042\ue034\ue03f\ue033\ue03a\ue040\ue03f\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue02f\ue02c\ue03f\ue02c\ue000\ue02c\ue038\ue03a\ue039\ue032\ue000\ue03f\ue033\ue030\ue000\ue00e\ue011\ue011\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037", "mimetype": "text/plain", "start_char_idx": 6442, "end_char_idx": 6614, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2e3696a3-945f-4702-a472-cba14f5a0386": {"__data__": {"id_": "2e3696a3-945f-4702-a472-cba14f5a0386", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6e54aa62-8012-4810-ac2e-9923970b0303", "node_type": "1", "metadata": {}, "hash": "79a7712af069ae7b105fcf55b0328033de2d7573629acc82831aa0969903f9b2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7976d0b0-a8c0-4895-a654-cad16a2d2963", "node_type": "1", "metadata": {}, "hash": "cae42475bacd92bcff4af0c4140d7a539939580a74556489130ce3a45437cdf2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue000\ue03f\ue033\ue030\ue000\ue00e\ue011\ue011\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue000\ue042\ue033\ue03a\ue03e\ue030\n\ue038\ue03a\ue03f\ue033\ue030\ue03d\ue03e\ue000\ue042\ue030\ue03d\ue030\ue000\ue034\ue039\ue03f\ue030\ue03d\ue041\ue034\ue030\ue042\ue030\ue02f\ue000\ue034\ue039\ue005\ue03b\ue030\ue03d\ue03e\ue03a\ue039\ue006\ue000\ue029\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue02f\ue02c\ue03f\ue02c\ue000\ue042\ue030\ue03d\ue030\ue000\ue02e\ue03a\ue02f\ue030\ue02f\n\ue040\ue03b\ue000\ue03f\ue03a\ue000\ue03f\ue033\ue030\ue000\ue02f\ue02c\ue03f\ue030\ue000\ue03a\ue031\ue000\ue02f\ue034\ue02c\ue032\ue039\ue03a\ue03e\ue034\ue03e\ue000\ue031\ue03a\ue03d\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue004\ue000\ue02c\ue039\ue02f\ue000\ue040\ue03b\ue000\ue03f\ue03a\ue000\ue03f\ue033\ue030\ue000\ue02f\ue02c\ue03f\ue030\ue000\ue03a\ue031\ue000\ue034\ue039\ue03f\ue030\ue03d\ue005\n\ue041\ue034\ue030\ue042\ue000\ue031\ue03a\ue03d\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037", "mimetype": "text/plain", "start_char_idx": 6598, "end_char_idx": 6770, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7976d0b0-a8c0-4895-a654-cad16a2d2963": {"__data__": {"id_": "7976d0b0-a8c0-4895-a654-cad16a2d2963", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2e3696a3-945f-4702-a472-cba14f5a0386", "node_type": "1", "metadata": {}, "hash": "942a481a1dbfac0efefc521a5a54fa253dbd0af6dede836943270b358a7e4baf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cfea8252-58e1-4f33-b15e-3a958c98cb89", "node_type": "1", "metadata": {}, "hash": "d57b50a4d86e465b84efeb3b6b38eaa7246db2680fb4402778bb470363db9008", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue041\ue034\ue030\ue042\ue000\ue031\ue03a\ue03d\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue006\n\ue027\ue03a\ue000\ue030\ue039\ue03e\ue040\ue03d\ue030\ue000\ue03f\ue033\ue02c\ue03f\ue000\ue03f\ue033\ue030\ue000\ue02e\ue02c\ue03e\ue030\ue000\ue02c\ue039\ue02f\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue000\ue042\ue034\ue03f\ue033\ue034\ue039\ue000\ue030\ue02c\ue02e\ue033\ue000\ue03b\ue02c\ue034\ue03d\ue000\ue042\ue030\ue03d\ue030\n\ue03a\ue02d\ue03e\ue030\ue03d\ue041\ue030\ue02f\ue000\ue031\ue03a\ue03d\ue000\ue03f\ue033\ue030\ue000\ue03e\ue02c\ue038\ue030\ue000\ue037\ue030\ue039\ue032\ue03f\ue033\ue000\ue03a\ue031\ue000\ue03f\ue034\ue038\ue030\ue004\ue000\ue042\ue030\ue000\ue02e\ue030\ue039\ue03e\ue03a\ue03d\ue030\ue02f\ue000\ue03f\ue033\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\n\ue02f\ue02c\ue03f\ue02c\ue000\ue02d\ue044\ue000\ue02c\ue02f\ue03a\ue03b\ue03f\ue034\ue039\ue032\ue000\ue02c\ue000\ue02e\ue03a\ue038\ue038\ue03a\ue039\ue000\ue048\ue02e\ue040", "mimetype": "text/plain", "start_char_idx": 6754, "end_char_idx": 6926, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cfea8252-58e1-4f33-b15e-3a958c98cb89": {"__data__": {"id_": "cfea8252-58e1-4f33-b15e-3a958c98cb89", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7976d0b0-a8c0-4895-a654-cad16a2d2963", "node_type": "1", "metadata": {}, "hash": "cae42475bacd92bcff4af0c4140d7a539939580a74556489130ce3a45437cdf2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7dda4f6f-aecc-4a91-afba-69e4eb9d40ea", "node_type": "1", "metadata": {}, "hash": "434aea9a83360fe654017485805dc30438008609ba2f0ce28330421439413251", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue034\ue039\ue032\ue000\ue02c\ue000\ue02e\ue03a\ue038\ue038\ue03a\ue039\ue000\ue048\ue02e\ue040\ue03f\ue005\ue03a\ue031\ue031\ue005\ue02c\ue032\ue030\ue049\ue000\ue002\ue03f\ue033\ue030\ue000\ue037\ue030\ue03e\ue03e\ue030\ue03d\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue02c\ue032\ue030\ue000\ue02c\ue03f\n\ue02f\ue034\ue02c\ue032\ue039\ue03a\ue03e\ue034\ue03e\ue000\ue031\ue03a\ue03d\ue000\ue03f\ue033\ue030\ue000\ue02e\ue02c\ue03e\ue030\ue000\ue03a\ue03d\ue000\ue03f\ue033\ue030\ue000\ue02c\ue032\ue030\ue000\ue02c\ue03f\ue000\ue034\ue039\ue03f\ue030\ue03d\ue041\ue034\ue030\ue042\ue000\ue031\ue03a\ue03d\ue000\ue03f\ue033\ue030\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue003\ue000\ue031\ue03a\ue03d\n\ue02d\ue03a\ue03f\ue033\ue000\ue038\ue030\ue038\ue02d\ue030\ue03d\ue03e\ue000\ue03a\ue031\ue000\ue030\ue02c\ue02e\ue033\ue000\ue038\ue02c\ue03f\ue02e\ue033\ue030\ue02f\ue000\ue03b\ue02c\ue034\ue03d\ue004\ue000\ue030\ue043\ue02e\ue037\ue040\ue02f\ue034\ue039\ue032\ue000\ue031\ue03d\ue03a\ue038\ue000\ue02c", "mimetype": "text/plain", "start_char_idx": 6910, "end_char_idx": 7082, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7dda4f6f-aecc-4a91-afba-69e4eb9d40ea": {"__data__": {"id_": "7dda4f6f-aecc-4a91-afba-69e4eb9d40ea", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cfea8252-58e1-4f33-b15e-3a958c98cb89", "node_type": "1", "metadata": {}, "hash": "d57b50a4d86e465b84efeb3b6b38eaa7246db2680fb4402778bb470363db9008", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "010487cc-7533-4da5-9ff1-7843f9bd5418", "node_type": "1", "metadata": {}, "hash": "f72ba68002096bf7c60cff44a35c4ce6b126a3f526ba0dcb0f18b5b68cac8733", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue030\ue043\ue02e\ue037\ue040\ue02f\ue034\ue039\ue032\ue000\ue031\ue03d\ue03a\ue038\ue000\ue02c\ue039\ue02c\ue037\ue044\ue03e\ue034\ue03e\ue000\ue02c\ue039\ue044\n\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue02f\ue03a\ue03e\ue030\ue03e\ue000\ue03d\ue030\ue02e\ue030\ue034\ue041\ue030\ue02f\ue000\ue02c\ue031\ue03f\ue030\ue03d\ue000\ue03f\ue033\ue030\ue000\ue02e\ue040\ue03f\ue005\ue03a\ue031\ue031\ue000\ue02c\ue032\ue030\ue006\ue000\ue02a\ue030\ue000\ue02e\ue02c\ue037\ue02e\ue040\ue037\ue02c\ue03f\ue030\ue02f\ue000\ue03d\ue030\ue037\ue02c\ue03f\ue034\ue041\ue030\n\ue03d\ue034\ue03e\ue036\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue011\ue00d\ue001\ue000\ue02e\ue03a\ue039\ue031\ue034\ue02f\ue030\ue039\ue02e\ue030\ue000\ue034\ue039\ue03f\ue030\ue03d\ue041\ue02c\ue037\ue03e\ue000\ue031\ue03a\ue03d\ue000\ue015\ue020\ue020\ue000\ue031\ue03a\ue037\ue037\ue03a\ue042\ue034\ue039\ue032\ue000\ue030\ue043\ue03b\ue03a\ue03e\ue040\ue03d\ue030\ue000\ue03f\ue03a\n\ue030\ue02c\ue02e\ue033\ue000\ue041\ue02c\ue02e\ue02e\ue034", "mimetype": "text/plain", "start_char_idx": 7066, "end_char_idx": 7238, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "010487cc-7533-4da5-9ff1-7843f9bd5418": {"__data__": {"id_": "010487cc-7533-4da5-9ff1-7843f9bd5418", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7dda4f6f-aecc-4a91-afba-69e4eb9d40ea", "node_type": "1", "metadata": {}, "hash": "434aea9a83360fe654017485805dc30438008609ba2f0ce28330421439413251", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "65f325f7-d90b-441e-b261-718065c75f71", "node_type": "1", "metadata": {}, "hash": "fc3e4b2c14c838b4443d2b27ebeeea25ed1e1eeb6696eece65266923b3645dee", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue040\ue03d\ue030\ue000\ue03f\ue03a\n\ue030\ue02c\ue02e\ue033\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue002\ue030\ue041\ue030\ue03d\ue000\ue041\ue03e\ue000\ue039\ue030\ue041\ue030\ue03d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue030\ue02f\ue003\ue006\ue000\ue02a\ue030\ue000\ue02c\ue037\ue03e\ue03a\ue000\ue030\ue041\ue02c\ue037\ue040\ue02c\ue03f\ue030\ue02f\n\ue039\ue040\ue038\ue02d\ue030\ue03d\ue000\ue03a\ue031\ue000\ue02f\ue03a\ue03e\ue030\ue03e\ue000\ue03a\ue031\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue03d\ue030\ue02e\ue030\ue034\ue041\ue030\ue02f\ue004\ue000\ue02c\ue032\ue030\ue000\ue02c\ue03f\ue000\ue031\ue034\ue03d\ue03e\ue03f\ue000\ue02f\ue03a\ue03e\ue030\ue004\ue000\ue02c\ue032\ue030\ue000\ue02c\ue03f\ue000\ue037\ue02c\ue03e\ue03f\n\ue02f\ue03a\ue03e\ue030\ue004\ue000\ue03f\ue034\ue038\ue030\ue000\ue02d\ue030\ue03f\ue042\ue030\ue030\ue039\ue000\ue031\ue034\ue03d\ue03e\ue03f\ue000\ue02f\ue03a\ue03e\ue030\ue000\ue03a\ue031\ue000\ue030\ue02c\ue02e\ue033\ue000", "mimetype": "text/plain", "start_char_idx": 7221, "end_char_idx": 7393, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "65f325f7-d90b-441e-b261-718065c75f71": {"__data__": {"id_": "65f325f7-d90b-441e-b261-718065c75f71", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "010487cc-7533-4da5-9ff1-7843f9bd5418", "node_type": "1", "metadata": {}, "hash": "f72ba68002096bf7c60cff44a35c4ce6b126a3f526ba0dcb0f18b5b68cac8733", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7226f582-afc1-4584-9bee-cfae5a8eabd9", "node_type": "1", "metadata": {}, "hash": "89a8406592313d55a52f5b74da2986b4ac6cae51c17e5d2ed53627c181cfee44", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03e\ue03f\ue000\ue02f\ue03a\ue03e\ue030\ue000\ue03a\ue031\ue000\ue030\ue02c\ue02e\ue033\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue02c\ue039\ue02f\ue000\ue02f\ue034\ue02c\ue032\ue039\ue03a\ue03e\ue034\ue03e\ue004\ue000\ue02c\ue039\ue02f\n\ue03f\ue034\ue038\ue030\ue000\ue02d\ue030\ue03f\ue042\ue030\ue030\ue039\ue000\ue037\ue02c\ue03e\ue03f\ue000\ue02f\ue03a\ue03e\ue030\ue000\ue03a\ue031\ue000\ue030\ue02c\ue02e\ue033\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue02c\ue039\ue02f\ue000\ue02f\ue034\ue02c\ue032\ue039\ue03a\ue03e\ue034\ue03e\ue006\ue000\ue026\ue034\ue039\ue02e\ue030\ue000\ue039\ue03a\ue039\ue030\n\ue03a\ue031\ue000\ue03f\ue033\ue030\ue03e\ue030\ue000\ue02c\ue039\ue02c\ue037\ue044\ue03e\ue030\ue03e\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue034\ue02d\ue040\ue03f\ue030\ue02f\ue000\ue02c\ue02f\ue02f\ue034\ue03f\ue034\ue03a\ue039\ue02c\ue037\ue000\ue040\ue03e\ue030\ue031\ue040\ue037\ue000\ue034\ue039\ue031\ue03a\ue03d\ue038\ue02c\ue03f\ue034\ue03a\ue039\ue004\ue000\ue03a\ue039\ue037", "mimetype": "text/plain", "start_char_idx": 7377, "end_char_idx": 7549, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7226f582-afc1-4584-9bee-cfae5a8eabd9": {"__data__": {"id_": "7226f582-afc1-4584-9bee-cfae5a8eabd9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "65f325f7-d90b-441e-b261-718065c75f71", "node_type": "1", "metadata": {}, "hash": "fc3e4b2c14c838b4443d2b27ebeeea25ed1e1eeb6696eece65266923b3645dee", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b0e178f2-554d-43a4-b735-9453c48e504d", "node_type": "1", "metadata": {}, "hash": "3fb4ebe6ca30cbad5ba4d6aa373acff9e1a042f5f7b54c063ea7529fafb7e3be", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue034\ue039\ue031\ue03a\ue03d\ue038\ue02c\ue03f\ue034\ue03a\ue039\ue004\ue000\ue03a\ue039\ue037\ue044\n\ue03f\ue033\ue030\ue000\ue030\ue041\ue030\ue03d\ue005\ue000\ue041\ue030\ue03d\ue03e\ue040\ue03e\ue000\ue039\ue030\ue041\ue030\ue03d\ue005\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue030\ue02f\ue000\ue03d\ue030\ue03e\ue040\ue037\ue03f\ue03e\ue000\ue02c\ue03d\ue030\ue000\ue03b\ue03d\ue030\ue03e\ue030\ue039\ue03f\ue030\ue02f\ue000\ue033\ue030\ue03d\ue030\ue006\n\ue025\ue030\ue037\ue02c\ue03f\ue034\ue041\ue030\ue000\ue03d\ue034\ue03e\ue036\ue03e\ue000\ue002\ue025\ue025\ue003\ue000\ue02c\ue039\ue02f\ue000\ue011\ue00d\ue001\ue000\ue02e\ue03a\ue039\ue031\ue034\ue02f\ue030\ue039\ue02e\ue030\ue000\ue034\ue039\ue03f\ue030\ue03d\ue041\ue02c\ue037\ue03e\ue000\ue002\ue017\ue01d\ue003\ue000\ue042\ue030\ue03d\ue030\n\ue02e\ue02c\ue037\ue02e\ue040\ue037\ue02c\ue03f\ue030\ue02f\ue000\ue02d\ue044\ue000\ue02e\ue03a\ue039\ue02f\ue034\ue03f\ue034\ue03a\ue039\ue02c\ue037\ue000\ue037\ue03a\ue032\ue034\ue03e\ue03f\ue034", "mimetype": "text/plain", "start_char_idx": 7533, "end_char_idx": 7705, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b0e178f2-554d-43a4-b735-9453c48e504d": {"__data__": {"id_": "b0e178f2-554d-43a4-b735-9453c48e504d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7226f582-afc1-4584-9bee-cfae5a8eabd9", "node_type": "1", "metadata": {}, "hash": "89a8406592313d55a52f5b74da2986b4ac6cae51c17e5d2ed53627c181cfee44", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bfa140c4-b783-46a7-96b5-032dec822d0e", "node_type": "1", "metadata": {}, "hash": "07a752f9321a931a12781c76ba10c0b29cc352a18107abffe3081ffeeef36a9b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue02f\ue034\ue03f\ue034\ue03a\ue039\ue02c\ue037\ue000\ue037\ue03a\ue032\ue034\ue03e\ue03f\ue034\ue02e\ue000\ue03d\ue030\ue032\ue03d\ue030\ue03e\ue03e\ue034\ue03a\ue039\ue000\ue002\ue016\ue03d\ue030\ue03e\ue037\ue03a\ue042\ue000\ue02c\ue039\ue02f\ue000\ue018\ue02c\ue044\ue004\n\ue009\ue011\ue010\ue008\ue003\ue000\ue040\ue03e\ue034\ue039\ue032\ue000\ue02c\ue000\ue038\ue02c\ue03f\ue02e\ue033\ue030\ue02f\ue005\ue03b\ue02c\ue034\ue03d\ue03e\ue000\ue02f\ue030\ue03e\ue034\ue032\ue039\ue000\ue02c\ue039\ue02f\ue000\ue02c\ue02f\ue035\ue040\ue03e\ue03f\ue034\ue039\ue032\ue000\ue031\ue03a\ue03d\ue000\ue02c\ue032\ue030\ue000\ue002\ue034\ue039\n\ue044\ue030\ue02c\ue03d\ue03e\ue003\ue000\ue02c\ue03f\ue000\ue02e\ue030\ue039\ue03e\ue03a\ue03d\ue034\ue039\ue032\ue004\ue000\ue044\ue030\ue02c\ue03d\ue000\ue03a\ue031\ue000\ue02d\ue034\ue03d\ue03f\ue033\ue004\ue000\ue03e\ue030\ue043\ue004\ue000\ue03d\ue02c\ue02e\ue030\ue004\ue000\ue031\ue02c\ue038\ue034\ue037\ue044\ue000\ue034\ue039\ue02e\ue03a\ue038\ue030\ue000\ue02c\ue039\ue02f", "mimetype": "text/plain", "start_char_idx": 7689, "end_char_idx": 7861, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bfa140c4-b783-46a7-96b5-032dec822d0e": {"__data__": {"id_": "bfa140c4-b783-46a7-96b5-032dec822d0e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b0e178f2-554d-43a4-b735-9453c48e504d", "node_type": "1", "metadata": {}, "hash": "3fb4ebe6ca30cbad5ba4d6aa373acff9e1a042f5f7b54c063ea7529fafb7e3be", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "90793003-2125-4b3e-b7e4-ff83187e3f71", "node_type": "1", "metadata": {}, "hash": "c20ece4a5aeb4ef6cd892858caab468fbd26dd89db7e371eac466b0ce6f76ddb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue02c\ue038\ue034\ue037\ue044\ue000\ue034\ue039\ue02e\ue03a\ue038\ue030\ue000\ue02c\ue039\ue02f\n\ue03b\ue02c\ue03d\ue030\ue039\ue03f\ue02c\ue037\ue000\ue030\ue02f\ue040\ue02e\ue02c\ue03f\ue034\ue03a\ue039\ue004\ue000\ue02c\ue03e\ue000\ue03e\ue033\ue03a\ue042\ue039\ue000\ue034\ue039\ue000\ue027\ue02c\ue02d\ue037\ue030\ue000\ue009\ue006\ue000\ue01a\ue03a\ue03d\ue000\ue039\ue034\ue039\ue030\ue000\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue03e\ue000\ue002\ue03e\ue030\ue041\ue030\ue039\n\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue03f\ue042\ue03a\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue003\ue000\ue042\ue034\ue03f\ue033\ue000\ue040\ue039\ue036\ue039\ue03a\ue042\ue039\ue000\ue031\ue02c\ue038\ue034\ue037\ue044\ue000\ue034\ue039\ue02e\ue03a\ue038\ue030\ue004\ue000\ue03f\ue033\ue030\ue000\ue038\ue030\ue02f\ue034\ue02c\ue039\n\ue031\ue02c\ue038\ue034\ue037\ue044\ue000\ue034\ue039\ue02e\ue03a\ue038\ue030\ue000\ue02c\ue038\ue03a\ue039\ue032\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a", "mimetype": "text/plain", "start_char_idx": 7845, "end_char_idx": 8017, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "90793003-2125-4b3e-b7e4-ff83187e3f71": {"__data__": {"id_": "90793003-2125-4b3e-b7e4-ff83187e3f71", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bfa140c4-b783-46a7-96b5-032dec822d0e", "node_type": "1", "metadata": {}, "hash": "07a752f9321a931a12781c76ba10c0b29cc352a18107abffe3081ffeeef36a9b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "04cf5f7c-0ecc-4717-ba04-9e36bbf0ca56", "node_type": "1", "metadata": {}, "hash": "3760f32f98145dc11dac83d4cebb0b127b6c5d32b7761a19727f9f4b6c15b7eb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03a\ue038\ue030\ue000\ue02c\ue038\ue03a\ue039\ue032\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue000\ue042\ue02c\ue03e\ue000\ue034\ue038\ue03b\ue040\ue03f\ue030\ue02f\ue000\ue02c\ue03e\ue000\ue03f\ue033\ue030\ue000\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue049\ue03e\ue000\ue031\ue02c\ue038\ue034\ue037\ue044\n\ue034\ue039\ue02e\ue03a\ue038\ue030\ue006\ue000\ue01a\ue03a\ue03d\ue000\ue03f\ue033\ue030\ue000\ue031\ue02c\ue03f\ue033\ue030\ue03d\ue03e\ue000\ue03a\ue031\ue000\ue00b\ue009\ue000\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue03e\ue000\ue002\ue009\ue00a\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue009\ue011\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue003\n\ue042\ue033\ue03a\ue03e\ue030\ue000\ue037\ue030\ue041\ue030\ue037\ue000\ue03a\ue031\ue000\ue030\ue02f\ue040\ue02e\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue042\ue02c\ue03e\ue000\ue040\ue039\ue036\ue039\ue03a\ue042\ue039\ue004\ue000\ue03f\ue033\ue030\ue000\ue038\ue030\ue02f\ue034\ue02c\ue039\ue000\ue030\ue02f", "mimetype": "text/plain", "start_char_idx": 8001, "end_char_idx": 8173, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "04cf5f7c-0ecc-4717-ba04-9e36bbf0ca56": {"__data__": {"id_": "04cf5f7c-0ecc-4717-ba04-9e36bbf0ca56", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "90793003-2125-4b3e-b7e4-ff83187e3f71", "node_type": "1", "metadata": {}, "hash": "c20ece4a5aeb4ef6cd892858caab468fbd26dd89db7e371eac466b0ce6f76ddb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "58abcfc5-76b1-469e-96ef-5db5b88da877", "node_type": "1", "metadata": {}, "hash": "b3024f10193eb3d2cc6eaa3bbabdbe0873ad3cc691bbcfb6c79cc7383aab5f96", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue039\ue004\ue000\ue03f\ue033\ue030\ue000\ue038\ue030\ue02f\ue034\ue02c\ue039\ue000\ue030\ue02f\ue040\ue02e\ue02c\ue03f\ue034\ue03a\ue039\n\ue037\ue030\ue041\ue030\ue037\ue000\ue031\ue03d\ue03a\ue038\ue000\ue03f\ue033\ue030\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue000\ue042\ue02c\ue03e\ue000\ue034\ue038\ue03b\ue040\ue03f\ue030\ue02f\ue006\ue000\ue026\ue034\ue039\ue02e\ue030\ue000\ue030\ue02c\ue03d\ue037\ue044\ue000\ue02f\ue02c\ue044\ue005\ue02e\ue02c\ue03d\ue030\ue000\ue03a\ue03d\n\ue03b\ue03d\ue030\ue03e\ue02e\ue033\ue03a\ue03a\ue037\ue000\ue02c\ue03f\ue03f\ue030\ue039\ue02f\ue02c\ue039\ue02e\ue030\ue000\ue033\ue02c\ue03e\ue000\ue02d\ue030\ue030\ue039\ue000\ue037\ue034\ue039\ue036\ue030\ue02f\ue000\ue042\ue034\ue03f\ue033\ue000\ue02f\ue030\ue02e\ue03d\ue030\ue02c\ue03e\ue030\ue02f\ue000\ue03d\ue034\ue03e\ue036\ue000\ue03a\ue031\ue000\ue015\ue020\ue020\n\ue034\ue039\ue000\ue03b\ue03d\ue034\ue03a\ue03d\ue000\ue03e\ue03f\ue040\ue02f\ue034\ue030\ue03e\ue000\ue002\ue024\ue030\ue03f\ue03d\ue034", "mimetype": "text/plain", "start_char_idx": 8157, "end_char_idx": 8329, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "58abcfc5-76b1-469e-96ef-5db5b88da877": {"__data__": {"id_": "58abcfc5-76b1-469e-96ef-5db5b88da877", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "04cf5f7c-0ecc-4717-ba04-9e36bbf0ca56", "node_type": "1", "metadata": {}, "hash": "3760f32f98145dc11dac83d4cebb0b127b6c5d32b7761a19727f9f4b6c15b7eb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f7b43ade-f895-4ce4-b93a-454812482efa", "node_type": "1", "metadata": {}, "hash": "d86d9ba7fb7d76e59ccafee2d7db4283570564df6b2b9fa170fe2d333f0ee5cc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03d\ue000\ue03e\ue03f\ue040\ue02f\ue034\ue030\ue03e\ue000\ue002\ue024\ue030\ue03f\ue03d\ue034\ue02f\ue03a\ue040\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue011\ue00b\ue003\ue004\ue000\ue042\ue030\ue000\ue02c\ue02f\ue035\ue040\ue03e\ue03f\ue030\ue02f\ue000\ue031\ue03a\ue03d\ue000\ue03f\ue033\ue030\ue03e\ue030\n\ue041\ue02c\ue03d\ue034\ue02c\ue02d\ue037\ue030\ue03e\ue000\ue02c\ue03e\ue000\ue042\ue030\ue037\ue037\ue006\n\ue021\ue03a\ue039\ue03a\ue041\ue02c\ue037\ue030\ue039\ue03f\ue000\ue034\ue039\ue035\ue030\ue02e\ue03f\ue030\ue02f\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue000\ue03f\ue03a\ue000\ue03b\ue03d\ue03a\ue03f\ue030\ue02e\ue03f\ue000\ue02c\ue032\ue02c\ue034\ue039\ue03e\ue03f\ue000\ue033\ue030\ue03b\ue02c\ue03f\ue034\ue03f\ue034\ue03e\ue000\ue016\n\ue041\ue034\ue03d\ue040\ue03e\ue004\ue000\ue03f\ue030\ue03f\ue02c\ue039\ue040\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue03b\ue03a\ue037\ue034\ue03a\ue041\ue034\ue03d\ue040\ue03e\ue000\ue042\ue030\ue03d\ue030\ue000\ue03d\ue030", "mimetype": "text/plain", "start_char_idx": 8313, "end_char_idx": 8485, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f7b43ade-f895-4ce4-b93a-454812482efa": {"__data__": {"id_": "f7b43ade-f895-4ce4-b93a-454812482efa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "58abcfc5-76b1-469e-96ef-5db5b88da877", "node_type": "1", "metadata": {}, "hash": "b3024f10193eb3d2cc6eaa3bbabdbe0873ad3cc691bbcfb6c79cc7383aab5f96", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0e9ad171-c0e2-469a-a5d4-de72034394ff", "node_type": "1", "metadata": {}, "hash": "e278d7aaa09d9afc9d82b68e289e4792b0fd1a5d02a07cdcb23db4b332f3f514", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue037\ue034\ue03a\ue041\ue034\ue03d\ue040\ue03e\ue000\ue042\ue030\ue03d\ue030\ue000\ue03d\ue030\ue02e\ue030\ue034\ue041\ue030\ue02f\ue000\ue02d\ue044\ue000\ue031\ue030\ue042\ue030\ue03d\ue000\ue03f\ue033\ue02c\ue039\ue000\ue009\ue001\ue000\ue03a\ue031\n\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue03e\ue004\ue000\ue02c\ue039\ue02f\ue000\ue038\ue03a\ue039\ue03a\ue041\ue02c\ue037\ue030\ue039\ue03f\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue000\ue03f\ue03a\ue000\ue03b\ue03d\ue03a\ue03f\ue030\ue02e\ue03f\ue000\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue03e\ue000\ue031\ue03d\ue03a\ue038\nNeisseria meningitidis\ue004\ue000Mycobacterium tuberculosis\ue004\ue000\ue041\ue02c\ue03d\ue034\ue02e\ue030\ue037\ue037\ue02c\ue004\ue000\ue03a\ue03d\n\ue038\ue040\ue038\ue03b\ue03e\ue004\ue000\ue042\ue030\ue03d\ue030\ue000\ue03d\ue030\ue02e\ue030\ue034\ue041\ue030\ue02f\ue000\ue02d\ue044\ue000\ue041\ue030\ue03d\ue044\ue000\ue031\ue030\ue042\ue000\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue03e\ue006", "mimetype": "text/plain", "start_char_idx": 8469, "end_char_idx": 8679, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0e9ad171-c0e2-469a-a5d4-de72034394ff": {"__data__": {"id_": "0e9ad171-c0e2-469a-a5d4-de72034394ff", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f7b43ade-f895-4ce4-b93a-454812482efa", "node_type": "1", "metadata": {}, "hash": "d86d9ba7fb7d76e59ccafee2d7db4283570564df6b2b9fa170fe2d333f0ee5cc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b291777f-e52e-4b45-98f2-646111d0f2a4", "node_type": "1", "metadata": {}, "hash": "0b0c2a8336ec5ad5f7cf23c4b1f77e63bc6cd975afe16ccdb59934df37631a11", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03d\ue044\ue000\ue031\ue030\ue042\ue000\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue03e\ue006\ue000\ue027\ue033\ue030\ue03d\ue030\ue031\ue03a\ue03d\ue030\ue004\ue000\ue039\ue03a\ue039\ue030\ue000\ue03a\ue031\n\ue03f\ue033\ue030\ue03e\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue000\ue042\ue030\ue03d\ue030\ue000\ue03e\ue030\ue03b\ue02c\ue03d\ue02c\ue03f\ue030\ue037\ue044\ue000\ue02c\ue039\ue02c\ue037\ue044\ue03e\ue030\ue02f\ue006\ue000\ue015\ue037\ue03f\ue033\ue03a\ue040\ue032\ue033\ue000\ue031\ue030\ue042\ue000\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue03e\n\ue03d\ue030\ue02e\ue030\ue034\ue041\ue030\ue02f\ue000\ue038\ue03a\ue039\ue03a\ue041\ue02c\ue037\ue030\ue039\ue03f\ue000\ue03a\ue03d\ue000\ue02d\ue034\ue041\ue02c\ue037\ue030\ue039\ue03f\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue000\ue02c\ue032\ue02c\ue034\ue039\ue03e\ue03f\ue000\ue03f\ue030\ue03f\ue02c\ue039\ue040\ue03e\ue000\ue02c\ue039\ue02f\ue007\ue03a\ue03d\n\ue02f\ue034\ue03b\ue033\ue03f\ue033\ue030\ue03d\ue034", "mimetype": "text/plain", "start_char_idx": 8663, "end_char_idx": 8835, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b291777f-e52e-4b45-98f2-646111d0f2a4": {"__data__": {"id_": "b291777f-e52e-4b45-98f2-646111d0f2a4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0e9ad171-c0e2-469a-a5d4-de72034394ff", "node_type": "1", "metadata": {}, "hash": "e278d7aaa09d9afc9d82b68e289e4792b0fd1a5d02a07cdcb23db4b332f3f514", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c3a16389-9142-4a7c-9eb5-f23a4e0327f6", "node_type": "1", "metadata": {}, "hash": "2434e899ccff73427eb914451e6a717e2d9b3a942c2862d035c9ddcc65dd9d21", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue000\ue02c\ue039\ue02f\ue007\ue03a\ue03d\n\ue02f\ue034\ue03b\ue033\ue03f\ue033\ue030\ue03d\ue034\ue02c\ue004\ue000\ue03e\ue040\ue038\ue038\ue02c\ue03d\ue044\ue000\ue041\ue02c\ue03d\ue034\ue02c\ue02d\ue037\ue030\ue03e\ue000\ue042\ue030\ue03d\ue030\ue000\ue02e\ue03d\ue030\ue02c\ue03f\ue030\ue02f\ue000\ue03f\ue03a\ue000\ue034\ue039\ue03f\ue030\ue032\ue03d\ue02c\ue03f\ue030\ue000\ue02c\ue037\ue037\n\ue03b\ue03a\ue03e\ue03e\ue034\ue02d\ue037\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue02f\ue03a\ue03e\ue030\ue03e\ue000\ue02e\ue03a\ue039\ue03f\ue02c\ue034\ue039\ue034\ue039\ue032\ue000\ue03f\ue030\ue03f\ue02c\ue039\ue040\ue03e\ue000\ue03a\ue03d\ue000\ue02f\ue034\ue03b\ue033\ue03f\ue033\ue030\ue03d\ue034\ue02c\ue000\ue03f\ue03a\ue043\ue03a\ue034\ue02f\ue03e\ue006\n\ue027\ue033\ue030\ue000\ue031\ue034\ue03d\ue03e\ue03f\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue02c\ue03b\ue03b\ue03d\ue03a\ue041\ue030\ue02f\ue000\ue02d\ue044\ue000\ue03f\ue033\ue030\ue000\ue028", "mimetype": "text/plain", "start_char_idx": 8818, "end_char_idx": 8990, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c3a16389-9142-4a7c-9eb5-f23a4e0327f6": {"__data__": {"id_": "c3a16389-9142-4a7c-9eb5-f23a4e0327f6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b291777f-e52e-4b45-98f2-646111d0f2a4", "node_type": "1", "metadata": {}, "hash": "0b0c2a8336ec5ad5f7cf23c4b1f77e63bc6cd975afe16ccdb59934df37631a11", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "72568c19-694f-43db-9a84-13aad5ec06aa", "node_type": "1", "metadata": {}, "hash": "7fbc00f0197ae896c842c86719ce949abf5a6843d5d7999954ef58f1512b346d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03b\ue03b\ue03d\ue03a\ue041\ue030\ue02f\ue000\ue02d\ue044\ue000\ue03f\ue033\ue030\ue000\ue028\ue026\ue000\ue01a\ue03a\ue03a\ue02f\ue000\ue02c\ue039\ue02f\ue000\ue018\ue03d\ue040\ue032\n\ue015\ue02f\ue038\ue034\ue039\ue034\ue03e\ue03f\ue03d\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue042\ue02c\ue03e\ue000\ue02c\ue000\ue03b\ue03a\ue037\ue044\ue03e\ue02c\ue02e\ue02e\ue033\ue02c\ue03d\ue034\ue02f\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue037\ue034\ue02e\ue030\ue039\ue03e\ue030\ue02f\ue000\ue034\ue039\ue000\ue015\ue03b\ue03d\ue034\ue037\n\ue009\ue011\ue010\ue00d\ue006\ue000\ue015\ue000\ue03e\ue034\ue039\ue032\ue037\ue030\ue000\ue02f\ue03a\ue03e\ue030\ue000\ue042\ue02c\ue03e\ue000\ue03f\ue03a\ue000\ue02d\ue030\ue000\ue02c\ue02f\ue038\ue034\ue039\ue034\ue03e\ue03f\ue030\ue03d\ue030\ue02f\ue000\ue02c\ue03f\ue000\ue03f\ue033\ue030\ue000\ue02c\ue032\ue030\ue000\ue03a\ue031\ue000\ue00a\ue00c\n\ue038\ue03a\ue039\ue03f\ue033\ue03e\ue000\ue002\ue015\ue02f\ue041\ue034\ue03e\ue03a\ue03d\ue044\ue000\ue017", "mimetype": "text/plain", "start_char_idx": 8974, "end_char_idx": 9146, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "72568c19-694f-43db-9a84-13aad5ec06aa": {"__data__": {"id_": "72568c19-694f-43db-9a84-13aad5ec06aa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c3a16389-9142-4a7c-9eb5-f23a4e0327f6", "node_type": "1", "metadata": {}, "hash": "2434e899ccff73427eb914451e6a717e2d9b3a942c2862d035c9ddcc65dd9d21", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a68a07c1-e623-4461-950a-b8aa56f4b86b", "node_type": "1", "metadata": {}, "hash": "240ddc7811bdcbdc2b864e40d3fdb36e6899b3af0538a23e2984fd55870e9826", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue039\ue03f\ue033\ue03e\ue000\ue002\ue015\ue02f\ue041\ue034\ue03e\ue03a\ue03d\ue044\ue000\ue017\ue03a\ue038\ue038\ue034\ue03f\ue03f\ue030\ue030\ue000\ue03a\ue039\ue000\ue01d\ue038\ue038\ue040\ue039\ue034\ue045\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue024\ue03d\ue02c\ue02e\ue03f\ue034\ue02e\ue030\ue03e\ue004\ue000\ue009\ue011\ue010\ue00d\ue003\ue004\n\ue03a\ue03d\ue000\ue02c\ue03f\ue000\ue009\ue010\ue000\ue038\ue03a\ue039\ue03f\ue033\ue03e\ue000\ue031\ue03a\ue03d\ue000\ue03f\ue033\ue03a\ue03e\ue030\ue000\ue034\ue039\ue000\ue02f\ue02c\ue044\ue005\ue02e\ue02c\ue03d\ue030\ue004\ue000\ue03e\ue034\ue039\ue02e\ue030\ue000\ue030\ue02c\ue03d\ue037\ue044\ue000\ue02f\ue02c\ue044\ue005\ue02e\ue02c\ue03d\ue030\ue000\ue02c\ue03f\ue03f\ue030\ue039\ue005\n\ue02f\ue02c\ue039\ue02e\ue030\ue000\ue042\ue02c\ue03e\ue000\ue037\ue034\ue039\ue036\ue030\ue02f\ue000\ue042\ue034\ue03f\ue033\ue000\ue034\ue039\ue02e\ue03d\ue030\ue02c\ue03e\ue030\ue02f\ue000\ue03d\ue034\ue03e\ue036\ue000\ue03a\ue031\ue000\ue034\ue039\ue041\ue02c\ue03e\ue034", "mimetype": "text/plain", "start_char_idx": 9130, "end_char_idx": 9302, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a68a07c1-e623-4461-950a-b8aa56f4b86b": {"__data__": {"id_": "a68a07c1-e623-4461-950a-b8aa56f4b86b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "72568c19-694f-43db-9a84-13aad5ec06aa", "node_type": "1", "metadata": {}, "hash": "7fbc00f0197ae896c842c86719ce949abf5a6843d5d7999954ef58f1512b346d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3af8dac1-4efa-4d56-92a0-07d09c0c251e", "node_type": "1", "metadata": {}, "hash": "e30359d393d8261bd748fa41a404149370c8c07f77ffc18cb799ac3ace2451db", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue02f\ue000\ue03d\ue034\ue03e\ue036\ue000\ue03a\ue031\ue000\ue034\ue039\ue041\ue02c\ue03e\ue034\ue041\ue030\ue000\ue01c\ue034\ue02d\ue000\ue034\ue039\ue031\ue030\ue02e\ue03f\ue034\ue03a\ue039\ue000\ue034\ue039\n\ue03e\ue030\ue041\ue030\ue03d\ue02c\ue037\ue000\ue028\ue026\ue000\ue03e\ue03f\ue040\ue02f\ue034\ue030\ue03e\ue000\ue002\ue025\ue030\ue02f\ue038\ue03a\ue039\ue02f\ue000\ue02c\ue039\ue02f\ue000\ue024\ue034\ue02e\ue033\ue034\ue02e\ue033\ue030\ue03d\ue03a\ue004\ue000\ue009\ue011\ue010\ue00c\ue013\ue000\ue01d\ue03e\ue03f\ue03d\ue030\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\n\ue009\ue011\ue010\ue00d\ue013\ue000\ue017\ue03a\ue02e\ue033\ue034\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue010\ue00e\ue003\ue006\ue000\ue027\ue033\ue030\ue000\ue031\ue034\ue03d\ue03e\ue03f\ue000\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue042\ue02c\ue03e\ue000\ue037\ue034\ue02e\ue030\ue039\ue03e\ue030\ue02f\n\ue034\ue039\ue000\ue018\ue030\ue02e", "mimetype": "text/plain", "start_char_idx": 9286, "end_char_idx": 9458, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3af8dac1-4efa-4d56-92a0-07d09c0c251e": {"__data__": {"id_": "3af8dac1-4efa-4d56-92a0-07d09c0c251e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a68a07c1-e623-4461-950a-b8aa56f4b86b", "node_type": "1", "metadata": {}, "hash": "240ddc7811bdcbdc2b864e40d3fdb36e6899b3af0538a23e2984fd55870e9826", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "53918863-ac91-4ab4-868f-63299207b8e5", "node_type": "1", "metadata": {}, "hash": "22f389e449261ca7f083f1717c2ace7b150a4930a476fcf8d5f77edaa714343d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03e\ue000\ue037\ue034\ue02e\ue030\ue039\ue03e\ue030\ue02f\n\ue034\ue039\ue000\ue018\ue030\ue02e\ue030\ue038\ue02d\ue030\ue03d\ue000\ue009\ue011\ue010\ue00f\ue013\ue000\ue02c\ue000\ue03e\ue034\ue039\ue032\ue037\ue030\ue000\ue02f\ue03a\ue03e\ue030\ue000\ue042\ue02c\ue03e\ue000\ue03f\ue03a\ue000\ue02d\ue030\ue000\ue02c\ue02f\ue038\ue034\ue039\ue034\ue03e\ue03f\ue030\ue03d\ue030\ue02f\ue000\ue02c\ue03f\ue000\ue03f\ue033\ue030\ue000\ue02c\ue032\ue030\n\ue03a\ue031\ue000\ue009\ue010\ue000\ue038\ue03a\ue039\ue03f\ue033\ue03e\ue000\ue002\ue015\ue02f\ue041\ue034\ue03e\ue03a\ue03d\ue044\ue000\ue017\ue03a\ue038\ue038\ue034\ue03f\ue03f\ue030\ue030\ue000\ue03a\ue039\ue000\ue01d\ue038\ue038\ue040\ue039\ue034\ue045\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue024\ue03d\ue02c\ue02e\ue03f\ue034\ue02e\ue030\ue03e\ue004\n\ue009\ue011\ue010\ue010\ue003\ue006\ue000\ue027\ue033\ue030\ue000\ue031\ue034\ue03d\ue03e\ue03f\ue000\ue02f\ue03a\ue03e\ue030\ue03e\ue000\ue03a\ue031\ue000\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030", "mimetype": "text/plain", "start_char_idx": 9441, "end_char_idx": 9613, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "53918863-ac91-4ab4-868f-63299207b8e5": {"__data__": {"id_": "53918863-ac91-4ab4-868f-63299207b8e5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3af8dac1-4efa-4d56-92a0-07d09c0c251e", "node_type": "1", "metadata": {}, "hash": "e30359d393d8261bd748fa41a404149370c8c07f77ffc18cb799ac3ace2451db", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7829125f-c088-4528-b0b2-3e08bdbde32b", "node_type": "1", "metadata": {}, "hash": "ca929c37da0642c914e3b8ab86b9c8e9a5cd1fb21d39e3ba2454df33d571d25e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03e\ue030\ue03e\ue000\ue03a\ue031\ue000\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue042\ue030\ue03d\ue030\ue000\ue03e\ue033\ue034\ue03b\ue03b\ue030\ue02f\ue000\ue034\ue039\n\ue009\ue011\ue010\ue010\ue000\ue002\ue015\ue02f\ue02c\ue038\ue03e\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue011\ue00b\ue003\ue006\ue000\ue01d\ue039\ue000\ue009\ue011\ue011\ue008\ue004\ue000\ue03f\ue042\ue03a\ue000\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue004\n\ue02f\ue030\ue041\ue030\ue037\ue03a\ue03b\ue030\ue02f\ue000\ue03e\ue040\ue02d\ue03e\ue030\ue03c\ue040\ue030\ue039\ue03f\ue000\ue03f\ue03a\ue000\ue03f\ue033\ue030\ue000\ue031\ue034\ue03d\ue03e\ue03f\ue000\ue031\ue03a\ue03d\ue038\ue040\ue037\ue02c\ue03f\ue034\ue03a\ue039\ue004\ue000\ue042\ue030\ue03d\ue030\ue000\ue03d\ue030\ue02e\ue03a\ue038\ue038\ue030\ue039\ue02f\ue030\ue02f\n\ue031\ue03a\ue03d\ue000", "mimetype": "text/plain", "start_char_idx": 9597, "end_char_idx": 9769, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7829125f-c088-4528-b0b2-3e08bdbde32b": {"__data__": {"id_": "7829125f-c088-4528-b0b2-3e08bdbde32b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "53918863-ac91-4ab4-868f-63299207b8e5", "node_type": "1", "metadata": {}, "hash": "22f389e449261ca7f083f1717c2ace7b150a4930a476fcf8d5f77edaa714343d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d7cd0926-af40-4319-abf9-069dec1c1e63", "node_type": "1", "metadata": {}, "hash": "6565f02e53e2b4c733dc3fc89179509286acbde1a4cab144be2cd4968ee9c5b8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue000\ue03d\ue030\ue02e\ue03a\ue038\ue038\ue030\ue039\ue02f\ue030\ue02f\n\ue031\ue03a\ue03d\ue000\ue040\ue03e\ue030\ue000\ue034\ue039\ue000\ue031\ue03a\ue040\ue03d\ue000\ue02f\ue03a\ue03e\ue030\ue03e\ue000\ue02c\ue03f\ue000\ue03f\ue033\ue030\ue000\ue02c\ue032\ue030\ue03e\ue000\ue03a\ue031\ue000\ue00a\ue004\ue000\ue00c\ue004\ue000\ue00e\ue000\ue02c\ue039\ue02f\ue000\ue009\ue00d\ue000\ue038\ue03a\ue039\ue03f\ue033\ue03e\ue000\ue002\ue015\ue02f\ue041\ue034\ue03e\ue03a\ue03d\ue044\n\ue017\ue03a\ue038\ue038\ue034\ue03f\ue03f\ue030\ue030\ue000\ue03a\ue039\ue000\ue01d\ue038\ue038\ue040\ue039\ue034\ue045\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue024\ue03d\ue02c\ue02e\ue03f\ue034\ue02e\ue030\ue03e\ue004\ue000\ue009\ue011\ue011\ue009\ue003\ue006\n\ue026\ue034\ue039\ue02e\ue030\ue000\ue03f\ue033\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue03d\ue030\ue02e\ue03a\ue03d\ue02f\ue03e\ue000\ue03b\ue03d\ue03a\ue041\ue034\ue02f\ue030\ue02f\ue000\ue02d\ue044\ue000\ue038\ue03a\ue03f\ue033\ue030\ue03d\ue03e\ue000", "mimetype": "text/plain", "start_char_idx": 9752, "end_char_idx": 9924, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d7cd0926-af40-4319-abf9-069dec1c1e63": {"__data__": {"id_": "d7cd0926-af40-4319-abf9-069dec1c1e63", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7829125f-c088-4528-b0b2-3e08bdbde32b", "node_type": "1", "metadata": {}, "hash": "ca929c37da0642c914e3b8ab86b9c8e9a5cd1fb21d39e3ba2454df33d571d25e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0bd6e078-2409-406a-89b8-9b0accf2d572", "node_type": "1", "metadata": {}, "hash": "8a10da48e78695f5f347d7c15a42a4ec57c8aeeab7ece1b9d823982f3f3b340f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue034\ue02f\ue030\ue02f\ue000\ue02d\ue044\ue000\ue038\ue03a\ue03f\ue033\ue030\ue03d\ue03e\ue000\ue03a\ue03d\ue000\ue03b\ue033\ue044\ue03e\ue034\ue02e\ue034\ue02c\ue039\ue03e\ue000\ue02f\ue034\ue02f\n\ue039\ue03a\ue03f\ue000\ue03e\ue03b\ue030\ue02e\ue034\ue031\ue044\ue000\ue03f\ue033\ue030\ue000\ue03f\ue044\ue03b\ue030\ue000\ue03a\ue031\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue004\ue000\ue02c\ue039\ue044\ue000\ue02f\ue03a\ue03e\ue030\ue000\ue02c\ue02f\ue038\ue034\ue039\ue034\ue03e\ue03f\ue030\ue03d\ue030\ue02f\ue000\ue02d\ue030\ue031\ue03a\ue03d\ue030\n\ue009\ue000\ue01e\ue02c\ue039\ue040\ue02c\ue03d\ue044\ue000\ue009\ue011\ue010\ue010\ue000\ue042\ue02c\ue03e\ue000\ue02c\ue03e\ue03e\ue040\ue038\ue030\ue02f\ue000\ue03f\ue03a\ue000\ue02d\ue030\ue000\ue03b\ue03a\ue037\ue044\ue03e\ue02c\ue02e\ue02e\ue033\ue02c\ue03d\ue034\ue02f\ue030\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue031\ue03a\ue03d\n\ue03b\ue040\ue03d\ue03b\ue03a\ue03e\ue030\ue03e", "mimetype": "text/plain", "start_char_idx": 9908, "end_char_idx": 10080, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0bd6e078-2409-406a-89b8-9b0accf2d572": {"__data__": {"id_": "0bd6e078-2409-406a-89b8-9b0accf2d572", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d7cd0926-af40-4319-abf9-069dec1c1e63", "node_type": "1", "metadata": {}, "hash": "6565f02e53e2b4c733dc3fc89179509286acbde1a4cab144be2cd4968ee9c5b8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "362d0b02-5582-4a61-a71e-09c19c1a5d8a", "node_type": "1", "metadata": {}, "hash": "1e9bb8dacd61ee07408bfddd3cfb30a5cdcd953adc9d9bc8306ac14678a9b6d6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue02e\ue034\ue039\ue030\ue000\ue031\ue03a\ue03d\n\ue03b\ue040\ue03d\ue03b\ue03a\ue03e\ue030\ue03e\ue000\ue03a\ue031\ue000\ue03f\ue033\ue034\ue03e\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue013\ue000\ue02f\ue03a\ue03e\ue030\ue03e\ue000\ue02c\ue02f\ue038\ue034\ue039\ue034\ue03e\ue03f\ue030\ue03d\ue030\ue02f\ue000\ue03a\ue039\ue000\ue03a\ue03d\ue000\ue02c\ue031\ue03f\ue030\ue03d\ue000\ue03f\ue033\ue02c\ue03f\ue000\ue02f\ue02c\ue03f\ue030\n\ue042\ue030\ue03d\ue030\ue000\ue02c\ue03e\ue03e\ue040\ue038\ue030\ue02f\ue000\ue03f\ue03a\ue000\ue02d\ue030\ue000\ue03f\ue033\ue030\ue000\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue006\ue000\ue023\ue039\ue037\ue044\ue000\ue00a\ue011\ue000\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue03e\n\ue002\ue009\ue00c\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue009\ue00d\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue003\ue000\ue03d\ue030\ue02e\ue030\ue034\ue041\ue030\ue02f", "mimetype": "text/plain", "start_char_idx": 10063, "end_char_idx": 10235, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "362d0b02-5582-4a61-a71e-09c19c1a5d8a": {"__data__": {"id_": "362d0b02-5582-4a61-a71e-09c19c1a5d8a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0bd6e078-2409-406a-89b8-9b0accf2d572", "node_type": "1", "metadata": {}, "hash": "8a10da48e78695f5f347d7c15a42a4ec57c8aeeab7ece1b9d823982f3f3b340f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "244411a3-6069-4ccf-becc-8bf8dc4f4b33", "node_type": "1", "metadata": {}, "hash": "6d6f6687b921e8a4c5b49fbc794cd603aec03849d7405fdbdd06409503f892b3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue003\ue000\ue03d\ue030\ue02e\ue030\ue034\ue041\ue030\ue02f\ue000\ue038\ue03a\ue03d\ue030\ue000\ue03f\ue033\ue02c\ue039\ue000\ue03a\ue039\ue030\ue000\ue02f\ue03a\ue03e\ue030\ue000\ue03a\ue031\ue000\ue01c\ue034\ue02d\n\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue013\ue000\ue00a\ue010\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue03e\ue030\ue000\ue042\ue030\ue03d\ue030\ue000\ue02d\ue03a\ue03d\ue039\ue000\ue02c\ue031\ue03f\ue030\ue03d\ue000\ue009\ue011\ue010\ue010\ue000\ue02c\ue039\ue02f\ue000\ue03b\ue03d\ue030\ue03e\ue040\ue038\ue02c\ue02d\ue037\ue044\ue000\ue03d\ue030\ue02e\ue030\ue034\ue041\ue030\ue02f\n\ue03a\ue039\ue037\ue044\ue000\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue006\ue000\ue018\ue040\ue030\ue000\ue03f\ue03a\ue000\ue03e\ue038\ue02c\ue037\ue037\ue000\ue039\ue040\ue038\ue02d\ue030\ue03d\ue03e\ue004\ue000\ue034\ue03f\ue000\ue042\ue02c\ue03e\ue000\ue02f\ue030\ue030\ue038\ue030\ue02f\n\ue034\ue038\ue03b", "mimetype": "text/plain", "start_char_idx": 10219, "end_char_idx": 10391, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "244411a3-6069-4ccf-becc-8bf8dc4f4b33": {"__data__": {"id_": "244411a3-6069-4ccf-becc-8bf8dc4f4b33", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "362d0b02-5582-4a61-a71e-09c19c1a5d8a", "node_type": "1", "metadata": {}, "hash": "1e9bb8dacd61ee07408bfddd3cfb30a5cdcd953adc9d9bc8306ac14678a9b6d6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cf7cbe5c-9bed-4bbb-ac81-ac5eb935dcdb", "node_type": "1", "metadata": {}, "hash": "43d2bdf7bfe5c4d8982350e942d28c414b8d75c1c9758d4c4a8513f03f55fc9b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue034\ue03f\ue000\ue042\ue02c\ue03e\ue000\ue02f\ue030\ue030\ue038\ue030\ue02f\n\ue034\ue038\ue03b\ue03a\ue03e\ue03e\ue034\ue02d\ue037\ue030\ue000\ue03f\ue03a\ue000\ue02c\ue03e\ue03e\ue030\ue03e\ue03e\ue000\ue03f\ue033\ue030\ue000\ue030\ue031\ue031\ue030\ue02e\ue03f\ue000\ue03a\ue031\ue000\ue038\ue040\ue037\ue03f\ue034\ue03b\ue037\ue030\ue000\ue02f\ue03a\ue03e\ue030\ue03e\ue000\ue03a\ue031\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue006\n\ue022\ue03a\ue000\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue000\ue03d\ue030\ue02e\ue030\ue034\ue041\ue030\ue02f\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue02f\ue03a\ue03e\ue030\ue03e\ue000\ue02d\ue03a\ue03f\ue033\ue000\ue02d\ue030\ue031\ue03a\ue03d\ue030\ue000\ue02c\ue039\ue02f\ue000\ue02c\ue031\ue03f\ue030\ue03d\n\ue009\ue000\ue01e\ue02c\ue039\ue040\ue02c\ue03d\ue044\ue000\ue009\ue011\ue010\ue010\ue006\ue000\ue01a\ue03a\ue03d\ue000\ue03f\ue033\ue030\ue000\ue02c\ue039\ue02c\ue037\ue044\ue03e\ue034\ue03e", "mimetype": "text/plain", "start_char_idx": 10374, "end_char_idx": 10546, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cf7cbe5c-9bed-4bbb-ac81-ac5eb935dcdb": {"__data__": {"id_": "cf7cbe5c-9bed-4bbb-ac81-ac5eb935dcdb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "244411a3-6069-4ccf-becc-8bf8dc4f4b33", "node_type": "1", "metadata": {}, "hash": "6d6f6687b921e8a4c5b49fbc794cd603aec03849d7405fdbdd06409503f892b3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8e376cd9-10b4-437c-b262-9930e2a86fa5", "node_type": "1", "metadata": {}, "hash": "ca08d667852075367b2f7d7a2c18a9742ca354a4e6b27cc6572d3e90f09eed0d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue01a\ue03a\ue03d\ue000\ue03f\ue033\ue030\ue000\ue02c\ue039\ue02c\ue037\ue044\ue03e\ue034\ue03e\ue000\ue03a\ue031\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue030\ue031\ue031\ue030\ue02e\ue03f\ue03e\ue004\ue000\ue03f\ue033\ue030\n\ue03b\ue03a\ue037\ue044\ue03e\ue02c\ue02e\ue02e\ue033\ue02c\ue03d\ue034\ue02f\ue030\ue000\ue02c\ue039\ue02f\ue000\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue03f\ue044\ue03b\ue030\ue03e\ue000\ue042\ue030\ue03d\ue030\ue000\ue038\ue03a\ue02f\ue030\ue037\ue037\ue030\ue02f\ue000\ue03e\ue034\ue038\ue040\ue037\ue005\n\ue03f\ue02c\ue039\ue030\ue03a\ue040\ue03e\ue037\ue044\ue004\ue000\ue02c\ue039\ue02f\ue000\ue03f\ue033\ue030\ue000\ue03d\ue030\ue031\ue030\ue03d\ue030\ue039\ue02e\ue030\ue000\ue032\ue03d\ue03a\ue040\ue03b\ue000\ue034\ue039\ue02e\ue037\ue040\ue02f\ue030\ue02f\ue000\ue03a\ue039\ue037\ue044\ue000\ue03f\ue033\ue03a\ue03e\ue030\ue000\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue03e", "mimetype": "text/plain", "start_char_idx": 10530, "end_char_idx": 10702, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8e376cd9-10b4-437c-b262-9930e2a86fa5": {"__data__": {"id_": "8e376cd9-10b4-437c-b262-9930e2a86fa5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cf7cbe5c-9bed-4bbb-ac81-ac5eb935dcdb", "node_type": "1", "metadata": {}, "hash": "43d2bdf7bfe5c4d8982350e942d28c414b8d75c1c9758d4c4a8513f03f55fc9b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5d88b57e-c986-4784-bf23-f304ce37956b", "node_type": "1", "metadata": {}, "hash": "07cbbd03d2bbe1c53a821eb7752e7952ba6988c9cc15c86c828f6fa942abaaf2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue044\ue000\ue03f\ue033\ue03a\ue03e\ue030\ue000\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue03e\n\ue042\ue033\ue03a\ue000\ue03d\ue030\ue02e\ue030\ue034\ue041\ue030\ue02f\ue000\ue039\ue030\ue034\ue03f\ue033\ue030\ue03d\ue000\ue03f\ue044\ue03b\ue030\ue006\n\ue00d\ue004\ue00e\ue010\ue009\ue00f\ue00e\n\ue018\ue030\ue038\ue03a\ue032\ue03d\ue02c\ue03b\ue033\ue034\ue02e\ue000\ue02f\ue02c\ue03f\ue02c\ue000\ue03a\ue039\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue000\ue002\ue027\ue02c\ue02d\ue037\ue030\ue000\ue009\ue003\ue000\ue03e\ue033\ue03a\ue042\ue000\ue03f\ue033\ue02c\ue03f\ue000\ue02e\ue02c\ue03e\ue030\ue03e\n\ue02e\ue02c\ue038\ue030\ue000\ue031\ue03d\ue03a\ue038\ue000\ue031\ue02c\ue038\ue034\ue037\ue034\ue030\ue03e\ue000\ue042\ue034\ue03f\ue033\ue000\ue037\ue03a\ue042\ue030\ue03d\ue000\ue034\ue039\ue02e\ue03a\ue038\ue030\ue000\ue02c\ue039\ue02f\ue000\ue03b\ue02c\ue03d\ue030\ue039\ue03f\ue02c\ue037\ue000\ue030\ue02f\ue040\ue02e\ue02c\ue03f", "mimetype": "text/plain", "start_char_idx": 10686, "end_char_idx": 10859, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5d88b57e-c986-4784-bf23-f304ce37956b": {"__data__": {"id_": "5d88b57e-c986-4784-bf23-f304ce37956b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8e376cd9-10b4-437c-b262-9930e2a86fa5", "node_type": "1", "metadata": {}, "hash": "ca08d667852075367b2f7d7a2c18a9742ca354a4e6b27cc6572d3e90f09eed0d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "25235517-f483-48c0-9d7d-46698a83e2cf", "node_type": "1", "metadata": {}, "hash": "109f870199b655425e06b2eeb732472ab5d99a21e7990624681b7b68d9f54941", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue000\ue03b\ue02c\ue03d\ue030\ue039\ue03f\ue02c\ue037\ue000\ue030\ue02f\ue040\ue02e\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue03f\ue033\ue02c\ue039\n\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue004\ue000\ue02d\ue040\ue03f\ue000\ue03f\ue033\ue030\ue03d\ue030\ue000\ue042\ue030\ue03d\ue030\ue000\ue031\ue030\ue042\ue000\ue02f\ue034\ue031\ue031\ue030\ue03d\ue030\ue039\ue02e\ue030\ue03e\ue000\ue034\ue039\ue000\ue044\ue030\ue02c\ue03d\ue000\ue03a\ue031\ue000\ue02d\ue034\ue03d\ue03f\ue033\ue004\ue000\ue02c\ue032\ue030\ue000\ue02c\ue03f\n\ue02e\ue030\ue039\ue03e\ue03a\ue03d\ue034\ue039\ue032\ue004\ue000\ue03a\ue03d\ue000\ue02c\ue03f\ue03f\ue030\ue039\ue02f\ue02c\ue039\ue02e\ue030\ue000\ue02c\ue03f\ue000\ue02f\ue02c\ue044\ue005\ue02e\ue02c\ue03d\ue030\ue000\ue03a\ue03d\ue000\ue03b\ue03d\ue030\ue03e\ue02e\ue033\ue03a\ue03a\ue037\ue006\ue000\ue025\ue030\ue03e\ue040\ue037\ue03f\ue03e\ue000\ue031\ue03a\ue03d\n\ue034\ue039\ue02f\ue034\ue041\ue034\ue02f\ue040\ue02c\ue037\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030", "mimetype": "text/plain", "start_char_idx": 10843, "end_char_idx": 11015, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "25235517-f483-48c0-9d7d-46698a83e2cf": {"__data__": {"id_": "25235517-f483-48c0-9d7d-46698a83e2cf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5d88b57e-c986-4784-bf23-f304ce37956b", "node_type": "1", "metadata": {}, "hash": "07cbbd03d2bbe1c53a821eb7752e7952ba6988c9cc15c86c828f6fa942abaaf2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "116ea4b1-65a0-4515-a085-007f81ba24eb", "node_type": "1", "metadata": {}, "hash": "ba6fdcccd5a3369320a4087e575166e3c27c8358c614220043d81e2b7a8547e4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue02f\ue034\ue041\ue034\ue02f\ue040\ue02c\ue037\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue004\ue000\ue02c\ue03e\ue000\ue042\ue030\ue037\ue037\ue000\ue02c\ue03e\ue000\ue031\ue03a\ue03d\ue000\ue03f\ue033\ue030\ue000\ue03f\ue042\ue03a\ue000\ue03e\ue040\ue038\ue038\ue02c\ue03d\ue044\ue000\ue041\ue02c\ue03d\ue034\ue02c\ue02d\ue037\ue030\ue03e\n\ue03d\ue030\ue031\ue037\ue030\ue02e\ue03f\ue034\ue039\ue032\ue000\ue02c\ue037\ue037\ue000\ue030\ue043\ue03b\ue03a\ue03e\ue040\ue03d\ue030\ue03e\ue000\ue03f\ue03a\ue000\ue03f\ue030\ue03f\ue02c\ue039\ue040\ue03e\ue000\ue03a\ue03d\ue000\ue02f\ue034\ue03b\ue033\ue03f\ue033\ue030\ue03d\ue034\ue02c\ue000\ue03f\ue03a\ue043\ue03a\ue034\ue02f\ue03e\ue004\ue000\ue02c\ue03d\ue030\n\ue03e\ue033\ue03a\ue042\ue039\ue000\ue034\ue039\ue000\ue027\ue02c\ue02d\ue037\ue030\ue000\ue00a\ue006\ue000\ue027\ue033\ue030\ue000\ue041\ue02c\ue03e\ue03f\ue000\ue038\ue02c\ue035\ue03a\ue03d\ue034\ue03f\ue044\ue000\ue03a\ue031\ue000\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue03e\ue000\ue03d", "mimetype": "text/plain", "start_char_idx": 10999, "end_char_idx": 11171, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "116ea4b1-65a0-4515-a085-007f81ba24eb": {"__data__": {"id_": "116ea4b1-65a0-4515-a085-007f81ba24eb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "25235517-f483-48c0-9d7d-46698a83e2cf", "node_type": "1", "metadata": {}, "hash": "109f870199b655425e06b2eeb732472ab5d99a21e7990624681b7b68d9f54941", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bb103203-5e65-4890-873c-3e51d251d60c", "node_type": "1", "metadata": {}, "hash": "258100c26b90d2c713c9df9b27d28e724aed95a6b9f18fec2b4db4db181fc0c5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03f\ue044\ue000\ue03a\ue031\ue000\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue03e\ue000\ue03d\ue030\ue02e\ue030\ue034\ue041\ue030\ue02f\ue000\ue02c\ue03f\ue000\ue037\ue030\ue02c\ue03e\ue03f\n\ue03a\ue039\ue030\ue000\ue02f\ue03a\ue03e\ue030\ue000\ue03a\ue031\ue000\ue03f\ue033\ue03d\ue030\ue030\ue000\ue038\ue02c\ue035\ue03a\ue03d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue012\ue000\ue03a\ue03d\ue02c\ue037\ue000\ue03b\ue03a\ue037\ue034\ue03a\ue041\ue034\ue03d\ue040\ue03e\ue000\ue002\ue011\ue010\ue001\ue003\ue004\ue000\ue02f\ue034\ue03b\ue033\ue005\n\ue03f\ue033\ue030\ue03d\ue034\ue02c\ue047\ue03f\ue030\ue03f\ue02c\ue039\ue040\ue03e\ue047\ue03b\ue030\ue03d\ue03f\ue040\ue03e\ue03e\ue034\ue03e\ue000\ue002\ue011\ue00f\ue001\ue003\ue004\ue000\ue02c\ue039\ue02f\ue000\ue038\ue030\ue02c\ue03e\ue037\ue030\ue03e\ue047\ue038\ue040\ue038\ue03b\ue03e\ue047\ue03d\ue040\ue02d\ue030\ue037\ue037\ue02c\n176\nFD Groves et al\nBritish Journal of Cancer (1999) 81(1), 175\u2013178\n\u00a9 Cancer Research Campaign 1999\nTable 1\nCharacteristics of cases and controls (439", "mimetype": "text/plain", "start_char_idx": 11155, "end_char_idx": 11459, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bb103203-5e65-4890-873c-3e51d251d60c": {"__data__": {"id_": "bb103203-5e65-4890-873c-3e51d251d60c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "116ea4b1-65a0-4515-a085-007f81ba24eb", "node_type": "1", "metadata": {}, "hash": "ba6fdcccd5a3369320a4087e575166e3c27c8358c614220043d81e2b7a8547e4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "08dff1b6-842b-4cae-9add-8c732d4ed927", "node_type": "1", "metadata": {}, "hash": "d1eaa9c01fde39110669ba7a5e1ccd8a0847c966418a20f4067c7924f1255c1d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "176\nFD Groves et al\nBritish Journal of Cancer (1999) 81(1), 175\u2013178\n\u00a9 Cancer Research Campaign 1999\nTable 1\nCharacteristics of cases and controls (439 pairs)\nCases\nControls\nMale\n234 (53%)\n248 (56%)\nBorn\n1974\u20131984\n142 (32%)\n139 (32%)\n1985\u20131987\n175 (40%)\n174 (40%)\n1988\u20131992\n122 (28%)\n126 (29%)\nAge at censoring\n< 6 months\n119 (27%)\n119 (27%)\n36\u201360 months\n144 (33%)\n144 (33%)\n> 60 months\n176 (40%)\n176 (40%)\nDay-care (ever)\n137 (31%)\n135 (31%)\nPreschool (ever)\n162 (37%)\n177 (40%)\nFamily income\n< $20 000\n91 (23%)\n66 (17%)\n$20 000\u2013$29 999\n118 (30%)\n101 (25%)\n$30 000\u2013$39 999\n84 (21%)\n91 (23%)\n$40 000+\n105 (26%)\n140 (35%)\nMother\u2019s education\nHigh School graduate or less\n184 (42%)\n168 (38%)\nSome post-High-School education\n145 (33%)\n139 (32%)\nCollege graduate\n110 (25%)\n132 (30%)\nFather\u2019s education\nHigh School graduate or less\n187 (43%)\n148 (34%)\nSome post-High-School education\n126 (29%)\n137 (31%)\nCollege graduate\n126 (29%)\n154 (35%)\n\ue002\ue011\ue008\ue001\ue003\ue006\ue000\ue022\ue03a\ue039\ue030\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue03e\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue000\ue03e\ue034\ue032\ue039\ue034\ue031\ue034\ue02e\ue02c\ue039\ue03f\ue037\ue044\ue000\ue02c", "mimetype": "text/plain", "start_char_idx": 11309, "end_char_idx": 12288, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "08dff1b6-842b-4cae-9add-8c732d4ed927": {"__data__": {"id_": "08dff1b6-842b-4cae-9add-8c732d4ed927", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bb103203-5e65-4890-873c-3e51d251d60c", "node_type": "1", "metadata": {}, "hash": "258100c26b90d2c713c9df9b27d28e724aed95a6b9f18fec2b4db4db181fc0c5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a685a6cb-6ece-4fcf-816c-58abc7abdd5f", "node_type": "1", "metadata": {}, "hash": "bdaea89e67ee1d8da9799403b1d33ea1ba175f9d27401212c928797e3a56bfe5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue000\ue03e\ue034\ue032\ue039\ue034\ue031\ue034\ue02e\ue02c\ue039\ue03f\ue037\ue044\ue000\ue02c\ue037\ue03f\ue030\ue03d\ue030\ue02f\ue000\ue03f\ue033\ue030\ue000\ue03d\ue034\ue03e\ue036\ue000\ue03a\ue031\n\ue03e\ue040\ue02d\ue03e\ue030\ue03c\ue040\ue030\ue039\ue03f\ue000\ue015\ue020\ue020\ue006\n\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue034\ue039\ue000\ue03e\ue03a\ue038\ue030\ue000\ue031\ue03a\ue03d\ue038\ue000\ue042\ue02c\ue03e\ue000\ue03d\ue030\ue02e\ue030\ue034\ue041\ue030\ue02f\ue000\ue02d\ue044\ue000\ue00d\ue00b\ue001\ue000\ue03a\ue031\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\n\ue041\ue030\ue03d\ue03e\ue040\ue03e\ue000\ue00c\ue00f\ue001\ue000\ue03a\ue031\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue002\ue025\ue025\ue000\ue014\ue000\ue008\ue006\ue00f\ue00b\ue013\ue000\ue011\ue00d\ue001\ue000\ue017\ue01d\ue000\ue008\ue006\ue00d\ue008\ue047\ue009\ue006\ue008\ue00e\ue003\ue006\ue000\ue026\ue034\ue038\ue034\ue037\ue02c\ue03d\n\ue03b\ue03d\ue03a\ue03b\ue03a\ue03d", "mimetype": "text/plain", "start_char_idx": 12272, "end_char_idx": 12445, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a685a6cb-6ece-4fcf-816c-58abc7abdd5f": {"__data__": {"id_": "a685a6cb-6ece-4fcf-816c-58abc7abdd5f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "08dff1b6-842b-4cae-9add-8c732d4ed927", "node_type": "1", "metadata": {}, "hash": "d1eaa9c01fde39110669ba7a5e1ccd8a0847c966418a20f4067c7924f1255c1d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4bbf79df-935f-4863-b56a-b56bc0bd23d5", "node_type": "1", "metadata": {}, "hash": "bc2504758dc853dc926c72cfc01c281e165321a2ad9215f3ed2596cb56abc8bc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue003\ue006\ue000\ue026\ue034\ue038\ue034\ue037\ue02c\ue03d\n\ue03b\ue03d\ue03a\ue03b\ue03a\ue03d\ue03f\ue034\ue03a\ue039\ue03e\ue000\ue03a\ue031\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue002\ue009\ue00a\ue001\ue003\ue000\ue02c\ue039\ue02f\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue000\ue002\ue009\ue009\ue001\ue003\ue000\ue03d\ue030\ue02e\ue030\ue034\ue041\ue030\ue02f\ue000\ue03f\ue033\ue030\n\ue03b\ue03a\ue037\ue044\ue03e\ue02c\ue02e\ue02e\ue033\ue02c\ue03d\ue034\ue02f\ue030\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue002\ue025\ue025\ue000\ue014\ue000\ue009\ue006\ue009\ue00b\ue013\ue000\ue011\ue00d\ue001\ue000\ue017\ue01d\ue000\ue008\ue006\ue00e\ue00c\ue047\ue009\ue006\ue011\ue010\ue003\ue006\ue000\ue015\n\ue033\ue034\ue032\ue033\ue030\ue03d\ue000\ue03b\ue03d\ue03a\ue03b\ue03a\ue03d\ue03f\ue034\ue03a\ue039\ue000\ue03a\ue031\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue000\ue002\ue00c\ue009\ue001\ue003\ue000\ue03f\ue033\ue02c\ue039\ue000\ue02e", "mimetype": "text/plain", "start_char_idx": 12428, "end_char_idx": 12600, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4bbf79df-935f-4863-b56a-b56bc0bd23d5": {"__data__": {"id_": "4bbf79df-935f-4863-b56a-b56bc0bd23d5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a685a6cb-6ece-4fcf-816c-58abc7abdd5f", "node_type": "1", "metadata": {}, "hash": "bdaea89e67ee1d8da9799403b1d33ea1ba175f9d27401212c928797e3a56bfe5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a897154a-5afb-4c98-9331-ff5ef84c29b9", "node_type": "1", "metadata": {}, "hash": "1a05eaa350076a7089d6e66c638a1b83bca8181e543bd2d25de014a63440d356", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03a\ue037\ue03e\ue000\ue002\ue00c\ue009\ue001\ue003\ue000\ue03f\ue033\ue02c\ue039\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue002\ue00b\ue00d\ue001\ue003\ue000\ue03d\ue030\ue02e\ue030\ue034\ue041\ue030\ue02f\n\ue03f\ue033\ue030\ue000\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue013\ue000\ue03f\ue033\ue040\ue03e\ue004\ue000\ue03f\ue033\ue030\ue000\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue042\ue02c\ue03e\n\ue02c\ue03e\ue03e\ue03a\ue02e\ue034\ue02c\ue03f\ue030\ue02f\ue000\ue042\ue034\ue03f\ue033\ue000\ue02c\ue000\ue03e\ue034\ue032\ue039\ue034\ue031\ue034\ue02e\ue02c\ue039\ue03f\ue037\ue044\ue000\ue03d\ue030\ue02f\ue040\ue02e\ue030\ue02f\ue000\ue03d\ue034\ue03e\ue036\ue000\ue03a\ue031\ue000\ue03e\ue040\ue02d\ue03e\ue030\ue03c\ue040\ue030\ue039\ue03f\ue000\ue015\ue020\ue020\n\ue002\ue025\ue025\ue000\ue014\ue000\ue008\ue006\ue00d\ue00f", "mimetype": "text/plain", "start_char_idx": 12584, "end_char_idx": 12756, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a897154a-5afb-4c98-9331-ff5ef84c29b9": {"__data__": {"id_": "a897154a-5afb-4c98-9331-ff5ef84c29b9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4bbf79df-935f-4863-b56a-b56bc0bd23d5", "node_type": "1", "metadata": {}, "hash": "bc2504758dc853dc926c72cfc01c281e165321a2ad9215f3ed2596cb56abc8bc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8183e9a7-fd32-41cb-9529-e209638dc35b", "node_type": "1", "metadata": {}, "hash": "f1d5edacbedb503114f68b09b00e44c7538ba1198860408a49e5e0c4cf31f4e2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue039\ue03f\ue000\ue015\ue020\ue020\n\ue002\ue025\ue025\ue000\ue014\ue000\ue008\ue006\ue00d\ue00f\ue013\ue000\ue011\ue00d\ue001\ue000\ue017\ue01d\ue000\ue008\ue006\ue00b\ue00e\ue047\ue008\ue006\ue010\ue011\ue003\ue006\ue000\ue02a\ue033\ue030\ue039\ue000\ue03f\ue033\ue030\ue000\ue030\ue031\ue031\ue030\ue02e\ue03f\ue000\ue03a\ue031\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue005\n\ue03f\ue034\ue03a\ue039\ue000\ue042\ue02c\ue03e\ue000\ue02c\ue039\ue02c\ue037\ue044\ue03e\ue030\ue02f\ue000\ue031\ue03a\ue03d\ue000\ue03f\ue033\ue03d\ue030\ue030\ue000\ue02f\ue034\ue031\ue031\ue030\ue03d\ue030\ue039\ue03f\ue000\ue02d\ue034\ue03d\ue03f\ue033\ue000\ue02e\ue03a\ue033\ue03a\ue03d\ue03f\ue03e\ue000\ue002\ue03b\ue03d\ue030\ue005\ue009\ue011\ue010\ue00c\ue004\n\ue009\ue011\ue010\ue00c\ue047\ue009\ue011\ue010\ue00e\ue004\ue000\ue02c\ue039\ue02f\ue000\ue03b\ue03a\ue03e\ue03f\ue005\ue009\ue011\ue010\ue00e\ue003\ue004\ue000\ue03f\ue033\ue030\ue000\ue03d\ue030\ue02f\ue040\ue02e\ue030\ue02f\ue000", "mimetype": "text/plain", "start_char_idx": 12739, "end_char_idx": 12911, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8183e9a7-fd32-41cb-9529-e209638dc35b": {"__data__": {"id_": "8183e9a7-fd32-41cb-9529-e209638dc35b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a897154a-5afb-4c98-9331-ff5ef84c29b9", "node_type": "1", "metadata": {}, "hash": "1a05eaa350076a7089d6e66c638a1b83bca8181e543bd2d25de014a63440d356", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7a03d6e5-bba7-4e30-8d6f-7bb6f4358294", "node_type": "1", "metadata": {}, "hash": "25fba9eabb95ca5d3b4fb8b12c613ff69f4236a34a7c54aa6159141ddca7ff79", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue00e\ue003\ue004\ue000\ue03f\ue033\ue030\ue000\ue03d\ue030\ue02f\ue040\ue02e\ue030\ue02f\ue000\ue03d\ue034\ue03e\ue036\ue000\ue042\ue02c\ue03e\ue000\ue03e\ue030\ue030\ue039\ue000\ue03a\ue039\ue037\ue044\ue000\ue02c\ue038\ue03a\ue039\ue032\n\ue02e\ue033\ue034\ue037\ue02f\ue03d\ue030\ue039\ue000\ue02d\ue03a\ue03d\ue039\ue000\ue02c\ue031\ue03f\ue030\ue03d\ue000\ue009\ue011\ue010\ue00e\ue004\ue000\ue042\ue033\ue03a\ue000\ue03b\ue03d\ue030\ue03e\ue040\ue038\ue02c\ue02d\ue037\ue044\ue000\ue03d\ue030\ue02e\ue030\ue034\ue041\ue030\ue02f\ue000\ue03a\ue039\ue037\ue044\ue000\ue03f\ue033\ue030\ue000\ue02e\ue03a\ue039\ue035\ue040\ue005\n\ue032\ue02c\ue03f\ue030\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue002\ue02f\ue02c\ue03f\ue02c\ue000\ue039\ue03a\ue03f\ue000\ue03e\ue033\ue03a\ue042\ue039\ue003\ue006\ue000\ue022\ue030\ue034\ue03f\ue033\ue030\ue03d\ue000\ue02c\ue032\ue030\ue000\ue02c\ue03f\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue039\ue03a\ue03d", "mimetype": "text/plain", "start_char_idx": 12895, "end_char_idx": 13067, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7a03d6e5-bba7-4e30-8d6f-7bb6f4358294": {"__data__": {"id_": "7a03d6e5-bba7-4e30-8d6f-7bb6f4358294", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8183e9a7-fd32-41cb-9529-e209638dc35b", "node_type": "1", "metadata": {}, "hash": "f1d5edacbedb503114f68b09b00e44c7538ba1198860408a49e5e0c4cf31f4e2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dbdfae55-6495-48a3-a856-6d2fc03c0933", "node_type": "1", "metadata": {}, "hash": "d7d6fa7445e9fcaa983d161800ebceea7207e659ba84dbc370e77b3cba128cd4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue039\ue03a\ue03d\n\ue034\ue039\ue03f\ue030\ue03d\ue041\ue02c\ue037\ue000\ue02d\ue030\ue03f\ue042\ue030\ue030\ue039\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue02c\ue039\ue02f\ue000\ue02f\ue034\ue02c\ue032\ue039\ue03a\ue03e\ue034\ue03e\ue000\ue02c\ue031\ue031\ue030\ue02e\ue03f\ue030\ue02f\ue000\ue03f\ue033\ue030\ue000\ue03d\ue034\ue03e\ue036\ue000\ue03a\ue031\n\ue015\ue020\ue020\ue000\ue031\ue03a\ue037\ue037\ue03a\ue042\ue034\ue039\ue032\ue000\ue02c\ue039\ue044\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue013\ue000\ue039\ue03a\ue03d\ue000\ue02f\ue034\ue02f\ue000\ue039\ue040\ue038\ue02d\ue030\ue03d\ue000\ue03a\ue031\ue000\ue02f\ue03a\ue03e\ue030\ue03e\ue000\ue03a\ue031\n\ue023\ue024\ue029\ue000\ue03a\ue03d\ue000\ue018\ue027\ue024\ue000\ue002\ue02f\ue02c\ue03f\ue02c\ue000\ue039\ue03a\ue03f\ue000\ue03e\ue033\ue03a\ue042\ue039\ue003\ue006\n\ue003", "mimetype": "text/plain", "start_char_idx": 13051, "end_char_idx": 13224, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dbdfae55-6495-48a3-a856-6d2fc03c0933": {"__data__": {"id_": "dbdfae55-6495-48a3-a856-6d2fc03c0933", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7a03d6e5-bba7-4e30-8d6f-7bb6f4358294", "node_type": "1", "metadata": {}, "hash": "25fba9eabb95ca5d3b4fb8b12c613ff69f4236a34a7c54aa6159141ddca7ff79", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ed0565ce-6e7d-4007-a786-8ea9043b7ada", "node_type": "1", "metadata": {}, "hash": "f4da2487bc2da40d6f9a26310fee18322ffae2e4bf73df23b32574e550628da1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue02c\ue03f\ue02c\ue000\ue039\ue03a\ue03f\ue000\ue03e\ue033\ue03a\ue042\ue039\ue003\ue006\n\ue003\ue007\ue00e\ue002\ue010\ue00e\ue00e\ue007\ue00c\ue00b\n\ue026\ue030\ue041\ue030\ue03d\ue02c\ue037\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue000\ue02e\ue03a\ue038\ue038\ue03a\ue039\ue037\ue044\ue000\ue02c\ue02f\ue038\ue034\ue039\ue034\ue03e\ue03f\ue030\ue03d\ue030\ue02f\ue000\ue03f\ue03a\ue000\ue028\ue026\ue000\ue034\ue039\ue031\ue02c\ue039\ue03f\ue03e\ue000\ue033\ue02c\ue041\ue030\ue000\ue02d\ue030\ue030\ue039\n\ue03d\ue030\ue03b\ue03a\ue03d\ue03f\ue030\ue02f\ue000\ue03f\ue03a\ue000\ue03d\ue030\ue02f\ue040\ue02e\ue030\ue000\ue03f\ue033\ue030\ue000\ue03d\ue034\ue03e\ue036\ue000\ue03a\ue031\ue000\ue03e\ue040\ue02d\ue03e\ue030\ue03c\ue040\ue030\ue039\ue03f\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034\ue02c\ue000\ue034\ue039\n\ue031\ue03a\ue040\ue03d\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue031\ue034\ue041\ue030\ue000\ue03b", "mimetype": "text/plain", "start_char_idx": 13207, "end_char_idx": 13380, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ed0565ce-6e7d-4007-a786-8ea9043b7ada": {"__data__": {"id_": "ed0565ce-6e7d-4007-a786-8ea9043b7ada", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dbdfae55-6495-48a3-a856-6d2fc03c0933", "node_type": "1", "metadata": {}, "hash": "d7d6fa7445e9fcaa983d161800ebceea7207e659ba84dbc370e77b3cba128cd4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f81f869d-f5fd-475a-9f94-fac5815ee754", "node_type": "1", "metadata": {}, "hash": "09f6692d1d110d57174214b3fdf0823eae0d450affcc8a203aafbf62ced0f8f9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue040\ue03d\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue031\ue034\ue041\ue030\ue000\ue03b\ue03d\ue030\ue041\ue034\ue03a\ue040\ue03e\ue037\ue044\ue005\ue02e\ue034\ue03f\ue030\ue02f\ue000\ue03e\ue03f\ue040\ue02f\ue034\ue030\ue03e\ue006\ue000\ue023\ue040\ue03d\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue034\ue03e\ue000\ue03a\ue039\ue030\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\n\ue037\ue02c\ue03d\ue032\ue030\ue03e\ue03f\ue000\ue02c\ue039\ue02f\ue000\ue038\ue03a\ue03e\ue03f\ue000\ue02e\ue03a\ue038\ue03b\ue03d\ue030\ue033\ue030\ue039\ue03e\ue034\ue041\ue030\ue000\ue030\ue041\ue02c\ue037\ue040\ue02c\ue03f\ue034\ue03a\ue039\ue03e\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue03d\ue030\ue037\ue02c\ue03f\ue034\ue03a\ue039\ue03e\ue033\ue034\ue03b\n\ue02d\ue030\ue03f\ue042\ue030\ue030\ue039\ue000\ue034\ue039\ue031\ue02c\ue039\ue03f\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000\ue015\ue020", "mimetype": "text/plain", "start_char_idx": 13364, "end_char_idx": 13536, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f81f869d-f5fd-475a-9f94-fac5815ee754": {"__data__": {"id_": "f81f869d-f5fd-475a-9f94-fac5815ee754", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ed0565ce-6e7d-4007-a786-8ea9043b7ada", "node_type": "1", "metadata": {}, "hash": "f4da2487bc2da40d6f9a26310fee18322ffae2e4bf73df23b32574e550628da1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "09ff906c-9ea2-4af0-bcb6-ab5aa794a625", "node_type": "1", "metadata": {}, "hash": "0118ed5d0d38450c96cab0d69db39b9c67b6d9d90d9f67eb16d0c092a84d7481", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue02c\ue039\ue02f\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000\ue015\ue020\ue020\ue006\ue000\ue01d\ue03f\ue000\ue034\ue03e\ue000\ue02c\ue037\ue03e\ue03a\ue000\ue02f\ue034\ue03e\ue03f\ue034\ue039\ue005\n\ue032\ue040\ue034\ue03e\ue033\ue030\ue02f\ue000\ue02d\ue044\ue000\ue03d\ue030\ue037\ue034\ue02c\ue039\ue02e\ue030\ue000\ue03a\ue039\ue000\ue042\ue03d\ue034\ue03f\ue03f\ue030\ue039\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue03d\ue030\ue02e\ue03a\ue03d\ue02f\ue03e\ue004\ue000\ue03d\ue02c\ue03f\ue033\ue030\ue03d\ue000\ue03f\ue033\ue02c\ue039\n\ue038\ue02c\ue03f\ue030\ue03d\ue039\ue02c\ue037\ue000\ue03d\ue030\ue02e\ue02c\ue037\ue037\ue006\ue000\ue01d\ue039\ue000\ue02c\ue02f\ue02f\ue034\ue03f\ue034\ue03a\ue039\ue004\ue000\ue03a\ue040\ue03d\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue034\ue03e\ue000\ue03a\ue039\ue030\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue031\ue034\ue03d\ue03e\ue03f\ue000\ue03f\ue03a\ue000\ue034\ue039\ue041\ue030\ue03e\ue03f\ue034", "mimetype": "text/plain", "start_char_idx": 13520, "end_char_idx": 13692, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "09ff906c-9ea2-4af0-bcb6-ab5aa794a625": {"__data__": {"id_": "09ff906c-9ea2-4af0-bcb6-ab5aa794a625", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f81f869d-f5fd-475a-9f94-fac5815ee754", "node_type": "1", "metadata": {}, "hash": "09f6692d1d110d57174214b3fdf0823eae0d450affcc8a203aafbf62ced0f8f9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "636f9c2d-f4f9-4fcc-b858-4cea92cb88ee", "node_type": "1", "metadata": {}, "hash": "bce0e155f174351076ba27066ed024101543172ee7e71bcb7f80c291bddd0c9d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue031\ue034\ue03d\ue03e\ue03f\ue000\ue03f\ue03a\ue000\ue034\ue039\ue041\ue030\ue03e\ue03f\ue034\ue005\n\ue032\ue02c\ue03f\ue030\ue000\ue03f\ue033\ue030\ue000\ue03d\ue030\ue037\ue02c\ue03f\ue034\ue03a\ue039\ue03e\ue033\ue034\ue03b\ue000\ue02d\ue030\ue03f\ue042\ue030\ue030\ue039\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000\ue015\ue020\ue020\ue006\n\ue015\ue02f\ue038\ue034\ue039\ue034\ue03e\ue03f\ue03d\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue042\ue02c\ue03e\ue000\ue02c\ue03e\ue03e\ue03a\ue02e\ue034\ue02c\ue03f\ue030\ue02f\ue000\ue042\ue034\ue03f\ue033\ue000\ue02c\n\ue03d\ue030\ue02f\ue040\ue02e\ue030\ue02f\ue000\ue03d\ue034\ue03e\ue036\ue000\ue03a\ue031\ue000\ue03e\ue040\ue02d\ue03e\ue030\ue03c\ue040\ue030\ue039\ue03f", "mimetype": "text/plain", "start_char_idx": 13676, "end_char_idx": 13848, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "636f9c2d-f4f9-4fcc-b858-4cea92cb88ee": {"__data__": {"id_": "636f9c2d-f4f9-4fcc-b858-4cea92cb88ee", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "09ff906c-9ea2-4af0-bcb6-ab5aa794a625", "node_type": "1", "metadata": {}, "hash": "0118ed5d0d38450c96cab0d69db39b9c67b6d9d90d9f67eb16d0c092a84d7481", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1e36c378-e5a2-4bd9-a0b2-17a9c39928cf", "node_type": "1", "metadata": {}, "hash": "a5909896b9bae40140f04b42875f8e9eb17671b6ce959b0670d0742f1eb1c937", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03e\ue036\ue000\ue03a\ue031\ue000\ue03e\ue040\ue02d\ue03e\ue030\ue03c\ue040\ue030\ue039\ue03f\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000\ue015\ue020\ue020\ue006\ue000\ue027\ue033\ue030\ue000\ue03b\ue03a\ue037\ue044\ue03e\ue02c\ue02e\ue02e\ue033\ue02c\ue03d\ue034\ue02f\ue030\n\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue030\ue043\ue033\ue034\ue02d\ue034\ue03f\ue030\ue02f\ue000\ue039\ue03a\ue000\ue03e\ue040\ue02e\ue033\ue000\ue034\ue039\ue041\ue030\ue03d\ue03e\ue030\ue000\ue02c\ue03e\ue03e\ue03a\ue02e\ue034\ue02c\ue03f\ue034\ue03a\ue039\ue006\ue000\ue01d\ue039\ue000\ue03f\ue033\ue030\ue000\ue02e\ue03a\ue039\ue035\ue040\ue005\n\ue032\ue02c\ue03f\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue004\ue000\ue03f\ue033\ue030\ue000\ue01c\ue034\ue02d\ue000\ue02e\ue02c\ue03b\ue03e\ue040\ue037\ue02c\ue03d\ue000\ue03b\ue03a\ue037\ue044\ue03e\ue02c\ue02e\ue02e\ue033\ue02c\ue03d\ue034\ue02f\ue030\ue000\ue034\ue03e\ue000\ue02e\ue03a\ue041\ue02c\ue037\ue030\ue039", "mimetype": "text/plain", "start_char_idx": 13832, "end_char_idx": 14004, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1e36c378-e5a2-4bd9-a0b2-17a9c39928cf": {"__data__": {"id_": "1e36c378-e5a2-4bd9-a0b2-17a9c39928cf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "636f9c2d-f4f9-4fcc-b858-4cea92cb88ee", "node_type": "1", "metadata": {}, "hash": "bce0e155f174351076ba27066ed024101543172ee7e71bcb7f80c291bddd0c9d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7c8921c6-2779-4795-a0ae-ffac15e47ddc", "node_type": "1", "metadata": {}, "hash": "4637a90f2e1190733522a1fd17fac9fb22fd74a022a4b7a7a9841fdbe06ee574", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue02c\ue03d\ue034\ue02f\ue030\ue000\ue034\ue03e\ue000\ue02e\ue03a\ue041\ue02c\ue037\ue030\ue039\ue03f\ue037\ue044\ue000\ue02d\ue03a\ue040\ue039\ue02f\n\ue002\ue034\ue006\ue030\ue006\ue000\ue048\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030\ue02f\ue049\ue003\ue000\ue03f\ue03a\ue000\ue02c\ue000\ue033\ue034\ue032\ue033\ue037\ue044\ue000\ue034\ue038\ue038\ue040\ue039\ue03a\ue032\ue030\ue039\ue034\ue02e\ue000\ue03b\ue03d\ue03a\ue03f\ue030\ue034\ue039\ue000\ue02c\ue039\ue03f\ue034\ue032\ue030\ue039\ue004\n\ue044\ue034\ue030\ue037\ue02f\ue034\ue039\ue032\ue000\ue02c\ue039\ue000\ue02c\ue039\ue03f\ue034\ue02d\ue03a\ue02f\ue044\ue000\ue03d\ue030\ue03e\ue03b\ue03a\ue039\ue03e\ue030\ue000\ue042\ue033\ue034\ue02e\ue033\ue000\ue02d\ue030\ue032\ue034\ue039\ue03e\ue000\ue030\ue02c\ue03d\ue037\ue034\ue030\ue03d\ue000\ue002\ue02c\ue03f\ue000\ue02c\ue000\ue044\ue03a\ue040\ue039\ue032\ue030\ue03d\n\ue02c\ue032\ue030\ue003\ue004\ue000\ue03d\ue034\ue03e\ue030\ue03e\ue000\ue033\ue034\ue032\ue033\ue030\ue03d\ue004\ue000", "mimetype": "text/plain", "start_char_idx": 13988, "end_char_idx": 14160, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7c8921c6-2779-4795-a0ae-ffac15e47ddc": {"__data__": {"id_": "7c8921c6-2779-4795-a0ae-ffac15e47ddc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1e36c378-e5a2-4bd9-a0b2-17a9c39928cf", "node_type": "1", "metadata": {}, "hash": "a5909896b9bae40140f04b42875f8e9eb17671b6ce959b0670d0742f1eb1c937", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aa50192b-7db7-492f-b9f5-6864c82b1478", "node_type": "1", "metadata": {}, "hash": "e1e99c12023f1b737a921addf2b5c9190dd614e35e4b657d8481ee40601c31fd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue004\ue000\ue03d\ue034\ue03e\ue030\ue03e\ue000\ue033\ue034\ue032\ue033\ue030\ue03d\ue004\ue000\ue02c\ue039\ue02f\ue000\ue037\ue02c\ue03e\ue03f\ue03e\ue000\ue037\ue03a\ue039\ue032\ue030\ue03d\ue000\ue03f\ue033\ue02c\ue039\ue000\ue03f\ue033\ue02c\ue03f\ue000\ue042\ue033\ue034\ue02e\ue033\ue000\ue031\ue03a\ue037\ue037\ue03a\ue042\ue03e\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue005\n\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue042\ue034\ue03f\ue033\ue000\ue03f\ue033\ue030\ue000\ue040\ue039\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030\ue02f\ue000\ue03b\ue03a\ue037\ue044\ue03e\ue02c\ue02e\ue02e\ue033\ue02c\ue03d\ue034\ue02f\ue030\ue000\ue002\ue02a\ue030\ue039\ue032\ue030\ue03d\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue010\ue011\ue003\ue006\n\ue015\ue037\ue03f\ue033\ue03a\ue040\ue032\ue033\ue000\ue03f\ue033\ue030\ue000\ue038\ue030\ue02e\ue033\ue02c\ue039\ue034\ue03e\ue038\ue000\ue03a\ue031\ue000\ue02c\ue039\ue044\ue000\ue02c\ue039\ue03f\ue034\ue005\ue037\ue030\ue040\ue036\ue02c\ue030\ue038", "mimetype": "text/plain", "start_char_idx": 14144, "end_char_idx": 14316, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aa50192b-7db7-492f-b9f5-6864c82b1478": {"__data__": {"id_": "aa50192b-7db7-492f-b9f5-6864c82b1478", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7c8921c6-2779-4795-a0ae-ffac15e47ddc", "node_type": "1", "metadata": {}, "hash": "4637a90f2e1190733522a1fd17fac9fb22fd74a022a4b7a7a9841fdbe06ee574", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9c46b82c-1e58-4bd2-998b-436cd2341066", "node_type": "1", "metadata": {}, "hash": "635d3259ae538f0c22d2a37493fd6cb6f361935747109855425208bd49061aeb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue02c\ue039\ue044\ue000\ue02c\ue039\ue03f\ue034\ue005\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034\ue02e\ue000\ue030\ue031\ue031\ue030\ue02e\ue03f\ue000\ue03a\ue031\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue005\n\ue03f\ue034\ue03a\ue039\ue000\ue03d\ue030\ue038\ue02c\ue034\ue039\ue03e\ue000\ue03f\ue03a\ue000\ue02d\ue030\ue000\ue030\ue037\ue040\ue02e\ue034\ue02f\ue02c\ue03f\ue030\ue02f\ue004\ue000\ue034\ue03f\ue000\ue034\ue03e\ue000\ue02c\ue03f\ue000\ue037\ue030\ue02c\ue03e\ue03f\ue000\ue03b\ue037\ue02c\ue040\ue03e\ue034\ue02d\ue037\ue030\ue000\ue03f\ue033\ue02c\ue03f\ue000\ue03e\ue040\ue02e\ue033\ue000\ue02c\ue039\n\ue030\ue031\ue031\ue030\ue02e\ue03f\ue000\ue042\ue03a\ue040\ue037\ue02f\ue000\ue02d\ue030\ue000\ue038\ue03a\ue03d\ue030\ue000\ue03b\ue03d\ue03a\ue039\ue03a\ue040\ue039\ue02e\ue030\ue02f\ue000\ue042\ue034\ue03f\ue033\ue000\ue03f\ue033\ue030\ue000\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue006\n\ue01d\ue039\ue000\ue02e\ue03a", "mimetype": "text/plain", "start_char_idx": 14300, "end_char_idx": 14472, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9c46b82c-1e58-4bd2-998b-436cd2341066": {"__data__": {"id_": "9c46b82c-1e58-4bd2-998b-436cd2341066", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aa50192b-7db7-492f-b9f5-6864c82b1478", "node_type": "1", "metadata": {}, "hash": "e1e99c12023f1b737a921addf2b5c9190dd614e35e4b657d8481ee40601c31fd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0539b7db-b334-4885-a691-e88cd895947c", "node_type": "1", "metadata": {}, "hash": "33e9365276ad9e8da4ffbf3f79e80437187b744de7a2f8501cc764c0a0e8e92d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03f\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue006\n\ue01d\ue039\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue02c\ue03e\ue03f\ue000\ue042\ue034\ue03f\ue033\ue000\ue031\ue03a\ue040\ue03d\ue000\ue03b\ue03d\ue030\ue041\ue034\ue03a\ue040\ue03e\ue000\ue03e\ue03f\ue040\ue02f\ue034\ue030\ue03e\ue000\ue002\ue01f\ue039\ue030\ue02c\ue037\ue030\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue010\ue00e\ue013\n\ue021\ue02e\ue01f\ue034\ue039\ue039\ue030\ue044\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue010\ue00f\ue013\ue000\ue022\ue034\ue03e\ue033\ue034\ue000\ue02c\ue039\ue02f\ue000\ue021\ue034\ue044\ue02c\ue036\ue030\ue004\ue000\ue009\ue011\ue010\ue011\ue013\ue000\ue01f\ue02c\ue02c\ue03f\ue03e\ue02e\ue033\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\n\ue009\ue011\ue011\ue00e\ue003\ue004\ue000\ue03a\ue040\ue03d\ue000\ue02f\ue02c\ue03f\ue02c\ue000\ue03b\ue03d\ue03a\ue041\ue034\ue02f\ue030\ue000\ue039\ue03a\ue000\ue030\ue041\ue034\ue02f\ue030\ue039\ue02e\ue030\ue000\ue03a\ue031\ue000", "mimetype": "text/plain", "start_char_idx": 14455, "end_char_idx": 14627, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0539b7db-b334-4885-a691-e88cd895947c": {"__data__": {"id_": "0539b7db-b334-4885-a691-e88cd895947c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9c46b82c-1e58-4bd2-998b-436cd2341066", "node_type": "1", "metadata": {}, "hash": "635d3259ae538f0c22d2a37493fd6cb6f361935747109855425208bd49061aeb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4193e1ee-80e2-463c-bfe0-ea650c12bac7", "node_type": "1", "metadata": {}, "hash": "ca4d8b2538f202e9253ffd228384ef7932bb5aa546767f6613e7275a2ff1d97a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue000\ue039\ue03a\ue000\ue030\ue041\ue034\ue02f\ue030\ue039\ue02e\ue030\ue000\ue03a\ue031\ue000\ue02c\ue000\ue03d\ue030\ue02f\ue040\ue02e\ue030\ue02f\ue000\ue015\ue020\ue020\ue000\ue03d\ue034\ue03e\ue036\n\ue031\ue03a\ue037\ue037\ue03a\ue042\ue034\ue039\ue032\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue042\ue034\ue03f\ue033\ue000\ue018\ue027\ue024\ue004\ue000\ue021\ue021\ue025\ue004\ue000\ue03a\ue03d\ue000\ue023\ue024\ue029\ue006\ue000\ue023\ue040\ue03d\ue000\ue031\ue02c\ue034\ue037\ue040\ue03d\ue030\ue000\ue03f\ue03a\n\ue02f\ue030\ue03f\ue030\ue02e\ue03f\ue000\ue03e\ue040\ue02e\ue033\ue000\ue034\ue039\ue041\ue030\ue03d\ue03e\ue030\ue000\ue02c\ue03e\ue03e\ue03a\ue02e\ue034\ue02c\ue03f\ue034\ue03a\ue039\ue03e\ue000\ue038\ue02c\ue044\ue000\ue02d\ue030\ue000\ue02f\ue040\ue030\ue000\ue03f\ue03a\ue000\ue02c\ue000\ue037\ue02c\ue02e\ue036\ue000\ue03a\ue031\ue000\ue03e\ue03f\ue02c\ue03f\ue034\ue03e\ue03f\ue034\ue02e\ue02c\ue037\n\ue03b\ue03a\ue042\ue030\ue03d\ue004\ue000\ue02d", "mimetype": "text/plain", "start_char_idx": 14611, "end_char_idx": 14783, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4193e1ee-80e2-463c-bfe0-ea650c12bac7": {"__data__": {"id_": "4193e1ee-80e2-463c-bfe0-ea650c12bac7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0539b7db-b334-4885-a691-e88cd895947c", "node_type": "1", "metadata": {}, "hash": "33e9365276ad9e8da4ffbf3f79e80437187b744de7a2f8501cc764c0a0e8e92d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "00e1381f-59d3-4379-bd69-109d3a5ee133", "node_type": "1", "metadata": {}, "hash": "19bf3b19bb051c48e21604256b780b2aee1040b5ef9253375579d029e3e136de", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03f\ue034\ue03e\ue03f\ue034\ue02e\ue02c\ue037\n\ue03b\ue03a\ue042\ue030\ue03d\ue004\ue000\ue02d\ue030\ue02e\ue02c\ue040\ue03e\ue030\ue000\ue018\ue027\ue024\ue004\ue000\ue021\ue021\ue025\ue000\ue02c\ue039\ue02f\ue000\ue023\ue024\ue029\ue000\ue042\ue030\ue03d\ue030\ue000\ue039\ue030\ue02c\ue03d\ue037\ue044\ue000\ue040\ue039\ue034\ue041\ue030\ue03d\ue03e\ue02c\ue037\ue000\ue02c\ue038\ue03a\ue039\ue032\n\ue02d\ue03a\ue03f\ue033\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue006\ue000\ue027\ue033\ue030\ue03d\ue030\ue000\ue02c\ue03d\ue030\ue000\ue03a\ue03f\ue033\ue030\ue03d\ue000\ue03b\ue03a\ue03e\ue03e\ue034\ue02d\ue037\ue030\ue000\ue03d\ue030\ue02c\ue03e\ue03a\ue039\ue03e\ue000\ue031\ue03a\ue03d\ue000\ue03f\ue033\ue034\ue03e\n\ue02f\ue034\ue03e\ue02e\ue03d\ue030\ue03b\ue02c\ue039\ue02e\ue044\ue004\ue000\ue033\ue03a\ue042\ue030\ue041\ue030\ue03d\ue006\ue000\ue023\ue040\ue03d\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue02f\ue034\ue031\ue031", "mimetype": "text/plain", "start_char_idx": 14766, "end_char_idx": 14938, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "00e1381f-59d3-4379-bd69-109d3a5ee133": {"__data__": {"id_": "00e1381f-59d3-4379-bd69-109d3a5ee133", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4193e1ee-80e2-463c-bfe0-ea650c12bac7", "node_type": "1", "metadata": {}, "hash": "ca4d8b2538f202e9253ffd228384ef7932bb5aa546767f6613e7275a2ff1d97a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bf043bf7-86cb-4460-8558-6c677fb11b94", "node_type": "1", "metadata": {}, "hash": "bbb270ab15a59ec2f2bc8b37f6bf550c7f8bdbda3f0c96ced0ba70c304d73030", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue006\ue000\ue023\ue040\ue03d\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue02f\ue034\ue031\ue031\ue030\ue03d\ue030\ue02f\ue000\ue034\ue039\ue000\ue03e\ue030\ue041\ue030\ue03d\ue02c\ue037\ue000\ue038\ue030\ue03f\ue033\ue03a\ue02f\ue03a\ue037\ue03a\ue032\ue034\ue02e\n\ue02c\ue03e\ue03b\ue030\ue02e\ue03f\ue03e\ue000\ue031\ue03d\ue03a\ue038\ue000\ue03b\ue03d\ue030\ue041\ue034\ue03a\ue040\ue03e\ue000\ue034\ue039\ue041\ue030\ue03e\ue03f\ue034\ue032\ue02c\ue03f\ue034\ue03a\ue039\ue03e\ue006\ue000\ue023\ue039\ue037\ue044\ue000\ue03a\ue039\ue030\ue000\ue03b\ue03d\ue030\ue041\ue034\ue03a\ue040\ue03e\ue000\ue03e\ue03f\ue040\ue02f\ue044\n\ue002\ue01d\ue039\ue039\ue034\ue03e\ue004\ue000\ue009\ue011\ue00e\ue00d\ue003\ue000\ue03a\ue02d\ue03f\ue02c\ue034\ue039\ue030\ue02f\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue02f\ue02c\ue03f\ue02c\ue000\ue031\ue03d\ue03a\ue038\ue000\ue042\ue03d\ue034\ue03f\ue03f\ue030\ue039\ue000\ue03d\ue030\ue02e\ue03a\ue03d\ue02f\ue03e\ue004\ue000\ue03a\ue039\ue037\ue044\ue000\ue03a\ue039", "mimetype": "text/plain", "start_char_idx": 14922, "end_char_idx": 15094, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bf043bf7-86cb-4460-8558-6c677fb11b94": {"__data__": {"id_": "bf043bf7-86cb-4460-8558-6c677fb11b94", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "00e1381f-59d3-4379-bd69-109d3a5ee133", "node_type": "1", "metadata": {}, "hash": "19bf3b19bb051c48e21604256b780b2aee1040b5ef9253375579d029e3e136de", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ff986c92-9e65-477d-a594-dbc7415709e8", "node_type": "1", "metadata": {}, "hash": "ecec33d176613eddfdb82356fd33f75db9a9040b74ea81119500d97ac4f71d7f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03d\ue030\ue02e\ue03a\ue03d\ue02f\ue03e\ue004\ue000\ue03a\ue039\ue037\ue044\ue000\ue03a\ue039\ue030\n\ue002\ue01f\ue039\ue030\ue02c\ue037\ue030\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue010\ue00e\ue003\ue000\ue034\ue039\ue02e\ue037\ue040\ue02f\ue030\ue02f\ue000\ue038\ue03a\ue03d\ue030\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue004\ue000\ue02c\ue039\ue02f\ue000\ue03a\ue039\ue037\ue044\ue000\ue03f\ue042\ue03a\ue000\ue002\ue022\ue034\ue03e\ue033\ue034\ue000\ue02c\ue039\ue02f\n\ue021\ue034\ue044\ue02c\ue036\ue030\ue004\ue000\ue009\ue011\ue010\ue011\ue013\ue000\ue01f\ue02c\ue02c\ue03f\ue03e\ue02e\ue033\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue011\ue00e\ue003\ue000\ue031\ue03a\ue02e\ue040\ue03e\ue030\ue02f\ue000\ue03e\ue03b\ue030\ue02e\ue034\ue031\ue034\ue02e\ue02c\ue037\ue037\ue044\ue000\ue03a\ue039\ue000\ue015\ue020\ue020\ue006\n\ue02a\ue033\ue034\ue037\ue030\ue000\ue031\ue03a\ue040\ue03d\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue03b\ue03d\ue030\ue041\ue034\ue03a", "mimetype": "text/plain", "start_char_idx": 15078, "end_char_idx": 15250, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ff986c92-9e65-477d-a594-dbc7415709e8": {"__data__": {"id_": "ff986c92-9e65-477d-a594-dbc7415709e8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bf043bf7-86cb-4460-8558-6c677fb11b94", "node_type": "1", "metadata": {}, "hash": "bbb270ab15a59ec2f2bc8b37f6bf550c7f8bdbda3f0c96ced0ba70c304d73030", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "167eccbd-3441-4069-8140-6854b20eb828", "node_type": "1", "metadata": {}, "hash": "8148cc290459b0e7d45e6d4f37a9269ecc6d6e41d85bab3e7c77f19f2fa832af", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue040\ue03d\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue03b\ue03d\ue030\ue041\ue034\ue03a\ue040\ue03e\ue000\ue03e\ue03f\ue040\ue02f\ue034\ue030\ue03e\ue000\ue002\ue01f\ue039\ue030\ue02c\ue037\ue030\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue010\ue00e\ue013\ue000\ue021\ue02e\ue01f\ue034\ue039\ue039\ue030\ue044\n\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue010\ue00f\ue013\ue000\ue022\ue034\ue03e\ue033\ue034\ue000\ue02c\ue039\ue02f\ue000\ue021\ue034\ue044\ue02c\ue036\ue030\ue004\ue000\ue009\ue011\ue010\ue011\ue013\ue000\ue01f\ue02c\ue02c\ue03f\ue03e\ue02e\ue033\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue011\ue00e\ue003\ue000\ue040\ue03f\ue034\ue037\ue034\ue045\ue030\ue02f\n\ue02c\ue032\ue030\ue005\ue038\ue02c\ue03f\ue02e\ue033\ue030\ue02f\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue004\ue000\ue03a\ue039\ue037\ue044\ue000\ue03a\ue039\ue030\ue000\ue002\ue01f\ue02c\ue02c\ue03f\ue03e\ue02e\ue033\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009", "mimetype": "text/plain", "start_char_idx": 15234, "end_char_idx": 15406, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "167eccbd-3441-4069-8140-6854b20eb828": {"__data__": {"id_": "167eccbd-3441-4069-8140-6854b20eb828", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ff986c92-9e65-477d-a594-dbc7415709e8", "node_type": "1", "metadata": {}, "hash": "ecec33d176613eddfdb82356fd33f75db9a9040b74ea81119500d97ac4f71d7f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "94bebd31-1a95-49d7-b6bd-c5d2343a4ba8", "node_type": "1", "metadata": {}, "hash": "a1e406228b9522080c8e35c50dcd6af68bf136848d5065aac18dcac9257d9b6a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue01f\ue02c\ue02c\ue03f\ue03e\ue02e\ue033\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue011\ue00e\ue003\ue000\ue02c\ue02f\ue035\ue040\ue03e\ue03f\ue030\ue02f\ue000\ue031\ue03a\ue03d\n\ue03e\ue03a\ue02e\ue034\ue03a\ue030\ue02e\ue03a\ue039\ue03a\ue038\ue034\ue02e\ue000\ue03e\ue03f\ue02c\ue03f\ue040\ue03e\ue006\ue000\ue023\ue039\ue037\ue044\ue000\ue03a\ue039\ue030\ue000\ue03b\ue03d\ue030\ue041\ue034\ue03a\ue040\ue03e\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue002\ue022\ue034\ue03e\ue033\ue034\ue000\ue02c\ue039\ue02f\ue000\ue021\ue034\ue044\ue02c\ue036\ue030\ue004\n\ue009\ue011\ue010\ue011\ue003\ue000\ue03e\ue030\ue03b\ue02c\ue03d\ue02c\ue03f\ue030\ue037\ue044\ue000\ue03d\ue030\ue03b\ue03a\ue03d\ue03f\ue030\ue02f\ue000\ue03f\ue033\ue030\ue000\ue03d\ue030\ue037\ue02c\ue03f\ue034\ue041\ue030\ue000\ue03d\ue034\ue03e\ue036\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue011\ue00d\ue001\ue000\ue02e\ue03a\ue039\ue031\ue034\ue02f\ue030\ue039\ue02e\ue030\n\ue034\ue039\ue03f\ue030\ue03d\ue041\ue02c\ue037\ue03e", "mimetype": "text/plain", "start_char_idx": 15390, "end_char_idx": 15562, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "94bebd31-1a95-49d7-b6bd-c5d2343a4ba8": {"__data__": {"id_": "94bebd31-1a95-49d7-b6bd-c5d2343a4ba8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "167eccbd-3441-4069-8140-6854b20eb828", "node_type": "1", "metadata": {}, "hash": "8148cc290459b0e7d45e6d4f37a9269ecc6d6e41d85bab3e7c77f19f2fa832af", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4c3456d4-458f-49db-b4cf-6ba2b7f2e5f0", "node_type": "1", "metadata": {}, "hash": "7f0972230730db26dc6cc2394524c4b0c69913226e192c6c31414cc8f3decda6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue031\ue034\ue02f\ue030\ue039\ue02e\ue030\n\ue034\ue039\ue03f\ue030\ue03d\ue041\ue02c\ue037\ue03e\ue000\ue031\ue03a\ue03d\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034\ue02c\ue000\ue031\ue03a\ue037\ue037\ue03a\ue042\ue034\ue039\ue032\ue000\ue03e\ue03b\ue030\ue02e\ue034\ue031\ue034\ue02e\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue03e\ue013\n\ue03a\ue03f\ue033\ue030\ue03d\ue000\ue03e\ue03f\ue040\ue02f\ue034\ue030\ue03e\ue000\ue03d\ue030\ue03b\ue03a\ue03d\ue03f\ue030\ue02f\ue000\ue03f\ue033\ue030\ue000\ue030\ue031\ue031\ue030\ue02e\ue03f\ue000\ue03a\ue031\ue000\ue03e\ue03b\ue030\ue02e\ue034\ue031\ue034\ue02e\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue000\ue03a\ue039\ue000\ue02c\ue037\ue037\ue000\ue038\ue02c\ue037\ue034\ue032\ue005\n\ue039\ue02c\ue039\ue02e\ue034\ue030\ue03e\ue000\ue02e\ue03a\ue038\ue02d\ue034\ue039\ue030\ue02f\ue000\ue002\ue01f\ue039\ue030\ue02c\ue037\ue030\ue000\ue030\ue03f\ue000", "mimetype": "text/plain", "start_char_idx": 15545, "end_char_idx": 15717, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4c3456d4-458f-49db-b4cf-6ba2b7f2e5f0": {"__data__": {"id_": "4c3456d4-458f-49db-b4cf-6ba2b7f2e5f0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "94bebd31-1a95-49d7-b6bd-c5d2343a4ba8", "node_type": "1", "metadata": {}, "hash": "a1e406228b9522080c8e35c50dcd6af68bf136848d5065aac18dcac9257d9b6a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8fe1853e-f70c-402e-a702-170e9074102b", "node_type": "1", "metadata": {}, "hash": "22fc34db0caa2ace791ae28add4c398b7bedf58131a3f78ed5bc8a626b55c090", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue034\ue039\ue030\ue02f\ue000\ue002\ue01f\ue039\ue030\ue02c\ue037\ue030\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue010\ue00e\ue003\ue004\ue000\ue02c\ue039\ue02f\ue007\ue03a\ue03d\ue000\ue03f\ue033\ue030\ue000\ue030\ue031\ue031\ue030\ue02e\ue03f\ue000\ue03a\ue031\n\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue000\ue034\ue039\ue000\ue032\ue030\ue039\ue030\ue03d\ue02c\ue037\ue000\ue03a\ue039\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034\ue02c\ue000\ue034\ue039\ue000\ue03b\ue02c\ue03d\ue03f\ue034\ue02e\ue040\ue037\ue02c\ue03d\ue000\ue002\ue01d\ue039\ue039\ue034\ue03e\ue004\n\ue009\ue011\ue00e\ue00d\ue013\ue000\ue01f\ue039\ue030\ue02c\ue037\ue030\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue010\ue00e\ue013\ue000\ue021\ue02e\ue01f\ue034\ue039\ue039\ue030\ue044\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue010\ue00f\ue013\ue000\ue01f\ue02c\ue02c\ue03f\ue03e\ue02e\ue033\ue000\ue030\ue03f\ue000", "mimetype": "text/plain", "start_char_idx": 15701, "end_char_idx": 15873, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8fe1853e-f70c-402e-a702-170e9074102b": {"__data__": {"id_": "8fe1853e-f70c-402e-a702-170e9074102b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4c3456d4-458f-49db-b4cf-6ba2b7f2e5f0", "node_type": "1", "metadata": {}, "hash": "7f0972230730db26dc6cc2394524c4b0c69913226e192c6c31414cc8f3decda6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6a7ce95c-2954-417c-a3c4-27b26f4792b5", "node_type": "1", "metadata": {}, "hash": "7b3534d02a75522eb8dbd3e90b96620abb8cc5ffd933b8160a5abef09c12f9ce", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue011\ue010\ue00f\ue013\ue000\ue01f\ue02c\ue02c\ue03f\ue03e\ue02e\ue033\ue000\ue030\ue03f\ue000\ue02c\ue037\ue004\n\ue009\ue011\ue011\ue00e\ue003\ue006\n\ue027\ue033\ue030\ue000\ue02c\ue03b\ue03b\ue02c\ue03d\ue030\ue039\ue03f\ue000\ue03d\ue030\ue02f\ue040\ue02e\ue030\ue02f\ue000\ue03d\ue034\ue03e\ue036\ue000\ue03a\ue031\ue000\ue015\ue020\ue020\ue000\ue02c\ue031\ue03f\ue030\ue03d\ue000\ue03d\ue030\ue02e\ue030\ue034\ue041\ue034\ue039\ue032\ue000\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030\ue000\ue01c\ue034\ue02d\n\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue038\ue02c\ue044\ue000\ue033\ue02c\ue041\ue030\ue000\ue02d\ue030\ue030\ue039\ue000\ue02c\ue000\ue02e\ue033\ue02c\ue039\ue02e\ue030\ue000\ue031\ue034\ue039\ue02f\ue034\ue039\ue032\ue004\ue000\ue03b\ue030\ue03d\ue033\ue02c\ue03b\ue03e\ue000\ue02f\ue040\ue030\ue000\ue03f\ue03a\ue000\ue038\ue040\ue037\ue03f\ue034\ue03b\ue037\ue030\n\ue02e\ue03a\ue038\ue03b\ue02c\ue03d\ue034\ue03e\ue03a\ue039\ue03e\ue006\ue000\ue015\ue039\ue03a\ue03f\ue033\ue030", "mimetype": "text/plain", "start_char_idx": 15857, "end_char_idx": 16030, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6a7ce95c-2954-417c-a3c4-27b26f4792b5": {"__data__": {"id_": "6a7ce95c-2954-417c-a3c4-27b26f4792b5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8fe1853e-f70c-402e-a702-170e9074102b", "node_type": "1", "metadata": {}, "hash": "22fc34db0caa2ace791ae28add4c398b7bedf58131a3f78ed5bc8a626b55c090", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "af4c2be1-fa65-4fd2-a07d-ac9db7b47892", "node_type": "1", "metadata": {}, "hash": "13c765812de6706f8ef1f8e8540995043c80a183d9a24ee6d717d844a098511b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03b\ue02c\ue03d\ue034\ue03e\ue03a\ue039\ue03e\ue006\ue000\ue015\ue039\ue03a\ue03f\ue033\ue030\ue03d\ue000\ue03b\ue03a\ue03e\ue03e\ue034\ue02d\ue037\ue030\ue000\ue030\ue043\ue03b\ue037\ue02c\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue03d\ue030\ue03e\ue040\ue037\ue03f\ue03e\ue000\ue031\ue03a\ue03d\ue000\ue01c\ue034\ue02d\n\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue038\ue02c\ue044\ue000\ue02d\ue030\ue000\ue02d\ue034\ue02c\ue03e\ue004\ue000\ue03e\ue034\ue039\ue02e\ue030\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue000\ue03e\ue030\ue037\ue030\ue02e\ue03f\ue030\ue02f\ue000\ue040\ue03e\ue034\ue039\ue032\ue000\ue03d\ue02c\ue039\ue02f\ue03a\ue038\ue005\ue02f\ue034\ue032\ue034\ue03f\n\ue02f\ue034\ue02c\ue037\ue034\ue039\ue032\ue000\ue042\ue030\ue03d\ue030\ue000\ue038\ue03a\ue03d\ue030\ue000\ue037\ue034\ue036\ue030\ue037\ue044\ue000\ue03f\ue03a\ue000\ue02d\ue030\ue000\ue03a\ue031\ue031\ue03e\ue03b\ue03d\ue034\ue039\ue032\ue000\ue03a\ue031\ue000\ue03b\ue02c", "mimetype": "text/plain", "start_char_idx": 16014, "end_char_idx": 16186, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "af4c2be1-fa65-4fd2-a07d-ac9db7b47892": {"__data__": {"id_": "af4c2be1-fa65-4fd2-a07d-ac9db7b47892", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6a7ce95c-2954-417c-a3c4-27b26f4792b5", "node_type": "1", "metadata": {}, "hash": "7b3534d02a75522eb8dbd3e90b96620abb8cc5ffd933b8160a5abef09c12f9ce", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d597a028-460f-432c-9a4f-9a66f724436a", "node_type": "1", "metadata": {}, "hash": "26369c85699774399458a9d3d6b0e68c0e409f9aa888b981462c79b357c5b9cb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue000\ue03a\ue031\ue031\ue03e\ue03b\ue03d\ue034\ue039\ue032\ue000\ue03a\ue031\ue000\ue03b\ue02c\ue03d\ue030\ue039\ue03f\ue03e\ue000\ue042\ue034\ue03f\ue033\ue000\ue033\ue034\ue032\ue033\ue030\ue03d\n\ue030\ue02f\ue040\ue02e\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue02c\ue039\ue02f\ue007\ue03a\ue03d\ue000\ue031\ue02c\ue038\ue034\ue037\ue044\ue000\ue034\ue039\ue02e\ue03a\ue038\ue030\ue000\ue02e\ue03a\ue038\ue03b\ue02c\ue03d\ue030\ue02f\ue000\ue042\ue034\ue03f\ue033\ue000\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue002\ue01f\ue037\ue030\ue034\ue039\ue030\ue03d\ue038\ue02c\ue039\n\ue030\ue03f\ue000\ue02c\ue037\ue004\ue000\ue009\ue011\ue011\ue00f\ue003\ue006\ue000\ue02a\ue033\ue034\ue037\ue030\ue000\ue03f\ue033\ue034\ue03e\ue000\ue038\ue02c\ue044\ue000\ue030\ue043\ue03b\ue037\ue02c\ue034\ue039\ue000\ue03f\ue033\ue030\ue000\ue03f\ue030\ue039\ue02f\ue030\ue039\ue02e\ue044\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue000\ue03f\ue03a\n\ue033\ue02c\ue041\ue030\ue000\ue038", "mimetype": "text/plain", "start_char_idx": 16170, "end_char_idx": 16342, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d597a028-460f-432c-9a4f-9a66f724436a": {"__data__": {"id_": "d597a028-460f-432c-9a4f-9a66f724436a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "af4c2be1-fa65-4fd2-a07d-ac9db7b47892", "node_type": "1", "metadata": {}, "hash": "13c765812de6706f8ef1f8e8540995043c80a183d9a24ee6d717d844a098511b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "819e1d8d-8ed8-48be-bb06-bdbc8edcbc6c", "node_type": "1", "metadata": {}, "hash": "3300fc7907dfe02d87e8b16fcbb24895cb7bc168ad18e57be79110c6635aaa78", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue000\ue03f\ue03a\n\ue033\ue02c\ue041\ue030\ue000\ue038\ue03a\ue03d\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue03e\ue004\ue000\ue03f\ue033\ue030\ue000\ue02c\ue03e\ue03e\ue03a\ue02e\ue034\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue02d\ue030\ue03f\ue042\ue030\ue030\ue039\ue000\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030\ue000\ue01c\ue034\ue02d\n\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue02c\ue039\ue02f\ue000\ue015\ue020\ue020\ue000\ue03b\ue030\ue03d\ue03e\ue034\ue03e\ue03f\ue030\ue02f\ue000\ue02c\ue031\ue03f\ue030\ue03d\ue000\ue03e\ue03f\ue02c\ue03f\ue034\ue03e\ue03f\ue034\ue02e\ue02c\ue037\ue000\ue02c\ue02f\ue035\ue040\ue03e\ue03f\ue038\ue030\ue039\ue03f\ue000\ue031\ue03a\ue03d\ue000\ue031\ue02c\ue038\ue034\ue037\ue044\n\ue034\ue039\ue02e\ue03a\ue038\ue030\ue000\ue02c\ue039\ue02f\ue000\ue03b\ue02c\ue03d\ue030\ue039\ue03f\ue02c\ue037\ue000\ue030\ue02f\ue040\ue02e\ue02c\ue03f\ue034\ue03a\ue039\ue004\ue000\ue02c\ue039", "mimetype": "text/plain", "start_char_idx": 16325, "end_char_idx": 16497, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "819e1d8d-8ed8-48be-bb06-bdbc8edcbc6c": {"__data__": {"id_": "819e1d8d-8ed8-48be-bb06-bdbc8edcbc6c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d597a028-460f-432c-9a4f-9a66f724436a", "node_type": "1", "metadata": {}, "hash": "26369c85699774399458a9d3d6b0e68c0e409f9aa888b981462c79b357c5b9cb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "508500e1-1ea1-412f-a095-62b1f01deca4", "node_type": "1", "metadata": {}, "hash": "38fce237d2b9c0d7b45414d3e27283a960aedb8dd4e9b81beaabcc5e929cafe4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue02c\ue037\ue000\ue030\ue02f\ue040\ue02e\ue02c\ue03f\ue034\ue03a\ue039\ue004\ue000\ue02c\ue039\ue02f\ue000\ue039\ue03a\ue000\ue03e\ue040\ue02e\ue033\ue000\ue034\ue039\ue041\ue030\ue03d\ue03e\ue030\ue000\ue02c\ue03e\ue03e\ue03a\ue02e\ue034\ue02c\ue03f\ue034\ue03a\ue039\n\ue042\ue02c\ue03e\ue000\ue03a\ue02d\ue03e\ue030\ue03d\ue041\ue030\ue02f\ue000\ue031\ue03a\ue03d\ue000\ue02c\ue039\ue044\ue000\ue03a\ue03f\ue033\ue030\ue03d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue006\ue000\ue017\ue03a\ue039\ue031\ue03a\ue040\ue039\ue02f\ue034\ue039\ue032\ue000\ue02d\ue044\ue000\ue03e\ue03a\ue02e\ue034\ue03a\ue005\n\ue030\ue02e\ue03a\ue039\ue03a\ue038\ue034\ue02e\ue000\ue03e\ue03f\ue02c\ue03f\ue040\ue03e\ue000\ue038\ue02c\ue044\ue000\ue02d\ue030\ue000\ue038\ue03a\ue03d\ue030\ue000\ue03b\ue037\ue02c\ue040\ue03e\ue034\ue02d\ue037\ue030\ue000\ue031\ue03a\ue03d\ue000\ue03f\ue033\ue030\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue03f\ue033\ue02c\ue039\n\ue031\ue03a\ue03d\ue000\ue03a", "mimetype": "text/plain", "start_char_idx": 16481, "end_char_idx": 16653, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "508500e1-1ea1-412f-a095-62b1f01deca4": {"__data__": {"id_": "508500e1-1ea1-412f-a095-62b1f01deca4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "819e1d8d-8ed8-48be-bb06-bdbc8edcbc6c", "node_type": "1", "metadata": {}, "hash": "3300fc7907dfe02d87e8b16fcbb24895cb7bc168ad18e57be79110c6635aaa78", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6077970c-c313-478a-b736-7650f267ddab", "node_type": "1", "metadata": {}, "hash": "43414de3bd19796355e166a3afc3a1fbfae88ad832669b0d28a7045f8f5e735b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue03f\ue033\ue02c\ue039\n\ue031\ue03a\ue03d\ue000\ue03a\ue03f\ue033\ue030\ue03d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue004\ue000\ue03e\ue034\ue039\ue02e\ue030\ue000\ue03b\ue02c\ue03d\ue030\ue039\ue03f\ue03e\ue000\ue03a\ue031\ue000\ue033\ue034\ue032\ue033\ue030\ue03d\ue000\ue03e\ue03a\ue02e\ue034\ue03a\ue030\ue02e\ue03a\ue039\ue03a\ue038\ue034\ue02e\ue000\ue03e\ue03f\ue02c\ue03f\ue040\ue03e\n\ue038\ue02c\ue044\ue000\ue033\ue02c\ue041\ue030\ue000\ue02d\ue030\ue030\ue039\ue000\ue038\ue03a\ue03d\ue030\ue000\ue034\ue039\ue02e\ue037\ue034\ue039\ue030\ue02f\ue000\ue03f\ue03a\ue000\ue02c\ue041\ue02c\ue034\ue037\ue000\ue03f\ue033\ue030\ue038\ue03e\ue030\ue037\ue041\ue030\ue03e\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue039\ue030\ue042\ue037\ue044\ue005\n\ue034\ue039\ue03f\ue03d\ue03a\ue02f\ue040\ue02e\ue030\ue02f\ue004\ue000\ue041\ue03a\ue037\ue040\ue039\ue03f\ue02c\ue03d\ue044\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030", "mimetype": "text/plain", "start_char_idx": 16636, "end_char_idx": 16808, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6077970c-c313-478a-b736-7650f267ddab": {"__data__": {"id_": "6077970c-c313-478a-b736-7650f267ddab", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "508500e1-1ea1-412f-a095-62b1f01deca4", "node_type": "1", "metadata": {}, "hash": "38fce237d2b9c0d7b45414d3e27283a960aedb8dd4e9b81beaabcc5e929cafe4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fb83d31e-9562-4119-81f9-8db7b980e22e", "node_type": "1", "metadata": {}, "hash": "a94454c2e81d768a1ba92acae71c3dc977754991ee3f32e008a5647aaf4ff3ac", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03f\ue02c\ue03d\ue044\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue006\n\ue016\ue030\ue02e\ue02c\ue040\ue03e\ue030\ue000\ue02d\ue03a\ue03f\ue033\ue000\ue02c\ue032\ue030\ue000\ue02c\ue039\ue02f\ue000\ue02e\ue02c\ue037\ue030\ue039\ue02f\ue02c\ue03d\ue000\ue03f\ue034\ue038\ue030\ue000\ue02c\ue03d\ue030\ue000\ue03e\ue03f\ue03d\ue03a\ue039\ue032\ue037\ue044\ue000\ue03d\ue030\ue037\ue02c\ue03f\ue030\ue02f\ue000\ue03f\ue03a\ue000\ue01c\ue034\ue02d\n\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue03d\ue02c\ue03f\ue030\ue004\ue000\ue042\ue030\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue037\ue030\ue02f\ue000\ue031\ue03a\ue03d\ue000\ue02d\ue03a\ue03f\ue033\ue000\ue03f\ue030\ue038\ue03b\ue03a\ue03d\ue02c\ue037\ue000\ue031\ue02c\ue02e\ue03f\ue03a\ue03d\ue03e\ue006\ue000\ue015\ue037\ue03f\ue033\ue03a\ue040\ue032\ue033\n\ue042\ue030\ue000\ue02c\ue03e\ue03e\ue040\ue038\ue030\ue02f\ue000\ue03f\ue033\ue02c\ue03f\ue000\ue03a\ue039\ue037\ue044\ue000\ue03f\ue033", "mimetype": "text/plain", "start_char_idx": 16792, "end_char_idx": 16964, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fb83d31e-9562-4119-81f9-8db7b980e22e": {"__data__": {"id_": "fb83d31e-9562-4119-81f9-8db7b980e22e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6077970c-c313-478a-b736-7650f267ddab", "node_type": "1", "metadata": {}, "hash": "43414de3bd19796355e166a3afc3a1fbfae88ad832669b0d28a7045f8f5e735b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c06dfb23-174d-47b9-84cb-bb828007c283", "node_type": "1", "metadata": {}, "hash": "8fc9186f253e106cfede0563fd1141f854a43c26323ef2c61ec5e456bebfbbeb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue038\ue030\ue02f\ue000\ue03f\ue033\ue02c\ue03f\ue000\ue03a\ue039\ue037\ue044\ue000\ue03f\ue033\ue030\ue000\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue042\ue02c\ue03e\ue000\ue02c\ue02f\ue038\ue034\ue039\ue034\ue03e\ue03f\ue030\ue03d\ue030\ue02f\n\ue02c\ue031\ue03f\ue030\ue03d\ue000\ue00b\ue009\ue000\ue018\ue030\ue02e\ue030\ue038\ue02d\ue030\ue03d\ue000\ue009\ue011\ue010\ue00f\ue004\ue000\ue03f\ue033\ue030\ue000\ue03b\ue03a\ue037\ue044\ue03e\ue02c\ue02e\ue02e\ue033\ue02c\ue03d\ue034\ue02f\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue038\ue034\ue032\ue033\ue03f\ue000\ue033\ue02c\ue041\ue030\n\ue02d\ue030\ue030\ue039\ue000\ue040\ue03e\ue030\ue02f\ue000\ue03e\ue03b\ue03a\ue03d\ue02c\ue02f\ue034\ue02e\ue02c\ue037\ue037\ue044\ue006\ue000\ue01c\ue03a\ue042\ue030\ue041\ue030\ue03d\ue004\ue000\ue03e\ue040\ue02e\ue033\ue000\ue038\ue034\ue03e\ue02e\ue037\ue02c\ue03e\ue03e\ue034\ue031\ue034\ue02e\ue02c\ue03f\ue034", "mimetype": "text/plain", "start_char_idx": 16948, "end_char_idx": 17120, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c06dfb23-174d-47b9-84cb-bb828007c283": {"__data__": {"id_": "c06dfb23-174d-47b9-84cb-bb828007c283", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fb83d31e-9562-4119-81f9-8db7b980e22e", "node_type": "1", "metadata": {}, "hash": "a94454c2e81d768a1ba92acae71c3dc977754991ee3f32e008a5647aaf4ff3ac", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "68f8f166-652c-406f-ad51-b1d9c9dfa1cc", "node_type": "1", "metadata": {}, "hash": "f7bd80f839ef1791ed4bcec9363d1cb934361221ff438dbb1bc5e0c4b4c1feec", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue000\ue038\ue034\ue03e\ue02e\ue037\ue02c\ue03e\ue03e\ue034\ue031\ue034\ue02e\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue042\ue03a\ue040\ue037\ue02f\ue000\ue033\ue02c\ue041\ue030\n\ue03d\ue030\ue02f\ue040\ue02e\ue030\ue02f\ue000\ue03f\ue033\ue030\ue000\ue03a\ue02d\ue03e\ue030\ue03d\ue041\ue030\ue02f\ue000\ue034\ue039\ue041\ue030\ue03d\ue03e\ue030\ue000\ue02c\ue03e\ue03e\ue03a\ue02e\ue034\ue02c\ue03f\ue034\ue03a\ue039\ue006\ue000\ue023\ue03f\ue033\ue030\ue03d\ue000\ue034\ue038\ue03b\ue03a\ue03d\ue03f\ue02c\ue039\ue03f\ue000\ue037\ue034\ue038\ue034\ue03f\ue02c\ue005\n\ue03f\ue034\ue03a\ue039\ue03e\ue000\ue03a\ue031\ue000\ue03a\ue040\ue03d\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue042\ue030\ue03d\ue030\ue000\ue03f\ue033\ue030\ue000\ue040\ue03e\ue030\ue000\ue03a\ue031\ue000\ue03d\ue02c\ue039\ue02f\ue03a\ue038\ue005\ue02f\ue034\ue032\ue034\ue03f\ue000\ue02f\ue034\ue02c\ue037\ue034\ue039\ue032\ue000\ue03f\ue03a\ue000\ue034\ue02f\ue030\ue039\ue03f\ue034\ue031\ue044\n\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e", "mimetype": "text/plain", "start_char_idx": 17104, "end_char_idx": 17276, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "68f8f166-652c-406f-ad51-b1d9c9dfa1cc": {"__data__": {"id_": "68f8f166-652c-406f-ad51-b1d9c9dfa1cc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c06dfb23-174d-47b9-84cb-bb828007c283", "node_type": "1", "metadata": {}, "hash": "8fc9186f253e106cfede0563fd1141f854a43c26323ef2c61ec5e456bebfbbeb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5f201471-3a10-42d7-af46-4057a07f3b48", "node_type": "1", "metadata": {}, "hash": "6a520d02ef4b207009b615422cc4298f5aa3102d901999f2d53a39428f821f2d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue034\ue02f\ue030\ue039\ue03f\ue034\ue031\ue044\n\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue004\ue000\ue02c\ue039\ue02f\ue000\ue03f\ue033\ue030\ue000\ue02c\ue03f\ue03f\ue030\ue039\ue02f\ue02c\ue039\ue03f\ue000\ue037\ue03a\ue042\ue000\ue03d\ue030\ue03e\ue03b\ue03a\ue039\ue03e\ue030\ue000\ue03d\ue02c\ue03f\ue030\ue000\ue002\ue03a\ue039\ue037\ue044\ue000\ue00d\ue008\ue001\ue003\ue000\ue031\ue03a\ue03d\n\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue006\ue000\ue027\ue033\ue030\ue000\ue03d\ue030\ue03e\ue03b\ue03a\ue039\ue03e\ue030\ue000\ue03d\ue02c\ue03f\ue030\ue000\ue042\ue02c\ue03e\ue000\ue037\ue03a\ue042\ue030\ue03d\ue000\ue03f\ue033\ue02c\ue039\ue000\ue03f\ue033\ue02c\ue03f\ue000\ue031\ue03a\ue03d\ue000\ue03a\ue03f\ue033\ue030\ue03d\ue000\ue02e\ue03a\ue038\ue03b\ue03a\ue005\n\ue039\ue030\ue039\ue03f\ue03e\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue02d\ue030\ue02e\ue02c\ue040\ue03e\ue030\ue000\ue042\ue03d\ue034\ue03f\ue03f\ue030\ue039\ue000\ue041\ue02c", "mimetype": "text/plain", "start_char_idx": 17259, "end_char_idx": 17431, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5f201471-3a10-42d7-af46-4057a07f3b48": {"__data__": {"id_": "5f201471-3a10-42d7-af46-4057a07f3b48", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "68f8f166-652c-406f-ad51-b1d9c9dfa1cc", "node_type": "1", "metadata": {}, "hash": "f7bd80f839ef1791ed4bcec9363d1cb934361221ff438dbb1bc5e0c4b4c1feec", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "335b6cdb-4059-427e-ae65-c2ba572c1ef5", "node_type": "1", "metadata": {}, "hash": "c61b61b92e53bb42a51f5fc23e04f3bdca911a0cca46797505859f70eb1ae248", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue02e\ue02c\ue040\ue03e\ue030\ue000\ue042\ue03d\ue034\ue03f\ue03f\ue030\ue039\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue03d\ue030\ue02e\ue03a\ue03d\ue02f\ue03e\ue000\ue042\ue034\ue03f\ue033\ue000\ue02f\ue02c\ue03f\ue030\ue03e\ue000\ue03a\ue031\n\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue042\ue030\ue03d\ue030\ue000\ue03d\ue030\ue03c\ue040\ue034\ue03d\ue030\ue02f\ue013\ue000\ue039\ue03a\ue039\ue030\ue03f\ue033\ue030\ue037\ue030\ue03e\ue03e\ue004\ue000\ue02d\ue030\ue02e\ue02c\ue040\ue03e\ue030\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue03d\ue030\ue03c\ue040\ue034\ue03d\ue030\ue038\ue030\ue039\ue03f\n\ue031\ue03a\ue03d\ue000\ue042\ue03d\ue034\ue03f\ue03f\ue030\ue039\ue000\ue03d\ue030\ue02e\ue03a\ue03d\ue02f\ue03e\ue004\ue000\ue03f\ue033\ue034\ue03e\ue000\ue034\ue03e\ue000\ue03a\ue039\ue030\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue037\ue02c\ue03d\ue032\ue030\ue03e\ue03f\ue000\ue02c\ue039\ue02f\ue000\ue038\ue03a\ue03e\ue03f\ue000", "mimetype": "text/plain", "start_char_idx": 17415, "end_char_idx": 17587, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "335b6cdb-4059-427e-ae65-c2ba572c1ef5": {"__data__": {"id_": "335b6cdb-4059-427e-ae65-c2ba572c1ef5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5f201471-3a10-42d7-af46-4057a07f3b48", "node_type": "1", "metadata": {}, "hash": "6a520d02ef4b207009b615422cc4298f5aa3102d901999f2d53a39428f821f2d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "62a2ccb1-bb33-4d40-8d3b-1833bb10066d", "node_type": "1", "metadata": {}, "hash": "87761c1d4f9f682a09cc6b1dfb90aff9006d213b0abbeff96c6f80b4ed4dff16", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue02c\ue03d\ue032\ue030\ue03e\ue03f\ue000\ue02c\ue039\ue02f\ue000\ue038\ue03a\ue03e\ue03f\ue000\ue03e\ue03f\ue03d\ue034\ue039\ue032\ue030\ue039\ue03f\n\ue034\ue039\ue041\ue030\ue03e\ue03f\ue034\ue032\ue02c\ue03f\ue034\ue03a\ue039\ue03e\ue000\ue03f\ue03a\ue000\ue02f\ue02c\ue03f\ue030\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue03d\ue03a\ue037\ue030\ue000\ue03a\ue031\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue03e\ue000\ue034\ue039\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000\ue015\ue020\ue020\ue006\nInfant vaccinations and risk of childhood leukaemia\n177\nBritish Journal of Cancer (1999) 81(1), 175\u2013178\n\u00a9 Cancer Research Campaign 1999\nTable 2\nEffect of vaccination (ever vs never) on subsequent risk of childhood acute lymphoblastic leukaemia (439 matched pairs)\nVaccine\nCases\nControls\nRRa\n95% CIb\nMeasles\u2013mumps\u2013rubella\n395 (90%)\n394 (90%)\n1.19\n(0.67\u20132.10)\nOral poliovirus\n429 (98%)\n428 (97%)\n1.05\n(0.41\u20132.67)\nDiphtheria\u2013tetanus\u2013pertussis\n424 (97%)\n428 (97%)\n0.66\n(0.27\u20131.65)\nTetanus (all)\n431 (98%)\n430 (98%)\n0.75\n(0.26\u20132.", "mimetype": "text/plain", "start_char_idx": 17571, "end_char_idx": 18190, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "62a2ccb1-bb33-4d40-8d3b-1833bb10066d": {"__data__": {"id_": "62a2ccb1-bb33-4d40-8d3b-1833bb10066d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "335b6cdb-4059-427e-ae65-c2ba572c1ef5", "node_type": "1", "metadata": {}, "hash": "c61b61b92e53bb42a51f5fc23e04f3bdca911a0cca46797505859f70eb1ae248", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7edd1f28-ad0c-4595-9eab-c732fa24cfdc", "node_type": "1", "metadata": {}, "hash": "edac517b32055940ee6a0e080c97f466cd41af782706ef2ca5b097141816d480", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "66\n(0.27\u20131.65)\nTetanus (all)\n431 (98%)\n430 (98%)\n0.75\n(0.26\u20132.16)\nDiphtheria (all)\n431 (98%)\n430 (98%)\n0.75\n(0.26\u20132.16)\nHaemophilus influenzae b (Hib)\n206 (47%)\n232 (53%)\n0.73\n(0.50\u20131.06)\n(Presumptive) polysaccharide vaccine\n53 (12%)\n50 (11%)\n1.13\n(0.64\u20131.98)\n(Presumptive) conjugate vaccine\n153 (35%)\n182 (41%)\n0.57\n(0.36\u20130.89)\naRelative risk, adjusted for age at censoring, year of birth, sex, race, family income, parental education and attendance at day-care and/or preschool. \nbNinety-five per cent confidence interval.\n\ue02a\ue030\ue000\ue02d\ue030\ue037\ue034\ue030\ue041\ue030\ue000\ue03f\ue033\ue02c\ue03f\ue000\ue03a\ue040\ue03d\ue000\ue031\ue034\ue039\ue02f\ue034\ue039\ue032\ue03e\ue000\ue035\ue040\ue03e\ue03f\ue034\ue031\ue044\ue000\ue02c\ue000\ue038\ue03a\ue03d\ue030\ue000\ue02f\ue030\ue031\ue034\ue039\ue034\ue03f\ue034\ue041\ue030\ue000\ue034\ue039\ue041\ue030\ue03e\ue03f\ue034\ue032\ue02c\ue005\n\ue03f\ue034\ue03a\ue039\ue000\ue03a\ue031\ue000\ue03f\ue033\ue034\ue03e\ue000\ue03c\ue040\ue030\ue03e\ue03f\ue034\ue03a\ue039\ue000\ue02d\ue030\ue02e\ue02c\ue040\ue03e\ue030\ue000\ue03a\ue031\ue000\ue03f", "mimetype": "text/plain", "start_char_idx": 18128, "end_char_idx": 18753, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7edd1f28-ad0c-4595-9eab-c732fa24cfdc": {"__data__": {"id_": "7edd1f28-ad0c-4595-9eab-c732fa24cfdc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "62a2ccb1-bb33-4d40-8d3b-1833bb10066d", "node_type": "1", "metadata": {}, "hash": "87761c1d4f9f682a09cc6b1dfb90aff9006d213b0abbeff96c6f80b4ed4dff16", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cc715502-62db-4c1d-b27d-a5527f4f8939", "node_type": "1", "metadata": {}, "hash": "73ee5922278b4da3a02da1852264a135ad7bd9a5ab69eb6ef2f564b28267922e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue034\ue03a\ue039\ue000\ue02d\ue030\ue02e\ue02c\ue040\ue03e\ue030\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue034\ue038\ue03b\ue03a\ue03d\ue03f\ue02c\ue039\ue03f\ue000\ue03e\ue02e\ue034\ue030\ue039\ue03f\ue034\ue031\ue034\ue02e\ue000\ue02c\ue039\ue02f\ue000\ue03b\ue040\ue02d\ue037\ue034\ue02e\n\ue033\ue030\ue02c\ue037\ue03f\ue033\ue000\ue034\ue038\ue03b\ue037\ue034\ue02e\ue02c\ue03f\ue034\ue03a\ue039\ue03e\ue000\ue034\ue031\ue000\ue03a\ue040\ue03d\ue000\ue031\ue034\ue039\ue02f\ue034\ue039\ue032\ue03e\ue000\ue031\ue03a\ue03d\ue000\ue03f\ue033\ue030\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue02c\ue03d\ue030\n\ue02e\ue03a\ue039\ue031\ue034\ue03d\ue038\ue030\ue02f\ue006\ue000\ue01a\ue040\ue03f\ue040\ue03d\ue030\ue000\ue03e\ue03f\ue040\ue02f\ue034\ue030\ue03e\ue000\ue03e\ue033\ue03a\ue040\ue037\ue02f\ue000\ue040\ue03f\ue034\ue037\ue034\ue045\ue030\ue000\ue03b\ue03a\ue03b\ue040\ue037\ue02c\ue03f\ue034\ue03a\ue039\ue005\ue02d\ue02c\ue03e\ue030\ue02f\ue000\ue02e\ue02c\ue03e", "mimetype": "text/plain", "start_char_idx": 18737, "end_char_idx": 18909, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cc715502-62db-4c1d-b27d-a5527f4f8939": {"__data__": {"id_": "cc715502-62db-4c1d-b27d-a5527f4f8939", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7edd1f28-ad0c-4595-9eab-c732fa24cfdc", "node_type": "1", "metadata": {}, "hash": "edac517b32055940ee6a0e080c97f466cd41af782706ef2ca5b097141816d480", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "380ce340-aef2-4319-9240-fec32a041fc1", "node_type": "1", "metadata": {}, "hash": "ee55d9b56dcbae394101a4b0331a56240eb938472e986d3aaa47dd7023f1c26f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue037\ue02c\ue03f\ue034\ue03a\ue039\ue005\ue02d\ue02c\ue03e\ue030\ue02f\ue000\ue02e\ue02c\ue03e\ue030\ue03e\n\ue02c\ue039\ue02f\ue000\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue03e\ue000\ue038\ue02c\ue03f\ue02e\ue033\ue030\ue02f\ue000\ue02c\ue03e\ue000\ue02e\ue037\ue03a\ue03e\ue030\ue037\ue044\ue000\ue02c\ue03e\ue000\ue03b\ue03a\ue03e\ue03e\ue034\ue02d\ue037\ue030\ue000\ue03a\ue039\ue000\ue02f\ue02c\ue03f\ue030\ue000\ue03a\ue031\ue000\ue02d\ue034\ue03d\ue03f\ue033\ue004\ue000\ue042\ue034\ue03f\ue033\n\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue033\ue034\ue03e\ue03f\ue03a\ue03d\ue034\ue030\ue03e\ue000\ue03a\ue02d\ue03f\ue02c\ue034\ue039\ue030\ue02f\ue000\ue031\ue03d\ue03a\ue038\ue000\ue038\ue030\ue02f\ue034\ue02e\ue02c\ue037\ue000\ue03d\ue030\ue02e\ue03a\ue03d\ue02f\ue03e\ue006\ue000\ue017\ue03a\ue033\ue03a\ue03d\ue03f\n\ue03e\ue03f\ue040\ue02f\ue034\ue030\ue03e\ue000\ue02e\ue03a\ue038\ue03b\ue02c\ue03d\ue034\ue039\ue032\ue000\ue03f\ue033\ue030\ue000\ue034\ue039\ue02e\ue034", "mimetype": "text/plain", "start_char_idx": 18893, "end_char_idx": 19065, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "380ce340-aef2-4319-9240-fec32a041fc1": {"__data__": {"id_": "380ce340-aef2-4319-9240-fec32a041fc1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cc715502-62db-4c1d-b27d-a5527f4f8939", "node_type": "1", "metadata": {}, "hash": "73ee5922278b4da3a02da1852264a135ad7bd9a5ab69eb6ef2f564b28267922e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4679ab0c-0f7f-4433-9c1c-e71cd8acbeee", "node_type": "1", "metadata": {}, "hash": "132ccace1d527402346f286c831876471598be379f8f1e6e1dcd437d0fb78d68", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue038\ue03b\ue02c\ue03d\ue034\ue039\ue032\ue000\ue03f\ue033\ue030\ue000\ue034\ue039\ue02e\ue034\ue02f\ue030\ue039\ue02e\ue030\ue000\ue03a\ue031\ue000\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034\ue02c\ue000\ue02c\ue038\ue03a\ue039\ue032\ue000\ue03e\ue040\ue02d\ue035\ue030\ue02e\ue03f\ue03e\ue000\ue042\ue033\ue03a\n\ue03b\ue02c\ue03d\ue03f\ue034\ue02e\ue034\ue03b\ue02c\ue03f\ue030\ue02f\ue000\ue034\ue039\ue000\ue03d\ue02c\ue039\ue02f\ue03a\ue038\ue034\ue045\ue030\ue02f\ue000\ue02e\ue037\ue034\ue039\ue034\ue02e\ue02c\ue037\ue000\ue03f\ue03d\ue034\ue02c\ue037\ue03e\ue000\ue03a\ue031\ue000\ue03f\ue033\ue030\ue000\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030\ue000\ue01c\ue034\ue02d\n\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue004\ue000\ue03a\ue03d\ue000\ue03a\ue03f\ue033\ue030\ue03d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue004\ue000\ue042\ue03a\ue040\ue037\ue02f\ue000\ue03a\ue031\ue031\ue030\ue03d\ue000\ue03e\ue03f\ue03d\ue03a\ue039\ue032\ue030\ue03d\ue000\ue030\ue041\ue034\ue02f\ue030", "mimetype": "text/plain", "start_char_idx": 19049, "end_char_idx": 19221, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4679ab0c-0f7f-4433-9c1c-e71cd8acbeee": {"__data__": {"id_": "4679ab0c-0f7f-4433-9c1c-e71cd8acbeee", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "380ce340-aef2-4319-9240-fec32a041fc1", "node_type": "1", "metadata": {}, "hash": "ee55d9b56dcbae394101a4b0331a56240eb938472e986d3aaa47dd7023f1c26f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4f69cb07-c9e9-418f-8855-174a293a8510", "node_type": "1", "metadata": {}, "hash": "7a810e0de5bc3cc9e4de56dbb8ee69677b6a9ee2c01ca7d030b81833963c433b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03d\ue000\ue03e\ue03f\ue03d\ue03a\ue039\ue032\ue030\ue03d\ue000\ue030\ue041\ue034\ue02f\ue030\ue039\ue02e\ue030\ue000\ue03f\ue03a\n\ue03e\ue040\ue03b\ue03b\ue03a\ue03d\ue03f\ue000\ue03a\ue03d\ue000\ue03d\ue030\ue031\ue040\ue03f\ue030\ue000\ue02c\ue000\ue03d\ue030\ue02f\ue040\ue02e\ue030\ue02f\ue000\ue015\ue020\ue020\ue000\ue03d\ue034\ue03e\ue036\ue000\ue031\ue03a\ue037\ue037\ue03a\ue042\ue034\ue039\ue032\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue006\n\ue001\ue002\ue008\ue00b\ue00c\ue011\ue009\ue004\ue003\ue005\ue004\ue00a\ue004\ue00b\ue00f\ue00e\n\ue027\ue033\ue030\ue000\ue02c\ue040\ue03f\ue033\ue03a\ue03d\ue03e\ue000\ue03f\ue033\ue02c\ue039\ue036\ue000\ue021\ue03e\ue000\ue026\ue03f\ue030\ue037\ue037\ue02c\ue000\ue026\ue030\ue038\ue034\ue03f\ue034\ue000\ue03a\ue031\ue000\ue01d\ue039\ue031\ue03a\ue03d\ue038\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue021\ue02c\ue039\ue02c\ue032\ue030\ue038\ue030\ue039\ue03f\n\ue026\ue02e\ue034\ue030\ue039\ue02e\ue030\ue03e\ue004\ue000\ue02c\ue039", "mimetype": "text/plain", "start_char_idx": 19205, "end_char_idx": 19378, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4f69cb07-c9e9-418f-8855-174a293a8510": {"__data__": {"id_": "4f69cb07-c9e9-418f-8855-174a293a8510", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4679ab0c-0f7f-4433-9c1c-e71cd8acbeee", "node_type": "1", "metadata": {}, "hash": "132ccace1d527402346f286c831876471598be379f8f1e6e1dcd437d0fb78d68", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a4d6ac81-6820-4869-86e6-585be430da93", "node_type": "1", "metadata": {}, "hash": "7fc5626419201915b3910f56c0ec96176583fd8285394a14f91b01721fce4877", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue038\ue030\ue039\ue03f\n\ue026\ue02e\ue034\ue030\ue039\ue02e\ue030\ue03e\ue004\ue000\ue02c\ue039\ue02f\ue000\ue021\ue03e\ue000\ue026\ue033\ue030\ue037\ue037\ue030\ue044\ue000\ue022\ue034\ue042\ue02c\ue000\ue03a\ue031\ue000\ue02a\ue030\ue03e\ue03f\ue02c\ue03f\ue004\ue000\ue01d\ue039\ue02e\ue006\ue004\ue000\ue02d\ue03a\ue03f\ue033\ue000\ue03a\ue031\ue000\ue025\ue03a\ue02e\ue036\ue041\ue034\ue037\ue037\ue030\ue004\n\ue021\ue02c\ue03d\ue044\ue037\ue02c\ue039\ue02f\ue004\ue000\ue031\ue03a\ue03d\ue000\ue03f\ue033\ue030\ue034\ue03d\ue000\ue041\ue02c\ue037\ue040\ue02c\ue02d\ue037\ue030\ue000\ue02e\ue03a\ue038\ue03b\ue040\ue03f\ue030\ue03d\ue000\ue03e\ue040\ue03b\ue03b\ue03a\ue03d\ue03f\ue004\ue000\ue02c\ue039\ue02f\ue000\ue021\ue03e\ue000\ue017\ue02c\ue03d\ue03a\ue037\n\ue01c\ue02c\ue034\ue039\ue030\ue03e\ue000\ue03a\ue031\ue000\ue02a\ue030\ue03e\ue03f\ue02c\ue03f\ue004\ue000\ue01d\ue039\ue02e\ue006\ue000\ue031\ue03a\ue03d\ue000\ue03a\ue041\ue030\ue03d\ue03e\ue030\ue030\ue034\ue039\ue032\ue000\ue03f\ue033\ue030", "mimetype": "text/plain", "start_char_idx": 19361, "end_char_idx": 19533, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a4d6ac81-6820-4869-86e6-585be430da93": {"__data__": {"id_": "a4d6ac81-6820-4869-86e6-585be430da93", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4f69cb07-c9e9-418f-8855-174a293a8510", "node_type": "1", "metadata": {}, "hash": "7a810e0de5bc3cc9e4de56dbb8ee69677b6a9ee2c01ca7d030b81833963c433b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "855e6e98-7546-4d29-aea1-4ae0226f064b", "node_type": "1", "metadata": {}, "hash": "962d90b6f7128007a670352476111a051de74685f398e05c105db214a1adacd0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03d\ue000\ue03a\ue041\ue030\ue03d\ue03e\ue030\ue030\ue034\ue039\ue032\ue000\ue03f\ue033\ue030\ue000\ue02f\ue02c\ue03f\ue02c\ue000\ue02e\ue03a\ue037\ue037\ue030\ue02e\ue03f\ue034\ue03a\ue039\ue006\nREFERENCES\n\ue015\ue02f\ue02c\ue038\ue03e\ue000\ue02a\ue01b\ue004\ue000\ue018\ue030\ue02c\ue041\ue030\ue03d\ue000\ue01f\ue015\ue004\ue000\ue017\ue03a\ue02e\ue033\ue034\ue000\ue026\ue020\ue004\ue000\ue024\ue037\ue034\ue036\ue02c\ue044\ue03f\ue034\ue03e\ue000\ue016\ue018\ue004\ue000\ue02b\ue030\ue037\ue037\ue000\ue019\ue025\ue004\ue000\ue016\ue03d\ue03a\ue03a\ue038\ue030\ue000\ue017\ue029\ue000\ue02c\ue039\ue02f\ue000\ue02a\ue030\ue039\ue032\ue030\ue03d\n\ue01e\ue018\ue000\ue002\ue009\ue011\ue011\ue00b\ue003\ue000\ue018\ue030\ue02e\ue037\ue034\ue039\ue030\ue000\ue03a\ue031\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000Haemophilus influenzae", "mimetype": "text/plain", "start_char_idx": 19517, "end_char_idx": 19690, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "855e6e98-7546-4d29-aea1-4ae0226f064b": {"__data__": {"id_": "855e6e98-7546-4d29-aea1-4ae0226f064b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a4d6ac81-6820-4869-86e6-585be430da93", "node_type": "1", "metadata": {}, "hash": "7fc5626419201915b3910f56c0ec96176583fd8285394a14f91b01721fce4877", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f457cf3e-8a81-4f46-b10e-9fb9c001979a", "node_type": "1", "metadata": {}, "hash": "004aff287bf75a21d5b4752bb0f2fc6839788e3ccada93dad1665814e64fdb06", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue031\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000Haemophilus influenzae \ue03f\ue044\ue03b\ue030\ue000\ue02d\ue000\ue002\ue01c\ue034\ue02d\ue003\ue000\ue02f\ue034\ue03e\ue030\ue02c\ue03e\ue030\n\ue034\ue039\ue000\ue03f\ue033\ue030\ue000\ue01c\ue034\ue02d\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue030\ue03d\ue02c\ue006\ue000J Am Med Assoc 269\ue012\ue000\ue00a\ue00a\ue009\ue047\ue00a\ue00a\ue00e\n\ue015\ue02f\ue041\ue034\ue03e\ue03a\ue03d\ue044\ue000\ue017\ue03a\ue038\ue038\ue034\ue03f\ue03f\ue030\ue030\ue000\ue03a\ue039\ue000\ue01d\ue038\ue038\ue040\ue039\ue034\ue045\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue024\ue03d\ue02c\ue02e\ue03f\ue034\ue02e\ue030\ue03e\ue000\ue002\ue009\ue011\ue010\ue00d\ue003\ue000\ue024\ue03a\ue037\ue044\ue03e\ue02c\ue02e\ue02e\ue033\ue02c\ue03d\ue034\ue02f\ue030\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue000\ue031\ue03a\ue03d\n\ue03b\ue03d\ue030\ue041\ue030\ue039\ue03f\ue034\ue03a\ue039\ue000\ue03a\ue031\ue000Haemophilus influenzae", "mimetype": "text/plain", "start_char_idx": 19656, "end_char_idx": 19879, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f457cf3e-8a81-4f46-b10e-9fb9c001979a": {"__data__": {"id_": "f457cf3e-8a81-4f46-b10e-9fb9c001979a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "855e6e98-7546-4d29-aea1-4ae0226f064b", "node_type": "1", "metadata": {}, "hash": "962d90b6f7128007a670352476111a051de74685f398e05c105db214a1adacd0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "739a05d3-b0a3-43f8-b057-521aa40e78cc", "node_type": "1", "metadata": {}, "hash": "5d247eaf3b5d4238ad4e1904261ab55cbce5a6a0eb182a797ae874984ccdf579", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "influenzae \ue03f\ue044\ue03b\ue030\ue000\ue02d\ue000\ue02f\ue034\ue03e\ue030\ue02c\ue03e\ue030\ue006\ue000Morbid Mortal Weekly\nReport 34\ue012\ue000\ue00a\ue008\ue009\ue047\ue00a\ue008\ue00d\n\ue015\ue02f\ue041\ue034\ue03e\ue03a\ue03d\ue044\ue000\ue017\ue03a\ue038\ue038\ue034\ue03f\ue03f\ue030\ue030\ue000\ue03a\ue039\ue000\ue01d\ue038\ue038\ue040\ue039\ue034\ue045\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue024\ue03d\ue02c\ue02e\ue03f\ue034\ue02e\ue030\ue03e\ue000\ue002\ue009\ue011\ue010\ue010\ue003\ue000\ue028\ue03b\ue02f\ue02c\ue03f\ue030\ue012\ue000\ue024\ue03d\ue030\ue041\ue030\ue039\ue03f\ue034\ue03a\ue039\ue000\ue03a\ue031\nHaemophilus influenzae \ue03f\ue044\ue03b\ue030\ue000\ue02d\ue000\ue02f\ue034\ue03e\ue030\ue02c\ue03e\ue030\ue006\ue000Morbid Mortal Weekly Report", "mimetype": "text/plain", "start_char_idx": 19869, "end_char_idx": 20076, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "739a05d3-b0a3-43f8-b057-521aa40e78cc": {"__data__": {"id_": "739a05d3-b0a3-43f8-b057-521aa40e78cc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f457cf3e-8a81-4f46-b10e-9fb9c001979a", "node_type": "1", "metadata": {}, "hash": "004aff287bf75a21d5b4752bb0f2fc6839788e3ccada93dad1665814e64fdb06", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9f4e8cc0-94ee-463e-997d-832bff087d39", "node_type": "1", "metadata": {}, "hash": "27f9847d44fb7c8e2f7e0e96c7764806e7f629d9db598da0a6b0fca937c43407", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Mortal Weekly Report 37\ue012\n\ue009\ue00b\ue047\ue009\ue00e\n\ue015\ue02f\ue041\ue034\ue03e\ue03a\ue03d\ue044\ue000\ue017\ue03a\ue038\ue038\ue034\ue03f\ue03f\ue030\ue030\ue000\ue03a\ue039\ue000\ue01d\ue038\ue038\ue040\ue039\ue034\ue045\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue024\ue03d\ue02c\ue02e\ue03f\ue034\ue02e\ue030\ue03e\ue000\ue002\ue009\ue011\ue011\ue009\ue003\ue000Haemophilus \ue02d\ue000\ue02e\ue03a\ue039\ue035\ue040\ue032\ue02c\ue03f\ue030\n\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue000\ue031\ue03a\ue03d\ue000\ue03b\ue03d\ue030\ue041\ue030\ue039\ue03f\ue034\ue03a\ue039\ue000\ue03a\ue031\ue000Haemophilus influenzae", "mimetype": "text/plain", "start_char_idx": 20056, "end_char_idx": 20212, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9f4e8cc0-94ee-463e-997d-832bff087d39": {"__data__": {"id_": "9f4e8cc0-94ee-463e-997d-832bff087d39", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "739a05d3-b0a3-43f8-b057-521aa40e78cc", "node_type": "1", "metadata": {}, "hash": "5d247eaf3b5d4238ad4e1904261ab55cbce5a6a0eb182a797ae874984ccdf579", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8931d05f-246c-4154-995b-07b0a6f271e8", "node_type": "1", "metadata": {}, "hash": "d19ccf4466d4fd14350b93f6ad6bd9a8742264d51654af92d0001d95904b588a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "influenzae \ue03f\ue044\ue03b\ue030\ue000\ue02d\ue000\ue02f\ue034\ue03e\ue030\ue02c\ue03e\ue030\ue000\ue02c\ue038\ue03a\ue039\ue032\n\ue034\ue039\ue031\ue02c\ue039\ue03f\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue02e\ue033\ue034\ue037\ue02f\ue03d\ue030\ue039\ue000\ue03f\ue042\ue03a\ue000\ue038\ue03a\ue039\ue03f\ue033\ue03e\ue000\ue03a\ue031\ue000\ue02c\ue032\ue030\ue000\ue02c\ue039\ue02f\ue000\ue03a\ue037\ue02f\ue030\ue03d\ue006\ue000Morbid Mortal Weekly\nReport 40 (RR-1)\ue012\ue000\ue009\ue047\ue00f\n\ue016\ue03d\ue030\ue03e\ue037\ue03a\ue042\ue000\ue022\ue019\ue000\ue02c\ue039\ue02f\ue000\ue018\ue02c\ue044\ue000\ue022\ue019\ue000\ue002\ue009\ue011\ue010\ue008\ue003\ue000Statistical Methods in Cancer Research. Vol. I. The\nAnalysis of Case-Control Studies\ue004\ue000\ue03b\ue03b\ue006\ue000\ue009\ue00a\ue00a\ue047\ue00a\ue00f\ue011\ue006\ue000\ue002\ue01d\ue015\ue025\ue017\ue000\ue026\ue02e\ue034\ue030\ue039\ue03f\ue034\ue031\ue034\ue02e\ue000\ue024\ue040\ue02d\ue037\ue034\ue02e\ue02c\ue03f\ue034\ue03a\ue039\n\ue022\ue03a\ue006\ue000\ue00b\ue00a\ue006\ue003", "mimetype": "text/plain", "start_char_idx": 20202, "end_char_idx": 20492, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8931d05f-246c-4154-995b-07b0a6f271e8": {"__data__": {"id_": "8931d05f-246c-4154-995b-07b0a6f271e8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9f4e8cc0-94ee-463e-997d-832bff087d39", "node_type": "1", "metadata": {}, "hash": "27f9847d44fb7c8e2f7e0e96c7764806e7f629d9db598da0a6b0fca937c43407", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2b89af34-1ed7-4326-a5b0-5bb153ea520f", "node_type": "1", "metadata": {}, "hash": "4e5da79d4cab4637f01fffcd8a7c01fbfb07582424d6b568d9348cd4fa90cf06", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue037\ue034\ue02e\ue02c\ue03f\ue034\ue03a\ue039\n\ue022\ue03a\ue006\ue000\ue00b\ue00a\ue006\ue003\ue000\ue01d\ue039\ue03f\ue030\ue03d\ue039\ue02c\ue03f\ue034\ue03a\ue039\ue02c\ue037\ue000\ue015\ue032\ue030\ue039\ue02e\ue044\ue000\ue031\ue03a\ue03d\ue000\ue025\ue030\ue03e\ue030\ue02c\ue03d\ue02e\ue033\ue000\ue03a\ue039\ue000\ue017\ue02c\ue039\ue02e\ue030\ue03d\ue012\ue000\ue020\ue044\ue03a\ue039\ue004\ue000\ue01a\ue03d\ue02c\ue039\ue02e\ue030\n\ue017\ue03a\ue02e\ue033\ue034\ue000\ue026\ue020\ue004\ue000\ue01a\ue037\ue030\ue038\ue034\ue039\ue032\ue000\ue018\ue02a\ue004\ue000\ue01c\ue034\ue032\ue033\ue03f\ue03a\ue042\ue030\ue03d\ue000\ue015\ue02a\ue004\ue000\ue020\ue034\ue038\ue03b\ue02c\ue036\ue02c\ue03d\ue039\ue035\ue02c\ue039\ue02c\ue03d\ue02c\ue03f\ue000\ue01f\ue004\ue000\ue01a\ue02c\ue02e\ue036\ue037\ue02c\ue038\ue000\ue025\ue025\ue004\ue000\ue026\ue038\ue034\ue03f\ue033\n\ue01e\ue018\ue004\ue000\ue026\ue034\ue036\ue030\ue03e\ue000\ue025\ue025\ue000\ue02c\ue039\ue02f\ue000\ue016\ue03d\ue03a\ue03a\ue038", "mimetype": "text/plain", "start_char_idx": 20475, "end_char_idx": 20647, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2b89af34-1ed7-4326-a5b0-5bb153ea520f": {"__data__": {"id_": "2b89af34-1ed7-4326-a5b0-5bb153ea520f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8931d05f-246c-4154-995b-07b0a6f271e8", "node_type": "1", "metadata": {}, "hash": "d19ccf4466d4fd14350b93f6ad6bd9a8742264d51654af92d0001d95904b588a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c4765ca3-a839-4fa9-bc35-3c01b9cc3073", "node_type": "1", "metadata": {}, "hash": "f934b6c654a187763ab0fab5d4dd49d0c1a9aa029748bab7fe6e4fdb4781ad79", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue036\ue030\ue03e\ue000\ue025\ue025\ue000\ue02c\ue039\ue02f\ue000\ue016\ue03d\ue03a\ue03a\ue038\ue030\ue000\ue017\ue029\ue000\ue002\ue009\ue011\ue010\ue00e\ue003\ue000\ue024\ue03d\ue034\ue038\ue02c\ue03d\ue044\ue000\ue034\ue039\ue041\ue02c\ue03e\ue034\ue041\ue030\ue000Haemophilus\ninfluenzae \ue03f\ue044\ue03b\ue030\ue000\ue02d\ue000\ue02f\ue034\ue03e\ue030\ue02c\ue03e\ue030\ue012\ue000\ue02c\ue000\ue03b\ue03a\ue03b\ue040\ue037\ue02c\ue03f\ue034\ue03a\ue039\ue005\ue02d\ue02c\ue03e\ue030\ue02f\ue000\ue02c\ue03e\ue03e\ue030\ue03e\ue03e\ue038\ue030\ue039\ue03f\ue000\ue03a\ue031\ue000\ue03d\ue034\ue03e\ue036\ue000\ue031\ue02c\ue02e\ue03f\ue03a\ue03d\ue03e\ue006\nJ Pediatr", "mimetype": "text/plain", "start_char_idx": 20631, "end_char_idx": 20771, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c4765ca3-a839-4fa9-bc35-3c01b9cc3073": {"__data__": {"id_": "c4765ca3-a839-4fa9-bc35-3c01b9cc3073", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2b89af34-1ed7-4326-a5b0-5bb153ea520f", "node_type": "1", "metadata": {}, "hash": "4e5da79d4cab4637f01fffcd8a7c01fbfb07582424d6b568d9348cd4fa90cf06", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4cbf9ac3-ab48-4165-a89d-c7555b4e7446", "node_type": "1", "metadata": {}, "hash": "344204b70d7a6e4d9db929c8c24fd247f2f5ac4633762fc93a0be6ac297bcbd9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Pediatr 108\ue012\ue000\ue010\ue010\ue00f\ue047\ue010\ue011\ue00e\n\ue01d\ue039\ue039\ue034\ue03e\ue000\ue021\ue018\ue000\ue002\ue009\ue011\ue00e\ue00d\ue003\ue000\ue01d\ue038\ue038\ue040\ue039\ue034\ue03e\ue02c\ue03f\ue034\ue03a\ue039\ue000\ue02c\ue039\ue02f\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034\ue02c\ue006\ue000Lancet", "mimetype": "text/plain", "start_char_idx": 20764, "end_char_idx": 20845, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4cbf9ac3-ab48-4165-a89d-c7555b4e7446": {"__data__": {"id_": "4cbf9ac3-ab48-4165-a89d-c7555b4e7446", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c4765ca3-a839-4fa9-bc35-3c01b9cc3073", "node_type": "1", "metadata": {}, "hash": "f934b6c654a187763ab0fab5d4dd49d0c1a9aa029748bab7fe6e4fdb4781ad79", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "79843dae-a6d9-4690-878f-cbdef63af7a1", "node_type": "1", "metadata": {}, "hash": "b72763258ec5edabb4ac4889496da0b3451838c599e784b576b0a01350298727", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1\ue012\ue000\ue00e\ue008\ue00d\n\ue01d\ue03e\ue03f\ue03d\ue030\ue000\ue01b\ue025\ue004\ue000\ue017\ue03a\ue039\ue039\ue030\ue03d\ue000\ue01e\ue026\ue004\ue000\ue016\ue03d\ue03a\ue03a\ue038\ue030\ue000\ue017\ue029\ue004\ue000\ue01c\ue034\ue032\ue033\ue03f\ue03a\ue042\ue030\ue03d\ue000\ue015\ue004\ue000\ue02c\ue039\ue02f\ue000\ue01c\ue03a\ue03b\ue036\ue034\ue039\ue03e\ue000\ue025\ue026\ue000\ue002\ue009\ue011\ue010\ue00d\ue003\ue000\ue025\ue034\ue03e\ue036\ue000\ue031\ue02c\ue02e\ue03f\ue03a\ue03d\ue03e\n\ue031\ue03a\ue03d\ue000\ue03b\ue03d\ue034\ue038\ue02c\ue03d\ue044\ue000\ue034\ue039\ue041\ue02c\ue03e\ue034\ue041\ue030\ue000Haemophilus influenzae", "mimetype": "text/plain", "start_char_idx": 20846, "end_char_idx": 20976, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "79843dae-a6d9-4690-878f-cbdef63af7a1": {"__data__": {"id_": "79843dae-a6d9-4690-878f-cbdef63af7a1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4cbf9ac3-ab48-4165-a89d-c7555b4e7446", "node_type": "1", "metadata": {}, "hash": "344204b70d7a6e4d9db929c8c24fd247f2f5ac4633762fc93a0be6ac297bcbd9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bc3c35e5-2890-4602-ba07-65dd2f9ccb0d", "node_type": "1", "metadata": {}, "hash": "9fddffc392a79bc5feb4cea94fcfbdcf60a388029b4e39c4508fa06c5c472120", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "influenzae \ue02f\ue034\ue03e\ue030\ue02c\ue03e\ue030\ue012\ue000\ue034\ue039\ue02e\ue03d\ue030\ue02c\ue03e\ue030\ue02f\ue000\ue03d\ue034\ue03e\ue036\ue000\ue031\ue03d\ue03a\ue038\ue000\ue02f\ue02c\ue044\ue005\n\ue02e\ue02c\ue03d\ue030\ue000\ue02c\ue03f\ue03f\ue030\ue039\ue02f\ue02c\ue039\ue02e\ue030\ue000\ue02c\ue039\ue02f\ue000\ue03e\ue02e\ue033\ue03a\ue03a\ue037\ue005\ue02c\ue032\ue030\ue02f\ue000\ue033\ue03a\ue040\ue03e\ue030\ue033\ue03a\ue037\ue02f\ue000\ue038\ue030\ue038\ue02d\ue030\ue03d\ue03e\ue006\ue000J Pediatr 106\ue012\ue000\ue009\ue011\ue008\ue047\ue009\ue011\ue00d\n\ue01f\ue02c\ue02c\ue03f\ue03e\ue02e\ue033\ue000\ue024\ue004\ue000\ue01f\ue02c\ue037\ue030\ue03f\ue03e\ue02e\ue033\ue000\ue028\ue004\ue000\ue01f\ue03d\ue040\ue038\ue038\ue030\ue039\ue02c\ue040\ue030\ue03d\ue000\ue01a\ue004\ue000\ue021\ue030\ue034\ue039\ue030\ue03d\ue03f\ue000\ue025\ue004\ue000\ue021\ue034\ue030\ue03e\ue039\ue030\ue03d\ue000\ue015\ue004\ue000\ue01c\ue02c\ue02c\ue031\ue000\ue01b\ue000\ue02c\ue039\ue02f\n\ue021\ue034\ue02e", "mimetype": "text/plain", "start_char_idx": 20966, "end_char_idx": 21159, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bc3c35e5-2890-4602-ba07-65dd2f9ccb0d": {"__data__": {"id_": "bc3c35e5-2890-4602-ba07-65dd2f9ccb0d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "79843dae-a6d9-4690-878f-cbdef63af7a1", "node_type": "1", "metadata": {}, "hash": "b72763258ec5edabb4ac4889496da0b3451838c599e784b576b0a01350298727", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "26d1b488-9f6d-4c8a-ad1e-9f06fa3840ae", "node_type": "1", "metadata": {}, "hash": "9560892796321667a1af1f7f43c998cdd0229c9fbc11d9fd44f53e1037a14702", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue015\ue004\ue000\ue01c\ue02c\ue02c\ue031\ue000\ue01b\ue000\ue02c\ue039\ue02f\n\ue021\ue034\ue02e\ue033\ue02c\ue030\ue037\ue034\ue03e\ue000\ue01e\ue000\ue002\ue009\ue011\ue011\ue00e\ue003\ue000\ue017\ue02c\ue03e\ue030\ue005\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue03a\ue039\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000\ue037\ue030\ue040\ue036\ue030\ue038\ue034\ue02c\ue000\ue034\ue039\ue000\ue020\ue03a\ue042\ue030\ue03d\n\ue026\ue02c\ue043\ue03a\ue039\ue044\ue004\ue000\ue01b\ue030\ue03d\ue038\ue02c\ue039\ue044\ue006\ue000\ue016\ue02c\ue03e\ue034\ue02e\ue000\ue02e\ue03a\ue039\ue03e\ue034\ue02f\ue030\ue03d\ue02c\ue03f\ue034\ue03a\ue039\ue03e\ue004\ue000\ue038\ue030\ue03f\ue033\ue03a\ue02f\ue03a\ue037\ue03a\ue032\ue044\ue004\ue000\ue02c\ue039\ue02f\ue000\ue03e\ue040\ue038\ue038\ue02c\ue03d\ue044\ue000\ue03a\ue031\ue000\ue03d\ue030\ue03e\ue040\ue037\ue03f\ue03e\ue006\nKlin Padiatr 208\ue012\ue000\ue009\ue00f\ue011\ue047\ue009\ue010\ue00d", "mimetype": "text/plain", "start_char_idx": 21142, "end_char_idx": 21326, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "26d1b488-9f6d-4c8a-ad1e-9f06fa3840ae": {"__data__": {"id_": "26d1b488-9f6d-4c8a-ad1e-9f06fa3840ae", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bc3c35e5-2890-4602-ba07-65dd2f9ccb0d", "node_type": "1", "metadata": {}, "hash": "9fddffc392a79bc5feb4cea94fcfbdcf60a388029b4e39c4508fa06c5c472120", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "907bf31d-0687-424d-b131-0dfc3bfd325d", "node_type": "1", "metadata": {}, "hash": "0ea8cb5d7817e535afd015047b22d09de4075c811d57fb83fa38ff1b7e18298a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue03f\ue03e\ue006\nKlin Padiatr 208\ue012\ue000\ue009\ue00f\ue011\ue047\ue009\ue010\ue00d\n\ue01f\ue037\ue030\ue034\ue039\ue030\ue03d\ue038\ue02c\ue039\ue000\ue025\ue015\ue004\ue000\ue020\ue034\ue039\ue030\ue03f\ue000\ue021\ue026\ue004\ue000\ue01c\ue02c\ue03f\ue02e\ue033\ue000\ue019\ue019\ue004\ue000\ue02a\ue02c\ue02e\ue033\ue03a\ue037\ue02f\ue030\ue03d\ue000\ue026\ue004\ue000\ue027\ue02c\ue03d\ue03a\ue039\ue030\ue000\ue025\ue019\ue004\ue000\ue026\ue030\ue041\ue030\ue03d\ue03e\ue03a\ue039\ue000\ue025\ue01f\ue004\n\ue01f\ue02c\ue040\ue039\ue030\ue000\ue02a\ue027\ue004\ue000\ue01a\ue03d\ue034\ue030\ue02f\ue038\ue02c\ue039\ue000\ue018\ue025\ue004\ue000\ue01c\ue02c\ue034\ue039\ue030\ue03e\ue000\ue017\ue021\ue004\ue000\ue021\ue040\ue034\ue03d\ue033\ue030\ue02c\ue02f\ue000\ue017\ue025\ue004\ue000\ue016\ue03a\ue034\ue02e\ue030\ue000\ue01e\ue018\ue000\ue02c\ue039\ue02f\ue000\ue025\ue03a\ue02d\ue034\ue03e\ue03a\ue039\n\ue020\ue020\ue000\ue002\ue009\ue011\ue011\ue00f\ue003\ue000\ue021\ue02c\ue032\ue039\ue030", "mimetype": "text/plain", "start_char_idx": 21297, "end_char_idx": 21482, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "907bf31d-0687-424d-b131-0dfc3bfd325d": {"__data__": {"id_": "907bf31d-0687-424d-b131-0dfc3bfd325d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "26d1b488-9f6d-4c8a-ad1e-9f06fa3840ae", "node_type": "1", "metadata": {}, "hash": "9560892796321667a1af1f7f43c998cdd0229c9fbc11d9fd44f53e1037a14702", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3c57c996-8a6d-4fa5-9843-9afcb13f6374", "node_type": "1", "metadata": {}, "hash": "a0a8e76c88240f8eda4e095e42561620c85887b6a5d987ada9446ccd48086535", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue039\n\ue020\ue020\ue000\ue002\ue009\ue011\ue011\ue00f\ue003\ue000\ue021\ue02c\ue032\ue039\ue030\ue03f\ue034\ue02e\ue000\ue031\ue034\ue030\ue037\ue02f\ue000\ue030\ue043\ue03b\ue03a\ue03e\ue040\ue03d\ue030\ue000\ue02c\ue03e\ue03e\ue030\ue03e\ue03e\ue038\ue030\ue039\ue03f\ue000\ue034\ue039\ue000\ue02c\ue000\ue02e\ue02c\ue03e\ue030\ue005\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue03a\ue031\n\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000\ue037\ue030\ue040\ue036\ue030\ue038\ue034\ue02c\ue006\ue000Epidemiology", "mimetype": "text/plain", "start_char_idx": 21465, "end_char_idx": 21571, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3c57c996-8a6d-4fa5-9843-9afcb13f6374": {"__data__": {"id_": "3c57c996-8a6d-4fa5-9843-9afcb13f6374", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "907bf31d-0687-424d-b131-0dfc3bfd325d", "node_type": "1", "metadata": {}, "hash": "0ea8cb5d7817e535afd015047b22d09de4075c811d57fb83fa38ff1b7e18298a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "379fcc76-0a1d-47cc-9a41-7b78c2c9b20d", "node_type": "1", "metadata": {}, "hash": "c6b8ac8af853f37a49187dce5e389b33a8a82422fcf6d153c23e2d5a04e88688", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue02f\ue000\ue037\ue030\ue040\ue036\ue030\ue038\ue034\ue02c\ue006\ue000Epidemiology 8\ue012\ue000\ue00d\ue00f\ue00d\ue047\ue00d\ue010\ue00b\n\ue01f\ue039\ue030\ue02c\ue037\ue030\ue000\ue01b\ue02a\ue004\ue000\ue026\ue03f\ue030\ue042\ue02c\ue03d\ue03f\ue000\ue015\ue000\ue02c\ue039\ue02f\ue000\ue01f\ue034\ue039\ue039\ue034\ue030\ue03d\ue000\ue02a\ue034\ue037\ue03e\ue03a\ue039\ue000\ue020\ue021\ue000\ue002\ue009\ue011\ue010\ue00e\ue003\ue000\ue01d\ue038\ue038\ue040\ue039\ue034\ue045\ue02c\ue03f\ue034\ue03a\ue039\ue03e\ue000\ue02c\ue032\ue02c\ue034\ue039\ue03e\ue03f\n\ue034\ue039\ue031\ue030\ue02e\ue03f\ue034\ue03a\ue040\ue03e\ue000\ue02f\ue034\ue03e\ue030\ue02c\ue03e\ue030\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000\ue02e\ue02c\ue039\ue02e\ue030\ue03d\ue03e\ue006\ue000Cancer Immunol Immunother 21\ue012\n\ue009\ue00a\ue011\ue047\ue009\ue00b\ue00a\n\ue021\ue02e\ue01f\ue034\ue039\ue039\ue030\ue044\ue000\ue024\ue015\ue004\ue000\ue017\ue02c\ue03d\ue03f\ue042", "mimetype": "text/plain", "start_char_idx": 21547, "end_char_idx": 21754, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "379fcc76-0a1d-47cc-9a41-7b78c2c9b20d": {"__data__": {"id_": "379fcc76-0a1d-47cc-9a41-7b78c2c9b20d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3c57c996-8a6d-4fa5-9843-9afcb13f6374", "node_type": "1", "metadata": {}, "hash": "a0a8e76c88240f8eda4e095e42561620c85887b6a5d987ada9446ccd48086535", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "61746eeb-1ef3-44d7-aa88-8eb557b8be36", "node_type": "1", "metadata": {}, "hash": "568536eece412f71af2d58c2eeec145f0d0da80ae2465a00f24e4e0f1a64d352", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue01f\ue034\ue039\ue039\ue030\ue044\ue000\ue024\ue015\ue004\ue000\ue017\ue02c\ue03d\ue03f\ue042\ue03d\ue034\ue032\ue033\ue03f\ue000\ue025\ue015\ue004\ue000\ue026\ue02c\ue034\ue040\ue000\ue01e\ue021\ue027\ue004\ue000\ue026\ue03f\ue034\ue037\ue037\ue030\ue03d\ue000\ue017\ue015\ue004\ue000\ue018\ue03d\ue02c\ue03b\ue030\ue03d\ue000\ue01b\ue01e\ue004\ue000\ue01c\ue02c\ue03d\ue03f\ue037\ue030\ue044\ue000\ue015\ue020\ue004\n\ue01c\ue03a\ue03b\ue03f\ue03a\ue039\ue000\ue024\ue015\ue004\ue000\ue016\ue034\ue03d\ue02e\ue033\ue000\ue01e\ue021\ue004\ue000\ue02a\ue02c\ue03f\ue030\ue03d\ue033\ue03a\ue040\ue03e\ue030\ue000\ue01e\ue015\ue01c\ue000\ue02c\ue039\ue02f\ue000\ue01e\ue03a\ue033\ue039\ue03e\ue03f\ue03a\ue039\ue000\ue01c\ue019\ue000\ue002\ue009\ue011\ue010\ue00f\ue003\ue000\ue027\ue033\ue030\ue000\ue034\ue039\ue03f\ue030\ue03d\ue005\n\ue03d\ue030\ue032\ue034\ue03a\ue039\ue02c\ue037\ue000\ue030\ue03b\ue034\ue02f\ue030\ue038\ue034\ue03a\ue037\ue03a\ue032\ue034\ue02e\ue02c\ue037\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000", "mimetype": "text/plain", "start_char_idx": 21738, "end_char_idx": 21910, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "61746eeb-1ef3-44d7-aa88-8eb557b8be36": {"__data__": {"id_": "61746eeb-1ef3-44d7-aa88-8eb557b8be36", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "379fcc76-0a1d-47cc-9a41-7b78c2c9b20d", "node_type": "1", "metadata": {}, "hash": "c6b8ac8af853f37a49187dce5e389b33a8a82422fcf6d153c23e2d5a04e88688", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c9bc4260-2e24-459b-a18d-3d45eb6543bc", "node_type": "1", "metadata": {}, "hash": "b3158cfd2097980ce39b8aa52860ecdce2d5978cb1c2d60c2f76b70f656bb766", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue034\ue03a\ue037\ue03a\ue032\ue034\ue02e\ue02c\ue037\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue03a\ue031\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000\ue02e\ue02c\ue039\ue02e\ue030\ue03d\ue000\ue002\ue01d\ue025\ue019\ue026\ue017\ue017\ue003\ue012\ue000\ue02c\ue000\ue02e\ue02c\ue03e\ue030\ue005\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\n\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue03a\ue031\ue000\ue02c\ue030\ue03f\ue034\ue03a\ue037\ue03a\ue032\ue034\ue02e\ue02c\ue037\ue000\ue031\ue02c\ue02e\ue03f\ue03a\ue03d\ue03e\ue000\ue034\ue039\ue000\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034\ue02c\ue000\ue02c\ue039\ue02f\ue000\ue037\ue044\ue038\ue03b\ue033\ue03a\ue038\ue02c\ue006\ue000Arch Dis Child", "mimetype": "text/plain", "start_char_idx": 21894, "end_char_idx": 22026, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c9bc4260-2e24-459b-a18d-3d45eb6543bc": {"__data__": {"id_": "c9bc4260-2e24-459b-a18d-3d45eb6543bc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "61746eeb-1ef3-44d7-aa88-8eb557b8be36", "node_type": "1", "metadata": {}, "hash": "568536eece412f71af2d58c2eeec145f0d0da80ae2465a00f24e4e0f1a64d352", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "410f96a7-7217-4e15-b144-0f420b7dc1d1", "node_type": "1", "metadata": {}, "hash": "d2e8521b9cf08a00883a04bdeb26d25aa302d2109d278d8d17edd7daba8b8c00", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue02c\ue039\ue02f\ue000\ue037\ue044\ue038\ue03b\ue033\ue03a\ue038\ue02c\ue006\ue000Arch Dis Child 62\ue012\n\ue00a\ue00f\ue011\ue047\ue00a\ue010\ue00f\n\ue022\ue034\ue03e\ue033\ue034\ue000\ue021\ue000\ue02c\ue039\ue02f\ue000\ue021\ue034\ue044\ue02c\ue036\ue030\ue000\ue01c\ue000\ue002\ue009\ue011\ue010\ue011\ue003\ue000\ue015\ue000\ue02e\ue02c\ue03e\ue030\ue005\ue02e\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue03a\ue031\ue000\ue039\ue03a\ue039\ue005\ue027\ue005\ue02e\ue030\ue037\ue037\ue000\ue02c\ue02e\ue040\ue03f\ue030\n\ue037\ue044\ue038\ue03b\ue033\ue03a\ue02d\ue037\ue02c\ue03e\ue03f\ue034\ue02e\ue000\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034\ue02c\ue000\ue03a\ue031\ue000\ue02e\ue033\ue034\ue037\ue02f\ue03d\ue030\ue039\ue000\ue034\ue039\ue000\ue01c\ue03a\ue036\ue036\ue02c\ue034\ue02f\ue03a\ue004\ue000\ue01e\ue02c\ue03b\ue02c\ue039\ue006\ue000J Epidemiol Commun\nHealth 43\ue012\ue000\ue00b\ue00d\ue00a\ue047\ue00b\ue00d\ue00d\n\ue024\ue030\ue03f\ue03d\ue034\ue02f\ue03a\ue040", "mimetype": "text/plain", "start_char_idx": 21998, "end_char_idx": 22210, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "410f96a7-7217-4e15-b144-0f420b7dc1d1": {"__data__": {"id_": "410f96a7-7217-4e15-b144-0f420b7dc1d1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c9bc4260-2e24-459b-a18d-3d45eb6543bc", "node_type": "1", "metadata": {}, "hash": "b3158cfd2097980ce39b8aa52860ecdce2d5978cb1c2d60c2f76b70f656bb766", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "caceb118-5164-46bd-9853-69c59f6d4f89", "node_type": "1", "metadata": {}, "hash": "682b6a46032bd4483b5891e8e6be7a7788a07c8e6ef3b1f7ffd7015f73b7e34d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue000\ue00b\ue00d\ue00a\ue047\ue00b\ue00d\ue00d\n\ue024\ue030\ue03f\ue03d\ue034\ue02f\ue03a\ue040\ue000\ue019\ue004\ue000\ue01f\ue02c\ue03e\ue03e\ue034\ue038\ue03a\ue03e\ue000\ue018\ue004\ue000\ue01f\ue02c\ue037\ue038\ue02c\ue039\ue03f\ue034\ue000\ue021\ue004\ue000\ue01f\ue03a\ue03e\ue038\ue034\ue02f\ue034\ue03e\ue000\ue01c\ue004\ue000\ue01c\ue02c\ue034\ue02f\ue02c\ue03e\ue000\ue026\ue004\ue000\ue01a\ue037\ue044\ue03f\ue045\ue02c\ue039\ue034\ue000\ue029\ue004\ue000\ue027\ue03a\ue039\ue032\ue000\ue018\n\ue02c\ue039\ue02f\ue000\ue027\ue03d\ue034\ue02e\ue033\ue03a\ue03b\ue03a\ue040\ue037\ue03a\ue03e\ue000\ue018\ue000\ue002\ue009\ue011\ue011\ue00b\ue003\ue000\ue015\ue032\ue030\ue000\ue03a\ue031\ue000\ue030\ue043\ue03b\ue03a\ue03e\ue040\ue03d\ue030\ue000\ue03f\ue03a\ue000\ue034\ue039\ue031\ue030\ue02e\ue03f\ue034\ue03a\ue039\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue03d\ue034\ue03e\ue036\ue000\ue03a\ue031\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\n\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034", "mimetype": "text/plain", "start_char_idx": 22193, "end_char_idx": 22365, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "caceb118-5164-46bd-9853-69c59f6d4f89": {"__data__": {"id_": "caceb118-5164-46bd-9853-69c59f6d4f89", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "410f96a7-7217-4e15-b144-0f420b7dc1d1", "node_type": "1", "metadata": {}, "hash": "d2e8521b9cf08a00883a04bdeb26d25aa302d2109d278d8d17edd7daba8b8c00", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "428f765c-c8a7-46e9-bc59-ed5686dabc78", "node_type": "1", "metadata": {}, "hash": "76e11fa64c695cb4360d6c6d082e6edc846d7b53bcebde627e28d7ce0aeea8e6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\n\ue037\ue030\ue040\ue036\ue02c\ue030\ue038\ue034\ue02c\ue006\ue000Br Med J 301\ue012\ue000\ue00f\ue00f\ue00c\n\ue025\ue030\ue02f\ue038\ue03a\ue039\ue02f\ue000\ue026\ue025\ue000\ue02c\ue039\ue02f\ue000\ue024\ue034\ue02e\ue033\ue034\ue02e\ue033\ue030\ue03d\ue03a\ue000\ue021\ue019\ue000\ue002\ue009\ue011\ue010\ue00c\ue003\ue000Haemophilus influenzae \ue03f\ue044\ue03b\ue030\ue000\ue02d\ue000\ue02f\ue034\ue03e\ue030\ue02c\ue03e\ue030\ue012\ue000\ue02c\ue039\n\ue030\ue03b\ue034\ue02f\ue030\ue038\ue034\ue03a\ue037\ue03a\ue032\ue034\ue02e\ue000\ue03e\ue03f\ue040\ue02f\ue044\ue000\ue042\ue034\ue03f\ue033\ue000\ue03e\ue03b\ue030\ue02e\ue034\ue02c\ue037\ue000\ue03d\ue030\ue031\ue030\ue03d\ue030\ue039\ue02e\ue030\ue000\ue03f\ue03a\ue000\ue02f\ue02c\ue044\ue005\ue02e\ue02c\ue03d\ue030\ue000\ue02e\ue030\ue039\ue03f\ue030\ue03d\ue03e\ue006\ue000J Am Med\nAssoc", "mimetype": "text/plain", "start_char_idx": 22348, "end_char_idx": 22542, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "428f765c-c8a7-46e9-bc59-ed5686dabc78": {"__data__": {"id_": "428f765c-c8a7-46e9-bc59-ed5686dabc78", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "caceb118-5164-46bd-9853-69c59f6d4f89", "node_type": "1", "metadata": {}, "hash": "682b6a46032bd4483b5891e8e6be7a7788a07c8e6ef3b1f7ffd7015f73b7e34d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "63bdd867-91ce-4ba8-9fe5-f4f423eb72bf", "node_type": "1", "metadata": {}, "hash": "a649b3d5ca3a8c2a1238877a548c010bf144271971e8911fa28d15ed5a85ce2c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Am Med\nAssoc 252\ue012\ue000\ue00a\ue00d\ue010\ue009\ue047\ue00a\ue00d\ue010\ue00c\n\ue025\ue03a\ue02d\ue034\ue03e\ue03a\ue039\ue000\ue020\ue020\ue000\ue02c\ue039\ue02f\ue000\ue018\ue02c\ue034\ue032\ue037\ue030\ue000\ue015\ue000\ue002\ue009\ue011\ue010\ue00c\ue003\ue000\ue017\ue03a\ue039\ue03f\ue03d\ue03a\ue037\ue000\ue03e\ue030\ue037\ue030\ue02e\ue03f\ue034\ue03a\ue039\ue000\ue040\ue03e\ue034\ue039\ue032\ue000\ue03d\ue02c\ue039\ue02f\ue03a\ue038\ue000\ue02f\ue034\ue032\ue034\ue03f\ue000\ue02f\ue034\ue02c\ue037\ue034\ue039\ue032\ue000\ue031\ue03a\ue03d\n\ue02e\ue02c\ue03e\ue030\ue03e\ue000\ue03a\ue031\ue000\ue02e\ue033\ue034\ue037\ue02f\ue033\ue03a\ue03a\ue02f\ue000\ue02e\ue02c\ue039\ue02e\ue030\ue03d\ue006\ue000Am J Epidemiol", "mimetype": "text/plain", "start_char_idx": 22530, "end_char_idx": 22679, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "63bdd867-91ce-4ba8-9fe5-f4f423eb72bf": {"__data__": {"id_": "63bdd867-91ce-4ba8-9fe5-f4f423eb72bf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "428f765c-c8a7-46e9-bc59-ed5686dabc78", "node_type": "1", "metadata": {}, "hash": "76e11fa64c695cb4360d6c6d082e6edc846d7b53bcebde627e28d7ce0aeea8e6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1d9c56dd-2ca5-42eb-a625-8ad33037cb78", "node_type": "1", "metadata": {}, "hash": "557c1d226eb4b1e395f63aadb225daa2f49647f84249a59d28c62603fbd5a4e7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "J Epidemiol 120\ue012\ue000\ue009\ue00e\ue00c\ue047\ue009\ue00e\ue00e\n\ue02a\ue030\ue039\ue032\ue030\ue03d\ue000\ue01e\ue018\ue004\ue000\ue02a\ue02c\ue03d\ue02f\ue000\ue01e\ue01d\ue000\ue02c\ue039\ue02f\ue000\ue016\ue03d\ue03a\ue03a\ue038\ue030\ue000\ue017\ue029\ue000\ue002\ue009\ue011\ue010\ue011\ue003\ue000\ue024\ue03d\ue030\ue041\ue030\ue039\ue03f\ue034\ue03a\ue039\ue000\ue03a\ue031\ue000Haemophilus influenzae\n\ue03f\ue044\ue03b\ue030\ue000\ue02d\ue000\ue02f\ue034\ue03e\ue030\ue02c\ue03e\ue030\ue012\ue000\ue041\ue02c\ue02e\ue02e\ue034\ue039\ue030\ue03e\ue000\ue02c\ue039\ue02f\ue000\ue03b\ue02c\ue03e\ue03e\ue034\ue041\ue030\ue000\ue03b\ue03d\ue03a\ue03b\ue033\ue044\ue037\ue02c\ue043\ue034\ue03e\ue006\ue000\ue01d\ue039\ue012\ue000Current Clinical Topics in\nInfectious", "mimetype": "text/plain", "start_char_idx": 22668, "end_char_idx": 22861, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1d9c56dd-2ca5-42eb-a625-8ad33037cb78": {"__data__": {"id_": "1d9c56dd-2ca5-42eb-a625-8ad33037cb78", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Groves (1999).pdf", "node_type": "4", "metadata": {}, "hash": "0d3f222f962d560f4236282c07dcaed4f39b3237b0e4fed3fcdf2c4d860ed90d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "63bdd867-91ce-4ba8-9fe5-f4f423eb72bf", "node_type": "1", "metadata": {}, "hash": "a649b3d5ca3a8c2a1238877a548c010bf144271971e8911fa28d15ed5a85ce2c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Clinical Topics in\nInfectious Disease\ue004\ue000\ue025\ue030\ue038\ue034\ue039\ue032\ue03f\ue03a\ue039\ue000\ue01e\ue026\ue000\ue02c\ue039\ue02f\ue000\ue026\ue042\ue02c\ue03d\ue03f\ue045\ue000\ue021\ue022\ue000\ue002\ue030\ue02f\ue03e\ue003\ue004\ue000\ue03b\ue03b\ue006\ue000\ue00b\ue009\ue010\ue047\ue00b\ue00a\ue008\ue006\n\ue016\ue037\ue02c\ue02e\ue036\ue042\ue030\ue037\ue037\ue000\ue026\ue02e\ue034\ue030\ue039\ue03f\ue034\ue031\ue034\ue02e\ue000\ue024\ue040\ue02d\ue037\ue034\ue03e\ue033\ue030\ue03d\ue03e\ue012\ue000\ue016\ue03a\ue03e\ue03f\ue03a\ue039\n178\nFD Groves et al\nBritish Journal of Cancer (1999) 81(1), 175\u2013178\n\u00a9 Cancer Research Campaign 1999", "mimetype": "text/plain", "start_char_idx": 22832, "end_char_idx": 23057, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4dc7b960-9f02-4e4e-8f0e-0a09751433bf": {"__data__": {"id_": "4dc7b960-9f02-4e4e-8f0e-0a09751433bf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Jick (2010).pdf", "node_type": "4", "metadata": {}, "hash": "1ba0f8f67e59b95a29eca6a617be5f77c04ff9b23efa450938f4ce6fa6eddc00", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "790d36ab-193d-45b9-a34b-210f0552ade3", "node_type": "1", "metadata": {}, "hash": "20feca2dbb2ec6a041e33e663122b60bcecd750ba52a60a69b4a6fb3aca68a98", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine 28 (2010) 4588\u20134592\nContents lists available at ScienceDirect\nVaccine\njournal homepage: www.elsevier.com/locate/vaccine\nMeasles in the United Kingdom 1990\u20132008 and the effectiveness\nof measles vaccines\nHershel Jick \u2217, Katrina Wilcox Hagberg\nBoston Collaborative Drug Surveillance Program, Boston University School of Medicine, 11 Muzzey Street, Lexington, MA 02421, USA\na r t i c l e\ni n f o\nArticle history:\nReceived 30 June 2009\nReceived in revised form 12 April 2010\nAccepted 28 April 2010\nAvailable online 12 May 2010\nKeywords:\nMeasles\nMMR\nVaccination\na b s t r a c t\nWe identi\ufb01ed all children in the UK General Practice Research Database diagnosed with measles from\n1990 to 2008 and calculated annual incidence according to age and geographic region by dividing the\nnumber of cases per year by the number of children who were active in the population. We evaluated\nthe effectiveness of the measles vaccines by comparing the vaccination histories of children who were\ndiagnosed with measles (cases) to children who were not (controls). The annual incidence of measles fell\nafter the introduction of the MMR vaccine in late 1988. However, a modest outbreak of measles occurred\nin 1994, leading to large nationwide programs to immunize children. Since 1996, the incidence of measles\nhas fallen by more than 80%. Prior measles vaccination is highly effective and has substantially reduced\nthe risk of measles.\n\u00a9 2010 Elsevier Ltd. All rights reserved.\n1. Introduction\nFrom 1950 through 1968, the annual number of noti\ufb01ed cases\nof measles in the United Kingdom (UK) varied from about 100,000\nto 800,000 [1]. In 1968, routine immunization of children with one\ndose of a single measles vaccine was begun [1]. From 1968 to 1988\nthe number of noti\ufb01ed cases of measles rapidly fell to a level of\nabout 30,000 per year [1].", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1825, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "790d36ab-193d-45b9-a34b-210f0552ade3": {"__data__": {"id_": "790d36ab-193d-45b9-a34b-210f0552ade3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Jick (2010).pdf", "node_type": "4", "metadata": {}, "hash": "1ba0f8f67e59b95a29eca6a617be5f77c04ff9b23efa450938f4ce6fa6eddc00", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4dc7b960-9f02-4e4e-8f0e-0a09751433bf", "node_type": "1", "metadata": {}, "hash": "1db861282784e6af03cbf764ce77e5718b984b9eaa14d7d6b3aecdf6baefbac6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "91559628-532a-4c6c-873e-7d6f0d219255", "node_type": "1", "metadata": {}, "hash": "048096f84a81cff15d200c94cdff9f6c0a1910d9ce3e43c2833797d1f87b85ec", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "From 1968 to 1988\nthe number of noti\ufb01ed cases of measles rapidly fell to a level of\nabout 30,000 per year [1].\nIn October 1988, a comprehensive campaign of vaccination with\ncombined measles, mumps, and rubella (MMR) vaccine was initi-\nated, and in 1989 about 900,000 children age 12\u201335 months were\nvaccinated in the UK [2]. This campaign also provided MMR for\nover 800,000 children age 3\u20139 years [2]. Despite the early program\nof single measles vaccine, as well as the 1988 nationwide immu-\nnization with MMR, a modest outbreak of measles occurred in 1994\n[1,3,4]. This led to a supplemental program of immunization with a\nvaccine against measles-rubella (MR) [1,3,4], as well as MMR, even\nthough at that time the MMR vaccine was reported to be in short\nsupply [1,3].\nIn this paper we describe, in detail, the incidence of measles in\nthe UK and the effectiveness of the measles vaccines given prior to\nand after the 1994 measles outbreak.\n\u2217Corresponding author.\nE-mail address: hjick@bu.edu (H. Jick).\n2. Materials and methods\n2.1. Data source\nThe study was based on information derived from the General\nPractice Research Database (the Database), a large automated UK\nmedical record database. The source population for the study is\nsome 3 million people enrolled in about 350 general practices since\n1988. The size of the population is stable over time according to\nage, gender and general practice. The comprehensive nature of the\ninformation on clinical diagnoses and drug exposure recorded in\nthis subset of the Database have been repeatedly validated and\nfound to be of high quality for the purpose of conducting epi-\ndemiologic research [2,5\u20138]. The general practitioners (GPs), who\ncontribute data to the Database use of\ufb01ce computers in their rou-\ntine practice, agreed to provide the data for research purposes,\nand have been trained to record medical information including\ndemographic data, medical diagnoses, details of hospital stays, and\ndeaths, in a standard, anonymous format. The GPs routinely record\nthe administration of vaccines.", "mimetype": "text/plain", "start_char_idx": 1715, "end_char_idx": 3761, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "91559628-532a-4c6c-873e-7d6f0d219255": {"__data__": {"id_": "91559628-532a-4c6c-873e-7d6f0d219255", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Jick (2010).pdf", "node_type": "4", "metadata": {}, "hash": "1ba0f8f67e59b95a29eca6a617be5f77c04ff9b23efa450938f4ce6fa6eddc00", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "790d36ab-193d-45b9-a34b-210f0552ade3", "node_type": "1", "metadata": {}, "hash": "20feca2dbb2ec6a041e33e663122b60bcecd750ba52a60a69b4a6fb3aca68a98", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ba82de14-9be3-47df-9ecf-864c2aba1b11", "node_type": "1", "metadata": {}, "hash": "6bfd8104d65cf655b8a6d985adeceb515f35f27352ef768c2dabd3446fb33e23", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The GPs routinely record\nthe administration of vaccines. Diagnoses, physical \ufb01ndings, symp-\ntoms, and administrative events such as referrals to specialists are\nrecorded by using Oxford Medical Information System (OXMIS) or\nRead codes. All information we receive is anonymized.\nThe distribution of age, gender, and geography in the practices\nthat contribute to the Database is closely similar to that of the\nUK except that London is somewhat underrepresented [9]. The UK\npopulation has been divided into regions by the Database group at\nthe Medicines and Healthcare Products Regulatory Agency (MHRA)\nwhich is responsible for the data collection and storage.\n0264-410X/$ \u2013 see front matter \u00a9 2010 Elsevier Ltd. All rights reserved.\ndoi:10.1016/j.vaccine.2010.04.084\nH. Jick, K.W. Hagberg / Vaccine 28 (2010) 4588\u20134592\n4589\nFig. 1. The annual incidence of measles according to age and calendar year.\nThe protocol for this study was reviewed and approved by the\nIndependent Scienti\ufb01c Advisory Committee (ISAC) of the MHRA.\n2.2. Incidence estimation and source population\nThe \ufb01rst part of this study was conducted using a cohort design\nto estimate incidence of clinically diagnosed measles according to\nage, region, and calendar year. We identi\ufb01ed all people for whom\ndata were recorded in the Database from January 1, 1990 through\nDecember 31, 2008.\n2.3. Case de\ufb01nition\nWe considered a person to be an incident case of measles if they\nhad a clinical diagnosis of measles recorded in their computerized\nmedical record. We could not obtain laboratory results to validate\nthe measles diagnoses; however, the accuracy of diagnoses in the\nGPRD has been shown to be of high quality [2,5\u20138] and surveillance\nreports have indicated that accuracy of measles diagnosis in the UK\nis high, especially during outbreaks [10].\n2.4. Measles vaccination use and effectiveness\nA person was considered to have been vaccinated against\nmeasles if they had a measles-containing vaccination recorded in\ntheir computerized medical record.", "mimetype": "text/plain", "start_char_idx": 3705, "end_char_idx": 5716, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ba82de14-9be3-47df-9ecf-864c2aba1b11": {"__data__": {"id_": "ba82de14-9be3-47df-9ecf-864c2aba1b11", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Jick (2010).pdf", "node_type": "4", "metadata": {}, "hash": "1ba0f8f67e59b95a29eca6a617be5f77c04ff9b23efa450938f4ce6fa6eddc00", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "91559628-532a-4c6c-873e-7d6f0d219255", "node_type": "1", "metadata": {}, "hash": "048096f84a81cff15d200c94cdff9f6c0a1910d9ce3e43c2833797d1f87b85ec", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ebb09f36-f957-4cf7-a635-c640fd6880a6", "node_type": "1", "metadata": {}, "hash": "8758ccbea12ab7c303c4e78a65ca9cf1adf2e6f8483179db536584ad04effaf6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2.4. Measles vaccination use and effectiveness\nA person was considered to have been vaccinated against\nmeasles if they had a measles-containing vaccination recorded in\ntheir computerized medical record.\nWe used a nested case\u2013control design to estimate the risk of\nmeasles in relation to the receipt or non-receipt of a measles-\ncontaining vaccine. We included cases who were diagnosed with\nmeasles in 1994, age 1\u201319 at the time of the diagnosis, and who\nwere born in or after 1982. We randomly selected up to 4 controls\nwho had no prior diagnosis of measles, matched to each case on\nyear of birth, gender, general practice attended, index date (the\ndate of the case\u2019s measles diagnosis), and the duration of time\nthe patient had been registered in the Database. We reviewed\nthe immunization history for each case and control to determine\nreceipt of a measles vaccine prior to the index date and how many\nprior measles vaccines had been received.\n2.5. Data analyses\nAnnual incidence rates (IR) were calculated by dividing the\nnumber of cases of measles each year by the estimated population\nat risk active in the Database. Annual region speci\ufb01c rates were\nestimated by age and calendar year. Since the Database represents\nabout 5% of the UK population [9], we estimated the number of\ncases in all of the UK by multiplying the number of cases recorded\nin the Database by 20.\nWe used conditional logistic regression in the case\u2013control anal-\nysis to estimate the relative risk of measles infection in those who\nreceived a measles vaccination compared to those who did not.\nOdds ratios (OR) and 95% con\ufb01dence intervals (CIs) are presented.\nThe statistical analysis was conducted using the software program\nSAS, version 9.1 (SAS Institute, Inc., Cary, NC).\n3. Results\n3.1. Incidence of measles\nThe annual incidence of measles for years 1990\u20132008 is shown\naccording to age in Fig. 1. There were over 8000 cases of measles\nrecorded in the Database during the study period, of which 53%\nwere male. The incidence of measles was highest in children less\nthan 5 years old in 1990 and 1991 (about 36/10,000).", "mimetype": "text/plain", "start_char_idx": 5514, "end_char_idx": 7610, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ebb09f36-f957-4cf7-a635-c640fd6880a6": {"__data__": {"id_": "ebb09f36-f957-4cf7-a635-c640fd6880a6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Jick (2010).pdf", "node_type": "4", "metadata": {}, "hash": "1ba0f8f67e59b95a29eca6a617be5f77c04ff9b23efa450938f4ce6fa6eddc00", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ba82de14-9be3-47df-9ecf-864c2aba1b11", "node_type": "1", "metadata": {}, "hash": "6bfd8104d65cf655b8a6d985adeceb515f35f27352ef768c2dabd3446fb33e23", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fc67256b-7582-4a0e-9597-875cd9cfdde1", "node_type": "1", "metadata": {}, "hash": "65302d419bc30be718c90dc11851fe0870a2808002e3ddb371deb12406a4611c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The incidence of measles was highest in children less\nthan 5 years old in 1990 and 1991 (about 36/10,000). It fell to about\n28/10,000 in 1993, rose to 35/10,000 in 1994, and fell rapidly and\nprogressively to less than 5/10,000 by 2005 and remained at this\nlevel through 2008. In children age 10\u201314, the incidence of measles\nrose more than 150%, from less than 5/10,000 in 1990\u20131991 to\nabout 16/10,000 in 1994 (Fig. 1), after which it fell to levels below\n2/10,000 in 1995 and remained at this level through 2008. The risk\n4590\nH. Jick, K.W. Hagberg / Vaccine 28 (2010) 4588\u20134592\nFig. 2. (A) Number of people with \ufb01rst-time measles-containing vaccine by age and calendar year. (B) Number of people who received a \ufb01rst or second measles-containing\nvaccine by age and calendar year.\nof measles in adults (age 20 or older) was less than 1/10,000 for the\nentire study period.\nBased on the \ufb01ndings in the Database, we estimate that for those\naged less than 15 years the number of cases of measles in the UK\nwas stable at about 16,000 cases per year from 1990 through 1993.\nIn 1994, the number of cases rose to an estimated 24,000 cases.\nAs a result of the 1994 outbreak, a campaign of immunization with\nmeasles-containing vaccines (MR and MMR) was initiated (see vac-\ncine frequency results).\nIn 1995, the number of noti\ufb01ed cases of measles fell to around\n10,000 per year, a level lower than the one that prevailed prior\nto the 1994 outbreak. In 1996, another large campaign of a two\ndose MMR vaccination regimen was initiated in the UK, primar-\nily to help prevent an outbreak of mumps while at the same time\nproviding additional protection against measles (see vaccine fre-\nquency results).", "mimetype": "text/plain", "start_char_idx": 7504, "end_char_idx": 9190, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fc67256b-7582-4a0e-9597-875cd9cfdde1": {"__data__": {"id_": "fc67256b-7582-4a0e-9597-875cd9cfdde1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Jick (2010).pdf", "node_type": "4", "metadata": {}, "hash": "1ba0f8f67e59b95a29eca6a617be5f77c04ff9b23efa450938f4ce6fa6eddc00", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ebb09f36-f957-4cf7-a635-c640fd6880a6", "node_type": "1", "metadata": {}, "hash": "8758ccbea12ab7c303c4e78a65ca9cf1adf2e6f8483179db536584ad04effaf6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "900151d1-f6ba-47d7-8b61-36c343346649", "node_type": "1", "metadata": {}, "hash": "a7b37beae9ba819df98b21a93e6b8dbe856d3fea2d8074cc9f1dd61ab9885ec0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In the years following 1996, the number of cases\nof measles in the GPRD fell to a low of around 100 per year\u2014an\nestimated 2000 nationwide (Fig. 1).\nThe incidence was highest in Scotland\u2019s practices for years\n1990\u20131995 after which it fell to levels of less than 5 per 10,000 in\nall regions. In addition to Scotland, the modest 1994 outbreak was\nmainly con\ufb01ned to Wales, the Northwest, and North Yorkshire.\n3.2. Measles vaccine use and effectiveness\nThe distribution of the \ufb01rst-time measles-containing vaccine is\nprovided in Fig. 2A by age and calendar year. As of 1994, about 90%\nof vaccinated children had received only one dose. We estimate that\nover 800,000 children age 5\u201314 years received a \ufb01rst-time measles-\ncontaining vaccination nationwide in 1994. Fig. 2B provides the\ntotal annual number of people who received a measles-containing\nvaccine (either \ufb01rst or second) according to age and calendar year. A\nsubstantial proportion of vaccinations in the later years were given\nto people who had already received a prior measles vaccination.\nThe major vaccination campaigns in 1989\u20131990, 1994, 1996\u20131998\nand 2004\u20132006 initiated in association with measles or mumps\noutbreaks are clearly demonstrated (Fig. 2A and B).\nWe evaluated the effectiveness of the measles-containing vac-\ncines by comparing vaccination status in cases of measles to that in\nmatched controls (Table 1). We identi\ufb01ed 1261 recorded cases of\nmeasles in children less than age 20 in 1994, the year of the measles\noutbreak. The frequency of vaccination in the cases was compared\nto that of 4996 controls matched on year of birth, gender, general\npractice, date of diagnosis in the case, and duration of enrollment\nin the practice. The OR was 0.49 (95% CI 0.41\u20130.58) in children who\nhad received one dose of a measles vaccine compared to those who\nreceived no vaccine.", "mimetype": "text/plain", "start_char_idx": 9191, "end_char_idx": 11030, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "900151d1-f6ba-47d7-8b61-36c343346649": {"__data__": {"id_": "900151d1-f6ba-47d7-8b61-36c343346649", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Jick (2010).pdf", "node_type": "4", "metadata": {}, "hash": "1ba0f8f67e59b95a29eca6a617be5f77c04ff9b23efa450938f4ce6fa6eddc00", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fc67256b-7582-4a0e-9597-875cd9cfdde1", "node_type": "1", "metadata": {}, "hash": "65302d419bc30be718c90dc11851fe0870a2808002e3ddb371deb12406a4611c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6333cd9f-b4a7-4408-ad35-0a1e69025805", "node_type": "1", "metadata": {}, "hash": "464832a86455d1eeef0575f86e73abda06c28a132768b1efc8db76334da03286", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The OR was 0.49 (95% CI 0.41\u20130.58) in children who\nhad received one dose of a measles vaccine compared to those who\nreceived no vaccine. It was 0.39 (95% CI 0.26\u20130.58) in those who\nhad received two vaccine doses compared to those who received\nnone (Table 1).\nBased on the controls, we estimate that, in 1994, 65% of children\nage 1\u20132 years had been vaccinated with the MMR vaccine, 87% of\nchildren age 3\u20134 years had been vaccinated, 77% of children age\n5\u20139 years had been vaccinated, and 28% of those aged 10\u201319 years\nhad been vaccinated.\n4. Discussion\nIn the UK, routine immunization of children with one dose of\nthe single measles vaccine began in 1968, with only moderate\nuptake [1]. Nevertheless, after 1968, the number of noti\ufb01ed cases of\nmeasles fell to an estimated 30,000 per year from prior levels some\nten times or higher. In October 1988, a comprehensive program of\nimmunization against measles, mumps, and rubella with the MMR\nvaccine was initiated for children 1\u20139 years of age. By 1998, some\nTable 1\nOdds ratios for 1994 cases of measles and controls according to measles vaccination status.\nMeasles vaccination status\nCases (N = 1261)\nControls (N = 4996)\nOR (95% CI)\n0 Measles vaccinations received\n812\n2738\n1.00 (reference)\n1 Measles vaccination received\n409\n2012\n0.49 (0.41\u20130.58)\n2+ Measles vaccinations received\n40\n246\n0.39 (0.26\u20130.58)\nH. Jick, K.W. Hagberg / Vaccine 28 (2010) 4588\u20134592\n4591\n10 years later, the uptake of MMR was estimated to be 90% in the\nyoungest children [1,2].\nDespite the prior programs of immunization begun in 1968\nand 1988, a mild outbreak of measles occurred in 1994.", "mimetype": "text/plain", "start_char_idx": 10894, "end_char_idx": 12505, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6333cd9f-b4a7-4408-ad35-0a1e69025805": {"__data__": {"id_": "6333cd9f-b4a7-4408-ad35-0a1e69025805", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Jick (2010).pdf", "node_type": "4", "metadata": {}, "hash": "1ba0f8f67e59b95a29eca6a617be5f77c04ff9b23efa450938f4ce6fa6eddc00", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "900151d1-f6ba-47d7-8b61-36c343346649", "node_type": "1", "metadata": {}, "hash": "a7b37beae9ba819df98b21a93e6b8dbe856d3fea2d8074cc9f1dd61ab9885ec0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f2936b68-ff05-4aa6-b672-f621cc42baea", "node_type": "1", "metadata": {}, "hash": "7ada2175cb732d29c7566e0b6e52bd59f32c3fbd333be8337f8a52b238525926", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Despite the prior programs of immunization begun in 1968\nand 1988, a mild outbreak of measles occurred in 1994. We esti-\nmate that an additional 8000 cases nationwide were diagnosed\nin that outbreak, primarily affecting children age 10\u201314 years,\nmost of whom had not received prior vaccination with a measles-\ncontaining vaccine.\nThe 1994 outbreak of measles led to a new immunization\ncampaign during that year (Fig. 2). Our results indicate that\nmeasles-containing vaccines distributed prior to 1994 and dur-\ning this immunization campaign provided substantial protection\nagainst measles for children age 1\u201319 years and that two doses\nprovided more protection than one (Table 1). The vaccination cam-\npaign of 1994 doubtless reduced the subsequent risk for measles,\nas did an additional large vaccination campaign begun in 1996 for\nchildren age 5\u201314 (Fig. 2B). After 1994, the incidence of measles\ncontinued to fall through 2008 when fewer than 100 cases were\ndiagnosed in the Database in children less than 20 years of age.\nBy that year, up to 90% of children less than 5 years of age had\nbeen vaccinated against measles at least once in general practices.\nMajor vaccination campaigns in 1989\u20131990, 1994, 1996\u20131998\nand 2004\u20132006 initiated in association with measles or mumps\noutbreaks are clearly demonstrated (Fig. 2A and B). In 1998, the fre-\nquency of \ufb01rst-time MMR vaccination began to fall in the youngest\nchildren as a result of public concern about possible side effects of\nthe vaccine [1,2]. By 2002, \ufb01rst-time MMR vaccinations had fallen\nby about 25% in the youngest children (Fig. 2A).\nDespite the vaccination of millions of children with a MMR vac-\ncine by October 1998 and a subsequent substantial reduction in the\nincidence of measles, a large epidemic of mumps began in the UK\nin 2003 and lasted through 2006 [2]. More than 100,000 mumps\ncases were diagnosed by general practitioners [2]. The epidemic of\nmumps primarily affected young adults age 18\u201324, most of whom\nhad not received prior MMR vaccination.", "mimetype": "text/plain", "start_char_idx": 12394, "end_char_idx": 14417, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f2936b68-ff05-4aa6-b672-f621cc42baea": {"__data__": {"id_": "f2936b68-ff05-4aa6-b672-f621cc42baea", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Jick (2010).pdf", "node_type": "4", "metadata": {}, "hash": "1ba0f8f67e59b95a29eca6a617be5f77c04ff9b23efa450938f4ce6fa6eddc00", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6333cd9f-b4a7-4408-ad35-0a1e69025805", "node_type": "1", "metadata": {}, "hash": "464832a86455d1eeef0575f86e73abda06c28a132768b1efc8db76334da03286", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "53bc1c2a-8146-44e3-b62f-8149f13f8bf0", "node_type": "1", "metadata": {}, "hash": "a2016e46bc0aa63793db59625326cc30c74761f86ae8a484de48de6b4f6ba87b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "More than 100,000 mumps\ncases were diagnosed by general practitioners [2]. The epidemic of\nmumps primarily affected young adults age 18\u201324, most of whom\nhad not received prior MMR vaccination. The 2003 mumps epi-\ndemic led to yet another vaccination campaign in 2004 and 2005\n(Fig. 2B) that demonstrably reduced, to some extent, the size of\nthe mumps epidemic [2], while at the same time, it increased the\nnumber of children and young adults protected from measles. Nev-\nertheless, there still remain some children in the UK who have not\nbeen vaccinated against measles (or mumps). Measles outbreaks\nsimilar to the one in 1994 may be expected in the future.\nReports have described UK outbreaks of measles in 2006\u20132008\n[11\u201315]. We found no evidence for a widespread increased inci-\ndence of measles in the Database for these years indicating that\nthese outbreaks were isolated and did not spread widely. In 2009\nthere was also an increase in the number of measles noti\ufb01cations\nreported to the government [16]. Our preliminary data suggest that\nthis increase was also not widespread since there were fewer than\n100 cases of measles recorded in the Database through September\nof 2009 in those less than 20 years of age. Limited local outbreaks\nof measles and mumps have not infrequently been reported in the\npast [4,12,13,16\u201318].\nThe accuracy of diagnoses made by the general practitioners has\nbeen established in numerous publications to be of high quality\nand completeness [2,5\u20138]. In addition, the recording of vaccina-\ntions in the Database has been found to be virtually complete and\nconsistent with reported vaccine coverage [5]. Published studies\non the incidence of mumps and in\ufb02uenza based on this Database\nhave yielded results closely similar to those reported to the gov-\nernment, which rely on general practitioner reports [2,8,19]. The\ncurrent measles study also provides incidence rates that are sim-\nilar to those reported by the UK government [20\u201322]. The results,\nin relation to measles vaccination, are entirely consistent with the\nreport and recommendations described by the World Health Orga-\nnization [23].", "mimetype": "text/plain", "start_char_idx": 14225, "end_char_idx": 16349, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "53bc1c2a-8146-44e3-b62f-8149f13f8bf0": {"__data__": {"id_": "53bc1c2a-8146-44e3-b62f-8149f13f8bf0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Jick (2010).pdf", "node_type": "4", "metadata": {}, "hash": "1ba0f8f67e59b95a29eca6a617be5f77c04ff9b23efa450938f4ce6fa6eddc00", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f2936b68-ff05-4aa6-b672-f621cc42baea", "node_type": "1", "metadata": {}, "hash": "7ada2175cb732d29c7566e0b6e52bd59f32c3fbd333be8337f8a52b238525926", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "67f04fde-5a4a-45da-b7e4-4412b45d1dd8", "node_type": "1", "metadata": {}, "hash": "fa4c0b31f955e410fa7196d147fbea92efc9d755d67b2d9e0a88875c452cb88e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The results,\nin relation to measles vaccination, are entirely consistent with the\nreport and recommendations described by the World Health Orga-\nnization [23].\nIn summary, the annual incidence of measles fell after the intro-\nduction of the MMR vaccine in late 1988. A modest outbreak\nof measles occurred in 1994 leading to large nationwide pro-\ngrams to immunize children. Since 1996, the incidence of measles\nhas fallen by more than 80%. Prior measles vaccination is highly\neffective and has substantially reduced the risk of measles. This\nlarge UK computerized general practice data resource has pro-\nvided comprehensive details about the incidence of measles in\nrelation to the history of immunizations against this infectious\ndisease. Standardized valid electronic population-based medical\nresources can provide real-time recording of infectious disease\ndiagnoses, as well as vaccinations, rapidly and at low cost com-\npared to other means that have been used to obtain this information\n[24\u201326].\nReferences\n[1] Asaria P, MacMahon E. Measles in the United Kingdom: can we eradicate it by\n2010? BMJ 2006;333:890\u20135.\n[2] Jick H, Chamberlin DP, Hagberg KW. The origin and spread of a mumps\nepidemic: United Kingdom, 2003\u20132006. Epidemiology 2009;20(September\n(5)):656\u201361.\n[3] Gay N, Ramsay M, Cohen B, Hesketh L, Morgan-Capner P, Brown D, et al. The\nepidemiology of measles in England and Wales since the 1994 vaccination\ncampaign. Commun Dis Rep CDR Rev 1997;7(February (2)):R17\u201321.\n[4] Skinner R, Christie P, Cowden JM. The measles/rubella immunization campaign\nin Scotland. Health Bull (Edinb) 1996;54(January (1)):88\u201398.\n[5] Kaye JA, Melero-Montes MM, Jick H. Mumps, measles, and rubella vaccine\nand the incidence of autism recorded by general practitioners: a time-trend\nanalysis. BMJ 2001;322:460\u20133.", "mimetype": "text/plain", "start_char_idx": 16190, "end_char_idx": 17994, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "67f04fde-5a4a-45da-b7e4-4412b45d1dd8": {"__data__": {"id_": "67f04fde-5a4a-45da-b7e4-4412b45d1dd8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Jick (2010).pdf", "node_type": "4", "metadata": {}, "hash": "1ba0f8f67e59b95a29eca6a617be5f77c04ff9b23efa450938f4ce6fa6eddc00", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "53bc1c2a-8146-44e3-b62f-8149f13f8bf0", "node_type": "1", "metadata": {}, "hash": "a2016e46bc0aa63793db59625326cc30c74761f86ae8a484de48de6b4f6ba87b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d3396a26-d4bf-40fe-9cbf-c933e6cfd721", "node_type": "1", "metadata": {}, "hash": "c4acb0ca3cf70d3e982b2a7cf3dad3016cbfda34906268f19efb04ae5a4b65fe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BMJ 2001;322:460\u20133.\n[6] Kaye JA, Derby LE, Melero-Montes MM, Quinn M, Jick H. The incidence of breast\ncancer in the General Practice Research Database compared with national can-\ncer registration data. Br J Cancer 2000;83:1556\u20138.\n[7] Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garc\u00eda Rodr\u00edguez LA, Ruig\u00f3mez A,\nMeier CR, et al. Validity of the General Practice Research Database. Pharma-\ncotherapy 2003;23:686\u20139.\n[8] Meier CR, Napalkov PN, Wegmuller Y, Jefferson T, Jick H. Population-based\nstudy on incidence, risk factors, clinical complications and drug utilization\nassociated with in\ufb02uenza in the United Kingdom. Eur J Clin Microbiol Infect\nDis 2000;19:834\u201342.\n[9] Hollowell J. General Practice Research Database (GRPD): scope and quality of\ndata. Of\ufb01ce of Population Censuses and Statistics. OPCS, now known as Of\ufb01ce\nof National Statistics (ONS); 1994. pp. 1\u201320.\n[10] Brown DW, Ramsay ME, Richards AF, Miller E. Salivary diagnosis of measles:\na study of noti\ufb01ed cases in the United Kingdom, 1991\u20133. BMJ 1994;308:\n1015\u20137.\n[11] Muscat M, Bang Henrik, Wohlfahrt J, Glismann S, Molbak K. Measles in Europe:\nan epidemiological assessment. Lancet 2009;373:383\u20138.\n[12] Health Protection Agency. Measles cases so far in 2006. Press release\ndated 15 June 2006. www.hpa.org.uk/webw/HPAweb&HPAwebStandard/\nHPAweb C/1231490136144?p=1158945065095\n[accessed\n21\nDecember\n2008].\n[13] Health Protection Agency. Increase in measles cases in 2006, in Eng-\nland\nand\nWales.", "mimetype": "text/plain", "start_char_idx": 17975, "end_char_idx": 19430, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d3396a26-d4bf-40fe-9cbf-c933e6cfd721": {"__data__": {"id_": "d3396a26-d4bf-40fe-9cbf-c933e6cfd721", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Jick (2010).pdf", "node_type": "4", "metadata": {}, "hash": "1ba0f8f67e59b95a29eca6a617be5f77c04ff9b23efa450938f4ce6fa6eddc00", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "67f04fde-5a4a-45da-b7e4-4412b45d1dd8", "node_type": "1", "metadata": {}, "hash": "fa4c0b31f955e410fa7196d147fbea92efc9d755d67b2d9e0a88875c452cb88e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a4a443df-0b10-4f52-9feb-f2c088aea3f4", "node_type": "1", "metadata": {}, "hash": "39134cbeb1a2a3b546dc2a2312d52716d904be4c6d15e2779cb84c2ec634f7e1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "[13] Health Protection Agency. Increase in measles cases in 2006, in Eng-\nland\nand\nWales.\nCommunicable\nDisease\nReport\nWeekly\n2006;16:3.\nwww.hpa.org.uk/cdr/archives/2006/cdr1206.pdf\n[accessed\n21\nDecember\n2008].\n[14] Health Protection Agency. Con\ufb01rmed cases of measles in England and\nWales\u2014an update. Health Protection Report HPR [serial online] 2008;2(21):\nnews.\nhttp://www.hpa.org.uk/hpr/archives/2008/news2108.htm#measls\n[accessed 2 February 2010].\n[15] Eaton L. Measles cases in England and Wales rise sharply in 2008. BMJ\n2009;338:b533.\n[16] Health\nProtection\nAgency.\nCon\ufb01rmed\nmeasles\ncases\nin\nEngland\nand\nWales: update to end-April 2009. Health Protection Report HPR [serial\nonline]\n2009;3(24):\nnews.\nhttp://www.hpa.org.uk/hpr/archives/2009/\nnews2209.htm#msls [accessed 2 February 2010].\n[17] Mackenzie DG, Hallam N, Stevenson J. Younger teenagers are also at risk of\nmumps outbreaks. BMJ 2005;330:1509.\n[18] Morse D, O\u2019Shea M, Hamilton G, Soltanpoor N, Leece G, Miller E, et al. Outbreak\nof measles in a teenage school population: the need to immunize susceptible\nadolescents. Epidemiol Infect 1994;113(October (2)):355\u201365.\n[19] Jick H, Chamberlin DP, Hagberg KW. Vaccine policy and incidence of in\ufb02uenza.\nEpidemiology 2010;21(March (2)):270\u20131.\n[20] Health\nProtection\nAgency.\nNoti\ufb01cations,\nby\nAge\nGroup;\n1989\u20132008.\nhttp://www.hpa.org.uk/web/HPAweb&HPAwebStandard/\nHPAweb C/1195733802298 [accessed 2 February 2010].\n[21] Health Protection Surveillance Center.", "mimetype": "text/plain", "start_char_idx": 19341, "end_char_idx": 20804, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a4a443df-0b10-4f52-9feb-f2c088aea3f4": {"__data__": {"id_": "a4a443df-0b10-4f52-9feb-f2c088aea3f4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba\u2010Jick (2010).pdf", "node_type": "4", "metadata": {}, "hash": "1ba0f8f67e59b95a29eca6a617be5f77c04ff9b23efa450938f4ce6fa6eddc00", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d3396a26-d4bf-40fe-9cbf-c933e6cfd721", "node_type": "1", "metadata": {}, "hash": "c4acb0ca3cf70d3e982b2a7cf3dad3016cbfda34906268f19efb04ae5a4b65fe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/\nHPAweb C/1195733802298 [accessed 2 February 2010].\n[21] Health Protection Surveillance Center. Epidemiology of measles in Ire-\nland;\n2006.\nhttp://www.ndsc.ie/hpsc/A-Z/VaccinePreventable/Measles/\nPublications/AnnualReportsonMeaslesinIreland/File,2648,en.pdf [accessed 2\nFebruary 2010].\n4592\nH. Jick, K.W. Hagberg / Vaccine 28 (2010) 4588\u20134592\n[22] Health Protection Scotland. Measles noti\ufb01cations and laboratory reports,\nScotland; 1988\u20132008. http://www.documents.hps.scot.nhs.uk/immunisation/\nmeasles/measles-noti\ufb01cations-lab-reports-1988-2008.pdf [accessed 2 Febru-\nary 2010].\n[23] World\nHealth\nOrganization.\nProgress\ntowards\nmeasles\nelimination\nin\nWHO\u2019s\nEuropean\nregion,\n2005\u20132008.\nWkly\nEpidemiol\nRec\n2009;84:\n57\u201364.\n[24] Ghebrehewet S, Falconer M, McDonald P, Schlecht B. MMR vaccine uptake rates:\na data validation study. Commun Dis Public Health 2003;6(June (2)):144\u20136.\n[25] Lyratzopoulos G, Aston R, Bailey K, Flitcroft J, Clarke H. Accuracy of routine data\non MMR vaccination coverage and validity of parental recall of vaccination.\nCommun Dis Public Health 2002 Dec;5(4):305\u201310.\n[26] Choi YH, Gay N, Fraser G, Ramsay M. The potential for measles transmission in\nEngland. BMC Public Health 2008;8(September):338.", "mimetype": "text/plain", "start_char_idx": 20661, "end_char_idx": 21928, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3b1c2460-663e-425b-a7f8-15d74313e1f4": {"__data__": {"id_": "3b1c2460-663e-425b-a7f8-15d74313e1f4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8e2de78c-9c99-4304-84cc-6131f49f30b0", "node_type": "1", "metadata": {}, "hash": "2cd3241260ec5bbc47b93d6532a634a9056413feda56def36dad992ee37dc881", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Vaccine\n 29 (2011) 8024\u2013\n 8031\nContents\n lists\n available\n at\n ScienceDirect\nVaccine\nj\n ourna\n l\n ho\n me\n pag\n e:\n www.elsevier.com/locate/vaccine\nMMR\n vaccine\n effectiveness\n in\n an\n outbreak\n that\n involved\n day-care\n and\n primary\nschools\nIrene\n Barrabeig a,\u2217, Ariadna\n Rovira a,  Pilar\n Mu\u02dcnoz b,c,  Joan\n Batalla d,b,  Cristina\n Rius e,\nJosep\n Anton\n S\u00e1nchez c, \u00c0ngela\n Dom\u00ednguez f,b\na Epidemiological\n Surveillance\n Unit\n of\n Barcelona-Zona\n Sud.\n Department\n of\n Health,\n Generalitat\n of\n Catalonia,\n Barcelona,\n Spain\nb CIBER\n Epidemiolog\u00eda\n y\n Salut\n P\u00fablica\n (CIBERESP),\n Spain\nc Dept.\n of\n Statistics\n and\n Operations\n Research,\n University\n Polit\u00e8cnica\n de\n Catalunya\n (UPC),\n Barcelona,\n Spain\nd Vaccine\n Service,\n Department\n of\n Health,\n Generalitat\n of\n Catalonia,\n Barcelona,\n Spain\ne Epidemiology\n Service\n of\n Public\n Health\n Agency\n of\n Barcelona,\n Barcelona,\n Spain\nf Department\n of\n Public\n Health,\n School\n of\n Medicine,\n University\n of\n Barcelona,\n Spain\na  r  t\n i  c  l  e  \ni n\n f\n o\nArticle\n history:\nReceived\n 22\n April\n 2011\nReceived\n in\n revised\n form\n 9\n August\n 2011\nAccepted\n 10\n August\n 2011\nAvailable online 3 September 2011\nKeywords:\nMeasles\nVaccination\nVaccine\n effectiveness\nEffective\n reproduction\n number\na\n b  s  t  r  a\n c  t\nObjective:\n In 2006,\n a large  measles\n outbreak\n occurred\n in  Catalonia\n (Spain),  where\n the  immunization\n sched-\nule\n included\n two  doses  of  MMR  vaccine\n at  15 months  and\n 4 years.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1459, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8e2de78c-9c99-4304-84cc-6131f49f30b0": {"__data__": {"id_": "8e2de78c-9c99-4304-84cc-6131f49f30b0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3b1c2460-663e-425b-a7f8-15d74313e1f4", "node_type": "1", "metadata": {}, "hash": "a0ff1f5a46ac7ccfb6d8a96897b85054e87a0c88bc4e91cda8ee3dbd95725619", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1424feb4-3ab0-41d6-84cd-892b8221924a", "node_type": "1", "metadata": {}, "hash": "67ab464f77c44aa10b6670b4e67073742c2f16e95bea976498b7d7efe6365a97", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\n aim  of this  study\n was  to investigate\nthe\n vaccine\n effectiveness\n (VE)\n of MMR\n in  children\n attending\n day-care\n and  pre-school\n centres\n and\n to esti-\nmate\n the number\n of  cases  that  would  have  been\n avoided  by  administering\n the  \ufb01rst  dose\n of MMR  at  12\nmonths.\nMethods:\n A  retrospective\n cohort\n study  was  carried  out  between\n October\n 2006  and\n January\n 2007\n in  day-\ncare\n and  pre-school\n centres\n with  con\ufb01rmed\n measles\n cases.  VE  was  calculated\n in  children\n aged  \u226515  months\nwithout\n previous\n measles\n infection.\n Cases\n avoided\n by  advancing\n the  \ufb01rst  dose  of  MMR  to 12  months\n were\nestimated\n by  calculating\n the\n basic  and  effective\n reproduction\n number\n in  centres\n where\n transmission\noutside\n the  class  was  observed.\nResults:\n Fifteen\n centres\n and  1394\n children\n were  included.\n There\n were  77  con\ufb01rmed\n cases  (attack\nrate\n =  5.5%).\n Vaccination\n coverage\n of  the  1121  children\n aged  \u226515  months\n was  91.6%  and  VE  was  96%\n(95%CI\n 89\u201398%).\nThere\n were  33 (41%)  cases  in  the  81  children\n aged  12\u201314  months.\n Advancing\n the  \ufb01rst  dose  to  12  months\nwould\n have  prevented\n 74  cases\n (91.5%)  and  lowered\n the  attack\n rate  from  41%  to\n 8.6%.\nConclusions:\n Over  90%\n of  cases\n in  children\n aged\n 12\u201314  months\n would\n have  been  avoided\n by  MMR\n admin-\nistration\n at  12  rather\n than  15  months.", "mimetype": "text/plain", "start_char_idx": 1461, "end_char_idx": 2858, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1424feb4-3ab0-41d6-84cd-892b8221924a": {"__data__": {"id_": "1424feb4-3ab0-41d6-84cd-892b8221924a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8e2de78c-9c99-4304-84cc-6131f49f30b0", "node_type": "1", "metadata": {}, "hash": "2cd3241260ec5bbc47b93d6532a634a9056413feda56def36dad992ee37dc881", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "75f8ac7f-54a9-4567-9a1f-0c34106d6288", "node_type": "1", "metadata": {}, "hash": "d1ac89ca5d8e3972577c250f293713e56a1b1bb4492a709284c26ed00a9360ed", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We\n strongly\n recommend\n advancing\n the  \ufb01rst\n dose  of  MMR  to  12\nmonths\n in  order\n to  reduce  the  risk  of measles\n outbreaks.\n\u00a9 2011 Elsevier Ltd. All rights reserved.\n1.\n Introduction\nMeasles,\n a\n disease\n caused\n by\n a\n Morbillivirus\n of\n the\n paramyx-\novirus\n family,\n is\n one\n of\n the\n most\n contagious\n human\n infectious\ndiseases,\n with\n a\n basic\n reproduction\n number\n (R0)\n of\n 15\u201318\n [1,2].\n The\nworldwide\n disease\n burden\n is\n high,\n with\n the\n case\n fatality\n rate\n esti-\nmated\n at\n approximately\n one\n death\n per\n 1000\n cases\n [3\u20135].\n In\n 2009,\nthere\n were\n 222,408\n cases\n worldwide\n [6].\nAbbreviations:\n \nR0, basic\n reproduction\n number;\n MMR,\n measles\n mumps\n and\nrubella\n vaccine;\n VE,\n direct\n effectiveness\n of\n vaccination;\n RR,\n relative\n risks;\n ARv, attack\nrate\n in\n vaccinated\n children;\n ARu, attack\n rate\n in\n unvaccinated\n children;\n CI,\n con\ufb01dence\ninterval;\n R,\n effective\n reproduction\n number;\n EUVAC,\n European\n surveillance\n network\nfor\n vaccine-preventable\n diseases.\n\u2217Corresponding\n author.\n Tel.:\n +34\n 93\n 551\n 5798;\n fax:\n +34\n 93\n 332\n 7607.\nE-mail\n address:\n ibarrabeig@catsalut.cat\n (I.\n Barrabeig).\nGiven\n the\n availability\n of\n a\n highly-effective\n vaccine,\n highly-\nspeci\ufb01c\n and\n sensitive\n diagnostic\n tests\n and\n the\n lack\n of\n animal\nreservoirs,\n some\n regions\n have\n adopted\n elimination\n targets.", "mimetype": "text/plain", "start_char_idx": 2860, "end_char_idx": 4210, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "75f8ac7f-54a9-4567-9a1f-0c34106d6288": {"__data__": {"id_": "75f8ac7f-54a9-4567-9a1f-0c34106d6288", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1424feb4-3ab0-41d6-84cd-892b8221924a", "node_type": "1", "metadata": {}, "hash": "67ab464f77c44aa10b6670b4e67073742c2f16e95bea976498b7d7efe6365a97", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2e9b704d-71d0-4c22-b425-ff513062d441", "node_type": "1", "metadata": {}, "hash": "6ca5a7ea27744d5aeb92edf849494b3bddcc297654fba98ca945a2e81460464f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In\n the\nAmericas,\n the\n 1994\n Pan\n American\n Sanitary\n Conference\n established\nthe\n goal\n of\n eliminating\n measles\n from\n the\n Americas,\n and\n the\n num-\nber\n of\n cases\n of\n measles\n was\n reduced\n by\n 99%\n in\n 1996\n in\n comparison\nto\n 1990\n levels\n [7].  Currently,\n measles\n is\n no\n longer\n endemic\n in\n the\nAmericas\n and\n most\n countries\n have\n interrupted\n transmission\n of\n the\nvirus\n [8].\nThe\n European\n Region\n of\n the\n World\n Health\n Organization\n set\n a\n goal\nof\n eliminating\n indigenous\n measles\n in\n the\n Region\n by\n 2010,\n but\n due\n to\nthe\n increase\n of\n cases\n and\n outbreaks\n in\n the\n central\n and\n western\n parts\nof\n the\n Region,\n this\n goal\n has\n been\n postponed\n to\n 2015\n [9].  Finland,\nwhere\n the\n coverage\n with\n two\n doses\n of\n vaccine\n was\n 95%,\n eliminated\nmeasles\n in\n 1993\n [10]. However,\n as\n vaccination\n coverage\n with\n two\ndoses\n is\n still\n suboptimal\n in\n some\n countries\n and\n population\n groups,\nthe\n virus\n still\n circulates\n widely\n in\n Europe\n [11].\n0264-410X/$\n \u2013\n see\n front\n matter \u00a9\n \n 2011 Elsevier Ltd. All rights reserved.\ndoi:10.1016/j.vaccine.2011.08.056\nI.\n Barrabeig\n et\n al.\n / Vaccine\n 29 (2011) 8024\u2013\n 8031\n8025\nDuring\n the\n period\n 2005\u20132008,\n 120\n outbreaks\n were\n reported\n in\nEurope,\n of\n which\n 17\n reported\n more\n than\n 250\n cases,\n with\n 25\n deaths\noccurring\n [12].", "mimetype": "text/plain", "start_char_idx": 4212, "end_char_idx": 5531, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2e9b704d-71d0-4c22-b425-ff513062d441": {"__data__": {"id_": "2e9b704d-71d0-4c22-b425-ff513062d441", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "75f8ac7f-54a9-4567-9a1f-0c34106d6288", "node_type": "1", "metadata": {}, "hash": "d1ac89ca5d8e3972577c250f293713e56a1b1bb4492a709284c26ed00a9360ed", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6daf9a60-6c79-489f-a49d-bd2c2f426e1d", "node_type": "1", "metadata": {}, "hash": "fc6449456c27708f211a43dd4f38fe43c011568134ae6e91b20c7a3835655987", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In\n Catalonia,\n a\n region\n in\n north-eastern\n Spain\n with\n over\n seven\nmillion\n inhabitants,\n there\n was\n an\n outbreak\n of\n measles\n involving\n 381\ncases\n between\n August\n 2006\n and\n July\n 2007\n due\n to\n a\n case\n imported\nfrom\n Bosnia\n [13]. The\n previous\n epidemic\n wave\n occurred\n in\n 1995,\nwhen\n 1860\n cases\n were\n reported\n [14].\n After\n this,\n cases\n appeared\nintermittently\n and\n irregularly,\n and\n between\n 2000\n and\n 2005\n there\nwere\n only\n 25\n cases\n reported\n (0.06/100,000\n persons-year),\n due\nto\n high\n vaccination\n coverages.\n In\n 2006\u20132007,\n the\n incidence\n rate\nwas\n 3.1/100,000\n persons-year.\n The\n outbreak\n occurred\n mainly\n in\nthe\n Barcelona-South\n Health\n Region,\n with\n a\n rate\n of\n 9.2/100,000\npersons-year,\n and\n the\n majority\n of\n cases\n occurred\n in\n children\n aged\nless\n than\n 15\n months.\n Seventy-nine\n percent\n of\n the\n cases\n occurred\nbetween\n October\n 2006\n and\n January\n 2007.\nThe\n measles\n vaccine\n was\n introduced\n in\n 1978\n in\n the\n publicly-\nfunded\n vaccination\n schedule\n of\n Catalonia,\n for\n children\n at\n the\n age\n of\n12\n months.\n In\n 1980,\n the\n measles\n vaccine\n was\n replaced\n by\n a\n single\ndose\n of\n the\n combined\n measles,\n mumps\n and\n rubella\n vaccine\n (MMR)\nat\n 12\n months.\n In\n 1987,\n the\n age\n of\n MMR\n administration\n was\n changed\nfrom\n 12\n to\n 15\n months,\n and\n in\n 1988\n a\n second\n dose\n of\n MMR\n at\n 11\n years\nwas\n added.", "mimetype": "text/plain", "start_char_idx": 5532, "end_char_idx": 6904, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6daf9a60-6c79-489f-a49d-bd2c2f426e1d": {"__data__": {"id_": "6daf9a60-6c79-489f-a49d-bd2c2f426e1d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2e9b704d-71d0-4c22-b425-ff513062d441", "node_type": "1", "metadata": {}, "hash": "6ca5a7ea27744d5aeb92edf849494b3bddcc297654fba98ca945a2e81460464f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "74e95cc5-147e-40f4-8b1a-b02f2b97f802", "node_type": "1", "metadata": {}, "hash": "77622319afbe30b1e44883fa8993c1592e1609cb8c8a8ea3fc075be4ec604b11", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "To\n ensure\n that\n the\n proportion\n of\n vaccinated\n children\naged\n less\n than\n 10\n years\n reached\n 95%\n and\n to\n achieve\n the\n elimination\nof\n measles\n by\n 2000,\n from\n the\n last\n quarter\n of\n 1998,\n the\n second\n dose\nof\n MMR\n was\n advanced\n to\n 4\n years\n [15].\n Therefore,\n at\n the\n time\n of\n the\noutbreak\n studied\n here,\n routine\n vaccination\n consisted\n of\n two\n doses\nof\n MMR\n at\n 15\n months\n and\n 4\n years,\n using\n the\n Schwarz\n (Priorix\u00ae) and\nEnders\n (MSD\u00ae) strains.\nAt\n the\n end\n of\n January\n 2007,\n to\n control\n the\n outbreak,\n in\n addition\n to\npost-exposure\n prophylaxis\n measures\n in\n the\n home\n and\n educational\ncentres\n where\n cases\n appeared,\n a\n mass\n vaccination\n campaign\n was\ncarried\n out\n consisting\n of\n the\n administration\n of\n one\n dose\n of\n MMR\n in\nchildren\n aged\n 9\n to\n 12\n months,\n with\n a\n second\n dose\n at\n 15\n months.\nThe\n objective\n of\n this\n study\n was\n to\n evaluate\n the\n direct,\n indirect\nand\n total\n effectiveness\n of\n the\n measles\n component\n of\n the\n MMR\n vac-\ncine\n in\n the\n context\n of\n a\n measles\n outbreak\n that\n affected\n mainly\nchildren\n attending\n day-care\n and\n pre-school\n centres\n and\n to\n esti-\nmate\n the\n number\n of\n cases\n that\n would\n have\n been\n avoided\n if\n the\n\ufb01rst\n dose\n of\n MMR\n vaccine\n had\n been\n administered\n at\n 12\n rather\n than\n15\n months.\n2.\n Materials\n and\n methods\n2.1.", "mimetype": "text/plain", "start_char_idx": 6906, "end_char_idx": 8238, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "74e95cc5-147e-40f4-8b1a-b02f2b97f802": {"__data__": {"id_": "74e95cc5-147e-40f4-8b1a-b02f2b97f802", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6daf9a60-6c79-489f-a49d-bd2c2f426e1d", "node_type": "1", "metadata": {}, "hash": "fc6449456c27708f211a43dd4f38fe43c011568134ae6e91b20c7a3835655987", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cd71cb46-f3b4-4fda-a931-e23d785e7feb", "node_type": "1", "metadata": {}, "hash": "90cec27f16f7ee05554a96ba0904c19be4d29c1e3a5bff18005b01ee64ccafb7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2.\n Materials\n and\n methods\n2.1.\n Study\n population\nWe\n carried\n out\n a\n retrospective\n cohort\n study\n in\n educational\n cen-\ntres\n in\n the\n Barcelona-South\n Health\n Region\n (population\n 2,853,658)\nattended\n by\n a\n con\ufb01rmed\n case\n of\n measles\n during\n his\n infectiousness\nperiod\n with\n rash\n onset\n between\n 1st\n October\n 2006\n and\n 15th\n January\n2007.\n The\n temporal\n distribution\n of\n all\n cases\n of\n the\n outbreak\n is\n shown\nin\n Fig.\n 1.\n The\n study\n cut-off\n was\n established\n as\n 15\n January\n 2007,\n in\norder\n to\n avoid\n possible\n bias\n due\n to\n the\n mass\n vaccination\n campaign.\nCentres\n where\n MMR\n administration\n within\n 72\n h\n after\n exposure,\nwhich\n could\n have\n prevented\n cases\n of\n measles,\n were\n excluded\n [16].\nThe\n steps\n of\n this\n process\n are\n shown\n in\n Fig.\n 2.\nA\n con\ufb01rmed\n case\n of\n measles\n was\n de\ufb01ned\n as\n a\n laboratory-\ncon\ufb01rmed\n case\n (positive\n serology\n for\n measles\n immunoglobulin\n M\nantibody\n by\n enzyme-linked\n immunosorbent\n assay\n testing\n or\n posi-\ntive\n polymerase\n chain\n reaction\n for\n measles\n virus\n in\n urine\n sample)\nor\n a\n case\n that\n met\n the\n WHO\n clinical\n case\n de\ufb01nition\n and\n was\n epi-\ndemiologically\n linked\n to\n a\n laboratory-con\ufb01rmed\n case\n [17].\nChildren\n were\n considered\n as\n vaccinated\n against\n measles\n if\n they\nhad\n received\n the\n MMR\n vaccine\n on\n or\n after\n the\n minimum\n recom-\nmended\n age\n for\n vaccination\n and\n at\n least\n 14\n days\n prior\n to\n the\n onset\nof\n disease\n in\n the\n index\n case\n for\n each\n educational\n centre.", "mimetype": "text/plain", "start_char_idx": 8206, "end_char_idx": 9693, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cd71cb46-f3b4-4fda-a931-e23d785e7feb": {"__data__": {"id_": "cd71cb46-f3b4-4fda-a931-e23d785e7feb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "74e95cc5-147e-40f4-8b1a-b02f2b97f802", "node_type": "1", "metadata": {}, "hash": "77622319afbe30b1e44883fa8993c1592e1609cb8c8a8ea3fc075be4ec604b11", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7d555d1e-558e-4738-bfee-8802d583d842", "node_type": "1", "metadata": {}, "hash": "9513b89042f53ba3f074eb24a638fd6ce1ba1a9e852bde608e7786f3721301ca", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Susceptible\n children\n were\n de\ufb01ned\n as\n non-vaccinated\n children\nwithout\n measles\n infection\n before\n the\n outbreak.\nCases\n were\n investigated\n by\n public\n health\n staff.\n Active\n surveil-\nlance\n of\n children\n attending\n educational\n centres\n was\n carried\n out\n to\ndetect\n secondary\n cases.\n Public\n health\n care\n centres\n provided\n written\nimmunization\n records\n to\n regional\n public\n health\n staff,\n to\n determine\nprevious\n vaccination\n or\n history\n of\n disease.\nAll\n children\n and\n educational\n staff\n who\n could\n not\n provide\n evi-\ndence\n of\n immunity\n were\n either\n vaccinated\n with\n the\n MMR\n vaccine\nor\n excluded\n and\n isolated\n at\n home\n until\n 21\n days\n after\n the\n appearance\nof\n rash\n in\n the\n last\n reported\n case.\nFig.\n 1.\n Distribution\n of\n patients\n with\n measles\n according\n to\n date\n of\n onset\n of\n symptoms\n in\n Barcelona-South\n Health\n Region\n (August\n 2006\n to\n July\n 2007).\n8026\nI.\n Barrabeig\n et\n al.", "mimetype": "text/plain", "start_char_idx": 9694, "end_char_idx": 10617, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7d555d1e-558e-4738-bfee-8802d583d842": {"__data__": {"id_": "7d555d1e-558e-4738-bfee-8802d583d842", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cd71cb46-f3b4-4fda-a931-e23d785e7feb", "node_type": "1", "metadata": {}, "hash": "90cec27f16f7ee05554a96ba0904c19be4d29c1e3a5bff18005b01ee64ccafb7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "50276873-cc5d-4cdb-9999-b5f6077f2ec3", "node_type": "1", "metadata": {}, "hash": "a9dd036c61c88d13ba8da1bde6198606a5ac50e48bc2a6ebd2bcad254d1bb3f8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "8026\nI.\n Barrabeig\n et\n al.\n / Vaccine\n 29 (2011) 8024\u2013\n 8031\nTotal number of cases \nduring the outbreak \n350 \nTotal number of cases during  \n October 2006-January 2007 \n276 (79%)\n15 cases were related to  \nday-care or  pre-school centre  \n(without post-exposure prophylaxis before 72 hours) \nTotal number of exposed \nchildren  \n1.394 \nNumber of exposed children  \nwith vaccination status known\n1.334 (96%)\nNumber of cases \n77 (6%) \n<15 months: 60 \n\u226515 months: 17\nNumber of no cases \n1.257 (94%) \n<15 months: 152 \n\u226515 months: 1.317\nNumber of index cases: 15 (20%) \n<15 months: 8 \n\u226515 months: 7\nNumber of secondary cases: 57(74%) \nNumber of tertiary cases: 5 (6%) \n<15 months: 4 \n<15 months: 48 \n\u226515 months: 9  \n\u226515 months: 1 \nFig.\n 2.\n Flow\n chart\n of\n measles\n cases\n according\n to\n day-care\n and\n pre-school\n centre.\n Barcelona-South\n Health\n Region,\n August\n 2006\n to\n July\n 2007.\n2.2.\n Vaccine\n effectiveness\nTo\n study\n direct\n vaccination\n effectiveness\n (VE),\n we  excluded\n (a)\nchildren\n aged\n <15\n months,\n (b)\n children\n with\n measles\n infection\n prior\nto\n the\n outbreak,\n and\n (c)\n children\n with\n unknown\n vaccination\n status.\nChildren\n vaccinated\n during\n the\n study\n period\n were\n classi\ufb01ed\naccording\n to\n the\n vaccination\n status\n before\n the\n outbreak.\nAccording\n to\n the\n methodology\n described\n by\n Orenstein\n et\n al.", "mimetype": "text/plain", "start_char_idx": 10590, "end_char_idx": 11924, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "50276873-cc5d-4cdb-9999-b5f6077f2ec3": {"__data__": {"id_": "50276873-cc5d-4cdb-9999-b5f6077f2ec3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7d555d1e-558e-4738-bfee-8802d583d842", "node_type": "1", "metadata": {}, "hash": "9513b89042f53ba3f074eb24a638fd6ce1ba1a9e852bde608e7786f3721301ca", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b8574b00-fe65-4bda-a4c4-733ae5a840f3", "node_type": "1", "metadata": {}, "hash": "2eedc9c95f5d3d9cc36560d25ccc9f1b3cee0ebce735fc7656c8759311a4b5da", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "According\n to\n the\n methodology\n described\n by\n Orenstein\n et\n al.\n[18],\n we\n estimated\n VE\n using\n the\n formula:\n VE\n =\n (1\n \u2212\n RR)\n \u00d7\n 100,\n were\nRR\n is\n the\n rate\n ratio\n between\n the\n attack\n rate\n in\n vaccinated\n chil-\ndren\n (ARv) and\n the\n attack\n rate\n in\n unvaccinated\n children\n (ARu).\nThe\n 95%\n con\ufb01dence\n intervals\n (CI)\n were\n calculated\n using\n a\n Taylor\nseries.\nWe\n also\n assessed\n the\n impact\n on\n effectiveness\n [19\u201321]\n using\n dif-\nferences\n in\n vaccination\n rates\n in\n the\n following\n age\n groups\n according\nto\n the\n distribution\n of\n children\n in\n different\n classrooms:\n <6\n months,\n6\u201311\n months,\n 12\u201323\n months,\n 24\u201335\n months\n and\n \u226536\n months.\n Indi-\nrect\n effectiveness\n or\n herd\n immunity\n was\n estimated\n by\n comparing\nthe\n risk\n in\n non-vaccinated\n children\n from\n an\n immunized\n population\nand\n an\n identical\n but\n fully\n unimmunized\n population.\n The\n formula\n1\n \u2212\n ARu/\u02c7\n was\n used,\n where\n \u02c7\n is\n the\n baseline\n rate\n of\n disease\n that\nwould\n occur\n in\n a\n different\n comparable\n population\n without\n immu-\nnization.\n In\n the\n case\n of\n measles,\n \u02c7\n is\n 1,\n since\n the\n disease\n would\n affect\nall\n susceptible\n children.\nTotal\n effectiveness\n (direct\n and\n indirect\n effect)\n was\n estimated\nby\n comparing\n the\n risk\n in\n vaccinated\n children\n from\n an\n immunized\npopulation\n versus\n an\n identical\n but\n fully\n unimmunized\n population,\nusing\n the\n formula\n 1\n \u2212\n ARv/\u02c7.\n2.3.", "mimetype": "text/plain", "start_char_idx": 11858, "end_char_idx": 13262, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b8574b00-fe65-4bda-a4c4-733ae5a840f3": {"__data__": {"id_": "b8574b00-fe65-4bda-a4c4-733ae5a840f3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "50276873-cc5d-4cdb-9999-b5f6077f2ec3", "node_type": "1", "metadata": {}, "hash": "a9dd036c61c88d13ba8da1bde6198606a5ac50e48bc2a6ebd2bcad254d1bb3f8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "07543120-4219-4b7e-9108-ed3d2d811212", "node_type": "1", "metadata": {}, "hash": "dee137cf18cfe124c5d597316b8fcb13b903178d2417ada2ff704aef135c37b3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2.3.\n Basic\n reproduction\n number\n (R0)\nR0 is\n the\n average\n number\n of\n secondary\n cases\n due\n to\n a\n single\n case\nintroduced\n into\n a\n totally\n susceptible\n population\n [22]. To\n estimate\nR0 we\n used\n Becker\u2019s\n deterministic\n model,\n using\n Eqs.\n (1)\n and\n (2)\nwhich\n include\n three\n parameters:\n the\n \ufb01nal\n number\n of\n cases\n (C),\n the\nnumber\n of\n susceptible\n children\n before\n the\n epidemic\n (S),\n and\n the\ntotal\n number\n of\n children\n attending\n the\n selected\n educational\n centres\n(N)\n [23].\n\u02c6R0 = N \u2212\n 1\nC\nS\n\u0002\ni=S\u2212C+1\n1\ni ,\n \n(1)\nwith\n standard\n error\nSE(\u02c6R0) = N \u2212\n 1\nC\n\u0003\nS\n\u0002\ni=S\u2212C+1\n1\ni2 +\nC \u02c6R2\n0\n(N\n \u2212\n 1)2\n\u00041/2\n(2)\nI.\n Barrabeig\n et\n al.\n / Vaccine\n 29 (2011) 8024\u2013\n 8031\n8027\n2.4.\n Effective\n reproduction\n number\n (R)\nR is\n the\n average\n number\n of\n secondary\n infections\n per\n primary\n case\nin\n a\n population\n containing\n both\n immune\n and\n susceptible\n people.\n In\na\n homogeneously-mixed\n vaccinated\n population\n we\n used\n the\n fol-\nlowing\n equation:\n[R\n =\n R0 \u2212\n (P\n \u00d7\n R0)]\n \n(3)\nwhere\n R0 is\n the\n basic\n reproduction\n number,\n P\n the\n proportion\n of\n peo-\nple\n vaccinated\n in\n the\n population\n and\n (P\n \u00d7\n R0)\n the\n number\n of\n people\nprotected\n [22,24].\nIn\n centres\n where\n the\n index\n cases\n only\n attended\n one\n day\n during\nthe\n infectiousness\n period,\n there\n were\n only\n secondary\n cases\n in\n the\nsame\n classroom.", "mimetype": "text/plain", "start_char_idx": 13258, "end_char_idx": 14597, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "07543120-4219-4b7e-9108-ed3d2d811212": {"__data__": {"id_": "07543120-4219-4b7e-9108-ed3d2d811212", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b8574b00-fe65-4bda-a4c4-733ae5a840f3", "node_type": "1", "metadata": {}, "hash": "2eedc9c95f5d3d9cc36560d25ccc9f1b3cee0ebce735fc7656c8759311a4b5da", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c7442915-99b0-48a4-a6b8-2135aba062fa", "node_type": "1", "metadata": {}, "hash": "60e3d817d4890e7dfac8a786aaceb3940cfac4c2e72b890c2ea73a3af83a36a8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In\n centres\n where\n the\n index\n cases\n only\n attended\n one\n day\n during\nthe\n infectiousness\n period,\n there\n were\n only\n secondary\n cases\n in\n the\nsame\n classroom.\n However,\n when\n they\n attended\n for\n more\n than\n one\nday,\n there\n were\n secondary\n cases\n in\n other\n classrooms.\n The\n estimates\nof\n R0 and\n R\n were\n made\n for\n the\n centres\n where\n there\n were\n cases\n in\nother\n classrooms\n (Table\n 1:\n centres\n D\u2013G,\n I,\n J,\n L\n and\n O).\n2.5.\n Cases\n avoided\n by\n advancing\n the\n \ufb01rst\n dose\n of\n MMR\n to\n 12\nmonths\nThe\n number\n of\n cases\n avoided\n was\n estimated\n using\n by\n calculat-\ning\n the\n basic\n reproduction\n number\n and\n the\n effective\n reproduction\nnumber,\n using\n Eq.\n (3).\n2.6.\n Statistical\n analysis\nThe\n unit\n of\n analysis\n for\n this\n study\n was\n the\n individual\n child.\nA\n generalized\n linear\n mixed\n model\n was\n used\n to\n estimate\n the\nrelationships\n between\n the\n previous\n vaccination\n status\n and\n the\ncovariates\n age\n groups\n and\n gender.\n The\n following\n explanatory\nvariables\n were\n considered\n as\n categorical:\n vaccination\n status\n (1\n(reference\n value)\n =\n child\n unvaccinated,\n 2\n =\n child\n had\n received\n one\ndose\n of\n measles-containing\n vaccine\n and\n 3\n =\n child\n had\n received\n two\ndoses);\n age\n groups\n (1\n (reference\n value)\n =\n 15\n months-\n <\n 4\n years\n and\n2\n =\n \u22654\n years);\n gender\n (1\n (reference\n value)\n =\n male\n and\n 2\n =\n female)\nand\n educational\n centres\n (each\n day-care\n or\n pre-school\n centre\n was\nassigned\n a\n category\n from\n 1\n to\n 15).\nAge\n groups\n and\n gender\n were\n the\n \ufb01xed\n effects\n and\n educational\ncentres\n the\n random\n effects.", "mimetype": "text/plain", "start_char_idx": 14434, "end_char_idx": 16013, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c7442915-99b0-48a4-a6b8-2135aba062fa": {"__data__": {"id_": "c7442915-99b0-48a4-a6b8-2135aba062fa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "07543120-4219-4b7e-9108-ed3d2d811212", "node_type": "1", "metadata": {}, "hash": "dee137cf18cfe124c5d597316b8fcb13b903178d2417ada2ff704aef135c37b3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "223f15e6-a846-408a-882f-1c9f922c49a9", "node_type": "1", "metadata": {}, "hash": "77c118e4be6d59fda534e5ad2cdfa000daf3dd55c70819af0626fa201fc9c870", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Age\n groups\n and\n gender\n were\n the\n \ufb01xed\n effects\n and\n educational\ncentres\n the\n random\n effects.\n These\n models\n can\n detect\n hypothetical\nclusters\n imposed\n by\n the\n variable\n educational\n centre.\nParameters\n were\n estimated\n using\n the\n library\n lme4\n implemented\non\n the\n R\n open\n source\n package\n [25].\nAnalyses\n were\n performed\n using\n the\n SPSS\n v18.0\n for\n Windows\n and\nEpidat\n statistical\n packages.\n3.\n Results\n3.1.\n Characteristics\n of\n the\n study\n population\nDuring\n the\n study\n period,\n we\n investigated\n 15\n centres\n (12\n day-\ncare\n [0\u20133\n years]\n and\n 3\n pre-school\n [3\u20136\n years]\n centres)\n with\n a\n total\n of\n1394\n children,\n of\n whom\n 51%\n (706)\n were\n male\n and\n with\n a\n median\n age\nof\n 27.3\n months\n (range:\n 3.5\u201370.3).\n The\n characteristics\n of\n the\n centres\ninvestigated\n are\n shown\n in\n Table\n 1.\nThe\n vaccination\n status\n was\n determined\n in\n 1334\n children\n(96%).\n The\n proportion\n of\n vaccinated\n children\n was\n 73.8%\n (range;\n45.7\u2013100%).\n Vaccination\n coverage\n was\n 91.6%\n in\n children\n aged\n \u226515\nmonths\n (1121),\n 89.8%\n (774/862)\n in\n children\n aged\n 15\n months-\n <\n 4\nyears\n and\n 97.7%\n (253/259)\n in\n children\n aged\n \u22654\n years.\n There\n was\na\n positive\n association\n between\n vaccination\n status\n and\n age\n groups\n(p\n <\n 0.001)\n but\n no\n association\n between\n vaccination\n status\n and\n gen-\nder\n (p\n =\n 0.91).\n There\n was\n no\n cluster\n effect\n imposed\n by\n the\n variable\neducational\n centre\n (variance\n =\n 0)\n (see\n Table\n 2).", "mimetype": "text/plain", "start_char_idx": 15914, "end_char_idx": 17371, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "223f15e6-a846-408a-882f-1c9f922c49a9": {"__data__": {"id_": "223f15e6-a846-408a-882f-1c9f922c49a9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c7442915-99b0-48a4-a6b8-2135aba062fa", "node_type": "1", "metadata": {}, "hash": "60e3d817d4890e7dfac8a786aaceb3940cfac4c2e72b890c2ea73a3af83a36a8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4d39accd-8b5f-4f39-af53-1ad82ba4daf5", "node_type": "1", "metadata": {}, "hash": "7c2df23d5b4a784cda28934416c129dfa8b1c3a924a646338aafabb9ed77cdac", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "There\n was\n no\n cluster\n effect\n imposed\n by\n the\n variable\neducational\n centre\n (variance\n =\n 0)\n (see\n Table\n 2).\nNo\n children\n with\n a\n history\n of\n measles\n were\n identi\ufb01ed.\nTable\n 1\nStudy\n children\n characteristics\n by\n day-care\n centres\n and\n primary\n schools.\n Barcelona-South\n Health\n Region,\n October\n 2006\n to\n 15th\n January\n 2007.\nA\n \nB\n \nC \nD \nE\n \nF\n \nG \nH \nI \nJ \nK \nL \nM \nN\n \nO \nTotal\nNo\n of\n children\n attending\n126\n135\n70\n122\n84\n95\n48\n55\n66\n40\n \n88\n \n310\n \n39\n \n68\n \n48\n \n1394\nGender\nMale\n65\n66\n38\n70\n45\n \n48\n \n26\n \n26\n \n34\n \n21\n \n45\n \n149\n \n19\n \n30\n \n24\n \n706\nFemale\n \n61\n \n69\n \n32\n \n52\n \n39\n \n47\n \n22\n \n29\n \n32\n \n19\n \n43\n \n161\n \n20\n \n38\n \n24\n \n688\nAge\n (median\n (min,\n max)\n in\nmonths)\n21.6\n(3.5\u2013\n32.5)\n49.2\n(34.0\u2013\n68.3)\n51.5\n(33.0\u2013\n67.1)\n21.9\n(3.6\u2013\n34.1)\n25.2\n(11.2\u2013\n34.2)\n25.5\n(8.1\u2013\n35.0)\n16.6\n(5.3\u2013\n22.8)\n25.1\n(6.0\u2013\n34.5)\n28.8\n(9.5\u2013\n70.1)\n23.3\n(7.1\u2013\n33.9)\n37.9\n(7.2\u2013\n70.3)\n27.3\n(3.9\u2013\n69.3)\n22.1\n(4.9\u2013\n35.2)\n57.3\n(36.6\u2013\n69.6)\n18.3\n(4.0\u2013\n25.7)\n27.3\n(3.5\u2013\n70.", "mimetype": "text/plain", "start_char_idx": 17256, "end_char_idx": 18232, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4d39accd-8b5f-4f39-af53-1ad82ba4daf5": {"__data__": {"id_": "4d39accd-8b5f-4f39-af53-1ad82ba4daf5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "223f15e6-a846-408a-882f-1c9f922c49a9", "node_type": "1", "metadata": {}, "hash": "77c118e4be6d59fda534e5ad2cdfa000daf3dd55c70819af0626fa201fc9c870", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "091c868d-1be0-4e7b-87ce-c334273b69a2", "node_type": "1", "metadata": {}, "hash": "3794f343cb2e9cd0811aacdd43ddd6f9d2a20d75997792a92488683efd474836", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "9\u2013\n35.2)\n57.3\n(36.6\u2013\n69.6)\n18.3\n(4.0\u2013\n25.7)\n27.3\n(3.5\u2013\n70.3)\nPeriod\n of\n infectiousness\n (in\n days)\n1\n1\n2\n7\n6\n2\n3\n \n1 \n3 \n3\n \n1\n \n2 \n1  \n1\n \n2\nVaccination\n status\n0\n dose\n39\n8\n5\n55\n \n22\n \n25\n \n19\n \n10\n \n9 \n9\n \n13\n \n58\n \n12\n \n0 \n18\n \n302\n1\n dose\n \n83\n \n71\n \n35\n \n61\n \n62\n \n67\n \n16\n \n44\n \n37\n \n14\n \n51\n \n212\n \n27\n \n27\n \n28\n \n835\n2\n doses\n0\n \n50\n \n30\n \n0 \n0 \n0 \n0 \n1 \n16\n \n1\n \n21\n \n37\n \n0 \n41\n \n0 \n197\nMissing\n information\n4\n6\n0\n6\n0\n3\n13\n0\n \n4 \n16\n \n3\n \n3 \n0 \n0 \n2 \n60\nPercentage\n of\n vaccinated\n \n68.0%\n \n93.8%\n \n92.9%\n \n52.6%\n \n73.8%\n \n72.8%\n \n45.7%\n \n81.8%\n \n85.5%\n \n62.5%\n \n84.7%\n \n81.1%\n \n69.2%\n \n100.0%\n \n60.9%\n \n77.4%\n<6\n months\n0.0%\n\u2013\n\u2013\n0.0%\n \n\u2013 \n\u2013\n \n0.0%\n \n0.0%\n \n\u2013 \n\u2013\n \n\u2013\n \n0.0%\n \n0.0%\n \n\u2013\n \n0.0%\n \n0.0%\n6\u201311\n months\n \n0.0%\n \n\u2013\n \n\u2013 \n0.0%\n \n0.0%\n \n0.0%\n \n0.0%\n \n0.0%\n \n20.0%\n \n0.0%\n \n0.0%\n \n0.0%\n \n0.0%\n \n\u2013\n \n9.0%\n \n1.7%\n12\u201323\n months\n \n69.0%\n \n\u2013\n \n\u2013 \n51.8%\n \n60.6%\n \n59.4%\n \n57.2%\n \n81.3%\n \n70.", "mimetype": "text/plain", "start_char_idx": 18174, "end_char_idx": 19075, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "091c868d-1be0-4e7b-87ce-c334273b69a2": {"__data__": {"id_": "091c868d-1be0-4e7b-87ce-c334273b69a2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4d39accd-8b5f-4f39-af53-1ad82ba4daf5", "node_type": "1", "metadata": {}, "hash": "7c2df23d5b4a784cda28934416c129dfa8b1c3a924a646338aafabb9ed77cdac", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "468275b3-54e8-485f-aadf-8af1dabb7796", "node_type": "1", "metadata": {}, "hash": "d1f3c5b87d49c14ded8dd09b8277c708347279c2a6fc67f385a76da1e2f516a4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "0%\n \n1.7%\n12\u201323\n months\n \n69.0%\n \n\u2013\n \n\u2013 \n51.8%\n \n60.6%\n \n59.4%\n \n57.2%\n \n81.3%\n \n70.6%\n \n60.0%\n \n75.0%\n \n75.0%\n \n69.2%\n \n\u2013\n \n75.0%\n \n66.8%\n24\u201335\n months\n \n97.7%\n100.0%\n83.3%\n78.1%\n89.4%\n90.7%\n\u2013\n100.0%\n100.0%\n100.0%\n \n100.0%\n \n100.0%\n \n100.0%\n \n\u2013\n \n100.0%\n \n95.1%\n>36\n months\n \n\u2013 \n93.4%\n \n93.7%\n \n\u2013 \n\u2013 \n\u2013\n \n\u2013 \n\u2013 \n100.0%\n \n\u2013\n \n97.6%\n \n95.7%\n \n\u2013  \n100.0%\n \n\u2013 \n95.9%\nCon\ufb01rmed\n cases\n (n)\n2\n1\n1\n22\n \n8 \n4\n \n11\n \n1 \n2 \n7\n \n2\n \n8 \n1  \n1\n \n6 \n77\nAttack\n rate\n (%)\n \n1.6%\n \n0.7%\n \n1.4%\n \n18.0%\n \n9.5%\n \n4.2%\n \n22.9%\n \n1.8%\n \n3.0%\n \n17.5%\n \n2.3%\n \n2.6%\n \n2.6%\n \n1.5%\n \n12.5%\n \n5.5%\nSecondary\n cases\n1\n \n0\n \n0\n \n16*\n7 \n3\n \n10\n \n0 \n1 \n6\n \n1\n \n7 \n0 \n0 \n5 \n57\nEligible\n for\n VE\n analysis\n in\n >15\nmonths,\n n/cases\n90/0\n \n129/1\n \n70/1\n \n83/1\n \n75/2\n \n76/4\n \n18/1\n \n46/0\n \n55/0\n \n17/2\n \n77/1\n \n261/0\n \n27/0\n \n68/1\n \n29/3\n \n1121/17\n* 5\n tertiary\n cases\n are\n included.\n8028\nI.\n Barrabeig\n et\n al.", "mimetype": "text/plain", "start_char_idx": 18991, "end_char_idx": 19870, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "468275b3-54e8-485f-aadf-8af1dabb7796": {"__data__": {"id_": "468275b3-54e8-485f-aadf-8af1dabb7796", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "091c868d-1be0-4e7b-87ce-c334273b69a2", "node_type": "1", "metadata": {}, "hash": "3794f343cb2e9cd0811aacdd43ddd6f9d2a20d75997792a92488683efd474836", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "48ad5349-c079-41ae-920b-33f0757d3e22", "node_type": "1", "metadata": {}, "hash": "b3d0074f7db35da7bf33ffef9f042a6681193cfe2e1a9ae5e832efb6a7c16173", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "8028\nI.\n Barrabeig\n et\n al.\n / Vaccine\n 29 (2011) 8024\u2013\n 8031\nTable\n 2\nGeneralized\n linear\n mixed\n model\n for\n estimating\n the\n relationships\n between\n the\n vaccination\n status\n and\n the\n covariates\n age\n group\n and\n gender\n using\n educational\n centres\n as\n cluster\nvariable.\nFormula:\n Previous\n Vaccination\n status\n \u223cAge\n +\n Gender\n +\n (1|Educational\n centre)\nRandom\n effects\nGroups\n \nName\n \nVariance\n \nStd.\n dev.\nEducational\n centre\n \n(Intercept)\n \n0 \n0\nNumber\n of\n obs:\n 1121,\n groups:\n Educational\n centre,\n 15\nFixed\n effects\nEstimate\nstd.\n Error\nz\n value\nPr(>|z|)\n(Intercept)\n0.64039\n0.03138\n \n20.407\n \n<2e\u221216***\nAge2\n0.35987\n \n0.04511\n \n7.977\n \n1.49e\u221215***\nGender2\n \n0.00470\n \n0.04140\n \n0.114\n \n0.91\nSignif.\n codes:\n 0\n \u2018***\u2019\n 0.001\n \u2018**\u2019\n 0.01\n \u2018*\u2019\n 0.05\n \u2018.\u2019\n 0.1\n \u2018\u00b7\u2019\n 1.\nRegarding\n the\n distribution\n of\n children\u2019s\n age\n groups\n according\n to\nschool\n classroom,\n the\n proportion\n of\n vaccines\n was:\n <6\n months\n 0%\n(0/16),\n 6\u201311\n months\n 1.7%\n (2/116),\n 12\u201323\n months\n 66.8%\n (272/407),\n24\u201335\n months\n 95.1%\n (384/404),\n 36\u201347\n months\n 92.4%\n (121/131)\nand\n \u22654\n years\n 97.3%\n (253/260)\n (p\n \u2264\n 0.001).\n Seventy-seven\n percent\nof\n children\n aged\n \u22654\n years\n had\n received\n two\n doses.", "mimetype": "text/plain", "start_char_idx": 19843, "end_char_idx": 21037, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "48ad5349-c079-41ae-920b-33f0757d3e22": {"__data__": {"id_": "48ad5349-c079-41ae-920b-33f0757d3e22", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "468275b3-54e8-485f-aadf-8af1dabb7796", "node_type": "1", "metadata": {}, "hash": "d1f3c5b87d49c14ded8dd09b8277c708347279c2a6fc67f385a76da1e2f516a4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "04f31a07-4857-4b9d-90ad-df5f4dbc847a", "node_type": "1", "metadata": {}, "hash": "5c41d9341e1a5d469714c6ae29ff29d8e4d80704b1b52713012dde25acb665ff", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Seventy-seven\n percent\nof\n children\n aged\n \u22654\n years\n had\n received\n two\n doses.\nSeventy-seven\n con\ufb01rmed\n cases\n were\n detected\n (62\n laboratory-\ncon\ufb01rmed\n and\n 15\n due\n to\n epidemiological\n link),\n of\n which\n 54%\n (42)\nwere\n male.\n Fifteen\n were\n index\n cases,\n 57\n secondary\n cases\n and\n 5\ntertiary\n cases.\n The\n median\n school\n attendance\n of\n cases\n during\n the\ninfectiousness\n period\n was\n <1\n day\n (range:\n 0\u20137\n days)\n for\n all\n cases,\n 1\nday\n (range:\n 1\u20137\n days)\n for\n index\n cases\n and\n <1\n day\n (range:\n 0\u20132\n days)\nfor\n secondary\n cases.\nIn 72\n (93.5%)\n cases\n there\n was\n no\n history\n of\n vaccination\n or\n pre-\nvious\n measles\n disease\n before\n the\n outbreak,\n while\n the\n remaining\n 5\ncases\n had\n received\n one\n dose\n of\n MMR.\nThe\n global\n attack\n rate\n was\n 5.5%\n (77\n cases\n in\n 1394\n children)\n range,\n0.7\u201322.9%.\n The\n attack\n rate\n in\n non-vaccinated\n children\n was\n much\nhigher\n than\n in\n vaccinated\n children\n (24.0%\n versus\n 0.5%,\n p\n <\n 0.001).\nThere\n were\n no\n cases\n in\n children\n vaccinated\n with\n two\n doses.", "mimetype": "text/plain", "start_char_idx": 20957, "end_char_idx": 21987, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "04f31a07-4857-4b9d-90ad-df5f4dbc847a": {"__data__": {"id_": "04f31a07-4857-4b9d-90ad-df5f4dbc847a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "48ad5349-c079-41ae-920b-33f0757d3e22", "node_type": "1", "metadata": {}, "hash": "b3d0074f7db35da7bf33ffef9f042a6681193cfe2e1a9ae5e832efb6a7c16173", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c5f3d955-7ee2-401d-9b24-e9e5f8410925", "node_type": "1", "metadata": {}, "hash": "f957f61194b891855ede15cc05be1c28766cec324682bb2b4b2957328c4bc12c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "There\n were\n no\n cases\n in\n children\n vaccinated\n with\n two\n doses.\n The\nattack\n rate\n according\n to\n age\n group\n was\n 6.3%\n (1/16)\n in\n the\n <6\n months\nage\n group;\n 22.4%\n (26/116)\n in\n the\n 6\u201311\n months\n age\n group;\n 9.7%\n(42/433)\n in\n the\n 12\u201323\n months\n age\n group;\n 1.1%\n (5/432)\n in\n the\n 24\u201335\nmonths\n age\n group,\n and\n 0.7%\n (3/397)\n in\n the\n \u226536\n months\n age\n group.\n3.2.\n Vaccine\n effectiveness\n3.2.1.\n Direct\n vaccination\n effectiveness\nIn\n the\n \u226515\n months\n age\n group,\n 1121\n children\n were\n eligible\n for\nthe\n VE\n analysis,\n of\n whom\n 1027\n were\n vaccinated\n (830\n had\n received\none\n and\n 197\n two\n doses).\n The\n ARu was\n 12.8%\n (12\n cases\n in\n 94\nnon-vaccinated\n children)\n and\n the\n ARv was\n 0.5%\n (5\n cases\n in\n 1027\nvaccinated\n children).\n The\n difference\n between\n ARu and\n ARv was\n sta-\ntistically\n signi\ufb01cant\n (p\n <\n 0.001).\n The\n VE\n for\n any\n dose\n of\n vaccine\n was\n96.2%\n (95%\n CI:\n 89.4\u201398.6%),\n and\n was\n similar\n in\n children\n vaccinated\nwith\n one\n dose,\n 95.3%\n (95%\n CI:\n 86.9\u201398.3%).", "mimetype": "text/plain", "start_char_idx": 21920, "end_char_idx": 22933, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c5f3d955-7ee2-401d-9b24-e9e5f8410925": {"__data__": {"id_": "c5f3d955-7ee2-401d-9b24-e9e5f8410925", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "04f31a07-4857-4b9d-90ad-df5f4dbc847a", "node_type": "1", "metadata": {}, "hash": "5c41d9341e1a5d469714c6ae29ff29d8e4d80704b1b52713012dde25acb665ff", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "38a50485-dcc3-4c5f-af54-9a61c6c4fe8d", "node_type": "1", "metadata": {}, "hash": "3b8d1afec3ff62b50efe0f4f9b9a5e612b1648d482184a4de782fb398ba0ecc4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "With\n respect\n to\n age\n groups,\n the\n VE\n was\n 89.4%\n (58.9\u201397.3%)\n in\nvaccinated\n children\n aged\n 15\n to\n 23\n months,\n 98.7%\n (88.9\u201399.8%)\n in\nthose\n aged\n 24\n to\n 35\n months\n and\n 97.7%\n (76.1\u201399.8%)\n in\n those\n aged\n\u226536\n months\n (Table\n 3).\n3.2.2.\n Indirect\n vaccination\n effectiveness\nVaccination\n conferred\n herd\n immunity\n in\n unvaccinated\n children\naged:\n 12\u201323\n months\n 71.1%\n (95%\n CI:\n 63.5\u201378.8%),\n 24\u201335\n months\n 80%\n(56.3\u201394.3%)\n and\n \u226536\n months\n 88.2%\n (63.6\u201398.5%).\n3.2.3.\n Total\n vaccination\n effectiveness\nTotal\n VE\n was\n 98.9%\n (96.8\u201399.8%)\n in\n vaccinated\n children\n aged\n12\u201323\n months\n and\n 99.7%\n (98.6\u201399.9%)\n in\n both\n the\n 24-35\n months\nand\n \u226536\n months\n age\n groups.\n3.3.\n Basic\n reproduction\n number\n (R0) and\n effective\n reproduction\nnumber\n (R)\nEstimated\n R0, using\n Eqs.\n (1)\n and\n (2),  was\n 4.23\n (95%\n CI:\n 2.79\u20135.66)\nfor\n the\n eight\n centres\n where\n virus\n transmission\n was\n observed\nbeyond\n the\n classroom\n of\n the\n index\n case.\nThe\n effective\n reproduction\n number\n (R)\n obtained\n from\n the\n ini-\ntial\n proportion\n of\n susceptible\n children\n (30%)\n was\n 1.29\n (95%\n CI:\n0.85\u20131.72)\n at\n the\n beginning\n of\n the\n study\n and\n 0.75\n (95%\n CI:\n0.50\u20130.90)\n at\n the\n end\n of\n the\n study.", "mimetype": "text/plain", "start_char_idx": 22934, "end_char_idx": 24151, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "38a50485-dcc3-4c5f-af54-9a61c6c4fe8d": {"__data__": {"id_": "38a50485-dcc3-4c5f-af54-9a61c6c4fe8d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c5f3d955-7ee2-401d-9b24-e9e5f8410925", "node_type": "1", "metadata": {}, "hash": "f957f61194b891855ede15cc05be1c28766cec324682bb2b4b2957328c4bc12c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d868b87e-a6b0-44e9-a45a-5530b95bdea1", "node_type": "1", "metadata": {}, "hash": "183c82548480e6de931e8619579c21d70c36a83c573fa2e8c19c3cb06c05908d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3.4.\n Cases\n avoided\n by\n advancing\n the\n \ufb01rst\n dose\n of\n MMR\n to\n 12\nmonths\nOf\n the\n 81\n children\n aged\n 12\n to\n 14\n months\n studied,\n 33\n were\ninfected\n (attack\n rate\n 41%).\nTable\n 3\nMMR\n vaccination\n status,\n attack\n rate\n and\n direct\n vaccine\n effectiveness\n (VE)\n of\n children\n aged\n \u226515\n months\n with\n known\n vaccination\n status,\n Barcelona-South\n Health\n Region,\nOctober\n 2006\n to\n 15th\n January\n 2007.\nn\n \nCases\n \nAttack\n rate,\n %\n \nRR\n (95%\n CI)\n \nVE,\n %\n (95%\n CI)\n \np\nVaccination\n status\n\u226515\n months\n \n1121\n \n17\n \n1.5\nNon-vaccinated\n \n94\n \n12\n \n12.8\n \n1.0\n (reference)\n \n\u2013\nVaccinated\n \n1027\n \n5\n \n0.5\n \n0.04\n (0.01\u20130.11)\n \n96.2\n (89.4\u201398.6)\n \n<0.001\n2-Doses\n \n197\n \n0\n \n0\n \n\u2013\n \n100.0\n1-Dose\n \n830\n \n5\n \n0.6\n \n0.05\n (0.02\u20130.13)\n \n95.3\n (86.9\u201398.3)\n \n<0.001\n15\u201323\n months\n \n326\n \n9\n \n2.8\nNon-vaccinated\n \n57\n \n6\n \n10.5\n \n1.0\n (reference)\n \n\u2013\nVaccinated\n \n269\n \n3\n \n1.1\n \n0.105\n (0.03\u20130.41)\n \n89.4\n (58.9\u201397.3)\n \n<0.001\n24\u201335\n months\n months\n \n404\n \n5\n \n1.2\nNon-vaccinated\n \n20\n \n4\n \n20.0\n \n1.0\n (reference)\n \n\u2013\nVaccinated\n384\n \n1\n \n0.3\n \n0.01\n (0.003\u20130.1)\n \n98.7\n (88.9\u201399.8)\n \n<0.001\n\u226536\n months\n months\n \n391\n \n3\n \n0.", "mimetype": "text/plain", "start_char_idx": 24152, "end_char_idx": 25280, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d868b87e-a6b0-44e9-a45a-5530b95bdea1": {"__data__": {"id_": "d868b87e-a6b0-44e9-a45a-5530b95bdea1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "38a50485-dcc3-4c5f-af54-9a61c6c4fe8d", "node_type": "1", "metadata": {}, "hash": "3b8d1afec3ff62b50efe0f4f9b9a5e612b1648d482184a4de782fb398ba0ecc4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "49a066d9-8028-4bd4-ab9c-0666ef1ee872", "node_type": "1", "metadata": {}, "hash": "267ae4c640fc4eec15c7df168231f790783a3afeb27ce9a00c6b42746764e66a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3\n \n0.01\n (0.003\u20130.1)\n \n98.7\n (88.9\u201399.8)\n \n<0.001\n\u226536\n months\n months\n \n391\n \n3\n \n0.8\nNon-vaccinated\n17\n \n2\n \n11.8\n \n1.0\n (reference)\n \n\u2013\nVaccinated\n \n374\n \n1\n \n0.3\n \n0.02\n (0.002\u20130.2)\n \n97.7\n (76.1\u201399.8)\n \n<0.001\nI.\n Barrabeig\n et\n al.\n / Vaccine\n 29 (2011) 8024\u2013\n 8031\n8029\nIf\n these\n children\n had\n received\n the\n MMR\n vaccine\n at\n 12\n months\nand\n assuming\n the\n same\n vaccination\n coverage\n in\n the\n study\n (91.6%)\nwith\n an\n R0 of\n 4.23,\n the\n number\n of\n children\n protected\n would\n have\nbeen\n 3.87\n (91.5%\n of\n 4.23);\n using\n equation\n 3\n [4.23\n \u2212\n (0.916\n *\n 4.23)]\nthe\n value\n of\n R\n obtained\n would\n be\n 0.36,\n and\n therefore\n 8.5%\n of\n children\nwould\n have\n developed\n measles\n (7\n cases)\n and\n 74\n cases\n would\n have\nbeen\n avoided.\n4.\n Discussion\nThis\n outbreak\n illustrates\n the\n current\n epidemiology\n of\n measles\nin\n Spain\n where,\n thanks\n to\n high\n MMR\n vaccine\n coverage,\n there\n is\n no\nendemic\n measles\n transmission,\n but\n there\n is\n a\n risk\n of\n outbreaks\n due\nto\n imported\n cases,\n as\n shown\n by\n the\n outbreak\n referred\n here,\n which\nwas\n due\n to\n an\n imported\n case\n that\n generated\n small\n clusters\n of\n short\nduration\n in\n unvaccinated\n people.", "mimetype": "text/plain", "start_char_idx": 25195, "end_char_idx": 26364, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "49a066d9-8028-4bd4-ab9c-0666ef1ee872": {"__data__": {"id_": "49a066d9-8028-4bd4-ab9c-0666ef1ee872", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d868b87e-a6b0-44e9-a45a-5530b95bdea1", "node_type": "1", "metadata": {}, "hash": "183c82548480e6de931e8619579c21d70c36a83c573fa2e8c19c3cb06c05908d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "99c21392-cbcb-4285-87b2-4945214051d4", "node_type": "1", "metadata": {}, "hash": "cd9e06252d491ab105fa75c3a4f5a2fec65b022625e417f98be6adda71b603dd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\n dif\ufb01culty\n in\n implementing\nadequate\n infection\n control\n measures\n in\n less\n than\n 72\n h\n outside\n the\nfamily\n environment\n may\n have\n contributed\n to\n the\n appearance\n of\nthese\n clusters\n [16].\nThe\n size\n of\n an\n outbreak\n depends\n on\n both\n the\n proportion\n of\n sus-\nceptible\n individuals\n in\n the\n population\n and\n on\n chance\n events\n in\nthe\n transmission\n process.\n Therefore,\n countries\n and\n regions\n with\nmeasles\n elimination\n strategies\n should\n monitor\n mean\n outbreak\n sizes\nas\n an\n indicator\n of\n the\n elimination\n status\n [17,26].\nIn\n our\n study,\n the\n highest\n attack\n rate\n was\n in\n children\n aged\n 6\u201311\nmonths\n (22.4%),\n followed\n by\n those\n aged\n 12\u201323\n months\n (9.7%).\nGiven\n the\n vaccination\n schedule\n when\n the\n outbreak\n occurred\n and\nthe\n distribution\n of\n children\n in\n educational\n centres,\n it\n may\n be\n sug-\ngested\n that\n children\n aged\n 6\u201311\n months\n had\n no\n immunity\n because\nthey\n had\n not\n previously\n been\n infected\n (no\n circulation\n of\n the\n virus),\nwere\n not\n vaccinated\n because\n of\n the\n vaccination\n schedule\n and\n had\nno\n maternal\n immunity.\n The\n percentage\n of\n susceptible\n children\n in\nthis\n age\n group\n was\n 98.3%\n and,\n for\n the\n reasons\n mentioned\n above,\n we\nconsider\n that\n herd\n immunity\n in\n the\n context\n of\n educational\n centres\nwas\n virtually\n non-existent.\nIn\n the\n 12\u201323\n months\n age\n group,\n vaccinated\n and\n non-vaccinated\nchildren\n shared\n classrooms.\n In\n vaccinated\n children,\n the\n VE\n was\n 89%,\nbut\n herd\n immunity\n could\n only\n prevent\n 71%\n of\n the\n expected\n cases\nin\n unvaccinated\n children\n and\n was\n totally\n inadequate\n in\n preventing\nthe\n spread\n of\n the\n outbreak.", "mimetype": "text/plain", "start_char_idx": 26366, "end_char_idx": 28007, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "99c21392-cbcb-4285-87b2-4945214051d4": {"__data__": {"id_": "99c21392-cbcb-4285-87b2-4945214051d4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "49a066d9-8028-4bd4-ab9c-0666ef1ee872", "node_type": "1", "metadata": {}, "hash": "267ae4c640fc4eec15c7df168231f790783a3afeb27ce9a00c6b42746764e66a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "be353aa2-fc81-4e33-8909-a39d9f37a02e", "node_type": "1", "metadata": {}, "hash": "7ead09d72844dcfc3dc0ee3603c03932e038b3b6dc57f0c3d7b0b02349c18221", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In\n the\n 24\u201335\n months\n and\n \u226536\n months\n age\n group,\n only\n 5%\n of\n chil-\ndren\n were\n susceptible\n to\n measles,\n because\n 70.7%\n had\n received\n one\ndose\n of\n MMR\n and\n 24.7%\n two\n doses.\n There\n was\n lower\n transmission\nof\n measles\n in\n the\n classroom\n (global\n attack\n rate\n of\n 0.9%),\n due\n to\n the\nhigh\n VE\n in\n vaccinated\n children\n and\n a\n herd\n immunity\n of\n nearly\n 90%.\nThe\n fact\n that\n 93.5%\n of\n cases\n were\n children\n non-vaccinated\n due\nto\n age\n meant\n that\n most\n of\n their\n school\n contacts\n were\n also\n non-\nvaccinated\n children.\n Therefore,\n the\n two\n main\n control\n measures\nconsisted\n of\n advancing\n the\n \ufb01rst\n dose\n of\n MMR\n in\n susceptible\n exposed\nchildren\n aged\n 9\n to\n 12\n months\n and\n the\n isolation\n of\n symptomatic\nchildren.\n With\n respect\n to\n post-exposure\n vaccination,\n vaccination\nwithin\n 72\n h\n after\n exposure\n was\n not\n possible\n in\n any\n centre,\n but\n sus-\nceptible\n children\n were\n vaccinated\n to\n avoid\n tertiary\n and\n quaternary\ncases.\n This\n intervention\n could\n only\n be\n carried\n out\n from\n mid-January\nonwards,\n after\n a\n public\n information\n campaign\n on\n measles\n preven-\ntion.\n Therefore,\n the\n previous\n control\n measure\n that\n allowed\n the\nspread\n of\n the\n outbreak\n to\n be\n controlled\n was\n principally\n active\nsurveillance\n of\n exposed\n people\n in\n order\n to\n isolate\n cases\n (a\n child\nwith\n fever\n should\n not\n attend\n the\n centre).This\n measure\n reduced\n the\nmedian\n period\n of\n transmissibility\n from\n 1\n day\n (1\u20137)\n to\n less\n than\n 1\nday\n (0\u20132),\n allowing\n the\n transmission\n chain\n to\n be\n broken.", "mimetype": "text/plain", "start_char_idx": 28008, "end_char_idx": 29560, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "be353aa2-fc81-4e33-8909-a39d9f37a02e": {"__data__": {"id_": "be353aa2-fc81-4e33-8909-a39d9f37a02e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "99c21392-cbcb-4285-87b2-4945214051d4", "node_type": "1", "metadata": {}, "hash": "cd9e06252d491ab105fa75c3a4f5a2fec65b022625e417f98be6adda71b603dd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "97f4e8be-4b41-4498-980c-d7351b0d9e2c", "node_type": "1", "metadata": {}, "hash": "cf4db85cb59bd173c3be5a320b0656d7d10b45ba24fc8cd095810c4ae1d0641e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "These\n community-based\n interventions\n require\n immediate\n and\neffective\n action\n by\n \ufb01eld\n epidemiology\n surveillance\n units\n and\n there-\nfore\n robust\n and\n sensitive\n surveillance\n systems,\n coordinated\n with\nmedical\n services,\n are\n essential.\nThe\n control\n measures\n mentioned\n above\n affect\n the\n transmis-\nsion\n of\n the\n virus.\n In\n our\n study,\n the\n estimated\n R0 was\n 4.3\n (95%\nCI\n 2.8\u20135.7),\n lower\n than\n that\n found\n by\n other\n reports\n in\n vaccinated\npopulations,\n although\n these\n studies\n did\n not\n state\n whether\n cases\nwere\n isolated.\n The\n isolation\n of\n cases\n may\n explain\n the\n reduced\ntransmission\n observed\n in\n our\n study\n [27,28]. It\n is\n accepted\n that,\n to\neliminate\n measles,\n the\n value\n of\n R0 should\n be\n below\n unity.\n The\n reduc-\ntion\n in\n the\n infectious\n period\n achieved\n by\n isolating\n cases\n limited\n the\nspread\n of\n the\n outbreak\n in\n schools,\n reducing\n the\n effective\n reproduc-\ntion\n number\n to\n <0.7\n (95%\n CI\n 0.5\u20130.9),\n the\n level\n recommended\n by\nthe\n WHO.\nIn\n our\n study,\n the\n VE\n with\n one\n dose\n of\n MMR\n in\n children\n aged\n\u226515\n months\n was\n 95%\n (87\u201398%)\n and\n 100%\n in\n children\n vaccinated\nwith\n two\n doses.\n These\n data\n are\n consistent\n with\n studies\n of\n previous\noutbreaks\n [29\u201331]\n and\n con\ufb01rm\n that\n vaccination\n with\n two\n doses\n of\nMMR\n is\n highly-effective\n in\n preventing\n measles\n [32\u201334].", "mimetype": "text/plain", "start_char_idx": 29561, "end_char_idx": 30912, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "97f4e8be-4b41-4498-980c-d7351b0d9e2c": {"__data__": {"id_": "97f4e8be-4b41-4498-980c-d7351b0d9e2c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "be353aa2-fc81-4e33-8909-a39d9f37a02e", "node_type": "1", "metadata": {}, "hash": "7ead09d72844dcfc3dc0ee3603c03932e038b3b6dc57f0c3d7b0b02349c18221", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4acb2b29-73f9-4160-a619-097bf52e6415", "node_type": "1", "metadata": {}, "hash": "a45d90f0976ab77028f768ecc57f40845f14732d403d1211407781127dc2165f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "When\n this\n outbreak\n began\n in\n Catalonia,\n the\n administration\nof\n MMR\n at\n 15\n months\n was\n recommended,\n based\n on\n studies\n of\nimmunogenicity\n and\n protective\n ef\ufb01cacy\n carried\n out\n in\n the\n 1970s\nand\n 1980s\n that\n showed\n that\n the\n risk\n of\n contracting\n measles\n in\n chil-\ndren\n vaccinated\n at\n 12\n months\n was\n 1.5\u20135\n times\n higher\n than\n in\n those\nvaccinated\n after\n this\n age\n [35\u201337].\nRecent\n studies\n show\n that,\n in\n populations\n with\n high\n vaccine\n cov-\nerages,\n the\n probability\n of\n natural\n boosting\n is\n reduced,\n causing\n an\nearlier\n loss\n of\n passive\n acquired\n immunity\n due\n to\n an\n earlier\n decrease\nin\n maternal\n antibodies\n transferred\n after\n 6\n months\n of\n age\n in\n children\nboth\n of\n vaccinated\n women\n and\n of\n women\n with\n naturally-acquired\nimmunity.\n This\n leads\n to\n an\n increasing\n gap\n in\n susceptibility\n between\nthe\n loss\n of\n maternal\n antibodies\n and\n administration\n of\n the\n \ufb01rst\n MMR\ndose\n [38\u201340].  On-time\n delivery\n of\n the\n \ufb01rst\n dose\n remains\n the\n highest\npriority\n for\n elimination\n programmes,\n and\n should\n be\n administered\nas\n soon\n as\n possible\n after\n the\n loss\n of\n protection\n by\n maternal\n antibod-\nies.\n The\n current\n WHO\n recommendation\n in\n countries\n with\n low\n rates\nof\n measles\n transmission\n is\n that\n the\n \ufb01rst\n dose\n may\n be\n administered\nat\n 12\n months\n [41].\nAnalysis\n of\n the\n outbreak\n led\n health\n authorities\n to\n recommend\nthe\n systematic\n advancement\n of\n the\n MMR\n vaccination\n from\n 15\n to\n 12\nmonths\n from\n 2008\n onwards\n [42].", "mimetype": "text/plain", "start_char_idx": 30913, "end_char_idx": 32420, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4acb2b29-73f9-4160-a619-097bf52e6415": {"__data__": {"id_": "4acb2b29-73f9-4160-a619-097bf52e6415", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "97f4e8be-4b41-4498-980c-d7351b0d9e2c", "node_type": "1", "metadata": {}, "hash": "cf4db85cb59bd173c3be5a320b0656d7d10b45ba24fc8cd095810c4ae1d0641e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d1b4961a-ff94-44a0-9e7b-f94a8a5452e8", "node_type": "1", "metadata": {}, "hash": "3313490124cb79538a0c1d6db3a6ceafc3afc0cfc326c80fd78b113b4d42646d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Assuming\n the\n same\n coverage\n of\nchildren\n vaccinated\n (91.6%),\n if\n vaccination\n at\n 12\n months\n had\n been\ncarried\n out,\n the\n effective\n reproduction\n number\n would\n have\n been\n0.4,\n meaning\n that\n 8.5%\n of\n children\n would\n have\n been\n infected.\n This\nmeans\n that,\n in\n the\n 81\n children\n aged\n 12\u201314\n months,\n there\n would\nhave\n been\n 7\n cases\n instead\n of\n 33,\n and\n therefore\n 32%\n (26/81)\n of\n cases\nwould\n have\n been\n prevented\n and\n the\n attack\n rate\n in\n this\n age\n group\nwould\n have\n been\n 8.6%\n instead\n of\n 41%.\nThe\n evolution\n of\n measles\n in\n our\n region\n after\n the\n outbreak\n stud-\nied\n con\ufb01rms\n this\n approach.\n In\n December\n 2010,\n a\n new\n outbreak\nof\n measles\n due\n to\n an\n imported\n case\n was\n detected\n in\n our\n region.\nBetween\n December\n 2010\n and\n July\n 2011,\n 92\n con\ufb01rmed\n cases\n have\nbeen\n detected\n with\n a\n median\n age\n of\n 26\n years\n (range\n 2\n months-46\nyears)\n [43].\n Eighty-four\n percent\n were\n non-vaccinated\n people,\n 25%\nof\n them\n were\n <12\n months\n and\n 62%\n \u226515\n years.\n No\n transmission\n in\neducational\n centres\n has\n been\n observed\n in\n children\n over\n 12\n months.\nIn\n the\n period\n December\n 2006\n to\n February\n 2007,\n when\n the\n MMR\nwas\n administered\n at\n 15\n months,\n there\n were\n 52\n con\ufb01rmed\n cases\n in\nchildren\n 12\u201315\n months.", "mimetype": "text/plain", "start_char_idx": 32422, "end_char_idx": 33694, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d1b4961a-ff94-44a0-9e7b-f94a8a5452e8": {"__data__": {"id_": "d1b4961a-ff94-44a0-9e7b-f94a8a5452e8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4acb2b29-73f9-4160-a619-097bf52e6415", "node_type": "1", "metadata": {}, "hash": "a45d90f0976ab77028f768ecc57f40845f14732d403d1211407781127dc2165f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "adc27230-84d6-43a0-9266-79503f62d560", "node_type": "1", "metadata": {}, "hash": "883df4fc88a91ab633e85edd64b27179bb68b2c6c894e4f084c67faaa23538d2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The\n huge\n difference\n between\n the\n two\n out-\nbreaks\n (52\n cases\n when\n the\n vaccine\n was\n administered\n at\n 15\n months\nand\n only\n 1\n when\n administered\n at\n 12\n months)\n is\n probably\n due\n to\n the\nincrease\n in\n the\n proportion\n of\n children\n vaccinated\n in\n this\n age\n range.\nAt\n present,\n only\n 34.4%\n of\n countries\n included\n in\n the\n EUVAC\n net-\nwork\n include\n routine\n administration\n of\n the\n \ufb01rst\n dose\n of\n MMR\n at\n 12\nor\n 13\n months,\n while\n 37.5%\n administer\n it\n at\n different\n ages\n from\n 14\nmonths\n onwards,\n including\n some\n at\n 18\n months,\n while\n 28.1%\n have\na\n recommended\n interval\n between\n a\n lower\n limit\n of\n 11\u201313\n months\nand\n an\n upper\n limit\n of\n 14\u201324\n months\n [44].\n Thus,\n there\n may\n be\n chil-\ndren\n vaccinated\n after\n 13\n months\n of\n age\n in\n accordance\n with\n national\n8030\nI.\n Barrabeig\n et\n al.\n / Vaccine\n 29 (2011) 8024\u2013\n 8031\nvaccination\n schedules.\n This\n is\n the\n situation\n in\n Spain,\n where\n the\nnational\n vaccination\n schedule\n establishes\n an\n interval\n for\n the\n \ufb01rst\ndose\n of\n between\n 12\n and\n 15\n months:\n however,\n only\n 3\n of\n the\n 19\nSpanish\n regions\n vaccinate\n at\n 12\n months\n [45]\n while\n the\n remaining\n16\n vaccinate\n at\n 15\n months.\n In\n Europe,\n more\n than\n half\n the\n EUVAC\ncountries\n recommend\n the\n \ufb01rst\n dose\n of\n MMR\n after\n 13\n months.", "mimetype": "text/plain", "start_char_idx": 33696, "end_char_idx": 34993, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "adc27230-84d6-43a0-9266-79503f62d560": {"__data__": {"id_": "adc27230-84d6-43a0-9266-79503f62d560", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d1b4961a-ff94-44a0-9e7b-f94a8a5452e8", "node_type": "1", "metadata": {}, "hash": "3313490124cb79538a0c1d6db3a6ceafc3afc0cfc326c80fd78b113b4d42646d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e4980a8c-cee1-4640-8ee0-6c8e6e386b1f", "node_type": "1", "metadata": {}, "hash": "a72314141c3fae2d3eed4d4d922bef728d5b779da3432d54e35e195b516a6656", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In\n Europe,\n more\n than\n half\n the\n EUVAC\ncountries\n recommend\n the\n \ufb01rst\n dose\n of\n MMR\n after\n 13\n months.\n As\nthe\n measles\n virus\n circulates\n widely\n in\n Europe\n and\n outbreaks\n con-\ntinue\n to\n emerge\n in\n different\n EU\n countries,\n in\n addition\n to\n achieving\nand\n maintaining\n very-high\n vaccination\n coverages\n (\u226595%)\n of\n each\nnew\n birth\n cohort\n with\n two\n doses\n of\n MMR,\n it\n would\n be\n desirable\n to\nadminister\n the\n \ufb01rst\n dose\n at\n 12\n months.\nSome\n potential\n limitations\n of\n this\n study\n might\n bias\n the\n calcu-\nlation\n of\n vaccine\n effectiveness\n [18],\n including\n the\n veri\ufb01cation\n of\nvaccination\n and\n the\n underdetection\n of\n cases.\n However,\n the\n vac-\ncination\n status\n was\n veri\ufb01ed\n directly\n by\n public\n health\n staff\n and\n a\nfollow-up\n was\n conducted\n in\n each\n centre\n until\n the\n end\n of\n the\n out-\nbreak\n to\n capture\n all\n cases.\n Therefore,\n we\n believe\n that\n these\n factors\nhad\n no\n in\ufb02uence.\nLikewise,\n another\n possible\n limitation\n is\n that\n the\n method\n for\n esti-\nmating\n R0 assumes\n no\n heterogeneity\n in\n mixing.\n This\n means\n that\nevery\n child\n has\n the\n same\n probability\n of\n contact\n with\n other\n children.\nR0 was\n calculated\n in\n centres\n attended\n by\n the\n index\n case\n for\n two\n or\nmore\n days\n during\n the\n infectious\n period,\n ensuring\n the\n possibility\n of\ncontact\n between\n children.\n Vaccinated\n and\n non-vaccinated\n people\nare\n not\n distributed\n at\n random.\n We  did\n not\n use\n stochastic\n models,\nas\n the\n study\n population\n was\n closed\n with\n only\n two\n generations\n of\ncases.\n5.", "mimetype": "text/plain", "start_char_idx": 34885, "end_char_idx": 36417, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e4980a8c-cee1-4640-8ee0-6c8e6e386b1f": {"__data__": {"id_": "e4980a8c-cee1-4640-8ee0-6c8e6e386b1f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "adc27230-84d6-43a0-9266-79503f62d560", "node_type": "1", "metadata": {}, "hash": "883df4fc88a91ab633e85edd64b27179bb68b2c6c894e4f084c67faaa23538d2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7a6652e6-e187-4e1c-99e0-b9392c4a888c", "node_type": "1", "metadata": {}, "hash": "ac8e897a9c4102144c409ebd0df9f979150362f9376987458c0617e6eb9166ea", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "We  did\n not\n use\n stochastic\n models,\nas\n the\n study\n population\n was\n closed\n with\n only\n two\n generations\n of\ncases.\n5.\n Conclusions\nDirect\n vaccine\n effectiveness\n after\n receiving\n at\n least\n 1\n dose\n of\nMMR vaccine\n was\n high\n (>96%).\n However,\n the\n outbreak\n could\n not\nbe\n avoided\n due\n to\n the\n large\n number\n of\n exposed\n children\n who\n had\nnot\n reached\n the\n recommended\n vaccination\n age.\n It\n is\n important\n to\nmonitor\n the\n changes\n in\n the\n fraction\n of\n susceptible\n individuals\n over\ntime.\nIf\n the\n \ufb01rst\n dose\n of\n MMR\n vaccine\n had\n been\n administered\n at\n 12\ninstead\n of\n 15\n months,\n 91.5%\n of\n cases\n in\n children\n aged\n 12\n to\n 14\nmonths\n would\n have\n been\n avoided.\n In\n order\n to\n achieve\n the\n goal\n of\neliminating\n measles\n in\n Europe,\n we\n consider\n it\n essential\n to\n advance\nthe\n \ufb01rst\n dose\n of\n MMR\n to\n 12\n months,\n as\n recommended\n by\n the\n WHO.\nAcknowledgements\nThis\n work\n was\n partially\n funded\n by\n CIBER\n Epidemiolog\u00eda\n y\n Salud\nP\u00fablica\n (CIBERESP)\n Spain,\n FEDER\n and\n AGAUR\n (expedient\n number\n2009\n SGR\n 42).\nWe\n thank\n the\n reporting\n physicians\n and\n the\n staff\n and\n parents\n of\nthe\n day-care\n and\n primary\n schools.\nCon\ufb02ict\n of\n interest\n statement:\n None\n declared.\nReferences\n[1]\n Anderson\n RM,\n May\n RM.\n Infectious\n diseases\n of\n humans:\n dynamics\n and\n control.\nOxford,\n United\n Kingdom:\n Oxford\n University\n Press;\n 1991.\n[2]\n Dietz\n K.\n The\n estimation\n of\n the\n basic\n reproduction\n number\n for\n infectious\n dis-\neases.\n Stat\n Methods\n Med\n Res\n 1993;2:23\u201341.\n[3]\n Gershon\n AA.", "mimetype": "text/plain", "start_char_idx": 36295, "end_char_idx": 37825, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7a6652e6-e187-4e1c-99e0-b9392c4a888c": {"__data__": {"id_": "7a6652e6-e187-4e1c-99e0-b9392c4a888c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e4980a8c-cee1-4640-8ee0-6c8e6e386b1f", "node_type": "1", "metadata": {}, "hash": "a72314141c3fae2d3eed4d4d922bef728d5b779da3432d54e35e195b516a6656", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4e7fc939-e0a9-4837-b316-ecf0cc15b050", "node_type": "1", "metadata": {}, "hash": "5bbb71b0bf55a4f3c5ed3fd93b79683f2290f151e2e628fea43b2d97462104fd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Stat\n Methods\n Med\n Res\n 1993;2:23\u201341.\n[3]\n Gershon\n AA.\n Measles\n virus.\n In:\n Mandell\n GL,\n Bennett\n JE,\n Dolin\n R,\n editors.\n Princi-\nples  and\n practice\n of\n infectious\n diseases.\n 7th\n ed.\n Philadelphia:\n Elsevier;\n 2010.\n p.\n2229\u201336.\n[4] Grif\ufb01n\n DE.\n Measles\n virus.\n In:\n Kniper\n DM,\n Howley\n PM,\n editors.\n Fields\n virology.\n5th\n ed.\n Philadelphia:\n Wolters\n Kluwer;\n 2007.\n p.\n 1552\u201385.\n[5]  American\n Academy\n of\n Pediatrics.\n Measles.\n In:\n Pickering\n LK,\n Baker\n CJ,\n Kimberlin\nDW,\n Long\n SS,\n editors.\n Red\n Book:\n 2009\n Report\n of\n the\n Committee\n on\n Infectious\nDiseases.\n 28th\n ed.\n Elk\n Grove\n Village,\n IL:\n American\n Academy\n of\n Pediatrics;\n 2009.\np.\n 444\u201355.\n[6] Word\n Health\n Organization.\n WHO\n vaccine-preventable\n diseases:\n monitoring\nsystem.\n 2010\n global\n summary.\n WHO:\n Immunization,\n Vaccines\n and\n Biologicals;\n2009.\n[7]\n Pan\n American\n Health\n Organization.\n Measles\n elimination\n by\n the\n year\n 2000.\n EPI\nNewslett\n 1994;16:1\u20132.\n[8]\n De\n Quadros\n CA.\n Can\n measles\n be\n eradicated\n globally?\n Bull\n World\n Health\n Organ\n2004;82:134\u20138.\n[9]  Word\n Health\n Organization.\n Eliminating\n measles\n and\n rubella\n and\n prevent-\ning  congenital\n rubella\n infection.\n WHO\n European\n Region\n strategic\n plan\n2005\u20132010.\n Copenhagen,\n WHO\n Regional\n Of\ufb01ce\n for\n Europe,\n http://www.\neuro.who.int/documE87772ent/.pdf;\n 2005\n [accessed\n 16.06.11].", "mimetype": "text/plain", "start_char_idx": 37769, "end_char_idx": 39134, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4e7fc939-e0a9-4837-b316-ecf0cc15b050": {"__data__": {"id_": "4e7fc939-e0a9-4837-b316-ecf0cc15b050", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7a6652e6-e187-4e1c-99e0-b9392c4a888c", "node_type": "1", "metadata": {}, "hash": "ac8e897a9c4102144c409ebd0df9f979150362f9376987458c0617e6eb9166ea", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6a41fdd3-c90a-4b26-b022-2d8d16b65502", "node_type": "1", "metadata": {}, "hash": "cd7488c5086e6fed77678c5af536d9c0785df195ae89f591dafab2e10f292d47", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Copenhagen,\n WHO\n Regional\n Of\ufb01ce\n for\n Europe,\n http://www.\neuro.who.int/documE87772ent/.pdf;\n 2005\n [accessed\n 16.06.11].\n[10] Peltola\n H,\n Heinonen\n P,\n Valle\n M,  Paunio\n M,\n Virtanen\n M,\n Karanko\n V,\n et\n al.\n The\nelimination\n of\n indigenous\n measles,\n mumps\n and\n rubella\n from\n Finland\n by\n a 12\nyears,\n two\n dose\n vaccination\n program.\n N\n Engl\n J Med\n 1994;331:1397\u2013402.\n[11] Pe\u02dcna-Rey\n I,\n Mart\u00ednez\n V,\n Mosquera\n M,\n de\n Ory\n F,\n Echevarr\u00eda\n JE.\n Measles\n risk\n groups\nin  Spain:\n implications\n for\n the\n European\n measles-elimination\n target.\n Vaccine\n2009;27:3927\u201334.\n[12]\n Martin\n R,\n Eshevoi\n S,\n Jankovi\n D,\n Goel\n A,\n Mercer\n D,\n Laurent\n E.\n Progress\n toward\nmeasles\n elimination-European\n region,\n 2005\u20132008.\n MMWR\n 2009;58:142\u20135.\n[13] Dom\u00ednguez\n A,\n Torner\n N,\n Barrabeig\n I, Rovira\n A,\n Rius\n C,\n Cayl\u00e0\n J,\n et\n al.\n Large\nmeasles\n outbreak\n in\n a\n community\n with\n high\n vaccination\n coverage.\n Clin\n Infect\nDis\n 2008;47:1143\u20139.\n[14] Departament\n de\n Sanitat\n i Segueretat\n and\n Social.\n L\u2019eliminaci\u00f3\n del\n xarampi\u00f3\n a\nCatalunya\n per\n l\u2019any\n 2000.\n 1st\n ed.\n Barcelona:\n Generalitat\n de\n Catalunya;\n 1991.\n[15] Dom\u00ednguez\n A,\n Vidal\n J, Plans\n P,\n Carmona\n G,\n Godoy\n P,\n Batalla\n J,\n et\n al.\n Measles\nimmunity\n and\n vaccination\n policy\n in\n Catalonia.", "mimetype": "text/plain", "start_char_idx": 39011, "end_char_idx": 40284, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6a41fdd3-c90a-4b26-b022-2d8d16b65502": {"__data__": {"id_": "6a41fdd3-c90a-4b26-b022-2d8d16b65502", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4e7fc939-e0a9-4837-b316-ecf0cc15b050", "node_type": "1", "metadata": {}, "hash": "5bbb71b0bf55a4f3c5ed3fd93b79683f2290f151e2e628fea43b2d97462104fd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d18a18df-30bd-42b2-ae96-037b030136fc", "node_type": "1", "metadata": {}, "hash": "60c37b058111cf59a90e86246c62b6bdb4919b4b9a19093574cd30c35bd4f8f9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Measles\nimmunity\n and\n vaccination\n policy\n in\n Catalonia.\n Vaccine\n 1999;17:530\u20134.\n[16] Barrabeig\n I,\n Rovira\n A,\n Rius\n C,\n Mu\u02dcnoz\n P,\n Soldevila\n N,\n Batalla\n J,\n et\n al.\n Effective-\nness\n of\n measles\n vaccination\n for\n control\n of\n exposed\n children.\n Pediatr\n Infect\n Dis\nJ\n 2011;30(1):78\u201380,\n doi:10.1097/INF.0b013e3181f7001c.\n[17]\n WHO.\n \nSurveillance\n \nguidelines\n \nfor\n \nmeasles,\n \nrubella\n \nand\n \ncongenital\nrubella\n \nsyndrome\n \nin\n \nthe\n \nWHO\n \nEuropean\n \nRegion.\n \nCopenhagen,\n \nWHO\nRegional\n Of\ufb01ce\n for\n Europe,\n http://www.euro.who.int/\n data/assets/pdf\n \ufb01le/\n0018/79020/E93035.pdf;\n 2009\n [accessed\n 16.06.11].\n[18]\n Orenstein\n W,\n Bernier\n RH,\n Dondero\n TJ,\n Hinman\n AR,\n Marks\n JS,\n Bart\n KJ,\n et\n al.\n Field\nevaluation\n of\n vaccine\n ef\ufb01cacy.\n Bull\n World\n Health\n Organ\n 1985;63:1055\u201368.\n[19] Halloran\n ME,\n Haber\n M,\n Longini\n Jr\n IM,\n Struchiner\n CJ.\n Direct\n and\n indirect\n effects\nin  vaccine\n ef\ufb01cacy\n and\n effectiveness.\n Am\n J\n Epidemiol\n 1991;133(4):323\u201331.\n[20]\n Halloran\n ME,\n Struchiner\n CJ,\n Longini\n Jr\n IM.\n Study\n designs\n for\n evaluating\ndifferent\n ef\ufb01cacy\n and\n effectiveness\n aspects\n of\n vaccines.\n Am\n J\n Epidemiol\n1997;146(10):789\u2013803.\n[21] Patel\n MM,\n Tate\n J,\n Cortese\n M,\n Payne\n DC,\n Armstrong\n G,\n Parashar\n UD,\n et\n al.", "mimetype": "text/plain", "start_char_idx": 40226, "end_char_idx": 41490, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d18a18df-30bd-42b2-ae96-037b030136fc": {"__data__": {"id_": "d18a18df-30bd-42b2-ae96-037b030136fc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6a41fdd3-c90a-4b26-b022-2d8d16b65502", "node_type": "1", "metadata": {}, "hash": "cd7488c5086e6fed77678c5af536d9c0785df195ae89f591dafab2e10f292d47", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9cb9ed12-98bf-42b9-975c-a74efb49499c", "node_type": "1", "metadata": {}, "hash": "4a29088003b5c1da5c95295f3711557fd6ebf8e50a331ca96a177703ef0321f1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "[21] Patel\n MM,\n Tate\n J,\n Cortese\n M,\n Payne\n DC,\n Armstrong\n G,\n Parashar\n UD,\n et\n al.\n The\nimpact\n of\n indirect\n bene\ufb01ts\n of\n vaccination\n on\n postlicensure\n vaccine\n effectiveness\nestimates:\n a scenario\n analysis.\n Vaccine\n 2010;28(50):7987\u201392.\n[22] Strebel\n PM,\n Papania\n MJ,\n Dayan\n GH,\n Halsey\n NA.\n Measles\n vaccine.\n In:\n Plotkin\n SA,\nOrenstein\n WA,\n Of\ufb01t\n PA,\n editors.\n Vaccines.\n 5th\n ed.\n Philadelphia:\n Saunders;\n 2008.\np.\n 353\u201398.\n[23]\n Becker\n NG.\n Analysis\n of\n infectious\n disease\n data.\n Chapman\n and\n Hall;\n 1989.\n[24]\n Gay\n NJ.\n The\n theory\n of\n measles\n elimination:\n Implications\n for\n the\n design\n of\n elim-\nination\n strategies.\n JID\n 2004;189(Suppl.\n 1):S27\u201335.\n[25] R\n Development\n Core\n Team.\n R:\n a language\n and\n environment\n for\n statis-\ntical  computing.\n R\n Foundation\n for\n Statistical\n Computing.\n Vienna,\n Austria,\nhttp://cran.r-project.org/;\n 2011\n [accessed\n 16.06.11].\n[26] De\n Serres\n G,\n Gay\n NJ,\n Farrington\n CP.\n Epidemiology\n of\n transmissible\n diseases\n after\nelimination.\n Am\n J Epidemiol\n 2000;151:1039\u201348.\n[27]\n Mossong\n J,\n Muller\n CP.\n Estimation\n of\n the\n basic\n reproduction\n number\n of\n measles\nduring\n an\n outbreak\n in\n a\n partially\n vaccinated\n population.\n Epidemiol\n Infect\n2000;124(2):273\u20138.\n[28]\n Mori\n N,\n Ohkusa\n Y,\n Ohyama\n T,\n Tanaka-Taya\n K,\n Taniguchi\n K,\n Kobayashi\n JM,\n et\n al.\nEstimation\n of\n measles\n vaccine\n coverage\n needed\n to\n prevent\n transmission\n in\nschools.", "mimetype": "text/plain", "start_char_idx": 41401, "end_char_idx": 42837, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9cb9ed12-98bf-42b9-975c-a74efb49499c": {"__data__": {"id_": "9cb9ed12-98bf-42b9-975c-a74efb49499c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d18a18df-30bd-42b2-ae96-037b030136fc", "node_type": "1", "metadata": {}, "hash": "60c37b058111cf59a90e86246c62b6bdb4919b4b9a19093574cd30c35bd4f8f9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "37f61395-b41b-4b3c-9d10-4201951f2c48", "node_type": "1", "metadata": {}, "hash": "fee16a452b65468722ebbc49858202fb28e224bbbd55e48ce1a3e4e5d527e769", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Estimation\n of\n measles\n vaccine\n coverage\n needed\n to\n prevent\n transmission\n in\nschools.\n Pediatr\n Int\n 2008;50(4):464\u20138.\n[29] King\n GE,\n Markowitz\n LE,\n Patriarca\n PE,\n Dales\n LG.\n Clinical\n ef\ufb01cacy\n of\n measles\n vac-\ncine\n during\n the\n 1990\n measles\n epidemic.\n Pediatr\n Infect\n Dis\n J 1991;10:883\u20137.\n[30] Ramsay\n M,\n Moffatt\n D,\n O\u2019Connor\n M.\n Measles\n vaccine:\n a\n 27-year\n follow-up.\n Epi-\ndemiol\n Infect\n 1994;112:409\u201312.\n[31]\n Davis\n RM,\n Whitman\n ED,\n Orenstein\n WA,\n Preblud\n SR,\n Markowitz\n LE,\n Hinman\n AR.\nA\n persistent\n outbreak\n of\n measles\n despite\n appropriate\n prevention\n and\n control\nmeasures.\n Am\n J Epidemiol\n 1987;126:438\u201349.\n[32]\n Watson\n JC,\n Pearson\n JA,\n Markowitz\n LE,\n Baughman\n AL,\n Erdman\n DD,\n Bellini\n WJ,\net  al.\n An\n evaluation\n of\n measles\n revaccination\n among\n school-entry-aged\n chil-\ndren.\n Pediatric\n 1996;97:613\u20138.\n[33]\n American\n Academy\n of\n Pediatrics.\n Committee\n of\n infectious\n diseases.\n Age\n of\n rou-\ntine\n administration\n of\n the\n second\n dose\n of\n measles\u2013mumps\u2013rubella\n vaccine.\nPediatric\n 1998;101:129\u201333.\n[34] Viteck\n CR,\n Aduddell\n M,\n Brinton\n MJ,\n Hoffman\n RE,\n Redd\n SC.\n Increased\n protections\nduring\n a measles\n outbreak\n of\n children\n previously\n vaccinated\n with\n a\n second\n dose\nof\n measles\u2013mumps\u2013rubella\n vaccine.\n Pediatr\n Infect\n Dis\n J 1999;18:620\u20133.", "mimetype": "text/plain", "start_char_idx": 42747, "end_char_idx": 44066, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "37f61395-b41b-4b3c-9d10-4201951f2c48": {"__data__": {"id_": "37f61395-b41b-4b3c-9d10-4201951f2c48", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9cb9ed12-98bf-42b9-975c-a74efb49499c", "node_type": "1", "metadata": {}, "hash": "4a29088003b5c1da5c95295f3711557fd6ebf8e50a331ca96a177703ef0321f1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2568623e-3e73-470e-a5d1-0f04b1a13881", "node_type": "1", "metadata": {}, "hash": "13c037b7567fa981536391cad18ebdb7d50e4d84ad6c54b3b2510563240ab7da", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Pediatr\n Infect\n Dis\n J 1999;18:620\u20133.\n[35]\n Krugman\n S.\n Present\n status\n of\n measles\n and\n rubella\n immunization\n in\n the\n United\nStates:\n a\n medical\n progress\n report.\n J Pediatr\n 1971;78:1\u201316.\n[36]\n Orenstein\n WA,\n Markowitz\n L,\n Preblud\n Sr,\n Hinman\n AR,\n Tomasi\n A,\n Bart\n KJ.\nAppropriate\n age\n for\n measles\n vaccination\n in\n the\n United\n States.\n Dev\n Biol\n Stand\n1986;65:13\u201321.\n[37] Marks\n JS,\n Halpin\n TJ,\n Orenstein\n WA.\n Measles\n vaccine\n ef\ufb01cacy\n in\n children\n previ-\nously\n vaccinated\n at\n 12\n month\n of\n age.\n Pediatrics\n 1978;62:955\u201360.\n[38] Leuridan\n E,\n Hens\n N,\n Hutse\n V,\n Ieven\n M,\n Aerts\n M,\n Van\n Damme\n P.\n Early\n waning\n of\nmaternal\n measles\n antibodies\n in\n era\n of\n measles\n elimination:\n longitudinal\n study.\nBr  Med\n J 2010;340:C1626.\n[39]\n Johansen\n K,\n Lopalco\n P.\n Passive\n immunity\n against\n measles\n in\n infants:\n is\n there\n a\nneed\n for\n policy\n changes\n in\n the\n European\n vaccination\n schedules?\n Euro\n Surveill\n2007;12(9):E3\u20134.\nI.\n Barrabeig\n et\n al.\n / Vaccine\n 29 (2011) 8024\u2013\n 8031\n8031\n[40]  Markowitz\n LE,\n Albrecht\n P,\n Rhodes\n P,\n Demonteverde\n R,\n Swint\n E,\n Maes\n EF,\n et\n al.\nChanging\n levels\n of\n measles\n antibody\n titers\n in\n women\n and\n children\n in\n the\n United\nStates:\n impact\n on\n response\n to\n vaccination.\n Kaiser\n Permanente\n Measles\n Vaccine\nTrial\n Team.\n Pediatrics\n 1996;97(1):53\u20138.", "mimetype": "text/plain", "start_char_idx": 44028, "end_char_idx": 45369, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2568623e-3e73-470e-a5d1-0f04b1a13881": {"__data__": {"id_": "2568623e-3e73-470e-a5d1-0f04b1a13881", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca\u2010Barrabeig (2011b).pdf", "node_type": "4", "metadata": {}, "hash": "9fc584f519af2351a247f4a6757b4e7dea05ae358252fde1bed8112055feb8ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "37f61395-b41b-4b3c-9d10-4201951f2c48", "node_type": "1", "metadata": {}, "hash": "fee16a452b65468722ebbc49858202fb28e224bbbd55e48ce1a3e4e5d527e769", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Kaiser\n Permanente\n Measles\n Vaccine\nTrial\n Team.\n Pediatrics\n 1996;97(1):53\u20138.\n[41]\n Word\n Health\n Organization.\n WHO\n position\n on\n measles\n vaccines.\n Vaccine\n2009;27:7219\u201321.\n[42]\n DECRET\n 219/2008,\n d\u201911\n de\n novembre,\n pel\n qual\n s\u2019estableix\n el\n calendari\n de\nvacunacions\n sistem\u00e0tiques.\n Generalitat\n de\n Catalunya,\n http://www.gencat.cat/\ndiari/5257/08310104.htm; 2008\n [accessed\n 16.06.11].\n[43]\n Boletin\n epidemiologico\n semanal\n en\n red.\n Informaci\u00f3n\n sobre\n sarampion.\n Informe\nsemanal\n de\n vigilancia\n 26\n de\n julio\n de\n 2011.\n Instituto\n de\n Salud\n Carlos\nIII,  http://www.isciii.es/htdocs/centros/epidemiologia/boletin\n red/IS-110726-\nWEB.pdf;\n 2011\n [accessed\n 08.08.11].\n[44]\n EUVAC.net,\n \nhttp://www.euvac.net/graphics/euvac/vaccination/mmr.html\n[accessed\n 16.06.11].\n[45]\n Ministerio\n de\n Sanidad,\n Pol\u00edtica\n Social\n e\n Igualdad,\n http://www.msps.es/\nciudadanos/proteccionSalud/infancia/vacunaciones/programa/vacunaciones.\nhtm;\n 2011\n [accessed\n 16.06.11].", "mimetype": "text/plain", "start_char_idx": 45290, "end_char_idx": 46266, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "67b3be09-6415-496a-9a26-5b2fc4361269": {"__data__": {"id_": "67b3be09-6415-496a-9a26-5b2fc4361269", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9f958d35-9d3a-4603-8e4a-888305596bc7", "node_type": "1", "metadata": {}, "hash": "c6495bcf7b5f1c91318cdef51dd7614cbd6eb329eb2268c3f21f1fa377784f53", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "INFLAMMATORY BOWEL DISEASE\nEnvironmental risk factors in paediatric inflammatory bowel\ndiseases: a population based case control study\nS Baron, D Turck, C Leplat, V Merle, C Gower-Rousseau, R Marti, T Yzet, E Lerebours, J-L Dupas,\nS Debeugny, J-L Salomez, A Cortot, J-F Colombel\n. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .\nSee end of article for\nauthors\u2019 affiliations\n. . . . . . . . . . . . . . . . . . . . . . .\nCorrespondence to:\nProfessor J-F Colombel,\nDepartment of Hepato-\nGastroenterology and\nRegistre EPIMAD, Hopital\nClaude Huriez, CH et U de\nLille, 59037 Lille Cedex,\nFrance; jfcolombel@\nchru-lille.fr\nRevised version received\n9 September 2004\nAccepted for publication\n12 September 2004\n. . . . . . . . . . .", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 927, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9f958d35-9d3a-4603-8e4a-888305596bc7": {"__data__": {"id_": "9f958d35-9d3a-4603-8e4a-888305596bc7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "67b3be09-6415-496a-9a26-5b2fc4361269", "node_type": "1", "metadata": {}, "hash": "091ea445572bb35c1fb08bb9f2ca476d5375adb762c0795a849be91ad26bc15f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f7c7132b-4579-46f1-a0cb-51fb05484063", "node_type": "1", "metadata": {}, "hash": "ddb8cd803ddd9e5e3746fa60f79cb4942d50da508c5c782e871b1ffdaea19462", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": ". . . . . . . . . . . . . . . . . . . . . .\nGut 2005;54:357\u2013363. doi: 10.1136/gut.2004.054353\nBackground: Environmental exposures in early life have been implicated in the aetiology of inflammatory\nbowel disease.\nObjective: To examine environmental risk factors prior to the development of inflammatory bowel disease\nin a paediatric population based case control study.\nMethods: A total of 222 incident cases of Crohn\u2019s disease and 60 incident cases of ulcerative colitis\noccurring before 17 years of age between January 1988 and December 1997 were matched with one\ncontrol subject by sex, age, and geographical location. We recorded 140 study variables in a\nquestionnaire that covered familial history of inflammatory bowel disease, events during the perinatal\nperiod, infant and child diet, vaccinations and childhood diseases, household amenities, and the family\u2019s\nsocioeconomic status.\nResults: In a multivariate model, familial history of inflammatory bowel disease (odds ratio (OR) 4.3 (95%\nconfidence interval 2.3\u20138)), breast feeding (OR 2.1 (1.3\u20133.4)), bacille Calmette-Guerin vaccination (OR\n3.6 (1.1\u201311.9)), and history of eczema (OR 2.1 (1\u20134.5)) were significant risk factors for Crohn\u2019s disease\nwhereas regular drinking of tap water was a protective factor (OR 0.56 (0.3\u20131)). Familial history of\ninflammatory bowel disease (OR 12.5 (2.2\u201371.4)), disease during pregnancy (OR 8.9 (1.5\u201352)), and\nbedroom sharing (OR 7.1 (1.9\u201327.4)) were risk factors for ulcerative colitis whereas appendicectomy was\na protective factor (OR 0.06 (0.01\u20130.36)).\nConclusions: While family history and appendicectomy are known risk factors, changes in risk based on\ndomestic promiscuity, certain vaccinations, and dietary factors may provide new aetiological clues.", "mimetype": "text/plain", "start_char_idx": 908, "end_char_idx": 2661, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f7c7132b-4579-46f1-a0cb-51fb05484063": {"__data__": {"id_": "f7c7132b-4579-46f1-a0cb-51fb05484063", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9f958d35-9d3a-4603-8e4a-888305596bc7", "node_type": "1", "metadata": {}, "hash": "c6495bcf7b5f1c91318cdef51dd7614cbd6eb329eb2268c3f21f1fa377784f53", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "00d11e34-4c82-4454-a039-911cf7875890", "node_type": "1", "metadata": {}, "hash": "e627b6c680553230953af13d75c63c0c3d8507513962c52ba0214ac492c4a137", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Conclusions: While family history and appendicectomy are known risk factors, changes in risk based on\ndomestic promiscuity, certain vaccinations, and dietary factors may provide new aetiological clues.\nT\nhe pathophysiology of inflammatory bowel diseases\n(IBD) is still unknown but epidemiological studies show\nclear evidence of genetic susceptibility.1 2 This evidence\nhas been supplemented by molecular genetic data from\ngenome wide linkage scans and candidate gene studies.\nIdentification of the first IBD susceptibility gene, NOD2/\nCARD15, has been a major breakthrough in genetic research\nand may provide a key step towards unravelling the aetiology\nof the disease. However, fundamental features of IBD such as\nthe significant geographical variation in disease incidence\nand rapid rise in the incidence of Crohn\u2019s disease (CD) over\nthe past century cannot be accounted for by genetic\npredisposition alone.3 4\nThere is accumulating evidence that events early in life\nmay have long term effects on health and disease. Several\nepidemiological studies have suggested a role for perinatal or\nchildhood events in the aetiology of IBD.3 4 Both non-specific\nexposures and specific exposures have been studied. Non-\nspecific exposures include gastroenteritis and other non-\nspecific infections. Specific exposures include measles virus\ninfection and vaccines, appendicectomy, and passive smok-\ning. As for autoimmune diseases, a consistent finding in early\nobservational studies for both CD and ulcerative colitis (UC)\nwas the association between high socioeconomic status and\nan increased risk.5\u20137 An attractive theory to explain this\nassociation is that it may result from a decrease in the\nprevalence of early childhood infections.8 However, there are\nno solid data indicating either a positive or negative role of\nhygiene in the development of IBD.\nA registry of IBD (EPIMAD) has been running in Northern\nFrance since 1988.9 10 It provides access to a large population\nbased cohort of patients with IBD which is suitable for\nenvironmental studies. Here we report the results of a case\ncontrol study examining environmental risk factors prior to\nthe development of IBD in the subset of patients who were\nless than 17 years old at diagnosis.\nMATERIAL AND METHODS\nStudy design\nThis was a population based matched case control study.", "mimetype": "text/plain", "start_char_idx": 2460, "end_char_idx": 4788, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "00d11e34-4c82-4454-a039-911cf7875890": {"__data__": {"id_": "00d11e34-4c82-4454-a039-911cf7875890", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f7c7132b-4579-46f1-a0cb-51fb05484063", "node_type": "1", "metadata": {}, "hash": "ddb8cd803ddd9e5e3746fa60f79cb4942d50da508c5c782e871b1ffdaea19462", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1badba83-9133-452c-9ee7-221d4c5e5ed6", "node_type": "1", "metadata": {}, "hash": "a61b56f213a1d9a610fdb93d47ec362ce8d3d89a22acb3639e3949ab0cb6014f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MATERIAL AND METHODS\nStudy design\nThis was a population based matched case control study.\nCases were all patients from the EPIMAD registry who had a\ndiagnosis of either CD or UC between January 1988 and\nDecember 1997 and were less than 17 years old at the time of\nIBD diagnosis. Controls were randomly selected from tele-\nphone number lists (random digit dialling) and matched 1:1\nto each case by age (\u00a12 years), sex, and living area (region).\nCase identification and diagnostic criteria\nThe study area was the northern part of France which has\n5 790 526 inhabitants (1999 national population census) and\nis divided into four regions: Nord, Pas-de-Calais, Somme, and\nSeine-Maritime. The paediatric population under 17 years of\nage is as follows: Nord = 593 837; Pas de Calais = 332 228\n(these 2 regions constitute and will be referred as the Nord-\nPas de Calais region); Somme = 115 969; Seine-Maritime =\n270 107 (total 1 312 141). The methodology of the EPIMAD\nregistry has previously been described in details.9 10 Briefly,\ninterviewer\npractitioners\ncollected\ndata\non\nall\npatients\ndiagnosed between 1 January 1988 and 31 December 1997\nfrom all gastroenterologists (including paediatric gastro-\nenterologists) in the whole area. Only patients who had\nbeen residents in the defined study areas at the time of\nAbbreviations: IBD, inflammatory bowel disease; CD, Crohn\u2019s disease;\nUC, ulcerative colitis; BCG, bacille Calmette-Guerin; MMR, measles-\nmumps-rubella; OR, odds ratio\n357\nwww.gutjnl.com\ncopyright.\n on January 9, 2025 at Assistance Publique Hopitaux de Paris. Protected by\nhttp://gut.bmj.com/\nGut: first published as 10.1136/gut.2004.054353 on 11 February 2005. Downloaded from \ndiagnosis of their disease were included.", "mimetype": "text/plain", "start_char_idx": 4699, "end_char_idx": 6427, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1badba83-9133-452c-9ee7-221d4c5e5ed6": {"__data__": {"id_": "1badba83-9133-452c-9ee7-221d4c5e5ed6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "00d11e34-4c82-4454-a039-911cf7875890", "node_type": "1", "metadata": {}, "hash": "e627b6c680553230953af13d75c63c0c3d8507513962c52ba0214ac492c4a137", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eb0c48d5-0d0a-4f4c-9c51-d2fa324bead1", "node_type": "1", "metadata": {}, "hash": "62954b7108a2c712c76d7f11d1c6ececf37c6e8a9ba23c121787537053f24102", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Downloaded from \ndiagnosis of their disease were included. A final diagnosis of\nCD or UC was made by two expert gastroenterologists and\nrecorded as definite, probable, or possible, following criteria\npreviously published.9 For the purpose of this study, only\npatients with definite or probable CD or UC were considered.\nQuestionnaires\nTrained investigators personally interviewed both the study\nsubject and his (her) mother at home. Investigators and\nparticipants were blind to the study hypotheses. Questions\ncovered the period from birth to the date of diagnosis or\ncorresponding period for controls (from birth to age at\ndiagnosis of the matched case). The \u2018\u2018carnet de sante\u00b4\u2019\u2019\n(paediatric health booklet that is mandatory in France for\ninfants, children, and adolescents, with information on\npregnancy, delivery, child\u2019s growth, vaccination, childhood\ninfections, etc) was required to validate questions about the\nchild\u2019s health. A questionnaire was devised comprising 140\nquestions relating to six different areas: (i) family history of\nIBD; (ii) perinatal period (disease during pregnancy, gesta-\ntional age at birth, birth weight and height, and infection and\nhospitalisation during the first month of life); (iii) infant and\nchild diet (including questions on passive and active smok-\ning); (iv) childhood infections (measles, mumps, rubella,\nchicken pox, whooping cough, croup, scarlet fever, hepatitis),\nother childhood diseases (asthma, eczema), surgery (tonsil-\nlectomy, adenoidectomy, appendicectomy, and others) and\nvaccines (measles- mumps-rubella (MMR) vaccine, bacille\nCalmette-Guerin vaccine (BCG), diphtheria, tetanus, polio-\nmyelitis, pertussis vaccine, and others). In France, smallpox\nvaccination within the first two years of life was mandatory\nuntil 1978 and BCG within the first six years of life until the\npresent.", "mimetype": "text/plain", "start_char_idx": 6369, "end_char_idx": 8209, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "eb0c48d5-0d0a-4f4c-9c51-d2fa324bead1": {"__data__": {"id_": "eb0c48d5-0d0a-4f4c-9c51-d2fa324bead1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1badba83-9133-452c-9ee7-221d4c5e5ed6", "node_type": "1", "metadata": {}, "hash": "a61b56f213a1d9a610fdb93d47ec362ce8d3d89a22acb3639e3949ab0cb6014f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "89571ed3-a606-4d79-9fc6-3e49d91fec1c", "node_type": "1", "metadata": {}, "hash": "026166d49fb5256d9f8c30defc84cd65528f754bf3cfa7dadfb755a6fb7362cf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In France, smallpox\nvaccination within the first two years of life was mandatory\nuntil 1978 and BCG within the first six years of life until the\npresent. More than one dose of BCG can be administered in\nthe case of a negative skin tuberculin test; (v) home ameni-\nties (presence of bathroom, hot water, mains drainage, septic\ntank, etc), water consumption (tap water, bottle water, water\nfrom well), type and size of housing (flat, house, other), and\npresence of animals\n(pets, others\nanimals). Area was\nregistered as urban or rural according to the INSEE (French\nnational statistics institute) classification of French commu-\nnities. For each house, entry date and leaving date were\nregistered allowing evaluation of the duration of exposure to\neach risk factor. If there were major changes in housing\n(septic tank replaced by mains drainage, for example), it was\nconsidered as two different housings; (vi) parents\u2019 and\nchild\u2019s socioeconomic status. Total duration of the interview\nwas approximately two hours. A copy of the interview form is\navailable on request from one of the authors (CGR).\nData management\nEach investigator coded most of the answers for computer\nanalysis using standard rules. Questionnaires were sent to\nthe Department of Epidemiology and Public Health, Lille\nUniversity Hospital, and the remaining answers were coded\nand incoherences checked. Particular attention was paid to\nthe date of each event in order to consider only those\noccurring before the onset of disease for cases and in the\ncorresponding time period for controls.\nParents of affected children or controls and children who\nwere more than 18 years at the time of inquiry gave informed\nwritten consent. Approval for the survey was obtained from\nlocal and national ethics committees for human studies.\nStatistical analysis\nSeparate analysis was performed for patients with CD and\ntheir matched controls, and for patients with UC and their\nmatched controls. Characteristics of the populations were\ndescribed\nusing\nmedian\nvalues\n(with\n25th\nand\n75th\npercentiles) for quantitative variables and frequencies for\nqualitative variables.", "mimetype": "text/plain", "start_char_idx": 8056, "end_char_idx": 10172, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "89571ed3-a606-4d79-9fc6-3e49d91fec1c": {"__data__": {"id_": "89571ed3-a606-4d79-9fc6-3e49d91fec1c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eb0c48d5-0d0a-4f4c-9c51-d2fa324bead1", "node_type": "1", "metadata": {}, "hash": "62954b7108a2c712c76d7f11d1c6ececf37c6e8a9ba23c121787537053f24102", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "398d9d7e-33d1-42ce-9241-29f6750a3bd3", "node_type": "1", "metadata": {}, "hash": "2d97c2a70769d0b0b8317d93216201d64c9bd6735767647da447e429bc3a0d46", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Characteristics of the populations were\ndescribed\nusing\nmedian\nvalues\n(with\n25th\nand\n75th\npercentiles) for quantitative variables and frequencies for\nqualitative variables.\nUnivariate associations between potential risk factors and\nCD or UC were compared with tests for matched series: for\nqualitative variables the McNemar x2 test was used and for\nquantitative variables the Wilcoxon rank sum test. A p value\nof ,0.05 was considered to denote a statistically significant\ndifference. In multivariate analysis, based on conditional\nTable 1\nSociodemographic characteristics of the children and parents\nCrohn\u2019s disease\nUlcerative colitis\nCases (%)\n(n = 222)\nControls (%)\n(n = 222)\np Value\nCases (%)\n(n = 60)\nControls (%)\n(n = 60)\np Value\nSex\nMale\n120 (54)\n120 (54)\n23 (38)\n23 (38)\nFemale\n102 (46)\n102 (46)\n37 (62)\n37 (62)\nMedian age at diagnosis (y)\n13.5\n\u2014\n14.1\n\u2014\nLiving area\nNord-Pas de Calais\n152 (68)\n152 (68)\n46 (77)\n46 (77)\nSomme\n34 (15)\n34 (15)\n4 (6)\n4 (6)\nSeine Maritime\n36 (17)\n36 (17)\n10 (17)\n10 (17)\nChild\u2019s educational level\n0.58\n0.16\n(5 y\n12 (5)\n10 (5)\n0 (0)\n3 (5)\n5\u201311 y\n86 (39)\n97 (44)\n28 (47)\n23 (38)\n12 y\n49 (22)\n41 (18)\n10 (17)\n16 (27)\n.12 y\n75 (34)\n74 (33)\n22 (36)\n18 (30)\nSiblings\nNo sibling\n17 (8)\n33 (15)\n0.02\n7 (12)\n7 (12)\n1\nOlder siblings\n137\n114\n0.02\n40\n29\n0.05\nYounger siblings\n130\n121\n0.39\n37\n28\n0.14\nFather\u2019s educational level\n0.", "mimetype": "text/plain", "start_char_idx": 10000, "end_char_idx": 11353, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "398d9d7e-33d1-42ce-9241-29f6750a3bd3": {"__data__": {"id_": "398d9d7e-33d1-42ce-9241-29f6750a3bd3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "89571ed3-a606-4d79-9fc6-3e49d91fec1c", "node_type": "1", "metadata": {}, "hash": "026166d49fb5256d9f8c30defc84cd65528f754bf3cfa7dadfb755a6fb7362cf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bab38f01-555b-4755-af85-dfc9450e051f", "node_type": "1", "metadata": {}, "hash": "d02825d13d688a8cc65f4c741e9280204c7ededee3f653603e649ba3c6d253af", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "02\n40\n29\n0.05\nYounger siblings\n130\n121\n0.39\n37\n28\n0.14\nFather\u2019s educational level\n0.44\n(5 y\n37 (17)\n28 (13)\n7 (12)\n1 (2)\n5\u201311 y\n118 (53)\n115 (52)\n35 (58)\n31 (52)\n12 y\n28 (13)\n37 (17)\n7 (12)\n12 (20)\n.12 y\n35 (17)\n38 (18)\n10 (18)\n15 (25)\nMother\u2019s educational level\n0.55\n0.24\n(5 y\n34 (15)\n30 (14)\n5 (8)\n4 (7)\n5\u201311 y\n123 (55)\n116 (52)\n41 (68)\n32 (53)\n12 y\n30 (13)\n43 (19)\n8 (13)\n11 (18)\n.12 y\n35 (17)\n33 (15)\n6 (11)\n13 (22)\n358\nBaron, Turck, Leplat, et al\nwww.gutjnl.com\ncopyright.\n on January 9, 2025 at Assistance Publique Hopitaux de Paris. Protected by\nhttp://gut.bmj.com/\nGut: first published as 10.1136/gut.2004.054353 on 11 February 2005. Downloaded from \nlogistic regression, variables with a p value ,0.2 in the\nunivariate analysis were proposed for entry into the model.\nPotential confounding factors were proposed in the model.\nWe used a forward procedure in which we set p = 0.1 for the\nindependent variables to enter into the model. In most\npaediatric studies, mother\u2019s educational level is the most\nrelevant variable associated with child\u2019s health and child\u2019s\nuse of health services. Therefore, in multivariate analysis,\nresults were adjusted on mother\u2019s educational level and\nfather\u2019s educational level, irrespective of statistical signifi-\ncance in the univariate analysis. Adequacy of the models to\nthe data was tested using the Hosmer and Lesmeshow test.\nFor multivariate analysis, odds ratios (OR) and confidence\nintervals (CI) were estimated by maximising the conditional\nlikelihood function.", "mimetype": "text/plain", "start_char_idx": 11269, "end_char_idx": 12777, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bab38f01-555b-4755-af85-dfc9450e051f": {"__data__": {"id_": "bab38f01-555b-4755-af85-dfc9450e051f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "398d9d7e-33d1-42ce-9241-29f6750a3bd3", "node_type": "1", "metadata": {}, "hash": "2d97c2a70769d0b0b8317d93216201d64c9bd6735767647da447e429bc3a0d46", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "10fbb794-0e81-4b09-b177-94887d4b939e", "node_type": "1", "metadata": {}, "hash": "7a3d0863bfed26101604300f038202b004e39ba231dc634db628066090ab3641", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For multivariate analysis, odds ratios (OR) and confidence\nintervals (CI) were estimated by maximising the conditional\nlikelihood function. Univariate and multivariate analyses\nwere performed using SAS V8 software (SAS Institute, Cary,\nNorth Carolina, USA).\nRESULTS\nCohort description (table 1)\nAll IBD cases but two and all selected controls agreed to\nparticipate in the study. No child had died since 1988 and all\nnatural mothers were available for interview. Two children\nwho moved from the area were lost to follow up. Four pairs\nwere not maintained in the study because of inappropriate\nmatching. Among the 282 remaining subjects, 222 had CD\nand 60 had UC. Median age at diagnosis was 13.5 years for\nCD (interquartile range 11\u201315) and 14 years for UC (11\u201315).\nThere was a majority of males in the CD group (54%) and a\nmajority of females in the UC group (61.6%); 70.3% of\nchildren were from the Nord-Pas de Calais region, 13.4%\nfrom Somme, and 16.3% from Seine Maritime, reflecting the\nrespective populations of each region. A total of 3525 phone\ncalls were made in order to recruit 282 controls (8%): 905\npeople (26%) answered, among whom 554 did not meet the\ninclusion criteria. Among the 351 remaining who met the\ninclusion criteria, 69 did not want to participate. Educational\nlevel was similar in cases and controls (p = 0.9). There was no\nsignificant difference between cases and controls regarding\nsocioeconomic\nstatus\n(mother\nand\nfather)\nor\nparents\u2019\neducational level. The paediatric health booklet was available\nfor 96% of patients and 93% of controls. Patients with CD had\nmore siblings than controls (p = 0.02) and patients with CD\nand UC had more older siblings than controls (p = 0.02 and\np = 0.05, respectively).\nCrohn\u2019s disease\nDue to the number of questions, only positive findings are\nreported and what we consider the most important results.", "mimetype": "text/plain", "start_char_idx": 12638, "end_char_idx": 14502, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "10fbb794-0e81-4b09-b177-94887d4b939e": {"__data__": {"id_": "10fbb794-0e81-4b09-b177-94887d4b939e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bab38f01-555b-4755-af85-dfc9450e051f", "node_type": "1", "metadata": {}, "hash": "d02825d13d688a8cc65f4c741e9280204c7ededee3f653603e649ba3c6d253af", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "600247cd-0ace-4321-8d48-9b6e651f0eed", "node_type": "1", "metadata": {}, "hash": "616a16aa57cb0a02f47cc56618d7c29c9f7c4c429c2cf0627d3900e1c3317c09", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Crohn\u2019s disease\nDue to the number of questions, only positive findings are\nreported and what we consider the most important results.\nUnivariate analysis (table 2)\nFamily IBD history\nA family history of IBD was the strongest risk factor for CD in\nunivariate analysis with an OR of 4.6 (95% CI 2.6\u20138.3;\np,0.001).\nPerinatal period\nNo specific factor was associated with CD in univariate\nanalysis. None of the mothers reported measles during\npregnancy. Gestational age and anthropometric measure-\nments at birth were similar in cases and controls.\nInfant and child diet\nBreast feeding, either partial or exclusive, was a risk factor for\nCD with an OR of 1.6 (1.1\u20132.4; p = 0.01) and of 1.6 (1.1\u20132.5;\nTable 2\nAssociation of Crohn\u2019s disease (CD) with childhood factors: univariate analysis\nCD\nOR\n95% CI\nFamilial history of IBD\n4.6\n2.6\u20138.3\nPairs with exposed cases/non-exposed controls\n65\nPairs with non-exposed cases/exposed controls\n14\nConcordant pairs\n141\nBreast feeding\n1.6\n1.1\u20132.4\nPairs with exposed cases/non-exposed controls\n66\nPairs with non-exposed cases/exposed controls\n41\nConcordant pairs\n115\nEczema\n2.9\n1.5\u20135.6\nPairs with exposed cases/non-exposed controls\n35\nPairs with non-exposed cases/exposed controls\n12\nConcordant pairs\n175\nMMR vaccination\n0.5\n0.35\u20130.9\nPairs with exposed cases/non-exposed controls\n16\nPairs with non-exposed cases/exposed controls\n32\nConcordant pairs\n184\nSmallpox vaccination\n2.1\n1\u20134.3\nPairs with exposed cases/non-exposed controls\n23\nPairs with non-exposed cases/exposed controls\n11\nConcordant pairs\n188\nBCG vaccination\n2.8\n1.1\u20137.", "mimetype": "text/plain", "start_char_idx": 14370, "end_char_idx": 15929, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "600247cd-0ace-4321-8d48-9b6e651f0eed": {"__data__": {"id_": "600247cd-0ace-4321-8d48-9b6e651f0eed", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "10fbb794-0e81-4b09-b177-94887d4b939e", "node_type": "1", "metadata": {}, "hash": "7a3d0863bfed26101604300f038202b004e39ba231dc634db628066090ab3641", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b0ec85cf-4421-40b3-babe-65da48ce16f0", "node_type": "1", "metadata": {}, "hash": "8a16a5c25cdc809670989d7f0350da4cefe362a167d0d2a9c8c15fa4bef21cb0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3\nPairs with exposed cases/non-exposed controls\n23\nPairs with non-exposed cases/exposed controls\n11\nConcordant pairs\n188\nBCG vaccination\n2.8\n1.1\u20137.2\nPairs with exposed cases/non-exposed controls\n17\nPairs with non-exposed cases/exposed controls\n6\nConcordant pairs\n199\nPoliomyelitis vaccination\n2.6\n1.1\u20136.2\nPairs with exposed cases/non-exposed controls\n18\nPairs with non-exposed cases/exposed controls\n7\nConcordant pairs\n197\nTap water consumption\n0.5\n0.3\u20130.8\nPairs with exposed cases/non-exposed controls\n25\nPairs with non-exposed cases/exposed controls\n49\nConcordant pairs\n148\nBedroom sharing\n1.6\n1\u20132.4\nPairs with exposed cases/non-exposed controls\n58\nPairs with non-exposed cases/exposed controls\n27\nConcordant pairs\n148\nResults are expressed as odds ratios (OR) with 95% confidence interval (CI).\nIBD, inflammatory bowel disease; MMR, measles-mumps-rubella; BCG, bacille Calmette Guerin.\nEnvironment and paediatric inflammatory bowel disease\n359\nwww.gutjnl.com\ncopyright.\n on January 9, 2025 at Assistance Publique Hopitaux de Paris. Protected by\nhttp://gut.bmj.com/\nGut: first published as 10.1136/gut.2004.054353 on 11 February 2005. Downloaded from \np = 0.01), respectively. CD children were breast fed exclu-\nsively and non-exclusively on average two weeks more than\ncontrols but the difference was not significant (10 weeks v\neight weeks, and eight weeks v six weeks, respectively)\n(p = 0.08). There was no significant difference in the age of\nintroduction of flour, meat, and vegetables. There was no\ndifference between cases and controls for passive smoking\ndue to parents or caregivers (OR 0.84 (0.55\u20131.3)).\nChildhood diseases, vaccinations\nThere were no significant differences between cases and\ncontrols regarding measles, (OR 1.1 (0.7\u20131.6)), mumps,\nrubella, or other infections.", "mimetype": "text/plain", "start_char_idx": 15782, "end_char_idx": 17572, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b0ec85cf-4421-40b3-babe-65da48ce16f0": {"__data__": {"id_": "b0ec85cf-4421-40b3-babe-65da48ce16f0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "600247cd-0ace-4321-8d48-9b6e651f0eed", "node_type": "1", "metadata": {}, "hash": "616a16aa57cb0a02f47cc56618d7c29c9f7c4c429c2cf0627d3900e1c3317c09", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5341445d-cbfa-43cf-97ac-b8602f78b153", "node_type": "1", "metadata": {}, "hash": "051b27e43c67a34f1c639bb5761a6b5c3678ff0b5cc01bdd66bc52f17f6daf6a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Childhood diseases, vaccinations\nThere were no significant differences between cases and\ncontrols regarding measles, (OR 1.1 (0.7\u20131.6)), mumps,\nrubella, or other infections. Eczema before the age of two\nyears was more frequent in CD than in controls with an OR of\n2.9 (1.5\u20135.6; p = 0.001). Appendicectomy was a risk factor for\nCD (OR 1.7). Surgical and pathological reports of appendi-\ncectomies were then reviewed when appendicectomy was\nperformed within one year before the onset of symptoms (13\nchildren). Appendicectomy revealed CD in 9/13 cases and was\nthus considered incidental. After excluding these cases the\nassociation did not remain significant. No difference was\nnoted between CD and controls regarding other surgeries\nfrequently performed during childhood such as adenoidect-\nomy and tonsillectomy. CD children were exposed more often\nto smallpox vaccination (OR 2.1 (1\u20134.3); p = 0.04), polio-\nmyelitis vaccination (OR 2.6 (1.1\u20136.2); p = 0.03), and BCG\nvaccination (OR 2.8 (1\u20134.3); p = 0.04). For BCG, there was a\ndose effect: OR 2.6 (1\u20136.5; p = 0.05) for one shot versus no\nvaccination, and OR 3.65 (1.4\u20139.7; p = 0.01) for more than\none shot versus no vaccination. CD children were exposed\nless often to MMR vaccination (OR 0.5 (0.35\u20130.9); p = 0.01).\nHome amenities\nMore than 95% of children had permanent access to separate\nbathrooms and fixed hot water during their whole childhood.\nCD cases reported less tap water consumption than controls\n(OR 0.5 (0.3\u20130.8); p = 0.006). CD children shared their\nbedroom with family members more often (OR 1.6 (1\u20132.4);\np = 0.02).", "mimetype": "text/plain", "start_char_idx": 17399, "end_char_idx": 18980, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5341445d-cbfa-43cf-97ac-b8602f78b153": {"__data__": {"id_": "5341445d-cbfa-43cf-97ac-b8602f78b153", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b0ec85cf-4421-40b3-babe-65da48ce16f0", "node_type": "1", "metadata": {}, "hash": "8a16a5c25cdc809670989d7f0350da4cefe362a167d0d2a9c8c15fa4bef21cb0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b33e5653-f4fe-4bb2-8059-39fc0b4821d4", "node_type": "1", "metadata": {}, "hash": "b3e1ba41d1ddad3cd7427014921f0a04e9fdf99836a274ff82617436c79f6613", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CD children shared their\nbedroom with family members more often (OR 1.6 (1\u20132.4);\np = 0.02).\nMultivariate analysis (table 3)\nIn multivariate analysis, adjusted for mother\u2019s educational\nlevel, five variables remained significant: family history of\nIBD, breast feeding, history of eczema, and BCG vaccination\nwere independent risk factors while drinking tap water was\nprotective.\nUlcerative colitis\nUnivariate analysis (table 4)\nFamily IBD history\nA family history of IBD was the strongest risk factor for UC in\nunivariate analysis with an OR of 5 (1.45\u201317.2; p = 0.005).\nPerinatal period\nDisease during pregnancy, including risk of premature\ndelivery (n = 6), hormonal treatment (n = 2), hypertension\n(n = 3), rubella vaccine (n = 2), and other (n = 4), were more\nfrequent in mothers of UC patients (OR 4.67 (1.3\u201316.1);\np = 0.008). None of the mothers reported measles during\npregnancy.\nTable 3\nAssociation of Crohn\u2019s disease with childhood\nfactors: multivariate analysis\nOR\nCI\np Value\nFamily IBD history\n4.3\n2.3\u20138\n,0.001\nBreast feeding\n2.1\n1.3\u20133.4\n0.003\nEczema\n2.1\n1\u20134.5\n0.04\nBCG vaccination\n3.6\n1.1\u201311.9\n0.03\nDrinking tap water\n0.6\n0.3\u20131\n0.05\nResults are expressed as odds ratios (OR) with 95% confidence interval\n(CI).\nIBD, inflammatory bowel disease; BCG, bacille Calmette-Guerin.\nTable 4\nAssociation of ulcerative colitis (UC) with childhood factors.", "mimetype": "text/plain", "start_char_idx": 18889, "end_char_idx": 20242, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b33e5653-f4fe-4bb2-8059-39fc0b4821d4": {"__data__": {"id_": "b33e5653-f4fe-4bb2-8059-39fc0b4821d4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5341445d-cbfa-43cf-97ac-b8602f78b153", "node_type": "1", "metadata": {}, "hash": "051b27e43c67a34f1c639bb5761a6b5c3678ff0b5cc01bdd66bc52f17f6daf6a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "77c5d586-37cf-44f4-8127-9bd31536a522", "node_type": "1", "metadata": {}, "hash": "a61baa3a7975e9a92cd8cffab4e0b7f12a01b8b1dd01d91f3dc1ec131f1afe3c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "IBD, inflammatory bowel disease; BCG, bacille Calmette-Guerin.\nTable 4\nAssociation of ulcerative colitis (UC) with childhood factors. Univariate analysis\nUC\nOR\n95% CI\nFamilial history of IBD\n5\n1.45\u201317.2\nPairs with exposed cases/non-exposed controls\n15\nPairs with non-exposed cases/exposed controls\n3\nConcordant pairs\n42\nDisease during pregnancy*\n4.7\n1.3\u201316.1\nPairs with exposed cases/non-exposed controls\n14\nPairs with non-exposed cases/exposed controls\n3\nConcordant pairs\n43\nSucrose supplemented milk\n2.25\n1\u20135.2\nPairs with exposed cases/non-exposed controls\n18\nPairs with non-exposed cases/exposed controls\n8\nConcordant pairs\n34\nAppendicectomy\n0.3\n0.1\u20130.95\nPairs with exposed cases/non-exposed controls\n3\nPairs with non-exposed cases/exposed controls\n11\nConcordant pairs\n46\nSmallpox vaccination\n10\n1.3\u2013208\nPairs with exposed cases/non-exposed controls\n10\nPairs with non-exposed cases/exposed controls\n1\nConcordant pairs\n49\nPoliomyelitis vaccination\n7\n1.1\u2013151\nPairs with exposed cases/non-exposed controls\n7\nPairs with non-exposed cases/exposed controls\n1\nConcordant pairs\n52\nBedroom sharing\n3.4\n1.5\u20137.9\nPairs with exposed cases/non-exposed controls\n24\nPairs with non-exposed cases/exposed controls\n7\nConcordant pairs\n29\nValues are expressed as odds ratios (OR) with 95% confidence interval (CI).\n*Disease during pregnancy: risk of premature delivery (n = 6); hormonal treatment during pregnancy (n = 2);\nhypertension (n = 3); rubella vaccine (n = 2); and other (n = 4).\n360\nBaron, Turck, Leplat, et al\nwww.gutjnl.com\ncopyright.\n on January 9, 2025 at Assistance Publique Hopitaux de Paris.", "mimetype": "text/plain", "start_char_idx": 20109, "end_char_idx": 21699, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "77c5d586-37cf-44f4-8127-9bd31536a522": {"__data__": {"id_": "77c5d586-37cf-44f4-8127-9bd31536a522", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b33e5653-f4fe-4bb2-8059-39fc0b4821d4", "node_type": "1", "metadata": {}, "hash": "b3e1ba41d1ddad3cd7427014921f0a04e9fdf99836a274ff82617436c79f6613", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3ad6dfd1-fce5-4b11-ac93-388140eeb946", "node_type": "1", "metadata": {}, "hash": "38c17a606a2b934fff9f5e0ba72b7749a1657b750cf305289509f7fdec4a2215", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "360\nBaron, Turck, Leplat, et al\nwww.gutjnl.com\ncopyright.\n on January 9, 2025 at Assistance Publique Hopitaux de Paris. Protected by\nhttp://gut.bmj.com/\nGut: first published as 10.1136/gut.2004.054353 on 11 February 2005. Downloaded from \nInfant and child diet\nChildren with UC received sucrose supplemented milk more\noften than controls (OR 2.25 (1\u20135.2); p = 0.05). There was no\nsignificant difference in the age of introduction of flour,\nmeat, and vegetables. As in CD, there was no difference for\npassive smoking between UC and controls.\nChildhood diseases, vaccinations\nAppendicectomy was a strong protective factor for UC with\nan OR of 0.3 (0.1\u20130.95; p = 0.03). There were no significant\ndifferences between cases and controls regarding childhood\ninfectious diseases, including mumps, measles, and rubella.\nUC cases were more often vaccinated against smallpox and\npoliomyelitis with no differences for other vaccinations,\nincluding MMR, BCG, and hepatitis B.\nHome amenities\nAll but three children had permanent access to separate bath-\nroom and fixed hot water. In UC, there was no difference in\nwater consumption or water evacuation. UC children shared\ntheir bedroom more often (OR 3.4 (1.5\u20137.9); p = 0.002).\nMultivariate analysis (table 5)\nWhen adjusting for mother\u2019s educational level, four variables\nremained significant: family history of IBD, disease during\npregnancy, and bedroom sharing, as independent risk factors,\nand appendicectomy as an independent protective factor.\nDISCUSSION\nOur study addressed for the first time in a population based\ncohort the hypothesis that the development of IBD is\nassociated with early childhood events. Our findings confirm\nthe importance of familial IBD as a risk factor and the strong\ninverse association between appendicectomy and subsequent\nUC. It revealed that breast feeding and BCG may be\nassociated with an increased risk of CD. Conversely, no\nevidence was found for the hygiene hypothesis.\nThe validity of these findings depends on the reduction of\nbias and confoundings.", "mimetype": "text/plain", "start_char_idx": 21580, "end_char_idx": 23608, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3ad6dfd1-fce5-4b11-ac93-388140eeb946": {"__data__": {"id_": "3ad6dfd1-fce5-4b11-ac93-388140eeb946", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "77c5d586-37cf-44f4-8127-9bd31536a522", "node_type": "1", "metadata": {}, "hash": "a61baa3a7975e9a92cd8cffab4e0b7f12a01b8b1dd01d91f3dc1ec131f1afe3c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "89c0eb28-4e1f-4bee-8687-4e3c29b9a273", "node_type": "1", "metadata": {}, "hash": "8fd32e892f4cb69f182a61b87a09222076b29b61ce18f86207f98e2533f905ce", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Conversely, no\nevidence was found for the hygiene hypothesis.\nThe validity of these findings depends on the reduction of\nbias and confoundings. We used a population based incident\nseries which was representative of the spectrum of IBD. All\nchildren who had a diagnosis of certain or probable CD and\nUC within the study period were offered a place in the study.\nNo deaths occurred in this population since 1988 and only\ntwo patients were lost to follow up. The predominance of CD\nover UC has been a consistent finding in our area,9 10\nexplaining the limited number of UC cases recruited. More\nmales with CD and more females with UC (which differs\nfrom the distribution observed in adults) has also been a\nconsistent finding in our paediatric population since 1988.\nWe also assume that controls were representative of the\ngeneral population as they were randomly selected using\ntelephone number lists. Recall bias was minimised by\ninterviewing both children and mothers at home and by\nchecking answers to questions in the paediatric health\nbooklet which was available for almost all cases and controls.\nA positive family history was the strongest risk factor for\nIBD. Having a first degree relative with IBD represents the\nsingle most important factor determining an individual\u2019s risk\nof developing the disease.2 Polito et al reported the proportion of\npatients with relatives affected with IBD according to age at\ndiagnosis in the proband.11 Thirty per cent of patients\ndiagnosed under 20 years of age had a positive family history,\ndecreasing to 18% for those diagnosed between 20 and 39 years\nof age, and to 13% among those diagnosed after 40 years.\nGilat et al noted a lower than expected rate of appendi-\ncectomy in patients diagnosed with UC in childhood.12\nThirteen published case control studies were summarised\nby Koutroubakis et al13 concluding that appendicectomy\nreduced the risk of UC by 69% (62\u201375%). The inverse relation\nbetween UC and appendicectomy was particularly strong in\nour paediatric population with an OR of 0.06.", "mimetype": "text/plain", "start_char_idx": 23465, "end_char_idx": 25501, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "89c0eb28-4e1f-4bee-8687-4e3c29b9a273": {"__data__": {"id_": "89c0eb28-4e1f-4bee-8687-4e3c29b9a273", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3ad6dfd1-fce5-4b11-ac93-388140eeb946", "node_type": "1", "metadata": {}, "hash": "38c17a606a2b934fff9f5e0ba72b7749a1657b750cf305289509f7fdec4a2215", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c876dd93-d369-4fcb-a5c3-7a5743ee3c1e", "node_type": "1", "metadata": {}, "hash": "b80a8de0644f21596f60ab993d6d66272455cf8a748ea4c0d3a2a374a25ee1c7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The inverse relation\nbetween UC and appendicectomy was particularly strong in\nour paediatric population with an OR of 0.06. Other studies\nhave noted that this relation was stronger with appendicect-\nomy performed before the age of 20 years.14 15 Several studies\nfound an increased frequency of appendicectomy in CD\npatients.16 17 Abdominal pain caused by incipient CD at the\ntime of appendicectomy has been thought to explain this\nassociation.18 This was confirmed in our series in which 9/13\nappendectomies performed within one year before the onset\nof symptoms were actually undetected CD at the time of\noperation. In a large cohort study, the risk of CD associated\nwith appendicectomy remained when the follow up started\n10 years after appendicectomy, arguing against this hypoth-\nesis.19 Nevertheless, patients operated on before the age of\n10 years had a low risk, suggesting an age dependent\ndifference in the pathogenesis of appendicitis.19\nWe explored various factors relevant to the infectious\nhypothesis in IBD and conversely the hygiene hypothesis.\nLack of infections in early childhood could increase the risk of\nIBD later in life. Studies by Gent and colleagues20 and Duggan\nand colleagues14 showing that CD was more common in\nchildren who had access to a hot water supply and a separate\nbathroom supported this hypothesis. We could not confirm\nthis finding as almost all cases and controls had access to\nthese facilities. Earlier work by Gilat and colleagues12 was\nalso unable to support this hypothesis. Bedroom sharing was\na risk factor for both CD and UC in univariate analysis and\nfor UC in multivariate analysis (adjusted on educational level\nand family size). This may be a surrogate marker of exposure\nto infections early in life because the more crowded the living\nconditions, the more frequent is exposure to infections.\nChildren with IBD also had more older siblings than controls.\nIn recent studies, it was shown that the number of older\nsiblings conferred an incremental increased risk of develop-\ning UC21 and that lower birth rank, as a possible indicator of\nincreased childhood infection exposure, was associated with\na higher risk of IBD.22 These findings are consistent with the\nobservation that older siblings increase the risk and severity\nof secondary infections in younger siblings.", "mimetype": "text/plain", "start_char_idx": 25378, "end_char_idx": 27695, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c876dd93-d369-4fcb-a5c3-7a5743ee3c1e": {"__data__": {"id_": "c876dd93-d369-4fcb-a5c3-7a5743ee3c1e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "89c0eb28-4e1f-4bee-8687-4e3c29b9a273", "node_type": "1", "metadata": {}, "hash": "8fd32e892f4cb69f182a61b87a09222076b29b61ce18f86207f98e2533f905ce", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b8705ff6-80ed-46f2-a2b2-9a66a232b4dd", "node_type": "1", "metadata": {}, "hash": "99121089b896f1760adde4d014c56d242f423a02e5c633a6647ef369117696f4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The role of\ninfections early in life has been the focus of many investi-\ngations. Increased frequency of gastroenteritis,23 and respira-\ntory12 and perinatal24 infections in IBD has been reported. A\nhistory of frequent childhood infections or exposure to\nantibiotics has also been proposed as a risk factor for IBD.25\nOur study thus adds to the notion that indicators of child-\nhood infection exposure are associated with an increased risk\nof IBD. On the other hand, drinking tap water made a\nsignificant contribution to the multivariate model in CD.\nSource of drinking water has not previously been recognised\nas a risk or protective factor in IBD. One explanation could be\nthe presence in tap water of harmless environmental species\n(as opposed to infectious organisms) which may have a\nparticular ability to trigger regulatory T cells.26\nAn increased risk of IBD among persons born during a\nmeasles epidemic27 as well as a close temporal relationship\nTable 5\nAssociation of ulcerative colitis with childhood\nfactors: multivariate analysis\nOR\nCI\np Value\nFamily IBD history\n12.5\n2.2\u201371.4\n0.005\nDisease during pregnancy\n8.9\n1.5\u201352\n0.02\nBedroom sharing\n7.1\n1.9\u201327.4\n0.004\nAppendicectomy\n0.06\n0.01\u20130.36\n0.002\nValues are expressed as odds ratios (OR) with 95% confidence interval\n(CI).\nIBD, inflammatory bowel disease.\nEnvironment and paediatric inflammatory bowel disease\n361\nwww.gutjnl.com\ncopyright.\n on January 9, 2025 at Assistance Publique Hopitaux de Paris. Protected by\nhttp://gut.bmj.com/\nGut: first published as 10.1136/gut.2004.054353 on 11 February 2005. Downloaded from \nbetween measles infection and the development of IBD has\nbeen suggested.28 Live attenuated measles vaccination has\nalso been implicated.29 Furthermore, a high risk of CD in\npatients whose mothers were infected with measles around\nthe time of birth has been reported.30 We could not confirm\nthese findings. There was no difference between cases and\ncontrols regarding exposure to measles as the wild or\nattenuated virus.", "mimetype": "text/plain", "start_char_idx": 27696, "end_char_idx": 29696, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b8705ff6-80ed-46f2-a2b2-9a66a232b4dd": {"__data__": {"id_": "b8705ff6-80ed-46f2-a2b2-9a66a232b4dd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c876dd93-d369-4fcb-a5c3-7a5743ee3c1e", "node_type": "1", "metadata": {}, "hash": "b80a8de0644f21596f60ab993d6d66272455cf8a748ea4c0d3a2a374a25ee1c7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f30c995c-2e66-49e8-a04f-c29e96791830", "node_type": "1", "metadata": {}, "hash": "3485e0060ab7eba758dafc70bf7f9b12c742895efe1edaa98748c84f4f0dd868", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "There was no difference between cases and\ncontrols regarding exposure to measles as the wild or\nattenuated virus. None of the mothers reported measles\nduring pregnancy. MMR vaccination was negatively asso-\nciated with a risk of CD, confirming data from four large\nhealth maintenance organisations in the USA.31 In contrast,\nsmallpox and poliomyelitis vaccination were associated with\nan increased risk of both CD and UC.\nThe association between BCG and an increased risk of CD\nwas particularly convincing because it was dose dependent\nand remained in the multivariate analysis. BCG is associated\nwith a Th1 immune response.32 It has been proposed that\nadministration of BCG early in life could protect against the\ndevelopment\nof\nallergic\ndisorders\nwith\na\npredominant\nTh2 response.33 It is generally accepted that CD is a disorder\nwith a predominant Th1 immune response.1 Modulation\nof the immature immune system early in life towards a\nTh1 immune response could thus favour the development of\nCD.\nThe results of this study were essentially negative with\nregard to dietary factors. Sucrose supplemented milk was\nassociated with an increased risk of UC, thus confirming a\nconsistent positive association in the literature.34\u201339 However,\nin most studies, high sugar intake could have reflected a shift\nto a more palatable diet as a consequence of the illness.\nAdult cigarette smoking is associated with the develop-\nment of CD and protection from the development of UC.\nStudies on exposure to passive smoking in childhood have\nprovided controversial results: association with an increased\nrisk of both CD and UC,40 lower incidence of UC,41 not\nconfirmed in another study.42 Our results do not support a\nrole for passive smoking on the occurrence of either UC or CD\namong children and adolescents.\nSeveral studies have suggested a protective effect of breast\nfeeding against the subsequent development of IBD.3 43\nCertainly, the unexpected finding of our study was that\nbreast feeding was associated with an increased risk of CD.\nBreast feeding is known to provide immunological protection\nto the newborn. Delayed infections occurring at weaning may\nlead to an inappropriate immune response and persistence of\nintestinal inflammation. Another hypothesis may be related\nto breast milk pollution in our highly industrialised area.", "mimetype": "text/plain", "start_char_idx": 29583, "end_char_idx": 31907, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f30c995c-2e66-49e8-a04f-c29e96791830": {"__data__": {"id_": "f30c995c-2e66-49e8-a04f-c29e96791830", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b8705ff6-80ed-46f2-a2b2-9a66a232b4dd", "node_type": "1", "metadata": {}, "hash": "99121089b896f1760adde4d014c56d242f423a02e5c633a6647ef369117696f4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0cd26f78-6b04-425d-861b-444a4e41b325", "node_type": "1", "metadata": {}, "hash": "27d8b67f5636c04cae92efa74eee3309092335a31c67b518c22721e7752a092b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Delayed infections occurring at weaning may\nlead to an inappropriate immune response and persistence of\nintestinal inflammation. Another hypothesis may be related\nto breast milk pollution in our highly industrialised area.\nDrugs, industrial chemicals, and environmental contami-\nnants can be present in breast milk.44 Ultrafine and fine\nparticles are potent adjuvants in antigen mediated immune\nresponse and cause inflammation in susceptible individuals;\na relationship between microparticles and CD has recently\nbeen considered.45\u201348\nFinally, we have confirmed previous reports of an associa-\ntion between CD and childhood eczema12 49 and between UC\nand disease during pregnancy.24 Non-infectious events in the\nmother before delivery, including pre-eclampsia and threa-\ntened delivery, increased by 3.6-fold (2.1\u20136.2) the risk of IBD\nin children.24 The explanation for these apparent links is\nunclear.\nIn conclusion, this study confirms the strong risk of IBD\nassociated with familial disease and the protective effect for\nlater occurrence of UC of appendicectomy in childhood. It\nprovides some important negative findings regarding the role\nof hygiene, some viral infections, and dietary factors. It\nshows for the first time an association between IBD and\nenvironmental factors such as drinking water, BCG, and\nbreast feeding. Epidemiology of IBD in our region is unique\nand characterised by a much higher incidence of CD than\nUC,9 10 a still increasing incidence of CD and a decreasing\nincidence of UC,10 and the presence of unusual familial\naggregations.50\u201353 It is thus worth stressing that studies in\nother populations are needed to confirm or refute these\nresults. Meanwhile, no practical conclusions should be\ndrawn. In particular, extensive biological and epidemiological\nresearch has documented compelling benefits for breast fed\ninfants. Breast feeding should not in any case be discouraged\nin young infants at the present time. In a public health\nperspective, the short and long term benefits of breast\nfeeding overrule by far the increased risk of CD that was\nobserved in the present study.\nACKNOWLEDGEMENTS\nWe thank all of the children and their mothers who participated in\nthe study.", "mimetype": "text/plain", "start_char_idx": 31685, "end_char_idx": 33883, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0cd26f78-6b04-425d-861b-444a4e41b325": {"__data__": {"id_": "0cd26f78-6b04-425d-861b-444a4e41b325", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f30c995c-2e66-49e8-a04f-c29e96791830", "node_type": "1", "metadata": {}, "hash": "3485e0060ab7eba758dafc70bf7f9b12c742895efe1edaa98748c84f4f0dd868", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "039b43e0-7806-40cc-9e86-ee0154293547", "node_type": "1", "metadata": {}, "hash": "826ef86494c0801a58b20501e6cb0a51a82c3b86a64f4cf50306c51414041983", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ACKNOWLEDGEMENTS\nWe thank all of the children and their mothers who participated in\nthe study. The authors thank the interviewer practitioners who\ncollected the data: B Lemaire, N Guillon, M Inglard, I Rousseau,\nN Wauquier, P Fosse, M Lecomte, D Panis, L Yzet, C Dias, M.\nBoddaert, M Malo, M Dard, and S Richon. EPIMAD is organised\nunder an agreement between the Institut National de la Sante\u00b4 et de\nla Recherche Me\u00b4dicale (INSERM), the Direction Ge\u00b4ne\u00b4rale de la Sante\u00b4\n(DGS), and the Institut National de Veille Sanitaire (InVS), and is\nalso supported by the Franc\u00b8ois Aupetit Association, the Ferring\nLaboratories, IRMAD (Astra Company), the Observatoire Re\u00b4gional de\nla Sante\u00b4 du Nord-Pas-de-Calais, the Caisse Re\u00b4gionale d\u2019Assurance\nMaladie de Nord Picardie, and the CH et U and Faculte de Medecine\nde Lille.\nWe thank all of the gastroenterologists and specialists who\nparticipated in this study: Andre\u00b4 JM, Antonietti M, Armand A,\nAroichane I, Aubet JP, Auxenfants E, Barbry B, Bardoux N, Baron P,\nBaudet A, Bazin B, Bebahani A, Becqwort JP, Benet V, Benguigui C,\nBen Soussan E, Bental A, Berkelmans I, Bernet J, Bernou-Dron C,\nBertot P, Biron N, Bleuet M, Blondel F, Bohon F, Boniface E,\nBonnie`re P, Bonvarlet E, Bonvarlet P, Boruchowicz A, Bostvironnois\nR, Bouche B, Boudaillez C, Bourgeaux C, Bourguet A, Bourienne A,\nBray G, Brazier F, Breban P, Brung-Lefebvre V, Burgiere P, Butel J,\nCanva JY, Canva-Delcambre V, Capron JP, Cardot F, Carpentier P,", "mimetype": "text/plain", "start_char_idx": 33789, "end_char_idx": 35248, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "039b43e0-7806-40cc-9e86-ee0154293547": {"__data__": {"id_": "039b43e0-7806-40cc-9e86-ee0154293547", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0cd26f78-6b04-425d-861b-444a4e41b325", "node_type": "1", "metadata": {}, "hash": "27d8b67f5636c04cae92efa74eee3309092335a31c67b518c22721e7752a092b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f451e828-8997-4234-8002-c1567f75f0cb", "node_type": "1", "metadata": {}, "hash": "da361bad995969862c2d07a482e3fdae6da36be69ce4286576a845216feaab6b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Breban P, Brung-Lefebvre V, Burgiere P, Butel J,\nCanva JY, Canva-Delcambre V, Capron JP, Cardot F, Carpentier P,\nCartier E, Cassar JF, Castex JF, Catteau L, Caujolle B, Cayron G,\nChantre M, Charles J, Charneau T, Claerbout JF, Clergue PY, Cohen\nG, Collet R, Crinquette JF, Dadamessi I, Dapvril V, Davion T, Debas J,\nDehont F, Delatre C, Delcenserie R, Delette O, Delgrange T,\nDelhoustal L, Delmotte JS, Deregnaucourt G, Descombes P,\nDesechalliers JP, Desmet P, Desseaux G, Desurmont P, Devienne A,\nDevred M, Devroux A, Dewailly A, Dubois R, Ducatillon P, Duclay J,\nDucrocq B, Ducrot F, Ducrotte P, Dufilho J, Duhamel C, Dujardin D,\nDupont F, Duranton Y, Elie-Legrend MC, Evrard JP, Filoche B, Finet\nL, Foissey D, Foutrein-Comes MC, Foutrein P, Frere T, Gallet P,\nGamblin C, Geslin G, Gheyssens Y, Gilbert T, Godard P, Godchaux\nJM, Godchaux R, Goria O, Gottrand F, Gower P, Grandmaison B,\nGuedon C, Guillard JF, Guillem L, Guillemot F, Hanon D,\nHeckestweiller P, Hedde JP, Hellal H, Heyman B, Heraud M, Herve\nS, Hochain P, Houcke P, Ivanovic A, Janicki E, Jeu J, Jonas C,\nKerleveo A, Kiriakos A, Kiriakos J, Klein O, Kornhauser R,\nKoutsomanis D, Laberenne JE, Laffineur G, Lannoy P, Lapchin J,", "mimetype": "text/plain", "start_char_idx": 35136, "end_char_idx": 36328, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f451e828-8997-4234-8002-c1567f75f0cb": {"__data__": {"id_": "f451e828-8997-4234-8002-c1567f75f0cb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "039b43e0-7806-40cc-9e86-ee0154293547", "node_type": "1", "metadata": {}, "hash": "826ef86494c0801a58b20501e6cb0a51a82c3b86a64f4cf50306c51414041983", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6ae54e56-86ff-47bc-ad9a-ff5d9b8819eb", "node_type": "1", "metadata": {}, "hash": "1a4886797fa03586906e307b5e669ac6b2f6420d07e255cf5291088a2a8e165c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Kiriakos A, Kiriakos J, Klein O, Kornhauser R,\nKoutsomanis D, Laberenne JE, Laffineur G, Lannoy P, Lapchin J,\nLaprand M, Laude D, Lecieux P, Leclerc N, Le Couteulx C, Ledent J,\nLefebvre J, Le Grix A, Lelong P, Lenaerts C, Leplat A, Leroi H, Leroy\nMY, Lesage JP, Lesage X, Lesage J, Lescanne-Darchis I, Lescut J,\nLescut D, Leurent B, Lhermie M, Lion A, Lisambert B, Loire F, Luciani\nM, Lucidarme D, Lugand J, Macaigne O, Maetz D, Maillard D,\nMancheron H, Marti R, Martin F, Martin G, Marzloff E, Mathieu-\nChandelier C, Mauillon J, Maunoury V, Maupas JL, Mesnard B,\nMetayer P, Meurisse B, Meurisse F, Mirmaran X, Modaine T, Morel L,\nMoulin E, Mouterde O, Mudry J, N\u2019GuyenTack R, Notteghem B,\nOstyn A, Ouvry D, Panien-Claudot N, Paoletti C, Papazian A,\nParent B, Paris JC, Patrier P, Paupart L, Pauwels B, Pauwels M,\nPetit R, Piat M, Piotte S, Plane C, Plouvier B, Pollet E, Pommelet P,\nPouchain G, Prades P, Prevost A, Prevost JC, Queuniet AM, Quinton\nJF, Rabache A, Rabelle P, Razemon V, Reix N, Richez C, Robinson P,\nRodriguez J, Roger J, Roux JM, Rudelli A, Savoye G, Schlosseberg P,\nSegrestin M, Seryer A, Sevenet F, Silvie J, Simon V, Spyckerelle C,\nTalbodec N, Thelu JL, Thorel JM,", "mimetype": "text/plain", "start_char_idx": 36219, "end_char_idx": 37404, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6ae54e56-86ff-47bc-ad9a-ff5d9b8819eb": {"__data__": {"id_": "6ae54e56-86ff-47bc-ad9a-ff5d9b8819eb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f451e828-8997-4234-8002-c1567f75f0cb", "node_type": "1", "metadata": {}, "hash": "da361bad995969862c2d07a482e3fdae6da36be69ce4286576a845216feaab6b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d1108ef3-489c-4015-ab97-3c9862008bda", "node_type": "1", "metadata": {}, "hash": "288ae0c8a1a098e72aa8361dc1d5f1425a8b9154eedddb73ab81c0fdfa5fb440", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Schlosseberg P,\nSegrestin M, Seryer A, Sevenet F, Silvie J, Simon V, Spyckerelle C,\nTalbodec N, Thelu JL, Thorel JM, Toisin J, Tonnel J, Touchais JY,\nTranvouez JL, Triplet C, Turck D, Vaillant E, Valmage C, Vanco D,\nVanderbecq E, Vandermolen P, Vandevenne P, Vandewalle C,\nVanhoove JP, Verbiese G, Vermelle P, Verne C, Vincendet M, Viot\nJ, Voiment YM, Waeghemaecker L, Wallez JY, Wantiez M, Weber J,\nWillocquet JL, Wolschies E, Zellweger A, Ziade C.\n362\nBaron, Turck, Leplat, et al\nwww.gutjnl.com\ncopyright.\n on January 9, 2025 at Assistance Publique Hopitaux de Paris. Protected by\nhttp://gut.bmj.com/\nGut: first published as 10.1136/gut.2004.054353 on 11 February 2005. Downloaded from \nAuthors\u2019 affiliations\n. . . . . . . . . . . . . . . . . . . . .", "mimetype": "text/plain", "start_char_idx": 37288, "end_char_idx": 38040, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d1108ef3-489c-4015-ab97-3c9862008bda": {"__data__": {"id_": "d1108ef3-489c-4015-ab97-3c9862008bda", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6ae54e56-86ff-47bc-ad9a-ff5d9b8819eb", "node_type": "1", "metadata": {}, "hash": "1a4886797fa03586906e307b5e669ac6b2f6420d07e255cf5291088a2a8e165c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "949107f4-03aa-41cb-8bce-c82d4c35ec4d", "node_type": "1", "metadata": {}, "hash": "af9bd056308b081ffdc51d57d3a02d7ee97ba0db83e7e56afdca49d32cd7bf08", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Downloaded from \nAuthors\u2019 affiliations\n. . . . . . . . . . . . . . . . . . . . .\nS Baron, C Leplat, C Gower-Rousseau, R Marti, S Debeugny, J-L\nSalomez, Registre des Maladies Inflammatoires Chroniques de l\u2019Intestin\n(EPIMAD), Service d\u2019Epide\u00b4miologie et de Sante\u00b4 Publique, Ho\u02c6pital\nCalmette, Lille, France\nD Turck, EPIMAD, Clinique de Pe\u00b4diatrie, Ho\u02c6pital Jeanne de Falndre,\nLille, France\nV Merle, E Lerebours, EPIMAD, Centre de Rouen, Ho\u02c6pital Charles\nNicolle, Rouen, France\nT Yzet, J-L Dupas, EPIMAD, Centre d\u2019 Amiens, Ho\u02c6pital Nord, Amiens,\nFrance\nA Cortot, J-F Colombel, EPIMAD, Service d\u2019He\u00b4pato-Gastroente\u00b4rologie,\nHo\u02c6pital Huriez, Lille, France\nConflict of interest: None declared.\nREFERENCES\n1 Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417\u201329.\n2 Ahmad T, Tamboli CP, Jewell DP, et al. Clinical relevance of advances in\ngenetics and pharmacogenetics of IBD. Gastroenterology\n2004;126:1533\u201349.\n3 Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence,\nprevalence, and environmental influences. Gastroenterology\n2004;126:1504\u201317.\n4 Marshall JK, Hilsden RJ. Environment and epidemiology of inflammatory\nbowel diseases. In: Satsangi J, Sutherland RL, eds. Inflammatory bowel\ndiseases. London: Churchill Livingston, 2003:17\u201328.\n5 Montgomery SM, Pounder RE, Wakefield AJ. Infant mortality and the\nincidence of inflammatory bowel disease. Lancet 1997;349:472\u20133.", "mimetype": "text/plain", "start_char_idx": 37960, "end_char_idx": 39363, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "949107f4-03aa-41cb-8bce-c82d4c35ec4d": {"__data__": {"id_": "949107f4-03aa-41cb-8bce-c82d4c35ec4d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d1108ef3-489c-4015-ab97-3c9862008bda", "node_type": "1", "metadata": {}, "hash": "288ae0c8a1a098e72aa8361dc1d5f1425a8b9154eedddb73ab81c0fdfa5fb440", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c78db142-5a92-4704-9de9-b3e8b2cfa654", "node_type": "1", "metadata": {}, "hash": "4ab72bdd202ed7e50439e5a84f11ef42475815f6d94a5d668c0f4a24fa4b4dc1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "5 Montgomery SM, Pounder RE, Wakefield AJ. Infant mortality and the\nincidence of inflammatory bowel disease. Lancet 1997;349:472\u20133.\n6 Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory\nbowel disease across Europe: is there a difference between north and south?\nResults of the European Collaborative Study on Inflammatory Bowel Disease\n(EC-IBD). Gut 1996;39:690\u20137.\n7 Ekbom A. The epidemiology of IBD: a lot of data but little knowledge. How\nshall we proceed? Inflamm Bowel Dis 2004;10:S32\u20134.\n8 Bach JF. The effect of infections on susceptibility to autoimmune and allergic\ndiseases. N Engl J Med 2002;347:911\u201320.\n9 Gower-Rousseau C, Salomez JL, Dupas JL, et al. Incidence of inflammatory\nbowel disease in northern France (1988\u20131990). Gut 1994;35:1433\u20138.\n10 Molinie F, Gower-Rousseau C, Yzet T, et al. Opposite evolution in incidence of\nCrohn\u2019s disease and ulcerative colitis in Northern France (1988\u20131999). Gut\n2004;53:843\u20138.\n11 Polito JM 2nd, Childs B, Mellits ED, et al. Crohn\u2019s disease: influence of age at\ndiagnosis on site and clinical type of disease. Gastroenterology\n1996;111:580\u20136.\n12 Gilat T, Hacohen D, Lilos P, et al. Childhood factors in ulcerative colitis and\nCrohn\u2019s disease. An international cooperative study. Scand J Gastroenterol\n1987;22:1009\u201324.\n13 Koutroubakis IE, Vlachonikolis IG, Kouroumalis EA. Role of appendicitis and\nappendectomy in the pathogenesis of ulcerative colitis: a critical review.\nInflamm Bowel Dis 2002;8:277\u201386.\n14 Duggan AE, Usmani I, Neal KR, et al.", "mimetype": "text/plain", "start_char_idx": 39232, "end_char_idx": 40745, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c78db142-5a92-4704-9de9-b3e8b2cfa654": {"__data__": {"id_": "c78db142-5a92-4704-9de9-b3e8b2cfa654", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "949107f4-03aa-41cb-8bce-c82d4c35ec4d", "node_type": "1", "metadata": {}, "hash": "af9bd056308b081ffdc51d57d3a02d7ee97ba0db83e7e56afdca49d32cd7bf08", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "67f36992-3402-4428-a50d-8e97c23f5e0f", "node_type": "1", "metadata": {}, "hash": "eddf858c6da2b651b3394411fcb64de3ad65e140ecf0ca4588393e74b22d30d3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Inflamm Bowel Dis 2002;8:277\u201386.\n14 Duggan AE, Usmani I, Neal KR, et al. Appendicectomy, childhood hygiene,\nHelicobacter pylori status, and risk of inflammatory bowel disease: a case\ncontrol study. Gut 1998;43:494\u20138.\n15 Andersson RE, Olaison G, Tysk C, et al. Appendectomy and protection\nagainst ulcerative colitis. N Engl J Med 2001;344:808\u201314.\n16 Russel MG, Dorant E, Brummer RJ, et al. Appendectomy and the risk of\ndeveloping ulcerative colitis or Crohn\u2019s disease: results of a large case-control\nstudy. South Limburg Inflammatory Bowel Disease Study Group.\nGastroenterology 1997;113:377\u201382.\n17 Koutroubakis IE, Vlachonikolis IG, Kapsoritakis A, et al. Appendectomy,\ntonsillectomy, and risk of inflammatory bowel disease: case-controlled study in\nCrete. Dis Colon Rectum 1999;42:225\u201330.\n18 Frisch M, Johansen C, Mellemkjaer L, et al. Appendectomy and subsequent\nrisk of inflammatory bowel diseases. Surgery 2001;130:36\u201343.\n19 Andersson RE, Olaison G, Tysk C, et al. Appendectomy is followed by\nincreased risk of Crohn\u2019s disease. Gastroenterology 2003;124:40\u20136.\n20 Gent AE, Hellier MD, Grace RH, et al. Inflammatory bowel disease and\ndomestic hygiene in infancy. Lancet 1994;343:766\u20137.\n21 Montgomery SM, Lambe M, Wakefield AJ, et al. Siblings and the risk of\ninflammatory bowel disease. Scand J Gastroenterol 2002;37:1301\u20138.\n22 Hampe J, Heymann K, Krawczak M, et al. Association of inflammatory bowel\ndisease with indicators for childhood antigen and infection exposure.\nInt J Colorectal Dis 2003;18:413\u201317.\n23 Whorwell PJ, Holdstock G, Whorwell GM, et al.", "mimetype": "text/plain", "start_char_idx": 40673, "end_char_idx": 42231, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "67f36992-3402-4428-a50d-8e97c23f5e0f": {"__data__": {"id_": "67f36992-3402-4428-a50d-8e97c23f5e0f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c78db142-5a92-4704-9de9-b3e8b2cfa654", "node_type": "1", "metadata": {}, "hash": "4ab72bdd202ed7e50439e5a84f11ef42475815f6d94a5d668c0f4a24fa4b4dc1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0b81cc86-adf8-417c-b4c3-b1e569d7f69b", "node_type": "1", "metadata": {}, "hash": "b200dcf4ea311678545c1cc264d8678120391b80f4723e15881e981522d37f38", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Int J Colorectal Dis 2003;18:413\u201317.\n23 Whorwell PJ, Holdstock G, Whorwell GM, et al. Bottle feeding, early\ngastroenteritis, and inflammatory bowel disease. Br Med J 1979;1:382.\n24 Ekbom A, Adami HO, Helmick CG, et al. Perinatal risk factors for\ninflammatory bowel disease: a case-control study. Am J Epidemiol\n1990;132:1111\u201319.\n25 Wurzelmann JI, Lyles CM, Sandler RS. Childhood infections and the risk of\ninflammatory bowel disease. Dig Dis Sci 1994;39:555\u201360.\n26 Rook GA, Adams V, Hunt J, et al. Mycobacteria and other environmental\norganisms as immunomodulators for immunoregulatory disorders. Springer\nSemin Immunopathol 2004;25:237\u201355.\n27 Ekbom A, Wakefield AJ, Zack M, et al. Perinatal measles infection and\nsubsequent Crohn\u2019s disease. Lancet 1994;344:508\u201310.\n28 Montgomery SM, Morris DL, Pounder RE, et al. Paramyxovirus infections in\nchildhood and subsequent inflammatory bowel disease. Gastroenterology\n1999;116:796\u2013803.\n29 Thompson NP, Montgomery SM, Pounder RE, et al. Is measles vaccination a\nrisk factor for inflammatory bowel disease? Lancet 1995;345:1071\u20134.\n30 Ekbom A, Daszak P, Kraaz W, et al. Crohn\u2019s disease after in-utero measles\nvirus exposure. Lancet 1996;348:515\u201317.\n31 Davis RL, Bohlke K. Measles vaccination and inflammatory bowel disease:\ncontroversy laid to rest? Drug Safety 2001;24:939\u201346.\n32 Ota MO, Vekemans J, Schlegel-Haueter SE, et al. Influence of Mycobacterium\nbovis bacillus Calmette-Guerin on antibody and cytokine responses to human\nneonatal vaccination. J Immunol 2002;168:919\u201325.\n33 Krishna MT, Salvi SS.", "mimetype": "text/plain", "start_char_idx": 42146, "end_char_idx": 43691, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0b81cc86-adf8-417c-b4c3-b1e569d7f69b": {"__data__": {"id_": "0b81cc86-adf8-417c-b4c3-b1e569d7f69b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "67f36992-3402-4428-a50d-8e97c23f5e0f", "node_type": "1", "metadata": {}, "hash": "eddf858c6da2b651b3394411fcb64de3ad65e140ecf0ca4588393e74b22d30d3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "da3ead35-d881-41f3-bfd9-bc1020016601", "node_type": "1", "metadata": {}, "hash": "af2dac9ed040b260004204b95dd67ab1dc6171d30a5b3ab6d28896e68d7ad519", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "J Immunol 2002;168:919\u201325.\n33 Krishna MT, Salvi SS. Could administration of bacille Calmette-Guerin\nvaccination at birth protect from the development of asthma and allergic\ndiseases in the western world? Has this question been adequately\ninvestigated? Pediatr Allergy Immunol 2002;13:172\u20136.\n34 Mayberry JF, Rhodes J, Newcombe RG. Increased sugar consumption in\nCrohn\u2019s disease. Digestion 1980;20:323\u20136.\n35 Jarnerot G, Jarnmark I, Nilsson K. Consumption of refined sugar by patients\nwith Crohn\u2019s disease, ulcerative colitis, or irritable bowel syndrome.\nScand J Gastroenterol 1983;18:999\u20131002.\n36 Katschinski B, Logan RF, Edmond M, et al. Smoking and sugar intake are\nseparate but interactive risk factors in Crohn\u2019s disease. Gut 1988;29:1202\u20136.\n37 Persson PG, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: a\ncase-control study. Epidemiology 1992;3:47\u201352.\n38 Reif S, Klein I, Lubin F, et al. Pre-illness dietary factors in inflammatory bowel\ndisease. Gut 1997;40:754\u201360.\n39 Riordan AM, Ruxton CH, Hunter JO. A review of associations between\nCrohn\u2019s disease and consumption of sugars. Eur J Clin Nutr\n1998;52:229\u201338.\n40 Lashner BA, Shaheen NJ, Hanauer SB, et al. Passive smoking is associated\nwith an increased risk of developing inflammatory bowel disease in children.\nAm J Gastroenterol 1993;88:356\u20139.\n41 Sandler RS, Sandler DP, McDonnell CW, et al. Childhood exposure to\nenvironmental tobacco smoke and the risk of ulcerative colitis. Am J Epidemiol\n1992;135:603\u20138.\n42 Persson PG, Ahlbom A, Hellers G. Inflammatory bowel disease and tobacco\nsmoke\u2014a case-control study. Gut 1990;31:1377\u201381.\n43 Davis MK.", "mimetype": "text/plain", "start_char_idx": 43640, "end_char_idx": 45255, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "da3ead35-d881-41f3-bfd9-bc1020016601": {"__data__": {"id_": "da3ead35-d881-41f3-bfd9-bc1020016601", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0b81cc86-adf8-417c-b4c3-b1e569d7f69b", "node_type": "1", "metadata": {}, "hash": "b200dcf4ea311678545c1cc264d8678120391b80f4723e15881e981522d37f38", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f96e9532-beef-4516-9c13-b23c5ea6e4c3", "node_type": "1", "metadata": {}, "hash": "a5e214b9188f5d8a26df484e67551418e36f548c2bfd259e4a00eca3aa7fb2f1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "42 Persson PG, Ahlbom A, Hellers G. Inflammatory bowel disease and tobacco\nsmoke\u2014a case-control study. Gut 1990;31:1377\u201381.\n43 Davis MK. Breastfeeding and chronic disease in childhood and adolescence.\nPediatr Clin North Am 2001;48:125\u201341.\n44 Pronczuk J, Akre J, Moy G, et al. Global perspectives in breast milk\ncontamination: infectious and toxic hazards. Environ Health Perspect\n2002;110:A349\u201351.\n45 Lomer MC, Harvey RS, Evans SM, et al. Efficacy and tolerability of a low\nmicroparticle diet in a double blind, randomized, pilot study in Crohn\u2019s\ndisease. Eur J Gastroenterol Hepatol 2001;13:101\u20136.\n46 Lomer MC, Thompson RP, Powell JJ. Fine and ultrafine particles of the diet:\ninfluence on the mucosal immune response and association with Crohn\u2019s\ndisease. Proc Nutr Soc 2002;61:123\u201330.\n47 Powell JJ, Harvey RS, Thompson RP. Microparticles in Crohn\u2019s disease\u2014has\nthe dust settled? Gut 1996;39:340\u20131.\n48 Powell JJ, Harvey RS, Ashwood P, et al. Immune potentiation of ultrafine\ndietary particles in normal subjects and patients with inflammatory bowel\ndisease. J Autoimmun 2000;14:99\u2013105.\n49 Feeney MA, Murphy F, Clegg AJ, et al. A case-control study of childhood\nenvironmental risk factors for the development of inflammatory bowel disease.\nEur J Gastroenterol Hepatol 2002;14:529\u201334.\n50 Van Kruiningen HJ, Colombel JF, Cartun RW, et al. An in-depth study of\nCrohn\u2019s disease in two French families. Gastroenterology 1993;104:351\u201360.\n51 Colombel JF, Grandbastien B, Gower-Rousseau C, et al. Clinical\ncharacteristics of Crohn\u2019s disease in 72 families. Gastroenterology\n1996;111:604\u20137.\n52 Van Kruiningen HJ, Cortot A, Colombel JF.", "mimetype": "text/plain", "start_char_idx": 45119, "end_char_idx": 46745, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f96e9532-beef-4516-9c13-b23c5ea6e4c3": {"__data__": {"id_": "f96e9532-beef-4516-9c13-b23c5ea6e4c3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb\u2010Baron (2005).pdf", "node_type": "4", "metadata": {}, "hash": "f41941fe623d22bf3b4ee356cb4b156b560c8ec45379a8999ecb31c8f3196e4a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "da3ead35-d881-41f3-bfd9-bc1020016601", "node_type": "1", "metadata": {}, "hash": "af2dac9ed040b260004204b95dd67ab1dc6171d30a5b3ab6d28896e68d7ad519", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Clinical\ncharacteristics of Crohn\u2019s disease in 72 families. Gastroenterology\n1996;111:604\u20137.\n52 Van Kruiningen HJ, Cortot A, Colombel JF. The importance of familial\nclusterings in Crohn\u2019s disease. Inflamm Bowel Dis 2001;7:170\u20133.\n53 Laharie D, Debeugny S, Peeters M, et al. Inflammatory bowel disease in\nspouses and their offspring. Gastroenterology 2001;120:816\u201319.\nRegister now!\n10th European Forum on Quality Improvement in Health Care\n13\u201315 April 2005, ExCel Conference Centre, London\nFor further information on how to register please go to:\nhttp://www.quality.bmjpg.com\nEnvironment and paediatric inflammatory bowel disease\n363\nwww.gutjnl.com\ncopyright.\n on January 9, 2025 at Assistance Publique Hopitaux de Paris. Protected by\nhttp://gut.bmj.com/\nGut: first published as 10.1136/gut.2004.054353 on 11 February 2005. Downloaded from", "mimetype": "text/plain", "start_char_idx": 46608, "end_char_idx": 47445, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}}, "docstore/metadata": {"0072325b-63d7-4325-941e-47f2eed7b3a3": {"doc_hash": "199df34ac296075596fc900af3a31704f7f507116e1635b9d21ad6534f8d5d24", "ref_doc_id": "ba\u2010Harling (2005).pdf"}, "b5ea6b0e-bf6d-4d14-a523-7e66e0c1fe73": {"doc_hash": "b5e673f708bc32d9ab84ad6805988629d22cd82b2d1334d14a3062a68b341982", "ref_doc_id": "ba\u2010Harling (2005).pdf"}, "119c4351-9042-4a6c-a897-4ebcbb8a0cbd": {"doc_hash": "d3e953501177640494be7aabe334684af068812016f16efb302bf899f9b56060", "ref_doc_id": "ba\u2010Harling (2005).pdf"}, "c69556f8-3e61-4b9f-9c7c-42aeb698ceda": {"doc_hash": "8bd1aaece13f0e1ebfdde76f7910cf24ede8b3dc1a28a2204782eb606dfbc4df", "ref_doc_id": "ba\u2010Harling (2005).pdf"}, "9b4f136e-3ce9-4774-89d5-6056298b5368": {"doc_hash": "0589f6ae4890ec733a3c0dd2eb1725cddb413731b6686d761e3da4cca2e25410", "ref_doc_id": "ba\u2010Harling (2005).pdf"}, "2d65ebc3-8265-4b82-bb4c-36964cd2b75f": {"doc_hash": "feb473499289c5e3031158758ddb82dc866ee098614f94cbcf6794b1056a62b3", "ref_doc_id": "ba\u2010Harling (2005).pdf"}, "d0f5bfc4-5b76-4c5f-b065-a6ed195766e0": {"doc_hash": "a38b87235b266aadab1ab4e1ba902146f4ea51b4291f4eed80eebd4d80ee658f", "ref_doc_id": "ba\u2010Harling (2005).pdf"}, "524abb49-1a47-4c96-8e5a-5dbc499b436e": {"doc_hash": "e741c0391b473e6a71c6ff052cabda83024cac34c15f8f15078c062daa154bad", "ref_doc_id": "ba\u2010Harling (2005).pdf"}, "ab8b2fd3-1a25-4715-af5b-1b32993344fe": {"doc_hash": "997308d39b6064aa501153b1299076d60bec952e412d604e1df8b90f5ffeb301", "ref_doc_id": "ba\u2010Harling (2005).pdf"}, "15b1478d-8936-4738-8dee-d810375d162c": {"doc_hash": "5ec664bf6f3c8bdd66a89f8a838c46df0f15d1e3c0968cced944263fdd2e7b92", "ref_doc_id": "ba\u2010Harling (2005).pdf"}, "774490ad-fe86-45fe-916f-f2b0914b98f4": {"doc_hash": "b6e895c6664883d1367e31711c2348c55687166f24dde1c99fd13af5ccbcd530", "ref_doc_id": "ba\u2010Harling (2005).pdf"}, "80bca55e-44c9-4153-b904-90a271535b99": {"doc_hash": "1f22f9993e57bef6d86a792067d93f2829d2cafd457a26d5a7e01556df3638fd", "ref_doc_id": "ba\u2010Harling (2005).pdf"}, "21899d0b-a719-4851-9129-27cbd2ac0e3a": {"doc_hash": "1f22ae227238b479b50bbee7ce21ca93d259075f529e96e45d39f16830dfe32d", "ref_doc_id": "ba\u2010Harling (2005).pdf"}, "45242edb-dac4-4f8f-9f5a-458c6ef4025e": {"doc_hash": "bdc63b15fda7c493f3e1cfd5d29c94b4539866816d5b75d8ea696bd0a4ecf434", "ref_doc_id": "ba\u2010Harling (2005).pdf"}, "b362d4b3-850e-465e-bc69-3592add02d33": {"doc_hash": "9831d2833abf0e859ad723d1f8225f04e856424f051e9645b2dc2a5db5bee7ea", "ref_doc_id": "ba\u2010Harling (2005).pdf"}, "dbd875df-9895-402f-a065-0ecb6bd47e70": {"doc_hash": "8c86a1fa8303d531c827351d77f4e84de03f7e5915b3357531c20f42749d88e6", "ref_doc_id": "ba\u2010Harling (2005).pdf"}, "bcca9640-96fa-4b00-9261-c2927b8c36d8": {"doc_hash": "5592efde7df8dd30bf8b750eac54cf69b907ec0f826743a7934350c57d910a8e", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "4398996b-2c76-407d-b6d8-cff1ca576a24": {"doc_hash": "88db3cd4ae7fa675d40c5cbe4bdb91b1e9d04eb0afa6e71b61e90539da3df1ce", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "75f6f1fb-c9b5-49d4-8594-990a7d9af86d": {"doc_hash": "a59af63d2d0d136c87336214ec9e9c34b0fa251b2efff74afc454d009630303b", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "fb3326ca-c29b-4fe2-b9a4-53a7fe69f922": {"doc_hash": "3b1e2f5ec354cdb76d4de43d85fc143847f16dac57ed18b84cda5a3a5bba879b", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "6fc83280-069d-47cb-8794-76ee676141aa": {"doc_hash": "d4f0fadf1bd4be8448b7385c2a5f08a266dfd3fcda89a5d2fb737a5e0c552040", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "6091fb79-c4d6-4187-bb0e-b2415ae2a46f": {"doc_hash": "e43a22dfbf775bbce94776447f8445c62020bcd582a95ccc02b94d0011aec6db", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "cd210aa1-f1d5-47b6-b19f-c38ee8bdbf87": {"doc_hash": "cc827ea3a1daaaa5d08632e65d93e79c204294fa2be0c5de4e6b7707815d53d0", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "9822c839-e974-4d47-9844-58817545fb19": {"doc_hash": "844b9dee5232512b66328b307e7828d3935b45f4cf9c60f3195aa2fc0df1ddb8", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "ad82d4a2-7edf-493e-9fad-a15c83dd640a": {"doc_hash": "dec590d84bdf43420ec79ff042c79efd623073989c594c70a4c477d0d6599c78", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "9916b2ef-db94-452a-bdde-1e26190c9298": {"doc_hash": "f2f58ee6042bbc9cc048a973b86e7dda8b71545d23d0c1a6e3eb03259a9ca572", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "6b1839a0-ccf9-402a-938f-d464cda531fe": {"doc_hash": "82cc61df5a3769ab3f41684661ff57d48ba63bbf1f84cc38ceb19d72ba81a916", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "049c3368-5add-40ee-9e40-d0b276d7d821": {"doc_hash": "2dec15548e3a3548a80871d55817193b50a4f1b5f5803e130597ff950c964a30", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "a1fabe26-1bb4-470d-979e-e3edc08d0bb6": {"doc_hash": "70d8b38d3e089c947881c6934ae7cfda1db7dbffd74ba615b3dad9525609c80f", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "5f665828-58ba-4c37-ad50-8c2708fa5d85": {"doc_hash": "a520bacf47a5caab20dd08636e45056a619316f9b7ad2306801061274abe7a09", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "2aa27631-6a39-499e-8b8e-bc395a532fc8": {"doc_hash": "e1e9aa03f7211564ef55ef6cf1cef17d421bc47306828c5b68f54a30b1b4e131", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "9b042a23-136a-4468-b17e-668fc9648637": {"doc_hash": "d859ed52cb4bb37da3dde6ba3a36bc99f035af03fb05f28be2a185b455ae68e0", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "054f2ba4-577f-4f11-95c8-b954254cfbaf": {"doc_hash": "591b348f6ce907fba0c3c5bea030e115b8fb735119677a078dca34e329a7927c", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "8ee82aa2-7c3c-44f2-a7a7-e91bb33eb78a": {"doc_hash": "d98a4d21c002125a41cf2fec2404bf7bd93c5392746b0eaad6f97b5b4c1c4411", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "28838138-079c-497d-a473-0a155276f25f": {"doc_hash": "a1609eb16bbf9d7aeed06f367c8202fbe28d0cc166b67179c31895591aa5e862", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "604d8e78-1d35-4029-ad96-c1997a329b76": {"doc_hash": "262ab979ce9f332cbd12a52576bb4ca03d584cc37f640054e7ca7ad7ff30b610", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "acf86d59-341b-4c83-90a4-6eccdf40bb3e": {"doc_hash": "35ade7d00ebb1f21051f85691282280a0835b8ffc6ab644dfb090bbf35fcdecc", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "2b7e277f-5418-45e9-8271-789c4e97fd04": {"doc_hash": "95868bdea926d99328ac2ae9226ef8e9007f06e853b8d985b02d92e1f5c41092", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "0199d9f7-b86c-4092-8654-79e13f9e3c79": {"doc_hash": "90ed1de1758d22ffa6708af1b3a6e9415ca00330db49434d6136435931d79ff6", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "977c0a86-9759-4dc4-8924-409bb946e467": {"doc_hash": "2937ba0c8603c48ea2c2b44ae7179bdbdb4863383f7edd5d723eccd409a5ce90", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "7d2d8d2d-797c-4228-ae74-2dd9f47378f5": {"doc_hash": "ecbe301dcadd63244a1c242fffb534cb7c12da7b0cd453e23aa8461d7c6051f6", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "bdea3ea8-1b26-40bc-bb57-0950cbe040ee": {"doc_hash": "f6e93eebfb36dd14b7237807782487f081a3906a9aaf495c524266ba879cffc5", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "6cf68996-d2f4-4cc4-9754-f865df09a6e5": {"doc_hash": "5d4fb3661e8119fcc5840715ee2c3ba8d54da54b5cfcc75c50ff805430045a95", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "253fb3e3-f169-47e6-a7cc-3869f515e06a": {"doc_hash": "18706c90fb6d7b70739e1a17c069c6ce860e458c632a83acdf9a471824f07ff9", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "ca4be5ef-909c-47ba-ba91-c4ab01b16b26": {"doc_hash": "b4bd156639643de7c578087ff4d756bd40805262d12e8c2e6a56d81927c6a2ff", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "55bdacb0-c668-446a-af57-e53cfd43b712": {"doc_hash": "55937231551efe765b7d074c82c0be9c00290930162b9c2812b841b6fa0af5ae", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "62d81115-8fd7-4f73-8246-127cf5b85bcc": {"doc_hash": "a6f72432a580f9520d3c2f32a3e67da7595eec8e0859c84835e9740d59865aed", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "d6fd9591-d93f-451e-b8ab-244b079196dd": {"doc_hash": "9f20701d0113456b1dc294e4c7fc20b5b6edb1f5c7ee9af2a05960753722bafc", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "fc02603f-e10f-4dbd-9696-b0e58ecf640e": {"doc_hash": "037026ed3abea3f805c463f61e140a9c18805057116ac8049a7a37bd95dcabef", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "e3e89a02-7152-4dc1-896a-c5c304982251": {"doc_hash": "575ccf94ea9d23d3ac86783c8cc7bb3421b027b28ca8fbb9674aa19340e92abe", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "f5a6705c-1c6d-44cb-b4e2-d4be07d3860d": {"doc_hash": "79a8146af69478f874367bb92a1bf10513826b19cb8f019fee8c4bb84949159d", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "1ad9e93a-2aaa-46a7-8825-07ab5fc6e2ca": {"doc_hash": "7b8213c7ff5acf8ad17fe358f45097e259e1772453fe6df8f25186e98ac7ad02", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "889fc074-4691-4196-8121-c44da471cf73": {"doc_hash": "7a36c3527efea01d82848710055e23f4d2161127e87d16a38b01aa3f2a0c3616", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "80844067-38f8-49ae-9e5b-2fabec648e4a": {"doc_hash": "0bc8f9d8d2dcc37ed3c3a1cdc2ed3d4ee2458cb4f1ab901e8b92d9c006675150", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "f8db0ec0-d6af-48e7-b6ea-72e26ed76e50": {"doc_hash": "6409a00c8f2da25d67c07dca1c773974f48b7837ee1b77f85d36208be1973742", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "1542bc85-5f93-41b9-9d01-800f2b2eb2b6": {"doc_hash": "8250c5c29b6af63aaed9566d0b45984f4e7f0b2de0d41ffb94adced0fa2cacfa", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "e40aee59-19aa-4e0f-b1df-fa3ce391201d": {"doc_hash": "64b7d91b563bf34fef0510ffe857df5bd95115ae14d4357c0cfc10d5fae9b18e", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "4b23f3cb-0635-4ee0-958e-224c3b0c8111": {"doc_hash": "5e45b2d69fb6943f134f74dfd6130cd55efc359a15e023518eff9aca9bead777", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "40c9f61f-3297-40c2-adb4-3f462b526b20": {"doc_hash": "c4a83925789418332e174e3645d23e3899f8bac68243e3424d33ea6c234a2ad9", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "1843683d-ffa7-4ecf-915f-57a63d0996c8": {"doc_hash": "29b4d9bc7cd0140f88d1fbe383c0ec0e0254674e85f8e6cf2c581c0ef33b53d5", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "d4d5a6c7-ec07-4605-9ee0-87367d43de7f": {"doc_hash": "f163802400664c6154123016ad584a2db0c0bb758352fb35a885afd6b4af7bf1", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "4454de05-53cf-4e1b-b77e-bb7ade65e93f": {"doc_hash": "1403ad5986f487990f6932c93f6734a856d466635c5679d3b348c50a895dd753", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "268d6229-ffc8-47ed-a4be-78d80aefac70": {"doc_hash": "fa820db73d2652264965ffa75adc9443f6082ee3a03113d327667b22bb7260c9", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "82294b88-ec20-4e27-a2b0-b0700debd9e9": {"doc_hash": "b7d1cc4a463913eba243fe7a695a2d3f77799858bc6e0ff3c420ac24a314b005", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "bc50da0b-b4e2-4f88-8639-45d2d503893c": {"doc_hash": "265447964ad170863f87a32ece7214193f92d8047a9654b2a98d5afaf96e1c3e", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "1c187eb2-7341-4875-b47c-1ade48bd7ebf": {"doc_hash": "1d757ad8ae6ce54139978faa13e7c629efadf1dbeebccf79e50aae542483bf2c", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "ae8229a3-cae2-4725-8a55-32a8702889a0": {"doc_hash": "2a5533441b3d62b62e4c3d282b4a2d1c142666f2896d8c4fc775579b0db4a8ae", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "15e38c69-7725-4ebc-a38a-4877498bfda5": {"doc_hash": "4ebd190dc5992f7348927886f8bc05d417495327e631f86a77b20c5fca5c8456", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "705eeea2-dbd3-4556-880b-289de4102112": {"doc_hash": "08f235ada6e11dd651e3a7cc081ffa924597cd2ba9f9a6107fd4fbb5b47da0cd", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "587c1eee-4cf4-4cae-8620-20be695fe7d7": {"doc_hash": "a0b3bccd4d345fb24c3c1d001a3a822f05c4059374c999ccf991b59e60bb9440", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "a3ebd531-2a42-4518-af7c-6b1e69e2f40f": {"doc_hash": "c412f2c87ebc43fb91062e6ee5014f62119c901e6c4577261748b3e0709c2f80", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "f55db0f1-a4c2-4f8f-bd43-4bf8e943dda8": {"doc_hash": "892ca980c468bab593d87d90842dfedf50ffa9224cedc5913c52c18affcd4065", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "3617cea9-fc77-45de-83ff-405fb4a423aa": {"doc_hash": "2131635b0f9eb53276c5f2a297e1c0f46c368e2943760745734ad324edf6b740", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "40c9202d-d320-4148-a2ee-b3ccfac60252": {"doc_hash": "7d790dfe7996fb549beafae399444fe950241610fd100752dd90f2175cbea35e", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "2371b6f0-d552-423f-bdab-d6393be3a74c": {"doc_hash": "8cdc959e80173280eb8ab0e65d07048a503aa2b4b94f37f32e2038a3efe5993a", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "e3a2bf53-00de-417f-8573-e19224eeb7ca": {"doc_hash": "04b2cd667ddeb46f14e455bc4b62956ed59681bba33c21f8cbb8f79fe93f7852", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "2a568958-637c-4e31-aaa7-34ac03d416bd": {"doc_hash": "be5d61eb60358ce37f5a47be4e13b3a87437826001eda75b8f17ce14ac067552", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "0253b27b-ae7d-4790-be90-69ece29c8991": {"doc_hash": "58ee502071eae917598c462cab7a423ea64283e0f395cab30dd8acfb4addbd14", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "002ec97d-7a4e-4803-a963-5f5fdead98bc": {"doc_hash": "60393015e6c4df108874917e6a00375f901224d8a9c0ef9a97be69677d404b5e", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "f3d02287-1589-4ed1-8af9-553806f87c92": {"doc_hash": "979b7501aba01a3427dfafea67c645f3dd5cf923142ad06803946bcaaf3dbcf8", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "b4ed3a3d-b3b7-4a2e-8f51-30141cb1c82f": {"doc_hash": "34d21bc3b84421a07c88ad2e336932f2b17b2f7c3780587d7710a3153bdb901d", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "dc69620c-13fb-4791-b1b7-754dc8bff01d": {"doc_hash": "d0c92ebd8501d21a4699987d76932fc1228577fe129a220a7065a2edfac6d326", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "5347124b-e311-40e1-9214-ef68828ff18b": {"doc_hash": "131f94d81ff200b352f703390615cc1b4fcf993ef5adfe7496509a3184ccbbf4", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "1d70940f-28ef-4df9-bfb2-31cd50c4870a": {"doc_hash": "1ef9dcafe3b62a4d3123cdc269f24ecf3dbcd46eb8c8c054d6b77388ac1d9f66", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "e278cf35-dc45-4baa-a67d-ffdc909a04a0": {"doc_hash": "7da49d89e6131fa34f1c6d024327b3ce77a85308cc10660a75c5b073a1518fa3", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "a20cf248-5c4c-4aab-862c-64c86bef9d2e": {"doc_hash": "11adea4da20107a41ab01c567cd97259939743471c9b241f64720173ee3ff1fb", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "34ca1773-5109-4631-81b4-6a21df0d0852": {"doc_hash": "b9b0bd269812ece50ec91c37c5cb43edb126f45eef8a1b906a9ee37d588ddbec", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "1c6b9e35-845a-40c7-90aa-a1bdd3fa85bc": {"doc_hash": "6bd5838a2d97d21e8f24f9aa2d91af3946ca35243f65103e18010bf4ef32aba9", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "aaf34641-6822-4462-ad58-2a74e61dbf1e": {"doc_hash": "1a72faea9ca32e37297789c0fdbe266297650112d27194f79fd591bd9b263618", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "126d4d7a-9101-4a5b-8220-67d710e55954": {"doc_hash": "c2fc92522d1037ffac10be4790677268e5f9d6bfadf5f5fecf978ef56c4f976b", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "992b4ada-cd12-4145-a7b7-cb4d0d25928f": {"doc_hash": "0988e13efc3d2604ea07ef664ac75c71c1773752db33f83752542bb136a54fc5", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "2060ace3-3f84-4ab8-8afb-275e4a603aed": {"doc_hash": "e16870364f2b755a99403a5edb649f3583b31174727153a28f8e94b2d0bedebe", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "725c72ad-6a76-495e-9c9e-7c252344ccb0": {"doc_hash": "8c29f0443edda2d2f592064ccea2c0d3e094d214f98627892615bc05fa56a5c0", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "7a3727d1-d832-4c62-a307-e798ff3e0a4c": {"doc_hash": "446bacc846a3884f383d7225fb8933bbb6f186dcfe5d11f8744b9e46d3a834eb", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "dc8bab62-f2bf-4951-84bd-7bf12125dc3a": {"doc_hash": "82e132e714b16f2fcd2aba509613e6fbcee6deb7a714ada544cede1b89a5e03f", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "83539b8f-24f9-457e-8b51-112ce37ac806": {"doc_hash": "2e7b40b2234f7b600b2e66d2c18822c39492c40c0be5e3007f2126632329946e", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "cc230894-2625-42e6-b17d-b3bf2f63c291": {"doc_hash": "4afe1bb0829f82879b44ba3dafc553e69de81eb0da3cee4a64ac6f7bb35a3106", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "7bc25279-3a53-492f-b388-6b4bb5251317": {"doc_hash": "f498454696d116fbbe6a7f706811fbd65fbd28fd67ced030fe046a26221776f4", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "f040eb24-1455-4579-a091-ab0bf63affcb": {"doc_hash": "f67c442610aa60646bfbb5d3dbcd00ed838ed4294bed8d0d40d975a20581d97e", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "7b56425e-2f83-456d-94ff-f51d94ed20a3": {"doc_hash": "1274167c3f8d5fe393258c08eec5a88031a9a5ddf106f9f863ce0bc3f1702117", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "e5eaa04c-65f5-446b-97fc-f3e061994196": {"doc_hash": "39813abc407303e8eecdb0ea4df3985eef4151739010d65177d4bcac735f8983", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "7a740802-b4bb-4cdd-86e4-93183006f2f3": {"doc_hash": "249ef12baa58074b71e79fcfeba6d4e7a52d4ec65c02b3a41ce806c1366324af", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "46eef006-d8cb-4cda-b796-dab3f58d1428": {"doc_hash": "a938ff09be4dc66fcdf563cb02cb9f5b65b3579ff1441a271e408b31f7809c0b", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "c2b891c9-0bf8-4846-ae83-84b4d33c9afe": {"doc_hash": "99a315fbf7c13a41b78c090a6a0802aac3d8ae444f5b98c178b19e28d03c5c4c", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "640ac5e9-f3f7-45bb-afc5-89a251dab860": {"doc_hash": "d682e951470d86d81c52c6b622cfed55b3cf914a336a1a636e9a7fe6ed16c683", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "99f75413-c160-49fd-9d0f-665a236075be": {"doc_hash": "6a34cb69ef7081e673e2991b954e32c0cf3d7e07d57b4314ff65fe175484cb9b", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "16faa05a-01cb-458f-8b01-f4e48f341fa3": {"doc_hash": "12c7dc6e2985e14c7104b69887429994b70088843f0278d0c5856ba4fe23e92a", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "147dfc5b-2672-4bd9-a5d8-d37c8b830839": {"doc_hash": "335c7a0f4bcd440473545dee463102ac0647ff76196cefa0cd3ffe864f1c48f6", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "c6609416-296d-4996-aca4-2e2d660bc359": {"doc_hash": "cf7cd19f7bef87bbd062c421f8d8c9a79f7c802f2fe345022249a396e4ffaede", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "8f308ea1-14be-4986-b9d0-6a583f786280": {"doc_hash": "3a604ca51d961cbc951525d341fcbb8ab0246cd12929df2d72d36285e856877b", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "5b8b8817-2dd0-4418-9349-6c1f5b734f7a": {"doc_hash": "109688ce3870349516776a7c876d480b578a894f2c8c24b36f9a85dced0c75e9", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "1e4feb1c-c51a-44db-b152-87e5eb62cf72": {"doc_hash": "18db76fa0a2139e2200bb01889e14952065bc3b4bb001c720b0eaf70bd2f017a", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "a31f1939-7751-417c-abfb-8efca3561716": {"doc_hash": "c71a7bc10667e3a6eca4aee8999b42553b842b1163251aa01029003da6ebda73", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "ab82e223-0226-4a71-8bb4-1290975cd63c": {"doc_hash": "f26af4580b638c4b22147fbbd387d8c71886502c5cecd44380f15d589e2ee918", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "3fd9745a-e8f4-4285-add6-21b637f8b5b2": {"doc_hash": "e2ac91573a614840e18f445c78c8a8cc95fc14e77dc548c5df1ce4e52972d33d", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "fbaa9766-028a-40ac-80d6-c9abecbc2b29": {"doc_hash": "71f594e9d6f2b6dcc3cb688ad65edcb284b41a5128f734ab9ee71e6a222df4cc", "ref_doc_id": "ca\u2010Barrabeig (2011a).pdf"}, "4bdcbfe5-ee0b-47ae-acd3-4d333fb274d7": {"doc_hash": "3acf90a74ad9cd71fdea68891c655d642c180a510bdba1022ddef6599effee88", "ref_doc_id": "ab\u2010Bloom (1975).pdf"}, "ced21b70-51e1-4333-893e-6caf411ceaea": {"doc_hash": "27927355b8c7684ca002f3b0b8c4a7263f1f7b8b98c54ad0778fc2d606f7ac05", "ref_doc_id": "ab\u2010Bloom (1975).pdf"}, "8f8a15ae-7760-476a-8584-e8be10ae9faf": {"doc_hash": "4075714e286a597d1fee4edcc658e0226135627e20c7749ea5cf8b79e81f2607", "ref_doc_id": "ab\u2010Bloom (1975).pdf"}, "f3c61168-eddc-44d5-967f-8654a533be9c": {"doc_hash": "82e8250dea0a14f3cec70ee84f204858294670310d8307a85d5edc6d71aacd4d", "ref_doc_id": "ab\u2010Bloom (1975).pdf"}, "5caa5813-73ad-4d5f-85ac-bf0c4cf6da8c": {"doc_hash": "8ba81e4389e49a2c6d8480a1957d4463d66a552f3e06de8b92182fae09291efc", "ref_doc_id": "ab\u2010Bloom (1975).pdf"}, "a80ed783-7f29-4da5-bc70-97530d4c5d53": {"doc_hash": "e0319b3fbc1dcb351d8be4ad8c483cfb1d97b192b0bd88e24d7c8d09c155bc06", "ref_doc_id": "ab\u2010Bloom (1975).pdf"}, "d6b319c3-c436-4e8f-b165-46142290b014": {"doc_hash": "299bc3bea062d80bb510f89dc8b22d6c658c0bb76614d9bd0c1f4686ec85d53e", "ref_doc_id": "ab\u2010Bloom (1975).pdf"}, "457370e7-1207-486b-be46-66b9b0fe8828": {"doc_hash": "7eb171d3b0cc431fd1b7cc599d12aa1f48113bcdefb06b36039e9d41ed5f8962", "ref_doc_id": "ab\u2010Bloom (1975).pdf"}, "d43abda5-6a41-4b26-8383-199c98d07abc": {"doc_hash": "44b01e31bbf27013dd7e828f91e1f61d860c413228ca7bf4967560c78040cdd5", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "550d182c-e186-4126-9de2-7c9f2f93a088": {"doc_hash": "532f89f08eed85ffdd45de10ec969f793bcdea734f99354e8853afb67253c068", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "c045a63a-0bab-4075-85ed-4b7c1b78ce95": {"doc_hash": "2ab23aed09278a55759ee8b0fe7f56cd3d69841452cba23bf3af07d3dfb6c237", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "112ec265-0f66-4079-8725-8e08984f1fae": {"doc_hash": "f34750f768d899186c12f0dfd514f91dd8fd403344144bbbc822396799425160", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "24804042-bb5b-4fbe-be0c-1f23ff810a4d": {"doc_hash": "f42ab3574e2c980027dc435e12fb52f273b2d583a97853075b15adc9346efbcd", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "f3299ac7-7419-4573-9440-faf93a274f95": {"doc_hash": "1d0722664fe60995217d8f7b2989313b60428d6d8fc1927418aa54a6b5ac19c5", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "e976a8b5-029f-48cd-a7bb-31b6ccd6fadc": {"doc_hash": "7bf13ca288cace9116d12aa4560d1d8ebee55127a85e07bbffaf96b5d5df8fbd", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "ed9c7574-97da-4551-8edb-cc9bec0d7738": {"doc_hash": "96bc6a4a83a079dcfec9d06455aac7dc1836238c44da13e671e2e537c6a5ce8f", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "dc44b349-a31c-454c-aad5-a1b4e4f0f339": {"doc_hash": "eb8c827688342e8dade0ecc3b325904d76a9c3a012953ca202bb078be9cdb720", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "7556660d-6a22-40e3-ab48-2436679a9789": {"doc_hash": "fa59c338dd1dfd1021b745af23bcf300ec94c2f7a050a49e3162dd39fa444d2c", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "6c0bb162-f1cd-4777-b94b-369aabaa801f": {"doc_hash": "277ccbf7ebb276b58906adec79209b329fbc998a1eb22c7dfc9d5d1dff5d078d", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "740f4e25-a8d6-411f-82c9-cf88b0cae0d8": {"doc_hash": "beda3403f17c0f0a79e1af8d84089d35b5d5f4c0d5ab252b07d3456f98ea7fa6", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "e582f22a-f2c8-4c18-be99-07624670f51f": {"doc_hash": "a1f60b89ca00a95e30386512d6eaff8e9270e7b79e9dcdc4b44c245020be0a0b", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "986bc4c9-6385-439c-9faa-2cb314330bd8": {"doc_hash": "617c80d0bfc3a44c29ac564602a283956dcea4f5bdd7cacff520cb73a4217332", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "d1fc5fee-261c-4bc7-aa40-afb5da35e523": {"doc_hash": "d66c81c4d6604140dac0fb00ff59e0d99dc7da0f5e083c589f3fdb35ca375ae3", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "88502d7f-25d5-40b2-99a2-8fe0d6787bc4": {"doc_hash": "5adcf2d8c8e3572e087ec62300513b38293677f5c23f22f77191cea4efa0ca1c", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "7e347ccc-4c72-49d1-8930-617d0f064d75": {"doc_hash": "f7331e10648e46e9c4e281b2c4a8860d1ecc1b4be038e0f542de2d301cf85399", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "65231cf1-6629-4e2c-bdc4-4ba5d743d100": {"doc_hash": "06245959e991e4de0373605daad011e09ed2b627d0f73b3be7403d4fb61f49dc", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "980da00c-e8ab-4009-9ae9-3817e2066d99": {"doc_hash": "0ac89677f740ef3fa227fc02ac6b64a92ef53bd9ca8607389178b6e8637e6294", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "aa1ce4c2-89f7-4bef-8ca1-f752275fe104": {"doc_hash": "deb182d3b6825487d210c3082fae8d14de0b312409bef2985238d6e25b624c52", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "d0ed2038-935d-41a7-a09a-aec456c2ab9d": {"doc_hash": "6ebb0ff7a24a036a04060c385e6ddedbeea04f5b059b190a941262ddaae1003b", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "e81d5508-1bfb-471f-9805-1fe516560d2e": {"doc_hash": "c53a024bd7f6d42d0fb6900e69617fcaa8bd59c30295d4b59149edadccc43783", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "8bfa9866-05c9-493c-9b0a-a41520229ba8": {"doc_hash": "537046607c8d041bded2fb3fd2bcc73f8b33afdf543dc14c565b4729eb73b7ef", "ref_doc_id": "bb\u2010Ray (2006).pdf"}, "68ad193b-50d1-4438-a3f3-d66e897ad8de": {"doc_hash": "564dbd71fe0c64b60005b7c1e279da5e4ee9fecafc43c587adafda5152be734b", "ref_doc_id": "ab\u2010Ceyhan (2001).pdf"}, "a771e287-9a7c-4454-88c4-3c6295f56faf": {"doc_hash": "5c6578792849b085762186a5f41a4409a9fb3e8eb396241f63206a2be047d404", "ref_doc_id": "ab\u2010Ceyhan (2001).pdf"}, "23713cb7-39cd-4bc6-9c3a-829add7c33e9": {"doc_hash": "1854825572b7564caca9c79c5aefcafb8d31cae18ddcbbb608b8684be36eea65", "ref_doc_id": "ab\u2010Ceyhan (2001).pdf"}, "836c8174-4b2e-47a7-a733-5aabeabe57cd": {"doc_hash": "12e9aa812d1125bb18d70df8d7db2aa4f4d3d198ef10bf938c83f6111d4603fc", "ref_doc_id": "ab\u2010Ceyhan (2001).pdf"}, "cc19cf07-a542-4d3b-acba-45aedac94b71": {"doc_hash": "0c69a6e7988e0eb4f5464b05046d634c7532f076950b8fc2b9b7886a163902e3", "ref_doc_id": "ab\u2010Ceyhan (2001).pdf"}, "47eff50b-be12-48b1-9658-d082eca28293": {"doc_hash": "c28ff8a5765b3a50db1d2365cdb6ad290bd966f0484295ad3fd26f43409980dd", "ref_doc_id": "ab\u2010Ceyhan (2001).pdf"}, "34fc559e-8978-4356-bae6-95abb438674a": {"doc_hash": "46f1911acfd16a110e3559f46bfe17b8b544e2596dc3d7dcd8c0c10d83c6044f", "ref_doc_id": "ab\u2010Ceyhan (2001).pdf"}, "97c61abe-8bf3-4702-b629-0fa6bc2b61db": {"doc_hash": "65a123ecedd2be0668a1067967fc647a7e489980c8af4b9c81fec0d2fcad698a", "ref_doc_id": "ab\u2010Ceyhan (2001).pdf"}, "1fea1f89-ee51-47f6-809f-c760f9fb083a": {"doc_hash": "c6bd4c91877fd851b6462042f0f2e7345023271809a724a651ebe8b784a13a5a", "ref_doc_id": "ab\u2010Ceyhan (2001).pdf"}, "f0868f32-ac14-4ca2-9acc-606cb5cff72e": {"doc_hash": "80799eb9dd7ac19ade9dda3f65b84077e555b3f0425d71b6adc650ae8ed75aad", "ref_doc_id": "ab\u2010Ceyhan (2001).pdf"}, "8636e930-aeb5-4714-a8d7-13ece4dddd82": {"doc_hash": "3bff6cdebf04b8b9b6f96fa91aaea45117632b54d8d2e36958f372d945acc06c", "ref_doc_id": "ab\u2010Ceyhan (2001).pdf"}, "3babe2cc-f06b-413b-b3d9-53d9cb31566d": {"doc_hash": "876dda1a5d20f2765ced5ecebd36324acd8bb10823d0d1b1b87bbc3aaf6cd535", "ref_doc_id": "ab\u2010Ceyhan (2001).pdf"}, "c3ef59b6-540f-41af-80e7-95ea1f4258f4": {"doc_hash": "398c7362a9d548bd5cd630e11740a3e7bdec2302e5de049d0aa89b7ff5dfb21f", "ref_doc_id": "ab\u2010Ceyhan (2001).pdf"}, "eca27f4b-8a62-499b-b9aa-07520f3c9c41": {"doc_hash": "fd2973fddd5ebfb681c65d0b6f17197571647c0d53c3f6f0eaf977e3bd3e4c76", "ref_doc_id": "ab\u2010Ceyhan (2001).pdf"}, "c3d19289-39f2-43c3-a22a-ee7ce7a4f65f": {"doc_hash": "3ab3f8142892b49631b016751427749fc5fba982b44d3263f59395bf503a19ce", "ref_doc_id": "ab\u2010Ceyhan (2001).pdf"}, "b4649b97-19f7-4509-9d84-8f6012a0f4d9": {"doc_hash": "483b1da43920654f355a711925421831defc28bab5628c30a48549f8bbaa7b65", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "5774bd5d-358c-463b-94d6-7fba145dd828": {"doc_hash": "13c061b324c541eca4113c66a279f7d8c0f126a7867df1305233b765e9ab88d5", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "b5b1f0c3-64c0-499e-a305-ebe24142b6d8": {"doc_hash": "4b8e0979610ec4dc60bf52cb86357217164354d533da49b61ccd1ce5726722b4", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "2f05a9c1-5af5-4b45-b67b-f6ce6f0b7e6b": {"doc_hash": "6e030fea22673d59cdce65fb54ed86e2d06d23cabaae03744a97d2b1116f8849", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "b975d129-aeb9-4a30-ae9e-13270caad675": {"doc_hash": "310c4b2169968db8a2fc0faa9f49018ceb1a6a517fd0f33fa82682fea8c38855", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "18b63421-ae10-49b6-ba08-49f96fcd95a2": {"doc_hash": "b7d440aaefa6e2993d9e5b7a76562682ef05cf0df4fe76f7d4c51f53e7ad5a6b", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "e92e388b-93c1-4b1b-a5c0-5169e8e6d4e8": {"doc_hash": "c65ba9f78eb02e910d169cc53deabf68eb168c021c2185aeeea378c6d693a2c0", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "a40236bf-cccc-43d0-9b0c-b9e98147703d": {"doc_hash": "a4de47ce9ed92ed42a4e43d18df073f8bd272280d166cf5a39cc1865438ea52f", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "52a6b198-21bb-4c7c-942a-228f6da1d60d": {"doc_hash": "c196204cd09ceaf9b3a7555a87888082e5b05293e8eb3feebc17cbea0ab66874", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "d6ae9f94-00d4-4673-870b-12c0e4be539e": {"doc_hash": "a21c895bba8d42bf1a71da39e683fde1d8ca74d26ae1d558e799d79e83433d1c", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "48bb7875-e7b3-40e8-98f8-befbb60ec43b": {"doc_hash": "6e55203bff17ca5b53d2fc98c108f3b3daf06761b3b6ba48be8f85719e0f993b", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "333631cc-b477-421a-84f3-2400efca1adb": {"doc_hash": "24698978941c257cd76aba2b6173596a9fbe70e5d00830ab1833905337876fd7", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "f2def86b-b77f-4fa9-89ec-3af1fd662c01": {"doc_hash": "0256fd9f05969d2c898040579072d7225cdfd10c725725d5a255c5b0c634e8e4", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "3eb9b1a2-da23-4959-86b4-f6788b860e86": {"doc_hash": "e12265d4dc119d6cb6981a37fc86ae2a3a240dfdaaf2d3838028d0f81eeffa99", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "c47c7bb1-bfc9-40c0-9c5e-0d4d240bcfbb": {"doc_hash": "f02b752ebc6cbac590239e52572a43dea71bd22aa4ca328d48163506c0cec917", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "dcbc23d2-d207-4e5a-bab0-a9d60e5b954e": {"doc_hash": "e1707cc76277aa0ccf8eb91cd02cfc28947753d15f58091b5bf60897f4ea6d7d", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "67509cee-d37e-4828-b878-a3debd4f016b": {"doc_hash": "f7bc338add0e53e4baa2e594eaa665dec6900fba97a6ad359040024985450d48", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "c4d02321-0411-405c-a0c9-713bc7d5b62d": {"doc_hash": "5bf6a1c713e57d4badf7591df771ffbaed3be921652359eb3490729b6695bf2a", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "91e0ceaf-a6b2-405b-9801-9686311c2fa5": {"doc_hash": "ee96b63aa807c1c3bccd72b8ec43ce2d0c2a476908a58fb17ac9dc09fde2fe96", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "ff7938e7-9338-4ab3-a2c5-85927f9d7ac3": {"doc_hash": "128de7d671856f815c7f97a0d922bb775539dc2439bbc8757287b3054a64f29f", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "1807b73c-6e9e-4e57-bd02-d142121e7aa3": {"doc_hash": "fb0aa8416a7a497be7ac558226f8dcfdc3abdc995f55769c2619dc5bbd40330e", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "53fc5a5c-1e84-4072-a34c-103f88eaaaba": {"doc_hash": "1460baecc70ffcbc03a83aad2df620cbaab6cfcaa56dae2a1a5c2f4b96ce59b9", "ref_doc_id": "ab\u2010Lerman (1981).pdf"}, "a8b734ff-07c1-449f-9320-8f8c9e04002b": {"doc_hash": "e03d82849f0c073c2a3a5917b528f4a91eb8b6eaa40f7ab6434fed6b82d2934c", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "c2f67558-7b4b-4492-8fc7-446e8b547fce": {"doc_hash": "5ff9899e2dcaf17cac0b4904b8fb2869fcb13e6644ae5fdfcb4a0db5e7c4b564", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "4836e8db-cb6c-4b25-9778-8a58655227aa": {"doc_hash": "99ce9251a3d57ffe929aca980856c8076bc214644e25c6c3c7cc4921fa278430", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "20922e2b-35f0-4f05-994c-7e253de08d1d": {"doc_hash": "a09d26d3a2ea8c6452f238b842e3eb2ae027763061661ec79e02e178d18d3d87", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "a7ca7dd1-bf02-49ef-9fa6-31aa12f6aeba": {"doc_hash": "f756fede5ad8d882accff21fa0e2a4894f6154e98f9234b3e8736cfd5d292c2f", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "d9448665-c074-48a3-915c-965cf1d58186": {"doc_hash": "1d2e5b15129dde7761f71717f38e500dc3193b782d0d03114e170a33b4435153", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "eec22ca8-ae20-4dd6-8064-f6285d5e2509": {"doc_hash": "458530e84a33cdf9b98e5b7675cac61423aaed28ee15a1d251b4ce2b1e876ecf", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "acbb9940-332e-460b-80d9-933fb731008e": {"doc_hash": "8f4f1fa622b93041be24a1453d34c84a45148a10a735facd4d41fe2efd903af4", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "460f6a3d-5284-4a18-9ffe-75dd62f88002": {"doc_hash": "de805e276d5362da2a88f1d5b6b2dab08572d582bd7a6fbd0f9caebb367b643a", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "cb325113-9ade-41ef-aa62-675e17a2faad": {"doc_hash": "2ae928df3a75411c99d0c1c6c3aac801d51590e083c2f729a04ef399df6eb05e", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "ac2379e7-d0c4-4ef2-bc56-bc97e0628d7e": {"doc_hash": "1463070fd9b42398c7bd31aca926b997f8f367ccdad8a156a1da52c2daf23fb0", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "b1ebf17b-fc82-48ba-b303-a6c26977502e": {"doc_hash": "3f79e84496c697edb36b58a5a32f2391285a6ebe7b394c8b76859a483b0822c3", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "74ebfd9a-228f-40a5-bb16-ff2c8208d5b1": {"doc_hash": "228a0f8ebbbf99a0b2a9b7c4ab7a8c472b5ffebed7843c601b21bf0a2f13b99a", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "8e10dd72-e77e-44af-8ae3-f0c37acd9a93": {"doc_hash": "05b054b26551110b9e72df7ca4df79ade1236cbf85f002c95da861fb4d694557", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "ac01ed96-a4ba-4cc0-a931-175852c31fd5": {"doc_hash": "60d1e3c2b83216e9ce002564396996dff7c731b6c1cb2ae4ac9f56b774c72907", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "3866d82f-d642-430e-bda9-1016a897d7ae": {"doc_hash": "0aa37fdec7a728e40a4bd864440b9b917e5930629ca652ceff2e5dfc96ef6452", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "11bf6f0d-99f2-4187-8cec-8963849dbb5e": {"doc_hash": "aaba433f2aaa84660c1ea07a16a411c49b4d30f5894bc9be97bd9dc0bfb23926", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "7498c2d8-1106-42b4-80de-c560b2b37676": {"doc_hash": "68c8d779e1d52423dc9d2b96c0100e260c5a87318d2907dc3e0d584721a6dac7", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "d4c57282-731b-4433-abf9-9599037e027f": {"doc_hash": "077dde1a00dbdd3758e39b719ea925b1909cb7aaa0871c6aec81b9a4ad5545c3", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "bd04f3b3-20a8-4f10-91b9-cb084f16de1d": {"doc_hash": "ec2c926a65913141482cf10d492c7ae1eded0408e9a10975843e5383f489e1b7", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "eca410df-939d-4b67-98fa-0354efc69608": {"doc_hash": "3eebb5597ed9a3c733ebc7020b01121292f24a87de81aac4ac05f1d2b723662b", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "675523ea-d308-487f-b318-557c781329d2": {"doc_hash": "199fb82c411e3084f5cb24269aaf236ab59cec525ba5d93a37f98e9466ebef65", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "3dfac74b-4c7c-42ba-8946-89e72f98b0ce": {"doc_hash": "576e21d6851413108c7a7d75ac51af627754e2952bd6cab047ecc57a29acc892", "ref_doc_id": "ca\u2010Giaquinto (2018).pdf"}, "89f6eee5-cbf5-45fb-9099-e4155562b7d9": {"doc_hash": "7bb7e8b83bbf5a3a232d58a76f4fa5caf11e72505995df5cd9956dfd6c02f493", "ref_doc_id": "ab\u2010Peltola (1986).pdf"}, "7774f92b-7938-4039-869f-04155511f9a0": {"doc_hash": "24e4f2a42ec51af0768fb0e799b78abfb200129ac18fb22d278b54fe10a069e3", "ref_doc_id": "ab\u2010Peltola (1986).pdf"}, "ff1cba29-c0ac-41c5-ab8b-27d2fe8c520b": {"doc_hash": "1024980b1f46672320c8bb77a35be8993e1968f92caba5dfcaf74e74a65596ef", "ref_doc_id": "ab\u2010Peltola (1986).pdf"}, "8fb550d7-04fb-4084-aec7-ea0049241050": {"doc_hash": "3615a8b4a1415198154de7d36e17cc7bdb33596621a1030890d6141ecfb8e3a2", "ref_doc_id": "ab\u2010Peltola (1986).pdf"}, "5767c3c4-e893-426f-90f5-c0d055525115": {"doc_hash": "8f4bcb803276000952c983788fee39a55c6b30bc360a1b3591ab6b4ff43724e4", "ref_doc_id": "ab\u2010Peltola (1986).pdf"}, "3addb771-d90d-4b93-996e-fb4724df85d9": {"doc_hash": "33a7509fe7e4f86665a9396228efda4685f2c32f020352ac633f562f949fd0d7", "ref_doc_id": "ab\u2010Peltola (1986).pdf"}, "d4412bd7-624d-457e-8d08-22cab9456a54": {"doc_hash": "520823407045ff3b12fd4677a36733ef24749a5564d3933e50b24592a84a4273", "ref_doc_id": "ab\u2010Peltola (1986).pdf"}, "951f0630-346c-477a-8839-d22e3f35b9dd": {"doc_hash": "ccb23fc1896186843d85b3c38174fe7e09972d656dfe2fb1504ef4b39d6514dc", "ref_doc_id": "ab\u2010Peltola (1986).pdf"}, "7d3622bc-8e05-4894-a24f-16c109adc616": {"doc_hash": "04bd256322df62106eddf1d22cff38faa14f058c578406d0bc4b97a058763a9e", "ref_doc_id": "ab\u2010Peltola (1986).pdf"}, "198d121c-5e10-443f-90b6-2c1093372c2b": {"doc_hash": "0271ecbc79900a5daad3bb2df88cbca20edcafc9b8ff1ba6906345a5458d2180", "ref_doc_id": "ab\u2010Peltola (1986).pdf"}, "7c685245-867d-4240-8bc1-d3629544fc02": {"doc_hash": "f97e86233e872b54e0a32d6e156e867457dae5681df242baa76dce8d85c4904f", "ref_doc_id": "ab\u2010Peltola (1986).pdf"}, "95e1a054-f62e-49ca-8a8c-ee7a669b3d0a": {"doc_hash": "01fd30c67696779cd11a87c53fa1990f1778d601fbe0ce9916665e9374366622", "ref_doc_id": "ab\u2010Peltola (1986).pdf"}, "a516b913-d062-4c22-838f-41a75bf41b11": {"doc_hash": "c92f03ffc03019d8b0162567704ebe2d257d553d9fc367b412ce610c02554b94", "ref_doc_id": "ab\u2010Peltola (1986).pdf"}, "96a56b84-cc59-468a-abdc-0addbcdd3a65": {"doc_hash": "3675f3eb0d895edfeae623103a177bfe656c36fd9aef26b05c7b954e34e53941", "ref_doc_id": "ab\u2010Peltola (1986).pdf"}, "b003ffa2-4983-444c-8898-461367faf906": {"doc_hash": "deef92c3c5c2b5f269716de24620ded9536c4c3a4f243bbc40dcf72ad7a46e1e", "ref_doc_id": "ab\u2010Peltola (1986).pdf"}, "1c3bcf3b-99f1-40ec-a3af-3f7a1dc8fabf": {"doc_hash": "d832ceda6914219e81b64e629c7dd6d258e532214123cdbffa8de9b344beb1d0", "ref_doc_id": "ab\u2010Peltola (1986).pdf"}, "1713277e-c4a7-444e-b04e-627280a8395d": {"doc_hash": "9b7664706a67ab460bb11dd14b58d8bcaf99f626e9c6007246a960c302da8085", "ref_doc_id": "ba\u2010Castilla-2 (2009).pdf"}, "990b22cf-3e85-4b37-9e7e-512c1fefac6d": {"doc_hash": "cb631641c916250d87a83c0d8eed326778a8e763e4960dd168598b888f2eb669", "ref_doc_id": "ba\u2010Castilla-2 (2009).pdf"}, "26e555cc-405f-4ba3-828a-851efb4a4038": {"doc_hash": "011026f7b21c88cdbfa38f314be4ee9b04525c9586c95960dad7e7d89a1d60ee", "ref_doc_id": "ba\u2010Castilla-2 (2009).pdf"}, "62133204-8ef2-4376-a21d-8b062ff05286": {"doc_hash": "9325baae607b211d8ac0c87ed4c5dbcf959419a4bfdf733da5f637671563332b", "ref_doc_id": "ba\u2010Castilla-2 (2009).pdf"}, "b9a2b559-f1e8-422e-88b2-9afc7b26ef5d": {"doc_hash": "dbb6baaf90f3b65fd91c3cdfc6806a4011d6d46e92537d8d110371d2563a8202", "ref_doc_id": "ba\u2010Castilla-2 (2009).pdf"}, "e13c1e0b-95f1-4736-be2e-f067dfc27676": {"doc_hash": "8939d8f185b5cad81f8cb3652a9ac808010f59143266e2faa3153c784c990476", "ref_doc_id": "ba\u2010Castilla-2 (2009).pdf"}, "65bc5800-4a90-4307-a91f-bf26eabde2d6": {"doc_hash": "50aad6aa288e14f5ff2b52ae0586ab39de321ef11bda16a9833bcfeca4697fc1", "ref_doc_id": "ba\u2010Castilla-2 (2009).pdf"}, "73a5fc3e-e278-445c-84a9-7e942faf63a3": {"doc_hash": "1e8a2e2d83c05d71ff6ca8dc93197ec1398c3234435558a091918d7461cce710", "ref_doc_id": "ba\u2010Castilla-2 (2009).pdf"}, "0e7810e8-171c-4d22-aec7-e76c28b43865": {"doc_hash": "a65b2b12d2c53ecdf04e53a1ec23349ef4dbc41e86861817185967b8ccbc7974", "ref_doc_id": "ba\u2010Castilla-2 (2009).pdf"}, "d66ffa74-b647-4ce4-8314-76b59afb535f": {"doc_hash": "70948fc8dc95babfbc61ab54d16f99e551a24fa2c9327179ec3d7981af80ab07", "ref_doc_id": "ba\u2010Castilla-2 (2009).pdf"}, "eb3adba2-a092-488c-81d9-135b0e85e239": {"doc_hash": "3bef40536db522bc455424e147dbbc17bec85f2fc594363da476e0e66320023b", "ref_doc_id": "ba\u2010Castilla-2 (2009).pdf"}, "840ab5e6-b14b-4134-ac9b-78b7c9f4bcd4": {"doc_hash": "08f7d330cb09107151017b4a0edefcecd64d62101316f66be6bbf393939ce5d4", "ref_doc_id": "ba\u2010Castilla-2 (2009).pdf"}, "50d58dea-e6d8-46d8-b1e5-cbe7f85f8ecd": {"doc_hash": "877d729c4ecb16dc9c088f9cabf328eb3c2e620016f7dc13493f077759cbaf12", "ref_doc_id": "ba\u2010Castilla-2 (2009).pdf"}, "cbe91ee3-f074-446c-b899-95c6c09c4e44": {"doc_hash": "d57932339a4338545dca802639493074f2e1a42adc77e470157af1844d7b3423", "ref_doc_id": "ba\u2010Castilla-2 (2009).pdf"}, "bef7fc85-5114-4702-b813-1335e852a846": {"doc_hash": "811b37e6c1ecfaf129e8dfeaba097b613bbb3806cbf1a7ec648036a524d6eff0", "ref_doc_id": "ba\u2010Castilla-2 (2009).pdf"}, "54c68dc7-b08c-43b1-bfba-488a7508bd1d": {"doc_hash": "fb0ed34c6cc26d979c425825202b0b803be2d628420723deadcd701b4609a7f5", "ref_doc_id": "ba\u2010Castilla-2 (2009).pdf"}, "e2629ae6-1cd1-400d-a4ef-0428ac885d0b": {"doc_hash": "7cc1f9765595d8a1e9155360de5eb74dbf0c996223d0905a598f6df600de048f", "ref_doc_id": "bb\u2010Da Dalt (2016).pdf"}, "003f21c3-020e-4a8a-9475-aad2a94c0e8e": {"doc_hash": "057a957187dc8fb8272607de3426f47b667ed2145bc89d1e7f64afbe87070380", "ref_doc_id": "bb\u2010Da Dalt (2016).pdf"}, "452fe716-154b-4737-9e0c-f35e9ea5a2cd": {"doc_hash": "90d5cd669d99aa38b3925ab0cbe9b9af67c175da224e3bd54e2a6a4dd3e00283", "ref_doc_id": "bb\u2010Da Dalt (2016).pdf"}, "938ae48d-8af1-41df-a9a0-a6d16691b6a4": {"doc_hash": "36b81b5d94e968a7735ce21caa3ed386ef11c02cdbd580c61246d125e164882d", "ref_doc_id": "bb\u2010Da Dalt (2016).pdf"}, "77fc7df6-b34f-4b06-8826-959923110b04": {"doc_hash": "bcee0e71b7df53eb6882f45ecab3fe7ba67ea9f9d67378b1b2001c6a92ba0e2c", "ref_doc_id": "bb\u2010Da Dalt (2016).pdf"}, "1f12261d-eda7-4d28-9c19-4860d928ac6b": {"doc_hash": "e74fa8d0a02b5843535579b9d89d3f3c2200cf086c2f223b30dae88ea23242c8", "ref_doc_id": "bb\u2010Da Dalt (2016).pdf"}, "fc8a70f0-59f3-467c-b311-b5ba57e0e820": {"doc_hash": "bd59510453dbbebe7af959caad74e7b879d7cb3a0e6e0068d62d339c4af65ff4", "ref_doc_id": "bb\u2010Da Dalt (2016).pdf"}, "554a968d-b24e-41dc-8b6b-a8135eeb9320": {"doc_hash": "898cdf9be077c2f302cb93395f5ae91d28f2d4cf97639d09582b4bb1b6763366", "ref_doc_id": "bb\u2010Da Dalt (2016).pdf"}, "d35fb1d9-7c3a-45b3-a73b-4626c2269ab2": {"doc_hash": "ea708205f008b55a9efe0e4311cd75651c083ee6dbef2e1d74480da600e163c9", "ref_doc_id": "bb\u2010Da Dalt (2016).pdf"}, "bbce3c97-7a59-4ff8-b552-e16eb7541320": {"doc_hash": "62ac90a3e02bdd7777255ec0d13f8eb81dc3c5635268e22db5f3d8866e509837", "ref_doc_id": "bb\u2010Da Dalt (2016).pdf"}, "1a5ffec5-b436-468e-a637-41088bdf72d5": {"doc_hash": "7727849f4bc229d0d0aa64ca726397d318b6f152282e70019569a4c11b15a2c0", "ref_doc_id": "bb\u2010Da Dalt (2016).pdf"}, "8bace470-19f8-4d23-971d-d654635516b2": {"doc_hash": "2755dfdaf83b24c3eb598a2b2bdbc9d247b5547ac7ab800c1190736d59080a8d", "ref_doc_id": "bb\u2010Da Dalt (2016).pdf"}, "c45d1c31-43ec-42ac-a1a7-6d915ab4d96b": {"doc_hash": "ac58616021dd0269f684067e512f95258235021cfe7de6c81e3fee14fa86125a", "ref_doc_id": "bb\u2010Da Dalt (2016).pdf"}, "85692f1f-a2fc-4905-9079-9c9d8b233568": {"doc_hash": "1cf2b7ed50460aea9cca9f9313775495acbf591d3659c110b58080c2614ca6c4", "ref_doc_id": "bb\u2010Da Dalt (2016).pdf"}, "1dce144b-830b-46aa-b81c-a74ff293fa7a": {"doc_hash": "0d9a5ec8c9e20996cb98175033e091848614cada493cd135d2ce7af3d445db1d", "ref_doc_id": "bb\u2010Da Dalt (2016).pdf"}, "12a22081-6624-4514-ab13-b23224a4d056": {"doc_hash": "18766df20b644ee65839198d1a7a3565f962fedfb008da814cfa9eb80775fd97", "ref_doc_id": "bb\u2010Da Dalt (2016).pdf"}, "f28d4263-d446-4573-a07a-f80d07c97d02": {"doc_hash": "9616b45c63501ef10265be8dfdba186763b6722423a785b554e5f81548a80156", "ref_doc_id": "bb\u2010Da Dalt (2016).pdf"}, "2a82c6ab-ecb9-4cff-b7f4-9351a9b2715e": {"doc_hash": "10ec9e158cf45fdad8e34f8fee28f681ea124ae6d8c910913a89a06ba8db91f6", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "5cc2527c-c840-4f00-994c-ccc06acca6b6": {"doc_hash": "76bc8f41c737d5aebf7c4b4055818c790f78f7f35f66f8de6098ed2c2992fb65", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "40546cc7-1b15-4fb9-8488-d47cd21aa768": {"doc_hash": "30ce418950fe5bb45857420878aa2c4017f72264d7c3ce08b1a561aa975a859e", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "33969ee0-64f4-490d-a08a-722322847058": {"doc_hash": "076ded33c45ade2a2e6615542e8274dff1c129f658e7a3e9442ad58cb3cd9c0d", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "4b19b7e0-9338-4554-a362-78a44b37d612": {"doc_hash": "dfc447ba94c8726df485bc4c4877b2b97f590d363f695f12fa0fe531d5a04e55", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "f92e145b-761e-4311-98ea-19d958d09838": {"doc_hash": "ef2654587d2630757588d5ffc6352768c621416d3c2360a026130616ad638fa7", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "16bd29b8-9cc9-4e03-91c6-68b1585e111f": {"doc_hash": "3665105c3b14a6b2ac0332ad3b475e2fa9c0e98128cb46621880c2fdbec1e520", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "2141b6eb-9bf1-423d-a7bd-865a7211d9d9": {"doc_hash": "a517d82e74df697e082d1b0654fdb28afafcb1d616688537ba250b2c3ecd77ea", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "53401598-0851-448e-bfa3-68f13210a3ed": {"doc_hash": "134b88a5fca46cf8746d377ff7cbdd6d42e5175016db6eb07ccdd3cd51fa9f6f", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "cf96e409-2b9f-4c66-ac31-c5f0c4eca753": {"doc_hash": "fa70f41d5922e48ce6694ef0e3981d36fb9b783285a4bc7738f7fd56b2fe163d", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "c1e28fc8-1ddd-4f1f-8043-3d76a86dbcf4": {"doc_hash": "8a024eecfe180f56e9c8163b31e4983419242002b8212d986d05ee8a5a79a99e", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "ecb8e59d-9d21-4cee-979b-c4e29f0b5d68": {"doc_hash": "e744e6900a26eb6134b05173a5c3f544760e1836914aad87eef59a3ee371e0aa", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "1995bf94-8c4b-47b1-9a0f-3fdb876e6ada": {"doc_hash": "5aba4bd32dfa3724dd2ba968c9e48765a6b4c6f0bdcac59ad428e67bdb76a70d", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "0deb71ea-139d-464d-96b9-e845e67cdb8e": {"doc_hash": "35b4b960ca0f4eec0cf327b0028e401d3d64b1fdabeba2eb1103ee6f56719d56", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "25ca4f5b-18a5-441c-862f-a2b311391b9d": {"doc_hash": "b2312352cac5c36b3e94b28ea3ed63c3943d829aef7cd59ac15af2b62135492d", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "4fcf3457-84ce-4fa0-86fa-1ab4f59eaac6": {"doc_hash": "7b63acb9bb4898d181ddb06a93f1ba2ac41cec54aba770c1905238aae8ce6ad5", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "3bf559de-e4a9-4cf8-bfca-4408cb96dbb5": {"doc_hash": "bc3307a7aac64f7ed4dab3a442a6c6944772b8b13bdfe91181c45fee41d8bc71", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "5e0397c4-b95a-4633-b07d-cf7958e8ca78": {"doc_hash": "f180845ecd300d10803d9a2f09851b6954d587bf52a3e692ebb70a7a7535b6bc", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "b11544b7-0799-4e3b-9ae3-72cc3aaa93dc": {"doc_hash": "00d80a4f63228df3e786c6b21b852a114a0fc790f4a7e16815bb22ce5acdc3f4", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "9275ca13-8c98-4aed-851b-3c7f698445fb": {"doc_hash": "478786dfb6682039348ee534ecff6d6477c8ce80e493ee78a5c09a3d76233025", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "70d0bd37-d530-4d46-95e3-305e1e05d4bb": {"doc_hash": "0e413e57de1d1aa1c793e69e23668e8433f1c7aa8eed1ff38c6c4ec7496fbfc7", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "dc86d51c-ddce-4d5e-9b5e-60a648574057": {"doc_hash": "c8408b454a309e180ef7d0f77c88ca0d43bf0e76db19a3db48ac3337f7bcdf71", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "629f49b9-c0b0-4f42-b68f-a890a58f4040": {"doc_hash": "f6442fbcd280bfa954a2a704c65e034f814e745649a11f016f506504b33b6e34", "ref_doc_id": "ca\u2010Chang (2015).pdf"}, "73016733-65dd-4d18-b9d1-a415114efe0e": {"doc_hash": "42d232fa75b5e98942eb397bd9518351016aaf40f210c261083bb8e8b385b4e2", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "e1289309-8886-496d-80e5-ea5d11f984b3": {"doc_hash": "80b880a941aa17533d14a1096d7d529c3ae26b900aafb73961720d39fe39de5d", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "0ec127bb-0a26-46ca-b403-5fed1f9937ab": {"doc_hash": "f332c479f6925fcbcd81f7e44ef25d8d693f317b26cd8829723edb2e3280eb20", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "820a1d60-a9de-4af8-a67c-a5ccecb82621": {"doc_hash": "bd34886c6c9599c1f6e9701b05ccc610be7d0ba977129b849dcbaa0d96abb8c6", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "89ac91b9-1605-4949-8492-5968b14696b3": {"doc_hash": "89eda0db8cf476d3317067f632609818a084c9b37362f451b57b824404e1503b", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "cf34d22d-c706-4d25-8eb9-1c99e45bb86a": {"doc_hash": "91671026ffbe072afd738536437b708ff5b23f81e0e707845a50d36624ae9c60", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "6f1170d9-71c6-4c9d-b24b-6b2eb168db2f": {"doc_hash": "1adfa1159f849464c88ef6f62fcd0522ed502be7146a897f4ba8a81b664ac10f", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "2406422a-ab5b-4d23-a769-2a5238bb9b7d": {"doc_hash": "f91042c539c85cbbfe9f06be473bae85a160bf9a15425a61f1c9a067fd8826c1", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "4282b136-a878-478a-9294-cbf69624d90d": {"doc_hash": "0bd10a19c0dd96c607e90d9a1fce98e09f51cd10a1d50298953f0fbbbf1023f9", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "d4fe7c92-6d3a-4dbe-a528-3c7c20824ef1": {"doc_hash": "55e0ee2906ade68960d1978e3b0ae70ef66f155d7e3a6ba1487ba0b727734991", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "7aa965c1-c31c-4daf-818a-047057d6f7a4": {"doc_hash": "6d64eebc17d9dda1021cca30c4a68db9755fef7c768d1bbc9789c2e3b2e3e488", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "250e01ca-2f8f-4ffe-8d10-199eed7285dc": {"doc_hash": "e6a33c67b867a4196bb259409e9b6e8ef427dc063f300ca0e9ed4aca75363510", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "2db8fedc-92e5-4eb8-b439-0ff1f72b57a7": {"doc_hash": "51089546be96cc80bf72553f7a322e8b5285bb2f7b46338c7738c21e3f275d8f", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "a041df7f-3acf-42ea-b7a8-07ef09891632": {"doc_hash": "a27d090d82ea0f11e64927d75a6d05fc6acf4ac8adb2ddd26e2f416eb7b5bf1f", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "e58752c0-5a65-43f6-a8d6-cf30ba79fae8": {"doc_hash": "8a6aee8b4c744aff73fc1982fda2a3336bde37d88b241380ad30fdd801db49e4", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "28bf89a7-dd8d-42b1-bb5d-5455f11c3bf9": {"doc_hash": "b58f7807d72c4e655f24ee502fdafb53036264d17acefe83a83e108f3b995ce9", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "6676acf4-c655-4a9e-a9f1-e3876f7ccae1": {"doc_hash": "e668cef70f003e8969bab16e3ed2e939ecb0d0e19f203144a5fc1abd1abbf1de", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "b4da066c-5f85-4d65-b532-26d266ff1cf6": {"doc_hash": "04c6eadb20d1dbcde4994be5133a9e4f17cd56b4ed702bc33af84a444c94e245", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "0e2c1309-3f37-4de9-b714-598517d33dc9": {"doc_hash": "a3ea3823376ca01d4be48024eaf3099b4539834c954044fc6d6a8f6038308c83", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "5c58ac3d-bd03-4ead-b080-3fc77511262a": {"doc_hash": "bd46c223c353cb020a9c8d91bc33ae0dfa90da3f931eae5aead0312f63b590da", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "b64443a8-dd8f-4347-bb30-37f90bba1bc6": {"doc_hash": "ae0802e816a15e005d0acc7251ec663fee4e71b3ef2c0975135ef59851bab3e5", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "ad2cf0fe-e160-4995-897b-e1a6a82da68a": {"doc_hash": "91e181548ee3375cb417ae0fa6402d3750d49914f46dfaba76c58b5f6649065c", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "f924f5a8-0bfb-42e0-94b9-3434116fce7f": {"doc_hash": "4145590f0055fc92e6dd453d69a0470b89d21a2a1fd974f8185dcf14d66cdf30", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "d9919bff-8eec-4d4e-beb8-1d62182e4cc4": {"doc_hash": "c570a7af2372d12aeac82adf553032181c85b9c5feb4034fbe7890a10f98d9d1", "ref_doc_id": "ca\u2010Greenland (2012).pdf"}, "061190ad-53a3-4452-8551-18326ba7547a": {"doc_hash": "cb94719a0dfab5eefed525c608b79446549e679a00796ab0dc7846e51a5b16f0", "ref_doc_id": "ab\u2010Schwarz-1 (1975).pdf"}, "5c7dc29b-3410-4f8a-9cd5-bd27bca63b0b": {"doc_hash": "cd574b30f51473a1a9a74175b682679d9543881a57876c790a74a0b8d9860d19", "ref_doc_id": "ab\u2010Schwarz-1 (1975).pdf"}, "ec68ddde-0362-41d5-af8f-fcc50acbd5a1": {"doc_hash": "41ea816a665057bd6258f69e1a03de2d75143178d556e1c5393fa188c0e0e429", "ref_doc_id": "ab\u2010Schwarz-1 (1975).pdf"}, "7cd07369-9d45-4b31-928a-5b6b89dd4319": {"doc_hash": "52e5ed658eed3d1c78ab07281c8ef2d96baa315f0ff3f39b4c5ba849b5958c9c", "ref_doc_id": "ab\u2010Schwarz-1 (1975).pdf"}, "bd8ee1cf-6ba1-4675-9ebc-2d2ceb5dc2e3": {"doc_hash": "120dfc391614701edd032875f2f6d165a40ecdb52ca375541709206238bfa53e", "ref_doc_id": "ab\u2010Schwarz-1 (1975).pdf"}, "2a5c8876-b6f7-4303-b669-06a2a7dd224d": {"doc_hash": "6adf596ff66bb88739169d11689d12370d4c096592b5ac796824bf594f4b00ff", "ref_doc_id": "ab\u2010Schwarz-1 (1975).pdf"}, "e5bb471b-24c4-4bc0-bed6-c65f47c3c3be": {"doc_hash": "8f70a73acebad165d0bfb55ad0094fe4dc8a98d71726f1694feb49c238a7d2f2", "ref_doc_id": "ab\u2010Schwarz-1 (1975).pdf"}, "e188ea5f-16be-4632-bf2c-952c0fec0809": {"doc_hash": "ad2705e7f4d4ee32132d87f0564336317be43d2f94c7199ae322f9a3d3f3fee1", "ref_doc_id": "ab\u2010Schwarz-1 (1975).pdf"}, "721d2bfb-91b0-4087-8fea-a4b7ba94af43": {"doc_hash": "51dadb5d4e40a8896f7e3d08e8af4ae001eaaa41fc3ba74c6f0971959093a3d9", "ref_doc_id": "ab\u2010Schwarz-1 (1975).pdf"}, "c2ee3628-16ec-4ac2-b414-d21be14d79a2": {"doc_hash": "9faa3773dac0e735a42acb7e8c69c32b883d3657633a7abe8b4e09c2b67ec65b", "ref_doc_id": "ab\u2010Schwarz-1 (1975).pdf"}, "ced8905b-3983-4732-adcb-75c6448f3d43": {"doc_hash": "b40286a770ef73263cf62ce79187d29b746a55cdefb14c5525fe6cf1e93e9abd", "ref_doc_id": "ab\u2010Schwarz-1 (1975).pdf"}, "8eb66fc3-e352-42be-bb8c-453d5bc70034": {"doc_hash": "9b37f68177c84a8aa4bbe95be9d36e2e34b11d6bb3e601e399b888ae958e2ad1", "ref_doc_id": "ab\u2010Schwarz-1 (1975).pdf"}, "47429d00-ed9f-4af7-9cc8-50842d93e1b2": {"doc_hash": "2d147b263afd6ce1fa36074a34322cfcacbc6014239c8d83c47a3c9003d535f0", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "4e628428-4cbe-40dd-b2e1-731e16cf88b7": {"doc_hash": "7b3bfb0deb8da52712a301c2e98ff682e81f1fc4088099e89e1b6d92b5e4afae", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "18d2775c-25a4-49a1-ae96-ff2495410f03": {"doc_hash": "b9d2d34d645b667c28ecbf7128f34064aa06b54cfebdbf513808641df1689f4b", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "4a96653a-80af-4a9e-bc9c-df73c465f057": {"doc_hash": "d296435470a72f45d0f55d742b2913e15706be61cac0b8f924112aaa2c90bd1b", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "f8f5d9b2-5208-4dac-8403-08846d36eca5": {"doc_hash": "829fed9cf6adf051e425c7597da9518d32d8779ec987c09c73821e402ccf2488", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "7df26906-5f1f-4d9b-8d85-6a47a3ee2872": {"doc_hash": "54f73770f991e9dfa8b6ecea6d140f7f20f89970070203dbcfe8f6a7f6c96717", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "8bfe67e0-bb11-4ac4-8ee7-762299fd5eac": {"doc_hash": "12add2f8decd8010f862a01d8c1e8cdb2165d750970a047ac3ed5851e66cfe0a", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "c45bdbad-97e3-4f01-a9f5-9ccb2a3654ae": {"doc_hash": "3b3bad4fcdb3f9ccdb6ef66db02140753eb1e5f17daf36dc6b4d88b485229a27", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "82024a5b-5749-4c8d-8fa4-28bcade8a6c9": {"doc_hash": "22a7d591caf69468a89a8f008faa14a517bf88b6c3ea62f19b9ba827cf0b2027", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "a009f680-bc03-4f30-809d-a6a46e3d4a56": {"doc_hash": "f3ea59602b219138252a4de85fc38d44270b061d2667b80066bb85c748978f9e", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "7c04e516-00c5-4d53-8647-e4420b8d6973": {"doc_hash": "ca58c1f282c2e57a8026403025a111082ea9b665ff18f566ef23a294c414a2ec", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "88194bcd-903a-4406-97fc-1cb60157ffdf": {"doc_hash": "9182b8f22daebb175215fb8c667aab71f6875842ce6f784ac52b26d70d77e749", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "11afe8af-f94d-4992-abf7-e82fc945537e": {"doc_hash": "ed1268602ad5e61c18e8dcc637afeb7e11ed1efabb7aa9458dc04487c6147fd9", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "8224b931-1d9d-475e-8885-d99931b444ac": {"doc_hash": "f764268f65224b8c11fde8291eacc0248b4e29168afaa2a98d002a251de2eec8", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "b3af395e-7ba4-4df2-b5ec-af356673f22e": {"doc_hash": "de62d7f44ab7283f42fd0ffe91e9ebebc8d32894185de38208bfd90196e9cfa3", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "6d3793f2-7289-4bf3-8d0c-f3050a34fc3a": {"doc_hash": "ba3d2c9f21a8e9e485748eb6fad8e96873cfbdf8407d6f52b6c50fe67add06b4", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "f36e5450-53f4-46d2-be29-5e26dff66503": {"doc_hash": "e916eed41b7283cb67cc06f1c09a07a26660104e05db0ede79cb8a4edb12e9a0", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "55061f8d-f73b-4825-87c4-78d126c39626": {"doc_hash": "58ddfe6c4d862a52cbd1949ca917a6e350d58917433470dcc24f538adc7d63f7", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "dd7bb911-e35d-4634-ac2e-57729dcd8f1e": {"doc_hash": "5d20750ab7d8806968886913cfbc8e3e94567badbe9c281b951f714d1ba7ccd7", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "32881efd-16db-490a-a1ae-28f44e0fa744": {"doc_hash": "696294f04626fcf2c623a476b54f653e47aafa0bb34832678e798b77af3bb4fd", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "116fb4b6-e68e-412b-86fd-17fe3e14de55": {"doc_hash": "5a445de3d50a870c89c727f0f4bf0950a10564d94649114a1a9a8627d4eb0a7e", "ref_doc_id": "ba\u2010Andrade (2018).pdf"}, "aa243b3e-93fc-4252-9166-d7b4fdc51168": {"doc_hash": "dc5321e98a87d84a82058d8840dfb4891e05b20bb4baeb64f1087299db92e88e", "ref_doc_id": "ba\u2010Kim (2012).pdf"}, "71c283b1-d0cf-48cf-ba31-eca7aceea162": {"doc_hash": "d7bfdf385e80ed8f3c0e6a4d40a787cd447a1796b4e652cff0bf93014cb67f6e", "ref_doc_id": "ba\u2010Kim (2012).pdf"}, "2976b789-f63a-4e42-a882-7d33a608add6": {"doc_hash": "03a9bc79422863083975c117dc4e054af8831e0e3bb419221bc66387ea2844a7", "ref_doc_id": "ba\u2010Kim (2012).pdf"}, "42c513f7-3ed2-463f-b373-88e8452e0680": {"doc_hash": "3eefb076734cf652a84e2888f243e90420d0730debff311cd4c0f0bb3db3eb56", "ref_doc_id": "ba\u2010Kim (2012).pdf"}, "40f2d7cf-88bd-40ed-a9f1-83e16a6ad753": {"doc_hash": "b1bb39daa304a4bc3b9feaa80bdbfbeeff63aea7f3bd4b97dbff8571a1d53909", "ref_doc_id": "ab\u2010Schwarz-4 (1975).pdf"}, "b3e81449-ddc4-4cf5-9613-9d2e9d3b039d": {"doc_hash": "7c40646784768e69713bfa426f121973c94e6572bcc572e26a47db1a7b33545a", "ref_doc_id": "ab\u2010Schwarz-4 (1975).pdf"}, "a6166427-a67f-4ecb-a765-8934319c6d8b": {"doc_hash": "9622f90633305af01308850c4c4252448e23fe1e5a6f56e316f9c1a790e81e26", "ref_doc_id": "ab\u2010Schwarz-4 (1975).pdf"}, "430033b1-295c-4d42-81f6-88b8d1ef94e3": {"doc_hash": "c4bd34b5291937266adc90b18e587aec08afd4917326f2c91e4f38a2d1d06b99", "ref_doc_id": "ab\u2010Schwarz-4 (1975).pdf"}, "cf0a777c-bc16-490a-b79d-d98bf141bdec": {"doc_hash": "79ee186111370c88ce4fa3222e4a39c3e84bfcd840e6659af21c17deb8cd6cab", "ref_doc_id": "ab\u2010Schwarz-4 (1975).pdf"}, "060b5109-b2b4-4b8b-9a1f-14a9011b892a": {"doc_hash": "3b897bbb624d077e780143fb6477039ccd34a1b2d0b1ca61c49b2b0b2515ecd1", "ref_doc_id": "ab\u2010Schwarz-4 (1975).pdf"}, "7dfc6cf1-8c62-484d-970f-2302029e9179": {"doc_hash": "b0dac79545808574b83fe4e5eef58122ad2afc124ad5619618c5de81f12c7f0e", "ref_doc_id": "ab\u2010Schwarz-4 (1975).pdf"}, "3eb22b53-64f8-4eac-9c43-f67da2757e64": {"doc_hash": "f021b73662b2b7f0c86b7a6a997c1a2262f45db6b33e2aa26b6425749be7544d", "ref_doc_id": "ab\u2010Schwarz-4 (1975).pdf"}, "ad806b6d-f82b-43e3-985d-e2617eae0ab1": {"doc_hash": "255c46761a27c83650431b1c20106968fb4c5518d0f3ebc2e05b42912b18b33d", "ref_doc_id": "ab\u2010Schwarz-4 (1975).pdf"}, "ec75bb58-c57c-4680-882e-57488526baa0": {"doc_hash": "9f4a21ad0c15bc931546c395945fda9cf069278ae42f88f7955e74326d6109d9", "ref_doc_id": "ab\u2010Schwarz-4 (1975).pdf"}, "590c58cf-3a21-46a2-a6be-5896ee31cb7a": {"doc_hash": "f9251c2831e74052d5c6b17ec6d7ddc82bd476a01a6ff4f523709560da4913e3", "ref_doc_id": "ab\u2010Schwarz-4 (1975).pdf"}, "e28e97ba-f3e5-4e08-9049-8b226930752e": {"doc_hash": "30b9c4728fac482d4330b96c2e282e90626a0cca1badcaa1222da01845dc7a73", "ref_doc_id": "ca\u2010Choe (2017).pdf"}, "3676c032-fcfa-4653-9b0f-ed4cacd350a1": {"doc_hash": "29be7083db6f3ba9b0aaff934fb627cacaebf601d7128917b4b02ed0a793eb37", "ref_doc_id": "ca\u2010Choe (2017).pdf"}, "83144482-627b-4218-b47d-7503b5fad02a": {"doc_hash": "e46b52a7e00117500cf1e807dbd89221c95bcdac7916096c43364a1aa521811a", "ref_doc_id": "ca\u2010Choe (2017).pdf"}, "fc2dc9ba-facf-46b8-b822-8c3b2384392e": {"doc_hash": "1f568b202f0d4a520a56e3c9918e972fd8d2675e9bc19b87ab3b5a7b061c1243", "ref_doc_id": "ca\u2010Choe (2017).pdf"}, "d2c9ca65-f22c-442d-99bb-428a8628174a": {"doc_hash": "69e366720b2038599b639f2b9432803a3c28590aa62e5db75738f54785124f32", "ref_doc_id": "ca\u2010Choe (2017).pdf"}, "1171826d-4c53-4fff-bf9e-75f23e05c743": {"doc_hash": "aee2c80ecbb24c08887650580eccb316fdd972a9b99290be645380c061fe30ea", "ref_doc_id": "ca\u2010Choe (2017).pdf"}, "cccc3b89-29a7-47d0-9dc6-6de3a7c83c9d": {"doc_hash": "a3843fe76d515d5ca9b1f56c9b838c8752c8fc5d3def4e7f551129fd0b54aedb", "ref_doc_id": "ca\u2010Choe (2017).pdf"}, "23e45c0e-fe72-4116-a167-0e8e9939ad24": {"doc_hash": "6ba254baff89de644c1386e0ce83aedbba4e99d6fdbb61ac84fa6de088ff21fa", "ref_doc_id": "ca\u2010Choe (2017).pdf"}, "218c516a-fd58-4a01-9543-279ec2031693": {"doc_hash": "34023319d6fa6bf9f34fd23515182f03c1f205c7a1c1b4805674705ecb7fdd2f", "ref_doc_id": "ca\u2010Choe (2017).pdf"}, "b7235ce1-9762-4b87-ad66-b13999026a9a": {"doc_hash": "a7c91908657c81578f59542b8167b5dff8ce0bb76967ecc53fd9a127a4cb979e", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "9a3c4d58-5eb5-46a1-a537-ff771b73a835": {"doc_hash": "42519793a92d6f036c4cec96ff3c498aa35617545e3bd2a6f99e86f412c6ec84", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "967cbd78-e42f-4538-a650-b86bbdcbe2f9": {"doc_hash": "8e90c63de89050c80ecfff81fe001754cef581f52092b0f8d2b00125e935229b", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "8d28964a-c55f-401c-b607-ed088663e4fa": {"doc_hash": "ef666cb8fc1b6005d61364fbe49096fafb53ff59d35a307b7f8885c87b48ecd4", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "615e5e00-076a-4976-b6ce-b81f475ca745": {"doc_hash": "7bbefe057b7935d5274214df60e761cb981efad48262ef5683aa4420ef3d70f6", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "ae3f5656-3125-4bb2-96df-2bc7a4fbb1e0": {"doc_hash": "f7f90ac88f9ff527f5410e00381da5a3a3a6f3c087b6e98152aa93b3582e8a86", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "028390e9-3bf2-4bf9-b222-a79381132c67": {"doc_hash": "a1ae89683cb182e011006219c3559495ee126429e04c0fbf29c0968d3e5f4b50", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "ead53e04-4528-4856-b8db-540e63184b3f": {"doc_hash": "cec83332c3b22096bd444089965a993373f2e9da64e6a747e6a1263bf813ada0", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "6f8340d8-9106-4b80-b120-a9b49ea3ac02": {"doc_hash": "d201e5d0d13d59c962d1332c8d194cb0c1098f05366c9802ee10e0b4df4e2a9d", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "4a6773e4-a202-4502-8c16-11264f7423ad": {"doc_hash": "8fd414b03e35ed7af6033e4d26d7fcd2f91d458db3359e342be0b86569fbcefe", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "6a0caeb5-100c-49c1-94c9-c11a66ecf482": {"doc_hash": "582db1c9ae895e9e996e12d75c729a36ab0b2eeeba457da48c09b1d212b90ef9", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "76b7adb8-966b-4883-9e9c-ab75b605204e": {"doc_hash": "7097f5025d9f350b3beb8bbb35fa06e825fa2331574d9e2bd4a87c429e96aa04", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "9f46c312-ae96-41e5-85ea-d61a02010207": {"doc_hash": "fd56577ea86740b598857e70d82399cc8c73274d9909fc878291c60da5a98498", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "91b8df91-5475-4ad3-aab5-d500508f7f3b": {"doc_hash": "b802759d15fc3cfb00d615fff272c17296bf944cabf8ed0affd3d44036880d15", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "a98a5da6-d3f8-4eb7-abd4-f13142d39243": {"doc_hash": "2b76851f9997dccd64e213f972031070c070c5bf5b003156019c5e8061972824", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "8c23af5a-a06d-4fa5-a962-d4ee6790dadd": {"doc_hash": "1ca9133d6b356f167104d90b1c72c998459ae4674823ed90edea6ab19f3bf3dd", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "4fc8ef7c-a2ee-46f3-85f0-03ed1353c1eb": {"doc_hash": "32b8760934e6134e192671a1323c7989dfd9a1b2ac14134950bb255d13ded424", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "60f3e837-dac1-4011-b262-7d9419c62e63": {"doc_hash": "f304eb896a824e03475b4b61f09f963d10fbea316ac2753045576b08a9e7405b", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "5914c0a4-63af-4ff4-a2e2-42c3822daf6e": {"doc_hash": "2eb9dc54d58f800bd29ccb78f2ea0139b6b154b7804f9f5314cb2cdc05a7dc3c", "ref_doc_id": "ca\u2010La Torre (2017).pdf"}, "5ff1928a-3cd3-4c4e-a817-a0756d5f7d34": {"doc_hash": "d703aab317b78b129a5b636eff4b3dd59eab2be6bd619caf6950afd6bfce0b34", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "5618ed92-fe2a-4bd7-84cb-b9c9b73853d0": {"doc_hash": "366733d907bcf8c1fa11f494aafe2729f4fa73a6d89eea14992b7aa618313571", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "59763974-5c91-4e00-82ba-d9e225faa8f0": {"doc_hash": "ce22a16788babc7982fe3a9299eba590c2c84b8d51915d0de5670bfda77af01e", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "3914fbfe-d743-4231-9881-dad6ffa831b6": {"doc_hash": "d104f16f0235df37669478bc736de0add7f1373024f8db439724381879b71bcb", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "ee3b8dde-6a80-4eca-998c-da8f0b5c7d33": {"doc_hash": "247881e9ad124def2dbf66db02c4c32f58d4d2ad337c43b78a9e2bb98aba5018", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "41050adb-ca9a-402a-b03f-2996b44171a8": {"doc_hash": "d11cd8f397ca89b1ca1256b0409dd5de9d05d9acf6a57cc2dcd8ee0808fc85ba", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "24eaef6e-c334-45d2-a5ea-346712a332b6": {"doc_hash": "8ba7023772fdeca72094f7c03a45ab23926f7c2385686d432821a43365fc908c", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "815f6bda-403e-462a-96a1-e841c513d4d6": {"doc_hash": "8dd5a431de33d296a497c175374a89aaa1136e8fcaa999538ceedf5b0687e097", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "d9dd3f07-7c23-4ad9-85ca-fc7f4abb0232": {"doc_hash": "e838a813ebeb305be440db2fa5256d4586e852920b5bfe471f86c5ad02812cb8", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "07378c42-9506-4173-891f-7719a5676e13": {"doc_hash": "609e6e6237d6b1687e067ac39cd41746fe195209e27e5e3521a3c2883777b5f6", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "c93b98e1-ded6-46d9-b143-e99e3cc5b8c6": {"doc_hash": "0f1f09a49d4298bcfaf63c13b338d0b32f4210c5ff74b2e4a1bbc526250465ab", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "f50a5b2b-ada5-4cc3-bda1-f064062f7841": {"doc_hash": "eac0c9eee8bdee47bcf3e96c46e9607d692cd481737bb68d9b1d107b63db03e9", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "36d2be3d-805f-49f5-a081-8e153c0b2f2e": {"doc_hash": "fbaebc06b0751da716807d5d746facf0b762e3e1412c2b25d169a7d42f351b1e", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "c8ccd7db-97f5-4b90-b3ab-cc46c3619b1c": {"doc_hash": "e00505def544224b1c5a615b477b4259b9669eea17d25e943a5b6c1460d13c39", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "4c848230-58af-4f84-8f15-627bbf357a63": {"doc_hash": "9e23e8ff4313d8aa412ffc8a4c4002f9e2ec9785c3cdb56458ed868b958f355c", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "fe9b0c82-9b44-4f87-b4ca-45b78ed44eec": {"doc_hash": "8fba094ad4f97780540ba208433babdf912bee253a6575a7ef5c07707897a04a", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "0bbbc694-5a47-4aa9-a5e2-43c00e9111ca": {"doc_hash": "be102e9bb98240e7cd880e2bfe6455bc1721ee79a7a8ccc271aad87f56ec9578", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "3de153b9-08a1-44f3-b4c3-44403dac8f80": {"doc_hash": "6b05a9c1fddfe6d30c937106b2da7160e047ebdedd6b059bc8c89c00ef2181d0", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "9747d265-d890-4252-982e-eeecda1d86d3": {"doc_hash": "3f682de7461f0f4570123a300374c8719524f68d1cf879237b0b1b999fb7384c", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "e865cdb3-5993-4174-89ce-86726dbb290e": {"doc_hash": "d897b863cb78f52c459dc1a319fa0906373e35d37641e59aea7ebf6272e71b4c", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "7b337b74-e084-41ad-8579-18c9983d9283": {"doc_hash": "398d6a83573195a1ed8021dcb11146830377a12d0d7d747a9f1a15651cf96dda", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "cab4667c-04ef-400d-bb83-67649ee0f937": {"doc_hash": "2737f1f224ebdfb8c050f7d1301cf7f65530d10fd4e338f9ee8240cc4b46109f", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "94e39d20-fc08-4e86-8638-3123a29b7b30": {"doc_hash": "0371ff0986ba147ad3a49603098056fa493b47bf4bd0428d0b91ae6d6287b010", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "1d13d7b6-69d7-4297-a9e7-3403e3534496": {"doc_hash": "e9bf979b53aba1bbb96f82d6cbd530b45217675ce603fadc48c68ad15aeafc25", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "20b55d25-d125-42b8-80b0-db7781694664": {"doc_hash": "707d4e412163d1fb2d4134c9a3ef439c3cc0a0a93e18f1e9c20a0acd23e861d3", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "211dbb4c-78ba-437a-847c-5c153dbe7181": {"doc_hash": "4a354318362beb5c5c2e11307d14c36bd6a8a6c0171e0bb6da8cf7dbaf3d08ec", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "86a9bd09-5c1a-48e4-9ce6-532b5c61a8dd": {"doc_hash": "96d5dfbaaecb69ccdefd8cd247f4cb14bdcad9339ab155985dd46d9099ce2101", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "6befac3e-2acb-4f0b-a964-4991d85ee0c4": {"doc_hash": "cee1c4977ab23473589ebb483cd6afbb4870e09e9884c2f43e150a4c5ee0f492", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "1e6dc7ec-7455-4cf7-a018-40ba55cfca40": {"doc_hash": "caf311c7e599509c8aceb5551e4a7f8fc93eb45fd8ff2fc0b604dec882e7318b", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "312abb4d-20cc-4d5f-a37e-18115cba86eb": {"doc_hash": "b160d143aad39ef142a84ee698e5c664a6ed410df9c0f1ca7f38d19d652ad51d", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "fa81edf5-769e-4132-92c7-e3f82252530c": {"doc_hash": "151e3af00a557b787232c6decf41da6881026c9a36c118d7d36be7d348473294", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "fea227ba-3e24-4421-b8cf-94d849198af5": {"doc_hash": "3fcf0206d6f0cc0338f4a1bc381c6f883f6050c11de069aaf19818a79b9f5ff2", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "2b32d2b0-e89d-47a7-887c-ecedff8d9199": {"doc_hash": "0d216063908ac942a37580d5ba30470c84be64cd76aaa5be92d3108291c40a78", "ref_doc_id": "bb\u2010Uno-2 (2012).pdf"}, "2ad0d831-4f9f-4aa0-be5f-5f8b58f48d9f": {"doc_hash": "d8282c79292d2dcf2641d54ccbf388950ccf435828023ee6af25f5505fbdcced", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "131283bb-14fd-4179-8b57-4c80d1930d66": {"doc_hash": "964a970975422226877088d93d3827131e797193829e524ff24c766de367cd1b", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "5548bd02-b502-4808-9c9c-b10d27b1c448": {"doc_hash": "a7997d2f21e7f799f448b546213ebec813da63e3278a0745bcea8438909c4e85", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "7d698684-1436-4aa3-8449-b29c70a0d638": {"doc_hash": "948271d98997401c66cb314d8794f66e682bac0cc9a06e9a8a966e0fce84b48f", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "3d16adb7-901b-4d2a-b062-26aa6a10f038": {"doc_hash": "d2a782b81d905ed071b3f733b87eae6a3609213aeb7bce5f3d5ff12d665b0642", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "cafe85ce-b378-47ef-8b87-9da7ec981229": {"doc_hash": "df779a877b40b04f90ee4fd43fa129d083f375ae64e179f492e6356620944531", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "b308a02c-c053-4d7c-b3a7-fc34c2b74394": {"doc_hash": "145175fda20400183e2af9383d0aeb55602cfc439aa3a12f2a25a06a63d86dcf", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "0f8c0ba1-2f03-484e-b0b6-06bb6204518d": {"doc_hash": "5e24aed8d42bd9c4e71227b88669f7fee5b95127b258adda450aa3446abb0ac5", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "b96538d6-f042-4e19-9fa9-0b61651d8b18": {"doc_hash": "fcc6e63ae89e1468b00989f38ba8ae9250e14a20816074c4822ca5c2832a4378", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "a6bd9956-ba0b-4bd7-b6a9-2ab96bac9d84": {"doc_hash": "17a411c6baa3dc37cf4ce7fc3c2010d79e0bb657162e309ecb9a9b60af4e8b16", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "009400ab-a053-4db1-a608-dcfc1576e30d": {"doc_hash": "af40f05579b8b0d98821fe77d21f9a29304af7576e480a8804865b350570abcd", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "c875a373-f9dc-4e48-b907-25a725734423": {"doc_hash": "37fcf5399851284d9f16baaf82e57e0bcc2c3f62ad733b4da4bb9be5ab67398e", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "bdf8d3b1-068b-44c0-b839-f3519f7c727d": {"doc_hash": "fbaa10856c485d9a1d6d9aeecda7df77cb6033f521865312b52fc83b29118511", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "5be868f9-874b-40fe-8248-caf280977b59": {"doc_hash": "bedea6d13c3d95e6765c67d7ee0c64e80ae9af57e25ece0a3d7e10b703044d9c", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "936bf859-5e50-4ead-a66c-bbee5fb6b51e": {"doc_hash": "172f251bd46a7b7f6166ab2a117f49c2cfd79ba7bbbe4754a4597e6eda0473dc", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "777bb992-5f3c-41ef-a932-b75aa7e0753b": {"doc_hash": "f46333d6b24302067d92ab2d21f642c458f911cb80df996f47bec715160501b4", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "f4e74f33-654b-4cb6-9321-3ceb85b4c678": {"doc_hash": "ef3ddd6f4e2c88cc0ba8ee28bfd12e4b0df1a7a7f3f4e0697b840e03c06a9e31", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "51029807-d168-4d24-ba8c-512fa3178f0b": {"doc_hash": "ce221f8eb2b399143a329209f6f5e77941a28e2b2f40b51c85cb0b9cf2fe04e0", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "fc339b9b-e915-4135-b279-d26d722f96a3": {"doc_hash": "705b280454259dd95a6ce4850a046915b480998ac2cb3705c32db760ca467043", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "8cc5425e-44ad-4d5d-a800-a710e687d717": {"doc_hash": "8af2cdaa860fb294822d0b60f1856f454e5e50f57970c5a7d625eb9ab5bbc975", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "2584f57c-437e-4bec-91ed-6b15b5f9c2ef": {"doc_hash": "00c0250ff494946bb6a2e634811f53f01b76a045758424f4e0323997bf1ff441", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "e7a70616-ea7e-4b21-b4c9-037bd31a27e0": {"doc_hash": "e4c1cc8517652217af81203bbf998b709e66ec9a3c76acc5d1ce279e91797fa2", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "66764eee-cd51-44b5-a758-34c31e317919": {"doc_hash": "4dd5e9e0cd9baa316a8e432900d6ef724448255440c0f4f43d18b6c520b74fc7", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "16319c5d-e5cf-4fc6-a25b-113bdbe7c853": {"doc_hash": "01a2131be06fc399f8f1844cf0bbba1e25bff27dd2e5f38b8ead676af5e33646", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "f95f3b4a-2370-4c4a-9477-536ce9754eff": {"doc_hash": "ace30c32d4a63747dc9c74207d6bc6bfa76b6b7c0a9ee48128d90d2cbda55d79", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "653fec17-3a27-4c20-ae94-7d275575714d": {"doc_hash": "f35e04701ae4db3fa16caf5c2eaab75256f06ddc78ce851a3002b7504b48604b", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "a570ccc1-808d-4f46-8dd3-1414e6e726e7": {"doc_hash": "53d86c8411c72f9fd9df4f46bbc42645c340536b37faa6b7e50b2e3d8b2272ab", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "cd09000f-1e4c-4243-9eec-ed38f3afe889": {"doc_hash": "d9801dd4d3e11eefb56b5bc864f050668b3c690440446c149ef5cfebf425efcb", "ref_doc_id": "bb\u2010Dockerty (1999).pdf"}, "f5bf758f-8c8b-4a26-b87f-0a49a0d1b17f": {"doc_hash": "d589632fa5169cfdac2fb839e5ae87943e487f280ec8d5d1d8b0f209bf10a76b", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "5b204e55-5058-4051-87f0-5201f4bdd5af": {"doc_hash": "30958a26eca0d5e4239d2890dcdbcc9f1cd59bc4e4ba983b56e9d37a2fde9ded", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "815e7035-fc0d-4701-adf6-73e6caf8b80b": {"doc_hash": "42359f4a931f48e93db39baa70c507fc003082f57ff20e06b803cb5afa97b338", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "2884c249-5c5c-47c7-9b42-f3f7180fd711": {"doc_hash": "41297b8be67209d2b5f1817bec6121fa7c55a15b045647a09c4f06c6a33061f3", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "05a3e6da-7a24-43ad-a22a-f219213af2ce": {"doc_hash": "2523cc38056ba2d173c36d1fc8e3fcca2bdb6e253f8bb37000b01578269cf3cd", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "1f63207a-e09b-4bce-ab61-2707f0de2aea": {"doc_hash": "0d835173db4ac45645e46ab46b139e2bd8450772edaaf2009950733140556c64", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "726c5610-c1a5-4e84-a043-9a7259abc6ce": {"doc_hash": "35fbf50207b98cf5771063865536e79d5aee776f186aafe1f2fb5d6f41ae17d9", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "378a10ed-a4b2-4084-9484-4fb52f1af0dd": {"doc_hash": "2517e8addba678792d7a43197e1b896453d96139dc2479c743d5a72bf761d185", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "5d2c9a84-b00d-4a30-8669-e32470848f7e": {"doc_hash": "4e916eddd268645f95b3769cb1a001c13b7b5aed329fa31514ae3dc6324c3697", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "d32283c2-b3ba-4aad-8c38-9c3d7fbe486e": {"doc_hash": "b126afa28221245c1a00a5124a2798332f6f4c5c65ae6ca7d9b8279243746f8c", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "8ad885d8-c67e-44ac-82df-b546f08ef7cd": {"doc_hash": "dced422d2ba3f71ab6cb19c9313481ffd66bff9249744e0c20260cca85e87bf8", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "2a856edd-2b04-4f34-a0a9-83626305f597": {"doc_hash": "48331550e088eab59ddad26c21477a0088172821525af36b5e9118215df805af", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "25e1dd38-e198-49ea-8dde-6f332a9f935e": {"doc_hash": "4d70011a9ef211d19b54c431b64c99621130e451e90e851b0fd893a45ae0d5c2", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "cc2d5e59-f4e4-428f-a98e-fac7e610b47e": {"doc_hash": "a9c3dfd28ba26c394cc35b8f34c281a4331adda34aa07d2ed39c1c0dc149ca5b", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "c0317ea4-25e4-4163-ab66-c3f03ef29ede": {"doc_hash": "b0098e97e4e315c573c562e65685f6d014b4f0b77ce2505195818b2777ff9abd", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "819f552d-19ff-4dd3-a429-e8ce7e73983a": {"doc_hash": "41eef922e8e69f64d7ccd5697cd1fd9c1f402a5b1afa3a5e3cfab3795ca58db9", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "4e8f5af4-8d35-4d07-973e-47c23c465733": {"doc_hash": "6bd35c0640bd22072b6e44e2f88fe0aefe7921fd1760ecf8cb1daabb26a5a9af", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "766be6f7-c70e-438a-a5ab-d8f6944718cf": {"doc_hash": "c17ea0ed3c0895e68623bf45363ac9efa9ee13f3773f51b95e98b0857fb1d0bd", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "49c63b2f-6293-48d1-bc84-a54bfb486211": {"doc_hash": "18619e305c6dc478dee760a97018337717582eb4500e389cb14f0d85508add3d", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "be5c8ad4-ac53-47cf-8d35-420e7cee9e36": {"doc_hash": "7b7c26fa43b1c95e9fb8bd9e287531412c48f7827903d6fac506aba93a457a5c", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "47c29f19-b47f-482b-80b1-aee1db56f304": {"doc_hash": "5b26f6257031edc85bb834f8d717a49eab6e3e8d0810e0a11c9e08f55a3243ae", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "5874c871-6835-4296-a620-7a3b7daad93f": {"doc_hash": "3ea635053f9606394cbffe7686086c271f91bc1d55d04402d7ba156b5ef522c7", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "856f8351-ecfa-421d-92fb-ecdd9332f5fa": {"doc_hash": "f922321b3e3734de13169fac3a5abfaa95814aa4a9114deea3abf3b93cef08e5", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "609c2577-db86-415f-aea2-bdda94c84725": {"doc_hash": "5ea6edfc4797c2afbc6ff81ccd1b645ab6d9e11479831c05d5598f48c978d1c3", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "6bcc70bd-d454-45e4-a449-0ea29ab124fa": {"doc_hash": "c525bc6e7ad430e720cd378b034b89a370819a9245407f1343e2d8d9e28488f3", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "ab44d843-5e28-4039-a127-b5971bb1f0c8": {"doc_hash": "937ac6852f7fa69ea76e762bcfb35f7fe30ecd1df923295e664f21281e73f2ed", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "f24eae03-b18b-4eb4-a1aa-566a828d0350": {"doc_hash": "f9e8cdc4698608b40c6750e8723d62e589586591a85dfa15b58abb6d56057a06", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "3dcd8adf-07aa-4eed-85c4-e96748424ba7": {"doc_hash": "491d988b23869bdb302884d8e858f6c43dad1d0ef68f79a0e9c716c5d3305d8e", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "ef6edcdf-b8a1-4bb1-b835-5be16ba75336": {"doc_hash": "d4e5fdafede083906648055240ac1cf1587e3d01513c8a6103c0ab399faafaf5", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "e1364a3c-55b2-4f49-86de-b6b5645f1641": {"doc_hash": "76d2150f946f9ca3bee02f64f136585b173036f811ecda2ba252e1181487ae95", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "95f4b75d-e118-4dc9-86df-dfd9f29a4101": {"doc_hash": "de2fda66a2807676ac3a482063bf5ea5cde70d428681ec8acdac93a4c2741fdf", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "dac560a0-05b7-4e0d-8ee3-2b754e989e60": {"doc_hash": "6c61fd67b7abf4b5d17c20dc471d96f35331fa45a4ceecde99582e80c627d9da", "ref_doc_id": "bb\u2010Ahlgren (2009).pdf"}, "67897cfa-1086-4124-9198-fd87a04e1c1e": {"doc_hash": "083c31be3080379067770e0befe03ccc9ca6f3b976a8c8303f71bd893f563653", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "bbc46158-6629-43e9-86be-d39d7419eb99": {"doc_hash": "53d41a3fae2cecbfc8bef14cf2f83303736d047c4173a8ab7f4e9ab332f296d3", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "de6a0703-ed14-478f-b0ed-87f56ebcf0dc": {"doc_hash": "2f477406088b92e328ed89d77973531ecc014e592eec17a7ca95cf3d9acd20b5", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "bae0e601-b2c3-4bf8-a641-5651b2854747": {"doc_hash": "8fcbfdc8fe996daba4e5cb3ffb8440867991c05ea18e82d67a5e03f412bcde0d", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "a0ea5a75-3f72-49a0-8b7e-73cd505e2518": {"doc_hash": "78aa05b089547b63029751e5322ed22036abddf7a2b4e10e72363ec4ca7b8257", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "2e12124b-5709-441b-94ab-344732117f40": {"doc_hash": "57612288448ab280f3edc961865aec4cd1cc4589d398b062caa3b0a792814a16", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "a933cb49-76c8-4830-b37a-eab925d0b487": {"doc_hash": "ec9d4178abbb551d09b35efa29f3210d2dddd89e471bad1c185f041b4e2eff27", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "76e27594-9ba4-4bb8-9b5c-291678859916": {"doc_hash": "79955bf747f108617b197825cf10f4cb314e3d12a2456e09c56b4b32582dee51", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "17416c11-a704-4c5e-a2dd-34d5dfa75987": {"doc_hash": "febd4a35f526f295207bd9832fb85cfcda7b89842fea983df65a165f3be2d98b", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "44fddeea-7f77-47a2-8831-b47652414413": {"doc_hash": "21d530c5a976f77923609994be2cc228ea57631c839865088d8158a98296f5d7", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "36f0f793-eb0f-4d3f-86ff-06d5c8e9f56c": {"doc_hash": "93a08c1cbe96a830d46591c55a19a370d60d77b5e5280812056c73c983254363", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "f4f35c9d-c364-452a-ae27-f92d76e874b7": {"doc_hash": "d634387819caf9c35dd71dc26dc935a1684e1a80c19ccc9ed2fa19c6956eb8ab", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "8905277d-48cf-4250-9ed6-a3a4fbe6ff58": {"doc_hash": "69b88c12fb95d8900cf4eae20933d734399b2a5a478438eee315ccf5e7e5b5e8", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "dbec8102-e036-4a27-8fad-587ae906d2cd": {"doc_hash": "1897823a70249312affecdd78a1f537c257e3f3b0587fe1edc1f996d8dec633e", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "571845a8-8109-449d-85d1-dc60dc2e3b88": {"doc_hash": "76b903c6b0f182d3ec83b8f20b75bbab759912b92e92a7d839aab62b08b12051", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "9834e6b4-e6b4-409e-b944-0a4af604bebe": {"doc_hash": "839f9204f4d88a6d14dc0e8a2ea02c1097d839d47b1b146e5e464f4996c99179", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "375c018f-5983-4f5a-b29f-29998e46dfdc": {"doc_hash": "c3e271794574639be1466bcf4ed5d69cb4f310e065177fad0676a6d3e16bce11", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "08a21e80-31bb-4403-8296-0626ebfaed80": {"doc_hash": "ee294603d4e7534ac4c89a6ad31261fe05e15996192768d05d18e7f0b52ca4f8", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "080a38f5-4bbc-475c-8e0f-f1ad2c7fb849": {"doc_hash": "7a63697a5a0dd04d1febba90bd98cb5275d268df1e34cf276080781062bee685", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "2b47c8a3-7739-42e5-ac58-1b886a12e0af": {"doc_hash": "ba5b564540e405c4ebce13c2d26bf743d721de7407fec865496c922641c7d62b", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "13ff4ca8-fcda-4487-9cc7-919f56ffccf5": {"doc_hash": "7d7f1b77d815a4fa2d17243f26ed3d308572b1b7151a265f85a1f3442227b61b", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "762c6422-b5a0-4463-ada4-e8032aaca145": {"doc_hash": "c9a29fcf9e95c5efec6a957d4ba7ebfad596549e72a8805045c5faa5dbe1a301", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "c1e95909-09d5-4a4e-9dd8-d36c5674da61": {"doc_hash": "e3bc99357aeccea2eeebbe2bae2fb76faa6db4e45c74fa589437aba288e35e45", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "43935815-0253-4ff1-9ca5-b8c401d0ecef": {"doc_hash": "bacaf2106b85066639dbea8d68fef983d5265c6345aa3b2adf509e8307e90442", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "57de5bbe-353b-491a-a0b8-262076531c0a": {"doc_hash": "42e064d48d6d6fb022cb9bfe14745e76873b297d28bc1769e3a323d2ccd4482d", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "63537c09-11f1-4208-82a9-50ac9022e8c6": {"doc_hash": "2376e7bf8ba03ea0b0246d216b7a2d0127513c0cdc3364ae4c5f47ac86dec242", "ref_doc_id": "bb\u2010Bremner (2005).pdf"}, "77b59b22-68db-4add-b504-4f8a356d45db": {"doc_hash": "05dcd26294729ebd130e97f7e255a10b05eb6c76abcff4bbce6026e92a64fc2f", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "1802f041-f25d-4d95-bf4b-c1d1d8e541c0": {"doc_hash": "7534fbd8c634c13eac51049e9cdef08c44e3c8228a0c57a7fbdcc35f383d47ac", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "cb1c02d1-a79b-4c4f-ad69-e44270927751": {"doc_hash": "7abb33ee8c33a90f40fb74132f28ec1fc431cb07a2583f3eedb36d138d76c6e8", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "775c4247-f24f-46d7-81c8-93681dbcfc7f": {"doc_hash": "751728a192c51530a0146d518895a6375c638dfc507afa72bc680d6ae97091f6", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "20cee29a-f767-4faa-8a01-97e28709cb8e": {"doc_hash": "bc31be740c21f89f9c605d08cc4074aac700e06735754c6c28a1c24685584140", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "d2dd06ff-478a-4681-b746-c7090c88a933": {"doc_hash": "bfebe31a1c4958dec7f0e6aadd085f7cc2c6271f0d789d7afcdbeb8c5cb7a187", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "79117fb5-95e0-47cf-9dc4-6f4ebb24537d": {"doc_hash": "18adbf57c9d22e814fd746622f2a18dcf2addf3cc9861b87ff23d8d9478e245d", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "9b6f722d-cf2c-4ce7-9dcd-43a3901d2b18": {"doc_hash": "f964d37eca2b99d149c63c1d4c8557f614fed00649f9f3c815e352e51d052eb8", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "fc98050d-9005-4eda-801a-d3190e96d7d8": {"doc_hash": "f1f5007caefaf772df9b5fdb7da460a237a08e7675d07c28be2b535d4b9643d3", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "260842f7-5d98-4a58-8685-4110e0712e0b": {"doc_hash": "4c8bd7dfc7ed61adddac74d780f8b93bf0dad8ff8066e2affae3a3207b83fb90", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "ea798cc5-5ed3-4f00-9e00-4ef84fd1daf2": {"doc_hash": "023d0ff909a345c44a44b1268132c6123f760ac935e49df2499cbf85b3a12da1", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "6ece4a43-7555-4408-b0e7-50396b962b6e": {"doc_hash": "a67551fb8ef82cbc62bafb7244982b7d634f28adb9b322cdeee72ea2907340b4", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "200a5689-4ac5-4338-94d0-d99fcdb0d19a": {"doc_hash": "222416d3f4fae9e7e82bc224a14455fd1fa92fb8937aa74be55be75724b88c56", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "085be720-af62-4ff3-82f2-ae98f0cb350f": {"doc_hash": "a7682e144ff5f377b228e955d3f0ee4c7afb0d56b7bbfbb87b51889b03bf11c0", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "8a347705-d70f-4e0f-b39a-c3c15f382418": {"doc_hash": "2a54d425a35f405857e8393610ffa2bd1fb6756567df5e018ce1a96b1518d6d0", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "12a5a5e4-3380-43f6-803b-c92dcd23f2d6": {"doc_hash": "1d2981e0baedb9170fe561766fee278e3cb868beca3b3793dbf3d35f5b022594", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "aa8296bb-8cc6-49fb-8fe6-7f495712fd47": {"doc_hash": "de9a46abfdd2d6f74b6ce045c1e18091c74d41ab7be4469f27f6bdd3b09685fa", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "c99bda0d-a23f-4935-a869-dc80c3a652ca": {"doc_hash": "d3ca31c12117773480d0fe925ccb071a663e8cd2847eea399a5a6029ace5675f", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "81e16349-8057-4a80-b110-3bdc958a1a3c": {"doc_hash": "e90fb2f9c074a4c9f274bc168c8cb5aa2389b9c63642f7cea11dce81eaf88cf4", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "ca6ab770-a78f-492c-88ee-129ea16262d3": {"doc_hash": "3ae6e507a0d9e256e7c477a61aeb89247658984c485a214bdf4155a5006c7d2b", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "c6695782-74cd-4512-a00a-06bb558ec445": {"doc_hash": "53b3dc073f5f3016e98ae759fcec65e5c083e71ca46db6fa9e6d005b2f3f431f", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "b8be6716-f8ea-43ec-b438-0321dc8896da": {"doc_hash": "d63afb38c44683aaa00ba7409bf4a7848680f8cf59dcaf7944f2704d08f7b976", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "de48dbda-c980-4a31-96bf-6df837fd486d": {"doc_hash": "2415a333358157e7465a1cb5bf0f856291b85f40d0065a12465790827a72a79c", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "3cc37b5e-f905-4d21-82bd-25c4f5ed3540": {"doc_hash": "ccfd79c56edd6d52e4b74504920f38dd69cded7523822a182d603443813f1439", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "971ca21e-adec-4b42-b22c-ac5fb62b809e": {"doc_hash": "df7dc9dcd36c8dd52dc84b2bf30659317a43dd12035a025c4d7ab8013a6bb4a1", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "87837c79-bdfd-439e-902e-4e7ec399a964": {"doc_hash": "04314c582f59f08ad7459a1e91dd24ab43226b425ef1e8cf3d0ff5e2e4b3b9df", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "c0d608ae-e619-4b8d-af9b-157b451137b9": {"doc_hash": "dc1d91745cd5c175d5248f71eef43ee3aab16df05fb24daaa76c0091db3f0426", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "6e437bc5-2d9a-4054-9d48-9223d9b7c470": {"doc_hash": "db3701fe7ed26ac0a34ef812ca87d3013fb8b55a9c647ad5bccc5cd6709e41ca", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "f7fec461-dc6e-4a24-913f-a1e37c68eb60": {"doc_hash": "3029d693e6bd970f3520b16d51dbab539cb2b4018499918024f72ec27ed4f689", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "a46ce135-3b82-40e3-9705-87789283acee": {"doc_hash": "c2565c699f67a651049a1b6c3aef7b20dc5910ea3c62415890f7347354e28971", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "e0094cdc-4771-4633-b97a-db6a817bfdc4": {"doc_hash": "f41403b21504218f1162ba5a73c6656e4965c335af659e22aec91e902be2b86c", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "c895db56-1d2b-4d25-9de9-4ec7c7813279": {"doc_hash": "03c7c0ef1c950eb6f58a93877e167aa20d3199498ad3ae00b11375e3e52eeff9", "ref_doc_id": "bb\u2010Uno-1 (2012).pdf"}, "ac45745a-4213-4f9e-8e88-52cbe41c5938": {"doc_hash": "6f5b7ecda7c47140428b9421973653a08deded0b9c001ade7b7157654724fcf6", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "9ce94375-b60d-495d-8bfe-d5b965f40ccf": {"doc_hash": "ff619cf273a068f27bb2f77f002e996a73dd0677b091793ac4fae5edb86e298b", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "31568e6b-b0d7-4c9b-9559-3ce21298dff0": {"doc_hash": "4b7ce2f1ed55016584ea545dca301741ce6fe9deb8f673c44bc49b159ce5ad4e", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "e6f62207-4b02-44fe-819d-5b07c55e073d": {"doc_hash": "0fbdc47b2270ae7eef4366e66495eb7efd7929eaac7c070df5f806184d2effff", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "dc1cd5ce-6071-4527-98dd-6ebf7ff37a41": {"doc_hash": "4e15d0e61b3346ae23d74e59808d2bdbe4631e2bb18bf6ca12118e1757768fec", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "5e870399-ced2-441f-b3b3-840cc2accdb1": {"doc_hash": "4c3db3575d323819fd315379dd61112f357d0697ba9b6f64808956961ea7fcda", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "99d21b6f-6ea8-41f6-b93c-8c443d44d730": {"doc_hash": "2c7abcd5c1c11cf33040f03f8418bbd699ae04db258bb2811855ecf9d4028e68", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "518ffb4d-1525-4bbc-b685-397960c377b6": {"doc_hash": "c7d2bcff2b4ad075533c0fe83c400efce783851e959feb549e7a756dbc89c9d4", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "002890c6-abbc-434a-ba48-fcc509802680": {"doc_hash": "98e484c726b50c9fc03772ce0984da5a117d6b4da27c997c8ce789a189093966", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "359d8f48-b9ed-4886-9d41-cdec548c9a69": {"doc_hash": "6db86165ab1017123b7602699d73dc1c401a1c3f3f90320374469175df06644b", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "f4fdcf86-7afc-4c71-914e-d368ed96436f": {"doc_hash": "c16297c6e10977639c0d77eaad46370b67ad3f39b05f5baac0025f43be84b96b", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "3065b60e-c26f-4587-ad0b-c79a11623407": {"doc_hash": "4f46cd7931c02fa0e080275ba8355c6be4fdc26a5a5d08d76171493ac1176e35", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "dec1f9c9-a590-4e6a-a8ad-2ee2a4048d83": {"doc_hash": "efdfbdd0b9c5922f888f5a1147545689ded06a721610a0ca4da952f62dd11fed", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "106387c6-c05e-4b28-bf93-0efa90ac862d": {"doc_hash": "73ad0b013096ef9c3fbb94def622a0fa0c6808404f0afe3758680dee75798ac5", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "65658d3a-af0e-4054-b333-de7b5b8158d0": {"doc_hash": "56349c4683314da4a9f8945e41a2c3d86c252cc22441aae4d7742ea2284a85ee", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "99cbd9fa-eef1-4136-a47b-5c400bfc5e45": {"doc_hash": "3a069991928a86ded48fe26bfd781a70577282a28d18be1c346e66efcadc879c", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "d83d39bb-760b-4fe6-b481-2618a5d3c517": {"doc_hash": "b0d4a5b799be7c8c36e02dc310f0b766956781be1129caa77da3fc3ed7bb7ce2", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "b5b18356-2f76-4b6c-8b9a-ce593ef02176": {"doc_hash": "f5be054f743a6d0bd0bd056b5fc748c216795a66d252959b826d57b7c5f7fc50", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "828cec01-6372-4bfa-8c0c-2259e42e6484": {"doc_hash": "ae46597d809d8ec74bede2f0472d49ba9339dd14afea8558b31d7c2aa89e8b9f", "ref_doc_id": "bb\u2010Bertuola (2010).pdf"}, "fa82595c-0044-4c8d-b0bc-28b326d718c3": {"doc_hash": "e2cdfe3a65b938222da849f7a0f130aea0c2d62bd8661c81c580f216ddf23f7a", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "30a1cd42-0618-4468-98c3-89f29cc4e455": {"doc_hash": "558bf694b1a9dcf71e175ae8896e152e63c9cbeb09c8923c6b9d41d03228eed7", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "4a1b4a39-7d67-4252-8ea9-8bf5f0894487": {"doc_hash": "c305945b2343f168f5bfc5838441c6d86fbbfca53caca1d975cea2d4af26ccf7", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "601950e8-2efe-443e-aa19-1b1c8389fe39": {"doc_hash": "60b8be003a525a9a71b91f37a69e0de0e9861f0de3357de93acfa323a366c4e7", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "7f6ed2c9-007d-48b5-962e-f655e418b78e": {"doc_hash": "56ed599c377e1337b354476034fbc8e246305ee20bd48b0b87e8d64a62953fd4", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "08b2d910-5eb6-401d-8170-c3267ad3063e": {"doc_hash": "e9a47a75137482041aacba37ecb88f4b6026e670cbd97cd4c90fbc01362190c9", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "a5080844-04dd-4638-8972-365a03917376": {"doc_hash": "4189ada4470801adcf62cfd96d24b7b2685b45ab892fec6cc1ebb7ec3de0e2c6", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "2bcdda16-bc7a-429f-97df-0615d181750c": {"doc_hash": "201c3fa6713b1ca99d867903ad2118fb18f8b38fac4d9fadfa0078e01e8a5364", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "0663c540-22b5-4e1d-9672-24c0e9a7ea5a": {"doc_hash": "0c96b4b9e5348aac49061cd8ab6b1d3b20575845c4cc2751de96f112e6bd3b1e", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "1bc8405c-3491-4d7e-ab88-2560594cb44e": {"doc_hash": "55acca52771cee3820a44176a503b8b4a8dca6ea53df54a77134230eefe65843", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "a7fe8a93-03bd-40df-a9eb-15d95aee6a5e": {"doc_hash": "fcfe634df7a1069893fe6b82c059d61370149bbcc7d75cb448ddc62eb97cc06e", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "1bead9d1-a802-4a72-9862-4a2447ebcdf4": {"doc_hash": "2a3f279ce66bd4b176adbf328c964d82bb5e404008326141e14dbe271ecab6cb", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "8658329d-3cd8-4ef2-a6a5-e74e0db692a5": {"doc_hash": "3414a676589a44de3a42ba1f25ec8e92ab8f0c0ee3449edc22215cf8da96e654", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "de439c8d-f2de-4e3b-843f-d5f758469f39": {"doc_hash": "7ad3a7e6f0817f9fd0b063441038baef690324d7a15bae2502e6fdce27d879a6", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "464b332b-ee09-455a-981f-a837a5f962b6": {"doc_hash": "b850dc20af43d2da683f17cfbffe9236d1f9fceef3335aa9794b4da47e582f7a", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "f4a29f19-582c-4ce8-aae9-882c95f979bd": {"doc_hash": "2e281b75514d00d3708175ede07d2b097b125668f6e08465bb217d674705eccd", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "76d1b04c-c3b1-4a78-bf19-a4df63a1c621": {"doc_hash": "ae4c8969ca62ed5ff7276316e1bd8d66bcdf446f23d7c9d85a80f6ed8fb71894", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "314db8d3-38dc-45dd-8f6c-7184e251946e": {"doc_hash": "ffb83f2a7fe7cf76772a9877790d06edf1f55ab2e2b92667c4794e0ba4b345f7", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "6fb635f7-767d-49e5-8312-d5ff88e5342e": {"doc_hash": "261df7255c6edb2b761944df58b5ea12d179954cb574843a4dfd06726d666dda", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "c21b6d4c-aca5-4d71-9b53-53789ddf4b5f": {"doc_hash": "20a068318501aec0cf9fdb31032c6e64b079fa926a12b1af0132329695970ba2", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "8b13f4bd-acab-44ab-a6ef-1d299a8052e2": {"doc_hash": "413e386cf293abb9299c4085fe45104d4246ea0d7af40773ca1e157a5db0be11", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "8a00169c-2683-49a3-8669-ccb34c630ecb": {"doc_hash": "98d5eb5353d7fad96c08b76c834f1daf77a5ad6e85ec7bce8cc0caf4294c4083", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "ffffe5fb-cda7-4cc3-9b0d-f5bf72d78cc8": {"doc_hash": "6e7d53afa95b3535b07a6d68e267447ed054f78a015532725ef59c2c390deb48", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "a3d2ca21-81e4-46eb-a691-eec68d0f2358": {"doc_hash": "a396aebf4c78fa9a21f000739c8cae87a954043d53cd93e96eaf9dd100f1b8c3", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "dd4c0257-c3a8-4583-a27f-e4b20ca59e47": {"doc_hash": "b168c4ce21801a5611c3f40592037ce395543f197cd7ad30040e80cfe1181fb0", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "96f9758a-c81d-4b4e-84e6-ada94e519d00": {"doc_hash": "4760b7a7582d0eefc4121362c48ac709ce8159d3d35152ae3288d15849716fe1", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "2efc6e76-ad95-42f7-9cd1-c7cf9659a411": {"doc_hash": "2ce1555883449b9a2c4caa9a9b99a0770d6451edbf1adb4646deb01ad3917ace", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "f3e1433f-f9c2-4509-acc4-603639271d03": {"doc_hash": "56ab52c02bb5bde20b645428290952480b82e93176bf2fd8797a6f5f627a84cc", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "d2963986-3c37-45e4-a0b3-c80e3177ce6b": {"doc_hash": "331a3ca3d12c4913b572a79d1a0bb61a93e4334266e8264d0debc506c1f1db0c", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "ff371d50-0bf7-462d-9011-71e5c1fbbdc9": {"doc_hash": "d3426395b5986414c1703c8f509b7b03833f5f738dc4a382fd89f17726faad9d", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "e60a2f6a-89d9-47fc-bf46-43338d19b50b": {"doc_hash": "111096cd191bff4b0a386a3bd289d826f5a03aafdd23d67e1665e181a4a1be74", "ref_doc_id": "ca\u2010Livingston (2013).pdf"}, "b2669964-82f2-4fa7-8359-92ba8691f651": {"doc_hash": "c0d20f23a91126045669f27da5ee1ecc57bcd8795fabf575becb780b76c8a856", "ref_doc_id": "ab\u2010Freeman (1993).pdf"}, "b9467b42-bfd2-498f-a1c4-d177f294e63f": {"doc_hash": "68346f9bd4060e9f1adc9f366fcff23889ee37487def0d0042deed014ebe9e48", "ref_doc_id": "ab\u2010Freeman (1993).pdf"}, "b8d1b3af-00d3-447a-9f98-a02df4a064de": {"doc_hash": "081410a7efba9186d411734e2b463d81162420293899d5a7aacf4748cce6d21f", "ref_doc_id": "ab\u2010Freeman (1993).pdf"}, "25390829-26cf-4cec-9bb3-5907124d5284": {"doc_hash": "73fdc21cf676b1b6e26f9a411c4971ad538489e39fc2da44ce35bc03a1f78651", "ref_doc_id": "ab\u2010Freeman (1993).pdf"}, "26db15ea-7b22-4151-a16c-2b1fc55921b7": {"doc_hash": "17246f1a0bc5e472057dc8fb825615e6e020cde26a157d9735e03039dd2dfeae", "ref_doc_id": "ab\u2010Freeman (1993).pdf"}, "8a9a7cf7-9878-484b-a324-c686482f77a6": {"doc_hash": "761a237a0c18210b204eb010e2fcf05e536d39513bb67000c4f64fdc76a054d1", "ref_doc_id": "ab\u2010Freeman (1993).pdf"}, "e7583468-e34b-4f13-ad38-ead763c36800": {"doc_hash": "f9da0a9486553e172e08f4a6caf6d6b71dbf3e76f8df031e61373e9f0902d57e", "ref_doc_id": "ab\u2010Freeman (1993).pdf"}, "cca18bfe-3779-4f9f-b533-d9b9d73efbd9": {"doc_hash": "ffbaf6e928c5d93542345a05782651f001c5c339a9071066d54ea27f32f9b97c", "ref_doc_id": "ab\u2010Freeman (1993).pdf"}, "a7248631-d7cf-486a-b3d3-c665d9eaab06": {"doc_hash": "7af35cb8ca93319e8c2edb14496a549ddf2515ffdd6db231d5c6e68e24316744", "ref_doc_id": "ab\u2010Freeman (1993).pdf"}, "9739e15e-4138-48cd-ad46-b796ddb1b3d0": {"doc_hash": "6b6a3e73070a3f4ae8a85fe8b303fbffacce7b578e62137a5818294c1944462d", "ref_doc_id": "ab\u2010Freeman (1993).pdf"}, "33500868-a951-470f-85e8-2ed001c76714": {"doc_hash": "197d77ac05b387c8665d240380437eebbb048903fc2efe3ed267ac70350afcb5", "ref_doc_id": "ab\u2010Freeman (1993).pdf"}, "3bc083cc-3028-49ec-9c6b-05af9633877a": {"doc_hash": "b52e1f3434cd2cfaab22ecd4c6c9517883b8e6738e26e6c7a7ed16b8c515a0e7", "ref_doc_id": "ab\u2010Freeman (1993).pdf"}, "ed799ce4-b737-42cf-af97-4f78f60900a3": {"doc_hash": "4dc6385429129a67fc68b13f05e9ccef9deecacbb68747cb599ef7880badd5df", "ref_doc_id": "ab\u2010Freeman (1993).pdf"}, "66c1d50a-1c71-4f8b-8833-f8868c9dc5ee": {"doc_hash": "cd37e393431289d5ac1c103e0a8e533922ed1a96414109c77b1e10a110d14fb9", "ref_doc_id": "ab\u2010Freeman (1993).pdf"}, "7e9e024f-6259-4614-8867-26865766040c": {"doc_hash": "54f7d6d84068fe00ddba8931550296a61beec75e05683c9d1eb1aba09ef8f00e", "ref_doc_id": "ab\u2010Freeman (1993).pdf"}, "6f9b48a3-30ed-47c5-91fb-8d35dc38cbf6": {"doc_hash": "19e427f12d8e5cb7823419c275c63c00ccb2336a09089d03ac33a718afdbc2e9", "ref_doc_id": "ab\u2010Freeman (1993).pdf"}, "2b8834dc-140d-41ff-8c64-ece4c1eef6f0": {"doc_hash": "5f184cd1538116c185ed332caf6cbc74bccef300b81f02aff501daeb77c91d9d", "ref_doc_id": "ab\u2010Freeman (1993).pdf"}, "eb4dba73-ef55-4202-a43c-483554f62f5f": {"doc_hash": "ea007b74c8fad014cba9c632fe367ac17220ebb5d9fd540ef025e340318f7696", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "45ac5908-816f-488a-b9ac-cbb5796d040e": {"doc_hash": "05283343faf5eacde56d9dc8aefe450f39684e71a72a19aee665f5334652f4d6", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "724611ac-747c-4330-bef6-d157579a12a3": {"doc_hash": "be67f5bca191c2d077a31bad43e7d4561d5b784c244626982534f87b3d6d7bed", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "314242a5-f537-44ba-8564-dcdf3a7320c0": {"doc_hash": "eb7105b488a05c8d4edb375108171614401cdbcca2637ee6585cfdcff82a1fec", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "86fc3426-945e-4ed7-ae57-1ceb5820d405": {"doc_hash": "8dd999ea2c68e736c935ea8699fd85bcde67e90d92fc36314571b7e509c904b4", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "335d0851-a6ff-485c-b6a4-ca66afc72b77": {"doc_hash": "16d0a14f1df6fc28e5d6e9e79536ccfb20b9769e73f73f6701fc4dc8e28b3d8f", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "cb97391b-079e-4f22-927e-b4ac2543df1d": {"doc_hash": "e1ef37f216a6d1084fe680dc06c98870a150c578b9661c0bd056e48083cb716d", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "3fa27b8e-4603-4b09-9f22-242e1e163cb8": {"doc_hash": "631c8a7fbb047c1ca6399a4d21f6a429431f9ce546c79f5e9e305ddaffa32413", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "1166e94e-e6d9-4576-bcb8-6b8c21c79340": {"doc_hash": "d401a2ce52ef2f803a01c43788912f14df6a565c8b329db05b3998f2326c64c9", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "469b2088-2087-44da-808f-bb4cf8f46886": {"doc_hash": "f1811739f36a1003e3f531dc8e92123f4869bf3e9d1828e891e5560b7ddbb7ae", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "0a2be063-d5cf-4d5a-b33e-246049f88c2e": {"doc_hash": "9e785065e17a48de49951f0a2b01bbb32c19d5cc73d9f2b8bcb02fecae11e948", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "98e06273-cf66-407b-9433-d1c6b808e571": {"doc_hash": "ad461941c86420e0b6337f8f3222cf96f2ca0c3802ee44dea59ca303dddf3dce", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "3da51b5f-7b44-46f6-b0c5-41f6a99c2018": {"doc_hash": "7bf7a719611b6c3c33d2259792aaf6bec4e5ad762790d5a6749ad1d367dca55d", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "05d6d891-6047-44b0-aeec-c96d893c106b": {"doc_hash": "be51793c8f798b897edf4aa1d4031919eb3a872e218d18d1ec95295208fa71cd", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "a743d653-e23f-4c37-9cef-d54c91f12f2a": {"doc_hash": "b714bb69d4089ab1b96696fe44dec6c9ddc4f0dde5f536f1e78a584bc5b8ecaa", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "30478ce1-585b-4290-b790-92a5b233d6ac": {"doc_hash": "06fd46742415753fbb45c3729dcba7c467e63641d94c31a9122b833e9da8fe22", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "5d33927e-00c7-4919-aac5-507bfd9f0f08": {"doc_hash": "3161b68dace4a84a70c1cb5893f4ca270c957ba74cd9989167425b0358112933", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "04134b00-3801-42d4-a448-1d97b3a6e38c": {"doc_hash": "26340829327cc898f7f150b065a286af75c36a0e4663280e9578a1279753e7b3", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "ed869e31-0b34-4b2c-943c-fb4b3b4c0597": {"doc_hash": "abc2f6b60ddb3cd18c10288ec5ab44d320e3a5f9c79ae7f4659679665c0ded56", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "8b890c95-f78b-40bd-a1a8-e61454397a84": {"doc_hash": "8644debf6d9ba059d8630d1e001fc077794991f8ce71c65b3bc025853baf0060", "ref_doc_id": "ba\u2010Vazquez (2001).pdf"}, "3fb243b1-f5ae-488f-8704-ba092792b9ac": {"doc_hash": "2927486485646a1bc8d95150a198fee10e6aa1e080ddfe6ef1f7346a38bbac3f", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "aa1668da-e3ff-4486-abf8-942919b0be53": {"doc_hash": "0e6317b7a329ef86a1ac944f794bfccc51790d2b9a8eeef3b4d4587fb72e1edf", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "9f164277-2729-4702-80a4-6f2f28278e0b": {"doc_hash": "069a36ce35cfaa46507c9f5784f85b60903bf3e718a4725fc72076a04e26a6a5", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "6a46f61a-6fc4-4711-8847-0c393981a35f": {"doc_hash": "739fc0ef8f5f605e30e5352be25e1841359abe2013cc0e8dccd8debcbdf4dcdd", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "97ae60aa-dc55-4532-a0bf-67dd155cfde9": {"doc_hash": "37690ebdf620bcdecfcdd53e0c0bbe27a1b068eebb89693b7d623a96ef23cb43", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "43754de9-f9ee-4b76-adda-8ed45fed841d": {"doc_hash": "31029ad6f17dee6bc3d40b5e173a787f058df7b26de5bdde23a58d601ff54b4c", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "c2a49a5e-cad7-4ccb-815c-384866dc694a": {"doc_hash": "1c87a6388364a5ae6d611ad7f1330276af7b16036a81c89d26de345ebbfa1cae", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "dfb0a5fc-7f48-4fe5-a9e7-1eb9a0b75876": {"doc_hash": "f4f7d6f59e79d40f3afe9a776a99c0ea36e1e91ca701ebb5eb6fc4fd123cfd48", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "d80df529-199f-4c74-b482-82f105128887": {"doc_hash": "f101a8a3a639156205689aa4d0b57ddf437240cc7e0d7545ac4058cfb5946460", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "3d6fece6-cdbf-4630-8fd2-56d244f229b5": {"doc_hash": "293c11540f18fbe8467524afc2b96652c842938d2afe3da3716b97a0385e6341", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "1a371629-4354-45ad-8953-46cdbb9be0f0": {"doc_hash": "2e7e798637a77874c353d8e5602f3ce1e88be3b5e3e227ebb46a5152810d6d89", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "554c24d8-15a9-4846-8298-e9243702e39f": {"doc_hash": "2f8fecfbbe82fb9ae5552be983956675c04b8dadca0490cab98bdc623e16326d", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "46ace99f-2cd4-4b71-ae88-8cf6f3176c87": {"doc_hash": "d92f7648d08d3f295fee59481970aef8d9c7af0e7199afa0622e9b1854b3aea2", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "022a0787-3714-44c1-b284-e2232bbfe814": {"doc_hash": "ba1f8a130f2e9edced783baf82133cc3ff82bec51a0098d01961feadd4b2c33d", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "b262be08-ebc5-434d-b893-302028f4998b": {"doc_hash": "8d5f7eea313adf3856365ad9d0e771f4d8672458a8bdd2645f1f933c2e715751", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "cd0efde0-268f-402f-827c-ebb0639968f0": {"doc_hash": "e1bc154922f9b77ad3e673a511a50da84a982a3ca86c04e854e76d489dbe5c02", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "c38e94b8-7b10-4c5a-9ab8-c12845d0952a": {"doc_hash": "eb75cf0501652540e098a3c4f9b9fd13d922d9c80c64722cd71579ddc30d8660", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "a3893a42-362e-4c76-9e89-03d5d98c38ce": {"doc_hash": "a768cbc55ba3c9989843521a273296a0beec9db34fe9ae77b11610bf3535e9f4", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "7f2bee7d-1f6f-4da2-a4e4-3befd79ef5c2": {"doc_hash": "ec1fa1f73d2c43e3cd611a948bfc01b9390546099cc3d657ce04883cbb948239", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "8615f1ba-dda7-4301-b254-1ec63028c748": {"doc_hash": "c223e17a872faefa44811381e7d7fae4fd07e241e5a8a9186c12e566798d9294", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "78b494ca-ca34-4f58-b9b5-05bc7b2530a6": {"doc_hash": "15c469c4a7ab52c566f6c3457176a3394d24f0868edc4fbb4fd6e3d7ab555bdd", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "df098aee-87ef-4a64-8d09-05a908a03ffd": {"doc_hash": "a35a1db22fafecf5b319509371be262be356a1f0938af4b500a66e44d600f81f", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "c1f57c9a-4d8b-49b0-a708-4960594e2abd": {"doc_hash": "fe8801d2b9d781629b7d4c5cbb11a06e3217c6297120dc8255db4ca484459b32", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "df34f173-8d46-4b83-9daa-9455e83e4eab": {"doc_hash": "747e9ecb7571eb17f967f910ddcc686a1cf13627f0f9fa0e208daa2aa93ebcf5", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "59a15939-27a8-48a1-8d31-19ea0d83cfe7": {"doc_hash": "97f821a0cb3eb4729248bb57b64363dc3407f073380830167ff77fe6f647c181", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "dbedbd08-9e8b-4e24-9123-e1567c1b436c": {"doc_hash": "2f5a47f97ea01eb57593435f96807f523aaf831bf2f3b18ec7a142e1779fea12", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "bdbf7a3b-5d63-4ec0-8a6c-33d511b19e4b": {"doc_hash": "7ff7feef985ba23288fb31413e97a68133b58b09755b5eda64184d42979d6887", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "1aae36e4-da49-4dbb-8a76-f61b25fdf6c1": {"doc_hash": "5971785f55c9394b8d37cff2b9f5e6c1a3dd7228b65407fe3889318ea30d0a35", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "55417efd-558f-40d3-b881-f0979d8610bf": {"doc_hash": "88481b3a6067502750ec5510d4e43385443fc20fc288748040c42deb06bdc257", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "855b6a76-5fa7-497e-b988-b1f8b9b3ed00": {"doc_hash": "90ae7170b833aef9bc16268b6c1072679982d90d72d4c7264ebb339aa0513c92", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "c1b151ff-275c-41c9-a899-014221999c53": {"doc_hash": "9200e25bc0c79dc9ad4a1e14416219ec9fe02f520fcf57f1fcf155749f89106c", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "ef3cb886-76b3-4014-96e8-484f2752c8fb": {"doc_hash": "a3cd8069fc6a1b4e1a49b17928fe6684bb15a461b70871a422f1ce5cb6e07490", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "c7a689c6-71c4-4fff-8e5b-0a70f1c69b8d": {"doc_hash": "42d3b99a0adec1c9381360539ab3c7cc793da02b48f007391371267d8c44b8fe", "ref_doc_id": "ba\u2010Liese (2013).pdf"}, "a79a2dc0-943e-4f80-8ada-748dcef1262f": {"doc_hash": "0f46935298e8c359c386e92e67fb6890d5eff26a7c46434f62e053ad980b0e61", "ref_doc_id": "ba\u2010Mackenzie (2006).pdf"}, "96c9871d-5215-45c7-826c-4d18b6126a2f": {"doc_hash": "4923284963f661fd8c476fe9f760f5596b07ec160c0601ca6b390cad9b7aabff", "ref_doc_id": "ba\u2010Mackenzie (2006).pdf"}, "557e54de-3f51-4487-884f-df706bbe4720": {"doc_hash": "a077838aece1f95526cb581f8d9d79f7ee17aaed3f8299b01fc04ddc6259b82e", "ref_doc_id": "ba\u2010Mackenzie (2006).pdf"}, "47341b9f-e3bb-4a7c-aa08-231889991fa2": {"doc_hash": "f5dfc6e7c418ec3e9ee7d3a6a9a5542b39ef8ea93e462dbf70b85849fa901a7d", "ref_doc_id": "ba\u2010Mackenzie (2006).pdf"}, "2591e22b-be26-41c4-af66-27d6cd6ef983": {"doc_hash": "cf7f976d76120d3f03ea8596eb978e947a2661e24852e1db3ef8f04ac505774c", "ref_doc_id": "ba\u2010Mackenzie (2006).pdf"}, "4c7b8f27-3ff5-4842-8b1b-dd0713893ee6": {"doc_hash": "d720b8f4a1c119f745fcd8b37b9d1f6545200b46e23326734fc22667667e2fa2", "ref_doc_id": "ba\u2010Mackenzie (2006).pdf"}, "b5a0d3af-b355-4088-806c-e7f2ee70087d": {"doc_hash": "c95d653eef8c4af82ee55ac91a6f39cf3f96cf106c5df5e18496d5d0efb24b42", "ref_doc_id": "ba\u2010Mackenzie (2006).pdf"}, "29c02703-206d-48c9-b6eb-8de89140447f": {"doc_hash": "20f9b9b48097b1a2e98f4bdbe6df0efb04ee8759ec59851ed142ddcb638269d7", "ref_doc_id": "ba\u2010Mackenzie (2006).pdf"}, "b9eaf0b8-50a4-403b-a3bd-34ce57e46564": {"doc_hash": "74a64bc2a2fde306a2b93b3e9df43f74af242b947a3226d0a5acb040cc129527", "ref_doc_id": "ba\u2010Mackenzie (2006).pdf"}, "892478ff-0dba-4146-a64d-e6e490872a0a": {"doc_hash": "1d72a997816f204c6acfdbcc98bebb02ef7536bf10d7a68e6695a73cf0ffd985", "ref_doc_id": "ba\u2010Mackenzie (2006).pdf"}, "7fe3b69d-8721-4171-ab41-2f819925f9e0": {"doc_hash": "fcd4f0decc55e175e9926365b3519af961ec38cb6d0f3509a53e32ad21c2a3e7", "ref_doc_id": "ca\u2010Bhuniya (2013).pdf"}, "e4bfe047-e804-424f-b782-bbd0ec482b9c": {"doc_hash": "2628d7dafe56c94aaf5c569835cc853a692b945220c6870cc743112a1c8ebaab", "ref_doc_id": "ca\u2010Bhuniya (2013).pdf"}, "4e95fd08-60f2-4209-a6ad-6feed0dd0a14": {"doc_hash": "b142e93433e61c4a4719caa25625c6da72f17ecda4bb0f6ba8d0af6274e703bc", "ref_doc_id": "ca\u2010Bhuniya (2013).pdf"}, "09365b1b-f2df-45c9-8de2-242fce505a35": {"doc_hash": "75555c72aa4539c22783a24e67e117153c96d2143f02d628c61b7f5ad6e43c44", "ref_doc_id": "ca\u2010Bhuniya (2013).pdf"}, "f00f5055-636a-4b87-a529-5199081c901c": {"doc_hash": "b9efb79d822bf7c5e991c38ba123dc0fae25fc2c83274fccd8c2164689bb4c7e", "ref_doc_id": "ca\u2010Bhuniya (2013).pdf"}, "e3a8e410-eaea-4708-8847-ca1ff8afefd3": {"doc_hash": "883479fa5b5824eabc9a2ccc067c65475233fb2d20960bbf1f9ac070bb317d36", "ref_doc_id": "ca\u2010Bhuniya (2013).pdf"}, "901d9370-70f6-42fc-b3e3-8b9bf0315e8d": {"doc_hash": "9e5da6e3ae889af1c7d2fc6611613ffcbd0968dfe2a259ffef61c9194e87b3ea", "ref_doc_id": "ca\u2010Bhuniya (2013).pdf"}, "1a51ab27-7480-44b9-93ac-27cdf0a87cd9": {"doc_hash": "04a51ca23dcbba9e03f51b04801bcd91fcadf3524061ceb1231c6d359566022f", "ref_doc_id": "ca\u2010Bhuniya (2013).pdf"}, "56167494-277c-4aa9-8264-1626d8a21133": {"doc_hash": "f155989157d575d6f1f54530f667be0c709dcb4feeab8d18cd2d6dfe289a22b4", "ref_doc_id": "ca\u2010Bhuniya (2013).pdf"}, "6a037f3e-6123-481b-8353-0091850379e3": {"doc_hash": "240d590ed944131ea798bb0a0b8457168fba11cf96a2bbb93deec8f37383401b", "ref_doc_id": "ca\u2010Bhuniya (2013).pdf"}, "9abc49aa-d7fd-4204-8a0b-ef95d68d50d4": {"doc_hash": "bd70bc95176afd531f2c1798c215e8b293ecce887833889880530ad83b467020", "ref_doc_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf"}, "7858b58e-8c8d-4ded-b420-a2e9ce5bf117": {"doc_hash": "2f8bd0ae12e1b96907110efb9ca530b8dd102f250abe03068716b674398b9893", "ref_doc_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf"}, "531e4ff5-2072-4ca9-ba21-cd15216e598b": {"doc_hash": "1fd7430bae8ee6a1b39ec0e9c5da4675217aaf570c3915c3959b02fd3917b702", "ref_doc_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf"}, "7f314f68-e111-4932-87ab-657b5affac0d": {"doc_hash": "b5a7637f444f52a738ea7571232d91c4ec13d9262718a2fce93c5d918ffaf729", "ref_doc_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf"}, "50077128-90c5-4e65-b1fb-4ad35c0165ea": {"doc_hash": "6c80823b665adcc3001f19822dbcdc9eab064ab964aae4e37241849cdafbfa13", "ref_doc_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf"}, "8d5d92ac-dd75-4db9-950f-64f931768fc0": {"doc_hash": "0c78b4e44a52055fd5c82b2c0a676d7d49dc5620a6ee33073cda99fb3b4c0569", "ref_doc_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf"}, "fe15bde7-7f1a-4e07-9ded-5b958a0db54e": {"doc_hash": "9038557459d8c94ec97b0ec7fbf757dca2afb1474be908265a36f9bf84011e29", "ref_doc_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf"}, "4de7dbfa-a22d-4899-8259-8c6d16884033": {"doc_hash": "62dc113fcfe5b7cbb94b6f590474fb4948c39d9ddcd13382047de4a64872c530", "ref_doc_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf"}, "c38e6b79-2d89-4361-b064-38240a634980": {"doc_hash": "2bca579f96e1de23db0ee2144f22659615a6f40bb7d6dcb0b44f62872951b9ee", "ref_doc_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf"}, "be94d891-14df-42c0-8b6c-244257671464": {"doc_hash": "28b351589a5ffcbbf1d286717a0334681881c93322ef4cc500399b9ca0377c0c", "ref_doc_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf"}, "af49053f-7243-4cfa-b72e-934be6f1c7bd": {"doc_hash": "96bddb604245d827f493edafcf889cc58d080914c01fb2a80903d30ee64bac62", "ref_doc_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf"}, "87e8f3cf-7efc-415f-9488-34252726521a": {"doc_hash": "94af71f6d75cc7acd83ee63429f82f04728265baf969b2f85f2f885305da370f", "ref_doc_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf"}, "9db18719-12a8-4520-8cb2-74068ab3c8a1": {"doc_hash": "7b57f5e09b17e3109bc1c83a47919333ec7357ac2ad16f89ccaec46fdb316852", "ref_doc_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf"}, "fc6041ce-5bdf-4b8e-a087-0ba5d878d77f": {"doc_hash": "527cebc86f807eaea25f47a1a8defc602a227e5fcaf06078a524320a6469ed96", "ref_doc_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf"}, "92fb437a-8b3d-405f-8154-c4b5c6ed952f": {"doc_hash": "c6f6cb4677e3b64399bb09045012c98e36de61929bfb29b8d058e32c50e6c832", "ref_doc_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf"}, "bd0e5e2a-e2a3-4d5e-aea9-63c8449ba15d": {"doc_hash": "5d2bac4931956389efa1f5af82695b735146bc7a1528f33fff288b74ba48d41f", "ref_doc_id": "bb\u2010Mrozek\u2010Budzyn (2010).pdf"}, "1c5bcba6-b696-4efa-bcbe-495a5b0fd3ad": {"doc_hash": "4fc3cc9a6f6aeccef10929c06ce0a5b936011aa1327f3aa26a6b9d3bdad6a004", "ref_doc_id": "ba\u2010Cenoz (2013).pdf"}, "79f1a250-c48b-4bf1-9ba0-900bd351de9c": {"doc_hash": "194b0ff6ccdbbcf2bba1cd94f6cc1b28ed2f719bb532cc5fc21cfacd16dbf08e", "ref_doc_id": "ba\u2010Cenoz (2013).pdf"}, "fc5b7164-4a6b-4f07-ad62-d84fb553a122": {"doc_hash": "7dde7d21a1c6a5bb43e1537bd1d6609167460cd44e388a8d511262e0c51d4119", "ref_doc_id": "ba\u2010Cenoz (2013).pdf"}, "5eb39918-e3eb-47db-a622-c71effa6c5b2": {"doc_hash": "456eafe08a5cdcd7aaf2626a68f60494e80adcc8f537aa7c1bdbacb305f53c9f", "ref_doc_id": "ba\u2010Cenoz (2013).pdf"}, "d8586f51-3e71-4910-a40b-a102a332398a": {"doc_hash": "4c078c4aca2e48e93b58d8fcebd323be5facd66f57cf8515b9b5dd394a35f981", "ref_doc_id": "ba\u2010Cenoz (2013).pdf"}, "8804bce7-1c1c-49a0-9790-b8c33c53efef": {"doc_hash": "c0f274ba5564700f32280a12f3d37121986713b7e38e32872d80bbc723484ffe", "ref_doc_id": "ba\u2010Cenoz (2013).pdf"}, "2b346bfc-c74a-43e6-840f-1065859f3bd8": {"doc_hash": "7445ac4a70de8070e2c6d948a1544edccdc01e3cc8ab7ab17507b6fa37e25aab", "ref_doc_id": "ba\u2010Cenoz (2013).pdf"}, "8c134f85-7fd9-44f4-8d10-cae0a3818cb4": {"doc_hash": "55fa40462b07cde07cc4a27ff68f9312b1960cd88afaee59a844411e68a6c7b8", "ref_doc_id": "ba\u2010Cenoz (2013).pdf"}, "01430f57-e2cb-4562-b33c-b53432329299": {"doc_hash": "ec97eb4065bb752fa62b9040b6d33e55a82cf94be87bb04014e8f1853164d9f6", "ref_doc_id": "ba\u2010Cenoz (2013).pdf"}, "9539f2ab-a8a3-4492-ad2b-01392e1f2319": {"doc_hash": "28a9cc18a792a56b74ffc99ef17f2da85316df2d14ba2248d401395306535d3c", "ref_doc_id": "ba\u2010Cenoz (2013).pdf"}, "42848b44-0486-4429-8fce-5a5db5ceff37": {"doc_hash": "c995377c239938c7cbc5a43abfd2673d3905be5ff6eb617db359f84b65002c34", "ref_doc_id": "ba\u2010Cenoz (2013).pdf"}, "4ec51779-3da5-4aeb-ac1d-ea7e2930445b": {"doc_hash": "f27315e6a42154ae0831eb6718258f2589011220feac855a1c62dc81451b36a4", "ref_doc_id": "ba\u2010Cenoz (2013).pdf"}, "f55e3477-1036-44f2-9b38-644455849215": {"doc_hash": "704c3fcb69a0ed056325cee4c0a1b00ddbe1e57942421bcfa2c522719f72e381", "ref_doc_id": "ba\u2010Cenoz (2013).pdf"}, "1b13d24b-2914-4162-b45c-e367990f6a17": {"doc_hash": "702275d682efe1aa989f9409ba853e2e3563e1e1b33a43273b8f00df2ec1dc34", "ref_doc_id": "ba\u2010Cenoz (2013).pdf"}, "470af235-e630-45ba-935e-bb0c19340244": {"doc_hash": "039253ed8d115e2a12e9211ab4e773149e37c2d614b448f20ff05abcb7215d4d", "ref_doc_id": "ba\u2010Cenoz (2013).pdf"}, "fb4d89a4-3de5-4f9c-a300-14c6fb5140b0": {"doc_hash": "df9ff264cef4dc078d0fd50ebfe92a80f78842139b02e95dbbd3d873e66cc67f", "ref_doc_id": "ba\u2010Cenoz (2013).pdf"}, "c800a5a8-5887-4726-a9d2-e050a6e84f9e": {"doc_hash": "6b82f9f894843f2b8b1cd69c4dd43243cfdd83f86a48feea3884c1f6411f9033", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "89364d7e-2288-41b5-aa50-2e683b8a55a4": {"doc_hash": "93320fb8d6ec684cf26b8039f90e1d894db76f34f1a6272d4bfb890a11a70de7", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "112e92fb-0a63-49c3-8ef8-6d9d3c092c68": {"doc_hash": "eefc388d3e982663f9d07fcd8f9b64ca98a9ce6b04a63a0bb3ff2f4b48e88520", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "bb4e2bc2-e312-498d-aad2-15a53a94c04b": {"doc_hash": "97639c88f01f6b730b8852282275182dac26ab18f2197a56318087287306e3c5", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "34cf3a1f-c68c-4e96-9176-206fd39045a2": {"doc_hash": "2327981dd88069f116753cdb82819c6a5b13db653df9b77f357faae7a5ff6ca9", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "6ffcfcf5-7fd8-4d3c-9e32-0d26ea6b86b3": {"doc_hash": "e2224367c3f69bdf908bc6e5b18f8040309952fe71615c3a5403601cc95a4a43", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "7d9686fb-303a-4643-8a3c-1f16fb367ba4": {"doc_hash": "a8198831a099f657cbfb0ed47fb30b6f0c1905ac7e841cace497cfd74d602441", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "bdb0d9e5-4aab-4c2f-b23c-6fa98e7eb88c": {"doc_hash": "6c3918c1142af0ce488da314c784224d709809d8e817a241545301395e746d65", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "6c8138f2-1838-411d-914f-982c47ce5bfd": {"doc_hash": "ddde1cdf931cdaa9acba6a0d8ea83cc74913e2d1a6f05ea328f594d39702e254", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "72e7103f-f60c-4751-b404-87ac33170c3f": {"doc_hash": "d2abff1401ef202a3ae749e8bead2181db5d4b973964b211904a4bce27d30be2", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "38b141f7-097f-4293-8b3d-04bb207a7cf1": {"doc_hash": "285460a8ab9d124f0f1629acebc58b3137658730c101417ae9e6dc3ac8f8433d", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "2025d05e-25b2-4df6-af1c-c91cc2f1265d": {"doc_hash": "22f623a7d88f03f70ddbfdefb42fbd4c78a5813e452df318e5ceb36f59263f20", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "a59e25e7-2299-4b2c-af81-1e9fb5801de9": {"doc_hash": "2a8d85e27d63127a2a70f42d83e290d0f504648edd90108abd21d67256b4425d", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "ec56494a-2cd5-4882-93ab-defaf4b74a1b": {"doc_hash": "0e16af6bad672f9b11a359a935294bafdc55bbcd86c52124cd40714ff9f97143", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "8c26f933-c200-4104-807f-0d728c1a4b5b": {"doc_hash": "0278ff2a7ef14bdab7a049e5525cf2ed0b0c723cf03a91b839cecfd040f6c512", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "13bbdb23-df50-4103-8648-eabc0e5524cd": {"doc_hash": "b03ce6e72dfd46c40df822291c779eaba2a1fa730a0c1315956c289b920861c6", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "124fd7b4-616d-4a87-907a-440e65d0354f": {"doc_hash": "6348c1a4588b1dd13dcc3e831f7cef4c021746f3555026bb2c58292084201dae", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "fdf2b368-df0b-4e91-8b67-327fc75872bb": {"doc_hash": "4ce593d54a648121a7780823f1248ea4f0f101ab677e825c2f32801501f9ccf2", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "059691ec-b286-408d-8399-91cc26358c6e": {"doc_hash": "c1e0b968ea82b18be5e22259fe4df58a6a0c2b75894abac0c551a827ec189725", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "54bf8267-ffd9-47de-84ae-39044aba0549": {"doc_hash": "adb310735b172e3ed26ea3f6dbab4486067a0b7fa33ecc5c536d778454c80589", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "5198105c-23a3-4b92-b585-bd167ed1e39e": {"doc_hash": "9d465329bc083f5a923bea5824e10d4593ab853f896ec8b0838b6af8bf600c66", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "163bb8b0-fa69-4fff-ad6c-6ac1f81f1dc9": {"doc_hash": "acb171f8525faeb522f20edf6fd9b04a63cff24453f0490787fe73e35574284a", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "fe9a13ee-c36e-4b5d-b452-aa430ad1cc4e": {"doc_hash": "528922ed1ef93e6c57f1c663a16ba5c421cfa5342f73fa31dbb16102c8be682c", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "67fc1903-5ea5-4253-9296-49cdc05fe8d3": {"doc_hash": "6b2f6488cdd4f7bae0c483123ba8f8843741fd74812bdfad37e73d1d49441bc4", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "62760ccb-8578-4851-b3c1-4cb49b0d2b80": {"doc_hash": "f304bf629e0253493c88ba03d74431724a985030899cce19f1fdd24aa48ee4b0", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "58f04a92-1494-44ac-a8e1-f85c8a027577": {"doc_hash": "658c82d45b7cd4d5964cd3e4f36101f17231ff4722ddcf487c48c53c4b89a702", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "a24958b9-8ead-4430-b21d-3de059e33ebd": {"doc_hash": "66ed7a5abe6a018c811fd32e3dd2ba1903e675f33678034c32c49f70de8f1cce", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "c4ae90ec-6d86-4400-bc3a-fb1ec1003238": {"doc_hash": "cde1f28b45b6b7bebb0d73ddcdac11696123d499528c10ec0311758746b58a47", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "ffc2c2b5-ba57-4d3d-9f09-57fbe2d03823": {"doc_hash": "7dc850861ed02cc2bca7d8047b11bb3089c2da98e6838152bb4fff98f21c9a0b", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "85ea9e8d-9d21-42d6-b570-5454e89e91d5": {"doc_hash": "b39df352c838896c7946300391ff2db1aca64e58a0612d543a52b4b4360971c0", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "ba12e42b-d335-4b8b-abd2-e65348210076": {"doc_hash": "9b1a058587186bd6a65eb20efaa2a276cd5bc9f1a2067f934fd6d1c0fdcfbc41", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "1b5bafec-d74b-49ff-93d9-029beea4d359": {"doc_hash": "337d22a8b1253e0442beb4e9f0f0cc2815904993375b9e9eb85600376cd18863", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "bedbdc48-a4e1-4fbd-9a8a-5bc47cccff55": {"doc_hash": "1338e7a49eca154db2e00614407ba932f14f6be2d8dc222fe3fd6ace9d596924", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "14135fa3-2c79-4606-aace-410478184e63": {"doc_hash": "690b86379ce668ca0d1509d1db3a3c9cac774d202d431b2e878ca4084ffad9e8", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "c5cf9988-3284-4624-b8e4-4893ebbb1a35": {"doc_hash": "eb35303cdbc0ab6499e1dbe5ad40a811798a56133eb6ebb6d54bffac5e54ea34", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "14601df2-22dd-4e36-b4ca-b3e7b812d287": {"doc_hash": "ccc4d94675cbfb4368ec0614201a2136cde36a3f7b9bbf2b30eff99770eb0a94", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "1e730da3-d39e-4ceb-b4a0-4ea134ea93f9": {"doc_hash": "3bcb8e3e74aa579c6c3880e89d7190c55f01b0f3e9cdd770affb138d2b270c3a", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "c175bca9-2774-4d34-b6d7-a8f751b822c2": {"doc_hash": "5fc481d7f00b36ba2f643d22aea1fd985f0bef7cf1f0e5762b4651fdf34d9ca4", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "83d0c219-5137-46df-8d9c-ed71f80f3968": {"doc_hash": "c2d47ffbf8de13fbbd10e9b753204a0f8b6147ea71211abcf36431dc08009dbf", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "7c0cc80d-33a8-48ad-87c4-ceb8c4762322": {"doc_hash": "b8fa7c236e1b687bcae38c8a9be707897c53074d6e56cfc00c0e17750e678bb3", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "6f7a92b6-c4e0-46ce-b837-5a00ec35d649": {"doc_hash": "7acfa1c0618033b0c21423a133e1fe84dcd9a0b0ee885e6e5d03a163a49076a2", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "b148c180-2136-4627-a27f-5deabcd93cb6": {"doc_hash": "90849c0452ba7b7dad8820402fe974b084a7a443bf873a93890e9697f0ae8fc9", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "10895ccf-cfae-4c69-b8b8-747c86df97ee": {"doc_hash": "c22fbc46dc35ab362ac4a88335ed5c37d7f3b6125f805c09fca8b011c2644ef0", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "5ccec8f6-b0fd-4386-b622-9ec41d8c7a72": {"doc_hash": "076caa3a03d49b3b83b854cdc6b8fc8c468f2d54a98abfd3879ec13be10673a5", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "450ff60f-73f3-44d4-a882-b6009a590807": {"doc_hash": "bee100de83ff3263ae511b0d04d9b07ab063178ca31d923a6de092fa4059903b", "ref_doc_id": "aa\u2010Prymula (2014).pdf"}, "af884ecd-239d-4a7f-aef8-ae545251bf69": {"doc_hash": "1a8fdb533d9ebcc97bfa48b1693e9303e883080d9ca7f2ad56d0de4f1d4023a2", "ref_doc_id": "aa-Henry (2018).pdf"}, "7594fab0-d929-463a-bd62-486512aa707e": {"doc_hash": "82524518423e6397c6df694f82f7a32f78aa90e70fcc9cf85007f967f14c7d6c", "ref_doc_id": "aa-Henry (2018).pdf"}, "84fc3ae0-ff29-4c01-9c2f-c457dac8c20c": {"doc_hash": "984dd90205ddde5dc6ca9067cbf69825d2a62275df0cafc2b17171b71d21069a", "ref_doc_id": "aa-Henry (2018).pdf"}, "dcd2c745-c2bb-4ae7-9187-1a82dc074f12": {"doc_hash": "cb852e91120e7a429811555f6c700564d4250a79a044624b4a493b0ce1b53ec5", "ref_doc_id": "aa-Henry (2018).pdf"}, "99e674af-33a4-4afa-8720-f070a89b29ea": {"doc_hash": "00b3cda274c2af883059990b0615507b372510257d08a8408a294f6f8994ab98", "ref_doc_id": "aa-Henry (2018).pdf"}, "32dfb671-5c82-4f01-ae1b-30cb27ba9fc6": {"doc_hash": "5fc4b3b189c212b90b02d5579805ced2f7cedcd66e5786dea21a382ea00adc0e", "ref_doc_id": "aa-Henry (2018).pdf"}, "7c556ca9-451a-4b79-8a56-148c332262f5": {"doc_hash": "d9013470c1c7eef641071bde5500a63d03f355db99f52fcf609599e4f52c3476", "ref_doc_id": "aa-Henry (2018).pdf"}, "1d1eedda-d70c-4178-82d4-397e172de1a6": {"doc_hash": "861dd183a67169f2b9e72e6a4dedcf6b5a3c1ebfeb150fa3e50284e66fcf7326", "ref_doc_id": "aa-Henry (2018).pdf"}, "4b9abe0d-81a2-4206-84e9-927b3830fe39": {"doc_hash": "4ff79328e853ca38b4e8cc1db9f6588a92644ea0623cd54fc9e34d21c2f73592", "ref_doc_id": "aa-Henry (2018).pdf"}, "0432e6b8-04d3-45af-b59c-2c4651c2077f": {"doc_hash": "e165db17af64941cfd56ab7cb51ced76046cfcaabb9cb7fe789aac1050576ae3", "ref_doc_id": "aa-Henry (2018).pdf"}, "1ccf0c49-7f3b-476f-8be8-3ecf0ba299e6": {"doc_hash": "d6924eddfea9d7a71491a68757519ca0519abf102746a4a83d2b49ea3d420cf4", "ref_doc_id": "aa-Henry (2018).pdf"}, "6d67bcea-9c99-49e4-8e39-88c4b5abecc7": {"doc_hash": "831ea8c6a4c489fdeca4db03299123fbb0771406e99a23b748088d9e5c05c95c", "ref_doc_id": "aa-Henry (2018).pdf"}, "14d0f3d1-58ba-4fc3-9aef-d8e707748e28": {"doc_hash": "23a2cf6ed9e3860f8ebd310d07404c4d68417802d50b31d8d2f9e141cf08c6f3", "ref_doc_id": "aa-Henry (2018).pdf"}, "022b209b-2a85-4821-ab1d-f05c184541c3": {"doc_hash": "c80c0ee719b174ea5d75f5f4b39fee2b8a966771dd81b5d5129a3be9e60a66c3", "ref_doc_id": "aa-Henry (2018).pdf"}, "932873de-b58e-4e0c-a797-f60b1d74cce1": {"doc_hash": "a74e39fd15db7cd1ba4eb2ea5ee53264d51d42a9530a058e5b555a9c2f8e566f", "ref_doc_id": "aa-Henry (2018).pdf"}, "89257aff-5380-433c-9826-af5c536d653f": {"doc_hash": "650043c429f7fcf58674930a25f04eef4012520cfbc2817121fe5c4b2b03bb37", "ref_doc_id": "aa-Henry (2018).pdf"}, "e339712a-495d-4f2a-921a-802e2815b390": {"doc_hash": "47744498ebe065c2b0e64c7eaa7ddf3d88049612695e1124301b066db53463cc", "ref_doc_id": "aa-Henry (2018).pdf"}, "7dfb43b1-c99e-4a84-88f9-f0abed1a0aba": {"doc_hash": "d8c8802f3ac43bc59f5f3b528691d2678d8825373ed585f6ca36325a7198beb9", "ref_doc_id": "aa-Henry (2018).pdf"}, "96ca1451-2e10-4bfd-a3e3-90ebeb8db844": {"doc_hash": "07543161405d35382157f95ecdac0a8a318208ec07c3d815b4d509e468bd644b", "ref_doc_id": "aa-Henry (2018).pdf"}, "8509db5f-77a6-4649-8925-0ae1116beb27": {"doc_hash": "7333df93224e0b5bd9ba1010bc2069b8a2dfb85f795f086ae7002395b78c7ac7", "ref_doc_id": "aa-Henry (2018).pdf"}, "aca3613b-2e60-4eee-b439-ab69b9ed740b": {"doc_hash": "e8c3afc728d5792c241566bf93a8676fc8f8051aeb2ab0412ef16d421650faae", "ref_doc_id": "aa-Henry (2018).pdf"}, "68a7b4b4-e8e2-4938-a35c-f86b4b650d4b": {"doc_hash": "56e2008336b672e63b31aadae0dd3e9034083c6e7b02fa64612011700b0240cc", "ref_doc_id": "aa-Henry (2018).pdf"}, "021d82cc-c6f3-4443-9d9f-1072049b3722": {"doc_hash": "2674997d1cf54a7fb0bf165b136e7f0ef0df5bec6afabb658dcad608171f0b3f", "ref_doc_id": "aa-Henry (2018).pdf"}, "7be29463-6861-4ab3-8c9a-1bf2d8f47141": {"doc_hash": "14a97416d3649c783f3c1f095877f2c8d666419c0b411d8be09651724a70cd3c", "ref_doc_id": "aa-Henry (2018).pdf"}, "882a92c5-0a84-4013-bcda-a6de97d78293": {"doc_hash": "53ab38d592317ec9cafbee4996f27f7a95bdeb9831d82c7dfa98cd3397a8f3b0", "ref_doc_id": "aa-Henry (2018).pdf"}, "3acb2c33-0ba9-462b-a85a-44844c2fdd72": {"doc_hash": "f7fe3c1b46c413b0ae755d62092177a5c711d22b51d9dace1abd7ac0d74e295f", "ref_doc_id": "aa-Henry (2018).pdf"}, "6836d020-1f7b-4a2e-8d6e-68a010f0e520": {"doc_hash": "8f28987f07a5e1c048bb86cc4279f7988c017b7a4b81ab3d7e9fab445d4af204", "ref_doc_id": "aa-Henry (2018).pdf"}, "c765c0e7-d52b-455b-9a0c-ff60e064c3c1": {"doc_hash": "374943fd99b64e5db8d3a2b9be7070737fb1e5679e5dc4625f57e68cbaa60549", "ref_doc_id": "aa-Henry (2018).pdf"}, "ddf8cb74-3b72-4304-b445-850fe6a4ca99": {"doc_hash": "029c57dca0d6693ec13228082896f7683065e87ff90fde84bb60c84d92add14e", "ref_doc_id": "aa-Henry (2018).pdf"}, "ac23e213-8735-4477-8133-1e048571dd7d": {"doc_hash": "0365fc49ebfd517ee08a746a0819849e3f7cac11a6327ae456d2ee947b08e7bc", "ref_doc_id": "aa-Henry (2018).pdf"}, "25b25392-2296-4d44-ae31-5e5f6645ca0b": {"doc_hash": "d96ad002cf1c8c10884a90855019633f4baa5430afdbf81778e374988ff0a472", "ref_doc_id": "aa-Henry (2018).pdf"}, "28d7e561-d3fa-4493-8beb-11f9a0aff374": {"doc_hash": "88ea4907c7f243cfccbf39c65c10902b82a173995f8a0eb2b809d7b1a32155c6", "ref_doc_id": "bb\u2010Bremner (2007).pdf"}, "30439b62-bcdf-43d0-9264-c637c6eba573": {"doc_hash": "171c95c2a37e79bb2f9bb2d13c5e0f057dd8be9e70acc7f768ba27ea00b8b69e", "ref_doc_id": "bb\u2010Bremner (2007).pdf"}, "bda59f27-7081-41b5-be79-07d7160ac046": {"doc_hash": "2a0a12999f45e618362b55f6b70108a3ad9a4b1353ec8fd44c7cea016436b91a", "ref_doc_id": "bb\u2010Bremner (2007).pdf"}, "3141b514-dbc1-4ccd-bd08-4b74a1af9d71": {"doc_hash": "4bb492ffc8e76908ac149b6addfa527a2924b8fe9573171df04d7559ba77dc48", "ref_doc_id": "bb\u2010Bremner (2007).pdf"}, "bbec1a35-d6d9-422b-99ea-f784eaee9f55": {"doc_hash": "e6c3c7e92c9fdd7fb0c4a4159fbe28a84ca6de472ad88227d4ef1d1aaf8b338d", "ref_doc_id": "bb\u2010Bremner (2007).pdf"}, "aa14ee17-5cc9-4d9b-9e93-c4aa4f5ca061": {"doc_hash": "f96bb794713995570dc915c186dc0b9e69742215bf22e8eb3549cfb3c92ec395", "ref_doc_id": "bb\u2010Bremner (2007).pdf"}, "61fd618e-a7df-4bda-820b-9d3ad9af3aba": {"doc_hash": "951549b71a50687b8cfdbd2689657d599563b7d43fcb2c1c97694d687445f646", "ref_doc_id": "bb\u2010Bremner (2007).pdf"}, "d31dc2d7-8b50-446e-9f06-1b203d7d884e": {"doc_hash": "3db8acbf75319deb31063808e97773cb343e32856ee9a139e20be5ede676f0bf", "ref_doc_id": "bb\u2010Bremner (2007).pdf"}, "25afd740-88f3-4381-b8dd-b0ed1c49d658": {"doc_hash": "26588ee85dc4c667b2ae3d4c280cf93f1cdba49fd2705f60d88879de8b4f3af6", "ref_doc_id": "bb\u2010Bremner (2007).pdf"}, "0577dd9b-883b-4800-aa74-08ccfe26d749": {"doc_hash": "6dd361af16742314791bb7405ea308d082f7b1b7e3f0ff8f9f43acafe4445a2a", "ref_doc_id": "bb\u2010Bremner (2007).pdf"}, "b06fc4bf-c7b7-4bbb-a630-006e8c65b729": {"doc_hash": "cf89b612c44f200fa977bda545dd3dee5584052c66b28a22faa2de0f33235b19", "ref_doc_id": "bb\u2010Bremner (2007).pdf"}, "e44dce7c-2d1a-42a4-a630-6912b901d23c": {"doc_hash": "50323d29ea9ac8a268d23794ebf4618746eec39ef3734a7a43917641749bcb25", "ref_doc_id": "bb\u2010Bremner (2007).pdf"}, "f2bc1ece-2d34-49b5-8473-bb5208cf59b0": {"doc_hash": "07e261833f086fd785e36a0f091f24ea75f0492b31c17effd421194db4e86d99", "ref_doc_id": "bb\u2010Bremner (2007).pdf"}, "26a37c1d-46de-4754-a492-e84cdd5de950": {"doc_hash": "1b044b6a192cc0b20b570218cfc57bfb75ded57f816df59f9b33afb936234b9b", "ref_doc_id": "bb\u2010Bremner (2007).pdf"}, "e8560f9b-399a-4855-b61e-6ff14e62996e": {"doc_hash": "c4d537de56c4880ffc7b72370b4111cd93bc24147ce006f61aa10f2f48b71380", "ref_doc_id": "bb\u2010Bremner (2007).pdf"}, "e6ee1549-7422-434f-9a4d-903dc6401306": {"doc_hash": "7cecc60ff266ab4d3e2c58eacf695431c7c0b0f65da1ed2627482f65b92af5f9", "ref_doc_id": "bb\u2010Bremner (2007).pdf"}, "f1fe7710-9297-4819-85d7-f2a45dca1e44": {"doc_hash": "54fd978f3a90fce2ed56c72b2d209ba7854e0283b815fb3dbd0014f5cba55cd2", "ref_doc_id": "bb\u2010Bremner (2007).pdf"}, "1100bea9-7e88-4ce7-a920-1ed56b391dc6": {"doc_hash": "f7119f6a8cacc88b2b40418512534ef42b6ab5729189e984a1ca5a752c36b6c9", "ref_doc_id": "bb\u2010Black (2003).pdf"}, "f3b1375b-8110-44c1-818f-0d83155e59b5": {"doc_hash": "832a7eb3ad3811919dd3d5a7cc9a6c99dc9009cfdffd5cb69a9aff52bf625f1d", "ref_doc_id": "bb\u2010Black (2003).pdf"}, "aa8fbc69-a5d5-4c30-be60-dfd792fbef3f": {"doc_hash": "7901a269c952c02b831326f4166c59f26b058c8cd67f8089a88ec94ae65f836e", "ref_doc_id": "bb\u2010Black (2003).pdf"}, "7d88bc7c-6735-4d77-8f7f-32e8b82330f1": {"doc_hash": "a708f66f9f6ba8e5fcafb5e063fca95f455f1a679d0cdcf1e4049d3329ab2caa", "ref_doc_id": "bb\u2010Black (2003).pdf"}, "39efb49f-bce6-4d02-a8c5-5ee9b8c5edbb": {"doc_hash": "b9b1ae073f922265521a5217eb276c9ff80bdcd16628679aed11860dbff09625", "ref_doc_id": "bb\u2010Black (2003).pdf"}, "b2db4a03-45e4-4d2b-886c-797ccff3efd2": {"doc_hash": "9e92340eb7a87c1a0831dfa84fca73b0487d7ef2ba415f19dded6debba30d45e", "ref_doc_id": "bb\u2010Black (2003).pdf"}, "f47e8133-47a1-47f9-9d68-b70a2c6c1c44": {"doc_hash": "9c75f24fdc18059399ed6bdb6d11935fb8601a43cd291283ac282b5b56ce525c", "ref_doc_id": "bb\u2010Black (2003).pdf"}, "7bbd786b-a3b7-4173-8e9b-f1cfd162d7df": {"doc_hash": "767fd67ea77290f38bddaceaf6cc1d5d86cab67b6d137a939605b18591d67ee2", "ref_doc_id": "bb\u2010Black (2003).pdf"}, "9151a37c-6dfd-4652-aec7-4e8c8e574d4c": {"doc_hash": "81eb033470cb3418efb3530ef66dd30fb56950c8212c27a4e7b3026cec138754", "ref_doc_id": "bb\u2010Black (2003).pdf"}, "9e3c84e5-124a-4c25-8faa-959cb414f1be": {"doc_hash": "9950fa947dc115af423890753b29ed610b6cfc900b252a967ca36f21dc4a7836", "ref_doc_id": "bb\u2010Black (2003).pdf"}, "330eb42a-766b-48b8-b0f5-316ebc8e76ab": {"doc_hash": "f1732aebe81c8980053931f311f677e160243ab51252f18e37f73ac7af4640bf", "ref_doc_id": "bb\u2010Black (2003).pdf"}, "ff62dbf0-1a65-4d00-b5bd-f9748630a3ea": {"doc_hash": "d71f3583047fca1757478c858e997dc25890349b4a54fd81521f7a8fc5490d83", "ref_doc_id": "bb\u2010Black (2003).pdf"}, "d1cda7b2-fcb6-409d-a467-f790aa7ff127": {"doc_hash": "96e90fc584b74bb7885a776e58e24a28864d75c8a308034c6b9616a15cd2998c", "ref_doc_id": "bb\u2010Black (2003).pdf"}, "063bd937-826a-4cf9-ab3d-1f6f19322e15": {"doc_hash": "c37e3a4ec20d753f10b569112b1c94ecf28ecd7607f3073dcce2d0cb1a2e19e9", "ref_doc_id": "bb\u2010Black (2003).pdf"}, "89575e18-210d-431a-bbbd-59340052d7ae": {"doc_hash": "cb03ce307ed8f174a1fe06ec3f5cf4396db762405d50c1650fb0594329d057a6", "ref_doc_id": "bb\u2010Black (2003).pdf"}, "9df0c3f4-afe9-461c-b510-d446e9a1d4a6": {"doc_hash": "768bb70429fa4a1e33cd784344b8a199b5c65616a8af9304483e144d94141e4e", "ref_doc_id": "ab\u2010Edees (1991).pdf"}, "40e9346a-c98d-4f78-bfad-8412ee39923a": {"doc_hash": "242e21068064fc66849c2e6bc89a7a8db0b83395bf1909ceff83e1ab3fe4fbf9", "ref_doc_id": "ab\u2010Edees (1991).pdf"}, "b23943fc-d734-4362-8277-1b585de6acec": {"doc_hash": "2ae0633539a8328cdef2b997308d93859797832d970488fad73072689c281304", "ref_doc_id": "ab\u2010Edees (1991).pdf"}, "7e0c15e9-5de4-4dc0-a83d-dab4425ce902": {"doc_hash": "53db4dd6c9e364edc467e0a95445f7b8d28752aa526e3ec6a858595a236dc5af", "ref_doc_id": "ab\u2010Edees (1991).pdf"}, "04a63fb2-2891-448b-b010-eec64514cb89": {"doc_hash": "9a4c0175bfe01cdbfc38b821879584dcb79323260f1457994a505d012858bf9b", "ref_doc_id": "ab\u2010Edees (1991).pdf"}, "c213f53c-e004-47e9-98d0-c1237f6629b2": {"doc_hash": "4f912ca3cfed42e699c7e1275eb5f994c52336b0fe1b25a80e1d6bf0ba1f9218", "ref_doc_id": "ab\u2010Edees (1991).pdf"}, "d7c54a47-6187-4e8f-ab8b-7f7ad1f0271b": {"doc_hash": "2e82497df5b53fc24b274cf4cf039b0ed8af991034aa4a55cda88aa5cbf98649", "ref_doc_id": "ab\u2010Edees (1991).pdf"}, "7dcff453-0ba8-4ca9-9d44-3fa3190183e8": {"doc_hash": "a1ebb15582dba25c3d4fc13e9827027e285b274a96eb1a7bff28bfe70db75254", "ref_doc_id": "ab\u2010Edees (1991).pdf"}, "d69033a1-e1ff-4a44-ba05-f9c54da58de9": {"doc_hash": "8d292d2d6003ef688356298f0b17b0cfa13858831c8479347a360faf0d61e7ce", "ref_doc_id": "ab\u2010Edees (1991).pdf"}, "79a6d93b-02b1-478a-b246-33d22f6bff0b": {"doc_hash": "6a2e71a1013a781b3a243f71abe13ec2fe9ed5efc06aa7c219a32c4ae3f60e84", "ref_doc_id": "ab\u2010Edees (1991).pdf"}, "25e3c987-ab2c-483a-8865-00f8a2230531": {"doc_hash": "d6982fd75d9d1a71d2bc0ba0f4a2f8fe79f3614b6357b56c992d835f6ef8d05f", "ref_doc_id": "ab\u2010Edees (1991).pdf"}, "8cb9aaad-b7fc-4cf6-b9a3-2492314ab51e": {"doc_hash": "3dca14312f3d1c41170de7130fa795d2999e63e0be506f553bff15ae77605912", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "dd1f8b49-cec6-4394-898e-080918d0e7b0": {"doc_hash": "501dfcfa73bf22c07b77d3926bd6690902a95154e29d6d73e8cb892f53b2c932", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "3976c430-341e-4970-a98a-81b2093afe0c": {"doc_hash": "5dae22ea89d758af30735ae7b1d2f938c6bb9f45d86a787b2c76ba5ddd4c4858", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "5f617676-81f3-4984-9b6a-865d3d3804ec": {"doc_hash": "745b0c8c7ddde92008aa9758e47f497b2f42fe0fee1d64127ffb26b1d7a5ac61", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "76695f1a-8798-458a-a797-be3fbbda8f85": {"doc_hash": "4819753dc6b54fdfb8abc82846e7d2aaa802e70b60c94e850c7ea3ebf1cedb86", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "68c7e3ce-e5ac-441e-bd36-fc1f8f95109e": {"doc_hash": "ce80a5337fc5aec0c4511a790bf86801d3d3aea0a26359873617beb1deb380e8", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "d211cd0b-1839-4017-81c3-db17934b9210": {"doc_hash": "a2571f7cf3fcb70f030438ac54abadbc7b835c0438e11f36b9657774a5a71b01", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "13ca1353-2e60-42e6-a5e6-ef8ab6ec1d85": {"doc_hash": "e6eff39baa49bdfcbfc9916635f1a2de2dddbcd49b05bd80e43a6604ec56d223", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "787ed6b9-31cf-4f82-99a2-b8f59c1ed440": {"doc_hash": "0966276f0b39e9fc11001a94a2429942dfd99506d4d1609225e28e4541b64037", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "269903f8-4576-4aa8-9da4-08b11faa69e9": {"doc_hash": "0e905430c53ed11fe5bb9794cf8367448e1551c9f366d3ef44779c2110305626", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "beb36809-5a60-41f3-b472-94b0860898b2": {"doc_hash": "041f943b331e64defaf107756c35b306ae7d9a214e31cd6a7bf48eedfdeb3a02", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "28f25062-2a41-466b-b0a8-7e0dd47b48ce": {"doc_hash": "e73b1b5ea998f19500e465707b4219d5816e02dba3c8137df2c385de4d020ce2", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "f473b478-5509-4d2c-aac5-ae89da349883": {"doc_hash": "5824b69326d13f4a7213ac1687389ac7bc523c4409446e6d9e5406d838241048", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "d2595d05-dda3-45ee-a0cc-7a129fad3c7c": {"doc_hash": "40c0cd3f74f35c3a6af1073640b7b59651696a8b42054965c2a3fc3cea7a7c3c", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "ec2a71b0-4cdf-4d37-a1b7-636690f59441": {"doc_hash": "072d438e2f0e74e0c14c91906d04169f9bf1993d927f22e9218b59af69077d3f", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "b8d641ac-25c7-4eff-ab34-240510d1ca3a": {"doc_hash": "fe2905d5365e616944e77ecd96f6b17b19eb5bc931c4ebedb927f5a8cda53e6c", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "d9be7f00-07c6-4925-9b79-fbb28d1476e1": {"doc_hash": "18aa71d715c3d6e62b43c6901c454a34baf58f38bcdd637afb8b2b884e1af8f4", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "abfd97c7-212c-49a6-aefa-47fd3c0c5c04": {"doc_hash": "ed19d95fb2fa33bb65fd46ad0290076d722ceb167705d1188557048213e78f1f", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "c1f1de9c-a6ff-462e-beed-4f4c2c20427f": {"doc_hash": "e96cf63922450670c346ed9431e69bd4faa77638126a2002a0d2e37bc40d50cb", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "eb4fe5a3-bc16-41ea-9793-47d8766f7e89": {"doc_hash": "ce58e26b210e980b5bae3f1d661308ab0764540bd340ac35bb6afaba234e7d66", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "8b201d2d-e611-4d7f-9d55-112065fcba80": {"doc_hash": "82e8dcabf991db9a46d295e022975d129ccfbc7952bee01c047cdec2bdd85500", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "79144015-d1b4-4b0d-93c7-967f8a5d57ca": {"doc_hash": "fe9fb0cc42543dc324aa4c5c63209f7f0cf1c651209aa2db48ead9c5cb892e63", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "22edc40a-1e8c-4d05-85bf-7b82e40569c5": {"doc_hash": "a2bcfb076ea7512e400b16dfe9af64a3ae6f8740610416f724e8aed88362c084", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "f2f2182e-ee2f-4ccf-859d-35af46e21330": {"doc_hash": "9c534561997b89fc95901705d898d9190dda7a1c5a73359ca122940c0639e939", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "64a55bf2-d438-4960-8b89-d349c417c271": {"doc_hash": "198cc5cd8ccc54ec396bda5046b30255b273222a228501f8a5f82961a4d79260", "ref_doc_id": "bb\u2010Chen (2018).pdf"}, "b9b6779f-48f2-4062-ac6d-1e5a09d6605c": {"doc_hash": "dc28c6a18321ef2a423cb7f52df84d497c4f38a11cd68e94897a4011b31cbd34", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "89885db5-31ce-4f82-ae00-1927e2f72cb1": {"doc_hash": "9d490d1c01a400551342b41620be19a742d051289dde778135d18796b29c1eac", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "ec95059d-2800-4536-81ee-b6232f13b315": {"doc_hash": "deb03e47b308e4754722cac5a2e42e0a20b26df2840d3a8ad73a077b30d7ca58", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "8c0c90f9-aabc-45b9-9a6d-d822e9264f58": {"doc_hash": "b0ab1597a3aaa7b3158bb9c62b80ef00931c7ac29134289008b10a862fa8e80a", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "1a1f1f4c-19e2-45ff-a22f-550a1651322c": {"doc_hash": "6148355b4a68727f0a60467e4fe58045a3029c8c00759b82b4cf1ffa304b29de", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "ffa9822f-08fe-4e49-a180-e0162c32067d": {"doc_hash": "0b3c65b62993ef4bdf2c4448b9ec200ee57436dab6d016087e8c1e1488334c5d", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "7892dc11-3fdd-4b8b-97aa-654c3bbc57a2": {"doc_hash": "baa77d2f3edf5cb8a15da48471a69e449b7b673d816d00e88250763a47f09c7b", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "4a1a6deb-2010-4f64-b37e-3cc5f9dc7b5e": {"doc_hash": "584be10ff42e46011e36ce2aed98157eee136893101f17b0ab12e6dbc634524a", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "7486f986-b16c-4043-a8f3-b79682e8cfc7": {"doc_hash": "8c829a5e5838fd8f176021a50d97296e15dd43f9ba646b1ccfad4f8b27d39437", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "5a5ab1d5-346a-47df-9cf5-58225285cdc5": {"doc_hash": "163270f19c31f6b93e7bc626f8e4fed4824d5f0fa3119961d6e3b6660e8ef974", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "57626620-a440-491d-a101-23dcf27f3302": {"doc_hash": "7b1620fe6e4b0c1c65233de4835f08e18ae8c1dc4ee584cecfa3ff490e39861b", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "3bf723be-d664-4668-95c2-2a0a88275e01": {"doc_hash": "defd989e58e4b4b0ae2a419c015bbcb55692fee986e4fc167ec10b233c981731", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "7de8fef1-2d33-48bb-ab43-05b16068d4b2": {"doc_hash": "f94b1f6d9de6d71453d708ca13e66ed4f9398ee6585f22a25e81bf4b37dc4296", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "617226ab-148a-4322-8762-7db2bbe8e389": {"doc_hash": "26b61e6e4687eb5c960493b560c4a7409c85a9843c7e1c8afe18cb24fa376799", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "85e65315-3369-43d9-8cd2-7ab97358b775": {"doc_hash": "ff3ed237e9b9b494239fbae38cc0309c7c5cc6f5b91622153ebc2c0f340d91c3", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "ced813cd-8deb-47ae-8ac1-e4f712701b78": {"doc_hash": "0954c2c858cab10b2e43f22440e037d52c09cc93f2e1663d0788f0fe4446dca4", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "f59dd4b5-a2f0-48e8-b476-c758b7810311": {"doc_hash": "0e06346fc2274a10b022d3fb889108fcda3136a8349d2b9f4094a7d03cbcdb96", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "d3ce73a7-95f9-4d8b-a2ff-0fbf0ce9ad14": {"doc_hash": "bef2f4cbd2332f2a36869d214e227e0ee57372f4d9e0e4b67f54d176036e44b2", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "bed4e3b3-d714-41d6-af8e-952c6759044a": {"doc_hash": "b3191538baf52ce9a8378583fbbceacc5ab9c0dbf3aaaa16ed85c749ff331f1c", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "fb968f96-11a0-437d-bd06-962f0a4e944d": {"doc_hash": "a972e856dff6782a91d81f8791512459b831f93761b17f8828fd77b3684d855f", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "746cbf4a-d692-4323-b145-7d84f98a57a8": {"doc_hash": "0f2db95fe996bbe7b621b7f09eb35213d7dd79792e9ce49e040f0632ff7d7850", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "f87add3c-454a-4bfa-a0d1-be1b81cf1de7": {"doc_hash": "6bee0e918e00fee3b08664512ee30bf1f59990d57214d6b0f01aaed51dc18bbb", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "2b010ffb-92a8-4656-8756-17f252c23e6b": {"doc_hash": "964c057d824456ab9480043a6465d405d3ac8d7c9b56276b0d74104e2eec0041", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "62b6f08d-85a2-4fbe-9d9c-6c6260911d80": {"doc_hash": "0b002ed776afb225b2d2cc2bbc87a9bae18fdfcdd02fc62524445c0fa2a2693b", "ref_doc_id": "bb\u2010Smeeth (2004).pdf"}, "99bd6e87-aa8c-41cb-b59f-3fc44eec5979": {"doc_hash": "528e9e50ef852780e0c0b8257665e123f085a753638d9074498da3963789f7d5", "ref_doc_id": "ca\u2010Arenz (2005).pdf"}, "b7020cd3-e0ad-4da0-bd79-c796794e7c7e": {"doc_hash": "d20fc941b9725b41d24a15781c326d9c97ab2796bc2d1276cc54130d462facb7", "ref_doc_id": "ca\u2010Arenz (2005).pdf"}, "3f981c5c-cac4-40fd-a3cf-c9f65e7938d6": {"doc_hash": "cc54fa61efcbd3f2d48f1c9e30514ae1dc8fe0ed0fe7867510434b54d1029e96", "ref_doc_id": "ca\u2010Arenz (2005).pdf"}, "9c6bde03-70ea-432a-8616-2945b6624aec": {"doc_hash": "f34a94f0289b13d366bd46833dc90663385d48e0762f3b8257548f5541e84a8a", "ref_doc_id": "ca\u2010Arenz (2005).pdf"}, "464f0591-1c4c-46e4-899b-c56cda9e9e91": {"doc_hash": "0a6cc03a5a8722032e79d6c5b1825c5ad37904b9114afa919edf781c9df86bf1", "ref_doc_id": "ca\u2010Arenz (2005).pdf"}, "dd223dd4-3f70-48b0-806e-2373be6c6e83": {"doc_hash": "0cfb9ec600884dd6d83dbde5ce8d9d13025377965e7f0dee0c6eaae3f1d501ec", "ref_doc_id": "ca\u2010Arenz (2005).pdf"}, "efcef278-fdc8-4d61-937f-bd30b82c43ea": {"doc_hash": "6d986426410ca3210cf5ec0b4bc8ff4b0be8fae27946fa574fcbdcb7633b2386", "ref_doc_id": "ca\u2010Arenz (2005).pdf"}, "1e0585d8-1ac3-46d2-a807-ed3b793d8402": {"doc_hash": "e47e6afa9f368ae950c785619d71a0a2b10d2ee296ab71495a0c0327cdf848c4", "ref_doc_id": "ca\u2010Arenz (2005).pdf"}, "b7fe84a7-6607-4614-9f23-657b3dcaf70b": {"doc_hash": "84013b3cbe8b369b0ae339730b83e7381a5f6da1fdadac502ff91e0a27681476", "ref_doc_id": "ca\u2010Arenz (2005).pdf"}, "218b15e3-5b0a-45fe-8a69-e768faff6d4f": {"doc_hash": "f03b5c4bb30a109bc210dee97f6c26dbaef7fe8d0ee3da6ba3521001d039a7ae", "ref_doc_id": "ca\u2010Arenz (2005).pdf"}, "bf44dac5-4ebb-4605-9ca5-50e4fb922b93": {"doc_hash": "a4d5c00df8b48b9dbb2b290c22b52e9e69dd7f8dd7c444736743dc75ee0ecc32", "ref_doc_id": "ba\u2010Hungerford (2014).pdf"}, "5dcf5578-a39a-4cb6-acf1-6cf1b2d736c9": {"doc_hash": "256beb689e4ee2a987490eebe72eb6444ef7e6ced2365aa4d208a58b7b439c60", "ref_doc_id": "ba\u2010Hungerford (2014).pdf"}, "56eeed07-6e02-4dad-8928-5fb8db76abbc": {"doc_hash": "a40e99b8dd6c6c467a5de945f34a05c823f6146f2c22b8398b6b5af8bfcdf276", "ref_doc_id": "ba\u2010Hungerford (2014).pdf"}, "134513ea-b471-4d90-9124-72539314d3b2": {"doc_hash": "5dc78fd85ee13e0856b5c07d557b70d388b2e318eb397b031eb5abb2e3bb9944", "ref_doc_id": "ba\u2010Hungerford (2014).pdf"}, "72fee3fd-8000-408b-b5cd-132e6b072d63": {"doc_hash": "a9bdc7f614808d770b042ff58799f7fabe56ff3ae181663ad7a16ed2551a0ff4", "ref_doc_id": "ba\u2010Hungerford (2014).pdf"}, "bbd96f11-c650-427f-a176-8968ecfd6256": {"doc_hash": "fba9ca8f1db53387203db26965d897f5cb721b6bfb3baa108d52ceabc51b2cc6", "ref_doc_id": "ba\u2010Hungerford (2014).pdf"}, "919f383b-0b84-41a3-a2ab-34ea9c85480f": {"doc_hash": "d66e0dc5127a1ecc84349259d087af8aafb4a9edb67e8d41e5f7b5e49f7417c1", "ref_doc_id": "ba\u2010Hungerford (2014).pdf"}, "1d48c3f9-98c3-4f1c-b00f-82eaa3ec5c62": {"doc_hash": "0367b078e57c741cf250b29146ef65a8fd5b0601737d943698c43934c3379950", "ref_doc_id": "ba\u2010Hungerford (2014).pdf"}, "42d785e8-085d-4345-baee-d02b9e4f1bb9": {"doc_hash": "07d7c4753fde113260b64bf84bcbe149facc640e771dd247c615fba316edc449", "ref_doc_id": "ba\u2010Hungerford (2014).pdf"}, "5d3bfec2-5b71-4765-a2b0-c7ddcd62b72d": {"doc_hash": "54f34f3d829bb49f7e810c86f92c5475648a8072e9bb98c388a79ae22156c518", "ref_doc_id": "ba\u2010Hungerford (2014).pdf"}, "3804c975-701b-4618-8e08-551b81157a58": {"doc_hash": "6453a5f8ef41876ce94818fe4beadfafb46b04bc021e6a7ef8639b53acd22148", "ref_doc_id": "ba\u2010Hungerford (2014).pdf"}, "17b5a8b3-1598-4065-bcd3-763b96fc7967": {"doc_hash": "a41d5a75ccd0bb6c748e44c106f69e681969d6c743f1b0a3d9eef159ac2773dd", "ref_doc_id": "ba\u2010Hungerford (2014).pdf"}, "3e0f98b4-e9e0-4a2d-b10e-d9cc2e57c8e2": {"doc_hash": "cd69ff8f969228be174fbfa4c53310385ef1311f6fee0251cb34a1ebbbab20d1", "ref_doc_id": "ba\u2010Hungerford (2014).pdf"}, "fe384b07-e257-40c0-9b64-51b321179104": {"doc_hash": "e654c3daa5ba12ac7e318fcb1b05e09151471d9ac0dcd39eff42077dbb467112", "ref_doc_id": "ba\u2010Hungerford (2014).pdf"}, "d15e755d-2f8a-4d76-960a-7cdfd366f768": {"doc_hash": "d6ee12d85551d4a0506c87b8645446a0bbb2a155ead2c14867179e20a895f28e", "ref_doc_id": "ba\u2010Hungerford (2014).pdf"}, "92239001-9bd2-4976-9234-ce57245bee53": {"doc_hash": "8c1062b0453670001bfe22764e439f1a77c17ce4e37a1b526661f2cef0d9ba0a", "ref_doc_id": "ba\u2010Hungerford (2014).pdf"}, "89a3dc0c-a05e-4c99-a895-af0b483f0de4": {"doc_hash": "169450305b365246fa207dad3cd9bf1a23184d2cc1dcdb4837389ad3be469e67", "ref_doc_id": "aa-Povey (2019).pdf"}, "820ee6ce-6632-495e-9e65-51f2dca8bd47": {"doc_hash": "c1239054d9468bc90857c3cb5be79f34dc58adc1f886593ce1f9c38d263238f6", "ref_doc_id": "aa-Povey (2019).pdf"}, "414314c9-27c0-4f37-afca-9781873930d7": {"doc_hash": "76e72accb346333c8089fc52d5f23dc26b78b329f56572524f887e349643647c", "ref_doc_id": "aa-Povey (2019).pdf"}, "76711df1-632e-4048-97f1-545d4d5bf743": {"doc_hash": "6d9c2dd5ac725eb81c2c51aecdcfe3e2fa8912a0cdd0ad8e86f424d39c904a03", "ref_doc_id": "aa-Povey (2019).pdf"}, "22185fb8-05a9-4c9c-a06c-17bb9d01e683": {"doc_hash": "03ab31b6f69dcef72ba52c0090bb061148a082d1eea06491d695bf447efcee16", "ref_doc_id": "aa-Povey (2019).pdf"}, "1bbc4280-b997-499d-bc46-d6d350230ee6": {"doc_hash": "a0e70099ff3c67a409d4230728ec9fca7833bd3de7f964d80d01898538d75c77", "ref_doc_id": "aa-Povey (2019).pdf"}, "eb35fe5a-e72c-46af-a5a9-4609a133ecbc": {"doc_hash": "bc0d339014fc0601c2995f926911bf35903e122120af0388d6396f56ce8bd8ec", "ref_doc_id": "aa-Povey (2019).pdf"}, "19db6951-bdb0-47f2-a7ad-92ea1cdf72c5": {"doc_hash": "fa8d80035a3ff1761abbd04c569d3d5dc8d9d9ad6997a01f44ad9b33d92c21a9", "ref_doc_id": "aa-Povey (2019).pdf"}, "d81ee5c9-81a1-46a0-98bf-bc901a50a9ff": {"doc_hash": "e063b2c46f554b4e5100e8ac2d91b883def3bf0a7c31425ea44de8edef60b0fe", "ref_doc_id": "aa-Povey (2019).pdf"}, "e935b5e7-10d0-43f2-b425-7eb98d07abde": {"doc_hash": "3ae25d6226c303c199a0677b1d3c2e4bb8deedb1187e5a27270b583242b0d67e", "ref_doc_id": "aa-Povey (2019).pdf"}, "6643e548-cc27-4f37-b1f2-a3f7322dbbab": {"doc_hash": "845353830c8ef4d1b47d967bc3e66199cf198f9739a53a3a2ceb4aec43a58127", "ref_doc_id": "aa-Povey (2019).pdf"}, "0b4a3aab-a887-4043-846d-cfb4d23753c9": {"doc_hash": "eaf56afd3f2bfbbd68ef0b446c85679942576844b195cd8360d0173dab6c09a2", "ref_doc_id": "aa-Povey (2019).pdf"}, "30a904ed-8315-44b0-8102-b83596246498": {"doc_hash": "b77df6cedab068737b961e973bd09acad0275ddd40ddacf19eca727d9d8378e8", "ref_doc_id": "aa-Povey (2019).pdf"}, "15c64ba2-1b8c-41ff-b8c3-5c91b8e54d02": {"doc_hash": "5128152a30e6987b43d3f61c31bf46986ffa751af8d02323880680340838ec29", "ref_doc_id": "aa-Povey (2019).pdf"}, "138d72bb-e583-4bd3-b568-db5f4bf90183": {"doc_hash": "a24b770e43ebf2ba0e348d93b8fea755eb27a344c888e5062d9021464d574817", "ref_doc_id": "aa-Povey (2019).pdf"}, "f208f906-3b05-4c46-baaa-57e87bc24eaa": {"doc_hash": "f14f0972e6d2362c401448ae4100bc58fcc23c6e22f73053b0b9dbd0f1ba834f", "ref_doc_id": "aa-Povey (2019).pdf"}, "b9e6b753-9284-4930-bccc-4c4c0696a6bd": {"doc_hash": "ca7fa6543533aae6025983211f83764adad3fb9b4c05469de67e6a5080394c62", "ref_doc_id": "aa-Povey (2019).pdf"}, "67f5848a-c0d4-4474-be54-040dea62f499": {"doc_hash": "4665da590806d4c49a190f70db83e95b30f9cd60e54facb466e58f6a1d9c3dc5", "ref_doc_id": "aa-Povey (2019).pdf"}, "27b564f2-d9b4-449f-a5f7-e2ff581be6bb": {"doc_hash": "5479e108fadb42f565395dde23afbbdf8f1b6df43cbf3749e5bd04f8f9294ba2", "ref_doc_id": "aa-Povey (2019).pdf"}, "8094eb9b-2bd0-4fc0-91ad-74fbb59a638d": {"doc_hash": "b03574b218a7ee0f372a575422d45a2403fa12d92878bd66dfaf3fcefdb78a2d", "ref_doc_id": "aa-Povey (2019).pdf"}, "772b2b5b-0ee2-4839-a5b7-f3f2d3137e2e": {"doc_hash": "6bf5e92d93e5d50c57fbe7d757bbd5bef61ccb38982985db63bafcd02aad8629", "ref_doc_id": "aa-Povey (2019).pdf"}, "3601d46b-fcea-452c-bd71-65c48f9597c8": {"doc_hash": "0c5512eac548e8fd6cf25696418e1afdf489022a307003f0f7f0d5ed3b2f72a8", "ref_doc_id": "aa-Povey (2019).pdf"}, "574c1c82-5777-434f-8934-72f2ac04af9e": {"doc_hash": "dbe2eea8ce061198bb1a01f80ba906b585313e5fc67490f9ec9cde0e03e07f6e", "ref_doc_id": "aa-Povey (2019).pdf"}, "312f4e06-d476-45ae-a3e2-9d69a46d327e": {"doc_hash": "dd7852d1c5b7d1d93d110965319e174353689c7c76c8f167d5c10a04778d1466", "ref_doc_id": "aa-Povey (2019).pdf"}, "0006ca69-d207-425d-9be0-40f74536c40e": {"doc_hash": "707f80af871e8ca451ee8374236c2890d11bc6cecf13d3aacc505841e821cea9", "ref_doc_id": "aa-Povey (2019).pdf"}, "721c97ba-e2ff-4957-bad4-2f335c5a82e8": {"doc_hash": "3557437e1df4e48e39ae11d4871a46dcc9cab0c955118ae677e1d925a31e7dee", "ref_doc_id": "aa-Povey (2019).pdf"}, "44f156d0-51c8-4d16-ae43-4aace24b76e5": {"doc_hash": "d1d3dde90ee9d7acb76af93958516d23bd3579091cf7d0ac326bb818722ff6c6", "ref_doc_id": "aa-Povey (2019).pdf"}, "c4b5515f-3098-423b-900f-ace51384fa19": {"doc_hash": "4b20b350041f30ab94610cf006a69b49d335fefb91adb6fe40c10f518e5bb78f", "ref_doc_id": "aa-Povey (2019).pdf"}, "3dfe8ff5-6622-4291-a249-f8b3e131fb9d": {"doc_hash": "bcc0e7131233559c6147a7cd55a8ff6cfd935848ff8ab4a3a03b1d3db50fc6de", "ref_doc_id": "aa-Povey (2019).pdf"}, "e9b2edeb-158e-4702-9878-3fc98d7b66e4": {"doc_hash": "064e038eb372ad4883e06453d055197bcd0f7985b8d244dd169e56a090abfa9a", "ref_doc_id": "aa-Povey (2019).pdf"}, "a3c7c0a4-d715-4f9a-98c2-7706987d5ff7": {"doc_hash": "f22c2676c554d6546adf43615f03b33c5d58499e7491a2272ddf82f5d95f8d57", "ref_doc_id": "aa-Povey (2019).pdf"}, "1e005c00-f3e2-4b13-a3f0-7d27b8779c58": {"doc_hash": "7d9c8277d85d5aa5785287ae53cc9690afbebeca8100b3bb2e3d643ef500681b", "ref_doc_id": "aa-Povey (2019).pdf"}, "95d1f976-44cb-4e4e-bb2c-5f3e6221bd42": {"doc_hash": "5fbae4636fab3395f91be4aaaa82af61c205dee741ad30a0e5e3948588cd978f", "ref_doc_id": "aa-Povey (2019).pdf"}, "b5a96e81-fd0f-48ce-9f9b-b6fd9493c809": {"doc_hash": "ce360564452e329d5a9c59ae6b6588cc4c60dc0f090c6a74fecc7fbe40658707", "ref_doc_id": "aa-Povey (2019).pdf"}, "dd5749fd-6293-4960-89a1-e571b7dbaa3c": {"doc_hash": "c3965384bd76dc2621d6d2033654a18b3eeae743baf04b6e7ddbc81ff444dfae", "ref_doc_id": "aa-Povey (2019).pdf"}, "39b37a7c-7070-4149-adfc-225c8dbd2c03": {"doc_hash": "20bbd28389afbccbf1c13e554d2a106603499c37bf07098a45b5ad51bec06afc", "ref_doc_id": "aa-Povey (2019).pdf"}, "5777a53d-6489-46d9-9239-9e116196a259": {"doc_hash": "56c96b3bdc0acdc762dae3b515387210e9ab08e1875c9939ba46a0dbb7072e73", "ref_doc_id": "aa-Povey (2019).pdf"}, "647246f9-711e-424b-8675-b14f8ee040a4": {"doc_hash": "01f481fa400596e6dfe9f2127384fe1f0c7e6d0e415ea9a948822ad160f02a13", "ref_doc_id": "aa-Povey (2019).pdf"}, "9861027e-8bd2-45b8-a02d-a7ddf35a2e7a": {"doc_hash": "fbaeb6bd66db6fca19f05b0d4d0cf4579d0d5065402afc77f0495127b97baf86", "ref_doc_id": "aa-Povey (2019).pdf"}, "565a0f89-7dca-44e3-9190-dd2f0ae3708c": {"doc_hash": "b210042237475d663d570a0b9637e8c8a60830fbf156c813e48993630a58c387", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "c1f4ce2e-0d71-4329-a846-e4d4aa7b7c3c": {"doc_hash": "84ecbbd476c294889262eafaeb0a8db82b1677f8133183b0b61b1b9818e9ba59", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "5ef2dc49-ac1e-470e-97db-68baa3761b9e": {"doc_hash": "440f2873ff03366e0f30138c98b3428e148df095c87d09f4aa2b15af7c87ac73", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "ee92081b-0fc2-4319-9a3a-0762d9a77df1": {"doc_hash": "de836daceba4b9594c5b54b5e6edcc0720dc2251468c648d63ee02f7568048c9", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "5b09f1d5-6a37-4ab1-9831-0dc9580b20bd": {"doc_hash": "72a497389e2232e3423c6a0bdf61a224afb4b6f826bb9ce385b14345af748d21", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "a090bae2-6e6b-479f-a252-8a00bfc85dc9": {"doc_hash": "1240f4b6312a274964fc8ca85d4fd8b08693fac3c9e8084316e4dc830c003e12", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "1c17262d-58b2-4838-8717-46fe90a7c9d0": {"doc_hash": "4e4c0edebaf46c317b6f958e3ebabc0784b832e8dd359c396fc45a1b64186e20", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "9bb79566-e4f4-4614-a454-84545d6a1493": {"doc_hash": "b77e8935074b3b6acece11d60cb81f7514f1e2be057ff2b0a558fbad7656d071", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "68e975fa-6982-401c-a7a6-9acf1366de01": {"doc_hash": "ea6ee459f9b5b2cbdb3fa7c3f0b4eead2eaf23772dab61bc0073e636f8bd4dea", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "252ec247-3290-4361-9688-3df0ae02c986": {"doc_hash": "e45f6bb2d73bddf12559f8693540450db0d6fe2950a021d320383e08e2dcd744", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "315e93d3-e8c1-4982-b3e4-411b20568e92": {"doc_hash": "2e04ba075965ca1283c112dad6e43c9b8eaadb14f1d456d54d505069fd2f50d3", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "a38ae011-abd5-448e-bf01-18afa421570f": {"doc_hash": "f7e7e15bce3d95c2c37cbc29b52f89f6a5ae4367b242c0654454af68783603c1", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "362d480b-a168-4fc7-973c-bb3292d77dc5": {"doc_hash": "76d012e548fb1c3b0a094ad2f73fde90ecd7cd372f915c296a74b1dde2c6f86b", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "cb47377d-d18b-42d9-9df7-871b1d9fd4cf": {"doc_hash": "c654ff6ee58fc9cd26b3319098cbacf83795a36d39420dc9e78bd3d0832c50f9", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "7889789b-8ac8-4f0a-9195-61c9f89f5ba9": {"doc_hash": "37a0fb94413b34667ecabb512c02d140e30b2458a2fd8bec11a29db2aeb0176b", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "f7eaa3e7-44d8-4489-a604-25a581d7c64a": {"doc_hash": "c90715fdf78c2e3d09ae9f8784c80b0e6060bfad3670e84ea0ed768e77cbeaf1", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "3b9a86e9-005c-468b-a813-2cc627b41550": {"doc_hash": "517b562974d6233450fb1a221f1fa2de9ca5b904688ed506bda4c5fa8455e085", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "64a7dc35-d954-4ce6-8fa3-30ecfa46c2f9": {"doc_hash": "c301baae8ccbbe6203548a4db5468004ba9a232455e4cab39879f778c1a69be2", "ref_doc_id": "ba\u2010Fu (2013).pdf"}, "336a2dff-f095-470d-918c-f80a901ddb0d": {"doc_hash": "7898a204e748127524295831c45c9fd02be18b69786b9c00ac6176ca3cdd4b55", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "e7112721-1998-4089-bd06-7153b55dbe0b": {"doc_hash": "ae611ca1a839ca7235ba9c764c50cae6ab8e82f8e656961acab15d5dd262e40d", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "62ca3026-9bbf-41b0-aa62-caef9da8ff81": {"doc_hash": "683a9e2478b37173506e2fcd0ad933900667982dd86a2dc948fb77b99493272a", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "b684e8a2-c8fb-4df2-8c71-d22fbf715ee4": {"doc_hash": "a514f7346646c06f0499a429bb70835c12e9626f5997259a8dac94df5a027cb3", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "f395342a-cb76-4bb6-a0a9-c204e3487571": {"doc_hash": "85008d478b8420deb4a70e608cb400cff218ebf4c5719d6f2519c80c2da8c174", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "063ba50f-4c8b-4d5f-94db-e193735ae62c": {"doc_hash": "8f7f2524dfbb801e2573553d211e8a85b9b5f2b76aa592152f2cb03798808005", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "cac686cb-52c0-4fb2-9013-596c2381201b": {"doc_hash": "e6d5962c3cf83f6fa7373eaeb36a77d0cdcab360e8b56ad64339a9f9b0efec53", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "7f0a0007-f933-4723-b21c-7e54803771af": {"doc_hash": "670bc9c26a6431de8f683cdf11be51d932ae9f730369f7d16cb4b54c207b631d", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "8eb15c5b-ac89-48e2-ab04-d63a408c3300": {"doc_hash": "d351d8bc704351fc7306ff746f23dfebe2ff9add70e145721587836ea881be86", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "750bd2e6-734c-4c49-889a-e856fbe1573f": {"doc_hash": "cffdef5186e496771561c887e7b51d5c9480c1d6b037a86b8af79a8fc22554b3", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "9cbf00fc-c3de-46ed-ac44-19de2fed978d": {"doc_hash": "113dc854f60ab4f885ece52a85d3bf553fb60a28de202e97802f41b7b945444a", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "76640b05-437d-4c5e-ad65-3459aa81188e": {"doc_hash": "feb145cb0334628d9697491b214703b7ab55d0717e0a02f08c0d5207d5bcf3dc", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "3299e4e9-3225-47c6-9555-8ebbcdf9d032": {"doc_hash": "365b9b85c5d09c87ea302a9806eab113782c09e982a44705713ae0379f905df2", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "017508ae-7d25-4ebb-8909-e7503bf872fb": {"doc_hash": "a0759d3feeea6681b16d9caa278eb697ba885e0fb38118cefca401d104ef340e", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "3f5e83a9-5cc6-48b5-80e0-9d5893fdd423": {"doc_hash": "3a45187e15b904db020bd0396d44b3909b951402fb46cae7da87c6f6b8e77129", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "005b2222-49ff-4b69-a0b8-974cef38001f": {"doc_hash": "ce2a610b90d5003f19b32429b523cac4796d2d1949039d04b392a5151f5f38f4", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "a8072cee-8df3-4a9a-956e-770eb686fa3f": {"doc_hash": "9f888633b2b560d4af15ffbc84a57067a31ca128ddd4ca36cb02b2e1fb8fdf67", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "a75922f5-2197-49db-beb7-6a9728804ec4": {"doc_hash": "4db0b32c0f541218ab75b4059d3cbfc31c4fb1a4f9c21cd0a1bbb1f64aa361c8", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "f26fbf1e-4334-4aff-8edf-89c057639c1e": {"doc_hash": "5f713b54cc6e179042f1e967049d615e43bf0d9bbfe9371a264d96d819e95db2", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "9fe87c3b-34e0-4267-ac75-bca1be82f3ef": {"doc_hash": "51bd3e19dc8972051a10c7e1824a4bd7c1033ca4af3098c7c4a426d9c6cb7ba8", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "fefc6bd8-9070-423d-98bd-5812948f31c3": {"doc_hash": "254efd47f0dee581eea23d63da46bc9677e2c1a92e0aa761e74f7875df82ccb8", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "1e128941-05a6-4b66-979c-aecd0e1fe41a": {"doc_hash": "b57911ea8a73b198aa024f42610e9586da404a58fe7ac530cc448a8a052e3522", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "e94a0253-4e50-4245-bccf-c148e27e9272": {"doc_hash": "57c2fa41c02bde9f2a8c1c0abbbf0490c445f37aef68d705fdde59f2f14fb450", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "bf99d17f-2b4d-4c76-aa8a-e741cc557fc6": {"doc_hash": "b0563cc6907e3e9ba69996b2d794a0fea12d793de4021b3694790709c745cffd", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "f9f16392-9d9d-4cea-9550-a212f171934d": {"doc_hash": "c346bf981be936ff0499531ee8a86cfe4128c3b9b1315bccb79a1ae24f26e780", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "aeea1d91-69e2-49ca-89f0-9a79be8a02df": {"doc_hash": "c0c157df89c954f9e5897eb852e2f23b7d96abe895295dfd685012930f6b6947", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "f17d2dfa-e141-4339-9e5a-16b555dda23f": {"doc_hash": "d10d9ddbb9b0c4f125ceaac880c49fbd66017cee4440e964c6b02bf7d7b93894", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "cbf91903-648b-4d14-8767-95b0ed1f30fc": {"doc_hash": "33c69c0223363bbce3d5b2e45225f99d2ac4a79e45313729302561f718a95129", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "6e54aa62-8012-4810-ac2e-9923970b0303": {"doc_hash": "79a7712af069ae7b105fcf55b0328033de2d7573629acc82831aa0969903f9b2", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "2e3696a3-945f-4702-a472-cba14f5a0386": {"doc_hash": "942a481a1dbfac0efefc521a5a54fa253dbd0af6dede836943270b358a7e4baf", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "7976d0b0-a8c0-4895-a654-cad16a2d2963": {"doc_hash": "cae42475bacd92bcff4af0c4140d7a539939580a74556489130ce3a45437cdf2", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "cfea8252-58e1-4f33-b15e-3a958c98cb89": {"doc_hash": "d57b50a4d86e465b84efeb3b6b38eaa7246db2680fb4402778bb470363db9008", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "7dda4f6f-aecc-4a91-afba-69e4eb9d40ea": {"doc_hash": "434aea9a83360fe654017485805dc30438008609ba2f0ce28330421439413251", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "010487cc-7533-4da5-9ff1-7843f9bd5418": {"doc_hash": "f72ba68002096bf7c60cff44a35c4ce6b126a3f526ba0dcb0f18b5b68cac8733", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "65f325f7-d90b-441e-b261-718065c75f71": {"doc_hash": "fc3e4b2c14c838b4443d2b27ebeeea25ed1e1eeb6696eece65266923b3645dee", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "7226f582-afc1-4584-9bee-cfae5a8eabd9": {"doc_hash": "89a8406592313d55a52f5b74da2986b4ac6cae51c17e5d2ed53627c181cfee44", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "b0e178f2-554d-43a4-b735-9453c48e504d": {"doc_hash": "3fb4ebe6ca30cbad5ba4d6aa373acff9e1a042f5f7b54c063ea7529fafb7e3be", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "bfa140c4-b783-46a7-96b5-032dec822d0e": {"doc_hash": "07a752f9321a931a12781c76ba10c0b29cc352a18107abffe3081ffeeef36a9b", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "90793003-2125-4b3e-b7e4-ff83187e3f71": {"doc_hash": "c20ece4a5aeb4ef6cd892858caab468fbd26dd89db7e371eac466b0ce6f76ddb", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "04cf5f7c-0ecc-4717-ba04-9e36bbf0ca56": {"doc_hash": "3760f32f98145dc11dac83d4cebb0b127b6c5d32b7761a19727f9f4b6c15b7eb", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "58abcfc5-76b1-469e-96ef-5db5b88da877": {"doc_hash": "b3024f10193eb3d2cc6eaa3bbabdbe0873ad3cc691bbcfb6c79cc7383aab5f96", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "f7b43ade-f895-4ce4-b93a-454812482efa": {"doc_hash": "d86d9ba7fb7d76e59ccafee2d7db4283570564df6b2b9fa170fe2d333f0ee5cc", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "0e9ad171-c0e2-469a-a5d4-de72034394ff": {"doc_hash": "e278d7aaa09d9afc9d82b68e289e4792b0fd1a5d02a07cdcb23db4b332f3f514", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "b291777f-e52e-4b45-98f2-646111d0f2a4": {"doc_hash": "0b0c2a8336ec5ad5f7cf23c4b1f77e63bc6cd975afe16ccdb59934df37631a11", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "c3a16389-9142-4a7c-9eb5-f23a4e0327f6": {"doc_hash": "2434e899ccff73427eb914451e6a717e2d9b3a942c2862d035c9ddcc65dd9d21", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "72568c19-694f-43db-9a84-13aad5ec06aa": {"doc_hash": "7fbc00f0197ae896c842c86719ce949abf5a6843d5d7999954ef58f1512b346d", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "a68a07c1-e623-4461-950a-b8aa56f4b86b": {"doc_hash": "240ddc7811bdcbdc2b864e40d3fdb36e6899b3af0538a23e2984fd55870e9826", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "3af8dac1-4efa-4d56-92a0-07d09c0c251e": {"doc_hash": "e30359d393d8261bd748fa41a404149370c8c07f77ffc18cb799ac3ace2451db", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "53918863-ac91-4ab4-868f-63299207b8e5": {"doc_hash": "22f389e449261ca7f083f1717c2ace7b150a4930a476fcf8d5f77edaa714343d", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "7829125f-c088-4528-b0b2-3e08bdbde32b": {"doc_hash": "ca929c37da0642c914e3b8ab86b9c8e9a5cd1fb21d39e3ba2454df33d571d25e", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "d7cd0926-af40-4319-abf9-069dec1c1e63": {"doc_hash": "6565f02e53e2b4c733dc3fc89179509286acbde1a4cab144be2cd4968ee9c5b8", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "0bd6e078-2409-406a-89b8-9b0accf2d572": {"doc_hash": "8a10da48e78695f5f347d7c15a42a4ec57c8aeeab7ece1b9d823982f3f3b340f", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "362d0b02-5582-4a61-a71e-09c19c1a5d8a": {"doc_hash": "1e9bb8dacd61ee07408bfddd3cfb30a5cdcd953adc9d9bc8306ac14678a9b6d6", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "244411a3-6069-4ccf-becc-8bf8dc4f4b33": {"doc_hash": "6d6f6687b921e8a4c5b49fbc794cd603aec03849d7405fdbdd06409503f892b3", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "cf7cbe5c-9bed-4bbb-ac81-ac5eb935dcdb": {"doc_hash": "43d2bdf7bfe5c4d8982350e942d28c414b8d75c1c9758d4c4a8513f03f55fc9b", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "8e376cd9-10b4-437c-b262-9930e2a86fa5": {"doc_hash": "ca08d667852075367b2f7d7a2c18a9742ca354a4e6b27cc6572d3e90f09eed0d", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "5d88b57e-c986-4784-bf23-f304ce37956b": {"doc_hash": "07cbbd03d2bbe1c53a821eb7752e7952ba6988c9cc15c86c828f6fa942abaaf2", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "25235517-f483-48c0-9d7d-46698a83e2cf": {"doc_hash": "109f870199b655425e06b2eeb732472ab5d99a21e7990624681b7b68d9f54941", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "116ea4b1-65a0-4515-a085-007f81ba24eb": {"doc_hash": "ba6fdcccd5a3369320a4087e575166e3c27c8358c614220043d81e2b7a8547e4", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "bb103203-5e65-4890-873c-3e51d251d60c": {"doc_hash": "258100c26b90d2c713c9df9b27d28e724aed95a6b9f18fec2b4db4db181fc0c5", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "08dff1b6-842b-4cae-9add-8c732d4ed927": {"doc_hash": "d1eaa9c01fde39110669ba7a5e1ccd8a0847c966418a20f4067c7924f1255c1d", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "a685a6cb-6ece-4fcf-816c-58abc7abdd5f": {"doc_hash": "bdaea89e67ee1d8da9799403b1d33ea1ba175f9d27401212c928797e3a56bfe5", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "4bbf79df-935f-4863-b56a-b56bc0bd23d5": {"doc_hash": "bc2504758dc853dc926c72cfc01c281e165321a2ad9215f3ed2596cb56abc8bc", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "a897154a-5afb-4c98-9331-ff5ef84c29b9": {"doc_hash": "1a05eaa350076a7089d6e66c638a1b83bca8181e543bd2d25de014a63440d356", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "8183e9a7-fd32-41cb-9529-e209638dc35b": {"doc_hash": "f1d5edacbedb503114f68b09b00e44c7538ba1198860408a49e5e0c4cf31f4e2", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "7a03d6e5-bba7-4e30-8d6f-7bb6f4358294": {"doc_hash": "25fba9eabb95ca5d3b4fb8b12c613ff69f4236a34a7c54aa6159141ddca7ff79", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "dbdfae55-6495-48a3-a856-6d2fc03c0933": {"doc_hash": "d7d6fa7445e9fcaa983d161800ebceea7207e659ba84dbc370e77b3cba128cd4", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "ed0565ce-6e7d-4007-a786-8ea9043b7ada": {"doc_hash": "f4da2487bc2da40d6f9a26310fee18322ffae2e4bf73df23b32574e550628da1", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "f81f869d-f5fd-475a-9f94-fac5815ee754": {"doc_hash": "09f6692d1d110d57174214b3fdf0823eae0d450affcc8a203aafbf62ced0f8f9", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "09ff906c-9ea2-4af0-bcb6-ab5aa794a625": {"doc_hash": "0118ed5d0d38450c96cab0d69db39b9c67b6d9d90d9f67eb16d0c092a84d7481", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "636f9c2d-f4f9-4fcc-b858-4cea92cb88ee": {"doc_hash": "bce0e155f174351076ba27066ed024101543172ee7e71bcb7f80c291bddd0c9d", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "1e36c378-e5a2-4bd9-a0b2-17a9c39928cf": {"doc_hash": "a5909896b9bae40140f04b42875f8e9eb17671b6ce959b0670d0742f1eb1c937", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "7c8921c6-2779-4795-a0ae-ffac15e47ddc": {"doc_hash": "4637a90f2e1190733522a1fd17fac9fb22fd74a022a4b7a7a9841fdbe06ee574", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "aa50192b-7db7-492f-b9f5-6864c82b1478": {"doc_hash": "e1e99c12023f1b737a921addf2b5c9190dd614e35e4b657d8481ee40601c31fd", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "9c46b82c-1e58-4bd2-998b-436cd2341066": {"doc_hash": "635d3259ae538f0c22d2a37493fd6cb6f361935747109855425208bd49061aeb", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "0539b7db-b334-4885-a691-e88cd895947c": {"doc_hash": "33e9365276ad9e8da4ffbf3f79e80437187b744de7a2f8501cc764c0a0e8e92d", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "4193e1ee-80e2-463c-bfe0-ea650c12bac7": {"doc_hash": "ca4d8b2538f202e9253ffd228384ef7932bb5aa546767f6613e7275a2ff1d97a", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "00e1381f-59d3-4379-bd69-109d3a5ee133": {"doc_hash": "19bf3b19bb051c48e21604256b780b2aee1040b5ef9253375579d029e3e136de", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "bf043bf7-86cb-4460-8558-6c677fb11b94": {"doc_hash": "bbb270ab15a59ec2f2bc8b37f6bf550c7f8bdbda3f0c96ced0ba70c304d73030", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "ff986c92-9e65-477d-a594-dbc7415709e8": {"doc_hash": "ecec33d176613eddfdb82356fd33f75db9a9040b74ea81119500d97ac4f71d7f", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "167eccbd-3441-4069-8140-6854b20eb828": {"doc_hash": "8148cc290459b0e7d45e6d4f37a9269ecc6d6e41d85bab3e7c77f19f2fa832af", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "94bebd31-1a95-49d7-b6bd-c5d2343a4ba8": {"doc_hash": "a1e406228b9522080c8e35c50dcd6af68bf136848d5065aac18dcac9257d9b6a", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "4c3456d4-458f-49db-b4cf-6ba2b7f2e5f0": {"doc_hash": "7f0972230730db26dc6cc2394524c4b0c69913226e192c6c31414cc8f3decda6", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "8fe1853e-f70c-402e-a702-170e9074102b": {"doc_hash": "22fc34db0caa2ace791ae28add4c398b7bedf58131a3f78ed5bc8a626b55c090", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "6a7ce95c-2954-417c-a3c4-27b26f4792b5": {"doc_hash": "7b3534d02a75522eb8dbd3e90b96620abb8cc5ffd933b8160a5abef09c12f9ce", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "af4c2be1-fa65-4fd2-a07d-ac9db7b47892": {"doc_hash": "13c765812de6706f8ef1f8e8540995043c80a183d9a24ee6d717d844a098511b", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "d597a028-460f-432c-9a4f-9a66f724436a": {"doc_hash": "26369c85699774399458a9d3d6b0e68c0e409f9aa888b981462c79b357c5b9cb", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "819e1d8d-8ed8-48be-bb06-bdbc8edcbc6c": {"doc_hash": "3300fc7907dfe02d87e8b16fcbb24895cb7bc168ad18e57be79110c6635aaa78", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "508500e1-1ea1-412f-a095-62b1f01deca4": {"doc_hash": "38fce237d2b9c0d7b45414d3e27283a960aedb8dd4e9b81beaabcc5e929cafe4", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "6077970c-c313-478a-b736-7650f267ddab": {"doc_hash": "43414de3bd19796355e166a3afc3a1fbfae88ad832669b0d28a7045f8f5e735b", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "fb83d31e-9562-4119-81f9-8db7b980e22e": {"doc_hash": "a94454c2e81d768a1ba92acae71c3dc977754991ee3f32e008a5647aaf4ff3ac", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "c06dfb23-174d-47b9-84cb-bb828007c283": {"doc_hash": "8fc9186f253e106cfede0563fd1141f854a43c26323ef2c61ec5e456bebfbbeb", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "68f8f166-652c-406f-ad51-b1d9c9dfa1cc": {"doc_hash": "f7bd80f839ef1791ed4bcec9363d1cb934361221ff438dbb1bc5e0c4b4c1feec", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "5f201471-3a10-42d7-af46-4057a07f3b48": {"doc_hash": "6a520d02ef4b207009b615422cc4298f5aa3102d901999f2d53a39428f821f2d", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "335b6cdb-4059-427e-ae65-c2ba572c1ef5": {"doc_hash": "c61b61b92e53bb42a51f5fc23e04f3bdca911a0cca46797505859f70eb1ae248", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "62a2ccb1-bb33-4d40-8d3b-1833bb10066d": {"doc_hash": "87761c1d4f9f682a09cc6b1dfb90aff9006d213b0abbeff96c6f80b4ed4dff16", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "7edd1f28-ad0c-4595-9eab-c732fa24cfdc": {"doc_hash": "edac517b32055940ee6a0e080c97f466cd41af782706ef2ca5b097141816d480", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "cc715502-62db-4c1d-b27d-a5527f4f8939": {"doc_hash": "73ee5922278b4da3a02da1852264a135ad7bd9a5ab69eb6ef2f564b28267922e", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "380ce340-aef2-4319-9240-fec32a041fc1": {"doc_hash": "ee55d9b56dcbae394101a4b0331a56240eb938472e986d3aaa47dd7023f1c26f", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "4679ab0c-0f7f-4433-9c1c-e71cd8acbeee": {"doc_hash": "132ccace1d527402346f286c831876471598be379f8f1e6e1dcd437d0fb78d68", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "4f69cb07-c9e9-418f-8855-174a293a8510": {"doc_hash": "7a810e0de5bc3cc9e4de56dbb8ee69677b6a9ee2c01ca7d030b81833963c433b", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "a4d6ac81-6820-4869-86e6-585be430da93": {"doc_hash": "7fc5626419201915b3910f56c0ec96176583fd8285394a14f91b01721fce4877", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "855e6e98-7546-4d29-aea1-4ae0226f064b": {"doc_hash": "962d90b6f7128007a670352476111a051de74685f398e05c105db214a1adacd0", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "f457cf3e-8a81-4f46-b10e-9fb9c001979a": {"doc_hash": "004aff287bf75a21d5b4752bb0f2fc6839788e3ccada93dad1665814e64fdb06", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "739a05d3-b0a3-43f8-b057-521aa40e78cc": {"doc_hash": "5d247eaf3b5d4238ad4e1904261ab55cbce5a6a0eb182a797ae874984ccdf579", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "9f4e8cc0-94ee-463e-997d-832bff087d39": {"doc_hash": "27f9847d44fb7c8e2f7e0e96c7764806e7f629d9db598da0a6b0fca937c43407", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "8931d05f-246c-4154-995b-07b0a6f271e8": {"doc_hash": "d19ccf4466d4fd14350b93f6ad6bd9a8742264d51654af92d0001d95904b588a", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "2b89af34-1ed7-4326-a5b0-5bb153ea520f": {"doc_hash": "4e5da79d4cab4637f01fffcd8a7c01fbfb07582424d6b568d9348cd4fa90cf06", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "c4765ca3-a839-4fa9-bc35-3c01b9cc3073": {"doc_hash": "f934b6c654a187763ab0fab5d4dd49d0c1a9aa029748bab7fe6e4fdb4781ad79", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "4cbf9ac3-ab48-4165-a89d-c7555b4e7446": {"doc_hash": "344204b70d7a6e4d9db929c8c24fd247f2f5ac4633762fc93a0be6ac297bcbd9", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "79843dae-a6d9-4690-878f-cbdef63af7a1": {"doc_hash": "b72763258ec5edabb4ac4889496da0b3451838c599e784b576b0a01350298727", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "bc3c35e5-2890-4602-ba07-65dd2f9ccb0d": {"doc_hash": "9fddffc392a79bc5feb4cea94fcfbdcf60a388029b4e39c4508fa06c5c472120", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "26d1b488-9f6d-4c8a-ad1e-9f06fa3840ae": {"doc_hash": "9560892796321667a1af1f7f43c998cdd0229c9fbc11d9fd44f53e1037a14702", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "907bf31d-0687-424d-b131-0dfc3bfd325d": {"doc_hash": "0ea8cb5d7817e535afd015047b22d09de4075c811d57fb83fa38ff1b7e18298a", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "3c57c996-8a6d-4fa5-9843-9afcb13f6374": {"doc_hash": "a0a8e76c88240f8eda4e095e42561620c85887b6a5d987ada9446ccd48086535", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "379fcc76-0a1d-47cc-9a41-7b78c2c9b20d": {"doc_hash": "c6b8ac8af853f37a49187dce5e389b33a8a82422fcf6d153c23e2d5a04e88688", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "61746eeb-1ef3-44d7-aa88-8eb557b8be36": {"doc_hash": "568536eece412f71af2d58c2eeec145f0d0da80ae2465a00f24e4e0f1a64d352", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "c9bc4260-2e24-459b-a18d-3d45eb6543bc": {"doc_hash": "b3158cfd2097980ce39b8aa52860ecdce2d5978cb1c2d60c2f76b70f656bb766", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "410f96a7-7217-4e15-b144-0f420b7dc1d1": {"doc_hash": "d2e8521b9cf08a00883a04bdeb26d25aa302d2109d278d8d17edd7daba8b8c00", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "caceb118-5164-46bd-9853-69c59f6d4f89": {"doc_hash": "682b6a46032bd4483b5891e8e6be7a7788a07c8e6ef3b1f7ffd7015f73b7e34d", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "428f765c-c8a7-46e9-bc59-ed5686dabc78": {"doc_hash": "76e11fa64c695cb4360d6c6d082e6edc846d7b53bcebde627e28d7ce0aeea8e6", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "63bdd867-91ce-4ba8-9fe5-f4f423eb72bf": {"doc_hash": "a649b3d5ca3a8c2a1238877a548c010bf144271971e8911fa28d15ed5a85ce2c", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "1d9c56dd-2ca5-42eb-a625-8ad33037cb78": {"doc_hash": "557c1d226eb4b1e395f63aadb225daa2f49647f84249a59d28c62603fbd5a4e7", "ref_doc_id": "bb\u2010Groves (1999).pdf"}, "4dc7b960-9f02-4e4e-8f0e-0a09751433bf": {"doc_hash": "1db861282784e6af03cbf764ce77e5718b984b9eaa14d7d6b3aecdf6baefbac6", "ref_doc_id": "ba\u2010Jick (2010).pdf"}, "790d36ab-193d-45b9-a34b-210f0552ade3": {"doc_hash": "20feca2dbb2ec6a041e33e663122b60bcecd750ba52a60a69b4a6fb3aca68a98", "ref_doc_id": "ba\u2010Jick (2010).pdf"}, "91559628-532a-4c6c-873e-7d6f0d219255": {"doc_hash": "048096f84a81cff15d200c94cdff9f6c0a1910d9ce3e43c2833797d1f87b85ec", "ref_doc_id": "ba\u2010Jick (2010).pdf"}, "ba82de14-9be3-47df-9ecf-864c2aba1b11": {"doc_hash": "6bfd8104d65cf655b8a6d985adeceb515f35f27352ef768c2dabd3446fb33e23", "ref_doc_id": "ba\u2010Jick (2010).pdf"}, "ebb09f36-f957-4cf7-a635-c640fd6880a6": {"doc_hash": "8758ccbea12ab7c303c4e78a65ca9cf1adf2e6f8483179db536584ad04effaf6", "ref_doc_id": "ba\u2010Jick (2010).pdf"}, "fc67256b-7582-4a0e-9597-875cd9cfdde1": {"doc_hash": "65302d419bc30be718c90dc11851fe0870a2808002e3ddb371deb12406a4611c", "ref_doc_id": "ba\u2010Jick (2010).pdf"}, "900151d1-f6ba-47d7-8b61-36c343346649": {"doc_hash": "a7b37beae9ba819df98b21a93e6b8dbe856d3fea2d8074cc9f1dd61ab9885ec0", "ref_doc_id": "ba\u2010Jick (2010).pdf"}, "6333cd9f-b4a7-4408-ad35-0a1e69025805": {"doc_hash": "464832a86455d1eeef0575f86e73abda06c28a132768b1efc8db76334da03286", "ref_doc_id": "ba\u2010Jick (2010).pdf"}, "f2936b68-ff05-4aa6-b672-f621cc42baea": {"doc_hash": "7ada2175cb732d29c7566e0b6e52bd59f32c3fbd333be8337f8a52b238525926", "ref_doc_id": "ba\u2010Jick (2010).pdf"}, "53bc1c2a-8146-44e3-b62f-8149f13f8bf0": {"doc_hash": "a2016e46bc0aa63793db59625326cc30c74761f86ae8a484de48de6b4f6ba87b", "ref_doc_id": "ba\u2010Jick (2010).pdf"}, "67f04fde-5a4a-45da-b7e4-4412b45d1dd8": {"doc_hash": "fa4c0b31f955e410fa7196d147fbea92efc9d755d67b2d9e0a88875c452cb88e", "ref_doc_id": "ba\u2010Jick (2010).pdf"}, "d3396a26-d4bf-40fe-9cbf-c933e6cfd721": {"doc_hash": "c4acb0ca3cf70d3e982b2a7cf3dad3016cbfda34906268f19efb04ae5a4b65fe", "ref_doc_id": "ba\u2010Jick (2010).pdf"}, "a4a443df-0b10-4f52-9feb-f2c088aea3f4": {"doc_hash": "39134cbeb1a2a3b546dc2a2312d52716d904be4c6d15e2779cb84c2ec634f7e1", "ref_doc_id": "ba\u2010Jick (2010).pdf"}, "3b1c2460-663e-425b-a7f8-15d74313e1f4": {"doc_hash": "a0ff1f5a46ac7ccfb6d8a96897b85054e87a0c88bc4e91cda8ee3dbd95725619", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "8e2de78c-9c99-4304-84cc-6131f49f30b0": {"doc_hash": "2cd3241260ec5bbc47b93d6532a634a9056413feda56def36dad992ee37dc881", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "1424feb4-3ab0-41d6-84cd-892b8221924a": {"doc_hash": "67ab464f77c44aa10b6670b4e67073742c2f16e95bea976498b7d7efe6365a97", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "75f8ac7f-54a9-4567-9a1f-0c34106d6288": {"doc_hash": "d1ac89ca5d8e3972577c250f293713e56a1b1bb4492a709284c26ed00a9360ed", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "2e9b704d-71d0-4c22-b425-ff513062d441": {"doc_hash": "6ca5a7ea27744d5aeb92edf849494b3bddcc297654fba98ca945a2e81460464f", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "6daf9a60-6c79-489f-a49d-bd2c2f426e1d": {"doc_hash": "fc6449456c27708f211a43dd4f38fe43c011568134ae6e91b20c7a3835655987", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "74e95cc5-147e-40f4-8b1a-b02f2b97f802": {"doc_hash": "77622319afbe30b1e44883fa8993c1592e1609cb8c8a8ea3fc075be4ec604b11", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "cd71cb46-f3b4-4fda-a931-e23d785e7feb": {"doc_hash": "90cec27f16f7ee05554a96ba0904c19be4d29c1e3a5bff18005b01ee64ccafb7", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "7d555d1e-558e-4738-bfee-8802d583d842": {"doc_hash": "9513b89042f53ba3f074eb24a638fd6ce1ba1a9e852bde608e7786f3721301ca", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "50276873-cc5d-4cdb-9999-b5f6077f2ec3": {"doc_hash": "a9dd036c61c88d13ba8da1bde6198606a5ac50e48bc2a6ebd2bcad254d1bb3f8", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "b8574b00-fe65-4bda-a4c4-733ae5a840f3": {"doc_hash": "2eedc9c95f5d3d9cc36560d25ccc9f1b3cee0ebce735fc7656c8759311a4b5da", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "07543120-4219-4b7e-9108-ed3d2d811212": {"doc_hash": "dee137cf18cfe124c5d597316b8fcb13b903178d2417ada2ff704aef135c37b3", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "c7442915-99b0-48a4-a6b8-2135aba062fa": {"doc_hash": "60e3d817d4890e7dfac8a786aaceb3940cfac4c2e72b890c2ea73a3af83a36a8", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "223f15e6-a846-408a-882f-1c9f922c49a9": {"doc_hash": "77c118e4be6d59fda534e5ad2cdfa000daf3dd55c70819af0626fa201fc9c870", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "4d39accd-8b5f-4f39-af53-1ad82ba4daf5": {"doc_hash": "7c2df23d5b4a784cda28934416c129dfa8b1c3a924a646338aafabb9ed77cdac", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "091c868d-1be0-4e7b-87ce-c334273b69a2": {"doc_hash": "3794f343cb2e9cd0811aacdd43ddd6f9d2a20d75997792a92488683efd474836", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "468275b3-54e8-485f-aadf-8af1dabb7796": {"doc_hash": "d1f3c5b87d49c14ded8dd09b8277c708347279c2a6fc67f385a76da1e2f516a4", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "48ad5349-c079-41ae-920b-33f0757d3e22": {"doc_hash": "b3d0074f7db35da7bf33ffef9f042a6681193cfe2e1a9ae5e832efb6a7c16173", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "04f31a07-4857-4b9d-90ad-df5f4dbc847a": {"doc_hash": "5c41d9341e1a5d469714c6ae29ff29d8e4d80704b1b52713012dde25acb665ff", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "c5f3d955-7ee2-401d-9b24-e9e5f8410925": {"doc_hash": "f957f61194b891855ede15cc05be1c28766cec324682bb2b4b2957328c4bc12c", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "38a50485-dcc3-4c5f-af54-9a61c6c4fe8d": {"doc_hash": "3b8d1afec3ff62b50efe0f4f9b9a5e612b1648d482184a4de782fb398ba0ecc4", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "d868b87e-a6b0-44e9-a45a-5530b95bdea1": {"doc_hash": "183c82548480e6de931e8619579c21d70c36a83c573fa2e8c19c3cb06c05908d", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "49a066d9-8028-4bd4-ab9c-0666ef1ee872": {"doc_hash": "267ae4c640fc4eec15c7df168231f790783a3afeb27ce9a00c6b42746764e66a", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "99c21392-cbcb-4285-87b2-4945214051d4": {"doc_hash": "cd9e06252d491ab105fa75c3a4f5a2fec65b022625e417f98be6adda71b603dd", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "be353aa2-fc81-4e33-8909-a39d9f37a02e": {"doc_hash": "7ead09d72844dcfc3dc0ee3603c03932e038b3b6dc57f0c3d7b0b02349c18221", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "97f4e8be-4b41-4498-980c-d7351b0d9e2c": {"doc_hash": "cf4db85cb59bd173c3be5a320b0656d7d10b45ba24fc8cd095810c4ae1d0641e", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "4acb2b29-73f9-4160-a619-097bf52e6415": {"doc_hash": "a45d90f0976ab77028f768ecc57f40845f14732d403d1211407781127dc2165f", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "d1b4961a-ff94-44a0-9e7b-f94a8a5452e8": {"doc_hash": "3313490124cb79538a0c1d6db3a6ceafc3afc0cfc326c80fd78b113b4d42646d", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "adc27230-84d6-43a0-9266-79503f62d560": {"doc_hash": "883df4fc88a91ab633e85edd64b27179bb68b2c6c894e4f084c67faaa23538d2", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "e4980a8c-cee1-4640-8ee0-6c8e6e386b1f": {"doc_hash": "a72314141c3fae2d3eed4d4d922bef728d5b779da3432d54e35e195b516a6656", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "7a6652e6-e187-4e1c-99e0-b9392c4a888c": {"doc_hash": "ac8e897a9c4102144c409ebd0df9f979150362f9376987458c0617e6eb9166ea", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "4e7fc939-e0a9-4837-b316-ecf0cc15b050": {"doc_hash": "5bbb71b0bf55a4f3c5ed3fd93b79683f2290f151e2e628fea43b2d97462104fd", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "6a41fdd3-c90a-4b26-b022-2d8d16b65502": {"doc_hash": "cd7488c5086e6fed77678c5af536d9c0785df195ae89f591dafab2e10f292d47", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "d18a18df-30bd-42b2-ae96-037b030136fc": {"doc_hash": "60c37b058111cf59a90e86246c62b6bdb4919b4b9a19093574cd30c35bd4f8f9", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "9cb9ed12-98bf-42b9-975c-a74efb49499c": {"doc_hash": "4a29088003b5c1da5c95295f3711557fd6ebf8e50a331ca96a177703ef0321f1", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "37f61395-b41b-4b3c-9d10-4201951f2c48": {"doc_hash": "fee16a452b65468722ebbc49858202fb28e224bbbd55e48ce1a3e4e5d527e769", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "2568623e-3e73-470e-a5d1-0f04b1a13881": {"doc_hash": "13c037b7567fa981536391cad18ebdb7d50e4d84ad6c54b3b2510563240ab7da", "ref_doc_id": "ca\u2010Barrabeig (2011b).pdf"}, "67b3be09-6415-496a-9a26-5b2fc4361269": {"doc_hash": "091ea445572bb35c1fb08bb9f2ca476d5375adb762c0795a849be91ad26bc15f", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "9f958d35-9d3a-4603-8e4a-888305596bc7": {"doc_hash": "c6495bcf7b5f1c91318cdef51dd7614cbd6eb329eb2268c3f21f1fa377784f53", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "f7c7132b-4579-46f1-a0cb-51fb05484063": {"doc_hash": "ddb8cd803ddd9e5e3746fa60f79cb4942d50da508c5c782e871b1ffdaea19462", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "00d11e34-4c82-4454-a039-911cf7875890": {"doc_hash": "e627b6c680553230953af13d75c63c0c3d8507513962c52ba0214ac492c4a137", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "1badba83-9133-452c-9ee7-221d4c5e5ed6": {"doc_hash": "a61b56f213a1d9a610fdb93d47ec362ce8d3d89a22acb3639e3949ab0cb6014f", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "eb0c48d5-0d0a-4f4c-9c51-d2fa324bead1": {"doc_hash": "62954b7108a2c712c76d7f11d1c6ececf37c6e8a9ba23c121787537053f24102", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "89571ed3-a606-4d79-9fc6-3e49d91fec1c": {"doc_hash": "026166d49fb5256d9f8c30defc84cd65528f754bf3cfa7dadfb755a6fb7362cf", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "398d9d7e-33d1-42ce-9241-29f6750a3bd3": {"doc_hash": "2d97c2a70769d0b0b8317d93216201d64c9bd6735767647da447e429bc3a0d46", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "bab38f01-555b-4755-af85-dfc9450e051f": {"doc_hash": "d02825d13d688a8cc65f4c741e9280204c7ededee3f653603e649ba3c6d253af", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "10fbb794-0e81-4b09-b177-94887d4b939e": {"doc_hash": "7a3d0863bfed26101604300f038202b004e39ba231dc634db628066090ab3641", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "600247cd-0ace-4321-8d48-9b6e651f0eed": {"doc_hash": "616a16aa57cb0a02f47cc56618d7c29c9f7c4c429c2cf0627d3900e1c3317c09", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "b0ec85cf-4421-40b3-babe-65da48ce16f0": {"doc_hash": "8a16a5c25cdc809670989d7f0350da4cefe362a167d0d2a9c8c15fa4bef21cb0", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "5341445d-cbfa-43cf-97ac-b8602f78b153": {"doc_hash": "051b27e43c67a34f1c639bb5761a6b5c3678ff0b5cc01bdd66bc52f17f6daf6a", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "b33e5653-f4fe-4bb2-8059-39fc0b4821d4": {"doc_hash": "b3e1ba41d1ddad3cd7427014921f0a04e9fdf99836a274ff82617436c79f6613", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "77c5d586-37cf-44f4-8127-9bd31536a522": {"doc_hash": "a61baa3a7975e9a92cd8cffab4e0b7f12a01b8b1dd01d91f3dc1ec131f1afe3c", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "3ad6dfd1-fce5-4b11-ac93-388140eeb946": {"doc_hash": "38c17a606a2b934fff9f5e0ba72b7749a1657b750cf305289509f7fdec4a2215", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "89c0eb28-4e1f-4bee-8687-4e3c29b9a273": {"doc_hash": "8fd32e892f4cb69f182a61b87a09222076b29b61ce18f86207f98e2533f905ce", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "c876dd93-d369-4fcb-a5c3-7a5743ee3c1e": {"doc_hash": "b80a8de0644f21596f60ab993d6d66272455cf8a748ea4c0d3a2a374a25ee1c7", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "b8705ff6-80ed-46f2-a2b2-9a66a232b4dd": {"doc_hash": "99121089b896f1760adde4d014c56d242f423a02e5c633a6647ef369117696f4", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "f30c995c-2e66-49e8-a04f-c29e96791830": {"doc_hash": "3485e0060ab7eba758dafc70bf7f9b12c742895efe1edaa98748c84f4f0dd868", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "0cd26f78-6b04-425d-861b-444a4e41b325": {"doc_hash": "27d8b67f5636c04cae92efa74eee3309092335a31c67b518c22721e7752a092b", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "039b43e0-7806-40cc-9e86-ee0154293547": {"doc_hash": "826ef86494c0801a58b20501e6cb0a51a82c3b86a64f4cf50306c51414041983", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "f451e828-8997-4234-8002-c1567f75f0cb": {"doc_hash": "da361bad995969862c2d07a482e3fdae6da36be69ce4286576a845216feaab6b", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "6ae54e56-86ff-47bc-ad9a-ff5d9b8819eb": {"doc_hash": "1a4886797fa03586906e307b5e669ac6b2f6420d07e255cf5291088a2a8e165c", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "d1108ef3-489c-4015-ab97-3c9862008bda": {"doc_hash": "288ae0c8a1a098e72aa8361dc1d5f1425a8b9154eedddb73ab81c0fdfa5fb440", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "949107f4-03aa-41cb-8bce-c82d4c35ec4d": {"doc_hash": "af9bd056308b081ffdc51d57d3a02d7ee97ba0db83e7e56afdca49d32cd7bf08", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "c78db142-5a92-4704-9de9-b3e8b2cfa654": {"doc_hash": "4ab72bdd202ed7e50439e5a84f11ef42475815f6d94a5d668c0f4a24fa4b4dc1", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "67f36992-3402-4428-a50d-8e97c23f5e0f": {"doc_hash": "eddf858c6da2b651b3394411fcb64de3ad65e140ecf0ca4588393e74b22d30d3", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "0b81cc86-adf8-417c-b4c3-b1e569d7f69b": {"doc_hash": "b200dcf4ea311678545c1cc264d8678120391b80f4723e15881e981522d37f38", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "da3ead35-d881-41f3-bfd9-bc1020016601": {"doc_hash": "af2dac9ed040b260004204b95dd67ab1dc6171d30a5b3ab6d28896e68d7ad519", "ref_doc_id": "bb\u2010Baron (2005).pdf"}, "f96e9532-beef-4516-9c13-b23c5ea6e4c3": {"doc_hash": "a5e214b9188f5d8a26df484e67551418e36f548c2bfd259e4a00eca3aa7fb2f1", "ref_doc_id": "bb\u2010Baron (2005).pdf"}}, "docstore/ref_doc_info": {"ba\u2010Harling (2005).pdf": {"node_ids": ["0072325b-63d7-4325-941e-47f2eed7b3a3", "b5ea6b0e-bf6d-4d14-a523-7e66e0c1fe73", "119c4351-9042-4a6c-a897-4ebcbb8a0cbd", "c69556f8-3e61-4b9f-9c7c-42aeb698ceda", "9b4f136e-3ce9-4774-89d5-6056298b5368", "2d65ebc3-8265-4b82-bb4c-36964cd2b75f", "d0f5bfc4-5b76-4c5f-b065-a6ed195766e0", "524abb49-1a47-4c96-8e5a-5dbc499b436e", "ab8b2fd3-1a25-4715-af5b-1b32993344fe", "15b1478d-8936-4738-8dee-d810375d162c", "774490ad-fe86-45fe-916f-f2b0914b98f4", "80bca55e-44c9-4153-b904-90a271535b99", "21899d0b-a719-4851-9129-27cbd2ac0e3a", "45242edb-dac4-4f8f-9f5a-458c6ef4025e", "b362d4b3-850e-465e-bc69-3592add02d33", "dbd875df-9895-402f-a065-0ecb6bd47e70"], "metadata": {}}, "ca\u2010Barrabeig (2011a).pdf": {"node_ids": ["bcca9640-96fa-4b00-9261-c2927b8c36d8", "4398996b-2c76-407d-b6d8-cff1ca576a24", "75f6f1fb-c9b5-49d4-8594-990a7d9af86d", "fb3326ca-c29b-4fe2-b9a4-53a7fe69f922", "6fc83280-069d-47cb-8794-76ee676141aa", "6091fb79-c4d6-4187-bb0e-b2415ae2a46f", "cd210aa1-f1d5-47b6-b19f-c38ee8bdbf87", "9822c839-e974-4d47-9844-58817545fb19", "ad82d4a2-7edf-493e-9fad-a15c83dd640a", "9916b2ef-db94-452a-bdde-1e26190c9298", "6b1839a0-ccf9-402a-938f-d464cda531fe", "049c3368-5add-40ee-9e40-d0b276d7d821", "a1fabe26-1bb4-470d-979e-e3edc08d0bb6", "5f665828-58ba-4c37-ad50-8c2708fa5d85", "2aa27631-6a39-499e-8b8e-bc395a532fc8", "9b042a23-136a-4468-b17e-668fc9648637", "054f2ba4-577f-4f11-95c8-b954254cfbaf", "8ee82aa2-7c3c-44f2-a7a7-e91bb33eb78a", "28838138-079c-497d-a473-0a155276f25f", "604d8e78-1d35-4029-ad96-c1997a329b76", "acf86d59-341b-4c83-90a4-6eccdf40bb3e", "2b7e277f-5418-45e9-8271-789c4e97fd04", "0199d9f7-b86c-4092-8654-79e13f9e3c79", "977c0a86-9759-4dc4-8924-409bb946e467", "7d2d8d2d-797c-4228-ae74-2dd9f47378f5", "bdea3ea8-1b26-40bc-bb57-0950cbe040ee", "6cf68996-d2f4-4cc4-9754-f865df09a6e5", "253fb3e3-f169-47e6-a7cc-3869f515e06a", "ca4be5ef-909c-47ba-ba91-c4ab01b16b26", "55bdacb0-c668-446a-af57-e53cfd43b712", "62d81115-8fd7-4f73-8246-127cf5b85bcc", "d6fd9591-d93f-451e-b8ab-244b079196dd", "fc02603f-e10f-4dbd-9696-b0e58ecf640e", "e3e89a02-7152-4dc1-896a-c5c304982251", "f5a6705c-1c6d-44cb-b4e2-d4be07d3860d", "1ad9e93a-2aaa-46a7-8825-07ab5fc6e2ca", "889fc074-4691-4196-8121-c44da471cf73", "80844067-38f8-49ae-9e5b-2fabec648e4a", "f8db0ec0-d6af-48e7-b6ea-72e26ed76e50", "1542bc85-5f93-41b9-9d01-800f2b2eb2b6", "e40aee59-19aa-4e0f-b1df-fa3ce391201d", "4b23f3cb-0635-4ee0-958e-224c3b0c8111", "40c9f61f-3297-40c2-adb4-3f462b526b20", "1843683d-ffa7-4ecf-915f-57a63d0996c8", "d4d5a6c7-ec07-4605-9ee0-87367d43de7f", "4454de05-53cf-4e1b-b77e-bb7ade65e93f", "268d6229-ffc8-47ed-a4be-78d80aefac70", "82294b88-ec20-4e27-a2b0-b0700debd9e9", "bc50da0b-b4e2-4f88-8639-45d2d503893c", "1c187eb2-7341-4875-b47c-1ade48bd7ebf", "ae8229a3-cae2-4725-8a55-32a8702889a0", "15e38c69-7725-4ebc-a38a-4877498bfda5", "705eeea2-dbd3-4556-880b-289de4102112", "587c1eee-4cf4-4cae-8620-20be695fe7d7", "a3ebd531-2a42-4518-af7c-6b1e69e2f40f", "f55db0f1-a4c2-4f8f-bd43-4bf8e943dda8", "3617cea9-fc77-45de-83ff-405fb4a423aa", "40c9202d-d320-4148-a2ee-b3ccfac60252", "2371b6f0-d552-423f-bdab-d6393be3a74c", "e3a2bf53-00de-417f-8573-e19224eeb7ca", "2a568958-637c-4e31-aaa7-34ac03d416bd", "0253b27b-ae7d-4790-be90-69ece29c8991", "002ec97d-7a4e-4803-a963-5f5fdead98bc", "f3d02287-1589-4ed1-8af9-553806f87c92", "b4ed3a3d-b3b7-4a2e-8f51-30141cb1c82f", "dc69620c-13fb-4791-b1b7-754dc8bff01d", "5347124b-e311-40e1-9214-ef68828ff18b", "1d70940f-28ef-4df9-bfb2-31cd50c4870a", "e278cf35-dc45-4baa-a67d-ffdc909a04a0", "a20cf248-5c4c-4aab-862c-64c86bef9d2e", "34ca1773-5109-4631-81b4-6a21df0d0852", "1c6b9e35-845a-40c7-90aa-a1bdd3fa85bc", "aaf34641-6822-4462-ad58-2a74e61dbf1e", "126d4d7a-9101-4a5b-8220-67d710e55954", "992b4ada-cd12-4145-a7b7-cb4d0d25928f", "2060ace3-3f84-4ab8-8afb-275e4a603aed", "725c72ad-6a76-495e-9c9e-7c252344ccb0", "7a3727d1-d832-4c62-a307-e798ff3e0a4c", "dc8bab62-f2bf-4951-84bd-7bf12125dc3a", "83539b8f-24f9-457e-8b51-112ce37ac806", "cc230894-2625-42e6-b17d-b3bf2f63c291", "7bc25279-3a53-492f-b388-6b4bb5251317", "f040eb24-1455-4579-a091-ab0bf63affcb", "7b56425e-2f83-456d-94ff-f51d94ed20a3", "e5eaa04c-65f5-446b-97fc-f3e061994196", "7a740802-b4bb-4cdd-86e4-93183006f2f3", "46eef006-d8cb-4cda-b796-dab3f58d1428", "c2b891c9-0bf8-4846-ae83-84b4d33c9afe", "640ac5e9-f3f7-45bb-afc5-89a251dab860", "99f75413-c160-49fd-9d0f-665a236075be", "16faa05a-01cb-458f-8b01-f4e48f341fa3", "147dfc5b-2672-4bd9-a5d8-d37c8b830839", "c6609416-296d-4996-aca4-2e2d660bc359", "8f308ea1-14be-4986-b9d0-6a583f786280", "5b8b8817-2dd0-4418-9349-6c1f5b734f7a", "1e4feb1c-c51a-44db-b152-87e5eb62cf72", "a31f1939-7751-417c-abfb-8efca3561716", "ab82e223-0226-4a71-8bb4-1290975cd63c", "3fd9745a-e8f4-4285-add6-21b637f8b5b2", "fbaa9766-028a-40ac-80d6-c9abecbc2b29"], "metadata": {}}, "ab\u2010Bloom (1975).pdf": {"node_ids": ["4bdcbfe5-ee0b-47ae-acd3-4d333fb274d7", "ced21b70-51e1-4333-893e-6caf411ceaea", "8f8a15ae-7760-476a-8584-e8be10ae9faf", "f3c61168-eddc-44d5-967f-8654a533be9c", "5caa5813-73ad-4d5f-85ac-bf0c4cf6da8c", "a80ed783-7f29-4da5-bc70-97530d4c5d53", "d6b319c3-c436-4e8f-b165-46142290b014", "457370e7-1207-486b-be46-66b9b0fe8828"], "metadata": {}}, "bb\u2010Ray (2006).pdf": {"node_ids": ["d43abda5-6a41-4b26-8383-199c98d07abc", "550d182c-e186-4126-9de2-7c9f2f93a088", "c045a63a-0bab-4075-85ed-4b7c1b78ce95", "112ec265-0f66-4079-8725-8e08984f1fae", "24804042-bb5b-4fbe-be0c-1f23ff810a4d", "f3299ac7-7419-4573-9440-faf93a274f95", "e976a8b5-029f-48cd-a7bb-31b6ccd6fadc", "ed9c7574-97da-4551-8edb-cc9bec0d7738", "dc44b349-a31c-454c-aad5-a1b4e4f0f339", "7556660d-6a22-40e3-ab48-2436679a9789", "6c0bb162-f1cd-4777-b94b-369aabaa801f", "740f4e25-a8d6-411f-82c9-cf88b0cae0d8", "e582f22a-f2c8-4c18-be99-07624670f51f", "986bc4c9-6385-439c-9faa-2cb314330bd8", "d1fc5fee-261c-4bc7-aa40-afb5da35e523", "88502d7f-25d5-40b2-99a2-8fe0d6787bc4", "7e347ccc-4c72-49d1-8930-617d0f064d75", "65231cf1-6629-4e2c-bdc4-4ba5d743d100", "980da00c-e8ab-4009-9ae9-3817e2066d99", "aa1ce4c2-89f7-4bef-8ca1-f752275fe104", "d0ed2038-935d-41a7-a09a-aec456c2ab9d", "e81d5508-1bfb-471f-9805-1fe516560d2e", "8bfa9866-05c9-493c-9b0a-a41520229ba8"], "metadata": {}}, "ab\u2010Ceyhan (2001).pdf": {"node_ids": ["68ad193b-50d1-4438-a3f3-d66e897ad8de", "a771e287-9a7c-4454-88c4-3c6295f56faf", "23713cb7-39cd-4bc6-9c3a-829add7c33e9", "836c8174-4b2e-47a7-a733-5aabeabe57cd", "cc19cf07-a542-4d3b-acba-45aedac94b71", "47eff50b-be12-48b1-9658-d082eca28293", "34fc559e-8978-4356-bae6-95abb438674a", "97c61abe-8bf3-4702-b629-0fa6bc2b61db", "1fea1f89-ee51-47f6-809f-c760f9fb083a", "f0868f32-ac14-4ca2-9acc-606cb5cff72e", "8636e930-aeb5-4714-a8d7-13ece4dddd82", "3babe2cc-f06b-413b-b3d9-53d9cb31566d", "c3ef59b6-540f-41af-80e7-95ea1f4258f4", "eca27f4b-8a62-499b-b9aa-07520f3c9c41", "c3d19289-39f2-43c3-a22a-ee7ce7a4f65f"], "metadata": {}}, "ab\u2010Lerman (1981).pdf": {"node_ids": ["b4649b97-19f7-4509-9d84-8f6012a0f4d9", "5774bd5d-358c-463b-94d6-7fba145dd828", "b5b1f0c3-64c0-499e-a305-ebe24142b6d8", "2f05a9c1-5af5-4b45-b67b-f6ce6f0b7e6b", "b975d129-aeb9-4a30-ae9e-13270caad675", "18b63421-ae10-49b6-ba08-49f96fcd95a2", "e92e388b-93c1-4b1b-a5c0-5169e8e6d4e8", "a40236bf-cccc-43d0-9b0c-b9e98147703d", "52a6b198-21bb-4c7c-942a-228f6da1d60d", "d6ae9f94-00d4-4673-870b-12c0e4be539e", "48bb7875-e7b3-40e8-98f8-befbb60ec43b", "333631cc-b477-421a-84f3-2400efca1adb", "f2def86b-b77f-4fa9-89ec-3af1fd662c01", "3eb9b1a2-da23-4959-86b4-f6788b860e86", "c47c7bb1-bfc9-40c0-9c5e-0d4d240bcfbb", "dcbc23d2-d207-4e5a-bab0-a9d60e5b954e", "67509cee-d37e-4828-b878-a3debd4f016b", "c4d02321-0411-405c-a0c9-713bc7d5b62d", "91e0ceaf-a6b2-405b-9801-9686311c2fa5", "ff7938e7-9338-4ab3-a2c5-85927f9d7ac3", "1807b73c-6e9e-4e57-bd02-d142121e7aa3", "53fc5a5c-1e84-4072-a34c-103f88eaaaba"], "metadata": {}}, "ca\u2010Giaquinto (2018).pdf": {"node_ids": ["a8b734ff-07c1-449f-9320-8f8c9e04002b", "c2f67558-7b4b-4492-8fc7-446e8b547fce", "4836e8db-cb6c-4b25-9778-8a58655227aa", "20922e2b-35f0-4f05-994c-7e253de08d1d", "a7ca7dd1-bf02-49ef-9fa6-31aa12f6aeba", "d9448665-c074-48a3-915c-965cf1d58186", "eec22ca8-ae20-4dd6-8064-f6285d5e2509", "acbb9940-332e-460b-80d9-933fb731008e", "460f6a3d-5284-4a18-9ffe-75dd62f88002", "cb325113-9ade-41ef-aa62-675e17a2faad", "ac2379e7-d0c4-4ef2-bc56-bc97e0628d7e", "b1ebf17b-fc82-48ba-b303-a6c26977502e", "74ebfd9a-228f-40a5-bb16-ff2c8208d5b1", "8e10dd72-e77e-44af-8ae3-f0c37acd9a93", "ac01ed96-a4ba-4cc0-a931-175852c31fd5", "3866d82f-d642-430e-bda9-1016a897d7ae", "11bf6f0d-99f2-4187-8cec-8963849dbb5e", "7498c2d8-1106-42b4-80de-c560b2b37676", "d4c57282-731b-4433-abf9-9599037e027f", "bd04f3b3-20a8-4f10-91b9-cb084f16de1d", "eca410df-939d-4b67-98fa-0354efc69608", "675523ea-d308-487f-b318-557c781329d2", "3dfac74b-4c7c-42ba-8946-89e72f98b0ce"], "metadata": {}}, "ab\u2010Peltola (1986).pdf": {"node_ids": ["89f6eee5-cbf5-45fb-9099-e4155562b7d9", "7774f92b-7938-4039-869f-04155511f9a0", "ff1cba29-c0ac-41c5-ab8b-27d2fe8c520b", "8fb550d7-04fb-4084-aec7-ea0049241050", "5767c3c4-e893-426f-90f5-c0d055525115", "3addb771-d90d-4b93-996e-fb4724df85d9", "d4412bd7-624d-457e-8d08-22cab9456a54", "951f0630-346c-477a-8839-d22e3f35b9dd", "7d3622bc-8e05-4894-a24f-16c109adc616", "198d121c-5e10-443f-90b6-2c1093372c2b", "7c685245-867d-4240-8bc1-d3629544fc02", "95e1a054-f62e-49ca-8a8c-ee7a669b3d0a", "a516b913-d062-4c22-838f-41a75bf41b11", "96a56b84-cc59-468a-abdc-0addbcdd3a65", "b003ffa2-4983-444c-8898-461367faf906", "1c3bcf3b-99f1-40ec-a3af-3f7a1dc8fabf"], "metadata": {}}, "ba\u2010Castilla-2 (2009).pdf": {"node_ids": ["1713277e-c4a7-444e-b04e-627280a8395d", "990b22cf-3e85-4b37-9e7e-512c1fefac6d", "26e555cc-405f-4ba3-828a-851efb4a4038", "62133204-8ef2-4376-a21d-8b062ff05286", "b9a2b559-f1e8-422e-88b2-9afc7b26ef5d", "e13c1e0b-95f1-4736-be2e-f067dfc27676", "65bc5800-4a90-4307-a91f-bf26eabde2d6", "73a5fc3e-e278-445c-84a9-7e942faf63a3", "0e7810e8-171c-4d22-aec7-e76c28b43865", "d66ffa74-b647-4ce4-8314-76b59afb535f", "eb3adba2-a092-488c-81d9-135b0e85e239", "840ab5e6-b14b-4134-ac9b-78b7c9f4bcd4", "50d58dea-e6d8-46d8-b1e5-cbe7f85f8ecd", "cbe91ee3-f074-446c-b899-95c6c09c4e44", "bef7fc85-5114-4702-b813-1335e852a846", "54c68dc7-b08c-43b1-bfba-488a7508bd1d"], "metadata": {}}, "bb\u2010Da Dalt (2016).pdf": {"node_ids": ["e2629ae6-1cd1-400d-a4ef-0428ac885d0b", "003f21c3-020e-4a8a-9475-aad2a94c0e8e", "452fe716-154b-4737-9e0c-f35e9ea5a2cd", "938ae48d-8af1-41df-a9a0-a6d16691b6a4", "77fc7df6-b34f-4b06-8826-959923110b04", "1f12261d-eda7-4d28-9c19-4860d928ac6b", "fc8a70f0-59f3-467c-b311-b5ba57e0e820", "554a968d-b24e-41dc-8b6b-a8135eeb9320", "d35fb1d9-7c3a-45b3-a73b-4626c2269ab2", "bbce3c97-7a59-4ff8-b552-e16eb7541320", "1a5ffec5-b436-468e-a637-41088bdf72d5", "8bace470-19f8-4d23-971d-d654635516b2", "c45d1c31-43ec-42ac-a1a7-6d915ab4d96b", "85692f1f-a2fc-4905-9079-9c9d8b233568", "1dce144b-830b-46aa-b81c-a74ff293fa7a", "12a22081-6624-4514-ab13-b23224a4d056", "f28d4263-d446-4573-a07a-f80d07c97d02"], "metadata": {}}, "ca\u2010Chang (2015).pdf": {"node_ids": ["2a82c6ab-ecb9-4cff-b7f4-9351a9b2715e", "5cc2527c-c840-4f00-994c-ccc06acca6b6", "40546cc7-1b15-4fb9-8488-d47cd21aa768", "33969ee0-64f4-490d-a08a-722322847058", "4b19b7e0-9338-4554-a362-78a44b37d612", "f92e145b-761e-4311-98ea-19d958d09838", "16bd29b8-9cc9-4e03-91c6-68b1585e111f", "2141b6eb-9bf1-423d-a7bd-865a7211d9d9", "53401598-0851-448e-bfa3-68f13210a3ed", "cf96e409-2b9f-4c66-ac31-c5f0c4eca753", "c1e28fc8-1ddd-4f1f-8043-3d76a86dbcf4", "ecb8e59d-9d21-4cee-979b-c4e29f0b5d68", "1995bf94-8c4b-47b1-9a0f-3fdb876e6ada", "0deb71ea-139d-464d-96b9-e845e67cdb8e", "25ca4f5b-18a5-441c-862f-a2b311391b9d", "4fcf3457-84ce-4fa0-86fa-1ab4f59eaac6", "3bf559de-e4a9-4cf8-bfca-4408cb96dbb5", "5e0397c4-b95a-4633-b07d-cf7958e8ca78", "b11544b7-0799-4e3b-9ae3-72cc3aaa93dc", "9275ca13-8c98-4aed-851b-3c7f698445fb", "70d0bd37-d530-4d46-95e3-305e1e05d4bb", "dc86d51c-ddce-4d5e-9b5e-60a648574057", "629f49b9-c0b0-4f42-b68f-a890a58f4040"], "metadata": {}}, "ca\u2010Greenland (2012).pdf": {"node_ids": ["73016733-65dd-4d18-b9d1-a415114efe0e", "e1289309-8886-496d-80e5-ea5d11f984b3", "0ec127bb-0a26-46ca-b403-5fed1f9937ab", "820a1d60-a9de-4af8-a67c-a5ccecb82621", "89ac91b9-1605-4949-8492-5968b14696b3", "cf34d22d-c706-4d25-8eb9-1c99e45bb86a", "6f1170d9-71c6-4c9d-b24b-6b2eb168db2f", "2406422a-ab5b-4d23-a769-2a5238bb9b7d", "4282b136-a878-478a-9294-cbf69624d90d", "d4fe7c92-6d3a-4dbe-a528-3c7c20824ef1", "7aa965c1-c31c-4daf-818a-047057d6f7a4", "250e01ca-2f8f-4ffe-8d10-199eed7285dc", "2db8fedc-92e5-4eb8-b439-0ff1f72b57a7", "a041df7f-3acf-42ea-b7a8-07ef09891632", "e58752c0-5a65-43f6-a8d6-cf30ba79fae8", "28bf89a7-dd8d-42b1-bb5d-5455f11c3bf9", "6676acf4-c655-4a9e-a9f1-e3876f7ccae1", "b4da066c-5f85-4d65-b532-26d266ff1cf6", "0e2c1309-3f37-4de9-b714-598517d33dc9", "5c58ac3d-bd03-4ead-b080-3fc77511262a", "b64443a8-dd8f-4347-bb30-37f90bba1bc6", "ad2cf0fe-e160-4995-897b-e1a6a82da68a", "f924f5a8-0bfb-42e0-94b9-3434116fce7f", "d9919bff-8eec-4d4e-beb8-1d62182e4cc4"], "metadata": {}}, "ab\u2010Schwarz-1 (1975).pdf": {"node_ids": ["061190ad-53a3-4452-8551-18326ba7547a", "5c7dc29b-3410-4f8a-9cd5-bd27bca63b0b", "ec68ddde-0362-41d5-af8f-fcc50acbd5a1", "7cd07369-9d45-4b31-928a-5b6b89dd4319", "bd8ee1cf-6ba1-4675-9ebc-2d2ceb5dc2e3", "2a5c8876-b6f7-4303-b669-06a2a7dd224d", "e5bb471b-24c4-4bc0-bed6-c65f47c3c3be", "e188ea5f-16be-4632-bf2c-952c0fec0809", "721d2bfb-91b0-4087-8fea-a4b7ba94af43", "c2ee3628-16ec-4ac2-b414-d21be14d79a2", "ced8905b-3983-4732-adcb-75c6448f3d43", "8eb66fc3-e352-42be-bb8c-453d5bc70034"], "metadata": {}}, "ba\u2010Andrade (2018).pdf": {"node_ids": ["47429d00-ed9f-4af7-9cc8-50842d93e1b2", "4e628428-4cbe-40dd-b2e1-731e16cf88b7", "18d2775c-25a4-49a1-ae96-ff2495410f03", "4a96653a-80af-4a9e-bc9c-df73c465f057", "f8f5d9b2-5208-4dac-8403-08846d36eca5", "7df26906-5f1f-4d9b-8d85-6a47a3ee2872", "8bfe67e0-bb11-4ac4-8ee7-762299fd5eac", "c45bdbad-97e3-4f01-a9f5-9ccb2a3654ae", "82024a5b-5749-4c8d-8fa4-28bcade8a6c9", "a009f680-bc03-4f30-809d-a6a46e3d4a56", "7c04e516-00c5-4d53-8647-e4420b8d6973", "88194bcd-903a-4406-97fc-1cb60157ffdf", "11afe8af-f94d-4992-abf7-e82fc945537e", "8224b931-1d9d-475e-8885-d99931b444ac", "b3af395e-7ba4-4df2-b5ec-af356673f22e", "6d3793f2-7289-4bf3-8d0c-f3050a34fc3a", "f36e5450-53f4-46d2-be29-5e26dff66503", "55061f8d-f73b-4825-87c4-78d126c39626", "dd7bb911-e35d-4634-ac2e-57729dcd8f1e", "32881efd-16db-490a-a1ae-28f44e0fa744", "116fb4b6-e68e-412b-86fd-17fe3e14de55"], "metadata": {}}, "ba\u2010Kim (2012).pdf": {"node_ids": ["aa243b3e-93fc-4252-9166-d7b4fdc51168", "71c283b1-d0cf-48cf-ba31-eca7aceea162", "2976b789-f63a-4e42-a882-7d33a608add6", "42c513f7-3ed2-463f-b373-88e8452e0680"], "metadata": {}}, "ab\u2010Schwarz-4 (1975).pdf": {"node_ids": ["40f2d7cf-88bd-40ed-a9f1-83e16a6ad753", "b3e81449-ddc4-4cf5-9613-9d2e9d3b039d", "a6166427-a67f-4ecb-a765-8934319c6d8b", "430033b1-295c-4d42-81f6-88b8d1ef94e3", "cf0a777c-bc16-490a-b79d-d98bf141bdec", "060b5109-b2b4-4b8b-9a1f-14a9011b892a", "7dfc6cf1-8c62-484d-970f-2302029e9179", "3eb22b53-64f8-4eac-9c43-f67da2757e64", "ad806b6d-f82b-43e3-985d-e2617eae0ab1", "ec75bb58-c57c-4680-882e-57488526baa0", "590c58cf-3a21-46a2-a6be-5896ee31cb7a"], "metadata": {}}, "ca\u2010Choe (2017).pdf": {"node_ids": ["e28e97ba-f3e5-4e08-9049-8b226930752e", "3676c032-fcfa-4653-9b0f-ed4cacd350a1", "83144482-627b-4218-b47d-7503b5fad02a", "fc2dc9ba-facf-46b8-b822-8c3b2384392e", "d2c9ca65-f22c-442d-99bb-428a8628174a", "1171826d-4c53-4fff-bf9e-75f23e05c743", "cccc3b89-29a7-47d0-9dc6-6de3a7c83c9d", "23e45c0e-fe72-4116-a167-0e8e9939ad24", "218c516a-fd58-4a01-9543-279ec2031693"], "metadata": {}}, "ca\u2010La Torre (2017).pdf": {"node_ids": ["b7235ce1-9762-4b87-ad66-b13999026a9a", "9a3c4d58-5eb5-46a1-a537-ff771b73a835", "967cbd78-e42f-4538-a650-b86bbdcbe2f9", "8d28964a-c55f-401c-b607-ed088663e4fa", "615e5e00-076a-4976-b6ce-b81f475ca745", "ae3f5656-3125-4bb2-96df-2bc7a4fbb1e0", "028390e9-3bf2-4bf9-b222-a79381132c67", "ead53e04-4528-4856-b8db-540e63184b3f", "6f8340d8-9106-4b80-b120-a9b49ea3ac02", "4a6773e4-a202-4502-8c16-11264f7423ad", "6a0caeb5-100c-49c1-94c9-c11a66ecf482", "76b7adb8-966b-4883-9e9c-ab75b605204e", "9f46c312-ae96-41e5-85ea-d61a02010207", "91b8df91-5475-4ad3-aab5-d500508f7f3b", "a98a5da6-d3f8-4eb7-abd4-f13142d39243", "8c23af5a-a06d-4fa5-a962-d4ee6790dadd", "4fc8ef7c-a2ee-46f3-85f0-03ed1353c1eb", "60f3e837-dac1-4011-b262-7d9419c62e63", "5914c0a4-63af-4ff4-a2e2-42c3822daf6e"], "metadata": {}}, "bb\u2010Uno-2 (2012).pdf": {"node_ids": ["5ff1928a-3cd3-4c4e-a817-a0756d5f7d34", "5618ed92-fe2a-4bd7-84cb-b9c9b73853d0", "59763974-5c91-4e00-82ba-d9e225faa8f0", "3914fbfe-d743-4231-9881-dad6ffa831b6", "ee3b8dde-6a80-4eca-998c-da8f0b5c7d33", "41050adb-ca9a-402a-b03f-2996b44171a8", "24eaef6e-c334-45d2-a5ea-346712a332b6", "815f6bda-403e-462a-96a1-e841c513d4d6", "d9dd3f07-7c23-4ad9-85ca-fc7f4abb0232", "07378c42-9506-4173-891f-7719a5676e13", "c93b98e1-ded6-46d9-b143-e99e3cc5b8c6", "f50a5b2b-ada5-4cc3-bda1-f064062f7841", "36d2be3d-805f-49f5-a081-8e153c0b2f2e", "c8ccd7db-97f5-4b90-b3ab-cc46c3619b1c", "4c848230-58af-4f84-8f15-627bbf357a63", "fe9b0c82-9b44-4f87-b4ca-45b78ed44eec", "0bbbc694-5a47-4aa9-a5e2-43c00e9111ca", "3de153b9-08a1-44f3-b4c3-44403dac8f80", "9747d265-d890-4252-982e-eeecda1d86d3", "e865cdb3-5993-4174-89ce-86726dbb290e", "7b337b74-e084-41ad-8579-18c9983d9283", "cab4667c-04ef-400d-bb83-67649ee0f937", "94e39d20-fc08-4e86-8638-3123a29b7b30", "1d13d7b6-69d7-4297-a9e7-3403e3534496", "20b55d25-d125-42b8-80b0-db7781694664", "211dbb4c-78ba-437a-847c-5c153dbe7181", "86a9bd09-5c1a-48e4-9ce6-532b5c61a8dd", "6befac3e-2acb-4f0b-a964-4991d85ee0c4", "1e6dc7ec-7455-4cf7-a018-40ba55cfca40", "312abb4d-20cc-4d5f-a37e-18115cba86eb", "fa81edf5-769e-4132-92c7-e3f82252530c", "fea227ba-3e24-4421-b8cf-94d849198af5", "2b32d2b0-e89d-47a7-887c-ecedff8d9199"], "metadata": {}}, "bb\u2010Dockerty (1999).pdf": {"node_ids": ["2ad0d831-4f9f-4aa0-be5f-5f8b58f48d9f", "131283bb-14fd-4179-8b57-4c80d1930d66", "5548bd02-b502-4808-9c9c-b10d27b1c448", "7d698684-1436-4aa3-8449-b29c70a0d638", "3d16adb7-901b-4d2a-b062-26aa6a10f038", "cafe85ce-b378-47ef-8b87-9da7ec981229", "b308a02c-c053-4d7c-b3a7-fc34c2b74394", "0f8c0ba1-2f03-484e-b0b6-06bb6204518d", "b96538d6-f042-4e19-9fa9-0b61651d8b18", "a6bd9956-ba0b-4bd7-b6a9-2ab96bac9d84", "009400ab-a053-4db1-a608-dcfc1576e30d", "c875a373-f9dc-4e48-b907-25a725734423", "bdf8d3b1-068b-44c0-b839-f3519f7c727d", "5be868f9-874b-40fe-8248-caf280977b59", "936bf859-5e50-4ead-a66c-bbee5fb6b51e", "777bb992-5f3c-41ef-a932-b75aa7e0753b", "f4e74f33-654b-4cb6-9321-3ceb85b4c678", "51029807-d168-4d24-ba8c-512fa3178f0b", "fc339b9b-e915-4135-b279-d26d722f96a3", "8cc5425e-44ad-4d5d-a800-a710e687d717", "2584f57c-437e-4bec-91ed-6b15b5f9c2ef", "e7a70616-ea7e-4b21-b4c9-037bd31a27e0", "66764eee-cd51-44b5-a758-34c31e317919", "16319c5d-e5cf-4fc6-a25b-113bdbe7c853", "f95f3b4a-2370-4c4a-9477-536ce9754eff", "653fec17-3a27-4c20-ae94-7d275575714d", "a570ccc1-808d-4f46-8dd3-1414e6e726e7", "cd09000f-1e4c-4243-9eec-ed38f3afe889"], "metadata": {}}, "bb\u2010Ahlgren (2009).pdf": {"node_ids": ["f5bf758f-8c8b-4a26-b87f-0a49a0d1b17f", "5b204e55-5058-4051-87f0-5201f4bdd5af", "815e7035-fc0d-4701-adf6-73e6caf8b80b", "2884c249-5c5c-47c7-9b42-f3f7180fd711", "05a3e6da-7a24-43ad-a22a-f219213af2ce", "1f63207a-e09b-4bce-ab61-2707f0de2aea", "726c5610-c1a5-4e84-a043-9a7259abc6ce", "378a10ed-a4b2-4084-9484-4fb52f1af0dd", "5d2c9a84-b00d-4a30-8669-e32470848f7e", "d32283c2-b3ba-4aad-8c38-9c3d7fbe486e", "8ad885d8-c67e-44ac-82df-b546f08ef7cd", "2a856edd-2b04-4f34-a0a9-83626305f597", "25e1dd38-e198-49ea-8dde-6f332a9f935e", "cc2d5e59-f4e4-428f-a98e-fac7e610b47e", "c0317ea4-25e4-4163-ab66-c3f03ef29ede", "819f552d-19ff-4dd3-a429-e8ce7e73983a", "4e8f5af4-8d35-4d07-973e-47c23c465733", "766be6f7-c70e-438a-a5ab-d8f6944718cf", "49c63b2f-6293-48d1-bc84-a54bfb486211", "be5c8ad4-ac53-47cf-8d35-420e7cee9e36", "47c29f19-b47f-482b-80b1-aee1db56f304", "5874c871-6835-4296-a620-7a3b7daad93f", "856f8351-ecfa-421d-92fb-ecdd9332f5fa", "609c2577-db86-415f-aea2-bdda94c84725", "6bcc70bd-d454-45e4-a449-0ea29ab124fa", "ab44d843-5e28-4039-a127-b5971bb1f0c8", "f24eae03-b18b-4eb4-a1aa-566a828d0350", "3dcd8adf-07aa-4eed-85c4-e96748424ba7", "ef6edcdf-b8a1-4bb1-b835-5be16ba75336", "e1364a3c-55b2-4f49-86de-b6b5645f1641", "95f4b75d-e118-4dc9-86df-dfd9f29a4101", "dac560a0-05b7-4e0d-8ee3-2b754e989e60"], "metadata": {}}, "bb\u2010Bremner (2005).pdf": {"node_ids": ["67897cfa-1086-4124-9198-fd87a04e1c1e", "bbc46158-6629-43e9-86be-d39d7419eb99", "de6a0703-ed14-478f-b0ed-87f56ebcf0dc", "bae0e601-b2c3-4bf8-a641-5651b2854747", "a0ea5a75-3f72-49a0-8b7e-73cd505e2518", "2e12124b-5709-441b-94ab-344732117f40", "a933cb49-76c8-4830-b37a-eab925d0b487", "76e27594-9ba4-4bb8-9b5c-291678859916", "17416c11-a704-4c5e-a2dd-34d5dfa75987", "44fddeea-7f77-47a2-8831-b47652414413", "36f0f793-eb0f-4d3f-86ff-06d5c8e9f56c", "f4f35c9d-c364-452a-ae27-f92d76e874b7", "8905277d-48cf-4250-9ed6-a3a4fbe6ff58", "dbec8102-e036-4a27-8fad-587ae906d2cd", "571845a8-8109-449d-85d1-dc60dc2e3b88", "9834e6b4-e6b4-409e-b944-0a4af604bebe", "375c018f-5983-4f5a-b29f-29998e46dfdc", "08a21e80-31bb-4403-8296-0626ebfaed80", "080a38f5-4bbc-475c-8e0f-f1ad2c7fb849", "2b47c8a3-7739-42e5-ac58-1b886a12e0af", "13ff4ca8-fcda-4487-9cc7-919f56ffccf5", "762c6422-b5a0-4463-ada4-e8032aaca145", "c1e95909-09d5-4a4e-9dd8-d36c5674da61", "43935815-0253-4ff1-9ca5-b8c401d0ecef", "57de5bbe-353b-491a-a0b8-262076531c0a", "63537c09-11f1-4208-82a9-50ac9022e8c6"], "metadata": {}}, "bb\u2010Uno-1 (2012).pdf": {"node_ids": ["77b59b22-68db-4add-b504-4f8a356d45db", "1802f041-f25d-4d95-bf4b-c1d1d8e541c0", "cb1c02d1-a79b-4c4f-ad69-e44270927751", "775c4247-f24f-46d7-81c8-93681dbcfc7f", "20cee29a-f767-4faa-8a01-97e28709cb8e", "d2dd06ff-478a-4681-b746-c7090c88a933", "79117fb5-95e0-47cf-9dc4-6f4ebb24537d", "9b6f722d-cf2c-4ce7-9dcd-43a3901d2b18", "fc98050d-9005-4eda-801a-d3190e96d7d8", "260842f7-5d98-4a58-8685-4110e0712e0b", "ea798cc5-5ed3-4f00-9e00-4ef84fd1daf2", "6ece4a43-7555-4408-b0e7-50396b962b6e", "200a5689-4ac5-4338-94d0-d99fcdb0d19a", "085be720-af62-4ff3-82f2-ae98f0cb350f", "8a347705-d70f-4e0f-b39a-c3c15f382418", "12a5a5e4-3380-43f6-803b-c92dcd23f2d6", "aa8296bb-8cc6-49fb-8fe6-7f495712fd47", "c99bda0d-a23f-4935-a869-dc80c3a652ca", "81e16349-8057-4a80-b110-3bdc958a1a3c", "ca6ab770-a78f-492c-88ee-129ea16262d3", "c6695782-74cd-4512-a00a-06bb558ec445", "b8be6716-f8ea-43ec-b438-0321dc8896da", "de48dbda-c980-4a31-96bf-6df837fd486d", "3cc37b5e-f905-4d21-82bd-25c4f5ed3540", "971ca21e-adec-4b42-b22c-ac5fb62b809e", "87837c79-bdfd-439e-902e-4e7ec399a964", "c0d608ae-e619-4b8d-af9b-157b451137b9", "6e437bc5-2d9a-4054-9d48-9223d9b7c470", "f7fec461-dc6e-4a24-913f-a1e37c68eb60", "a46ce135-3b82-40e3-9705-87789283acee", "e0094cdc-4771-4633-b97a-db6a817bfdc4", "c895db56-1d2b-4d25-9de9-4ec7c7813279"], "metadata": {}}, "bb\u2010Bertuola (2010).pdf": {"node_ids": ["ac45745a-4213-4f9e-8e88-52cbe41c5938", "9ce94375-b60d-495d-8bfe-d5b965f40ccf", "31568e6b-b0d7-4c9b-9559-3ce21298dff0", "e6f62207-4b02-44fe-819d-5b07c55e073d", "dc1cd5ce-6071-4527-98dd-6ebf7ff37a41", "5e870399-ced2-441f-b3b3-840cc2accdb1", "99d21b6f-6ea8-41f6-b93c-8c443d44d730", "518ffb4d-1525-4bbc-b685-397960c377b6", "002890c6-abbc-434a-ba48-fcc509802680", "359d8f48-b9ed-4886-9d41-cdec548c9a69", "f4fdcf86-7afc-4c71-914e-d368ed96436f", "3065b60e-c26f-4587-ad0b-c79a11623407", "dec1f9c9-a590-4e6a-a8ad-2ee2a4048d83", "106387c6-c05e-4b28-bf93-0efa90ac862d", "65658d3a-af0e-4054-b333-de7b5b8158d0", "99cbd9fa-eef1-4136-a47b-5c400bfc5e45", "d83d39bb-760b-4fe6-b481-2618a5d3c517", "b5b18356-2f76-4b6c-8b9a-ce593ef02176", "828cec01-6372-4bfa-8c0c-2259e42e6484"], "metadata": {}}, "ca\u2010Livingston (2013).pdf": {"node_ids": ["fa82595c-0044-4c8d-b0bc-28b326d718c3", "30a1cd42-0618-4468-98c3-89f29cc4e455", "4a1b4a39-7d67-4252-8ea9-8bf5f0894487", "601950e8-2efe-443e-aa19-1b1c8389fe39", "7f6ed2c9-007d-48b5-962e-f655e418b78e", "08b2d910-5eb6-401d-8170-c3267ad3063e", "a5080844-04dd-4638-8972-365a03917376", "2bcdda16-bc7a-429f-97df-0615d181750c", "0663c540-22b5-4e1d-9672-24c0e9a7ea5a", "1bc8405c-3491-4d7e-ab88-2560594cb44e", "a7fe8a93-03bd-40df-a9eb-15d95aee6a5e", "1bead9d1-a802-4a72-9862-4a2447ebcdf4", "8658329d-3cd8-4ef2-a6a5-e74e0db692a5", "de439c8d-f2de-4e3b-843f-d5f758469f39", "464b332b-ee09-455a-981f-a837a5f962b6", "f4a29f19-582c-4ce8-aae9-882c95f979bd", "76d1b04c-c3b1-4a78-bf19-a4df63a1c621", "314db8d3-38dc-45dd-8f6c-7184e251946e", "6fb635f7-767d-49e5-8312-d5ff88e5342e", "c21b6d4c-aca5-4d71-9b53-53789ddf4b5f", "8b13f4bd-acab-44ab-a6ef-1d299a8052e2", "8a00169c-2683-49a3-8669-ccb34c630ecb", "ffffe5fb-cda7-4cc3-9b0d-f5bf72d78cc8", "a3d2ca21-81e4-46eb-a691-eec68d0f2358", "dd4c0257-c3a8-4583-a27f-e4b20ca59e47", "96f9758a-c81d-4b4e-84e6-ada94e519d00", "2efc6e76-ad95-42f7-9cd1-c7cf9659a411", "f3e1433f-f9c2-4509-acc4-603639271d03", "d2963986-3c37-45e4-a0b3-c80e3177ce6b", "ff371d50-0bf7-462d-9011-71e5c1fbbdc9", "e60a2f6a-89d9-47fc-bf46-43338d19b50b"], "metadata": {}}, "ab\u2010Freeman (1993).pdf": {"node_ids": ["b2669964-82f2-4fa7-8359-92ba8691f651", "b9467b42-bfd2-498f-a1c4-d177f294e63f", "b8d1b3af-00d3-447a-9f98-a02df4a064de", "25390829-26cf-4cec-9bb3-5907124d5284", "26db15ea-7b22-4151-a16c-2b1fc55921b7", "8a9a7cf7-9878-484b-a324-c686482f77a6", "e7583468-e34b-4f13-ad38-ead763c36800", "cca18bfe-3779-4f9f-b533-d9b9d73efbd9", "a7248631-d7cf-486a-b3d3-c665d9eaab06", "9739e15e-4138-48cd-ad46-b796ddb1b3d0", "33500868-a951-470f-85e8-2ed001c76714", "3bc083cc-3028-49ec-9c6b-05af9633877a", "ed799ce4-b737-42cf-af97-4f78f60900a3", "66c1d50a-1c71-4f8b-8833-f8868c9dc5ee", "7e9e024f-6259-4614-8867-26865766040c", "6f9b48a3-30ed-47c5-91fb-8d35dc38cbf6", "2b8834dc-140d-41ff-8c64-ece4c1eef6f0"], "metadata": {}}, "ba\u2010Vazquez (2001).pdf": {"node_ids": ["eb4dba73-ef55-4202-a43c-483554f62f5f", "45ac5908-816f-488a-b9ac-cbb5796d040e", "724611ac-747c-4330-bef6-d157579a12a3", "314242a5-f537-44ba-8564-dcdf3a7320c0", "86fc3426-945e-4ed7-ae57-1ceb5820d405", "335d0851-a6ff-485c-b6a4-ca66afc72b77", "cb97391b-079e-4f22-927e-b4ac2543df1d", "3fa27b8e-4603-4b09-9f22-242e1e163cb8", "1166e94e-e6d9-4576-bcb8-6b8c21c79340", "469b2088-2087-44da-808f-bb4cf8f46886", "0a2be063-d5cf-4d5a-b33e-246049f88c2e", "98e06273-cf66-407b-9433-d1c6b808e571", "3da51b5f-7b44-46f6-b0c5-41f6a99c2018", "05d6d891-6047-44b0-aeec-c96d893c106b", "a743d653-e23f-4c37-9cef-d54c91f12f2a", "30478ce1-585b-4290-b790-92a5b233d6ac", "5d33927e-00c7-4919-aac5-507bfd9f0f08", "04134b00-3801-42d4-a448-1d97b3a6e38c", "ed869e31-0b34-4b2c-943c-fb4b3b4c0597", "8b890c95-f78b-40bd-a1a8-e61454397a84"], "metadata": {}}, "ba\u2010Liese (2013).pdf": {"node_ids": ["3fb243b1-f5ae-488f-8704-ba092792b9ac", "aa1668da-e3ff-4486-abf8-942919b0be53", "9f164277-2729-4702-80a4-6f2f28278e0b", "6a46f61a-6fc4-4711-8847-0c393981a35f", "97ae60aa-dc55-4532-a0bf-67dd155cfde9", "43754de9-f9ee-4b76-adda-8ed45fed841d", "c2a49a5e-cad7-4ccb-815c-384866dc694a", "dfb0a5fc-7f48-4fe5-a9e7-1eb9a0b75876", "d80df529-199f-4c74-b482-82f105128887", "3d6fece6-cdbf-4630-8fd2-56d244f229b5", "1a371629-4354-45ad-8953-46cdbb9be0f0", "554c24d8-15a9-4846-8298-e9243702e39f", "46ace99f-2cd4-4b71-ae88-8cf6f3176c87", "022a0787-3714-44c1-b284-e2232bbfe814", "b262be08-ebc5-434d-b893-302028f4998b", "cd0efde0-268f-402f-827c-ebb0639968f0", "c38e94b8-7b10-4c5a-9ab8-c12845d0952a", "a3893a42-362e-4c76-9e89-03d5d98c38ce", "7f2bee7d-1f6f-4da2-a4e4-3befd79ef5c2", "8615f1ba-dda7-4301-b254-1ec63028c748", "78b494ca-ca34-4f58-b9b5-05bc7b2530a6", "df098aee-87ef-4a64-8d09-05a908a03ffd", "c1f57c9a-4d8b-49b0-a708-4960594e2abd", "df34f173-8d46-4b83-9daa-9455e83e4eab", "59a15939-27a8-48a1-8d31-19ea0d83cfe7", "dbedbd08-9e8b-4e24-9123-e1567c1b436c", "bdbf7a3b-5d63-4ec0-8a6c-33d511b19e4b", "1aae36e4-da49-4dbb-8a76-f61b25fdf6c1", "55417efd-558f-40d3-b881-f0979d8610bf", "855b6a76-5fa7-497e-b988-b1f8b9b3ed00", "c1b151ff-275c-41c9-a899-014221999c53", "ef3cb886-76b3-4014-96e8-484f2752c8fb", "c7a689c6-71c4-4fff-8e5b-0a70f1c69b8d"], "metadata": {}}, "ba\u2010Mackenzie (2006).pdf": {"node_ids": ["a79a2dc0-943e-4f80-8ada-748dcef1262f", "96c9871d-5215-45c7-826c-4d18b6126a2f", "557e54de-3f51-4487-884f-df706bbe4720", "47341b9f-e3bb-4a7c-aa08-231889991fa2", "2591e22b-be26-41c4-af66-27d6cd6ef983", "4c7b8f27-3ff5-4842-8b1b-dd0713893ee6", "b5a0d3af-b355-4088-806c-e7f2ee70087d", "29c02703-206d-48c9-b6eb-8de89140447f", "b9eaf0b8-50a4-403b-a3bd-34ce57e46564", "892478ff-0dba-4146-a64d-e6e490872a0a"], "metadata": {}}, "ca\u2010Bhuniya (2013).pdf": {"node_ids": ["7fe3b69d-8721-4171-ab41-2f819925f9e0", "e4bfe047-e804-424f-b782-bbd0ec482b9c", "4e95fd08-60f2-4209-a6ad-6feed0dd0a14", "09365b1b-f2df-45c9-8de2-242fce505a35", "f00f5055-636a-4b87-a529-5199081c901c", "e3a8e410-eaea-4708-8847-ca1ff8afefd3", "901d9370-70f6-42fc-b3e3-8b9bf0315e8d", "1a51ab27-7480-44b9-93ac-27cdf0a87cd9", "56167494-277c-4aa9-8264-1626d8a21133", "6a037f3e-6123-481b-8353-0091850379e3"], "metadata": {}}, "bb\u2010Mrozek\u2010Budzyn (2010).pdf": {"node_ids": ["9abc49aa-d7fd-4204-8a0b-ef95d68d50d4", "7858b58e-8c8d-4ded-b420-a2e9ce5bf117", "531e4ff5-2072-4ca9-ba21-cd15216e598b", "7f314f68-e111-4932-87ab-657b5affac0d", "50077128-90c5-4e65-b1fb-4ad35c0165ea", "8d5d92ac-dd75-4db9-950f-64f931768fc0", "fe15bde7-7f1a-4e07-9ded-5b958a0db54e", "4de7dbfa-a22d-4899-8259-8c6d16884033", "c38e6b79-2d89-4361-b064-38240a634980", "be94d891-14df-42c0-8b6c-244257671464", "af49053f-7243-4cfa-b72e-934be6f1c7bd", "87e8f3cf-7efc-415f-9488-34252726521a", "9db18719-12a8-4520-8cb2-74068ab3c8a1", "fc6041ce-5bdf-4b8e-a087-0ba5d878d77f", "92fb437a-8b3d-405f-8154-c4b5c6ed952f", "bd0e5e2a-e2a3-4d5e-aea9-63c8449ba15d"], "metadata": {}}, "ba\u2010Cenoz (2013).pdf": {"node_ids": ["1c5bcba6-b696-4efa-bcbe-495a5b0fd3ad", "79f1a250-c48b-4bf1-9ba0-900bd351de9c", "fc5b7164-4a6b-4f07-ad62-d84fb553a122", "5eb39918-e3eb-47db-a622-c71effa6c5b2", "d8586f51-3e71-4910-a40b-a102a332398a", "8804bce7-1c1c-49a0-9790-b8c33c53efef", "2b346bfc-c74a-43e6-840f-1065859f3bd8", "8c134f85-7fd9-44f4-8d10-cae0a3818cb4", "01430f57-e2cb-4562-b33c-b53432329299", "9539f2ab-a8a3-4492-ad2b-01392e1f2319", "42848b44-0486-4429-8fce-5a5db5ceff37", "4ec51779-3da5-4aeb-ac1d-ea7e2930445b", "f55e3477-1036-44f2-9b38-644455849215", "1b13d24b-2914-4162-b45c-e367990f6a17", "470af235-e630-45ba-935e-bb0c19340244", "fb4d89a4-3de5-4f9c-a300-14c6fb5140b0"], "metadata": {}}, "aa\u2010Prymula (2014).pdf": {"node_ids": ["c800a5a8-5887-4726-a9d2-e050a6e84f9e", "89364d7e-2288-41b5-aa50-2e683b8a55a4", "112e92fb-0a63-49c3-8ef8-6d9d3c092c68", "bb4e2bc2-e312-498d-aad2-15a53a94c04b", "34cf3a1f-c68c-4e96-9176-206fd39045a2", "6ffcfcf5-7fd8-4d3c-9e32-0d26ea6b86b3", "7d9686fb-303a-4643-8a3c-1f16fb367ba4", "bdb0d9e5-4aab-4c2f-b23c-6fa98e7eb88c", "6c8138f2-1838-411d-914f-982c47ce5bfd", "72e7103f-f60c-4751-b404-87ac33170c3f", "38b141f7-097f-4293-8b3d-04bb207a7cf1", "2025d05e-25b2-4df6-af1c-c91cc2f1265d", "a59e25e7-2299-4b2c-af81-1e9fb5801de9", "ec56494a-2cd5-4882-93ab-defaf4b74a1b", "8c26f933-c200-4104-807f-0d728c1a4b5b", "13bbdb23-df50-4103-8648-eabc0e5524cd", "124fd7b4-616d-4a87-907a-440e65d0354f", "fdf2b368-df0b-4e91-8b67-327fc75872bb", "059691ec-b286-408d-8399-91cc26358c6e", "54bf8267-ffd9-47de-84ae-39044aba0549", "5198105c-23a3-4b92-b585-bd167ed1e39e", "163bb8b0-fa69-4fff-ad6c-6ac1f81f1dc9", "fe9a13ee-c36e-4b5d-b452-aa430ad1cc4e", "67fc1903-5ea5-4253-9296-49cdc05fe8d3", "62760ccb-8578-4851-b3c1-4cb49b0d2b80", "58f04a92-1494-44ac-a8e1-f85c8a027577", "a24958b9-8ead-4430-b21d-3de059e33ebd", "c4ae90ec-6d86-4400-bc3a-fb1ec1003238", "ffc2c2b5-ba57-4d3d-9f09-57fbe2d03823", "85ea9e8d-9d21-42d6-b570-5454e89e91d5", "ba12e42b-d335-4b8b-abd2-e65348210076", "1b5bafec-d74b-49ff-93d9-029beea4d359", "bedbdc48-a4e1-4fbd-9a8a-5bc47cccff55", "14135fa3-2c79-4606-aace-410478184e63", "c5cf9988-3284-4624-b8e4-4893ebbb1a35", "14601df2-22dd-4e36-b4ca-b3e7b812d287", "1e730da3-d39e-4ceb-b4a0-4ea134ea93f9", "c175bca9-2774-4d34-b6d7-a8f751b822c2", "83d0c219-5137-46df-8d9c-ed71f80f3968", "7c0cc80d-33a8-48ad-87c4-ceb8c4762322", "6f7a92b6-c4e0-46ce-b837-5a00ec35d649", "b148c180-2136-4627-a27f-5deabcd93cb6", "10895ccf-cfae-4c69-b8b8-747c86df97ee", "5ccec8f6-b0fd-4386-b622-9ec41d8c7a72", "450ff60f-73f3-44d4-a882-b6009a590807"], "metadata": {}}, "aa-Henry (2018).pdf": {"node_ids": ["af884ecd-239d-4a7f-aef8-ae545251bf69", "7594fab0-d929-463a-bd62-486512aa707e", "84fc3ae0-ff29-4c01-9c2f-c457dac8c20c", "dcd2c745-c2bb-4ae7-9187-1a82dc074f12", "99e674af-33a4-4afa-8720-f070a89b29ea", "32dfb671-5c82-4f01-ae1b-30cb27ba9fc6", "7c556ca9-451a-4b79-8a56-148c332262f5", "1d1eedda-d70c-4178-82d4-397e172de1a6", "4b9abe0d-81a2-4206-84e9-927b3830fe39", "0432e6b8-04d3-45af-b59c-2c4651c2077f", "1ccf0c49-7f3b-476f-8be8-3ecf0ba299e6", "6d67bcea-9c99-49e4-8e39-88c4b5abecc7", "14d0f3d1-58ba-4fc3-9aef-d8e707748e28", "022b209b-2a85-4821-ab1d-f05c184541c3", "932873de-b58e-4e0c-a797-f60b1d74cce1", "89257aff-5380-433c-9826-af5c536d653f", "e339712a-495d-4f2a-921a-802e2815b390", "7dfb43b1-c99e-4a84-88f9-f0abed1a0aba", "96ca1451-2e10-4bfd-a3e3-90ebeb8db844", "8509db5f-77a6-4649-8925-0ae1116beb27", "aca3613b-2e60-4eee-b439-ab69b9ed740b", "68a7b4b4-e8e2-4938-a35c-f86b4b650d4b", "021d82cc-c6f3-4443-9d9f-1072049b3722", "7be29463-6861-4ab3-8c9a-1bf2d8f47141", "882a92c5-0a84-4013-bcda-a6de97d78293", "3acb2c33-0ba9-462b-a85a-44844c2fdd72", "6836d020-1f7b-4a2e-8d6e-68a010f0e520", "c765c0e7-d52b-455b-9a0c-ff60e064c3c1", "ddf8cb74-3b72-4304-b445-850fe6a4ca99", "ac23e213-8735-4477-8133-1e048571dd7d", "25b25392-2296-4d44-ae31-5e5f6645ca0b"], "metadata": {}}, "bb\u2010Bremner (2007).pdf": {"node_ids": ["28d7e561-d3fa-4493-8beb-11f9a0aff374", "30439b62-bcdf-43d0-9264-c637c6eba573", "bda59f27-7081-41b5-be79-07d7160ac046", "3141b514-dbc1-4ccd-bd08-4b74a1af9d71", "bbec1a35-d6d9-422b-99ea-f784eaee9f55", "aa14ee17-5cc9-4d9b-9e93-c4aa4f5ca061", "61fd618e-a7df-4bda-820b-9d3ad9af3aba", "d31dc2d7-8b50-446e-9f06-1b203d7d884e", "25afd740-88f3-4381-b8dd-b0ed1c49d658", "0577dd9b-883b-4800-aa74-08ccfe26d749", "b06fc4bf-c7b7-4bbb-a630-006e8c65b729", "e44dce7c-2d1a-42a4-a630-6912b901d23c", "f2bc1ece-2d34-49b5-8473-bb5208cf59b0", "26a37c1d-46de-4754-a492-e84cdd5de950", "e8560f9b-399a-4855-b61e-6ff14e62996e", "e6ee1549-7422-434f-9a4d-903dc6401306", "f1fe7710-9297-4819-85d7-f2a45dca1e44"], "metadata": {}}, "bb\u2010Black (2003).pdf": {"node_ids": ["1100bea9-7e88-4ce7-a920-1ed56b391dc6", "f3b1375b-8110-44c1-818f-0d83155e59b5", "aa8fbc69-a5d5-4c30-be60-dfd792fbef3f", "7d88bc7c-6735-4d77-8f7f-32e8b82330f1", "39efb49f-bce6-4d02-a8c5-5ee9b8c5edbb", "b2db4a03-45e4-4d2b-886c-797ccff3efd2", "f47e8133-47a1-47f9-9d68-b70a2c6c1c44", "7bbd786b-a3b7-4173-8e9b-f1cfd162d7df", "9151a37c-6dfd-4652-aec7-4e8c8e574d4c", "9e3c84e5-124a-4c25-8faa-959cb414f1be", "330eb42a-766b-48b8-b0f5-316ebc8e76ab", "ff62dbf0-1a65-4d00-b5bd-f9748630a3ea", "d1cda7b2-fcb6-409d-a467-f790aa7ff127", "063bd937-826a-4cf9-ab3d-1f6f19322e15", "89575e18-210d-431a-bbbd-59340052d7ae"], "metadata": {}}, "ab\u2010Edees (1991).pdf": {"node_ids": ["9df0c3f4-afe9-461c-b510-d446e9a1d4a6", "40e9346a-c98d-4f78-bfad-8412ee39923a", "b23943fc-d734-4362-8277-1b585de6acec", "7e0c15e9-5de4-4dc0-a83d-dab4425ce902", "04a63fb2-2891-448b-b010-eec64514cb89", "c213f53c-e004-47e9-98d0-c1237f6629b2", "d7c54a47-6187-4e8f-ab8b-7f7ad1f0271b", "7dcff453-0ba8-4ca9-9d44-3fa3190183e8", "d69033a1-e1ff-4a44-ba05-f9c54da58de9", "79a6d93b-02b1-478a-b246-33d22f6bff0b", "25e3c987-ab2c-483a-8865-00f8a2230531"], "metadata": {}}, "bb\u2010Chen (2018).pdf": {"node_ids": ["8cb9aaad-b7fc-4cf6-b9a3-2492314ab51e", "dd1f8b49-cec6-4394-898e-080918d0e7b0", "3976c430-341e-4970-a98a-81b2093afe0c", "5f617676-81f3-4984-9b6a-865d3d3804ec", "76695f1a-8798-458a-a797-be3fbbda8f85", "68c7e3ce-e5ac-441e-bd36-fc1f8f95109e", "d211cd0b-1839-4017-81c3-db17934b9210", "13ca1353-2e60-42e6-a5e6-ef8ab6ec1d85", "787ed6b9-31cf-4f82-99a2-b8f59c1ed440", "269903f8-4576-4aa8-9da4-08b11faa69e9", "beb36809-5a60-41f3-b472-94b0860898b2", "28f25062-2a41-466b-b0a8-7e0dd47b48ce", "f473b478-5509-4d2c-aac5-ae89da349883", "d2595d05-dda3-45ee-a0cc-7a129fad3c7c", "ec2a71b0-4cdf-4d37-a1b7-636690f59441", "b8d641ac-25c7-4eff-ab34-240510d1ca3a", "d9be7f00-07c6-4925-9b79-fbb28d1476e1", "abfd97c7-212c-49a6-aefa-47fd3c0c5c04", "c1f1de9c-a6ff-462e-beed-4f4c2c20427f", "eb4fe5a3-bc16-41ea-9793-47d8766f7e89", "8b201d2d-e611-4d7f-9d55-112065fcba80", "79144015-d1b4-4b0d-93c7-967f8a5d57ca", "22edc40a-1e8c-4d05-85bf-7b82e40569c5", "f2f2182e-ee2f-4ccf-859d-35af46e21330", "64a55bf2-d438-4960-8b89-d349c417c271"], "metadata": {}}, "bb\u2010Smeeth (2004).pdf": {"node_ids": ["b9b6779f-48f2-4062-ac6d-1e5a09d6605c", "89885db5-31ce-4f82-ae00-1927e2f72cb1", "ec95059d-2800-4536-81ee-b6232f13b315", "8c0c90f9-aabc-45b9-9a6d-d822e9264f58", "1a1f1f4c-19e2-45ff-a22f-550a1651322c", "ffa9822f-08fe-4e49-a180-e0162c32067d", "7892dc11-3fdd-4b8b-97aa-654c3bbc57a2", "4a1a6deb-2010-4f64-b37e-3cc5f9dc7b5e", "7486f986-b16c-4043-a8f3-b79682e8cfc7", "5a5ab1d5-346a-47df-9cf5-58225285cdc5", "57626620-a440-491d-a101-23dcf27f3302", "3bf723be-d664-4668-95c2-2a0a88275e01", "7de8fef1-2d33-48bb-ab43-05b16068d4b2", "617226ab-148a-4322-8762-7db2bbe8e389", "85e65315-3369-43d9-8cd2-7ab97358b775", "ced813cd-8deb-47ae-8ac1-e4f712701b78", "f59dd4b5-a2f0-48e8-b476-c758b7810311", "d3ce73a7-95f9-4d8b-a2ff-0fbf0ce9ad14", "bed4e3b3-d714-41d6-af8e-952c6759044a", "fb968f96-11a0-437d-bd06-962f0a4e944d", "746cbf4a-d692-4323-b145-7d84f98a57a8", "f87add3c-454a-4bfa-a0d1-be1b81cf1de7", "2b010ffb-92a8-4656-8756-17f252c23e6b", "62b6f08d-85a2-4fbe-9d9c-6c6260911d80"], "metadata": {}}, "ca\u2010Arenz (2005).pdf": {"node_ids": ["99bd6e87-aa8c-41cb-b59f-3fc44eec5979", "b7020cd3-e0ad-4da0-bd79-c796794e7c7e", "3f981c5c-cac4-40fd-a3cf-c9f65e7938d6", "9c6bde03-70ea-432a-8616-2945b6624aec", "464f0591-1c4c-46e4-899b-c56cda9e9e91", "dd223dd4-3f70-48b0-806e-2373be6c6e83", "efcef278-fdc8-4d61-937f-bd30b82c43ea", "1e0585d8-1ac3-46d2-a807-ed3b793d8402", "b7fe84a7-6607-4614-9f23-657b3dcaf70b", "218b15e3-5b0a-45fe-8a69-e768faff6d4f"], "metadata": {}}, "ba\u2010Hungerford (2014).pdf": {"node_ids": ["bf44dac5-4ebb-4605-9ca5-50e4fb922b93", "5dcf5578-a39a-4cb6-acf1-6cf1b2d736c9", "56eeed07-6e02-4dad-8928-5fb8db76abbc", "134513ea-b471-4d90-9124-72539314d3b2", "72fee3fd-8000-408b-b5cd-132e6b072d63", "bbd96f11-c650-427f-a176-8968ecfd6256", "919f383b-0b84-41a3-a2ab-34ea9c85480f", "1d48c3f9-98c3-4f1c-b00f-82eaa3ec5c62", "42d785e8-085d-4345-baee-d02b9e4f1bb9", "5d3bfec2-5b71-4765-a2b0-c7ddcd62b72d", "3804c975-701b-4618-8e08-551b81157a58", "17b5a8b3-1598-4065-bcd3-763b96fc7967", "3e0f98b4-e9e0-4a2d-b10e-d9cc2e57c8e2", "fe384b07-e257-40c0-9b64-51b321179104", "d15e755d-2f8a-4d76-960a-7cdfd366f768", "92239001-9bd2-4976-9234-ce57245bee53"], "metadata": {}}, "aa-Povey (2019).pdf": {"node_ids": ["89a3dc0c-a05e-4c99-a895-af0b483f0de4", "820ee6ce-6632-495e-9e65-51f2dca8bd47", "414314c9-27c0-4f37-afca-9781873930d7", "76711df1-632e-4048-97f1-545d4d5bf743", "22185fb8-05a9-4c9c-a06c-17bb9d01e683", "1bbc4280-b997-499d-bc46-d6d350230ee6", "eb35fe5a-e72c-46af-a5a9-4609a133ecbc", "19db6951-bdb0-47f2-a7ad-92ea1cdf72c5", "d81ee5c9-81a1-46a0-98bf-bc901a50a9ff", "e935b5e7-10d0-43f2-b425-7eb98d07abde", "6643e548-cc27-4f37-b1f2-a3f7322dbbab", "0b4a3aab-a887-4043-846d-cfb4d23753c9", "30a904ed-8315-44b0-8102-b83596246498", "15c64ba2-1b8c-41ff-b8c3-5c91b8e54d02", "138d72bb-e583-4bd3-b568-db5f4bf90183", "f208f906-3b05-4c46-baaa-57e87bc24eaa", "b9e6b753-9284-4930-bccc-4c4c0696a6bd", "67f5848a-c0d4-4474-be54-040dea62f499", "27b564f2-d9b4-449f-a5f7-e2ff581be6bb", "8094eb9b-2bd0-4fc0-91ad-74fbb59a638d", "772b2b5b-0ee2-4839-a5b7-f3f2d3137e2e", "3601d46b-fcea-452c-bd71-65c48f9597c8", "574c1c82-5777-434f-8934-72f2ac04af9e", "312f4e06-d476-45ae-a3e2-9d69a46d327e", "0006ca69-d207-425d-9be0-40f74536c40e", "721c97ba-e2ff-4957-bad4-2f335c5a82e8", "44f156d0-51c8-4d16-ae43-4aace24b76e5", "c4b5515f-3098-423b-900f-ace51384fa19", "3dfe8ff5-6622-4291-a249-f8b3e131fb9d", "e9b2edeb-158e-4702-9878-3fc98d7b66e4", "a3c7c0a4-d715-4f9a-98c2-7706987d5ff7", "1e005c00-f3e2-4b13-a3f0-7d27b8779c58", "95d1f976-44cb-4e4e-bb2c-5f3e6221bd42", "b5a96e81-fd0f-48ce-9f9b-b6fd9493c809", "dd5749fd-6293-4960-89a1-e571b7dbaa3c", "39b37a7c-7070-4149-adfc-225c8dbd2c03", "5777a53d-6489-46d9-9239-9e116196a259", "647246f9-711e-424b-8675-b14f8ee040a4", "9861027e-8bd2-45b8-a02d-a7ddf35a2e7a"], "metadata": {}}, "ba\u2010Fu (2013).pdf": {"node_ids": ["565a0f89-7dca-44e3-9190-dd2f0ae3708c", "c1f4ce2e-0d71-4329-a846-e4d4aa7b7c3c", "5ef2dc49-ac1e-470e-97db-68baa3761b9e", "ee92081b-0fc2-4319-9a3a-0762d9a77df1", "5b09f1d5-6a37-4ab1-9831-0dc9580b20bd", "a090bae2-6e6b-479f-a252-8a00bfc85dc9", "1c17262d-58b2-4838-8717-46fe90a7c9d0", "9bb79566-e4f4-4614-a454-84545d6a1493", "68e975fa-6982-401c-a7a6-9acf1366de01", "252ec247-3290-4361-9688-3df0ae02c986", "315e93d3-e8c1-4982-b3e4-411b20568e92", "a38ae011-abd5-448e-bf01-18afa421570f", "362d480b-a168-4fc7-973c-bb3292d77dc5", "cb47377d-d18b-42d9-9df7-871b1d9fd4cf", "7889789b-8ac8-4f0a-9195-61c9f89f5ba9", "f7eaa3e7-44d8-4489-a604-25a581d7c64a", "3b9a86e9-005c-468b-a813-2cc627b41550", "64a7dc35-d954-4ce6-8fa3-30ecfa46c2f9"], "metadata": {}}, "bb\u2010Groves (1999).pdf": {"node_ids": ["336a2dff-f095-470d-918c-f80a901ddb0d", "e7112721-1998-4089-bd06-7153b55dbe0b", "62ca3026-9bbf-41b0-aa62-caef9da8ff81", "b684e8a2-c8fb-4df2-8c71-d22fbf715ee4", "f395342a-cb76-4bb6-a0a9-c204e3487571", "063ba50f-4c8b-4d5f-94db-e193735ae62c", "cac686cb-52c0-4fb2-9013-596c2381201b", "7f0a0007-f933-4723-b21c-7e54803771af", "8eb15c5b-ac89-48e2-ab04-d63a408c3300", "750bd2e6-734c-4c49-889a-e856fbe1573f", "9cbf00fc-c3de-46ed-ac44-19de2fed978d", "76640b05-437d-4c5e-ad65-3459aa81188e", "3299e4e9-3225-47c6-9555-8ebbcdf9d032", "017508ae-7d25-4ebb-8909-e7503bf872fb", "3f5e83a9-5cc6-48b5-80e0-9d5893fdd423", "005b2222-49ff-4b69-a0b8-974cef38001f", "a8072cee-8df3-4a9a-956e-770eb686fa3f", "a75922f5-2197-49db-beb7-6a9728804ec4", "f26fbf1e-4334-4aff-8edf-89c057639c1e", "9fe87c3b-34e0-4267-ac75-bca1be82f3ef", "fefc6bd8-9070-423d-98bd-5812948f31c3", "1e128941-05a6-4b66-979c-aecd0e1fe41a", "e94a0253-4e50-4245-bccf-c148e27e9272", "bf99d17f-2b4d-4c76-aa8a-e741cc557fc6", "f9f16392-9d9d-4cea-9550-a212f171934d", "aeea1d91-69e2-49ca-89f0-9a79be8a02df", "f17d2dfa-e141-4339-9e5a-16b555dda23f", "cbf91903-648b-4d14-8767-95b0ed1f30fc", "6e54aa62-8012-4810-ac2e-9923970b0303", "2e3696a3-945f-4702-a472-cba14f5a0386", "7976d0b0-a8c0-4895-a654-cad16a2d2963", "cfea8252-58e1-4f33-b15e-3a958c98cb89", "7dda4f6f-aecc-4a91-afba-69e4eb9d40ea", "010487cc-7533-4da5-9ff1-7843f9bd5418", "65f325f7-d90b-441e-b261-718065c75f71", "7226f582-afc1-4584-9bee-cfae5a8eabd9", "b0e178f2-554d-43a4-b735-9453c48e504d", "bfa140c4-b783-46a7-96b5-032dec822d0e", "90793003-2125-4b3e-b7e4-ff83187e3f71", "04cf5f7c-0ecc-4717-ba04-9e36bbf0ca56", "58abcfc5-76b1-469e-96ef-5db5b88da877", "f7b43ade-f895-4ce4-b93a-454812482efa", "0e9ad171-c0e2-469a-a5d4-de72034394ff", "b291777f-e52e-4b45-98f2-646111d0f2a4", "c3a16389-9142-4a7c-9eb5-f23a4e0327f6", "72568c19-694f-43db-9a84-13aad5ec06aa", "a68a07c1-e623-4461-950a-b8aa56f4b86b", "3af8dac1-4efa-4d56-92a0-07d09c0c251e", "53918863-ac91-4ab4-868f-63299207b8e5", "7829125f-c088-4528-b0b2-3e08bdbde32b", "d7cd0926-af40-4319-abf9-069dec1c1e63", "0bd6e078-2409-406a-89b8-9b0accf2d572", "362d0b02-5582-4a61-a71e-09c19c1a5d8a", "244411a3-6069-4ccf-becc-8bf8dc4f4b33", "cf7cbe5c-9bed-4bbb-ac81-ac5eb935dcdb", "8e376cd9-10b4-437c-b262-9930e2a86fa5", "5d88b57e-c986-4784-bf23-f304ce37956b", "25235517-f483-48c0-9d7d-46698a83e2cf", "116ea4b1-65a0-4515-a085-007f81ba24eb", "bb103203-5e65-4890-873c-3e51d251d60c", "08dff1b6-842b-4cae-9add-8c732d4ed927", "a685a6cb-6ece-4fcf-816c-58abc7abdd5f", "4bbf79df-935f-4863-b56a-b56bc0bd23d5", "a897154a-5afb-4c98-9331-ff5ef84c29b9", "8183e9a7-fd32-41cb-9529-e209638dc35b", "7a03d6e5-bba7-4e30-8d6f-7bb6f4358294", "dbdfae55-6495-48a3-a856-6d2fc03c0933", "ed0565ce-6e7d-4007-a786-8ea9043b7ada", "f81f869d-f5fd-475a-9f94-fac5815ee754", "09ff906c-9ea2-4af0-bcb6-ab5aa794a625", "636f9c2d-f4f9-4fcc-b858-4cea92cb88ee", "1e36c378-e5a2-4bd9-a0b2-17a9c39928cf", "7c8921c6-2779-4795-a0ae-ffac15e47ddc", "aa50192b-7db7-492f-b9f5-6864c82b1478", "9c46b82c-1e58-4bd2-998b-436cd2341066", "0539b7db-b334-4885-a691-e88cd895947c", "4193e1ee-80e2-463c-bfe0-ea650c12bac7", "00e1381f-59d3-4379-bd69-109d3a5ee133", "bf043bf7-86cb-4460-8558-6c677fb11b94", "ff986c92-9e65-477d-a594-dbc7415709e8", "167eccbd-3441-4069-8140-6854b20eb828", "94bebd31-1a95-49d7-b6bd-c5d2343a4ba8", "4c3456d4-458f-49db-b4cf-6ba2b7f2e5f0", "8fe1853e-f70c-402e-a702-170e9074102b", "6a7ce95c-2954-417c-a3c4-27b26f4792b5", "af4c2be1-fa65-4fd2-a07d-ac9db7b47892", "d597a028-460f-432c-9a4f-9a66f724436a", "819e1d8d-8ed8-48be-bb06-bdbc8edcbc6c", "508500e1-1ea1-412f-a095-62b1f01deca4", "6077970c-c313-478a-b736-7650f267ddab", "fb83d31e-9562-4119-81f9-8db7b980e22e", "c06dfb23-174d-47b9-84cb-bb828007c283", "68f8f166-652c-406f-ad51-b1d9c9dfa1cc", "5f201471-3a10-42d7-af46-4057a07f3b48", "335b6cdb-4059-427e-ae65-c2ba572c1ef5", "62a2ccb1-bb33-4d40-8d3b-1833bb10066d", "7edd1f28-ad0c-4595-9eab-c732fa24cfdc", "cc715502-62db-4c1d-b27d-a5527f4f8939", "380ce340-aef2-4319-9240-fec32a041fc1", "4679ab0c-0f7f-4433-9c1c-e71cd8acbeee", "4f69cb07-c9e9-418f-8855-174a293a8510", "a4d6ac81-6820-4869-86e6-585be430da93", "855e6e98-7546-4d29-aea1-4ae0226f064b", "f457cf3e-8a81-4f46-b10e-9fb9c001979a", "739a05d3-b0a3-43f8-b057-521aa40e78cc", "9f4e8cc0-94ee-463e-997d-832bff087d39", "8931d05f-246c-4154-995b-07b0a6f271e8", "2b89af34-1ed7-4326-a5b0-5bb153ea520f", "c4765ca3-a839-4fa9-bc35-3c01b9cc3073", "4cbf9ac3-ab48-4165-a89d-c7555b4e7446", "79843dae-a6d9-4690-878f-cbdef63af7a1", "bc3c35e5-2890-4602-ba07-65dd2f9ccb0d", "26d1b488-9f6d-4c8a-ad1e-9f06fa3840ae", "907bf31d-0687-424d-b131-0dfc3bfd325d", "3c57c996-8a6d-4fa5-9843-9afcb13f6374", "379fcc76-0a1d-47cc-9a41-7b78c2c9b20d", "61746eeb-1ef3-44d7-aa88-8eb557b8be36", "c9bc4260-2e24-459b-a18d-3d45eb6543bc", "410f96a7-7217-4e15-b144-0f420b7dc1d1", "caceb118-5164-46bd-9853-69c59f6d4f89", "428f765c-c8a7-46e9-bc59-ed5686dabc78", "63bdd867-91ce-4ba8-9fe5-f4f423eb72bf", "1d9c56dd-2ca5-42eb-a625-8ad33037cb78"], "metadata": {}}, "ba\u2010Jick (2010).pdf": {"node_ids": ["4dc7b960-9f02-4e4e-8f0e-0a09751433bf", "790d36ab-193d-45b9-a34b-210f0552ade3", "91559628-532a-4c6c-873e-7d6f0d219255", "ba82de14-9be3-47df-9ecf-864c2aba1b11", "ebb09f36-f957-4cf7-a635-c640fd6880a6", "fc67256b-7582-4a0e-9597-875cd9cfdde1", "900151d1-f6ba-47d7-8b61-36c343346649", "6333cd9f-b4a7-4408-ad35-0a1e69025805", "f2936b68-ff05-4aa6-b672-f621cc42baea", "53bc1c2a-8146-44e3-b62f-8149f13f8bf0", "67f04fde-5a4a-45da-b7e4-4412b45d1dd8", "d3396a26-d4bf-40fe-9cbf-c933e6cfd721", "a4a443df-0b10-4f52-9feb-f2c088aea3f4"], "metadata": {}}, "ca\u2010Barrabeig (2011b).pdf": {"node_ids": ["3b1c2460-663e-425b-a7f8-15d74313e1f4", "8e2de78c-9c99-4304-84cc-6131f49f30b0", "1424feb4-3ab0-41d6-84cd-892b8221924a", "75f8ac7f-54a9-4567-9a1f-0c34106d6288", "2e9b704d-71d0-4c22-b425-ff513062d441", "6daf9a60-6c79-489f-a49d-bd2c2f426e1d", "74e95cc5-147e-40f4-8b1a-b02f2b97f802", "cd71cb46-f3b4-4fda-a931-e23d785e7feb", "7d555d1e-558e-4738-bfee-8802d583d842", "50276873-cc5d-4cdb-9999-b5f6077f2ec3", "b8574b00-fe65-4bda-a4c4-733ae5a840f3", "07543120-4219-4b7e-9108-ed3d2d811212", "c7442915-99b0-48a4-a6b8-2135aba062fa", "223f15e6-a846-408a-882f-1c9f922c49a9", "4d39accd-8b5f-4f39-af53-1ad82ba4daf5", "091c868d-1be0-4e7b-87ce-c334273b69a2", "468275b3-54e8-485f-aadf-8af1dabb7796", "48ad5349-c079-41ae-920b-33f0757d3e22", "04f31a07-4857-4b9d-90ad-df5f4dbc847a", "c5f3d955-7ee2-401d-9b24-e9e5f8410925", "38a50485-dcc3-4c5f-af54-9a61c6c4fe8d", "d868b87e-a6b0-44e9-a45a-5530b95bdea1", "49a066d9-8028-4bd4-ab9c-0666ef1ee872", "99c21392-cbcb-4285-87b2-4945214051d4", "be353aa2-fc81-4e33-8909-a39d9f37a02e", "97f4e8be-4b41-4498-980c-d7351b0d9e2c", "4acb2b29-73f9-4160-a619-097bf52e6415", "d1b4961a-ff94-44a0-9e7b-f94a8a5452e8", "adc27230-84d6-43a0-9266-79503f62d560", "e4980a8c-cee1-4640-8ee0-6c8e6e386b1f", "7a6652e6-e187-4e1c-99e0-b9392c4a888c", "4e7fc939-e0a9-4837-b316-ecf0cc15b050", "6a41fdd3-c90a-4b26-b022-2d8d16b65502", "d18a18df-30bd-42b2-ae96-037b030136fc", "9cb9ed12-98bf-42b9-975c-a74efb49499c", "37f61395-b41b-4b3c-9d10-4201951f2c48", "2568623e-3e73-470e-a5d1-0f04b1a13881"], "metadata": {}}, "bb\u2010Baron (2005).pdf": {"node_ids": ["67b3be09-6415-496a-9a26-5b2fc4361269", "9f958d35-9d3a-4603-8e4a-888305596bc7", "f7c7132b-4579-46f1-a0cb-51fb05484063", "00d11e34-4c82-4454-a039-911cf7875890", "1badba83-9133-452c-9ee7-221d4c5e5ed6", "eb0c48d5-0d0a-4f4c-9c51-d2fa324bead1", "89571ed3-a606-4d79-9fc6-3e49d91fec1c", "398d9d7e-33d1-42ce-9241-29f6750a3bd3", "bab38f01-555b-4755-af85-dfc9450e051f", "10fbb794-0e81-4b09-b177-94887d4b939e", "600247cd-0ace-4321-8d48-9b6e651f0eed", "b0ec85cf-4421-40b3-babe-65da48ce16f0", "5341445d-cbfa-43cf-97ac-b8602f78b153", "b33e5653-f4fe-4bb2-8059-39fc0b4821d4", "77c5d586-37cf-44f4-8127-9bd31536a522", "3ad6dfd1-fce5-4b11-ac93-388140eeb946", "89c0eb28-4e1f-4bee-8687-4e3c29b9a273", "c876dd93-d369-4fcb-a5c3-7a5743ee3c1e", "b8705ff6-80ed-46f2-a2b2-9a66a232b4dd", "f30c995c-2e66-49e8-a04f-c29e96791830", "0cd26f78-6b04-425d-861b-444a4e41b325", "039b43e0-7806-40cc-9e86-ee0154293547", "f451e828-8997-4234-8002-c1567f75f0cb", "6ae54e56-86ff-47bc-ad9a-ff5d9b8819eb", "d1108ef3-489c-4015-ab97-3c9862008bda", "949107f4-03aa-41cb-8bce-c82d4c35ec4d", "c78db142-5a92-4704-9de9-b3e8b2cfa654", "67f36992-3402-4428-a50d-8e97c23f5e0f", "0b81cc86-adf8-417c-b4c3-b1e569d7f69b", "da3ead35-d881-41f3-bfd9-bc1020016601", "f96e9532-beef-4516-9c13-b23c5ea6e4c3"], "metadata": {}}}}